primaryid,caseid,drug_seq,role_cod,drugname,prod_ai,val_vbm,route,dose_vbm,cum_dose_chr,cum_dose_unit,dechal,rechal,lot_num,exp_dt,nda_num,dose_amt,dose_unit,dose_form,dose_freq,year_x,quarter_x,pt,drug_rec_act,year_y,quarter_y,caseversion,i_f_code,event_dt,mfr_dt,init_fda_dt,fda_dt,rept_cod,auth_num,mfr_num,mfr_sndr,lit_ref,age,age_cod,age_grp,sex,e_sub,wt,wt_cod,rept_dt,to_mfr,occp_cod,reporter_country,occr_country,year,quarter,age_group
137218112,13721811,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Dehydration,,2022,Q1,2,F,20170601.0,20220125.0,20170706,20220201,EXP,,US-JAZZ-2017-US-008614,JAZZ,,59.0,YR,,M,Y,,,20220201,,MD,US,US,2022,Q1,Adult
137218112,13721811,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Arthropod bite,,2022,Q1,2,F,20170601.0,20220125.0,20170706,20220201,EXP,,US-JAZZ-2017-US-008614,JAZZ,,59.0,YR,,M,Y,,,20220201,,MD,US,US,2022,Q1,Adult
137218112,13721811,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Hyponatraemia,,2022,Q1,2,F,20170601.0,20220125.0,20170706,20220201,EXP,,US-JAZZ-2017-US-008614,JAZZ,,59.0,YR,,M,Y,,,20220201,,MD,US,US,2022,Q1,Adult
137218112,13721811,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Blood potassium decreased,,2022,Q1,2,F,20170601.0,20220125.0,20170706,20220201,EXP,,US-JAZZ-2017-US-008614,JAZZ,,59.0,YR,,M,Y,,,20220201,,MD,US,US,2022,Q1,Adult
147203363,14720336,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,End stage renal disease,,2022,Q1,3,F,20121025.0,20220228.0,20180405,20220309,EXP,,US-AstraZeneca-2018SE41389,ASTRAZENECA,,21406.0,DY,,M,Y,,,20220309,,LW,US,,2022,Q1,Elderly
147203363,14720336,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Chronic kidney disease-mineral and bone disorder,,2022,Q1,3,F,20121025.0,20220228.0,20180405,20220309,EXP,,US-AstraZeneca-2018SE41389,ASTRAZENECA,,21406.0,DY,,M,Y,,,20220309,,LW,US,,2022,Q1,Elderly
147203363,14720336,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Nephrogenic anaemia,,2022,Q1,3,F,20121025.0,20220228.0,20180405,20220309,EXP,,US-AstraZeneca-2018SE41389,ASTRAZENECA,,21406.0,DY,,M,Y,,,20220309,,LW,US,,2022,Q1,Elderly
147203363,14720336,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Tubulointerstitial nephritis,,2022,Q1,3,F,20121025.0,20220228.0,20180405,20220309,EXP,,US-AstraZeneca-2018SE41389,ASTRAZENECA,,21406.0,DY,,M,Y,,,20220309,,LW,US,,2022,Q1,Elderly
147203363,14720336,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Renal failure,,2022,Q1,3,F,20121025.0,20220228.0,20180405,20220309,EXP,,US-AstraZeneca-2018SE41389,ASTRAZENECA,,21406.0,DY,,M,Y,,,20220309,,LW,US,,2022,Q1,Elderly
147203363,14720336,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Hyperparathyroidism secondary,,2022,Q1,3,F,20121025.0,20220228.0,20180405,20220309,EXP,,US-AstraZeneca-2018SE41389,ASTRAZENECA,,21406.0,DY,,M,Y,,,20220309,,LW,US,,2022,Q1,Elderly
147203363,14720336,57,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Chronic kidney disease,,2022,Q1,3,F,20121025.0,20220228.0,20180405,20220309,EXP,,US-AstraZeneca-2018SE41389,ASTRAZENECA,,21406.0,DY,,M,Y,,,20220309,,LW,US,,2022,Q1,Elderly
1491931427,14919314,62,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ?g/m2, qd",4263.0,UG/M**2,D,,,,,21.0,UG/M**2,,QD,2022,Q1,Low birth weight baby,,2022,Q1,27,F,20170914.0,20220208.0,20180521,20220216,EXP,FR-AFSSAPS-PC20180352,FR-OTSUKA-2018_012300,OTSUKA,,0.0,YR,,M,Y,1.89,KG,20220216,,PH,FR,FR,2022,Q1,Child
1491931427,14919314,62,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ?g/m2, qd",4263.0,UG/M**2,D,,,,,21.0,UG/M**2,,QD,2022,Q1,Foetal exposure during pregnancy,,2022,Q1,27,F,20170914.0,20220208.0,20180521,20220216,EXP,FR-AFSSAPS-PC20180352,FR-OTSUKA-2018_012300,OTSUKA,,0.0,YR,,M,Y,1.89,KG,20220216,,PH,FR,FR,2022,Q1,Child
1491931427,14919314,62,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ?g/m2, qd",4263.0,UG/M**2,D,,,,,21.0,UG/M**2,,QD,2022,Q1,Foetal disorder,,2022,Q1,27,F,20170914.0,20220208.0,20180521,20220216,EXP,FR-AFSSAPS-PC20180352,FR-OTSUKA-2018_012300,OTSUKA,,0.0,YR,,M,Y,1.89,KG,20220216,,PH,FR,FR,2022,Q1,Child
1491931427,14919314,62,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ?g/m2, qd",4263.0,UG/M**2,D,,,,,21.0,UG/M**2,,QD,2022,Q1,Premature baby,,2022,Q1,27,F,20170914.0,20220208.0,20180521,20220216,EXP,FR-AFSSAPS-PC20180352,FR-OTSUKA-2018_012300,OTSUKA,,0.0,YR,,M,Y,1.89,KG,20220216,,PH,FR,FR,2022,Q1,Child
1491931427,14919314,62,SS,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,"21 ?g/m2, qd",4263.0,UG/M**2,D,,,,,21.0,UG/M**2,,QD,2022,Q1,Neutropenia neonatal,,2022,Q1,27,F,20170914.0,20220208.0,20180521,20220216,EXP,FR-AFSSAPS-PC20180352,FR-OTSUKA-2018_012300,OTSUKA,,0.0,YR,,M,Y,1.89,KG,20220216,,PH,FR,FR,2022,Q1,Child
152179915,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Drug intolerance,,2022,Q1,5,F,20180701.0,20220316.0,20180730,20220321,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220321,,CN,CA,CA,2022,Q1,Elderly
152179915,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Movement disorder,,2022,Q1,5,F,20180701.0,20220316.0,20180730,20220321,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220321,,CN,CA,CA,2022,Q1,Elderly
152179915,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Hepatic cirrhosis,,2022,Q1,5,F,20180701.0,20220316.0,20180730,20220321,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220321,,CN,CA,CA,2022,Q1,Elderly
152179915,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Bone loss,,2022,Q1,5,F,20180701.0,20220316.0,20180730,20220321,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220321,,CN,CA,CA,2022,Q1,Elderly
152179915,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Grip strength decreased,,2022,Q1,5,F,20180701.0,20220316.0,20180730,20220321,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220321,,CN,CA,CA,2022,Q1,Elderly
152179915,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Therapeutic product effect decreased,,2022,Q1,5,F,20180701.0,20220316.0,20180730,20220321,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220321,,CN,CA,CA,2022,Q1,Elderly
152179915,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Drug ineffective,,2022,Q1,5,F,20180701.0,20220316.0,20180730,20220321,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220321,,CN,CA,CA,2022,Q1,Elderly
152179915,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Arthropathy,,2022,Q1,5,F,20180701.0,20220316.0,20180730,20220321,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220321,,CN,CA,CA,2022,Q1,Elderly
152179915,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Arthralgia,,2022,Q1,5,F,20180701.0,20220316.0,20180730,20220321,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220321,,CN,CA,CA,2022,Q1,Elderly
152179915,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Hypertension,,2022,Q1,5,F,20180701.0,20220316.0,20180730,20220321,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220321,,CN,CA,CA,2022,Q1,Elderly
152179915,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Diabetes mellitus,,2022,Q1,5,F,20180701.0,20220316.0,20180730,20220321,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220321,,CN,CA,CA,2022,Q1,Elderly
152179915,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Headache,,2022,Q1,5,F,20180701.0,20220316.0,20180730,20220321,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220321,,CN,CA,CA,2022,Q1,Elderly
152179915,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Cardiac disorder,,2022,Q1,5,F,20180701.0,20220316.0,20180730,20220321,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220321,,CN,CA,CA,2022,Q1,Elderly
152179915,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Rheumatoid arthritis,,2022,Q1,5,F,20180701.0,20220316.0,20180730,20220321,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220321,,CN,CA,CA,2022,Q1,Elderly
152179915,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Pain in extremity,,2022,Q1,5,F,20180701.0,20220316.0,20180730,20220321,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220321,,CN,CA,CA,2022,Q1,Elderly
152179915,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Hepatotoxicity,,2022,Q1,5,F,20180701.0,20220316.0,20180730,20220321,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220321,,CN,CA,CA,2022,Q1,Elderly
152179915,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Psoriatic arthropathy,,2022,Q1,5,F,20180701.0,20220316.0,20180730,20220321,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220321,,CN,CA,CA,2022,Q1,Elderly
152179915,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Pain,,2022,Q1,5,F,20180701.0,20220316.0,20180730,20220321,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220321,,CN,CA,CA,2022,Q1,Elderly
152179915,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Osteoarthritis,,2022,Q1,5,F,20180701.0,20220316.0,20180730,20220321,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220321,,CN,CA,CA,2022,Q1,Elderly
152179915,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Diverticulum,,2022,Q1,5,F,20180701.0,20220316.0,20180730,20220321,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220321,,CN,CA,CA,2022,Q1,Elderly
152179915,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Abdominal discomfort,,2022,Q1,5,F,20180701.0,20220316.0,20180730,20220321,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220321,,CN,CA,CA,2022,Q1,Elderly
152179915,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Dyspnoea,,2022,Q1,5,F,20180701.0,20220316.0,20180730,20220321,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220321,,CN,CA,CA,2022,Q1,Elderly
153873074,15387307,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,unk,,,U,,,,,,,,,2022,Q1,Hypokalaemia,,2022,Q1,4,F,20180907.0,20220223.0,20180914,20220302,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-083932,BRISTOL MYERS SQUIBB,,59.0,YR,,M,Y,108.6,KG,20220302,,HP,US,US,2022,Q1,Adult
153873074,15387307,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,unk,,,U,,,,,,,,,2022,Q1,Encephalopathy,,2022,Q1,4,F,20180907.0,20220223.0,20180914,20220302,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-083932,BRISTOL MYERS SQUIBB,,59.0,YR,,M,Y,108.6,KG,20220302,,HP,US,US,2022,Q1,Adult
153873074,15387307,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,unk,,,U,,,,,,,,,2022,Q1,Acute kidney injury,,2022,Q1,4,F,20180907.0,20220223.0,20180914,20220302,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-083932,BRISTOL MYERS SQUIBB,,59.0,YR,,M,Y,108.6,KG,20220302,,HP,US,US,2022,Q1,Adult
1565076312,15650763,16,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 international unit, Once a Day  (25/75: + 20U 20U / d)",,,U,,,,,40.0,IU,Solution for injection,QD,2022,Q1,Ischaemic stroke,,2022,Q1,12,F,,20220304.0,20181123,20220318,EXP,,PT-AUROBINDO-AUR-APL-2018-056484,AUROBINDO,,54.0,YR,,F,Y,,,20220318,,MD,PT,PT,2022,Q1,Adult
1565076312,15650763,16,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 international unit, Once a Day  (25/75: + 20U 20U / d)",,,U,,,,,40.0,IU,Solution for injection,QD,2022,Q1,Headache,,2022,Q1,12,F,,20220304.0,20181123,20220318,EXP,,PT-AUROBINDO-AUR-APL-2018-056484,AUROBINDO,,54.0,YR,,F,Y,,,20220318,,MD,PT,PT,2022,Q1,Adult
1565076312,15650763,16,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 international unit, Once a Day  (25/75: + 20U 20U / d)",,,U,,,,,40.0,IU,Solution for injection,QD,2022,Q1,Chest pain,,2022,Q1,12,F,,20220304.0,20181123,20220318,EXP,,PT-AUROBINDO-AUR-APL-2018-056484,AUROBINDO,,54.0,YR,,F,Y,,,20220318,,MD,PT,PT,2022,Q1,Adult
157595995,15759599,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 international unit, Once a Day",,,U,,,,,40.0,IU,Solution for injection,QD,2022,Q1,Headache,,2022,Q1,5,F,,20220304.0,20181226,20220318,EXP,,PT-AUROBINDO-AUR-APL-2018-062670,AUROBINDO,,54.0,YR,,F,Y,,,20220318,,MD,PT,PT,2022,Q1,Adult
157595995,15759599,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 international unit, Once a Day",,,U,,,,,40.0,IU,Solution for injection,QD,2022,Q1,Ischaemic stroke,,2022,Q1,5,F,,20220304.0,20181226,20220318,EXP,,PT-AUROBINDO-AUR-APL-2018-062670,AUROBINDO,,54.0,YR,,F,Y,,,20220318,,MD,PT,PT,2022,Q1,Adult
157595995,15759599,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 international unit, Once a Day",,,U,,,,,40.0,IU,Solution for injection,QD,2022,Q1,Chest pain,,2022,Q1,5,F,,20220304.0,20181226,20220318,EXP,,PT-AUROBINDO-AUR-APL-2018-062670,AUROBINDO,,54.0,YR,,F,Y,,,20220318,,MD,PT,PT,2022,Q1,Adult
158844364,15884436,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, unknown freq.UNK",,,D,,,,,,,,,2022,Q1,Liver transplant rejection,,2022,Q1,4,F,20130101.0,20211231.0,20190129,20220105,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation./ Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220105,,MD,CZ,CZ,2022,Q1,Adult
158844364,15884436,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, unknown freq.UNK",,,D,,,,,,,,,2022,Q1,Nephrotic syndrome,,2022,Q1,4,F,20130101.0,20211231.0,20190129,20220105,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation./ Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220105,,MD,CZ,CZ,2022,Q1,Adult
158844364,15884436,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, unknown freq.UNK",,,D,,,,,,,,,2022,Q1,Proteinuria,,2022,Q1,4,F,20130101.0,20211231.0,20190129,20220105,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation./ Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220105,,MD,CZ,CZ,2022,Q1,Adult
158844364,15884436,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, unknown freq.UNK",,,D,,,,,,,,,2022,Q1,Hypoglycaemia,,2022,Q1,4,F,20130101.0,20211231.0,20190129,20220105,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation./ Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220105,,MD,CZ,CZ,2022,Q1,Adult
158844364,15884436,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, unknown freq.UNK",,,D,,,,,,,,,2022,Q1,Increased insulin requirement,,2022,Q1,4,F,20130101.0,20211231.0,20190129,20220105,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation./ Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220105,,MD,CZ,CZ,2022,Q1,Adult
158844364,15884436,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, unknown freq.UNK",,,D,,,,,,,,,2022,Q1,Weight increased,,2022,Q1,4,F,20130101.0,20211231.0,20190129,20220105,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation./ Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220105,,MD,CZ,CZ,2022,Q1,Adult
158844364,15884436,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, unknown freq.UNK",,,D,,,,,,,,,2022,Q1,Toxicity to various agents,,2022,Q1,4,F,20130101.0,20211231.0,20190129,20220105,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation./ Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220105,,MD,CZ,CZ,2022,Q1,Adult
158844364,15884436,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, unknown freq.UNK",,,D,,,,,,,,,2022,Q1,Insulin resistance,,2022,Q1,4,F,20130101.0,20211231.0,20190129,20220105,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation./ Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220105,,MD,CZ,CZ,2022,Q1,Adult
158844364,15884436,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"(IL 200) 24-24-24 U, unknown freq.UNK",,,D,,,,,,,,,2022,Q1,Renal failure,,2022,Q1,4,F,20130101.0,20211231.0,20190129,20220105,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation./ Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220105,,MD,CZ,CZ,2022,Q1,Adult
158844364,15884436,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ml (IL 100) at 20-20-20 U doses UNK,,,D,,,,,,,,,2022,Q1,Liver transplant rejection,,2022,Q1,4,F,20130101.0,20211231.0,20190129,20220105,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation./ Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220105,,MD,CZ,CZ,2022,Q1,Adult
158844364,15884436,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ml (IL 100) at 20-20-20 U doses UNK,,,D,,,,,,,,,2022,Q1,Nephrotic syndrome,,2022,Q1,4,F,20130101.0,20211231.0,20190129,20220105,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation./ Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220105,,MD,CZ,CZ,2022,Q1,Adult
158844364,15884436,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ml (IL 100) at 20-20-20 U doses UNK,,,D,,,,,,,,,2022,Q1,Proteinuria,,2022,Q1,4,F,20130101.0,20211231.0,20190129,20220105,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation./ Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220105,,MD,CZ,CZ,2022,Q1,Adult
158844364,15884436,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ml (IL 100) at 20-20-20 U doses UNK,,,D,,,,,,,,,2022,Q1,Hypoglycaemia,,2022,Q1,4,F,20130101.0,20211231.0,20190129,20220105,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation./ Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220105,,MD,CZ,CZ,2022,Q1,Adult
158844364,15884436,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ml (IL 100) at 20-20-20 U doses UNK,,,D,,,,,,,,,2022,Q1,Increased insulin requirement,,2022,Q1,4,F,20130101.0,20211231.0,20190129,20220105,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation./ Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220105,,MD,CZ,CZ,2022,Q1,Adult
158844364,15884436,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ml (IL 100) at 20-20-20 U doses UNK,,,D,,,,,,,,,2022,Q1,Weight increased,,2022,Q1,4,F,20130101.0,20211231.0,20190129,20220105,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation./ Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220105,,MD,CZ,CZ,2022,Q1,Adult
158844364,15884436,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ml (IL 100) at 20-20-20 U doses UNK,,,D,,,,,,,,,2022,Q1,Toxicity to various agents,,2022,Q1,4,F,20130101.0,20211231.0,20190129,20220105,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation./ Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220105,,MD,CZ,CZ,2022,Q1,Adult
158844364,15884436,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ml (IL 100) at 20-20-20 U doses UNK,,,D,,,,,,,,,2022,Q1,Insulin resistance,,2022,Q1,4,F,20130101.0,20211231.0,20190129,20220105,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation./ Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220105,,MD,CZ,CZ,2022,Q1,Adult
158844364,15884436,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ml (IL 100) at 20-20-20 U doses UNK,,,D,,,,,,,,,2022,Q1,Renal failure,,2022,Q1,4,F,20130101.0,20211231.0,20190129,20220105,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation./ Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220105,,MD,CZ,CZ,2022,Q1,Adult
159403376,15940337,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q1,Chronic kidney disease,,2022,Q1,6,F,20151101.0,20220314.0,20190208,20220322,EXP,,US-AstraZeneca-2018SF21004,ASTRAZENECA,,583.0,MON,,M,Y,94.3,KG,20220322,,LW,US,,2022,Q1,Elderly
159403376,15940337,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q1,Renal failure,,2022,Q1,6,F,20151101.0,20220314.0,20190208,20220322,EXP,,US-AstraZeneca-2018SF21004,ASTRAZENECA,,583.0,MON,,M,Y,94.3,KG,20220322,,LW,US,,2022,Q1,Elderly
159403376,15940337,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q1,Chronic kidney disease-mineral and bone disorder,,2022,Q1,6,F,20151101.0,20220314.0,20190208,20220322,EXP,,US-AstraZeneca-2018SF21004,ASTRAZENECA,,583.0,MON,,M,Y,94.3,KG,20220322,,LW,US,,2022,Q1,Elderly
159403376,15940337,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q1,Renal injury,,2022,Q1,6,F,20151101.0,20220314.0,20190208,20220322,EXP,,US-AstraZeneca-2018SF21004,ASTRAZENECA,,583.0,MON,,M,Y,94.3,KG,20220322,,LW,US,,2022,Q1,Elderly
159403376,15940337,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q1,End stage renal disease,,2022,Q1,6,F,20151101.0,20220314.0,20190208,20220322,EXP,,US-AstraZeneca-2018SF21004,ASTRAZENECA,,583.0,MON,,M,Y,94.3,KG,20220322,,LW,US,,2022,Q1,Elderly
159403376,15940337,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q1,Nephrogenic anaemia,,2022,Q1,6,F,20151101.0,20220314.0,20190208,20220322,EXP,,US-AstraZeneca-2018SF21004,ASTRAZENECA,,583.0,MON,,M,Y,94.3,KG,20220322,,LW,US,,2022,Q1,Elderly
159403376,15940337,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q1,Acute kidney injury,,2022,Q1,6,F,20151101.0,20220314.0,20190208,20220322,EXP,,US-AstraZeneca-2018SF21004,ASTRAZENECA,,583.0,MON,,M,Y,94.3,KG,20220322,,LW,US,,2022,Q1,Elderly
159403376,15940337,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q1,Secondary hyperthyroidism,,2022,Q1,6,F,20151101.0,20220314.0,20190208,20220322,EXP,,US-AstraZeneca-2018SF21004,ASTRAZENECA,,583.0,MON,,M,Y,94.3,KG,20220322,,LW,US,,2022,Q1,Elderly
160147987,16014798,13,C,INSULINE LISPRO,,1,Subcutaneous,1 dosage form,,,U,,,,,,,,,2022,Q1,Hepatotoxicity,,2022,Q1,7,F,20181129.0,20211229.0,20190227,20220103,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019935,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,80.0,KG,20220103,,HP,ES,ES,2022,Q1,Adult
160147987,16014798,13,C,INSULINE LISPRO,,1,Subcutaneous,1 dosage form,,,U,,,,,,,,,2022,Q1,Hepatitis,,2022,Q1,7,F,20181129.0,20211229.0,20190227,20220103,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-019935,BRISTOL MYERS SQUIBB,,60.0,YR,,M,Y,80.0,KG,20220103,,HP,ES,ES,2022,Q1,Adult
1608836711,16088367,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Renal disorder,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Haemoglobin increased,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Atrial fibrillation,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Renal injury,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Pulmonary congestion,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Hypotension,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Hypovolaemia,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Presyncope,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Dehydration,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Skin disorder,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Acute kidney injury,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Bradycardia,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Heart rate irregular,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Haematocrit increased,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Left atrial dilatation,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Dizziness,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Arrhythmia,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Oedema peripheral,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Syncope,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Mucosal dryness,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Renal disorder,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Haemoglobin increased,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Atrial fibrillation,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Renal injury,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Pulmonary congestion,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Hypotension,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Hypovolaemia,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Presyncope,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Dehydration,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Skin disorder,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Acute kidney injury,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Bradycardia,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Heart rate irregular,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Haematocrit increased,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Left atrial dilatation,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Dizziness,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Arrhythmia,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Oedema peripheral,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Syncope,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Mucosal dryness,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Renal disorder,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Haemoglobin increased,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Atrial fibrillation,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Renal injury,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Pulmonary congestion,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Hypotension,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Hypovolaemia,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Presyncope,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Dehydration,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Skin disorder,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Acute kidney injury,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Bradycardia,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Heart rate irregular,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Haematocrit increased,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Left atrial dilatation,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Dizziness,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Arrhythmia,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Oedema peripheral,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Syncope,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1608836711,16088367,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Mucosal dryness,,2022,Q1,11,F,20180101.0,20220304.0,20190319,20220317,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220317,,MD,PT,PT,2022,Q1,Elderly
1619976612,16199766,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q1,Cutaneous sarcoidosis,,2022,Q1,12,F,20190404.0,20220216.0,20190415,20220221,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20220221,,HP,BR,BR,2022,Q1,Elderly
1619976612,16199766,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q1,Sarcoidosis,,2022,Q1,12,F,20190404.0,20220216.0,20190415,20220221,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20220221,,HP,BR,BR,2022,Q1,Elderly
1619976612,16199766,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q1,Epiglottic oedema,,2022,Q1,12,F,20190404.0,20220216.0,20190415,20220221,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-036992,BRISTOL MYERS SQUIBB,,72.0,YR,,M,Y,96.0,KG,20220221,,HP,BR,BR,2022,Q1,Elderly
162271323,16227132,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Left atrial dilatation,,2022,Q1,3,F,20180101.0,20220304.0,20190423,20220316,EXP,,PT-AUROBINDO-AUR-APL-2019-021632,AUROBINDO,,71.0,YR,,M,Y,,,20220316,,MD,PT,PT,2022,Q1,Elderly
162271323,16227132,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Haemoglobin increased,,2022,Q1,3,F,20180101.0,20220304.0,20190423,20220316,EXP,,PT-AUROBINDO-AUR-APL-2019-021632,AUROBINDO,,71.0,YR,,M,Y,,,20220316,,MD,PT,PT,2022,Q1,Elderly
162271323,16227132,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Hypovolaemia,,2022,Q1,3,F,20180101.0,20220304.0,20190423,20220316,EXP,,PT-AUROBINDO-AUR-APL-2019-021632,AUROBINDO,,71.0,YR,,M,Y,,,20220316,,MD,PT,PT,2022,Q1,Elderly
162271323,16227132,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Mucosal dryness,,2022,Q1,3,F,20180101.0,20220304.0,20190423,20220316,EXP,,PT-AUROBINDO-AUR-APL-2019-021632,AUROBINDO,,71.0,YR,,M,Y,,,20220316,,MD,PT,PT,2022,Q1,Elderly
162271323,16227132,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Hypotension,,2022,Q1,3,F,20180101.0,20220304.0,20190423,20220316,EXP,,PT-AUROBINDO-AUR-APL-2019-021632,AUROBINDO,,71.0,YR,,M,Y,,,20220316,,MD,PT,PT,2022,Q1,Elderly
162271323,16227132,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Dehydration,,2022,Q1,3,F,20180101.0,20220304.0,20190423,20220316,EXP,,PT-AUROBINDO-AUR-APL-2019-021632,AUROBINDO,,71.0,YR,,M,Y,,,20220316,,MD,PT,PT,2022,Q1,Elderly
162271323,16227132,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Haematocrit increased,,2022,Q1,3,F,20180101.0,20220304.0,20190423,20220316,EXP,,PT-AUROBINDO-AUR-APL-2019-021632,AUROBINDO,,71.0,YR,,M,Y,,,20220316,,MD,PT,PT,2022,Q1,Elderly
162271323,16227132,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Presyncope,,2022,Q1,3,F,20180101.0,20220304.0,20190423,20220316,EXP,,PT-AUROBINDO-AUR-APL-2019-021632,AUROBINDO,,71.0,YR,,M,Y,,,20220316,,MD,PT,PT,2022,Q1,Elderly
162271323,16227132,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Syncope,,2022,Q1,3,F,20180101.0,20220304.0,20190423,20220316,EXP,,PT-AUROBINDO-AUR-APL-2019-021632,AUROBINDO,,71.0,YR,,M,Y,,,20220316,,MD,PT,PT,2022,Q1,Elderly
162271323,16227132,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Arrhythmia,,2022,Q1,3,F,20180101.0,20220304.0,20190423,20220316,EXP,,PT-AUROBINDO-AUR-APL-2019-021632,AUROBINDO,,71.0,YR,,M,Y,,,20220316,,MD,PT,PT,2022,Q1,Elderly
162271323,16227132,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Dizziness,,2022,Q1,3,F,20180101.0,20220304.0,20190423,20220316,EXP,,PT-AUROBINDO-AUR-APL-2019-021632,AUROBINDO,,71.0,YR,,M,Y,,,20220316,,MD,PT,PT,2022,Q1,Elderly
162271323,16227132,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Atrial fibrillation,,2022,Q1,3,F,20180101.0,20220304.0,20190423,20220316,EXP,,PT-AUROBINDO-AUR-APL-2019-021632,AUROBINDO,,71.0,YR,,M,Y,,,20220316,,MD,PT,PT,2022,Q1,Elderly
162271323,16227132,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Skin disorder,,2022,Q1,3,F,20180101.0,20220304.0,20190423,20220316,EXP,,PT-AUROBINDO-AUR-APL-2019-021632,AUROBINDO,,71.0,YR,,M,Y,,,20220316,,MD,PT,PT,2022,Q1,Elderly
162271323,16227132,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Acute kidney injury,,2022,Q1,3,F,20180101.0,20220304.0,20190423,20220316,EXP,,PT-AUROBINDO-AUR-APL-2019-021632,AUROBINDO,,71.0,YR,,M,Y,,,20220316,,MD,PT,PT,2022,Q1,Elderly
162271323,16227132,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Bradycardia,,2022,Q1,3,F,20180101.0,20220304.0,20190423,20220316,EXP,,PT-AUROBINDO-AUR-APL-2019-021632,AUROBINDO,,71.0,YR,,M,Y,,,20220316,,MD,PT,PT,2022,Q1,Elderly
166719502,16671950,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,AS NECESSARY,,,,,,,,,,,,2022,Q1,Bradycardia,,2022,Q1,2,F,20190619.0,20190730.0,20190806,20220203,EXP,,CH-TEVA-2019-CH-1087920,TEVA,,62.0,YR,A,F,Y,121.4,KG,20220203,,MD,CH,CH,2022,Q1,Adult
166719502,16671950,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,AS NECESSARY,,,,,,,,,,,,2022,Q1,Hyperkalaemia,,2022,Q1,2,F,20190619.0,20190730.0,20190806,20220203,EXP,,CH-TEVA-2019-CH-1087920,TEVA,,62.0,YR,A,F,Y,121.4,KG,20220203,,MD,CH,CH,2022,Q1,Adult
1686838410,16868384,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Vulvovaginal pruritus,,2022,Q1,10,F,20190101.0,20220103.0,20190930,20220118,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220118,,CN,US,US,2022,Q1,Elderly
1686838410,16868384,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Fatigue,,2022,Q1,10,F,20190101.0,20220103.0,20190930,20220118,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220118,,CN,US,US,2022,Q1,Elderly
1686838410,16868384,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Pruritus,,2022,Q1,10,F,20190101.0,20220103.0,20190930,20220118,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220118,,CN,US,US,2022,Q1,Elderly
1686838410,16868384,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Vulvovaginal mycotic infection,,2022,Q1,10,F,20190101.0,20220103.0,20190930,20220118,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220118,,CN,US,US,2022,Q1,Elderly
1686838410,16868384,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Paraesthesia,,2022,Q1,10,F,20190101.0,20220103.0,20190930,20220118,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220118,,CN,US,US,2022,Q1,Elderly
1686838410,16868384,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Constipation,,2022,Q1,10,F,20190101.0,20220103.0,20190930,20220118,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220118,,CN,US,US,2022,Q1,Elderly
1686838410,16868384,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Product dose omission issue,,2022,Q1,10,F,20190101.0,20220103.0,20190930,20220118,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220118,,CN,US,US,2022,Q1,Elderly
1686838410,16868384,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Alopecia,,2022,Q1,10,F,20190101.0,20220103.0,20190930,20220118,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220118,,CN,US,US,2022,Q1,Elderly
1686838410,16868384,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Blood glucose decreased,,2022,Q1,10,F,20190101.0,20220103.0,20190930,20220118,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220118,,CN,US,US,2022,Q1,Elderly
1686838410,16868384,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Full blood count abnormal,,2022,Q1,10,F,20190101.0,20220103.0,20190930,20220118,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220118,,CN,US,US,2022,Q1,Elderly
1686838410,16868384,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Dizziness,,2022,Q1,10,F,20190101.0,20220103.0,20190930,20220118,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220118,,CN,US,US,2022,Q1,Elderly
1686838410,16868384,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Anal pruritus,,2022,Q1,10,F,20190101.0,20220103.0,20190930,20220118,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220118,,CN,US,US,2022,Q1,Elderly
1686838410,16868384,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Diarrhoea,,2022,Q1,10,F,20190101.0,20220103.0,20190930,20220118,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220118,,CN,US,US,2022,Q1,Elderly
1686838410,16868384,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,White blood cell count decreased,,2022,Q1,10,F,20190101.0,20220103.0,20190930,20220118,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220118,,CN,US,US,2022,Q1,Elderly
1686838410,16868384,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Stomatitis,,2022,Q1,10,F,20190101.0,20220103.0,20190930,20220118,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220118,,CN,US,US,2022,Q1,Elderly
1686838410,16868384,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Pruritus,,2022,Q1,10,F,20190101.0,20220103.0,20190930,20220118,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220118,,CN,US,US,2022,Q1,Elderly
174087405,17408740,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Pneumonia,,2022,Q1,5,F,20200201.0,20220117.0,20200212,20220120,EXP,,NVSC2020JP028745,NOVARTIS,,60.0,YR,,M,Y,92.5,KG,20220120,,MD,JP,JP,2022,Q1,Adult
174242132,17424213,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,AS NECESSARY,,,U,,,,,,,,,2022,Q1,Acute generalised exanthematous pustulosis,,2022,Q1,2,F,20200121.0,20200211.0,20200217,20220131,EXP,,CH-TEVA-2020-CH-1187372,TEVA,,50.0,YR,A,F,Y,77.0,KG,20220131,,MD,CH,CH,2022,Q1,Adult
176844182,17684418,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Localised oedema,,2022,Q1,2,F,,20200413.0,20200420,20220310,EXP,,CN-Neopharma Inc-000326,NEOPHARMA,CN-Neopharma Inc-000326-01_Initial Source Document,76.0,YR,E,F,Y,,,20200420,,MD,CN,,2022,Q1,Elderly
176844182,17684418,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Weight increased,,2022,Q1,2,F,,20200413.0,20200420,20220310,EXP,,CN-Neopharma Inc-000326,NEOPHARMA,CN-Neopharma Inc-000326-01_Initial Source Document,76.0,YR,E,F,Y,,,20200420,,MD,CN,,2022,Q1,Elderly
176844182,17684418,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Oedema,,2022,Q1,2,F,,20200413.0,20200420,20220310,EXP,,CN-Neopharma Inc-000326,NEOPHARMA,CN-Neopharma Inc-000326-01_Initial Source Document,76.0,YR,E,F,Y,,,20200420,,MD,CN,,2022,Q1,Elderly
176844182,17684418,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Pleural effusion,,2022,Q1,2,F,,20200413.0,20200420,20220310,EXP,,CN-Neopharma Inc-000326,NEOPHARMA,CN-Neopharma Inc-000326-01_Initial Source Document,76.0,YR,E,F,Y,,,20200420,,MD,CN,,2022,Q1,Elderly
1820848927,18208489,93,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),CO,,,U,,,,,1.0,IU,,,2022,Q1,Toxic epidermal necrolysis,,2022,Q1,27,F,20200809.0,20220321.0,20200828,20220328,EXP,,FR-BAUSCH-BL-2020-024487,BAUSCH AND LOMB,,74.0,YR,,M,Y,,,20220328,,MD,FR,FR,2022,Q1,Elderly
183373905,18337390,62,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Anal abscess,,2022,Q1,5,F,20171222.0,20220127.0,20201002,20220201,EXP,,US-AstraZeneca-2020SF25300,ASTRAZENECA,,18493.0,DY,,F,Y,93.4,KG,20220201,,LW,US,,2022,Q1,Elderly
183373905,18337390,62,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Erythema,,2022,Q1,5,F,20171222.0,20220127.0,20201002,20220201,EXP,,US-AstraZeneca-2020SF25300,ASTRAZENECA,,18493.0,DY,,F,Y,93.4,KG,20220201,,LW,US,,2022,Q1,Elderly
183373905,18337390,62,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Necrotising soft tissue infection,,2022,Q1,5,F,20171222.0,20220127.0,20201002,20220201,EXP,,US-AstraZeneca-2020SF25300,ASTRAZENECA,,18493.0,DY,,F,Y,93.4,KG,20220201,,LW,US,,2022,Q1,Elderly
183373905,18337390,62,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Sepsis,,2022,Q1,5,F,20171222.0,20220127.0,20201002,20220201,EXP,,US-AstraZeneca-2020SF25300,ASTRAZENECA,,18493.0,DY,,F,Y,93.4,KG,20220201,,LW,US,,2022,Q1,Elderly
183373905,18337390,62,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Groin abscess,,2022,Q1,5,F,20171222.0,20220127.0,20201002,20220201,EXP,,US-AstraZeneca-2020SF25300,ASTRAZENECA,,18493.0,DY,,F,Y,93.4,KG,20220201,,LW,US,,2022,Q1,Elderly
183373905,18337390,62,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Abscess limb,,2022,Q1,5,F,20171222.0,20220127.0,20201002,20220201,EXP,,US-AstraZeneca-2020SF25300,ASTRAZENECA,,18493.0,DY,,F,Y,93.4,KG,20220201,,LW,US,,2022,Q1,Elderly
183373905,18337390,62,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Septic shock,,2022,Q1,5,F,20171222.0,20220127.0,20201002,20220201,EXP,,US-AstraZeneca-2020SF25300,ASTRAZENECA,,18493.0,DY,,F,Y,93.4,KG,20220201,,LW,US,,2022,Q1,Elderly
183373905,18337390,62,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Urinary tract infection,,2022,Q1,5,F,20171222.0,20220127.0,20201002,20220201,EXP,,US-AstraZeneca-2020SF25300,ASTRAZENECA,,18493.0,DY,,F,Y,93.4,KG,20220201,,LW,US,,2022,Q1,Elderly
183373905,18337390,62,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Fournier's gangrene,,2022,Q1,5,F,20171222.0,20220127.0,20201002,20220201,EXP,,US-AstraZeneca-2020SF25300,ASTRAZENECA,,18493.0,DY,,F,Y,93.4,KG,20220201,,LW,US,,2022,Q1,Elderly
184292529,18429252,34,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU,,,Y,,,,,10.0,IU,Injection,,2022,Q1,Wrong technique in product usage process,,2022,Q1,9,F,20200825.0,20220221.0,20201026,20220301,EXP,,NVSC2020CN285955,NOVARTIS,,57.0,YR,,M,Y,,,20220301,,MD,CN,CN,2022,Q1,Adult
184292529,18429252,34,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU,,,Y,,,,,10.0,IU,Injection,,2022,Q1,Ventricular arrhythmia,,2022,Q1,9,F,20200825.0,20220221.0,20201026,20220301,EXP,,NVSC2020CN285955,NOVARTIS,,57.0,YR,,M,Y,,,20220301,,MD,CN,CN,2022,Q1,Adult
184292529,18429252,34,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU,,,Y,,,,,10.0,IU,Injection,,2022,Q1,Cardiac ventricular thrombosis,,2022,Q1,9,F,20200825.0,20220221.0,20201026,20220301,EXP,,NVSC2020CN285955,NOVARTIS,,57.0,YR,,M,Y,,,20220301,,MD,CN,CN,2022,Q1,Adult
184292529,18429252,34,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU,,,Y,,,,,10.0,IU,Injection,,2022,Q1,Wrong technique in product usage process,,2022,Q1,9,F,20200825.0,20220221.0,20201026,20220301,EXP,,NVSC2020CN285955,NOVARTIS,,57.0,YR,,M,Y,,,20220301,,MD,CN,CN,2022,Q1,Adult
184292529,18429252,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU,,,Y,,,,,10.0,IU,Injection,,2022,Q1,Wrong technique in product usage process,,2022,Q1,9,F,20200825.0,20220221.0,20201026,20220301,EXP,,NVSC2020CN285955,NOVARTIS,,57.0,YR,,M,Y,,,20220301,,MD,CN,CN,2022,Q1,Adult
184292529,18429252,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU,,,Y,,,,,10.0,IU,Injection,,2022,Q1,Ventricular arrhythmia,,2022,Q1,9,F,20200825.0,20220221.0,20201026,20220301,EXP,,NVSC2020CN285955,NOVARTIS,,57.0,YR,,M,Y,,,20220301,,MD,CN,CN,2022,Q1,Adult
184292529,18429252,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU,,,Y,,,,,10.0,IU,Injection,,2022,Q1,Cardiac ventricular thrombosis,,2022,Q1,9,F,20200825.0,20220221.0,20201026,20220301,EXP,,NVSC2020CN285955,NOVARTIS,,57.0,YR,,M,Y,,,20220301,,MD,CN,CN,2022,Q1,Adult
184292529,18429252,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU,,,Y,,,,,10.0,IU,Injection,,2022,Q1,Wrong technique in product usage process,,2022,Q1,9,F,20200825.0,20220221.0,20201026,20220301,EXP,,NVSC2020CN285955,NOVARTIS,,57.0,YR,,M,Y,,,20220301,,MD,CN,CN,2022,Q1,Adult
186595773,18659577,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,300.0,IU,,,2022,Q1,Necrosis,,2022,Q1,3,F,20201209.0,20220322.0,20201224,20220327,EXP,,DE-JNJFOC-20201232483,JOHNSON AND JOHNSON,,8.0,DEC,E,F,Y,82.0,KG,20220328,,MD,DE,DE,2022,Q1,Child
186595773,18659577,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,300.0,IU,,,2022,Q1,Chills,,2022,Q1,3,F,20201209.0,20220322.0,20201224,20220327,EXP,,DE-JNJFOC-20201232483,JOHNSON AND JOHNSON,,8.0,DEC,E,F,Y,82.0,KG,20220328,,MD,DE,DE,2022,Q1,Child
186595773,18659577,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,300.0,IU,,,2022,Q1,Abdominal pain upper,,2022,Q1,3,F,20201209.0,20220322.0,20201224,20220327,EXP,,DE-JNJFOC-20201232483,JOHNSON AND JOHNSON,,8.0,DEC,E,F,Y,82.0,KG,20220328,,MD,DE,DE,2022,Q1,Child
186595773,18659577,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,300.0,IU,,,2022,Q1,Ecthyma,,2022,Q1,3,F,20201209.0,20220322.0,20201224,20220327,EXP,,DE-JNJFOC-20201232483,JOHNSON AND JOHNSON,,8.0,DEC,E,F,Y,82.0,KG,20220328,,MD,DE,DE,2022,Q1,Child
186639096,18663909,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Parasitic gastroenteritis,,2022,Q1,6,F,20200504.0,20220224.0,20201225,20220307,EXP,,IT-ROCHE-2628853,ROCHE,,53.0,YR,,M,Y,,,20220307,,MD,IT,,2022,Q1,Adult
186639096,18663909,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Cytomegalovirus enteritis,,2022,Q1,6,F,20200504.0,20220224.0,20201225,20220307,EXP,,IT-ROCHE-2628853,ROCHE,,53.0,YR,,M,Y,,,20220307,,MD,IT,,2022,Q1,Adult
186682945,18668294,11,C,INSULIN LISPRO (GENETICAL RECOMBINATION),,2,,UNK,,,,,,,,,,,,2022,Q1,Septic shock,,2022,Q1,5,F,20170623.0,20220214.0,20201228,20220218,EXP,,JP-GLAXOSMITHKLINE-JP2020254315,GLAXOSMITHKLINE,"Mizobata N, Suzuki S, Tasaka Y, Okamoto K, Matsumura T.. A case of sepsis after tooth extraction due to agranulocytosis caused by atovaquone. Japanese Journal of Oral and Maxillofacial Surgery. 2022;68:48-52",76.0,YR,,M,Y,55.0,KG,20220218,,MD,JP,JP,2022,Q1,Elderly
186682945,18668294,11,C,INSULIN LISPRO (GENETICAL RECOMBINATION),,2,,UNK,,,,,,,,,,,,2022,Q1,Neutropenia,,2022,Q1,5,F,20170623.0,20220214.0,20201228,20220218,EXP,,JP-GLAXOSMITHKLINE-JP2020254315,GLAXOSMITHKLINE,"Mizobata N, Suzuki S, Tasaka Y, Okamoto K, Matsumura T.. A case of sepsis after tooth extraction due to agranulocytosis caused by atovaquone. Japanese Journal of Oral and Maxillofacial Surgery. 2022;68:48-52",76.0,YR,,M,Y,55.0,KG,20220218,,MD,JP,JP,2022,Q1,Elderly
186682945,18668294,11,C,INSULIN LISPRO (GENETICAL RECOMBINATION),,2,,UNK,,,,,,,,,,,,2022,Q1,Blood pressure decreased,,2022,Q1,5,F,20170623.0,20220214.0,20201228,20220218,EXP,,JP-GLAXOSMITHKLINE-JP2020254315,GLAXOSMITHKLINE,"Mizobata N, Suzuki S, Tasaka Y, Okamoto K, Matsumura T.. A case of sepsis after tooth extraction due to agranulocytosis caused by atovaquone. Japanese Journal of Oral and Maxillofacial Surgery. 2022;68:48-52",76.0,YR,,M,Y,55.0,KG,20220218,,MD,JP,JP,2022,Q1,Elderly
186682945,18668294,11,C,INSULIN LISPRO (GENETICAL RECOMBINATION),,2,,UNK,,,,,,,,,,,,2022,Q1,Sepsis,,2022,Q1,5,F,20170623.0,20220214.0,20201228,20220218,EXP,,JP-GLAXOSMITHKLINE-JP2020254315,GLAXOSMITHKLINE,"Mizobata N, Suzuki S, Tasaka Y, Okamoto K, Matsumura T.. A case of sepsis after tooth extraction due to agranulocytosis caused by atovaquone. Japanese Journal of Oral and Maxillofacial Surgery. 2022;68:48-52",76.0,YR,,M,Y,55.0,KG,20220218,,MD,JP,JP,2022,Q1,Elderly
186682945,18668294,11,C,INSULIN LISPRO (GENETICAL RECOMBINATION),,2,,UNK,,,,,,,,,,,,2022,Q1,Pyrexia,,2022,Q1,5,F,20170623.0,20220214.0,20201228,20220218,EXP,,JP-GLAXOSMITHKLINE-JP2020254315,GLAXOSMITHKLINE,"Mizobata N, Suzuki S, Tasaka Y, Okamoto K, Matsumura T.. A case of sepsis after tooth extraction due to agranulocytosis caused by atovaquone. Japanese Journal of Oral and Maxillofacial Surgery. 2022;68:48-52",76.0,YR,,M,Y,55.0,KG,20220218,,MD,JP,JP,2022,Q1,Elderly
186682945,18668294,11,C,INSULIN LISPRO (GENETICAL RECOMBINATION),,2,,UNK,,,,,,,,,,,,2022,Q1,Tooth extraction,,2022,Q1,5,F,20170623.0,20220214.0,20201228,20220218,EXP,,JP-GLAXOSMITHKLINE-JP2020254315,GLAXOSMITHKLINE,"Mizobata N, Suzuki S, Tasaka Y, Okamoto K, Matsumura T.. A case of sepsis after tooth extraction due to agranulocytosis caused by atovaquone. Japanese Journal of Oral and Maxillofacial Surgery. 2022;68:48-52",76.0,YR,,M,Y,55.0,KG,20220218,,MD,JP,JP,2022,Q1,Elderly
186682945,18668294,11,C,INSULIN LISPRO (GENETICAL RECOMBINATION),,2,,UNK,,,,,,,,,,,,2022,Q1,Fall,,2022,Q1,5,F,20170623.0,20220214.0,20201228,20220218,EXP,,JP-GLAXOSMITHKLINE-JP2020254315,GLAXOSMITHKLINE,"Mizobata N, Suzuki S, Tasaka Y, Okamoto K, Matsumura T.. A case of sepsis after tooth extraction due to agranulocytosis caused by atovaquone. Japanese Journal of Oral and Maxillofacial Surgery. 2022;68:48-52",76.0,YR,,M,Y,55.0,KG,20220218,,MD,JP,JP,2022,Q1,Elderly
186682945,18668294,11,C,INSULIN LISPRO (GENETICAL RECOMBINATION),,2,,UNK,,,,,,,,,,,,2022,Q1,Balance disorder,,2022,Q1,5,F,20170623.0,20220214.0,20201228,20220218,EXP,,JP-GLAXOSMITHKLINE-JP2020254315,GLAXOSMITHKLINE,"Mizobata N, Suzuki S, Tasaka Y, Okamoto K, Matsumura T.. A case of sepsis after tooth extraction due to agranulocytosis caused by atovaquone. Japanese Journal of Oral and Maxillofacial Surgery. 2022;68:48-52",76.0,YR,,M,Y,55.0,KG,20220218,,MD,JP,JP,2022,Q1,Elderly
186682945,18668294,11,C,INSULIN LISPRO (GENETICAL RECOMBINATION),,2,,UNK,,,,,,,,,,,,2022,Q1,Depressed level of consciousness,,2022,Q1,5,F,20170623.0,20220214.0,20201228,20220218,EXP,,JP-GLAXOSMITHKLINE-JP2020254315,GLAXOSMITHKLINE,"Mizobata N, Suzuki S, Tasaka Y, Okamoto K, Matsumura T.. A case of sepsis after tooth extraction due to agranulocytosis caused by atovaquone. Japanese Journal of Oral and Maxillofacial Surgery. 2022;68:48-52",76.0,YR,,M,Y,55.0,KG,20220218,,MD,JP,JP,2022,Q1,Elderly
186966732,18696673,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,before meals,,,,,,,,5.0,IU,,TID,2022,Q1,Haemorrhagic transformation stroke,,2022,Q1,2,F,20200826.0,20201118.0,20210104,20220105,PER,,US-ROCHE-2668154,ROCHE,,97.0,YR,,M,Y,81.6,KG,20220105,,HP,US,US,2022,Q1,Elderly
186966732,18696673,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,before meals,,,,,,,,5.0,IU,,TID,2022,Q1,Product complaint,,2022,Q1,2,F,20200826.0,20201118.0,20210104,20220105,PER,,US-ROCHE-2668154,ROCHE,,97.0,YR,,M,Y,81.6,KG,20220105,,HP,US,US,2022,Q1,Elderly
187215662,18721566,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D051995D,,20563.0,12.0,IU,Injection,,2022,Q1,Anxiety,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D051995D,,20563.0,12.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D051995D,,20563.0,12.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D051995D,,20563.0,12.0,IU,Injection,,2022,Q1,Pollakiuria,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D051995D,,20563.0,12.0,IU,Injection,,2022,Q1,Poor quality sleep,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D051995D,,20563.0,12.0,IU,Injection,,2022,Q1,Drug ineffective,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D051995D,,20563.0,12.0,IU,Injection,,2022,Q1,Drug ineffective,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D051995D,,20563.0,12.0,IU,Injection,,2022,Q1,Anxiety,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D051995D,,20563.0,12.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D051995D,,20563.0,12.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D051995D,,20563.0,12.0,IU,Injection,,2022,Q1,Pollakiuria,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D051995D,,20563.0,12.0,IU,Injection,,2022,Q1,Poor quality sleep,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D051995D,,20563.0,12.0,IU,Injection,,2022,Q1,Drug ineffective,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D051995D,,20563.0,12.0,IU,Injection,,2022,Q1,Drug ineffective,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Anxiety,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Pollakiuria,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Poor quality sleep,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Drug ineffective,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Drug ineffective,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Anxiety,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Pollakiuria,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Poor quality sleep,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Drug ineffective,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187215662,18721566,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Drug ineffective,,2022,Q1,2,F,20210105.0,20220302.0,20210110,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202101002522,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
187849458,18784945,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q1,Proctalgia,,2022,Q1,8,F,20210220.0,20220304.0,20210125,20220310,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220310,,CN,CO,CO,2022,Q1,Adult
187849458,18784945,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q1,Pollakiuria,,2022,Q1,8,F,20210220.0,20220304.0,20210125,20220310,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220310,,CN,CO,CO,2022,Q1,Adult
187849458,18784945,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q1,Haematochezia,,2022,Q1,8,F,20210220.0,20220304.0,20210125,20220310,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220310,,CN,CO,CO,2022,Q1,Adult
187849458,18784945,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q1,Constipation,,2022,Q1,8,F,20210220.0,20220304.0,20210125,20220310,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220310,,CN,CO,CO,2022,Q1,Adult
187849458,18784945,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q1,Abdominal distension,,2022,Q1,8,F,20210220.0,20220304.0,20210125,20220310,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220310,,CN,CO,CO,2022,Q1,Adult
187849458,18784945,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q1,Abdominal pain upper,,2022,Q1,8,F,20210220.0,20220304.0,20210125,20220310,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220310,,CN,CO,CO,2022,Q1,Adult
187849458,18784945,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q1,Abdominal pain,,2022,Q1,8,F,20210220.0,20220304.0,20210125,20220310,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220310,,CN,CO,CO,2022,Q1,Adult
187849458,18784945,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q1,Weight increased,,2022,Q1,8,F,20210220.0,20220304.0,20210125,20220310,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220310,,CN,CO,CO,2022,Q1,Adult
187849458,18784945,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q1,Hyperhidrosis,,2022,Q1,8,F,20210220.0,20220304.0,20210125,20220310,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220310,,CN,CO,CO,2022,Q1,Adult
187849458,18784945,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q1,Rectal tenesmus,,2022,Q1,8,F,20210220.0,20220304.0,20210125,20220310,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220310,,CN,CO,CO,2022,Q1,Adult
187849458,18784945,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q1,Thirst,,2022,Q1,8,F,20210220.0,20220304.0,20210125,20220310,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220310,,CN,CO,CO,2022,Q1,Adult
187849458,18784945,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q1,Peripheral coldness,,2022,Q1,8,F,20210220.0,20220304.0,20210125,20220310,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220310,,CN,CO,CO,2022,Q1,Adult
187849458,18784945,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q1,Gastrointestinal inflammation,,2022,Q1,8,F,20210220.0,20220304.0,20210125,20220310,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220310,,CN,CO,CO,2022,Q1,Adult
187849458,18784945,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q1,Diarrhoea haemorrhagic,,2022,Q1,8,F,20210220.0,20220304.0,20210125,20220310,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220310,,CN,CO,CO,2022,Q1,Adult
187849458,18784945,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q1,Fatigue,,2022,Q1,8,F,20210220.0,20220304.0,20210125,20220310,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220310,,CN,CO,CO,2022,Q1,Adult
187849458,18784945,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q1,General physical health deterioration,,2022,Q1,8,F,20210220.0,20220304.0,20210125,20220310,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220310,,CN,CO,CO,2022,Q1,Adult
187849458,18784945,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q1,Blood glucose increased,,2022,Q1,8,F,20210220.0,20220304.0,20210125,20220310,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220310,,CN,CO,CO,2022,Q1,Adult
187849458,18784945,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q1,Colitis ulcerative,,2022,Q1,8,F,20210220.0,20220304.0,20210125,20220310,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220310,,CN,CO,CO,2022,Q1,Adult
188048733,18804873,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Drug ineffective,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Eye disorder,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Eye haemorrhage,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Ocular discomfort,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Incorrect dose administered,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Dyspepsia,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Pain in extremity,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Gait disturbance,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Drug ineffective,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Eye disorder,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Eye haemorrhage,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Ocular discomfort,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Incorrect dose administered,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Dyspepsia,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Pain in extremity,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Gait disturbance,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Drug ineffective,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Eye disorder,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Eye haemorrhage,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Ocular discomfort,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Incorrect dose administered,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Dyspepsia,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Pain in extremity,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Gait disturbance,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,,,,35.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Drug ineffective,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Eye disorder,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Eye haemorrhage,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Ocular discomfort,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Incorrect dose administered,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Dyspepsia,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Pain in extremity,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Gait disturbance,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Drug ineffective,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Eye disorder,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Eye haemorrhage,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Ocular discomfort,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Incorrect dose administered,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Dyspepsia,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Pain in extremity,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Gait disturbance,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Drug ineffective,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Eye disorder,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Eye haemorrhage,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Ocular discomfort,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Incorrect dose administered,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Dyspepsia,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Pain in extremity,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Gait disturbance,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"35 u, unknown",,,,,D195320A,,,35.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Drug ineffective,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Eye disorder,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Eye haemorrhage,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Ocular discomfort,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Incorrect dose administered,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Dyspepsia,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Pain in extremity,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Gait disturbance,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Drug ineffective,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Eye disorder,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Eye haemorrhage,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Ocular discomfort,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Incorrect dose administered,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Dyspepsia,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Pain in extremity,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Gait disturbance,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Drug ineffective,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Eye disorder,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Eye haemorrhage,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Ocular discomfort,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Incorrect dose administered,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Dyspepsia,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Pain in extremity,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Gait disturbance,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, unknown (at night)",,,,,D195320A,,,50.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Drug ineffective,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Eye disorder,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Eye haemorrhage,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Ocular discomfort,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Incorrect dose administered,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Dyspepsia,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Pain in extremity,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Gait disturbance,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Drug ineffective,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Eye disorder,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Eye haemorrhage,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Ocular discomfort,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Incorrect dose administered,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Dyspepsia,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Pain in extremity,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Gait disturbance,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,13,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Drug ineffective,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Eye disorder,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Eye haemorrhage,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Ocular discomfort,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Incorrect dose administered,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Dyspepsia,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Pain in extremity,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Gait disturbance,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188048733,18804873,14,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, unknown",,,,,,,,20.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20201201.0,20220211.0,20210129,20220223,EXP,,US-ELI_LILLY_AND_COMPANY-US202101006978,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220223,,CN,US,US,2022,Q1,Elderly
188232655,18823265,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,dose and frequency unknown,,,Y,,,,,,,Injection,,2022,Q1,Cellulitis,,2022,Q1,5,F,20200807.0,20220104.0,20210202,20220201,EXP,,JP-Eisai Medical Research-EC-2020-079010,EISAI,,68.0,YR,E,M,Y,90.0,KG,20220201,,MD,JP,JP,2022,Q1,Elderly
188232655,18823265,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,dose and frequency unknown,,,Y,,,,,,,Injection,,2022,Q1,Hypoglycaemia,,2022,Q1,5,F,20200807.0,20220104.0,20210202,20220201,EXP,,JP-Eisai Medical Research-EC-2020-079010,EISAI,,68.0,YR,E,M,Y,90.0,KG,20220201,,MD,JP,JP,2022,Q1,Elderly
188761862,18876186,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Pain,,2022,Q1,2,F,20210101.0,20220321.0,20210211,20220328,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005076,AEGERION,,25.0,YR,,F,Y,48.073,KG,20220328,,CN,US,US,2022,Q1,Young Adult
188761862,18876186,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Dry skin,,2022,Q1,2,F,20210101.0,20220321.0,20210211,20220328,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005076,AEGERION,,25.0,YR,,F,Y,48.073,KG,20220328,,CN,US,US,2022,Q1,Young Adult
188761862,18876186,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Therapy interrupted,,2022,Q1,2,F,20210101.0,20220321.0,20210211,20220328,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005076,AEGERION,,25.0,YR,,F,Y,48.073,KG,20220328,,CN,US,US,2022,Q1,Young Adult
188761862,18876186,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Product dose omission issue,,2022,Q1,2,F,20210101.0,20220321.0,20210211,20220328,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005076,AEGERION,,25.0,YR,,F,Y,48.073,KG,20220328,,CN,US,US,2022,Q1,Young Adult
188761862,18876186,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Cerebrovascular accident,,2022,Q1,2,F,20210101.0,20220321.0,20210211,20220328,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005076,AEGERION,,25.0,YR,,F,Y,48.073,KG,20220328,,CN,US,US,2022,Q1,Young Adult
188761862,18876186,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Insurance issue,,2022,Q1,2,F,20210101.0,20220321.0,20210211,20220328,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005076,AEGERION,,25.0,YR,,F,Y,48.073,KG,20220328,,CN,US,US,2022,Q1,Young Adult
189150196,18915019,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Localised infection,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Lower limb fracture,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Depressed level of consciousness,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Pain in extremity,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Muscular weakness,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Injury,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Fall,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Fall,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Arthralgia,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Diabetic ketoacidosis,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Localised infection,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Lower limb fracture,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Depressed level of consciousness,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Pain in extremity,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Muscular weakness,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Injury,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Fall,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Fall,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Arthralgia,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Diabetic ketoacidosis,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D051995D,,20563.0,,,Injection,,2022,Q1,Localised infection,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D051995D,,20563.0,,,Injection,,2022,Q1,Lower limb fracture,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D051995D,,20563.0,,,Injection,,2022,Q1,Depressed level of consciousness,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D051995D,,20563.0,,,Injection,,2022,Q1,Pain in extremity,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D051995D,,20563.0,,,Injection,,2022,Q1,Muscular weakness,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D051995D,,20563.0,,,Injection,,2022,Q1,Injury,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D051995D,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D051995D,,20563.0,,,Injection,,2022,Q1,Fall,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D051995D,,20563.0,,,Injection,,2022,Q1,Fall,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D051995D,,20563.0,,,Injection,,2022,Q1,Arthralgia,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D051995D,,20563.0,,,Injection,,2022,Q1,Diabetic ketoacidosis,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D051995D,,20563.0,,,Injection,,2022,Q1,Localised infection,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D051995D,,20563.0,,,Injection,,2022,Q1,Lower limb fracture,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D051995D,,20563.0,,,Injection,,2022,Q1,Depressed level of consciousness,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D051995D,,20563.0,,,Injection,,2022,Q1,Pain in extremity,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D051995D,,20563.0,,,Injection,,2022,Q1,Muscular weakness,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D051995D,,20563.0,,,Injection,,2022,Q1,Injury,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D051995D,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D051995D,,20563.0,,,Injection,,2022,Q1,Fall,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D051995D,,20563.0,,,Injection,,2022,Q1,Fall,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D051995D,,20563.0,,,Injection,,2022,Q1,Arthralgia,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
189150196,18915019,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D051995D,,20563.0,,,Injection,,2022,Q1,Diabetic ketoacidosis,,2022,Q1,6,F,20151015.0,20220119.0,20210219,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202102006743,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220128,,CN,US,US,2022,Q1,Elderly
1891829212,18918292,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Abscess limb,,2022,Q1,12,F,20210216.0,20220124.0,20210219,20220210,EXP,,US-GILEAD-2021-0518037,GILEAD,,72.0,YR,E,M,Y,121.09,KG,20220210,,HP,US,US,2022,Q1,Elderly
189693792,18969379,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,unk,,,D,,,,209196.0,,,,,2022,Q1,Renal failure,,2022,Q1,2,F,,20220203.0,20210304,20220205,EXP,GB-MHRA-EYC 00242362,GB-SA-2021SA072538,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20220205,,HP,GB,GB,2022,Q1,Elderly
189693792,18969379,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,unk,,,D,,,,209196.0,,,,,2022,Q1,Hypoglycaemia,,2022,Q1,2,F,,20220203.0,20210304,20220205,EXP,GB-MHRA-EYC 00242362,GB-SA-2021SA072538,SANOFI AVENTIS,,68.0,YR,E,M,Y,,,20220205,,HP,GB,GB,2022,Q1,Elderly
190574132,19057413,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-10 Units,,,,,,,,,,Injection,QID,2022,Q1,Immune effector cell-associated neurotoxicity syndrome,,2022,Q1,2,F,20210314.0,20220314.0,20210324,20220316,EXP,,US-CELGENEUS-USA-20210304462,CELGENE,,78.0,YR,,F,Y,75.2,KG,20220316,,MD,US,US,2022,Q1,Elderly
190574132,19057413,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-10 Units,,,,,,,,,,Injection,QID,2022,Q1,Cytokine release syndrome,,2022,Q1,2,F,20210314.0,20220314.0,20210324,20220316,EXP,,US-CELGENEUS-USA-20210304462,CELGENE,,78.0,YR,,F,Y,75.2,KG,20220316,,MD,US,US,2022,Q1,Elderly
190574132,19057413,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-10 Units,,,,,,,,,,Injection,QID,2022,Q1,Immune effector cell-associated neurotoxicity syndrome,,2022,Q1,2,F,20210314.0,20220314.0,20210324,20220316,EXP,,US-CELGENEUS-USA-20210304462,CELGENE,,78.0,YR,,F,Y,75.2,KG,20220316,,MD,US,US,2022,Q1,Elderly
190940952,19094095,7,C,"Insulin Lispro, human",,2,Subcutaneous,40 IU (International Unit),,,,,,,,20.0,IU,Injection,BID,2022,Q1,Basal cell carcinoma,,2022,Q1,2,F,20210325.0,20220302.0,20210405,20220310,EXP,,US-CELGENEUS-USA-20210307983,CELGENE,,71.0,YR,,M,Y,87.168,KG,20220310,,MD,US,US,2022,Q1,Elderly
190940952,19094095,7,C,"Insulin Lispro, human",,2,Subcutaneous,40 IU (International Unit),,,,,,,,20.0,IU,Injection,BID,2022,Q1,Squamous cell carcinoma of skin,,2022,Q1,2,F,20210325.0,20220302.0,20210405,20220310,EXP,,US-CELGENEUS-USA-20210307983,CELGENE,,71.0,YR,,M,Y,87.168,KG,20220310,,MD,US,US,2022,Q1,Elderly
190985952,19098595,5,C,LYUMJEV [INSULIN LISPRO AABC],,2,Unknown,"UNK UNK, unknown",,,U,,D198400AL,,,,,,,2022,Q1,Dyspepsia,,2022,Q1,2,F,20210301.0,20211220.0,20210406,20220111,PER,,US-ELI_LILLY_AND_COMPANY-US202104002201,ELI LILLY AND CO,,53.0,YR,,M,Y,,,20220111,,CN,US,US,2022,Q1,Adult
190985952,19098595,5,C,LYUMJEV [INSULIN LISPRO AABC],,2,Unknown,"UNK UNK, unknown",,,U,,D198400AL,,,,,,,2022,Q1,Ulcer,,2022,Q1,2,F,20210301.0,20211220.0,20210406,20220111,PER,,US-ELI_LILLY_AND_COMPANY-US202104002201,ELI LILLY AND CO,,53.0,YR,,M,Y,,,20220111,,CN,US,US,2022,Q1,Adult
190985952,19098595,5,C,LYUMJEV [INSULIN LISPRO AABC],,2,Unknown,"UNK UNK, unknown",,,U,,D198400AL,,,,,,,2022,Q1,Injection site pain,,2022,Q1,2,F,20210301.0,20211220.0,20210406,20220111,PER,,US-ELI_LILLY_AND_COMPANY-US202104002201,ELI LILLY AND CO,,53.0,YR,,M,Y,,,20220111,,CN,US,US,2022,Q1,Adult
190985952,19098595,5,C,LYUMJEV [INSULIN LISPRO AABC],,2,Unknown,"UNK UNK, unknown",,,U,,D198400AL,,,,,,,2022,Q1,Decreased appetite,,2022,Q1,2,F,20210301.0,20211220.0,20210406,20220111,PER,,US-ELI_LILLY_AND_COMPANY-US202104002201,ELI LILLY AND CO,,53.0,YR,,M,Y,,,20220111,,CN,US,US,2022,Q1,Adult
190985952,19098595,5,C,LYUMJEV [INSULIN LISPRO AABC],,2,Unknown,"UNK UNK, unknown",,,U,,D198400AL,,,,,,,2022,Q1,Eructation,,2022,Q1,2,F,20210301.0,20211220.0,20210406,20220111,PER,,US-ELI_LILLY_AND_COMPANY-US202104002201,ELI LILLY AND CO,,53.0,YR,,M,Y,,,20220111,,CN,US,US,2022,Q1,Adult
190985952,19098595,5,C,LYUMJEV [INSULIN LISPRO AABC],,2,Unknown,"UNK UNK, unknown",,,U,,D198400AL,,,,,,,2022,Q1,Product dose omission issue,,2022,Q1,2,F,20210301.0,20211220.0,20210406,20220111,PER,,US-ELI_LILLY_AND_COMPANY-US202104002201,ELI LILLY AND CO,,53.0,YR,,M,Y,,,20220111,,CN,US,US,2022,Q1,Adult
191125387,19112538,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1-2 U x 1 x 1 Days,,,,,,,,,,Unknown,QD,2022,Q1,Sepsis,,2022,Q1,7,F,20210403.0,20220105.0,20210408,20220107,EXP,,US-CELGENEUS-USA-20210401065,CELGENE,,80.0,YR,,F,Y,66.0,KG,20220107,,MD,US,US,2022,Q1,Elderly
191479399,19147939,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Intramuscular,8 U,,,,,,,,,,Injection,,2022,Q1,Embolism,,2022,Q1,9,F,20210224.0,20220204.0,20210416,20220210,EXP,,US-ROCHE-2802910,ROCHE,,72.0,YR,,M,Y,81.5,KG,20220209,,MD,US,,2022,Q1,Elderly
191479399,19147939,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Intramuscular,8 U,,,,,,,,,,Injection,,2022,Q1,Pneumonitis,,2022,Q1,9,F,20210224.0,20220204.0,20210416,20220210,EXP,,US-ROCHE-2802910,ROCHE,,72.0,YR,,M,Y,81.5,KG,20220209,,MD,US,,2022,Q1,Elderly
192597842,19259784,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (75/25 pen),,,,,,,,,,,,2022,Q1,Upper respiratory tract infection,,2022,Q1,2,F,,20211007.0,20210514,20220119,PER,,US-PFIZER INC-2021487513,PFIZER,,36.0,YR,,F,Y,,,20220119,,HP,US,US,2022,Q1,Adult
192597842,19259784,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (75/25 pen),,,,,,,,,,,,2022,Q1,Nasopharyngitis,,2022,Q1,2,F,,20211007.0,20210514,20220119,PER,,US-PFIZER INC-2021487513,PFIZER,,36.0,YR,,F,Y,,,20220119,,HP,US,US,2022,Q1,Adult
193943052,19394305,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Pain,,2022,Q1,2,F,20110101.0,20220117.0,20210609,20220120,EXP,,US-GILEAD-2021-0534932,GILEAD,,50.0,YR,A,F,Y,121.54,KG,20220120,,LW,US,US,2022,Q1,Adult
193943052,19394305,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Bone demineralisation,,2022,Q1,2,F,20110101.0,20220117.0,20210609,20220120,EXP,,US-GILEAD-2021-0534932,GILEAD,,50.0,YR,A,F,Y,121.54,KG,20220120,,LW,US,US,2022,Q1,Adult
193943052,19394305,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Chronic kidney disease,,2022,Q1,2,F,20110101.0,20220117.0,20210609,20220120,EXP,,US-GILEAD-2021-0534932,GILEAD,,50.0,YR,A,F,Y,121.54,KG,20220120,,LW,US,US,2022,Q1,Adult
193943052,19394305,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Anxiety,,2022,Q1,2,F,20110101.0,20220117.0,20210609,20220120,EXP,,US-GILEAD-2021-0534932,GILEAD,,50.0,YR,A,F,Y,121.54,KG,20220120,,LW,US,US,2022,Q1,Adult
193943052,19394305,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Asthenia,,2022,Q1,2,F,20110101.0,20220117.0,20210609,20220120,EXP,,US-GILEAD-2021-0534932,GILEAD,,50.0,YR,A,F,Y,121.54,KG,20220120,,LW,US,US,2022,Q1,Adult
193943052,19394305,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Anhedonia,,2022,Q1,2,F,20110101.0,20220117.0,20210609,20220120,EXP,,US-GILEAD-2021-0534932,GILEAD,,50.0,YR,A,F,Y,121.54,KG,20220120,,LW,US,US,2022,Q1,Adult
193943052,19394305,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Foot fracture,,2022,Q1,2,F,20110101.0,20220117.0,20210609,20220120,EXP,,US-GILEAD-2021-0534932,GILEAD,,50.0,YR,A,F,Y,121.54,KG,20220120,,LW,US,US,2022,Q1,Adult
193943052,19394305,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Fatigue,,2022,Q1,2,F,20110101.0,20220117.0,20210609,20220120,EXP,,US-GILEAD-2021-0534932,GILEAD,,50.0,YR,A,F,Y,121.54,KG,20220120,,LW,US,US,2022,Q1,Adult
193943052,19394305,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Urinary incontinence,,2022,Q1,2,F,20110101.0,20220117.0,20210609,20220120,EXP,,US-GILEAD-2021-0534932,GILEAD,,50.0,YR,A,F,Y,121.54,KG,20220120,,LW,US,US,2022,Q1,Adult
193943052,19394305,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Gait inability,,2022,Q1,2,F,20110101.0,20220117.0,20210609,20220120,EXP,,US-GILEAD-2021-0534932,GILEAD,,50.0,YR,A,F,Y,121.54,KG,20220120,,LW,US,US,2022,Q1,Adult
193943052,19394305,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Emotional distress,,2022,Q1,2,F,20110101.0,20220117.0,20210609,20220120,EXP,,US-GILEAD-2021-0534932,GILEAD,,50.0,YR,A,F,Y,121.54,KG,20220120,,LW,US,US,2022,Q1,Adult
193943052,19394305,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Foot fracture,,2022,Q1,2,F,20110101.0,20220117.0,20210609,20220120,EXP,,US-GILEAD-2021-0534932,GILEAD,,50.0,YR,A,F,Y,121.54,KG,20220120,,LW,US,US,2022,Q1,Adult
193943052,19394305,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Device related infection,,2022,Q1,2,F,20110101.0,20220117.0,20210609,20220120,EXP,,US-GILEAD-2021-0534932,GILEAD,,50.0,YR,A,F,Y,121.54,KG,20220120,,LW,US,US,2022,Q1,Adult
193943052,19394305,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Hypertension,,2022,Q1,2,F,20110101.0,20220117.0,20210609,20220120,EXP,,US-GILEAD-2021-0534932,GILEAD,,50.0,YR,A,F,Y,121.54,KG,20220120,,LW,US,US,2022,Q1,Adult
194738802,19473880,1,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D142268A,,,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20210626.0,20220323.0,20210629,20220330,PER,,US-ELI_LILLY_AND_COMPANY-US202106014278,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20220330,,HP,US,US,2022,Q1,Elderly
194738802,19473880,1,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D142268A,,,,,Injection,,2022,Q1,Drug ineffective,,2022,Q1,2,F,20210626.0,20220323.0,20210629,20220330,PER,,US-ELI_LILLY_AND_COMPANY-US202106014278,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20220330,,HP,US,US,2022,Q1,Elderly
194738802,19473880,1,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D142268A,,,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20210626.0,20220323.0,20210629,20220330,PER,,US-ELI_LILLY_AND_COMPANY-US202106014278,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20220330,,HP,US,US,2022,Q1,Elderly
194738802,19473880,1,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D142268A,,,,,Injection,,2022,Q1,Drug ineffective,,2022,Q1,2,F,20210626.0,20220323.0,20210629,20220330,PER,,US-ELI_LILLY_AND_COMPANY-US202106014278,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20220330,,HP,US,US,2022,Q1,Elderly
194738802,19473880,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 u, unknown, 60-80 units",,,,,D318637A,,,80.0,IU,Injection,QD,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20210626.0,20220323.0,20210629,20220330,PER,,US-ELI_LILLY_AND_COMPANY-US202106014278,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20220330,,HP,US,US,2022,Q1,Elderly
194738802,19473880,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 u, unknown, 60-80 units",,,,,D318637A,,,80.0,IU,Injection,QD,2022,Q1,Drug ineffective,,2022,Q1,2,F,20210626.0,20220323.0,20210629,20220330,PER,,US-ELI_LILLY_AND_COMPANY-US202106014278,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20220330,,HP,US,US,2022,Q1,Elderly
194738802,19473880,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 u, unknown, 60-80 units",,,,,D318637A,,,80.0,IU,Injection,QD,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20210626.0,20220323.0,20210629,20220330,PER,,US-ELI_LILLY_AND_COMPANY-US202106014278,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20220330,,HP,US,US,2022,Q1,Elderly
194738802,19473880,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 u, unknown, 60-80 units",,,,,D318637A,,,80.0,IU,Injection,QD,2022,Q1,Drug ineffective,,2022,Q1,2,F,20210626.0,20220323.0,20210629,20220330,PER,,US-ELI_LILLY_AND_COMPANY-US202106014278,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20220330,,HP,US,US,2022,Q1,Elderly
194846978,19484697,35,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1iu, CO",,,U,,ASKED BUT UNKNOWN,,,1.0,IU,Unknown,,2022,Q1,Toxic epidermal necrolysis,,2022,Q1,8,F,20200809.0,20220321.0,20210702,20220329,EXP,,FR-ROCHE-2860051,ROCHE,,74.0,YR,,M,Y,,,20220329,,MD,FR,FR,2022,Q1,Elderly
194986986,19498698,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2022,Q1,Febrile neutropenia,,2022,Q1,6,F,20210618.0,20220118.0,20210706,20220121,PER,,US-CELGENEUS-USA-20210607882,CELGENE,,69.0,YR,,M,Y,,,20220121,,MD,US,US,2022,Q1,Elderly
195136322,19513632,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Hyperparathyroidism secondary,,2022,Q1,2,F,20180101.0,20220124.0,20210709,20220201,EXP,,US-AstraZeneca-2019SE11736,ASTRAZENECA,,60.0,YR,,F,Y,78.0,KG,20220201,,LW,US,,2022,Q1,Adult
195136322,19513632,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Acute kidney injury,,2022,Q1,2,F,20180101.0,20220124.0,20210709,20220201,EXP,,US-AstraZeneca-2019SE11736,ASTRAZENECA,,60.0,YR,,F,Y,78.0,KG,20220201,,LW,US,,2022,Q1,Adult
195136322,19513632,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Nephrogenic anaemia,,2022,Q1,2,F,20180101.0,20220124.0,20210709,20220201,EXP,,US-AstraZeneca-2019SE11736,ASTRAZENECA,,60.0,YR,,F,Y,78.0,KG,20220201,,LW,US,,2022,Q1,Adult
195136322,19513632,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,End stage renal disease,,2022,Q1,2,F,20180101.0,20220124.0,20210709,20220201,EXP,,US-AstraZeneca-2019SE11736,ASTRAZENECA,,60.0,YR,,F,Y,78.0,KG,20220201,,LW,US,,2022,Q1,Adult
195136322,19513632,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Chronic kidney disease,,2022,Q1,2,F,20180101.0,20220124.0,20210709,20220201,EXP,,US-AstraZeneca-2019SE11736,ASTRAZENECA,,60.0,YR,,F,Y,78.0,KG,20220201,,LW,US,,2022,Q1,Adult
195136322,19513632,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Renal failure,,2022,Q1,2,F,20180101.0,20220124.0,20210709,20220201,EXP,,US-AstraZeneca-2019SE11736,ASTRAZENECA,,60.0,YR,,F,Y,78.0,KG,20220201,,LW,US,,2022,Q1,Adult
195412602,19541260,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q1,Diaphragmatic disorder,,2022,Q1,2,F,,20220209.0,20210713,20220221,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20220221,,HP,CA,CA,2022,Q1,Elderly
195412602,19541260,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q1,Obstructive airways disorder,,2022,Q1,2,F,,20220209.0,20210713,20220221,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20220221,,HP,CA,CA,2022,Q1,Elderly
195412602,19541260,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q1,Dyspnoea,,2022,Q1,2,F,,20220209.0,20210713,20220221,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20220221,,HP,CA,CA,2022,Q1,Elderly
195412602,19541260,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q1,Oropharyngeal pain,,2022,Q1,2,F,,20220209.0,20210713,20220221,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20220221,,HP,CA,CA,2022,Q1,Elderly
195412602,19541260,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q1,Chest discomfort,,2022,Q1,2,F,,20220209.0,20210713,20220221,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20220221,,HP,CA,CA,2022,Q1,Elderly
195412602,19541260,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q1,Full blood count abnormal,,2022,Q1,2,F,,20220209.0,20210713,20220221,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20220221,,HP,CA,CA,2022,Q1,Elderly
195412602,19541260,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q1,Cough,,2022,Q1,2,F,,20220209.0,20210713,20220221,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20220221,,HP,CA,CA,2022,Q1,Elderly
195412602,19541260,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q1,Left ventricular hypertrophy,,2022,Q1,2,F,,20220209.0,20210713,20220221,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20220221,,HP,CA,CA,2022,Q1,Elderly
195412602,19541260,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q1,Weight increased,,2022,Q1,2,F,,20220209.0,20210713,20220221,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20220221,,HP,CA,CA,2022,Q1,Elderly
195412602,19541260,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q1,Hypoxia,,2022,Q1,2,F,,20220209.0,20210713,20220221,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20220221,,HP,CA,CA,2022,Q1,Elderly
195412602,19541260,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q1,Discomfort,,2022,Q1,2,F,,20220209.0,20210713,20220221,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20220221,,HP,CA,CA,2022,Q1,Elderly
195412602,19541260,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q1,Asthma,,2022,Q1,2,F,,20220209.0,20210713,20220221,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20220221,,HP,CA,CA,2022,Q1,Elderly
195412602,19541260,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q1,Therapeutic product effect incomplete,,2022,Q1,2,F,,20220209.0,20210713,20220221,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20220221,,HP,CA,CA,2022,Q1,Elderly
195412602,19541260,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q1,Wheezing,,2022,Q1,2,F,,20220209.0,20210713,20220221,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20220221,,HP,CA,CA,2022,Q1,Elderly
195412602,19541260,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q1,Oedema peripheral,,2022,Q1,2,F,,20220209.0,20210713,20220221,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20220221,,HP,CA,CA,2022,Q1,Elderly
195412602,19541260,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q1,Pyrexia,,2022,Q1,2,F,,20220209.0,20210713,20220221,EXP,,CA-BAUSCH-BL-2021-024254,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20220221,,HP,CA,CA,2022,Q1,Elderly
195909903,19590990,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU at 12.00 a.m,,,D,,,,209196.0,10.0,IU,Solution for injection,,2022,Q1,Hypokalaemia,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU at 12.00 a.m,,,D,,,,209196.0,10.0,IU,Solution for injection,,2022,Q1,Hypertensive crisis,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU at 12.00 a.m,,,D,,,,209196.0,10.0,IU,Solution for injection,,2022,Q1,Phaeochromocytoma crisis,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU at 12.00 a.m,,,D,,,,209196.0,10.0,IU,Solution for injection,,2022,Q1,Proteinuria,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU at 12.00 a.m,,,D,,,,209196.0,10.0,IU,Solution for injection,,2022,Q1,Asthenia,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU at 12.00 a.m,,,D,,,,209196.0,10.0,IU,Solution for injection,,2022,Q1,Headache,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU at 12.00 a.m,,,D,,,,209196.0,10.0,IU,Solution for injection,,2022,Q1,Anxiety,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU at 12.00 a.m,,,D,,,,209196.0,10.0,IU,Solution for injection,,2022,Q1,Irritability,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU at 12.00 a.m,,,D,,,,209196.0,10.0,IU,Solution for injection,,2022,Q1,Exposure during pregnancy,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU at 12.00 a.m,,,D,,,,209196.0,10.0,IU,Solution for injection,,2022,Q1,Tachycardia,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU at 12.00 a.m,,,D,,,,209196.0,10.0,IU,Solution for injection,,2022,Q1,Condition aggravated,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU at 7.00 a.m,,,D,,,,209196.0,6.0,IU,Solution for injection,,2022,Q1,Hypokalaemia,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU at 7.00 a.m,,,D,,,,209196.0,6.0,IU,Solution for injection,,2022,Q1,Hypertensive crisis,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU at 7.00 a.m,,,D,,,,209196.0,6.0,IU,Solution for injection,,2022,Q1,Phaeochromocytoma crisis,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU at 7.00 a.m,,,D,,,,209196.0,6.0,IU,Solution for injection,,2022,Q1,Proteinuria,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU at 7.00 a.m,,,D,,,,209196.0,6.0,IU,Solution for injection,,2022,Q1,Asthenia,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU at 7.00 a.m,,,D,,,,209196.0,6.0,IU,Solution for injection,,2022,Q1,Headache,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU at 7.00 a.m,,,D,,,,209196.0,6.0,IU,Solution for injection,,2022,Q1,Anxiety,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU at 7.00 a.m,,,D,,,,209196.0,6.0,IU,Solution for injection,,2022,Q1,Irritability,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU at 7.00 a.m,,,D,,,,209196.0,6.0,IU,Solution for injection,,2022,Q1,Exposure during pregnancy,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU at 7.00 a.m,,,D,,,,209196.0,6.0,IU,Solution for injection,,2022,Q1,Tachycardia,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 IU at 7.00 a.m,,,D,,,,209196.0,6.0,IU,Solution for injection,,2022,Q1,Condition aggravated,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU at 06.00 p.m,,,D,,,,209196.0,10.0,IU,Solution for injection,,2022,Q1,Hypokalaemia,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU at 06.00 p.m,,,D,,,,209196.0,10.0,IU,Solution for injection,,2022,Q1,Hypertensive crisis,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU at 06.00 p.m,,,D,,,,209196.0,10.0,IU,Solution for injection,,2022,Q1,Phaeochromocytoma crisis,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU at 06.00 p.m,,,D,,,,209196.0,10.0,IU,Solution for injection,,2022,Q1,Proteinuria,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU at 06.00 p.m,,,D,,,,209196.0,10.0,IU,Solution for injection,,2022,Q1,Asthenia,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU at 06.00 p.m,,,D,,,,209196.0,10.0,IU,Solution for injection,,2022,Q1,Headache,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU at 06.00 p.m,,,D,,,,209196.0,10.0,IU,Solution for injection,,2022,Q1,Anxiety,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU at 06.00 p.m,,,D,,,,209196.0,10.0,IU,Solution for injection,,2022,Q1,Irritability,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU at 06.00 p.m,,,D,,,,209196.0,10.0,IU,Solution for injection,,2022,Q1,Exposure during pregnancy,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU at 06.00 p.m,,,D,,,,209196.0,10.0,IU,Solution for injection,,2022,Q1,Tachycardia,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
195909903,19590990,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 IU at 06.00 p.m,,,D,,,,209196.0,10.0,IU,Solution for injection,,2022,Q1,Condition aggravated,,2022,Q1,3,F,,20220124.0,20210721,20220128,EXP,,IT-SA-2021SA173822,SANOFI AVENTIS,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, et al.. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency.. Blood Press.. 2021;30(5):322-6",33.0,YR,A,F,Y,,,20220128,,MD,IT,IT,2022,Q1,Young Adult
196185633,19618563,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q1,Drug ineffective,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q1,Weight increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q1,Drug ineffective,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q1,Weight increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q1,Drug ineffective,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q1,Weight increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Drug ineffective,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Weight increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Drug ineffective,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Weight increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Drug ineffective,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Weight increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Drug ineffective,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q1,Weight increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q1,Drug ineffective,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q1,Weight increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q1,Drug ineffective,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196185633,19618563,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q1,Weight increased,,2022,Q1,3,F,20220101.0,20220126.0,20210728,20220202,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220202,,CN,US,US,2022,Q1,Elderly
196384485,19638448,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Acute respiratory failure,,2022,Q1,5,F,20210319.0,20220322.0,20210729,20220324,EXP,,US-GILEAD-2021-0526296,GILEAD,,49.0,YR,A,F,Y,,,20220324,,MD,US,US,2022,Q1,Adult
196384485,19638448,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Pulmonary embolism,,2022,Q1,5,F,20210319.0,20220322.0,20210729,20220324,EXP,,US-GILEAD-2021-0526296,GILEAD,,49.0,YR,A,F,Y,,,20220324,,MD,US,US,2022,Q1,Adult
196852648,19685264,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,"45 units, od",,,,,,,,,,,QD,2022,Q1,Portal hypertension,,2022,Q1,8,F,20201117.0,20220203.0,20210811,20220211,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005089,AEGERION,,41.0,YR,,F,Y,60.3,KG,20220211,,MD,US,US,2022,Q1,Adult
196852648,19685264,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,"45 units, od",,,,,,,,,,,QD,2022,Q1,Aortic valve incompetence,,2022,Q1,8,F,20201117.0,20220203.0,20210811,20220211,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005089,AEGERION,,41.0,YR,,F,Y,60.3,KG,20220211,,MD,US,US,2022,Q1,Adult
196852648,19685264,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,"45 units, od",,,,,,,,,,,QD,2022,Q1,Hospitalisation,,2022,Q1,8,F,20201117.0,20220203.0,20210811,20220211,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005089,AEGERION,,41.0,YR,,F,Y,60.3,KG,20220211,,MD,US,US,2022,Q1,Adult
196852648,19685264,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,"45 units, od",,,,,,,,,,,QD,2022,Q1,Endotracheal intubation,,2022,Q1,8,F,20201117.0,20220203.0,20210811,20220211,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005089,AEGERION,,41.0,YR,,F,Y,60.3,KG,20220211,,MD,US,US,2022,Q1,Adult
196852648,19685264,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,"45 units, od",,,,,,,,,,,QD,2022,Q1,Endocarditis,,2022,Q1,8,F,20201117.0,20220203.0,20210811,20220211,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005089,AEGERION,,41.0,YR,,F,Y,60.3,KG,20220211,,MD,US,US,2022,Q1,Adult
196852648,19685264,29,C,INSULIN LISPRO,INSULIN LISPRO,1,,"45 units, od",,,,,,,,,,,QD,2022,Q1,Palpitations,,2022,Q1,8,F,20201117.0,20220203.0,20210811,20220211,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005089,AEGERION,,41.0,YR,,F,Y,60.3,KG,20220211,,MD,US,US,2022,Q1,Adult
196852648,19685264,30,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"75 units, qd",,,,,,,,,,,QD,2022,Q1,Portal hypertension,,2022,Q1,8,F,20201117.0,20220203.0,20210811,20220211,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005089,AEGERION,,41.0,YR,,F,Y,60.3,KG,20220211,,MD,US,US,2022,Q1,Adult
196852648,19685264,30,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"75 units, qd",,,,,,,,,,,QD,2022,Q1,Aortic valve incompetence,,2022,Q1,8,F,20201117.0,20220203.0,20210811,20220211,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005089,AEGERION,,41.0,YR,,F,Y,60.3,KG,20220211,,MD,US,US,2022,Q1,Adult
196852648,19685264,30,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"75 units, qd",,,,,,,,,,,QD,2022,Q1,Hospitalisation,,2022,Q1,8,F,20201117.0,20220203.0,20210811,20220211,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005089,AEGERION,,41.0,YR,,F,Y,60.3,KG,20220211,,MD,US,US,2022,Q1,Adult
196852648,19685264,30,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"75 units, qd",,,,,,,,,,,QD,2022,Q1,Endotracheal intubation,,2022,Q1,8,F,20201117.0,20220203.0,20210811,20220211,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005089,AEGERION,,41.0,YR,,F,Y,60.3,KG,20220211,,MD,US,US,2022,Q1,Adult
196852648,19685264,30,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"75 units, qd",,,,,,,,,,,QD,2022,Q1,Endocarditis,,2022,Q1,8,F,20201117.0,20220203.0,20210811,20220211,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005089,AEGERION,,41.0,YR,,F,Y,60.3,KG,20220211,,MD,US,US,2022,Q1,Adult
196852648,19685264,30,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"75 units, qd",,,,,,,,,,,QD,2022,Q1,Palpitations,,2022,Q1,8,F,20201117.0,20220203.0,20210811,20220211,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005089,AEGERION,,41.0,YR,,F,Y,60.3,KG,20220211,,MD,US,US,2022,Q1,Adult
197444333,19744433,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q1,Drug ineffective,,2022,Q1,3,F,,20211112.0,20210825,20220207,PER,,US-PFIZER INC-2021713377,PFIZER,,57.0,YR,,F,Y,,,20220207,,CN,US,US,2022,Q1,Adult
197444333,19744433,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q1,Arthralgia,,2022,Q1,3,F,,20211112.0,20210825,20220207,PER,,US-PFIZER INC-2021713377,PFIZER,,57.0,YR,,F,Y,,,20220207,,CN,US,US,2022,Q1,Adult
197740755,19774075,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 units/ml,,,,,,,,,,,,2022,Q1,Injection site scar,Injection site scar,2022,Q1,5,F,20210301.0,20220308.0,20210901,20220323,EXP,,"US-Ipsen Biopharmaceuticals, Inc.-2021-21106",IPSEN,,60.0,YR,A,F,Y,108.0,KG,20220323,,MD,US,US,2022,Q1,Adult
197740755,19774075,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 units/ml,,,,,,,,,,,,2022,Q1,Abdominal pain upper,Abdominal pain upper,2022,Q1,5,F,20210301.0,20220308.0,20210901,20220323,EXP,,"US-Ipsen Biopharmaceuticals, Inc.-2021-21106",IPSEN,,60.0,YR,A,F,Y,108.0,KG,20220323,,MD,US,US,2022,Q1,Adult
197740755,19774075,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 units/ml,,,,,,,,,,,,2022,Q1,Disease progression,,2022,Q1,5,F,20210301.0,20220308.0,20210901,20220323,EXP,,"US-Ipsen Biopharmaceuticals, Inc.-2021-21106",IPSEN,,60.0,YR,A,F,Y,108.0,KG,20220323,,MD,US,US,2022,Q1,Adult
197740755,19774075,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 units/ml,,,,,,,,,,,,2022,Q1,Feeding intolerance,Feeding intolerance,2022,Q1,5,F,20210301.0,20220308.0,20210901,20220323,EXP,,"US-Ipsen Biopharmaceuticals, Inc.-2021-21106",IPSEN,,60.0,YR,A,F,Y,108.0,KG,20220323,,MD,US,US,2022,Q1,Adult
197740755,19774075,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 units/ml,,,,,,,,,,,,2022,Q1,Injection site mass,,2022,Q1,5,F,20210301.0,20220308.0,20210901,20220323,EXP,,"US-Ipsen Biopharmaceuticals, Inc.-2021-21106",IPSEN,,60.0,YR,A,F,Y,108.0,KG,20220323,,MD,US,US,2022,Q1,Adult
197740755,19774075,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 units/ml,,,,,,,,,,,,2022,Q1,Injection site haemorrhage,Injection site haemorrhage,2022,Q1,5,F,20210301.0,20220308.0,20210901,20220323,EXP,,"US-Ipsen Biopharmaceuticals, Inc.-2021-21106",IPSEN,,60.0,YR,A,F,Y,108.0,KG,20220323,,MD,US,US,2022,Q1,Adult
197744422,19774442,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,,,D058036A,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20210801.0,20220221.0,20210901,20220227,PER,,US-ELI_LILLY_AND_COMPANY-US202108009249,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220227,,CN,US,US,2022,Q1,Elderly
197744422,19774442,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,,,D058036A,,20563.0,,,Injection,,2022,Q1,Diabetes mellitus,,2022,Q1,2,F,20210801.0,20220221.0,20210901,20220227,PER,,US-ELI_LILLY_AND_COMPANY-US202108009249,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220227,,CN,US,US,2022,Q1,Elderly
197744422,19774442,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,,,D058036A,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20210801.0,20220221.0,20210901,20220227,PER,,US-ELI_LILLY_AND_COMPANY-US202108009249,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220227,,CN,US,US,2022,Q1,Elderly
197744422,19774442,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, daily",,,,,,,20563.0,20.0,IU,Injection,QD,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20210801.0,20220221.0,20210901,20220227,PER,,US-ELI_LILLY_AND_COMPANY-US202108009249,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220227,,CN,US,US,2022,Q1,Elderly
197744422,19774442,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, daily",,,,,,,20563.0,20.0,IU,Injection,QD,2022,Q1,Diabetes mellitus,,2022,Q1,2,F,20210801.0,20220221.0,20210901,20220227,PER,,US-ELI_LILLY_AND_COMPANY-US202108009249,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220227,,CN,US,US,2022,Q1,Elderly
197744422,19774442,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, daily",,,,,,,20563.0,20.0,IU,Injection,QD,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20210801.0,20220221.0,20210901,20220227,PER,,US-ELI_LILLY_AND_COMPANY-US202108009249,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220227,,CN,US,US,2022,Q1,Elderly
197744422,19774442,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, daily",,,,,,,20563.0,20.0,IU,Injection,QD,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20210801.0,20220221.0,20210901,20220227,PER,,US-ELI_LILLY_AND_COMPANY-US202108009249,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220227,,CN,US,US,2022,Q1,Elderly
197744422,19774442,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, daily",,,,,,,20563.0,20.0,IU,Injection,QD,2022,Q1,Diabetes mellitus,,2022,Q1,2,F,20210801.0,20220221.0,20210901,20220227,PER,,US-ELI_LILLY_AND_COMPANY-US202108009249,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220227,,CN,US,US,2022,Q1,Elderly
197744422,19774442,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, daily",,,,,,,20563.0,20.0,IU,Injection,QD,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20210801.0,20220221.0,20210901,20220227,PER,,US-ELI_LILLY_AND_COMPANY-US202108009249,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220227,,CN,US,US,2022,Q1,Elderly
197744422,19774442,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, daily",,,,,D395986A,,20563.0,20.0,IU,Injection,QD,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20210801.0,20220221.0,20210901,20220227,PER,,US-ELI_LILLY_AND_COMPANY-US202108009249,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220227,,CN,US,US,2022,Q1,Elderly
197744422,19774442,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, daily",,,,,D395986A,,20563.0,20.0,IU,Injection,QD,2022,Q1,Diabetes mellitus,,2022,Q1,2,F,20210801.0,20220221.0,20210901,20220227,PER,,US-ELI_LILLY_AND_COMPANY-US202108009249,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220227,,CN,US,US,2022,Q1,Elderly
197744422,19774442,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, daily",,,,,D395986A,,20563.0,20.0,IU,Injection,QD,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20210801.0,20220221.0,20210901,20220227,PER,,US-ELI_LILLY_AND_COMPANY-US202108009249,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220227,,CN,US,US,2022,Q1,Elderly
197938935,19793893,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 unit/ml, 3 ml",,,,,,,,1.0,IU,,Q8H,2022,Q1,Acute kidney injury,,2022,Q1,5,F,20210811.0,20220129.0,20210907,20220205,EXP,,ES-EMD Serono-9262879,EMD SERONO INC,,87.0,YR,E,M,Y,72.0,KG,20220205,,HP,ES,,2022,Q1,Elderly
197966116,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Cytokine release syndrome,,2022,Q1,6,F,20210815.0,20220120.0,20210907,20220125,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20220125,,MD,US,US,2022,Q1,Adult
197966116,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Deep vein thrombosis,,2022,Q1,6,F,20210815.0,20220120.0,20210907,20220125,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20220125,,MD,US,US,2022,Q1,Adult
197966116,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Pulmonary mass,,2022,Q1,6,F,20210815.0,20220120.0,20210907,20220125,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20220125,,MD,US,US,2022,Q1,Adult
197966116,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Decreased appetite,,2022,Q1,6,F,20210815.0,20220120.0,20210907,20220125,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20220125,,MD,US,US,2022,Q1,Adult
197966116,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Tachycardia,,2022,Q1,6,F,20210815.0,20220120.0,20210907,20220125,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20220125,,MD,US,US,2022,Q1,Adult
197966116,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Thrombocytopenia,,2022,Q1,6,F,20210815.0,20220120.0,20210907,20220125,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20220125,,MD,US,US,2022,Q1,Adult
197966116,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Thrombophlebitis,,2022,Q1,6,F,20210815.0,20220120.0,20210907,20220125,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20220125,,MD,US,US,2022,Q1,Adult
197966116,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Pyrexia,,2022,Q1,6,F,20210815.0,20220120.0,20210907,20220125,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20220125,,MD,US,US,2022,Q1,Adult
197966116,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Haemoptysis,,2022,Q1,6,F,20210815.0,20220120.0,20210907,20220125,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20220125,,MD,US,US,2022,Q1,Adult
197966116,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Septic shock,,2022,Q1,6,F,20210815.0,20220120.0,20210907,20220125,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20220125,,MD,US,US,2022,Q1,Adult
197966116,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Febrile neutropenia,,2022,Q1,6,F,20210815.0,20220120.0,20210907,20220125,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20220125,,MD,US,US,2022,Q1,Adult
197966116,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Sepsis,,2022,Q1,6,F,20210815.0,20220120.0,20210907,20220125,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20220125,,MD,US,US,2022,Q1,Adult
197966116,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Hypotension,,2022,Q1,6,F,20210815.0,20220120.0,20210907,20220125,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20220125,,MD,US,US,2022,Q1,Adult
197966116,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Asthenia,,2022,Q1,6,F,20210815.0,20220120.0,20210907,20220125,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20220125,,MD,US,US,2022,Q1,Adult
197966116,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Nausea,,2022,Q1,6,F,20210815.0,20220120.0,20210907,20220125,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20220125,,MD,US,US,2022,Q1,Adult
197966116,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Pleural effusion,,2022,Q1,6,F,20210815.0,20220120.0,20210907,20220125,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20220125,,MD,US,US,2022,Q1,Adult
197966116,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Hypoxia,,2022,Q1,6,F,20210815.0,20220120.0,20210907,20220125,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20220125,,MD,US,US,2022,Q1,Adult
198012503,19801250,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Sliding scale 0-8 units with meals,,,D,,,,,,,,,2022,Q1,Pneumonia,,2022,Q1,3,F,20210723.0,20220113.0,20210907,20220117,EXP,,NVSC2021US202125,NOVARTIS,,40.0,YR,,M,Y,90.4,KG,20220117,,MD,US,US,2022,Q1,Adult
198354944,19835494,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,UNK,,,,,,,,,,,,2022,Q1,Foetal heart rate deceleration abnormality,,2022,Q1,4,F,20210502.0,20220303.0,20210914,20220314,EXP,,US-GILEAD-2021-0547906,GILEAD,,0.0,YR,,,Y,,,20220314,,HP,US,US,2022,Q1,Child
198354944,19835494,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,UNK,,,,,,,,,,,,2022,Q1,Foetal macrosomia,,2022,Q1,4,F,20210502.0,20220303.0,20210914,20220314,EXP,,US-GILEAD-2021-0547906,GILEAD,,0.0,YR,,,Y,,,20220314,,HP,US,US,2022,Q1,Child
198354944,19835494,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,UNK,,,,,,,,,,,,2022,Q1,Foetal exposure during pregnancy,,2022,Q1,4,F,20210502.0,20220303.0,20210914,20220314,EXP,,US-GILEAD-2021-0547906,GILEAD,,0.0,YR,,,Y,,,20220314,,HP,US,US,2022,Q1,Child
198546784,19854678,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, Q8H (100 unit/ml, 3 ml)",,,U,,,,,1.0,IU,,Q8H,2022,Q1,Acute kidney injury,,2022,Q1,4,F,20210811.0,20220209.0,20210920,20220212,EXP,,NVSC2021ES207531,NOVARTIS,,87.0,YR,,M,Y,72.0,KG,20220212,,HP,ES,ES,2022,Q1,Elderly
198649844,19864984,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, 3 Times a Day(100 unit/ml, 3 ml)",,,U,,,,,1.0,IU,,TID,2022,Q1,Acute kidney injury,,2022,Q1,4,F,20210811.0,20220207.0,20210922,20220219,EXP,,ES-AUROBINDO-AUR-APL-2021-039219,AUROBINDO,,87.0,YR,,M,Y,72.0,KG,20220219,,HP,ES,ES,2022,Q1,Elderly
198651736,19865173,75,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Encephalopathy,,2022,Q1,6,F,20210812.0,20220222.0,20210921,20220307,EXP,,US-GILEAD-2021-0545614,GILEAD,,70.0,YR,E,M,Y,,,20220307,,HP,US,US,2022,Q1,Elderly
198651736,19865173,75,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Bacteraemia,,2022,Q1,6,F,20210812.0,20220222.0,20210921,20220307,EXP,,US-GILEAD-2021-0545614,GILEAD,,70.0,YR,E,M,Y,,,20220307,,HP,US,US,2022,Q1,Elderly
198651736,19865173,75,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Fungaemia,,2022,Q1,6,F,20210812.0,20220222.0,20210921,20220307,EXP,,US-GILEAD-2021-0545614,GILEAD,,70.0,YR,E,M,Y,,,20220307,,HP,US,US,2022,Q1,Elderly
198651736,19865173,75,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Cytomegalovirus viraemia,,2022,Q1,6,F,20210812.0,20220222.0,20210921,20220307,EXP,,US-GILEAD-2021-0545614,GILEAD,,70.0,YR,E,M,Y,,,20220307,,HP,US,US,2022,Q1,Elderly
198651736,19865173,75,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Opportunistic infection,,2022,Q1,6,F,20210812.0,20220222.0,20210921,20220307,EXP,,US-GILEAD-2021-0545614,GILEAD,,70.0,YR,E,M,Y,,,20220307,,HP,US,US,2022,Q1,Elderly
198653532,19865353,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 unit/ml, 3 ml",,,,,,,,,,,Q8H,2022,Q1,Acute kidney injury,,2022,Q1,2,F,20210811.0,20220209.0,20210922,20220218,EXP,,ES-BAUSCH-BL-2021-031580,BAUSCH AND LOMB,,87.0,YR,,M,Y,72.0,KG,20220218,,HP,ES,ES,2022,Q1,Elderly
198805303,19880530,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 international unit, tid",,,,,,,,10.0,IU,,TID,2022,Q1,Febrile neutropenia,,2022,Q1,3,F,20210904.0,20220125.0,20210924,20220127,EXP,,US-TAKEDA-2021TUS057379,TAKEDA,,67.0,YR,,M,Y,97.6,KG,20220127,,MD,US,US,2022,Q1,Elderly
198886924,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q1,Abdominal pain upper,,2022,Q1,4,F,,20220114.0,20210928,20220121,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220121,,CN,CA,CA,2022,Q1,Adult
198886924,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q1,Diarrhoea,,2022,Q1,4,F,,20220114.0,20210928,20220121,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220121,,CN,CA,CA,2022,Q1,Adult
198886924,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q1,Myalgia,,2022,Q1,4,F,,20220114.0,20210928,20220121,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220121,,CN,CA,CA,2022,Q1,Adult
198886924,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q1,Multi-organ disorder,,2022,Q1,4,F,,20220114.0,20210928,20220121,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220121,,CN,CA,CA,2022,Q1,Adult
198886924,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q1,Weight decreased,,2022,Q1,4,F,,20220114.0,20210928,20220121,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220121,,CN,CA,CA,2022,Q1,Adult
198886924,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q1,Pulmonary oedema,,2022,Q1,4,F,,20220114.0,20210928,20220121,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220121,,CN,CA,CA,2022,Q1,Adult
198886924,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q1,Pericardial effusion,,2022,Q1,4,F,,20220114.0,20210928,20220121,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220121,,CN,CA,CA,2022,Q1,Adult
198886924,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q1,Malnutrition,,2022,Q1,4,F,,20220114.0,20210928,20220121,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220121,,CN,CA,CA,2022,Q1,Adult
198886924,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q1,Chest pain,,2022,Q1,4,F,,20220114.0,20210928,20220121,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220121,,CN,CA,CA,2022,Q1,Adult
198886924,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q1,Arthritis,,2022,Q1,4,F,,20220114.0,20210928,20220121,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220121,,CN,CA,CA,2022,Q1,Adult
198886924,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q1,Eye haemorrhage,,2022,Q1,4,F,,20220114.0,20210928,20220121,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220121,,CN,CA,CA,2022,Q1,Adult
198886924,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q1,Neuropathy peripheral,,2022,Q1,4,F,,20220114.0,20210928,20220121,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220121,,CN,CA,CA,2022,Q1,Adult
198886924,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q1,Blood glucose increased,,2022,Q1,4,F,,20220114.0,20210928,20220121,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220121,,CN,CA,CA,2022,Q1,Adult
198886924,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q1,Cardiac failure congestive,,2022,Q1,4,F,,20220114.0,20210928,20220121,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220121,,CN,CA,CA,2022,Q1,Adult
198886924,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q1,Thyroid disorder,,2022,Q1,4,F,,20220114.0,20210928,20220121,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220121,,CN,CA,CA,2022,Q1,Adult
198886924,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q1,Headache,,2022,Q1,4,F,,20220114.0,20210928,20220121,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220121,,CN,CA,CA,2022,Q1,Adult
198902892,19890289,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, bid (100 U/mL Once after meals and at bedtime)",,,,,,,,,,,BID,2022,Q1,Myopathy,,2022,Q1,2,F,,20211223.0,20210928,20220103,EXP,,US-LUPIN PHARMACEUTICALS INC.-2021-18089,LUPIN,"Paramanathan P, Abbas M, Valchev P, Itua P, Taravati. A case of statin-induced myopathy. Consultant. 2021;61(5):e3-e5",79.0,YR,,M,Y,,,20220103,,HP,US,US,2022,Q1,Elderly
198977742,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q1,Therapeutic product effect incomplete,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q1,Weight increased,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q1,Diaphragmatic disorder,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q1,Pyrexia,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q1,Asthma,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q1,Oropharyngeal pain,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q1,Wheezing,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q1,Oedema peripheral,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q1,Full blood count abnormal,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q1,Obstructive airways disorder,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q1,Left ventricular hypertrophy,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q1,Cough,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q1,Discomfort,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q1,Hypoxia,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q1,Chest discomfort,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q1,Dyspnoea,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2022,Q1,Therapeutic product effect incomplete,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2022,Q1,Weight increased,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2022,Q1,Diaphragmatic disorder,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2022,Q1,Pyrexia,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2022,Q1,Asthma,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2022,Q1,Oropharyngeal pain,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2022,Q1,Wheezing,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2022,Q1,Oedema peripheral,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2022,Q1,Full blood count abnormal,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2022,Q1,Obstructive airways disorder,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2022,Q1,Left ventricular hypertrophy,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2022,Q1,Cough,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2022,Q1,Discomfort,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2022,Q1,Hypoxia,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2022,Q1,Chest discomfort,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
198977742,19897774,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,U,,,,,,,,Q12H,2022,Q1,Dyspnoea,,2022,Q1,2,F,,20220209.0,20210930,20220215,EXP,,CA-SA-2021SA317702,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220215,,HP,CA,CA,2022,Q1,Elderly
199560383,19956038,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Drug interaction,,2022,Q1,3,F,20210202.0,20220207.0,20211014,20220210,EXP,IT-MINISAL02-796107,NVSC2021IT234137,NOVARTIS,,75.0,YR,,M,Y,,,20220210,,HP,IT,IT,2022,Q1,Elderly
199560383,19956038,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Haematoma muscle,,2022,Q1,3,F,20210202.0,20220207.0,20211014,20220210,EXP,IT-MINISAL02-796107,NVSC2021IT234137,NOVARTIS,,75.0,YR,,M,Y,,,20220210,,HP,IT,IT,2022,Q1,Elderly
200000704,20000070,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,UNKNOWN,,,,,Injection,,2022,Q1,Colitis,,2022,Q1,4,F,20210823.0,20220112.0,20211027,20220124,EXP,,JP-ROCHE-2940068,ROCHE,,60.0,YR,,F,Y,58.1,KG,20220124,,MD,JP,JP,2022,Q1,Adult
200081352,20008135,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Dermatitis atopic,,2022,Q1,2,F,20210101.0,20220110.0,20211029,20220117,PER,,US-SA-2021SA352588,SANOFI AVENTIS,,66.0,YR,E,M,Y,,,20220117,,MD,US,US,2022,Q1,Elderly
200216712,20021671,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 unit/ml, 3 ml",,,,,,,,1.0,IU,,Q8H,2022,Q1,Acute kidney injury,,2022,Q1,2,F,20210811.0,20220209.0,20211101,20220216,EXP,,"ES-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-126575",BOEHRINGER INGELHEIM,,87.0,YR,E,M,Y,72.0,KG,20220216,,HP,ES,ES,2022,Q1,Elderly
200620362,20062036,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,with meals,,,U,U,,,,,,,,2022,Q1,Hypoglycaemia,,2022,Q1,2,F,,20220223.0,20211112,20220302,EXP,,US-MYLANLABS-2021M1083768,MYLAN,"Sasidharan Pillai S, Quintos JB, Topor LS. Acute Hepatitis due to Hepatic Glycogenosis after Insulin Overdose and Oral Glucose Administration in an Adolescent. J-Endocr-Soc 2021;5(11):1-6.",16.0,YR,,M,Y,,,20220302,,MD,US,US,2022,Q1,Youth
200620362,20062036,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,with meals,,,U,U,,,,,,,,2022,Q1,Hepatitis acute,,2022,Q1,2,F,,20220223.0,20211112,20220302,EXP,,US-MYLANLABS-2021M1083768,MYLAN,"Sasidharan Pillai S, Quintos JB, Topor LS. Acute Hepatitis due to Hepatic Glycogenosis after Insulin Overdose and Oral Glucose Administration in an Adolescent. J-Endocr-Soc 2021;5(11):1-6.",16.0,YR,,M,Y,,,20220302,,MD,US,US,2022,Q1,Youth
200620362,20062036,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,with meals,,,U,U,,,,,,,,2022,Q1,Glycogen storage disease type VIII,,2022,Q1,2,F,,20220223.0,20211112,20220302,EXP,,US-MYLANLABS-2021M1083768,MYLAN,"Sasidharan Pillai S, Quintos JB, Topor LS. Acute Hepatitis due to Hepatic Glycogenosis after Insulin Overdose and Oral Glucose Administration in an Adolescent. J-Endocr-Soc 2021;5(11):1-6.",16.0,YR,,M,Y,,,20220302,,MD,US,US,2022,Q1,Youth
200620362,20062036,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,with meals,,,U,U,,,,,,,,2022,Q1,Overdose,,2022,Q1,2,F,,20220223.0,20211112,20220302,EXP,,US-MYLANLABS-2021M1083768,MYLAN,"Sasidharan Pillai S, Quintos JB, Topor LS. Acute Hepatitis due to Hepatic Glycogenosis after Insulin Overdose and Oral Glucose Administration in an Adolescent. J-Endocr-Soc 2021;5(11):1-6.",16.0,YR,,M,Y,,,20220302,,MD,US,US,2022,Q1,Youth
200788082,20078808,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, each morning",,,,,,,20563.0,15.0,IU,Injection,QD,2022,Q1,Incorrect dose administered,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, each morning",,,,,,,20563.0,15.0,IU,Injection,QD,2022,Q1,Sinusitis,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, each morning",,,,,,,20563.0,15.0,IU,Injection,QD,2022,Q1,Hyperglycaemia,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, each morning",,,,,,,20563.0,15.0,IU,Injection,QD,2022,Q1,Incorrect dose administered,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, each morning",,,,,,,20563.0,15.0,IU,Injection,QD,2022,Q1,Sinusitis,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, each morning",,,,,,,20563.0,15.0,IU,Injection,QD,2022,Q1,Hyperglycaemia,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, each morning",,,,,D379507A,,20563.0,15.0,IU,Injection,QD,2022,Q1,Incorrect dose administered,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, each morning",,,,,D379507A,,20563.0,15.0,IU,Injection,QD,2022,Q1,Sinusitis,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, each morning",,,,,D379507A,,20563.0,15.0,IU,Injection,QD,2022,Q1,Hyperglycaemia,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, each morning",,,,,D379507A,,20563.0,15.0,IU,Injection,QD,2022,Q1,Incorrect dose administered,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, each morning",,,,,D379507A,,20563.0,15.0,IU,Injection,QD,2022,Q1,Sinusitis,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, each morning",,,,,D379507A,,20563.0,15.0,IU,Injection,QD,2022,Q1,Hyperglycaemia,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 u, daily (at lunch)",,,,,,,20563.0,25.0,IU,Injection,QD,2022,Q1,Incorrect dose administered,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 u, daily (at lunch)",,,,,,,20563.0,25.0,IU,Injection,QD,2022,Q1,Sinusitis,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 u, daily (at lunch)",,,,,,,20563.0,25.0,IU,Injection,QD,2022,Q1,Hyperglycaemia,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 u, daily (at lunch)",,,,,,,20563.0,25.0,IU,Injection,QD,2022,Q1,Incorrect dose administered,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 u, daily (at lunch)",,,,,,,20563.0,25.0,IU,Injection,QD,2022,Q1,Sinusitis,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 u, daily (at lunch)",,,,,,,20563.0,25.0,IU,Injection,QD,2022,Q1,Hyperglycaemia,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 u, daily (at lunch)",,,,,D379507A,,20563.0,25.0,IU,Injection,QD,2022,Q1,Incorrect dose administered,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 u, daily (at lunch)",,,,,D379507A,,20563.0,25.0,IU,Injection,QD,2022,Q1,Sinusitis,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 u, daily (at lunch)",,,,,D379507A,,20563.0,25.0,IU,Injection,QD,2022,Q1,Hyperglycaemia,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 u, daily (at lunch)",,,,,D379507A,,20563.0,25.0,IU,Injection,QD,2022,Q1,Incorrect dose administered,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 u, daily (at lunch)",,,,,D379507A,,20563.0,25.0,IU,Injection,QD,2022,Q1,Sinusitis,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 u, daily (at lunch)",,,,,D379507A,,20563.0,25.0,IU,Injection,QD,2022,Q1,Hyperglycaemia,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, daily (at dinner)",,,,,D379507A,,20563.0,40.0,IU,Injection,QD,2022,Q1,Incorrect dose administered,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, daily (at dinner)",,,,,D379507A,,20563.0,40.0,IU,Injection,QD,2022,Q1,Sinusitis,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, daily (at dinner)",,,,,D379507A,,20563.0,40.0,IU,Injection,QD,2022,Q1,Hyperglycaemia,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, daily (at dinner)",,,,,D379507A,,20563.0,40.0,IU,Injection,QD,2022,Q1,Incorrect dose administered,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, daily (at dinner)",,,,,D379507A,,20563.0,40.0,IU,Injection,QD,2022,Q1,Sinusitis,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, daily (at dinner)",,,,,D379507A,,20563.0,40.0,IU,Injection,QD,2022,Q1,Hyperglycaemia,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, daily (at dinner)",,,,,,,20563.0,40.0,IU,Injection,QD,2022,Q1,Incorrect dose administered,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, daily (at dinner)",,,,,,,20563.0,40.0,IU,Injection,QD,2022,Q1,Sinusitis,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, daily (at dinner)",,,,,,,20563.0,40.0,IU,Injection,QD,2022,Q1,Hyperglycaemia,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, daily (at dinner)",,,,,,,20563.0,40.0,IU,Injection,QD,2022,Q1,Incorrect dose administered,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, daily (at dinner)",,,,,,,20563.0,40.0,IU,Injection,QD,2022,Q1,Sinusitis,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200788082,20078808,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, daily (at dinner)",,,,,,,20563.0,40.0,IU,Injection,QD,2022,Q1,Hyperglycaemia,,2022,Q1,2,F,20211001.0,20220214.0,20211117,20220217,EXP,,US-ELI_LILLY_AND_COMPANY-US202111004946,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220217,,MD,US,US,2022,Q1,Adult
200912752,20091275,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"8 international unit, bid short-acting basal-bolus 8 iU, BID (at breakfast and dinner)",,,Y,U,,,,8.0,IU,Injection,BID,2022,Q1,Weight increased,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"8 international unit, bid short-acting basal-bolus 8 iU, BID (at breakfast and dinner)",,,Y,U,,,,8.0,IU,Injection,BID,2022,Q1,Hyperglycaemia,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"8 international unit, bid short-acting basal-bolus 8 iU, BID (at breakfast and dinner)",,,Y,U,,,,8.0,IU,Injection,BID,2022,Q1,Obesity,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"8 international unit, bid short-acting basal-bolus 8 iU, BID (at breakfast and dinner)",,,Y,U,,,,8.0,IU,Injection,BID,2022,Q1,Hypoglycaemia,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"8 international unit, bid short-acting basal-bolus 8 iU, BID (at breakfast and dinner)",,,Y,U,,,,8.0,IU,Injection,BID,2022,Q1,Diabetes mellitus inadequate control,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"8 international unit, bid short-acting basal-bolus 8 iU, BID (at breakfast and dinner)",,,Y,U,,,,8.0,IU,Injection,BID,2022,Q1,Condition aggravated,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"8 international unit, bid short-acting basal-bolus 8 iU, BID (at breakfast and dinner)",,,Y,U,,,,8.0,IU,Injection,BID,2022,Q1,Increased appetite,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"8 international unit, bid short-acting basal-bolus 8 iU, BID (at breakfast and dinner)",,,Y,U,,,,8.0,IU,Injection,BID,2022,Q1,Metabolic syndrome,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"15 international unit, qd (at lunch)",,,Y,U,,,,15.0,IU,Injection,QD,2022,Q1,Weight increased,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"15 international unit, qd (at lunch)",,,Y,U,,,,15.0,IU,Injection,QD,2022,Q1,Hyperglycaemia,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"15 international unit, qd (at lunch)",,,Y,U,,,,15.0,IU,Injection,QD,2022,Q1,Obesity,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"15 international unit, qd (at lunch)",,,Y,U,,,,15.0,IU,Injection,QD,2022,Q1,Hypoglycaemia,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"15 international unit, qd (at lunch)",,,Y,U,,,,15.0,IU,Injection,QD,2022,Q1,Diabetes mellitus inadequate control,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"15 international unit, qd (at lunch)",,,Y,U,,,,15.0,IU,Injection,QD,2022,Q1,Condition aggravated,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"15 international unit, qd (at lunch)",,,Y,U,,,,15.0,IU,Injection,QD,2022,Q1,Increased appetite,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"15 international unit, qd (at lunch)",,,Y,U,,,,15.0,IU,Injection,QD,2022,Q1,Metabolic syndrome,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,short-acting insulin dose was tapered,,,Y,U,,,,,,Injection,,2022,Q1,Weight increased,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,short-acting insulin dose was tapered,,,Y,U,,,,,,Injection,,2022,Q1,Hyperglycaemia,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,short-acting insulin dose was tapered,,,Y,U,,,,,,Injection,,2022,Q1,Obesity,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,short-acting insulin dose was tapered,,,Y,U,,,,,,Injection,,2022,Q1,Hypoglycaemia,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,short-acting insulin dose was tapered,,,Y,U,,,,,,Injection,,2022,Q1,Diabetes mellitus inadequate control,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,short-acting insulin dose was tapered,,,Y,U,,,,,,Injection,,2022,Q1,Condition aggravated,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,short-acting insulin dose was tapered,,,Y,U,,,,,,Injection,,2022,Q1,Increased appetite,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,short-acting insulin dose was tapered,,,Y,U,,,,,,Injection,,2022,Q1,Metabolic syndrome,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,increasing the doses of short-acting insulin at meals,,,Y,U,,,,,,Injection,,2022,Q1,Weight increased,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,increasing the doses of short-acting insulin at meals,,,Y,U,,,,,,Injection,,2022,Q1,Hyperglycaemia,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,increasing the doses of short-acting insulin at meals,,,Y,U,,,,,,Injection,,2022,Q1,Obesity,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,increasing the doses of short-acting insulin at meals,,,Y,U,,,,,,Injection,,2022,Q1,Hypoglycaemia,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,increasing the doses of short-acting insulin at meals,,,Y,U,,,,,,Injection,,2022,Q1,Diabetes mellitus inadequate control,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,increasing the doses of short-acting insulin at meals,,,Y,U,,,,,,Injection,,2022,Q1,Condition aggravated,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,increasing the doses of short-acting insulin at meals,,,Y,U,,,,,,Injection,,2022,Q1,Increased appetite,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,increasing the doses of short-acting insulin at meals,,,Y,U,,,,,,Injection,,2022,Q1,Metabolic syndrome,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 international unit, qd (at breakfast)",,,Y,U,,,,8.0,IU,Injection,QD,2022,Q1,Weight increased,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 international unit, qd (at breakfast)",,,Y,U,,,,8.0,IU,Injection,QD,2022,Q1,Hyperglycaemia,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 international unit, qd (at breakfast)",,,Y,U,,,,8.0,IU,Injection,QD,2022,Q1,Obesity,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 international unit, qd (at breakfast)",,,Y,U,,,,8.0,IU,Injection,QD,2022,Q1,Hypoglycaemia,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 international unit, qd (at breakfast)",,,Y,U,,,,8.0,IU,Injection,QD,2022,Q1,Diabetes mellitus inadequate control,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 international unit, qd (at breakfast)",,,Y,U,,,,8.0,IU,Injection,QD,2022,Q1,Condition aggravated,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 international unit, qd (at breakfast)",,,Y,U,,,,8.0,IU,Injection,QD,2022,Q1,Increased appetite,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 international unit, qd (at breakfast)",,,Y,U,,,,8.0,IU,Injection,QD,2022,Q1,Metabolic syndrome,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15 international unit, qd (at dinner)",,,Y,U,,,,15.0,IU,Injection,QD,2022,Q1,Weight increased,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15 international unit, qd (at dinner)",,,Y,U,,,,15.0,IU,Injection,QD,2022,Q1,Hyperglycaemia,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15 international unit, qd (at dinner)",,,Y,U,,,,15.0,IU,Injection,QD,2022,Q1,Obesity,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15 international unit, qd (at dinner)",,,Y,U,,,,15.0,IU,Injection,QD,2022,Q1,Hypoglycaemia,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15 international unit, qd (at dinner)",,,Y,U,,,,15.0,IU,Injection,QD,2022,Q1,Diabetes mellitus inadequate control,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15 international unit, qd (at dinner)",,,Y,U,,,,15.0,IU,Injection,QD,2022,Q1,Condition aggravated,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15 international unit, qd (at dinner)",,,Y,U,,,,15.0,IU,Injection,QD,2022,Q1,Increased appetite,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200912752,20091275,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15 international unit, qd (at dinner)",,,Y,U,,,,15.0,IU,Injection,QD,2022,Q1,Metabolic syndrome,,2022,Q1,2,F,,20220308.0,20211119,20220316,EXP,,IT-MYLANLABS-2021M1084663,MYLAN,"Volpe S.; Tortorella C.; Solfrizzi V.; Piazzolla G... When inappropriate use of insulin is dangerous: The utility of c-peptide assay in the era of cardioprotective antidiabetic drugs. Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy. 2021;14:3517-3521",72.0,YR,,M,Y,,,20220316,,HP,IT,IT,2022,Q1,Elderly
200916454,20091645,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, q8h (start date: 17-Aug-2021) 100 unit/ml, 3 ml",,,,,,,,1.0,IU,Injection,Q8H,2022,Q1,Acute kidney injury,,2022,Q1,4,F,20210811.0,20220310.0,20211119,20220315,EXP,,ES-MYLANLABS-2021M1084633,MYLAN,,87.0,YR,,M,Y,72.0,KG,20220315,,HP,ES,ES,2022,Q1,Elderly
200958973,20095897,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"11 IU, BID",,,U,,,,,11.0,IU,Injection,BID,2022,Q1,Lip pain,,2022,Q1,3,F,20211104.0,20220314.0,20211122,20220318,EXP,,NVSJ2021JP018950,NOVARTIS,,74.0,YR,,M,Y,54.0,KG,20220318,,PH,JP,JP,2022,Q1,Elderly
200958973,20095897,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"11 IU, BID",,,U,,,,,11.0,IU,Injection,BID,2022,Q1,Skin haemorrhage,,2022,Q1,3,F,20211104.0,20220314.0,20211122,20220318,EXP,,NVSJ2021JP018950,NOVARTIS,,74.0,YR,,M,Y,54.0,KG,20220318,,PH,JP,JP,2022,Q1,Elderly
200958973,20095897,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"11 IU, BID",,,U,,,,,11.0,IU,Injection,BID,2022,Q1,Rash,,2022,Q1,3,F,20211104.0,20220314.0,20211122,20220318,EXP,,NVSJ2021JP018950,NOVARTIS,,74.0,YR,,M,Y,54.0,KG,20220318,,PH,JP,JP,2022,Q1,Elderly
200958973,20095897,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"11 IU, BID",,,U,,,,,11.0,IU,Injection,BID,2022,Q1,Skin erosion,,2022,Q1,3,F,20211104.0,20220314.0,20211122,20220318,EXP,,NVSJ2021JP018950,NOVARTIS,,74.0,YR,,M,Y,54.0,KG,20220318,,PH,JP,JP,2022,Q1,Elderly
200958973,20095897,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"11 IU, BID",,,U,,,,,11.0,IU,Injection,BID,2022,Q1,Lip blister,,2022,Q1,3,F,20211104.0,20220314.0,20211122,20220318,EXP,,NVSJ2021JP018950,NOVARTIS,,74.0,YR,,M,Y,54.0,KG,20220318,,PH,JP,JP,2022,Q1,Elderly
200958973,20095897,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"11 IU, BID",,,U,,,,,11.0,IU,Injection,BID,2022,Q1,Erythema multiforme,,2022,Q1,3,F,20211104.0,20220314.0,20211122,20220318,EXP,,NVSJ2021JP018950,NOVARTIS,,74.0,YR,,M,Y,54.0,KG,20220318,,PH,JP,JP,2022,Q1,Elderly
201190522,20119052,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Nausea,,2022,Q1,2,F,20210901.0,20220201.0,20211126,20220208,EXP,,"ES-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-139574",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,,,20220208,,CN,ES,ES,2022,Q1,Elderly
201190522,20119052,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Abdominal pain,,2022,Q1,2,F,20210901.0,20220201.0,20211126,20220208,EXP,,"ES-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-139574",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,,,20220208,,CN,ES,ES,2022,Q1,Elderly
201190522,20119052,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Idiopathic pulmonary fibrosis,,2022,Q1,2,F,20210901.0,20220201.0,20211126,20220208,EXP,,"ES-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-139574",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,,,20220208,,CN,ES,ES,2022,Q1,Elderly
201190522,20119052,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Diarrhoea,,2022,Q1,2,F,20210901.0,20220201.0,20211126,20220208,EXP,,"ES-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-139574",BOEHRINGER INGELHEIM,,70.0,YR,E,M,Y,,,20220208,,CN,ES,ES,2022,Q1,Elderly
201451274,20145127,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,209196.0,,,Solution for injection,,2022,Q1,Lipodystrophy acquired,,2022,Q1,4,F,20210429.0,20220117.0,20211203,20220128,PER,,SE-SA-2021SA402452,SANOFI AVENTIS,,19.0,YR,A,F,Y,,,20220128,,MD,US,SE,2022,Q1,Youth
201471672,20147167,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,COVID-19,,2022,Q1,2,F,20211101.0,20220204.0,20211203,20220214,PER,,US-SA-2021SA395167,SANOFI AVENTIS,,43.0,YR,A,F,Y,,,20220214,,MD,US,US,2022,Q1,Adult
201471672,20147167,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Impaired quality of life,,2022,Q1,2,F,20211101.0,20220204.0,20211203,20220214,PER,,US-SA-2021SA395167,SANOFI AVENTIS,,43.0,YR,A,F,Y,,,20220214,,MD,US,US,2022,Q1,Adult
201471672,20147167,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Asthma,,2022,Q1,2,F,20211101.0,20220204.0,20211203,20220214,PER,,US-SA-2021SA395167,SANOFI AVENTIS,,43.0,YR,A,F,Y,,,20220214,,MD,US,US,2022,Q1,Adult
201471672,20147167,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,SARS-CoV-2 test positive,,2022,Q1,2,F,20211101.0,20220204.0,20211203,20220214,PER,,US-SA-2021SA395167,SANOFI AVENTIS,,43.0,YR,A,F,Y,,,20220214,,MD,US,US,2022,Q1,Adult
201610447,20161044,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q1,Hyperglycaemia,,2022,Q1,7,F,20211203.0,20220117.0,20211208,20220127,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-131602,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,96.0,KG,20220127,,HP,BR,BR,2022,Q1,Elderly
201610447,20161044,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q1,Hyperglycaemia,,2022,Q1,7,F,20211203.0,20220117.0,20211208,20220127,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-131602,BRISTOL MYERS SQUIBB,,74.0,YR,,M,Y,96.0,KG,20220127,,HP,BR,BR,2022,Q1,Elderly
201732922,20173292,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 IU, QD, (in the morning, started 1 year ago, lasted 6 months)",,,Y,,,,,12.0,IU,,QD,2022,Q1,Myocardial infarction,,2022,Q1,2,F,20190214.0,20220120.0,20211211,20220126,EXP,,NVSC2021MX283949,NOVARTIS,,61.0,YR,,F,Y,62.0,KG,20220126,,CN,MX,MX,2022,Q1,Adult
201732922,20173292,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 IU, QD, (in the morning, started 1 year ago, lasted 6 months)",,,Y,,,,,12.0,IU,,QD,2022,Q1,Localised infection,,2022,Q1,2,F,20190214.0,20220120.0,20211211,20220126,EXP,,NVSC2021MX283949,NOVARTIS,,61.0,YR,,F,Y,62.0,KG,20220126,,CN,MX,MX,2022,Q1,Adult
201732922,20173292,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 IU, QD, (in the morning, started 1 year ago, lasted 6 months)",,,Y,,,,,12.0,IU,,QD,2022,Q1,Fall,,2022,Q1,2,F,20190214.0,20220120.0,20211211,20220126,EXP,,NVSC2021MX283949,NOVARTIS,,61.0,YR,,F,Y,62.0,KG,20220126,,CN,MX,MX,2022,Q1,Adult
201732922,20173292,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 IU, QD, (in the morning, started 1 year ago, lasted 6 months)",,,Y,,,,,12.0,IU,,QD,2022,Q1,Arterial rupture,,2022,Q1,2,F,20190214.0,20220120.0,20211211,20220126,EXP,,NVSC2021MX283949,NOVARTIS,,61.0,YR,,F,Y,62.0,KG,20220126,,CN,MX,MX,2022,Q1,Adult
201732922,20173292,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 IU, QD, (in the morning, started 1 year ago, lasted 6 months)",,,Y,,,,,12.0,IU,,QD,2022,Q1,Haemorrhage,,2022,Q1,2,F,20190214.0,20220120.0,20211211,20220126,EXP,,NVSC2021MX283949,NOVARTIS,,61.0,YR,,F,Y,62.0,KG,20220126,,CN,MX,MX,2022,Q1,Adult
201732922,20173292,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 IU, QD, (in the morning, started 1 year ago, lasted 6 months)",,,Y,,,,,12.0,IU,,QD,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20190214.0,20220120.0,20211211,20220126,EXP,,NVSC2021MX283949,NOVARTIS,,61.0,YR,,F,Y,62.0,KG,20220126,,CN,MX,MX,2022,Q1,Adult
201732922,20173292,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 IU, QD, (in the morning, started 1 year ago, lasted 6 months)",,,Y,,,,,12.0,IU,,QD,2022,Q1,Skin laceration,,2022,Q1,2,F,20190214.0,20220120.0,20211211,20220126,EXP,,NVSC2021MX283949,NOVARTIS,,61.0,YR,,F,Y,62.0,KG,20220126,,CN,MX,MX,2022,Q1,Adult
201732922,20173292,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 IU, QD, (in the morning, started 1 year ago, lasted 6 months)",,,Y,,,,,12.0,IU,,QD,2022,Q1,Off label use,,2022,Q1,2,F,20190214.0,20220120.0,20211211,20220126,EXP,,NVSC2021MX283949,NOVARTIS,,61.0,YR,,F,Y,62.0,KG,20220126,,CN,MX,MX,2022,Q1,Adult
201764893,20176489,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Diarrhoea,,2022,Q1,3,F,20211215.0,20220103.0,20211213,20220106,EXP,,US-EXELIXIS-CABO-21044722,EXELIXIS,,61.0,YR,,M,Y,90.7,KG,20220106,,CN,US,US,2022,Q1,Adult
201764893,20176489,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Blood pressure decreased,,2022,Q1,3,F,20211215.0,20220103.0,20211213,20220106,EXP,,US-EXELIXIS-CABO-21044722,EXELIXIS,,61.0,YR,,M,Y,90.7,KG,20220106,,CN,US,US,2022,Q1,Adult
201764893,20176489,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Sepsis,,2022,Q1,3,F,20211215.0,20220103.0,20211213,20220106,EXP,,US-EXELIXIS-CABO-21044722,EXELIXIS,,61.0,YR,,M,Y,90.7,KG,20220106,,CN,US,US,2022,Q1,Adult
201764893,20176489,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Feeding disorder,,2022,Q1,3,F,20211215.0,20220103.0,20211213,20220106,EXP,,US-EXELIXIS-CABO-21044722,EXELIXIS,,61.0,YR,,M,Y,90.7,KG,20220106,,CN,US,US,2022,Q1,Adult
201764893,20176489,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Dehydration,,2022,Q1,3,F,20211215.0,20220103.0,20211213,20220106,EXP,,US-EXELIXIS-CABO-21044722,EXELIXIS,,61.0,YR,,M,Y,90.7,KG,20220106,,CN,US,US,2022,Q1,Adult
201764893,20176489,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Urinary tract infection,,2022,Q1,3,F,20211215.0,20220103.0,20211213,20220106,EXP,,US-EXELIXIS-CABO-21044722,EXELIXIS,,61.0,YR,,M,Y,90.7,KG,20220106,,CN,US,US,2022,Q1,Adult
201764893,20176489,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Vomiting,,2022,Q1,3,F,20211215.0,20220103.0,20211213,20220106,EXP,,US-EXELIXIS-CABO-21044722,EXELIXIS,,61.0,YR,,M,Y,90.7,KG,20220106,,CN,US,US,2022,Q1,Adult
201764893,20176489,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Blood glucose decreased,,2022,Q1,3,F,20211215.0,20220103.0,20211213,20220106,EXP,,US-EXELIXIS-CABO-21044722,EXELIXIS,,61.0,YR,,M,Y,90.7,KG,20220106,,CN,US,US,2022,Q1,Adult
201764893,20176489,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Stomatitis,,2022,Q1,3,F,20211215.0,20220103.0,20211213,20220106,EXP,,US-EXELIXIS-CABO-21044722,EXELIXIS,,61.0,YR,,M,Y,90.7,KG,20220106,,CN,US,US,2022,Q1,Adult
201764893,20176489,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Death,,2022,Q1,3,F,20211215.0,20220103.0,20211213,20220106,EXP,,US-EXELIXIS-CABO-21044722,EXELIXIS,,61.0,YR,,M,Y,90.7,KG,20220106,,CN,US,US,2022,Q1,Adult
201764893,20176489,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Product dose omission issue,,2022,Q1,3,F,20211215.0,20220103.0,20211213,20220106,EXP,,US-EXELIXIS-CABO-21044722,EXELIXIS,,61.0,YR,,M,Y,90.7,KG,20220106,,CN,US,US,2022,Q1,Adult
201764893,20176489,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Malignant neoplasm progression,,2022,Q1,3,F,20211215.0,20220103.0,20211213,20220106,EXP,,US-EXELIXIS-CABO-21044722,EXELIXIS,,61.0,YR,,M,Y,90.7,KG,20220106,,CN,US,US,2022,Q1,Adult
201808806,20180880,91,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Abdominal pain,,2022,Q1,6,F,20211205.0,20220204.0,20211214,20220208,EXP,,NVSC2021US281605,NOVARTIS,,42.0,YR,,F,Y,49.8,KG,20220208,,MD,US,US,2022,Q1,Adult
201808806,20180880,91,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Large intestine perforation,,2022,Q1,6,F,20211205.0,20220204.0,20211214,20220208,EXP,,NVSC2021US281605,NOVARTIS,,42.0,YR,,F,Y,49.8,KG,20220208,,MD,US,US,2022,Q1,Adult
201876183,20187618,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Pain in jaw,,2022,Q1,3,F,20211114.0,20211210.0,20211215,20220114,EXP,,US-BEH-2021138618,CSL BEHRING,,69.0,YR,E,M,Y,98.866,KG,20220114,,HP,US,US,2022,Q1,Elderly
201876183,20187618,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Headache,,2022,Q1,3,F,20211114.0,20211210.0,20211215,20220114,EXP,,US-BEH-2021138618,CSL BEHRING,,69.0,YR,E,M,Y,98.866,KG,20220114,,HP,US,US,2022,Q1,Elderly
201876183,20187618,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Injection site extravasation,,2022,Q1,3,F,20211114.0,20211210.0,20211215,20220114,EXP,,US-BEH-2021138618,CSL BEHRING,,69.0,YR,E,M,Y,98.866,KG,20220114,,HP,US,US,2022,Q1,Elderly
201876183,20187618,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Pain,,2022,Q1,3,F,20211114.0,20211210.0,20211215,20220114,EXP,,US-BEH-2021138618,CSL BEHRING,,69.0,YR,E,M,Y,98.866,KG,20220114,,HP,US,US,2022,Q1,Elderly
201876183,20187618,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Osteitis,,2022,Q1,3,F,20211114.0,20211210.0,20211215,20220114,EXP,,US-BEH-2021138618,CSL BEHRING,,69.0,YR,E,M,Y,98.866,KG,20220114,,HP,US,US,2022,Q1,Elderly
201876183,20187618,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Salivary gland pain,,2022,Q1,3,F,20211114.0,20211210.0,20211215,20220114,EXP,,US-BEH-2021138618,CSL BEHRING,,69.0,YR,E,M,Y,98.866,KG,20220114,,HP,US,US,2022,Q1,Elderly
201876183,20187618,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Infusion site haemorrhage,,2022,Q1,3,F,20211114.0,20211210.0,20211215,20220114,EXP,,US-BEH-2021138618,CSL BEHRING,,69.0,YR,E,M,Y,98.866,KG,20220114,,HP,US,US,2022,Q1,Elderly
201876183,20187618,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Muscle tightness,,2022,Q1,3,F,20211114.0,20211210.0,20211215,20220114,EXP,,US-BEH-2021138618,CSL BEHRING,,69.0,YR,E,M,Y,98.866,KG,20220114,,HP,US,US,2022,Q1,Elderly
201876183,20187618,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Infusion site haemorrhage,,2022,Q1,3,F,20211114.0,20211210.0,20211215,20220114,EXP,,US-BEH-2021138618,CSL BEHRING,,69.0,YR,E,M,Y,98.866,KG,20220114,,HP,US,US,2022,Q1,Elderly
201876183,20187618,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Pain in jaw,,2022,Q1,3,F,20211114.0,20211210.0,20211215,20220114,EXP,,US-BEH-2021138618,CSL BEHRING,,69.0,YR,E,M,Y,98.866,KG,20220114,,HP,US,US,2022,Q1,Elderly
201876183,20187618,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Fatigue,,2022,Q1,3,F,20211114.0,20211210.0,20211215,20220114,EXP,,US-BEH-2021138618,CSL BEHRING,,69.0,YR,E,M,Y,98.866,KG,20220114,,HP,US,US,2022,Q1,Elderly
201876183,20187618,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Infusion site pain,,2022,Q1,3,F,20211114.0,20211210.0,20211215,20220114,EXP,,US-BEH-2021138618,CSL BEHRING,,69.0,YR,E,M,Y,98.866,KG,20220114,,HP,US,US,2022,Q1,Elderly
201876183,20187618,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Noninfective sialoadenitis,,2022,Q1,3,F,20211114.0,20211210.0,20211215,20220114,EXP,,US-BEH-2021138618,CSL BEHRING,,69.0,YR,E,M,Y,98.866,KG,20220114,,HP,US,US,2022,Q1,Elderly
201876183,20187618,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Pain,,2022,Q1,3,F,20211114.0,20211210.0,20211215,20220114,EXP,,US-BEH-2021138618,CSL BEHRING,,69.0,YR,E,M,Y,98.866,KG,20220114,,HP,US,US,2022,Q1,Elderly
201876183,20187618,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Infusion site haemorrhage,,2022,Q1,3,F,20211114.0,20211210.0,20211215,20220114,EXP,,US-BEH-2021138618,CSL BEHRING,,69.0,YR,E,M,Y,98.866,KG,20220114,,HP,US,US,2022,Q1,Elderly
201876183,20187618,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Infusion site pain,,2022,Q1,3,F,20211114.0,20211210.0,20211215,20220114,EXP,,US-BEH-2021138618,CSL BEHRING,,69.0,YR,E,M,Y,98.866,KG,20220114,,HP,US,US,2022,Q1,Elderly
201876183,20187618,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Infusion site discomfort,,2022,Q1,3,F,20211114.0,20211210.0,20211215,20220114,EXP,,US-BEH-2021138618,CSL BEHRING,,69.0,YR,E,M,Y,98.866,KG,20220114,,HP,US,US,2022,Q1,Elderly
201887912,20188791,10,C,INSULINE LISPRO,,1,Unknown,UNK (100 eenheden/ml),,,D,,,,,,,Injection,,2022,Q1,Hypophagia,,2022,Q1,2,F,20211130.0,20220103.0,20211215,20220105,EXP,NL-LRB-00726673,NVSC2021NL286098,NOVARTIS,,85.0,YR,,M,Y,71.9,KG,20220105,,MD,NL,NL,2022,Q1,Elderly
201887912,20188791,10,C,INSULINE LISPRO,,1,Unknown,UNK (100 eenheden/ml),,,D,,,,,,,Injection,,2022,Q1,Malaise,,2022,Q1,2,F,20211130.0,20220103.0,20211215,20220105,EXP,NL-LRB-00726673,NVSC2021NL286098,NOVARTIS,,85.0,YR,,M,Y,71.9,KG,20220105,,MD,NL,NL,2022,Q1,Elderly
201887912,20188791,10,C,INSULINE LISPRO,,1,Unknown,UNK (100 eenheden/ml),,,D,,,,,,,Injection,,2022,Q1,Fatigue,,2022,Q1,2,F,20211130.0,20220103.0,20211215,20220105,EXP,NL-LRB-00726673,NVSC2021NL286098,NOVARTIS,,85.0,YR,,M,Y,71.9,KG,20220105,,MD,NL,NL,2022,Q1,Elderly
201887912,20188791,10,C,INSULINE LISPRO,,1,Unknown,UNK (100 eenheden/ml),,,D,,,,,,,Injection,,2022,Q1,Depressed level of consciousness,,2022,Q1,2,F,20211130.0,20220103.0,20211215,20220105,EXP,NL-LRB-00726673,NVSC2021NL286098,NOVARTIS,,85.0,YR,,M,Y,71.9,KG,20220105,,MD,NL,NL,2022,Q1,Elderly
201887912,20188791,10,C,INSULINE LISPRO,,1,Unknown,UNK (100 eenheden/ml),,,D,,,,,,,Injection,,2022,Q1,Pyrexia,,2022,Q1,2,F,20211130.0,20220103.0,20211215,20220105,EXP,NL-LRB-00726673,NVSC2021NL286098,NOVARTIS,,85.0,YR,,M,Y,71.9,KG,20220105,,MD,NL,NL,2022,Q1,Elderly
201887912,20188791,10,C,INSULINE LISPRO,,1,Unknown,UNK (100 eenheden/ml),,,D,,,,,,,Injection,,2022,Q1,Balance disorder,,2022,Q1,2,F,20211130.0,20220103.0,20211215,20220105,EXP,NL-LRB-00726673,NVSC2021NL286098,NOVARTIS,,85.0,YR,,M,Y,71.9,KG,20220105,,MD,NL,NL,2022,Q1,Elderly
201887912,20188791,10,C,INSULINE LISPRO,,1,Unknown,UNK (100 eenheden/ml),,,D,,,,,,,Injection,,2022,Q1,Oxygen saturation decreased,,2022,Q1,2,F,20211130.0,20220103.0,20211215,20220105,EXP,NL-LRB-00726673,NVSC2021NL286098,NOVARTIS,,85.0,YR,,M,Y,71.9,KG,20220105,,MD,NL,NL,2022,Q1,Elderly
201887912,20188791,10,C,INSULINE LISPRO,,1,Unknown,UNK (100 eenheden/ml),,,D,,,,,,,Injection,,2022,Q1,Somnolence,,2022,Q1,2,F,20211130.0,20220103.0,20211215,20220105,EXP,NL-LRB-00726673,NVSC2021NL286098,NOVARTIS,,85.0,YR,,M,Y,71.9,KG,20220105,,MD,NL,NL,2022,Q1,Elderly
202044086,20204408,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2022,Q1,Nasal congestion,,2022,Q1,6,F,20210101.0,20220217.0,20211220,20220227,EXP,,US-TEVA-2021-US-1988708,TEVA,,60.0,YR,A,F,Y,90.6,KG,20220227,,HP,US,US,2022,Q1,Adult
202044086,20204408,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2022,Q1,Acute kidney injury,,2022,Q1,6,F,20210101.0,20220217.0,20211220,20220227,EXP,,US-TEVA-2021-US-1988708,TEVA,,60.0,YR,A,F,Y,90.6,KG,20220227,,HP,US,US,2022,Q1,Adult
202044086,20204408,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2022,Q1,Hypotension,,2022,Q1,6,F,20210101.0,20220217.0,20211220,20220227,EXP,,US-TEVA-2021-US-1988708,TEVA,,60.0,YR,A,F,Y,90.6,KG,20220227,,HP,US,US,2022,Q1,Adult
202044086,20204408,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2022,Q1,Dysphagia,,2022,Q1,6,F,20210101.0,20220217.0,20211220,20220227,EXP,,US-TEVA-2021-US-1988708,TEVA,,60.0,YR,A,F,Y,90.6,KG,20220227,,HP,US,US,2022,Q1,Adult
202044086,20204408,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2022,Q1,Cough,,2022,Q1,6,F,20210101.0,20220217.0,20211220,20220227,EXP,,US-TEVA-2021-US-1988708,TEVA,,60.0,YR,A,F,Y,90.6,KG,20220227,,HP,US,US,2022,Q1,Adult
202044086,20204408,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2022,Q1,Blood creatinine increased,,2022,Q1,6,F,20210101.0,20220217.0,20211220,20220227,EXP,,US-TEVA-2021-US-1988708,TEVA,,60.0,YR,A,F,Y,90.6,KG,20220227,,HP,US,US,2022,Q1,Adult
202044086,20204408,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2022,Q1,Pyrexia,,2022,Q1,6,F,20210101.0,20220217.0,20211220,20220227,EXP,,US-TEVA-2021-US-1988708,TEVA,,60.0,YR,A,F,Y,90.6,KG,20220227,,HP,US,US,2022,Q1,Adult
202044086,20204408,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2022,Q1,Hypoxia,,2022,Q1,6,F,20210101.0,20220217.0,20211220,20220227,EXP,,US-TEVA-2021-US-1988708,TEVA,,60.0,YR,A,F,Y,90.6,KG,20220227,,HP,US,US,2022,Q1,Adult
202064115,20206411,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, BID",,,U,,,,,,,,Q12H,2022,Q1,Acute kidney injury,,2022,Q1,5,F,20211124.0,20220217.0,20211220,20220221,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220221,,HP,US,US,2022,Q1,Adult
202064115,20206411,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, BID",,,U,,,,,,,,Q12H,2022,Q1,Hypotension,,2022,Q1,5,F,20211124.0,20220217.0,20211220,20220221,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220221,,HP,US,US,2022,Q1,Adult
202064115,20206411,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, BID",,,U,,,,,,,,Q12H,2022,Q1,Hypoxia,,2022,Q1,5,F,20211124.0,20220217.0,20211220,20220221,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220221,,HP,US,US,2022,Q1,Adult
202064115,20206411,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, BID",,,U,,,,,,,,Q12H,2022,Q1,Pyrexia,,2022,Q1,5,F,20211124.0,20220217.0,20211220,20220221,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220221,,HP,US,US,2022,Q1,Adult
202064115,20206411,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, BID",,,U,,,,,,,,Q12H,2022,Q1,Blood creatinine increased,,2022,Q1,5,F,20211124.0,20220217.0,20211220,20220221,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220221,,HP,US,US,2022,Q1,Adult
202064115,20206411,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, BID",,,U,,,,,,,,Q12H,2022,Q1,Dysphagia,,2022,Q1,5,F,20211124.0,20220217.0,20211220,20220221,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220221,,HP,US,US,2022,Q1,Adult
202064115,20206411,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, TID",,,U,,,,,,,,Q8H,2022,Q1,Acute kidney injury,,2022,Q1,5,F,20211124.0,20220217.0,20211220,20220221,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220221,,HP,US,US,2022,Q1,Adult
202064115,20206411,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, TID",,,U,,,,,,,,Q8H,2022,Q1,Hypotension,,2022,Q1,5,F,20211124.0,20220217.0,20211220,20220221,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220221,,HP,US,US,2022,Q1,Adult
202064115,20206411,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, TID",,,U,,,,,,,,Q8H,2022,Q1,Hypoxia,,2022,Q1,5,F,20211124.0,20220217.0,20211220,20220221,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220221,,HP,US,US,2022,Q1,Adult
202064115,20206411,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, TID",,,U,,,,,,,,Q8H,2022,Q1,Pyrexia,,2022,Q1,5,F,20211124.0,20220217.0,20211220,20220221,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220221,,HP,US,US,2022,Q1,Adult
202064115,20206411,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, TID",,,U,,,,,,,,Q8H,2022,Q1,Blood creatinine increased,,2022,Q1,5,F,20211124.0,20220217.0,20211220,20220221,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220221,,HP,US,US,2022,Q1,Adult
202064115,20206411,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, TID",,,U,,,,,,,,Q8H,2022,Q1,Dysphagia,,2022,Q1,5,F,20211124.0,20220217.0,20211220,20220221,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220221,,HP,US,US,2022,Q1,Adult
202064115,20206411,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 U,,,U,,,,,,,,,2022,Q1,Acute kidney injury,,2022,Q1,5,F,20211124.0,20220217.0,20211220,20220221,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220221,,HP,US,US,2022,Q1,Adult
202064115,20206411,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 U,,,U,,,,,,,,,2022,Q1,Hypotension,,2022,Q1,5,F,20211124.0,20220217.0,20211220,20220221,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220221,,HP,US,US,2022,Q1,Adult
202064115,20206411,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 U,,,U,,,,,,,,,2022,Q1,Hypoxia,,2022,Q1,5,F,20211124.0,20220217.0,20211220,20220221,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220221,,HP,US,US,2022,Q1,Adult
202064115,20206411,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 U,,,U,,,,,,,,,2022,Q1,Pyrexia,,2022,Q1,5,F,20211124.0,20220217.0,20211220,20220221,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220221,,HP,US,US,2022,Q1,Adult
202064115,20206411,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 U,,,U,,,,,,,,,2022,Q1,Blood creatinine increased,,2022,Q1,5,F,20211124.0,20220217.0,20211220,20220221,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220221,,HP,US,US,2022,Q1,Adult
202064115,20206411,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 U,,,U,,,,,,,,,2022,Q1,Dysphagia,,2022,Q1,5,F,20211124.0,20220217.0,20211220,20220221,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220221,,HP,US,US,2022,Q1,Adult
202081775,20208177,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 Unit, 2 in 1 D",179100.0,IU,,,,,,50.0,IU,,BID,2022,Q1,Acute kidney injury,,2022,Q1,5,F,20211124.0,20220217.0,20211220,20220222,EXP,,US-PFIZER INC-202101752662,PFIZER,,60.0,YR,,F,Y,90.6,KG,20220222,,HP,US,US,2022,Q1,Adult
202081775,20208177,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 Unit, 2 in 1 D",179100.0,IU,,,,,,50.0,IU,,BID,2022,Q1,Pyrexia,,2022,Q1,5,F,20211124.0,20220217.0,20211220,20220222,EXP,,US-PFIZER INC-202101752662,PFIZER,,60.0,YR,,F,Y,90.6,KG,20220222,,HP,US,US,2022,Q1,Adult
202081775,20208177,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 Unit, 2 in 1 D",179100.0,IU,,,,,,50.0,IU,,BID,2022,Q1,Dysphagia,,2022,Q1,5,F,20211124.0,20220217.0,20211220,20220222,EXP,,US-PFIZER INC-202101752662,PFIZER,,60.0,YR,,F,Y,90.6,KG,20220222,,HP,US,US,2022,Q1,Adult
202081775,20208177,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 Unit, 2 in 1 D",179100.0,IU,,,,,,50.0,IU,,BID,2022,Q1,Blood creatinine increased,,2022,Q1,5,F,20211124.0,20220217.0,20211220,20220222,EXP,,US-PFIZER INC-202101752662,PFIZER,,60.0,YR,,F,Y,90.6,KG,20220222,,HP,US,US,2022,Q1,Adult
202081775,20208177,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 Unit, 2 in 1 D",179100.0,IU,,,,,,50.0,IU,,BID,2022,Q1,Hypotension,,2022,Q1,5,F,20211124.0,20220217.0,20211220,20220222,EXP,,US-PFIZER INC-202101752662,PFIZER,,60.0,YR,,F,Y,90.6,KG,20220222,,HP,US,US,2022,Q1,Adult
202081775,20208177,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 Unit, 2 in 1 D",179100.0,IU,,,,,,50.0,IU,,BID,2022,Q1,Hypoxia,,2022,Q1,5,F,20211124.0,20220217.0,20211220,20220222,EXP,,US-PFIZER INC-202101752662,PFIZER,,60.0,YR,,F,Y,90.6,KG,20220222,,HP,US,US,2022,Q1,Adult
202270792,20227079,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,as per scheme / routine,,,U,,,,,,,Solution for injection/infusion,,2022,Q1,Haematochezia,,2022,Q1,2,F,20200630.0,20211229.0,20211224,20220107,EXP,DE-ADRED-05804-01,DE-TORRENT-00021751,TORRENT,,67.0,YR,E,M,Y,95.0,KG,20220107,,PH,DE,DE,2022,Q1,Elderly
202274642,20227464,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Injection,,2022,Q1,Productive cough,,2022,Q1,2,F,20211209.0,20211216.0,20211224,20220114,EXP,,"US-REGENERON PHARMACEUTICALS, INC.-2021-117353",REGENERON,,61.0,YR,,M,Y,,,20220114,,HP,US,US,2022,Q1,Adult
202274642,20227464,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Injection,,2022,Q1,Blood creatinine increased,,2022,Q1,2,F,20211209.0,20211216.0,20211224,20220114,EXP,,"US-REGENERON PHARMACEUTICALS, INC.-2021-117353",REGENERON,,61.0,YR,,M,Y,,,20220114,,HP,US,US,2022,Q1,Adult
202274642,20227464,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Injection,,2022,Q1,Haemoglobin decreased,,2022,Q1,2,F,20211209.0,20211216.0,20211224,20220114,EXP,,"US-REGENERON PHARMACEUTICALS, INC.-2021-117353",REGENERON,,61.0,YR,,M,Y,,,20220114,,HP,US,US,2022,Q1,Adult
202274642,20227464,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Injection,,2022,Q1,Incorrect dose administered,,2022,Q1,2,F,20211209.0,20211216.0,20211224,20220114,EXP,,"US-REGENERON PHARMACEUTICALS, INC.-2021-117353",REGENERON,,61.0,YR,,M,Y,,,20220114,,HP,US,US,2022,Q1,Adult
202274642,20227464,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Injection,,2022,Q1,Prothrombin time prolonged,,2022,Q1,2,F,20211209.0,20211216.0,20211224,20220114,EXP,,"US-REGENERON PHARMACEUTICALS, INC.-2021-117353",REGENERON,,61.0,YR,,M,Y,,,20220114,,HP,US,US,2022,Q1,Adult
202274642,20227464,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Injection,,2022,Q1,Pyrexia,,2022,Q1,2,F,20211209.0,20211216.0,20211224,20220114,EXP,,"US-REGENERON PHARMACEUTICALS, INC.-2021-117353",REGENERON,,61.0,YR,,M,Y,,,20220114,,HP,US,US,2022,Q1,Adult
202341012,20234101,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU (6-6-8-0),,,U,N,,,,,,Infusion,,2022,Q1,Muscular weakness,,2022,Q1,2,F,,20220110.0,20211227,20220112,EXP,,DE-ANIPHARMA-2021-DE-000285,ANI,,79.0,YR,,M,Y,,,20220112,,PH,DE,DE,2022,Q1,Elderly
202341012,20234101,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU (6-6-8-0),,,U,N,,,,,,Infusion,,2022,Q1,Haematochezia,,2022,Q1,2,F,,20220110.0,20211227,20220112,EXP,,DE-ANIPHARMA-2021-DE-000285,ANI,,79.0,YR,,M,Y,,,20220112,,PH,DE,DE,2022,Q1,Elderly
202341012,20234101,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU (6-6-8-0),,,U,N,,,,,,Infusion,,2022,Q1,Anaemia,,2022,Q1,2,F,,20220110.0,20211227,20220112,EXP,,DE-ANIPHARMA-2021-DE-000285,ANI,,79.0,YR,,M,Y,,,20220112,,PH,DE,DE,2022,Q1,Elderly
202341012,20234101,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU (6-6-8-0),,,U,N,,,,,,Infusion,,2022,Q1,Product monitoring error,,2022,Q1,2,F,,20220110.0,20211227,20220112,EXP,,DE-ANIPHARMA-2021-DE-000285,ANI,,79.0,YR,,M,Y,,,20220112,,PH,DE,DE,2022,Q1,Elderly
202341012,20234101,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU (6-6-8-0),,,U,N,,,,,,Infusion,,2022,Q1,General physical health deterioration,,2022,Q1,2,F,,20220110.0,20211227,20220112,EXP,,DE-ANIPHARMA-2021-DE-000285,ANI,,79.0,YR,,M,Y,,,20220112,,PH,DE,DE,2022,Q1,Elderly
202403803,20240380,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,Solution for injection/infusion,,2022,Q1,Haematochezia,,2022,Q1,3,F,,20220114.0,20211228,20220125,EXP,,DE-PFIZER INC-202101852624,PFIZER,,79.0,YR,,M,Y,,,20220125,,PH,DE,DE,2022,Q1,Elderly
202403803,20240380,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,Solution for injection/infusion,,2022,Q1,Product monitoring error,,2022,Q1,3,F,,20220114.0,20211228,20220125,EXP,,DE-PFIZER INC-202101852624,PFIZER,,79.0,YR,,M,Y,,,20220125,,PH,DE,DE,2022,Q1,Elderly
202403803,20240380,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,Solution for injection/infusion,,2022,Q1,General physical health deterioration,,2022,Q1,3,F,,20220114.0,20211228,20220125,EXP,,DE-PFIZER INC-202101852624,PFIZER,,79.0,YR,,M,Y,,,20220125,,PH,DE,DE,2022,Q1,Elderly
202403803,20240380,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,Solution for injection/infusion,,2022,Q1,Anaemia,,2022,Q1,3,F,,20220114.0,20211228,20220125,EXP,,DE-PFIZER INC-202101852624,PFIZER,,79.0,YR,,M,Y,,,20220125,,PH,DE,DE,2022,Q1,Elderly
202403803,20240380,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,Solution for injection/infusion,,2022,Q1,Muscular weakness,,2022,Q1,3,F,,20220114.0,20211228,20220125,EXP,,DE-PFIZER INC-202101852624,PFIZER,,79.0,YR,,M,Y,,,20220125,,PH,DE,DE,2022,Q1,Elderly
202586162,20258616,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1000.0,ML,,Q8H,2022,Q1,Unresponsive to stimuli,,2022,Q1,2,F,20211201.0,20211223.0,20211230,20220105,EXP,,US-BAUSCH-BL-2021-007091,BAUSCH AND LOMB,,71.0,YR,,F,Y,69.4,KG,20220105,,MD,US,US,2022,Q1,Elderly
202586162,20258616,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1000.0,ML,,Q8H,2022,Q1,Constipation,,2022,Q1,2,F,20211201.0,20211223.0,20211230,20220105,EXP,,US-BAUSCH-BL-2021-007091,BAUSCH AND LOMB,,71.0,YR,,F,Y,69.4,KG,20220105,,MD,US,US,2022,Q1,Elderly
202586162,20258616,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1000.0,ML,,Q8H,2022,Q1,Depressed level of consciousness,,2022,Q1,2,F,20211201.0,20211223.0,20211230,20220105,EXP,,US-BAUSCH-BL-2021-007091,BAUSCH AND LOMB,,71.0,YR,,F,Y,69.4,KG,20220105,,MD,US,US,2022,Q1,Elderly
202586162,20258616,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1000.0,ML,,Q8H,2022,Q1,Ammonia increased,,2022,Q1,2,F,20211201.0,20211223.0,20211230,20220105,EXP,,US-BAUSCH-BL-2021-007091,BAUSCH AND LOMB,,71.0,YR,,F,Y,69.4,KG,20220105,,MD,US,US,2022,Q1,Elderly
202586162,20258616,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1000.0,ML,,Q8H,2022,Q1,Inability to afford medication,,2022,Q1,2,F,20211201.0,20211223.0,20211230,20220105,EXP,,US-BAUSCH-BL-2021-007091,BAUSCH AND LOMB,,71.0,YR,,F,Y,69.4,KG,20220105,,MD,US,US,2022,Q1,Elderly
202586162,20258616,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,1000.0,ML,,Q8H,2022,Q1,Disorientation,,2022,Q1,2,F,20211201.0,20211223.0,20211230,20220105,EXP,,US-BAUSCH-BL-2021-007091,BAUSCH AND LOMB,,71.0,YR,,F,Y,69.4,KG,20220105,,MD,US,US,2022,Q1,Elderly
202788111,20278811,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q1,Injection site pain,,2022,Q1,1,I,20211201.0,20211222.0,20220103,20220103,PER,,US-SA-2021SA433078,SANOFI AVENTIS,,34.0,YR,A,F,Y,,,20220103,,MD,US,US,2022,Q1,Young Adult
202788111,20278811,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q1,Injection site urticaria,,2022,Q1,1,I,20211201.0,20211222.0,20220103,20220103,PER,,US-SA-2021SA433078,SANOFI AVENTIS,,34.0,YR,A,F,Y,,,20220103,,MD,US,US,2022,Q1,Young Adult
202795851,20279585,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, tid (300 IU, 1-1-1-0, injection/infusion solution)",,,U,U,,,,300.0,IU,Injection,TID,2022,Q1,Pain,,2022,Q1,1,I,,20211224.0,20220103,20220103,EXP,,DE-MYLANLABS-2021M1096448,MYLAN,,64.0,YR,,F,Y,63.0,KG,20220103,,PH,DE,DE,2022,Q1,Adult
202795851,20279585,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, tid (300 IU, 1-1-1-0, injection/infusion solution)",,,U,U,,,,300.0,IU,Injection,TID,2022,Q1,Therapeutic drug monitoring analysis not performed,,2022,Q1,1,I,,20211224.0,20220103,20220103,EXP,,DE-MYLANLABS-2021M1096448,MYLAN,,64.0,YR,,F,Y,63.0,KG,20220103,,PH,DE,DE,2022,Q1,Adult
202795851,20279585,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, tid (300 IU, 1-1-1-0, injection/infusion solution)",,,U,U,,,,300.0,IU,Injection,TID,2022,Q1,Medication error,,2022,Q1,1,I,,20211224.0,20220103,20220103,EXP,,DE-MYLANLABS-2021M1096448,MYLAN,,64.0,YR,,F,Y,63.0,KG,20220103,,PH,DE,DE,2022,Q1,Adult
202795851,20279585,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, tid (300 IU, 1-1-1-0, injection/infusion solution)",,,U,U,,,,300.0,IU,Injection,TID,2022,Q1,Peripheral coldness,,2022,Q1,1,I,,20211224.0,20220103,20220103,EXP,,DE-MYLANLABS-2021M1096448,MYLAN,,64.0,YR,,F,Y,63.0,KG,20220103,,PH,DE,DE,2022,Q1,Adult
202802331,20280233,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,300.0,IU,,,2022,Q1,Anaemia,,2022,Q1,1,I,,20200714.0,20220103,20220103,EXP,DE-ADRED-04543-01,NVSC2020DE191324,NOVARTIS,,70.0,YR,,M,Y,78.0,KG,20220103,,PH,DE,DE,2022,Q1,Elderly
202802331,20280233,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,300.0,IU,,,2022,Q1,Product monitoring error,,2022,Q1,1,I,,20200714.0,20220103,20220103,EXP,DE-ADRED-04543-01,NVSC2020DE191324,NOVARTIS,,70.0,YR,,M,Y,78.0,KG,20220103,,PH,DE,DE,2022,Q1,Elderly
202802331,20280233,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,300.0,IU,,,2022,Q1,Electrolyte imbalance,,2022,Q1,1,I,,20200714.0,20220103,20220103,EXP,DE-ADRED-04543-01,NVSC2020DE191324,NOVARTIS,,70.0,YR,,M,Y,78.0,KG,20220103,,PH,DE,DE,2022,Q1,Elderly
202802331,20280233,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,300.0,IU,,,2022,Q1,Renal impairment,,2022,Q1,1,I,,20200714.0,20220103,20220103,EXP,DE-ADRED-04543-01,NVSC2020DE191324,NOVARTIS,,70.0,YR,,M,Y,78.0,KG,20220103,,PH,DE,DE,2022,Q1,Elderly
202802331,20280233,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,300.0,IU,,,2022,Q1,Hyperkalaemia,,2022,Q1,1,I,,20200714.0,20220103,20220103,EXP,DE-ADRED-04543-01,NVSC2020DE191324,NOVARTIS,,70.0,YR,,M,Y,78.0,KG,20220103,,PH,DE,DE,2022,Q1,Elderly
202802331,20280233,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 IU,,,U,,,,,300.0,IU,,,2022,Q1,Labelled drug-drug interaction medication error,,2022,Q1,1,I,,20200714.0,20220103,20220103,EXP,DE-ADRED-04543-01,NVSC2020DE191324,NOVARTIS,,70.0,YR,,M,Y,78.0,KG,20220103,,PH,DE,DE,2022,Q1,Elderly
202802331,20280233,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 iU,,,U,,,,,300.0,IU,,,2022,Q1,Anaemia,,2022,Q1,1,I,,20200714.0,20220103,20220103,EXP,DE-ADRED-04543-01,NVSC2020DE191324,NOVARTIS,,70.0,YR,,M,Y,78.0,KG,20220103,,PH,DE,DE,2022,Q1,Elderly
202802331,20280233,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 iU,,,U,,,,,300.0,IU,,,2022,Q1,Product monitoring error,,2022,Q1,1,I,,20200714.0,20220103,20220103,EXP,DE-ADRED-04543-01,NVSC2020DE191324,NOVARTIS,,70.0,YR,,M,Y,78.0,KG,20220103,,PH,DE,DE,2022,Q1,Elderly
202802331,20280233,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 iU,,,U,,,,,300.0,IU,,,2022,Q1,Electrolyte imbalance,,2022,Q1,1,I,,20200714.0,20220103,20220103,EXP,DE-ADRED-04543-01,NVSC2020DE191324,NOVARTIS,,70.0,YR,,M,Y,78.0,KG,20220103,,PH,DE,DE,2022,Q1,Elderly
202802331,20280233,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 iU,,,U,,,,,300.0,IU,,,2022,Q1,Renal impairment,,2022,Q1,1,I,,20200714.0,20220103,20220103,EXP,DE-ADRED-04543-01,NVSC2020DE191324,NOVARTIS,,70.0,YR,,M,Y,78.0,KG,20220103,,PH,DE,DE,2022,Q1,Elderly
202802331,20280233,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 iU,,,U,,,,,300.0,IU,,,2022,Q1,Hyperkalaemia,,2022,Q1,1,I,,20200714.0,20220103,20220103,EXP,DE-ADRED-04543-01,NVSC2020DE191324,NOVARTIS,,70.0,YR,,M,Y,78.0,KG,20220103,,PH,DE,DE,2022,Q1,Elderly
202802331,20280233,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 iU,,,U,,,,,300.0,IU,,,2022,Q1,Labelled drug-drug interaction medication error,,2022,Q1,1,I,,20200714.0,20220103,20220103,EXP,DE-ADRED-04543-01,NVSC2020DE191324,NOVARTIS,,70.0,YR,,M,Y,78.0,KG,20220103,,PH,DE,DE,2022,Q1,Elderly
202818761,20281876,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 international unit,,,,,,,,300.0,IU,Injection,,2022,Q1,Weight increased,,2022,Q1,1,I,,20211224.0,20220103,20220103,EXP,,DE-MYLANLABS-2021M1096421,MYLAN,,62.0,YR,,M,Y,124.0,KG,20220103,,PH,DE,DE,2022,Q1,Adult
202818761,20281876,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 international unit,,,,,,,,300.0,IU,Injection,,2022,Q1,Oedema peripheral,,2022,Q1,1,I,,20211224.0,20220103,20220103,EXP,,DE-MYLANLABS-2021M1096421,MYLAN,,62.0,YR,,M,Y,124.0,KG,20220103,,PH,DE,DE,2022,Q1,Adult
202818761,20281876,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 international unit,,,,,,,,300.0,IU,Injection,,2022,Q1,Contraindicated product administered,,2022,Q1,1,I,,20211224.0,20220103,20220103,EXP,,DE-MYLANLABS-2021M1096421,MYLAN,,62.0,YR,,M,Y,124.0,KG,20220103,,PH,DE,DE,2022,Q1,Adult
202821031,20282103,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,Injection,,2022,Q1,Maternal exposure during pregnancy,,2022,Q1,1,I,20200118.0,20211224.0,20220103,20220103,EXP,FR-AFSSAPS-CN20213885,FR-MYLANLABS-2021M1096496,MYLAN,,19.0,YR,,F,Y,33.0,KG,20220103,,MD,FR,FR,2022,Q1,Youth
202821031,20282103,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,Injection,,2022,Q1,Abortion spontaneous,,2022,Q1,1,I,20200118.0,20211224.0,20220103,20220103,EXP,FR-AFSSAPS-CN20213885,FR-MYLANLABS-2021M1096496,MYLAN,,19.0,YR,,F,Y,33.0,KG,20220103,,MD,FR,FR,2022,Q1,Youth
202909811,20290981,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit (1 IE, nach BZ, Injektions-/Infusionslosung)",,,,,,,,1.0,IU,Injection,,2022,Q1,General physical health deterioration,,2022,Q1,1,I,,20211230.0,20220104,20220104,EXP,,DE-MYLANLABS-2021M1098084,MYLAN,,64.0,YR,,M,Y,,,20220104,,PH,DE,DE,2022,Q1,Adult
202909811,20290981,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit (1 IE, nach BZ, Injektions-/Infusionslosung)",,,,,,,,1.0,IU,Injection,,2022,Q1,Diarrhoea,,2022,Q1,1,I,,20211230.0,20220104,20220104,EXP,,DE-MYLANLABS-2021M1098084,MYLAN,,64.0,YR,,M,Y,,,20220104,,PH,DE,DE,2022,Q1,Adult
202909811,20290981,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit (1 IE, nach BZ, Injektions-/Infusionslosung)",,,,,,,,1.0,IU,Injection,,2022,Q1,Vomiting,,2022,Q1,1,I,,20211230.0,20220104,20220104,EXP,,DE-MYLANLABS-2021M1098084,MYLAN,,64.0,YR,,M,Y,,,20220104,,PH,DE,DE,2022,Q1,Adult
202909811,20290981,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit (1 IE, nach BZ, Injektions-/Infusionslosung)",,,,,,,,1.0,IU,Injection,,2022,Q1,Dizziness,,2022,Q1,1,I,,20211230.0,20220104,20220104,EXP,,DE-MYLANLABS-2021M1098084,MYLAN,,64.0,YR,,M,Y,,,20220104,,PH,DE,DE,2022,Q1,Adult
202909811,20290981,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit (1 IE, nach BZ, Injektions-/Infusionslosung)",,,,,,,,1.0,IU,Injection,,2022,Q1,Muscular weakness,,2022,Q1,1,I,,20211230.0,20220104,20220104,EXP,,DE-MYLANLABS-2021M1098084,MYLAN,,64.0,YR,,M,Y,,,20220104,,PH,DE,DE,2022,Q1,Adult
202909811,20290981,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit (1 IE, nach BZ, Injektions-/Infusionslosung)",,,,,,,,1.0,IU,Injection,,2022,Q1,Abdominal pain,,2022,Q1,1,I,,20211230.0,20220104,20220104,EXP,,DE-MYLANLABS-2021M1098084,MYLAN,,64.0,YR,,M,Y,,,20220104,,PH,DE,DE,2022,Q1,Adult
202909811,20290981,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit (1 IE, nach BZ, Injektions-/Infusionslosung)",,,,,,,,1.0,IU,Injection,,2022,Q1,Headache,,2022,Q1,1,I,,20211230.0,20220104,20220104,EXP,,DE-MYLANLABS-2021M1098084,MYLAN,,64.0,YR,,M,Y,,,20220104,,PH,DE,DE,2022,Q1,Adult
202909811,20290981,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit (1 IE, nach BZ, Injektions-/Infusionslosung)",,,,,,,,1.0,IU,Injection,,2022,Q1,Decreased appetite,,2022,Q1,1,I,,20211230.0,20220104,20220104,EXP,,DE-MYLANLABS-2021M1098084,MYLAN,,64.0,YR,,M,Y,,,20220104,,PH,DE,DE,2022,Q1,Adult
202909811,20290981,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit (1 IE, nach BZ, Injektions-/Infusionslosung)",,,,,,,,1.0,IU,Injection,,2022,Q1,Chills,,2022,Q1,1,I,,20211230.0,20220104,20220104,EXP,,DE-MYLANLABS-2021M1098084,MYLAN,,64.0,YR,,M,Y,,,20220104,,PH,DE,DE,2022,Q1,Adult
202919211,20291921,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0, Injektions-/Infusionsl?sung",,,U,U,,,,,,Injection,,2022,Q1,General physical health deterioration,,2022,Q1,1,I,,20211230.0,20220104,20220104,EXP,,DE-MYLANLABS-2021M1097720,MYLAN,,79.0,YR,,M,Y,,,20220104,,PH,DE,DE,2022,Q1,Elderly
202919211,20291921,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0, Injektions-/Infusionsl?sung",,,U,U,,,,,,Injection,,2022,Q1,Product monitoring error,,2022,Q1,1,I,,20211230.0,20220104,20220104,EXP,,DE-MYLANLABS-2021M1097720,MYLAN,,79.0,YR,,M,Y,,,20220104,,PH,DE,DE,2022,Q1,Elderly
202919211,20291921,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0, Injektions-/Infusionsl?sung",,,U,U,,,,,,Injection,,2022,Q1,Anaemia,,2022,Q1,1,I,,20211230.0,20220104,20220104,EXP,,DE-MYLANLABS-2021M1097720,MYLAN,,79.0,YR,,M,Y,,,20220104,,PH,DE,DE,2022,Q1,Elderly
202919211,20291921,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0, Injektions-/Infusionsl?sung",,,U,U,,,,,,Injection,,2022,Q1,Haematochezia,,2022,Q1,1,I,,20211230.0,20220104,20220104,EXP,,DE-MYLANLABS-2021M1097720,MYLAN,,79.0,YR,,M,Y,,,20220104,,PH,DE,DE,2022,Q1,Elderly
202919211,20291921,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0, Injektions-/Infusionsl?sung",,,U,U,,,,,,Injection,,2022,Q1,Muscular weakness,,2022,Q1,1,I,,20211230.0,20220104,20220104,EXP,,DE-MYLANLABS-2021M1097720,MYLAN,,79.0,YR,,M,Y,,,20220104,,PH,DE,DE,2022,Q1,Elderly
202919591,20291959,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2022,Q1,Arthritis,,2022,Q1,1,I,,20211227.0,20220104,20220104,EXP,,CA-SA-2021SA433630,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220104,,HP,CA,CA,2022,Q1,Adult
202919591,20291959,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2022,Q1,Pericardial effusion,,2022,Q1,1,I,,20211227.0,20220104,20220104,EXP,,CA-SA-2021SA433630,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220104,,HP,CA,CA,2022,Q1,Adult
202919591,20291959,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2022,Q1,Headache,,2022,Q1,1,I,,20211227.0,20220104,20220104,EXP,,CA-SA-2021SA433630,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220104,,HP,CA,CA,2022,Q1,Adult
202919591,20291959,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2022,Q1,Diarrhoea,,2022,Q1,1,I,,20211227.0,20220104,20220104,EXP,,CA-SA-2021SA433630,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220104,,HP,CA,CA,2022,Q1,Adult
202919591,20291959,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2022,Q1,Cardiac failure congestive,,2022,Q1,1,I,,20211227.0,20220104,20220104,EXP,,CA-SA-2021SA433630,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220104,,HP,CA,CA,2022,Q1,Adult
202919591,20291959,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2022,Q1,Myalgia,,2022,Q1,1,I,,20211227.0,20220104,20220104,EXP,,CA-SA-2021SA433630,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220104,,HP,CA,CA,2022,Q1,Adult
202919591,20291959,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,,20211227.0,20220104,20220104,EXP,,CA-SA-2021SA433630,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220104,,HP,CA,CA,2022,Q1,Adult
202919591,20291959,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2022,Q1,Malnutrition,,2022,Q1,1,I,,20211227.0,20220104,20220104,EXP,,CA-SA-2021SA433630,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220104,,HP,CA,CA,2022,Q1,Adult
202919591,20291959,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2022,Q1,Weight decreased,,2022,Q1,1,I,,20211227.0,20220104,20220104,EXP,,CA-SA-2021SA433630,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220104,,HP,CA,CA,2022,Q1,Adult
202919591,20291959,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2022,Q1,Eye haemorrhage,,2022,Q1,1,I,,20211227.0,20220104,20220104,EXP,,CA-SA-2021SA433630,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220104,,HP,CA,CA,2022,Q1,Adult
202919591,20291959,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2022,Q1,Abdominal pain upper,,2022,Q1,1,I,,20211227.0,20220104,20220104,EXP,,CA-SA-2021SA433630,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220104,,HP,CA,CA,2022,Q1,Adult
202919591,20291959,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2022,Q1,Chest pain,,2022,Q1,1,I,,20211227.0,20220104,20220104,EXP,,CA-SA-2021SA433630,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220104,,HP,CA,CA,2022,Q1,Adult
202919591,20291959,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2022,Q1,Pulmonary oedema,,2022,Q1,1,I,,20211227.0,20220104,20220104,EXP,,CA-SA-2021SA433630,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220104,,HP,CA,CA,2022,Q1,Adult
202919591,20291959,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2022,Q1,Thyroid disorder,,2022,Q1,1,I,,20211227.0,20220104,20220104,EXP,,CA-SA-2021SA433630,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220104,,HP,CA,CA,2022,Q1,Adult
202919591,20291959,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2022,Q1,Multi-organ disorder,,2022,Q1,1,I,,20211227.0,20220104,20220104,EXP,,CA-SA-2021SA433630,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220104,,HP,CA,CA,2022,Q1,Adult
202919591,20291959,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Solution for injection,,2022,Q1,Neuropathy peripheral,,2022,Q1,1,I,,20211227.0,20220104,20220104,EXP,,CA-SA-2021SA433630,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220104,,HP,CA,CA,2022,Q1,Adult
202922112,20292211,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Illness,,2022,Q1,2,F,,20211227.0,20220104,20220110,EXP,,CA-SA-2021SA433316,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20220110,,CN,CA,CA,2022,Q1,Elderly
202922112,20292211,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Weight increased,,2022,Q1,2,F,,20211227.0,20220104,20220110,EXP,,CA-SA-2021SA433316,SANOFI AVENTIS,,79.0,YR,E,M,Y,,,20220110,,CN,CA,CA,2022,Q1,Elderly
202922141,20292214,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 iU, PRN",,,U,,,,209196.0,14.0,IU,Solution for injection,,2022,Q1,Hypokalaemia,,2022,Q1,1,I,,20211227.0,20220104,20220104,EXP,,CA-SA-2021SA433038,SANOFI AVENTIS,,33.0,YR,A,M,Y,,,20220104,,PH,CA,CA,2022,Q1,Young Adult
202972931,20297293,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, solution for injection / infusion",,,U,,,,,,,,,2022,Q1,Weight increased,,2022,Q1,1,I,,20211222.0,20220105,20220105,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322803,RANBAXY,,62.0,YR,,M,Y,124.0,KG,20220105,,PH,DE,DE,2022,Q1,Adult
202972931,20297293,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, solution for injection / infusion",,,U,,,,,,,,,2022,Q1,Oedema peripheral,,2022,Q1,1,I,,20211222.0,20220105,20220105,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322803,RANBAXY,,62.0,YR,,M,Y,124.0,KG,20220105,,PH,DE,DE,2022,Q1,Adult
202972931,20297293,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, solution for injection / infusion",,,U,,,,,,,,,2022,Q1,Contraindicated product administered,,2022,Q1,1,I,,20211222.0,20220105,20220105,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322803,RANBAXY,,62.0,YR,,M,Y,124.0,KG,20220105,,PH,DE,DE,2022,Q1,Adult
202992971,20299297,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,,,20563.0,,,Injection,,2022,Q1,Feeling abnormal,,2022,Q1,1,I,20211229.0,20211229.0,20220105,20220105,EXP,,US-ELI_LILLY_AND_COMPANY-US202201000004,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20220105,,CN,US,US,2022,Q1,Elderly
202992971,20299297,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,,,20563.0,,,Injection,,2022,Q1,Injury associated with device,,2022,Q1,1,I,20211229.0,20211229.0,20220105,20220105,EXP,,US-ELI_LILLY_AND_COMPANY-US202201000004,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20220105,,CN,US,US,2022,Q1,Elderly
202992971,20299297,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,,,20563.0,,,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,1,I,20211229.0,20211229.0,20220105,20220105,EXP,,US-ELI_LILLY_AND_COMPANY-US202201000004,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20220105,,CN,US,US,2022,Q1,Elderly
202992971,20299297,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,,,20563.0,,,Injection,,2022,Q1,Haemorrhage,,2022,Q1,1,I,20211229.0,20211229.0,20220105,20220105,EXP,,US-ELI_LILLY_AND_COMPANY-US202201000004,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20220105,,CN,US,US,2022,Q1,Elderly
202992971,20299297,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,,,20563.0,,,Injection,,2022,Q1,Deafness,,2022,Q1,1,I,20211229.0,20211229.0,20220105,20220105,EXP,,US-ELI_LILLY_AND_COMPANY-US202201000004,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20220105,,CN,US,US,2022,Q1,Elderly
202992971,20299297,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,,,20563.0,,,Injection,,2022,Q1,Feeling abnormal,,2022,Q1,1,I,20211229.0,20211229.0,20220105,20220105,EXP,,US-ELI_LILLY_AND_COMPANY-US202201000004,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20220105,,CN,US,US,2022,Q1,Elderly
202992971,20299297,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,,,20563.0,,,Injection,,2022,Q1,Injury associated with device,,2022,Q1,1,I,20211229.0,20211229.0,20220105,20220105,EXP,,US-ELI_LILLY_AND_COMPANY-US202201000004,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20220105,,CN,US,US,2022,Q1,Elderly
202992971,20299297,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,,,20563.0,,,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,1,I,20211229.0,20211229.0,20220105,20220105,EXP,,US-ELI_LILLY_AND_COMPANY-US202201000004,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20220105,,CN,US,US,2022,Q1,Elderly
202992971,20299297,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,,,20563.0,,,Injection,,2022,Q1,Haemorrhage,,2022,Q1,1,I,20211229.0,20211229.0,20220105,20220105,EXP,,US-ELI_LILLY_AND_COMPANY-US202201000004,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20220105,,CN,US,US,2022,Q1,Elderly
202992971,20299297,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,,,20563.0,,,Injection,,2022,Q1,Deafness,,2022,Q1,1,I,20211229.0,20211229.0,20220105,20220105,EXP,,US-ELI_LILLY_AND_COMPANY-US202201000004,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20220105,,CN,US,US,2022,Q1,Elderly
202992971,20299297,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,D371840A,,20563.0,,,Injection,,2022,Q1,Feeling abnormal,,2022,Q1,1,I,20211229.0,20211229.0,20220105,20220105,EXP,,US-ELI_LILLY_AND_COMPANY-US202201000004,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20220105,,CN,US,US,2022,Q1,Elderly
202992971,20299297,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,D371840A,,20563.0,,,Injection,,2022,Q1,Injury associated with device,,2022,Q1,1,I,20211229.0,20211229.0,20220105,20220105,EXP,,US-ELI_LILLY_AND_COMPANY-US202201000004,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20220105,,CN,US,US,2022,Q1,Elderly
202992971,20299297,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,D371840A,,20563.0,,,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,1,I,20211229.0,20211229.0,20220105,20220105,EXP,,US-ELI_LILLY_AND_COMPANY-US202201000004,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20220105,,CN,US,US,2022,Q1,Elderly
202992971,20299297,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,D371840A,,20563.0,,,Injection,,2022,Q1,Haemorrhage,,2022,Q1,1,I,20211229.0,20211229.0,20220105,20220105,EXP,,US-ELI_LILLY_AND_COMPANY-US202201000004,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20220105,,CN,US,US,2022,Q1,Elderly
202992971,20299297,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,D371840A,,20563.0,,,Injection,,2022,Q1,Deafness,,2022,Q1,1,I,20211229.0,20211229.0,20220105,20220105,EXP,,US-ELI_LILLY_AND_COMPANY-US202201000004,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20220105,,CN,US,US,2022,Q1,Elderly
202992971,20299297,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,D371840A,,20563.0,,,Injection,,2022,Q1,Feeling abnormal,,2022,Q1,1,I,20211229.0,20211229.0,20220105,20220105,EXP,,US-ELI_LILLY_AND_COMPANY-US202201000004,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20220105,,CN,US,US,2022,Q1,Elderly
202992971,20299297,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,D371840A,,20563.0,,,Injection,,2022,Q1,Injury associated with device,,2022,Q1,1,I,20211229.0,20211229.0,20220105,20220105,EXP,,US-ELI_LILLY_AND_COMPANY-US202201000004,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20220105,,CN,US,US,2022,Q1,Elderly
202992971,20299297,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,D371840A,,20563.0,,,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,1,I,20211229.0,20211229.0,20220105,20220105,EXP,,US-ELI_LILLY_AND_COMPANY-US202201000004,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20220105,,CN,US,US,2022,Q1,Elderly
202992971,20299297,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,D371840A,,20563.0,,,Injection,,2022,Q1,Haemorrhage,,2022,Q1,1,I,20211229.0,20211229.0,20220105,20220105,EXP,,US-ELI_LILLY_AND_COMPANY-US202201000004,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20220105,,CN,US,US,2022,Q1,Elderly
202992971,20299297,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,D371840A,,20563.0,,,Injection,,2022,Q1,Deafness,,2022,Q1,1,I,20211229.0,20211229.0,20220105,20220105,EXP,,US-ELI_LILLY_AND_COMPANY-US202201000004,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20220105,,CN,US,US,2022,Q1,Elderly
202993001,20299300,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, tid",,,,,,,20563.0,12.0,IU,Injection,TID,2022,Q1,Gait disturbance,,2022,Q1,1,I,20211121.0,20211229.0,20220105,20220105,EXP,,US-ELI_LILLY_AND_COMPANY-US202112013156,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20220105,,CN,US,US,2022,Q1,Elderly
202993001,20299300,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, tid",,,,,,,20563.0,12.0,IU,Injection,TID,2022,Q1,COVID-19,,2022,Q1,1,I,20211121.0,20211229.0,20220105,20220105,EXP,,US-ELI_LILLY_AND_COMPANY-US202112013156,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20220105,,CN,US,US,2022,Q1,Elderly
202993001,20299300,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,,,D379508A,,20563.0,12.0,IU,Injection,,2022,Q1,Gait disturbance,,2022,Q1,1,I,20211121.0,20211229.0,20220105,20220105,EXP,,US-ELI_LILLY_AND_COMPANY-US202112013156,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20220105,,CN,US,US,2022,Q1,Elderly
202993001,20299300,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,,,D379508A,,20563.0,12.0,IU,Injection,,2022,Q1,COVID-19,,2022,Q1,1,I,20211121.0,20211229.0,20220105,20220105,EXP,,US-ELI_LILLY_AND_COMPANY-US202112013156,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20220105,,CN,US,US,2022,Q1,Elderly
202999553,20299955,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,I.E. 8-8-9,,,U,,,,,,,,,2022,Q1,Embolism,,2022,Q1,3,F,20220103.0,20220228.0,20220105,20220302,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-000480,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,81.2,KG,20220302,,HP,DE,DE,2022,Q1,Elderly
202999553,20299955,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,I.E. 8-8-9,,,U,,,,,,,,,2022,Q1,Gastric perforation,,2022,Q1,3,F,20220103.0,20220228.0,20220105,20220302,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-000480,BRISTOL MYERS SQUIBB,,65.0,YR,,M,Y,81.2,KG,20220302,,HP,DE,DE,2022,Q1,Elderly
203031631,20303163,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"according to scheme, injection / infusion solution ()",,,U,,,,,,,,,2022,Q1,Haematochezia,,2022,Q1,1,I,20200630.0,20211223.0,20220106,20220106,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322868,RANBAXY,,67.0,YR,,M,Y,95.0,KG,20220106,,PH,DE,DE,2022,Q1,Elderly
203032861,20303286,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, according to BZ, solution for injection / infusion",,,U,,,,,,,,,2022,Q1,Chills,,2022,Q1,1,I,,20211223.0,20220106,20220106,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322985,RANBAXY,,64.0,YR,,M,Y,,,20220106,,PH,DE,DE,2022,Q1,Adult
203032861,20303286,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, according to BZ, solution for injection / infusion",,,U,,,,,,,,,2022,Q1,Decreased appetite,,2022,Q1,1,I,,20211223.0,20220106,20220106,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322985,RANBAXY,,64.0,YR,,M,Y,,,20220106,,PH,DE,DE,2022,Q1,Adult
203032861,20303286,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, according to BZ, solution for injection / infusion",,,U,,,,,,,,,2022,Q1,Abdominal pain,,2022,Q1,1,I,,20211223.0,20220106,20220106,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322985,RANBAXY,,64.0,YR,,M,Y,,,20220106,,PH,DE,DE,2022,Q1,Adult
203032861,20303286,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, according to BZ, solution for injection / infusion",,,U,,,,,,,,,2022,Q1,Dizziness,,2022,Q1,1,I,,20211223.0,20220106,20220106,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322985,RANBAXY,,64.0,YR,,M,Y,,,20220106,,PH,DE,DE,2022,Q1,Adult
203032861,20303286,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, according to BZ, solution for injection / infusion",,,U,,,,,,,,,2022,Q1,Muscular weakness,,2022,Q1,1,I,,20211223.0,20220106,20220106,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322985,RANBAXY,,64.0,YR,,M,Y,,,20220106,,PH,DE,DE,2022,Q1,Adult
203032861,20303286,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, according to BZ, solution for injection / infusion",,,U,,,,,,,,,2022,Q1,Diarrhoea,,2022,Q1,1,I,,20211223.0,20220106,20220106,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322985,RANBAXY,,64.0,YR,,M,Y,,,20220106,,PH,DE,DE,2022,Q1,Adult
203032861,20303286,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, according to BZ, solution for injection / infusion",,,U,,,,,,,,,2022,Q1,General physical health deterioration,,2022,Q1,1,I,,20211223.0,20220106,20220106,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322985,RANBAXY,,64.0,YR,,M,Y,,,20220106,,PH,DE,DE,2022,Q1,Adult
203032861,20303286,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, according to BZ, solution for injection / infusion",,,U,,,,,,,,,2022,Q1,Vomiting,,2022,Q1,1,I,,20211223.0,20220106,20220106,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322985,RANBAXY,,64.0,YR,,M,Y,,,20220106,,PH,DE,DE,2022,Q1,Adult
203032861,20303286,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, according to BZ, solution for injection / infusion",,,U,,,,,,,,,2022,Q1,Headache,,2022,Q1,1,I,,20211223.0,20220106,20220106,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322985,RANBAXY,,64.0,YR,,M,Y,,,20220106,,PH,DE,DE,2022,Q1,Adult
203033111,20303311,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0, solution for injection / infusion ()",,,U,,,,,,,,,2022,Q1,Abdominal distension,,2022,Q1,1,I,,20211223.0,20220106,20220106,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322763,RANBAXY,,84.0,YR,,M,Y,101.4,KG,20220106,,PH,DE,DE,2022,Q1,Elderly
203033111,20303311,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0, solution for injection / infusion ()",,,U,,,,,,,,,2022,Q1,Constipation,,2022,Q1,1,I,,20211223.0,20220106,20220106,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322763,RANBAXY,,84.0,YR,,M,Y,101.4,KG,20220106,,PH,DE,DE,2022,Q1,Elderly
203033111,20303311,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0, solution for injection / infusion ()",,,U,,,,,,,,,2022,Q1,Decreased appetite,,2022,Q1,1,I,,20211223.0,20220106,20220106,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322763,RANBAXY,,84.0,YR,,M,Y,101.4,KG,20220106,,PH,DE,DE,2022,Q1,Elderly
203033111,20303311,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0, solution for injection / infusion ()",,,U,,,,,,,,,2022,Q1,Decreased appetite,,2022,Q1,1,I,,20211223.0,20220106,20220106,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322763,RANBAXY,,84.0,YR,,M,Y,101.4,KG,20220106,,PH,DE,DE,2022,Q1,Elderly
203033111,20303311,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0, solution for injection / infusion ()",,,U,,,,,,,,,2022,Q1,Abdominal pain,,2022,Q1,1,I,,20211223.0,20220106,20220106,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322763,RANBAXY,,84.0,YR,,M,Y,101.4,KG,20220106,,PH,DE,DE,2022,Q1,Elderly
203033111,20303311,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0, solution for injection / infusion ()",,,U,,,,,,,,,2022,Q1,Dysuria,,2022,Q1,1,I,,20211223.0,20220106,20220106,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322763,RANBAXY,,84.0,YR,,M,Y,101.4,KG,20220106,,PH,DE,DE,2022,Q1,Elderly
203033111,20303311,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0, solution for injection / infusion ()",,,U,,,,,,,,,2022,Q1,Nausea,,2022,Q1,1,I,,20211223.0,20220106,20220106,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322763,RANBAXY,,84.0,YR,,M,Y,101.4,KG,20220106,,PH,DE,DE,2022,Q1,Elderly
203041111,20304111,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"By regime, injection solution/infusion solution",,,,,,,,,,Injection,,2022,Q1,General physical health deterioration,,2022,Q1,1,I,20200630.0,20211230.0,20220106,20220106,EXP,,DE-MYLANLABS-2021M1097721,MYLAN,,67.0,YR,,M,Y,95.0,KG,20220106,,PH,DE,DE,2022,Q1,Elderly
203041111,20304111,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"By regime, injection solution/infusion solution",,,,,,,,,,Injection,,2022,Q1,Haematochezia,,2022,Q1,1,I,20200630.0,20211230.0,20220106,20220106,EXP,,DE-MYLANLABS-2021M1097721,MYLAN,,67.0,YR,,M,Y,95.0,KG,20220106,,PH,DE,DE,2022,Q1,Elderly
203041111,20304111,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"By regime, injection solution/infusion solution",,,,,,,,,,Injection,,2022,Q1,Medication error,,2022,Q1,1,I,20200630.0,20211230.0,20220106,20220106,EXP,,DE-MYLANLABS-2021M1097721,MYLAN,,67.0,YR,,M,Y,95.0,KG,20220106,,PH,DE,DE,2022,Q1,Elderly
203041111,20304111,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"By regime, injection solution/infusion solution",,,,,,,,,,Injection,,2022,Q1,Angina pectoris,,2022,Q1,1,I,20200630.0,20211230.0,20220106,20220106,EXP,,DE-MYLANLABS-2021M1097721,MYLAN,,67.0,YR,,M,Y,95.0,KG,20220106,,PH,DE,DE,2022,Q1,Elderly
203041111,20304111,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"By regime, injection solution/infusion solution",,,,,,,,,,Injection,,2022,Q1,Asthenia,,2022,Q1,1,I,20200630.0,20211230.0,20220106,20220106,EXP,,DE-MYLANLABS-2021M1097721,MYLAN,,67.0,YR,,M,Y,95.0,KG,20220106,,PH,DE,DE,2022,Q1,Elderly
203063872,20306387,11,C,INSULINE LISPRO,,1,,"Injectievloeistof, 100 eenheden/ml (eenheden per milliliter)",,,,,,,,,,Injection,,2022,Q1,Pyrexia,,2022,Q1,2,F,20211130.0,20220106.0,20220106,20220111,EXP,NL-LRB-00726673,NL-MYLANLABS-2021M1098014,MYLAN,,85.0,YR,,M,Y,71.9,KG,20220111,,MD,NL,NL,2022,Q1,Elderly
203063872,20306387,11,C,INSULINE LISPRO,,1,,"Injectievloeistof, 100 eenheden/ml (eenheden per milliliter)",,,,,,,,,,Injection,,2022,Q1,Hypophagia,,2022,Q1,2,F,20211130.0,20220106.0,20220106,20220111,EXP,NL-LRB-00726673,NL-MYLANLABS-2021M1098014,MYLAN,,85.0,YR,,M,Y,71.9,KG,20220111,,MD,NL,NL,2022,Q1,Elderly
203063872,20306387,11,C,INSULINE LISPRO,,1,,"Injectievloeistof, 100 eenheden/ml (eenheden per milliliter)",,,,,,,,,,Injection,,2022,Q1,Balance disorder,,2022,Q1,2,F,20211130.0,20220106.0,20220106,20220111,EXP,NL-LRB-00726673,NL-MYLANLABS-2021M1098014,MYLAN,,85.0,YR,,M,Y,71.9,KG,20220111,,MD,NL,NL,2022,Q1,Elderly
203063872,20306387,11,C,INSULINE LISPRO,,1,,"Injectievloeistof, 100 eenheden/ml (eenheden per milliliter)",,,,,,,,,,Injection,,2022,Q1,Somnolence,,2022,Q1,2,F,20211130.0,20220106.0,20220106,20220111,EXP,NL-LRB-00726673,NL-MYLANLABS-2021M1098014,MYLAN,,85.0,YR,,M,Y,71.9,KG,20220111,,MD,NL,NL,2022,Q1,Elderly
203063872,20306387,11,C,INSULINE LISPRO,,1,,"Injectievloeistof, 100 eenheden/ml (eenheden per milliliter)",,,,,,,,,,Injection,,2022,Q1,Malaise,,2022,Q1,2,F,20211130.0,20220106.0,20220106,20220111,EXP,NL-LRB-00726673,NL-MYLANLABS-2021M1098014,MYLAN,,85.0,YR,,M,Y,71.9,KG,20220111,,MD,NL,NL,2022,Q1,Elderly
203063872,20306387,11,C,INSULINE LISPRO,,1,,"Injectievloeistof, 100 eenheden/ml (eenheden per milliliter)",,,,,,,,,,Injection,,2022,Q1,Fatigue,,2022,Q1,2,F,20211130.0,20220106.0,20220106,20220111,EXP,NL-LRB-00726673,NL-MYLANLABS-2021M1098014,MYLAN,,85.0,YR,,M,Y,71.9,KG,20220111,,MD,NL,NL,2022,Q1,Elderly
203063872,20306387,11,C,INSULINE LISPRO,,1,,"Injectievloeistof, 100 eenheden/ml (eenheden per milliliter)",,,,,,,,,,Injection,,2022,Q1,Oxygen saturation decreased,,2022,Q1,2,F,20211130.0,20220106.0,20220106,20220111,EXP,NL-LRB-00726673,NL-MYLANLABS-2021M1098014,MYLAN,,85.0,YR,,M,Y,71.9,KG,20220111,,MD,NL,NL,2022,Q1,Elderly
203063872,20306387,11,C,INSULINE LISPRO,,1,,"Injectievloeistof, 100 eenheden/ml (eenheden per milliliter)",,,,,,,,,,Injection,,2022,Q1,Depressed level of consciousness,,2022,Q1,2,F,20211130.0,20220106.0,20220106,20220111,EXP,NL-LRB-00726673,NL-MYLANLABS-2021M1098014,MYLAN,,85.0,YR,,M,Y,71.9,KG,20220111,,MD,NL,NL,2022,Q1,Elderly
203069561,20306956,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0,Solution for injection / infusion",,,U,,,,,,,,,2022,Q1,Product monitoring error,,2022,Q1,1,I,,20211223.0,20220107,20220107,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322998,RANBAXY,,79.0,YR,,M,Y,,,20220107,,PH,DE,DE,2022,Q1,Elderly
203069561,20306956,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0,Solution for injection / infusion",,,U,,,,,,,,,2022,Q1,Muscular weakness,,2022,Q1,1,I,,20211223.0,20220107,20220107,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322998,RANBAXY,,79.0,YR,,M,Y,,,20220107,,PH,DE,DE,2022,Q1,Elderly
203069561,20306956,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0,Solution for injection / infusion",,,U,,,,,,,,,2022,Q1,General physical health deterioration,,2022,Q1,1,I,,20211223.0,20220107,20220107,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322998,RANBAXY,,79.0,YR,,M,Y,,,20220107,,PH,DE,DE,2022,Q1,Elderly
203069561,20306956,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0,Solution for injection / infusion",,,U,,,,,,,,,2022,Q1,Haematochezia,,2022,Q1,1,I,,20211223.0,20220107,20220107,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322998,RANBAXY,,79.0,YR,,M,Y,,,20220107,,PH,DE,DE,2022,Q1,Elderly
203069561,20306956,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-8-0,Solution for injection / infusion",,,U,,,,,,,,,2022,Q1,Anaemia,,2022,Q1,1,I,,20211223.0,20220107,20220107,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-322998,RANBAXY,,79.0,YR,,M,Y,,,20220107,,PH,DE,DE,2022,Q1,Elderly
203092841,20309284,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0, Injektions-/Infusionsl?sung",,,,,,,,,,,,2022,Q1,Decreased appetite,,2022,Q1,1,I,,20211230.0,20220107,20220107,EXP,,DE-MYLANLABS-2021M1097621,MYLAN,,84.0,YR,,M,Y,101.4,KG,20220107,,PH,DE,DE,2022,Q1,Elderly
203092841,20309284,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0, Injektions-/Infusionsl?sung",,,,,,,,,,,,2022,Q1,Dysuria,,2022,Q1,1,I,,20211230.0,20220107,20220107,EXP,,DE-MYLANLABS-2021M1097621,MYLAN,,84.0,YR,,M,Y,101.4,KG,20220107,,PH,DE,DE,2022,Q1,Elderly
203092841,20309284,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0, Injektions-/Infusionsl?sung",,,,,,,,,,,,2022,Q1,Abdominal pain,,2022,Q1,1,I,,20211230.0,20220107,20220107,EXP,,DE-MYLANLABS-2021M1097621,MYLAN,,84.0,YR,,M,Y,101.4,KG,20220107,,PH,DE,DE,2022,Q1,Elderly
203092841,20309284,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0, Injektions-/Infusionsl?sung",,,,,,,,,,,,2022,Q1,Constipation,,2022,Q1,1,I,,20211230.0,20220107,20220107,EXP,,DE-MYLANLABS-2021M1097621,MYLAN,,84.0,YR,,M,Y,101.4,KG,20220107,,PH,DE,DE,2022,Q1,Elderly
203092841,20309284,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0, Injektions-/Infusionsl?sung",,,,,,,,,,,,2022,Q1,Abdominal distension,,2022,Q1,1,I,,20211230.0,20220107,20220107,EXP,,DE-MYLANLABS-2021M1097621,MYLAN,,84.0,YR,,M,Y,101.4,KG,20220107,,PH,DE,DE,2022,Q1,Elderly
203092841,20309284,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0, Injektions-/Infusionsl?sung",,,,,,,,,,,,2022,Q1,Nausea,,2022,Q1,1,I,,20211230.0,20220107,20220107,EXP,,DE-MYLANLABS-2021M1097621,MYLAN,,84.0,YR,,M,Y,101.4,KG,20220107,,PH,DE,DE,2022,Q1,Elderly
203099512,20309951,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"17, DF",,,U,,,,,,,Solution for injection,,2022,Q1,Hypoglycaemia,,2022,Q1,2,F,20211122.0,20211230.0,20220107,20220113,EXP,IT-MINISAL02-825155,IT-SA-2022SA000054,SANOFI AVENTIS,,46.0,YR,A,M,Y,,,20220113,,PH,IT,IT,2022,Q1,Adult
203107181,20310718,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, tid",,,Y,,D293492C,,20563.0,8.0,IU,,TID,2022,Q1,Respiratory rate increased,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202112013495,ELI LILLY AND CO,,76.0,YR,,M,Y,59.0,KG,20220107,,CN,CN,CN,2022,Q1,Elderly
203107181,20310718,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, tid",,,Y,,D293492C,,20563.0,8.0,IU,,TID,2022,Q1,Injection site pruritus,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202112013495,ELI LILLY AND CO,,76.0,YR,,M,Y,59.0,KG,20220107,,CN,CN,CN,2022,Q1,Elderly
203107181,20310718,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, tid",,,Y,,D293492C,,20563.0,8.0,IU,,TID,2022,Q1,Haemoglobin decreased,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202112013495,ELI LILLY AND CO,,76.0,YR,,M,Y,59.0,KG,20220107,,CN,CN,CN,2022,Q1,Elderly
203107181,20310718,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, tid",,,Y,,D293492C,,20563.0,8.0,IU,,TID,2022,Q1,Drug hypersensitivity,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202112013495,ELI LILLY AND CO,,76.0,YR,,M,Y,59.0,KG,20220107,,CN,CN,CN,2022,Q1,Elderly
203107181,20310718,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, tid",,,Y,,D293492C,,20563.0,8.0,IU,,TID,2022,Q1,Subcutaneous haematoma,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202112013495,ELI LILLY AND CO,,76.0,YR,,M,Y,59.0,KG,20220107,,CN,CN,CN,2022,Q1,Elderly
203107181,20310718,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, tid",,,Y,,D293492C,,20563.0,8.0,IU,,TID,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202112013495,ELI LILLY AND CO,,76.0,YR,,M,Y,59.0,KG,20220107,,CN,CN,CN,2022,Q1,Elderly
203107181,20310718,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, tid",,,Y,,D293492C,,20563.0,8.0,IU,,TID,2022,Q1,Injection site induration,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202112013495,ELI LILLY AND CO,,76.0,YR,,M,Y,59.0,KG,20220107,,CN,CN,CN,2022,Q1,Elderly
203107181,20310718,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, tid",,,Y,,D293492C,,20563.0,8.0,IU,,TID,2022,Q1,Blood pressure increased,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202112013495,ELI LILLY AND CO,,76.0,YR,,M,Y,59.0,KG,20220107,,CN,CN,CN,2022,Q1,Elderly
203107181,20310718,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, tid",,,Y,,D293492C,,20563.0,8.0,IU,,TID,2022,Q1,Eosinophil count increased,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202112013495,ELI LILLY AND CO,,76.0,YR,,M,Y,59.0,KG,20220107,,CN,CN,CN,2022,Q1,Elderly
203107181,20310718,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, tid",,,Y,,D293492C,,20563.0,8.0,IU,,TID,2022,Q1,Red blood cell count decreased,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202112013495,ELI LILLY AND CO,,76.0,YR,,M,Y,59.0,KG,20220107,,CN,CN,CN,2022,Q1,Elderly
203107181,20310718,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, tid",,,Y,,D293492C,,20563.0,8.0,IU,,TID,2022,Q1,Injection site induration,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202112013495,ELI LILLY AND CO,,76.0,YR,,M,Y,59.0,KG,20220107,,CN,CN,CN,2022,Q1,Elderly
203107181,20310718,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, tid",,,Y,,D293492C,,20563.0,8.0,IU,,TID,2022,Q1,Injection site induration,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202112013495,ELI LILLY AND CO,,76.0,YR,,M,Y,59.0,KG,20220107,,CN,CN,CN,2022,Q1,Elderly
203107181,20310718,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, tid",,,Y,,D293492C,,20563.0,8.0,IU,,TID,2022,Q1,Haematocrit decreased,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202112013495,ELI LILLY AND CO,,76.0,YR,,M,Y,59.0,KG,20220107,,CN,CN,CN,2022,Q1,Elderly
203107181,20310718,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, tid",,,Y,,D293492C,,20563.0,8.0,IU,,TID,2022,Q1,Respiratory rate increased,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202112013495,ELI LILLY AND CO,,76.0,YR,,M,Y,59.0,KG,20220107,,CN,CN,CN,2022,Q1,Elderly
203107181,20310718,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, tid",,,Y,,D293492C,,20563.0,8.0,IU,,TID,2022,Q1,Injection site pruritus,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202112013495,ELI LILLY AND CO,,76.0,YR,,M,Y,59.0,KG,20220107,,CN,CN,CN,2022,Q1,Elderly
203107181,20310718,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, tid",,,Y,,D293492C,,20563.0,8.0,IU,,TID,2022,Q1,Haemoglobin decreased,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202112013495,ELI LILLY AND CO,,76.0,YR,,M,Y,59.0,KG,20220107,,CN,CN,CN,2022,Q1,Elderly
203107181,20310718,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, tid",,,Y,,D293492C,,20563.0,8.0,IU,,TID,2022,Q1,Drug hypersensitivity,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202112013495,ELI LILLY AND CO,,76.0,YR,,M,Y,59.0,KG,20220107,,CN,CN,CN,2022,Q1,Elderly
203107181,20310718,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, tid",,,Y,,D293492C,,20563.0,8.0,IU,,TID,2022,Q1,Subcutaneous haematoma,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202112013495,ELI LILLY AND CO,,76.0,YR,,M,Y,59.0,KG,20220107,,CN,CN,CN,2022,Q1,Elderly
203107181,20310718,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, tid",,,Y,,D293492C,,20563.0,8.0,IU,,TID,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202112013495,ELI LILLY AND CO,,76.0,YR,,M,Y,59.0,KG,20220107,,CN,CN,CN,2022,Q1,Elderly
203107181,20310718,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, tid",,,Y,,D293492C,,20563.0,8.0,IU,,TID,2022,Q1,Injection site induration,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202112013495,ELI LILLY AND CO,,76.0,YR,,M,Y,59.0,KG,20220107,,CN,CN,CN,2022,Q1,Elderly
203107181,20310718,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, tid",,,Y,,D293492C,,20563.0,8.0,IU,,TID,2022,Q1,Blood pressure increased,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202112013495,ELI LILLY AND CO,,76.0,YR,,M,Y,59.0,KG,20220107,,CN,CN,CN,2022,Q1,Elderly
203107181,20310718,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, tid",,,Y,,D293492C,,20563.0,8.0,IU,,TID,2022,Q1,Eosinophil count increased,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202112013495,ELI LILLY AND CO,,76.0,YR,,M,Y,59.0,KG,20220107,,CN,CN,CN,2022,Q1,Elderly
203107181,20310718,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, tid",,,Y,,D293492C,,20563.0,8.0,IU,,TID,2022,Q1,Red blood cell count decreased,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202112013495,ELI LILLY AND CO,,76.0,YR,,M,Y,59.0,KG,20220107,,CN,CN,CN,2022,Q1,Elderly
203107181,20310718,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, tid",,,Y,,D293492C,,20563.0,8.0,IU,,TID,2022,Q1,Injection site induration,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202112013495,ELI LILLY AND CO,,76.0,YR,,M,Y,59.0,KG,20220107,,CN,CN,CN,2022,Q1,Elderly
203107181,20310718,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, tid",,,Y,,D293492C,,20563.0,8.0,IU,,TID,2022,Q1,Injection site induration,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202112013495,ELI LILLY AND CO,,76.0,YR,,M,Y,59.0,KG,20220107,,CN,CN,CN,2022,Q1,Elderly
203107181,20310718,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, tid",,,Y,,D293492C,,20563.0,8.0,IU,,TID,2022,Q1,Haematocrit decreased,,2022,Q1,1,I,20211001.0,20211228.0,20220107,20220107,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202112013495,ELI LILLY AND CO,,76.0,YR,,M,Y,59.0,KG,20220107,,CN,CN,CN,2022,Q1,Elderly
203111253,20311125,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,,,,,,2022,Q1,Vomiting,,2022,Q1,3,F,20211201.0,20220103.0,20220107,20220118,EXP,,MX-ELI_LILLY_AND_COMPANY-MX202201000133,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20220118,,CN,MX,MX,2022,Q1,Adult
203111253,20311125,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,,,,,,2022,Q1,Decreased appetite,,2022,Q1,3,F,20211201.0,20220103.0,20220107,20220118,EXP,,MX-ELI_LILLY_AND_COMPANY-MX202201000133,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20220118,,CN,MX,MX,2022,Q1,Adult
203111253,20311125,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,,,,,,2022,Q1,Kidney infection,,2022,Q1,3,F,20211201.0,20220103.0,20220107,20220118,EXP,,MX-ELI_LILLY_AND_COMPANY-MX202201000133,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20220118,,CN,MX,MX,2022,Q1,Adult
203111253,20311125,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,,,,,,2022,Q1,Thirst decreased,,2022,Q1,3,F,20211201.0,20220103.0,20220107,20220118,EXP,,MX-ELI_LILLY_AND_COMPANY-MX202201000133,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20220118,,CN,MX,MX,2022,Q1,Adult
203111253,20311125,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,,,,,,2022,Q1,Nausea,,2022,Q1,3,F,20211201.0,20220103.0,20220107,20220118,EXP,,MX-ELI_LILLY_AND_COMPANY-MX202201000133,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20220118,,CN,MX,MX,2022,Q1,Adult
203111253,20311125,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,,,,,,2022,Q1,Abdominal pain upper,,2022,Q1,3,F,20211201.0,20220103.0,20220107,20220118,EXP,,MX-ELI_LILLY_AND_COMPANY-MX202201000133,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20220118,,CN,MX,MX,2022,Q1,Adult
203111451,20311145,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,100 IE/ml,,,,,,,,,,Unknown,,2022,Q1,Back pain,,2022,Q1,1,I,20211225.0,20220104.0,20220107,20220107,EXP,,AT-CELGENEUS-AUT-20220101213,CELGENE,,81.0,YR,,F,Y,85.0,KG,20220107,,HP,AT,AT,2022,Q1,Elderly
203161241,20316124,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D395986A,,20563.0,,,Injection,,2022,Q1,Wrong patient,,2022,Q1,1,I,,20220107.0,20220110,20220110,PER,,US-ELI_LILLY_AND_COMPANY-US202201002671,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20220110,,CN,US,US,2022,Q1,Elderly
203170241,20317024,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"60 international unit, qd",,,,,,,,60.0,IU,,QD,2022,Q1,Steroid diabetes,,2022,Q1,1,I,,20211228.0,20220110,20220110,EXP,,CN-LUPIN PHARMACEUTICALS INC.-2021-26592,LUPIN,"Zhang J, Chen Y, Wang J, Xia H, Zheng Y. The effect of liraglutide on insulin allergy in a patient with glucocorticoid-induced diabetes and multiple sclerosis. Nagoya Journal of Medical Science. 2021;83:343-351",55.0,YR,,M,Y,85.0,KG,20220110,,HP,CN,CN,2022,Q1,Adult
203170241,20317024,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"60 international unit, qd",,,,,,,,60.0,IU,,QD,2022,Q1,Weight increased,,2022,Q1,1,I,,20211228.0,20220110,20220110,EXP,,CN-LUPIN PHARMACEUTICALS INC.-2021-26592,LUPIN,"Zhang J, Chen Y, Wang J, Xia H, Zheng Y. The effect of liraglutide on insulin allergy in a patient with glucocorticoid-induced diabetes and multiple sclerosis. Nagoya Journal of Medical Science. 2021;83:343-351",55.0,YR,,M,Y,85.0,KG,20220110,,HP,CN,CN,2022,Q1,Adult
203170241,20317024,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"54 international unit, qd",,,,,,,,54.0,IU,,QD,2022,Q1,Steroid diabetes,,2022,Q1,1,I,,20211228.0,20220110,20220110,EXP,,CN-LUPIN PHARMACEUTICALS INC.-2021-26592,LUPIN,"Zhang J, Chen Y, Wang J, Xia H, Zheng Y. The effect of liraglutide on insulin allergy in a patient with glucocorticoid-induced diabetes and multiple sclerosis. Nagoya Journal of Medical Science. 2021;83:343-351",55.0,YR,,M,Y,85.0,KG,20220110,,HP,CN,CN,2022,Q1,Adult
203170241,20317024,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"54 international unit, qd",,,,,,,,54.0,IU,,QD,2022,Q1,Weight increased,,2022,Q1,1,I,,20211228.0,20220110,20220110,EXP,,CN-LUPIN PHARMACEUTICALS INC.-2021-26592,LUPIN,"Zhang J, Chen Y, Wang J, Xia H, Zheng Y. The effect of liraglutide on insulin allergy in a patient with glucocorticoid-induced diabetes and multiple sclerosis. Nagoya Journal of Medical Science. 2021;83:343-351",55.0,YR,,M,Y,85.0,KG,20220110,,HP,CN,CN,2022,Q1,Adult
203170241,20317024,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"46 international unit, qd",,,,,,,,46.0,IU,,QD,2022,Q1,Steroid diabetes,,2022,Q1,1,I,,20211228.0,20220110,20220110,EXP,,CN-LUPIN PHARMACEUTICALS INC.-2021-26592,LUPIN,"Zhang J, Chen Y, Wang J, Xia H, Zheng Y. The effect of liraglutide on insulin allergy in a patient with glucocorticoid-induced diabetes and multiple sclerosis. Nagoya Journal of Medical Science. 2021;83:343-351",55.0,YR,,M,Y,85.0,KG,20220110,,HP,CN,CN,2022,Q1,Adult
203170241,20317024,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"46 international unit, qd",,,,,,,,46.0,IU,,QD,2022,Q1,Weight increased,,2022,Q1,1,I,,20211228.0,20220110,20220110,EXP,,CN-LUPIN PHARMACEUTICALS INC.-2021-26592,LUPIN,"Zhang J, Chen Y, Wang J, Xia H, Zheng Y. The effect of liraglutide on insulin allergy in a patient with glucocorticoid-induced diabetes and multiple sclerosis. Nagoya Journal of Medical Science. 2021;83:343-351",55.0,YR,,M,Y,85.0,KG,20220110,,HP,CN,CN,2022,Q1,Adult
203170241,20317024,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 international unit, qd",,,,,,,,30.0,IU,,QD,2022,Q1,Steroid diabetes,,2022,Q1,1,I,,20211228.0,20220110,20220110,EXP,,CN-LUPIN PHARMACEUTICALS INC.-2021-26592,LUPIN,"Zhang J, Chen Y, Wang J, Xia H, Zheng Y. The effect of liraglutide on insulin allergy in a patient with glucocorticoid-induced diabetes and multiple sclerosis. Nagoya Journal of Medical Science. 2021;83:343-351",55.0,YR,,M,Y,85.0,KG,20220110,,HP,CN,CN,2022,Q1,Adult
203170241,20317024,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 international unit, qd",,,,,,,,30.0,IU,,QD,2022,Q1,Weight increased,,2022,Q1,1,I,,20211228.0,20220110,20220110,EXP,,CN-LUPIN PHARMACEUTICALS INC.-2021-26592,LUPIN,"Zhang J, Chen Y, Wang J, Xia H, Zheng Y. The effect of liraglutide on insulin allergy in a patient with glucocorticoid-induced diabetes and multiple sclerosis. Nagoya Journal of Medical Science. 2021;83:343-351",55.0,YR,,M,Y,85.0,KG,20220110,,HP,CN,CN,2022,Q1,Adult
203170241,20317024,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 international unit, qd",,,,,,,,18.0,IU,,QD,2022,Q1,Steroid diabetes,,2022,Q1,1,I,,20211228.0,20220110,20220110,EXP,,CN-LUPIN PHARMACEUTICALS INC.-2021-26592,LUPIN,"Zhang J, Chen Y, Wang J, Xia H, Zheng Y. The effect of liraglutide on insulin allergy in a patient with glucocorticoid-induced diabetes and multiple sclerosis. Nagoya Journal of Medical Science. 2021;83:343-351",55.0,YR,,M,Y,85.0,KG,20220110,,HP,CN,CN,2022,Q1,Adult
203170241,20317024,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"18 international unit, qd",,,,,,,,18.0,IU,,QD,2022,Q1,Weight increased,,2022,Q1,1,I,,20211228.0,20220110,20220110,EXP,,CN-LUPIN PHARMACEUTICALS INC.-2021-26592,LUPIN,"Zhang J, Chen Y, Wang J, Xia H, Zheng Y. The effect of liraglutide on insulin allergy in a patient with glucocorticoid-induced diabetes and multiple sclerosis. Nagoya Journal of Medical Science. 2021;83:343-351",55.0,YR,,M,Y,85.0,KG,20220110,,HP,CN,CN,2022,Q1,Adult
203232351,20323235,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Arthralgia,,2022,Q1,1,I,20210801.0,20210826.0,20220111,20220111,PER,,US-NOVOPROD-845067,NOVO NORDISK,,74.0,YR,,F,Y,,,20220111,,CN,US,US,2022,Q1,Elderly
203232351,20323235,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Swelling face,,2022,Q1,1,I,20210801.0,20210826.0,20220111,20220111,PER,,US-NOVOPROD-845067,NOVO NORDISK,,74.0,YR,,F,Y,,,20220111,,CN,US,US,2022,Q1,Elderly
203232351,20323235,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Headache,,2022,Q1,1,I,20210801.0,20210826.0,20220111,20220111,PER,,US-NOVOPROD-845067,NOVO NORDISK,,74.0,YR,,F,Y,,,20220111,,CN,US,US,2022,Q1,Elderly
203232351,20323235,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Product dose omission issue,,2022,Q1,1,I,20210801.0,20210826.0,20220111,20220111,PER,,US-NOVOPROD-845067,NOVO NORDISK,,74.0,YR,,F,Y,,,20220111,,CN,US,US,2022,Q1,Elderly
203232351,20323235,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Neck pain,,2022,Q1,1,I,20210801.0,20210826.0,20220111,20220111,PER,,US-NOVOPROD-845067,NOVO NORDISK,,74.0,YR,,F,Y,,,20220111,,CN,US,US,2022,Q1,Elderly
203232351,20323235,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Swelling,,2022,Q1,1,I,20210801.0,20210826.0,20220111,20220111,PER,,US-NOVOPROD-845067,NOVO NORDISK,,74.0,YR,,F,Y,,,20220111,,CN,US,US,2022,Q1,Elderly
203232351,20323235,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Swelling,,2022,Q1,1,I,20210801.0,20210826.0,20220111,20220111,PER,,US-NOVOPROD-845067,NOVO NORDISK,,74.0,YR,,F,Y,,,20220111,,CN,US,US,2022,Q1,Elderly
203232351,20323235,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Facial pain,,2022,Q1,1,I,20210801.0,20210826.0,20220111,20220111,PER,,US-NOVOPROD-845067,NOVO NORDISK,,74.0,YR,,F,Y,,,20220111,,CN,US,US,2022,Q1,Elderly
203324901,20332490,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Death,,2022,Q1,1,I,20210818.0,,20220113,20220113,DIR,599003,,FDA-CTU,,64.0,YR,,M,N,,,20220113,N,PH,US,,2022,Q1,Adult
203382991,20338299,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 u, each morning",,,U,,D395986A,,20563.0,4.0,IU,Injection,QD,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20211228.0,20211228.0,20220115,20220115,PER,,US-ELI_LILLY_AND_COMPANY-US202112012955,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20220115,,CN,US,US,2022,Q1,Elderly
203382991,20338299,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 u, each morning",,,U,,D395986A,,20563.0,4.0,IU,Injection,QD,2022,Q1,Incorrect dose administered,,2022,Q1,1,I,20211228.0,20211228.0,20220115,20220115,PER,,US-ELI_LILLY_AND_COMPANY-US202112012955,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20220115,,CN,US,US,2022,Q1,Elderly
203382991,20338299,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 u, daily (afternoon)",,,U,,D395986A,,20563.0,6.0,IU,Injection,QD,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20211228.0,20211228.0,20220115,20220115,PER,,US-ELI_LILLY_AND_COMPANY-US202112012955,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20220115,,CN,US,US,2022,Q1,Elderly
203382991,20338299,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6 u, daily (afternoon)",,,U,,D395986A,,20563.0,6.0,IU,Injection,QD,2022,Q1,Incorrect dose administered,,2022,Q1,1,I,20211228.0,20211228.0,20220115,20220115,PER,,US-ELI_LILLY_AND_COMPANY-US202112012955,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20220115,,CN,US,US,2022,Q1,Elderly
203382991,20338299,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 u, daily (at night)",,,U,,D395986A,,20563.0,3.0,IU,Injection,QD,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20211228.0,20211228.0,20220115,20220115,PER,,US-ELI_LILLY_AND_COMPANY-US202112012955,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20220115,,CN,US,US,2022,Q1,Elderly
203382991,20338299,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 u, daily (at night)",,,U,,D395986A,,20563.0,3.0,IU,Injection,QD,2022,Q1,Incorrect dose administered,,2022,Q1,1,I,20211228.0,20211228.0,20220115,20220115,PER,,US-ELI_LILLY_AND_COMPANY-US202112012955,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20220115,,CN,US,US,2022,Q1,Elderly
203427001,20342700,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D379508A,,20563.0,,,Injection,,2022,Q1,Visual impairment,,2022,Q1,1,I,,20220112.0,20220117,20220117,PER,,US-ELI_LILLY_AND_COMPANY-US202201004638,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220117,,CN,US,US,2022,Q1,Adult
203435102,20343510,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,15-16-14 UI,,,U,,,,,,,,,2022,Q1,Condition aggravated,,2022,Q1,2,F,20220108.0,20220121.0,20220118,20220130,EXP,,CO-SA-2022SA012256,SANOFI AVENTIS,,36.0,YR,A,F,Y,,,20220130,,CN,CO,CO,2022,Q1,Adult
203435102,20343510,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,15-16-14 UI,,,U,,,,,,,,,2022,Q1,Hypothyroidism,,2022,Q1,2,F,20220108.0,20220121.0,20220118,20220130,EXP,,CO-SA-2022SA012256,SANOFI AVENTIS,,36.0,YR,A,F,Y,,,20220130,,CN,CO,CO,2022,Q1,Adult
203435102,20343510,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,15-16-14 UI,,,U,,,,,,,,,2022,Q1,Stress,,2022,Q1,2,F,20220108.0,20220121.0,20220118,20220130,EXP,,CO-SA-2022SA012256,SANOFI AVENTIS,,36.0,YR,A,F,Y,,,20220130,,CN,CO,CO,2022,Q1,Adult
203465901,20346590,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Speech disorder,,2022,Q1,1,I,20211227.0,,20220115,20220115,DIR,599337,,FDA-CTU,,79.0,DY,,F,N,54.0,KG,20220115,N,CN,US,,2022,Q1,Elderly
203465901,20346590,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Fall,,2022,Q1,1,I,20211227.0,,20220115,20220115,DIR,599337,,FDA-CTU,,79.0,DY,,F,N,54.0,KG,20220115,N,CN,US,,2022,Q1,Elderly
203465901,20346590,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Confusional state,,2022,Q1,1,I,20211227.0,,20220115,20220115,DIR,599337,,FDA-CTU,,79.0,DY,,F,N,54.0,KG,20220115,N,CN,US,,2022,Q1,Elderly
203465901,20346590,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Injury,,2022,Q1,1,I,20211227.0,,20220115,20220115,DIR,599337,,FDA-CTU,,79.0,DY,,F,N,54.0,KG,20220115,N,CN,US,,2022,Q1,Elderly
203465901,20346590,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Urinary tract infection,,2022,Q1,1,I,20211227.0,,20220115,20220115,DIR,599337,,FDA-CTU,,79.0,DY,,F,N,54.0,KG,20220115,N,CN,US,,2022,Q1,Elderly
203465901,20346590,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Cerebral haemorrhage,,2022,Q1,1,I,20211227.0,,20220115,20220115,DIR,599337,,FDA-CTU,,79.0,DY,,F,N,54.0,KG,20220115,N,CN,US,,2022,Q1,Elderly
203465901,20346590,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Dysuria,,2022,Q1,1,I,20211227.0,,20220115,20220115,DIR,599337,,FDA-CTU,,79.0,DY,,F,N,54.0,KG,20220115,N,CN,US,,2022,Q1,Elderly
203465901,20346590,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Thrombosis,,2022,Q1,1,I,20211227.0,,20220115,20220115,DIR,599337,,FDA-CTU,,79.0,DY,,F,N,54.0,KG,20220115,N,CN,US,,2022,Q1,Elderly
203465901,20346590,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,General physical health deterioration,,2022,Q1,1,I,20211227.0,,20220115,20220115,DIR,599337,,FDA-CTU,,79.0,DY,,F,N,54.0,KG,20220115,N,CN,US,,2022,Q1,Elderly
203475561,20347556,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D371847A,,20563.0,,,Injection,,2022,Q1,COVID-19,,2022,Q1,1,I,20220103.0,20220113.0,20220118,20220118,EXP,,US-ELI_LILLY_AND_COMPANY-US202201005815,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20220118,,CN,US,US,2022,Q1,Elderly
203481502,20348150,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Blood glucose decreased,,2022,Q1,2,F,20211216.0,20220324.0,20220119,20220330,EXP,,AT-JNJFOC-20220132048,JOHNSON AND JOHNSON,,66.0,YR,E,F,Y,,,20220330,,CN,AT,AT,2022,Q1,Elderly
203481502,20348150,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Loss of consciousness,,2022,Q1,2,F,20211216.0,20220324.0,20220119,20220330,EXP,,AT-JNJFOC-20220132048,JOHNSON AND JOHNSON,,66.0,YR,E,F,Y,,,20220330,,CN,AT,AT,2022,Q1,Elderly
203481502,20348150,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Syncope,,2022,Q1,2,F,20211216.0,20220324.0,20220119,20220330,EXP,,AT-JNJFOC-20220132048,JOHNSON AND JOHNSON,,66.0,YR,E,F,Y,,,20220330,,CN,AT,AT,2022,Q1,Elderly
203481502,20348150,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Blood glucose decreased,,2022,Q1,2,F,20211216.0,20220324.0,20220119,20220330,EXP,,AT-JNJFOC-20220132048,JOHNSON AND JOHNSON,,66.0,YR,E,F,Y,,,20220330,,CN,AT,AT,2022,Q1,Elderly
203481502,20348150,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Loss of consciousness,,2022,Q1,2,F,20211216.0,20220324.0,20220119,20220330,EXP,,AT-JNJFOC-20220132048,JOHNSON AND JOHNSON,,66.0,YR,E,F,Y,,,20220330,,CN,AT,AT,2022,Q1,Elderly
203481502,20348150,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q1,Syncope,,2022,Q1,2,F,20211216.0,20220324.0,20220119,20220330,EXP,,AT-JNJFOC-20220132048,JOHNSON AND JOHNSON,,66.0,YR,E,F,Y,,,20220330,,CN,AT,AT,2022,Q1,Elderly
203541583,20354158,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100unit/ml-20units daily,,,,,,,,,,Injection,,2022,Q1,Pneumonia,,2022,Q1,3,F,20211222.0,20220131.0,20220120,20220203,EXP,,US-CELGENEUS-USA-20220104288,CELGENE,,92.0,YR,,F,Y,58.566,KG,20220203,,MD,US,US,2022,Q1,Elderly
203561881,20356188,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Vomiting,,2022,Q1,1,I,20211101.0,20220110.0,20220120,20220120,EXP,,US-BAYER-2022A003938,BAYER,,70.0,YR,E,M,Y,102.0,KG,20220120,,CN,US,US,2022,Q1,Elderly
203561881,20356188,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Oedema peripheral,,2022,Q1,1,I,20211101.0,20220110.0,20220120,20220120,EXP,,US-BAYER-2022A003938,BAYER,,70.0,YR,E,M,Y,102.0,KG,20220120,,CN,US,US,2022,Q1,Elderly
203561881,20356188,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Hepatic enzyme increased,,2022,Q1,1,I,20211101.0,20220110.0,20220120,20220120,EXP,,US-BAYER-2022A003938,BAYER,,70.0,YR,E,M,Y,102.0,KG,20220120,,CN,US,US,2022,Q1,Elderly
203561881,20356188,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Pruritus,,2022,Q1,1,I,20211101.0,20220110.0,20220120,20220120,EXP,,US-BAYER-2022A003938,BAYER,,70.0,YR,E,M,Y,102.0,KG,20220120,,CN,US,US,2022,Q1,Elderly
203561881,20356188,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Oedema,,2022,Q1,1,I,20211101.0,20220110.0,20220120,20220120,EXP,,US-BAYER-2022A003938,BAYER,,70.0,YR,E,M,Y,102.0,KG,20220120,,CN,US,US,2022,Q1,Elderly
203561881,20356188,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Nausea,,2022,Q1,1,I,20211101.0,20220110.0,20220120,20220120,EXP,,US-BAYER-2022A003938,BAYER,,70.0,YR,E,M,Y,102.0,KG,20220120,,CN,US,US,2022,Q1,Elderly
203561881,20356188,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Blood potassium decreased,,2022,Q1,1,I,20211101.0,20220110.0,20220120,20220120,EXP,,US-BAYER-2022A003938,BAYER,,70.0,YR,E,M,Y,102.0,KG,20220120,,CN,US,US,2022,Q1,Elderly
203593971,20359397,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,1 unit for 3 g,,,Y,,,,,,,,,2022,Q1,Hypoglycaemia,,2022,Q1,1,I,,20220109.0,20220121,20220121,EXP,,"CA-Saptalis Pharmaceuticals,LLC-000164",SAPTALIS PHARMACEUTICALS,"CA-Saptalis Pharmaceuticals,LLC-000164-01_Intial Source Document",17.0,YR,T,M,Y,,,20220121,,MD,CA,,2022,Q1,Youth
203593971,20359397,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,1 unit for 3 g,,,Y,,,,,,,,,2022,Q1,Treatment noncompliance,,2022,Q1,1,I,,20220109.0,20220121,20220121,EXP,,"CA-Saptalis Pharmaceuticals,LLC-000164",SAPTALIS PHARMACEUTICALS,"CA-Saptalis Pharmaceuticals,LLC-000164-01_Intial Source Document",17.0,YR,T,M,Y,,,20220121,,MD,CA,,2022,Q1,Youth
203593971,20359397,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,1 unit for 3 g,,,Y,,,,,,,,,2022,Q1,Vomiting,,2022,Q1,1,I,,20220109.0,20220121,20220121,EXP,,"CA-Saptalis Pharmaceuticals,LLC-000164",SAPTALIS PHARMACEUTICALS,"CA-Saptalis Pharmaceuticals,LLC-000164-01_Intial Source Document",17.0,YR,T,M,Y,,,20220121,,MD,CA,,2022,Q1,Youth
203675641,20367564,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,,,D429228A,,20563.0,,,Solution for injection,,2022,Q1,Blood glucose abnormal,,2022,Q1,1,I,20220101.0,20220112.0,20220124,20220124,PER,,US-ELI_LILLY_AND_COMPANY-US202201005340,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220124,,CN,US,US,2022,Q1,Elderly
203675641,20367564,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,,,D429228A,,20563.0,,,Solution for injection,,2022,Q1,Pancreatic disorder,,2022,Q1,1,I,20220101.0,20220112.0,20220124,20220124,PER,,US-ELI_LILLY_AND_COMPANY-US202201005340,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220124,,CN,US,US,2022,Q1,Elderly
203675641,20367564,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, unknown",,,,,D429228A,,20563.0,,,Solution for injection,,2022,Q1,Drug ineffective,,2022,Q1,1,I,20220101.0,20220112.0,20220124,20220124,PER,,US-ELI_LILLY_AND_COMPANY-US202201005340,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220124,,CN,US,US,2022,Q1,Elderly
203690551,20369055,6,C,LISPRO ,,2,,,,,,,,,,,,,,2022,Q1,Intestinal mass,,2022,Q1,1,I,20220118.0,,20220121,20220121,DIR,FDA-CDER-CTU-2022-5938,,FDA-CTU,,66.0,YR,,F,N,101.6,KG,20220124,N,PH,US,,2022,Q1,Elderly
203690551,20369055,6,C,LISPRO ,,2,,,,,,,,,,,,,,2022,Q1,COVID-19,,2022,Q1,1,I,20220118.0,,20220121,20220121,DIR,FDA-CDER-CTU-2022-5938,,FDA-CTU,,66.0,YR,,F,N,101.6,KG,20220124,N,PH,US,,2022,Q1,Elderly
203690551,20369055,6,C,LISPRO ,,2,,,,,,,,,,,,,,2022,Q1,Sepsis,,2022,Q1,1,I,20220118.0,,20220121,20220121,DIR,FDA-CDER-CTU-2022-5938,,FDA-CTU,,66.0,YR,,F,N,101.6,KG,20220124,N,PH,US,,2022,Q1,Elderly
203704051,20370405,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID (AM, PM, plus sliding scale with meals)",,,Y,,,,209196.0,,,Solution for injection,Q12H,2022,Q1,Hypothermia,,2022,Q1,1,I,,20220117.0,20220124,20220124,EXP,,US-SA-2022SA014035,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20220124,,HP,US,US,2022,Q1,Elderly
203704051,20370405,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 U, BID (AM, PM, plus sliding scale with meals)",,,Y,,,,209196.0,,,Solution for injection,Q12H,2022,Q1,Hypoglycaemia,,2022,Q1,1,I,,20220117.0,20220124,20220124,EXP,,US-SA-2022SA014035,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20220124,,HP,US,US,2022,Q1,Elderly
203704051,20370405,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 U, BID (AM, PM, plus sliding scale with meals)",,,Y,,,,209196.0,,,Solution for injection,Q12H,2022,Q1,Hypothermia,,2022,Q1,1,I,,20220117.0,20220124,20220124,EXP,,US-SA-2022SA014035,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20220124,,HP,US,US,2022,Q1,Elderly
203704051,20370405,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 U, BID (AM, PM, plus sliding scale with meals)",,,Y,,,,209196.0,,,Solution for injection,Q12H,2022,Q1,Hypoglycaemia,,2022,Q1,1,I,,20220117.0,20220124,20220124,EXP,,US-SA-2022SA014035,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20220124,,HP,US,US,2022,Q1,Elderly
203720182,20372018,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D361915F,,20563.0,,,Injection,,2022,Q1,Drug ineffective,,2022,Q1,2,F,20210701.0,20220125.0,20220124,20220130,PER,,US-ELI_LILLY_AND_COMPANY-US202201008661,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220130,,CN,US,US,2022,Q1,Elderly
203720182,20372018,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D361915F,,20563.0,,,Injection,,2022,Q1,Incorrect product administration duration,,2022,Q1,2,F,20210701.0,20220125.0,20220124,20220130,PER,,US-ELI_LILLY_AND_COMPANY-US202201008661,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220130,,CN,US,US,2022,Q1,Elderly
203720182,20372018,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D361915F,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20210701.0,20220125.0,20220124,20220130,PER,,US-ELI_LILLY_AND_COMPANY-US202201008661,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220130,,CN,US,US,2022,Q1,Elderly
203720182,20372018,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,UNKNOWN,,20563.0,,,Injection,,2022,Q1,Drug ineffective,,2022,Q1,2,F,20210701.0,20220125.0,20220124,20220130,PER,,US-ELI_LILLY_AND_COMPANY-US202201008661,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220130,,CN,US,US,2022,Q1,Elderly
203720182,20372018,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,UNKNOWN,,20563.0,,,Injection,,2022,Q1,Incorrect product administration duration,,2022,Q1,2,F,20210701.0,20220125.0,20220124,20220130,PER,,US-ELI_LILLY_AND_COMPANY-US202201008661,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220130,,CN,US,US,2022,Q1,Elderly
203720182,20372018,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,UNKNOWN,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20210701.0,20220125.0,20220124,20220130,PER,,US-ELI_LILLY_AND_COMPANY-US202201008661,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220130,,CN,US,US,2022,Q1,Elderly
203723701,20372370,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),UNK (10 units),,,U,,,,,,,,,2022,Q1,Condition aggravated,,2022,Q1,1,I,,20220111.0,20220124,20220124,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2021R1-284561,RANBAXY,"Kutner S, Scaturo N, Williams B. Idarucizumab (PRADAXA) as a sole reversal agent in an unstablehemorrhagic shock patient on an unknown anticoagulant with elevated protime/international normalized ratio (PT/INR). Am J Emerg Med. 2021;46:800e1-800.e3 (1-3)",85.0,YR,,F,Y,,,20220125,,HP,US,US,2022,Q1,Elderly
203750835,20375083,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 unit /ml,,,,,,,,,,Solution,,2022,Q1,Cardiac ventricular thrombosis,,2022,Q1,5,F,20220107.0,20220202.0,20220125,20220211,EXP,,US-CELGENEUS-USA-20220105561,CELGENE,,65.0,YR,,M,Y,85.352,KG,20220211,,HP,US,US,2022,Q1,Elderly
203750835,20375083,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 unit /ml,,,,,,,,,,Solution,,2022,Q1,Coronary artery disease,,2022,Q1,5,F,20220107.0,20220202.0,20220125,20220211,EXP,,US-CELGENEUS-USA-20220105561,CELGENE,,65.0,YR,,M,Y,85.352,KG,20220211,,HP,US,US,2022,Q1,Elderly
203755531,20375553,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 iU,,,U,,,,,10.0,IU,,,2022,Q1,Arthritis,,2022,Q1,1,I,20210901.0,20220114.0,20220125,20220125,EXP,,US-SA-2022SA017564,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20220125,,CN,US,US,2022,Q1,Elderly
203755531,20375553,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 iU,,,U,,,,,10.0,IU,,,2022,Q1,Unevaluable event,,2022,Q1,1,I,20210901.0,20220114.0,20220125,20220125,EXP,,US-SA-2022SA017564,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20220125,,CN,US,US,2022,Q1,Elderly
203755531,20375553,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 iU,,,U,,,,,10.0,IU,,,2022,Q1,Lung neoplasm malignant,,2022,Q1,1,I,20210901.0,20220114.0,20220125,20220125,EXP,,US-SA-2022SA017564,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20220125,,CN,US,US,2022,Q1,Elderly
203755531,20375553,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 iU,,,U,,,,,10.0,IU,,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20210901.0,20220114.0,20220125,20220125,EXP,,US-SA-2022SA017564,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20220125,,CN,US,US,2022,Q1,Elderly
203755531,20375553,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 iU,,,U,,,,,10.0,IU,,,2022,Q1,Night sweats,,2022,Q1,1,I,20210901.0,20220114.0,20220125,20220125,EXP,,US-SA-2022SA017564,SANOFI AVENTIS,,83.0,YR,E,F,Y,,,20220125,,CN,US,US,2022,Q1,Elderly
203778611,20377861,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,Injection,,2022,Q1,Autoimmune haemolytic anaemia,,2022,Q1,1,I,,20220117.0,20220126,20220126,EXP,,CN-ROCHE-3004208,ROCHE,"Dong Q, Shen Y, Li L and Wang R. Severe autoimmune hemolytic anemia caused by Pegylated Interferon alfa-2a injection: a pharmaceutical practice. Clinical Medication Journal 2021 Dec;19 (12):90-2.",43.0,YR,,M,Y,80.0,KG,20220126,,HP,CN,,2022,Q1,Adult
203781001,20378100,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q1,Off label use,,2022,Q1,1,I,,20220112.0,20220126,20220126,EXP,,CA-TAKEDA-2022TUS004046,TAKEDA,,20.0,YR,,F,Y,,,20220126,,HP,CA,CA,2022,Q1,Youth
203781001,20378100,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q1,Drug ineffective for unapproved indication,,2022,Q1,1,I,,20220112.0,20220126,20220126,EXP,,CA-TAKEDA-2022TUS004046,TAKEDA,,20.0,YR,,F,Y,,,20220126,,HP,CA,CA,2022,Q1,Youth
203789181,20378918,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Disease progression,,2022,Q1,1,I,20220108.0,,20220126,20220126,DIR,FDA-CDER-CTU-2022-6944,,FDA-CTU,,67.0,YR,,M,N,74.1,KG,20220119,N,,US,,2022,Q1,Elderly
203789181,20378918,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Metastases to lung,,2022,Q1,1,I,20220108.0,,20220126,20220126,DIR,FDA-CDER-CTU-2022-6944,,FDA-CTU,,67.0,YR,,M,N,74.1,KG,20220119,N,,US,,2022,Q1,Elderly
203789181,20378918,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Asthenia,,2022,Q1,1,I,20220108.0,,20220126,20220126,DIR,FDA-CDER-CTU-2022-6944,,FDA-CTU,,67.0,YR,,M,N,74.1,KG,20220119,N,,US,,2022,Q1,Elderly
203789181,20378918,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Metastases to bone,,2022,Q1,1,I,20220108.0,,20220126,20220126,DIR,FDA-CDER-CTU-2022-6944,,FDA-CTU,,67.0,YR,,M,N,74.1,KG,20220119,N,,US,,2022,Q1,Elderly
203794991,20379499,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Proteus test positive,,2022,Q1,1,I,20220126.0,,20220126,20220126,DIR,600922,,FDA-CTU,,45.0,YR,,F,N,122.2,KG,20220126,N,PH,US,,2022,Q1,Adult
203794991,20379499,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Intestinal perforation,,2022,Q1,1,I,20220126.0,,20220126,20220126,DIR,600922,,FDA-CTU,,45.0,YR,,F,N,122.2,KG,20220126,N,PH,US,,2022,Q1,Adult
203794991,20379499,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Blood culture positive,,2022,Q1,1,I,20220126.0,,20220126,20220126,DIR,600922,,FDA-CTU,,45.0,YR,,F,N,122.2,KG,20220126,N,PH,US,,2022,Q1,Adult
203794991,20379499,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Haemodialysis,,2022,Q1,1,I,20220126.0,,20220126,20220126,DIR,600922,,FDA-CTU,,45.0,YR,,F,N,122.2,KG,20220126,N,PH,US,,2022,Q1,Adult
203794991,20379499,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Device related infection,,2022,Q1,1,I,20220126.0,,20220126,20220126,DIR,600922,,FDA-CTU,,45.0,YR,,F,N,122.2,KG,20220126,N,PH,US,,2022,Q1,Adult
203794991,20379499,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Pelvic abscess,,2022,Q1,1,I,20220126.0,,20220126,20220126,DIR,600922,,FDA-CTU,,45.0,YR,,F,N,122.2,KG,20220126,N,PH,US,,2022,Q1,Adult
203796361,20379636,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Staphylococcus test positive,,2022,Q1,1,I,20220108.0,,20220126,20220126,DIR,600935,,FDA-CTU,,59.0,YR,,F,N,118.5,KG,20220126,N,PH,US,,2022,Q1,Adult
203796361,20379636,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Streptococcus test positive,,2022,Q1,1,I,20220108.0,,20220126,20220126,DIR,600935,,FDA-CTU,,59.0,YR,,F,N,118.5,KG,20220126,N,PH,US,,2022,Q1,Adult
203796361,20379636,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Dialysis,,2022,Q1,1,I,20220108.0,,20220126,20220126,DIR,600935,,FDA-CTU,,59.0,YR,,F,N,118.5,KG,20220126,N,PH,US,,2022,Q1,Adult
203796361,20379636,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Culture positive,,2022,Q1,1,I,20220108.0,,20220126,20220126,DIR,600935,,FDA-CTU,,59.0,YR,,F,N,118.5,KG,20220126,N,PH,US,,2022,Q1,Adult
203796361,20379636,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Candida test positive,,2022,Q1,1,I,20220108.0,,20220126,20220126,DIR,600935,,FDA-CTU,,59.0,YR,,F,N,118.5,KG,20220126,N,PH,US,,2022,Q1,Adult
203796361,20379636,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Acute kidney injury,,2022,Q1,1,I,20220108.0,,20220126,20220126,DIR,600935,,FDA-CTU,,59.0,YR,,F,N,118.5,KG,20220126,N,PH,US,,2022,Q1,Adult
203796361,20379636,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Pleural effusion,,2022,Q1,1,I,20220108.0,,20220126,20220126,DIR,600935,,FDA-CTU,,59.0,YR,,F,N,118.5,KG,20220126,N,PH,US,,2022,Q1,Adult
203819581,20381958,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D395986A,,20563.0,,,Injection,,2022,Q1,Incorrect dose administered,,2022,Q1,1,I,20211229.0,20211230.0,20220127,20220127,PER,,US-ELI_LILLY_AND_COMPANY-US202201000112,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20220127,,CN,US,US,2022,Q1,Elderly
203843711,20384371,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5-10 depending on what he eat, 3-4 times a day",,,,,D214632C,,20563.0,,,Injection,QD,2022,Q1,Blindness unilateral,,2022,Q1,1,I,20210518.0,20220118.0,20220127,20220127,EXP,,US-ELI_LILLY_AND_COMPANY-US202201007220,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20220127,,CN,US,US,2022,Q1,Elderly
203843711,20384371,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5-10 depending on what he eat, 3-4 times a day",,,,,D214632C,,20563.0,,,Injection,QD,2022,Q1,Macular degeneration,,2022,Q1,1,I,20210518.0,20220118.0,20220127,20220127,EXP,,US-ELI_LILLY_AND_COMPANY-US202201007220,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20220127,,CN,US,US,2022,Q1,Elderly
203843711,20384371,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5-10 depending on what he eat, 3-4 times a day",,,,,D214632C,,20563.0,,,Injection,QD,2022,Q1,Head injury,,2022,Q1,1,I,20210518.0,20220118.0,20220127,20220127,EXP,,US-ELI_LILLY_AND_COMPANY-US202201007220,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20220127,,CN,US,US,2022,Q1,Elderly
203843711,20384371,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5-10 depending on what he eat, 3-4 times a day",,,,,D214632C,,20563.0,,,Injection,QD,2022,Q1,Hypoglycaemic unconsciousness,,2022,Q1,1,I,20210518.0,20220118.0,20220127,20220127,EXP,,US-ELI_LILLY_AND_COMPANY-US202201007220,ELI LILLY AND CO,,76.0,YR,,M,Y,,,20220127,,CN,US,US,2022,Q1,Elderly
203910141,20391014,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2022,Q1,Hypoaesthesia,,2022,Q1,1,I,20220101.0,20220120.0,20220128,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202201009048,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220128,,CN,US,US,2022,Q1,Adult
203910141,20391014,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2022,Q1,Mobility decreased,,2022,Q1,1,I,20220101.0,20220120.0,20220128,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202201009048,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220128,,CN,US,US,2022,Q1,Adult
203910141,20391014,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220101.0,20220120.0,20220128,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202201009048,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220128,,CN,US,US,2022,Q1,Adult
203910141,20391014,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2022,Q1,General physical health deterioration,,2022,Q1,1,I,20220101.0,20220120.0,20220128,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202201009048,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220128,,CN,US,US,2022,Q1,Adult
203910141,20391014,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220101.0,20220120.0,20220128,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202201009048,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220128,,CN,US,US,2022,Q1,Adult
203910141,20391014,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2022,Q1,Nasal dryness,,2022,Q1,1,I,20220101.0,20220120.0,20220128,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202201009048,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220128,,CN,US,US,2022,Q1,Adult
203910141,20391014,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2022,Q1,Dry mouth,,2022,Q1,1,I,20220101.0,20220120.0,20220128,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202201009048,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220128,,CN,US,US,2022,Q1,Adult
203910141,20391014,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D429228A,,20563.0,,,Solution for injection,,2022,Q1,Hypoaesthesia,,2022,Q1,1,I,20220101.0,20220120.0,20220128,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202201009048,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220128,,CN,US,US,2022,Q1,Adult
203910141,20391014,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D429228A,,20563.0,,,Solution for injection,,2022,Q1,Mobility decreased,,2022,Q1,1,I,20220101.0,20220120.0,20220128,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202201009048,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220128,,CN,US,US,2022,Q1,Adult
203910141,20391014,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D429228A,,20563.0,,,Solution for injection,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220101.0,20220120.0,20220128,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202201009048,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220128,,CN,US,US,2022,Q1,Adult
203910141,20391014,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D429228A,,20563.0,,,Solution for injection,,2022,Q1,General physical health deterioration,,2022,Q1,1,I,20220101.0,20220120.0,20220128,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202201009048,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220128,,CN,US,US,2022,Q1,Adult
203910141,20391014,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D429228A,,20563.0,,,Solution for injection,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220101.0,20220120.0,20220128,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202201009048,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220128,,CN,US,US,2022,Q1,Adult
203910141,20391014,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D429228A,,20563.0,,,Solution for injection,,2022,Q1,Nasal dryness,,2022,Q1,1,I,20220101.0,20220120.0,20220128,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202201009048,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220128,,CN,US,US,2022,Q1,Adult
203910141,20391014,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D429228A,,20563.0,,,Solution for injection,,2022,Q1,Dry mouth,,2022,Q1,1,I,20220101.0,20220120.0,20220128,20220128,EXP,,US-ELI_LILLY_AND_COMPANY-US202201009048,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220128,,CN,US,US,2022,Q1,Adult
203933621,20393362,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,COVID-19 pneumonia,,2022,Q1,1,I,20210728.0,,20220128,20220128,DIR,601281,,FDA-CTU,,48.0,YR,,M,N,79.8,KG,20220128,Y,PH,US,,2022,Q1,Adult
203933621,20393362,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Infusion related reaction,,2022,Q1,1,I,20210728.0,,20220128,20220128,DIR,601281,,FDA-CTU,,48.0,YR,,M,N,79.8,KG,20220128,Y,PH,US,,2022,Q1,Adult
203943661,20394366,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,according to scheme Solution for injection/infusion,,,,,,,,,,,,2022,Q1,Medication error,,2022,Q1,1,I,20200630.0,20220118.0,20220129,20220129,EXP,DE-BFARM-21011797,DE-Accord-251657,ACCORD,,67.0,YR,E,M,Y,95.0,KG,20220129,,PH,DE,DE,2022,Q1,Elderly
203943661,20394366,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,according to scheme Solution for injection/infusion,,,,,,,,,,,,2022,Q1,Angina pectoris,,2022,Q1,1,I,20200630.0,20220118.0,20220129,20220129,EXP,DE-BFARM-21011797,DE-Accord-251657,ACCORD,,67.0,YR,E,M,Y,95.0,KG,20220129,,PH,DE,DE,2022,Q1,Elderly
203943661,20394366,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,according to scheme Solution for injection/infusion,,,,,,,,,,,,2022,Q1,Haematochezia,,2022,Q1,1,I,20200630.0,20220118.0,20220129,20220129,EXP,DE-BFARM-21011797,DE-Accord-251657,ACCORD,,67.0,YR,E,M,Y,95.0,KG,20220129,,PH,DE,DE,2022,Q1,Elderly
203943661,20394366,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,according to scheme Solution for injection/infusion,,,,,,,,,,,,2022,Q1,General physical health deterioration,,2022,Q1,1,I,20200630.0,20220118.0,20220129,20220129,EXP,DE-BFARM-21011797,DE-Accord-251657,ACCORD,,67.0,YR,E,M,Y,95.0,KG,20220129,,PH,DE,DE,2022,Q1,Elderly
203943661,20394366,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,according to scheme Solution for injection/infusion,,,,,,,,,,,,2022,Q1,Asthenia,,2022,Q1,1,I,20200630.0,20220118.0,20220129,20220129,EXP,DE-BFARM-21011797,DE-Accord-251657,ACCORD,,67.0,YR,E,M,Y,95.0,KG,20220129,,PH,DE,DE,2022,Q1,Elderly
203944771,20394477,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q1,Ulcer,,2022,Q1,1,I,20220126.0,20220126.0,20220129,20220129,PER,,US-ELI_LILLY_AND_COMPANY-US202201010765,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20220129,,CN,US,US,2022,Q1,Elderly
203944771,20394477,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q1,Injury associated with device,,2022,Q1,1,I,20220126.0,20220126.0,20220129,20220129,PER,,US-ELI_LILLY_AND_COMPANY-US202201010765,ELI LILLY AND CO,,67.0,YR,,F,Y,,,20220129,,CN,US,US,2022,Q1,Elderly
203952011,20395201,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,20 E-0-20 E?Translation: 20 unit - 0 - 20 unit,,,,,,,,,,,,2022,Q1,Fournier's gangrene,,2022,Q1,1,I,20211213.0,20220128.0,20220130,20220130,EXP,AT-BASGAGES-2021-075863,"AT-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-150752",BOEHRINGER INGELHEIM,,50.0,YR,A,M,Y,100.0,KG,20220131,,MD,AT,AT,2022,Q1,Adult
204003832,20400383,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Irritable bowel syndrome,,2022,Q1,2,F,20210101.0,20210730.0,20220131,20220201,PER,,US-ABBVIE-21K-163-4001253-00,ABBVIE,,60.0,YR,,F,Y,238.35,KG,20220201,,CN,US,US,2022,Q1,Adult
204003832,20400383,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Weight increased,,2022,Q1,2,F,20210101.0,20210730.0,20220131,20220201,PER,,US-ABBVIE-21K-163-4001253-00,ABBVIE,,60.0,YR,,F,Y,238.35,KG,20220201,,CN,US,US,2022,Q1,Adult
204003832,20400383,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Dry eye,,2022,Q1,2,F,20210101.0,20210730.0,20220131,20220201,PER,,US-ABBVIE-21K-163-4001253-00,ABBVIE,,60.0,YR,,F,Y,238.35,KG,20220201,,CN,US,US,2022,Q1,Adult
204003832,20400383,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Dry mouth,,2022,Q1,2,F,20210101.0,20210730.0,20220131,20220201,PER,,US-ABBVIE-21K-163-4001253-00,ABBVIE,,60.0,YR,,F,Y,238.35,KG,20220201,,CN,US,US,2022,Q1,Adult
204003832,20400383,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Blood potassium decreased,,2022,Q1,2,F,20210101.0,20210730.0,20220131,20220201,PER,,US-ABBVIE-21K-163-4001253-00,ABBVIE,,60.0,YR,,F,Y,238.35,KG,20220201,,CN,US,US,2022,Q1,Adult
204003832,20400383,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Clostridium difficile infection,,2022,Q1,2,F,20210101.0,20210730.0,20220131,20220201,PER,,US-ABBVIE-21K-163-4001253-00,ABBVIE,,60.0,YR,,F,Y,238.35,KG,20220201,,CN,US,US,2022,Q1,Adult
204041141,20404114,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Ketoacidosis,,2022,Q1,1,I,20210426.0,20220128.0,20220131,20220131,EXP,SE-MPA-2021-053847,"SE-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-150793",BOEHRINGER INGELHEIM,,58.0,YR,A,M,Y,,,20220131,,MD,SE,SE,2022,Q1,Adult
204045781,20404578,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,70/30,,,,,,,,,,,,2022,Q1,Myocardial infarction,,2022,Q1,1,I,20140101.0,20220124.0,20220131,20220131,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-150015",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,,,20220131,,CN,US,US,2022,Q1,Adult
204045781,20404578,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,70/30,,,,,,,,,,,,2022,Q1,Pleurisy,,2022,Q1,1,I,20140101.0,20220124.0,20220131,20220131,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-150015",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,,,20220131,,CN,US,US,2022,Q1,Adult
204045781,20404578,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,70/30,,,,,,,,,,,,2022,Q1,Bronchitis,,2022,Q1,1,I,20140101.0,20220124.0,20220131,20220131,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-150015",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,,,20220131,,CN,US,US,2022,Q1,Adult
204045781,20404578,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,70/30,,,,,,,,,,,,2022,Q1,Pneumonia aspiration,,2022,Q1,1,I,20140101.0,20220124.0,20220131,20220131,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-150015",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,,,20220131,,CN,US,US,2022,Q1,Adult
204045781,20404578,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,70/30,,,,,,,,,,,,2022,Q1,Back injury,,2022,Q1,1,I,20140101.0,20220124.0,20220131,20220131,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-150015",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,,,20220131,,CN,US,US,2022,Q1,Adult
204045781,20404578,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,70/30,,,,,,,,,,,,2022,Q1,Upper respiratory tract infection,,2022,Q1,1,I,20140101.0,20220124.0,20220131,20220131,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-150015",BOEHRINGER INGELHEIM,,54.0,YR,A,F,Y,,,20220131,,CN,US,US,2022,Q1,Adult
204046981,20404698,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0,",,,U,,,,,,,Solution for injection/infusion,,2022,Q1,Decreased appetite,,2022,Q1,1,I,,20220118.0,20220131,20220131,EXP,DE-BFARM-21011763,DE-Accord-251654,ACCORD,,84.0,YR,E,M,Y,101.4,KG,20220131,,PH,DE,DE,2022,Q1,Elderly
204046981,20404698,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0,",,,U,,,,,,,Solution for injection/infusion,,2022,Q1,Abdominal pain,,2022,Q1,1,I,,20220118.0,20220131,20220131,EXP,DE-BFARM-21011763,DE-Accord-251654,ACCORD,,84.0,YR,E,M,Y,101.4,KG,20220131,,PH,DE,DE,2022,Q1,Elderly
204046981,20404698,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0,",,,U,,,,,,,Solution for injection/infusion,,2022,Q1,Abdominal distension,,2022,Q1,1,I,,20220118.0,20220131,20220131,EXP,DE-BFARM-21011763,DE-Accord-251654,ACCORD,,84.0,YR,E,M,Y,101.4,KG,20220131,,PH,DE,DE,2022,Q1,Elderly
204046981,20404698,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0,",,,U,,,,,,,Solution for injection/infusion,,2022,Q1,Nausea,,2022,Q1,1,I,,20220118.0,20220131,20220131,EXP,DE-BFARM-21011763,DE-Accord-251654,ACCORD,,84.0,YR,E,M,Y,101.4,KG,20220131,,PH,DE,DE,2022,Q1,Elderly
204046981,20404698,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0,",,,U,,,,,,,Solution for injection/infusion,,2022,Q1,Dysuria,,2022,Q1,1,I,,20220118.0,20220131,20220131,EXP,DE-BFARM-21011763,DE-Accord-251654,ACCORD,,84.0,YR,E,M,Y,101.4,KG,20220131,,PH,DE,DE,2022,Q1,Elderly
204046981,20404698,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 ml, 10-0-8-0,",,,U,,,,,,,Solution for injection/infusion,,2022,Q1,Constipation,,2022,Q1,1,I,,20220118.0,20220131,20220131,EXP,DE-BFARM-21011763,DE-Accord-251654,ACCORD,,84.0,YR,E,M,Y,101.4,KG,20220131,,PH,DE,DE,2022,Q1,Elderly
204065821,20406582,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Limb injury,,2022,Q1,1,I,20220124.0,20220128.0,20220131,20220131,PER,,US-ELI_LILLY_AND_COMPANY-US202201011847,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20220131,,CN,US,US,2022,Q1,Adult
204066251,20406625,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid (3/day)",,,U,,,,,,,,TID,2022,Q1,Product use in unapproved indication,,2022,Q1,1,I,,20220127.0,20220131,20220131,EXP,,NVSC2022IT018546,NOVARTIS,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. EUROPEAN HEART JOURNAL. 2021;23(suppl G):G92-3",68.0,YR,,M,Y,,,20220131,,HP,IT,IT,2022,Q1,Elderly
204066251,20406625,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid (3/day)",,,U,,,,,,,,TID,2022,Q1,Hemiplegia,,2022,Q1,1,I,,20220127.0,20220131,20220131,EXP,,NVSC2022IT018546,NOVARTIS,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. EUROPEAN HEART JOURNAL. 2021;23(suppl G):G92-3",68.0,YR,,M,Y,,,20220131,,HP,IT,IT,2022,Q1,Elderly
204066251,20406625,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid (3/day)",,,U,,,,,,,,TID,2022,Q1,Dyspnoea,,2022,Q1,1,I,,20220127.0,20220131,20220131,EXP,,NVSC2022IT018546,NOVARTIS,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. EUROPEAN HEART JOURNAL. 2021;23(suppl G):G92-3",68.0,YR,,M,Y,,,20220131,,HP,IT,IT,2022,Q1,Elderly
204066251,20406625,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid (3/day)",,,U,,,,,,,,TID,2022,Q1,Off label use,,2022,Q1,1,I,,20220127.0,20220131,20220131,EXP,,NVSC2022IT018546,NOVARTIS,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. EUROPEAN HEART JOURNAL. 2021;23(suppl G):G92-3",68.0,YR,,M,Y,,,20220131,,HP,IT,IT,2022,Q1,Elderly
204066251,20406625,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid (3/day)",,,U,,,,,,,,TID,2022,Q1,Electrocardiogram ST segment elevation,,2022,Q1,1,I,,20220127.0,20220131,20220131,EXP,,NVSC2022IT018546,NOVARTIS,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. EUROPEAN HEART JOURNAL. 2021;23(suppl G):G92-3",68.0,YR,,M,Y,,,20220131,,HP,IT,IT,2022,Q1,Elderly
204066251,20406625,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid (3/day)",,,U,,,,,,,,TID,2022,Q1,Acute right ventricular failure,,2022,Q1,1,I,,20220127.0,20220131,20220131,EXP,,NVSC2022IT018546,NOVARTIS,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. EUROPEAN HEART JOURNAL. 2021;23(suppl G):G92-3",68.0,YR,,M,Y,,,20220131,,HP,IT,IT,2022,Q1,Elderly
204067871,20406787,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, tid",,,Y,,D386814A,,20563.0,10.0,IU,Solution for injection,TID,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220123.0,20220127.0,20220131,20220131,PER,,US-ELI_LILLY_AND_COMPANY-US202201011637,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20220131,,CN,US,US,2022,Q1,Elderly
204067871,20406787,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, tid",,,Y,,D386814A,,20563.0,10.0,IU,Solution for injection,TID,2022,Q1,Back pain,,2022,Q1,1,I,20220123.0,20220127.0,20220131,20220131,PER,,US-ELI_LILLY_AND_COMPANY-US202201011637,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20220131,,CN,US,US,2022,Q1,Elderly
204067871,20406787,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"17 u, tid",,,Y,,D386814A,,20563.0,17.0,IU,Solution for injection,TID,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220123.0,20220127.0,20220131,20220131,PER,,US-ELI_LILLY_AND_COMPANY-US202201011637,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20220131,,CN,US,US,2022,Q1,Elderly
204067871,20406787,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"17 u, tid",,,Y,,D386814A,,20563.0,17.0,IU,Solution for injection,TID,2022,Q1,Back pain,,2022,Q1,1,I,20220123.0,20220127.0,20220131,20220131,PER,,US-ELI_LILLY_AND_COMPANY-US202201011637,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20220131,,CN,US,US,2022,Q1,Elderly
204073951,20407395,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, tid",36.0,IU,N,,D312549A,,20563.0,6.0,IU,Solution for injection,TID,2022,Q1,PCO2 increased,,2022,Q1,1,I,20220109.0,20220121.0,20220131,20220131,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202201009788,ELI LILLY AND CO,,68.0,YR,,M,Y,65.0,KG,20220131,,CN,CN,CN,2022,Q1,Elderly
204073951,20407395,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, tid",36.0,IU,N,,D312549A,,20563.0,6.0,IU,Solution for injection,TID,2022,Q1,Hypokalaemia,,2022,Q1,1,I,20220109.0,20220121.0,20220131,20220131,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202201009788,ELI LILLY AND CO,,68.0,YR,,M,Y,65.0,KG,20220131,,CN,CN,CN,2022,Q1,Elderly
204126141,20412614,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, tid (6/8/8 UI three times a day)",,,,,,,,,,,TID,2022,Q1,Off label use,,2022,Q1,1,I,,20220119.0,20220201,20220201,PER,,IT-LUPIN PHARMACEUTICALS INC.-2022-01077,LUPIN,"Ianniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. European Heart Journal Supplements. 2021;23:1-2",68.0,YR,,M,Y,,,20220201,,HP,IT,IT,2022,Q1,Elderly
204126651,20412665,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, prn (as per sliding scale)",,,,,D379507A,,20563.0,15.0,IU,Injection,,2022,Q1,Insulin resistance,,2022,Q1,1,I,,20220131.0,20220201,20220201,PER,,US-ELI_LILLY_AND_COMPANY-US202202000550,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20220201,,CN,US,US,2022,Q1,Adult
204126651,20412665,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, prn (as per sliding scale)",,,,,D379507A,,20563.0,15.0,IU,Injection,,2022,Q1,Insulin resistance,,2022,Q1,1,I,,20220131.0,20220201,20220201,PER,,US-ELI_LILLY_AND_COMPANY-US202202000550,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20220201,,CN,US,US,2022,Q1,Adult
204126651,20412665,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q1,Insulin resistance,,2022,Q1,1,I,,20220131.0,20220201,20220201,PER,,US-ELI_LILLY_AND_COMPANY-US202202000550,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20220201,,CN,US,US,2022,Q1,Adult
204126651,20412665,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q1,Insulin resistance,,2022,Q1,1,I,,20220131.0,20220201,20220201,PER,,US-ELI_LILLY_AND_COMPANY-US202202000550,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20220201,,CN,US,US,2022,Q1,Adult
204127982,20412798,18,C,INSULIN LISPRO KWIKPEN,,2,,100/ml,,,,,,,,,,,,2022,Q1,Thrombosis,,2022,Q1,2,F,20220101.0,20220314.0,20220201,20220318,EXP,,US-Eisai Medical Research-EC-2022-107523,EISAI,,71.0,YR,E,M,Y,83.9,KG,20220318,,CN,US,,2022,Q1,Elderly
204152691,20415269,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid",,,U,,,,,,,,Q8H,2022,Q1,Off label use,,2022,Q1,1,I,,20220119.0,20220202,20220202,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-325586,RANBAXY,"Ianniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. Eur Heart J Suppl. 2021;23 (Suppl.):G92-G93; 659",68.0,YR,,M,Y,,,20220202,,HP,IT,IT,2022,Q1,Elderly
204152691,20415269,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid",,,U,,,,,,,,Q8H,2022,Q1,Drug ineffective,,2022,Q1,1,I,,20220119.0,20220202,20220202,EXP,,IT-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-325586,RANBAXY,"Ianniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. Eur Heart J Suppl. 2021;23 (Suppl.):G92-G93; 659",68.0,YR,,M,Y,,,20220202,,HP,IT,IT,2022,Q1,Elderly
204176881,20417688,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,three time a day,,,,,,,,10.0,IU,Unknown,,2022,Q1,Febrile neutropenia,,2022,Q1,1,I,20210904.0,20220125.0,20220202,20220202,EXP,,US-JNJFOC-20210929344,JOHNSON AND JOHNSON,,67.0,YR,E,M,Y,97.6,KG,20220202,,HP,US,US,2022,Q1,Elderly
204220932,20422093,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid (10-12 units at breakfast and at dinner)",,,U,,D379508A,,20563.0,,,Injection,BID,2022,Q1,Visual impairment,,2022,Q1,2,F,20220202.0,20220225.0,20220203,20220301,PER,,US-ELI_LILLY_AND_COMPANY-US202202001509,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20220301,,CN,US,US,2022,Q1,Elderly
204220932,20422093,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid (10-12 units at breakfast and at dinner)",,,U,,D379508A,,20563.0,,,Injection,BID,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20220202.0,20220225.0,20220203,20220301,PER,,US-ELI_LILLY_AND_COMPANY-US202202001509,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20220301,,CN,US,US,2022,Q1,Elderly
204220932,20422093,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid (10-12 units at breakfast and at dinner)",,,U,,D379508A,,20563.0,,,Injection,BID,2022,Q1,Visual impairment,,2022,Q1,2,F,20220202.0,20220225.0,20220203,20220301,PER,,US-ELI_LILLY_AND_COMPANY-US202202001509,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20220301,,CN,US,US,2022,Q1,Elderly
204220932,20422093,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid (10-12 units at breakfast and at dinner)",,,U,,D379508A,,20563.0,,,Injection,BID,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20220202.0,20220225.0,20220203,20220301,PER,,US-ELI_LILLY_AND_COMPANY-US202202001509,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20220301,,CN,US,US,2022,Q1,Elderly
204220932,20422093,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid (10-12 units at breakfast and at dinner)",,,U,,,,20563.0,,,Injection,BID,2022,Q1,Visual impairment,,2022,Q1,2,F,20220202.0,20220225.0,20220203,20220301,PER,,US-ELI_LILLY_AND_COMPANY-US202202001509,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20220301,,CN,US,US,2022,Q1,Elderly
204220932,20422093,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid (10-12 units at breakfast and at dinner)",,,U,,,,20563.0,,,Injection,BID,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20220202.0,20220225.0,20220203,20220301,PER,,US-ELI_LILLY_AND_COMPANY-US202202001509,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20220301,,CN,US,US,2022,Q1,Elderly
204220932,20422093,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid (10-12 units at breakfast and at dinner)",,,U,,,,20563.0,,,Injection,BID,2022,Q1,Visual impairment,,2022,Q1,2,F,20220202.0,20220225.0,20220203,20220301,PER,,US-ELI_LILLY_AND_COMPANY-US202202001509,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20220301,,CN,US,US,2022,Q1,Elderly
204220932,20422093,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid (10-12 units at breakfast and at dinner)",,,U,,,,20563.0,,,Injection,BID,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20220202.0,20220225.0,20220203,20220301,PER,,US-ELI_LILLY_AND_COMPANY-US202202001509,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20220301,,CN,US,US,2022,Q1,Elderly
204220932,20422093,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid (10-12 units at breakfast and at dinner)",,,U,,,,20563.0,,,Injection,BID,2022,Q1,Visual impairment,,2022,Q1,2,F,20220202.0,20220225.0,20220203,20220301,PER,,US-ELI_LILLY_AND_COMPANY-US202202001509,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20220301,,CN,US,US,2022,Q1,Elderly
204220932,20422093,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid (10-12 units at breakfast and at dinner)",,,U,,,,20563.0,,,Injection,BID,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20220202.0,20220225.0,20220203,20220301,PER,,US-ELI_LILLY_AND_COMPANY-US202202001509,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20220301,,CN,US,US,2022,Q1,Elderly
204220932,20422093,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid (10-12 units at breakfast and at dinner)",,,U,,D420814A,,20563.0,,,Injection,BID,2022,Q1,Visual impairment,,2022,Q1,2,F,20220202.0,20220225.0,20220203,20220301,PER,,US-ELI_LILLY_AND_COMPANY-US202202001509,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20220301,,CN,US,US,2022,Q1,Elderly
204220932,20422093,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid (10-12 units at breakfast and at dinner)",,,U,,D420814A,,20563.0,,,Injection,BID,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20220202.0,20220225.0,20220203,20220301,PER,,US-ELI_LILLY_AND_COMPANY-US202202001509,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20220301,,CN,US,US,2022,Q1,Elderly
204220932,20422093,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid (10-12 units at breakfast and at dinner)",,,U,,D420814A,,20563.0,,,Injection,BID,2022,Q1,Visual impairment,,2022,Q1,2,F,20220202.0,20220225.0,20220203,20220301,PER,,US-ELI_LILLY_AND_COMPANY-US202202001509,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20220301,,CN,US,US,2022,Q1,Elderly
204220932,20422093,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid (10-12 units at breakfast and at dinner)",,,U,,D420814A,,20563.0,,,Injection,BID,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20220202.0,20220225.0,20220203,20220301,PER,,US-ELI_LILLY_AND_COMPANY-US202202001509,ELI LILLY AND CO,,85.0,YR,,F,Y,,,20220301,,CN,US,US,2022,Q1,Elderly
204232361,20423236,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,D,,,,20563.0,,,,,2022,Q1,Seizure,,2022,Q1,1,I,,20220124.0,20220203,20220203,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202201009900,ELI LILLY AND CO,"Joana Sousa Martins, Rita Ramos, Sofia Fraga, Margarida Pinto..Intoxicacao Voluntaria por Insulina: Uma Causa Rara de Hipoglicemia.Rev Port Endocrinol Diabetes Metab 2021;16(3-4):139-142.DOI:https://doi.org/10.26497/cc210068",14.0,YR,,F,Y,,,20220203,,HP,PT,PT,2022,Q1,Youth
204232361,20423236,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,D,,,,20563.0,,,,,2022,Q1,Intentional overdose,,2022,Q1,1,I,,20220124.0,20220203,20220203,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202201009900,ELI LILLY AND CO,"Joana Sousa Martins, Rita Ramos, Sofia Fraga, Margarida Pinto..Intoxicacao Voluntaria por Insulina: Uma Causa Rara de Hipoglicemia.Rev Port Endocrinol Diabetes Metab 2021;16(3-4):139-142.DOI:https://doi.org/10.26497/cc210068",14.0,YR,,F,Y,,,20220203,,HP,PT,PT,2022,Q1,Youth
204232361,20423236,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,D,,,,20563.0,,,,,2022,Q1,Hypoglycaemia,,2022,Q1,1,I,,20220124.0,20220203,20220203,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202201009900,ELI LILLY AND CO,"Joana Sousa Martins, Rita Ramos, Sofia Fraga, Margarida Pinto..Intoxicacao Voluntaria por Insulina: Uma Causa Rara de Hipoglicemia.Rev Port Endocrinol Diabetes Metab 2021;16(3-4):139-142.DOI:https://doi.org/10.26497/cc210068",14.0,YR,,F,Y,,,20220203,,HP,PT,PT,2022,Q1,Youth
204232361,20423236,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,D,,,,20563.0,,,,,2022,Q1,Depression,,2022,Q1,1,I,,20220124.0,20220203,20220203,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202201009900,ELI LILLY AND CO,"Joana Sousa Martins, Rita Ramos, Sofia Fraga, Margarida Pinto..Intoxicacao Voluntaria por Insulina: Uma Causa Rara de Hipoglicemia.Rev Port Endocrinol Diabetes Metab 2021;16(3-4):139-142.DOI:https://doi.org/10.26497/cc210068",14.0,YR,,F,Y,,,20220203,,HP,PT,PT,2022,Q1,Youth
204232361,20423236,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,D,,,,20563.0,,,,,2022,Q1,Blood glucose fluctuation,,2022,Q1,1,I,,20220124.0,20220203,20220203,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202201009900,ELI LILLY AND CO,"Joana Sousa Martins, Rita Ramos, Sofia Fraga, Margarida Pinto..Intoxicacao Voluntaria por Insulina: Uma Causa Rara de Hipoglicemia.Rev Port Endocrinol Diabetes Metab 2021;16(3-4):139-142.DOI:https://doi.org/10.26497/cc210068",14.0,YR,,F,Y,,,20220203,,HP,PT,PT,2022,Q1,Youth
204232361,20423236,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,D,,,,20563.0,,,,,2022,Q1,Suicide attempt,,2022,Q1,1,I,,20220124.0,20220203,20220203,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202201009900,ELI LILLY AND CO,"Joana Sousa Martins, Rita Ramos, Sofia Fraga, Margarida Pinto..Intoxicacao Voluntaria por Insulina: Uma Causa Rara de Hipoglicemia.Rev Port Endocrinol Diabetes Metab 2021;16(3-4):139-142.DOI:https://doi.org/10.26497/cc210068",14.0,YR,,F,Y,,,20220203,,HP,PT,PT,2022,Q1,Youth
204232361,20423236,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,D,,,,20563.0,,,,,2022,Q1,Disorganised speech,,2022,Q1,1,I,,20220124.0,20220203,20220203,EXP,,PT-ELI_LILLY_AND_COMPANY-PT202201009900,ELI LILLY AND CO,"Joana Sousa Martins, Rita Ramos, Sofia Fraga, Margarida Pinto..Intoxicacao Voluntaria por Insulina: Uma Causa Rara de Hipoglicemia.Rev Port Endocrinol Diabetes Metab 2021;16(3-4):139-142.DOI:https://doi.org/10.26497/cc210068",14.0,YR,,F,Y,,,20220203,,HP,PT,PT,2022,Q1,Youth
204240801,20424080,11,C,Insulin lispro;Insulin lispro protamine,,2,,UNK,,,,,,,,,,,,2022,Q1,Weight decreased,,2022,Q1,1,I,20210317.0,20210722.0,20220203,20220203,PER,,US-EXELIXIS-CABO-21038743,EXELIXIS,,54.0,YR,,F,Y,,,20220203,,HP,US,US,2022,Q1,Adult
204240801,20424080,11,C,Insulin lispro;Insulin lispro protamine,,2,,UNK,,,,,,,,,,,,2022,Q1,Hypertension,,2022,Q1,1,I,20210317.0,20210722.0,20220203,20220203,PER,,US-EXELIXIS-CABO-21038743,EXELIXIS,,54.0,YR,,F,Y,,,20220203,,HP,US,US,2022,Q1,Adult
204240801,20424080,11,C,Insulin lispro;Insulin lispro protamine,,2,,UNK,,,,,,,,,,,,2022,Q1,Palmar-plantar erythrodysaesthesia syndrome,,2022,Q1,1,I,20210317.0,20210722.0,20220203,20220203,PER,,US-EXELIXIS-CABO-21038743,EXELIXIS,,54.0,YR,,F,Y,,,20220203,,HP,US,US,2022,Q1,Adult
204240801,20424080,11,C,Insulin lispro;Insulin lispro protamine,,2,,UNK,,,,,,,,,,,,2022,Q1,Hyperglycaemia,,2022,Q1,1,I,20210317.0,20210722.0,20220203,20220203,PER,,US-EXELIXIS-CABO-21038743,EXELIXIS,,54.0,YR,,F,Y,,,20220203,,HP,US,US,2022,Q1,Adult
204240801,20424080,11,C,Insulin lispro;Insulin lispro protamine,,2,,UNK,,,,,,,,,,,,2022,Q1,Glossitis,,2022,Q1,1,I,20210317.0,20210722.0,20220203,20220203,PER,,US-EXELIXIS-CABO-21038743,EXELIXIS,,54.0,YR,,F,Y,,,20220203,,HP,US,US,2022,Q1,Adult
204240801,20424080,11,C,Insulin lispro;Insulin lispro protamine,,2,,UNK,,,,,,,,,,,,2022,Q1,Nausea,,2022,Q1,1,I,20210317.0,20210722.0,20220203,20220203,PER,,US-EXELIXIS-CABO-21038743,EXELIXIS,,54.0,YR,,F,Y,,,20220203,,HP,US,US,2022,Q1,Adult
204240801,20424080,11,C,Insulin lispro;Insulin lispro protamine,,2,,UNK,,,,,,,,,,,,2022,Q1,Taste disorder,,2022,Q1,1,I,20210317.0,20210722.0,20220203,20220203,PER,,US-EXELIXIS-CABO-21038743,EXELIXIS,,54.0,YR,,F,Y,,,20220203,,HP,US,US,2022,Q1,Adult
204240801,20424080,11,C,Insulin lispro;Insulin lispro protamine,,2,,UNK,,,,,,,,,,,,2022,Q1,Rash,,2022,Q1,1,I,20210317.0,20210722.0,20220203,20220203,PER,,US-EXELIXIS-CABO-21038743,EXELIXIS,,54.0,YR,,F,Y,,,20220203,,HP,US,US,2022,Q1,Adult
204240801,20424080,11,C,Insulin lispro;Insulin lispro protamine,,2,,UNK,,,,,,,,,,,,2022,Q1,Migraine with aura,,2022,Q1,1,I,20210317.0,20210722.0,20220203,20220203,PER,,US-EXELIXIS-CABO-21038743,EXELIXIS,,54.0,YR,,F,Y,,,20220203,,HP,US,US,2022,Q1,Adult
204240801,20424080,11,C,Insulin lispro;Insulin lispro protamine,,2,,UNK,,,,,,,,,,,,2022,Q1,Blood pressure decreased,,2022,Q1,1,I,20210317.0,20210722.0,20220203,20220203,PER,,US-EXELIXIS-CABO-21038743,EXELIXIS,,54.0,YR,,F,Y,,,20220203,,HP,US,US,2022,Q1,Adult
204240801,20424080,11,C,Insulin lispro;Insulin lispro protamine,,2,,UNK,,,,,,,,,,,,2022,Q1,Gastrooesophageal reflux disease,,2022,Q1,1,I,20210317.0,20210722.0,20220203,20220203,PER,,US-EXELIXIS-CABO-21038743,EXELIXIS,,54.0,YR,,F,Y,,,20220203,,HP,US,US,2022,Q1,Adult
204240801,20424080,11,C,Insulin lispro;Insulin lispro protamine,,2,,UNK,,,,,,,,,,,,2022,Q1,Headache,,2022,Q1,1,I,20210317.0,20210722.0,20220203,20220203,PER,,US-EXELIXIS-CABO-21038743,EXELIXIS,,54.0,YR,,F,Y,,,20220203,,HP,US,US,2022,Q1,Adult
204240801,20424080,11,C,Insulin lispro;Insulin lispro protamine,,2,,UNK,,,,,,,,,,,,2022,Q1,Diarrhoea,,2022,Q1,1,I,20210317.0,20210722.0,20220203,20220203,PER,,US-EXELIXIS-CABO-21038743,EXELIXIS,,54.0,YR,,F,Y,,,20220203,,HP,US,US,2022,Q1,Adult
204240801,20424080,11,C,Insulin lispro;Insulin lispro protamine,,2,,UNK,,,,,,,,,,,,2022,Q1,Fibromyalgia,,2022,Q1,1,I,20210317.0,20210722.0,20220203,20220203,PER,,US-EXELIXIS-CABO-21038743,EXELIXIS,,54.0,YR,,F,Y,,,20220203,,HP,US,US,2022,Q1,Adult
204240801,20424080,11,C,Insulin lispro;Insulin lispro protamine,,2,,UNK,,,,,,,,,,,,2022,Q1,Constipation,,2022,Q1,1,I,20210317.0,20210722.0,20220203,20220203,PER,,US-EXELIXIS-CABO-21038743,EXELIXIS,,54.0,YR,,F,Y,,,20220203,,HP,US,US,2022,Q1,Adult
204240801,20424080,11,C,Insulin lispro;Insulin lispro protamine,,2,,UNK,,,,,,,,,,,,2022,Q1,Fatigue,,2022,Q1,1,I,20210317.0,20210722.0,20220203,20220203,PER,,US-EXELIXIS-CABO-21038743,EXELIXIS,,54.0,YR,,F,Y,,,20220203,,HP,US,US,2022,Q1,Adult
204240801,20424080,11,C,Insulin lispro;Insulin lispro protamine,,2,,UNK,,,,,,,,,,,,2022,Q1,Decreased appetite,,2022,Q1,1,I,20210317.0,20210722.0,20220203,20220203,PER,,US-EXELIXIS-CABO-21038743,EXELIXIS,,54.0,YR,,F,Y,,,20220203,,HP,US,US,2022,Q1,Adult
204329784,20432978,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Injection site erythema,,2022,Q1,4,F,,20220125.0,20220205,20220214,PER,,US-SA-2022SA029402,SANOFI AVENTIS,,40.0,YR,A,F,Y,,,20220214,,HP,US,US,2022,Q1,Adult
204329784,20432978,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Diabetes mellitus inadequate control,,2022,Q1,4,F,,20220125.0,20220205,20220214,PER,,US-SA-2022SA029402,SANOFI AVENTIS,,40.0,YR,A,F,Y,,,20220214,,HP,US,US,2022,Q1,Adult
204329784,20432978,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q1,Injection site swelling,,2022,Q1,4,F,,20220125.0,20220205,20220214,PER,,US-SA-2022SA029402,SANOFI AVENTIS,,40.0,YR,A,F,Y,,,20220214,,HP,US,US,2022,Q1,Adult
204388531,20438853,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,Unk (75-25),,,,,,,,,,,,2022,Q1,Nasopharyngitis,,2022,Q1,1,I,,20211111.0,20220207,20220207,PER,,US-PFIZER INC-202101577241,PFIZER,,67.0,YR,,M,Y,,,20220207,,HP,US,US,2022,Q1,Elderly
204411851,20441185,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, Once a Day (6/8/8 UI, tid (3/day))",,,U,,,,,,,,QD,2022,Q1,Off label use,,2022,Q1,1,I,,20220125.0,20220208,20220208,EXP,,IT-AUROBINDO-AUR-APL-2022-003090,AUROBINDO,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance.. European Heart Journal. 2021;23 (SUPPL G):G92-3",68.0,YR,,M,Y,,,20220208,,HP,IT,IT,2022,Q1,Elderly
204411851,20441185,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, Once a Day (6/8/8 UI, tid (3/day))",,,U,,,,,,,,QD,2022,Q1,Electrocardiogram ST segment elevation,,2022,Q1,1,I,,20220125.0,20220208,20220208,EXP,,IT-AUROBINDO-AUR-APL-2022-003090,AUROBINDO,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance.. European Heart Journal. 2021;23 (SUPPL G):G92-3",68.0,YR,,M,Y,,,20220208,,HP,IT,IT,2022,Q1,Elderly
204411851,20441185,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, Once a Day (6/8/8 UI, tid (3/day))",,,U,,,,,,,,QD,2022,Q1,Acute right ventricular failure,,2022,Q1,1,I,,20220125.0,20220208,20220208,EXP,,IT-AUROBINDO-AUR-APL-2022-003090,AUROBINDO,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance.. European Heart Journal. 2021;23 (SUPPL G):G92-3",68.0,YR,,M,Y,,,20220208,,HP,IT,IT,2022,Q1,Elderly
204411851,20441185,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, Once a Day (6/8/8 UI, tid (3/day))",,,U,,,,,,,,QD,2022,Q1,Dyspnoea,,2022,Q1,1,I,,20220125.0,20220208,20220208,EXP,,IT-AUROBINDO-AUR-APL-2022-003090,AUROBINDO,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance.. European Heart Journal. 2021;23 (SUPPL G):G92-3",68.0,YR,,M,Y,,,20220208,,HP,IT,IT,2022,Q1,Elderly
204411851,20441185,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, Once a Day (6/8/8 UI, tid (3/day))",,,U,,,,,,,,QD,2022,Q1,Product use in unapproved indication,,2022,Q1,1,I,,20220125.0,20220208,20220208,EXP,,IT-AUROBINDO-AUR-APL-2022-003090,AUROBINDO,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance.. European Heart Journal. 2021;23 (SUPPL G):G92-3",68.0,YR,,M,Y,,,20220208,,HP,IT,IT,2022,Q1,Elderly
204411851,20441185,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, Once a Day (6/8/8 UI, tid (3/day))",,,U,,,,,,,,QD,2022,Q1,Hemiplegia,,2022,Q1,1,I,,20220125.0,20220208,20220208,EXP,,IT-AUROBINDO-AUR-APL-2022-003090,AUROBINDO,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance.. European Heart Journal. 2021;23 (SUPPL G):G92-3",68.0,YR,,M,Y,,,20220208,,HP,IT,IT,2022,Q1,Elderly
204420211,20442021,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D134925J,,21017.0,,,Injection,,2022,Q1,Visual impairment,,2022,Q1,1,I,20210801.0,20220204.0,20220208,20220208,PER,,US-ELI_LILLY_AND_COMPANY-US202202003057,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20220208,,CN,US,US,2022,Q1,Adult
204420211,20442021,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D134925J,,21017.0,,,Injection,,2022,Q1,Memory impairment,,2022,Q1,1,I,20210801.0,20220204.0,20220208,20220208,PER,,US-ELI_LILLY_AND_COMPANY-US202202003057,ELI LILLY AND CO,,60.0,YR,,F,Y,,,20220208,,CN,US,US,2022,Q1,Adult
204456821,20445682,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2022,Q1,Oedema peripheral,,2022,Q1,1,I,20211022.0,20220201.0,20220208,20220208,EXP,,US-JNJFOC-20220207675,JOHNSON AND JOHNSON,,62.0,YR,A,M,Y,94.7,KG,20220208,,HP,US,US,2022,Q1,Adult
204456821,20445682,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2022,Q1,Platelet count decreased,,2022,Q1,1,I,20211022.0,20220201.0,20220208,20220208,EXP,,US-JNJFOC-20220207675,JOHNSON AND JOHNSON,,62.0,YR,A,M,Y,94.7,KG,20220208,,HP,US,US,2022,Q1,Adult
204456821,20445682,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2022,Q1,Abdominal lymphadenopathy,,2022,Q1,1,I,20211022.0,20220201.0,20220208,20220208,EXP,,US-JNJFOC-20220207675,JOHNSON AND JOHNSON,,62.0,YR,A,M,Y,94.7,KG,20220208,,HP,US,US,2022,Q1,Adult
204456821,20445682,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2022,Q1,Dry skin,,2022,Q1,1,I,20211022.0,20220201.0,20220208,20220208,EXP,,US-JNJFOC-20220207675,JOHNSON AND JOHNSON,,62.0,YR,A,M,Y,94.7,KG,20220208,,HP,US,US,2022,Q1,Adult
204456821,20445682,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2022,Q1,Haemoglobin decreased,,2022,Q1,1,I,20211022.0,20220201.0,20220208,20220208,EXP,,US-JNJFOC-20220207675,JOHNSON AND JOHNSON,,62.0,YR,A,M,Y,94.7,KG,20220208,,HP,US,US,2022,Q1,Adult
204456821,20445682,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2022,Q1,Off label use,,2022,Q1,1,I,20211022.0,20220201.0,20220208,20220208,EXP,,US-JNJFOC-20220207675,JOHNSON AND JOHNSON,,62.0,YR,A,M,Y,94.7,KG,20220208,,HP,US,US,2022,Q1,Adult
204456821,20445682,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2022,Q1,Hypertension,,2022,Q1,1,I,20211022.0,20220201.0,20220208,20220208,EXP,,US-JNJFOC-20220207675,JOHNSON AND JOHNSON,,62.0,YR,A,M,Y,94.7,KG,20220208,,HP,US,US,2022,Q1,Adult
204456821,20445682,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2022,Q1,Constipation,,2022,Q1,1,I,20211022.0,20220201.0,20220208,20220208,EXP,,US-JNJFOC-20220207675,JOHNSON AND JOHNSON,,62.0,YR,A,M,Y,94.7,KG,20220208,,HP,US,US,2022,Q1,Adult
204456821,20445682,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2022,Q1,Hypoxia,,2022,Q1,1,I,20211022.0,20220201.0,20220208,20220208,EXP,,US-JNJFOC-20220207675,JOHNSON AND JOHNSON,,62.0,YR,A,M,Y,94.7,KG,20220208,,HP,US,US,2022,Q1,Adult
204456821,20445682,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2022,Q1,Product use in unapproved indication,,2022,Q1,1,I,20211022.0,20220201.0,20220208,20220208,EXP,,US-JNJFOC-20220207675,JOHNSON AND JOHNSON,,62.0,YR,A,M,Y,94.7,KG,20220208,,HP,US,US,2022,Q1,Adult
204456821,20445682,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2022,Q1,Pleural effusion,,2022,Q1,1,I,20211022.0,20220201.0,20220208,20220208,EXP,,US-JNJFOC-20220207675,JOHNSON AND JOHNSON,,62.0,YR,A,M,Y,94.7,KG,20220208,,HP,US,US,2022,Q1,Adult
204456821,20445682,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2022,Q1,Atrial fibrillation,,2022,Q1,1,I,20211022.0,20220201.0,20220208,20220208,EXP,,US-JNJFOC-20220207675,JOHNSON AND JOHNSON,,62.0,YR,A,M,Y,94.7,KG,20220208,,HP,US,US,2022,Q1,Adult
204456821,20445682,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2022,Q1,Neutropenia,,2022,Q1,1,I,20211022.0,20220201.0,20220208,20220208,EXP,,US-JNJFOC-20220207675,JOHNSON AND JOHNSON,,62.0,YR,A,M,Y,94.7,KG,20220208,,HP,US,US,2022,Q1,Adult
204456821,20445682,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2022,Q1,Blood creatinine decreased,,2022,Q1,1,I,20211022.0,20220201.0,20220208,20220208,EXP,,US-JNJFOC-20220207675,JOHNSON AND JOHNSON,,62.0,YR,A,M,Y,94.7,KG,20220208,,HP,US,US,2022,Q1,Adult
204456821,20445682,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2022,Q1,Cough,,2022,Q1,1,I,20211022.0,20220201.0,20220208,20220208,EXP,,US-JNJFOC-20220207675,JOHNSON AND JOHNSON,,62.0,YR,A,M,Y,94.7,KG,20220208,,HP,US,US,2022,Q1,Adult
204472061,20447206,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D379508A,,20563.0,,,Injection,,2022,Q1,Limb injury,,2022,Q1,1,I,20220101.0,20220207.0,20220209,20220209,PER,,US-ELI_LILLY_AND_COMPANY-US202202003304,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220209,,CN,US,US,2022,Q1,Elderly
204472061,20447206,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q1,Limb injury,,2022,Q1,1,I,20220101.0,20220207.0,20220209,20220209,PER,,US-ELI_LILLY_AND_COMPANY-US202202003304,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220209,,CN,US,US,2022,Q1,Elderly
204476962,20447696,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D390489A,,20563.0,,,Injection,,2022,Q1,Wrong technique in product usage process,,2022,Q1,2,F,20220316.0,20220317.0,20220209,20220319,PER,,US-ELI_LILLY_AND_COMPANY-US202201007808,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220319,,CN,US,US,2022,Q1,Elderly
204476962,20447696,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D390489A,,20563.0,,,Injection,,2022,Q1,Drug ineffective,,2022,Q1,2,F,20220316.0,20220317.0,20220209,20220319,PER,,US-ELI_LILLY_AND_COMPANY-US202201007808,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220319,,CN,US,US,2022,Q1,Elderly
204476962,20447696,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D390489A,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20220316.0,20220317.0,20220209,20220319,PER,,US-ELI_LILLY_AND_COMPANY-US202201007808,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220319,,CN,US,US,2022,Q1,Elderly
204476962,20447696,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D390489A,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20220316.0,20220317.0,20220209,20220319,PER,,US-ELI_LILLY_AND_COMPANY-US202201007808,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220319,,CN,US,US,2022,Q1,Elderly
204476962,20447696,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D390489A,,20563.0,,,Injection,,2022,Q1,Drug ineffective,,2022,Q1,2,F,20220316.0,20220317.0,20220209,20220319,PER,,US-ELI_LILLY_AND_COMPANY-US202201007808,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220319,,CN,US,US,2022,Q1,Elderly
204476962,20447696,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D390489A,,20563.0,,,Injection,,2022,Q1,Drug ineffective,,2022,Q1,2,F,20220316.0,20220317.0,20220209,20220319,PER,,US-ELI_LILLY_AND_COMPANY-US202201007808,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220319,,CN,US,US,2022,Q1,Elderly
204476962,20447696,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q1,Wrong technique in product usage process,,2022,Q1,2,F,20220316.0,20220317.0,20220209,20220319,PER,,US-ELI_LILLY_AND_COMPANY-US202201007808,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220319,,CN,US,US,2022,Q1,Elderly
204476962,20447696,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q1,Drug ineffective,,2022,Q1,2,F,20220316.0,20220317.0,20220209,20220319,PER,,US-ELI_LILLY_AND_COMPANY-US202201007808,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220319,,CN,US,US,2022,Q1,Elderly
204476962,20447696,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20220316.0,20220317.0,20220209,20220319,PER,,US-ELI_LILLY_AND_COMPANY-US202201007808,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220319,,CN,US,US,2022,Q1,Elderly
204476962,20447696,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20220316.0,20220317.0,20220209,20220319,PER,,US-ELI_LILLY_AND_COMPANY-US202201007808,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220319,,CN,US,US,2022,Q1,Elderly
204476962,20447696,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q1,Drug ineffective,,2022,Q1,2,F,20220316.0,20220317.0,20220209,20220319,PER,,US-ELI_LILLY_AND_COMPANY-US202201007808,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220319,,CN,US,US,2022,Q1,Elderly
204476962,20447696,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q1,Drug ineffective,,2022,Q1,2,F,20220316.0,20220317.0,20220209,20220319,PER,,US-ELI_LILLY_AND_COMPANY-US202201007808,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220319,,CN,US,US,2022,Q1,Elderly
204476962,20447696,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (variarble)",,,,,D429229C,,20563.0,,,Injection,,2022,Q1,Wrong technique in product usage process,,2022,Q1,2,F,20220316.0,20220317.0,20220209,20220319,PER,,US-ELI_LILLY_AND_COMPANY-US202201007808,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220319,,CN,US,US,2022,Q1,Elderly
204476962,20447696,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (variarble)",,,,,D429229C,,20563.0,,,Injection,,2022,Q1,Drug ineffective,,2022,Q1,2,F,20220316.0,20220317.0,20220209,20220319,PER,,US-ELI_LILLY_AND_COMPANY-US202201007808,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220319,,CN,US,US,2022,Q1,Elderly
204476962,20447696,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (variarble)",,,,,D429229C,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20220316.0,20220317.0,20220209,20220319,PER,,US-ELI_LILLY_AND_COMPANY-US202201007808,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220319,,CN,US,US,2022,Q1,Elderly
204476962,20447696,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (variarble)",,,,,D429229C,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20220316.0,20220317.0,20220209,20220319,PER,,US-ELI_LILLY_AND_COMPANY-US202201007808,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220319,,CN,US,US,2022,Q1,Elderly
204476962,20447696,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (variarble)",,,,,D429229C,,20563.0,,,Injection,,2022,Q1,Drug ineffective,,2022,Q1,2,F,20220316.0,20220317.0,20220209,20220319,PER,,US-ELI_LILLY_AND_COMPANY-US202201007808,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220319,,CN,US,US,2022,Q1,Elderly
204476962,20447696,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (variarble)",,,,,D429229C,,20563.0,,,Injection,,2022,Q1,Drug ineffective,,2022,Q1,2,F,20220316.0,20220317.0,20220209,20220319,PER,,US-ELI_LILLY_AND_COMPANY-US202201007808,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220319,,CN,US,US,2022,Q1,Elderly
204476962,20447696,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D429228A,,20563.0,,,Injection,,2022,Q1,Wrong technique in product usage process,,2022,Q1,2,F,20220316.0,20220317.0,20220209,20220319,PER,,US-ELI_LILLY_AND_COMPANY-US202201007808,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220319,,CN,US,US,2022,Q1,Elderly
204476962,20447696,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D429228A,,20563.0,,,Injection,,2022,Q1,Drug ineffective,,2022,Q1,2,F,20220316.0,20220317.0,20220209,20220319,PER,,US-ELI_LILLY_AND_COMPANY-US202201007808,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220319,,CN,US,US,2022,Q1,Elderly
204476962,20447696,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D429228A,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20220316.0,20220317.0,20220209,20220319,PER,,US-ELI_LILLY_AND_COMPANY-US202201007808,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220319,,CN,US,US,2022,Q1,Elderly
204476962,20447696,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D429228A,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20220316.0,20220317.0,20220209,20220319,PER,,US-ELI_LILLY_AND_COMPANY-US202201007808,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220319,,CN,US,US,2022,Q1,Elderly
204476962,20447696,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D429228A,,20563.0,,,Injection,,2022,Q1,Drug ineffective,,2022,Q1,2,F,20220316.0,20220317.0,20220209,20220319,PER,,US-ELI_LILLY_AND_COMPANY-US202201007808,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220319,,CN,US,US,2022,Q1,Elderly
204476962,20447696,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D429228A,,20563.0,,,Injection,,2022,Q1,Drug ineffective,,2022,Q1,2,F,20220316.0,20220317.0,20220209,20220319,PER,,US-ELI_LILLY_AND_COMPANY-US202201007808,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220319,,CN,US,US,2022,Q1,Elderly
204486101,20448610,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid (3/day)",,,U,,Unknown,,,,,,TID,2022,Q1,Hemiplegia,,2022,Q1,1,I,,20220127.0,20220209,20220209,EXP,,IT-PFIZER INC-202200153933,PFIZER,"Ianniciello, A.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. European Heart Journal. 2021;(SUPPL G):G92-3",68.0,YR,,M,Y,,,20220209,,HP,IT,IT,2022,Q1,Elderly
204486101,20448610,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid (3/day)",,,U,,Unknown,,,,,,TID,2022,Q1,Electrocardiogram ST segment elevation,,2022,Q1,1,I,,20220127.0,20220209,20220209,EXP,,IT-PFIZER INC-202200153933,PFIZER,"Ianniciello, A.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. European Heart Journal. 2021;(SUPPL G):G92-3",68.0,YR,,M,Y,,,20220209,,HP,IT,IT,2022,Q1,Elderly
204486101,20448610,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid (3/day)",,,U,,Unknown,,,,,,TID,2022,Q1,Dyspnoea,,2022,Q1,1,I,,20220127.0,20220209,20220209,EXP,,IT-PFIZER INC-202200153933,PFIZER,"Ianniciello, A.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. European Heart Journal. 2021;(SUPPL G):G92-3",68.0,YR,,M,Y,,,20220209,,HP,IT,IT,2022,Q1,Elderly
204486101,20448610,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid (3/day)",,,U,,Unknown,,,,,,TID,2022,Q1,Acute right ventricular failure,,2022,Q1,1,I,,20220127.0,20220209,20220209,EXP,,IT-PFIZER INC-202200153933,PFIZER,"Ianniciello, A.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. European Heart Journal. 2021;(SUPPL G):G92-3",68.0,YR,,M,Y,,,20220209,,HP,IT,IT,2022,Q1,Elderly
204486101,20448610,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid (3/day)",,,U,,Unknown,,,,,,TID,2022,Q1,Off label use,,2022,Q1,1,I,,20220127.0,20220209,20220209,EXP,,IT-PFIZER INC-202200153933,PFIZER,"Ianniciello, A.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. European Heart Journal. 2021;(SUPPL G):G92-3",68.0,YR,,M,Y,,,20220209,,HP,IT,IT,2022,Q1,Elderly
204486101,20448610,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid (3/day)",,,U,,Unknown,,,,,,TID,2022,Q1,Drug effective for unapproved indication,,2022,Q1,1,I,,20220127.0,20220209,20220209,EXP,,IT-PFIZER INC-202200153933,PFIZER,"Ianniciello, A.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. European Heart Journal. 2021;(SUPPL G):G92-3",68.0,YR,,M,Y,,,20220209,,HP,IT,IT,2022,Q1,Elderly
204541011,20454101,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 U,,,Y,,D312549A,,,,,,,2022,Q1,Hypoglycaemia,,2022,Q1,1,I,20220114.0,20220131.0,20220210,20220210,EXP,,CN-SA-2022SA037474,SANOFI AVENTIS,,46.0,YR,A,M,Y,,,20220210,,HP,CN,CN,2022,Q1,Adult
204541011,20454101,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 U,,,Y,,D312549A,,,,,,,2022,Q1,Palpitations,,2022,Q1,1,I,20220114.0,20220131.0,20220210,20220210,EXP,,CN-SA-2022SA037474,SANOFI AVENTIS,,46.0,YR,A,M,Y,,,20220210,,HP,CN,CN,2022,Q1,Adult
204541011,20454101,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 U,,,Y,,D312549A,,,,,,,2022,Q1,Tremor,,2022,Q1,1,I,20220114.0,20220131.0,20220210,20220210,EXP,,CN-SA-2022SA037474,SANOFI AVENTIS,,46.0,YR,A,M,Y,,,20220210,,HP,CN,CN,2022,Q1,Adult
204541011,20454101,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 U,,,Y,,D312549A,,,,,,,2022,Q1,Asthenia,,2022,Q1,1,I,20220114.0,20220131.0,20220210,20220210,EXP,,CN-SA-2022SA037474,SANOFI AVENTIS,,46.0,YR,A,M,Y,,,20220210,,HP,CN,CN,2022,Q1,Adult
204544311,20454431,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Protrusion tongue,,2022,Q1,1,I,20220205.0,,20220209,20220209,DIR,603014,,FDA-CTU,,34.0,YR,,F,N,123.0,KG,20220209,N,PH,US,,2022,Q1,Young Adult
204544311,20454431,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Swollen tongue,,2022,Q1,1,I,20220205.0,,20220209,20220209,DIR,603014,,FDA-CTU,,34.0,YR,,F,N,123.0,KG,20220209,N,PH,US,,2022,Q1,Young Adult
204551171,20455117,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,Y,,,,,,,,2022,Q1,Exposure during pregnancy,,2022,Q1,1,I,20220209.0,,20220209,20220209,DIR,FDA-CDER-CTU-2022-11521,,FDA-CTU,,21.0,YR,,F,N,,,20220209,N,,US,,2022,Q1,Youth
204551171,20455117,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,Y,,,,,,,,2022,Q1,Pregnancy,,2022,Q1,1,I,20220209.0,,20220209,20220209,DIR,FDA-CDER-CTU-2022-11521,,FDA-CTU,,21.0,YR,,F,N,,,20220209,N,,US,,2022,Q1,Youth
204574331,20457433,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1 unit for 3 g of carbohydrate with meals and snacks,,,D,,,,,,,Unknown,,2022,Q1,Off label use,,2022,Q1,1,I,,20220118.0,20220210,20220210,EXP,,CA-JNJFOC-20220203941,JOHNSON AND JOHNSON,,17.0,YR,T,M,Y,,,20220211,,HP,CA,CA,2022,Q1,Youth
204574331,20457433,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1 unit for 3 g of carbohydrate with meals and snacks,,,D,,,,,,,Unknown,,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,,20220118.0,20220210,20220210,EXP,,CA-JNJFOC-20220203941,JOHNSON AND JOHNSON,,17.0,YR,T,M,Y,,,20220211,,HP,CA,CA,2022,Q1,Youth
204574331,20457433,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1 unit for 3 g of carbohydrate with meals and snacks,,,D,,,,,,,Unknown,,2022,Q1,Product prescribing error,,2022,Q1,1,I,,20220118.0,20220210,20220210,EXP,,CA-JNJFOC-20220203941,JOHNSON AND JOHNSON,,17.0,YR,T,M,Y,,,20220211,,HP,CA,CA,2022,Q1,Youth
204601051,20460105,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown",,,U,,D403916C,,20563.0,10.0,IU,Injection,,2022,Q1,Hyperhidrosis,,2022,Q1,1,I,20220112.0,20220113.0,20220211,20220211,PER,,US-ELI_LILLY_AND_COMPANY-US202201006101,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20220211,,CN,US,US,2022,Q1,Elderly
204620101,20462010,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Dialysis,,2022,Q1,1,I,20220210.0,,20220211,20220211,DIR,603239,,FDA-CTU,,39.0,YR,,M,N,96.8,KG,20220211,N,PH,US,,2022,Q1,Adult
204620101,20462010,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Gastrointestinal haemorrhage,,2022,Q1,1,I,20220210.0,,20220211,20220211,DIR,603239,,FDA-CTU,,39.0,YR,,M,N,96.8,KG,20220211,N,PH,US,,2022,Q1,Adult
204630921,20463092,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,UNK,,,,,Injection,,2022,Q1,Hypotension,,2022,Q1,1,I,,20220209.0,20220211,20220211,EXP,,CA-Fresenius Kabi-FK202201591,FRESENIUS KABI,,70.0,YR,,F,Y,,,20220211,,HP,CA,,2022,Q1,Elderly
204630921,20463092,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,UNK,,,,,Injection,,2022,Q1,Vasoplegia syndrome,,2022,Q1,1,I,,20220209.0,20220211,20220211,EXP,,CA-Fresenius Kabi-FK202201591,FRESENIUS KABI,,70.0,YR,,F,Y,,,20220211,,HP,CA,,2022,Q1,Elderly
204663061,20466306,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,UNKNOWN,,20563.0,,,Injection,,2022,Q1,Rotator cuff syndrome,,2022,Q1,1,I,20211001.0,20220208.0,20220213,20220213,PER,,US-ELI_LILLY_AND_COMPANY-US202202004057,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220213,,CN,US,US,2022,Q1,Elderly
204684281,20468428,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,U,Unknown,,,,,,,2022,Q1,Phaeochromocytoma,,2022,Q1,1,I,,20220202.0,20220214,20220214,EXP,,IT-Appco Pharma LLC-2125859,APPCO PHARMA,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, Giunta A, Cunzi D, Coghi P, Volpi R, Cabassi A. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency. Blood pressure. 2021 Sep 3;30(5):322-6, Doi: 10.1080/08037051.2021.1945428",33.0,YR,,F,Y,,,20220214,,HP,IT,IT,2022,Q1,Young Adult
204684281,20468428,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,U,Unknown,,,,,,,2022,Q1,Maternal exposure during pregnancy,,2022,Q1,1,I,,20220202.0,20220214,20220214,EXP,,IT-Appco Pharma LLC-2125859,APPCO PHARMA,"Negro A, Verzicco I, Tedeschi S, Santi R, Palladini B, Calvi A, Giunta A, Cunzi D, Coghi P, Volpi R, Cabassi A. Unrecognised pheochromocytoma in pregnancy discovered through metoclopramide-triggered hypertensive emergency. Blood pressure. 2021 Sep 3;30(5):322-6, Doi: 10.1080/08037051.2021.1945428",33.0,YR,,F,Y,,,20220214,,HP,IT,IT,2022,Q1,Young Adult
204750781,20475078,10,C,insulin lispro (HumaLOG KwikPen Insulin) 100 unit/mL flexpen,,2,,,,,,,,,,,,,,2022,Q1,Dyspnoea,,2022,Q1,1,I,20220207.0,,20220214,20220214,DIR,603529,,FDA-CTU,,70.0,YR,,M,N,,,20220214,Y,,US,,2022,Q1,Elderly
204750781,20475078,10,C,insulin lispro (HumaLOG KwikPen Insulin) 100 unit/mL flexpen,,2,,,,,,,,,,,,,,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,20220207.0,,20220214,20220214,DIR,603529,,FDA-CTU,,70.0,YR,,M,N,,,20220214,Y,,US,,2022,Q1,Elderly
204750781,20475078,10,C,insulin lispro (HumaLOG KwikPen Insulin) 100 unit/mL flexpen,,2,,,,,,,,,,,,,,2022,Q1,Hyperglycaemia,,2022,Q1,1,I,20220207.0,,20220214,20220214,DIR,603529,,FDA-CTU,,70.0,YR,,M,N,,,20220214,Y,,US,,2022,Q1,Elderly
204831581,20483158,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q1,Feeling abnormal,,2022,Q1,1,I,20220117.0,20220118.0,20220217,20220217,PER,,US-ELI_LILLY_AND_COMPANY-US202201007218,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20220217,,CN,US,US,2022,Q1,Elderly
204831581,20483158,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q1,Product dose omission issue,,2022,Q1,1,I,20220117.0,20220118.0,20220217,20220217,PER,,US-ELI_LILLY_AND_COMPANY-US202201007218,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20220217,,CN,US,US,2022,Q1,Elderly
204831581,20483158,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q1,Feeling abnormal,,2022,Q1,1,I,20220117.0,20220118.0,20220217,20220217,PER,,US-ELI_LILLY_AND_COMPANY-US202201007218,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20220217,,CN,US,US,2022,Q1,Elderly
204831581,20483158,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q1,Product dose omission issue,,2022,Q1,1,I,20220117.0,20220118.0,20220217,20220217,PER,,US-ELI_LILLY_AND_COMPANY-US202201007218,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20220217,,CN,US,US,2022,Q1,Elderly
204831581,20483158,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D379508A,,20563.0,,,Injection,,2022,Q1,Feeling abnormal,,2022,Q1,1,I,20220117.0,20220118.0,20220217,20220217,PER,,US-ELI_LILLY_AND_COMPANY-US202201007218,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20220217,,CN,US,US,2022,Q1,Elderly
204831581,20483158,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D379508A,,20563.0,,,Injection,,2022,Q1,Product dose omission issue,,2022,Q1,1,I,20220117.0,20220118.0,20220217,20220217,PER,,US-ELI_LILLY_AND_COMPANY-US202201007218,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20220217,,CN,US,US,2022,Q1,Elderly
204831581,20483158,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D379508A,,20563.0,,,Injection,,2022,Q1,Feeling abnormal,,2022,Q1,1,I,20220117.0,20220118.0,20220217,20220217,PER,,US-ELI_LILLY_AND_COMPANY-US202201007218,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20220217,,CN,US,US,2022,Q1,Elderly
204831581,20483158,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D379508A,,20563.0,,,Injection,,2022,Q1,Product dose omission issue,,2022,Q1,1,I,20220117.0,20220118.0,20220217,20220217,PER,,US-ELI_LILLY_AND_COMPANY-US202201007218,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20220217,,CN,US,US,2022,Q1,Elderly
204878751,20487875,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220215.0,20220216.0,20220218,20220218,PER,,US-ELI_LILLY_AND_COMPANY-US202202007655,ELI LILLY AND CO,,72.0,YR,,F,Y,,,20220218,,CN,US,US,2022,Q1,Elderly
204941261,20494126,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,10 divided units daily,,,U,,,,209196.0,,,,QD,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,,20220209.0,20220221,20220221,EXP,,QA-SA-2022SA047142,SANOFI AVENTIS,,12.0,YR,T,F,Y,41.9,KG,20220221,,HP,QA,QA,2022,Q1,Child
204941261,20494126,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,10 divided units daily,,,U,,,,209196.0,,,,QD,2022,Q1,Treatment noncompliance,,2022,Q1,1,I,,20220209.0,20220221,20220221,EXP,,QA-SA-2022SA047142,SANOFI AVENTIS,,12.0,YR,T,F,Y,41.9,KG,20220221,,HP,QA,QA,2022,Q1,Child
204956701,20495670,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Accidental underdose,,2022,Q1,1,I,20220209.0,20220209.0,20220221,20220221,EXP,,US-ELI_LILLY_AND_COMPANY-US202202005897,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20220221,,CN,US,US,2022,Q1,Elderly
204956701,20495670,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Neoplasm malignant,,2022,Q1,1,I,20220209.0,20220209.0,20220221,20220221,EXP,,US-ELI_LILLY_AND_COMPANY-US202202005897,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20220221,,CN,US,US,2022,Q1,Elderly
204956701,20495670,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q1,Injury associated with device,,2022,Q1,1,I,20220209.0,20220209.0,20220221,20220221,EXP,,US-ELI_LILLY_AND_COMPANY-US202202005897,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20220221,,CN,US,US,2022,Q1,Elderly
204956701,20495670,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D420813A,,20563.0,,,Injection,,2022,Q1,Accidental underdose,,2022,Q1,1,I,20220209.0,20220209.0,20220221,20220221,EXP,,US-ELI_LILLY_AND_COMPANY-US202202005897,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20220221,,CN,US,US,2022,Q1,Elderly
204956701,20495670,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D420813A,,20563.0,,,Injection,,2022,Q1,Neoplasm malignant,,2022,Q1,1,I,20220209.0,20220209.0,20220221,20220221,EXP,,US-ELI_LILLY_AND_COMPANY-US202202005897,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20220221,,CN,US,US,2022,Q1,Elderly
204956701,20495670,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D420813A,,20563.0,,,Injection,,2022,Q1,Injury associated with device,,2022,Q1,1,I,20220209.0,20220209.0,20220221,20220221,EXP,,US-ELI_LILLY_AND_COMPANY-US202202005897,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20220221,,CN,US,US,2022,Q1,Elderly
204971752,20497175,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Delirium,,2022,Q1,2,F,20211005.0,20220323.0,20220221,20220323,EXP,,NVSC2022CA013241,NOVARTIS,,81.0,YR,,F,Y,75.0,KG,20220323,,MD,CA,CA,2022,Q1,Elderly
205001711,20500171,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D379508A,,,,,Injection,,2022,Q1,Decubitus ulcer,,2022,Q1,1,I,20210801.0,20220221.0,20220222,20220222,PER,,US-ELI_LILLY_AND_COMPANY-US202202009020,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20220222,,CN,US,US,2022,Q1,Adult
205001711,20500171,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D379508A,,,,,Injection,,2022,Q1,Limb injury,,2022,Q1,1,I,20210801.0,20220221.0,20220222,20220222,PER,,US-ELI_LILLY_AND_COMPANY-US202202009020,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20220222,,CN,US,US,2022,Q1,Adult
205001711,20500171,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D379508A,,,,,Injection,,2022,Q1,Impaired healing,,2022,Q1,1,I,20210801.0,20220221.0,20220222,20220222,PER,,US-ELI_LILLY_AND_COMPANY-US202202009020,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20220222,,CN,US,US,2022,Q1,Adult
205002101,20500210,8,C,INSULIN LISPRO,,1,,,,,,,,,,,,,,2022,Q1,Death,,2022,Q1,1,I,20220217.0,,20220218,20220218,DIR,FDA-CDER-CTU-2022-14412,,FDA-CTU,,85.0,YR,,M,N,,,20220218,N,,US,,2022,Q1,Elderly
205005041,20500504,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1 international unit (1 unit/12 g of carbohydrate),,,U,U,,,,1.0,IU,,,2022,Q1,Neurological symptom,,2022,Q1,1,I,,20220214.0,20220222,20220222,EXP,,US-MYLANLABS-2022M1014117,MYLAN,"Mintz JL, Jameson MB, Akinseye L, Los EA. Pediatric diabetic ketoacidosis presenting with Streptococcus intermedius brain abscess. J-Pediatr-Endocrinol-Metab 2021;34(6):817-820.",12.0,YR,,F,Y,,,20220222,,HP,US,US,2022,Q1,Child
205005041,20500504,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1 international unit (1 unit/12 g of carbohydrate),,,U,U,,,,1.0,IU,,,2022,Q1,Brain abscess,,2022,Q1,1,I,,20220214.0,20220222,20220222,EXP,,US-MYLANLABS-2022M1014117,MYLAN,"Mintz JL, Jameson MB, Akinseye L, Los EA. Pediatric diabetic ketoacidosis presenting with Streptococcus intermedius brain abscess. J-Pediatr-Endocrinol-Metab 2021;34(6):817-820.",12.0,YR,,F,Y,,,20220222,,HP,US,US,2022,Q1,Child
205005041,20500504,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1 international unit (1 unit/12 g of carbohydrate),,,U,U,,,,1.0,IU,,,2022,Q1,Unmasking of previously unidentified disease,,2022,Q1,1,I,,20220214.0,20220222,20220222,EXP,,US-MYLANLABS-2022M1014117,MYLAN,"Mintz JL, Jameson MB, Akinseye L, Los EA. Pediatric diabetic ketoacidosis presenting with Streptococcus intermedius brain abscess. J-Pediatr-Endocrinol-Metab 2021;34(6):817-820.",12.0,YR,,F,Y,,,20220222,,HP,US,US,2022,Q1,Child
205005041,20500504,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1 international unit (1 unit/12 g of carbohydrate),,,U,U,,,,1.0,IU,,,2022,Q1,Streptococcal infection,,2022,Q1,1,I,,20220214.0,20220222,20220222,EXP,,US-MYLANLABS-2022M1014117,MYLAN,"Mintz JL, Jameson MB, Akinseye L, Los EA. Pediatric diabetic ketoacidosis presenting with Streptococcus intermedius brain abscess. J-Pediatr-Endocrinol-Metab 2021;34(6):817-820.",12.0,YR,,F,Y,,,20220222,,HP,US,US,2022,Q1,Child
205005041,20500504,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2022,Q1,Neurological symptom,,2022,Q1,1,I,,20220214.0,20220222,20220222,EXP,,US-MYLANLABS-2022M1014117,MYLAN,"Mintz JL, Jameson MB, Akinseye L, Los EA. Pediatric diabetic ketoacidosis presenting with Streptococcus intermedius brain abscess. J-Pediatr-Endocrinol-Metab 2021;34(6):817-820.",12.0,YR,,F,Y,,,20220222,,HP,US,US,2022,Q1,Child
205005041,20500504,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2022,Q1,Brain abscess,,2022,Q1,1,I,,20220214.0,20220222,20220222,EXP,,US-MYLANLABS-2022M1014117,MYLAN,"Mintz JL, Jameson MB, Akinseye L, Los EA. Pediatric diabetic ketoacidosis presenting with Streptococcus intermedius brain abscess. J-Pediatr-Endocrinol-Metab 2021;34(6):817-820.",12.0,YR,,F,Y,,,20220222,,HP,US,US,2022,Q1,Child
205005041,20500504,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2022,Q1,Unmasking of previously unidentified disease,,2022,Q1,1,I,,20220214.0,20220222,20220222,EXP,,US-MYLANLABS-2022M1014117,MYLAN,"Mintz JL, Jameson MB, Akinseye L, Los EA. Pediatric diabetic ketoacidosis presenting with Streptococcus intermedius brain abscess. J-Pediatr-Endocrinol-Metab 2021;34(6):817-820.",12.0,YR,,F,Y,,,20220222,,HP,US,US,2022,Q1,Child
205005041,20500504,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2022,Q1,Streptococcal infection,,2022,Q1,1,I,,20220214.0,20220222,20220222,EXP,,US-MYLANLABS-2022M1014117,MYLAN,"Mintz JL, Jameson MB, Akinseye L, Los EA. Pediatric diabetic ketoacidosis presenting with Streptococcus intermedius brain abscess. J-Pediatr-Endocrinol-Metab 2021;34(6):817-820.",12.0,YR,,F,Y,,,20220222,,HP,US,US,2022,Q1,Child
205040921,20504092,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,21017.0,,,Injection,,2022,Q1,Visual impairment,,2022,Q1,1,I,20220221.0,20220221.0,20220222,20220222,PER,,US-ELI_LILLY_AND_COMPANY-US202202009090,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20220222,,CN,US,US,2022,Q1,Elderly
205040921,20504092,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,21017.0,,,Injection,,2022,Q1,Wrong technique in product usage process,,2022,Q1,1,I,20220221.0,20220221.0,20220222,20220222,PER,,US-ELI_LILLY_AND_COMPANY-US202202009090,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20220222,,CN,US,US,2022,Q1,Elderly
205041201,20504120,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,100.0,ML,Injection,,2022,Q1,SARS-CoV-2 test positive,,2022,Q1,1,I,20220105.0,20220216.0,20220222,20220222,PER,,US-CELGENEUS-USA-20220205431,CELGENE,,75.0,YR,,F,Y,,,20220222,,PH,US,US,2022,Q1,Elderly
205052881,20505288,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Hypertriglyceridaemia,,2022,Q1,1,I,,20220211.0,20220223,20220223,PER,,US-APOTEX-2022AP003617,APOTEX,"Schweiger J, Phillips K, Patel A, Echols C.. Drug induced very severe hypertriglyceridemia in a pediatric stem cell transplant recipient. Pediatric Blood and Cancer. 2022;69(2):e29379",16.0,YR,,F,Y,,,20220223,,HP,US,US,2022,Q1,Youth
205052881,20505288,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Drug level below therapeutic,,2022,Q1,1,I,,20220211.0,20220223,20220223,PER,,US-APOTEX-2022AP003617,APOTEX,"Schweiger J, Phillips K, Patel A, Echols C.. Drug induced very severe hypertriglyceridemia in a pediatric stem cell transplant recipient. Pediatric Blood and Cancer. 2022;69(2):e29379",16.0,YR,,F,Y,,,20220223,,HP,US,US,2022,Q1,Youth
205100011,20510001,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, tid",,,,,,,20563.0,20.0,IU,Injection,TID,2022,Q1,Accidental underdose,,2022,Q1,1,I,20220101.0,20220128.0,20220224,20220224,PER,,US-ELI_LILLY_AND_COMPANY-US202201011754,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20220224,,CN,US,US,2022,Q1,Adult
205100011,20510001,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, tid",,,,,,,20563.0,20.0,IU,Injection,TID,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220101.0,20220128.0,20220224,20220224,PER,,US-ELI_LILLY_AND_COMPANY-US202201011754,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20220224,,CN,US,US,2022,Q1,Adult
205100011,20510001,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, tid",,,,,,,20563.0,20.0,IU,Injection,TID,2022,Q1,Product storage error,,2022,Q1,1,I,20220101.0,20220128.0,20220224,20220224,PER,,US-ELI_LILLY_AND_COMPANY-US202201011754,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20220224,,CN,US,US,2022,Q1,Adult
205100011,20510001,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, tid",,,,,D379508A,,20563.0,20.0,IU,Injection,TID,2022,Q1,Accidental underdose,,2022,Q1,1,I,20220101.0,20220128.0,20220224,20220224,PER,,US-ELI_LILLY_AND_COMPANY-US202201011754,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20220224,,CN,US,US,2022,Q1,Adult
205100011,20510001,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, tid",,,,,D379508A,,20563.0,20.0,IU,Injection,TID,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220101.0,20220128.0,20220224,20220224,PER,,US-ELI_LILLY_AND_COMPANY-US202201011754,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20220224,,CN,US,US,2022,Q1,Adult
205100011,20510001,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"20 u, tid",,,,,D379508A,,20563.0,20.0,IU,Injection,TID,2022,Q1,Product storage error,,2022,Q1,1,I,20220101.0,20220128.0,20220224,20220224,PER,,US-ELI_LILLY_AND_COMPANY-US202201011754,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20220224,,CN,US,US,2022,Q1,Adult
205115982,20511598,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D395986A,,20563.0,10.0,IU,Injection,,2022,Q1,Foot deformity,,2022,Q1,2,F,20220223.0,20220302.0,20220224,20220308,PER,,US-ELI_LILLY_AND_COMPANY-US202202010054,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220308,,CN,US,US,2022,Q1,Elderly
205115982,20511598,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D395986A,,20563.0,10.0,IU,Injection,,2022,Q1,Blood pressure increased,,2022,Q1,2,F,20220223.0,20220302.0,20220224,20220308,PER,,US-ELI_LILLY_AND_COMPANY-US202202010054,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220308,,CN,US,US,2022,Q1,Elderly
205115982,20511598,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D395986A,,20563.0,10.0,IU,Injection,,2022,Q1,Dizziness,,2022,Q1,2,F,20220223.0,20220302.0,20220224,20220308,PER,,US-ELI_LILLY_AND_COMPANY-US202202010054,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220308,,CN,US,US,2022,Q1,Elderly
205115982,20511598,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D395986A,,20563.0,10.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20220223.0,20220302.0,20220224,20220308,PER,,US-ELI_LILLY_AND_COMPANY-US202202010054,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220308,,CN,US,US,2022,Q1,Elderly
205115982,20511598,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D395986A,,20563.0,10.0,IU,Injection,,2022,Q1,Feeling abnormal,,2022,Q1,2,F,20220223.0,20220302.0,20220224,20220308,PER,,US-ELI_LILLY_AND_COMPANY-US202202010054,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220308,,CN,US,US,2022,Q1,Elderly
205115982,20511598,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D395986A,,20563.0,10.0,IU,Injection,,2022,Q1,Limb injury,,2022,Q1,2,F,20220223.0,20220302.0,20220224,20220308,PER,,US-ELI_LILLY_AND_COMPANY-US202202010054,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220308,,CN,US,US,2022,Q1,Elderly
205115982,20511598,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D395986A,,20563.0,10.0,IU,Injection,,2022,Q1,Incorrect dose administered,,2022,Q1,2,F,20220223.0,20220302.0,20220224,20220308,PER,,US-ELI_LILLY_AND_COMPANY-US202202010054,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220308,,CN,US,US,2022,Q1,Elderly
205115982,20511598,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D395986A,,20563.0,10.0,IU,Injection,,2022,Q1,Vertigo,,2022,Q1,2,F,20220223.0,20220302.0,20220224,20220308,PER,,US-ELI_LILLY_AND_COMPANY-US202202010054,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220308,,CN,US,US,2022,Q1,Elderly
205115982,20511598,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D395986A,,20563.0,10.0,IU,Injection,,2022,Q1,Wrong technique in product usage process,,2022,Q1,2,F,20220223.0,20220302.0,20220224,20220308,PER,,US-ELI_LILLY_AND_COMPANY-US202202010054,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220308,,CN,US,US,2022,Q1,Elderly
205115982,20511598,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D395986A,,20563.0,10.0,IU,Injection,,2022,Q1,Thermal burn,,2022,Q1,2,F,20220223.0,20220302.0,20220224,20220308,PER,,US-ELI_LILLY_AND_COMPANY-US202202010054,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220308,,CN,US,US,2022,Q1,Elderly
205115982,20511598,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D395986A,,20563.0,10.0,IU,Injection,,2022,Q1,Visual impairment,,2022,Q1,2,F,20220223.0,20220302.0,20220224,20220308,PER,,US-ELI_LILLY_AND_COMPANY-US202202010054,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220308,,CN,US,US,2022,Q1,Elderly
205115982,20511598,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"16 u, unknown (14 to 16)",,,U,,D395986A,,20563.0,16.0,IU,Injection,,2022,Q1,Foot deformity,,2022,Q1,2,F,20220223.0,20220302.0,20220224,20220308,PER,,US-ELI_LILLY_AND_COMPANY-US202202010054,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220308,,CN,US,US,2022,Q1,Elderly
205115982,20511598,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"16 u, unknown (14 to 16)",,,U,,D395986A,,20563.0,16.0,IU,Injection,,2022,Q1,Blood pressure increased,,2022,Q1,2,F,20220223.0,20220302.0,20220224,20220308,PER,,US-ELI_LILLY_AND_COMPANY-US202202010054,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220308,,CN,US,US,2022,Q1,Elderly
205115982,20511598,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"16 u, unknown (14 to 16)",,,U,,D395986A,,20563.0,16.0,IU,Injection,,2022,Q1,Dizziness,,2022,Q1,2,F,20220223.0,20220302.0,20220224,20220308,PER,,US-ELI_LILLY_AND_COMPANY-US202202010054,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220308,,CN,US,US,2022,Q1,Elderly
205115982,20511598,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"16 u, unknown (14 to 16)",,,U,,D395986A,,20563.0,16.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,2,F,20220223.0,20220302.0,20220224,20220308,PER,,US-ELI_LILLY_AND_COMPANY-US202202010054,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220308,,CN,US,US,2022,Q1,Elderly
205115982,20511598,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"16 u, unknown (14 to 16)",,,U,,D395986A,,20563.0,16.0,IU,Injection,,2022,Q1,Feeling abnormal,,2022,Q1,2,F,20220223.0,20220302.0,20220224,20220308,PER,,US-ELI_LILLY_AND_COMPANY-US202202010054,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220308,,CN,US,US,2022,Q1,Elderly
205115982,20511598,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"16 u, unknown (14 to 16)",,,U,,D395986A,,20563.0,16.0,IU,Injection,,2022,Q1,Limb injury,,2022,Q1,2,F,20220223.0,20220302.0,20220224,20220308,PER,,US-ELI_LILLY_AND_COMPANY-US202202010054,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220308,,CN,US,US,2022,Q1,Elderly
205115982,20511598,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"16 u, unknown (14 to 16)",,,U,,D395986A,,20563.0,16.0,IU,Injection,,2022,Q1,Incorrect dose administered,,2022,Q1,2,F,20220223.0,20220302.0,20220224,20220308,PER,,US-ELI_LILLY_AND_COMPANY-US202202010054,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220308,,CN,US,US,2022,Q1,Elderly
205115982,20511598,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"16 u, unknown (14 to 16)",,,U,,D395986A,,20563.0,16.0,IU,Injection,,2022,Q1,Vertigo,,2022,Q1,2,F,20220223.0,20220302.0,20220224,20220308,PER,,US-ELI_LILLY_AND_COMPANY-US202202010054,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220308,,CN,US,US,2022,Q1,Elderly
205115982,20511598,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"16 u, unknown (14 to 16)",,,U,,D395986A,,20563.0,16.0,IU,Injection,,2022,Q1,Wrong technique in product usage process,,2022,Q1,2,F,20220223.0,20220302.0,20220224,20220308,PER,,US-ELI_LILLY_AND_COMPANY-US202202010054,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220308,,CN,US,US,2022,Q1,Elderly
205115982,20511598,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"16 u, unknown (14 to 16)",,,U,,D395986A,,20563.0,16.0,IU,Injection,,2022,Q1,Thermal burn,,2022,Q1,2,F,20220223.0,20220302.0,20220224,20220308,PER,,US-ELI_LILLY_AND_COMPANY-US202202010054,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220308,,CN,US,US,2022,Q1,Elderly
205115982,20511598,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"16 u, unknown (14 to 16)",,,U,,D395986A,,20563.0,16.0,IU,Injection,,2022,Q1,Visual impairment,,2022,Q1,2,F,20220223.0,20220302.0,20220224,20220308,PER,,US-ELI_LILLY_AND_COMPANY-US202202010054,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220308,,CN,US,US,2022,Q1,Elderly
205128781,20512878,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Inject 0.06 milliliter (12 units total) 3 times a day,,,,,,,,0.06,ML,Injection,,2022,Q1,Osteonecrosis,,2022,Q1,1,I,20200731.0,20220221.0,20220224,20220224,EXP,,US-AMERICAN REGENT INC-2022000434,AMERICAN REGENT,,53.0,YR,,M,Y,119.0,KG,20220224,,MD,US,US,2022,Q1,Adult
205128781,20512878,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Inject 0.06 milliliter (12 units total) 3 times a day,,,,,,,,0.06,ML,Injection,,2022,Q1,Osteomalacia,,2022,Q1,1,I,20200731.0,20220221.0,20220224,20220224,EXP,,US-AMERICAN REGENT INC-2022000434,AMERICAN REGENT,,53.0,YR,,M,Y,119.0,KG,20220224,,MD,US,US,2022,Q1,Adult
205128781,20512878,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Inject 0.06 milliliter (12 units total) 3 times a day,,,,,,,,0.06,ML,Injection,,2022,Q1,Stress fracture,,2022,Q1,1,I,20200731.0,20220221.0,20220224,20220224,EXP,,US-AMERICAN REGENT INC-2022000434,AMERICAN REGENT,,53.0,YR,,M,Y,119.0,KG,20220224,,MD,US,US,2022,Q1,Adult
205128781,20512878,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Inject 0.06 milliliter (12 units total) 3 times a day,,,,,,,,0.06,ML,Injection,,2022,Q1,Hypophosphataemia,,2022,Q1,1,I,20200731.0,20220221.0,20220224,20220224,EXP,,US-AMERICAN REGENT INC-2022000434,AMERICAN REGENT,,53.0,YR,,M,Y,119.0,KG,20220224,,MD,US,US,2022,Q1,Adult
205138552,20513855,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,16 kIU,,,U,,,,,16.0,KIU,,,2022,Q1,Thrombosis,,2022,Q1,2,F,20220129.0,20220309.0,20220224,20220310,EXP,IT-MINISAL02-844595,NVSC2022IT040208,NOVARTIS,,64.0,YR,,M,Y,130.0,KG,20220310,,MD,IT,IT,2022,Q1,Adult
205138552,20513855,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,16 kIU,,,U,,,,,16.0,KIU,,,2022,Q1,Thrombocytopenia,,2022,Q1,2,F,20220129.0,20220309.0,20220224,20220310,EXP,IT-MINISAL02-844595,NVSC2022IT040208,NOVARTIS,,64.0,YR,,M,Y,130.0,KG,20220310,,MD,IT,IT,2022,Q1,Adult
205200061,20520006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 units/ml, prn",,,,,,,,,,,,2022,Q1,Muscle spasms,,2022,Q1,1,I,20210928.0,20210928.0,20220225,20220225,PER,,US-LANTHEUS-LMI-2021-01212,LANTHEUS MEDICAL IMAGING,,48.0,YR,,M,Y,117.0,KG,20220211,,CN,US,US,2022,Q1,Adult
205200061,20520006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 units/ml, prn",,,,,,,,,,,,2022,Q1,Back pain,,2022,Q1,1,I,20210928.0,20210928.0,20220225,20220225,PER,,US-LANTHEUS-LMI-2021-01212,LANTHEUS MEDICAL IMAGING,,48.0,YR,,M,Y,117.0,KG,20220211,,CN,US,US,2022,Q1,Adult
205201743,20520174,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q1,Uveitis,,2022,Q1,3,F,20210721.0,20220316.0,20220225,20220323,EXP,,PL-ROCHE-2895531,ROCHE,,63.0,YR,,M,Y,,,20220323,,MD,PL,,2022,Q1,Adult
205261851,20526185,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,unknown,,,,,UNK,,,,,,,2022,Q1,Off label use,,2022,Q1,1,I,20210601.0,20210723.0,20220228,20220228,PER,,US-HRARD-2021000863,HRA PHARMA,,21.0,YR,,F,Y,,,20220228,,CN,US,US,2022,Q1,Youth
205263421,20526342,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Off label use,,2022,Q1,1,I,20220226.0,,20220228,20220228,DIR,FDA-CDER-CTU-2022-16245,,FDA-CTU,,73.0,YR,,F,N,69.9,KG,20220228,,CN,US,,2022,Q1,Elderly
205263421,20526342,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Psychotic disorder,,2022,Q1,1,I,20220226.0,,20220228,20220228,DIR,FDA-CDER-CTU-2022-16245,,FDA-CTU,,73.0,YR,,F,N,69.9,KG,20220228,,CN,US,,2022,Q1,Elderly
205288661,20528866,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q1,Therapeutic product effect incomplete,,2022,Q1,1,I,,20220223.0,20220228,20220228,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20220228,,CN,CA,CA,2022,Q1,Elderly
205288661,20528866,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q1,Pyrexia,,2022,Q1,1,I,,20220223.0,20220228,20220228,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20220228,,CN,CA,CA,2022,Q1,Elderly
205288661,20528866,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q1,Asthma,,2022,Q1,1,I,,20220223.0,20220228,20220228,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20220228,,CN,CA,CA,2022,Q1,Elderly
205288661,20528866,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q1,Oropharyngeal pain,,2022,Q1,1,I,,20220223.0,20220228,20220228,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20220228,,CN,CA,CA,2022,Q1,Elderly
205288661,20528866,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q1,Left ventricular hypertrophy,,2022,Q1,1,I,,20220223.0,20220228,20220228,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20220228,,CN,CA,CA,2022,Q1,Elderly
205288661,20528866,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q1,Diaphragmatic disorder,,2022,Q1,1,I,,20220223.0,20220228,20220228,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20220228,,CN,CA,CA,2022,Q1,Elderly
205288661,20528866,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q1,Weight increased,,2022,Q1,1,I,,20220223.0,20220228,20220228,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20220228,,CN,CA,CA,2022,Q1,Elderly
205288661,20528866,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q1,Hypoxia,,2022,Q1,1,I,,20220223.0,20220228,20220228,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20220228,,CN,CA,CA,2022,Q1,Elderly
205288661,20528866,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q1,Cough,,2022,Q1,1,I,,20220223.0,20220228,20220228,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20220228,,CN,CA,CA,2022,Q1,Elderly
205288661,20528866,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q1,Obstructive airways disorder,,2022,Q1,1,I,,20220223.0,20220228,20220228,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20220228,,CN,CA,CA,2022,Q1,Elderly
205288661,20528866,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q1,Oedema peripheral,,2022,Q1,1,I,,20220223.0,20220228,20220228,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20220228,,CN,CA,CA,2022,Q1,Elderly
205288661,20528866,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q1,Discomfort,,2022,Q1,1,I,,20220223.0,20220228,20220228,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20220228,,CN,CA,CA,2022,Q1,Elderly
205288661,20528866,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q1,Wheezing,,2022,Q1,1,I,,20220223.0,20220228,20220228,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20220228,,CN,CA,CA,2022,Q1,Elderly
205288661,20528866,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q1,Dyspnoea,,2022,Q1,1,I,,20220223.0,20220228,20220228,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20220228,,CN,CA,CA,2022,Q1,Elderly
205288661,20528866,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q1,Full blood count abnormal,,2022,Q1,1,I,,20220223.0,20220228,20220228,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20220228,,CN,CA,CA,2022,Q1,Elderly
205288661,20528866,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q1,Chest discomfort,,2022,Q1,1,I,,20220223.0,20220228,20220228,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20220228,,CN,CA,CA,2022,Q1,Elderly
205297022,20529702,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Steroid diabetes,,2022,Q1,2,F,,20220224.0,20220301,20220308,EXP,,US-AUROBINDO-AUR-APL-2022-006329,AUROBINDO,"Schweiger J, Phillips K, Patel A, Echols C. Drug induced very severe hypertriglyceridemia in a pediatric stem cell transplant recipient. Pediatric-Blood-Cancer. 2022;69:2",16.0,YR,,F,Y,,,20220308,,HP,US,US,2022,Q1,Youth
205297022,20529702,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q1,Treatment failure,,2022,Q1,2,F,,20220224.0,20220301,20220308,EXP,,US-AUROBINDO-AUR-APL-2022-006329,AUROBINDO,"Schweiger J, Phillips K, Patel A, Echols C. Drug induced very severe hypertriglyceridemia in a pediatric stem cell transplant recipient. Pediatric-Blood-Cancer. 2022;69:2",16.0,YR,,F,Y,,,20220308,,HP,US,US,2022,Q1,Youth
205300921,20530092,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D429228A,,,,,Solution for injection,,2022,Q1,Drug ineffective,,2022,Q1,1,I,20220220.0,20220224.0,20220301,20220301,PER,,US-ELI_LILLY_AND_COMPANY-US202104000003,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20220301,,CN,US,US,2022,Q1,Adult
205300921,20530092,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D429228A,,,,,Solution for injection,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220220.0,20220224.0,20220301,20220301,PER,,US-ELI_LILLY_AND_COMPANY-US202104000003,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20220301,,CN,US,US,2022,Q1,Adult
205300921,20530092,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D429228A,,,,,Solution for injection,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220220.0,20220224.0,20220301,20220301,PER,,US-ELI_LILLY_AND_COMPANY-US202104000003,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20220301,,CN,US,US,2022,Q1,Adult
205300921,20530092,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D429228A,,,,,Solution for injection,,2022,Q1,Drug ineffective,,2022,Q1,1,I,20220220.0,20220224.0,20220301,20220301,PER,,US-ELI_LILLY_AND_COMPANY-US202104000003,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20220301,,CN,US,US,2022,Q1,Adult
205300921,20530092,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Solution for injection,,2022,Q1,Drug ineffective,,2022,Q1,1,I,20220220.0,20220224.0,20220301,20220301,PER,,US-ELI_LILLY_AND_COMPANY-US202104000003,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20220301,,CN,US,US,2022,Q1,Adult
205300921,20530092,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Solution for injection,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220220.0,20220224.0,20220301,20220301,PER,,US-ELI_LILLY_AND_COMPANY-US202104000003,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20220301,,CN,US,US,2022,Q1,Adult
205300921,20530092,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Solution for injection,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220220.0,20220224.0,20220301,20220301,PER,,US-ELI_LILLY_AND_COMPANY-US202104000003,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20220301,,CN,US,US,2022,Q1,Adult
205300921,20530092,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Solution for injection,,2022,Q1,Drug ineffective,,2022,Q1,1,I,20220220.0,20220224.0,20220301,20220301,PER,,US-ELI_LILLY_AND_COMPANY-US202104000003,ELI LILLY AND CO,,50.0,YR,,F,Y,,,20220301,,CN,US,US,2022,Q1,Adult
205320121,20532012,38,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU international unit(s) qid,,,,,,,,,,Solution for injection/infusion,,2022,Q1,COVID-19,,2022,Q1,1,I,20211208.0,20220224.0,20220301,20220301,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005403,AEGERION,,39.0,YR,,F,Y,61.678,KG,20220301,,CN,US,US,2022,Q1,Adult
205320121,20532012,38,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU international unit(s) qid,,,,,,,,,,Solution for injection/infusion,,2022,Q1,Product dose omission issue,,2022,Q1,1,I,20211208.0,20220224.0,20220301,20220301,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005403,AEGERION,,39.0,YR,,F,Y,61.678,KG,20220301,,CN,US,US,2022,Q1,Adult
205320121,20532012,38,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU international unit(s) qid,,,,,,,,,,Solution for injection/infusion,,2022,Q1,Upper gastrointestinal haemorrhage,,2022,Q1,1,I,20211208.0,20220224.0,20220301,20220301,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005403,AEGERION,,39.0,YR,,F,Y,61.678,KG,20220301,,CN,US,US,2022,Q1,Adult
205320121,20532012,38,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU international unit(s) qid,,,,,,,,,,Solution for injection/infusion,,2022,Q1,Off label use,,2022,Q1,1,I,20211208.0,20220224.0,20220301,20220301,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005403,AEGERION,,39.0,YR,,F,Y,61.678,KG,20220301,,CN,US,US,2022,Q1,Adult
205320121,20532012,38,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU international unit(s) qid,,,,,,,,,,Solution for injection/infusion,,2022,Q1,Intentional product use issue,,2022,Q1,1,I,20211208.0,20220224.0,20220301,20220301,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005403,AEGERION,,39.0,YR,,F,Y,61.678,KG,20220301,,CN,US,US,2022,Q1,Adult
205320121,20532012,38,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU international unit(s) qid,,,,,,,,,,Solution for injection/infusion,,2022,Q1,Insurance issue,,2022,Q1,1,I,20211208.0,20220224.0,20220301,20220301,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005403,AEGERION,,39.0,YR,,F,Y,61.678,KG,20220301,,CN,US,US,2022,Q1,Adult
205320121,20532012,38,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,20 IU international unit(s) qid,,,,,,,,,,Solution for injection/infusion,,2022,Q1,Therapy interrupted,,2022,Q1,1,I,20211208.0,20220224.0,20220301,20220301,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005403,AEGERION,,39.0,YR,,F,Y,61.678,KG,20220301,,CN,US,US,2022,Q1,Adult
205320121,20532012,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.9 IU international unit(s)/hr, continous pump",,,,,,,,,,Solution for injection/infusion,,2022,Q1,COVID-19,,2022,Q1,1,I,20211208.0,20220224.0,20220301,20220301,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005403,AEGERION,,39.0,YR,,F,Y,61.678,KG,20220301,,CN,US,US,2022,Q1,Adult
205320121,20532012,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.9 IU international unit(s)/hr, continous pump",,,,,,,,,,Solution for injection/infusion,,2022,Q1,Product dose omission issue,,2022,Q1,1,I,20211208.0,20220224.0,20220301,20220301,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005403,AEGERION,,39.0,YR,,F,Y,61.678,KG,20220301,,CN,US,US,2022,Q1,Adult
205320121,20532012,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.9 IU international unit(s)/hr, continous pump",,,,,,,,,,Solution for injection/infusion,,2022,Q1,Upper gastrointestinal haemorrhage,,2022,Q1,1,I,20211208.0,20220224.0,20220301,20220301,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005403,AEGERION,,39.0,YR,,F,Y,61.678,KG,20220301,,CN,US,US,2022,Q1,Adult
205320121,20532012,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.9 IU international unit(s)/hr, continous pump",,,,,,,,,,Solution for injection/infusion,,2022,Q1,Off label use,,2022,Q1,1,I,20211208.0,20220224.0,20220301,20220301,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005403,AEGERION,,39.0,YR,,F,Y,61.678,KG,20220301,,CN,US,US,2022,Q1,Adult
205320121,20532012,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.9 IU international unit(s)/hr, continous pump",,,,,,,,,,Solution for injection/infusion,,2022,Q1,Intentional product use issue,,2022,Q1,1,I,20211208.0,20220224.0,20220301,20220301,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005403,AEGERION,,39.0,YR,,F,Y,61.678,KG,20220301,,CN,US,US,2022,Q1,Adult
205320121,20532012,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.9 IU international unit(s)/hr, continous pump",,,,,,,,,,Solution for injection/infusion,,2022,Q1,Insurance issue,,2022,Q1,1,I,20211208.0,20220224.0,20220301,20220301,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005403,AEGERION,,39.0,YR,,F,Y,61.678,KG,20220301,,CN,US,US,2022,Q1,Adult
205320121,20532012,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"0.9 IU international unit(s)/hr, continous pump",,,,,,,,,,Solution for injection/infusion,,2022,Q1,Therapy interrupted,,2022,Q1,1,I,20211208.0,20220224.0,20220301,20220301,PER,,US-AMRYT PHARMACEUTICALS DAC-AEGR005403,AEGERION,,39.0,YR,,F,Y,61.678,KG,20220301,,CN,US,US,2022,Q1,Adult
205331621,20533162,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Immune-mediated lung disease,,2022,Q1,1,I,20210419.0,,20220301,20220301,DIR,FDA-CDER-CTU-2022-16803,,FDA-CTU,,61.0,YR,,M,N,88.7,KG,20220228,N,,US,,2022,Q1,Adult
205350481,20535048,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"16 kilo-international unit, Once a Day",,,U,,,,,16.0,KIU,,QD,2022,Q1,Thrombocytopenia,,2022,Q1,1,I,20220129.0,20220219.0,20220302,20220302,EXP,,IT-AUROBINDO-AUR-APL-2022-006030,AUROBINDO,,64.0,YR,,M,Y,130.0,KG,20220302,,MD,IT,IT,2022,Q1,Adult
205350481,20535048,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"16 kilo-international unit, Once a Day",,,U,,,,,16.0,KIU,,QD,2022,Q1,Thrombosis,,2022,Q1,1,I,20220129.0,20220219.0,20220302,20220302,EXP,,IT-AUROBINDO-AUR-APL-2022-006030,AUROBINDO,,64.0,YR,,M,Y,130.0,KG,20220302,,MD,IT,IT,2022,Q1,Adult
205374142,20537414,3,C,INSULIN LISPRO (GENETICAL RECOMBINATION),,2,Intravenous (not otherwise specified),"8 units in the morning, 13 units at noon and 19 units at night, tid",,,,,,,,,,,TID,2022,Q1,COVID-19,,2022,Q1,2,F,,20220308.0,20220302,20220315,EXP,,JP-GLAXOSMITHKLINE-JP2022JPN034157,GLAXOSMITHKLINE,,51.0,YR,,M,Y,77.9,KG,20220315,,PH,JP,JP,2022,Q1,Adult
205476531,20547653,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, unknown",,,U,,D420813A,,20563.0,40.0,IU,Injection,,2022,Q1,Feeling abnormal,,2022,Q1,1,I,20220201.0,20220201.0,20220303,20220303,PER,,US-ELI_LILLY_AND_COMPANY-US202202001852,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220303,,CN,US,US,2022,Q1,Adult
205476531,20547653,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, unknown",,,U,,D420813A,,20563.0,40.0,IU,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220201.0,20220201.0,20220303,20220303,PER,,US-ELI_LILLY_AND_COMPANY-US202202001852,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220303,,CN,US,US,2022,Q1,Adult
205476531,20547653,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, unknown",,,U,,D420813A,,20563.0,40.0,IU,Injection,,2022,Q1,Product dose omission issue,,2022,Q1,1,I,20220201.0,20220201.0,20220303,20220303,PER,,US-ELI_LILLY_AND_COMPANY-US202202001852,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220303,,CN,US,US,2022,Q1,Adult
205483521,20548352,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Dyspnoea,,2022,Q1,1,I,20181113.0,20220114.0,20220303,20220303,EXP,,CA-GILEAD-2022-0570606,GILEAD,,59.0,YR,A,M,Y,96.1,KG,20220303,,MD,CA,CA,2022,Q1,Adult
205483521,20548352,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Aspiration,,2022,Q1,1,I,20181113.0,20220114.0,20220303,20220303,EXP,,CA-GILEAD-2022-0570606,GILEAD,,59.0,YR,A,M,Y,96.1,KG,20220303,,MD,CA,CA,2022,Q1,Adult
205483521,20548352,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Transplant rejection,,2022,Q1,1,I,20181113.0,20220114.0,20220303,20220303,EXP,,CA-GILEAD-2022-0570606,GILEAD,,59.0,YR,A,M,Y,96.1,KG,20220303,,MD,CA,CA,2022,Q1,Adult
205483521,20548352,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Impaired gastric emptying,,2022,Q1,1,I,20181113.0,20220114.0,20220303,20220303,EXP,,CA-GILEAD-2022-0570606,GILEAD,,59.0,YR,A,M,Y,96.1,KG,20220303,,MD,CA,CA,2022,Q1,Adult
205483521,20548352,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Pneumonia,,2022,Q1,1,I,20181113.0,20220114.0,20220303,20220303,EXP,,CA-GILEAD-2022-0570606,GILEAD,,59.0,YR,A,M,Y,96.1,KG,20220303,,MD,CA,CA,2022,Q1,Adult
205483521,20548352,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Procedural pain,,2022,Q1,1,I,20181113.0,20220114.0,20220303,20220303,EXP,,CA-GILEAD-2022-0570606,GILEAD,,59.0,YR,A,M,Y,96.1,KG,20220303,,MD,CA,CA,2022,Q1,Adult
205483521,20548352,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Pleural effusion,,2022,Q1,1,I,20181113.0,20220114.0,20220303,20220303,EXP,,CA-GILEAD-2022-0570606,GILEAD,,59.0,YR,A,M,Y,96.1,KG,20220303,,MD,CA,CA,2022,Q1,Adult
205507601,20550760,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D420813A,,20563.0,,,Injection,,2022,Q1,Underdose,,2022,Q1,1,I,20220201.0,20220302.0,20220304,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202203001725,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
205507601,20550760,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D420813A,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220201.0,20220302.0,20220304,20220304,PER,,US-ELI_LILLY_AND_COMPANY-US202203001725,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
205511631,20551163,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Cough,,2022,Q1,1,I,20220214.0,20220223.0,20220304,20220304,EXP,,US-GILEAD-2022-0571099,GILEAD,,10.0,YR,C,F,Y,,,20220304,,CN,US,US,2022,Q1,Child
205511631,20551163,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Respiration abnormal,,2022,Q1,1,I,20220214.0,20220223.0,20220304,20220304,EXP,,US-GILEAD-2022-0571099,GILEAD,,10.0,YR,C,F,Y,,,20220304,,CN,US,US,2022,Q1,Child
205511631,20551163,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q1,Cystic fibrosis related diabetes,,2022,Q1,1,I,20220214.0,20220223.0,20220304,20220304,EXP,,US-GILEAD-2022-0571099,GILEAD,,10.0,YR,C,F,Y,,,20220304,,CN,US,US,2022,Q1,Child
205523801,20552380,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Injection,,2022,Q1,Anaemia,,2022,Q1,1,I,20201117.0,20220303.0,20220304,20220304,EXP,,US-ASTELLAS-2020US045445,ASTELLAS,,69.0,YR,,M,Y,,,20220304,,CN,US,US,2022,Q1,Elderly
205568571,20556857,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"70 u, daily",,,U,,,,20563.0,70.0,IU,Solution for injection,QD,2022,Q1,Rash,,2022,Q1,1,I,20211101.0,20220302.0,20220307,20220307,PER,,US-ELI_LILLY_AND_COMPANY-US202203002296,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20220307,,CN,US,US,2022,Q1,Elderly
205568571,20556857,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"70 u, daily",,,U,,,,20563.0,70.0,IU,Solution for injection,QD,2022,Q1,Pruritus,,2022,Q1,1,I,20211101.0,20220302.0,20220307,20220307,PER,,US-ELI_LILLY_AND_COMPANY-US202203002296,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20220307,,CN,US,US,2022,Q1,Elderly
205606081,20560608,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D386814A,,20563.0,,,Solution for injection,,2022,Q1,Off label use,,2022,Q1,1,I,20220216.0,20220301.0,20220307,20220307,PER,,US-ELI_LILLY_AND_COMPANY-US202203001602,ELI LILLY AND CO,,2.0,YR,,M,Y,,,20220306,,CN,US,US,2022,Q1,Child
205606081,20560608,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D386814A,,20563.0,,,Solution for injection,,2022,Q1,Urine ketone body present,,2022,Q1,1,I,20220216.0,20220301.0,20220307,20220307,PER,,US-ELI_LILLY_AND_COMPANY-US202203001602,ELI LILLY AND CO,,2.0,YR,,M,Y,,,20220306,,CN,US,US,2022,Q1,Child
205606081,20560608,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D386814A,,20563.0,,,Solution for injection,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220216.0,20220301.0,20220307,20220307,PER,,US-ELI_LILLY_AND_COMPANY-US202203001602,ELI LILLY AND CO,,2.0,YR,,M,Y,,,20220306,,CN,US,US,2022,Q1,Child
205610551,20561055,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Other,OTHER QUANTITY : 1 units;?Frequency : As needed;?OTHER ROUTE : insulin pump;?,,,Y,D,D390489A,20240430.0,,1.0,IU,,PRN,2022,Q1,Therapeutic product effect decreased,,2022,Q1,1,I,20220305.0,,20220306,20220306,DIR,606034,,FDA-CTU,,41.0,YR,,F,N,63.9,KG,20220306,N,CN,US,,2022,Q1,Adult
205610551,20561055,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Other,OTHER QUANTITY : 1 units;?Frequency : As needed;?OTHER ROUTE : insulin pump;?,,,Y,D,D390489A,20240430.0,,1.0,IU,,PRN,2022,Q1,Insulin resistance,,2022,Q1,1,I,20220305.0,,20220306,20220306,DIR,606034,,FDA-CTU,,41.0,YR,,F,N,63.9,KG,20220306,N,CN,US,,2022,Q1,Adult
205610551,20561055,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Other,OTHER QUANTITY : 1 units;?Frequency : As needed;?OTHER ROUTE : insulin pump;?,,,Y,D,D390489A,20240430.0,,1.0,IU,,PRN,2022,Q1,Hyperglycaemia,,2022,Q1,1,I,20220305.0,,20220306,20220306,DIR,606034,,FDA-CTU,,41.0,YR,,F,N,63.9,KG,20220306,N,CN,US,,2022,Q1,Adult
205610551,20561055,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Other,OTHER QUANTITY : 1 units;?Frequency : As needed;?OTHER ROUTE : insulin pump;?,,,Y,D,D390489A,20240430.0,,1.0,IU,,PRN,2022,Q1,Product measured potency issue,,2022,Q1,1,I,20220305.0,,20220306,20220306,DIR,606034,,FDA-CTU,,41.0,YR,,F,N,63.9,KG,20220306,N,CN,US,,2022,Q1,Adult
205610551,20561055,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Other,OTHER QUANTITY : 1 units;?Frequency : As needed;?OTHER ROUTE : insulin pump;?,,,Y,D,D390489A,20240430.0,,1.0,IU,,PRN,2022,Q1,Injection site inflammation,,2022,Q1,1,I,20220305.0,,20220306,20220306,DIR,606034,,FDA-CTU,,41.0,YR,,F,N,63.9,KG,20220306,N,CN,US,,2022,Q1,Adult
205610551,20561055,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Other,OTHER QUANTITY : 1 units;?Frequency : As needed;?OTHER ROUTE : insulin pump;?,,,Y,D,D390489A,20240430.0,,1.0,IU,,PRN,2022,Q1,Drug hypersensitivity,,2022,Q1,1,I,20220305.0,,20220306,20220306,DIR,606034,,FDA-CTU,,41.0,YR,,F,N,63.9,KG,20220306,N,CN,US,,2022,Q1,Adult
205610551,20561055,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Other,OTHER QUANTITY : 1 units;?Frequency : As needed;?OTHER ROUTE : insulin pump;?,,,Y,D,D390489A,20240430.0,,1.0,IU,,PRN,2022,Q1,Product substitution issue,,2022,Q1,1,I,20220305.0,,20220306,20220306,DIR,606034,,FDA-CTU,,41.0,YR,,F,N,63.9,KG,20220306,N,CN,US,,2022,Q1,Adult
205610551,20561055,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Other,OTHER QUANTITY : 1 units;?Frequency : As needed;?OTHER ROUTE : insulin pump;?,,,Y,D,D390489A,20240430.0,,1.0,IU,,PRN,2022,Q1,Injection site pain,,2022,Q1,1,I,20220305.0,,20220306,20220306,DIR,606034,,FDA-CTU,,41.0,YR,,F,N,63.9,KG,20220306,N,CN,US,,2022,Q1,Adult
205622031,20562203,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,16 KU,,,,,Unknown,,,16.0,KIU,,,2022,Q1,Thrombosis,,2022,Q1,1,I,20220129.0,20220228.0,20220307,20220307,EXP,IT-MINISAL02-844595,IT-TEVA-2022-IT-2013734,TEVA,,64.0,YR,A,M,Y,130.0,KG,20220307,,MD,IT,IT,2022,Q1,Adult
205622031,20562203,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,16 KU,,,,,Unknown,,,16.0,KIU,,,2022,Q1,Thrombocytopenia,,2022,Q1,1,I,20220129.0,20220228.0,20220307,20220307,EXP,IT-MINISAL02-844595,IT-TEVA-2022-IT-2013734,TEVA,,64.0,YR,A,M,Y,130.0,KG,20220307,,MD,IT,IT,2022,Q1,Adult
205653471,20565347,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q1,Pneumonia,,2022,Q1,1,I,20211223.0,20220306.0,20220308,20220308,EXP,,IT-BAUSCH-BL-2022-006125,BAUSCH AND LOMB,,77.0,YR,,M,Y,76.0,KG,20220308,,HP,IT,IT,2022,Q1,Elderly
205673451,20567345,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Pulmonary embolism,,2022,Q1,1,I,20220126.0,20220307.0,20220308,20220308,EXP,,NVSC2022ES053778,NOVARTIS,,74.0,YR,,F,Y,,,20220308,,MD,ES,ES,2022,Q1,Elderly
205673451,20567345,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Pneumonitis,,2022,Q1,1,I,20220126.0,20220307.0,20220308,20220308,EXP,,NVSC2022ES053778,NOVARTIS,,74.0,YR,,F,Y,,,20220308,,MD,ES,ES,2022,Q1,Elderly
205675341,20567534,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q1,Febrile neutropenia,,2022,Q1,1,I,20211003.0,20220302.0,20220308,20220308,EXP,,US-PFIZER INC-202200355257,PFIZER,,14.0,YR,,M,Y,117.0,KG,20220308,,HP,US,US,2022,Q1,Youth
205711291,20571129,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D379508A,,20563.0,,,Injection,,2022,Q1,Visual impairment,,2022,Q1,1,I,,20220307.0,20220309,20220309,PER,,US-ELI_LILLY_AND_COMPANY-US202203003206,ELI LILLY AND CO,,84.0,YR,,M,Y,,,20220309,,CN,US,US,2022,Q1,Elderly
205712461,20571246,17,C,INSULIN LISPRO BS,,2,Parenteral,UNK,,,,,,,,,,Solution for injection,,2022,Q1,Alanine aminotransferase increased,,2022,Q1,1,I,20211227.0,20220303.0,20220309,20220309,EXP,,JP-009507513-2203JPN000380J,MERCK,,86.0,YR,,M,Y,48.0,KG,20220309,,PH,JP,JP,2022,Q1,Elderly
205712461,20571246,17,C,INSULIN LISPRO BS,,2,Parenteral,UNK,,,,,,,,,,Solution for injection,,2022,Q1,Aspartate aminotransferase increased,,2022,Q1,1,I,20211227.0,20220303.0,20220309,20220309,EXP,,JP-009507513-2203JPN000380J,MERCK,,86.0,YR,,M,Y,48.0,KG,20220309,,PH,JP,JP,2022,Q1,Elderly
205728951,20572895,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 international unit, at breakfast",,,Y,,,,20563.0,14.0,IU,,QD,2022,Q1,Diabetic metabolic decompensation,,2022,Q1,1,I,,20220224.0,20220309,20220309,EXP,,IT-ELI_LILLY_AND_COMPANY-IT202202010447,ELI LILLY AND CO,"Vincenzo Maria Monda, Lucilla Maria Grazia Mantione, Lisa Lungaro, Marcello Monesi, Giorgio Zoli.Association of GLP-1 RA once weekly and basal insulin: a valid therapeutic option from the complications of SARS-CoV-2  infection too?.THE JOURNAL OF AMD 2021;24:295-299.DOI:10.36171/jamd21.24.4.5",82.0,YR,,F,Y,,,20220309,,HP,IT,IT,2022,Q1,Elderly
205728951,20572895,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 international unit, at breakfast",,,Y,,,,20563.0,14.0,IU,,QD,2022,Q1,COVID-19 pneumonia,,2022,Q1,1,I,,20220224.0,20220309,20220309,EXP,,IT-ELI_LILLY_AND_COMPANY-IT202202010447,ELI LILLY AND CO,"Vincenzo Maria Monda, Lucilla Maria Grazia Mantione, Lisa Lungaro, Marcello Monesi, Giorgio Zoli.Association of GLP-1 RA once weekly and basal insulin: a valid therapeutic option from the complications of SARS-CoV-2  infection too?.THE JOURNAL OF AMD 2021;24:295-299.DOI:10.36171/jamd21.24.4.5",82.0,YR,,F,Y,,,20220309,,HP,IT,IT,2022,Q1,Elderly
205728951,20572895,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 international unit, at lunch",,,Y,,,,20563.0,24.0,IU,,QD,2022,Q1,Diabetic metabolic decompensation,,2022,Q1,1,I,,20220224.0,20220309,20220309,EXP,,IT-ELI_LILLY_AND_COMPANY-IT202202010447,ELI LILLY AND CO,"Vincenzo Maria Monda, Lucilla Maria Grazia Mantione, Lisa Lungaro, Marcello Monesi, Giorgio Zoli.Association of GLP-1 RA once weekly and basal insulin: a valid therapeutic option from the complications of SARS-CoV-2  infection too?.THE JOURNAL OF AMD 2021;24:295-299.DOI:10.36171/jamd21.24.4.5",82.0,YR,,F,Y,,,20220309,,HP,IT,IT,2022,Q1,Elderly
205728951,20572895,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"24 international unit, at lunch",,,Y,,,,20563.0,24.0,IU,,QD,2022,Q1,COVID-19 pneumonia,,2022,Q1,1,I,,20220224.0,20220309,20220309,EXP,,IT-ELI_LILLY_AND_COMPANY-IT202202010447,ELI LILLY AND CO,"Vincenzo Maria Monda, Lucilla Maria Grazia Mantione, Lisa Lungaro, Marcello Monesi, Giorgio Zoli.Association of GLP-1 RA once weekly and basal insulin: a valid therapeutic option from the complications of SARS-CoV-2  infection too?.THE JOURNAL OF AMD 2021;24:295-299.DOI:10.36171/jamd21.24.4.5",82.0,YR,,F,Y,,,20220309,,HP,IT,IT,2022,Q1,Elderly
205728951,20572895,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"22 international unit, at dinner",,,Y,,,,20563.0,22.0,IU,,QD,2022,Q1,Diabetic metabolic decompensation,,2022,Q1,1,I,,20220224.0,20220309,20220309,EXP,,IT-ELI_LILLY_AND_COMPANY-IT202202010447,ELI LILLY AND CO,"Vincenzo Maria Monda, Lucilla Maria Grazia Mantione, Lisa Lungaro, Marcello Monesi, Giorgio Zoli.Association of GLP-1 RA once weekly and basal insulin: a valid therapeutic option from the complications of SARS-CoV-2  infection too?.THE JOURNAL OF AMD 2021;24:295-299.DOI:10.36171/jamd21.24.4.5",82.0,YR,,F,Y,,,20220309,,HP,IT,IT,2022,Q1,Elderly
205728951,20572895,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"22 international unit, at dinner",,,Y,,,,20563.0,22.0,IU,,QD,2022,Q1,COVID-19 pneumonia,,2022,Q1,1,I,,20220224.0,20220309,20220309,EXP,,IT-ELI_LILLY_AND_COMPANY-IT202202010447,ELI LILLY AND CO,"Vincenzo Maria Monda, Lucilla Maria Grazia Mantione, Lisa Lungaro, Marcello Monesi, Giorgio Zoli.Association of GLP-1 RA once weekly and basal insulin: a valid therapeutic option from the complications of SARS-CoV-2  infection too?.THE JOURNAL OF AMD 2021;24:295-299.DOI:10.36171/jamd21.24.4.5",82.0,YR,,F,Y,,,20220309,,HP,IT,IT,2022,Q1,Elderly
205736851,20573685,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"16kiU, unk",,,U,,,,,16.0,KIU,,,2022,Q1,Thrombocytopenia,,2022,Q1,1,I,20220129.0,20220224.0,20220309,20220309,EXP,IT-MINISAL02-844595,IT-SAKK-2022SA065406AA,SANOFI AVENTIS,,64.0,YR,A,M,Y,130.0,KG,20220309,,MD,IT,IT,2022,Q1,Adult
205736851,20573685,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"16kiU, unk",,,U,,,,,16.0,KIU,,,2022,Q1,Thrombosis,,2022,Q1,1,I,20220129.0,20220224.0,20220309,20220309,EXP,IT-MINISAL02-844595,IT-SAKK-2022SA065406AA,SANOFI AVENTIS,,64.0,YR,A,M,Y,130.0,KG,20220309,,MD,IT,IT,2022,Q1,Adult
205751781,20575178,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q1,Pneumonia,,2022,Q1,1,I,20210916.0,20220225.0,20220310,20220310,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-00654,HIKMA,,14.0,YR,,M,Y,121.6,KG,20220310,,MD,US,,2022,Q1,Youth
205751781,20575178,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q1,Oropharyngeal pain,,2022,Q1,1,I,20210916.0,20220225.0,20220310,20220310,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-00654,HIKMA,,14.0,YR,,M,Y,121.6,KG,20220310,,MD,US,,2022,Q1,Youth
205751781,20575178,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q1,Fatigue,,2022,Q1,1,I,20210916.0,20220225.0,20220310,20220310,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-00654,HIKMA,,14.0,YR,,M,Y,121.6,KG,20220310,,MD,US,,2022,Q1,Youth
205751781,20575178,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q1,Total lung capacity decreased,,2022,Q1,1,I,20210916.0,20220225.0,20220310,20220310,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-00654,HIKMA,,14.0,YR,,M,Y,121.6,KG,20220310,,MD,US,,2022,Q1,Youth
205751781,20575178,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q1,Chills,,2022,Q1,1,I,20210916.0,20220225.0,20220310,20220310,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-00654,HIKMA,,14.0,YR,,M,Y,121.6,KG,20220310,,MD,US,,2022,Q1,Youth
205751781,20575178,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q1,Sinus tachycardia,,2022,Q1,1,I,20210916.0,20220225.0,20220310,20220310,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-00654,HIKMA,,14.0,YR,,M,Y,121.6,KG,20220310,,MD,US,,2022,Q1,Youth
205751781,20575178,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q1,Pyrexia,,2022,Q1,1,I,20210916.0,20220225.0,20220310,20220310,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-00654,HIKMA,,14.0,YR,,M,Y,121.6,KG,20220310,,MD,US,,2022,Q1,Youth
205751781,20575178,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q1,Headache,,2022,Q1,1,I,20210916.0,20220225.0,20220310,20220310,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-00654,HIKMA,,14.0,YR,,M,Y,121.6,KG,20220310,,MD,US,,2022,Q1,Youth
205751781,20575178,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q1,Cough,,2022,Q1,1,I,20210916.0,20220225.0,20220310,20220310,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-00654,HIKMA,,14.0,YR,,M,Y,121.6,KG,20220310,,MD,US,,2022,Q1,Youth
205751781,20575178,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q1,Nausea,,2022,Q1,1,I,20210916.0,20220225.0,20220310,20220310,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-00654,HIKMA,,14.0,YR,,M,Y,121.6,KG,20220310,,MD,US,,2022,Q1,Youth
205752551,20575255,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Humalog Mix50,,,U,,,,,,,,,2022,Q1,Drug ineffective,,2022,Q1,1,I,,20220228.0,20220310,20220310,EXP,,GB-TEVA-2022-GB-2014660,TEVA,"Vutipongsatorn K, Farah Z. Inflammatory myopathy occurring shortly after severe acute respiratory syndrome coronavirus 2 vaccination: two case reports. J-Med-Case-Rep. 2022;16:.",55.0,YR,A,F,Y,,,20220310,,HP,GB,GB,2022,Q1,Adult
205752551,20575255,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Humalog Mix50,,,U,,,,,,,,,2022,Q1,Idiopathic inflammatory myopathy,,2022,Q1,1,I,,20220228.0,20220310,20220310,EXP,,GB-TEVA-2022-GB-2014660,TEVA,"Vutipongsatorn K, Farah Z. Inflammatory myopathy occurring shortly after severe acute respiratory syndrome coronavirus 2 vaccination: two case reports. J-Med-Case-Rep. 2022;16:.",55.0,YR,A,F,Y,,,20220310,,HP,GB,GB,2022,Q1,Adult
205752751,20575275,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,UNKNOWN,,,,,,,2022,Q1,Wrong technique in product usage process,,2022,Q1,1,I,,20220228.0,20220310,20220310,EXP,,JP-NOVOPROD-897214,NOVO NORDISK,"Eri Kumagai, et al.. Two cases of ketoacidosis that were caused by improper refill during the use of insulin cartridge preparation. Abstracts of the 59th Tohoku Regional Meeting of the Japan Diabetes Society. 2021;42",69.0,YR,,M,Y,,,20220310,,MD,JP,JP,2022,Q1,Elderly
205752751,20575275,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,UNKNOWN,,,,,,,2022,Q1,Ketoacidosis,,2022,Q1,1,I,,20220228.0,20220310,20220310,EXP,,JP-NOVOPROD-897214,NOVO NORDISK,"Eri Kumagai, et al.. Two cases of ketoacidosis that were caused by improper refill during the use of insulin cartridge preparation. Abstracts of the 59th Tohoku Regional Meeting of the Japan Diabetes Society. 2021;42",69.0,YR,,M,Y,,,20220310,,MD,JP,JP,2022,Q1,Elderly
205752751,20575275,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,UNKNOWN,,,,,,,2022,Q1,Decreased appetite,,2022,Q1,1,I,,20220228.0,20220310,20220310,EXP,,JP-NOVOPROD-897214,NOVO NORDISK,"Eri Kumagai, et al.. Two cases of ketoacidosis that were caused by improper refill during the use of insulin cartridge preparation. Abstracts of the 59th Tohoku Regional Meeting of the Japan Diabetes Society. 2021;42",69.0,YR,,M,Y,,,20220310,,MD,JP,JP,2022,Q1,Elderly
205781931,20578193,5,C,insulin lispro 100 unit/mL injection,,2,,,,,,,,,,,,,,2022,Q1,Hypotension,,2022,Q1,1,I,20220309.0,,20220310,20220310,DIR,606520,,FDA-CTU,,56.0,YR,,M,N,,,20220310,Y,,US,,2022,Q1,Adult
205781931,20578193,5,C,insulin lispro 100 unit/mL injection,,2,,,,,,,,,,,,,,2022,Q1,Hypotension,,2022,Q1,1,I,20220309.0,,20220310,20220310,DIR,606520,,FDA-CTU,,56.0,YR,,M,N,,,20220310,Y,,US,,2022,Q1,Adult
205781931,20578193,5,C,insulin lispro 100 unit/mL injection,,2,,,,,,,,,,,,,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220309.0,,20220310,20220310,DIR,606520,,FDA-CTU,,56.0,YR,,M,N,,,20220310,Y,,US,,2022,Q1,Adult
205781931,20578193,5,C,insulin lispro 100 unit/mL injection,,2,,,,,,,,,,,,,,2022,Q1,Hyperhidrosis,,2022,Q1,1,I,20220309.0,,20220310,20220310,DIR,606520,,FDA-CTU,,56.0,YR,,M,N,,,20220310,Y,,US,,2022,Q1,Adult
205781931,20578193,5,C,insulin lispro 100 unit/mL injection,,2,,,,,,,,,,,,,,2022,Q1,Nausea,,2022,Q1,1,I,20220309.0,,20220310,20220310,DIR,606520,,FDA-CTU,,56.0,YR,,M,N,,,20220310,Y,,US,,2022,Q1,Adult
205781931,20578193,5,C,insulin lispro 100 unit/mL injection,,2,,,,,,,,,,,,,,2022,Q1,Cold sweat,,2022,Q1,1,I,20220309.0,,20220310,20220310,DIR,606520,,FDA-CTU,,56.0,YR,,M,N,,,20220310,Y,,US,,2022,Q1,Adult
205899271,20589927,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,unknown,,,,,,,,,,Unknown,,2022,Q1,Febrile neutropenia,,2022,Q1,1,I,20211001.0,20220302.0,20220314,20220314,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-00683,HIKMA,,14.0,YR,,M,Y,117.0,KG,20220314,,HP,US,,2022,Q1,Youth
205899271,20589927,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,unknown,,,,,,,,,,Unknown,,2022,Q1,Vomiting,,2022,Q1,1,I,20211001.0,20220302.0,20220314,20220314,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-00683,HIKMA,,14.0,YR,,M,Y,117.0,KG,20220314,,HP,US,,2022,Q1,Youth
205899271,20589927,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,unknown,,,,,,,,,,Unknown,,2022,Q1,Transaminases increased,,2022,Q1,1,I,20211001.0,20220302.0,20220314,20220314,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-00683,HIKMA,,14.0,YR,,M,Y,117.0,KG,20220314,,HP,US,,2022,Q1,Youth
205899271,20589927,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,unknown,,,,,,,,,,Unknown,,2022,Q1,Abdominal tenderness,,2022,Q1,1,I,20211001.0,20220302.0,20220314,20220314,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-00683,HIKMA,,14.0,YR,,M,Y,117.0,KG,20220314,,HP,US,,2022,Q1,Youth
205899271,20589927,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,unknown,,,,,,,,,,Unknown,,2022,Q1,Nausea,,2022,Q1,1,I,20211001.0,20220302.0,20220314,20220314,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-00683,HIKMA,,14.0,YR,,M,Y,117.0,KG,20220314,,HP,US,,2022,Q1,Youth
205899271,20589927,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,unknown,,,,,,,,,,Unknown,,2022,Q1,Tachycardia,,2022,Q1,1,I,20211001.0,20220302.0,20220314,20220314,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-00683,HIKMA,,14.0,YR,,M,Y,117.0,KG,20220314,,HP,US,,2022,Q1,Youth
205899271,20589927,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,unknown,,,,,,,,,,Unknown,,2022,Q1,Diarrhoea,,2022,Q1,1,I,20211001.0,20220302.0,20220314,20220314,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-00683,HIKMA,,14.0,YR,,M,Y,117.0,KG,20220314,,HP,US,,2022,Q1,Youth
205899271,20589927,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,unknown,,,,,,,,,,Unknown,,2022,Q1,Gastritis,,2022,Q1,1,I,20211001.0,20220302.0,20220314,20220314,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-00683,HIKMA,,14.0,YR,,M,Y,117.0,KG,20220314,,HP,US,,2022,Q1,Youth
205899271,20589927,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,unknown,,,,,,,,,,Unknown,,2022,Q1,Abdominal pain,,2022,Q1,1,I,20211001.0,20220302.0,20220314,20220314,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-00683,HIKMA,,14.0,YR,,M,Y,117.0,KG,20220314,,HP,US,,2022,Q1,Youth
205899271,20589927,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,unknown,,,,,,,,,,Unknown,,2022,Q1,Abdominal pain upper,,2022,Q1,1,I,20211001.0,20220302.0,20220314,20220314,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-00683,HIKMA,,14.0,YR,,M,Y,117.0,KG,20220314,,HP,US,,2022,Q1,Youth
205906921,20590692,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,D420813A,,,8.0,IU,Injection,TID,2022,Q1,Ankylosing spondylitis,,2022,Q1,1,I,20210801.0,20220303.0,20220314,20220314,PER,,US-ELI_LILLY_AND_COMPANY-US202203002352,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220314,,CN,US,US,2022,Q1,Elderly
205906921,20590692,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,,,,8.0,IU,Injection,TID,2022,Q1,Ankylosing spondylitis,,2022,Q1,1,I,20210801.0,20220303.0,20220314,20220314,PER,,US-ELI_LILLY_AND_COMPANY-US202203002352,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220314,,CN,US,US,2022,Q1,Elderly
205960491,20596049,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"9 international unit, qd",,,U,,,,,9.0,IU,Injection,QD,2022,Q1,Adrenocortical insufficiency acute,,2022,Q1,1,I,20210623.0,20220307.0,20220315,20220315,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-020252,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,,,20220315,,PH,JP,JP,2022,Q1,Elderly
205960491,20596049,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"9 international unit, qd",,,U,,,,,9.0,IU,Injection,QD,2022,Q1,Diabetic ketoacidosis,,2022,Q1,1,I,20210623.0,20220307.0,20220315,20220315,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-020252,BRISTOL MYERS SQUIBB,,69.0,YR,,M,Y,,,20220315,,PH,JP,JP,2022,Q1,Elderly
206017101,20601710,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK, 100 unit/mL",,,U,,,,,,,,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220309.0,20220310.0,20220316,20220316,EXP,,US-GLAXOSMITHKLINE-US2022AMR044681,GLAXOSMITHKLINE,,56.0,YR,,M,Y,,,20220316,,HP,US,US,2022,Q1,Adult
206017101,20601710,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK, 100 unit/mL",,,U,,,,,,,,,2022,Q1,Hyperhidrosis,,2022,Q1,1,I,20220309.0,20220310.0,20220316,20220316,EXP,,US-GLAXOSMITHKLINE-US2022AMR044681,GLAXOSMITHKLINE,,56.0,YR,,M,Y,,,20220316,,HP,US,US,2022,Q1,Adult
206017101,20601710,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"UNK, 100 unit/mL",,,U,,,,,,,,,2022,Q1,Hypotension,,2022,Q1,1,I,20220309.0,20220310.0,20220316,20220316,EXP,,US-GLAXOSMITHKLINE-US2022AMR044681,GLAXOSMITHKLINE,,56.0,YR,,M,Y,,,20220316,,HP,US,US,2022,Q1,Adult
206017951,20601795,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Injection,,2022,Q1,Depression,,2022,Q1,1,I,,20220310.0,20220316,20220316,EXP,,PT-MYLANLABS-2022M1019078,MYLAN,"Martins JS, Ramos R, Fraga S, Pinto M.. Voluntary Insulin Intoxication: A Rare Cause of Hypoglycemia. Rev Port Endocrinol Diabetes Metab.. 2021;16(3-4):139-142",14.0,YR,,F,Y,,,20220316,,HP,PT,PT,2022,Q1,Youth
206017951,20601795,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Injection,,2022,Q1,Seizure,,2022,Q1,1,I,,20220310.0,20220316,20220316,EXP,,PT-MYLANLABS-2022M1019078,MYLAN,"Martins JS, Ramos R, Fraga S, Pinto M.. Voluntary Insulin Intoxication: A Rare Cause of Hypoglycemia. Rev Port Endocrinol Diabetes Metab.. 2021;16(3-4):139-142",14.0,YR,,F,Y,,,20220316,,HP,PT,PT,2022,Q1,Youth
206017951,20601795,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Injection,,2022,Q1,Intentional overdose,,2022,Q1,1,I,,20220310.0,20220316,20220316,EXP,,PT-MYLANLABS-2022M1019078,MYLAN,"Martins JS, Ramos R, Fraga S, Pinto M.. Voluntary Insulin Intoxication: A Rare Cause of Hypoglycemia. Rev Port Endocrinol Diabetes Metab.. 2021;16(3-4):139-142",14.0,YR,,F,Y,,,20220316,,HP,PT,PT,2022,Q1,Youth
206017951,20601795,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Injection,,2022,Q1,Suicide attempt,,2022,Q1,1,I,,20220310.0,20220316,20220316,EXP,,PT-MYLANLABS-2022M1019078,MYLAN,"Martins JS, Ramos R, Fraga S, Pinto M.. Voluntary Insulin Intoxication: A Rare Cause of Hypoglycemia. Rev Port Endocrinol Diabetes Metab.. 2021;16(3-4):139-142",14.0,YR,,F,Y,,,20220316,,HP,PT,PT,2022,Q1,Youth
206017951,20601795,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Injection,,2022,Q1,Blood glucose fluctuation,,2022,Q1,1,I,,20220310.0,20220316,20220316,EXP,,PT-MYLANLABS-2022M1019078,MYLAN,"Martins JS, Ramos R, Fraga S, Pinto M.. Voluntary Insulin Intoxication: A Rare Cause of Hypoglycemia. Rev Port Endocrinol Diabetes Metab.. 2021;16(3-4):139-142",14.0,YR,,F,Y,,,20220316,,HP,PT,PT,2022,Q1,Youth
206017951,20601795,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Injection,,2022,Q1,Suicidal ideation,,2022,Q1,1,I,,20220310.0,20220316,20220316,EXP,,PT-MYLANLABS-2022M1019078,MYLAN,"Martins JS, Ramos R, Fraga S, Pinto M.. Voluntary Insulin Intoxication: A Rare Cause of Hypoglycemia. Rev Port Endocrinol Diabetes Metab.. 2021;16(3-4):139-142",14.0,YR,,F,Y,,,20220316,,HP,PT,PT,2022,Q1,Youth
206017951,20601795,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Injection,,2022,Q1,Hypoglycaemia,,2022,Q1,1,I,,20220310.0,20220316,20220316,EXP,,PT-MYLANLABS-2022M1019078,MYLAN,"Martins JS, Ramos R, Fraga S, Pinto M.. Voluntary Insulin Intoxication: A Rare Cause of Hypoglycemia. Rev Port Endocrinol Diabetes Metab.. 2021;16(3-4):139-142",14.0,YR,,F,Y,,,20220316,,HP,PT,PT,2022,Q1,Youth
206017951,20601795,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Injection,,2022,Q1,Disorganised speech,,2022,Q1,1,I,,20220310.0,20220316,20220316,EXP,,PT-MYLANLABS-2022M1019078,MYLAN,"Martins JS, Ramos R, Fraga S, Pinto M.. Voluntary Insulin Intoxication: A Rare Cause of Hypoglycemia. Rev Port Endocrinol Diabetes Metab.. 2021;16(3-4):139-142",14.0,YR,,F,Y,,,20220316,,HP,PT,PT,2022,Q1,Youth
206032321,20603232,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (according to blood sugar level),,,U,,,,,,,,,2022,Q1,Angina pectoris,,2022,Q1,1,I,20211006.0,20211203.0,20220316,20220316,EXP,,NVSC2021DE231230,NOVARTIS,,70.0,YR,,F,Y,,,20220316,,MD,DE,DE,2022,Q1,Elderly
206119471,20611947,62,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"insulin lispro (HumaLOG) 100 units/mL injection 4 UNITS, Admin Instructions: This is premeal insulin",,,,,,,,,,Injection,,2022,Q1,Myelitis,,2022,Q1,1,I,20220213.0,20220308.0,20220318,20220318,EXP,,US-Fresenius Kabi-FK202203113,FRESENIUS KABI,,53.0,YR,,M,Y,75.7,KG,20220318,,MD,US,US,2022,Q1,Adult
206119471,20611947,63,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"insulin lispro (HumaLOG) 100 units/mL injection 4 UNITS, Admin Instructions: This is premeal insulin",,,,,,,,,,Injection,,2022,Q1,Myelitis,,2022,Q1,1,I,20220213.0,20220308.0,20220318,20220318,EXP,,US-Fresenius Kabi-FK202203113,FRESENIUS KABI,,53.0,YR,,M,Y,75.7,KG,20220318,,MD,US,US,2022,Q1,Adult
206125131,20612513,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 u, tid",,,,,,,,60.0,IU,Injection,TID,2022,Q1,Pruritus,,2022,Q1,1,I,20211001.0,20220218.0,20220318,20220318,PER,,US-ELI_LILLY_AND_COMPANY-US202202009638,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20220318,,CN,US,US,2022,Q1,Elderly
206125131,20612513,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 u, tid",,,,,,,,60.0,IU,Injection,TID,2022,Q1,Hyperhidrosis,,2022,Q1,1,I,20211001.0,20220218.0,20220318,20220318,PER,,US-ELI_LILLY_AND_COMPANY-US202202009638,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20220318,,CN,US,US,2022,Q1,Elderly
206125131,20612513,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 u, tid",,,,,,,,60.0,IU,Injection,TID,2022,Q1,Neck pain,,2022,Q1,1,I,20211001.0,20220218.0,20220318,20220318,PER,,US-ELI_LILLY_AND_COMPANY-US202202009638,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20220318,,CN,US,US,2022,Q1,Elderly
206125131,20612513,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 u, tid",,,,,D395986A,,,60.0,IU,Injection,TID,2022,Q1,Pruritus,,2022,Q1,1,I,20211001.0,20220218.0,20220318,20220318,PER,,US-ELI_LILLY_AND_COMPANY-US202202009638,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20220318,,CN,US,US,2022,Q1,Elderly
206125131,20612513,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 u, tid",,,,,D395986A,,,60.0,IU,Injection,TID,2022,Q1,Hyperhidrosis,,2022,Q1,1,I,20211001.0,20220218.0,20220318,20220318,PER,,US-ELI_LILLY_AND_COMPANY-US202202009638,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20220318,,CN,US,US,2022,Q1,Elderly
206125131,20612513,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"60 u, tid",,,,,D395986A,,,60.0,IU,Injection,TID,2022,Q1,Neck pain,,2022,Q1,1,I,20211001.0,20220218.0,20220318,20220318,PER,,US-ELI_LILLY_AND_COMPANY-US202202009638,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20220318,,CN,US,US,2022,Q1,Elderly
206153631,20615363,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D379508A,,20563.0,,,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,1,I,20220301.0,20220314.0,20220321,20220321,PER,,US-ELI_LILLY_AND_COMPANY-US202203006940,ELI LILLY AND CO,,22.0,YR,,F,Y,,,20220321,,CN,US,US,2022,Q1,Youth
206153631,20615363,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D379508A,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220301.0,20220314.0,20220321,20220321,PER,,US-ELI_LILLY_AND_COMPANY-US202203006940,ELI LILLY AND CO,,22.0,YR,,F,Y,,,20220321,,CN,US,US,2022,Q1,Youth
206153631,20615363,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D379508A,,20563.0,,,Injection,,2022,Q1,Accidental underdose,,2022,Q1,1,I,20220301.0,20220314.0,20220321,20220321,PER,,US-ELI_LILLY_AND_COMPANY-US202203006940,ELI LILLY AND CO,,22.0,YR,,F,Y,,,20220321,,CN,US,US,2022,Q1,Youth
206160811,20616081,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q1,Myelosuppression,,2022,Q1,1,I,20220120.0,20220317.0,20220321,20220321,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,,71.0,YR,,M,Y,,,20220321,,MD,JP,JP,2022,Q1,Elderly
206160811,20616081,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q1,Toxic epidermal necrolysis,,2022,Q1,1,I,20220120.0,20220317.0,20220321,20220321,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,,71.0,YR,,M,Y,,,20220321,,MD,JP,JP,2022,Q1,Elderly
206160811,20616081,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q1,Pyrexia,,2022,Q1,1,I,20220120.0,20220317.0,20220321,20220321,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,,71.0,YR,,M,Y,,,20220321,,MD,JP,JP,2022,Q1,Elderly
206160811,20616081,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q1,Erythema,,2022,Q1,1,I,20220120.0,20220317.0,20220321,20220321,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,,71.0,YR,,M,Y,,,20220321,,MD,JP,JP,2022,Q1,Elderly
206160811,20616081,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q1,Pruritus,,2022,Q1,1,I,20220120.0,20220317.0,20220321,20220321,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,,71.0,YR,,M,Y,,,20220321,,MD,JP,JP,2022,Q1,Elderly
206160811,20616081,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q1,Hyperglycaemia,,2022,Q1,1,I,20220120.0,20220317.0,20220321,20220321,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,,71.0,YR,,M,Y,,,20220321,,MD,JP,JP,2022,Q1,Elderly
206183321,20618332,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,UNKNOWN,,,,,,,2022,Q1,Pyelonephritis,,2022,Q1,1,I,20211105.0,20220307.0,20220321,20220321,EXP,,DE-ROCHE-3044829,ROCHE,,61.0,YR,,F,Y,,,20220321,,MD,DE,,2022,Q1,Adult
206183321,20618332,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,UNKNOWN,,,,,,,2022,Q1,Urinary tract infection,,2022,Q1,1,I,20211105.0,20220307.0,20220321,20220321,EXP,,DE-ROCHE-3044829,ROCHE,,61.0,YR,,F,Y,,,20220321,,MD,DE,,2022,Q1,Adult
206266761,20626676,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q1,Inflammation,,2022,Q1,1,I,20211101.0,20220311.0,20220323,20220323,EXP,,US-ELI_LILLY_AND_COMPANY-US202203006056,ELI LILLY AND CO,,44.0,YR,,M,Y,,,20220323,,CN,US,US,2022,Q1,Adult
206266761,20626676,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q1,Skin ulcer,,2022,Q1,1,I,20211101.0,20220311.0,20220323,20220323,EXP,,US-ELI_LILLY_AND_COMPANY-US202203006056,ELI LILLY AND CO,,44.0,YR,,M,Y,,,20220323,,CN,US,US,2022,Q1,Adult
206308871,20630887,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D420814C,,20563.0,,,Injection,,2022,Q1,Memory impairment,,2022,Q1,1,I,20220323.0,20220323.0,20220324,20220324,PER,,US-ELI_LILLY_AND_COMPANY-US202203010508,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20220324,,CN,US,US,2022,Q1,Elderly
206308871,20630887,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D420814C,,20563.0,,,Injection,,2022,Q1,Gait disturbance,,2022,Q1,1,I,20220323.0,20220323.0,20220324,20220324,PER,,US-ELI_LILLY_AND_COMPANY-US202203010508,ELI LILLY AND CO,,74.0,YR,,F,Y,,,20220324,,CN,US,US,2022,Q1,Elderly
206318771,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q1,Myalgia,,2022,Q1,1,I,,20220314.0,20220324,20220324,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220324,,CN,CA,CA,2022,Q1,Adult
206318771,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q1,Abdominal pain upper,,2022,Q1,1,I,,20220314.0,20220324,20220324,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220324,,CN,CA,CA,2022,Q1,Adult
206318771,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q1,Pericardial effusion,,2022,Q1,1,I,,20220314.0,20220324,20220324,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220324,,CN,CA,CA,2022,Q1,Adult
206318771,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q1,Thyroid disorder,,2022,Q1,1,I,,20220314.0,20220324,20220324,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220324,,CN,CA,CA,2022,Q1,Adult
206318771,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q1,Cardiac failure congestive,,2022,Q1,1,I,,20220314.0,20220324,20220324,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220324,,CN,CA,CA,2022,Q1,Adult
206318771,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q1,Weight decreased,,2022,Q1,1,I,,20220314.0,20220324,20220324,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220324,,CN,CA,CA,2022,Q1,Adult
206318771,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q1,Chest pain,,2022,Q1,1,I,,20220314.0,20220324,20220324,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220324,,CN,CA,CA,2022,Q1,Adult
206318771,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q1,Eye haemorrhage,,2022,Q1,1,I,,20220314.0,20220324,20220324,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220324,,CN,CA,CA,2022,Q1,Adult
206318771,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q1,Malnutrition,,2022,Q1,1,I,,20220314.0,20220324,20220324,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220324,,CN,CA,CA,2022,Q1,Adult
206318771,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q1,Headache,,2022,Q1,1,I,,20220314.0,20220324,20220324,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220324,,CN,CA,CA,2022,Q1,Adult
206318771,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q1,Multi-organ disorder,,2022,Q1,1,I,,20220314.0,20220324,20220324,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220324,,CN,CA,CA,2022,Q1,Adult
206318771,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,,20220314.0,20220324,20220324,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220324,,CN,CA,CA,2022,Q1,Adult
206318771,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q1,Arthritis,,2022,Q1,1,I,,20220314.0,20220324,20220324,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220324,,CN,CA,CA,2022,Q1,Adult
206318771,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q1,Diarrhoea,,2022,Q1,1,I,,20220314.0,20220324,20220324,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220324,,CN,CA,CA,2022,Q1,Adult
206318771,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q1,Neuropathy peripheral,,2022,Q1,1,I,,20220314.0,20220324,20220324,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220324,,CN,CA,CA,2022,Q1,Adult
206318771,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q1,Pulmonary oedema,,2022,Q1,1,I,,20220314.0,20220324,20220324,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220324,,CN,CA,CA,2022,Q1,Adult
206332771,20633277,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Solution for injection,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20210901.0,20220317.0,20220324,20220324,PER,,US-ELI_LILLY_AND_COMPANY-US202203009402,ELI LILLY AND CO,,37.0,YR,,M,Y,,,20220324,,CN,US,US,2022,Q1,Adult
206371941,20637194,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Pen-injector as directed, 100 Unit/ml",,,,,,,,,,Solution,,2022,Q1,Confusional state,,2022,Q1,1,I,20200101.0,20220321.0,20220325,20220325,EXP,,US-BAUSCH-BL-2021-005315,BAUSCH AND LOMB,,73.0,YR,,F,Y,100.79,KG,20220325,,MD,US,US,2022,Q1,Elderly
206371941,20637194,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Pen-injector as directed, 100 Unit/ml",,,,,,,,,,Solution,,2022,Q1,Fluid retention,,2022,Q1,1,I,20200101.0,20220321.0,20220325,20220325,EXP,,US-BAUSCH-BL-2021-005315,BAUSCH AND LOMB,,73.0,YR,,F,Y,100.79,KG,20220325,,MD,US,US,2022,Q1,Elderly
206371941,20637194,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Pen-injector as directed, 100 Unit/ml",,,,,,,,,,Solution,,2022,Q1,Breast cancer metastatic,,2022,Q1,1,I,20200101.0,20220321.0,20220325,20220325,EXP,,US-BAUSCH-BL-2021-005315,BAUSCH AND LOMB,,73.0,YR,,F,Y,100.79,KG,20220325,,MD,US,US,2022,Q1,Elderly
206371941,20637194,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Pen-injector as directed, 100 Unit/ml",,,,,,,,,,Solution,,2022,Q1,Cardiac failure congestive,,2022,Q1,1,I,20200101.0,20220321.0,20220325,20220325,EXP,,US-BAUSCH-BL-2021-005315,BAUSCH AND LOMB,,73.0,YR,,F,Y,100.79,KG,20220325,,MD,US,US,2022,Q1,Elderly
206371941,20637194,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Pen-injector as directed, 100 Unit/ml",,,,,,,,,,Solution,,2022,Q1,Abdominal distension,,2022,Q1,1,I,20200101.0,20220321.0,20220325,20220325,EXP,,US-BAUSCH-BL-2021-005315,BAUSCH AND LOMB,,73.0,YR,,F,Y,100.79,KG,20220325,,MD,US,US,2022,Q1,Elderly
206371941,20637194,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Pen-injector as directed, 100 Unit/ml",,,,,,,,,,Solution,,2022,Q1,Inability to afford medication,,2022,Q1,1,I,20200101.0,20220321.0,20220325,20220325,EXP,,US-BAUSCH-BL-2021-005315,BAUSCH AND LOMB,,73.0,YR,,F,Y,100.79,KG,20220325,,MD,US,US,2022,Q1,Elderly
206371941,20637194,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Pen-injector as directed, 100 Unit/ml",,,,,,,,,,Solution,,2022,Q1,Blood potassium decreased,,2022,Q1,1,I,20200101.0,20220321.0,20220325,20220325,EXP,,US-BAUSCH-BL-2021-005315,BAUSCH AND LOMB,,73.0,YR,,F,Y,100.79,KG,20220325,,MD,US,US,2022,Q1,Elderly
206401241,20640124,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D456541A,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220323.0,20220324.0,20220326,20220326,PER,,US-ELI_LILLY_AND_COMPANY-US202203011406,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20220326,,CN,US,US,2022,Q1,Elderly
206417231,20641723,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q1,Febrile neutropenia,,2022,Q1,1,I,,20220316.0,20220328,20220328,EXP,,CA-APOTEX-2022AP005050,APOTEX,,66.0,YR,,M,Y,89.0,KG,20220328,,HP,CA,CA,2022,Q1,Elderly
206429831,20642983,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220307.0,20220317.0,20220328,20220328,PER,,US-ELI_LILLY_AND_COMPANY-US202203008347,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220328,,CN,US,US,2022,Q1,Elderly
206429831,20642983,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220307.0,20220317.0,20220328,20220328,PER,,US-ELI_LILLY_AND_COMPANY-US202203008347,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220328,,CN,US,US,2022,Q1,Elderly
206429831,20642983,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, other (Sliding scale)",,,,,D395986A,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220307.0,20220317.0,20220328,20220328,PER,,US-ELI_LILLY_AND_COMPANY-US202203008347,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220328,,CN,US,US,2022,Q1,Elderly
206429831,20642983,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, other (Sliding scale)",,,,,D395986A,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220307.0,20220317.0,20220328,20220328,PER,,US-ELI_LILLY_AND_COMPANY-US202203008347,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20220328,,CN,US,US,2022,Q1,Elderly
206437091,20643709,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 iU, Q8H",36.0,IU,Y,U,222109022,,,4.0,IU,,Q8H,2022,Q1,Dizziness,,2022,Q1,1,I,20220310.0,20220316.0,20220328,20220328,EXP,,CN-SA-2022SA097699,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20220328,,HP,CN,CN,2022,Q1,Adult
206437091,20643709,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 iU, Q8H",36.0,IU,Y,U,222109022,,,4.0,IU,,Q8H,2022,Q1,Cold sweat,,2022,Q1,1,I,20220310.0,20220316.0,20220328,20220328,EXP,,CN-SA-2022SA097699,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20220328,,HP,CN,CN,2022,Q1,Adult
206437091,20643709,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 iU, Q8H",36.0,IU,Y,U,222109022,,,4.0,IU,,Q8H,2022,Q1,Asthenia,,2022,Q1,1,I,20220310.0,20220316.0,20220328,20220328,EXP,,CN-SA-2022SA097699,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20220328,,HP,CN,CN,2022,Q1,Adult
206437091,20643709,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 iU, Q8H",36.0,IU,Y,U,222109022,,,4.0,IU,,Q8H,2022,Q1,Hypoglycaemia,,2022,Q1,1,I,20220310.0,20220316.0,20220328,20220328,EXP,,CN-SA-2022SA097699,SANOFI AVENTIS,,59.0,YR,A,M,Y,,,20220328,,HP,CN,CN,2022,Q1,Adult
206450371,20645037,13,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,UNKNOWN,,,,,,,2022,Q1,Recurrence of neuromuscular blockade,,2022,Q1,1,I,20220227.0,20220321.0,20220328,20220328,EXP,,ES-Fresenius Kabi-FK202203567,FRESENIUS KABI,,72.0,YR,,M,Y,,,20220328,,HP,NL,,2022,Q1,Elderly
206450371,20645037,13,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,UNKNOWN,,,,,,,2022,Q1,Respiratory failure,,2022,Q1,1,I,20220227.0,20220321.0,20220328,20220328,EXP,,ES-Fresenius Kabi-FK202203567,FRESENIUS KABI,,72.0,YR,,M,Y,,,20220328,,HP,NL,,2022,Q1,Elderly
206464101,20646410,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK iu,,,U,U,,,,,,,,2022,Q1,Pruritus,,2022,Q1,1,I,20220317.0,20220318.0,20220329,20220329,EXP,RU-RZN-1376482,RU-NOVOPROD-902723,NOVO NORDISK,,42.0,YR,,M,Y,80.0,KG,20220329,,HP,RU,RU,2022,Q1,Adult
206464101,20646410,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK iu,,,U,U,,,,,,,,2022,Q1,Asphyxia,,2022,Q1,1,I,20220317.0,20220318.0,20220329,20220329,EXP,RU-RZN-1376482,RU-NOVOPROD-902723,NOVO NORDISK,,42.0,YR,,M,Y,80.0,KG,20220329,,HP,RU,RU,2022,Q1,Adult
206464101,20646410,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK iu,,,U,U,,,,,,,,2022,Q1,Headache,,2022,Q1,1,I,20220317.0,20220318.0,20220329,20220329,EXP,RU-RZN-1376482,RU-NOVOPROD-902723,NOVO NORDISK,,42.0,YR,,M,Y,80.0,KG,20220329,,HP,RU,RU,2022,Q1,Adult
206464101,20646410,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK iu,,,U,U,,,,,,,,2022,Q1,Injection site pruritus,,2022,Q1,1,I,20220317.0,20220318.0,20220329,20220329,EXP,RU-RZN-1376482,RU-NOVOPROD-902723,NOVO NORDISK,,42.0,YR,,M,Y,80.0,KG,20220329,,HP,RU,RU,2022,Q1,Adult
206464101,20646410,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK iu,,,U,U,,,,,,,,2022,Q1,Dizziness,,2022,Q1,1,I,20220317.0,20220318.0,20220329,20220329,EXP,RU-RZN-1376482,RU-NOVOPROD-902723,NOVO NORDISK,,42.0,YR,,M,Y,80.0,KG,20220329,,HP,RU,RU,2022,Q1,Adult
206489451,20648945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"16 kilo-international unit, qd",,,,,,,,16.0,KIU,,QD,2022,Q1,Thrombocytopenia,,2022,Q1,1,I,20220129.0,20220323.0,20220329,20220329,EXP,IT-MINISAL02-844595,IT-MYLANLABS-2022M1022241,MYLAN,,64.0,YR,,M,Y,130.0,KG,20220329,,MD,IT,IT,2022,Q1,Adult
206489451,20648945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"16 kilo-international unit, qd",,,,,,,,16.0,KIU,,QD,2022,Q1,Drug interaction,,2022,Q1,1,I,20220129.0,20220323.0,20220329,20220329,EXP,IT-MINISAL02-844595,IT-MYLANLABS-2022M1022241,MYLAN,,64.0,YR,,M,Y,130.0,KG,20220329,,MD,IT,IT,2022,Q1,Adult
206489451,20648945,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,"16 kilo-international unit, qd",,,,,,,,16.0,KIU,,QD,2022,Q1,Thrombosis,,2022,Q1,1,I,20220129.0,20220323.0,20220329,20220329,EXP,IT-MINISAL02-844595,IT-MYLANLABS-2022M1022241,MYLAN,,64.0,YR,,M,Y,130.0,KG,20220329,,MD,IT,IT,2022,Q1,Adult
206519741,20651974,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D134925J,,21017.0,,,Injection,,2022,Q1,Visual impairment,,2022,Q1,1,I,,20220328.0,20220330,20220330,PER,,US-ELI_LILLY_AND_COMPANY-US202203012536,ELI LILLY AND CO,,79.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Elderly
206527021,20652702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q1,Dyspnoea,,2022,Q1,1,I,,20220321.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-TREX2022-0059,ORION,,65.0,YR,E,F,Y,,,20220330,,HP,CA,,2022,Q1,Elderly
206527021,20652702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q1,Hepatotoxicity,,2022,Q1,1,I,,20220321.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-TREX2022-0059,ORION,,65.0,YR,E,F,Y,,,20220330,,HP,CA,,2022,Q1,Elderly
206527021,20652702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q1,Movement disorder,,2022,Q1,1,I,,20220321.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-TREX2022-0059,ORION,,65.0,YR,E,F,Y,,,20220330,,HP,CA,,2022,Q1,Elderly
206527021,20652702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q1,Drug intolerance,,2022,Q1,1,I,,20220321.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-TREX2022-0059,ORION,,65.0,YR,E,F,Y,,,20220330,,HP,CA,,2022,Q1,Elderly
206527021,20652702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q1,Psoriatic arthropathy,,2022,Q1,1,I,,20220321.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-TREX2022-0059,ORION,,65.0,YR,E,F,Y,,,20220330,,HP,CA,,2022,Q1,Elderly
206527021,20652702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q1,Headache,,2022,Q1,1,I,,20220321.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-TREX2022-0059,ORION,,65.0,YR,E,F,Y,,,20220330,,HP,CA,,2022,Q1,Elderly
206527021,20652702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q1,Grip strength decreased,,2022,Q1,1,I,,20220321.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-TREX2022-0059,ORION,,65.0,YR,E,F,Y,,,20220330,,HP,CA,,2022,Q1,Elderly
206527021,20652702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q1,Osteoarthritis,,2022,Q1,1,I,,20220321.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-TREX2022-0059,ORION,,65.0,YR,E,F,Y,,,20220330,,HP,CA,,2022,Q1,Elderly
206527021,20652702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q1,Pain in extremity,,2022,Q1,1,I,,20220321.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-TREX2022-0059,ORION,,65.0,YR,E,F,Y,,,20220330,,HP,CA,,2022,Q1,Elderly
206527021,20652702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q1,Drug ineffective,,2022,Q1,1,I,,20220321.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-TREX2022-0059,ORION,,65.0,YR,E,F,Y,,,20220330,,HP,CA,,2022,Q1,Elderly
206527021,20652702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q1,Diabetes mellitus,,2022,Q1,1,I,,20220321.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-TREX2022-0059,ORION,,65.0,YR,E,F,Y,,,20220330,,HP,CA,,2022,Q1,Elderly
206527021,20652702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q1,Hepatic cirrhosis,,2022,Q1,1,I,,20220321.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-TREX2022-0059,ORION,,65.0,YR,E,F,Y,,,20220330,,HP,CA,,2022,Q1,Elderly
206527021,20652702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q1,Pain,,2022,Q1,1,I,,20220321.0,20220330,20220330,EXP,,CA-Orion Corporation ORION PHARMA-TREX2022-0059,ORION,,65.0,YR,E,F,Y,,,20220330,,HP,CA,,2022,Q1,Elderly
206547011,20654701,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,,,,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,,,,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,,,,Injection,,2022,Q1,Impaired gastric emptying,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,,,,Injection,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,,,,Injection,,2022,Q1,Inappropriate schedule of product administration,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,,,,Injection,,2022,Q1,Weight decreased,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,,,,Injection,,2022,Q1,Extra dose administered,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,,,,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,,,,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,,,,Injection,,2022,Q1,Impaired gastric emptying,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,,,,Injection,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,,,,Injection,,2022,Q1,Inappropriate schedule of product administration,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,,,,Injection,,2022,Q1,Weight decreased,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,,,,Injection,,2022,Q1,Extra dose administered,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,D420814A,,,,,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,D420814A,,,,,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,D420814A,,,,,Injection,,2022,Q1,Impaired gastric emptying,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,D420814A,,,,,Injection,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,D420814A,,,,,Injection,,2022,Q1,Inappropriate schedule of product administration,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,D420814A,,,,,Injection,,2022,Q1,Weight decreased,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,D420814A,,,,,Injection,,2022,Q1,Extra dose administered,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,D420814A,,,,,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,D420814A,,,,,Injection,,2022,Q1,Blood glucose decreased,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,D420814A,,,,,Injection,,2022,Q1,Impaired gastric emptying,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,D420814A,,,,,Injection,,2022,Q1,Glycosylated haemoglobin increased,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,D420814A,,,,,Injection,,2022,Q1,Inappropriate schedule of product administration,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,D420814A,,,,,Injection,,2022,Q1,Weight decreased,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206547011,20654701,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,D420814A,,,,,Injection,,2022,Q1,Extra dose administered,,2022,Q1,1,I,20211001.0,20220318.0,20220330,20220330,EXP,,US-ELI_LILLY_AND_COMPANY-US202203009756,ELI LILLY AND CO,,39.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206552171,20655217,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D341139A,,,,,,,2022,Q1,Injection site pain,,2022,Q1,1,I,20220320.0,20220324.0,20220330,20220330,PER,,US-ELI_LILLY_AND_COMPANY-US202203012382,ELI LILLY AND CO,,44.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206552171,20655217,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D341139A,,,,,,,2022,Q1,Extra dose administered,,2022,Q1,1,I,20220320.0,20220324.0,20220330,20220330,PER,,US-ELI_LILLY_AND_COMPANY-US202203012382,ELI LILLY AND CO,,44.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206552171,20655217,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D341139A,,,,,,,2022,Q1,Injection site haemorrhage,,2022,Q1,1,I,20220320.0,20220324.0,20220330,20220330,PER,,US-ELI_LILLY_AND_COMPANY-US202203012382,ELI LILLY AND CO,,44.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206552171,20655217,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,,,,,,2022,Q1,Injection site pain,,2022,Q1,1,I,20220320.0,20220324.0,20220330,20220330,PER,,US-ELI_LILLY_AND_COMPANY-US202203012382,ELI LILLY AND CO,,44.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206552171,20655217,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,,,,,,2022,Q1,Extra dose administered,,2022,Q1,1,I,20220320.0,20220324.0,20220330,20220330,PER,,US-ELI_LILLY_AND_COMPANY-US202203012382,ELI LILLY AND CO,,44.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206552171,20655217,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,,,,,,2022,Q1,Injection site haemorrhage,,2022,Q1,1,I,20220320.0,20220324.0,20220330,20220330,PER,,US-ELI_LILLY_AND_COMPANY-US202203012382,ELI LILLY AND CO,,44.0,YR,,F,Y,,,20220330,,CN,US,US,2022,Q1,Adult
206556281,20655628,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,D420814C,,20563.0,,,Injection,,2022,Q1,Underdose,,2022,Q1,1,I,20220325.0,20220325.0,20220330,20220330,PER,,US-ELI_LILLY_AND_COMPANY-US202203011681,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20220330,,CN,US,US,2022,Q1,Elderly
206556281,20655628,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,D420814C,,20563.0,,,Injection,,2022,Q1,Drug ineffective,,2022,Q1,1,I,20220325.0,20220325.0,20220330,20220330,PER,,US-ELI_LILLY_AND_COMPANY-US202203011681,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20220330,,CN,US,US,2022,Q1,Elderly
206556281,20655628,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,D420814C,,20563.0,,,Injection,,2022,Q1,Mood altered,,2022,Q1,1,I,20220325.0,20220325.0,20220330,20220330,PER,,US-ELI_LILLY_AND_COMPANY-US202203011681,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20220330,,CN,US,US,2022,Q1,Elderly
206556281,20655628,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,D420814C,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220325.0,20220325.0,20220330,20220330,PER,,US-ELI_LILLY_AND_COMPANY-US202203011681,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20220330,,CN,US,US,2022,Q1,Elderly
206556281,20655628,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,D420814C,,20563.0,,,Injection,,2022,Q1,Poor quality sleep,,2022,Q1,1,I,20220325.0,20220325.0,20220330,20220330,PER,,US-ELI_LILLY_AND_COMPANY-US202203011681,ELI LILLY AND CO,,70.0,YR,,M,Y,,,20220330,,CN,US,US,2022,Q1,Elderly
206560571,20656057,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D385999S,,20563.0,,,Injection,,2022,Q1,Product storage error,,2022,Q1,1,I,20220317.0,20220317.0,20220330,20220330,PER,,US-ELI_LILLY_AND_COMPANY-US202203011432,ELI LILLY AND CO,,5.0,YR,,M,Y,,,20220330,,CN,US,US,2022,Q1,Child
206560571,20656057,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D385999S,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220317.0,20220317.0,20220330,20220330,PER,,US-ELI_LILLY_AND_COMPANY-US202203011432,ELI LILLY AND CO,,5.0,YR,,M,Y,,,20220330,,CN,US,US,2022,Q1,Child
206560571,20656057,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D306029W,,20563.0,,,Injection,,2022,Q1,Product storage error,,2022,Q1,1,I,20220317.0,20220317.0,20220330,20220330,PER,,US-ELI_LILLY_AND_COMPANY-US202203011432,ELI LILLY AND CO,,5.0,YR,,M,Y,,,20220330,,CN,US,US,2022,Q1,Child
206560571,20656057,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D306029W,,20563.0,,,Injection,,2022,Q1,Blood glucose increased,,2022,Q1,1,I,20220317.0,20220317.0,20220330,20220330,PER,,US-ELI_LILLY_AND_COMPANY-US202203011432,ELI LILLY AND CO,,5.0,YR,,M,Y,,,20220330,,CN,US,US,2022,Q1,Child
148612792,14861279,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Blood creatinine increased,,2022,Q2,2,F,20180216.0,20220325.0,20180508,20220405,EXP,,PHHY2018US059119,NOVARTIS,,62.0,YR,,F,Y,126.98,KG,20220405,,MD,US,US,2022,Q2,Adult
148612792,14861279,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,White blood cell count increased,,2022,Q2,2,F,20180216.0,20220325.0,20180508,20220405,EXP,,PHHY2018US059119,NOVARTIS,,62.0,YR,,F,Y,126.98,KG,20220405,,MD,US,US,2022,Q2,Adult
148612792,14861279,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Blood urea increased,,2022,Q2,2,F,20180216.0,20220325.0,20180508,20220405,EXP,,PHHY2018US059119,NOVARTIS,,62.0,YR,,F,Y,126.98,KG,20220405,,MD,US,US,2022,Q2,Adult
148612792,14861279,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Dehydration,,2022,Q2,2,F,20180216.0,20220325.0,20180508,20220405,EXP,,PHHY2018US059119,NOVARTIS,,62.0,YR,,F,Y,126.98,KG,20220405,,MD,US,US,2022,Q2,Adult
148612792,14861279,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Haematocrit decreased,,2022,Q2,2,F,20180216.0,20220325.0,20180508,20220405,EXP,,PHHY2018US059119,NOVARTIS,,62.0,YR,,F,Y,126.98,KG,20220405,,MD,US,US,2022,Q2,Adult
148612792,14861279,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Arteriosclerosis,,2022,Q2,2,F,20180216.0,20220325.0,20180508,20220405,EXP,,PHHY2018US059119,NOVARTIS,,62.0,YR,,F,Y,126.98,KG,20220405,,MD,US,US,2022,Q2,Adult
148612792,14861279,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Blood glucose increased,,2022,Q2,2,F,20180216.0,20220325.0,20180508,20220405,EXP,,PHHY2018US059119,NOVARTIS,,62.0,YR,,F,Y,126.98,KG,20220405,,MD,US,US,2022,Q2,Adult
148612792,14861279,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Syncope,,2022,Q2,2,F,20180216.0,20220325.0,20180508,20220405,EXP,,PHHY2018US059119,NOVARTIS,,62.0,YR,,F,Y,126.98,KG,20220405,,MD,US,US,2022,Q2,Adult
151666348,15166634,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,UNK,,,D,,,,,,,,,2022,Q2,Foetal exposure during pregnancy,,2022,Q2,8,F,20170914.0,20220325.0,20180719,20220408,EXP,PHHY2018FR049315,PHHY2018FR049315,NOVARTIS,,1.0,DY,,M,Y,1.89,KG,20220408,,PH,FR,FR,2022,Q2,Child
151666348,15166634,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,UNK,,,D,,,,,,,,,2022,Q2,Low birth weight baby,,2022,Q2,8,F,20170914.0,20220325.0,20180719,20220408,EXP,PHHY2018FR049315,PHHY2018FR049315,NOVARTIS,,1.0,DY,,M,Y,1.89,KG,20220408,,PH,FR,FR,2022,Q2,Child
151666348,15166634,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,UNK,,,D,,,,,,,,,2022,Q2,Premature baby,,2022,Q2,8,F,20170914.0,20220325.0,20180719,20220408,EXP,PHHY2018FR049315,PHHY2018FR049315,NOVARTIS,,1.0,DY,,M,Y,1.89,KG,20220408,,PH,FR,FR,2022,Q2,Child
151666348,15166634,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,UNK,,,D,,,,,,,,,2022,Q2,Neutropenia neonatal,,2022,Q2,8,F,20170914.0,20220325.0,20180719,20220408,EXP,PHHY2018FR049315,PHHY2018FR049315,NOVARTIS,,1.0,DY,,M,Y,1.89,KG,20220408,,PH,FR,FR,2022,Q2,Child
151666348,15166634,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Transplacental,UNK,,,D,,,,,,,,,2022,Q2,Foetal disorder,,2022,Q2,8,F,20170914.0,20220325.0,20180719,20220408,EXP,PHHY2018FR049315,PHHY2018FR049315,NOVARTIS,,1.0,DY,,M,Y,1.89,KG,20220408,,PH,FR,FR,2022,Q2,Child
153613934,15361393,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 U/ml, UNK ((IL 100) at 20?-20?-20 U doses) ((IL 200) 20-?20?-20 U)",,,U,,,,,,,,,2022,Q2,Nephrotic syndrome,,2022,Q2,4,F,20130101.0,20220425.0,20180907,20220426,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. Lecba koncentrovanym prandialnim inzulinem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater [A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation]. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20220427,,HP,CZ,CZ,2022,Q2,Adult
153613934,15361393,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 U/ml, UNK ((IL 100) at 20?-20?-20 U doses) ((IL 200) 20-?20?-20 U)",,,U,,,,,,,,,2022,Q2,Liver transplant rejection,,2022,Q2,4,F,20130101.0,20220425.0,20180907,20220426,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. Lecba koncentrovanym prandialnim inzulinem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater [A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation]. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20220427,,HP,CZ,CZ,2022,Q2,Adult
153613934,15361393,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 U/ml, UNK ((IL 100) at 20?-20?-20 U doses) ((IL 200) 20-?20?-20 U)",,,U,,,,,,,,,2022,Q2,Toxicity to various agents,,2022,Q2,4,F,20130101.0,20220425.0,20180907,20220426,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. Lecba koncentrovanym prandialnim inzulinem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater [A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation]. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20220427,,HP,CZ,CZ,2022,Q2,Adult
153613934,15361393,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 U/ml, UNK ((IL 100) at 20?-20?-20 U doses) ((IL 200) 20-?20?-20 U)",,,U,,,,,,,,,2022,Q2,Weight increased,,2022,Q2,4,F,20130101.0,20220425.0,20180907,20220426,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. Lecba koncentrovanym prandialnim inzulinem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater [A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation]. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20220427,,HP,CZ,CZ,2022,Q2,Adult
153613934,15361393,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 U/ml, UNK ((IL 100) at 20?-20?-20 U doses) ((IL 200) 20-?20?-20 U)",,,U,,,,,,,,,2022,Q2,Hypoglycaemia,,2022,Q2,4,F,20130101.0,20220425.0,20180907,20220426,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. Lecba koncentrovanym prandialnim inzulinem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater [A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation]. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20220427,,HP,CZ,CZ,2022,Q2,Adult
153613934,15361393,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 U/ml, UNK ((IL 100) at 20?-20?-20 U doses) ((IL 200) 20-?20?-20 U)",,,U,,,,,,,,,2022,Q2,Renal failure,,2022,Q2,4,F,20130101.0,20220425.0,20180907,20220426,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. Lecba koncentrovanym prandialnim inzulinem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater [A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation]. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20220427,,HP,CZ,CZ,2022,Q2,Adult
153613934,15361393,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 U/ml, UNK ((IL 100) at 20?-20?-20 U doses) ((IL 200) 20-?20?-20 U)",,,U,,,,,,,,,2022,Q2,Increased insulin requirement,,2022,Q2,4,F,20130101.0,20220425.0,20180907,20220426,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. Lecba koncentrovanym prandialnim inzulinem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater [A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation]. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20220427,,HP,CZ,CZ,2022,Q2,Adult
153613934,15361393,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"100 U/ml, UNK ((IL 100) at 20?-20?-20 U doses) ((IL 200) 20-?20?-20 U)",,,U,,,,,,,,,2022,Q2,Proteinuria,,2022,Q2,4,F,20130101.0,20220425.0,20180907,20220426,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. Lecba koncentrovanym prandialnim inzulinem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater [A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation]. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20220427,,HP,CZ,CZ,2022,Q2,Adult
153613934,15361393,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, UNK",,,U,,,,,,,,,2022,Q2,Nephrotic syndrome,,2022,Q2,4,F,20130101.0,20220425.0,20180907,20220426,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. Lecba koncentrovanym prandialnim inzulinem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater [A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation]. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20220427,,HP,CZ,CZ,2022,Q2,Adult
153613934,15361393,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, UNK",,,U,,,,,,,,,2022,Q2,Liver transplant rejection,,2022,Q2,4,F,20130101.0,20220425.0,20180907,20220426,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. Lecba koncentrovanym prandialnim inzulinem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater [A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation]. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20220427,,HP,CZ,CZ,2022,Q2,Adult
153613934,15361393,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, UNK",,,U,,,,,,,,,2022,Q2,Toxicity to various agents,,2022,Q2,4,F,20130101.0,20220425.0,20180907,20220426,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. Lecba koncentrovanym prandialnim inzulinem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater [A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation]. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20220427,,HP,CZ,CZ,2022,Q2,Adult
153613934,15361393,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, UNK",,,U,,,,,,,,,2022,Q2,Weight increased,,2022,Q2,4,F,20130101.0,20220425.0,20180907,20220426,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. Lecba koncentrovanym prandialnim inzulinem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater [A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation]. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20220427,,HP,CZ,CZ,2022,Q2,Adult
153613934,15361393,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, UNK",,,U,,,,,,,,,2022,Q2,Hypoglycaemia,,2022,Q2,4,F,20130101.0,20220425.0,20180907,20220426,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. Lecba koncentrovanym prandialnim inzulinem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater [A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation]. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20220427,,HP,CZ,CZ,2022,Q2,Adult
153613934,15361393,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, UNK",,,U,,,,,,,,,2022,Q2,Renal failure,,2022,Q2,4,F,20130101.0,20220425.0,20180907,20220426,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. Lecba koncentrovanym prandialnim inzulinem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater [A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation]. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20220427,,HP,CZ,CZ,2022,Q2,Adult
153613934,15361393,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, UNK",,,U,,,,,,,,,2022,Q2,Increased insulin requirement,,2022,Q2,4,F,20130101.0,20220425.0,20180907,20220426,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. Lecba koncentrovanym prandialnim inzulinem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater [A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation]. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20220427,,HP,CZ,CZ,2022,Q2,Adult
153613934,15361393,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, UNK",,,U,,,,,,,,,2022,Q2,Proteinuria,,2022,Q2,4,F,20130101.0,20220425.0,20180907,20220426,EXP,,PHHY2018CZ092274,NOVARTIS,Zak P. Lecba koncentrovanym prandialnim inzulinem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater [A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation]. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-4,61.0,YR,,F,Y,,,20220427,,HP,CZ,CZ,2022,Q2,Adult
153873076,15387307,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q2,Acute kidney injury,,2022,Q2,6,F,20180907.0,20220620.0,20180914,20220628,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-083932,BRISTOL MYERS SQUIBB,,59.0,YR,A,M,Y,108.59,KG,20220628,,HP,US,US,2022,Q2,Adult
153873076,15387307,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q2,Encephalopathy,,2022,Q2,6,F,20180907.0,20220620.0,20180914,20220628,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-083932,BRISTOL MYERS SQUIBB,,59.0,YR,A,M,Y,108.59,KG,20220628,,HP,US,US,2022,Q2,Adult
153873076,15387307,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q2,Hypokalaemia,,2022,Q2,6,F,20180907.0,20220620.0,20180914,20220628,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-083932,BRISTOL MYERS SQUIBB,,59.0,YR,A,M,Y,108.59,KG,20220628,,HP,US,US,2022,Q2,Adult
158844365,15884436,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, unknown freq.UNK",,,U,,,,,,,,,2022,Q2,Insulin resistance,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
158844365,15884436,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, unknown freq.UNK",,,U,,,,,,,,,2022,Q2,Weight increased,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
158844365,15884436,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, unknown freq.UNK",,,U,,,,,,,,,2022,Q2,Toxicity to various agents,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
158844365,15884436,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, unknown freq.UNK",,,U,,,,,,,,,2022,Q2,Proteinuria,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
158844365,15884436,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, unknown freq.UNK",,,U,,,,,,,,,2022,Q2,Liver transplant rejection,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
158844365,15884436,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, unknown freq.UNK",,,U,,,,,,,,,2022,Q2,Increased insulin requirement,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
158844365,15884436,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, unknown freq.UNK",,,U,,,,,,,,,2022,Q2,Nephrotic syndrome,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
158844365,15884436,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, unknown freq.UNK",,,U,,,,,,,,,2022,Q2,Hypoglycaemia,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
158844365,15884436,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U, unknown freq.UNK",,,U,,,,,,,,,2022,Q2,Renal failure,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
158844365,15884436,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ml (IL 100) at 20-20-20 U doses UNK,,,U,,,,,,,,,2022,Q2,Insulin resistance,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
158844365,15884436,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ml (IL 100) at 20-20-20 U doses UNK,,,U,,,,,,,,,2022,Q2,Weight increased,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
158844365,15884436,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ml (IL 100) at 20-20-20 U doses UNK,,,U,,,,,,,,,2022,Q2,Toxicity to various agents,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
158844365,15884436,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ml (IL 100) at 20-20-20 U doses UNK,,,U,,,,,,,,,2022,Q2,Proteinuria,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
158844365,15884436,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ml (IL 100) at 20-20-20 U doses UNK,,,U,,,,,,,,,2022,Q2,Liver transplant rejection,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
158844365,15884436,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ml (IL 100) at 20-20-20 U doses UNK,,,U,,,,,,,,,2022,Q2,Increased insulin requirement,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
158844365,15884436,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ml (IL 100) at 20-20-20 U doses UNK,,,U,,,,,,,,,2022,Q2,Nephrotic syndrome,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
158844365,15884436,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ml (IL 100) at 20-20-20 U doses UNK,,,U,,,,,,,,,2022,Q2,Hypoglycaemia,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
158844365,15884436,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U/ml (IL 100) at 20-20-20 U doses UNK,,,U,,,,,,,,,2022,Q2,Renal failure,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
158844365,15884436,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ml (IL 100) at 20-20-20 U doses,,,U,,,,,,,,,2022,Q2,Insulin resistance,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
158844365,15884436,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ml (IL 100) at 20-20-20 U doses,,,U,,,,,,,,,2022,Q2,Weight increased,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
158844365,15884436,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ml (IL 100) at 20-20-20 U doses,,,U,,,,,,,,,2022,Q2,Toxicity to various agents,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
158844365,15884436,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ml (IL 100) at 20-20-20 U doses,,,U,,,,,,,,,2022,Q2,Proteinuria,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
158844365,15884436,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ml (IL 100) at 20-20-20 U doses,,,U,,,,,,,,,2022,Q2,Liver transplant rejection,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
158844365,15884436,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ml (IL 100) at 20-20-20 U doses,,,U,,,,,,,,,2022,Q2,Increased insulin requirement,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
158844365,15884436,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ml (IL 100) at 20-20-20 U doses,,,U,,,,,,,,,2022,Q2,Nephrotic syndrome,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
158844365,15884436,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ml (IL 100) at 20-20-20 U doses,,,U,,,,,,,,,2022,Q2,Hypoglycaemia,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
158844365,15884436,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 U/ml (IL 100) at 20-20-20 U doses,,,U,,,,,,,,,2022,Q2,Renal failure,,2022,Q2,5,F,20130101.0,20220506.0,20190129,20220509,EXP,,CZ-MYLANLABS-2019M1007390,MYLAN,Zak P.. A treatment with concentrated prandial insulin lispro 200 u/mL in a patient with the type 2 diabetes mellitus after liver transplantation. Lecba koncentrovanym prandialnim inzulimem lispro 200 U/ml u pacientky s diabetes mellitus 2. typu po transplantaci jater. KAZUISTIKY V DIABETOLOGII. 2018;16(2):32-34,61.0,YR,,F,Y,,,20220509,,MD,CZ,CZ,2022,Q2,Adult
160055472,16005547,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"20 U, TID",,,Y,U,,,209196.0,,,Solution for injection,Q8H,2022,Q2,Lipodystrophy acquired,,2022,Q2,2,F,,20220427.0,20190226,20220504,EXP,,CZ-SA-2018SA341004,SANOFI AVENTIS,Zak P.. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation.. Kazuistiky v diabetologii.. 2018;16(2):32-4,61.0,YR,A,F,Y,,,20220504,,MD,CZ,CZ,2022,Q2,Adult
160055472,16005547,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"20 U, TID",,,Y,U,,,209196.0,,,Solution for injection,Q8H,2022,Q2,Treatment noncompliance,,2022,Q2,2,F,,20220427.0,20190226,20220504,EXP,,CZ-SA-2018SA341004,SANOFI AVENTIS,Zak P.. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation.. Kazuistiky v diabetologii.. 2018;16(2):32-4,61.0,YR,A,F,Y,,,20220504,,MD,CZ,CZ,2022,Q2,Adult
160055472,16005547,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"20 U, TID",,,Y,U,,,209196.0,,,Solution for injection,Q8H,2022,Q2,Increased insulin requirement,,2022,Q2,2,F,,20220427.0,20190226,20220504,EXP,,CZ-SA-2018SA341004,SANOFI AVENTIS,Zak P.. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation.. Kazuistiky v diabetologii.. 2018;16(2):32-4,61.0,YR,A,F,Y,,,20220504,,MD,CZ,CZ,2022,Q2,Adult
160055472,16005547,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"20 U, TID",,,Y,U,,,209196.0,,,Solution for injection,Q8H,2022,Q2,Glycosuria,,2022,Q2,2,F,,20220427.0,20190226,20220504,EXP,,CZ-SA-2018SA341004,SANOFI AVENTIS,Zak P.. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation.. Kazuistiky v diabetologii.. 2018;16(2):32-4,61.0,YR,A,F,Y,,,20220504,,MD,CZ,CZ,2022,Q2,Adult
160055472,16005547,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"20 U, TID",,,Y,U,,,209196.0,,,Solution for injection,Q8H,2022,Q2,Weight increased,,2022,Q2,2,F,,20220427.0,20190226,20220504,EXP,,CZ-SA-2018SA341004,SANOFI AVENTIS,Zak P.. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation.. Kazuistiky v diabetologii.. 2018;16(2):32-4,61.0,YR,A,F,Y,,,20220504,,MD,CZ,CZ,2022,Q2,Adult
160055472,16005547,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"20 U, TID",,,Y,U,,,209196.0,,,Solution for injection,Q8H,2022,Q2,Diabetes mellitus inadequate control,,2022,Q2,2,F,,20220427.0,20190226,20220504,EXP,,CZ-SA-2018SA341004,SANOFI AVENTIS,Zak P.. A treatment with concentrated prandial insulin lispro 200 U/mL in a patient with type 2 diabetes mellitus after liver transplantation.. Kazuistiky v diabetologii.. 2018;16(2):32-4,61.0,YR,A,F,Y,,,20220504,,MD,CZ,CZ,2022,Q2,Adult
160068977,16006897,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Acute kidney injury,,2022,Q2,7,F,20060101.0,20220606.0,20190222,20220614,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20220614,,LW,US,,2022,Q2,Adult
160068977,16006897,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Renal injury,,2022,Q2,7,F,20060101.0,20220606.0,20190222,20220614,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20220614,,LW,US,,2022,Q2,Adult
160068977,16006897,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Renal failure,,2022,Q2,7,F,20060101.0,20220606.0,20190222,20220614,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20220614,,LW,US,,2022,Q2,Adult
160068977,16006897,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,End stage renal disease,,2022,Q2,7,F,20060101.0,20220606.0,20190222,20220614,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20220614,,LW,US,,2022,Q2,Adult
160068977,16006897,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Chronic kidney disease,,2022,Q2,7,F,20060101.0,20220606.0,20190222,20220614,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20220614,,LW,US,,2022,Q2,Adult
160068977,16006897,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Tubulointerstitial nephritis,,2022,Q2,7,F,20060101.0,20220606.0,20190222,20220614,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20220614,,LW,US,,2022,Q2,Adult
161211852,16121185,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U,",,,,,,,,,,Formulation unknown,,2022,Q2,Hypoglycaemia,,2022,Q2,2,F,20130101.0,20220610.0,20190327,20220620,EXP,CZ-EMA-DD-20181204-SINGH_N3-203033,CZ-Accord-114900,ACCORD,,61.0,YR,,F,Y,,,20220620,,HP,CZ,CZ,2022,Q2,Adult
161211852,16121185,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U,",,,,,,,,,,Formulation unknown,,2022,Q2,Weight increased,,2022,Q2,2,F,20130101.0,20220610.0,20190327,20220620,EXP,CZ-EMA-DD-20181204-SINGH_N3-203033,CZ-Accord-114900,ACCORD,,61.0,YR,,F,Y,,,20220620,,HP,CZ,CZ,2022,Q2,Adult
161211852,16121185,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U,",,,,,,,,,,Formulation unknown,,2022,Q2,Nephrotic syndrome,,2022,Q2,2,F,20130101.0,20220610.0,20190327,20220620,EXP,CZ-EMA-DD-20181204-SINGH_N3-203033,CZ-Accord-114900,ACCORD,,61.0,YR,,F,Y,,,20220620,,HP,CZ,CZ,2022,Q2,Adult
161211852,16121185,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U,",,,,,,,,,,Formulation unknown,,2022,Q2,Renal failure,,2022,Q2,2,F,20130101.0,20220610.0,20190327,20220620,EXP,CZ-EMA-DD-20181204-SINGH_N3-203033,CZ-Accord-114900,ACCORD,,61.0,YR,,F,Y,,,20220620,,HP,CZ,CZ,2022,Q2,Adult
161211852,16121185,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U,",,,,,,,,,,Formulation unknown,,2022,Q2,Insulin resistance,,2022,Q2,2,F,20130101.0,20220610.0,20190327,20220620,EXP,CZ-EMA-DD-20181204-SINGH_N3-203033,CZ-Accord-114900,ACCORD,,61.0,YR,,F,Y,,,20220620,,HP,CZ,CZ,2022,Q2,Adult
161211852,16121185,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U,",,,,,,,,,,Formulation unknown,,2022,Q2,Proteinuria,,2022,Q2,2,F,20130101.0,20220610.0,20190327,20220620,EXP,CZ-EMA-DD-20181204-SINGH_N3-203033,CZ-Accord-114900,ACCORD,,61.0,YR,,F,Y,,,20220620,,HP,CZ,CZ,2022,Q2,Adult
161211852,16121185,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U,",,,,,,,,,,Formulation unknown,,2022,Q2,Increased insulin requirement,,2022,Q2,2,F,20130101.0,20220610.0,20190327,20220620,EXP,CZ-EMA-DD-20181204-SINGH_N3-203033,CZ-Accord-114900,ACCORD,,61.0,YR,,F,Y,,,20220620,,HP,CZ,CZ,2022,Q2,Adult
161211852,16121185,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"(IL 200) 24-24-24 U,",,,,,,,,,,Formulation unknown,,2022,Q2,Liver transplant rejection,,2022,Q2,2,F,20130101.0,20220610.0,20190327,20220620,EXP,CZ-EMA-DD-20181204-SINGH_N3-203033,CZ-Accord-114900,ACCORD,,61.0,YR,,F,Y,,,20220620,,HP,CZ,CZ,2022,Q2,Adult
1686838411,16868384,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Paraesthesia,,2022,Q2,11,F,20190101.0,20220606.0,20190930,20220608,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220608,,CN,US,US,2022,Q2,Elderly
1686838411,16868384,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Anal pruritus,,2022,Q2,11,F,20190101.0,20220606.0,20190930,20220608,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220608,,CN,US,US,2022,Q2,Elderly
1686838411,16868384,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Pruritus,,2022,Q2,11,F,20190101.0,20220606.0,20190930,20220608,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220608,,CN,US,US,2022,Q2,Elderly
1686838411,16868384,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Diarrhoea,,2022,Q2,11,F,20190101.0,20220606.0,20190930,20220608,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220608,,CN,US,US,2022,Q2,Elderly
1686838411,16868384,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Stomatitis,,2022,Q2,11,F,20190101.0,20220606.0,20190930,20220608,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220608,,CN,US,US,2022,Q2,Elderly
1686838411,16868384,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Pruritus,,2022,Q2,11,F,20190101.0,20220606.0,20190930,20220608,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220608,,CN,US,US,2022,Q2,Elderly
1686838411,16868384,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Dizziness,,2022,Q2,11,F,20190101.0,20220606.0,20190930,20220608,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220608,,CN,US,US,2022,Q2,Elderly
1686838411,16868384,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Vulvovaginal mycotic infection,,2022,Q2,11,F,20190101.0,20220606.0,20190930,20220608,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220608,,CN,US,US,2022,Q2,Elderly
1686838411,16868384,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Fatigue,,2022,Q2,11,F,20190101.0,20220606.0,20190930,20220608,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220608,,CN,US,US,2022,Q2,Elderly
1686838411,16868384,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Blood glucose decreased,,2022,Q2,11,F,20190101.0,20220606.0,20190930,20220608,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220608,,CN,US,US,2022,Q2,Elderly
1686838411,16868384,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Alopecia,,2022,Q2,11,F,20190101.0,20220606.0,20190930,20220608,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220608,,CN,US,US,2022,Q2,Elderly
1686838411,16868384,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,White blood cell count decreased,,2022,Q2,11,F,20190101.0,20220606.0,20190930,20220608,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220608,,CN,US,US,2022,Q2,Elderly
1686838411,16868384,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Product dose omission issue,,2022,Q2,11,F,20190101.0,20220606.0,20190930,20220608,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220608,,CN,US,US,2022,Q2,Elderly
1686838411,16868384,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Constipation,,2022,Q2,11,F,20190101.0,20220606.0,20190930,20220608,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220608,,CN,US,US,2022,Q2,Elderly
1686838411,16868384,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Full blood count abnormal,,2022,Q2,11,F,20190101.0,20220606.0,20190930,20220608,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220608,,CN,US,US,2022,Q2,Elderly
1686838411,16868384,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Vulvovaginal pruritus,,2022,Q2,11,F,20190101.0,20220606.0,20190930,20220608,PER,,US-PFIZER INC-2019415692,PFIZER,,68.0,YR,,F,Y,,,20220608,,CN,US,US,2022,Q2,Elderly
170998193,17099819,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,sliding scale,,,,,,,,,,Injection,,2022,Q2,Herpes zoster,,2022,Q2,3,F,20191114.0,20220616.0,20191202,20220622,EXP,,US-ROCHE-2482986,ROCHE,,45.0,YR,,M,Y,79.45,KG,20220622,,CN,US,,2022,Q2,Adult
170998193,17099819,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,sliding scale,,,,,,,,,,Injection,,2022,Q2,COVID-19,,2022,Q2,3,F,20191114.0,20220616.0,20191202,20220622,EXP,,US-ROCHE-2482986,ROCHE,,45.0,YR,,M,Y,79.45,KG,20220622,,CN,US,,2022,Q2,Adult
180401415,18040141,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Disturbance in attention,,2022,Q2,5,F,20210813.0,20220112.0,20200717,20220407,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,86.26,KG,20220407,,CN,US,US,2022,Q2,Elderly
180401415,18040141,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Toxicologic test abnormal,,2022,Q2,5,F,20210813.0,20220112.0,20200717,20220407,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,86.26,KG,20220407,,CN,US,US,2022,Q2,Elderly
180401415,18040141,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Dialysis,,2022,Q2,5,F,20210813.0,20220112.0,20200717,20220407,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,86.26,KG,20220407,,CN,US,US,2022,Q2,Elderly
180401415,18040141,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Therapy interrupted,,2022,Q2,5,F,20210813.0,20220112.0,20200717,20220407,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,86.26,KG,20220407,,CN,US,US,2022,Q2,Elderly
180401415,18040141,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Inability to afford medication,,2022,Q2,5,F,20210813.0,20220112.0,20200717,20220407,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,86.26,KG,20220407,,CN,US,US,2022,Q2,Elderly
180401415,18040141,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Confusional state,,2022,Q2,5,F,20210813.0,20220112.0,20200717,20220407,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,86.26,KG,20220407,,CN,US,US,2022,Q2,Elderly
180401415,18040141,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Hallucination,,2022,Q2,5,F,20210813.0,20220112.0,20200717,20220407,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,86.26,KG,20220407,,CN,US,US,2022,Q2,Elderly
180401415,18040141,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Liver dialysis,,2022,Q2,5,F,20210813.0,20220112.0,20200717,20220407,EXP,,US-BAUSCH-BL-2020-020194,BAUSCH AND LOMB,,70.0,YR,,M,Y,86.26,KG,20220407,,CN,US,US,2022,Q2,Elderly
1822548714,18225487,77,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),1 international unit,,,U,,,,,1.0,IU,,,2022,Q2,Toxic epidermal necrolysis,,2022,Q2,14,F,20200809.0,20220331.0,20200903,20220414,EXP,,FR-AUROBINDO-AUR-APL-2020-045739,AUROBINDO,,75.0,YR,,M,Y,,,20220414,,MD,FR,FR,2022,Q2,Elderly
1822823732,18228237,97,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 iU, CO",,,U,,,,,1.0,IU,,,2022,Q2,Toxic epidermal necrolysis,,2022,Q2,32,F,20200809.0,20220405.0,20200903,20220412,EXP,,FR-PFIZER INC-2020340763,PFIZER,,74.0,YR,,M,Y,,,20220412,,MD,FR,FR,2022,Q2,Elderly
1823583918,18235839,66,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),1 international unit,,,U,,,,,1.0,IU,,,2022,Q2,Toxic epidermal necrolysis,,2022,Q2,18,F,20200809.0,20220405.0,20200905,20220418,EXP,,FR-SA-2020SA239827,SANOFI AVENTIS,,74.0,YR,E,M,Y,,,20220418,,HP,FR,FR,2022,Q2,Elderly
182375756,18237575,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),CO,,,U,,Asked But Unknown,,,1.0,IU,Unknown,,2022,Q2,Toxic epidermal necrolysis,,2022,Q2,6,F,20200809.0,20220404.0,20200907,20220406,EXP,,"FR-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-044811",BOEHRINGER INGELHEIM,,74.0,YR,E,M,Y,,,20220406,,MD,FR,FR,2022,Q2,Elderly
182375756,18237575,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q2,Toxic epidermal necrolysis,,2022,Q2,6,F,20200809.0,20220404.0,20200907,20220406,EXP,,"FR-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-044811",BOEHRINGER INGELHEIM,,74.0,YR,E,M,Y,,,20220406,,MD,FR,FR,2022,Q2,Elderly
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Pseudomonal bacteraemia,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Ascites,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Increased appetite,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Blood pressure diastolic abnormal,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Hypoglycaemia,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Nasopharyngitis,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Osteoarthritis,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Gamma-glutamyltransferase increased,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Congestive hepatopathy,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Hypersensitivity,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Intervertebral disc protrusion,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Enterococcus test positive,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Nerve compression,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Joint effusion,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Influenza,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Injection site extravasation,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Infusion related reaction,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Nausea,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Gastrointestinal disorder,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Blood alkaline phosphatase increased,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Abscess,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Weight decreased,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Peritonitis,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Abdominal pain,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Endometrial disorder,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Septic shock,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Weight increased,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Herpes zoster,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Fibrosis,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Myelopathy,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Depression,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Myopathy,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Blood bilirubin increased,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Therapeutic response decreased,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Alanine aminotransferase increased,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Vomiting,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Generalised oedema,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Diverticulitis,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Hypotension,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Intensive care unit acquired weakness,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Heart rate increased,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Blood potassium decreased,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Neuropathy peripheral,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Micturition disorder,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Rheumatoid arthritis,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Joint swelling,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Adrenal insufficiency,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Blood pressure increased,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Asthenia,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Pneumonia,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Peripheral sensorimotor neuropathy,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Neutropenia,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
182478712,18247871,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Pancytopenia,,2022,Q2,2,F,,20220509.0,20200909,20220516,EXP,,CA-AstraZeneca-2020SF10768,ASTRAZENECA,,62.0,YR,,F,Y,67.0,KG,20220516,,MD,CA,,2022,Q2,Adult
184534198,18453419,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid, 2 every 1 days",,,D,,,,,,,,,2022,Q2,Cough,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid, 2 every 1 days",,,D,,,,,,,,,2022,Q2,Diaphragmatic disorder,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid, 2 every 1 days",,,D,,,,,,,,,2022,Q2,Oropharyngeal pain,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid, 2 every 1 days",,,D,,,,,,,,,2022,Q2,Chest discomfort,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid, 2 every 1 days",,,D,,,,,,,,,2022,Q2,Therapeutic product effect incomplete,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid, 2 every 1 days",,,D,,,,,,,,,2022,Q2,Obstructive airways disorder,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid, 2 every 1 days",,,D,,,,,,,,,2022,Q2,Wheezing,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid, 2 every 1 days",,,D,,,,,,,,,2022,Q2,Asthma,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid, 2 every 1 days",,,D,,,,,,,,,2022,Q2,Weight increased,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid, 2 every 1 days",,,D,,,,,,,,,2022,Q2,Dyspnoea,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid, 2 every 1 days",,,D,,,,,,,,,2022,Q2,Oedema peripheral,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid, 2 every 1 days",,,D,,,,,,,,,2022,Q2,Left ventricular hypertrophy,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid, 2 every 1 days",,,D,,,,,,,,,2022,Q2,Hypoxia,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid, 2 every 1 days",,,D,,,,,,,,,2022,Q2,Discomfort,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid, 2 every 1 days",,,D,,,,,,,,,2022,Q2,Full blood count abnormal,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, bid, 2 every 1 days",,,D,,,,,,,,,2022,Q2,Pyrexia,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, bid",,,D,,,,,,,,BID,2022,Q2,Cough,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, bid",,,D,,,,,,,,BID,2022,Q2,Diaphragmatic disorder,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, bid",,,D,,,,,,,,BID,2022,Q2,Oropharyngeal pain,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, bid",,,D,,,,,,,,BID,2022,Q2,Chest discomfort,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, bid",,,D,,,,,,,,BID,2022,Q2,Therapeutic product effect incomplete,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, bid",,,D,,,,,,,,BID,2022,Q2,Obstructive airways disorder,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, bid",,,D,,,,,,,,BID,2022,Q2,Wheezing,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, bid",,,D,,,,,,,,BID,2022,Q2,Asthma,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, bid",,,D,,,,,,,,BID,2022,Q2,Weight increased,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, bid",,,D,,,,,,,,BID,2022,Q2,Dyspnoea,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, bid",,,D,,,,,,,,BID,2022,Q2,Oedema peripheral,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, bid",,,D,,,,,,,,BID,2022,Q2,Left ventricular hypertrophy,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, bid",,,D,,,,,,,,BID,2022,Q2,Hypoxia,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, bid",,,D,,,,,,,,BID,2022,Q2,Discomfort,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, bid",,,D,,,,,,,,BID,2022,Q2,Full blood count abnormal,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184534198,18453419,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, bid",,,D,,,,,,,,BID,2022,Q2,Pyrexia,,2022,Q2,8,F,,20220603.0,20201102,20220607,EXP,,CA-APOTEX-2020AP020569,APOTEX,,83.0,YR,,M,Y,100.0,KG,20220607,,HP,CA,CA,2022,Q2,Elderly
184821758,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,TID,2022,Q2,Angina pectoris,,2022,Q2,8,F,20201019.0,20220420.0,20201110,20220426,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20220426,,MD,COUNTRY NOT SPECIFIED,JP,2022,Q2,Adult
184821758,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,TID,2022,Q2,Cataract,,2022,Q2,8,F,20201019.0,20220420.0,20201110,20220426,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20220426,,MD,COUNTRY NOT SPECIFIED,JP,2022,Q2,Adult
184821758,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,TID,2022,Q2,Rash pruritic,,2022,Q2,8,F,20201019.0,20220420.0,20201110,20220426,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20220426,,MD,COUNTRY NOT SPECIFIED,JP,2022,Q2,Adult
184821758,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,TID,2022,Q2,Eczema asteatotic,,2022,Q2,8,F,20201019.0,20220420.0,20201110,20220426,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20220426,,MD,COUNTRY NOT SPECIFIED,JP,2022,Q2,Adult
184821758,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,TID,2022,Q2,Arthralgia,,2022,Q2,8,F,20201019.0,20220420.0,20201110,20220426,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20220426,,MD,COUNTRY NOT SPECIFIED,JP,2022,Q2,Adult
1866534811,18665348,74,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),1 international unit,,,U,,,,,1.0,IU,,,2022,Q2,Toxic epidermal necrolysis,,2022,Q2,11,F,20200809.0,20220405.0,20201225,20220408,EXP,,FR-TAKEDA-2020TEU008275,TAKEDA,,74.0,YR,,M,Y,,,20220408,,HP,FR,FR,2022,Q2,Elderly
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Nerve compression,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Weight decreased,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Intervertebral disc protrusion,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Alanine aminotransferase increased,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Infusion related reaction,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Septic shock,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Therapeutic response decreased,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Peripheral sensorimotor neuropathy,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Rheumatoid arthritis,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Osteoarthritis,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Neutropenia,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Diverticulitis,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Fibrosis,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Asthenia,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Pseudomonal bacteraemia,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Nasopharyngitis,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Blood pressure diastolic abnormal,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Generalised oedema,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Tooth disorder,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Ascites,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Blood potassium decreased,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Hypotension,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Myelopathy,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Weight increased,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Influenza,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Pain,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Neuropathy peripheral,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Herpes zoster,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Depression,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Micturition disorder,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Vomiting,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Blood alkaline phosphatase increased,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Injection site extravasation,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Heart rate increased,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Peritonitis,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Enterococcus test positive,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Synovitis,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Nausea,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Abscess,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Adrenal insufficiency,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Pneumonia,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Hypoglycaemia,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Gamma-glutamyltransferase increased,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Increased appetite,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Congestive hepatopathy,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Bone erosion,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Endometrial disorder,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Gait disturbance,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Joint effusion,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Abdominal pain,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Peripheral swelling,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Blood pressure increased,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Myopathy,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Blood bilirubin increased,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Pancytopenia,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Intensive care unit acquired weakness,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Gastrointestinal disorder,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Hypersensitivity,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
189813993,18981399,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3.0 Dosage forms,,,,,,,,,,,QD,2022,Q2,Joint swelling,,2022,Q2,3,F,,20220527.0,20210308,20220601,EXP,,CA-ROCHE-2780132,ROCHE,,62.0,YR,,F,Y,67.0,KG,20220601,,CN,CA,,2022,Q2,Adult
190983784,19098378,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2022,Q2,Therapeutic product effect incomplete,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2022,Q2,Discomfort,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2022,Q2,Hypoxia,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2022,Q2,Cough,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2022,Q2,Left ventricular hypertrophy,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2022,Q2,Wheezing,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2022,Q2,Dyspnoea,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2022,Q2,Obstructive airways disorder,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2022,Q2,Asthma,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2022,Q2,Oedema peripheral,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2022,Q2,Full blood count abnormal,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2022,Q2,Chest discomfort,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2022,Q2,Oropharyngeal pain,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2022,Q2,Pyrexia,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2022,Q2,Weight increased,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,BID,2022,Q2,Diaphragmatic disorder,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 Dosage forms Daily;,,,,,,,,,,,QD,2022,Q2,Therapeutic product effect incomplete,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 Dosage forms Daily;,,,,,,,,,,,QD,2022,Q2,Discomfort,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 Dosage forms Daily;,,,,,,,,,,,QD,2022,Q2,Hypoxia,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 Dosage forms Daily;,,,,,,,,,,,QD,2022,Q2,Cough,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 Dosage forms Daily;,,,,,,,,,,,QD,2022,Q2,Left ventricular hypertrophy,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 Dosage forms Daily;,,,,,,,,,,,QD,2022,Q2,Wheezing,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 Dosage forms Daily;,,,,,,,,,,,QD,2022,Q2,Dyspnoea,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 Dosage forms Daily;,,,,,,,,,,,QD,2022,Q2,Obstructive airways disorder,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 Dosage forms Daily;,,,,,,,,,,,QD,2022,Q2,Asthma,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 Dosage forms Daily;,,,,,,,,,,,QD,2022,Q2,Oedema peripheral,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 Dosage forms Daily;,,,,,,,,,,,QD,2022,Q2,Full blood count abnormal,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 Dosage forms Daily;,,,,,,,,,,,QD,2022,Q2,Chest discomfort,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 Dosage forms Daily;,,,,,,,,,,,QD,2022,Q2,Oropharyngeal pain,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 Dosage forms Daily;,,,,,,,,,,,QD,2022,Q2,Pyrexia,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 Dosage forms Daily;,,,,,,,,,,,QD,2022,Q2,Weight increased,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
190983784,19098378,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 Dosage forms Daily;,,,,,,,,,,,QD,2022,Q2,Diaphragmatic disorder,,2022,Q2,4,F,,20220615.0,20210406,20220625,EXP,,CA-TEVA-2019-CA-1126731,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220625,,CN,CA,CA,2022,Q2,Elderly
194363982,19436398,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Incorrect dose administered,,2022,Q2,2,F,20210606.0,20220411.0,20210618,20220422,EXP,,US-ELI_LILLY_AND_COMPANY-US202106004148,ELI LILLY AND CO,,16.0,YR,,M,Y,,,20220422,,MD,US,US,2022,Q2,Youth
194363982,19436398,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Blood glucose decreased,,2022,Q2,2,F,20210606.0,20220411.0,20210618,20220422,EXP,,US-ELI_LILLY_AND_COMPANY-US202106004148,ELI LILLY AND CO,,16.0,YR,,M,Y,,,20220422,,MD,US,US,2022,Q2,Youth
194363982,19436398,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Blood glucose increased,,2022,Q2,2,F,20210606.0,20220411.0,20210618,20220422,EXP,,US-ELI_LILLY_AND_COMPANY-US202106004148,ELI LILLY AND CO,,16.0,YR,,M,Y,,,20220422,,MD,US,US,2022,Q2,Youth
194840546,19484054,90,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1iu, CO",,,D,,,,,1.0,IU,,,2022,Q2,Toxic epidermal necrolysis,,2022,Q2,6,F,20200809.0,20220404.0,20210701,20220419,EXP,,NVSC2021FR146473,NOVARTIS,,74.0,YR,,M,Y,,,20220419,,MD,FR,FR,2022,Q2,Elderly
195840273,19584027,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q2,Hypoxia,,2022,Q2,3,F,,20220606.0,20210720,20220612,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20220613,,CN,CA,CA,2022,Q2,Elderly
195840273,19584027,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q2,Hypoxia,,2022,Q2,3,F,,20220606.0,20210720,20220612,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20220613,,CN,CA,CA,2022,Q2,Elderly
195840273,19584027,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q2,Pyrexia,,2022,Q2,3,F,,20220606.0,20210720,20220612,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20220613,,CN,CA,CA,2022,Q2,Elderly
195840273,19584027,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q2,Cough,,2022,Q2,3,F,,20220606.0,20210720,20220612,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20220613,,CN,CA,CA,2022,Q2,Elderly
195840273,19584027,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q2,Left ventricular hypertrophy,,2022,Q2,3,F,,20220606.0,20210720,20220612,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20220613,,CN,CA,CA,2022,Q2,Elderly
195840273,19584027,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q2,Weight increased,,2022,Q2,3,F,,20220606.0,20210720,20220612,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20220613,,CN,CA,CA,2022,Q2,Elderly
195840273,19584027,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q2,Therapeutic product effect incomplete,,2022,Q2,3,F,,20220606.0,20210720,20220612,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20220613,,CN,CA,CA,2022,Q2,Elderly
195840273,19584027,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q2,Discomfort,,2022,Q2,3,F,,20220606.0,20210720,20220612,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20220613,,CN,CA,CA,2022,Q2,Elderly
195840273,19584027,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q2,Diaphragmatic disorder,,2022,Q2,3,F,,20220606.0,20210720,20220612,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20220613,,CN,CA,CA,2022,Q2,Elderly
195840273,19584027,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q2,Chest discomfort,,2022,Q2,3,F,,20220606.0,20210720,20220612,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20220613,,CN,CA,CA,2022,Q2,Elderly
195840273,19584027,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q2,Asthma,,2022,Q2,3,F,,20220606.0,20210720,20220612,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20220613,,CN,CA,CA,2022,Q2,Elderly
195840273,19584027,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q2,Full blood count abnormal,,2022,Q2,3,F,,20220606.0,20210720,20220612,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20220613,,CN,CA,CA,2022,Q2,Elderly
195840273,19584027,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q2,Oedema peripheral,,2022,Q2,3,F,,20220606.0,20210720,20220612,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20220613,,CN,CA,CA,2022,Q2,Elderly
195840273,19584027,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q2,Obstructive airways disorder,,2022,Q2,3,F,,20220606.0,20210720,20220612,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20220613,,CN,CA,CA,2022,Q2,Elderly
195840273,19584027,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q2,Wheezing,,2022,Q2,3,F,,20220606.0,20210720,20220612,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20220613,,CN,CA,CA,2022,Q2,Elderly
195840273,19584027,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q2,Dyspnoea,,2022,Q2,3,F,,20220606.0,20210720,20220612,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2021-BI-116149",BOEHRINGER INGELHEIM,,83.0,YR,E,M,Y,100.0,KG,20220613,,CN,CA,CA,2022,Q2,Elderly
196042635,19604263,125,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 international unit, CO",,,,,Unknown,,,1.0,IU,,,2022,Q2,Toxic epidermal necrolysis,,2022,Q2,5,F,20200809.0,20220321.0,20210723,20220408,EXP,FR-EMA-DD-20200828-KUMARVN_P-112010,FR-MALLINCKRODT-T202101014,MALLINCKRODT,,74.0,YR,,M,Y,,,20220408,,MD,FR,FR,2022,Q2,Elderly
196042635,19604263,125,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 international unit, CO",,,,,Unknown,,,1.0,IU,,,2022,Q2,Achromobacter infection,,2022,Q2,5,F,20200809.0,20220321.0,20210723,20220408,EXP,FR-EMA-DD-20200828-KUMARVN_P-112010,FR-MALLINCKRODT-T202101014,MALLINCKRODT,,74.0,YR,,M,Y,,,20220408,,MD,FR,FR,2022,Q2,Elderly
196042635,19604263,125,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 international unit, CO",,,,,Unknown,,,1.0,IU,,,2022,Q2,Pneumonia bacterial,,2022,Q2,5,F,20200809.0,20220321.0,20210723,20220408,EXP,FR-EMA-DD-20200828-KUMARVN_P-112010,FR-MALLINCKRODT-T202101014,MALLINCKRODT,,74.0,YR,,M,Y,,,20220408,,MD,FR,FR,2022,Q2,Elderly
196452163,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,UNKNOWN,,,,,,,2022,Q2,Therapeutic product effect incomplete,,2022,Q2,3,F,,20220613.0,20210802,20220617,EXP,,CA-Covis Pharma GmbH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20220617,,CN,CA,CA,2022,Q2,Elderly
196452163,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,UNKNOWN,,,,,,,2022,Q2,Chest discomfort,,2022,Q2,3,F,,20220613.0,20210802,20220617,EXP,,CA-Covis Pharma GmbH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20220617,,CN,CA,CA,2022,Q2,Elderly
196452163,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,UNKNOWN,,,,,,,2022,Q2,Pyrexia,,2022,Q2,3,F,,20220613.0,20210802,20220617,EXP,,CA-Covis Pharma GmbH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20220617,,CN,CA,CA,2022,Q2,Elderly
196452163,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,UNKNOWN,,,,,,,2022,Q2,Cough,,2022,Q2,3,F,,20220613.0,20210802,20220617,EXP,,CA-Covis Pharma GmbH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20220617,,CN,CA,CA,2022,Q2,Elderly
196452163,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,UNKNOWN,,,,,,,2022,Q2,Weight increased,,2022,Q2,3,F,,20220613.0,20210802,20220617,EXP,,CA-Covis Pharma GmbH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20220617,,CN,CA,CA,2022,Q2,Elderly
196452163,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,UNKNOWN,,,,,,,2022,Q2,Asthma,,2022,Q2,3,F,,20220613.0,20210802,20220617,EXP,,CA-Covis Pharma GmbH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20220617,,CN,CA,CA,2022,Q2,Elderly
196452163,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,UNKNOWN,,,,,,,2022,Q2,Full blood count abnormal,,2022,Q2,3,F,,20220613.0,20210802,20220617,EXP,,CA-Covis Pharma GmbH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20220617,,CN,CA,CA,2022,Q2,Elderly
196452163,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,UNKNOWN,,,,,,,2022,Q2,Oedema peripheral,,2022,Q2,3,F,,20220613.0,20210802,20220617,EXP,,CA-Covis Pharma GmbH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20220617,,CN,CA,CA,2022,Q2,Elderly
196452163,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,UNKNOWN,,,,,,,2022,Q2,Hypoxia,,2022,Q2,3,F,,20220613.0,20210802,20220617,EXP,,CA-Covis Pharma GmbH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20220617,,CN,CA,CA,2022,Q2,Elderly
196452163,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,UNKNOWN,,,,,,,2022,Q2,Left ventricular hypertrophy,,2022,Q2,3,F,,20220613.0,20210802,20220617,EXP,,CA-Covis Pharma GmbH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20220617,,CN,CA,CA,2022,Q2,Elderly
196452163,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,UNKNOWN,,,,,,,2022,Q2,Dyspnoea,,2022,Q2,3,F,,20220613.0,20210802,20220617,EXP,,CA-Covis Pharma GmbH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20220617,,CN,CA,CA,2022,Q2,Elderly
196452163,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,UNKNOWN,,,,,,,2022,Q2,Discomfort,,2022,Q2,3,F,,20220613.0,20210802,20220617,EXP,,CA-Covis Pharma GmbH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20220617,,CN,CA,CA,2022,Q2,Elderly
196452163,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,UNKNOWN,,,,,,,2022,Q2,Diaphragmatic disorder,,2022,Q2,3,F,,20220613.0,20210802,20220617,EXP,,CA-Covis Pharma GmbH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20220617,,CN,CA,CA,2022,Q2,Elderly
196452163,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,UNKNOWN,,,,,,,2022,Q2,Wheezing,,2022,Q2,3,F,,20220613.0,20210802,20220617,EXP,,CA-Covis Pharma GmbH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20220617,,CN,CA,CA,2022,Q2,Elderly
196452163,19645216,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,UNKNOWN,,,,,,,2022,Q2,Obstructive airways disorder,,2022,Q2,3,F,,20220613.0,20210802,20220617,EXP,,CA-Covis Pharma GmbH-2021COV23510,COVIS PHARMA,,83.0,YR,E,M,Y,,,20220617,,CN,CA,CA,2022,Q2,Elderly
1966698211,19666982,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q2,Abdominal pain,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q2,Viral infection,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q2,Menstrual disorder,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q2,Treatment noncompliance,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q2,Drug ineffective,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q2,Hepatitis acute,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q2,Therapy interrupted,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q2,Autoimmune hepatitis,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q2,Steatohepatitis,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q2,Jaundice,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q2,Weight decreased,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q2,Blood bilirubin increased,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q2,Hyperglycaemia,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q2,Hepatic cirrhosis,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q2,Abdominal pain,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q2,Viral infection,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q2,Menstrual disorder,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q2,Treatment noncompliance,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q2,Drug ineffective,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q2,Hepatitis acute,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q2,Therapy interrupted,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q2,Autoimmune hepatitis,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q2,Steatohepatitis,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q2,Jaundice,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q2,Weight decreased,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q2,Blood bilirubin increased,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q2,Hyperglycaemia,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
1966698211,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q2,Hepatic cirrhosis,,2022,Q2,11,F,20201201.0,20220505.0,20210806,20220510,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,,,20220510,,CN,US,US,2022,Q2,Youth
196754753,19675475,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Appendicitis perforated,,2022,Q2,3,F,20210429.0,20220412.0,20210809,20220419,EXP,,US-EXELIXIS-XL18421042981,EXELIXIS,,58.0,YR,,M,Y,112.0,KG,20220419,,MD,US,US,2022,Q2,Adult
197663842,19766384,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D392597D,,,,,Injection,,2022,Q2,Eye swelling,,2022,Q2,2,F,20210501.0,20220425.0,20210830,20220505,EXP,,US-ELI_LILLY_AND_COMPANY-US202108007774,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20220505,,CN,US,US,2022,Q2,Adult
197663842,19766384,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D392597D,,,,,Injection,,2022,Q2,Visual impairment,,2022,Q2,2,F,20210501.0,20220425.0,20210830,20220505,EXP,,US-ELI_LILLY_AND_COMPANY-US202108007774,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20220505,,CN,US,US,2022,Q2,Adult
197663842,19766384,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D392597D,,,,,Injection,,2022,Q2,Eye swelling,,2022,Q2,2,F,20210501.0,20220425.0,20210830,20220505,EXP,,US-ELI_LILLY_AND_COMPANY-US202108007774,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20220505,,CN,US,US,2022,Q2,Adult
197663842,19766384,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D392597D,,,,,Injection,,2022,Q2,Visual impairment,,2022,Q2,2,F,20210501.0,20220425.0,20210830,20220505,EXP,,US-ELI_LILLY_AND_COMPANY-US202108007774,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20220505,,CN,US,US,2022,Q2,Adult
197663842,19766384,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2022,Q2,Eye swelling,,2022,Q2,2,F,20210501.0,20220425.0,20210830,20220505,EXP,,US-ELI_LILLY_AND_COMPANY-US202108007774,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20220505,,CN,US,US,2022,Q2,Adult
197663842,19766384,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2022,Q2,Visual impairment,,2022,Q2,2,F,20210501.0,20220425.0,20210830,20220505,EXP,,US-ELI_LILLY_AND_COMPANY-US202108007774,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20220505,,CN,US,US,2022,Q2,Adult
197663842,19766384,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2022,Q2,Eye swelling,,2022,Q2,2,F,20210501.0,20220425.0,20210830,20220505,EXP,,US-ELI_LILLY_AND_COMPANY-US202108007774,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20220505,,CN,US,US,2022,Q2,Adult
197663842,19766384,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2022,Q2,Visual impairment,,2022,Q2,2,F,20210501.0,20220425.0,20210830,20220505,EXP,,US-ELI_LILLY_AND_COMPANY-US202108007774,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20220505,,CN,US,US,2022,Q2,Adult
198012504,19801250,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Sliding scale 0-8 units with meals,,,D,,,,,,,,,2022,Q2,Ventricular fibrillation,,2022,Q2,4,F,20210723.0,20220519.0,20210907,20220525,EXP,,NVSC2021US202125,NOVARTIS,,40.0,YR,,M,Y,101.3,KG,20220525,,MD,US,US,2022,Q2,Adult
198012504,19801250,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Sliding scale 0-8 units with meals,,,D,,,,,,,,,2022,Q2,Pneumonia,,2022,Q2,4,F,20210723.0,20220519.0,20210907,20220525,EXP,,NVSC2021US202125,NOVARTIS,,40.0,YR,,M,Y,101.3,KG,20220525,,MD,US,US,2022,Q2,Adult
198012504,19801250,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Sliding scale 0-8 units with meals,,,D,,,,,,,,,2022,Q2,Pneumothorax,,2022,Q2,4,F,20210723.0,20220519.0,20210907,20220525,EXP,,NVSC2021US202125,NOVARTIS,,40.0,YR,,M,Y,101.3,KG,20220525,,MD,US,US,2022,Q2,Adult
198012504,19801250,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Sliding scale 0-8 units with meals,,,D,,,,,,,,,2022,Q2,Acute kidney injury,,2022,Q2,4,F,20210723.0,20220519.0,20210907,20220525,EXP,,NVSC2021US202125,NOVARTIS,,40.0,YR,,M,Y,101.3,KG,20220525,,MD,US,US,2022,Q2,Adult
198172712,19817271,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,,,,,,,,,,2022,Q2,Condition aggravated,,2022,Q2,2,F,,20210903.0,20210910,20220623,EXP,,DE-BAUSCH-BL-2021-030087,BAUSCH AND LOMB,,75.0,YR,,M,Y,90.0,KG,20220623,,PH,DE,DE,2022,Q2,Elderly
198172712,19817271,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,,,,,,,,,,2022,Q2,Renal impairment,,2022,Q2,2,F,,20210903.0,20210910,20220623,EXP,,DE-BAUSCH-BL-2021-030087,BAUSCH AND LOMB,,75.0,YR,,M,Y,90.0,KG,20220623,,PH,DE,DE,2022,Q2,Elderly
198172712,19817271,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,,,,,,,,,,2022,Q2,General physical health deterioration,,2022,Q2,2,F,,20210903.0,20210910,20220623,EXP,,DE-BAUSCH-BL-2021-030087,BAUSCH AND LOMB,,75.0,YR,,M,Y,90.0,KG,20220623,,PH,DE,DE,2022,Q2,Elderly
198172712,19817271,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,,,,,,,,,,2022,Q2,Hyperglycaemia,,2022,Q2,2,F,,20210903.0,20210910,20220623,EXP,,DE-BAUSCH-BL-2021-030087,BAUSCH AND LOMB,,75.0,YR,,M,Y,90.0,KG,20220623,,PH,DE,DE,2022,Q2,Elderly
198172712,19817271,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,,,,,,,,,,2022,Q2,Pyrexia,,2022,Q2,2,F,,20210903.0,20210910,20220623,EXP,,DE-BAUSCH-BL-2021-030087,BAUSCH AND LOMB,,75.0,YR,,M,Y,90.0,KG,20220623,,PH,DE,DE,2022,Q2,Elderly
198172712,19817271,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,,,,,,,,,,2022,Q2,Oedema peripheral,,2022,Q2,2,F,,20210903.0,20210910,20220623,EXP,,DE-BAUSCH-BL-2021-030087,BAUSCH AND LOMB,,75.0,YR,,M,Y,90.0,KG,20220623,,PH,DE,DE,2022,Q2,Elderly
198172712,19817271,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,,,,,,,,,,2022,Q2,Tachycardia,,2022,Q2,2,F,,20210903.0,20210910,20220623,EXP,,DE-BAUSCH-BL-2021-030087,BAUSCH AND LOMB,,75.0,YR,,M,Y,90.0,KG,20220623,,PH,DE,DE,2022,Q2,Elderly
198172712,19817271,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,,,,,,,,,,2022,Q2,Disorientation,,2022,Q2,2,F,,20210903.0,20210910,20220623,EXP,,DE-BAUSCH-BL-2021-030087,BAUSCH AND LOMB,,75.0,YR,,M,Y,90.0,KG,20220623,,PH,DE,DE,2022,Q2,Elderly
198172712,19817271,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,,,,,,,,,,2022,Q2,Hypertension,,2022,Q2,2,F,,20210903.0,20210910,20220623,EXP,,DE-BAUSCH-BL-2021-030087,BAUSCH AND LOMB,,75.0,YR,,M,Y,90.0,KG,20220623,,PH,DE,DE,2022,Q2,Elderly
198172712,19817271,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,,,,,,,,,,2022,Q2,Electrocardiogram abnormal,,2022,Q2,2,F,,20210903.0,20210910,20220623,EXP,,DE-BAUSCH-BL-2021-030087,BAUSCH AND LOMB,,75.0,YR,,M,Y,90.0,KG,20220623,,PH,DE,DE,2022,Q2,Elderly
198172712,19817271,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,,,,,,,,,,2022,Q2,Systemic infection,,2022,Q2,2,F,,20210903.0,20210910,20220623,EXP,,DE-BAUSCH-BL-2021-030087,BAUSCH AND LOMB,,75.0,YR,,M,Y,90.0,KG,20220623,,PH,DE,DE,2022,Q2,Elderly
198172712,19817271,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,,,,,,,,,,2022,Q2,Tachypnoea,,2022,Q2,2,F,,20210903.0,20210910,20220623,EXP,,DE-BAUSCH-BL-2021-030087,BAUSCH AND LOMB,,75.0,YR,,M,Y,90.0,KG,20220623,,PH,DE,DE,2022,Q2,Elderly
198172712,19817271,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,,,,,,,,,,2022,Q2,Anaemia,,2022,Q2,2,F,,20210903.0,20210910,20220623,EXP,,DE-BAUSCH-BL-2021-030087,BAUSCH AND LOMB,,75.0,YR,,M,Y,90.0,KG,20220623,,PH,DE,DE,2022,Q2,Elderly
198830312,19883031,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,,,,Solution for injection,,2022,Q2,Therapeutic product effect delayed,,2022,Q2,2,F,20210919.0,20220620.0,20210926,20220624,PER,,US-ELI_LILLY_AND_COMPANY-US202109010068,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20220624,,CN,US,US,2022,Q2,Adult
198830312,19883031,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,,,,Solution for injection,,2022,Q2,Blood glucose increased,,2022,Q2,2,F,20210919.0,20220620.0,20210926,20220624,PER,,US-ELI_LILLY_AND_COMPANY-US202109010068,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20220624,,CN,US,US,2022,Q2,Adult
198830312,19883031,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,,,,Solution for injection,,2022,Q2,Drug ineffective,,2022,Q2,2,F,20210919.0,20220620.0,20210926,20220624,PER,,US-ELI_LILLY_AND_COMPANY-US202109010068,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20220624,,CN,US,US,2022,Q2,Adult
198830312,19883031,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,,,,Solution for injection,,2022,Q2,Therapeutic product effect delayed,,2022,Q2,2,F,20210919.0,20220620.0,20210926,20220624,PER,,US-ELI_LILLY_AND_COMPANY-US202109010068,ELI LILLY AND CO,,41.0,YR,,F,Y,,,20220624,,CN,US,US,2022,Q2,Adult
198886926,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q2,Neuropathy peripheral,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q2,Malnutrition,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q2,Diarrhoea,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q2,Cardiac failure congestive,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q2,Eye haemorrhage,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q2,Thyroid disorder,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q2,Headache,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q2,Chest pain,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q2,Blood glucose increased,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q2,Pericardial effusion,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q2,Pulmonary oedema,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q2,Abdominal pain upper,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q2,Multi-organ disorder,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q2,Myalgia,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q2,Arthritis,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,Solution for injection,,2022,Q2,Weight decreased,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q2,Neuropathy peripheral,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q2,Malnutrition,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q2,Diarrhoea,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q2,Cardiac failure congestive,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q2,Eye haemorrhage,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q2,Thyroid disorder,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q2,Headache,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q2,Chest pain,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q2,Blood glucose increased,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q2,Pericardial effusion,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q2,Pulmonary oedema,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q2,Abdominal pain upper,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q2,Multi-organ disorder,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q2,Myalgia,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q2,Arthritis,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
198886926,19888692,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q2,Weight decreased,,2022,Q2,6,F,,20220525.0,20210928,20220602,EXP,,CA-SA-2021SA312423,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220602,,MD,CA,CA,2022,Q2,Adult
199316253,19931625,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 unit/ml - Inject 50 units into the skin daily,,,,,,,,,,Injection,,2022,Q2,Partial seizures,,2022,Q2,3,F,20210102.0,20220405.0,20211008,20220415,EXP,,US-BIOGEN-2021BI01055041,BIOGEN,,50.0,YR,,F,Y,78.0,KG,20220415,,CN,US,US,2022,Q2,Adult
199316253,19931625,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 unit/ml - Inject 50 units into the skin daily,,,,,,,,,,Injection,,2022,Q2,Road traffic accident,,2022,Q2,3,F,20210102.0,20220405.0,20211008,20220415,EXP,,US-BIOGEN-2021BI01055041,BIOGEN,,50.0,YR,,F,Y,78.0,KG,20220415,,CN,US,US,2022,Q2,Adult
199316253,19931625,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 unit/ml - Inject 50 units into the skin daily,,,,,,,,,,Injection,,2022,Q2,Vitamin D deficiency,,2022,Q2,3,F,20210102.0,20220405.0,20211008,20220415,EXP,,US-BIOGEN-2021BI01055041,BIOGEN,,50.0,YR,,F,Y,78.0,KG,20220415,,CN,US,US,2022,Q2,Adult
200376724,20037672,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U,,,,,,,,,,Injection,TID,2022,Q2,Hyponatraemia,,2022,Q2,4,F,20211025.0,20220518.0,20211105,20220519,EXP,,US-ROCHE-2945935,ROCHE,,74.0,YR,,M,Y,79.0,KG,20220520,,MD,US,,2022,Q2,Elderly
200376724,20037672,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U,,,,,,,,,,Injection,TID,2022,Q2,Adrenal insufficiency,,2022,Q2,4,F,20211025.0,20220518.0,20211105,20220519,EXP,,US-ROCHE-2945935,ROCHE,,74.0,YR,,M,Y,79.0,KG,20220520,,MD,US,,2022,Q2,Elderly
200755754,20075575,5,C,INSULINE LISPRO,,1,,,,,,,,,,,,,,2022,Q2,Immune-mediated hepatitis,,2022,Q2,4,F,20210923.0,20220322.0,20211116,20220401,EXP,,IT-ROCHE-2952017,ROCHE,,45.0,YR,,F,Y,65.0,KG,20220401,,MD,IT,,2022,Q2,Adult
200983318,20098331,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Bradycardia,,2022,Q2,8,F,20211111.0,20220404.0,20211122,20220406,EXP,,US-GILEAD-2021-0556989,GILEAD,,36.0,YR,A,F,Y,172.4,KG,20220406,,HP,US,US,2022,Q2,Adult
201166257,20116625,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q2,Atrial fibrillation,,2022,Q2,7,F,20211117.0,20220420.0,20211126,20220426,EXP,,US-ROCHE-2963208,ROCHE,,82.0,YR,,M,Y,74.7,KG,20220427,,MD,US,,2022,Q2,Elderly
201166257,20116625,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,,,,,,,,,,2022,Q2,Atrial fibrillation,,2022,Q2,7,F,20211117.0,20220420.0,20211126,20220426,EXP,,US-ROCHE-2963208,ROCHE,,82.0,YR,,M,Y,74.7,KG,20220427,,MD,US,,2022,Q2,Elderly
201192776,20119277,73,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q2,Pulmonary embolism,,2022,Q2,6,F,20211118.0,20220420.0,20211126,20220423,EXP,,US-ROCHE-2962989,ROCHE,,82.0,YR,,M,Y,74.7,KG,20220423,,MD,US,,2022,Q2,Elderly
201192776,20119277,74,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q2,Pulmonary embolism,,2022,Q2,6,F,20211118.0,20220420.0,20211126,20220423,EXP,,US-ROCHE-2962989,ROCHE,,82.0,YR,,M,Y,74.7,KG,20220423,,MD,US,,2022,Q2,Elderly
201192776,20119277,75,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 U,,,,,,,,,,,,2022,Q2,Pulmonary embolism,,2022,Q2,6,F,20211118.0,20220420.0,20211126,20220423,EXP,,US-ROCHE-2962989,ROCHE,,82.0,YR,,M,Y,74.7,KG,20220423,,MD,US,,2022,Q2,Elderly
201192776,20119277,76,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,,,,,,,,,,2022,Q2,Pulmonary embolism,,2022,Q2,6,F,20211118.0,20220420.0,20211126,20220423,EXP,,US-ROCHE-2962989,ROCHE,,82.0,YR,,M,Y,74.7,KG,20220423,,MD,US,,2022,Q2,Elderly
201418925,20141892,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Bacteraemia,,2022,Q2,5,F,20211104.0,20220422.0,20211202,20220425,EXP,,US-GILEAD-2021-0558900,GILEAD,,51.0,YR,A,M,Y,,,20220425,,HP,US,US,2022,Q2,Adult
201418925,20141892,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Pneumomediastinum,,2022,Q2,5,F,20211104.0,20220422.0,20211202,20220425,EXP,,US-GILEAD-2021-0558900,GILEAD,,51.0,YR,A,M,Y,,,20220425,,HP,US,US,2022,Q2,Adult
201418925,20141892,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Acute kidney injury,,2022,Q2,5,F,20211104.0,20220422.0,20211202,20220425,EXP,,US-GILEAD-2021-0558900,GILEAD,,51.0,YR,A,M,Y,,,20220425,,HP,US,US,2022,Q2,Adult
201418925,20141892,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,COVID-19,,2022,Q2,5,F,20211104.0,20220422.0,20211202,20220425,EXP,,US-GILEAD-2021-0558900,GILEAD,,51.0,YR,A,M,Y,,,20220425,,HP,US,US,2022,Q2,Adult
202044087,20204408,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2022,Q2,Dysphagia,,2022,Q2,7,F,20210101.0,20220617.0,20211220,20220628,EXP,,US-TEVA-2021-US-1988708,TEVA,,60.0,YR,A,F,Y,90.6,KG,20220628,,HP,US,US,2022,Q2,Adult
202044087,20204408,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2022,Q2,Hypotension,,2022,Q2,7,F,20210101.0,20220617.0,20211220,20220628,EXP,,US-TEVA-2021-US-1988708,TEVA,,60.0,YR,A,F,Y,90.6,KG,20220628,,HP,US,US,2022,Q2,Adult
202044087,20204408,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2022,Q2,Pyrexia,,2022,Q2,7,F,20210101.0,20220617.0,20211220,20220628,EXP,,US-TEVA-2021-US-1988708,TEVA,,60.0,YR,A,F,Y,90.6,KG,20220628,,HP,US,US,2022,Q2,Adult
202044087,20204408,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2022,Q2,Cough,,2022,Q2,7,F,20210101.0,20220617.0,20211220,20220628,EXP,,US-TEVA-2021-US-1988708,TEVA,,60.0,YR,A,F,Y,90.6,KG,20220628,,HP,US,US,2022,Q2,Adult
202044087,20204408,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2022,Q2,Nasal congestion,,2022,Q2,7,F,20210101.0,20220617.0,20211220,20220628,EXP,,US-TEVA-2021-US-1988708,TEVA,,60.0,YR,A,F,Y,90.6,KG,20220628,,HP,US,US,2022,Q2,Adult
202044087,20204408,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2022,Q2,Blood creatinine increased,,2022,Q2,7,F,20210101.0,20220617.0,20211220,20220628,EXP,,US-TEVA-2021-US-1988708,TEVA,,60.0,YR,A,F,Y,90.6,KG,20220628,,HP,US,US,2022,Q2,Adult
202044087,20204408,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2022,Q2,Hypoxia,,2022,Q2,7,F,20210101.0,20220617.0,20211220,20220628,EXP,,US-TEVA-2021-US-1988708,TEVA,,60.0,YR,A,F,Y,90.6,KG,20220628,,HP,US,US,2022,Q2,Adult
202044087,20204408,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,BID,2022,Q2,Acute kidney injury,,2022,Q2,7,F,20210101.0,20220617.0,20211220,20220628,EXP,,US-TEVA-2021-US-1988708,TEVA,,60.0,YR,A,F,Y,90.6,KG,20220628,,HP,US,US,2022,Q2,Adult
202064116,20206411,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, BID",,,U,,,,,,,,Q12H,2022,Q2,Blood creatinine increased,,2022,Q2,6,F,20211124.0,20220617.0,20211220,20220622,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220622,,HP,US,US,2022,Q2,Adult
202064116,20206411,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, BID",,,U,,,,,,,,Q12H,2022,Q2,Pyrexia,,2022,Q2,6,F,20211124.0,20220617.0,20211220,20220622,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220622,,HP,US,US,2022,Q2,Adult
202064116,20206411,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, BID",,,U,,,,,,,,Q12H,2022,Q2,Hypotension,,2022,Q2,6,F,20211124.0,20220617.0,20211220,20220622,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220622,,HP,US,US,2022,Q2,Adult
202064116,20206411,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, BID",,,U,,,,,,,,Q12H,2022,Q2,Acute kidney injury,,2022,Q2,6,F,20211124.0,20220617.0,20211220,20220622,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220622,,HP,US,US,2022,Q2,Adult
202064116,20206411,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, BID",,,U,,,,,,,,Q12H,2022,Q2,Dysphagia,,2022,Q2,6,F,20211124.0,20220617.0,20211220,20220622,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220622,,HP,US,US,2022,Q2,Adult
202064116,20206411,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, BID",,,U,,,,,,,,Q12H,2022,Q2,Hypoxia,,2022,Q2,6,F,20211124.0,20220617.0,20211220,20220622,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220622,,HP,US,US,2022,Q2,Adult
202064116,20206411,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, TID",,,U,,,,,,,,Q8H,2022,Q2,Blood creatinine increased,,2022,Q2,6,F,20211124.0,20220617.0,20211220,20220622,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220622,,HP,US,US,2022,Q2,Adult
202064116,20206411,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, TID",,,U,,,,,,,,Q8H,2022,Q2,Pyrexia,,2022,Q2,6,F,20211124.0,20220617.0,20211220,20220622,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220622,,HP,US,US,2022,Q2,Adult
202064116,20206411,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, TID",,,U,,,,,,,,Q8H,2022,Q2,Hypotension,,2022,Q2,6,F,20211124.0,20220617.0,20211220,20220622,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220622,,HP,US,US,2022,Q2,Adult
202064116,20206411,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, TID",,,U,,,,,,,,Q8H,2022,Q2,Acute kidney injury,,2022,Q2,6,F,20211124.0,20220617.0,20211220,20220622,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220622,,HP,US,US,2022,Q2,Adult
202064116,20206411,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, TID",,,U,,,,,,,,Q8H,2022,Q2,Dysphagia,,2022,Q2,6,F,20211124.0,20220617.0,20211220,20220622,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220622,,HP,US,US,2022,Q2,Adult
202064116,20206411,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 U, TID",,,U,,,,,,,,Q8H,2022,Q2,Hypoxia,,2022,Q2,6,F,20211124.0,20220617.0,20211220,20220622,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220622,,HP,US,US,2022,Q2,Adult
202064116,20206411,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 U,,,U,,,,,,,,,2022,Q2,Blood creatinine increased,,2022,Q2,6,F,20211124.0,20220617.0,20211220,20220622,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220622,,HP,US,US,2022,Q2,Adult
202064116,20206411,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 U,,,U,,,,,,,,,2022,Q2,Pyrexia,,2022,Q2,6,F,20211124.0,20220617.0,20211220,20220622,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220622,,HP,US,US,2022,Q2,Adult
202064116,20206411,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 U,,,U,,,,,,,,,2022,Q2,Hypotension,,2022,Q2,6,F,20211124.0,20220617.0,20211220,20220622,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220622,,HP,US,US,2022,Q2,Adult
202064116,20206411,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 U,,,U,,,,,,,,,2022,Q2,Acute kidney injury,,2022,Q2,6,F,20211124.0,20220617.0,20211220,20220622,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220622,,HP,US,US,2022,Q2,Adult
202064116,20206411,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 U,,,U,,,,,,,,,2022,Q2,Dysphagia,,2022,Q2,6,F,20211124.0,20220617.0,20211220,20220622,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220622,,HP,US,US,2022,Q2,Adult
202064116,20206411,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 U,,,U,,,,,,,,,2022,Q2,Hypoxia,,2022,Q2,6,F,20211124.0,20220617.0,20211220,20220622,EXP,,US-SA-2021SA419605,SANOFI AVENTIS,,60.0,YR,A,F,Y,90.6,KG,20220622,,HP,US,US,2022,Q2,Adult
202081776,20208177,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 Unit, 2 in 1 D",179100.0,IU,,,,,,50.0,IU,,BID,2022,Q2,Blood creatinine increased,,2022,Q2,6,F,20211124.0,20220617.0,20211220,20220623,EXP,,US-PFIZER INC-202101752662,PFIZER,,60.0,YR,,F,Y,90.6,KG,20220623,,HP,US,US,2022,Q2,Adult
202081776,20208177,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 Unit, 2 in 1 D",179100.0,IU,,,,,,50.0,IU,,BID,2022,Q2,Acute kidney injury,,2022,Q2,6,F,20211124.0,20220617.0,20211220,20220623,EXP,,US-PFIZER INC-202101752662,PFIZER,,60.0,YR,,F,Y,90.6,KG,20220623,,HP,US,US,2022,Q2,Adult
202081776,20208177,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 Unit, 2 in 1 D",179100.0,IU,,,,,,50.0,IU,,BID,2022,Q2,Pyrexia,,2022,Q2,6,F,20211124.0,20220617.0,20211220,20220623,EXP,,US-PFIZER INC-202101752662,PFIZER,,60.0,YR,,F,Y,90.6,KG,20220623,,HP,US,US,2022,Q2,Adult
202081776,20208177,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 Unit, 2 in 1 D",179100.0,IU,,,,,,50.0,IU,,BID,2022,Q2,Hypoxia,,2022,Q2,6,F,20211124.0,20220617.0,20211220,20220623,EXP,,US-PFIZER INC-202101752662,PFIZER,,60.0,YR,,F,Y,90.6,KG,20220623,,HP,US,US,2022,Q2,Adult
202081776,20208177,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 Unit, 2 in 1 D",179100.0,IU,,,,,,50.0,IU,,BID,2022,Q2,Hypotension,,2022,Q2,6,F,20211124.0,20220617.0,20211220,20220623,EXP,,US-PFIZER INC-202101752662,PFIZER,,60.0,YR,,F,Y,90.6,KG,20220623,,HP,US,US,2022,Q2,Adult
202081776,20208177,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 Unit, 2 in 1 D",179100.0,IU,,,,,,50.0,IU,,BID,2022,Q2,Dysphagia,,2022,Q2,6,F,20211124.0,20220617.0,20211220,20220623,EXP,,US-PFIZER INC-202101752662,PFIZER,,60.0,YR,,F,Y,90.6,KG,20220623,,HP,US,US,2022,Q2,Adult
202275352,20227535,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Off label use,,2022,Q2,2,F,,20220519.0,20211224,20220601,EXP,,CA-APOTEX-2021AP046757,APOTEX,,20.0,YR,,F,Y,,,20220601,,HP,CA,CA,2022,Q2,Youth
202275352,20227535,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Drug ineffective for unapproved indication,,2022,Q2,2,F,,20220519.0,20211224,20220601,EXP,,CA-APOTEX-2021AP046757,APOTEX,,20.0,YR,,F,Y,,,20220601,,HP,CA,CA,2022,Q2,Youth
202635286,20263528,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,As needed,,,,,,,,,,,,2022,Q2,Drug-induced liver injury,,2022,Q2,6,F,20211224.0,20220324.0,20211231,20220408,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-142058,BRISTOL MYERS SQUIBB,,58.0,YR,A,F,Y,58.0,KG,20220408,,HP,JP,JP,2022,Q2,Adult
204066252,20406625,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid (3/day)",,,U,,,,,,,,TID,2022,Q2,Hemiplegia,,2022,Q2,2,F,,20220613.0,20220131,20220615,EXP,,NVSC2022IT018546,NOVARTIS,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. EUROPEAN HEART JOURNAL. 2021;23(suppl G):G92-3",68.0,YR,,M,Y,,,20220615,,HP,IT,IT,2022,Q2,Elderly
204066252,20406625,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid (3/day)",,,U,,,,,,,,TID,2022,Q2,Product use in unapproved indication,,2022,Q2,2,F,,20220613.0,20220131,20220615,EXP,,NVSC2022IT018546,NOVARTIS,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. EUROPEAN HEART JOURNAL. 2021;23(suppl G):G92-3",68.0,YR,,M,Y,,,20220615,,HP,IT,IT,2022,Q2,Elderly
204066252,20406625,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid (3/day)",,,U,,,,,,,,TID,2022,Q2,Cerebral ischaemia,,2022,Q2,2,F,,20220613.0,20220131,20220615,EXP,,NVSC2022IT018546,NOVARTIS,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. EUROPEAN HEART JOURNAL. 2021;23(suppl G):G92-3",68.0,YR,,M,Y,,,20220615,,HP,IT,IT,2022,Q2,Elderly
204066252,20406625,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid (3/day)",,,U,,,,,,,,TID,2022,Q2,Acute right ventricular failure,,2022,Q2,2,F,,20220613.0,20220131,20220615,EXP,,NVSC2022IT018546,NOVARTIS,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. EUROPEAN HEART JOURNAL. 2021;23(suppl G):G92-3",68.0,YR,,M,Y,,,20220615,,HP,IT,IT,2022,Q2,Elderly
204066252,20406625,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid (3/day)",,,U,,,,,,,,TID,2022,Q2,Off label use,,2022,Q2,2,F,,20220613.0,20220131,20220615,EXP,,NVSC2022IT018546,NOVARTIS,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. EUROPEAN HEART JOURNAL. 2021;23(suppl G):G92-3",68.0,YR,,M,Y,,,20220615,,HP,IT,IT,2022,Q2,Elderly
204066252,20406625,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid (3/day)",,,U,,,,,,,,TID,2022,Q2,Coronary artery stenosis,,2022,Q2,2,F,,20220613.0,20220131,20220615,EXP,,NVSC2022IT018546,NOVARTIS,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. EUROPEAN HEART JOURNAL. 2021;23(suppl G):G92-3",68.0,YR,,M,Y,,,20220615,,HP,IT,IT,2022,Q2,Elderly
204066252,20406625,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid (3/day)",,,U,,,,,,,,TID,2022,Q2,Electrocardiogram ST segment elevation,,2022,Q2,2,F,,20220613.0,20220131,20220615,EXP,,NVSC2022IT018546,NOVARTIS,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. EUROPEAN HEART JOURNAL. 2021;23(suppl G):G92-3",68.0,YR,,M,Y,,,20220615,,HP,IT,IT,2022,Q2,Elderly
204066252,20406625,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid (3/day)",,,U,,,,,,,,TID,2022,Q2,Dyspnoea,,2022,Q2,2,F,,20220613.0,20220131,20220615,EXP,,NVSC2022IT018546,NOVARTIS,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. EUROPEAN HEART JOURNAL. 2021;23(suppl G):G92-3",68.0,YR,,M,Y,,,20220615,,HP,IT,IT,2022,Q2,Elderly
204411852,20441185,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, Once a Day (6/8/8 UI, tid (3/day))",,,U,,,,,,,,QD,2022,Q2,Electrocardiogram ST segment elevation,,2022,Q2,2,F,,20220610.0,20220208,20220622,EXP,,IT-AUROBINDO-AUR-APL-2022-003090,AUROBINDO,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance.. European Heart Journal. 2021;23 (SUPPL G):G92-3",68.0,YR,,M,Y,,,20220622,,HP,IT,IT,2022,Q2,Elderly
204411852,20441185,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, Once a Day (6/8/8 UI, tid (3/day))",,,U,,,,,,,,QD,2022,Q2,Coronary artery stenosis,,2022,Q2,2,F,,20220610.0,20220208,20220622,EXP,,IT-AUROBINDO-AUR-APL-2022-003090,AUROBINDO,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance.. European Heart Journal. 2021;23 (SUPPL G):G92-3",68.0,YR,,M,Y,,,20220622,,HP,IT,IT,2022,Q2,Elderly
204411852,20441185,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, Once a Day (6/8/8 UI, tid (3/day))",,,U,,,,,,,,QD,2022,Q2,Acute right ventricular failure,,2022,Q2,2,F,,20220610.0,20220208,20220622,EXP,,IT-AUROBINDO-AUR-APL-2022-003090,AUROBINDO,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance.. European Heart Journal. 2021;23 (SUPPL G):G92-3",68.0,YR,,M,Y,,,20220622,,HP,IT,IT,2022,Q2,Elderly
204411852,20441185,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, Once a Day (6/8/8 UI, tid (3/day))",,,U,,,,,,,,QD,2022,Q2,Product use in unapproved indication,,2022,Q2,2,F,,20220610.0,20220208,20220622,EXP,,IT-AUROBINDO-AUR-APL-2022-003090,AUROBINDO,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance.. European Heart Journal. 2021;23 (SUPPL G):G92-3",68.0,YR,,M,Y,,,20220622,,HP,IT,IT,2022,Q2,Elderly
204411852,20441185,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, Once a Day (6/8/8 UI, tid (3/day))",,,U,,,,,,,,QD,2022,Q2,Cerebral ischaemia,,2022,Q2,2,F,,20220610.0,20220208,20220622,EXP,,IT-AUROBINDO-AUR-APL-2022-003090,AUROBINDO,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance.. European Heart Journal. 2021;23 (SUPPL G):G92-3",68.0,YR,,M,Y,,,20220622,,HP,IT,IT,2022,Q2,Elderly
204411852,20441185,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, Once a Day (6/8/8 UI, tid (3/day))",,,U,,,,,,,,QD,2022,Q2,Off label use,,2022,Q2,2,F,,20220610.0,20220208,20220622,EXP,,IT-AUROBINDO-AUR-APL-2022-003090,AUROBINDO,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance.. European Heart Journal. 2021;23 (SUPPL G):G92-3",68.0,YR,,M,Y,,,20220622,,HP,IT,IT,2022,Q2,Elderly
204411852,20441185,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, Once a Day (6/8/8 UI, tid (3/day))",,,U,,,,,,,,QD,2022,Q2,Dyspnoea,,2022,Q2,2,F,,20220610.0,20220208,20220622,EXP,,IT-AUROBINDO-AUR-APL-2022-003090,AUROBINDO,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance.. European Heart Journal. 2021;23 (SUPPL G):G92-3",68.0,YR,,M,Y,,,20220622,,HP,IT,IT,2022,Q2,Elderly
204411852,20441185,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 dosage form, Once a Day (6/8/8 UI, tid (3/day))",,,U,,,,,,,,QD,2022,Q2,Hemiplegia,,2022,Q2,2,F,,20220610.0,20220208,20220622,EXP,,IT-AUROBINDO-AUR-APL-2022-003090,AUROBINDO,"Lanniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V et al.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance.. European Heart Journal. 2021;23 (SUPPL G):G92-3",68.0,YR,,M,Y,,,20220622,,HP,IT,IT,2022,Q2,Elderly
204843666,20484366,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,1-11 units TID AC; 2-7 units nightly,,,,,,,,,,,,2022,Q2,Liver function test abnormal,,2022,Q2,6,F,20220202.0,20220329.0,20220217,20220408,EXP,,US-JNJFOC-20220214179,JOHNSON AND JOHNSON,,52.0,YR,A,M,Y,90.8,KG,20220408,,MD,US,US,2022,Q2,Adult
204843666,20484366,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,1-11 units TID AC; 2-7 units nightly,,,,,,,,,,,,2022,Q2,Stevens-Johnson syndrome,,2022,Q2,6,F,20220202.0,20220329.0,20220217,20220408,EXP,,US-JNJFOC-20220214179,JOHNSON AND JOHNSON,,52.0,YR,A,M,Y,90.8,KG,20220408,,MD,US,US,2022,Q2,Adult
204878224,20487822,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 IU, qd",,,,,UNKNOWN,,,24.0,IU,,QD,2022,Q2,Decreased activity,,2022,Q2,4,F,20211211.0,20220404.0,20220218,20220415,EXP,,JP-NOVOPROD-890564,NOVO NORDISK,,78.0,YR,,M,Y,68.5,KG,20220415,,MD,JP,JP,2022,Q2,Elderly
204878224,20487822,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 IU, qd",,,,,UNKNOWN,,,24.0,IU,,QD,2022,Q2,Decreased appetite,,2022,Q2,4,F,20211211.0,20220404.0,20220218,20220415,EXP,,JP-NOVOPROD-890564,NOVO NORDISK,,78.0,YR,,M,Y,68.5,KG,20220415,,MD,JP,JP,2022,Q2,Elderly
205081645,20508164,28,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,Mental impairment,,2022,Q2,5,F,20220113.0,20220407.0,20220223,20220412,EXP,,US-GLAXOSMITHKLINE-US2022GSK010549,GLAXOSMITHKLINE,,66.0,YR,,F,Y,85.7,KG,20220412,,MD,US,US,2022,Q2,Elderly
205081645,20508164,28,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,Hypotension,,2022,Q2,5,F,20220113.0,20220407.0,20220223,20220412,EXP,,US-GLAXOSMITHKLINE-US2022GSK010549,GLAXOSMITHKLINE,,66.0,YR,,F,Y,85.7,KG,20220412,,MD,US,US,2022,Q2,Elderly
205081645,20508164,28,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,Oesophageal ulcer,,2022,Q2,5,F,20220113.0,20220407.0,20220223,20220412,EXP,,US-GLAXOSMITHKLINE-US2022GSK010549,GLAXOSMITHKLINE,,66.0,YR,,F,Y,85.7,KG,20220412,,MD,US,US,2022,Q2,Elderly
205081645,20508164,28,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,Respiratory failure,,2022,Q2,5,F,20220113.0,20220407.0,20220223,20220412,EXP,,US-GLAXOSMITHKLINE-US2022GSK010549,GLAXOSMITHKLINE,,66.0,YR,,F,Y,85.7,KG,20220412,,MD,US,US,2022,Q2,Elderly
205081645,20508164,28,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,Gastrointestinal mucosal exfoliation,,2022,Q2,5,F,20220113.0,20220407.0,20220223,20220412,EXP,,US-GLAXOSMITHKLINE-US2022GSK010549,GLAXOSMITHKLINE,,66.0,YR,,F,Y,85.7,KG,20220412,,MD,US,US,2022,Q2,Elderly
205081645,20508164,28,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,Hypoxia,,2022,Q2,5,F,20220113.0,20220407.0,20220223,20220412,EXP,,US-GLAXOSMITHKLINE-US2022GSK010549,GLAXOSMITHKLINE,,66.0,YR,,F,Y,85.7,KG,20220412,,MD,US,US,2022,Q2,Elderly
205081645,20508164,28,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,Oesophagitis haemorrhagic,,2022,Q2,5,F,20220113.0,20220407.0,20220223,20220412,EXP,,US-GLAXOSMITHKLINE-US2022GSK010549,GLAXOSMITHKLINE,,66.0,YR,,F,Y,85.7,KG,20220412,,MD,US,US,2022,Q2,Elderly
205189975,20518997,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Pulmonary embolism,,2022,Q2,5,F,20190624.0,20220420.0,20220225,20220427,EXP,,US-Eisai Medical Research-EC-2019-058239,EISAI,,71.0,YR,E,M,Y,79.8,KG,20220427,,MD,US,,2022,Q2,Elderly
205189975,20518997,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Acute kidney injury,,2022,Q2,5,F,20190624.0,20220420.0,20220225,20220427,EXP,,US-Eisai Medical Research-EC-2019-058239,EISAI,,71.0,YR,E,M,Y,79.8,KG,20220427,,MD,US,,2022,Q2,Elderly
205189975,20518997,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Pemphigoid,,2022,Q2,5,F,20190624.0,20220420.0,20220225,20220427,EXP,,US-Eisai Medical Research-EC-2019-058239,EISAI,,71.0,YR,E,M,Y,79.8,KG,20220427,,MD,US,,2022,Q2,Elderly
205189975,20518997,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Aspiration,,2022,Q2,5,F,20190624.0,20220420.0,20220225,20220427,EXP,,US-Eisai Medical Research-EC-2019-058239,EISAI,,71.0,YR,E,M,Y,79.8,KG,20220427,,MD,US,,2022,Q2,Elderly
205189975,20518997,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Anaemia,,2022,Q2,5,F,20190624.0,20220420.0,20220225,20220427,EXP,,US-Eisai Medical Research-EC-2019-058239,EISAI,,71.0,YR,E,M,Y,79.8,KG,20220427,,MD,US,,2022,Q2,Elderly
205189975,20518997,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Ataxia,,2022,Q2,5,F,20190624.0,20220420.0,20220225,20220427,EXP,,US-Eisai Medical Research-EC-2019-058239,EISAI,,71.0,YR,E,M,Y,79.8,KG,20220427,,MD,US,,2022,Q2,Elderly
205239363,20523936,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q2,Intraocular pressure increased,,2022,Q2,3,F,20210806.0,20220329.0,20220228,20220406,EXP,,US-ROCHE-2898802,ROCHE,,68.0,YR,,F,Y,,,20220406,,MD,US,,2022,Q2,Elderly
205239363,20523936,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q2,Migraine,,2022,Q2,3,F,20210806.0,20220329.0,20220228,20220406,EXP,,US-ROCHE-2898802,ROCHE,,68.0,YR,,F,Y,,,20220406,,MD,US,,2022,Q2,Elderly
205239363,20523936,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q2,Iridocyclitis,,2022,Q2,3,F,20210806.0,20220329.0,20220228,20220406,EXP,,US-ROCHE-2898802,ROCHE,,68.0,YR,,F,Y,,,20220406,,MD,US,,2022,Q2,Elderly
205267673,20526767,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn (with meals and bedtime)",,,U,,,,,,,Solution for injection,,2022,Q2,Blood glucose increased,,2022,Q2,3,F,20220215.0,20220407.0,20220228,20220419,EXP,,US-ELI_LILLY_AND_COMPANY-US202202010765,ELI LILLY AND CO,,30.0,YR,,F,Y,123.81,KG,20220419,,CN,US,US,2022,Q2,Young Adult
205267673,20526767,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn (with meals and bedtime)",,,U,,,,,,,Solution for injection,,2022,Q2,Glycosylated haemoglobin increased,,2022,Q2,3,F,20220215.0,20220407.0,20220228,20220419,EXP,,US-ELI_LILLY_AND_COMPANY-US202202010765,ELI LILLY AND CO,,30.0,YR,,F,Y,123.81,KG,20220419,,CN,US,US,2022,Q2,Young Adult
205267673,20526767,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn (with meals and bedtime)",,,U,,,,,,,Solution for injection,,2022,Q2,Uterine leiomyoma,,2022,Q2,3,F,20220215.0,20220407.0,20220228,20220419,EXP,,US-ELI_LILLY_AND_COMPANY-US202202010765,ELI LILLY AND CO,,30.0,YR,,F,Y,123.81,KG,20220419,,CN,US,US,2022,Q2,Young Adult
205267673,20526767,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn (with meals and bedtime)",,,U,,,,,,,Solution for injection,,2022,Q2,Adnexa uteri mass,,2022,Q2,3,F,20220215.0,20220407.0,20220228,20220419,EXP,,US-ELI_LILLY_AND_COMPANY-US202202010765,ELI LILLY AND CO,,30.0,YR,,F,Y,123.81,KG,20220419,,CN,US,US,2022,Q2,Young Adult
205267673,20526767,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn (with meals and bedtime)",,,U,,,,,,,Solution for injection,,2022,Q2,Pancreatitis acute,,2022,Q2,3,F,20220215.0,20220407.0,20220228,20220419,EXP,,US-ELI_LILLY_AND_COMPANY-US202202010765,ELI LILLY AND CO,,30.0,YR,,F,Y,123.81,KG,20220419,,CN,US,US,2022,Q2,Young Adult
205267673,20526767,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn (with meals and bedtime)",,,U,,,,,,,Solution for injection,,2022,Q2,Hepatomegaly,,2022,Q2,3,F,20220215.0,20220407.0,20220228,20220419,EXP,,US-ELI_LILLY_AND_COMPANY-US202202010765,ELI LILLY AND CO,,30.0,YR,,F,Y,123.81,KG,20220419,,CN,US,US,2022,Q2,Young Adult
205267673,20526767,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn (with meals and bedtime)",,,U,,,,,,,Solution for injection,,2022,Q2,Diabetes mellitus inadequate control,,2022,Q2,3,F,20220215.0,20220407.0,20220228,20220419,EXP,,US-ELI_LILLY_AND_COMPANY-US202202010765,ELI LILLY AND CO,,30.0,YR,,F,Y,123.81,KG,20220419,,CN,US,US,2022,Q2,Young Adult
205267673,20526767,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn (with meals and bedtime)",,,U,,,,,,,Solution for injection,,2022,Q2,Hepatic steatosis,,2022,Q2,3,F,20220215.0,20220407.0,20220228,20220419,EXP,,US-ELI_LILLY_AND_COMPANY-US202202010765,ELI LILLY AND CO,,30.0,YR,,F,Y,123.81,KG,20220419,,CN,US,US,2022,Q2,Young Adult
205355662,20535566,6,C,Insulin lispro bs,,2,Subcutaneous,"12 units, thrice daily",,,,,,,,,,Injection,,2022,Q2,Enterocolitis,,2022,Q2,2,F,20220218.0,20220523.0,20220302,20220531,EXP,,JP-ASTELLAS-2022JP003532,ASTELLAS,,73.0,YR,,M,Y,,,20220531,,CN,JP,JP,2022,Q2,Elderly
205434712,20543471,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Pneumocystis jirovecii pneumonia,,2022,Q2,2,F,20211202.0,20220328.0,20220302,20220405,EXP,,US-AstraZeneca-2022A088416,ASTRAZENECA,,21386.0,DY,,M,Y,119.7,KG,20220405,,HP,US,,2022,Q2,Elderly
205434712,20543471,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Bladder transitional cell carcinoma,,2022,Q2,2,F,20211202.0,20220328.0,20220302,20220405,EXP,,US-AstraZeneca-2022A088416,ASTRAZENECA,,21386.0,DY,,M,Y,119.7,KG,20220405,,HP,US,,2022,Q2,Elderly
205434712,20543471,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Haematuria,,2022,Q2,2,F,20211202.0,20220328.0,20220302,20220405,EXP,,US-AstraZeneca-2022A088416,ASTRAZENECA,,21386.0,DY,,M,Y,119.7,KG,20220405,,HP,US,,2022,Q2,Elderly
205605423,20560542,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Constipation,,2022,Q2,3,F,20210101.0,20220425.0,20220307,20220509,PER,,US-PFIZER INC-202101830939,PFIZER,,61.0,YR,,F,Y,,,20220509,,HP,US,US,2022,Q2,Adult
205605423,20560542,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Stomatitis,,2022,Q2,3,F,20210101.0,20220425.0,20220307,20220509,PER,,US-PFIZER INC-202101830939,PFIZER,,61.0,YR,,F,Y,,,20220509,,HP,US,US,2022,Q2,Adult
205605423,20560542,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Full blood count abnormal,,2022,Q2,3,F,20210101.0,20220425.0,20220307,20220509,PER,,US-PFIZER INC-202101830939,PFIZER,,61.0,YR,,F,Y,,,20220509,,HP,US,US,2022,Q2,Adult
205605423,20560542,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Platelet count decreased,,2022,Q2,3,F,20210101.0,20220425.0,20220307,20220509,PER,,US-PFIZER INC-202101830939,PFIZER,,61.0,YR,,F,Y,,,20220509,,HP,US,US,2022,Q2,Adult
205605423,20560542,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Chapped lips,,2022,Q2,3,F,20210101.0,20220425.0,20220307,20220509,PER,,US-PFIZER INC-202101830939,PFIZER,,61.0,YR,,F,Y,,,20220509,,HP,US,US,2022,Q2,Adult
205605423,20560542,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Lip dry,,2022,Q2,3,F,20210101.0,20220425.0,20220307,20220509,PER,,US-PFIZER INC-202101830939,PFIZER,,61.0,YR,,F,Y,,,20220509,,HP,US,US,2022,Q2,Adult
205605423,20560542,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Fatigue,,2022,Q2,3,F,20210101.0,20220425.0,20220307,20220509,PER,,US-PFIZER INC-202101830939,PFIZER,,61.0,YR,,F,Y,,,20220509,,HP,US,US,2022,Q2,Adult
205605423,20560542,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Nasal dryness,,2022,Q2,3,F,20210101.0,20220425.0,20220307,20220509,PER,,US-PFIZER INC-202101830939,PFIZER,,61.0,YR,,F,Y,,,20220509,,HP,US,US,2022,Q2,Adult
205653472,20565347,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Pneumonia,,2022,Q2,2,F,20211223.0,20220616.0,20220308,20220620,EXP,,IT-BAUSCH-BL-2022-006125,BAUSCH AND LOMB,,77.0,YR,,M,Y,76.0,KG,20220620,,HP,IT,IT,2022,Q2,Elderly
205738714,20573871,62,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Acute kidney injury,,2022,Q2,4,F,20220216.0,20220628.0,20220309,20220630,EXP,,US-GILEAD-2022-0572892,GILEAD,,63.0,YR,A,M,Y,65.7,KG,20220630,,HP,US,US,2022,Q2,Adult
205738714,20573871,62,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Immune effector cell-associated neurotoxicity syndrome,,2022,Q2,4,F,20220216.0,20220628.0,20220309,20220630,EXP,,US-GILEAD-2022-0572892,GILEAD,,63.0,YR,A,M,Y,65.7,KG,20220630,,HP,US,US,2022,Q2,Adult
205738714,20573871,62,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Visual impairment,,2022,Q2,4,F,20220216.0,20220628.0,20220309,20220630,EXP,,US-GILEAD-2022-0572892,GILEAD,,63.0,YR,A,M,Y,65.7,KG,20220630,,HP,US,US,2022,Q2,Adult
205738714,20573871,62,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Posterior reversible encephalopathy syndrome,,2022,Q2,4,F,20220216.0,20220628.0,20220309,20220630,EXP,,US-GILEAD-2022-0572892,GILEAD,,63.0,YR,A,M,Y,65.7,KG,20220630,,HP,US,US,2022,Q2,Adult
205738714,20573871,62,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Hydrocephalus,,2022,Q2,4,F,20220216.0,20220628.0,20220309,20220630,EXP,,US-GILEAD-2022-0572892,GILEAD,,63.0,YR,A,M,Y,65.7,KG,20220630,,HP,US,US,2022,Q2,Adult
205738714,20573871,62,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Cytokine release syndrome,,2022,Q2,4,F,20220216.0,20220628.0,20220309,20220630,EXP,,US-GILEAD-2022-0572892,GILEAD,,63.0,YR,A,M,Y,65.7,KG,20220630,,HP,US,US,2022,Q2,Adult
205738714,20573871,62,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Diplopia,,2022,Q2,4,F,20220216.0,20220628.0,20220309,20220630,EXP,,US-GILEAD-2022-0572892,GILEAD,,63.0,YR,A,M,Y,65.7,KG,20220630,,HP,US,US,2022,Q2,Adult
206103932,20610393,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Respiratory failure,,2022,Q2,2,F,20220227.0,20220330.0,20220318,20220406,EXP,,ES-009507513-2203ESP005084,MERCK,,72.0,YR,,M,Y,,,20220406,,MD,ES,ES,2022,Q2,Elderly
206103932,20610393,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Recurrence of neuromuscular blockade,,2022,Q2,2,F,20220227.0,20220330.0,20220318,20220406,EXP,,ES-009507513-2203ESP005084,MERCK,,72.0,YR,,M,Y,,,20220406,,MD,ES,ES,2022,Q2,Elderly
206144304,20614430,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Hyperlactacidaemia,,2022,Q2,4,F,,20220517.0,20220321,20220601,EXP,,US-AUROBINDO-AUR-APL-2022-009052,AUROBINDO,"Comstock G, Kilgallon K, Wang GS, Bourne D, Blanchette E, Stenson E.. Management and Associated Toxicokinetics of Massive Valproic Acid Ingestion with High Flow Continuous Venovenous Hemodiafiltration.. J Med Toxicol. 2022",17.0,YR,,F,Y,,,20220601,,MD,US,US,2022,Q2,Youth
206144304,20614430,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Hypotension,,2022,Q2,4,F,,20220517.0,20220321,20220601,EXP,,US-AUROBINDO-AUR-APL-2022-009052,AUROBINDO,"Comstock G, Kilgallon K, Wang GS, Bourne D, Blanchette E, Stenson E.. Management and Associated Toxicokinetics of Massive Valproic Acid Ingestion with High Flow Continuous Venovenous Hemodiafiltration.. J Med Toxicol. 2022",17.0,YR,,F,Y,,,20220601,,MD,US,US,2022,Q2,Youth
206144304,20614430,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Metabolic disorder,,2022,Q2,4,F,,20220517.0,20220321,20220601,EXP,,US-AUROBINDO-AUR-APL-2022-009052,AUROBINDO,"Comstock G, Kilgallon K, Wang GS, Bourne D, Blanchette E, Stenson E.. Management and Associated Toxicokinetics of Massive Valproic Acid Ingestion with High Flow Continuous Venovenous Hemodiafiltration.. J Med Toxicol. 2022",17.0,YR,,F,Y,,,20220601,,MD,US,US,2022,Q2,Youth
206144304,20614430,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Haemodynamic instability,,2022,Q2,4,F,,20220517.0,20220321,20220601,EXP,,US-AUROBINDO-AUR-APL-2022-009052,AUROBINDO,"Comstock G, Kilgallon K, Wang GS, Bourne D, Blanchette E, Stenson E.. Management and Associated Toxicokinetics of Massive Valproic Acid Ingestion with High Flow Continuous Venovenous Hemodiafiltration.. J Med Toxicol. 2022",17.0,YR,,F,Y,,,20220601,,MD,US,US,2022,Q2,Youth
206144304,20614430,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Thrombocytopenia,,2022,Q2,4,F,,20220517.0,20220321,20220601,EXP,,US-AUROBINDO-AUR-APL-2022-009052,AUROBINDO,"Comstock G, Kilgallon K, Wang GS, Bourne D, Blanchette E, Stenson E.. Management and Associated Toxicokinetics of Massive Valproic Acid Ingestion with High Flow Continuous Venovenous Hemodiafiltration.. J Med Toxicol. 2022",17.0,YR,,F,Y,,,20220601,,MD,US,US,2022,Q2,Youth
206144304,20614430,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Seizure,,2022,Q2,4,F,,20220517.0,20220321,20220601,EXP,,US-AUROBINDO-AUR-APL-2022-009052,AUROBINDO,"Comstock G, Kilgallon K, Wang GS, Bourne D, Blanchette E, Stenson E.. Management and Associated Toxicokinetics of Massive Valproic Acid Ingestion with High Flow Continuous Venovenous Hemodiafiltration.. J Med Toxicol. 2022",17.0,YR,,F,Y,,,20220601,,MD,US,US,2022,Q2,Youth
206144304,20614430,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Acute kidney injury,,2022,Q2,4,F,,20220517.0,20220321,20220601,EXP,,US-AUROBINDO-AUR-APL-2022-009052,AUROBINDO,"Comstock G, Kilgallon K, Wang GS, Bourne D, Blanchette E, Stenson E.. Management and Associated Toxicokinetics of Massive Valproic Acid Ingestion with High Flow Continuous Venovenous Hemodiafiltration.. J Med Toxicol. 2022",17.0,YR,,F,Y,,,20220601,,MD,US,US,2022,Q2,Youth
206144304,20614430,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Shock,,2022,Q2,4,F,,20220517.0,20220321,20220601,EXP,,US-AUROBINDO-AUR-APL-2022-009052,AUROBINDO,"Comstock G, Kilgallon K, Wang GS, Bourne D, Blanchette E, Stenson E.. Management and Associated Toxicokinetics of Massive Valproic Acid Ingestion with High Flow Continuous Venovenous Hemodiafiltration.. J Med Toxicol. 2022",17.0,YR,,F,Y,,,20220601,,MD,US,US,2022,Q2,Youth
206144304,20614430,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Hypernatraemia,,2022,Q2,4,F,,20220517.0,20220321,20220601,EXP,,US-AUROBINDO-AUR-APL-2022-009052,AUROBINDO,"Comstock G, Kilgallon K, Wang GS, Bourne D, Blanchette E, Stenson E.. Management and Associated Toxicokinetics of Massive Valproic Acid Ingestion with High Flow Continuous Venovenous Hemodiafiltration.. J Med Toxicol. 2022",17.0,YR,,F,Y,,,20220601,,MD,US,US,2022,Q2,Youth
206144304,20614430,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Hyperammonaemia,,2022,Q2,4,F,,20220517.0,20220321,20220601,EXP,,US-AUROBINDO-AUR-APL-2022-009052,AUROBINDO,"Comstock G, Kilgallon K, Wang GS, Bourne D, Blanchette E, Stenson E.. Management and Associated Toxicokinetics of Massive Valproic Acid Ingestion with High Flow Continuous Venovenous Hemodiafiltration.. J Med Toxicol. 2022",17.0,YR,,F,Y,,,20220601,,MD,US,US,2022,Q2,Youth
206144304,20614430,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Pancreatitis necrotising,,2022,Q2,4,F,,20220517.0,20220321,20220601,EXP,,US-AUROBINDO-AUR-APL-2022-009052,AUROBINDO,"Comstock G, Kilgallon K, Wang GS, Bourne D, Blanchette E, Stenson E.. Management and Associated Toxicokinetics of Massive Valproic Acid Ingestion with High Flow Continuous Venovenous Hemodiafiltration.. J Med Toxicol. 2022",17.0,YR,,F,Y,,,20220601,,MD,US,US,2022,Q2,Youth
206144304,20614430,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Depressed level of consciousness,,2022,Q2,4,F,,20220517.0,20220321,20220601,EXP,,US-AUROBINDO-AUR-APL-2022-009052,AUROBINDO,"Comstock G, Kilgallon K, Wang GS, Bourne D, Blanchette E, Stenson E.. Management and Associated Toxicokinetics of Massive Valproic Acid Ingestion with High Flow Continuous Venovenous Hemodiafiltration.. J Med Toxicol. 2022",17.0,YR,,F,Y,,,20220601,,MD,US,US,2022,Q2,Youth
206144304,20614430,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Continuous haemodiafiltration,,2022,Q2,4,F,,20220517.0,20220321,20220601,EXP,,US-AUROBINDO-AUR-APL-2022-009052,AUROBINDO,"Comstock G, Kilgallon K, Wang GS, Bourne D, Blanchette E, Stenson E.. Management and Associated Toxicokinetics of Massive Valproic Acid Ingestion with High Flow Continuous Venovenous Hemodiafiltration.. J Med Toxicol. 2022",17.0,YR,,F,Y,,,20220601,,MD,US,US,2022,Q2,Youth
206144304,20614430,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Encephalopathy,,2022,Q2,4,F,,20220517.0,20220321,20220601,EXP,,US-AUROBINDO-AUR-APL-2022-009052,AUROBINDO,"Comstock G, Kilgallon K, Wang GS, Bourne D, Blanchette E, Stenson E.. Management and Associated Toxicokinetics of Massive Valproic Acid Ingestion with High Flow Continuous Venovenous Hemodiafiltration.. J Med Toxicol. 2022",17.0,YR,,F,Y,,,20220601,,MD,US,US,2022,Q2,Youth
206144304,20614430,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Extrasystoles,,2022,Q2,4,F,,20220517.0,20220321,20220601,EXP,,US-AUROBINDO-AUR-APL-2022-009052,AUROBINDO,"Comstock G, Kilgallon K, Wang GS, Bourne D, Blanchette E, Stenson E.. Management and Associated Toxicokinetics of Massive Valproic Acid Ingestion with High Flow Continuous Venovenous Hemodiafiltration.. J Med Toxicol. 2022",17.0,YR,,F,Y,,,20220601,,MD,US,US,2022,Q2,Youth
206144304,20614430,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Toxicity to various agents,,2022,Q2,4,F,,20220517.0,20220321,20220601,EXP,,US-AUROBINDO-AUR-APL-2022-009052,AUROBINDO,"Comstock G, Kilgallon K, Wang GS, Bourne D, Blanchette E, Stenson E.. Management and Associated Toxicokinetics of Massive Valproic Acid Ingestion with High Flow Continuous Venovenous Hemodiafiltration.. J Med Toxicol. 2022",17.0,YR,,F,Y,,,20220601,,MD,US,US,2022,Q2,Youth
206144304,20614430,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Anaemia,,2022,Q2,4,F,,20220517.0,20220321,20220601,EXP,,US-AUROBINDO-AUR-APL-2022-009052,AUROBINDO,"Comstock G, Kilgallon K, Wang GS, Bourne D, Blanchette E, Stenson E.. Management and Associated Toxicokinetics of Massive Valproic Acid Ingestion with High Flow Continuous Venovenous Hemodiafiltration.. J Med Toxicol. 2022",17.0,YR,,F,Y,,,20220601,,MD,US,US,2022,Q2,Youth
206144304,20614430,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Type 3 diabetes mellitus,,2022,Q2,4,F,,20220517.0,20220321,20220601,EXP,,US-AUROBINDO-AUR-APL-2022-009052,AUROBINDO,"Comstock G, Kilgallon K, Wang GS, Bourne D, Blanchette E, Stenson E.. Management and Associated Toxicokinetics of Massive Valproic Acid Ingestion with High Flow Continuous Venovenous Hemodiafiltration.. J Med Toxicol. 2022",17.0,YR,,F,Y,,,20220601,,MD,US,US,2022,Q2,Youth
206144304,20614430,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Intentional overdose,,2022,Q2,4,F,,20220517.0,20220321,20220601,EXP,,US-AUROBINDO-AUR-APL-2022-009052,AUROBINDO,"Comstock G, Kilgallon K, Wang GS, Bourne D, Blanchette E, Stenson E.. Management and Associated Toxicokinetics of Massive Valproic Acid Ingestion with High Flow Continuous Venovenous Hemodiafiltration.. J Med Toxicol. 2022",17.0,YR,,F,Y,,,20220601,,MD,US,US,2022,Q2,Youth
206144304,20614430,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Pancytopenia,,2022,Q2,4,F,,20220517.0,20220321,20220601,EXP,,US-AUROBINDO-AUR-APL-2022-009052,AUROBINDO,"Comstock G, Kilgallon K, Wang GS, Bourne D, Blanchette E, Stenson E.. Management and Associated Toxicokinetics of Massive Valproic Acid Ingestion with High Flow Continuous Venovenous Hemodiafiltration.. J Med Toxicol. 2022",17.0,YR,,F,Y,,,20220601,,MD,US,US,2022,Q2,Youth
206144304,20614430,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Unresponsive to stimuli,,2022,Q2,4,F,,20220517.0,20220321,20220601,EXP,,US-AUROBINDO-AUR-APL-2022-009052,AUROBINDO,"Comstock G, Kilgallon K, Wang GS, Bourne D, Blanchette E, Stenson E.. Management and Associated Toxicokinetics of Massive Valproic Acid Ingestion with High Flow Continuous Venovenous Hemodiafiltration.. J Med Toxicol. 2022",17.0,YR,,F,Y,,,20220601,,MD,US,US,2022,Q2,Youth
206144304,20614430,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Respiratory acidosis,,2022,Q2,4,F,,20220517.0,20220321,20220601,EXP,,US-AUROBINDO-AUR-APL-2022-009052,AUROBINDO,"Comstock G, Kilgallon K, Wang GS, Bourne D, Blanchette E, Stenson E.. Management and Associated Toxicokinetics of Massive Valproic Acid Ingestion with High Flow Continuous Venovenous Hemodiafiltration.. J Med Toxicol. 2022",17.0,YR,,F,Y,,,20220601,,MD,US,US,2022,Q2,Youth
206144304,20614430,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Metabolic acidosis,,2022,Q2,4,F,,20220517.0,20220321,20220601,EXP,,US-AUROBINDO-AUR-APL-2022-009052,AUROBINDO,"Comstock G, Kilgallon K, Wang GS, Bourne D, Blanchette E, Stenson E.. Management and Associated Toxicokinetics of Massive Valproic Acid Ingestion with High Flow Continuous Venovenous Hemodiafiltration.. J Med Toxicol. 2022",17.0,YR,,F,Y,,,20220601,,MD,US,US,2022,Q2,Youth
206144304,20614430,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q2,Coma,,2022,Q2,4,F,,20220517.0,20220321,20220601,EXP,,US-AUROBINDO-AUR-APL-2022-009052,AUROBINDO,"Comstock G, Kilgallon K, Wang GS, Bourne D, Blanchette E, Stenson E.. Management and Associated Toxicokinetics of Massive Valproic Acid Ingestion with High Flow Continuous Venovenous Hemodiafiltration.. J Med Toxicol. 2022",17.0,YR,,F,Y,,,20220601,,MD,US,US,2022,Q2,Youth
206160813,20616081,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q2,Myelosuppression,,2022,Q2,3,F,20220120.0,20220603.0,20220321,20220617,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,,71.0,YR,,M,Y,,,20220617,,MD,JP,JP,2022,Q2,Elderly
206160813,20616081,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q2,Toxic epidermal necrolysis,,2022,Q2,3,F,20220120.0,20220603.0,20220321,20220617,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,,71.0,YR,,M,Y,,,20220617,,MD,JP,JP,2022,Q2,Elderly
206160813,20616081,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q2,Oral candidiasis,,2022,Q2,3,F,20220120.0,20220603.0,20220321,20220617,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,,71.0,YR,,M,Y,,,20220617,,MD,JP,JP,2022,Q2,Elderly
206160813,20616081,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q2,Renal failure,,2022,Q2,3,F,20220120.0,20220603.0,20220321,20220617,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,,71.0,YR,,M,Y,,,20220617,,MD,JP,JP,2022,Q2,Elderly
206160813,20616081,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q2,Hyperglycaemia,,2022,Q2,3,F,20220120.0,20220603.0,20220321,20220617,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,,71.0,YR,,M,Y,,,20220617,,MD,JP,JP,2022,Q2,Elderly
206340442,20634044,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,Y,,,,,4.0,IU,Unknown,,2022,Q2,Traumatic intracranial haemorrhage,,2022,Q2,2,F,20220201.0,20220325.0,20220324,20220408,EXP,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-040281,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-040281,BRISTOL MYERS SQUIBB,,83.0,YR,E,F,Y,63.0,KG,20220408,,MD,IT,IT,2022,Q2,Elderly
206340442,20634044,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,Y,,,,,,,,,2022,Q2,Traumatic intracranial haemorrhage,,2022,Q2,2,F,20220201.0,20220325.0,20220324,20220408,EXP,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-040281,IT-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-040281,BRISTOL MYERS SQUIBB,,83.0,YR,E,F,Y,63.0,KG,20220408,,MD,IT,IT,2022,Q2,Elderly
206371532,20637153,5,C,INSULINE LISPRO,,1,,UNK,,,,,,,,,,,,2022,Q2,Immune-mediated hepatitis,,2022,Q2,2,F,20210923.0,20220405.0,20220325,20220411,PER,,IT-AMGEN-ITASP2022049241,AMGEN,,45.0,YR,A,F,Y,65.0,KG,20220411,,MD,IT,IT,2022,Q2,Adult
206471363,20647136,26,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Renal tubular necrosis,,2022,Q2,3,F,20220306.0,20220407.0,20220329,20220418,EXP,FR-AFSSAPS-AM20220794,NVSC2022FR070174,NOVARTIS,,89.0,YR,,F,Y,96.2,KG,20220418,,MD,FR,FR,2022,Q2,Elderly
206471363,20647136,26,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,D,,,,,,,Solution for injection,,2022,Q2,Acute kidney injury,,2022,Q2,3,F,20220306.0,20220407.0,20220329,20220418,EXP,FR-AFSSAPS-AM20220794,NVSC2022FR070174,NOVARTIS,,89.0,YR,,F,Y,96.2,KG,20220418,,MD,FR,FR,2022,Q2,Elderly
206527022,20652702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Headache,,2022,Q2,2,F,,20220321.0,20220330,20220614,EXP,,CA-Orion Corporation ORION PHARMA-TREX2022-0059,ORION,,65.0,YR,E,F,Y,,,20220614,,HP,CA,,2022,Q2,Elderly
206527022,20652702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Pain in extremity,,2022,Q2,2,F,,20220321.0,20220330,20220614,EXP,,CA-Orion Corporation ORION PHARMA-TREX2022-0059,ORION,,65.0,YR,E,F,Y,,,20220614,,HP,CA,,2022,Q2,Elderly
206527022,20652702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Diabetes mellitus,,2022,Q2,2,F,,20220321.0,20220330,20220614,EXP,,CA-Orion Corporation ORION PHARMA-TREX2022-0059,ORION,,65.0,YR,E,F,Y,,,20220614,,HP,CA,,2022,Q2,Elderly
206527022,20652702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Psoriatic arthropathy,,2022,Q2,2,F,,20220321.0,20220330,20220614,EXP,,CA-Orion Corporation ORION PHARMA-TREX2022-0059,ORION,,65.0,YR,E,F,Y,,,20220614,,HP,CA,,2022,Q2,Elderly
206527022,20652702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Pain,,2022,Q2,2,F,,20220321.0,20220330,20220614,EXP,,CA-Orion Corporation ORION PHARMA-TREX2022-0059,ORION,,65.0,YR,E,F,Y,,,20220614,,HP,CA,,2022,Q2,Elderly
206527022,20652702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Grip strength decreased,,2022,Q2,2,F,,20220321.0,20220330,20220614,EXP,,CA-Orion Corporation ORION PHARMA-TREX2022-0059,ORION,,65.0,YR,E,F,Y,,,20220614,,HP,CA,,2022,Q2,Elderly
206527022,20652702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Hepatotoxicity,,2022,Q2,2,F,,20220321.0,20220330,20220614,EXP,,CA-Orion Corporation ORION PHARMA-TREX2022-0059,ORION,,65.0,YR,E,F,Y,,,20220614,,HP,CA,,2022,Q2,Elderly
206527022,20652702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Osteoarthritis,,2022,Q2,2,F,,20220321.0,20220330,20220614,EXP,,CA-Orion Corporation ORION PHARMA-TREX2022-0059,ORION,,65.0,YR,E,F,Y,,,20220614,,HP,CA,,2022,Q2,Elderly
206527022,20652702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Movement disorder,,2022,Q2,2,F,,20220321.0,20220330,20220614,EXP,,CA-Orion Corporation ORION PHARMA-TREX2022-0059,ORION,,65.0,YR,E,F,Y,,,20220614,,HP,CA,,2022,Q2,Elderly
206527022,20652702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Drug intolerance,,2022,Q2,2,F,,20220321.0,20220330,20220614,EXP,,CA-Orion Corporation ORION PHARMA-TREX2022-0059,ORION,,65.0,YR,E,F,Y,,,20220614,,HP,CA,,2022,Q2,Elderly
206527022,20652702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Drug ineffective,,2022,Q2,2,F,,20220321.0,20220330,20220614,EXP,,CA-Orion Corporation ORION PHARMA-TREX2022-0059,ORION,,65.0,YR,E,F,Y,,,20220614,,HP,CA,,2022,Q2,Elderly
206527022,20652702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Hepatic cirrhosis,,2022,Q2,2,F,,20220321.0,20220330,20220614,EXP,,CA-Orion Corporation ORION PHARMA-TREX2022-0059,ORION,,65.0,YR,E,F,Y,,,20220614,,HP,CA,,2022,Q2,Elderly
206527022,20652702,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Dyspnoea,,2022,Q2,2,F,,20220321.0,20220330,20220614,EXP,,CA-Orion Corporation ORION PHARMA-TREX2022-0059,ORION,,65.0,YR,E,F,Y,,,20220614,,HP,CA,,2022,Q2,Elderly
206646351,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Arthralgia,,2022,Q2,1,I,,20220325.0,20220401,20220401,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
206646351,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Hepatotoxicity,,2022,Q2,1,I,,20220325.0,20220401,20220401,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
206646351,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Drug ineffective,,2022,Q2,1,I,,20220325.0,20220401,20220401,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
206646351,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Pain,,2022,Q2,1,I,,20220325.0,20220401,20220401,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
206646351,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Diabetes mellitus,,2022,Q2,1,I,,20220325.0,20220401,20220401,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
206646351,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Grip strength decreased,,2022,Q2,1,I,,20220325.0,20220401,20220401,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
206646351,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Pain in extremity,,2022,Q2,1,I,,20220325.0,20220401,20220401,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
206646351,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Psoriatic arthropathy,,2022,Q2,1,I,,20220325.0,20220401,20220401,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
206646351,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Hepatic cirrhosis,,2022,Q2,1,I,,20220325.0,20220401,20220401,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
206646351,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Arthropathy,,2022,Q2,1,I,,20220325.0,20220401,20220401,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
206646351,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Movement disorder,,2022,Q2,1,I,,20220325.0,20220401,20220401,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
206646351,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Headache,,2022,Q2,1,I,,20220325.0,20220401,20220401,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
206646351,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Therapeutic product effect decreased,,2022,Q2,1,I,,20220325.0,20220401,20220401,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
206646351,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Osteoarthritis,,2022,Q2,1,I,,20220325.0,20220401,20220401,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
206646351,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Drug intolerance,,2022,Q2,1,I,,20220325.0,20220401,20220401,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
206646351,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Dyspnoea,,2022,Q2,1,I,,20220325.0,20220401,20220401,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220401,,CN,CA,CA,2022,Q2,Elderly
206659521,20665952,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q2,Adverse event,,2022,Q2,1,I,,20220321.0,20220403,20220403,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-012208,BRISTOL MYERS SQUIBB,,51.0,YR,A,M,Y,89.81,KG,20220403,,HP,US,US,2022,Q2,Adult
206660911,20666091,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,209196.0,,,Solution for injection,,2022,Q2,Acute kidney injury,,2022,Q2,1,I,20220306.0,20220329.0,20220403,20220403,EXP,FR-AFSSAPS-AM20220794,FR-SANOFI US-2022SA111699,SANOFI AVENTIS,,89.0,YR,E,F,Y,96.2,KG,20220401,,MD,FR,FR,2022,Q2,Elderly
206660911,20666091,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,209196.0,,,Solution for injection,,2022,Q2,Renal tubular necrosis,,2022,Q2,1,I,20220306.0,20220329.0,20220403,20220403,EXP,FR-AFSSAPS-AM20220794,FR-SANOFI US-2022SA111699,SANOFI AVENTIS,,89.0,YR,E,F,Y,96.2,KG,20220401,,MD,FR,FR,2022,Q2,Elderly
206669241,20666924,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,100.0,ML,Unknown,,2022,Q2,Neuropathy peripheral,,2022,Q2,1,I,20210101.0,20220321.0,20220403,20220403,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20211107134,BRISTOL MYERS SQUIBB,,79.0,YR,E,F,Y,58.9,KG,20220404,,HP,US,US,2022,Q2,Elderly
206669241,20666924,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,100.0,ML,Unknown,,2022,Q2,Haemoglobin decreased,,2022,Q2,1,I,20210101.0,20220321.0,20220403,20220403,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20211107134,BRISTOL MYERS SQUIBB,,79.0,YR,E,F,Y,58.9,KG,20220404,,HP,US,US,2022,Q2,Elderly
206669241,20666924,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,100.0,ML,Unknown,,2022,Q2,Pruritus,,2022,Q2,1,I,20210101.0,20220321.0,20220403,20220403,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20211107134,BRISTOL MYERS SQUIBB,,79.0,YR,E,F,Y,58.9,KG,20220404,,HP,US,US,2022,Q2,Elderly
206669241,20666924,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,100.0,ML,Unknown,,2022,Q2,Constipation,,2022,Q2,1,I,20210101.0,20220321.0,20220403,20220403,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20211107134,BRISTOL MYERS SQUIBB,,79.0,YR,E,F,Y,58.9,KG,20220404,,HP,US,US,2022,Q2,Elderly
206669241,20666924,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,100.0,ML,Unknown,,2022,Q2,Full blood count abnormal,,2022,Q2,1,I,20210101.0,20220321.0,20220403,20220403,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20211107134,BRISTOL MYERS SQUIBB,,79.0,YR,E,F,Y,58.9,KG,20220404,,HP,US,US,2022,Q2,Elderly
206669241,20666924,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,100.0,ML,Unknown,,2022,Q2,Diarrhoea,,2022,Q2,1,I,20210101.0,20220321.0,20220403,20220403,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20211107134,BRISTOL MYERS SQUIBB,,79.0,YR,E,F,Y,58.9,KG,20220404,,HP,US,US,2022,Q2,Elderly
206669241,20666924,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,100.0,ML,Unknown,,2022,Q2,Headache,,2022,Q2,1,I,20210101.0,20220321.0,20220403,20220403,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20211107134,BRISTOL MYERS SQUIBB,,79.0,YR,E,F,Y,58.9,KG,20220404,,HP,US,US,2022,Q2,Elderly
206692032,20669203,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, TID (8 units)",,,U,,,,,,,,TID,2022,Q2,IgA nephropathy,,2022,Q2,2,F,20220319.0,20220407.0,20220404,20220414,EXP,,NVSC2022IN072660,NOVARTIS,,49.0,YR,,M,Y,,,20220414,,HP,IN,IN,2022,Q2,Adult
206692032,20669203,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, TID (8 units)",,,U,,,,,,,,TID,2022,Q2,Oedematous kidney,,2022,Q2,2,F,20220319.0,20220407.0,20220404,20220414,EXP,,NVSC2022IN072660,NOVARTIS,,49.0,YR,,M,Y,,,20220414,,HP,IN,IN,2022,Q2,Adult
206692032,20669203,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, TID (8 units)",,,U,,,,,,,,TID,2022,Q2,Blood creatinine increased,,2022,Q2,2,F,20220319.0,20220407.0,20220404,20220414,EXP,,NVSC2022IN072660,NOVARTIS,,49.0,YR,,M,Y,,,20220414,,HP,IN,IN,2022,Q2,Adult
206692032,20669203,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, TID (8 units)",,,U,,,,,,,,TID,2022,Q2,Kidney transplant rejection,,2022,Q2,2,F,20220319.0,20220407.0,20220404,20220414,EXP,,NVSC2022IN072660,NOVARTIS,,49.0,YR,,M,Y,,,20220414,,HP,IN,IN,2022,Q2,Adult
206692032,20669203,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, TID (8 units)",,,U,,,,,,,,TID,2022,Q2,Urine output decreased,,2022,Q2,2,F,20220319.0,20220407.0,20220404,20220414,EXP,,NVSC2022IN072660,NOVARTIS,,49.0,YR,,M,Y,,,20220414,,HP,IN,IN,2022,Q2,Adult
206692032,20669203,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, TID (8 units)",,,U,,,,,,,,TID,2022,Q2,Oedema peripheral,,2022,Q2,2,F,20220319.0,20220407.0,20220404,20220414,EXP,,NVSC2022IN072660,NOVARTIS,,49.0,YR,,M,Y,,,20220414,,HP,IN,IN,2022,Q2,Adult
206692032,20669203,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, TID (8 units)",,,U,,,,,,,,TID,2022,Q2,Hypotension,,2022,Q2,2,F,20220319.0,20220407.0,20220404,20220414,EXP,,NVSC2022IN072660,NOVARTIS,,49.0,YR,,M,Y,,,20220414,,HP,IN,IN,2022,Q2,Adult
206692032,20669203,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, TID (8 units)",,,U,,,,,,,,TID,2022,Q2,Arterial fibrosis,,2022,Q2,2,F,20220319.0,20220407.0,20220404,20220414,EXP,,NVSC2022IN072660,NOVARTIS,,49.0,YR,,M,Y,,,20220414,,HP,IN,IN,2022,Q2,Adult
206692032,20669203,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, TID (8 units)",,,U,,,,,,,,TID,2022,Q2,Tubulointerstitial nephritis,,2022,Q2,2,F,20220319.0,20220407.0,20220404,20220414,EXP,,NVSC2022IN072660,NOVARTIS,,49.0,YR,,M,Y,,,20220414,,HP,IN,IN,2022,Q2,Adult
206696641,20669664,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,White blood cell count decreased,,2022,Q2,1,I,20220101.0,20220330.0,20220404,20220404,EXP,,US-SA-2022SA113426,SANOFI AVENTIS,,65.0,YR,E,M,Y,101.0,KG,20220404,,MD,US,US,2022,Q2,Elderly
206696641,20669664,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,Catheter management,,2022,Q2,1,I,20220101.0,20220330.0,20220404,20220404,EXP,,US-SA-2022SA113426,SANOFI AVENTIS,,65.0,YR,E,M,Y,101.0,KG,20220404,,MD,US,US,2022,Q2,Elderly
206696641,20669664,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,Cardiac arrest,,2022,Q2,1,I,20220101.0,20220330.0,20220404,20220404,EXP,,US-SA-2022SA113426,SANOFI AVENTIS,,65.0,YR,E,M,Y,101.0,KG,20220404,,MD,US,US,2022,Q2,Elderly
206696641,20669664,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,COVID-19 pneumonia,,2022,Q2,1,I,20220101.0,20220330.0,20220404,20220404,EXP,,US-SA-2022SA113426,SANOFI AVENTIS,,65.0,YR,E,M,Y,101.0,KG,20220404,,MD,US,US,2022,Q2,Elderly
206696641,20669664,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,Tissue injury,,2022,Q2,1,I,20220101.0,20220330.0,20220404,20220404,EXP,,US-SA-2022SA113426,SANOFI AVENTIS,,65.0,YR,E,M,Y,101.0,KG,20220404,,MD,US,US,2022,Q2,Elderly
206696641,20669664,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,Sepsis syndrome,,2022,Q2,1,I,20220101.0,20220330.0,20220404,20220404,EXP,,US-SA-2022SA113426,SANOFI AVENTIS,,65.0,YR,E,M,Y,101.0,KG,20220404,,MD,US,US,2022,Q2,Elderly
206696641,20669664,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,Urinary tract infection,,2022,Q2,1,I,20220101.0,20220330.0,20220404,20220404,EXP,,US-SA-2022SA113426,SANOFI AVENTIS,,65.0,YR,E,M,Y,101.0,KG,20220404,,MD,US,US,2022,Q2,Elderly
206696641,20669664,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,Pyrexia,,2022,Q2,1,I,20220101.0,20220330.0,20220404,20220404,EXP,,US-SA-2022SA113426,SANOFI AVENTIS,,65.0,YR,E,M,Y,101.0,KG,20220404,,MD,US,US,2022,Q2,Elderly
206696641,20669664,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,Cough,,2022,Q2,1,I,20220101.0,20220330.0,20220404,20220404,EXP,,US-SA-2022SA113426,SANOFI AVENTIS,,65.0,YR,E,M,Y,101.0,KG,20220404,,MD,US,US,2022,Q2,Elderly
206696641,20669664,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,Urinary retention,,2022,Q2,1,I,20220101.0,20220330.0,20220404,20220404,EXP,,US-SA-2022SA113426,SANOFI AVENTIS,,65.0,YR,E,M,Y,101.0,KG,20220404,,MD,US,US,2022,Q2,Elderly
206696641,20669664,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,Erythema,,2022,Q2,1,I,20220101.0,20220330.0,20220404,20220404,EXP,,US-SA-2022SA113426,SANOFI AVENTIS,,65.0,YR,E,M,Y,101.0,KG,20220404,,MD,US,US,2022,Q2,Elderly
206705511,20670551,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 IU, TID ih",,,U,,,,,8.0,IU,Injection,TID,2022,Q2,Renal ischaemia,,2022,Q2,1,I,20210103.0,20220328.0,20220404,20220404,EXP,,NVSC2022CN075880,NOVARTIS,"Lu S, Li L, Wang S, Lu D, Pan D, Dou N. One case of acute kidney injury caused by dapagliflozin. CENTRAL SOUTH PHARMACY. 2022;20(3):712-4",55.0,YR,,F,Y,,,20220404,,HP,CN,CN,2022,Q2,Adult
206705511,20670551,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 IU, TID ih",,,U,,,,,8.0,IU,Injection,TID,2022,Q2,Drug interaction,,2022,Q2,1,I,20210103.0,20220328.0,20220404,20220404,EXP,,NVSC2022CN075880,NOVARTIS,"Lu S, Li L, Wang S, Lu D, Pan D, Dou N. One case of acute kidney injury caused by dapagliflozin. CENTRAL SOUTH PHARMACY. 2022;20(3):712-4",55.0,YR,,F,Y,,,20220404,,HP,CN,CN,2022,Q2,Adult
206705511,20670551,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 IU, TID ih",,,U,,,,,8.0,IU,Injection,TID,2022,Q2,Blood creatinine increased,,2022,Q2,1,I,20210103.0,20220328.0,20220404,20220404,EXP,,NVSC2022CN075880,NOVARTIS,"Lu S, Li L, Wang S, Lu D, Pan D, Dou N. One case of acute kidney injury caused by dapagliflozin. CENTRAL SOUTH PHARMACY. 2022;20(3):712-4",55.0,YR,,F,Y,,,20220404,,HP,CN,CN,2022,Q2,Adult
206806472,20680647,242,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Chronic kidney disease,,2022,Q2,2,F,20190906.0,20220413.0,20220406,20220422,EXP,,US-PFIZER INC-202200292259,PFIZER,,49.0,YR,,F,Y,,,20220422,,LW,US,US,2022,Q2,Adult
206806472,20680647,242,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,End stage renal disease,,2022,Q2,2,F,20190906.0,20220413.0,20220406,20220422,EXP,,US-PFIZER INC-202200292259,PFIZER,,49.0,YR,,F,Y,,,20220422,,LW,US,US,2022,Q2,Adult
206806472,20680647,242,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Acute kidney injury,,2022,Q2,2,F,20190906.0,20220413.0,20220406,20220422,EXP,,US-PFIZER INC-202200292259,PFIZER,,49.0,YR,,F,Y,,,20220422,,LW,US,US,2022,Q2,Adult
206833122,20683312,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,U,,,,,,,,2022,Q2,Drug reaction with eosinophilia and systemic symptoms,,2022,Q2,2,F,,20220414.0,20220407,20220426,EXP,,US-Renata Limited-2127488,RENATA LIMITED,"Khan N. Statin induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome via Annals of Allergy, Asthma and Immunology 127 (Suppl.): S63, No. 5, Nov 2021. http://doi.org/10.1016/j.anai.2021.08.194.",63.0,YR,,F,Y,,,20220426,,HP,US,US,2022,Q2,Adult
206850111,20685011,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,18.0kIU UNKNOWN,,,,,,,,18.0,KIU,,,2022,Q2,Melaena,,2022,Q2,1,I,,20220330.0,20220407,20220407,EXP,,IT-AstraZeneca-2022A131990,ASTRAZENECA,,72.0,YR,,F,Y,,,20220407,,MD,IT,,2022,Q2,Elderly
206850111,20685011,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,18.0kIU UNKNOWN,,,,,,,,18.0,KIU,,,2022,Q2,Anaemia,,2022,Q2,1,I,,20220330.0,20220407,20220407,EXP,,IT-AstraZeneca-2022A131990,ASTRAZENECA,,72.0,YR,,F,Y,,,20220407,,MD,IT,,2022,Q2,Elderly
206852265,20685226,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNK,,,,,,,,,,,,2022,Q2,Dyspnoea,,2022,Q2,5,F,20220402.0,20220510.0,20220407,20220511,PER,,US-AMGEN-USACT2022059516,AMGEN,,78.0,YR,E,M,Y,93.73,KG,20220511,,MD,US,US,2022,Q2,Elderly
206852265,20685226,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNK,,,,,,,,,,,,2022,Q2,Angina pectoris,,2022,Q2,5,F,20220402.0,20220510.0,20220407,20220511,PER,,US-AMGEN-USACT2022059516,AMGEN,,78.0,YR,E,M,Y,93.73,KG,20220511,,MD,US,US,2022,Q2,Elderly
206873281,20687328,2,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Subcutaneous,See narrative,,,U,,,,,,,Injection,,2022,Q2,Abdominal pain,,2022,Q2,1,I,,20220331.0,20220408,20220408,EXP,,JP-AstraZeneca-2022A137858,ASTRAZENECA,,68.0,YR,,F,Y,,,20220408,,MD,JP,,2022,Q2,Elderly
206873281,20687328,2,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Subcutaneous,See narrative,,,U,,,,,,,Injection,,2022,Q2,Decreased appetite,,2022,Q2,1,I,,20220331.0,20220408,20220408,EXP,,JP-AstraZeneca-2022A137858,ASTRAZENECA,,68.0,YR,,F,Y,,,20220408,,MD,JP,,2022,Q2,Elderly
206873281,20687328,2,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Subcutaneous,See narrative,,,U,,,,,,,Injection,,2022,Q2,Diarrhoea,,2022,Q2,1,I,,20220331.0,20220408,20220408,EXP,,JP-AstraZeneca-2022A137858,ASTRAZENECA,,68.0,YR,,F,Y,,,20220408,,MD,JP,,2022,Q2,Elderly
206873281,20687328,2,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Subcutaneous,See narrative,,,U,,,,,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,,20220331.0,20220408,20220408,EXP,,JP-AstraZeneca-2022A137858,ASTRAZENECA,,68.0,YR,,F,Y,,,20220408,,MD,JP,,2022,Q2,Elderly
206873281,20687328,2,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Subcutaneous,See narrative,,,U,,,,,,,Injection,,2022,Q2,Nausea,,2022,Q2,1,I,,20220331.0,20220408,20220408,EXP,,JP-AstraZeneca-2022A137858,ASTRAZENECA,,68.0,YR,,F,Y,,,20220408,,MD,JP,,2022,Q2,Elderly
206891261,20689126,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,16.0,KIU,,,2022,Q2,Thrombosis,,2022,Q2,1,I,20220129.0,20220401.0,20220408,20220408,EXP,IT-MINISAL02-844595,IT-Accord-260138,ACCORD,,64.0,YR,,M,Y,130.0,KG,20220408,,MD,IT,IT,2022,Q2,Adult
206891261,20689126,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,16.0,KIU,,,2022,Q2,Thrombocytopenia,,2022,Q2,1,I,20220129.0,20220401.0,20220408,20220408,EXP,IT-MINISAL02-844595,IT-Accord-260138,ACCORD,,64.0,YR,,M,Y,130.0,KG,20220408,,MD,IT,IT,2022,Q2,Adult
206891261,20689126,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,16.0,KIU,,,2022,Q2,Drug interaction,,2022,Q2,1,I,20220129.0,20220401.0,20220408,20220408,EXP,IT-MINISAL02-844595,IT-Accord-260138,ACCORD,,64.0,YR,,M,Y,130.0,KG,20220408,,MD,IT,IT,2022,Q2,Adult
206898372,20689837,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,34 units/day via insulin pump,,,D,,UNKNOWN,,,,,,,2022,Q2,Exposure during pregnancy,,2022,Q2,2,F,,20220407.0,20220408,20220420,EXP,,US-drreddys-LIT/USA/22/0148735,DR REDDYS,"Bayless D, Caldarera T, Harirah H. Autoimmune polyglandular syndrome type 2 in pregnancy: A case report and review of the literature. Case Reports in Perinatal Medicine. 2022;11(1):1-4. doi:10.1515/crpm-2020-0058",35.0,YR,A,F,Y,,,20220420,,HP,US,US,2022,Q2,Adult
206898372,20689837,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,34 units/day via insulin pump,,,D,,UNKNOWN,,,,,,,2022,Q2,Drug ineffective,,2022,Q2,2,F,,20220407.0,20220408,20220420,EXP,,US-drreddys-LIT/USA/22/0148735,DR REDDYS,"Bayless D, Caldarera T, Harirah H. Autoimmune polyglandular syndrome type 2 in pregnancy: A case report and review of the literature. Case Reports in Perinatal Medicine. 2022;11(1):1-4. doi:10.1515/crpm-2020-0058",35.0,YR,A,F,Y,,,20220420,,HP,US,US,2022,Q2,Adult
206914821,20691482,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,,,,,,Injection,,2022,Q2,Glycosylated haemoglobin increased,,2022,Q2,1,I,20210801.0,20220329.0,20220408,20220408,EXP,,US-ELI_LILLY_AND_COMPANY-US202204002858,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20220408,,CN,US,US,2022,Q2,Elderly
206914821,20691482,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,,,,,,Injection,,2022,Q2,Cataract,,2022,Q2,1,I,20210801.0,20220329.0,20220408,20220408,EXP,,US-ELI_LILLY_AND_COMPANY-US202204002858,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20220408,,CN,US,US,2022,Q2,Elderly
206914821,20691482,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,,,,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20210801.0,20220329.0,20220408,20220408,EXP,,US-ELI_LILLY_AND_COMPANY-US202204002858,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20220408,,CN,US,US,2022,Q2,Elderly
206914821,20691482,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,,,,,,Injection,,2022,Q2,COVID-19,,2022,Q2,1,I,20210801.0,20220329.0,20220408,20220408,EXP,,US-ELI_LILLY_AND_COMPANY-US202204002858,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20220408,,CN,US,US,2022,Q2,Elderly
206914821,20691482,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,,,,,,Injection,,2022,Q2,Glycosylated haemoglobin increased,,2022,Q2,1,I,20210801.0,20220329.0,20220408,20220408,EXP,,US-ELI_LILLY_AND_COMPANY-US202204002858,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20220408,,CN,US,US,2022,Q2,Elderly
206914821,20691482,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,,,,,,Injection,,2022,Q2,Cataract,,2022,Q2,1,I,20210801.0,20220329.0,20220408,20220408,EXP,,US-ELI_LILLY_AND_COMPANY-US202204002858,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20220408,,CN,US,US,2022,Q2,Elderly
206914821,20691482,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,,,,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20210801.0,20220329.0,20220408,20220408,EXP,,US-ELI_LILLY_AND_COMPANY-US202204002858,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20220408,,CN,US,US,2022,Q2,Elderly
206914821,20691482,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,U,,,,,,,Injection,,2022,Q2,COVID-19,,2022,Q2,1,I,20210801.0,20220329.0,20220408,20220408,EXP,,US-ELI_LILLY_AND_COMPANY-US202204002858,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20220408,,CN,US,US,2022,Q2,Elderly
206914821,20691482,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 u, tid",,,U,,D420813A,,,16.0,IU,Injection,TID,2022,Q2,Glycosylated haemoglobin increased,,2022,Q2,1,I,20210801.0,20220329.0,20220408,20220408,EXP,,US-ELI_LILLY_AND_COMPANY-US202204002858,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20220408,,CN,US,US,2022,Q2,Elderly
206914821,20691482,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 u, tid",,,U,,D420813A,,,16.0,IU,Injection,TID,2022,Q2,Cataract,,2022,Q2,1,I,20210801.0,20220329.0,20220408,20220408,EXP,,US-ELI_LILLY_AND_COMPANY-US202204002858,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20220408,,CN,US,US,2022,Q2,Elderly
206914821,20691482,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 u, tid",,,U,,D420813A,,,16.0,IU,Injection,TID,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20210801.0,20220329.0,20220408,20220408,EXP,,US-ELI_LILLY_AND_COMPANY-US202204002858,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20220408,,CN,US,US,2022,Q2,Elderly
206914821,20691482,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 u, tid",,,U,,D420813A,,,16.0,IU,Injection,TID,2022,Q2,COVID-19,,2022,Q2,1,I,20210801.0,20220329.0,20220408,20220408,EXP,,US-ELI_LILLY_AND_COMPANY-US202204002858,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20220408,,CN,US,US,2022,Q2,Elderly
206914821,20691482,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 u, tid",,,U,,D420813A,,,16.0,IU,Injection,TID,2022,Q2,Glycosylated haemoglobin increased,,2022,Q2,1,I,20210801.0,20220329.0,20220408,20220408,EXP,,US-ELI_LILLY_AND_COMPANY-US202204002858,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20220408,,CN,US,US,2022,Q2,Elderly
206914821,20691482,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 u, tid",,,U,,D420813A,,,16.0,IU,Injection,TID,2022,Q2,Cataract,,2022,Q2,1,I,20210801.0,20220329.0,20220408,20220408,EXP,,US-ELI_LILLY_AND_COMPANY-US202204002858,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20220408,,CN,US,US,2022,Q2,Elderly
206914821,20691482,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 u, tid",,,U,,D420813A,,,16.0,IU,Injection,TID,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20210801.0,20220329.0,20220408,20220408,EXP,,US-ELI_LILLY_AND_COMPANY-US202204002858,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20220408,,CN,US,US,2022,Q2,Elderly
206914821,20691482,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"16 u, tid",,,U,,D420813A,,,16.0,IU,Injection,TID,2022,Q2,COVID-19,,2022,Q2,1,I,20210801.0,20220329.0,20220408,20220408,EXP,,US-ELI_LILLY_AND_COMPANY-US202204002858,ELI LILLY AND CO,,80.0,YR,,M,Y,,,20220408,,CN,US,US,2022,Q2,Elderly
206917472,20691747,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,Injection,,2022,Q2,Dehydration,,2022,Q2,2,F,20211215.0,20220427.0,20220408,20220503,EXP,,JP-009507513-2203JPN001295J,MERCK,,56.0,YR,,F,Y,51.0,KG,20220503,,MD,JP,JP,2022,Q2,Adult
206917472,20691747,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,Injection,,2022,Q2,Adrenal insufficiency,,2022,Q2,2,F,20211215.0,20220427.0,20220408,20220503,EXP,,JP-009507513-2203JPN001295J,MERCK,,56.0,YR,,F,Y,51.0,KG,20220503,,MD,JP,JP,2022,Q2,Adult
206917472,20691747,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,Injection,,2022,Q2,Hyperkalaemia,,2022,Q2,2,F,20211215.0,20220427.0,20220408,20220503,EXP,,JP-009507513-2203JPN001295J,MERCK,,56.0,YR,,F,Y,51.0,KG,20220503,,MD,JP,JP,2022,Q2,Adult
206917472,20691747,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,Injection,,2022,Q2,Hypopituitarism,,2022,Q2,2,F,20211215.0,20220427.0,20220408,20220503,EXP,,JP-009507513-2203JPN001295J,MERCK,,56.0,YR,,F,Y,51.0,KG,20220503,,MD,JP,JP,2022,Q2,Adult
206948531,20694853,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, qd; administered via insulin pump (total of 34 units daily))",,,Y,U,,,,,,,QD,2022,Q2,Maternal exposure during pregnancy,,2022,Q2,1,I,,20220331.0,20220411,20220411,EXP,,US-MYLANLABS-2022M1025614,MYLAN,"Bayless DR, Caldarera TM, Harirah HM. Autoimmune polyglandular syndrome type 2 in pregnancy: A case report and review of the literature. Case-Rep-Perinat-Med 2022;11:No. 1.",35.0,YR,,F,Y,,,20220411,,MD,US,US,2022,Q2,Adult
206948531,20694853,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, qd; administered via insulin pump (total of 34 units daily))",,,Y,U,,,,,,,QD,2022,Q2,Drug ineffective,,2022,Q2,1,I,,20220331.0,20220411,20220411,EXP,,US-MYLANLABS-2022M1025614,MYLAN,"Bayless DR, Caldarera TM, Harirah HM. Autoimmune polyglandular syndrome type 2 in pregnancy: A case report and review of the literature. Case-Rep-Perinat-Med 2022;11:No. 1.",35.0,YR,,F,Y,,,20220411,,MD,US,US,2022,Q2,Adult
206951532,20695153,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,administered via insulin pump (total of 34 units daily),,,D,,Unknown,,,,,,,2022,Q2,Exposure during pregnancy,,2022,Q2,2,F,,20220427.0,20220411,20220510,PER,,US-LUPIN PHARMACEUTICALS INC.-2022-05295,LUPIN,"Bayless DR, Caldarera TM, Harirah HM. Autoimmune polyglandular syndrome type 2 in pregnancy: A case report and review of the literature. Case Reports in Perinatal Medicine. 2022;11(1):20200058:1-4",35.0,YR,,F,Y,,,20220510,,HP,US,US,2022,Q2,Adult
206951532,20695153,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,administered via insulin pump (total of 34 units daily),,,D,,Unknown,,,,,,,2022,Q2,Drug ineffective,,2022,Q2,2,F,,20220427.0,20220411,20220510,PER,,US-LUPIN PHARMACEUTICALS INC.-2022-05295,LUPIN,"Bayless DR, Caldarera TM, Harirah HM. Autoimmune polyglandular syndrome type 2 in pregnancy: A case report and review of the literature. Case Reports in Perinatal Medicine. 2022;11(1):20200058:1-4",35.0,YR,,F,Y,,,20220510,,HP,US,US,2022,Q2,Adult
206956351,20695635,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"12 u, unknown",,,,,D403916C,,20563.0,12.0,IU,Injection,,2022,Q2,Cerebrovascular accident,,2022,Q2,1,I,20211024.0,20220401.0,20220411,20220411,EXP,,US-ELI_LILLY_AND_COMPANY-US202204001600,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20220411,,CN,US,US,2022,Q2,Elderly
206977701,20697770,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,24 iu,,,D,,,,,24.0,IU,Solution for injection,,2022,Q2,Off label use,,2022,Q2,1,I,,20220405.0,20220411,20220411,PER,,US-SA-2022SA122002,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20220412,,CN,US,US,2022,Q2,Elderly
207003351,20700335,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency : As needed?,,,D,D,unk,,,40.0,IU,,PRN,2022,Q2,Incorrect dose administered,,2022,Q2,1,I,20220329.0,,20220410,20220410,DIR,610018,,FDA-CTU,,59.0,YR,,F,N,64.0,KG,20220410,N,PH,US,,2022,Q2,Adult
207009231,20700923,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q2,Product use in unapproved indication,,2022,Q2,1,I,20120103.0,20211018.0,20220412,20220412,PER,,US-ASTELLAS-2021US028147,ASTELLAS,,54.0,YR,,F,Y,56.0,KG,20220412,,CN,US,US,2022,Q2,Adult
207009231,20700923,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q2,Metastatic squamous cell carcinoma,,2022,Q2,1,I,20120103.0,20211018.0,20220412,20220412,PER,,US-ASTELLAS-2021US028147,ASTELLAS,,54.0,YR,,F,Y,56.0,KG,20220412,,CN,US,US,2022,Q2,Adult
207019912,20701991,38,C,INSULIN LISPRO 100 UNIT/ML SOLUTION PEN-INJECTOR,,2,Subcutaneous,UNKNOWN mL?Frequency : UNKNOWN,,,U,,,,,,,Unknown,,2022,Q2,Sepsis,,2022,Q2,2,F,20220329.0,20220510.0,20220412,20220520,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-014254,BRISTOL MYERS SQUIBB,,70.0,YR,E,M,Y,94.0,KG,20220520,,HP,US,US,2022,Q2,Elderly
207028752,20702875,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Parenteral,"morning:10unit, noon:7unit, evening:20unit, tid",,,,,,,,,,Injection,TID,2022,Q2,Hypernatraemia,,2022,Q2,2,F,,20220418.0,20220412,20220426,EXP,,JP-JNJFOC-20220421561,JOHNSON AND JOHNSON,,80.0,YR,E,M,Y,,,20220426,,MD,JP,JP,2022,Q2,Elderly
207028752,20702875,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Parenteral,"morning:10unit, noon:7unit, evening:20unit, tid",,,,,,,,,,Injection,TID,2022,Q2,Dehydration,,2022,Q2,2,F,,20220418.0,20220412,20220426,EXP,,JP-JNJFOC-20220421561,JOHNSON AND JOHNSON,,80.0,YR,E,M,Y,,,20220426,,MD,JP,JP,2022,Q2,Elderly
207028752,20702875,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Parenteral,"morning:10unit, noon:7unit, evening:20unit, tid",,,,,,,,,,Injection,TID,2022,Q2,Rhabdomyolysis,,2022,Q2,2,F,,20220418.0,20220412,20220426,EXP,,JP-JNJFOC-20220421561,JOHNSON AND JOHNSON,,80.0,YR,E,M,Y,,,20220426,,MD,JP,JP,2022,Q2,Elderly
207028752,20702875,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Parenteral,"morning:10unit, noon:7unit, evening:20unit, tid",,,,,,,,,,Injection,TID,2022,Q2,Cardiac failure acute,,2022,Q2,2,F,,20220418.0,20220412,20220426,EXP,,JP-JNJFOC-20220421561,JOHNSON AND JOHNSON,,80.0,YR,E,M,Y,,,20220426,,MD,JP,JP,2022,Q2,Elderly
207028752,20702875,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Parenteral,"morning:10unit, noon:7unit, evening:20unit, tid",,,,,,,,,,Injection,TID,2022,Q2,Diabetic ketoacidosis,,2022,Q2,2,F,,20220418.0,20220412,20220426,EXP,,JP-JNJFOC-20220421561,JOHNSON AND JOHNSON,,80.0,YR,E,M,Y,,,20220426,,MD,JP,JP,2022,Q2,Elderly
207046211,20704621,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,lispro 16-16-16,,,U,,,,,,,,,2022,Q2,Hypoglycaemia,,2022,Q2,1,I,20150101.0,20220407.0,20220413,20220413,EXP,,SK-MYLANLABS-2022M1026227,MYLAN,Galajda P.. How to minimize the risk of hypoglycemia. unk. 2022;E2:29-34,60.0,YR,,F,Y,,,20220413,,MD,SK,SK,2022,Q2,Adult
207046211,20704621,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,lispro 16-16-16,,,U,,,,,,,,,2022,Q2,Diabetes mellitus inadequate control,,2022,Q2,1,I,20150101.0,20220407.0,20220413,20220413,EXP,,SK-MYLANLABS-2022M1026227,MYLAN,Galajda P.. How to minimize the risk of hypoglycemia. unk. 2022;E2:29-34,60.0,YR,,F,Y,,,20220413,,MD,SK,SK,2022,Q2,Adult
207046211,20704621,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,lispro 16-16-16,,,U,,,,,,,,,2022,Q2,Weight increased,,2022,Q2,1,I,20150101.0,20220407.0,20220413,20220413,EXP,,SK-MYLANLABS-2022M1026227,MYLAN,Galajda P.. How to minimize the risk of hypoglycemia. unk. 2022;E2:29-34,60.0,YR,,F,Y,,,20220413,,MD,SK,SK,2022,Q2,Adult
207046211,20704621,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,lispro 16-16-16,,,U,,,,,,,,,2022,Q2,Hyperglycaemia,,2022,Q2,1,I,20150101.0,20220407.0,20220413,20220413,EXP,,SK-MYLANLABS-2022M1026227,MYLAN,Galajda P.. How to minimize the risk of hypoglycemia. unk. 2022;E2:29-34,60.0,YR,,F,Y,,,20220413,,MD,SK,SK,2022,Q2,Adult
207073102,20707310,5,C,INSULINE LISPRO,,1,,UNK,,,,,,,,,,,,2022,Q2,Immune-mediated hepatitis,,2022,Q2,2,F,20210923.0,20220421.0,20220413,20220427,EXP,,IT-MYLANLABS-2022M1026499,MYLAN,,45.0,YR,,F,Y,65.0,KG,20220427,,MD,IT,IT,2022,Q2,Adult
207079781,20707978,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,,,20563.0,8.0,IU,Injection,TID,2022,Q2,Product dose omission issue,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,,,20563.0,8.0,IU,Injection,TID,2022,Q2,Asthenia,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,,,20563.0,8.0,IU,Injection,TID,2022,Q2,Fatigue,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,,,20563.0,8.0,IU,Injection,TID,2022,Q2,Dizziness,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,,,20563.0,8.0,IU,Injection,TID,2022,Q2,COVID-19,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,,,20563.0,8.0,IU,Injection,TID,2022,Q2,Migraine,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,,,20563.0,8.0,IU,Injection,TID,2022,Q2,Nausea,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,,,20563.0,8.0,IU,Injection,TID,2022,Q2,Product dose omission issue,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,,,20563.0,8.0,IU,Injection,TID,2022,Q2,Asthenia,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,,,20563.0,8.0,IU,Injection,TID,2022,Q2,Fatigue,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,,,20563.0,8.0,IU,Injection,TID,2022,Q2,Dizziness,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,,,20563.0,8.0,IU,Injection,TID,2022,Q2,COVID-19,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,,,20563.0,8.0,IU,Injection,TID,2022,Q2,Migraine,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,,,20563.0,8.0,IU,Injection,TID,2022,Q2,Nausea,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,D456541A,,20563.0,8.0,IU,Injection,TID,2022,Q2,Product dose omission issue,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,D456541A,,20563.0,8.0,IU,Injection,TID,2022,Q2,Asthenia,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,D456541A,,20563.0,8.0,IU,Injection,TID,2022,Q2,Fatigue,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,D456541A,,20563.0,8.0,IU,Injection,TID,2022,Q2,Dizziness,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,D456541A,,20563.0,8.0,IU,Injection,TID,2022,Q2,COVID-19,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,D456541A,,20563.0,8.0,IU,Injection,TID,2022,Q2,Migraine,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,D456541A,,20563.0,8.0,IU,Injection,TID,2022,Q2,Nausea,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,D456541A,,20563.0,8.0,IU,Injection,TID,2022,Q2,Product dose omission issue,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,D456541A,,20563.0,8.0,IU,Injection,TID,2022,Q2,Asthenia,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,D456541A,,20563.0,8.0,IU,Injection,TID,2022,Q2,Fatigue,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,D456541A,,20563.0,8.0,IU,Injection,TID,2022,Q2,Dizziness,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,D456541A,,20563.0,8.0,IU,Injection,TID,2022,Q2,COVID-19,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,D456541A,,20563.0,8.0,IU,Injection,TID,2022,Q2,Migraine,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207079781,20707978,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,U,,D456541A,,20563.0,8.0,IU,Injection,TID,2022,Q2,Nausea,,2022,Q2,1,I,20220101.0,20220317.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008253,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207080181,20708018,1,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, daily (before each meal)",,,,,D341139A,,,10.0,IU,Injection,QD,2022,Q2,Drug ineffective,,2022,Q2,1,I,20211201.0,20220315.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203007032,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Elderly
207080181,20708018,1,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, daily (before each meal)",,,,,D341139A,,,10.0,IU,Injection,QD,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20211201.0,20220315.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203007032,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Elderly
207080181,20708018,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, prn (10-12 u sliding scale at night)",,,,,D341139A,,,12.0,IU,Injection,,2022,Q2,Drug ineffective,,2022,Q2,1,I,20211201.0,20220315.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203007032,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Elderly
207080181,20708018,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, prn (10-12 u sliding scale at night)",,,,,D341139A,,,12.0,IU,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20211201.0,20220315.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203007032,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220414,,CN,US,US,2022,Q2,Elderly
207081681,20708168,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D395986A,,20563.0,,,Injection,,2022,Q2,Visual impairment,,2022,Q2,1,I,20210101.0,20220318.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203009003,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20220414,,CN,US,US,2022,Q2,Elderly
207081681,20708168,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D395986A,,20563.0,,,Injection,,2022,Q2,Wrong technique in product usage process,,2022,Q2,1,I,20210101.0,20220318.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203009003,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20220414,,CN,US,US,2022,Q2,Elderly
207081681,20708168,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D395986A,,20563.0,,,Injection,,2022,Q2,COVID-19,,2022,Q2,1,I,20210101.0,20220318.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203009003,ELI LILLY AND CO,,67.0,YR,,M,Y,,,20220414,,CN,US,US,2022,Q2,Elderly
207089071,20708907,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, daily",,,,,D420814A,,20563.0,12.0,IU,Injection,QD,2022,Q2,Incorrect dose administered,,2022,Q2,1,I,20220317.0,20220318.0,20220414,20220414,PER,,US-ELI_LILLY_AND_COMPANY-US202203008727,ELI LILLY AND CO,,60.0,YR,,M,Y,,,20220414,,CN,US,US,2022,Q2,Adult
207098102,20709810,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2022,Q2,Acute kidney injury,,2022,Q2,2,F,20220306.0,20220408.0,20220414,20220415,EXP,FR-AFSSAPS-AM20220794,FR-PFIZER INC-202200536010,PFIZER,,89.0,YR,,F,Y,96.2,KG,20220415,,MD,FR,FR,2022,Q2,Elderly
207098102,20709810,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2022,Q2,Renal tubular necrosis,,2022,Q2,2,F,20220306.0,20220408.0,20220414,20220415,EXP,FR-AFSSAPS-AM20220794,FR-PFIZER INC-202200536010,PFIZER,,89.0,YR,,F,Y,96.2,KG,20220415,,MD,FR,FR,2022,Q2,Elderly
207098141,20709814,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Gait disturbance,,2022,Q2,1,I,20220324.0,,20220413,20220413,DIR,610407,,FDA-CTU,,41.0,YR,,F,N,85.5,KG,20220413,N,CN,US,,2022,Q2,Adult
207098141,20709814,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Pain in extremity,,2022,Q2,1,I,20220324.0,,20220413,20220413,DIR,610407,,FDA-CTU,,41.0,YR,,F,N,85.5,KG,20220413,N,CN,US,,2022,Q2,Adult
207098141,20709814,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Pain in extremity,,2022,Q2,1,I,20220324.0,,20220413,20220413,DIR,610407,,FDA-CTU,,41.0,YR,,F,N,85.5,KG,20220413,N,CN,US,,2022,Q2,Adult
207123863,20712386,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 UNK,,,,,,,,,,,,2022,Q2,COVID-19 pneumonia,,2022,Q2,3,F,20211223.0,20220525.0,20220415,20220526,PER,,IT-AMGEN-ITACT2021206230,AMGEN,,77.0,YR,E,M,Y,76.0,KG,20220526,,MD,IT,IT,2022,Q2,Elderly
207126141,20712614,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"13 u, ih",,,U,,,,,13.0,IU,Injection,,2022,Q2,Drug ineffective,,2022,Q2,1,I,,20220404.0,20220415,20220415,EXP,,CN-ALS-000653,ALIGNSCIENCE PHARMA,,65.0,YR,E,M,Y,68.0,KG,20220415,,HP,CN,CN,2022,Q2,Elderly
207132441,20713244,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q2,Renal tubular necrosis,,2022,Q2,1,I,20220306.0,20220407.0,20220415,20220415,EXP,FR-AFSSAPS-AM20220794,FR-BAUSCH-BL-2022-008746,BAUSCH AND LOMB,,89.0,YR,,F,Y,96.2,KG,20220415,,MD,FR,FR,2022,Q2,Elderly
207132441,20713244,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q2,Acute kidney injury,,2022,Q2,1,I,20220306.0,20220407.0,20220415,20220415,EXP,FR-AFSSAPS-AM20220794,FR-BAUSCH-BL-2022-008746,BAUSCH AND LOMB,,89.0,YR,,F,Y,96.2,KG,20220415,,MD,FR,FR,2022,Q2,Elderly
207138931,20713893,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,insulin pump (total of 34 units daily),,,U,,,,,,,,,2022,Q2,Exposure during pregnancy,,2022,Q2,1,I,,20220331.0,20220415,20220415,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-332954,RANBAXY,"Bayless DR, Caldarera TM, Harirah HM. Autoimmune polyglandular syndrome type 2 in pregnancy: A case report and review of the literature. Case Rep Perinat Med. 2022;11(1):20200058",35.0,YR,,F,Y,,,20220415,,HP,US,US,2022,Q2,Adult
207138931,20713893,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,insulin pump (total of 34 units daily),,,U,,,,,,,,,2022,Q2,Eclampsia,,2022,Q2,1,I,,20220331.0,20220415,20220415,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-332954,RANBAXY,"Bayless DR, Caldarera TM, Harirah HM. Autoimmune polyglandular syndrome type 2 in pregnancy: A case report and review of the literature. Case Rep Perinat Med. 2022;11(1):20200058",35.0,YR,,F,Y,,,20220415,,HP,US,US,2022,Q2,Adult
207138931,20713893,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,insulin pump (total of 34 units daily),,,U,,,,,,,,,2022,Q2,Premature delivery,,2022,Q2,1,I,,20220331.0,20220415,20220415,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-332954,RANBAXY,"Bayless DR, Caldarera TM, Harirah HM. Autoimmune polyglandular syndrome type 2 in pregnancy: A case report and review of the literature. Case Rep Perinat Med. 2022;11(1):20200058",35.0,YR,,F,Y,,,20220415,,HP,US,US,2022,Q2,Adult
207138931,20713893,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,insulin pump (total of 34 units daily),,,U,,,,,,,,,2022,Q2,Live birth,,2022,Q2,1,I,,20220331.0,20220415,20220415,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-332954,RANBAXY,"Bayless DR, Caldarera TM, Harirah HM. Autoimmune polyglandular syndrome type 2 in pregnancy: A case report and review of the literature. Case Rep Perinat Med. 2022;11(1):20200058",35.0,YR,,F,Y,,,20220415,,HP,US,US,2022,Q2,Adult
207140071,20714007,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Product formulation issue,,2022,Q2,1,I,20220322.0,,20220415,20220415,DIR,FDA-CDER-CTU-2022-28963,,FDA-CTU,,27.0,YR,,F,N,27.0,KG,20220331,N,PH,US,,2022,Q2,Young Adult
207140071,20714007,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Cachexia,,2022,Q2,1,I,20220322.0,,20220415,20220415,DIR,FDA-CDER-CTU-2022-28963,,FDA-CTU,,27.0,YR,,F,N,27.0,KG,20220331,N,PH,US,,2022,Q2,Young Adult
207140071,20714007,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Clostridium difficile infection,,2022,Q2,1,I,20220322.0,,20220415,20220415,DIR,FDA-CDER-CTU-2022-28963,,FDA-CTU,,27.0,YR,,F,N,27.0,KG,20220331,N,PH,US,,2022,Q2,Young Adult
207140071,20714007,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Oral candidiasis,,2022,Q2,1,I,20220322.0,,20220415,20220415,DIR,FDA-CDER-CTU-2022-28963,,FDA-CTU,,27.0,YR,,F,N,27.0,KG,20220331,N,PH,US,,2022,Q2,Young Adult
207141731,20714173,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Vasoplegia syndrome,,2022,Q2,1,I,20220405.0,,20220415,20220415,DIR,610464,,FDA-CTU,,61.0,YR,,F,N,118.0,KG,20220415,N,PH,US,,2022,Q2,Adult
207141731,20714173,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Bundle branch block left,,2022,Q2,1,I,20220405.0,,20220415,20220415,DIR,610464,,FDA-CTU,,61.0,YR,,F,N,118.0,KG,20220415,N,PH,US,,2022,Q2,Adult
207141731,20714173,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Cardio-respiratory arrest,,2022,Q2,1,I,20220405.0,,20220415,20220415,DIR,610464,,FDA-CTU,,61.0,YR,,F,N,118.0,KG,20220415,N,PH,US,,2022,Q2,Adult
207141731,20714173,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Anaphylactic shock,,2022,Q2,1,I,20220405.0,,20220415,20220415,DIR,610464,,FDA-CTU,,61.0,YR,,F,N,118.0,KG,20220415,N,PH,US,,2022,Q2,Adult
207141731,20714173,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Cardiac arrest,,2022,Q2,1,I,20220405.0,,20220415,20220415,DIR,610464,,FDA-CTU,,61.0,YR,,F,N,118.0,KG,20220415,N,PH,US,,2022,Q2,Adult
207170641,20717064,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,Strength: 75-25 kwikpen,,,U,,,,,,,,,2022,Q2,Abdominal pain,,2022,Q2,1,I,,20220407.0,20220417,20220417,PER,,US-SA-2022SA130281,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20220417,,MD,US,US,2022,Q2,Elderly
207170641,20717064,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,Strength: 75-25 kwikpen,,,U,,,,,,,,,2022,Q2,Abdominal discomfort,,2022,Q2,1,I,,20220407.0,20220417,20220417,PER,,US-SA-2022SA130281,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20220417,,MD,US,US,2022,Q2,Elderly
207170641,20717064,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,Strength: 75-25 kwikpen,,,U,,,,,,,,,2022,Q2,Pruritus,,2022,Q2,1,I,,20220407.0,20220417,20220417,PER,,US-SA-2022SA130281,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20220417,,MD,US,US,2022,Q2,Elderly
207215591,20721559,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Low Dose,,,,,,,,,,,Q4H,2022,Q2,Bradyphrenia,,2022,Q2,1,I,20200101.0,20220412.0,20220418,20220418,EXP,,US-BAUSCH-BL-2020-012298,BAUSCH AND LOMB,,68.0,YR,,F,Y,,,20220418,,CN,US,US,2022,Q2,Elderly
207215591,20721559,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Low Dose,,,,,,,,,,,Q4H,2022,Q2,Intentional product use issue,,2022,Q2,1,I,20200101.0,20220412.0,20220418,20220418,EXP,,US-BAUSCH-BL-2020-012298,BAUSCH AND LOMB,,68.0,YR,,F,Y,,,20220418,,CN,US,US,2022,Q2,Elderly
207215591,20721559,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Low Dose,,,,,,,,,,,Q4H,2022,Q2,Mental status changes,,2022,Q2,1,I,20200101.0,20220412.0,20220418,20220418,EXP,,US-BAUSCH-BL-2020-012298,BAUSCH AND LOMB,,68.0,YR,,F,Y,,,20220418,,CN,US,US,2022,Q2,Elderly
207215591,20721559,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Low Dose,,,,,,,,,,,Q4H,2022,Q2,Constipation,,2022,Q2,1,I,20200101.0,20220412.0,20220418,20220418,EXP,,US-BAUSCH-BL-2020-012298,BAUSCH AND LOMB,,68.0,YR,,F,Y,,,20220418,,CN,US,US,2022,Q2,Elderly
207215591,20721559,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Low Dose,,,,,,,,,,,Q4H,2022,Q2,Ammonia increased,,2022,Q2,1,I,20200101.0,20220412.0,20220418,20220418,EXP,,US-BAUSCH-BL-2020-012298,BAUSCH AND LOMB,,68.0,YR,,F,Y,,,20220418,,CN,US,US,2022,Q2,Elderly
207215591,20721559,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Low Dose,,,,,,,,,,,Q4H,2022,Q2,Insurance issue,,2022,Q2,1,I,20200101.0,20220412.0,20220418,20220418,EXP,,US-BAUSCH-BL-2020-012298,BAUSCH AND LOMB,,68.0,YR,,F,Y,,,20220418,,CN,US,US,2022,Q2,Elderly
207215591,20721559,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Low Dose,,,,,,,,,,,Q4H,2022,Q2,Gait disturbance,,2022,Q2,1,I,20200101.0,20220412.0,20220418,20220418,EXP,,US-BAUSCH-BL-2020-012298,BAUSCH AND LOMB,,68.0,YR,,F,Y,,,20220418,,CN,US,US,2022,Q2,Elderly
207215591,20721559,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Low Dose,,,,,,,,,,,Q4H,2022,Q2,Slow speech,,2022,Q2,1,I,20200101.0,20220412.0,20220418,20220418,EXP,,US-BAUSCH-BL-2020-012298,BAUSCH AND LOMB,,68.0,YR,,F,Y,,,20220418,,CN,US,US,2022,Q2,Elderly
207215591,20721559,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Low Dose,,,,,,,,,,,Q4H,2022,Q2,Confusional state,,2022,Q2,1,I,20200101.0,20220412.0,20220418,20220418,EXP,,US-BAUSCH-BL-2020-012298,BAUSCH AND LOMB,,68.0,YR,,F,Y,,,20220418,,CN,US,US,2022,Q2,Elderly
207233911,20723391,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Respiratory (inhalation),,,,,,,,,,,,,2022,Q2,Arrhythmia,,2022,Q2,1,I,20201101.0,20220415.0,20220419,20220419,EXP,,CN-ROCHE-2725053,ROCHE,,58.0,YR,,M,Y,55.6,KG,20220419,,MD,CN,,2022,Q2,Adult
207252851,20725285,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (3-7 units)",,,U,,D371840A,,20563.0,,,Injection,,2022,Q2,Blood pressure decreased,,2022,Q2,1,I,20220418.0,20220418.0,20220419,20220419,PER,,US-ELI_LILLY_AND_COMPANY-US202204008537,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20220419,,CN,US,US,2022,Q2,Elderly
207252851,20725285,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (3-7 units)",,,U,,D371840A,,20563.0,,,Injection,,2022,Q2,Blood glucose decreased,,2022,Q2,1,I,20220418.0,20220418.0,20220419,20220419,PER,,US-ELI_LILLY_AND_COMPANY-US202204008537,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20220419,,CN,US,US,2022,Q2,Elderly
207252851,20725285,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (3-7 units)",,,U,,D371840A,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220418.0,20220418.0,20220419,20220419,PER,,US-ELI_LILLY_AND_COMPANY-US202204008537,ELI LILLY AND CO,,80.0,YR,,F,Y,,,20220419,,CN,US,US,2022,Q2,Elderly
207285763,20728576,68,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q6hr",,,,,,,,,,,Q6H,2022,Q2,Hypocalcaemia,,2022,Q2,3,F,20220211.0,20220619.0,20220420,20220624,EXP,,US-TAKEDA-2022TUS023827,TAKEDA,,70.0,YR,,F,Y,,,20220624,,HP,US,US,2022,Q2,Elderly
207285763,20728576,68,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q6hr",,,,,,,,,,,Q6H,2022,Q2,Thrombocytopenia,,2022,Q2,3,F,20220211.0,20220619.0,20220420,20220624,EXP,,US-TAKEDA-2022TUS023827,TAKEDA,,70.0,YR,,F,Y,,,20220624,,HP,US,US,2022,Q2,Elderly
207285763,20728576,68,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q6hr",,,,,,,,,,,Q6H,2022,Q2,Hypomagnesaemia,,2022,Q2,3,F,20220211.0,20220619.0,20220420,20220624,EXP,,US-TAKEDA-2022TUS023827,TAKEDA,,70.0,YR,,F,Y,,,20220624,,HP,US,US,2022,Q2,Elderly
207285763,20728576,68,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q6hr",,,,,,,,,,,Q6H,2022,Q2,Anaemia,,2022,Q2,3,F,20220211.0,20220619.0,20220420,20220624,EXP,,US-TAKEDA-2022TUS023827,TAKEDA,,70.0,YR,,F,Y,,,20220624,,HP,US,US,2022,Q2,Elderly
207290181,20729018,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2022,Q2,Acute kidney injury,,2022,Q2,1,I,20220306.0,20220405.0,20220420,20220420,EXP,,FR-MALLINCKRODT-T202201879,MALLINCKRODT,,89.0,YR,,F,Y,,,20220420,,MD,FR,FR,2022,Q2,Elderly
207290181,20729018,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2022,Q2,Renal tubular necrosis,,2022,Q2,1,I,20220306.0,20220405.0,20220420,20220420,EXP,,FR-MALLINCKRODT-T202201879,MALLINCKRODT,,89.0,YR,,F,Y,,,20220420,,MD,FR,FR,2022,Q2,Elderly
207300583,20730058,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 units with breakfast, lunch, dinner, TID (till review)",,,U,,,,,,,,TID,2022,Q2,Thrombosis,,2022,Q2,3,F,20220331.0,20220502.0,20220420,20220526,EXP,,NVSC2022IN089609,NOVARTIS,,51.0,YR,,M,Y,,,20220526,,CN,IN,IN,2022,Q2,Adult
207300583,20730058,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 units with breakfast, lunch, dinner, TID (till review)",,,U,,,,,,,,TID,2022,Q2,Blood creatinine increased,,2022,Q2,3,F,20220331.0,20220502.0,20220420,20220526,EXP,,NVSC2022IN089609,NOVARTIS,,51.0,YR,,M,Y,,,20220526,,CN,IN,IN,2022,Q2,Adult
207300583,20730058,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 units with breakfast, lunch, dinner, TID (till review)",,,U,,,,,,,,TID,2022,Q2,Capillaritis,,2022,Q2,3,F,20220331.0,20220502.0,20220420,20220526,EXP,,NVSC2022IN089609,NOVARTIS,,51.0,YR,,M,Y,,,20220526,,CN,IN,IN,2022,Q2,Adult
207300583,20730058,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 units with breakfast, lunch, dinner, TID (till review)",,,U,,,,,,,,TID,2022,Q2,Glomerulonephritis,,2022,Q2,3,F,20220331.0,20220502.0,20220420,20220526,EXP,,NVSC2022IN089609,NOVARTIS,,51.0,YR,,M,Y,,,20220526,,CN,IN,IN,2022,Q2,Adult
207300583,20730058,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 units with breakfast, lunch, dinner, TID (till review)",,,U,,,,,,,,TID,2022,Q2,Inflammation,,2022,Q2,3,F,20220331.0,20220502.0,20220420,20220526,EXP,,NVSC2022IN089609,NOVARTIS,,51.0,YR,,M,Y,,,20220526,,CN,IN,IN,2022,Q2,Adult
207300583,20730058,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 units with breakfast, lunch, dinner, TID (till review)",,,U,,,,,,,,TID,2022,Q2,Arteritis,,2022,Q2,3,F,20220331.0,20220502.0,20220420,20220526,EXP,,NVSC2022IN089609,NOVARTIS,,51.0,YR,,M,Y,,,20220526,,CN,IN,IN,2022,Q2,Adult
207300583,20730058,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 units with breakfast, lunch, dinner, TID (till review)",,,U,,,,,,,,TID,2022,Q2,Oedematous kidney,,2022,Q2,3,F,20220331.0,20220502.0,20220420,20220526,EXP,,NVSC2022IN089609,NOVARTIS,,51.0,YR,,M,Y,,,20220526,,CN,IN,IN,2022,Q2,Adult
207300583,20730058,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 units with breakfast, lunch, dinner, TID (till review)",,,U,,,,,,,,TID,2022,Q2,Kidney congestion,,2022,Q2,3,F,20220331.0,20220502.0,20220420,20220526,EXP,,NVSC2022IN089609,NOVARTIS,,51.0,YR,,M,Y,,,20220526,,CN,IN,IN,2022,Q2,Adult
207300583,20730058,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 units with breakfast, lunch, dinner, TID (till review)",,,U,,,,,,,,TID,2022,Q2,Tubulointerstitial nephritis,,2022,Q2,3,F,20220331.0,20220502.0,20220420,20220526,EXP,,NVSC2022IN089609,NOVARTIS,,51.0,YR,,M,Y,,,20220526,,CN,IN,IN,2022,Q2,Adult
207300583,20730058,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 units with breakfast, lunch, dinner, TID (till review)",,,U,,,,,,,,TID,2022,Q2,Kidney transplant rejection,,2022,Q2,3,F,20220331.0,20220502.0,20220420,20220526,EXP,,NVSC2022IN089609,NOVARTIS,,51.0,YR,,M,Y,,,20220526,,CN,IN,IN,2022,Q2,Adult
207300583,20730058,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 units with breakfast, lunch, dinner, TID (till review)",,,U,,,,,,,,TID,2022,Q2,Tissue infiltration,,2022,Q2,3,F,20220331.0,20220502.0,20220420,20220526,EXP,,NVSC2022IN089609,NOVARTIS,,51.0,YR,,M,Y,,,20220526,,CN,IN,IN,2022,Q2,Adult
207312914,20731291,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, q6hr",,,,,,,,1.0,IU,,Q6H,2022,Q2,Pleural effusion,,2022,Q2,4,F,20220211.0,20220623.0,20220420,20220627,EXP,,US-TAKEDA-2022TUS023839,TAKEDA,,70.0,YR,,F,Y,28.57,KG,20220627,,MD,US,US,2022,Q2,Elderly
207312914,20731291,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, q6hr",,,,,,,,1.0,IU,,Q6H,2022,Q2,Alkalosis,,2022,Q2,4,F,20220211.0,20220623.0,20220420,20220627,EXP,,US-TAKEDA-2022TUS023839,TAKEDA,,70.0,YR,,F,Y,28.57,KG,20220627,,MD,US,US,2022,Q2,Elderly
207312914,20731291,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, q6hr",,,,,,,,1.0,IU,,Q6H,2022,Q2,Tachycardia,,2022,Q2,4,F,20220211.0,20220623.0,20220420,20220627,EXP,,US-TAKEDA-2022TUS023839,TAKEDA,,70.0,YR,,F,Y,28.57,KG,20220627,,MD,US,US,2022,Q2,Elderly
207312914,20731291,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, q6hr",,,,,,,,1.0,IU,,Q6H,2022,Q2,Sepsis,,2022,Q2,4,F,20220211.0,20220623.0,20220420,20220627,EXP,,US-TAKEDA-2022TUS023839,TAKEDA,,70.0,YR,,F,Y,28.57,KG,20220627,,MD,US,US,2022,Q2,Elderly
207312914,20731291,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, q6hr",,,,,,,,1.0,IU,,Q6H,2022,Q2,Hypoxia,,2022,Q2,4,F,20220211.0,20220623.0,20220420,20220627,EXP,,US-TAKEDA-2022TUS023839,TAKEDA,,70.0,YR,,F,Y,28.57,KG,20220627,,MD,US,US,2022,Q2,Elderly
207312914,20731291,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, q6hr",,,,,,,,1.0,IU,,Q6H,2022,Q2,Hypertransaminasaemia,,2022,Q2,4,F,20220211.0,20220623.0,20220420,20220627,EXP,,US-TAKEDA-2022TUS023839,TAKEDA,,70.0,YR,,F,Y,28.57,KG,20220627,,MD,US,US,2022,Q2,Elderly
207343733,20734373,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"1 DF, QD",,,,,,,,,,,QD,2022,Q2,Gastrointestinal disorder,,2022,Q2,3,F,20220223.0,20220602.0,20220421,20220607,EXP,IT-MINISAL02-860575,IT-SA-2022SA140621,SANOFI AVENTIS,,73.0,YR,E,M,Y,,,20220608,,PH,IT,IT,2022,Q2,Elderly
207343733,20734373,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"1 DF, QD",,,,,,,,,,,QD,2022,Q2,Hyperglycaemia,,2022,Q2,3,F,20220223.0,20220602.0,20220421,20220607,EXP,IT-MINISAL02-860575,IT-SA-2022SA140621,SANOFI AVENTIS,,73.0,YR,E,M,Y,,,20220608,,PH,IT,IT,2022,Q2,Elderly
207343733,20734373,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"1 DF, QD",,,,,,,,,,,QD,2022,Q2,Medication error,,2022,Q2,3,F,20220223.0,20220602.0,20220421,20220607,EXP,IT-MINISAL02-860575,IT-SA-2022SA140621,SANOFI AVENTIS,,73.0,YR,E,M,Y,,,20220608,,PH,IT,IT,2022,Q2,Elderly
207343733,20734373,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"1 DF, QD",,,,,,,,,,,QD,2022,Q2,Anaemia,,2022,Q2,3,F,20220223.0,20220602.0,20220421,20220607,EXP,IT-MINISAL02-860575,IT-SA-2022SA140621,SANOFI AVENTIS,,73.0,YR,E,M,Y,,,20220608,,PH,IT,IT,2022,Q2,Elderly
207349941,20734994,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,UNKNOWN,,,,,Solution for injection,,2022,Q2,Acute kidney injury,,2022,Q2,1,I,20220306.0,20220411.0,20220421,20220421,EXP,FR-AFSSAPS-AM20220794,FR-Fresenius Kabi-FK202204393,FRESENIUS KABI,,89.0,YR,,F,Y,96.2,KG,20220421,,HP,NL,,2022,Q2,Elderly
207349941,20734994,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,UNKNOWN,,,,,Solution for injection,,2022,Q2,Renal tubular necrosis,,2022,Q2,1,I,20220306.0,20220411.0,20220421,20220421,EXP,FR-AFSSAPS-AM20220794,FR-Fresenius Kabi-FK202204393,FRESENIUS KABI,,89.0,YR,,F,Y,96.2,KG,20220421,,HP,NL,,2022,Q2,Elderly
207364082,20736408,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,4 international unit,,,,,,,,4.0,IU,,,2022,Q2,Therapy non-responder,,2022,Q2,2,F,,20220526.0,20220421,20220602,EXP,,CA-TAKEDA-2022TUS026362,TAKEDA,,20.0,YR,,F,Y,47.0,KG,20220602,,CN,CA,CA,2022,Q2,Youth
207364082,20736408,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10 international unit,,,,,,,,10.0,IU,,,2022,Q2,Therapy non-responder,,2022,Q2,2,F,,20220526.0,20220421,20220602,EXP,,CA-TAKEDA-2022TUS026362,TAKEDA,,20.0,YR,,F,Y,47.0,KG,20220602,,CN,CA,CA,2022,Q2,Youth
207364082,20736408,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,6 international unit,,,,,,,,6.0,IU,,,2022,Q2,Therapy non-responder,,2022,Q2,2,F,,20220526.0,20220421,20220602,EXP,,CA-TAKEDA-2022TUS026362,TAKEDA,,20.0,YR,,F,Y,47.0,KG,20220602,,CN,CA,CA,2022,Q2,Youth
207364082,20736408,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 international unit, qd",,,,,,,,2.0,IU,,QD,2022,Q2,Therapy non-responder,,2022,Q2,2,F,,20220526.0,20220421,20220602,EXP,,CA-TAKEDA-2022TUS026362,TAKEDA,,20.0,YR,,F,Y,47.0,KG,20220602,,CN,CA,CA,2022,Q2,Youth
207364082,20736408,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 international unit, qd",,,,,,,,5.0,IU,,QD,2022,Q2,Therapy non-responder,,2022,Q2,2,F,,20220526.0,20220421,20220602,EXP,,CA-TAKEDA-2022TUS026362,TAKEDA,,20.0,YR,,F,Y,47.0,KG,20220602,,CN,CA,CA,2022,Q2,Youth
207364082,20736408,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 international unit, qd",,,,,,,,8.0,IU,,QD,2022,Q2,Therapy non-responder,,2022,Q2,2,F,,20220526.0,20220421,20220602,EXP,,CA-TAKEDA-2022TUS026362,TAKEDA,,20.0,YR,,F,Y,47.0,KG,20220602,,CN,CA,CA,2022,Q2,Youth
207364082,20736408,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3 international unit,,,,,,,,3.0,IU,,,2022,Q2,Therapy non-responder,,2022,Q2,2,F,,20220526.0,20220421,20220602,EXP,,CA-TAKEDA-2022TUS026362,TAKEDA,,20.0,YR,,F,Y,47.0,KG,20220602,,CN,CA,CA,2022,Q2,Youth
207364082,20736408,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"7 international unit, qd",,,,,,,,7.0,IU,,QD,2022,Q2,Therapy non-responder,,2022,Q2,2,F,,20220526.0,20220421,20220602,EXP,,CA-TAKEDA-2022TUS026362,TAKEDA,,20.0,YR,,F,Y,47.0,KG,20220602,,CN,CA,CA,2022,Q2,Youth
207364082,20736408,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 international unit, qd",,,,,,,,1.0,IU,,QD,2022,Q2,Therapy non-responder,,2022,Q2,2,F,,20220526.0,20220421,20220602,EXP,,CA-TAKEDA-2022TUS026362,TAKEDA,,20.0,YR,,F,Y,47.0,KG,20220602,,CN,CA,CA,2022,Q2,Youth
207364082,20736408,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,9 international unit,,,,,,,,9.0,IU,,,2022,Q2,Therapy non-responder,,2022,Q2,2,F,,20220526.0,20220421,20220602,EXP,,CA-TAKEDA-2022TUS026362,TAKEDA,,20.0,YR,,F,Y,47.0,KG,20220602,,CN,CA,CA,2022,Q2,Youth
207364562,20736456,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Frequency text: not provided,,,U,,,,,,,Unknown,,2022,Q2,COVID-19 pneumonia,,2022,Q2,2,F,20211223.0,20220526.0,20220421,20220607,EXP,,IT-BRISTOL-MYERS SQUIBB COMPANY-ITA-20211209711,BRISTOL MYERS SQUIBB,,77.0,YR,E,M,Y,76.0,KG,20220607,,HP,IT,IT,2022,Q2,Elderly
207375801,20737580,5,C,insulin lispro SC pen,,2,,,,,,,,,,,,,,2022,Q2,Death,,2022,Q2,1,I,20220314.0,20220408.0,20220422,20220422,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-020426,BRISTOL MYERS SQUIBB,,51.0,YR,A,F,Y,65.77,KG,20220422,,HP,US,US,2022,Q2,Adult
207375801,20737580,5,C,insulin lispro SC pen,,2,,,,,,,,,,,,,,2022,Q2,Adverse event,,2022,Q2,1,I,20220314.0,20220408.0,20220422,20220422,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-020426,BRISTOL MYERS SQUIBB,,51.0,YR,A,F,Y,65.77,KG,20220422,,HP,US,US,2022,Q2,Adult
207375801,20737580,5,C,insulin lispro SC pen,,2,,,,,,,,,,,,,,2022,Q2,Off label use,,2022,Q2,1,I,20220314.0,20220408.0,20220422,20220422,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-020426,BRISTOL MYERS SQUIBB,,51.0,YR,A,F,Y,65.77,KG,20220422,,HP,US,US,2022,Q2,Adult
207405831,20740583,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2022,Q2,Hyperglycaemia,,2022,Q2,1,I,20211203.0,20220408.0,20220422,20220422,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-2022-019923,BRISTOL MYERS SQUIBB,,74.0,YR,E,M,Y,96.0,KG,20220422,,HP,BR,BR,2022,Q2,Elderly
207405831,20740583,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,,,2022,Q2,Hyperglycaemia,,2022,Q2,1,I,20211203.0,20220408.0,20220422,20220422,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-2022-019923,BRISTOL MYERS SQUIBB,,74.0,YR,E,M,Y,96.0,KG,20220422,,HP,BR,BR,2022,Q2,Elderly
207411502,20741150,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Immune effector cell-associated neurotoxicity syndrome,,2022,Q2,2,F,20220406.0,20220504.0,20220422,20220512,PER,,US-GILEAD-2022-0578645,GILEAD,,58.0,YR,A,M,Y,72.9,KG,20220512,,HP,US,US,2022,Q2,Adult
207411502,20741150,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Cytokine release syndrome,,2022,Q2,2,F,20220406.0,20220504.0,20220422,20220512,PER,,US-GILEAD-2022-0578645,GILEAD,,58.0,YR,A,M,Y,72.9,KG,20220512,,HP,US,US,2022,Q2,Adult
207418971,20741897,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2022,Q2,Injection site pain,,2022,Q2,1,I,20211201.0,20220420.0,20220423,20220423,PER,,US-ELI_LILLY_AND_COMPANY-US202204009806,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220423,,CN,US,US,2022,Q2,Elderly
207418971,20741897,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2022,Q2,Incorrect product administration duration,,2022,Q2,1,I,20211201.0,20220420.0,20220423,20220423,PER,,US-ELI_LILLY_AND_COMPANY-US202204009806,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220423,,CN,US,US,2022,Q2,Elderly
207418971,20741897,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2022,Q2,Drug ineffective,,2022,Q2,1,I,20211201.0,20220420.0,20220423,20220423,PER,,US-ELI_LILLY_AND_COMPANY-US202204009806,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220423,,CN,US,US,2022,Q2,Elderly
207418971,20741897,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2022,Q2,Memory impairment,,2022,Q2,1,I,20211201.0,20220420.0,20220423,20220423,PER,,US-ELI_LILLY_AND_COMPANY-US202204009806,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220423,,CN,US,US,2022,Q2,Elderly
207418971,20741897,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20211201.0,20220420.0,20220423,20220423,PER,,US-ELI_LILLY_AND_COMPANY-US202204009806,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220423,,CN,US,US,2022,Q2,Elderly
207418971,20741897,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2022,Q2,Blood glucose decreased,,2022,Q2,1,I,20211201.0,20220420.0,20220423,20220423,PER,,US-ELI_LILLY_AND_COMPANY-US202204009806,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220423,,CN,US,US,2022,Q2,Elderly
207418971,20741897,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Injection,,2022,Q2,Frustration tolerance decreased,,2022,Q2,1,I,20211201.0,20220420.0,20220423,20220423,PER,,US-ELI_LILLY_AND_COMPANY-US202204009806,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220423,,CN,US,US,2022,Q2,Elderly
207418971,20741897,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D371840A,,,,,Injection,,2022,Q2,Injection site pain,,2022,Q2,1,I,20211201.0,20220420.0,20220423,20220423,PER,,US-ELI_LILLY_AND_COMPANY-US202204009806,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220423,,CN,US,US,2022,Q2,Elderly
207418971,20741897,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D371840A,,,,,Injection,,2022,Q2,Incorrect product administration duration,,2022,Q2,1,I,20211201.0,20220420.0,20220423,20220423,PER,,US-ELI_LILLY_AND_COMPANY-US202204009806,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220423,,CN,US,US,2022,Q2,Elderly
207418971,20741897,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D371840A,,,,,Injection,,2022,Q2,Drug ineffective,,2022,Q2,1,I,20211201.0,20220420.0,20220423,20220423,PER,,US-ELI_LILLY_AND_COMPANY-US202204009806,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220423,,CN,US,US,2022,Q2,Elderly
207418971,20741897,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D371840A,,,,,Injection,,2022,Q2,Memory impairment,,2022,Q2,1,I,20211201.0,20220420.0,20220423,20220423,PER,,US-ELI_LILLY_AND_COMPANY-US202204009806,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220423,,CN,US,US,2022,Q2,Elderly
207418971,20741897,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D371840A,,,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20211201.0,20220420.0,20220423,20220423,PER,,US-ELI_LILLY_AND_COMPANY-US202204009806,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220423,,CN,US,US,2022,Q2,Elderly
207418971,20741897,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D371840A,,,,,Injection,,2022,Q2,Blood glucose decreased,,2022,Q2,1,I,20211201.0,20220420.0,20220423,20220423,PER,,US-ELI_LILLY_AND_COMPANY-US202204009806,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220423,,CN,US,US,2022,Q2,Elderly
207418971,20741897,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D371840A,,,,,Injection,,2022,Q2,Frustration tolerance decreased,,2022,Q2,1,I,20211201.0,20220420.0,20220423,20220423,PER,,US-ELI_LILLY_AND_COMPANY-US202204009806,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220423,,CN,US,US,2022,Q2,Elderly
207428421,20742842,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Drug ineffective,,2022,Q2,1,I,20220223.0,20220420.0,20220424,20220424,EXP,,BR-ABBVIE-22K-020-4338244-00,ABBVIE,,47.0,YR,,F,Y,90.0,KG,20220424,,CN,COUNTRY NOT SPECIFIED,BR,2022,Q2,Adult
207428421,20742842,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Hypophagia,,2022,Q2,1,I,20220223.0,20220420.0,20220424,20220424,EXP,,BR-ABBVIE-22K-020-4338244-00,ABBVIE,,47.0,YR,,F,Y,90.0,KG,20220424,,CN,COUNTRY NOT SPECIFIED,BR,2022,Q2,Adult
207428421,20742842,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Peripheral swelling,,2022,Q2,1,I,20220223.0,20220420.0,20220424,20220424,EXP,,BR-ABBVIE-22K-020-4338244-00,ABBVIE,,47.0,YR,,F,Y,90.0,KG,20220424,,CN,COUNTRY NOT SPECIFIED,BR,2022,Q2,Adult
207428421,20742842,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Decreased appetite,,2022,Q2,1,I,20220223.0,20220420.0,20220424,20220424,EXP,,BR-ABBVIE-22K-020-4338244-00,ABBVIE,,47.0,YR,,F,Y,90.0,KG,20220424,,CN,COUNTRY NOT SPECIFIED,BR,2022,Q2,Adult
207428421,20742842,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,COVID-19,,2022,Q2,1,I,20220223.0,20220420.0,20220424,20220424,EXP,,BR-ABBVIE-22K-020-4338244-00,ABBVIE,,47.0,YR,,F,Y,90.0,KG,20220424,,CN,COUNTRY NOT SPECIFIED,BR,2022,Q2,Adult
207428421,20742842,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Psoriasis,,2022,Q2,1,I,20220223.0,20220420.0,20220424,20220424,EXP,,BR-ABBVIE-22K-020-4338244-00,ABBVIE,,47.0,YR,,F,Y,90.0,KG,20220424,,CN,COUNTRY NOT SPECIFIED,BR,2022,Q2,Adult
207428421,20742842,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Pain in extremity,,2022,Q2,1,I,20220223.0,20220420.0,20220424,20220424,EXP,,BR-ABBVIE-22K-020-4338244-00,ABBVIE,,47.0,YR,,F,Y,90.0,KG,20220424,,CN,COUNTRY NOT SPECIFIED,BR,2022,Q2,Adult
207428421,20742842,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Loss of personal independence in daily activities,,2022,Q2,1,I,20220223.0,20220420.0,20220424,20220424,EXP,,BR-ABBVIE-22K-020-4338244-00,ABBVIE,,47.0,YR,,F,Y,90.0,KG,20220424,,CN,COUNTRY NOT SPECIFIED,BR,2022,Q2,Adult
207428421,20742842,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Arthralgia,,2022,Q2,1,I,20220223.0,20220420.0,20220424,20220424,EXP,,BR-ABBVIE-22K-020-4338244-00,ABBVIE,,47.0,YR,,F,Y,90.0,KG,20220424,,CN,COUNTRY NOT SPECIFIED,BR,2022,Q2,Adult
207428421,20742842,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Hypoglycaemia,,2022,Q2,1,I,20220223.0,20220420.0,20220424,20220424,EXP,,BR-ABBVIE-22K-020-4338244-00,ABBVIE,,47.0,YR,,F,Y,90.0,KG,20220424,,CN,COUNTRY NOT SPECIFIED,BR,2022,Q2,Adult
207446241,20744624,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,Unknown,,,,,Injection,,2022,Q2,Diplopia,,2022,Q2,1,I,20220323.0,20220413.0,20220425,20220425,EXP,,US-GRANULES-US-2022GRASPO00083,GRANULES INDIA,,63.0,YR,A,F,Y,211.0,KG,20220425,,CN,US,US,2022,Q2,Adult
207446241,20744624,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,Unknown,,,,,Injection,,2022,Q2,Vision blurred,,2022,Q2,1,I,20220323.0,20220413.0,20220425,20220425,EXP,,US-GRANULES-US-2022GRASPO00083,GRANULES INDIA,,63.0,YR,A,F,Y,211.0,KG,20220425,,CN,US,US,2022,Q2,Adult
207446241,20744624,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,Unknown,,,,,Injection,,2022,Q2,Eye pain,,2022,Q2,1,I,20220323.0,20220413.0,20220425,20220425,EXP,,US-GRANULES-US-2022GRASPO00083,GRANULES INDIA,,63.0,YR,A,F,Y,211.0,KG,20220425,,CN,US,US,2022,Q2,Adult
207446241,20744624,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,Unknown,,,,,Injection,,2022,Q2,Exophthalmos,,2022,Q2,1,I,20220323.0,20220413.0,20220425,20220425,EXP,,US-GRANULES-US-2022GRASPO00083,GRANULES INDIA,,63.0,YR,A,F,Y,211.0,KG,20220425,,CN,US,US,2022,Q2,Adult
207455491,20745549,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Anal incontinence,,2022,Q2,1,I,20220322.0,,20220425,20220425,DIR,FDA-CDER-CTU-2022-31407,,FDA-CTU,,27.0,YR,,F,N,,,20220425,N,HP,US,,2022,Q2,Young Adult
207455491,20745549,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Therapeutic product effect incomplete,,2022,Q2,1,I,20220322.0,,20220425,20220425,DIR,FDA-CDER-CTU-2022-31407,,FDA-CTU,,27.0,YR,,F,N,,,20220425,N,HP,US,,2022,Q2,Young Adult
207455491,20745549,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Anal incontinence,,2022,Q2,1,I,20220322.0,,20220425,20220425,DIR,FDA-CDER-CTU-2022-31407,,FDA-CTU,,27.0,YR,,F,N,,,20220425,N,HP,US,,2022,Q2,Young Adult
207455491,20745549,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Therapeutic product effect incomplete,,2022,Q2,1,I,20220322.0,,20220425,20220425,DIR,FDA-CDER-CTU-2022-31407,,FDA-CTU,,27.0,YR,,F,N,,,20220425,N,HP,US,,2022,Q2,Young Adult
207477571,20747757,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,209196.0,,,,,2022,Q2,Injection site atrophy,,2022,Q2,1,I,,20220412.0,20220425,20220425,EXP,,CN-SA-2022SA130925,SANOFI AVENTIS,"Lu L, Lingling X, Yuxiu L.. Insulin hypersensitivity with lipoatrophy and exogenous insulin autoimmune syndrome?a case report.. Chin J Intern Med.. 2020;59(10):813-5",34.0,YR,A,M,Y,,,20220426,,HP,CN,CN,2022,Q2,Young Adult
207477571,20747757,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,209196.0,,,,,2022,Q2,Insulin autoimmune syndrome,,2022,Q2,1,I,,20220412.0,20220425,20220425,EXP,,CN-SA-2022SA130925,SANOFI AVENTIS,"Lu L, Lingling X, Yuxiu L.. Insulin hypersensitivity with lipoatrophy and exogenous insulin autoimmune syndrome?a case report.. Chin J Intern Med.. 2020;59(10):813-5",34.0,YR,A,M,Y,,,20220426,,HP,CN,CN,2022,Q2,Young Adult
207477571,20747757,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,209196.0,,,,,2022,Q2,Rash,,2022,Q2,1,I,,20220412.0,20220425,20220425,EXP,,CN-SA-2022SA130925,SANOFI AVENTIS,"Lu L, Lingling X, Yuxiu L.. Insulin hypersensitivity with lipoatrophy and exogenous insulin autoimmune syndrome?a case report.. Chin J Intern Med.. 2020;59(10):813-5",34.0,YR,A,M,Y,,,20220426,,HP,CN,CN,2022,Q2,Young Adult
207477571,20747757,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,209196.0,,,,,2022,Q2,Pruritus,,2022,Q2,1,I,,20220412.0,20220425,20220425,EXP,,CN-SA-2022SA130925,SANOFI AVENTIS,"Lu L, Lingling X, Yuxiu L.. Insulin hypersensitivity with lipoatrophy and exogenous insulin autoimmune syndrome?a case report.. Chin J Intern Med.. 2020;59(10):813-5",34.0,YR,A,M,Y,,,20220426,,HP,CN,CN,2022,Q2,Young Adult
207477571,20747757,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,209196.0,,,,,2022,Q2,Drug hypersensitivity,,2022,Q2,1,I,,20220412.0,20220425,20220425,EXP,,CN-SA-2022SA130925,SANOFI AVENTIS,"Lu L, Lingling X, Yuxiu L.. Insulin hypersensitivity with lipoatrophy and exogenous insulin autoimmune syndrome?a case report.. Chin J Intern Med.. 2020;59(10):813-5",34.0,YR,A,M,Y,,,20220426,,HP,CN,CN,2022,Q2,Young Adult
207477571,20747757,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,pump,,,Y,Y,,,,,,,,2022,Q2,Injection site atrophy,,2022,Q2,1,I,,20220412.0,20220425,20220425,EXP,,CN-SA-2022SA130925,SANOFI AVENTIS,"Lu L, Lingling X, Yuxiu L.. Insulin hypersensitivity with lipoatrophy and exogenous insulin autoimmune syndrome?a case report.. Chin J Intern Med.. 2020;59(10):813-5",34.0,YR,A,M,Y,,,20220426,,HP,CN,CN,2022,Q2,Young Adult
207477571,20747757,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,pump,,,Y,Y,,,,,,,,2022,Q2,Insulin autoimmune syndrome,,2022,Q2,1,I,,20220412.0,20220425,20220425,EXP,,CN-SA-2022SA130925,SANOFI AVENTIS,"Lu L, Lingling X, Yuxiu L.. Insulin hypersensitivity with lipoatrophy and exogenous insulin autoimmune syndrome?a case report.. Chin J Intern Med.. 2020;59(10):813-5",34.0,YR,A,M,Y,,,20220426,,HP,CN,CN,2022,Q2,Young Adult
207477571,20747757,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,pump,,,Y,Y,,,,,,,,2022,Q2,Rash,,2022,Q2,1,I,,20220412.0,20220425,20220425,EXP,,CN-SA-2022SA130925,SANOFI AVENTIS,"Lu L, Lingling X, Yuxiu L.. Insulin hypersensitivity with lipoatrophy and exogenous insulin autoimmune syndrome?a case report.. Chin J Intern Med.. 2020;59(10):813-5",34.0,YR,A,M,Y,,,20220426,,HP,CN,CN,2022,Q2,Young Adult
207477571,20747757,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,pump,,,Y,Y,,,,,,,,2022,Q2,Pruritus,,2022,Q2,1,I,,20220412.0,20220425,20220425,EXP,,CN-SA-2022SA130925,SANOFI AVENTIS,"Lu L, Lingling X, Yuxiu L.. Insulin hypersensitivity with lipoatrophy and exogenous insulin autoimmune syndrome?a case report.. Chin J Intern Med.. 2020;59(10):813-5",34.0,YR,A,M,Y,,,20220426,,HP,CN,CN,2022,Q2,Young Adult
207477571,20747757,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,pump,,,Y,Y,,,,,,,,2022,Q2,Drug hypersensitivity,,2022,Q2,1,I,,20220412.0,20220425,20220425,EXP,,CN-SA-2022SA130925,SANOFI AVENTIS,"Lu L, Lingling X, Yuxiu L.. Insulin hypersensitivity with lipoatrophy and exogenous insulin autoimmune syndrome?a case report.. Chin J Intern Med.. 2020;59(10):813-5",34.0,YR,A,M,Y,,,20220426,,HP,CN,CN,2022,Q2,Young Adult
207480652,20748065,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"7 u, each morning  (sliding scale)",,,,,D361915C,,,7.0,IU,Injection,QD,2022,Q2,Incorrect dose administered,,2022,Q2,2,F,20220404.0,20220509.0,20220426,20220608,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20220608,,CN,US,US,2022,Q2,Adult
207480652,20748065,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"7 u, each morning  (sliding scale)",,,,,D361915C,,,7.0,IU,Injection,QD,2022,Q2,Blood glucose increased,,2022,Q2,2,F,20220404.0,20220509.0,20220426,20220608,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20220608,,CN,US,US,2022,Q2,Adult
207480652,20748065,3,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"4 u, bid (at lunch and dinner)  (sliding scale)",,,,,D361915C,,,4.0,IU,Injection,BID,2022,Q2,Incorrect dose administered,,2022,Q2,2,F,20220404.0,20220509.0,20220426,20220608,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20220608,,CN,US,US,2022,Q2,Adult
207480652,20748065,3,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"4 u, bid (at lunch and dinner)  (sliding scale)",,,,,D361915C,,,4.0,IU,Injection,BID,2022,Q2,Blood glucose increased,,2022,Q2,2,F,20220404.0,20220509.0,20220426,20220608,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20220608,,CN,US,US,2022,Q2,Adult
207480652,20748065,4,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"6.5 u, unknown  (sliding scale)",,,,,D361915C,,,6.5,IU,Injection,,2022,Q2,Incorrect dose administered,,2022,Q2,2,F,20220404.0,20220509.0,20220426,20220608,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20220608,,CN,US,US,2022,Q2,Adult
207480652,20748065,4,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"6.5 u, unknown  (sliding scale)",,,,,D361915C,,,6.5,IU,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,2,F,20220404.0,20220509.0,20220426,20220608,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20220608,,CN,US,US,2022,Q2,Adult
207480652,20748065,5,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D385999S,,,,,Injection,,2022,Q2,Incorrect dose administered,,2022,Q2,2,F,20220404.0,20220509.0,20220426,20220608,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20220608,,CN,US,US,2022,Q2,Adult
207480652,20748065,5,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D385999S,,,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,2,F,20220404.0,20220509.0,20220426,20220608,PER,,US-ELI_LILLY_AND_COMPANY-US202204003346,ELI LILLY AND CO,,46.0,YR,,F,Y,,,20220608,,CN,US,US,2022,Q2,Adult
207490521,20749052,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 u, unknown (30-40 units on average)",,,U,,D261904A,,20563.0,40.0,IU,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220416.0,20220419.0,20220426,20220426,PER,,US-ELI_LILLY_AND_COMPANY-US202204010575,ELI LILLY AND CO,,11.0,YR,,M,Y,,,20220426,,CN,US,US,2022,Q2,Child
207491273,20749127,112,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q4hr",,,,,,,,,,,Q4H,2022,Q2,Hypotension,,2022,Q2,3,F,20220226.0,20220623.0,20220426,20220629,EXP,,US-TAKEDA-2022TUS025564,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20220629,,MD,US,US,2022,Q2,Elderly
207491273,20749127,112,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q4hr",,,,,,,,,,,Q4H,2022,Q2,Fall,,2022,Q2,3,F,20220226.0,20220623.0,20220426,20220629,EXP,,US-TAKEDA-2022TUS025564,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20220629,,MD,US,US,2022,Q2,Elderly
207491273,20749127,112,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q4hr",,,,,,,,,,,Q4H,2022,Q2,Diverticulum,,2022,Q2,3,F,20220226.0,20220623.0,20220426,20220629,EXP,,US-TAKEDA-2022TUS025564,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20220629,,MD,US,US,2022,Q2,Elderly
207491273,20749127,112,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q4hr",,,,,,,,,,,Q4H,2022,Q2,Stenotrophomonas infection,,2022,Q2,3,F,20220226.0,20220623.0,20220426,20220629,EXP,,US-TAKEDA-2022TUS025564,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20220629,,MD,US,US,2022,Q2,Elderly
207491273,20749127,112,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q4hr",,,,,,,,,,,Q4H,2022,Q2,Electrocardiogram QT prolonged,,2022,Q2,3,F,20220226.0,20220623.0,20220426,20220629,EXP,,US-TAKEDA-2022TUS025564,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20220629,,MD,US,US,2022,Q2,Elderly
207491273,20749127,112,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q4hr",,,,,,,,,,,Q4H,2022,Q2,Hypoalbuminaemia,,2022,Q2,3,F,20220226.0,20220623.0,20220426,20220629,EXP,,US-TAKEDA-2022TUS025564,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20220629,,MD,US,US,2022,Q2,Elderly
207491273,20749127,112,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q4hr",,,,,,,,,,,Q4H,2022,Q2,Bacteraemia,,2022,Q2,3,F,20220226.0,20220623.0,20220426,20220629,EXP,,US-TAKEDA-2022TUS025564,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20220629,,MD,US,US,2022,Q2,Elderly
207491273,20749127,112,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q4hr",,,,,,,,,,,Q4H,2022,Q2,Serratia infection,,2022,Q2,3,F,20220226.0,20220623.0,20220426,20220629,EXP,,US-TAKEDA-2022TUS025564,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20220629,,MD,US,US,2022,Q2,Elderly
207491273,20749127,112,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q4hr",,,,,,,,,,,Q4H,2022,Q2,Aspartate aminotransferase increased,,2022,Q2,3,F,20220226.0,20220623.0,20220426,20220629,EXP,,US-TAKEDA-2022TUS025564,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20220629,,MD,US,US,2022,Q2,Elderly
207491273,20749127,112,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q4hr",,,,,,,,,,,Q4H,2022,Q2,Hypercapnia,,2022,Q2,3,F,20220226.0,20220623.0,20220426,20220629,EXP,,US-TAKEDA-2022TUS025564,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20220629,,MD,US,US,2022,Q2,Elderly
207491273,20749127,112,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q4hr",,,,,,,,,,,Q4H,2022,Q2,Hypokalaemia,,2022,Q2,3,F,20220226.0,20220623.0,20220426,20220629,EXP,,US-TAKEDA-2022TUS025564,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20220629,,MD,US,US,2022,Q2,Elderly
207491273,20749127,112,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q4hr",,,,,,,,,,,Q4H,2022,Q2,Melaena,,2022,Q2,3,F,20220226.0,20220623.0,20220426,20220629,EXP,,US-TAKEDA-2022TUS025564,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20220629,,MD,US,US,2022,Q2,Elderly
207491273,20749127,112,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q4hr",,,,,,,,,,,Q4H,2022,Q2,Klebsiella infection,,2022,Q2,3,F,20220226.0,20220623.0,20220426,20220629,EXP,,US-TAKEDA-2022TUS025564,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20220629,,MD,US,US,2022,Q2,Elderly
207494092,20749409,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID(1 Unit Dial, 0-7 units)",,,U,,,,,,,,TID,2022,Q2,Peripheral swelling,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID(1 Unit Dial, 0-7 units)",,,U,,,,,,,,TID,2022,Q2,Ventricular hypokinesia,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID(1 Unit Dial, 0-7 units)",,,U,,,,,,,,TID,2022,Q2,Dyspnoea,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID(1 Unit Dial, 0-7 units)",,,U,,,,,,,,TID,2022,Q2,Orthopnoea,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID(1 Unit Dial, 0-7 units)",,,U,,,,,,,,TID,2022,Q2,Cardiac failure,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID(1 Unit Dial, 0-7 units)",,,U,,,,,,,,TID,2022,Q2,Fatigue,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID(1 Unit Dial, 0-7 units)",,,U,,,,,,,,TID,2022,Q2,Weight increased,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID(1 Unit Dial, 0-7 units)",,,U,,,,,,,,TID,2022,Q2,Hypoxia,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID(1 Unit Dial, 0-7 units)",,,U,,,,,,,,TID,2022,Q2,Product supply issue,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID(1 Unit Dial, 0-7 units)",,,U,,,,,,,,TID,2022,Q2,Fluid retention,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID(1 Unit Dial, 0-7 units)",,,U,,,,,,,,TID,2022,Q2,Weight decreased,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID(1 Unit Dial, 0-7 units)",,,U,,,,,,,,TID,2022,Q2,Left ventricular dilatation,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID(1 Unit Dial, 0-7 units)",,,U,,,,,,,,TID,2022,Q2,Inferior vena cava dilatation,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID(1 Unit Dial, 0-7 units)",,,U,,,,,,,,TID,2022,Q2,Left ventricular dysfunction,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,39,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, TID(1 Unit Dial, 0-7 units)",,,U,,,,,,,,TID,2022,Q2,Gout,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, QD (1 Unit Dial, 0-4 units)",,,U,,,,,,,,QD,2022,Q2,Peripheral swelling,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, QD (1 Unit Dial, 0-4 units)",,,U,,,,,,,,QD,2022,Q2,Ventricular hypokinesia,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, QD (1 Unit Dial, 0-4 units)",,,U,,,,,,,,QD,2022,Q2,Dyspnoea,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, QD (1 Unit Dial, 0-4 units)",,,U,,,,,,,,QD,2022,Q2,Orthopnoea,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, QD (1 Unit Dial, 0-4 units)",,,U,,,,,,,,QD,2022,Q2,Cardiac failure,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, QD (1 Unit Dial, 0-4 units)",,,U,,,,,,,,QD,2022,Q2,Fatigue,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, QD (1 Unit Dial, 0-4 units)",,,U,,,,,,,,QD,2022,Q2,Weight increased,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, QD (1 Unit Dial, 0-4 units)",,,U,,,,,,,,QD,2022,Q2,Hypoxia,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, QD (1 Unit Dial, 0-4 units)",,,U,,,,,,,,QD,2022,Q2,Product supply issue,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, QD (1 Unit Dial, 0-4 units)",,,U,,,,,,,,QD,2022,Q2,Fluid retention,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, QD (1 Unit Dial, 0-4 units)",,,U,,,,,,,,QD,2022,Q2,Weight decreased,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, QD (1 Unit Dial, 0-4 units)",,,U,,,,,,,,QD,2022,Q2,Left ventricular dilatation,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, QD (1 Unit Dial, 0-4 units)",,,U,,,,,,,,QD,2022,Q2,Inferior vena cava dilatation,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, QD (1 Unit Dial, 0-4 units)",,,U,,,,,,,,QD,2022,Q2,Left ventricular dysfunction,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207494092,20749409,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, QD (1 Unit Dial, 0-4 units)",,,U,,,,,,,,QD,2022,Q2,Gout,,2022,Q2,2,F,20220417.0,20220527.0,20220426,20220603,EXP,,NVSC2022US092137,NOVARTIS,,53.0,YR,,M,Y,,,20220603,,CN,US,US,2022,Q2,Adult
207581991,20758199,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q2,Vertigo,,2022,Q2,1,I,20220410.0,20220419.0,20220427,20220427,EXP,IT-MINISAL02-861774,NVSC2022IT091912,NOVARTIS,,80.0,YR,,F,Y,,,20220427,,PH,IT,IT,2022,Q2,Elderly
207581991,20758199,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q2,Paraesthesia,,2022,Q2,1,I,20220410.0,20220419.0,20220427,20220427,EXP,IT-MINISAL02-861774,NVSC2022IT091912,NOVARTIS,,80.0,YR,,F,Y,,,20220427,,PH,IT,IT,2022,Q2,Elderly
207581991,20758199,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q2,Headache,,2022,Q2,1,I,20220410.0,20220419.0,20220427,20220427,EXP,IT-MINISAL02-861774,NVSC2022IT091912,NOVARTIS,,80.0,YR,,F,Y,,,20220427,,PH,IT,IT,2022,Q2,Elderly
207581991,20758199,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q2,Paraesthesia,,2022,Q2,1,I,20220410.0,20220419.0,20220427,20220427,EXP,IT-MINISAL02-861774,NVSC2022IT091912,NOVARTIS,,80.0,YR,,F,Y,,,20220427,,PH,IT,IT,2022,Q2,Elderly
207583721,20758372,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,Injection,,2022,Q2,Sepsis,,2022,Q2,1,I,20220408.0,20220425.0,20220427,20220427,EXP,,US-PFIZER INC-202200625165,PFIZER,,17.0,YR,,F,Y,81.0,KG,20220427,,HP,US,US,2022,Q2,Youth
207610331,20761033,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,209196.0,,,,,2022,Q2,Pancreatitis,,2022,Q2,1,I,20220422.0,20220425.0,20220428,20220428,EXP,,US-SA-2022SA147962,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20220428,,HP,US,US,2022,Q2,Adult
207610331,20761033,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,209196.0,,,,,2022,Q2,Dysstasia,,2022,Q2,1,I,20220422.0,20220425.0,20220428,20220428,EXP,,US-SA-2022SA147962,SANOFI AVENTIS,,61.0,YR,A,F,Y,,,20220428,,HP,US,US,2022,Q2,Adult
207620591,20762059,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, tid (before meals)",,,U,,,,20563.0,6.0,IU,Injection,TID,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220301.0,20220401.0,20220428,20220428,PER,,US-ELI_LILLY_AND_COMPANY-US202204002635,ELI LILLY AND CO,,89.0,YR,,M,Y,,,20220428,,CN,US,US,2022,Q2,Elderly
207620591,20762059,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, tid (before meals)",,,U,,,,20563.0,6.0,IU,Injection,TID,2022,Q2,Incorrect dose administered,,2022,Q2,1,I,20220301.0,20220401.0,20220428,20220428,PER,,US-ELI_LILLY_AND_COMPANY-US202204002635,ELI LILLY AND CO,,89.0,YR,,M,Y,,,20220428,,CN,US,US,2022,Q2,Elderly
207620591,20762059,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, tid (before meals)",,,U,,D420814C,,20563.0,6.0,IU,Injection,TID,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220301.0,20220401.0,20220428,20220428,PER,,US-ELI_LILLY_AND_COMPANY-US202204002635,ELI LILLY AND CO,,89.0,YR,,M,Y,,,20220428,,CN,US,US,2022,Q2,Elderly
207620591,20762059,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, tid (before meals)",,,U,,D420814C,,20563.0,6.0,IU,Injection,TID,2022,Q2,Incorrect dose administered,,2022,Q2,1,I,20220301.0,20220401.0,20220428,20220428,PER,,US-ELI_LILLY_AND_COMPANY-US202204002635,ELI LILLY AND CO,,89.0,YR,,M,Y,,,20220428,,CN,US,US,2022,Q2,Elderly
207621461,20762146,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Clostridium test positive,,2022,Q2,1,I,,20220421.0,20220428,20220428,EXP,,NVSC2022CA094895,NOVARTIS,,62.0,YR,,F,Y,69.0,KG,20220428,,PH,CA,CA,2022,Q2,Adult
207648731,20764873,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2022,Q2,Therapeutic product effect delayed,,2022,Q2,1,I,,20220418.0,20220428,20220428,PER,,US-SA-2022SA142003,SANOFI AVENTIS,,62.0,YR,A,F,Y,,,20220428,,CN,US,US,2022,Q2,Adult
207691351,20769135,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Posterior reversible encephalopathy syndrome,,2022,Q2,1,I,20220106.0,,20220428,20220428,DIR,612425,,FDA-CTU,,68.0,YR,,F,N,151.0,KG,20220428,N,MD,US,,2022,Q2,Elderly
207691351,20769135,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Mental status changes,,2022,Q2,1,I,20220106.0,,20220428,20220428,DIR,612425,,FDA-CTU,,68.0,YR,,F,N,151.0,KG,20220428,N,MD,US,,2022,Q2,Elderly
207699061,20769906,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 ul/ml,,,,,,,,,,,,2022,Q2,Hyperglycaemia,,2022,Q2,1,I,20220419.0,20220419.0,20220429,20220429,EXP,,US-PFIZER INC-202200597613,PFIZER,,60.0,YR,,F,Y,71.2,KG,20220429,,HP,US,US,2022,Q2,Adult
207699061,20769906,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 ul/ml,,,,,,,,,,,,2022,Q2,Blood creatinine increased,,2022,Q2,1,I,20220419.0,20220419.0,20220429,20220429,EXP,,US-PFIZER INC-202200597613,PFIZER,,60.0,YR,,F,Y,71.2,KG,20220429,,HP,US,US,2022,Q2,Adult
207722441,20772244,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2022,Q2,Myocardial infarction,,2022,Q2,1,I,,20220425.0,20220502,20220502,EXP,,CA-JNJFOC-20220456095,JOHNSON AND JOHNSON,,77.0,YR,E,M,Y,,,20220502,,MD,CA,CA,2022,Q2,Elderly
207722441,20772244,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2022,Q2,Musculoskeletal discomfort,,2022,Q2,1,I,,20220425.0,20220502,20220502,EXP,,CA-JNJFOC-20220456095,JOHNSON AND JOHNSON,,77.0,YR,E,M,Y,,,20220502,,MD,CA,CA,2022,Q2,Elderly
207727422,20772742,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,Injection,,2022,Q2,Muscle spasms,,2022,Q2,2,F,20220415.0,20220518.0,20220502,20220525,EXP,,NVSJ2022JP089407,NOVARTIS,,73.0,YR,,M,Y,,,20220526,,PH,JP,JP,2022,Q2,Elderly
207727422,20772742,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,Injection,,2022,Q2,Musculoskeletal stiffness,,2022,Q2,2,F,20220415.0,20220518.0,20220502,20220525,EXP,,NVSJ2022JP089407,NOVARTIS,,73.0,YR,,M,Y,,,20220526,,PH,JP,JP,2022,Q2,Elderly
207756422,20775642,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2022,Q2,Urinary tract infection,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2022,Q2,General physical condition abnormal,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2022,Q2,Device intolerance,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2022,Q2,Drug intolerance,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2022,Q2,Blister,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2022,Q2,Blood glucose decreased,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2022,Q2,Abdominal pain upper,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2022,Q2,Drug ineffective,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2022,Q2,Nonspecific reaction,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2022,Q2,Injection site pain,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2022,Q2,Gastrointestinal disorder,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2022,Q2,Muscle spasms,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2022,Q2,Pain,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2022,Q2,Cystitis,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,,,,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D455780C,,,,,Injection,,2022,Q2,Urinary tract infection,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D455780C,,,,,Injection,,2022,Q2,General physical condition abnormal,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D455780C,,,,,Injection,,2022,Q2,Device intolerance,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D455780C,,,,,Injection,,2022,Q2,Drug intolerance,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D455780C,,,,,Injection,,2022,Q2,Blister,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D455780C,,,,,Injection,,2022,Q2,Blood glucose decreased,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D455780C,,,,,Injection,,2022,Q2,Abdominal pain upper,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D455780C,,,,,Injection,,2022,Q2,Drug ineffective,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D455780C,,,,,Injection,,2022,Q2,Nonspecific reaction,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D455780C,,,,,Injection,,2022,Q2,Injection site pain,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D455780C,,,,,Injection,,2022,Q2,Gastrointestinal disorder,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D455780C,,,,,Injection,,2022,Q2,Muscle spasms,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D455780C,,,,,Injection,,2022,Q2,Pain,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D455780C,,,,,Injection,,2022,Q2,Cystitis,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207756422,20775642,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,U,,D455780C,,,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,2,F,20220414.0,20220421.0,20220502,20220503,EXP,,US-ELI_LILLY_AND_COMPANY-US202204011101,ELI LILLY AND CO,,69.0,YR,,F,Y,,,20220503,,CN,US,US,2022,Q2,Elderly
207784383,20778438,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 unit, subcutaneously (SC) at 7.30 a.m.,",,,,,,,,,,,,2022,Q2,Neutropenia,,2022,Q2,3,F,20220101.0,20220518.0,20220503,20220524,PER,,PL-AMGEN-POLSP2022072582,AMGEN,,80.0,YR,E,F,Y,71.0,KG,20220524,,MD,PL,PL,2022,Q2,Elderly
207785021,20778502,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q2,Impaired insulin secretion,,2022,Q2,1,I,,20220421.0,20220503,20220503,EXP,,JP-PFIZER INC-202200617982,PFIZER,"Shibasaki, S.. A Case of Acute Onset Type I Diabetes Mellitus That Developed Three Months after Delivery With Depletion of Insulin Secretion from Just after the Onset. Journal of the Japan Diabetes Society. 2022;65(3):90-95",32.0,YR,,F,Y,,,20220503,,HP,JP,JP,2022,Q2,Young Adult
207785021,20778502,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q2,Pancreatic disorder,,2022,Q2,1,I,,20220421.0,20220503,20220503,EXP,,JP-PFIZER INC-202200617982,PFIZER,"Shibasaki, S.. A Case of Acute Onset Type I Diabetes Mellitus That Developed Three Months after Delivery With Depletion of Insulin Secretion from Just after the Onset. Journal of the Japan Diabetes Society. 2022;65(3):90-95",32.0,YR,,F,Y,,,20220503,,HP,JP,JP,2022,Q2,Young Adult
207811592,20781159,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Frequency text: Not provided,,,U,,,,,,,Unknown,,2022,Q2,Acute kidney injury,,2022,Q2,2,F,20210626.0,20220428.0,20220504,20220508,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20210700150,BRISTOL MYERS SQUIBB,,69.0,YR,E,M,Y,,,20220508,,HP,US,US,2022,Q2,Elderly
207811592,20781159,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Frequency text: Not provided,,,U,,,,,,,Unknown,,2022,Q2,Intentional product use issue,,2022,Q2,2,F,20210626.0,20220428.0,20220504,20220508,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20210700150,BRISTOL MYERS SQUIBB,,69.0,YR,E,M,Y,,,20220508,,HP,US,US,2022,Q2,Elderly
207811592,20781159,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Frequency text: Not provided,,,U,,,,,,,Unknown,,2022,Q2,Pneumonia fungal,,2022,Q2,2,F,20210626.0,20220428.0,20220504,20220508,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20210700150,BRISTOL MYERS SQUIBB,,69.0,YR,E,M,Y,,,20220508,,HP,US,US,2022,Q2,Elderly
207837161,20783716,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D455780C,,20563.0,,,Injection,,2022,Q2,Glaucoma,,2022,Q2,1,I,20220422.0,20220422.0,20220504,20220504,EXP,,US-ELI_LILLY_AND_COMPANY-US202204010914,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20220504,,CN,US,US,2022,Q2,Elderly
207837161,20783716,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D455780C,,20563.0,,,Injection,,2022,Q2,Blood electrolytes increased,,2022,Q2,1,I,20220422.0,20220422.0,20220504,20220504,EXP,,US-ELI_LILLY_AND_COMPANY-US202204010914,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20220504,,CN,US,US,2022,Q2,Elderly
207837161,20783716,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D455780C,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220422.0,20220422.0,20220504,20220504,EXP,,US-ELI_LILLY_AND_COMPANY-US202204010914,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20220504,,CN,US,US,2022,Q2,Elderly
207837161,20783716,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D455780C,,20563.0,,,Injection,,2022,Q2,Polymyalgia rheumatica,,2022,Q2,1,I,20220422.0,20220422.0,20220504,20220504,EXP,,US-ELI_LILLY_AND_COMPANY-US202204010914,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20220504,,CN,US,US,2022,Q2,Elderly
207837161,20783716,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, each morning",,,,,D455780C,,20563.0,10.0,IU,Injection,QD,2022,Q2,Glaucoma,,2022,Q2,1,I,20220422.0,20220422.0,20220504,20220504,EXP,,US-ELI_LILLY_AND_COMPANY-US202204010914,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20220504,,CN,US,US,2022,Q2,Elderly
207837161,20783716,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, each morning",,,,,D455780C,,20563.0,10.0,IU,Injection,QD,2022,Q2,Blood electrolytes increased,,2022,Q2,1,I,20220422.0,20220422.0,20220504,20220504,EXP,,US-ELI_LILLY_AND_COMPANY-US202204010914,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20220504,,CN,US,US,2022,Q2,Elderly
207837161,20783716,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, each morning",,,,,D455780C,,20563.0,10.0,IU,Injection,QD,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220422.0,20220422.0,20220504,20220504,EXP,,US-ELI_LILLY_AND_COMPANY-US202204010914,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20220504,,CN,US,US,2022,Q2,Elderly
207837161,20783716,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, each morning",,,,,D455780C,,20563.0,10.0,IU,Injection,QD,2022,Q2,Polymyalgia rheumatica,,2022,Q2,1,I,20220422.0,20220422.0,20220504,20220504,EXP,,US-ELI_LILLY_AND_COMPANY-US202204010914,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20220504,,CN,US,US,2022,Q2,Elderly
207839771,20783977,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q2,Ecchymosis,,2022,Q2,1,I,,20220422.0,20220504,20220504,EXP,,US-MYLANLABS-2022M1031731,MYLAN,"Naberhaus T, Jones MJ, Burns A, Raney EC. Topical Miconazole Cream and Warfarin Interaction: A Case Report. J-Pharm-Technol 2022;38(2):127-129.",85.0,YR,,M,Y,,,20220504,,PH,US,US,2022,Q2,Elderly
207839771,20783977,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q2,Drug interaction,,2022,Q2,1,I,,20220422.0,20220504,20220504,EXP,,US-MYLANLABS-2022M1031731,MYLAN,"Naberhaus T, Jones MJ, Burns A, Raney EC. Topical Miconazole Cream and Warfarin Interaction: A Case Report. J-Pharm-Technol 2022;38(2):127-129.",85.0,YR,,M,Y,,,20220504,,PH,US,US,2022,Q2,Elderly
207839771,20783977,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q2,Peripheral swelling,,2022,Q2,1,I,,20220422.0,20220504,20220504,EXP,,US-MYLANLABS-2022M1031731,MYLAN,"Naberhaus T, Jones MJ, Burns A, Raney EC. Topical Miconazole Cream and Warfarin Interaction: A Case Report. J-Pharm-Technol 2022;38(2):127-129.",85.0,YR,,M,Y,,,20220504,,PH,US,US,2022,Q2,Elderly
207839771,20783977,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q2,International normalised ratio increased,,2022,Q2,1,I,,20220422.0,20220504,20220504,EXP,,US-MYLANLABS-2022M1031731,MYLAN,"Naberhaus T, Jones MJ, Burns A, Raney EC. Topical Miconazole Cream and Warfarin Interaction: A Case Report. J-Pharm-Technol 2022;38(2):127-129.",85.0,YR,,M,Y,,,20220504,,PH,US,US,2022,Q2,Elderly
207883321,20788332,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Liver function test increased,,2022,Q2,1,I,20220405.0,,20220504,20220504,DIR,FDA-CDER-CTU-2022-34206,,FDA-CTU,,41.0,YR,,F,N,,,20220504,Y,PH,US,,2022,Q2,Adult
207883321,20788332,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Cholestasis,,2022,Q2,1,I,20220405.0,,20220504,20220504,DIR,FDA-CDER-CTU-2022-34206,,FDA-CTU,,41.0,YR,,F,N,,,20220504,Y,PH,US,,2022,Q2,Adult
207883321,20788332,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Liver transplant,,2022,Q2,1,I,20220405.0,,20220504,20220504,DIR,FDA-CDER-CTU-2022-34206,,FDA-CTU,,41.0,YR,,F,N,,,20220504,Y,PH,US,,2022,Q2,Adult
207883321,20788332,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Portopulmonary hypertension,,2022,Q2,1,I,20220405.0,,20220504,20220504,DIR,FDA-CDER-CTU-2022-34206,,FDA-CTU,,41.0,YR,,F,N,,,20220504,Y,PH,US,,2022,Q2,Adult
207883321,20788332,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Bile duct stenosis,,2022,Q2,1,I,20220405.0,,20220504,20220504,DIR,FDA-CDER-CTU-2022-34206,,FDA-CTU,,41.0,YR,,F,N,,,20220504,Y,PH,US,,2022,Q2,Adult
207883321,20788332,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Complications of transplanted liver,,2022,Q2,1,I,20220405.0,,20220504,20220504,DIR,FDA-CDER-CTU-2022-34206,,FDA-CTU,,41.0,YR,,F,N,,,20220504,Y,PH,US,,2022,Q2,Adult
207894832,20789483,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 8 ui/day",,,D,,,,,,,,,2022,Q2,Dysphagia,,2022,Q2,2,F,20220105.0,20220510.0,20220505,20220516,EXP,,NVSC2022IT004415,NOVARTIS,,81.0,YR,,M,Y,100.0,KG,20220516,,MD,IT,IT,2022,Q2,Elderly
207894832,20789483,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 8 ui/day",,,D,,,,,,,,,2022,Q2,Acute respiratory failure,,2022,Q2,2,F,20220105.0,20220510.0,20220505,20220516,EXP,,NVSC2022IT004415,NOVARTIS,,81.0,YR,,M,Y,100.0,KG,20220516,,MD,IT,IT,2022,Q2,Elderly
207894832,20789483,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 8 ui/day",,,D,,,,,,,,,2022,Q2,Staphylococcal sepsis,,2022,Q2,2,F,20220105.0,20220510.0,20220505,20220516,EXP,,NVSC2022IT004415,NOVARTIS,,81.0,YR,,M,Y,100.0,KG,20220516,,MD,IT,IT,2022,Q2,Elderly
207894832,20789483,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 8 ui/day",,,D,,,,,,,,,2022,Q2,Femur fracture,,2022,Q2,2,F,20220105.0,20220510.0,20220505,20220516,EXP,,NVSC2022IT004415,NOVARTIS,,81.0,YR,,M,Y,100.0,KG,20220516,,MD,IT,IT,2022,Q2,Elderly
207894832,20789483,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 8 ui/day",,,D,,,,,,,,,2022,Q2,General physical health deterioration,,2022,Q2,2,F,20220105.0,20220510.0,20220505,20220516,EXP,,NVSC2022IT004415,NOVARTIS,,81.0,YR,,M,Y,100.0,KG,20220516,,MD,IT,IT,2022,Q2,Elderly
207894832,20789483,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 14 ui/day",,,D,,,,,,,,,2022,Q2,Dysphagia,,2022,Q2,2,F,20220105.0,20220510.0,20220505,20220516,EXP,,NVSC2022IT004415,NOVARTIS,,81.0,YR,,M,Y,100.0,KG,20220516,,MD,IT,IT,2022,Q2,Elderly
207894832,20789483,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 14 ui/day",,,D,,,,,,,,,2022,Q2,Acute respiratory failure,,2022,Q2,2,F,20220105.0,20220510.0,20220505,20220516,EXP,,NVSC2022IT004415,NOVARTIS,,81.0,YR,,M,Y,100.0,KG,20220516,,MD,IT,IT,2022,Q2,Elderly
207894832,20789483,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 14 ui/day",,,D,,,,,,,,,2022,Q2,Staphylococcal sepsis,,2022,Q2,2,F,20220105.0,20220510.0,20220505,20220516,EXP,,NVSC2022IT004415,NOVARTIS,,81.0,YR,,M,Y,100.0,KG,20220516,,MD,IT,IT,2022,Q2,Elderly
207894832,20789483,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 14 ui/day",,,D,,,,,,,,,2022,Q2,Femur fracture,,2022,Q2,2,F,20220105.0,20220510.0,20220505,20220516,EXP,,NVSC2022IT004415,NOVARTIS,,81.0,YR,,M,Y,100.0,KG,20220516,,MD,IT,IT,2022,Q2,Elderly
207894832,20789483,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 14 ui/day",,,D,,,,,,,,,2022,Q2,General physical health deterioration,,2022,Q2,2,F,20220105.0,20220510.0,20220505,20220516,EXP,,NVSC2022IT004415,NOVARTIS,,81.0,YR,,M,Y,100.0,KG,20220516,,MD,IT,IT,2022,Q2,Elderly
207894832,20789483,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 12 ui/day",,,D,,,,,,,,,2022,Q2,Dysphagia,,2022,Q2,2,F,20220105.0,20220510.0,20220505,20220516,EXP,,NVSC2022IT004415,NOVARTIS,,81.0,YR,,M,Y,100.0,KG,20220516,,MD,IT,IT,2022,Q2,Elderly
207894832,20789483,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 12 ui/day",,,D,,,,,,,,,2022,Q2,Acute respiratory failure,,2022,Q2,2,F,20220105.0,20220510.0,20220505,20220516,EXP,,NVSC2022IT004415,NOVARTIS,,81.0,YR,,M,Y,100.0,KG,20220516,,MD,IT,IT,2022,Q2,Elderly
207894832,20789483,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 12 ui/day",,,D,,,,,,,,,2022,Q2,Staphylococcal sepsis,,2022,Q2,2,F,20220105.0,20220510.0,20220505,20220516,EXP,,NVSC2022IT004415,NOVARTIS,,81.0,YR,,M,Y,100.0,KG,20220516,,MD,IT,IT,2022,Q2,Elderly
207894832,20789483,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 12 ui/day",,,D,,,,,,,,,2022,Q2,Femur fracture,,2022,Q2,2,F,20220105.0,20220510.0,20220505,20220516,EXP,,NVSC2022IT004415,NOVARTIS,,81.0,YR,,M,Y,100.0,KG,20220516,,MD,IT,IT,2022,Q2,Elderly
207894832,20789483,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 12 ui/day",,,D,,,,,,,,,2022,Q2,General physical health deterioration,,2022,Q2,2,F,20220105.0,20220510.0,20220505,20220516,EXP,,NVSC2022IT004415,NOVARTIS,,81.0,YR,,M,Y,100.0,KG,20220516,,MD,IT,IT,2022,Q2,Elderly
207898771,20789877,11,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,UNKNOWN,,,,,,,2022,Q2,Respiratory failure,,2022,Q2,1,I,20220227.0,20220425.0,20220505,20220505,EXP,ES-AEMPS-1138752,ES-Fresenius Kabi-FK202204947,FRESENIUS KABI,,72.0,YR,,M,Y,80.0,KG,20220505,,HP,NL,,2022,Q2,Elderly
207898771,20789877,11,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,UNKNOWN,,,,,,,2022,Q2,Therapeutic response decreased,,2022,Q2,1,I,20220227.0,20220425.0,20220505,20220505,EXP,ES-AEMPS-1138752,ES-Fresenius Kabi-FK202204947,FRESENIUS KABI,,72.0,YR,,M,Y,80.0,KG,20220505,,HP,NL,,2022,Q2,Elderly
207898771,20789877,11,C,INSULIN LISPRO/INSULIN LISPRO PROTAMINE SUSPENSION,,2,,UNK,,,,,UNKNOWN,,,,,,,2022,Q2,Recurrence of neuromuscular blockade,,2022,Q2,1,I,20220227.0,20220425.0,20220505,20220505,EXP,ES-AEMPS-1138752,ES-Fresenius Kabi-FK202204947,FRESENIUS KABI,,72.0,YR,,M,Y,80.0,KG,20220505,,HP,NL,,2022,Q2,Elderly
207939671,20793967,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D420813A,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220429.0,20220503.0,20220506,20220506,PER,,US-ELI_LILLY_AND_COMPANY-US202205001861,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20220506,,CN,US,US,2022,Q2,Elderly
207939671,20793967,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D420813A,,20563.0,,,Injection,,2022,Q2,Product dose omission issue,,2022,Q2,1,I,20220429.0,20220503.0,20220506,20220506,PER,,US-ELI_LILLY_AND_COMPANY-US202205001861,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20220506,,CN,US,US,2022,Q2,Elderly
207939671,20793967,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D420813A,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220429.0,20220503.0,20220506,20220506,PER,,US-ELI_LILLY_AND_COMPANY-US202205001861,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20220506,,CN,US,US,2022,Q2,Elderly
207939671,20793967,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D420813A,,20563.0,,,Injection,,2022,Q2,Product dose omission issue,,2022,Q2,1,I,20220429.0,20220503.0,20220506,20220506,PER,,US-ELI_LILLY_AND_COMPANY-US202205001861,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20220506,,CN,US,US,2022,Q2,Elderly
207939671,20793967,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220429.0,20220503.0,20220506,20220506,PER,,US-ELI_LILLY_AND_COMPANY-US202205001861,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20220506,,CN,US,US,2022,Q2,Elderly
207939671,20793967,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q2,Product dose omission issue,,2022,Q2,1,I,20220429.0,20220503.0,20220506,20220506,PER,,US-ELI_LILLY_AND_COMPANY-US202205001861,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20220506,,CN,US,US,2022,Q2,Elderly
207939671,20793967,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220429.0,20220503.0,20220506,20220506,PER,,US-ELI_LILLY_AND_COMPANY-US202205001861,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20220506,,CN,US,US,2022,Q2,Elderly
207939671,20793967,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q2,Product dose omission issue,,2022,Q2,1,I,20220429.0,20220503.0,20220506,20220506,PER,,US-ELI_LILLY_AND_COMPANY-US202205001861,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20220506,,CN,US,US,2022,Q2,Elderly
207964741,20796474,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Intramuscular,20 dosage form (Injectable solution) (15 in the mornng and 5 in the night),,,,,,,,,,,,2022,Q2,Pain,,2022,Q2,1,I,20210905.0,20220502.0,20220506,20220506,EXP,,NVSC2022MX082678,NOVARTIS,,59.0,YR,,F,Y,62.0,KG,20220506,,CN,MX,MX,2022,Q2,Adult
207964741,20796474,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Intramuscular,20 dosage form (Injectable solution) (15 in the mornng and 5 in the night),,,,,,,,,,,,2022,Q2,Fear,,2022,Q2,1,I,20210905.0,20220502.0,20220506,20220506,EXP,,NVSC2022MX082678,NOVARTIS,,59.0,YR,,F,Y,62.0,KG,20220506,,CN,MX,MX,2022,Q2,Adult
207964741,20796474,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Intramuscular,20 dosage form (Injectable solution) (15 in the mornng and 5 in the night),,,,,,,,,,,,2022,Q2,Fall,,2022,Q2,1,I,20210905.0,20220502.0,20220506,20220506,EXP,,NVSC2022MX082678,NOVARTIS,,59.0,YR,,F,Y,62.0,KG,20220506,,CN,MX,MX,2022,Q2,Adult
207964741,20796474,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Intramuscular,20 dosage form (Injectable solution) (15 in the mornng and 5 in the night),,,,,,,,,,,,2022,Q2,Rotator cuff syndrome,,2022,Q2,1,I,20210905.0,20220502.0,20220506,20220506,EXP,,NVSC2022MX082678,NOVARTIS,,59.0,YR,,F,Y,62.0,KG,20220506,,CN,MX,MX,2022,Q2,Adult
207964741,20796474,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Intramuscular,20 dosage form (Injectable solution) (15 in the mornng and 5 in the night),,,,,,,,,,,,2022,Q2,Humerus fracture,,2022,Q2,1,I,20210905.0,20220502.0,20220506,20220506,EXP,,NVSC2022MX082678,NOVARTIS,,59.0,YR,,F,Y,62.0,KG,20220506,,CN,MX,MX,2022,Q2,Adult
207964741,20796474,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"25 mg (15 UI in morning, 5 UI in night)",,,,,,,,25.0,MG,,,2022,Q2,Pain,,2022,Q2,1,I,20210905.0,20220502.0,20220506,20220506,EXP,,NVSC2022MX082678,NOVARTIS,,59.0,YR,,F,Y,62.0,KG,20220506,,CN,MX,MX,2022,Q2,Adult
207964741,20796474,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"25 mg (15 UI in morning, 5 UI in night)",,,,,,,,25.0,MG,,,2022,Q2,Fear,,2022,Q2,1,I,20210905.0,20220502.0,20220506,20220506,EXP,,NVSC2022MX082678,NOVARTIS,,59.0,YR,,F,Y,62.0,KG,20220506,,CN,MX,MX,2022,Q2,Adult
207964741,20796474,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"25 mg (15 UI in morning, 5 UI in night)",,,,,,,,25.0,MG,,,2022,Q2,Fall,,2022,Q2,1,I,20210905.0,20220502.0,20220506,20220506,EXP,,NVSC2022MX082678,NOVARTIS,,59.0,YR,,F,Y,62.0,KG,20220506,,CN,MX,MX,2022,Q2,Adult
207964741,20796474,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"25 mg (15 UI in morning, 5 UI in night)",,,,,,,,25.0,MG,,,2022,Q2,Rotator cuff syndrome,,2022,Q2,1,I,20210905.0,20220502.0,20220506,20220506,EXP,,NVSC2022MX082678,NOVARTIS,,59.0,YR,,F,Y,62.0,KG,20220506,,CN,MX,MX,2022,Q2,Adult
207964741,20796474,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"25 mg (15 UI in morning, 5 UI in night)",,,,,,,,25.0,MG,,,2022,Q2,Humerus fracture,,2022,Q2,1,I,20210905.0,20220502.0,20220506,20220506,EXP,,NVSC2022MX082678,NOVARTIS,,59.0,YR,,F,Y,62.0,KG,20220506,,CN,MX,MX,2022,Q2,Adult
208024491,20802449,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Gallbladder operation,,2022,Q2,1,I,20220508.0,,20220509,20220509,DIR,FDA-CDER-CTU-2022-35265,,FDA-CTU,,53.0,YR,,F,N,166.0,LBS,20220509,N,,US,,2022,Q2,Adult
208069241,20806924,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,"Injection, suspension, sonicated",,2022,Q2,Tachycardia,,2022,Q2,1,I,20220408.0,20220425.0,20220510,20220510,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-01150,HIKMA,,17.0,YR,,F,Y,81.0,KG,20220510,,HP,US,US,2022,Q2,Youth
208069241,20806924,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,"Injection, suspension, sonicated",,2022,Q2,Hypotension,,2022,Q2,1,I,20220408.0,20220425.0,20220510,20220510,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-01150,HIKMA,,17.0,YR,,F,Y,81.0,KG,20220510,,HP,US,US,2022,Q2,Youth
208069241,20806924,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,"Injection, suspension, sonicated",,2022,Q2,Nausea,,2022,Q2,1,I,20220408.0,20220425.0,20220510,20220510,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-01150,HIKMA,,17.0,YR,,F,Y,81.0,KG,20220510,,HP,US,US,2022,Q2,Youth
208069241,20806924,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,"Injection, suspension, sonicated",,2022,Q2,Neutropenic sepsis,,2022,Q2,1,I,20220408.0,20220425.0,20220510,20220510,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-01150,HIKMA,,17.0,YR,,F,Y,81.0,KG,20220510,,HP,US,US,2022,Q2,Youth
208069241,20806924,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,"Injection, suspension, sonicated",,2022,Q2,Alanine aminotransferase increased,,2022,Q2,1,I,20220408.0,20220425.0,20220510,20220510,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-01150,HIKMA,,17.0,YR,,F,Y,81.0,KG,20220510,,HP,US,US,2022,Q2,Youth
208069241,20806924,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,"Injection, suspension, sonicated",,2022,Q2,Vomiting,,2022,Q2,1,I,20220408.0,20220425.0,20220510,20220510,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-01150,HIKMA,,17.0,YR,,F,Y,81.0,KG,20220510,,HP,US,US,2022,Q2,Youth
208069241,20806924,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,"Injection, suspension, sonicated",,2022,Q2,Septic shock,,2022,Q2,1,I,20220408.0,20220425.0,20220510,20220510,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-01150,HIKMA,,17.0,YR,,F,Y,81.0,KG,20220510,,HP,US,US,2022,Q2,Youth
208069241,20806924,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,"Injection, suspension, sonicated",,2022,Q2,Abdominal pain,,2022,Q2,1,I,20220408.0,20220425.0,20220510,20220510,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-01150,HIKMA,,17.0,YR,,F,Y,81.0,KG,20220510,,HP,US,US,2022,Q2,Youth
208069241,20806924,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,"Injection, suspension, sonicated",,2022,Q2,Aspartate aminotransferase increased,,2022,Q2,1,I,20220408.0,20220425.0,20220510,20220510,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-01150,HIKMA,,17.0,YR,,F,Y,81.0,KG,20220510,,HP,US,US,2022,Q2,Youth
208069962,20806996,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,Blood glucose fluctuation,,2022,Q2,2,F,,20220512.0,20220510,20220520,EXP,,FI-SA-2022SA156179,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20220520,,CN,FI,FI,2022,Q2,Elderly
208069962,20806996,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,Blood glucose decreased,,2022,Q2,2,F,,20220512.0,20220510,20220520,EXP,,FI-SA-2022SA156179,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20220520,,CN,FI,FI,2022,Q2,Elderly
208069962,20806996,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,Malaise,,2022,Q2,2,F,,20220512.0,20220510,20220520,EXP,,FI-SA-2022SA156179,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20220520,,CN,FI,FI,2022,Q2,Elderly
208069962,20806996,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,Blood glucose increased,,2022,Q2,2,F,,20220512.0,20220510,20220520,EXP,,FI-SA-2022SA156179,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20220520,,CN,FI,FI,2022,Q2,Elderly
208069962,20806996,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,Feeling abnormal,,2022,Q2,2,F,,20220512.0,20220510,20220520,EXP,,FI-SA-2022SA156179,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20220520,,CN,FI,FI,2022,Q2,Elderly
208069962,20806996,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,Lung disorder,,2022,Q2,2,F,,20220512.0,20220510,20220520,EXP,,FI-SA-2022SA156179,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20220520,,CN,FI,FI,2022,Q2,Elderly
208069962,20806996,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,Renal disorder,,2022,Q2,2,F,,20220512.0,20220510,20220520,EXP,,FI-SA-2022SA156179,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20220520,,CN,FI,FI,2022,Q2,Elderly
208069962,20806996,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,Feeling abnormal,,2022,Q2,2,F,,20220512.0,20220510,20220520,EXP,,FI-SA-2022SA156179,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20220520,,CN,FI,FI,2022,Q2,Elderly
208069962,20806996,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q2,Back pain,,2022,Q2,2,F,,20220512.0,20220510,20220520,EXP,,FI-SA-2022SA156179,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20220520,,CN,FI,FI,2022,Q2,Elderly
208069962,20806996,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q2,Blood glucose fluctuation,,2022,Q2,2,F,,20220512.0,20220510,20220520,EXP,,FI-SA-2022SA156179,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20220520,,CN,FI,FI,2022,Q2,Elderly
208069962,20806996,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q2,Blood glucose decreased,,2022,Q2,2,F,,20220512.0,20220510,20220520,EXP,,FI-SA-2022SA156179,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20220520,,CN,FI,FI,2022,Q2,Elderly
208069962,20806996,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q2,Malaise,,2022,Q2,2,F,,20220512.0,20220510,20220520,EXP,,FI-SA-2022SA156179,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20220520,,CN,FI,FI,2022,Q2,Elderly
208069962,20806996,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q2,Blood glucose increased,,2022,Q2,2,F,,20220512.0,20220510,20220520,EXP,,FI-SA-2022SA156179,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20220520,,CN,FI,FI,2022,Q2,Elderly
208069962,20806996,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q2,Feeling abnormal,,2022,Q2,2,F,,20220512.0,20220510,20220520,EXP,,FI-SA-2022SA156179,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20220520,,CN,FI,FI,2022,Q2,Elderly
208069962,20806996,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q2,Lung disorder,,2022,Q2,2,F,,20220512.0,20220510,20220520,EXP,,FI-SA-2022SA156179,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20220520,,CN,FI,FI,2022,Q2,Elderly
208069962,20806996,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q2,Renal disorder,,2022,Q2,2,F,,20220512.0,20220510,20220520,EXP,,FI-SA-2022SA156179,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20220520,,CN,FI,FI,2022,Q2,Elderly
208069962,20806996,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q2,Feeling abnormal,,2022,Q2,2,F,,20220512.0,20220510,20220520,EXP,,FI-SA-2022SA156179,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20220520,,CN,FI,FI,2022,Q2,Elderly
208069962,20806996,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q2,Back pain,,2022,Q2,2,F,,20220512.0,20220510,20220520,EXP,,FI-SA-2022SA156179,SANOFI AVENTIS,,76.0,YR,E,F,Y,,,20220520,,CN,FI,FI,2022,Q2,Elderly
208080411,20808041,26,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"120 IU, TID,60 IU also received,HUMALOG MIX 50",,,D,U,,,,60.0,IU,,,2022,Q2,Incorrect route of product administration,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,26,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"120 IU, TID,60 IU also received,HUMALOG MIX 50",,,D,U,,,,60.0,IU,,,2022,Q2,Multiple organ dysfunction syndrome,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,26,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"120 IU, TID,60 IU also received,HUMALOG MIX 50",,,D,U,,,,60.0,IU,,,2022,Q2,Loss of consciousness,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,26,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"120 IU, TID,60 IU also received,HUMALOG MIX 50",,,D,U,,,,60.0,IU,,,2022,Q2,Intentional product misuse,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,26,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"120 IU, TID,60 IU also received,HUMALOG MIX 50",,,D,U,,,,60.0,IU,,,2022,Q2,Off label use,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,26,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"120 IU, TID,60 IU also received,HUMALOG MIX 50",,,D,U,,,,60.0,IU,,,2022,Q2,Medication error,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,26,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"120 IU, TID,60 IU also received,HUMALOG MIX 50",,,D,U,,,,60.0,IU,,,2022,Q2,Pneumonia,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,26,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"120 IU, TID,60 IU also received,HUMALOG MIX 50",,,D,U,,,,60.0,IU,,,2022,Q2,Overdose,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,27,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"180 international units, tid/ 60 IU, TID HUMALOG MIX 50",,,D,U,,,,180.0,IU,,,2022,Q2,Incorrect route of product administration,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,27,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"180 international units, tid/ 60 IU, TID HUMALOG MIX 50",,,D,U,,,,180.0,IU,,,2022,Q2,Multiple organ dysfunction syndrome,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,27,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"180 international units, tid/ 60 IU, TID HUMALOG MIX 50",,,D,U,,,,180.0,IU,,,2022,Q2,Loss of consciousness,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,27,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"180 international units, tid/ 60 IU, TID HUMALOG MIX 50",,,D,U,,,,180.0,IU,,,2022,Q2,Intentional product misuse,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,27,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"180 international units, tid/ 60 IU, TID HUMALOG MIX 50",,,D,U,,,,180.0,IU,,,2022,Q2,Off label use,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,27,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"180 international units, tid/ 60 IU, TID HUMALOG MIX 50",,,D,U,,,,180.0,IU,,,2022,Q2,Medication error,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,27,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"180 international units, tid/ 60 IU, TID HUMALOG MIX 50",,,D,U,,,,180.0,IU,,,2022,Q2,Pneumonia,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,27,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,"180 international units, tid/ 60 IU, TID HUMALOG MIX 50",,,D,U,,,,180.0,IU,,,2022,Q2,Overdose,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,28,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,360 IU (International Unit) Daily; HUMALOG MIX 50,,,D,U,,,,120.0,IU,,TID,2022,Q2,Incorrect route of product administration,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,28,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,360 IU (International Unit) Daily; HUMALOG MIX 50,,,D,U,,,,120.0,IU,,TID,2022,Q2,Multiple organ dysfunction syndrome,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,28,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,360 IU (International Unit) Daily; HUMALOG MIX 50,,,D,U,,,,120.0,IU,,TID,2022,Q2,Loss of consciousness,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,28,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,360 IU (International Unit) Daily; HUMALOG MIX 50,,,D,U,,,,120.0,IU,,TID,2022,Q2,Intentional product misuse,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,28,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,360 IU (International Unit) Daily; HUMALOG MIX 50,,,D,U,,,,120.0,IU,,TID,2022,Q2,Off label use,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,28,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,360 IU (International Unit) Daily; HUMALOG MIX 50,,,D,U,,,,120.0,IU,,TID,2022,Q2,Medication error,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,28,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,360 IU (International Unit) Daily; HUMALOG MIX 50,,,D,U,,,,120.0,IU,,TID,2022,Q2,Pneumonia,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,28,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,360 IU (International Unit) Daily; HUMALOG MIX 50,,,D,U,,,,120.0,IU,,TID,2022,Q2,Overdose,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,29,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,1080 IU (International Unit) Daily; HUMALOG MIX 50,,,D,U,,,,360.0,IU,,Q8H,2022,Q2,Incorrect route of product administration,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,29,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,1080 IU (International Unit) Daily; HUMALOG MIX 50,,,D,U,,,,360.0,IU,,Q8H,2022,Q2,Multiple organ dysfunction syndrome,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,29,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,1080 IU (International Unit) Daily; HUMALOG MIX 50,,,D,U,,,,360.0,IU,,Q8H,2022,Q2,Loss of consciousness,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,29,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,1080 IU (International Unit) Daily; HUMALOG MIX 50,,,D,U,,,,360.0,IU,,Q8H,2022,Q2,Intentional product misuse,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,29,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,1080 IU (International Unit) Daily; HUMALOG MIX 50,,,D,U,,,,360.0,IU,,Q8H,2022,Q2,Off label use,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,29,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,1080 IU (International Unit) Daily; HUMALOG MIX 50,,,D,U,,,,360.0,IU,,Q8H,2022,Q2,Medication error,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,29,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,1080 IU (International Unit) Daily; HUMALOG MIX 50,,,D,U,,,,360.0,IU,,Q8H,2022,Q2,Pneumonia,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208080411,20808041,29,SS,INSULIN LISPRO,INSULIN LISPRO,1,Oral,1080 IU (International Unit) Daily; HUMALOG MIX 50,,,D,U,,,,360.0,IU,,Q8H,2022,Q2,Overdose,,2022,Q2,1,I,20180101.0,20220501.0,20220510,20220510,EXP,,GB-TEVA-2022-GB-2034485,TEVA,,47.0,YR,A,F,Y,,,20220509,,MD,GB,GB,2022,Q2,Adult
208146951,20814695,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 u, daily (breakfast)",,,,,,,,4.0,IU,Injection,QD,2022,Q2,Glycosylated haemoglobin increased,,2022,Q2,1,I,,20220411.0,20220511,20220511,PER,,US-ELI_LILLY_AND_COMPANY-US202204006040,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220511,,CN,US,US,2022,Q2,Elderly
208146951,20814695,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 u, daily (breakfast)",,,,,,,,4.0,IU,Injection,QD,2022,Q2,Mobility decreased,,2022,Q2,1,I,,20220411.0,20220511,20220511,PER,,US-ELI_LILLY_AND_COMPANY-US202204006040,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220511,,CN,US,US,2022,Q2,Elderly
208146951,20814695,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 u, daily (breakfast)",,,,,,,,4.0,IU,Injection,QD,2022,Q2,Arthropathy,,2022,Q2,1,I,,20220411.0,20220511,20220511,PER,,US-ELI_LILLY_AND_COMPANY-US202204006040,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220511,,CN,US,US,2022,Q2,Elderly
208146951,20814695,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, daily",,,,,,,,10.0,IU,Injection,QD,2022,Q2,Glycosylated haemoglobin increased,,2022,Q2,1,I,,20220411.0,20220511,20220511,PER,,US-ELI_LILLY_AND_COMPANY-US202204006040,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220511,,CN,US,US,2022,Q2,Elderly
208146951,20814695,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, daily",,,,,,,,10.0,IU,Injection,QD,2022,Q2,Mobility decreased,,2022,Q2,1,I,,20220411.0,20220511,20220511,PER,,US-ELI_LILLY_AND_COMPANY-US202204006040,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220511,,CN,US,US,2022,Q2,Elderly
208146951,20814695,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, daily",,,,,,,,10.0,IU,Injection,QD,2022,Q2,Arthropathy,,2022,Q2,1,I,,20220411.0,20220511,20220511,PER,,US-ELI_LILLY_AND_COMPANY-US202204006040,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220511,,CN,US,US,2022,Q2,Elderly
208146951,20814695,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 u, daily (breakfast)",,,,,D341139A,,,4.0,IU,Injection,QD,2022,Q2,Glycosylated haemoglobin increased,,2022,Q2,1,I,,20220411.0,20220511,20220511,PER,,US-ELI_LILLY_AND_COMPANY-US202204006040,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220511,,CN,US,US,2022,Q2,Elderly
208146951,20814695,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 u, daily (breakfast)",,,,,D341139A,,,4.0,IU,Injection,QD,2022,Q2,Mobility decreased,,2022,Q2,1,I,,20220411.0,20220511,20220511,PER,,US-ELI_LILLY_AND_COMPANY-US202204006040,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220511,,CN,US,US,2022,Q2,Elderly
208146951,20814695,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"4 u, daily (breakfast)",,,,,D341139A,,,4.0,IU,Injection,QD,2022,Q2,Arthropathy,,2022,Q2,1,I,,20220411.0,20220511,20220511,PER,,US-ELI_LILLY_AND_COMPANY-US202204006040,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220511,,CN,US,US,2022,Q2,Elderly
208146951,20814695,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, daily",,,,,D341139A,,,10.0,IU,Injection,QD,2022,Q2,Glycosylated haemoglobin increased,,2022,Q2,1,I,,20220411.0,20220511,20220511,PER,,US-ELI_LILLY_AND_COMPANY-US202204006040,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220511,,CN,US,US,2022,Q2,Elderly
208146951,20814695,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, daily",,,,,D341139A,,,10.0,IU,Injection,QD,2022,Q2,Mobility decreased,,2022,Q2,1,I,,20220411.0,20220511,20220511,PER,,US-ELI_LILLY_AND_COMPANY-US202204006040,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220511,,CN,US,US,2022,Q2,Elderly
208146951,20814695,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, daily",,,,,D341139A,,,10.0,IU,Injection,QD,2022,Q2,Arthropathy,,2022,Q2,1,I,,20220411.0,20220511,20220511,PER,,US-ELI_LILLY_AND_COMPANY-US202204006040,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220511,,CN,US,US,2022,Q2,Elderly
208187462,20818746,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q2,Drug interaction,,2022,Q2,2,F,,20220518.0,20220512,20220527,EXP,,US-TEVA-2022-US-2035078,TEVA,"Naberhaus T, Jones MJ, Burns A, Raney EC. Topical Miconazole Cream and Warfarin Interaction: A Case Report. J-Pharm-Technol 2022;38(2):127-129.",85.0,YR,E,M,Y,,,20220527,,PH,US,US,2022,Q2,Elderly
208187462,20818746,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q2,Swelling,,2022,Q2,2,F,,20220518.0,20220512,20220527,EXP,,US-TEVA-2022-US-2035078,TEVA,"Naberhaus T, Jones MJ, Burns A, Raney EC. Topical Miconazole Cream and Warfarin Interaction: A Case Report. J-Pharm-Technol 2022;38(2):127-129.",85.0,YR,E,M,Y,,,20220527,,PH,US,US,2022,Q2,Elderly
208187462,20818746,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q2,International normalised ratio increased,,2022,Q2,2,F,,20220518.0,20220512,20220527,EXP,,US-TEVA-2022-US-2035078,TEVA,"Naberhaus T, Jones MJ, Burns A, Raney EC. Topical Miconazole Cream and Warfarin Interaction: A Case Report. J-Pharm-Technol 2022;38(2):127-129.",85.0,YR,E,M,Y,,,20220527,,PH,US,US,2022,Q2,Elderly
208187462,20818746,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q2,Ecchymosis,,2022,Q2,2,F,,20220518.0,20220512,20220527,EXP,,US-TEVA-2022-US-2035078,TEVA,"Naberhaus T, Jones MJ, Burns A, Raney EC. Topical Miconazole Cream and Warfarin Interaction: A Case Report. J-Pharm-Technol 2022;38(2):127-129.",85.0,YR,E,M,Y,,,20220527,,PH,US,US,2022,Q2,Elderly
208266931,20826693,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Off label use,,2022,Q2,1,I,,20220110.0,20220513,20220513,EXP,,US-PFIZER INC-202200046573,PFIZER,"Schweiger, J.. Drug induced very severe hypertriglyceridemia in a pediatric stem cell transplant recipient. Pediatric Blood and Cancer. 2022;69 (2):10.1002/pbc.29379",16.0,YR,,F,Y,,,20220513,,HP,US,US,2022,Q2,Youth
208266931,20826693,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Hypertriglyceridaemia,,2022,Q2,1,I,,20220110.0,20220513,20220513,EXP,,US-PFIZER INC-202200046573,PFIZER,"Schweiger, J.. Drug induced very severe hypertriglyceridemia in a pediatric stem cell transplant recipient. Pediatric Blood and Cancer. 2022;69 (2):10.1002/pbc.29379",16.0,YR,,F,Y,,,20220513,,HP,US,US,2022,Q2,Youth
208289101,20828910,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,INJ 75/25KWP,,,U,,,,,,,Injection,,2022,Q2,Dermatitis atopic,,2022,Q2,1,I,,20220506.0,20220513,20220513,PER,,US-SA-2022SA170153,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20220513,,MD,US,US,2022,Q2,Adult
208289101,20828910,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,INJ 75/25KWP,,,U,,,,,,,Injection,,2022,Q2,Sleep disorder,,2022,Q2,1,I,,20220506.0,20220513,20220513,PER,,US-SA-2022SA170153,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20220513,,MD,US,US,2022,Q2,Adult
208289101,20828910,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,INJ 75/25KWP,,,U,,,,,,,Injection,,2022,Q2,Discomfort,,2022,Q2,1,I,,20220506.0,20220513,20220513,PER,,US-SA-2022SA170153,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20220513,,MD,US,US,2022,Q2,Adult
208289101,20828910,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,INJ 75/25KWP,,,U,,,,,,,Injection,,2022,Q2,Abdominal pain upper,,2022,Q2,1,I,,20220506.0,20220513,20220513,PER,,US-SA-2022SA170153,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20220513,,MD,US,US,2022,Q2,Adult
208313001,20831300,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Pyrexia,,2022,Q2,1,I,,20220502.0,20220516,20220516,EXP,,CA-AUROBINDO-AUR-APL-2022-016503,AUROBINDO,,65.0,YR,,M,Y,110.0,KG,20220516,,PH,CA,CA,2022,Q2,Elderly
208313001,20831300,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Urosepsis,,2022,Q2,1,I,,20220502.0,20220516,20220516,EXP,,CA-AUROBINDO-AUR-APL-2022-016503,AUROBINDO,,65.0,YR,,M,Y,110.0,KG,20220516,,PH,CA,CA,2022,Q2,Elderly
208313001,20831300,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Clostridium test positive,,2022,Q2,1,I,,20220502.0,20220516,20220516,EXP,,CA-AUROBINDO-AUR-APL-2022-016503,AUROBINDO,,65.0,YR,,M,Y,110.0,KG,20220516,,PH,CA,CA,2022,Q2,Elderly
208354661,20835466,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 U,,,U,,,,,,,,,2022,Q2,Inappropriate schedule of product administration,,2022,Q2,1,I,,20220510.0,20220516,20220516,PER,,US-SA-2022SA171174,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220516,,CN,US,US,2022,Q2,Adult
208354661,20835466,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,10 U,,,U,,,,,,,,,2022,Q2,Off label use,,2022,Q2,1,I,,20220510.0,20220516,20220516,PER,,US-SA-2022SA171174,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220516,,CN,US,US,2022,Q2,Adult
208373131,20837313,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"23% basal and 77% bolus, total insulin dose 2.23 IU/kg/ day",,,Y,,,,,,,,,2022,Q2,Disease progression,,2022,Q2,1,I,,20220508.0,20220517,20220517,EXP,,"ES-Saptalis Pharmaceuticals,LLC-000239",SAPTALIS PHARMACEUTICALS,"ES-Saptalis Pharmaceuticals,LLC-000239-01_Initial Source Document",22.0,YR,A,M,Y,,,20220517,,HP,ES,,2022,Q2,Youth
208373131,20837313,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"23% basal and 77% bolus, total insulin dose 2.23 IU/kg/ day",,,Y,,,,,,,,,2022,Q2,Blood glucose abnormal,,2022,Q2,1,I,,20220508.0,20220517,20220517,EXP,,"ES-Saptalis Pharmaceuticals,LLC-000239",SAPTALIS PHARMACEUTICALS,"ES-Saptalis Pharmaceuticals,LLC-000239-01_Initial Source Document",22.0,YR,A,M,Y,,,20220517,,HP,ES,,2022,Q2,Youth
208373131,20837313,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"23% basal and 77% bolus, total insulin dose 2.23 IU/kg/ day",,,Y,,,,,,,,,2022,Q2,Drug ineffective,,2022,Q2,1,I,,20220508.0,20220517,20220517,EXP,,"ES-Saptalis Pharmaceuticals,LLC-000239",SAPTALIS PHARMACEUTICALS,"ES-Saptalis Pharmaceuticals,LLC-000239-01_Initial Source Document",22.0,YR,A,M,Y,,,20220517,,HP,ES,,2022,Q2,Youth
208373131,20837313,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous bolus,"23% basal and 77% bolus, total insulin dose 2.23 IU/kg/ day",,,Y,,,,,,,,,2022,Q2,Glycosylated haemoglobin increased,,2022,Q2,1,I,,20220508.0,20220517,20220517,EXP,,"ES-Saptalis Pharmaceuticals,LLC-000239",SAPTALIS PHARMACEUTICALS,"ES-Saptalis Pharmaceuticals,LLC-000239-01_Initial Source Document",22.0,YR,A,M,Y,,,20220517,,HP,ES,,2022,Q2,Youth
208440071,20844007,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (sliding scale)",,,,,D473104C,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220517.0,20220517.0,20220518,20220518,PER,,US-ELI_LILLY_AND_COMPANY-US202205007347,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20220518,,CN,US,US,2022,Q2,Elderly
208440071,20844007,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (sliding scale)",,,,,D473104C,,20563.0,,,Injection,,2022,Q2,Wrong technique in product usage process,,2022,Q2,1,I,20220517.0,20220517.0,20220518,20220518,PER,,US-ELI_LILLY_AND_COMPANY-US202205007347,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20220518,,CN,US,US,2022,Q2,Elderly
208440071,20844007,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (sliding scale)",,,,,D473104C,,20563.0,,,Injection,,2022,Q2,Product dose omission issue,,2022,Q2,1,I,20220517.0,20220517.0,20220518,20220518,PER,,US-ELI_LILLY_AND_COMPANY-US202205007347,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20220518,,CN,US,US,2022,Q2,Elderly
208466862,20846686,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,Immune-mediated hepatic disorder,,2022,Q2,2,F,20220428.0,20220513.0,20220519,20220523,EXP,,JP-009507513-2205JPN000868J,MERCK,,65.0,YR,,M,Y,,,20220523,,PH,JP,JP,2022,Q2,Elderly
208472071,20847207,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,18 Dosage forms,,,,,,,,,,,,2022,Q2,Respiratory failure,,2022,Q2,1,I,,20070808.0,20220519,20220519,EXP,,IT-GLENMARK PHARMACEUTICALS-GGEL20110200039,GLENMARK,"Tuccori M,Giuseppe L,Lapi F,et al. Gabapentin - Induced Severe Myopathy. The Annals of Pharmacotherapy 2007 Jul;41:1301-1305.",85.0,YR,,F,Y,,,20220519,,HP,IT,IT,2022,Q2,Elderly
208472071,20847207,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,18 Dosage forms,,,,,,,,,,,,2022,Q2,Acute kidney injury,,2022,Q2,1,I,,20070808.0,20220519,20220519,EXP,,IT-GLENMARK PHARMACEUTICALS-GGEL20110200039,GLENMARK,"Tuccori M,Giuseppe L,Lapi F,et al. Gabapentin - Induced Severe Myopathy. The Annals of Pharmacotherapy 2007 Jul;41:1301-1305.",85.0,YR,,F,Y,,,20220519,,HP,IT,IT,2022,Q2,Elderly
208472071,20847207,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,18 Dosage forms,,,,,,,,,,,,2022,Q2,Myopathy,,2022,Q2,1,I,,20070808.0,20220519,20220519,EXP,,IT-GLENMARK PHARMACEUTICALS-GGEL20110200039,GLENMARK,"Tuccori M,Giuseppe L,Lapi F,et al. Gabapentin - Induced Severe Myopathy. The Annals of Pharmacotherapy 2007 Jul;41:1301-1305.",85.0,YR,,F,Y,,,20220519,,HP,IT,IT,2022,Q2,Elderly
208472071,20847207,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,18 Dosage forms,,,,,,,,,,,,2022,Q2,Rhabdomyolysis,,2022,Q2,1,I,,20070808.0,20220519,20220519,EXP,,IT-GLENMARK PHARMACEUTICALS-GGEL20110200039,GLENMARK,"Tuccori M,Giuseppe L,Lapi F,et al. Gabapentin - Induced Severe Myopathy. The Annals of Pharmacotherapy 2007 Jul;41:1301-1305.",85.0,YR,,F,Y,,,20220519,,HP,IT,IT,2022,Q2,Elderly
208502671,20850267,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, daily",,,U,,,,20563.0,,,,QD,2022,Q2,Diabetic retinopathy,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, daily",,,U,,,,20563.0,,,,QD,2022,Q2,Peripheral sensory neuropathy,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, daily",,,U,,,,20563.0,,,,QD,2022,Q2,Impaired gastric emptying,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, daily",,,U,,,,20563.0,,,,QD,2022,Q2,Pain in extremity,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, daily",,,U,,,,20563.0,,,,QD,2022,Q2,Acute painful neuropathy of rapid glycaemic control,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, daily",,,U,,,,20563.0,,,,QD,2022,Q2,Hypoglycaemia,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, daily",,,U,,,,20563.0,,,,QD,2022,Q2,Nausea,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, daily",,,U,,,,20563.0,,,,QD,2022,Q2,Autonomic nervous system imbalance,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, daily",,,U,,,,20563.0,,,,QD,2022,Q2,Vomiting,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, daily",,,U,,,,20563.0,,,,QD,2022,Q2,Dizziness,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, daily",,,U,,,,20563.0,,,,QD,2022,Q2,Microalbuminuria,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, daily",,,U,,,,20563.0,,,,QD,2022,Q2,Orthostatic hypotension,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, daily",,,U,,,,20563.0,,,,QD,2022,Q2,Pain,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, qid",,,U,,,,20563.0,,,,QID,2022,Q2,Diabetic retinopathy,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, qid",,,U,,,,20563.0,,,,QID,2022,Q2,Peripheral sensory neuropathy,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, qid",,,U,,,,20563.0,,,,QID,2022,Q2,Impaired gastric emptying,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, qid",,,U,,,,20563.0,,,,QID,2022,Q2,Pain in extremity,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, qid",,,U,,,,20563.0,,,,QID,2022,Q2,Acute painful neuropathy of rapid glycaemic control,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, qid",,,U,,,,20563.0,,,,QID,2022,Q2,Hypoglycaemia,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, qid",,,U,,,,20563.0,,,,QID,2022,Q2,Nausea,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, qid",,,U,,,,20563.0,,,,QID,2022,Q2,Autonomic nervous system imbalance,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, qid",,,U,,,,20563.0,,,,QID,2022,Q2,Vomiting,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, qid",,,U,,,,20563.0,,,,QID,2022,Q2,Dizziness,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, qid",,,U,,,,20563.0,,,,QID,2022,Q2,Microalbuminuria,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, qid",,,U,,,,20563.0,,,,QID,2022,Q2,Orthostatic hypotension,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, qid",,,U,,,,20563.0,,,,QID,2022,Q2,Pain,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, bid",,,U,,,,20563.0,,,,BID,2022,Q2,Diabetic retinopathy,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, bid",,,U,,,,20563.0,,,,BID,2022,Q2,Peripheral sensory neuropathy,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, bid",,,U,,,,20563.0,,,,BID,2022,Q2,Impaired gastric emptying,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, bid",,,U,,,,20563.0,,,,BID,2022,Q2,Pain in extremity,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, bid",,,U,,,,20563.0,,,,BID,2022,Q2,Acute painful neuropathy of rapid glycaemic control,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, bid",,,U,,,,20563.0,,,,BID,2022,Q2,Hypoglycaemia,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, bid",,,U,,,,20563.0,,,,BID,2022,Q2,Nausea,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, bid",,,U,,,,20563.0,,,,BID,2022,Q2,Autonomic nervous system imbalance,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, bid",,,U,,,,20563.0,,,,BID,2022,Q2,Vomiting,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, bid",,,U,,,,20563.0,,,,BID,2022,Q2,Dizziness,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, bid",,,U,,,,20563.0,,,,BID,2022,Q2,Microalbuminuria,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, bid",,,U,,,,20563.0,,,,BID,2022,Q2,Orthostatic hypotension,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208502671,20850267,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1, bid",,,U,,,,20563.0,,,,BID,2022,Q2,Pain,,2022,Q2,1,I,,20220510.0,20220519,20220519,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202205004524,ELI LILLY AND CO,,20.0,YR,,F,Y,47.0,KG,20220519,,CN,CA,CA,2022,Q2,Youth
208508261,20850826,8,C,LISPRO 50LIS50NPL,,2,,dosage form- NOT SPECIFIED,,,,,,,,,,,,2022,Q2,Urosepsis,,2022,Q2,1,I,,20220516.0,20220519,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-171002",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,91.0,KG,20220519,,PH,CA,CA,2022,Q2,Elderly
208508261,20850826,8,C,LISPRO 50LIS50NPL,,2,,dosage form- NOT SPECIFIED,,,,,,,,,,,,2022,Q2,Bacteraemia,,2022,Q2,1,I,,20220516.0,20220519,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-171002",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,91.0,KG,20220519,,PH,CA,CA,2022,Q2,Elderly
208508261,20850826,8,C,LISPRO 50LIS50NPL,,2,,dosage form- NOT SPECIFIED,,,,,,,,,,,,2022,Q2,Klebsiella sepsis,,2022,Q2,1,I,,20220516.0,20220519,20220519,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-171002",BOEHRINGER INGELHEIM,,76.0,YR,E,M,Y,91.0,KG,20220519,,PH,CA,CA,2022,Q2,Elderly
208515251,20851525,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,(Insulin glargine and lispro) reaching 156 IU/day (total insulin dose 2.23 IU/kg/day).,,,Y,,,,,,,,,2022,Q2,Drug ineffective for unapproved indication,,2022,Q2,1,I,,20220509.0,20220520,20220520,EXP,,ES-ALS-000727,ALIGNSCIENCE PHARMA,"Martinez-Montoro J.I., Pinzon-Martin J.L., Damas-Fuentes M., Fernandez-Valero A., Tinahones F.J. Combination Therapy with Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report. Front Endocrinol (Lausanne) 2022; 13:838887. doi:10.3389/fendo.2022.838887.",13.0,YR,T,M,Y,,,20220519,,HP,ES,ES,2022,Q2,Child
208515251,20851525,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,(Insulin glargine and lispro) reaching 156 IU/day (total insulin dose 2.23 IU/kg/day).,,,Y,,,,,,,,,2022,Q2,Oedema peripheral,,2022,Q2,1,I,,20220509.0,20220520,20220520,EXP,,ES-ALS-000727,ALIGNSCIENCE PHARMA,"Martinez-Montoro J.I., Pinzon-Martin J.L., Damas-Fuentes M., Fernandez-Valero A., Tinahones F.J. Combination Therapy with Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report. Front Endocrinol (Lausanne) 2022; 13:838887. doi:10.3389/fendo.2022.838887.",13.0,YR,T,M,Y,,,20220519,,HP,ES,ES,2022,Q2,Child
208515251,20851525,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,(Insulin glargine and lispro) reaching 156 IU/day (total insulin dose 2.23 IU/kg/day).,,,Y,,,,,,,,,2022,Q2,Hyperglycaemia,,2022,Q2,1,I,,20220509.0,20220520,20220520,EXP,,ES-ALS-000727,ALIGNSCIENCE PHARMA,"Martinez-Montoro J.I., Pinzon-Martin J.L., Damas-Fuentes M., Fernandez-Valero A., Tinahones F.J. Combination Therapy with Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report. Front Endocrinol (Lausanne) 2022; 13:838887. doi:10.3389/fendo.2022.838887.",13.0,YR,T,M,Y,,,20220519,,HP,ES,ES,2022,Q2,Child
208515251,20851525,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,(Insulin glargine and lispro) reaching 156 IU/day (total insulin dose 2.23 IU/kg/day).,,,Y,,,,,,,,,2022,Q2,Condition aggravated,,2022,Q2,1,I,,20220509.0,20220520,20220520,EXP,,ES-ALS-000727,ALIGNSCIENCE PHARMA,"Martinez-Montoro J.I., Pinzon-Martin J.L., Damas-Fuentes M., Fernandez-Valero A., Tinahones F.J. Combination Therapy with Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report. Front Endocrinol (Lausanne) 2022; 13:838887. doi:10.3389/fendo.2022.838887.",13.0,YR,T,M,Y,,,20220519,,HP,ES,ES,2022,Q2,Child
208545751,20854575,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q2,International normalised ratio increased,,2022,Q2,1,I,20220509.0,20220515.0,20220520,20220520,EXP,,GB-OTSUKA-2022_027760,OTSUKA,,43.0,YR,,F,Y,,,20220520,,MD,GB,GB,2022,Q2,Adult
208651701,20865170,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Off label use,,2022,Q2,1,I,,20220516.0,20220524,20220524,EXP,,CA-BAUSCH-BL-2022-012165,BAUSCH AND LOMB,,20.0,YR,,F,Y,,,20220524,,HP,CA,CA,2022,Q2,Youth
208651701,20865170,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Drug ineffective for unapproved indication,,2022,Q2,1,I,,20220516.0,20220524,20220524,EXP,,CA-BAUSCH-BL-2022-012165,BAUSCH AND LOMB,,20.0,YR,,F,Y,,,20220524,,HP,CA,CA,2022,Q2,Youth
208663551,20866355,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D420814C,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220513.0,20220520.0,20220524,20220524,PER,,US-ELI_LILLY_AND_COMPANY-US202205009406,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20220524,,CN,US,US,2022,Q2,Elderly
208668801,20866880,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,Unknown,,,U,,,,,,,,,2022,Q2,Intra-abdominal haemorrhage,,2022,Q2,1,I,20220509.0,20220515.0,20220524,20220524,EXP,GB-MHRA-MED-202205140830138900-QA49W,GB-TORRENT-00028149,TORRENT,,43.0,YR,A,F,Y,,,20220524,,MD,GB,GB,2022,Q2,Adult
208668801,20866880,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,Unknown,,,U,,,,,,,,,2022,Q2,International normalised ratio increased,,2022,Q2,1,I,20220509.0,20220515.0,20220524,20220524,EXP,GB-MHRA-MED-202205140830138900-QA49W,GB-TORRENT-00028149,TORRENT,,43.0,YR,A,F,Y,,,20220524,,MD,GB,GB,2022,Q2,Adult
208673481,20867348,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,9 units,,,,,,,,,,,QD,2022,Q2,Atrial fibrillation,,2022,Q2,1,I,20210610.0,20220513.0,20220524,20220524,EXP,,JP-JNJFOC-20220141078,JOHNSON AND JOHNSON,,71.0,YR,E,M,Y,75.0,KG,20220524,,MD,JP,JP,2022,Q2,Elderly
208673481,20867348,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,8 units,,,,,,,,,,,QD,2022,Q2,Atrial fibrillation,,2022,Q2,1,I,20210610.0,20220513.0,20220524,20220524,EXP,,JP-JNJFOC-20220141078,JOHNSON AND JOHNSON,,71.0,YR,E,M,Y,75.0,KG,20220524,,MD,JP,JP,2022,Q2,Elderly
208673481,20867348,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 units,,,,,,,,,,,QD,2022,Q2,Atrial fibrillation,,2022,Q2,1,I,20210610.0,20220513.0,20220524,20220524,EXP,,JP-JNJFOC-20220141078,JOHNSON AND JOHNSON,,71.0,YR,E,M,Y,75.0,KG,20220524,,MD,JP,JP,2022,Q2,Elderly
208673481,20867348,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,3 units,,,,,,,,,,,QD,2022,Q2,Atrial fibrillation,,2022,Q2,1,I,20210610.0,20220513.0,20220524,20220524,EXP,,JP-JNJFOC-20220141078,JOHNSON AND JOHNSON,,71.0,YR,E,M,Y,75.0,KG,20220524,,MD,JP,JP,2022,Q2,Elderly
208673481,20867348,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 units,,,,,,,,,,,QD,2022,Q2,Atrial fibrillation,,2022,Q2,1,I,20210610.0,20220513.0,20220524,20220524,EXP,,JP-JNJFOC-20220141078,JOHNSON AND JOHNSON,,71.0,YR,E,M,Y,75.0,KG,20220524,,MD,JP,JP,2022,Q2,Elderly
208673481,20867348,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 units,,,,,,,,,,,QD,2022,Q2,Atrial fibrillation,,2022,Q2,1,I,20210610.0,20220513.0,20220524,20220524,EXP,,JP-JNJFOC-20220141078,JOHNSON AND JOHNSON,,71.0,YR,E,M,Y,75.0,KG,20220524,,MD,JP,JP,2022,Q2,Elderly
208673481,20867348,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 units,,,,,,,,,,,TID,2022,Q2,Atrial fibrillation,,2022,Q2,1,I,20210610.0,20220513.0,20220524,20220524,EXP,,JP-JNJFOC-20220141078,JOHNSON AND JOHNSON,,71.0,YR,E,M,Y,75.0,KG,20220524,,MD,JP,JP,2022,Q2,Elderly
208687511,20868751,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Bradycardia,,2022,Q2,1,I,,20220522.0,20220524,20220524,EXP,,GB-AstraZeneca-2022A193522,ASTRAZENECA,,74.0,YR,,F,Y,105.0,KG,20220524,,MD,GB,,2022,Q2,Elderly
208687511,20868751,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Dizziness,,2022,Q2,1,I,,20220522.0,20220524,20220524,EXP,,GB-AstraZeneca-2022A193522,ASTRAZENECA,,74.0,YR,,F,Y,105.0,KG,20220524,,MD,GB,,2022,Q2,Elderly
208687511,20868751,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Diabetic ketoacidosis,,2022,Q2,1,I,,20220522.0,20220524,20220524,EXP,,GB-AstraZeneca-2022A193522,ASTRAZENECA,,74.0,YR,,F,Y,105.0,KG,20220524,,MD,GB,,2022,Q2,Elderly
208687511,20868751,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Acute kidney injury,,2022,Q2,1,I,,20220522.0,20220524,20220524,EXP,,GB-AstraZeneca-2022A193522,ASTRAZENECA,,74.0,YR,,F,Y,105.0,KG,20220524,,MD,GB,,2022,Q2,Elderly
208687511,20868751,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Confusional state,,2022,Q2,1,I,,20220522.0,20220524,20220524,EXP,,GB-AstraZeneca-2022A193522,ASTRAZENECA,,74.0,YR,,F,Y,105.0,KG,20220524,,MD,GB,,2022,Q2,Elderly
208687511,20868751,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Renal failure,,2022,Q2,1,I,,20220522.0,20220524,20220524,EXP,,GB-AstraZeneca-2022A193522,ASTRAZENECA,,74.0,YR,,F,Y,105.0,KG,20220524,,MD,GB,,2022,Q2,Elderly
208687511,20868751,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Urine output decreased,,2022,Q2,1,I,,20220522.0,20220524,20220524,EXP,,GB-AstraZeneca-2022A193522,ASTRAZENECA,,74.0,YR,,F,Y,105.0,KG,20220524,,MD,GB,,2022,Q2,Elderly
208687511,20868751,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Diarrhoea,,2022,Q2,1,I,,20220522.0,20220524,20220524,EXP,,GB-AstraZeneca-2022A193522,ASTRAZENECA,,74.0,YR,,F,Y,105.0,KG,20220524,,MD,GB,,2022,Q2,Elderly
208687511,20868751,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q2,Vomiting,,2022,Q2,1,I,,20220522.0,20220524,20220524,EXP,,GB-AstraZeneca-2022A193522,ASTRAZENECA,,74.0,YR,,F,Y,105.0,KG,20220524,,MD,GB,,2022,Q2,Elderly
208864101,20886410,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 u, tid",,,U,,D395986A,,20563.0,25.0,IU,Injection,TID,2022,Q2,Diabetic ketoacidosis,,2022,Q2,1,I,20220430.0,20220516.0,20220527,20220527,EXP,,US-ELI_LILLY_AND_COMPANY-US202205006781,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20220527,,CN,US,US,2022,Q2,Adult
208880941,20888094,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, each morning",,,Y,,D341138C,,20563.0,5.0,IU,Solution for injection,QD,2022,Q2,Feeling abnormal,,2022,Q2,1,I,20220501.0,20220526.0,20220529,20220529,PER,,US-ELI_LILLY_AND_COMPANY-US202205011913,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20220529,,CN,US,US,2022,Q2,Elderly
208880941,20888094,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, each morning",,,Y,,D341138C,,20563.0,5.0,IU,Solution for injection,QD,2022,Q2,Pain,,2022,Q2,1,I,20220501.0,20220526.0,20220529,20220529,PER,,US-ELI_LILLY_AND_COMPANY-US202205011913,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20220529,,CN,US,US,2022,Q2,Elderly
208880941,20888094,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, each morning",,,Y,,D341138C,,20563.0,5.0,IU,Solution for injection,QD,2022,Q2,Intervertebral disc protrusion,,2022,Q2,1,I,20220501.0,20220526.0,20220529,20220529,PER,,US-ELI_LILLY_AND_COMPANY-US202205011913,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20220529,,CN,US,US,2022,Q2,Elderly
208880941,20888094,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, each morning",,,Y,,D341138C,,20563.0,5.0,IU,Solution for injection,QD,2022,Q2,Dizziness,,2022,Q2,1,I,20220501.0,20220526.0,20220529,20220529,PER,,US-ELI_LILLY_AND_COMPANY-US202205011913,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20220529,,CN,US,US,2022,Q2,Elderly
208880941,20888094,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, each morning",,,Y,,D341138C,,20563.0,5.0,IU,Solution for injection,QD,2022,Q2,Headache,,2022,Q2,1,I,20220501.0,20220526.0,20220529,20220529,PER,,US-ELI_LILLY_AND_COMPANY-US202205011913,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20220529,,CN,US,US,2022,Q2,Elderly
208880941,20888094,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, each morning",,,Y,,D341138C,,20563.0,5.0,IU,Solution for injection,QD,2022,Q2,Blood glucose fluctuation,,2022,Q2,1,I,20220501.0,20220526.0,20220529,20220529,PER,,US-ELI_LILLY_AND_COMPANY-US202205011913,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20220529,,CN,US,US,2022,Q2,Elderly
208880941,20888094,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, each morning",,,Y,,D341138C,,20563.0,5.0,IU,Solution for injection,QD,2022,Q2,Abdominal pain upper,,2022,Q2,1,I,20220501.0,20220526.0,20220529,20220529,PER,,US-ELI_LILLY_AND_COMPANY-US202205011913,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20220529,,CN,US,US,2022,Q2,Elderly
208880941,20888094,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, each morning",,,Y,,D341138C,,20563.0,5.0,IU,Solution for injection,QD,2022,Q2,Nausea,,2022,Q2,1,I,20220501.0,20220526.0,20220529,20220529,PER,,US-ELI_LILLY_AND_COMPANY-US202205011913,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20220529,,CN,US,US,2022,Q2,Elderly
208880941,20888094,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, each morning",,,Y,,D341138C,,20563.0,5.0,IU,Solution for injection,QD,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220501.0,20220526.0,20220529,20220529,PER,,US-ELI_LILLY_AND_COMPANY-US202205011913,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20220529,,CN,US,US,2022,Q2,Elderly
208880941,20888094,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, each evening",,,Y,,D341138C,,20563.0,6.0,IU,Solution for injection,QD,2022,Q2,Feeling abnormal,,2022,Q2,1,I,20220501.0,20220526.0,20220529,20220529,PER,,US-ELI_LILLY_AND_COMPANY-US202205011913,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20220529,,CN,US,US,2022,Q2,Elderly
208880941,20888094,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, each evening",,,Y,,D341138C,,20563.0,6.0,IU,Solution for injection,QD,2022,Q2,Pain,,2022,Q2,1,I,20220501.0,20220526.0,20220529,20220529,PER,,US-ELI_LILLY_AND_COMPANY-US202205011913,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20220529,,CN,US,US,2022,Q2,Elderly
208880941,20888094,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, each evening",,,Y,,D341138C,,20563.0,6.0,IU,Solution for injection,QD,2022,Q2,Intervertebral disc protrusion,,2022,Q2,1,I,20220501.0,20220526.0,20220529,20220529,PER,,US-ELI_LILLY_AND_COMPANY-US202205011913,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20220529,,CN,US,US,2022,Q2,Elderly
208880941,20888094,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, each evening",,,Y,,D341138C,,20563.0,6.0,IU,Solution for injection,QD,2022,Q2,Dizziness,,2022,Q2,1,I,20220501.0,20220526.0,20220529,20220529,PER,,US-ELI_LILLY_AND_COMPANY-US202205011913,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20220529,,CN,US,US,2022,Q2,Elderly
208880941,20888094,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, each evening",,,Y,,D341138C,,20563.0,6.0,IU,Solution for injection,QD,2022,Q2,Headache,,2022,Q2,1,I,20220501.0,20220526.0,20220529,20220529,PER,,US-ELI_LILLY_AND_COMPANY-US202205011913,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20220529,,CN,US,US,2022,Q2,Elderly
208880941,20888094,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, each evening",,,Y,,D341138C,,20563.0,6.0,IU,Solution for injection,QD,2022,Q2,Blood glucose fluctuation,,2022,Q2,1,I,20220501.0,20220526.0,20220529,20220529,PER,,US-ELI_LILLY_AND_COMPANY-US202205011913,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20220529,,CN,US,US,2022,Q2,Elderly
208880941,20888094,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, each evening",,,Y,,D341138C,,20563.0,6.0,IU,Solution for injection,QD,2022,Q2,Abdominal pain upper,,2022,Q2,1,I,20220501.0,20220526.0,20220529,20220529,PER,,US-ELI_LILLY_AND_COMPANY-US202205011913,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20220529,,CN,US,US,2022,Q2,Elderly
208880941,20888094,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, each evening",,,Y,,D341138C,,20563.0,6.0,IU,Solution for injection,QD,2022,Q2,Nausea,,2022,Q2,1,I,20220501.0,20220526.0,20220529,20220529,PER,,US-ELI_LILLY_AND_COMPANY-US202205011913,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20220529,,CN,US,US,2022,Q2,Elderly
208880941,20888094,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, each evening",,,Y,,D341138C,,20563.0,6.0,IU,Solution for injection,QD,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220501.0,20220526.0,20220529,20220529,PER,,US-ELI_LILLY_AND_COMPANY-US202205011913,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20220529,,CN,US,US,2022,Q2,Elderly
208889741,20888974,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 u, unknown (with each meal)",,,U,,,,20563.0,14.0,IU,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220420.0,20220516.0,20220530,20220530,PER,,US-ELI_LILLY_AND_COMPANY-US202205006754,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20220530,,CN,US,US,2022,Q2,Adult
208889741,20888974,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 u, unknown (with each meal)",,,U,,,,20563.0,14.0,IU,Injection,,2022,Q2,Neuropathy peripheral,,2022,Q2,1,I,20220420.0,20220516.0,20220530,20220530,PER,,US-ELI_LILLY_AND_COMPANY-US202205006754,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20220530,,CN,US,US,2022,Q2,Adult
208889741,20888974,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 u, unknown (with each meal)",,,U,,,,20563.0,14.0,IU,Injection,,2022,Q2,Intermittent claudication,,2022,Q2,1,I,20220420.0,20220516.0,20220530,20220530,PER,,US-ELI_LILLY_AND_COMPANY-US202205006754,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20220530,,CN,US,US,2022,Q2,Adult
208889741,20888974,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 u, unknown (with each meal)",,,U,,,,20563.0,14.0,IU,Injection,,2022,Q2,Limb discomfort,,2022,Q2,1,I,20220420.0,20220516.0,20220530,20220530,PER,,US-ELI_LILLY_AND_COMPANY-US202205006754,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20220530,,CN,US,US,2022,Q2,Adult
208889741,20888974,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 u, unknown (with each meal)",,,U,,,,20563.0,14.0,IU,Injection,,2022,Q2,Drug ineffective,,2022,Q2,1,I,20220420.0,20220516.0,20220530,20220530,PER,,US-ELI_LILLY_AND_COMPANY-US202205006754,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20220530,,CN,US,US,2022,Q2,Adult
208889741,20888974,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 u, unknown (with each meal)",,,U,,,,20563.0,14.0,IU,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220420.0,20220516.0,20220530,20220530,PER,,US-ELI_LILLY_AND_COMPANY-US202205006754,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20220530,,CN,US,US,2022,Q2,Adult
208889741,20888974,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 u, unknown (with each meal)",,,U,,,,20563.0,14.0,IU,Injection,,2022,Q2,Neuropathy peripheral,,2022,Q2,1,I,20220420.0,20220516.0,20220530,20220530,PER,,US-ELI_LILLY_AND_COMPANY-US202205006754,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20220530,,CN,US,US,2022,Q2,Adult
208889741,20888974,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 u, unknown (with each meal)",,,U,,,,20563.0,14.0,IU,Injection,,2022,Q2,Intermittent claudication,,2022,Q2,1,I,20220420.0,20220516.0,20220530,20220530,PER,,US-ELI_LILLY_AND_COMPANY-US202205006754,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20220530,,CN,US,US,2022,Q2,Adult
208889741,20888974,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 u, unknown (with each meal)",,,U,,,,20563.0,14.0,IU,Injection,,2022,Q2,Limb discomfort,,2022,Q2,1,I,20220420.0,20220516.0,20220530,20220530,PER,,US-ELI_LILLY_AND_COMPANY-US202205006754,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20220530,,CN,US,US,2022,Q2,Adult
208889741,20888974,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 u, unknown (with each meal)",,,U,,,,20563.0,14.0,IU,Injection,,2022,Q2,Drug ineffective,,2022,Q2,1,I,20220420.0,20220516.0,20220530,20220530,PER,,US-ELI_LILLY_AND_COMPANY-US202205006754,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20220530,,CN,US,US,2022,Q2,Adult
208889741,20888974,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 u, unknown (with each meal)",,,U,,D456541A,,20563.0,14.0,IU,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220420.0,20220516.0,20220530,20220530,PER,,US-ELI_LILLY_AND_COMPANY-US202205006754,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20220530,,CN,US,US,2022,Q2,Adult
208889741,20888974,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 u, unknown (with each meal)",,,U,,D456541A,,20563.0,14.0,IU,Injection,,2022,Q2,Neuropathy peripheral,,2022,Q2,1,I,20220420.0,20220516.0,20220530,20220530,PER,,US-ELI_LILLY_AND_COMPANY-US202205006754,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20220530,,CN,US,US,2022,Q2,Adult
208889741,20888974,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 u, unknown (with each meal)",,,U,,D456541A,,20563.0,14.0,IU,Injection,,2022,Q2,Intermittent claudication,,2022,Q2,1,I,20220420.0,20220516.0,20220530,20220530,PER,,US-ELI_LILLY_AND_COMPANY-US202205006754,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20220530,,CN,US,US,2022,Q2,Adult
208889741,20888974,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 u, unknown (with each meal)",,,U,,D456541A,,20563.0,14.0,IU,Injection,,2022,Q2,Limb discomfort,,2022,Q2,1,I,20220420.0,20220516.0,20220530,20220530,PER,,US-ELI_LILLY_AND_COMPANY-US202205006754,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20220530,,CN,US,US,2022,Q2,Adult
208889741,20888974,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 u, unknown (with each meal)",,,U,,D456541A,,20563.0,14.0,IU,Injection,,2022,Q2,Drug ineffective,,2022,Q2,1,I,20220420.0,20220516.0,20220530,20220530,PER,,US-ELI_LILLY_AND_COMPANY-US202205006754,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20220530,,CN,US,US,2022,Q2,Adult
208889741,20888974,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 u, unknown (with each meal)",,,U,,D456541A,,20563.0,14.0,IU,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220420.0,20220516.0,20220530,20220530,PER,,US-ELI_LILLY_AND_COMPANY-US202205006754,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20220530,,CN,US,US,2022,Q2,Adult
208889741,20888974,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 u, unknown (with each meal)",,,U,,D456541A,,20563.0,14.0,IU,Injection,,2022,Q2,Neuropathy peripheral,,2022,Q2,1,I,20220420.0,20220516.0,20220530,20220530,PER,,US-ELI_LILLY_AND_COMPANY-US202205006754,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20220530,,CN,US,US,2022,Q2,Adult
208889741,20888974,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 u, unknown (with each meal)",,,U,,D456541A,,20563.0,14.0,IU,Injection,,2022,Q2,Intermittent claudication,,2022,Q2,1,I,20220420.0,20220516.0,20220530,20220530,PER,,US-ELI_LILLY_AND_COMPANY-US202205006754,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20220530,,CN,US,US,2022,Q2,Adult
208889741,20888974,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 u, unknown (with each meal)",,,U,,D456541A,,20563.0,14.0,IU,Injection,,2022,Q2,Limb discomfort,,2022,Q2,1,I,20220420.0,20220516.0,20220530,20220530,PER,,US-ELI_LILLY_AND_COMPANY-US202205006754,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20220530,,CN,US,US,2022,Q2,Adult
208889741,20888974,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 u, unknown (with each meal)",,,U,,D456541A,,20563.0,14.0,IU,Injection,,2022,Q2,Drug ineffective,,2022,Q2,1,I,20220420.0,20220516.0,20220530,20220530,PER,,US-ELI_LILLY_AND_COMPANY-US202205006754,ELI LILLY AND CO,,56.0,YR,,M,Y,,,20220530,,CN,US,US,2022,Q2,Adult
208920841,20892084,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Other,"vial, 100u/ml via an unknown insulin pump",,,U,,Unknown,,,,,,,2022,Q2,Medullary thyroid cancer,,2022,Q2,1,I,,20220519.0,20220530,20220530,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-173412",BOEHRINGER INGELHEIM,,58.0,YR,A,,Y,,,20220530,,MD,US,US,2022,Q2,Adult
208931161,20893116,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Frequency text: 3 Times a day with meals as needed?Adjust by 0.5,,,,,,,,100.0,MG,Unknown,,2022,Q2,Fatigue,,2022,Q2,1,I,20210101.0,20220421.0,20220531,20220531,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20211101761,BRISTOL MYERS SQUIBB,,70.0,YR,E,M,Y,70.76,KG,20220531,,HP,US,US,2022,Q2,Elderly
208931161,20893116,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Frequency text: 3 Times a day with meals as needed?Adjust by 0.5,,,,,,,,100.0,MG,Unknown,,2022,Q2,Pyrexia,,2022,Q2,1,I,20210101.0,20220421.0,20220531,20220531,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20211101761,BRISTOL MYERS SQUIBB,,70.0,YR,E,M,Y,70.76,KG,20220531,,HP,US,US,2022,Q2,Elderly
208931161,20893116,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Frequency text: 3 Times a day with meals as needed?Adjust by 0.5,,,,,,,,100.0,MG,Unknown,,2022,Q2,Peripheral swelling,,2022,Q2,1,I,20210101.0,20220421.0,20220531,20220531,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20211101761,BRISTOL MYERS SQUIBB,,70.0,YR,E,M,Y,70.76,KG,20220531,,HP,US,US,2022,Q2,Elderly
208931161,20893116,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Frequency text: 3 Times a day with meals as needed?Adjust by 0.5,,,,,,,,100.0,MG,Unknown,,2022,Q2,Back pain,,2022,Q2,1,I,20210101.0,20220421.0,20220531,20220531,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20211101761,BRISTOL MYERS SQUIBB,,70.0,YR,E,M,Y,70.76,KG,20220531,,HP,US,US,2022,Q2,Elderly
208934211,20893421,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Drug ineffective,,2022,Q2,1,I,20220526.0,20220525.0,20220531,20220531,PER,,US-ELI_LILLY_AND_COMPANY-US202205012846,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20220531,,CN,US,US,2022,Q2,Adult
208934211,20893421,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Musculoskeletal discomfort,,2022,Q2,1,I,20220526.0,20220525.0,20220531,20220531,PER,,US-ELI_LILLY_AND_COMPANY-US202205012846,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20220531,,CN,US,US,2022,Q2,Adult
208934211,20893421,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Myopia,,2022,Q2,1,I,20220526.0,20220525.0,20220531,20220531,PER,,US-ELI_LILLY_AND_COMPANY-US202205012846,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20220531,,CN,US,US,2022,Q2,Adult
208934211,20893421,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220526.0,20220525.0,20220531,20220531,PER,,US-ELI_LILLY_AND_COMPANY-US202205012846,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20220531,,CN,US,US,2022,Q2,Adult
208934211,20893421,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D455780C,,20563.0,,,Injection,,2022,Q2,Drug ineffective,,2022,Q2,1,I,20220526.0,20220525.0,20220531,20220531,PER,,US-ELI_LILLY_AND_COMPANY-US202205012846,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20220531,,CN,US,US,2022,Q2,Adult
208934211,20893421,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D455780C,,20563.0,,,Injection,,2022,Q2,Musculoskeletal discomfort,,2022,Q2,1,I,20220526.0,20220525.0,20220531,20220531,PER,,US-ELI_LILLY_AND_COMPANY-US202205012846,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20220531,,CN,US,US,2022,Q2,Adult
208934211,20893421,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D455780C,,20563.0,,,Injection,,2022,Q2,Myopia,,2022,Q2,1,I,20220526.0,20220525.0,20220531,20220531,PER,,US-ELI_LILLY_AND_COMPANY-US202205012846,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20220531,,CN,US,US,2022,Q2,Adult
208934211,20893421,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D455780C,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220526.0,20220525.0,20220531,20220531,PER,,US-ELI_LILLY_AND_COMPANY-US202205012846,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20220531,,CN,US,US,2022,Q2,Adult
208943671,20894367,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10 IU,,,U,,,,,,,,,2022,Q2,Dyspnoea,,2022,Q2,1,I,20211220.0,20220520.0,20220531,20220531,EXP,RU-RUS-1290703,RU-NOVOPROD-921412,NOVO NORDISK,,35.0,YR,,M,Y,61.0,KG,20220531,,MD,RU,RU,2022,Q2,Adult
208943671,20894367,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10 IU,,,U,,,,,,,,,2022,Q2,Injection site pruritus,,2022,Q2,1,I,20211220.0,20220520.0,20220531,20220531,EXP,RU-RUS-1290703,RU-NOVOPROD-921412,NOVO NORDISK,,35.0,YR,,M,Y,61.0,KG,20220531,,MD,RU,RU,2022,Q2,Adult
208943671,20894367,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10 IU,,,U,,,,,,,,,2022,Q2,Injection site erythema,,2022,Q2,1,I,20211220.0,20220520.0,20220531,20220531,EXP,RU-RUS-1290703,RU-NOVOPROD-921412,NOVO NORDISK,,35.0,YR,,M,Y,61.0,KG,20220531,,MD,RU,RU,2022,Q2,Adult
208968071,20896807,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,ICR 1u:10g and correction factor 1u:50mg/dL above 120mg/dL,,,U,,,,,,,,,2022,Q2,Hypoglycaemia,,2022,Q2,1,I,,20220523.0,20220531,20220531,EXP,,US-SA-2022SA193810,SANOFI AVENTIS,"Silparshetty S, Bhatt B.. Abstract #1004292: Type 1 Diabetes, Adrenal Insufficiency and Preeclampsia: A Case Report.. Endocrine Practice. 2021;27(6):S19-S20",20.0,YR,A,F,Y,,,20220531,,HP,US,US,2022,Q2,Youth
208968071,20896807,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,ICR 1u:10g and correction factor 1u:50mg/dL above 120mg/dL,,,U,,,,,,,,,2022,Q2,Unresponsive to stimuli,,2022,Q2,1,I,,20220523.0,20220531,20220531,EXP,,US-SA-2022SA193810,SANOFI AVENTIS,"Silparshetty S, Bhatt B.. Abstract #1004292: Type 1 Diabetes, Adrenal Insufficiency and Preeclampsia: A Case Report.. Endocrine Practice. 2021;27(6):S19-S20",20.0,YR,A,F,Y,,,20220531,,HP,US,US,2022,Q2,Youth
208968071,20896807,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,ICR 1u:10g and correction factor 1u:50mg/dL above 120mg/dL,,,U,,,,,,,,,2022,Q2,Exposure during pregnancy,,2022,Q2,1,I,,20220523.0,20220531,20220531,EXP,,US-SA-2022SA193810,SANOFI AVENTIS,"Silparshetty S, Bhatt B.. Abstract #1004292: Type 1 Diabetes, Adrenal Insufficiency and Preeclampsia: A Case Report.. Endocrine Practice. 2021;27(6):S19-S20",20.0,YR,A,F,Y,,,20220531,,HP,US,US,2022,Q2,Youth
208968071,20896807,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,dose titration,,,U,,,,,,,,,2022,Q2,Hypoglycaemia,,2022,Q2,1,I,,20220523.0,20220531,20220531,EXP,,US-SA-2022SA193810,SANOFI AVENTIS,"Silparshetty S, Bhatt B.. Abstract #1004292: Type 1 Diabetes, Adrenal Insufficiency and Preeclampsia: A Case Report.. Endocrine Practice. 2021;27(6):S19-S20",20.0,YR,A,F,Y,,,20220531,,HP,US,US,2022,Q2,Youth
208968071,20896807,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,dose titration,,,U,,,,,,,,,2022,Q2,Unresponsive to stimuli,,2022,Q2,1,I,,20220523.0,20220531,20220531,EXP,,US-SA-2022SA193810,SANOFI AVENTIS,"Silparshetty S, Bhatt B.. Abstract #1004292: Type 1 Diabetes, Adrenal Insufficiency and Preeclampsia: A Case Report.. Endocrine Practice. 2021;27(6):S19-S20",20.0,YR,A,F,Y,,,20220531,,HP,US,US,2022,Q2,Youth
208968071,20896807,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,dose titration,,,U,,,,,,,,,2022,Q2,Exposure during pregnancy,,2022,Q2,1,I,,20220523.0,20220531,20220531,EXP,,US-SA-2022SA193810,SANOFI AVENTIS,"Silparshetty S, Bhatt B.. Abstract #1004292: Type 1 Diabetes, Adrenal Insufficiency and Preeclampsia: A Case Report.. Endocrine Practice. 2021;27(6):S19-S20",20.0,YR,A,F,Y,,,20220531,,HP,US,US,2022,Q2,Youth
208995631,20899563,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 u, each morning",,,,,,,21017.0,24.0,IU,Injection,QD,2022,Q2,Accidental underdose,,2022,Q2,1,I,20220430.0,20220502.0,20220601,20220601,PER,,US-ELI_LILLY_AND_COMPANY-US202205001121,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20220601,,CN,US,US,2022,Q2,Elderly
208995631,20899563,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 u, each morning",,,,,,,21017.0,24.0,IU,Injection,QD,2022,Q2,Product storage error,,2022,Q2,1,I,20220430.0,20220502.0,20220601,20220601,PER,,US-ELI_LILLY_AND_COMPANY-US202205001121,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20220601,,CN,US,US,2022,Q2,Elderly
208995631,20899563,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 u, each evening",,,,,,,21017.0,3.0,IU,Injection,QD,2022,Q2,Accidental underdose,,2022,Q2,1,I,20220430.0,20220502.0,20220601,20220601,PER,,US-ELI_LILLY_AND_COMPANY-US202205001121,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20220601,,CN,US,US,2022,Q2,Elderly
208995631,20899563,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 u, each evening",,,,,,,21017.0,3.0,IU,Injection,QD,2022,Q2,Product storage error,,2022,Q2,1,I,20220430.0,20220502.0,20220601,20220601,PER,,US-ELI_LILLY_AND_COMPANY-US202205001121,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20220601,,CN,US,US,2022,Q2,Elderly
208995631,20899563,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 u, each morning",,,,,D134925J,,21017.0,24.0,IU,Injection,QD,2022,Q2,Accidental underdose,,2022,Q2,1,I,20220430.0,20220502.0,20220601,20220601,PER,,US-ELI_LILLY_AND_COMPANY-US202205001121,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20220601,,CN,US,US,2022,Q2,Elderly
208995631,20899563,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 u, each morning",,,,,D134925J,,21017.0,24.0,IU,Injection,QD,2022,Q2,Product storage error,,2022,Q2,1,I,20220430.0,20220502.0,20220601,20220601,PER,,US-ELI_LILLY_AND_COMPANY-US202205001121,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20220601,,CN,US,US,2022,Q2,Elderly
208995631,20899563,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 u, each evening",,,,,D134925J,,21017.0,3.0,IU,Injection,QD,2022,Q2,Accidental underdose,,2022,Q2,1,I,20220430.0,20220502.0,20220601,20220601,PER,,US-ELI_LILLY_AND_COMPANY-US202205001121,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20220601,,CN,US,US,2022,Q2,Elderly
208995631,20899563,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 u, each evening",,,,,D134925J,,21017.0,3.0,IU,Injection,QD,2022,Q2,Product storage error,,2022,Q2,1,I,20220430.0,20220502.0,20220601,20220601,PER,,US-ELI_LILLY_AND_COMPANY-US202205001121,ELI LILLY AND CO,,83.0,YR,,F,Y,,,20220601,,CN,US,US,2022,Q2,Elderly
209001901,20900190,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,U,,,,20563.0,12.0,IU,Injection,,2022,Q2,Injection site dryness,,2022,Q2,1,I,20220520.0,20220520.0,20220601,20220601,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20220601,,CN,US,US,2022,Q2,Elderly
209001901,20900190,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,U,,,,20563.0,12.0,IU,Injection,,2022,Q2,Accidental underdose,,2022,Q2,1,I,20220520.0,20220520.0,20220601,20220601,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20220601,,CN,US,US,2022,Q2,Elderly
209001901,20900190,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,U,,,,20563.0,12.0,IU,Injection,,2022,Q2,Blood glucose decreased,,2022,Q2,1,I,20220520.0,20220520.0,20220601,20220601,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20220601,,CN,US,US,2022,Q2,Elderly
209001901,20900190,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,U,,,,20563.0,12.0,IU,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220520.0,20220520.0,20220601,20220601,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20220601,,CN,US,US,2022,Q2,Elderly
209001901,20900190,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,U,,,,20563.0,12.0,IU,Injection,,2022,Q2,Injection site dryness,,2022,Q2,1,I,20220520.0,20220520.0,20220601,20220601,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20220601,,CN,US,US,2022,Q2,Elderly
209001901,20900190,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,U,,,,20563.0,12.0,IU,Injection,,2022,Q2,Accidental underdose,,2022,Q2,1,I,20220520.0,20220520.0,20220601,20220601,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20220601,,CN,US,US,2022,Q2,Elderly
209001901,20900190,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,U,,,,20563.0,12.0,IU,Injection,,2022,Q2,Blood glucose decreased,,2022,Q2,1,I,20220520.0,20220520.0,20220601,20220601,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20220601,,CN,US,US,2022,Q2,Elderly
209001901,20900190,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,U,,,,20563.0,12.0,IU,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220520.0,20220520.0,20220601,20220601,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20220601,,CN,US,US,2022,Q2,Elderly
209001901,20900190,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,U,,D420814C,,20563.0,12.0,IU,Injection,,2022,Q2,Injection site dryness,,2022,Q2,1,I,20220520.0,20220520.0,20220601,20220601,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20220601,,CN,US,US,2022,Q2,Elderly
209001901,20900190,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,U,,D420814C,,20563.0,12.0,IU,Injection,,2022,Q2,Accidental underdose,,2022,Q2,1,I,20220520.0,20220520.0,20220601,20220601,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20220601,,CN,US,US,2022,Q2,Elderly
209001901,20900190,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,U,,D420814C,,20563.0,12.0,IU,Injection,,2022,Q2,Blood glucose decreased,,2022,Q2,1,I,20220520.0,20220520.0,20220601,20220601,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20220601,,CN,US,US,2022,Q2,Elderly
209001901,20900190,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,U,,D420814C,,20563.0,12.0,IU,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220520.0,20220520.0,20220601,20220601,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20220601,,CN,US,US,2022,Q2,Elderly
209001901,20900190,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,U,,D420814C,,20563.0,12.0,IU,Injection,,2022,Q2,Injection site dryness,,2022,Q2,1,I,20220520.0,20220520.0,20220601,20220601,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20220601,,CN,US,US,2022,Q2,Elderly
209001901,20900190,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,U,,D420814C,,20563.0,12.0,IU,Injection,,2022,Q2,Accidental underdose,,2022,Q2,1,I,20220520.0,20220520.0,20220601,20220601,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20220601,,CN,US,US,2022,Q2,Elderly
209001901,20900190,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,U,,D420814C,,20563.0,12.0,IU,Injection,,2022,Q2,Blood glucose decreased,,2022,Q2,1,I,20220520.0,20220520.0,20220601,20220601,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20220601,,CN,US,US,2022,Q2,Elderly
209001901,20900190,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown",,,U,,D420814C,,20563.0,12.0,IU,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220520.0,20220520.0,20220601,20220601,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20220601,,CN,US,US,2022,Q2,Elderly
209008351,20900835,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 u, unknown",,,,,D386746C,,20563.0,1.0,IU,Solution for injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220526.0,20220531.0,20220601,20220601,PER,,US-ELI_LILLY_AND_COMPANY-US202206000319,ELI LILLY AND CO,,41.0,YR,,M,Y,,,20220601,,CN,US,US,2022,Q2,Adult
209008351,20900835,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 u, unknown",,,,,D386746C,,20563.0,1.0,IU,Solution for injection,,2022,Q2,Blood glucose decreased,,2022,Q2,1,I,20220526.0,20220531.0,20220601,20220601,PER,,US-ELI_LILLY_AND_COMPANY-US202206000319,ELI LILLY AND CO,,41.0,YR,,M,Y,,,20220601,,CN,US,US,2022,Q2,Adult
209014401,20901440,2,C,LISPRO ,,2,,,,,,,,,,,,,,2022,Q2,Amnesia,,2022,Q2,1,I,20211116.0,,20220601,20220601,DIR,617529,,FDA-CTU,,64.0,YR,,F,N,119.25,KG,20220601,N,CN,US,,2022,Q2,Adult
209014401,20901440,2,C,LISPRO ,,2,,,,,,,,,,,,,,2022,Q2,Seizure,,2022,Q2,1,I,20211116.0,,20220601,20220601,DIR,617529,,FDA-CTU,,64.0,YR,,F,N,119.25,KG,20220601,N,CN,US,,2022,Q2,Adult
209014401,20901440,2,C,LISPRO ,,2,,,,,,,,,,,,,,2022,Q2,Altered state of consciousness,,2022,Q2,1,I,20211116.0,,20220601,20220601,DIR,617529,,FDA-CTU,,64.0,YR,,F,N,119.25,KG,20220601,N,CN,US,,2022,Q2,Adult
209014401,20901440,2,C,LISPRO ,,2,,,,,,,,,,,,,,2022,Q2,Aphasia,,2022,Q2,1,I,20211116.0,,20220601,20220601,DIR,617529,,FDA-CTU,,64.0,YR,,F,N,119.25,KG,20220601,N,CN,US,,2022,Q2,Adult
209019301,20901930,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (gradually up titrated to 100 units daily),,,D,,Unknown,,,,,,,2022,Q2,Exposure during pregnancy,,2022,Q2,1,I,,20220518.0,20220601,20220601,PER,,US-LUPIN PHARMACEUTICALS INC.-2022-07792,LUPIN,Shiffrin E. A Case of using u-500 during pregnancy for optimal glycemic control. Endocrine Practice. 2022;28(5):S48-S49,24.0,YR,,F,Y,,,20220601,,MD,US,US,2022,Q2,Young Adult
209019301,20901930,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (gradually up titrated to 100 units daily),,,D,,Unknown,,,,,,,2022,Q2,Normal newborn,,2022,Q2,1,I,,20220518.0,20220601,20220601,PER,,US-LUPIN PHARMACEUTICALS INC.-2022-07792,LUPIN,Shiffrin E. A Case of using u-500 during pregnancy for optimal glycemic control. Endocrine Practice. 2022;28(5):S48-S49,24.0,YR,,F,Y,,,20220601,,MD,US,US,2022,Q2,Young Adult
209064351,20906435,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220527.0,20220531.0,20220602,20220602,PER,,US-PFIZER INC-202200780524,PFIZER,,39.0,YR,,M,Y,,,20220602,,CN,US,US,2022,Q2,Adult
209079581,20907958,19,C,premixed insulin lispro protamine suspension,,2,,suspension,,,,,,,,,,,,2022,Q2,Acute kidney injury,,2022,Q2,1,I,,20220523.0,20220602,20220602,EXP,,PL-TEVA-2022-PL-2041160,TEVA,Szymanek-Pasternak A. Severe chronic atopic dermatitis improvement after hepatitis C virus elimination with sofosbuvir/ledipasvir treatment. ADVANCES IN DERMATOLOGY AND ALLERGOLOGY. 2022;(2):424-425.,59.0,YR,A,M,Y,,,20220602,,MD,PL,PL,2022,Q2,Adult
209079581,20907958,19,C,premixed insulin lispro protamine suspension,,2,,suspension,,,,,,,,,,,,2022,Q2,Hypertension,,2022,Q2,1,I,,20220523.0,20220602,20220602,EXP,,PL-TEVA-2022-PL-2041160,TEVA,Szymanek-Pasternak A. Severe chronic atopic dermatitis improvement after hepatitis C virus elimination with sofosbuvir/ledipasvir treatment. ADVANCES IN DERMATOLOGY AND ALLERGOLOGY. 2022;(2):424-425.,59.0,YR,A,M,Y,,,20220602,,MD,PL,PL,2022,Q2,Adult
209079581,20907958,19,C,premixed insulin lispro protamine suspension,,2,,suspension,,,,,,,,,,,,2022,Q2,Drug ineffective,,2022,Q2,1,I,,20220523.0,20220602,20220602,EXP,,PL-TEVA-2022-PL-2041160,TEVA,Szymanek-Pasternak A. Severe chronic atopic dermatitis improvement after hepatitis C virus elimination with sofosbuvir/ledipasvir treatment. ADVANCES IN DERMATOLOGY AND ALLERGOLOGY. 2022;(2):424-425.,59.0,YR,A,M,Y,,,20220602,,MD,PL,PL,2022,Q2,Adult
209115961,20911596,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ICR 1U:10g and correction factor 1U:50 mg/dL above 120 mg/dL,,,U,U,UNK,,,,,,,2022,Q2,Unresponsive to stimuli,,2022,Q2,1,I,,20220527.0,20220603,20220603,EXP,,US-MYLANLABS-2022M1041993,MYLAN,"Silparshetty S, Bhatt B. Abstract #1004292: Type 1 Diabetes, Adrenal Insufficiency and Preeclampsia: A Case Report. Endocr-Pract 2021;27 (Suppl.)(6):S19-S20.",20.0,YR,,F,Y,,,20220603,,HP,US,US,2022,Q2,Youth
209115961,20911596,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ICR 1U:10g and correction factor 1U:50 mg/dL above 120 mg/dL,,,U,U,UNK,,,,,,,2022,Q2,Hypoglycaemia,,2022,Q2,1,I,,20220527.0,20220603,20220603,EXP,,US-MYLANLABS-2022M1041993,MYLAN,"Silparshetty S, Bhatt B. Abstract #1004292: Type 1 Diabetes, Adrenal Insufficiency and Preeclampsia: A Case Report. Endocr-Pract 2021;27 (Suppl.)(6):S19-S20.",20.0,YR,,F,Y,,,20220603,,HP,US,US,2022,Q2,Youth
209115961,20911596,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,ICR 1U:10g and correction factor 1U:50 mg/dL above 120 mg/dL,,,U,U,UNK,,,,,,,2022,Q2,Maternal exposure during pregnancy,,2022,Q2,1,I,,20220527.0,20220603,20220603,EXP,,US-MYLANLABS-2022M1041993,MYLAN,"Silparshetty S, Bhatt B. Abstract #1004292: Type 1 Diabetes, Adrenal Insufficiency and Preeclampsia: A Case Report. Endocr-Pract 2021;27 (Suppl.)(6):S19-S20.",20.0,YR,,F,Y,,,20220603,,HP,US,US,2022,Q2,Youth
209123431,20912343,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,5-10 Units before meals,,,D,,,,,,,,,2022,Q2,Vaginal haemorrhage,,2022,Q2,1,I,,20220525.0,20220603,20220603,EXP,,US-CORCEPT THERAPEUTICS INC.-US-2022CRT000862,CORCEPT,"Santos A., Branis N.. Abstract #1002287: A Case of Diabetic Ketoacidosis in Medical Management of Miscarriage. Endocrine Practice. 2021;27:6:1-5",31.0,YR,,F,Y,,,20220603,,HP,US,US,2022,Q2,Young Adult
209123431,20912343,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,5-10 Units before meals,,,D,,,,,,,,,2022,Q2,Diabetic ketoacidosis,,2022,Q2,1,I,,20220525.0,20220603,20220603,EXP,,US-CORCEPT THERAPEUTICS INC.-US-2022CRT000862,CORCEPT,"Santos A., Branis N.. Abstract #1002287: A Case of Diabetic Ketoacidosis in Medical Management of Miscarriage. Endocrine Practice. 2021;27:6:1-5",31.0,YR,,F,Y,,,20220603,,HP,US,US,2022,Q2,Young Adult
209165111,20916511,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: As required?2-12 units,,,,,,,,,,Unknown,,2022,Q2,Asthenia,,2022,Q2,1,I,20210706.0,20220325.0,20220605,20220605,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20210800965,BRISTOL MYERS SQUIBB,,85.0,YR,E,F,Y,55.79,KG,20220605,,HP,US,US,2022,Q2,Elderly
209165111,20916511,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: As required?2-12 units,,,,,,,,,,Unknown,,2022,Q2,Lung infiltration,,2022,Q2,1,I,20210706.0,20220325.0,20220605,20220605,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20210800965,BRISTOL MYERS SQUIBB,,85.0,YR,E,F,Y,55.79,KG,20220605,,HP,US,US,2022,Q2,Elderly
209166492,20916649,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 units per meal,,,,,,,,,,,,2022,Q2,Tremor,,2022,Q2,2,F,20220609.0,20220614.0,20220605,20220624,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-042842,BRISTOL MYERS SQUIBB,,80.0,YR,E,M,Y,77.0,KG,20220625,,HP,US,US,2022,Q2,Elderly
209166492,20916649,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 units per meal,,,,,,,,,,,,2022,Q2,Thrombocytopenia,,2022,Q2,2,F,20220609.0,20220614.0,20220605,20220624,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-042842,BRISTOL MYERS SQUIBB,,80.0,YR,E,M,Y,77.0,KG,20220625,,HP,US,US,2022,Q2,Elderly
209166492,20916649,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 units per meal,,,,,,,,,,,,2022,Q2,Off label use,,2022,Q2,2,F,20220609.0,20220614.0,20220605,20220624,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-042842,BRISTOL MYERS SQUIBB,,80.0,YR,E,M,Y,77.0,KG,20220625,,HP,US,US,2022,Q2,Elderly
209166492,20916649,14,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 units per meal,,,,,,,,,,,,2022,Q2,Fatigue,,2022,Q2,2,F,20220609.0,20220614.0,20220605,20220624,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-042842,BRISTOL MYERS SQUIBB,,80.0,YR,E,M,Y,77.0,KG,20220625,,HP,US,US,2022,Q2,Elderly
209182891,20918289,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,10.0,IU,,,2022,Q2,Product use issue,,2022,Q2,1,I,,20220531.0,20220606,20220606,EXP,,US-SA-2022SA206026,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20220606,,CN,US,US,2022,Q2,Elderly
209182891,20918289,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,10.0,IU,,,2022,Q2,Emotional distress,,2022,Q2,1,I,,20220531.0,20220606,20220606,EXP,,US-SA-2022SA206026,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20220606,,CN,US,US,2022,Q2,Elderly
209182891,20918289,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,10.0,IU,,,2022,Q2,Insomnia,,2022,Q2,1,I,,20220531.0,20220606,20220606,EXP,,US-SA-2022SA206026,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20220606,,CN,US,US,2022,Q2,Elderly
209182891,20918289,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,10.0,IU,,,2022,Q2,Crying,,2022,Q2,1,I,,20220531.0,20220606,20220606,EXP,,US-SA-2022SA206026,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20220606,,CN,US,US,2022,Q2,Elderly
209182891,20918289,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,10.0,IU,,,2022,Q2,Loss of consciousness,,2022,Q2,1,I,,20220531.0,20220606,20220606,EXP,,US-SA-2022SA206026,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20220606,,CN,US,US,2022,Q2,Elderly
209182891,20918289,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,10.0,IU,,,2022,Q2,Off label use,,2022,Q2,1,I,,20220531.0,20220606,20220606,EXP,,US-SA-2022SA206026,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20220606,,CN,US,US,2022,Q2,Elderly
209182891,20918289,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,10.0,IU,,,2022,Q2,Nervousness,,2022,Q2,1,I,,20220531.0,20220606,20220606,EXP,,US-SA-2022SA206026,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20220606,,CN,US,US,2022,Q2,Elderly
209182891,20918289,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,10.0,IU,,,2022,Q2,Tremor,,2022,Q2,1,I,,20220531.0,20220606,20220606,EXP,,US-SA-2022SA206026,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20220606,,CN,US,US,2022,Q2,Elderly
209182891,20918289,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,10.0,IU,,,2022,Q2,Suicidal ideation,,2022,Q2,1,I,,20220531.0,20220606,20220606,EXP,,US-SA-2022SA206026,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20220606,,CN,US,US,2022,Q2,Elderly
209182891,20918289,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,10.0,IU,,,2022,Q2,Inappropriate schedule of product administration,,2022,Q2,1,I,,20220531.0,20220606,20220606,EXP,,US-SA-2022SA206026,SANOFI AVENTIS,,67.0,YR,E,F,Y,,,20220606,,CN,US,US,2022,Q2,Elderly
209202881,20920288,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Abscess,,2022,Q2,1,I,20211207.0,20220525.0,20220606,20220606,EXP,,US-ELI_LILLY_AND_COMPANY-US202205012208,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20220606,,CN,US,US,2022,Q2,Adult
209202881,20920288,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Urinary tract infection,,2022,Q2,1,I,20211207.0,20220525.0,20220606,20220606,EXP,,US-ELI_LILLY_AND_COMPANY-US202205012208,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20220606,,CN,US,US,2022,Q2,Adult
209202881,20920288,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Vaginal cancer,,2022,Q2,1,I,20211207.0,20220525.0,20220606,20220606,EXP,,US-ELI_LILLY_AND_COMPANY-US202205012208,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20220606,,CN,US,US,2022,Q2,Adult
209202881,20920288,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Nausea,,2022,Q2,1,I,20211207.0,20220525.0,20220606,20220606,EXP,,US-ELI_LILLY_AND_COMPANY-US202205012208,ELI LILLY AND CO,,40.0,YR,,F,Y,,,20220606,,CN,US,US,2022,Q2,Adult
209208651,20920865,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Blood creatinine increased,,2022,Q2,1,I,20220521.0,,20220606,20220606,DIR,618178,,FDA-CTU,,67.0,YR,,F,N,90.5,KG,20220606,N,PH,US,,2022,Q2,Elderly
209322601,20932260,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 5-10 units before meals",,,,,,,,,,,,2022,Q2,Off label use,,2022,Q2,1,I,,20220526.0,20220608,20220608,EXP,,US-LUPIN PHARMACEUTICALS INC.-2022-08177,LUPIN,"Santos A, Branis N. A Case of diabetic ketoacidosis in medical management of miscarriage. Endocrine Practice. 2021;27 (6):S42",31.0,YR,,F,Y,,,20220608,,HP,US,US,2022,Q2,Young Adult
209322601,20932260,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 5-10 units before meals",,,,,,,,,,,,2022,Q2,Diabetic ketoacidosis,,2022,Q2,1,I,,20220526.0,20220608,20220608,EXP,,US-LUPIN PHARMACEUTICALS INC.-2022-08177,LUPIN,"Santos A, Branis N. A Case of diabetic ketoacidosis in medical management of miscarriage. Endocrine Practice. 2021;27 (6):S42",31.0,YR,,F,Y,,,20220608,,HP,US,US,2022,Q2,Young Adult
209322601,20932260,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 5-10 units before meals",,,,,,,,,,,,2022,Q2,Exposure during pregnancy,,2022,Q2,1,I,,20220526.0,20220608,20220608,EXP,,US-LUPIN PHARMACEUTICALS INC.-2022-08177,LUPIN,"Santos A, Branis N. A Case of diabetic ketoacidosis in medical management of miscarriage. Endocrine Practice. 2021;27 (6):S42",31.0,YR,,F,Y,,,20220608,,HP,US,US,2022,Q2,Young Adult
209332691,20933269,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 u, each morning",,,U,,D355431A,,20563.0,3.0,IU,Injection,QD,2022,Q2,Incorrect dose administered,,2022,Q2,1,I,20220506.0,20220509.0,20220608,20220608,PER,,US-ELI_LILLY_AND_COMPANY-US202205004661,ELI LILLY AND CO,,89.0,YR,,M,Y,,,20220608,,CN,US,US,2022,Q2,Elderly
209332691,20933269,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 u, each morning",,,U,,D355431A,,20563.0,3.0,IU,Injection,QD,2022,Q2,Incorrect dose administered,,2022,Q2,1,I,20220506.0,20220509.0,20220608,20220608,PER,,US-ELI_LILLY_AND_COMPANY-US202205004661,ELI LILLY AND CO,,89.0,YR,,M,Y,,,20220608,,CN,US,US,2022,Q2,Elderly
209332691,20933269,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, daily",,,U,,D355431A,,20563.0,5.0,IU,Injection,QD,2022,Q2,Incorrect dose administered,,2022,Q2,1,I,20220506.0,20220509.0,20220608,20220608,PER,,US-ELI_LILLY_AND_COMPANY-US202205004661,ELI LILLY AND CO,,89.0,YR,,M,Y,,,20220608,,CN,US,US,2022,Q2,Elderly
209332691,20933269,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, daily",,,U,,D355431A,,20563.0,5.0,IU,Injection,QD,2022,Q2,Incorrect dose administered,,2022,Q2,1,I,20220506.0,20220509.0,20220608,20220608,PER,,US-ELI_LILLY_AND_COMPANY-US202205004661,ELI LILLY AND CO,,89.0,YR,,M,Y,,,20220608,,CN,US,US,2022,Q2,Elderly
209332691,20933269,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 u, each evening",,,U,,D355431A,,20563.0,3.0,IU,Injection,QD,2022,Q2,Incorrect dose administered,,2022,Q2,1,I,20220506.0,20220509.0,20220608,20220608,PER,,US-ELI_LILLY_AND_COMPANY-US202205004661,ELI LILLY AND CO,,89.0,YR,,M,Y,,,20220608,,CN,US,US,2022,Q2,Elderly
209332691,20933269,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"3 u, each evening",,,U,,D355431A,,20563.0,3.0,IU,Injection,QD,2022,Q2,Incorrect dose administered,,2022,Q2,1,I,20220506.0,20220509.0,20220608,20220608,PER,,US-ELI_LILLY_AND_COMPANY-US202205004661,ELI LILLY AND CO,,89.0,YR,,M,Y,,,20220608,,CN,US,US,2022,Q2,Elderly
209332691,20933269,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Incorrect dose administered,,2022,Q2,1,I,20220506.0,20220509.0,20220608,20220608,PER,,US-ELI_LILLY_AND_COMPANY-US202205004661,ELI LILLY AND CO,,89.0,YR,,M,Y,,,20220608,,CN,US,US,2022,Q2,Elderly
209332691,20933269,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Incorrect dose administered,,2022,Q2,1,I,20220506.0,20220509.0,20220608,20220608,PER,,US-ELI_LILLY_AND_COMPANY-US202205004661,ELI LILLY AND CO,,89.0,YR,,M,Y,,,20220608,,CN,US,US,2022,Q2,Elderly
209367072,20936707,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D371847A,,20563.0,,,Injection,,2022,Q2,Wrong patient received product,,2022,Q2,2,F,20220602.0,20220610.0,20220609,20220615,PER,,US-ELI_LILLY_AND_COMPANY-US202206002169,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20220615,,CN,US,US,2022,Q2,Adult
209367072,20936707,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D371847A,,20563.0,,,Injection,,2022,Q2,Wrong patient received product,,2022,Q2,2,F,20220602.0,20220610.0,20220609,20220615,PER,,US-ELI_LILLY_AND_COMPANY-US202206002169,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20220615,,CN,US,US,2022,Q2,Adult
209367072,20936707,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D379508A,,20563.0,,,Injection,,2022,Q2,Wrong patient received product,,2022,Q2,2,F,20220602.0,20220610.0,20220609,20220615,PER,,US-ELI_LILLY_AND_COMPANY-US202206002169,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20220615,,CN,US,US,2022,Q2,Adult
209367072,20936707,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D379508A,,20563.0,,,Injection,,2022,Q2,Wrong patient received product,,2022,Q2,2,F,20220602.0,20220610.0,20220609,20220615,PER,,US-ELI_LILLY_AND_COMPANY-US202206002169,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20220615,,CN,US,US,2022,Q2,Adult
209401121,20940112,3,C,Insulin Lispro BS Injection HU,,2,Subcutaneous,UNK,,,,,,,,,,Injection,,2022,Q2,Hypophagia,,2022,Q2,1,I,20220416.0,20220602.0,20220609,20220609,EXP,,JP-PFIZER INC-202200791083,PFIZER,,42.0,YR,,M,Y,73.0,KG,20220609,,PH,JP,JP,2022,Q2,Adult
209401121,20940112,3,C,Insulin Lispro BS Injection HU,,2,Subcutaneous,UNK,,,,,,,,,,Injection,,2022,Q2,Diarrhoea,,2022,Q2,1,I,20220416.0,20220602.0,20220609,20220609,EXP,,JP-PFIZER INC-202200791083,PFIZER,,42.0,YR,,M,Y,73.0,KG,20220609,,PH,JP,JP,2022,Q2,Adult
209401121,20940112,3,C,Insulin Lispro BS Injection HU,,2,Subcutaneous,UNK,,,,,,,,,,Injection,,2022,Q2,Dehydration,,2022,Q2,1,I,20220416.0,20220602.0,20220609,20220609,EXP,,JP-PFIZER INC-202200791083,PFIZER,,42.0,YR,,M,Y,73.0,KG,20220609,,PH,JP,JP,2022,Q2,Adult
209401121,20940112,3,C,Insulin Lispro BS Injection HU,,2,Subcutaneous,UNK,,,,,,,,,,Injection,,2022,Q2,Abdominal pain,,2022,Q2,1,I,20220416.0,20220602.0,20220609,20220609,EXP,,JP-PFIZER INC-202200791083,PFIZER,,42.0,YR,,M,Y,73.0,KG,20220609,,PH,JP,JP,2022,Q2,Adult
209401121,20940112,3,C,Insulin Lispro BS Injection HU,,2,Subcutaneous,UNK,,,,,,,,,,Injection,,2022,Q2,Renal impairment,,2022,Q2,1,I,20220416.0,20220602.0,20220609,20220609,EXP,,JP-PFIZER INC-202200791083,PFIZER,,42.0,YR,,M,Y,73.0,KG,20220609,,PH,JP,JP,2022,Q2,Adult
209401121,20940112,3,C,Insulin Lispro BS Injection HU,,2,Subcutaneous,UNK,,,,,,,,,,Injection,,2022,Q2,Abdominal discomfort,,2022,Q2,1,I,20220416.0,20220602.0,20220609,20220609,EXP,,JP-PFIZER INC-202200791083,PFIZER,,42.0,YR,,M,Y,73.0,KG,20220609,,PH,JP,JP,2022,Q2,Adult
209401121,20940112,3,C,Insulin Lispro BS Injection HU,,2,Subcutaneous,UNK,,,,,,,,,,Injection,,2022,Q2,C-reactive protein increased,,2022,Q2,1,I,20220416.0,20220602.0,20220609,20220609,EXP,,JP-PFIZER INC-202200791083,PFIZER,,42.0,YR,,M,Y,73.0,KG,20220609,,PH,JP,JP,2022,Q2,Adult
209401121,20940112,3,C,Insulin Lispro BS Injection HU,,2,Subcutaneous,UNK,,,,,,,,,,Injection,,2022,Q2,Vomiting,,2022,Q2,1,I,20220416.0,20220602.0,20220609,20220609,EXP,,JP-PFIZER INC-202200791083,PFIZER,,42.0,YR,,M,Y,73.0,KG,20220609,,PH,JP,JP,2022,Q2,Adult
209401121,20940112,3,C,Insulin Lispro BS Injection HU,,2,Subcutaneous,UNK,,,,,,,,,,Injection,,2022,Q2,Drug level increased,,2022,Q2,1,I,20220416.0,20220602.0,20220609,20220609,EXP,,JP-PFIZER INC-202200791083,PFIZER,,42.0,YR,,M,Y,73.0,KG,20220609,,PH,JP,JP,2022,Q2,Adult
209401121,20940112,3,C,Insulin Lispro BS Injection HU,,2,Subcutaneous,UNK,,,,,,,,,,Injection,,2022,Q2,Nausea,,2022,Q2,1,I,20220416.0,20220602.0,20220609,20220609,EXP,,JP-PFIZER INC-202200791083,PFIZER,,42.0,YR,,M,Y,73.0,KG,20220609,,PH,JP,JP,2022,Q2,Adult
209401121,20940112,3,C,Insulin Lispro BS Injection HU,,2,Subcutaneous,UNK,,,,,,,,,,Injection,,2022,Q2,Drug interaction,,2022,Q2,1,I,20220416.0,20220602.0,20220609,20220609,EXP,,JP-PFIZER INC-202200791083,PFIZER,,42.0,YR,,M,Y,73.0,KG,20220609,,PH,JP,JP,2022,Q2,Adult
209401121,20940112,3,C,Insulin Lispro BS Injection HU,,2,Subcutaneous,UNK,,,,,,,,,,Injection,,2022,Q2,Back pain,,2022,Q2,1,I,20220416.0,20220602.0,20220609,20220609,EXP,,JP-PFIZER INC-202200791083,PFIZER,,42.0,YR,,M,Y,73.0,KG,20220609,,PH,JP,JP,2022,Q2,Adult
209401121,20940112,3,C,Insulin Lispro BS Injection HU,,2,Subcutaneous,UNK,,,,,,,,,,Injection,,2022,Q2,Urine output increased,,2022,Q2,1,I,20220416.0,20220602.0,20220609,20220609,EXP,,JP-PFIZER INC-202200791083,PFIZER,,42.0,YR,,M,Y,73.0,KG,20220609,,PH,JP,JP,2022,Q2,Adult
209418371,20941837,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK administered via insulin pump (total of 34 units daily),,,D,,,,,,,,,2022,Q2,Maternal exposure during pregnancy,,2022,Q2,1,I,,20220331.0,20220610,20220610,PER,,US-STRIDES ARCOLAB LIMITED-2022SP003668,STRIDES,"Bayless DR, Caldarera TM, Harirah HM. Autoimmune polyglandular syndrome type 2 in pregnancy: A case report and review of the literature. Case-Rep-Perinat-Med. 2022;11(1)",35.0,YR,,F,Y,,,20220610,,MD,US,US,2022,Q2,Adult
209418371,20941837,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, prenatal dose",,,D,,,,,,,,,2022,Q2,Maternal exposure during pregnancy,,2022,Q2,1,I,,20220331.0,20220610,20220610,PER,,US-STRIDES ARCOLAB LIMITED-2022SP003668,STRIDES,"Bayless DR, Caldarera TM, Harirah HM. Autoimmune polyglandular syndrome type 2 in pregnancy: A case report and review of the literature. Case-Rep-Perinat-Med. 2022;11(1)",35.0,YR,,F,Y,,,20220610,,MD,US,US,2022,Q2,Adult
209418461,20941846,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,COVID-19,,2022,Q2,1,I,20220510.0,20220511.0,20220610,20220610,PER,,US-ELI_LILLY_AND_COMPANY-US202205005608,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220610,,CN,US,US,2022,Q2,Adult
209418461,20941846,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Drug ineffective,,2022,Q2,1,I,20220510.0,20220511.0,20220610,20220610,PER,,US-ELI_LILLY_AND_COMPANY-US202205005608,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220610,,CN,US,US,2022,Q2,Adult
209418461,20941846,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Eye disorder,,2022,Q2,1,I,20220510.0,20220511.0,20220610,20220610,PER,,US-ELI_LILLY_AND_COMPANY-US202205005608,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220610,,CN,US,US,2022,Q2,Adult
209418461,20941846,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220510.0,20220511.0,20220610,20220610,PER,,US-ELI_LILLY_AND_COMPANY-US202205005608,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220610,,CN,US,US,2022,Q2,Adult
209418461,20941846,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D455780C,,20563.0,,,Injection,,2022,Q2,COVID-19,,2022,Q2,1,I,20220510.0,20220511.0,20220610,20220610,PER,,US-ELI_LILLY_AND_COMPANY-US202205005608,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220610,,CN,US,US,2022,Q2,Adult
209418461,20941846,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D455780C,,20563.0,,,Injection,,2022,Q2,Drug ineffective,,2022,Q2,1,I,20220510.0,20220511.0,20220610,20220610,PER,,US-ELI_LILLY_AND_COMPANY-US202205005608,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220610,,CN,US,US,2022,Q2,Adult
209418461,20941846,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D455780C,,20563.0,,,Injection,,2022,Q2,Eye disorder,,2022,Q2,1,I,20220510.0,20220511.0,20220610,20220610,PER,,US-ELI_LILLY_AND_COMPANY-US202205005608,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220610,,CN,US,US,2022,Q2,Adult
209418461,20941846,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D455780C,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220510.0,20220511.0,20220610,20220610,PER,,US-ELI_LILLY_AND_COMPANY-US202205005608,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220610,,CN,US,US,2022,Q2,Adult
209496371,20949637,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Solution for injection,,2022,Q2,Hypoglycaemic seizure,,2022,Q2,1,I,20220530.0,20220601.0,20220613,20220613,PER,,US-ELI_LILLY_AND_COMPANY-US202206001200,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20220613,,CN,US,US,2022,Q2,Elderly
209496371,20949637,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Solution for injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220530.0,20220601.0,20220613,20220613,PER,,US-ELI_LILLY_AND_COMPANY-US202206001200,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20220613,,CN,US,US,2022,Q2,Elderly
209496371,20949637,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D455233C,,20563.0,,,Solution for injection,,2022,Q2,Hypoglycaemic seizure,,2022,Q2,1,I,20220530.0,20220601.0,20220613,20220613,PER,,US-ELI_LILLY_AND_COMPANY-US202206001200,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20220613,,CN,US,US,2022,Q2,Elderly
209496371,20949637,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D455233C,,20563.0,,,Solution for injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220530.0,20220601.0,20220613,20220613,PER,,US-ELI_LILLY_AND_COMPANY-US202206001200,ELI LILLY AND CO,,77.0,YR,,M,Y,,,20220613,,CN,US,US,2022,Q2,Elderly
209498141,20949814,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q2,Therapeutic product effect incomplete,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q2,Hypoxia,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q2,Oropharyngeal pain,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q2,Left ventricular hypertrophy,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q2,Chest discomfort,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q2,Discomfort,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q2,Pyrexia,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q2,Full blood count abnormal,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q2,Asthma,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q2,Diaphragmatic disorder,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q2,Obstructive airways disorder,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q2,Wheezing,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q2,Cough,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q2,Dyspnoea,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q2,Oedema peripheral,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,7,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, BID",,,D,,,,209196.0,,,Solution for injection,Q12H,2022,Q2,Weight increased,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,Q12H,2022,Q2,Therapeutic product effect incomplete,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,Q12H,2022,Q2,Hypoxia,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,Q12H,2022,Q2,Oropharyngeal pain,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,Q12H,2022,Q2,Left ventricular hypertrophy,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,Q12H,2022,Q2,Chest discomfort,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,Q12H,2022,Q2,Discomfort,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,Q12H,2022,Q2,Pyrexia,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,Q12H,2022,Q2,Full blood count abnormal,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,Q12H,2022,Q2,Asthma,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,Q12H,2022,Q2,Diaphragmatic disorder,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,Q12H,2022,Q2,Obstructive airways disorder,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,Q12H,2022,Q2,Wheezing,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,Q12H,2022,Q2,Cough,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,Q12H,2022,Q2,Dyspnoea,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,Q12H,2022,Q2,Oedema peripheral,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209498141,20949814,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, BID",,,U,,,,,,,,Q12H,2022,Q2,Weight increased,,2022,Q2,1,I,,20220607.0,20220613,20220613,EXP,,CA-SANOFI US-2022SA218182,SANOFI AVENTIS,,83.0,YR,E,M,Y,100.0,KG,20220613,,HP,CA,CA,2022,Q2,Elderly
209516291,20951629,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Adrenomegaly,,2022,Q2,1,I,,20220527.0,20220613,20220613,EXP,,DE-B.Braun Medical Inc.-2129768,B BRAUN,,71.0,YR,,M,Y,,,20220613,,,DE,DE,2022,Q2,Elderly
209516291,20951629,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Heparin-induced thrombocytopenia,,2022,Q2,1,I,,20220527.0,20220613,20220613,EXP,,DE-B.Braun Medical Inc.-2129768,B BRAUN,,71.0,YR,,M,Y,,,20220613,,,DE,DE,2022,Q2,Elderly
209516291,20951629,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Colitis,,2022,Q2,1,I,,20220527.0,20220613,20220613,EXP,,DE-B.Braun Medical Inc.-2129768,B BRAUN,,71.0,YR,,M,Y,,,20220613,,,DE,DE,2022,Q2,Elderly
209516291,20951629,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Addison's disease,,2022,Q2,1,I,,20220527.0,20220613,20220613,EXP,,DE-B.Braun Medical Inc.-2129768,B BRAUN,,71.0,YR,,M,Y,,,20220613,,,DE,DE,2022,Q2,Elderly
209516291,20951629,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Blood pressure increased,,2022,Q2,1,I,,20220527.0,20220613,20220613,EXP,,DE-B.Braun Medical Inc.-2129768,B BRAUN,,71.0,YR,,M,Y,,,20220613,,,DE,DE,2022,Q2,Elderly
209516291,20951629,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Tachycardia,,2022,Q2,1,I,,20220527.0,20220613,20220613,EXP,,DE-B.Braun Medical Inc.-2129768,B BRAUN,,71.0,YR,,M,Y,,,20220613,,,DE,DE,2022,Q2,Elderly
209516291,20951629,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Metastases to meninges,,2022,Q2,1,I,,20220527.0,20220613,20220613,EXP,,DE-B.Braun Medical Inc.-2129768,B BRAUN,,71.0,YR,,M,Y,,,20220613,,,DE,DE,2022,Q2,Elderly
209516291,20951629,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Adrenal insufficiency,,2022,Q2,1,I,,20220527.0,20220613,20220613,EXP,,DE-B.Braun Medical Inc.-2129768,B BRAUN,,71.0,YR,,M,Y,,,20220613,,,DE,DE,2022,Q2,Elderly
209516291,20951629,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Dyspnoea,,2022,Q2,1,I,,20220527.0,20220613,20220613,EXP,,DE-B.Braun Medical Inc.-2129768,B BRAUN,,71.0,YR,,M,Y,,,20220613,,,DE,DE,2022,Q2,Elderly
209516291,20951629,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Device related infection,,2022,Q2,1,I,,20220527.0,20220613,20220613,EXP,,DE-B.Braun Medical Inc.-2129768,B BRAUN,,71.0,YR,,M,Y,,,20220613,,,DE,DE,2022,Q2,Elderly
209516291,20951629,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Malignant neoplasm progression,,2022,Q2,1,I,,20220527.0,20220613,20220613,EXP,,DE-B.Braun Medical Inc.-2129768,B BRAUN,,71.0,YR,,M,Y,,,20220613,,,DE,DE,2022,Q2,Elderly
209516291,20951629,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Pulmonary oedema,,2022,Q2,1,I,,20220527.0,20220613,20220613,EXP,,DE-B.Braun Medical Inc.-2129768,B BRAUN,,71.0,YR,,M,Y,,,20220613,,,DE,DE,2022,Q2,Elderly
209516291,20951629,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Urosepsis,,2022,Q2,1,I,,20220527.0,20220613,20220613,EXP,,DE-B.Braun Medical Inc.-2129768,B BRAUN,,71.0,YR,,M,Y,,,20220613,,,DE,DE,2022,Q2,Elderly
209516291,20951629,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Hypertensive crisis,,2022,Q2,1,I,,20220527.0,20220613,20220613,EXP,,DE-B.Braun Medical Inc.-2129768,B BRAUN,,71.0,YR,,M,Y,,,20220613,,,DE,DE,2022,Q2,Elderly
209516291,20951629,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Meningitis,,2022,Q2,1,I,,20220527.0,20220613,20220613,EXP,,DE-B.Braun Medical Inc.-2129768,B BRAUN,,71.0,YR,,M,Y,,,20220613,,,DE,DE,2022,Q2,Elderly
209516291,20951629,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Retinal detachment,,2022,Q2,1,I,,20220527.0,20220613,20220613,EXP,,DE-B.Braun Medical Inc.-2129768,B BRAUN,,71.0,YR,,M,Y,,,20220613,,,DE,DE,2022,Q2,Elderly
209516291,20951629,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Acute kidney injury,,2022,Q2,1,I,,20220527.0,20220613,20220613,EXP,,DE-B.Braun Medical Inc.-2129768,B BRAUN,,71.0,YR,,M,Y,,,20220613,,,DE,DE,2022,Q2,Elderly
209516291,20951629,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Klebsiella infection,,2022,Q2,1,I,,20220527.0,20220613,20220613,EXP,,DE-B.Braun Medical Inc.-2129768,B BRAUN,,71.0,YR,,M,Y,,,20220613,,,DE,DE,2022,Q2,Elderly
209516291,20951629,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Hyperglycaemia,,2022,Q2,1,I,,20220527.0,20220613,20220613,EXP,,DE-B.Braun Medical Inc.-2129768,B BRAUN,,71.0,YR,,M,Y,,,20220613,,,DE,DE,2022,Q2,Elderly
209516291,20951629,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Chest pain,,2022,Q2,1,I,,20220527.0,20220613,20220613,EXP,,DE-B.Braun Medical Inc.-2129768,B BRAUN,,71.0,YR,,M,Y,,,20220613,,,DE,DE,2022,Q2,Elderly
209560901,20956090,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 IU, tid (3/day) before meals",,,D,,,,,5.0,IU,,TID,2022,Q2,Product use issue,,2022,Q2,1,I,,20200616.0,20220614,20220614,PER,,US-PFM-2020-15008,PIERRE FABRE MEDICAMENT,"Patel K, Stummer L, Patel K. Stiff-person syndrome in a patient with comorbid bipolar and panic disorders: a case report and literature review. Ment Health Clin. 2020;10:95-9",58.0,YR,,F,Y,,,20220614,,HP,US,US,2022,Q2,Adult
209560901,20956090,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 IU, tid (3/day) before meals",,,D,,,,,5.0,IU,,TID,2022,Q2,Oedema,,2022,Q2,1,I,,20200616.0,20220614,20220614,PER,,US-PFM-2020-15008,PIERRE FABRE MEDICAMENT,"Patel K, Stummer L, Patel K. Stiff-person syndrome in a patient with comorbid bipolar and panic disorders: a case report and literature review. Ment Health Clin. 2020;10:95-9",58.0,YR,,F,Y,,,20220614,,HP,US,US,2022,Q2,Adult
209560901,20956090,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 IU, tid (3/day) before meals",,,D,,,,,5.0,IU,,TID,2022,Q2,Intentional product misuse,,2022,Q2,1,I,,20200616.0,20220614,20220614,PER,,US-PFM-2020-15008,PIERRE FABRE MEDICAMENT,"Patel K, Stummer L, Patel K. Stiff-person syndrome in a patient with comorbid bipolar and panic disorders: a case report and literature review. Ment Health Clin. 2020;10:95-9",58.0,YR,,F,Y,,,20220614,,HP,US,US,2022,Q2,Adult
209560901,20956090,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 IU, tid (3/day) before meals",,,D,,,,,5.0,IU,,TID,2022,Q2,Off label use,,2022,Q2,1,I,,20200616.0,20220614,20220614,PER,,US-PFM-2020-15008,PIERRE FABRE MEDICAMENT,"Patel K, Stummer L, Patel K. Stiff-person syndrome in a patient with comorbid bipolar and panic disorders: a case report and literature review. Ment Health Clin. 2020;10:95-9",58.0,YR,,F,Y,,,20220614,,HP,US,US,2022,Q2,Adult
209560901,20956090,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 IU, tid (3/day) before meals",,,D,,,,,5.0,IU,,TID,2022,Q2,Product use in unapproved indication,,2022,Q2,1,I,,20200616.0,20220614,20220614,PER,,US-PFM-2020-15008,PIERRE FABRE MEDICAMENT,"Patel K, Stummer L, Patel K. Stiff-person syndrome in a patient with comorbid bipolar and panic disorders: a case report and literature review. Ment Health Clin. 2020;10:95-9",58.0,YR,,F,Y,,,20220614,,HP,US,US,2022,Q2,Adult
209588501,20958850,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D429199E,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220529.0,20220601.0,20220614,20220614,PER,,US-ELI_LILLY_AND_COMPANY-US202206001965,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20220614,,CN,US,US,2022,Q2,Child
209588501,20958850,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D429199E,,20563.0,,,Injection,,2022,Q2,Insulin resistance,,2022,Q2,1,I,20220529.0,20220601.0,20220614,20220614,PER,,US-ELI_LILLY_AND_COMPANY-US202206001965,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20220614,,CN,US,US,2022,Q2,Child
209588501,20958850,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D429199E,,20563.0,,,Injection,,2022,Q2,Drug ineffective,,2022,Q2,1,I,20220529.0,20220601.0,20220614,20220614,PER,,US-ELI_LILLY_AND_COMPANY-US202206001965,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20220614,,CN,US,US,2022,Q2,Child
209588501,20958850,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D429199E,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220529.0,20220601.0,20220614,20220614,PER,,US-ELI_LILLY_AND_COMPANY-US202206001965,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20220614,,CN,US,US,2022,Q2,Child
209588501,20958850,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D429199E,,20563.0,,,Injection,,2022,Q2,Insulin resistance,,2022,Q2,1,I,20220529.0,20220601.0,20220614,20220614,PER,,US-ELI_LILLY_AND_COMPANY-US202206001965,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20220614,,CN,US,US,2022,Q2,Child
209588501,20958850,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D429199E,,20563.0,,,Injection,,2022,Q2,Drug ineffective,,2022,Q2,1,I,20220529.0,20220601.0,20220614,20220614,PER,,US-ELI_LILLY_AND_COMPANY-US202206001965,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20220614,,CN,US,US,2022,Q2,Child
209588501,20958850,3,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D429199E,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220529.0,20220601.0,20220614,20220614,PER,,US-ELI_LILLY_AND_COMPANY-US202206001965,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20220614,,CN,US,US,2022,Q2,Child
209588501,20958850,3,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D429199E,,20563.0,,,Injection,,2022,Q2,Insulin resistance,,2022,Q2,1,I,20220529.0,20220601.0,20220614,20220614,PER,,US-ELI_LILLY_AND_COMPANY-US202206001965,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20220614,,CN,US,US,2022,Q2,Child
209588501,20958850,3,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D429199E,,20563.0,,,Injection,,2022,Q2,Drug ineffective,,2022,Q2,1,I,20220529.0,20220601.0,20220614,20220614,PER,,US-ELI_LILLY_AND_COMPANY-US202206001965,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20220614,,CN,US,US,2022,Q2,Child
209588501,20958850,4,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D429199E,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220529.0,20220601.0,20220614,20220614,PER,,US-ELI_LILLY_AND_COMPANY-US202206001965,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20220614,,CN,US,US,2022,Q2,Child
209588501,20958850,4,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D429199E,,20563.0,,,Injection,,2022,Q2,Insulin resistance,,2022,Q2,1,I,20220529.0,20220601.0,20220614,20220614,PER,,US-ELI_LILLY_AND_COMPANY-US202206001965,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20220614,,CN,US,US,2022,Q2,Child
209588501,20958850,4,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D429199E,,20563.0,,,Injection,,2022,Q2,Drug ineffective,,2022,Q2,1,I,20220529.0,20220601.0,20220614,20220614,PER,,US-ELI_LILLY_AND_COMPANY-US202206001965,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20220614,,CN,US,US,2022,Q2,Child
209588501,20958850,5,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D385999Y,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220529.0,20220601.0,20220614,20220614,PER,,US-ELI_LILLY_AND_COMPANY-US202206001965,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20220614,,CN,US,US,2022,Q2,Child
209588501,20958850,5,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D385999Y,,20563.0,,,Injection,,2022,Q2,Insulin resistance,,2022,Q2,1,I,20220529.0,20220601.0,20220614,20220614,PER,,US-ELI_LILLY_AND_COMPANY-US202206001965,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20220614,,CN,US,US,2022,Q2,Child
209588501,20958850,5,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D385999Y,,20563.0,,,Injection,,2022,Q2,Drug ineffective,,2022,Q2,1,I,20220529.0,20220601.0,20220614,20220614,PER,,US-ELI_LILLY_AND_COMPANY-US202206001965,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20220614,,CN,US,US,2022,Q2,Child
209588501,20958850,6,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220529.0,20220601.0,20220614,20220614,PER,,US-ELI_LILLY_AND_COMPANY-US202206001965,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20220614,,CN,US,US,2022,Q2,Child
209588501,20958850,6,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q2,Insulin resistance,,2022,Q2,1,I,20220529.0,20220601.0,20220614,20220614,PER,,US-ELI_LILLY_AND_COMPANY-US202206001965,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20220614,,CN,US,US,2022,Q2,Child
209588501,20958850,6,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q2,Drug ineffective,,2022,Q2,1,I,20220529.0,20220601.0,20220614,20220614,PER,,US-ELI_LILLY_AND_COMPANY-US202206001965,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20220614,,CN,US,US,2022,Q2,Child
209588501,20958850,7,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220529.0,20220601.0,20220614,20220614,PER,,US-ELI_LILLY_AND_COMPANY-US202206001965,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20220614,,CN,US,US,2022,Q2,Child
209588501,20958850,7,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q2,Insulin resistance,,2022,Q2,1,I,20220529.0,20220601.0,20220614,20220614,PER,,US-ELI_LILLY_AND_COMPANY-US202206001965,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20220614,,CN,US,US,2022,Q2,Child
209588501,20958850,7,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q2,Drug ineffective,,2022,Q2,1,I,20220529.0,20220601.0,20220614,20220614,PER,,US-ELI_LILLY_AND_COMPANY-US202206001965,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20220614,,CN,US,US,2022,Q2,Child
209588501,20958850,8,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220529.0,20220601.0,20220614,20220614,PER,,US-ELI_LILLY_AND_COMPANY-US202206001965,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20220614,,CN,US,US,2022,Q2,Child
209588501,20958850,8,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q2,Insulin resistance,,2022,Q2,1,I,20220529.0,20220601.0,20220614,20220614,PER,,US-ELI_LILLY_AND_COMPANY-US202206001965,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20220614,,CN,US,US,2022,Q2,Child
209588501,20958850,8,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q2,Drug ineffective,,2022,Q2,1,I,20220529.0,20220601.0,20220614,20220614,PER,,US-ELI_LILLY_AND_COMPANY-US202206001965,ELI LILLY AND CO,,10.0,YR,,F,Y,,,20220614,,CN,US,US,2022,Q2,Child
209595632,20959563,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Tremor,,2022,Q2,2,F,20220529.0,20220620.0,20220614,20220623,PER,,US-GILEAD-2022-0585406,GILEAD,,68.0,YR,E,M,Y,92.0,KG,20220623,,HP,US,US,2022,Q2,Elderly
209595632,20959563,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Immune effector cell-associated neurotoxicity syndrome,,2022,Q2,2,F,20220529.0,20220620.0,20220614,20220623,PER,,US-GILEAD-2022-0585406,GILEAD,,68.0,YR,E,M,Y,92.0,KG,20220623,,HP,US,US,2022,Q2,Elderly
209595861,20959586,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,,,,,,,Solution for injection,,2022,Q2,Hypoglycaemia,,2022,Q2,1,I,20200504.0,20200623.0,20220614,20220614,EXP,,IT-BAUSCH-BL-2022-014742,BAUSCH AND LOMB,,82.0,YR,,M,Y,,,20220614,,MD,IT,IT,2022,Q2,Elderly
209595861,20959586,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,,,,,,,Solution for injection,,2022,Q2,Syncope,,2022,Q2,1,I,20200504.0,20200623.0,20220614,20220614,EXP,,IT-BAUSCH-BL-2022-014742,BAUSCH AND LOMB,,82.0,YR,,M,Y,,,20220614,,MD,IT,IT,2022,Q2,Elderly
209595861,20959586,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,,,,,,,Solution for injection,,2022,Q2,Bradycardia,,2022,Q2,1,I,20200504.0,20200623.0,20220614,20220614,EXP,,IT-BAUSCH-BL-2022-014742,BAUSCH AND LOMB,,82.0,YR,,M,Y,,,20220614,,MD,IT,IT,2022,Q2,Elderly
209595861,20959586,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,Y,,,,,,,Solution for injection,,2022,Q2,Drug interaction,,2022,Q2,1,I,20200504.0,20200623.0,20220614,20220614,EXP,,IT-BAUSCH-BL-2022-014742,BAUSCH AND LOMB,,82.0,YR,,M,Y,,,20220614,,MD,IT,IT,2022,Q2,Elderly
209604872,20960487,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Accidental underdose,,2022,Q2,2,F,20220523.0,20220523.0,20220615,20220617,PER,,US-ELI_LILLY_AND_COMPANY-US202205009805,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20220617,,CN,US,US,2022,Q2,Elderly
209604872,20960487,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,2,F,20220523.0,20220523.0,20220615,20220617,PER,,US-ELI_LILLY_AND_COMPANY-US202205009805,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20220617,,CN,US,US,2022,Q2,Elderly
209604872,20960487,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Accidental underdose,,2022,Q2,2,F,20220523.0,20220523.0,20220615,20220617,PER,,US-ELI_LILLY_AND_COMPANY-US202205009805,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20220617,,CN,US,US,2022,Q2,Elderly
209604872,20960487,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,2,F,20220523.0,20220523.0,20220615,20220617,PER,,US-ELI_LILLY_AND_COMPANY-US202205009805,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20220617,,CN,US,US,2022,Q2,Elderly
209604872,20960487,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Accidental underdose,,2022,Q2,2,F,20220523.0,20220523.0,20220615,20220617,PER,,US-ELI_LILLY_AND_COMPANY-US202205009805,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20220617,,CN,US,US,2022,Q2,Elderly
209604872,20960487,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,2,F,20220523.0,20220523.0,20220615,20220617,PER,,US-ELI_LILLY_AND_COMPANY-US202205009805,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20220617,,CN,US,US,2022,Q2,Elderly
209604872,20960487,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Accidental underdose,,2022,Q2,2,F,20220523.0,20220523.0,20220615,20220617,PER,,US-ELI_LILLY_AND_COMPANY-US202205009805,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20220617,,CN,US,US,2022,Q2,Elderly
209604872,20960487,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,2,F,20220523.0,20220523.0,20220615,20220617,PER,,US-ELI_LILLY_AND_COMPANY-US202205009805,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20220617,,CN,US,US,2022,Q2,Elderly
209604872,20960487,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D395986A,,20563.0,,,Injection,,2022,Q2,Accidental underdose,,2022,Q2,2,F,20220523.0,20220523.0,20220615,20220617,PER,,US-ELI_LILLY_AND_COMPANY-US202205009805,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20220617,,CN,US,US,2022,Q2,Elderly
209604872,20960487,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D395986A,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,2,F,20220523.0,20220523.0,20220615,20220617,PER,,US-ELI_LILLY_AND_COMPANY-US202205009805,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20220617,,CN,US,US,2022,Q2,Elderly
209604872,20960487,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D395986A,,20563.0,,,Injection,,2022,Q2,Accidental underdose,,2022,Q2,2,F,20220523.0,20220523.0,20220615,20220617,PER,,US-ELI_LILLY_AND_COMPANY-US202205009805,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20220617,,CN,US,US,2022,Q2,Elderly
209604872,20960487,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D395986A,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,2,F,20220523.0,20220523.0,20220615,20220617,PER,,US-ELI_LILLY_AND_COMPANY-US202205009805,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20220617,,CN,US,US,2022,Q2,Elderly
209604872,20960487,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D341139A,,20563.0,,,Injection,,2022,Q2,Accidental underdose,,2022,Q2,2,F,20220523.0,20220523.0,20220615,20220617,PER,,US-ELI_LILLY_AND_COMPANY-US202205009805,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20220617,,CN,US,US,2022,Q2,Elderly
209604872,20960487,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D341139A,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,2,F,20220523.0,20220523.0,20220615,20220617,PER,,US-ELI_LILLY_AND_COMPANY-US202205009805,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20220617,,CN,US,US,2022,Q2,Elderly
209604872,20960487,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D341139A,,20563.0,,,Injection,,2022,Q2,Accidental underdose,,2022,Q2,2,F,20220523.0,20220523.0,20220615,20220617,PER,,US-ELI_LILLY_AND_COMPANY-US202205009805,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20220617,,CN,US,US,2022,Q2,Elderly
209604872,20960487,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D341139A,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,2,F,20220523.0,20220523.0,20220615,20220617,PER,,US-ELI_LILLY_AND_COMPANY-US202205009805,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20220617,,CN,US,US,2022,Q2,Elderly
209604872,20960487,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D341139,,20563.0,,,Injection,,2022,Q2,Accidental underdose,,2022,Q2,2,F,20220523.0,20220523.0,20220615,20220617,PER,,US-ELI_LILLY_AND_COMPANY-US202205009805,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20220617,,CN,US,US,2022,Q2,Elderly
209604872,20960487,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D341139,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,2,F,20220523.0,20220523.0,20220615,20220617,PER,,US-ELI_LILLY_AND_COMPANY-US202205009805,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20220617,,CN,US,US,2022,Q2,Elderly
209604872,20960487,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D341139,,20563.0,,,Injection,,2022,Q2,Accidental underdose,,2022,Q2,2,F,20220523.0,20220523.0,20220615,20220617,PER,,US-ELI_LILLY_AND_COMPANY-US202205009805,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20220617,,CN,US,US,2022,Q2,Elderly
209604872,20960487,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D341139,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,2,F,20220523.0,20220523.0,20220615,20220617,PER,,US-ELI_LILLY_AND_COMPANY-US202205009805,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20220617,,CN,US,US,2022,Q2,Elderly
209609372,20960937,21,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,UNK,,,U,,,,,,,Suspension,,2022,Q2,Therapeutic response decreased,,2022,Q2,2,F,,20220617.0,20220615,20220624,EXP,,PL-AUROBINDO-AUR-APL-2022-019175,AUROBINDO,"Szymanek-Pasternak A, Janocha-Litwin J, Simon K. Severe chronic atopic dermatitis improvement after hepatitis C virus elimination with sofosbuvir/ledipasvir treatment. ADVANCES IN DERMATOLOGY AND ALLERGOLOGY.. 2022;(2):424?425",59.0,YR,,M,Y,,,20220624,,MD,PL,PL,2022,Q2,Adult
209609372,20960937,21,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,UNK,,,U,,,,,,,Suspension,,2022,Q2,Acute kidney injury,,2022,Q2,2,F,,20220617.0,20220615,20220624,EXP,,PL-AUROBINDO-AUR-APL-2022-019175,AUROBINDO,"Szymanek-Pasternak A, Janocha-Litwin J, Simon K. Severe chronic atopic dermatitis improvement after hepatitis C virus elimination with sofosbuvir/ledipasvir treatment. ADVANCES IN DERMATOLOGY AND ALLERGOLOGY.. 2022;(2):424?425",59.0,YR,,M,Y,,,20220624,,MD,PL,PL,2022,Q2,Adult
209609372,20960937,21,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,UNK,,,U,,,,,,,Suspension,,2022,Q2,Hypertension,,2022,Q2,2,F,,20220617.0,20220615,20220624,EXP,,PL-AUROBINDO-AUR-APL-2022-019175,AUROBINDO,"Szymanek-Pasternak A, Janocha-Litwin J, Simon K. Severe chronic atopic dermatitis improvement after hepatitis C virus elimination with sofosbuvir/ledipasvir treatment. ADVANCES IN DERMATOLOGY AND ALLERGOLOGY.. 2022;(2):424?425",59.0,YR,,M,Y,,,20220624,,MD,PL,PL,2022,Q2,Adult
209609372,20960937,21,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,UNK,,,U,,,,,,,Suspension,,2022,Q2,Drug ineffective,,2022,Q2,2,F,,20220617.0,20220615,20220624,EXP,,PL-AUROBINDO-AUR-APL-2022-019175,AUROBINDO,"Szymanek-Pasternak A, Janocha-Litwin J, Simon K. Severe chronic atopic dermatitis improvement after hepatitis C virus elimination with sofosbuvir/ledipasvir treatment. ADVANCES IN DERMATOLOGY AND ALLERGOLOGY.. 2022;(2):424?425",59.0,YR,,M,Y,,,20220624,,MD,PL,PL,2022,Q2,Adult
209609372,20960937,21,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,UNK,,,U,,,,,,,Suspension,,2022,Q2,Hypoglycaemia,,2022,Q2,2,F,,20220617.0,20220615,20220624,EXP,,PL-AUROBINDO-AUR-APL-2022-019175,AUROBINDO,"Szymanek-Pasternak A, Janocha-Litwin J, Simon K. Severe chronic atopic dermatitis improvement after hepatitis C virus elimination with sofosbuvir/ledipasvir treatment. ADVANCES IN DERMATOLOGY AND ALLERGOLOGY.. 2022;(2):424?425",59.0,YR,,M,Y,,,20220624,,MD,PL,PL,2022,Q2,Adult
209609611,20960961,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Solution for injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220603.0,20220603.0,20220615,20220615,PER,,US-ELI_LILLY_AND_COMPANY-US202206002504,ELI LILLY AND CO,,54.0,YR,,M,Y,,,20220615,,CN,US,US,2022,Q2,Adult
209609611,20960961,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Solution for injection,,2022,Q2,Headache,,2022,Q2,1,I,20220603.0,20220603.0,20220615,20220615,PER,,US-ELI_LILLY_AND_COMPANY-US202206002504,ELI LILLY AND CO,,54.0,YR,,M,Y,,,20220615,,CN,US,US,2022,Q2,Adult
209609611,20960961,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Solution for injection,,2022,Q2,Muscular weakness,,2022,Q2,1,I,20220603.0,20220603.0,20220615,20220615,PER,,US-ELI_LILLY_AND_COMPANY-US202206002504,ELI LILLY AND CO,,54.0,YR,,M,Y,,,20220615,,CN,US,US,2022,Q2,Adult
209609611,20960961,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D416539C,,20563.0,,,Solution for injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220603.0,20220603.0,20220615,20220615,PER,,US-ELI_LILLY_AND_COMPANY-US202206002504,ELI LILLY AND CO,,54.0,YR,,M,Y,,,20220615,,CN,US,US,2022,Q2,Adult
209609611,20960961,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D416539C,,20563.0,,,Solution for injection,,2022,Q2,Headache,,2022,Q2,1,I,20220603.0,20220603.0,20220615,20220615,PER,,US-ELI_LILLY_AND_COMPANY-US202206002504,ELI LILLY AND CO,,54.0,YR,,M,Y,,,20220615,,CN,US,US,2022,Q2,Adult
209609611,20960961,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D416539C,,20563.0,,,Solution for injection,,2022,Q2,Muscular weakness,,2022,Q2,1,I,20220603.0,20220603.0,20220615,20220615,PER,,US-ELI_LILLY_AND_COMPANY-US202206002504,ELI LILLY AND CO,,54.0,YR,,M,Y,,,20220615,,CN,US,US,2022,Q2,Adult
209621351,20962135,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q2,Vomiting,,2022,Q2,1,I,20220612.0,20220610.0,20220615,20220615,PER,,US-ELI_LILLY_AND_COMPANY-US202206006229,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20220615,,CN,US,US,2022,Q2,Adult
209621351,20962135,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q2,Vomiting,,2022,Q2,1,I,20220612.0,20220610.0,20220615,20220615,PER,,US-ELI_LILLY_AND_COMPANY-US202206006229,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20220615,,CN,US,US,2022,Q2,Adult
209621351,20962135,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D473104C,,20563.0,,,Injection,,2022,Q2,Vomiting,,2022,Q2,1,I,20220612.0,20220610.0,20220615,20220615,PER,,US-ELI_LILLY_AND_COMPANY-US202206006229,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20220615,,CN,US,US,2022,Q2,Adult
209621351,20962135,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,,,D473104C,,20563.0,,,Injection,,2022,Q2,Vomiting,,2022,Q2,1,I,20220612.0,20220610.0,20220615,20220615,PER,,US-ELI_LILLY_AND_COMPANY-US202206006229,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20220615,,CN,US,US,2022,Q2,Adult
209646371,20964637,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D477301A,,20563.0,,,Solution for injection,,2022,Q2,Wrong technique in product usage process,,2022,Q2,1,I,20220607.0,20220608.0,20220615,20220615,PER,,US-ELI_LILLY_AND_COMPANY-US202206005270,ELI LILLY AND CO,,22.0,YR,,F,Y,,,20220615,,CN,US,US,2022,Q2,Youth
209646371,20964637,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D477301A,,20563.0,,,Solution for injection,,2022,Q2,Blood glucose abnormal,,2022,Q2,1,I,20220607.0,20220608.0,20220615,20220615,PER,,US-ELI_LILLY_AND_COMPANY-US202206005270,ELI LILLY AND CO,,22.0,YR,,F,Y,,,20220615,,CN,US,US,2022,Q2,Youth
209657111,20965711,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Product prescribing error,,2022,Q2,1,I,,20220608.0,20220616,20220616,EXP,,CA-APOTEX-2022AP009047,APOTEX,,17.0,YR,,M,Y,,,20220616,,HP,CA,CA,2022,Q2,Youth
209657111,20965711,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Off label use,,2022,Q2,1,I,,20220608.0,20220616,20220616,EXP,,CA-APOTEX-2022AP009047,APOTEX,,17.0,YR,,M,Y,,,20220616,,HP,CA,CA,2022,Q2,Youth
209657111,20965711,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q2,Diabetic ketoacidosis,,2022,Q2,1,I,,20220608.0,20220616,20220616,EXP,,CA-APOTEX-2022AP009047,APOTEX,,17.0,YR,,M,Y,,,20220616,,HP,CA,CA,2022,Q2,Youth
209667031,20966703,21,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,,suspension,,,,,,,,,,Suspension,,2022,Q2,Acute kidney injury,,2022,Q2,1,I,,20220610.0,20220616,20220616,EXP,,PL-MYLANLABS-2022M1039282,MYLAN,"Szymanek-Pasternak A, Janocha-Litwin J, Simon K.. Severe chronic atopic dermatitis improvement after hepatitis C virus elimination with sofosbuvir/ledipasvir treatment. Advances in dermatology and allergology. 2022;2:424-425",59.0,YR,,M,Y,,,20220616,,HP,PL,PL,2022,Q2,Adult
209667031,20966703,21,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,,suspension,,,,,,,,,,Suspension,,2022,Q2,Drug ineffective,,2022,Q2,1,I,,20220610.0,20220616,20220616,EXP,,PL-MYLANLABS-2022M1039282,MYLAN,"Szymanek-Pasternak A, Janocha-Litwin J, Simon K.. Severe chronic atopic dermatitis improvement after hepatitis C virus elimination with sofosbuvir/ledipasvir treatment. Advances in dermatology and allergology. 2022;2:424-425",59.0,YR,,M,Y,,,20220616,,HP,PL,PL,2022,Q2,Adult
209667031,20966703,21,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,,suspension,,,,,,,,,,Suspension,,2022,Q2,Hypertension,,2022,Q2,1,I,,20220610.0,20220616,20220616,EXP,,PL-MYLANLABS-2022M1039282,MYLAN,"Szymanek-Pasternak A, Janocha-Litwin J, Simon K.. Severe chronic atopic dermatitis improvement after hepatitis C virus elimination with sofosbuvir/ledipasvir treatment. Advances in dermatology and allergology. 2022;2:424-425",59.0,YR,,M,Y,,,20220616,,HP,PL,PL,2022,Q2,Adult
209667031,20966703,21,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,,suspension,,,,,,,,,,Suspension,,2022,Q2,Hypoglycaemia,,2022,Q2,1,I,,20220610.0,20220616,20220616,EXP,,PL-MYLANLABS-2022M1039282,MYLAN,"Szymanek-Pasternak A, Janocha-Litwin J, Simon K.. Severe chronic atopic dermatitis improvement after hepatitis C virus elimination with sofosbuvir/ledipasvir treatment. Advances in dermatology and allergology. 2022;2:424-425",59.0,YR,,M,Y,,,20220616,,HP,PL,PL,2022,Q2,Adult
209670131,20967013,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2022,Q2,Off label use,,2022,Q2,1,I,,20220607.0,20220616,20220616,EXP,,CA-SA-2022SA213299,SANOFI AVENTIS,unk. unk. unk. unk;unk:unk,17.0,YR,T,M,Y,,,20220616,,HP,CA,CA,2022,Q2,Youth
209670131,20967013,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2022,Q2,Diabetic ketoacidosis,,2022,Q2,1,I,,20220607.0,20220616,20220616,EXP,,CA-SA-2022SA213299,SANOFI AVENTIS,unk. unk. unk. unk;unk:unk,17.0,YR,T,M,Y,,,20220616,,HP,CA,CA,2022,Q2,Youth
209670131,20967013,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2022,Q2,Product prescribing error,,2022,Q2,1,I,,20220607.0,20220616,20220616,EXP,,CA-SA-2022SA213299,SANOFI AVENTIS,unk. unk. unk. unk;unk:unk,17.0,YR,T,M,Y,,,20220616,,HP,CA,CA,2022,Q2,Youth
209677461,20967746,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,,,D420814C,,20563.0,12.0,IU,Injection,,2022,Q2,Product storage error,,2022,Q2,1,I,20220609.0,20220613.0,20220616,20220616,PER,,US-ELI_LILLY_AND_COMPANY-US202206007062,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20220616,,CN,US,US,2022,Q2,Adult
209677461,20967746,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,,,D420814C,,20563.0,12.0,IU,Injection,,2022,Q2,Injection site haemorrhage,,2022,Q2,1,I,20220609.0,20220613.0,20220616,20220616,PER,,US-ELI_LILLY_AND_COMPANY-US202206007062,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20220616,,CN,US,US,2022,Q2,Adult
209677461,20967746,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,,,,,20563.0,12.0,IU,Injection,,2022,Q2,Product storage error,,2022,Q2,1,I,20220609.0,20220613.0,20220616,20220616,PER,,US-ELI_LILLY_AND_COMPANY-US202206007062,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20220616,,CN,US,US,2022,Q2,Adult
209677461,20967746,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,,,,,20563.0,12.0,IU,Injection,,2022,Q2,Injection site haemorrhage,,2022,Q2,1,I,20220609.0,20220613.0,20220616,20220616,PER,,US-ELI_LILLY_AND_COMPANY-US202206007062,ELI LILLY AND CO,,52.0,YR,,F,Y,,,20220616,,CN,US,US,2022,Q2,Adult
209686351,20968635,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,Frequency : 3 times a day;?,,,,Y,,,99.0,,,,TID,2022,Q2,Blood glucose abnormal,,2022,Q2,1,I,20220613.0,,20220616,20220616,DIR,619576,,FDA-CTU,,31.0,YR,,F,N,67.5,KG,20220616,Y,CN,US,,2022,Q2,Young Adult
209701161,20970116,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q2,Gait disturbance,,2022,Q2,1,I,20220519.0,20220601.0,20220616,20220616,PER,,US-SA-2022SA211062,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20220617,,MD,US,US,2022,Q2,Elderly
209701161,20970116,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q2,Back pain,,2022,Q2,1,I,20220519.0,20220601.0,20220616,20220616,PER,,US-SA-2022SA211062,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20220617,,MD,US,US,2022,Q2,Elderly
209701161,20970116,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q2,Abdominal pain upper,,2022,Q2,1,I,20220519.0,20220601.0,20220616,20220616,PER,,US-SA-2022SA211062,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20220617,,MD,US,US,2022,Q2,Elderly
209701161,20970116,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q2,Injection site joint pain,,2022,Q2,1,I,20220519.0,20220601.0,20220616,20220616,PER,,US-SA-2022SA211062,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20220617,,MD,US,US,2022,Q2,Elderly
209701161,20970116,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q2,Pain in extremity,,2022,Q2,1,I,20220519.0,20220601.0,20220616,20220616,PER,,US-SA-2022SA211062,SANOFI AVENTIS,,70.0,YR,E,M,Y,,,20220617,,MD,US,US,2022,Q2,Elderly
209743391,20974339,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D477301A,,20563.0,,,Injection,,2022,Q2,Wrong technique in product usage process,,2022,Q2,1,I,20220607.0,20220609.0,20220617,20220617,PER,,US-ELI_LILLY_AND_COMPANY-US202206005277,ELI LILLY AND CO,,22.0,YR,,F,Y,,,20220617,,CN,US,US,2022,Q2,Youth
209743391,20974339,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D477301A,,20563.0,,,Injection,,2022,Q2,Blood glucose abnormal,,2022,Q2,1,I,20220607.0,20220609.0,20220617,20220617,PER,,US-ELI_LILLY_AND_COMPANY-US202206005277,ELI LILLY AND CO,,22.0,YR,,F,Y,,,20220617,,CN,US,US,2022,Q2,Youth
209755541,20975554,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,insulin syr mis  0.5/31G,,,U,,,,,,,Unknown,,2022,Q2,Fatigue,,2022,Q2,1,I,,20220615.0,20220617,20220617,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20211201320,BRISTOL MYERS SQUIBB,,58.0,YR,A,M,Y,86.18,KG,20220617,,HP,US,US,2022,Q2,Adult
209755541,20975554,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,insulin syr mis  0.5/31G,,,U,,,,,,,Unknown,,2022,Q2,Diarrhoea,,2022,Q2,1,I,,20220615.0,20220617,20220617,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20211201320,BRISTOL MYERS SQUIBB,,58.0,YR,A,M,Y,86.18,KG,20220617,,HP,US,US,2022,Q2,Adult
209812472,20981247,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Drug ineffective,,2022,Q2,2,F,,20220614.0,20220620,20220621,EXP,,ES-009507513-2206ESP004394,MERCK,"Martinez-montoro JI, Pinzon-Martin JL, Damas-Fuentes M, Fernandez-Valero A, Tinahones FJ.. Combination Therapy With Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report. Frontiers in Endocrinology. 2022;13",22.0,YR,,M,Y,,,20220621,,HP,ES,ES,2022,Q2,Youth
209812472,20981247,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q2,Diabetes mellitus inadequate control,,2022,Q2,2,F,,20220614.0,20220620,20220621,EXP,,ES-009507513-2206ESP004394,MERCK,"Martinez-montoro JI, Pinzon-Martin JL, Damas-Fuentes M, Fernandez-Valero A, Tinahones FJ.. Combination Therapy With Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report. Frontiers in Endocrinology. 2022;13",22.0,YR,,M,Y,,,20220621,,HP,ES,ES,2022,Q2,Youth
209815261,20981526,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, tid",,,U,,,,20563.0,10.0,IU,Injection,TID,2022,Q2,Malignant neoplasm of ampulla of Vater,,2022,Q2,1,I,20180101.0,20220608.0,20220620,20220620,EXP,,US-ELI_LILLY_AND_COMPANY-US202206004263,ELI LILLY AND CO,,64.0,YR,,M,Y,,,20220620,,CN,US,US,2022,Q2,Adult
209920311,20992031,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (strength: 200 units/ml miriopen/kwikpen),,,U,,,,,,,,,2022,Q2,Clostridium test positive,,2022,Q2,1,I,,20220615.0,20220622,20220622,EXP,,NVSC2022CA138762,NOVARTIS,,58.0,YR,,M,Y,91.0,KG,20220622,,PH,CA,CA,2022,Q2,Adult
209940111,20994011,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Hyperglycaemia,,2022,Q2,1,I,20220621.0,,20220621,20220621,DIR,FDA-CDER-CTU-2022-49319,,FDA-CTU,,42.0,YR,,M,N,86.18,KG,20220621,,CN,US,,2022,Q2,Adult
209971641,20997164,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,Unknown,,2022,Q2,"Hallucination, visual",,2022,Q2,1,I,20190430.0,20220602.0,20220623,20220623,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20190501185,BRISTOL MYERS SQUIBB,,63.0,YR,A,F,Y,122.4,KG,20220623,,MD,US,US,2022,Q2,Adult
209971641,20997164,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,Unknown,,2022,Q2,Aphasia,,2022,Q2,1,I,20190430.0,20220602.0,20220623,20220623,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20190501185,BRISTOL MYERS SQUIBB,,63.0,YR,A,F,Y,122.4,KG,20220623,,MD,US,US,2022,Q2,Adult
209971641,20997164,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,Unknown,,2022,Q2,Confusional state,,2022,Q2,1,I,20190430.0,20220602.0,20220623,20220623,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20190501185,BRISTOL MYERS SQUIBB,,63.0,YR,A,F,Y,122.4,KG,20220623,,MD,US,US,2022,Q2,Adult
209971641,20997164,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,Unknown,,2022,Q2,Hyperglycaemia,,2022,Q2,1,I,20190430.0,20220602.0,20220623,20220623,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20190501185,BRISTOL MYERS SQUIBB,,63.0,YR,A,F,Y,122.4,KG,20220623,,MD,US,US,2022,Q2,Adult
209997371,20999737,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"60 u, daily (50-60 units daily)",,,U,,D420814C,,20563.0,60.0,IU,Injection,QD,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220527.0,20220527.0,20220623,20220623,PER,,US-ELI_LILLY_AND_COMPANY-US202205012523,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20220623,,CN,US,US,2022,Q2,Adult
209997371,20999737,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"60 u, daily (50-60 units daily)",,,U,,D420814C,,20563.0,60.0,IU,Injection,QD,2022,Q2,Visual impairment,,2022,Q2,1,I,20220527.0,20220527.0,20220623,20220623,PER,,US-ELI_LILLY_AND_COMPANY-US202205012523,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20220623,,CN,US,US,2022,Q2,Adult
209997371,20999737,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"60 u, daily (50-60 units daily)",,,U,,D420814C,,20563.0,60.0,IU,Injection,QD,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220527.0,20220527.0,20220623,20220623,PER,,US-ELI_LILLY_AND_COMPANY-US202205012523,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20220623,,CN,US,US,2022,Q2,Adult
209997371,20999737,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"60 u, daily (50-60 units daily)",,,U,,D420814C,,20563.0,60.0,IU,Injection,QD,2022,Q2,Visual impairment,,2022,Q2,1,I,20220527.0,20220527.0,20220623,20220623,PER,,US-ELI_LILLY_AND_COMPANY-US202205012523,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20220623,,CN,US,US,2022,Q2,Adult
209997371,20999737,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"60 u, daily (50-60 units daily)",,,U,,D455780C,,20563.0,60.0,IU,Injection,QD,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220527.0,20220527.0,20220623,20220623,PER,,US-ELI_LILLY_AND_COMPANY-US202205012523,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20220623,,CN,US,US,2022,Q2,Adult
209997371,20999737,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"60 u, daily (50-60 units daily)",,,U,,D455780C,,20563.0,60.0,IU,Injection,QD,2022,Q2,Visual impairment,,2022,Q2,1,I,20220527.0,20220527.0,20220623,20220623,PER,,US-ELI_LILLY_AND_COMPANY-US202205012523,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20220623,,CN,US,US,2022,Q2,Adult
209997371,20999737,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"60 u, daily (50-60 units daily)",,,U,,D455780C,,20563.0,60.0,IU,Injection,QD,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220527.0,20220527.0,20220623,20220623,PER,,US-ELI_LILLY_AND_COMPANY-US202205012523,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20220623,,CN,US,US,2022,Q2,Adult
209997371,20999737,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"60 u, daily (50-60 units daily)",,,U,,D455780C,,20563.0,60.0,IU,Injection,QD,2022,Q2,Visual impairment,,2022,Q2,1,I,20220527.0,20220527.0,20220623,20220623,PER,,US-ELI_LILLY_AND_COMPANY-US202205012523,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20220623,,CN,US,US,2022,Q2,Adult
209997371,20999737,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220527.0,20220527.0,20220623,20220623,PER,,US-ELI_LILLY_AND_COMPANY-US202205012523,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20220623,,CN,US,US,2022,Q2,Adult
209997371,20999737,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Visual impairment,,2022,Q2,1,I,20220527.0,20220527.0,20220623,20220623,PER,,US-ELI_LILLY_AND_COMPANY-US202205012523,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20220623,,CN,US,US,2022,Q2,Adult
209997371,20999737,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220527.0,20220527.0,20220623,20220623,PER,,US-ELI_LILLY_AND_COMPANY-US202205012523,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20220623,,CN,US,US,2022,Q2,Adult
209997371,20999737,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Visual impairment,,2022,Q2,1,I,20220527.0,20220527.0,20220623,20220623,PER,,US-ELI_LILLY_AND_COMPANY-US202205012523,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20220623,,CN,US,US,2022,Q2,Adult
209997371,20999737,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220527.0,20220527.0,20220623,20220623,PER,,US-ELI_LILLY_AND_COMPANY-US202205012523,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20220623,,CN,US,US,2022,Q2,Adult
209997371,20999737,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q2,Visual impairment,,2022,Q2,1,I,20220527.0,20220527.0,20220623,20220623,PER,,US-ELI_LILLY_AND_COMPANY-US202205012523,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20220623,,CN,US,US,2022,Q2,Adult
210004081,21000408,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Frequency text: Not provided,,,,,,,,,,Unknown,,2022,Q2,Mobility decreased,,2022,Q2,1,I,,20220613.0,20220623,20220623,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20210900672,BRISTOL MYERS SQUIBB,,81.0,YR,E,M,Y,74.4,KG,20220623,,PH,CA,CA,2022,Q2,Elderly
210004081,21000408,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Frequency text: Not provided,,,,,,,,,,Unknown,,2022,Q2,General physical health deterioration,,2022,Q2,1,I,,20220613.0,20220623,20220623,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20210900672,BRISTOL MYERS SQUIBB,,81.0,YR,E,M,Y,74.4,KG,20220623,,PH,CA,CA,2022,Q2,Elderly
210004081,21000408,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Frequency text: Not provided,,,,,,,,,,Unknown,,2022,Q2,Fall,,2022,Q2,1,I,,20220613.0,20220623,20220623,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20210900672,BRISTOL MYERS SQUIBB,,81.0,YR,E,M,Y,74.4,KG,20220623,,PH,CA,CA,2022,Q2,Elderly
210009881,21000988,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, tid",,,U,,,,,,,Injection,TID,2022,Q2,Food allergy,,2022,Q2,1,I,20220401.0,20220525.0,20220624,20220624,PER,,US-ELI_LILLY_AND_COMPANY-US202205011966,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220624,,CN,US,US,2022,Q2,Elderly
210009881,21000988,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, tid",,,U,,D456541A,,,,,Injection,TID,2022,Q2,Food allergy,,2022,Q2,1,I,20220401.0,20220525.0,20220624,20220624,PER,,US-ELI_LILLY_AND_COMPANY-US202205011966,ELI LILLY AND CO,,66.0,YR,,F,Y,,,20220624,,CN,US,US,2022,Q2,Elderly
210009911,21000991,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D420813A,,20563.0,,,Injection,,2022,Q2,Visual impairment,,2022,Q2,1,I,20220525.0,20220526.0,20220624,20220624,PER,,US-ELI_LILLY_AND_COMPANY-US202205011915,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20220624,,CN,US,US,2022,Q2,Elderly
210009911,21000991,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D420813A,,20563.0,,,Injection,,2022,Q2,Incorrect dose administered,,2022,Q2,1,I,20220525.0,20220526.0,20220624,20220624,PER,,US-ELI_LILLY_AND_COMPANY-US202205011915,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20220624,,CN,US,US,2022,Q2,Elderly
210009911,21000991,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D420813A,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220525.0,20220526.0,20220624,20220624,PER,,US-ELI_LILLY_AND_COMPANY-US202205011915,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20220624,,CN,US,US,2022,Q2,Elderly
210037171,21003717,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Drug interaction,,2022,Q2,1,I,20220606.0,,20220623,20220623,DIR,620441,,FDA-CTU,,45.0,YR,,F,N,83.7,KG,20220623,N,CN,US,,2022,Q2,Adult
210037171,21003717,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Feeling abnormal,,2022,Q2,1,I,20220606.0,,20220623,20220623,DIR,620441,,FDA-CTU,,45.0,YR,,F,N,83.7,KG,20220623,N,CN,US,,2022,Q2,Adult
210037171,21003717,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Skin lesion,,2022,Q2,1,I,20220606.0,,20220623,20220623,DIR,620441,,FDA-CTU,,45.0,YR,,F,N,83.7,KG,20220623,N,CN,US,,2022,Q2,Adult
210037171,21003717,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Abdominal pain upper,,2022,Q2,1,I,20220606.0,,20220623,20220623,DIR,620441,,FDA-CTU,,45.0,YR,,F,N,83.7,KG,20220623,N,CN,US,,2022,Q2,Adult
210037171,21003717,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Vascular procedure complication,,2022,Q2,1,I,20220606.0,,20220623,20220623,DIR,620441,,FDA-CTU,,45.0,YR,,F,N,83.7,KG,20220623,N,CN,US,,2022,Q2,Adult
210037171,21003717,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Diabetic ketoacidosis,,2022,Q2,1,I,20220606.0,,20220623,20220623,DIR,620441,,FDA-CTU,,45.0,YR,,F,N,83.7,KG,20220623,N,CN,US,,2022,Q2,Adult
210037171,21003717,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Headache,,2022,Q2,1,I,20220606.0,,20220623,20220623,DIR,620441,,FDA-CTU,,45.0,YR,,F,N,83.7,KG,20220623,N,CN,US,,2022,Q2,Adult
210037171,21003717,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Nausea,,2022,Q2,1,I,20220606.0,,20220623,20220623,DIR,620441,,FDA-CTU,,45.0,YR,,F,N,83.7,KG,20220623,N,CN,US,,2022,Q2,Adult
210037171,21003717,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Vomiting,,2022,Q2,1,I,20220606.0,,20220623,20220623,DIR,620441,,FDA-CTU,,45.0,YR,,F,N,83.7,KG,20220623,N,CN,US,,2022,Q2,Adult
210037171,21003717,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Dehydration,,2022,Q2,1,I,20220606.0,,20220623,20220623,DIR,620441,,FDA-CTU,,45.0,YR,,F,N,83.7,KG,20220623,N,CN,US,,2022,Q2,Adult
210037171,21003717,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Contusion,,2022,Q2,1,I,20220606.0,,20220623,20220623,DIR,620441,,FDA-CTU,,45.0,YR,,F,N,83.7,KG,20220623,N,CN,US,,2022,Q2,Adult
210037171,21003717,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Pain,,2022,Q2,1,I,20220606.0,,20220623,20220623,DIR,620441,,FDA-CTU,,45.0,YR,,F,N,83.7,KG,20220623,N,CN,US,,2022,Q2,Adult
210037171,21003717,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q2,Adverse drug reaction,,2022,Q2,1,I,20220606.0,,20220623,20220623,DIR,620441,,FDA-CTU,,45.0,YR,,F,N,83.7,KG,20220623,N,CN,US,,2022,Q2,Adult
210070481,21007048,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,,,20563.0,10.0,IU,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220622.0,20220623.0,20220625,20220625,PER,,US-ELI_LILLY_AND_COMPANY-US202206011857,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220625,,CN,US,US,2022,Q2,Elderly
210070481,21007048,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,,,20563.0,10.0,IU,Injection,,2022,Q2,Product dose omission issue,,2022,Q2,1,I,20220622.0,20220623.0,20220625,20220625,PER,,US-ELI_LILLY_AND_COMPANY-US202206011857,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220625,,CN,US,US,2022,Q2,Elderly
210070481,21007048,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,,,20563.0,10.0,IU,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220622.0,20220623.0,20220625,20220625,PER,,US-ELI_LILLY_AND_COMPANY-US202206011857,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220625,,CN,US,US,2022,Q2,Elderly
210070481,21007048,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,,,20563.0,10.0,IU,Injection,,2022,Q2,Product dose omission issue,,2022,Q2,1,I,20220622.0,20220623.0,20220625,20220625,PER,,US-ELI_LILLY_AND_COMPANY-US202206011857,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220625,,CN,US,US,2022,Q2,Elderly
210070481,21007048,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D473104C,,20563.0,10.0,IU,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220622.0,20220623.0,20220625,20220625,PER,,US-ELI_LILLY_AND_COMPANY-US202206011857,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220625,,CN,US,US,2022,Q2,Elderly
210070481,21007048,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D473104C,,20563.0,10.0,IU,Injection,,2022,Q2,Product dose omission issue,,2022,Q2,1,I,20220622.0,20220623.0,20220625,20220625,PER,,US-ELI_LILLY_AND_COMPANY-US202206011857,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220625,,CN,US,US,2022,Q2,Elderly
210070481,21007048,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D473104C,,20563.0,10.0,IU,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220622.0,20220623.0,20220625,20220625,PER,,US-ELI_LILLY_AND_COMPANY-US202206011857,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220625,,CN,US,US,2022,Q2,Elderly
210070481,21007048,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D473104C,,20563.0,10.0,IU,Injection,,2022,Q2,Product dose omission issue,,2022,Q2,1,I,20220622.0,20220623.0,20220625,20220625,PER,,US-ELI_LILLY_AND_COMPANY-US202206011857,ELI LILLY AND CO,,66.0,YR,,M,Y,,,20220625,,CN,US,US,2022,Q2,Elderly
210074141,21007414,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"62 u, bid (twice a day on a sliding scale of 52-60 units per dose)",,,U,,D088600C,,21017.0,62.0,IU,Injection,BID,2022,Q2,Product storage error,,2022,Q2,1,I,20220621.0,20220622.0,20220626,20220626,PER,,US-ELI_LILLY_AND_COMPANY-US202206011863,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220626,,CN,US,US,2022,Q2,Adult
210074141,21007414,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"62 u, bid (twice a day on a sliding scale of 52-60 units per dose)",,,U,,D088600C,,21017.0,62.0,IU,Injection,BID,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220621.0,20220622.0,20220626,20220626,PER,,US-ELI_LILLY_AND_COMPANY-US202206011863,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220626,,CN,US,US,2022,Q2,Adult
210074141,21007414,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"62 u, bid (twice a day on a sliding scale of 52-60 units per dose)",,,U,,D088600C,,21017.0,62.0,IU,Injection,BID,2022,Q2,Chest pain,,2022,Q2,1,I,20220621.0,20220622.0,20220626,20220626,PER,,US-ELI_LILLY_AND_COMPANY-US202206011863,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220626,,CN,US,US,2022,Q2,Adult
210074141,21007414,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"62 u, bid (twice a day on a sliding scale of 52-60 units per dose)",,,U,,D088600C,,21017.0,62.0,IU,Injection,BID,2022,Q2,Expired product administered,,2022,Q2,1,I,20220621.0,20220622.0,20220626,20220626,PER,,US-ELI_LILLY_AND_COMPANY-US202206011863,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220626,,CN,US,US,2022,Q2,Adult
210096692,21009669,2,C,INSULIN LISPRO BS,,2,Unknown,"Morning, noon and evening, 2 -2 -4",,,,,,,,,,Solution for injection,,2022,Q2,Toxic epidermal necrolysis,,2022,Q2,2,F,20220422.0,20220621.0,20220627,20220628,EXP,,JP-009507513-2206JPN002581J,MERCK,,71.0,YR,,F,Y,63.0,KG,20220628,,PH,JP,JP,2022,Q2,Elderly
210153511,21015351,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q2,Atelectasis,,2022,Q2,1,I,20200715.0,20220615.0,20220628,20220628,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-01590,HIKMA,,69.0,YR,,M,Y,103.1,KG,20220628,,HP,US,,2022,Q2,Elderly
210153511,21015351,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q2,Fungal test positive,,2022,Q2,1,I,20200715.0,20220615.0,20220628,20220628,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-01590,HIKMA,,69.0,YR,,M,Y,103.1,KG,20220628,,HP,US,,2022,Q2,Elderly
210153511,21015351,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q2,Lung opacity,,2022,Q2,1,I,20200715.0,20220615.0,20220628,20220628,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-01590,HIKMA,,69.0,YR,,M,Y,103.1,KG,20220628,,HP,US,,2022,Q2,Elderly
210153511,21015351,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q2,Orthopnoea,,2022,Q2,1,I,20200715.0,20220615.0,20220628,20220628,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-01590,HIKMA,,69.0,YR,,M,Y,103.1,KG,20220628,,HP,US,,2022,Q2,Elderly
210153511,21015351,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q2,Dyspnoea exertional,,2022,Q2,1,I,20200715.0,20220615.0,20220628,20220628,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-01590,HIKMA,,69.0,YR,,M,Y,103.1,KG,20220628,,HP,US,,2022,Q2,Elderly
210153511,21015351,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q2,Pneumocystis jirovecii pneumonia,,2022,Q2,1,I,20200715.0,20220615.0,20220628,20220628,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-01590,HIKMA,,69.0,YR,,M,Y,103.1,KG,20220628,,HP,US,,2022,Q2,Elderly
210153511,21015351,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q2,Pleural effusion,,2022,Q2,1,I,20200715.0,20220615.0,20220628,20220628,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-01590,HIKMA,,69.0,YR,,M,Y,103.1,KG,20220628,,HP,US,,2022,Q2,Elderly
210153511,21015351,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q2,Diarrhoea,,2022,Q2,1,I,20200715.0,20220615.0,20220628,20220628,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-01590,HIKMA,,69.0,YR,,M,Y,103.1,KG,20220628,,HP,US,,2022,Q2,Elderly
210153511,21015351,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q2,Dyspnoea,,2022,Q2,1,I,20200715.0,20220615.0,20220628,20220628,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-01590,HIKMA,,69.0,YR,,M,Y,103.1,KG,20220628,,HP,US,,2022,Q2,Elderly
210153511,21015351,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q2,Asthenia,,2022,Q2,1,I,20200715.0,20220615.0,20220628,20220628,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-01590,HIKMA,,69.0,YR,,M,Y,103.1,KG,20220628,,HP,US,,2022,Q2,Elderly
210153511,21015351,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q2,Decreased appetite,,2022,Q2,1,I,20200715.0,20220615.0,20220628,20220628,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-01590,HIKMA,,69.0,YR,,M,Y,103.1,KG,20220628,,HP,US,,2022,Q2,Elderly
210153511,21015351,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q2,Pneumonia,,2022,Q2,1,I,20200715.0,20220615.0,20220628,20220628,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-01590,HIKMA,,69.0,YR,,M,Y,103.1,KG,20220628,,HP,US,,2022,Q2,Elderly
210153511,21015351,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q2,Pyrexia,,2022,Q2,1,I,20200715.0,20220615.0,20220628,20220628,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-01590,HIKMA,,69.0,YR,,M,Y,103.1,KG,20220628,,HP,US,,2022,Q2,Elderly
210153511,21015351,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q2,Condition aggravated,,2022,Q2,1,I,20200715.0,20220615.0,20220628,20220628,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-01590,HIKMA,,69.0,YR,,M,Y,103.1,KG,20220628,,HP,US,,2022,Q2,Elderly
210170321,21017032,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,U,,,,,,,,2022,Q2,Diabetes mellitus inadequate control,,2022,Q2,1,I,,20220624.0,20220628,20220628,EXP,,ES-MYLANLABS-2022M1048327,MYLAN,"Martinez-montoro JI, Pinzon-Martin JL, Damas-Fuentes M, Fernandez-Valero A, Tinahones FJ. Combination Therapy With Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report.. Front. Endocrinol.. 2022;13",22.0,YR,,M,Y,,,20220628,,HP,ES,ES,2022,Q2,Youth
210170321,21017032,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,U,,,,,,,,2022,Q2,Drug ineffective,,2022,Q2,1,I,,20220624.0,20220628,20220628,EXP,,ES-MYLANLABS-2022M1048327,MYLAN,"Martinez-montoro JI, Pinzon-Martin JL, Damas-Fuentes M, Fernandez-Valero A, Tinahones FJ. Combination Therapy With Semaglutide and Dapagliflozin as an Effective Approach for the Management of Type A Insulin Resistance Syndrome: A Case Report.. Front. Endocrinol.. 2022;13",22.0,YR,,M,Y,,,20220628,,HP,ES,ES,2022,Q2,Youth
210188981,21018898,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,,,2022,Q2,Diabetic ketoacidosis,,2022,Q2,1,I,,20220616.0,20220628,20220628,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202206013221,ELI LILLY AND CO,,17.0,YR,,M,Y,,,20220628,,CN,CA,CA,2022,Q2,Youth
210227341,21022734,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D261904A,,20563.0,,,Injection,,2022,Q2,Blood glucose increased,,2022,Q2,1,I,20220623.0,20220627.0,20220629,20220629,PER,,US-ELI_LILLY_AND_COMPANY-US202206013205,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20220629,,CN,US,US,2022,Q2,Elderly
210242511,21024251,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (Sliding sacle)",,,U,,D455780C,,,,,Injection,,2022,Q2,Blood glucose decreased,,2022,Q2,1,I,20220301.0,20220627.0,20220629,20220629,PER,,US-ELI_LILLY_AND_COMPANY-US202206013593,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20220629,,CN,US,US,2022,Q2,Elderly
210242511,21024251,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (Sliding sacle)",,,U,,D455780C,,,,,Injection,,2022,Q2,Incorrect dose administered,,2022,Q2,1,I,20220301.0,20220627.0,20220629,20220629,PER,,US-ELI_LILLY_AND_COMPANY-US202206013593,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20220629,,CN,US,US,2022,Q2,Elderly
210292911,21029291,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 international unit, before meal",,,U,,,,,5.0,IU,,,2022,Q2,Exposure during pregnancy,,2022,Q2,1,I,,20220621.0,20220630,20220630,EXP,,US-ELI_LILLY_AND_COMPANY-US202206011131,ELI LILLY AND CO,"Abuzeid O.,Heiligenstein M.,Noureddine L.,Heiselman C.,Bernasko J..Acute glycogenic hepatopathy in pregnancy: A case report and literature review.Case Rep. Perinat. Med. 2022;11(1):1-4.DOI:https://doi.org/10.1515/crpm-2021-0065",46.0,YR,,F,Y,,,20220630,,HP,US,US,2022,Q2,Adult
210292911,21029291,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 international unit, before meal",,,U,,,,,5.0,IU,,,2022,Q2,Dermatitis allergic,,2022,Q2,1,I,,20220621.0,20220630,20220630,EXP,,US-ELI_LILLY_AND_COMPANY-US202206011131,ELI LILLY AND CO,"Abuzeid O.,Heiligenstein M.,Noureddine L.,Heiselman C.,Bernasko J..Acute glycogenic hepatopathy in pregnancy: A case report and literature review.Case Rep. Perinat. Med. 2022;11(1):1-4.DOI:https://doi.org/10.1515/crpm-2021-0065",46.0,YR,,F,Y,,,20220630,,HP,US,US,2022,Q2,Adult
152179916,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Rheumatoid arthritis,,2022,Q3,6,F,20180701.0,20220913.0,20180730,20220916,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
152179916,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Pain in extremity,,2022,Q3,6,F,20180701.0,20220913.0,20180730,20220916,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
152179916,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Pain,,2022,Q3,6,F,20180701.0,20220913.0,20180730,20220916,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
152179916,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Hepatic cirrhosis,,2022,Q3,6,F,20180701.0,20220913.0,20180730,20220916,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
152179916,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Arthralgia,,2022,Q3,6,F,20180701.0,20220913.0,20180730,20220916,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
152179916,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Abdominal discomfort,,2022,Q3,6,F,20180701.0,20220913.0,20180730,20220916,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
152179916,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Arthropathy,,2022,Q3,6,F,20180701.0,20220913.0,20180730,20220916,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
152179916,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Osteoarthritis,,2022,Q3,6,F,20180701.0,20220913.0,20180730,20220916,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
152179916,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Hepatotoxicity,,2022,Q3,6,F,20180701.0,20220913.0,20180730,20220916,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
152179916,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Drug intolerance,,2022,Q3,6,F,20180701.0,20220913.0,20180730,20220916,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
152179916,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Therapeutic product effect decreased,,2022,Q3,6,F,20180701.0,20220913.0,20180730,20220916,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
152179916,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Psoriatic arthropathy,,2022,Q3,6,F,20180701.0,20220913.0,20180730,20220916,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
152179916,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Headache,,2022,Q3,6,F,20180701.0,20220913.0,20180730,20220916,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
152179916,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Movement disorder,,2022,Q3,6,F,20180701.0,20220913.0,20180730,20220916,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
152179916,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Hypertension,,2022,Q3,6,F,20180701.0,20220913.0,20180730,20220916,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
152179916,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Grip strength decreased,,2022,Q3,6,F,20180701.0,20220913.0,20180730,20220916,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
152179916,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Diverticulum,,2022,Q3,6,F,20180701.0,20220913.0,20180730,20220916,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
152179916,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Bone loss,,2022,Q3,6,F,20180701.0,20220913.0,20180730,20220916,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
152179916,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Drug ineffective,,2022,Q3,6,F,20180701.0,20220913.0,20180730,20220916,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
152179916,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Diabetes mellitus,,2022,Q3,6,F,20180701.0,20220913.0,20180730,20220916,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
152179916,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Cardiac disorder,,2022,Q3,6,F,20180701.0,20220913.0,20180730,20220916,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
152179916,15217991,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,6,F,20180701.0,20220913.0,20180730,20220916,PER,,CA-AMGEN-CANSP2018101832,AMGEN,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
153873077,15387307,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Hypokalaemia,,2022,Q3,7,F,20180907.0,20220826.0,20180914,20220901,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-083932,BRISTOL MYERS SQUIBB,,59.0,YR,A,M,Y,108.59,KG,20220901,,HP,US,US,2022,Q3,Adult
153873077,15387307,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Encephalopathy,,2022,Q3,7,F,20180907.0,20220826.0,20180914,20220901,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-083932,BRISTOL MYERS SQUIBB,,59.0,YR,A,M,Y,108.59,KG,20220901,,HP,US,US,2022,Q3,Adult
153873077,15387307,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Acute kidney injury,,2022,Q3,7,F,20180907.0,20220826.0,20180914,20220901,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2018-083932,BRISTOL MYERS SQUIBB,,59.0,YR,A,M,Y,108.59,KG,20220901,,HP,US,US,2022,Q3,Adult
154969608,15496960,67,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Addison's disease,,2022,Q3,8,F,20180819.0,20220714.0,20181015,20220716,EXP,,US-ROCHE-2186872,ROCHE,,56.0,YR,,F,Y,73.5,KG,20220716,,MD,US,,2022,Q3,Adult
154969608,15496960,67,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Hyperthyroidism,,2022,Q3,8,F,20180819.0,20220714.0,20181015,20220716,EXP,,US-ROCHE-2186872,ROCHE,,56.0,YR,,F,Y,73.5,KG,20220716,,MD,US,,2022,Q3,Adult
154969608,15496960,67,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Hypothyroidism,,2022,Q3,8,F,20180819.0,20220714.0,20181015,20220716,EXP,,US-ROCHE-2186872,ROCHE,,56.0,YR,,F,Y,73.5,KG,20220716,,MD,US,,2022,Q3,Adult
1560450612,15604506,18,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD ( (25/75: + 20U 20U / d)",,,U,,,,,40.0,IU,Solution for injection,QD,2022,Q3,Chest pain,,2022,Q3,12,F,,20220801.0,20181110,20220805,EXP,,PHHY2018PT147150,NOVARTIS,,54.0,YR,,F,Y,,,20220805,,PH,PT,PT,2022,Q3,Adult
1560450612,15604506,18,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD ( (25/75: + 20U 20U / d)",,,U,,,,,40.0,IU,Solution for injection,QD,2022,Q3,Ischaemic stroke,,2022,Q3,12,F,,20220801.0,20181110,20220805,EXP,,PHHY2018PT147150,NOVARTIS,,54.0,YR,,F,Y,,,20220805,,PH,PT,PT,2022,Q3,Adult
1560450612,15604506,18,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 IU, QD ( (25/75: + 20U 20U / d)",,,U,,,,,40.0,IU,Solution for injection,QD,2022,Q3,Headache,,2022,Q3,12,F,,20220801.0,20181110,20220805,EXP,,PHHY2018PT147150,NOVARTIS,,54.0,YR,,F,Y,,,20220805,,PH,PT,PT,2022,Q3,Adult
1560450612,15604506,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 dosage form, QD",,,U,,,,,,,Solution for injection,QD,2022,Q3,Chest pain,,2022,Q3,12,F,,20220801.0,20181110,20220805,EXP,,PHHY2018PT147150,NOVARTIS,,54.0,YR,,F,Y,,,20220805,,PH,PT,PT,2022,Q3,Adult
1560450612,15604506,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 dosage form, QD",,,U,,,,,,,Solution for injection,QD,2022,Q3,Ischaemic stroke,,2022,Q3,12,F,,20220801.0,20181110,20220805,EXP,,PHHY2018PT147150,NOVARTIS,,54.0,YR,,F,Y,,,20220805,,PH,PT,PT,2022,Q3,Adult
1560450612,15604506,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 dosage form, QD",,,U,,,,,,,Solution for injection,QD,2022,Q3,Headache,,2022,Q3,12,F,,20220801.0,20181110,20220805,EXP,,PHHY2018PT147150,NOVARTIS,,54.0,YR,,F,Y,,,20220805,,PH,PT,PT,2022,Q3,Adult
1561839712,15618397,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, daily",,,U,,,,20563.0,,,,QD,2022,Q3,Headache,,2022,Q3,12,F,,20220728.0,20181114,20220810,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201811005909,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20220810,,HP,PT,PT,2022,Q3,Adult
1561839712,15618397,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, daily",,,U,,,,20563.0,,,,QD,2022,Q3,Ischaemic stroke,,2022,Q3,12,F,,20220728.0,20181114,20220810,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201811005909,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20220810,,HP,PT,PT,2022,Q3,Adult
1561839712,15618397,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, daily",,,U,,,,20563.0,,,,QD,2022,Q3,Chest pain,,2022,Q3,12,F,,20220728.0,20181114,20220810,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201811005909,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20220810,,HP,PT,PT,2022,Q3,Adult
1561839712,15618397,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 international unit, daily",,,U,,,,20563.0,40.0,IU,,QD,2022,Q3,Headache,,2022,Q3,12,F,,20220728.0,20181114,20220810,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201811005909,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20220810,,HP,PT,PT,2022,Q3,Adult
1561839712,15618397,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 international unit, daily",,,U,,,,20563.0,40.0,IU,,QD,2022,Q3,Ischaemic stroke,,2022,Q3,12,F,,20220728.0,20181114,20220810,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201811005909,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20220810,,HP,PT,PT,2022,Q3,Adult
1561839712,15618397,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 international unit, daily",,,U,,,,20563.0,40.0,IU,,QD,2022,Q3,Chest pain,,2022,Q3,12,F,,20220728.0,20181114,20220810,EXP,,PT-ELI_LILLY_AND_COMPANY-PT201811005909,ELI LILLY AND CO,,54.0,YR,,F,Y,,,20220810,,HP,PT,PT,2022,Q3,Adult
156383793,15638379,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 milligram, qd",,,,,,,,40.0,MG,,QD,2022,Q3,Ischaemic stroke,,2022,Q3,3,F,20180101.0,20220728.0,20181120,20220803,PER,,PT-AMGEN-PRTSP2018165248,AMGEN,,54.0,YR,A,F,Y,110.0,KG,20220803,,PH,PT,PT,2022,Q3,Adult
156383793,15638379,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 milligram, qd",,,,,,,,40.0,MG,,QD,2022,Q3,Chest pain,,2022,Q3,3,F,20180101.0,20220728.0,20181120,20220803,PER,,PT-AMGEN-PRTSP2018165248,AMGEN,,54.0,YR,A,F,Y,110.0,KG,20220803,,PH,PT,PT,2022,Q3,Adult
1564428130,15644281,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"40 IU, 1x/day ((25/75: + 20U 20U daily)",,,U,,,,,40.0,IU,Solution for injection,QD,2022,Q3,Chest pain,,2022,Q3,30,F,,20220801.0,20181121,20220809,EXP,,PT-PFIZER INC-2018477132,PFIZER,,54.0,YR,,F,Y,,,20220809,,PH,PT,PT,2022,Q3,Adult
1564428130,15644281,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"40 IU, 1x/day ((25/75: + 20U 20U daily)",,,U,,,,,40.0,IU,Solution for injection,QD,2022,Q3,Headache,,2022,Q3,30,F,,20220801.0,20181121,20220809,EXP,,PT-PFIZER INC-2018477132,PFIZER,,54.0,YR,,F,Y,,,20220809,,PH,PT,PT,2022,Q3,Adult
1564428130,15644281,19,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"40 IU, 1x/day ((25/75: + 20U 20U daily)",,,U,,,,,40.0,IU,Solution for injection,QD,2022,Q3,Ischaemic stroke,,2022,Q3,30,F,,20220801.0,20181121,20220809,EXP,,PT-PFIZER INC-2018477132,PFIZER,,54.0,YR,,F,Y,,,20220809,,PH,PT,PT,2022,Q3,Adult
1564428130,15644281,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD (25/75: + 20U 20U / d)",,,U,,Unknown,,,,,Solution for injection,QD,2022,Q3,Chest pain,,2022,Q3,30,F,,20220801.0,20181121,20220809,EXP,,PT-PFIZER INC-2018477132,PFIZER,,54.0,YR,,F,Y,,,20220809,,PH,PT,PT,2022,Q3,Adult
1564428130,15644281,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD (25/75: + 20U 20U / d)",,,U,,Unknown,,,,,Solution for injection,QD,2022,Q3,Headache,,2022,Q3,30,F,,20220801.0,20181121,20220809,EXP,,PT-PFIZER INC-2018477132,PFIZER,,54.0,YR,,F,Y,,,20220809,,PH,PT,PT,2022,Q3,Adult
1564428130,15644281,20,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, QD (25/75: + 20U 20U / d)",,,U,,Unknown,,,,,Solution for injection,QD,2022,Q3,Ischaemic stroke,,2022,Q3,30,F,,20220801.0,20181121,20220809,EXP,,PT-PFIZER INC-2018477132,PFIZER,,54.0,YR,,F,Y,,,20220809,,PH,PT,PT,2022,Q3,Adult
1577022117,15770221,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Nervousness,,2022,Q3,17,F,,20220916.0,20181228,20220922,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20220922,,MD,US,US,2022,Q3,Elderly
1577022117,15770221,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Fungal infection,,2022,Q3,17,F,,20220916.0,20181228,20220922,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20220922,,MD,US,US,2022,Q3,Elderly
1577022117,15770221,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Product prescribing issue,,2022,Q3,17,F,,20220916.0,20181228,20220922,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20220922,,MD,US,US,2022,Q3,Elderly
1577022117,15770221,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Feeling jittery,,2022,Q3,17,F,,20220916.0,20181228,20220922,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20220922,,MD,US,US,2022,Q3,Elderly
1577022117,15770221,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Pain,,2022,Q3,17,F,,20220916.0,20181228,20220922,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20220922,,MD,US,US,2022,Q3,Elderly
1577022117,15770221,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Product prescribing error,,2022,Q3,17,F,,20220916.0,20181228,20220922,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20220922,,MD,US,US,2022,Q3,Elderly
1577022117,15770221,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Pruritus,,2022,Q3,17,F,,20220916.0,20181228,20220922,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20220922,,MD,US,US,2022,Q3,Elderly
1577022117,15770221,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Bladder cancer,,2022,Q3,17,F,,20220916.0,20181228,20220922,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20220922,,MD,US,US,2022,Q3,Elderly
1577022117,15770221,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Pain in extremity,,2022,Q3,17,F,,20220916.0,20181228,20220922,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20220922,,MD,US,US,2022,Q3,Elderly
1577022117,15770221,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Off label use,,2022,Q3,17,F,,20220916.0,20181228,20220922,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20220922,,MD,US,US,2022,Q3,Elderly
1577022117,15770221,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Product dispensing error,,2022,Q3,17,F,,20220916.0,20181228,20220922,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20220922,,MD,US,US,2022,Q3,Elderly
1577022117,15770221,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Infection,,2022,Q3,17,F,,20220916.0,20181228,20220922,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20220922,,MD,US,US,2022,Q3,Elderly
1577022117,15770221,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Self esteem decreased,,2022,Q3,17,F,,20220916.0,20181228,20220922,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20220922,,MD,US,US,2022,Q3,Elderly
1577022117,15770221,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Rash,,2022,Q3,17,F,,20220916.0,20181228,20220922,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20220922,,MD,US,US,2022,Q3,Elderly
1577022117,15770221,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Feeling abnormal,,2022,Q3,17,F,,20220916.0,20181228,20220922,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20220922,,MD,US,US,2022,Q3,Elderly
158546186,15854618,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Grip strength decreased,,2022,Q3,6,F,,20220808.0,20190122,20220815,EXP,,CA-ABBVIE-19K-028-2634391-00,ABBVIE,,65.0,YR,,F,Y,,,20220815,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q3,Elderly
158546186,15854618,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Hepatotoxicity,,2022,Q3,6,F,,20220808.0,20190122,20220815,EXP,,CA-ABBVIE-19K-028-2634391-00,ABBVIE,,65.0,YR,,F,Y,,,20220815,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q3,Elderly
158546186,15854618,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Osteoarthritis,,2022,Q3,6,F,,20220808.0,20190122,20220815,EXP,,CA-ABBVIE-19K-028-2634391-00,ABBVIE,,65.0,YR,,F,Y,,,20220815,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q3,Elderly
158546186,15854618,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Diabetes mellitus,,2022,Q3,6,F,,20220808.0,20190122,20220815,EXP,,CA-ABBVIE-19K-028-2634391-00,ABBVIE,,65.0,YR,,F,Y,,,20220815,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q3,Elderly
158546186,15854618,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Psoriatic arthropathy,,2022,Q3,6,F,,20220808.0,20190122,20220815,EXP,,CA-ABBVIE-19K-028-2634391-00,ABBVIE,,65.0,YR,,F,Y,,,20220815,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q3,Elderly
158546186,15854618,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Therapeutic product effect decreased,,2022,Q3,6,F,,20220808.0,20190122,20220815,EXP,,CA-ABBVIE-19K-028-2634391-00,ABBVIE,,65.0,YR,,F,Y,,,20220815,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q3,Elderly
158546186,15854618,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Pain,,2022,Q3,6,F,,20220808.0,20190122,20220815,EXP,,CA-ABBVIE-19K-028-2634391-00,ABBVIE,,65.0,YR,,F,Y,,,20220815,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q3,Elderly
158546186,15854618,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Drug ineffective,,2022,Q3,6,F,,20220808.0,20190122,20220815,EXP,,CA-ABBVIE-19K-028-2634391-00,ABBVIE,,65.0,YR,,F,Y,,,20220815,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q3,Elderly
158546186,15854618,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Arthralgia,,2022,Q3,6,F,,20220808.0,20190122,20220815,EXP,,CA-ABBVIE-19K-028-2634391-00,ABBVIE,,65.0,YR,,F,Y,,,20220815,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q3,Elderly
158546186,15854618,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Arthropathy,,2022,Q3,6,F,,20220808.0,20190122,20220815,EXP,,CA-ABBVIE-19K-028-2634391-00,ABBVIE,,65.0,YR,,F,Y,,,20220815,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q3,Elderly
158546186,15854618,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Hepatic cirrhosis,,2022,Q3,6,F,,20220808.0,20190122,20220815,EXP,,CA-ABBVIE-19K-028-2634391-00,ABBVIE,,65.0,YR,,F,Y,,,20220815,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q3,Elderly
158546186,15854618,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Movement disorder,,2022,Q3,6,F,,20220808.0,20190122,20220815,EXP,,CA-ABBVIE-19K-028-2634391-00,ABBVIE,,65.0,YR,,F,Y,,,20220815,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q3,Elderly
158546186,15854618,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Pain in extremity,,2022,Q3,6,F,,20220808.0,20190122,20220815,EXP,,CA-ABBVIE-19K-028-2634391-00,ABBVIE,,65.0,YR,,F,Y,,,20220815,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q3,Elderly
158546186,15854618,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Diverticulum,,2022,Q3,6,F,,20220808.0,20190122,20220815,EXP,,CA-ABBVIE-19K-028-2634391-00,ABBVIE,,65.0,YR,,F,Y,,,20220815,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q3,Elderly
158546186,15854618,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Hypertension,,2022,Q3,6,F,,20220808.0,20190122,20220815,EXP,,CA-ABBVIE-19K-028-2634391-00,ABBVIE,,65.0,YR,,F,Y,,,20220815,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q3,Elderly
158546186,15854618,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Cardiac disorder,,2022,Q3,6,F,,20220808.0,20190122,20220815,EXP,,CA-ABBVIE-19K-028-2634391-00,ABBVIE,,65.0,YR,,F,Y,,,20220815,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q3,Elderly
158546186,15854618,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Bone loss,,2022,Q3,6,F,,20220808.0,20190122,20220815,EXP,,CA-ABBVIE-19K-028-2634391-00,ABBVIE,,65.0,YR,,F,Y,,,20220815,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q3,Elderly
158546186,15854618,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,6,F,,20220808.0,20190122,20220815,EXP,,CA-ABBVIE-19K-028-2634391-00,ABBVIE,,65.0,YR,,F,Y,,,20220815,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q3,Elderly
158546186,15854618,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Rheumatoid arthritis,,2022,Q3,6,F,,20220808.0,20190122,20220815,EXP,,CA-ABBVIE-19K-028-2634391-00,ABBVIE,,65.0,YR,,F,Y,,,20220815,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q3,Elderly
158546186,15854618,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Drug intolerance,,2022,Q3,6,F,,20220808.0,20190122,20220815,EXP,,CA-ABBVIE-19K-028-2634391-00,ABBVIE,,65.0,YR,,F,Y,,,20220815,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q3,Elderly
158546186,15854618,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Abdominal discomfort,,2022,Q3,6,F,,20220808.0,20190122,20220815,EXP,,CA-ABBVIE-19K-028-2634391-00,ABBVIE,,65.0,YR,,F,Y,,,20220815,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q3,Elderly
158546186,15854618,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Headache,,2022,Q3,6,F,,20220808.0,20190122,20220815,EXP,,CA-ABBVIE-19K-028-2634391-00,ABBVIE,,65.0,YR,,F,Y,,,20220815,,CN,COUNTRY NOT SPECIFIED,CA,2022,Q3,Elderly
159052084,15905208,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,4,F,20190125.0,20220714.0,20190204,20220718,EXP,,US-ROCHE-2254708,ROCHE,,56.0,YR,,F,Y,76.0,KG,20220718,,MD,US,,2022,Q3,Adult
160068978,16006897,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Chronic kidney disease,,2022,Q3,8,F,20060101.0,20220810.0,20190222,20220817,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20220817,,LW,US,,2022,Q3,Adult
160068978,16006897,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Renal failure,,2022,Q3,8,F,20060101.0,20220810.0,20190222,20220817,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20220817,,LW,US,,2022,Q3,Adult
160068978,16006897,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Acute kidney injury,,2022,Q3,8,F,20060101.0,20220810.0,20190222,20220817,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20220817,,LW,US,,2022,Q3,Adult
160068978,16006897,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,End stage renal disease,,2022,Q3,8,F,20060101.0,20220810.0,20190222,20220817,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20220817,,LW,US,,2022,Q3,Adult
160068978,16006897,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Renal injury,,2022,Q3,8,F,20060101.0,20220810.0,20190222,20220817,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20220817,,LW,US,,2022,Q3,Adult
160068978,16006897,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Nephrogenic anaemia,,2022,Q3,8,F,20060101.0,20220810.0,20190222,20220817,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20220817,,LW,US,,2022,Q3,Adult
160068978,16006897,30,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Tubulointerstitial nephritis,,2022,Q3,8,F,20060101.0,20220810.0,20190222,20220817,EXP,,US-AstraZeneca-2018SF22114,ASTRAZENECA,,53.0,YR,,F,Y,90.3,KG,20220817,,LW,US,,2022,Q3,Adult
1608836713,16088367,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Bradycardia,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Heart rate irregular,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Arrhythmia,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Skin disorder,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Left atrial dilatation,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Acute kidney injury,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Dehydration,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Dizziness,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Haemoglobin increased,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Presyncope,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Renal disorder,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Hypovolaemia,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Syncope,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Pulmonary congestion,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Renal injury,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Drug interaction,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Mucosal dryness,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Haematocrit increased,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Oedema peripheral,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Bradycardia,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Heart rate irregular,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Arrhythmia,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Skin disorder,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Left atrial dilatation,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Acute kidney injury,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Dehydration,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Dizziness,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Haemoglobin increased,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Presyncope,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Renal disorder,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Hypovolaemia,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Syncope,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Pulmonary congestion,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Renal injury,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Drug interaction,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Mucosal dryness,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Haematocrit increased,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Oedema peripheral,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Bradycardia,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Heart rate irregular,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Arrhythmia,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Skin disorder,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Left atrial dilatation,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Acute kidney injury,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Dehydration,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Dizziness,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Haemoglobin increased,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Presyncope,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Renal disorder,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Hypovolaemia,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Syncope,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Pulmonary congestion,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Renal injury,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Drug interaction,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Mucosal dryness,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Haematocrit increased,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1608836713,16088367,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Oedema peripheral,,2022,Q3,13,F,20180101.0,20220727.0,20190319,20220810,EXP,,PT-AUROBINDO-AUR-APL-2019-015280,AUROBINDO,"Gouveia CC, Duque S, Campos L. Lipotymia by hypovolemia-A case of IATROGENIA to EMPAGLIFLOZINA. By Mariana Rocha. 2019;14(1):74P050",71.0,YR,,M,Y,,,20220810,,MD,PT,PT,2022,Q3,Elderly
1612368811,16123688,24,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Renal disorder,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,24,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Drug interaction,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,24,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Acute kidney injury,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,24,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Oedema peripheral,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,24,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Pulmonary congestion,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,24,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Hypovolaemia,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,24,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Haemoglobin increased,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,24,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Heart rate irregular,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,24,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Arrhythmia,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,24,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Bradycardia,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,24,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,24,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Hypotension,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,24,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Syncope,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,24,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Skin disorder,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,24,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Left atrial dilatation,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,24,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Haematocrit increased,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,24,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Mucosal dryness,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,24,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Dehydration,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,24,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Presyncope,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,24,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Dizziness,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,25,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2022,Q3,Renal disorder,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,25,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2022,Q3,Drug interaction,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,25,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2022,Q3,Acute kidney injury,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,25,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2022,Q3,Oedema peripheral,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,25,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2022,Q3,Pulmonary congestion,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,25,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2022,Q3,Hypovolaemia,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,25,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2022,Q3,Haemoglobin increased,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,25,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2022,Q3,Heart rate irregular,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,25,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2022,Q3,Arrhythmia,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,25,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2022,Q3,Bradycardia,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,25,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,25,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2022,Q3,Hypotension,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,25,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2022,Q3,Syncope,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,25,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2022,Q3,Skin disorder,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,25,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2022,Q3,Left atrial dilatation,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,25,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2022,Q3,Haematocrit increased,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,25,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2022,Q3,Mucosal dryness,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,25,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2022,Q3,Dehydration,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,25,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2022,Q3,Presyncope,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
1612368811,16123688,25,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,U,,,,,,,,2022,Q3,Dizziness,,2022,Q3,11,F,20180101.0,20220818.0,20190327,20220825,EXP,,PT-MYLANLABS-2019M1028062,MYLAN,"Gouveia C., Duque S., Campos L.. Lipothymia by hypovolemia- A case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes. 2019;14 (1) Suppl:Sup: 47-122",71.0,YR,,M,Y,,,20220825,,HP,PT,PT,2022,Q3,Elderly
161298285,16129828,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Oedema peripheral,,2022,Q3,5,F,20180101.0,20220722.0,20190328,20220728,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"Gouveia C. C., Duque S., Campos L.. Lipothymia by hypovolemia ? a case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes.. 2019;14(1)Sup:1-2",71.0,YR,E,M,Y,,,20220728,,MD,PT,PT,2022,Q3,Elderly
161298285,16129828,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Renal disorder,,2022,Q3,5,F,20180101.0,20220722.0,20190328,20220728,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"Gouveia C. C., Duque S., Campos L.. Lipothymia by hypovolemia ? a case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes.. 2019;14(1)Sup:1-2",71.0,YR,E,M,Y,,,20220728,,MD,PT,PT,2022,Q3,Elderly
161298285,16129828,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Hypovolaemia,,2022,Q3,5,F,20180101.0,20220722.0,20190328,20220728,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"Gouveia C. C., Duque S., Campos L.. Lipothymia by hypovolemia ? a case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes.. 2019;14(1)Sup:1-2",71.0,YR,E,M,Y,,,20220728,,MD,PT,PT,2022,Q3,Elderly
161298285,16129828,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Presyncope,,2022,Q3,5,F,20180101.0,20220722.0,20190328,20220728,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"Gouveia C. C., Duque S., Campos L.. Lipothymia by hypovolemia ? a case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes.. 2019;14(1)Sup:1-2",71.0,YR,E,M,Y,,,20220728,,MD,PT,PT,2022,Q3,Elderly
161298285,16129828,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Syncope,,2022,Q3,5,F,20180101.0,20220722.0,20190328,20220728,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"Gouveia C. C., Duque S., Campos L.. Lipothymia by hypovolemia ? a case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes.. 2019;14(1)Sup:1-2",71.0,YR,E,M,Y,,,20220728,,MD,PT,PT,2022,Q3,Elderly
161298285,16129828,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Dizziness,,2022,Q3,5,F,20180101.0,20220722.0,20190328,20220728,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"Gouveia C. C., Duque S., Campos L.. Lipothymia by hypovolemia ? a case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes.. 2019;14(1)Sup:1-2",71.0,YR,E,M,Y,,,20220728,,MD,PT,PT,2022,Q3,Elderly
161298285,16129828,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Dehydration,,2022,Q3,5,F,20180101.0,20220722.0,20190328,20220728,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"Gouveia C. C., Duque S., Campos L.. Lipothymia by hypovolemia ? a case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes.. 2019;14(1)Sup:1-2",71.0,YR,E,M,Y,,,20220728,,MD,PT,PT,2022,Q3,Elderly
161298285,16129828,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Bradycardia,,2022,Q3,5,F,20180101.0,20220722.0,20190328,20220728,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"Gouveia C. C., Duque S., Campos L.. Lipothymia by hypovolemia ? a case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes.. 2019;14(1)Sup:1-2",71.0,YR,E,M,Y,,,20220728,,MD,PT,PT,2022,Q3,Elderly
161298285,16129828,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Drug interaction,,2022,Q3,5,F,20180101.0,20220722.0,20190328,20220728,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"Gouveia C. C., Duque S., Campos L.. Lipothymia by hypovolemia ? a case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes.. 2019;14(1)Sup:1-2",71.0,YR,E,M,Y,,,20220728,,MD,PT,PT,2022,Q3,Elderly
161298285,16129828,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Arrhythmia,,2022,Q3,5,F,20180101.0,20220722.0,20190328,20220728,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"Gouveia C. C., Duque S., Campos L.. Lipothymia by hypovolemia ? a case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes.. 2019;14(1)Sup:1-2",71.0,YR,E,M,Y,,,20220728,,MD,PT,PT,2022,Q3,Elderly
161298285,16129828,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,5,F,20180101.0,20220722.0,20190328,20220728,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"Gouveia C. C., Duque S., Campos L.. Lipothymia by hypovolemia ? a case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes.. 2019;14(1)Sup:1-2",71.0,YR,E,M,Y,,,20220728,,MD,PT,PT,2022,Q3,Elderly
161298285,16129828,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Haemoglobin increased,,2022,Q3,5,F,20180101.0,20220722.0,20190328,20220728,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"Gouveia C. C., Duque S., Campos L.. Lipothymia by hypovolemia ? a case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes.. 2019;14(1)Sup:1-2",71.0,YR,E,M,Y,,,20220728,,MD,PT,PT,2022,Q3,Elderly
161298285,16129828,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,5,F,20180101.0,20220722.0,20190328,20220728,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"Gouveia C. C., Duque S., Campos L.. Lipothymia by hypovolemia ? a case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes.. 2019;14(1)Sup:1-2",71.0,YR,E,M,Y,,,20220728,,MD,PT,PT,2022,Q3,Elderly
161298285,16129828,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Haematocrit increased,,2022,Q3,5,F,20180101.0,20220722.0,20190328,20220728,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"Gouveia C. C., Duque S., Campos L.. Lipothymia by hypovolemia ? a case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes.. 2019;14(1)Sup:1-2",71.0,YR,E,M,Y,,,20220728,,MD,PT,PT,2022,Q3,Elderly
161298285,16129828,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Left atrial dilatation,,2022,Q3,5,F,20180101.0,20220722.0,20190328,20220728,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"Gouveia C. C., Duque S., Campos L.. Lipothymia by hypovolemia ? a case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes.. 2019;14(1)Sup:1-2",71.0,YR,E,M,Y,,,20220728,,MD,PT,PT,2022,Q3,Elderly
161298285,16129828,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Mucosal dryness,,2022,Q3,5,F,20180101.0,20220722.0,20190328,20220728,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"Gouveia C. C., Duque S., Campos L.. Lipothymia by hypovolemia ? a case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes.. 2019;14(1)Sup:1-2",71.0,YR,E,M,Y,,,20220728,,MD,PT,PT,2022,Q3,Elderly
161298285,16129828,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Acute kidney injury,,2022,Q3,5,F,20180101.0,20220722.0,20190328,20220728,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"Gouveia C. C., Duque S., Campos L.. Lipothymia by hypovolemia ? a case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes.. 2019;14(1)Sup:1-2",71.0,YR,E,M,Y,,,20220728,,MD,PT,PT,2022,Q3,Elderly
161298285,16129828,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Pulmonary congestion,,2022,Q3,5,F,20180101.0,20220722.0,20190328,20220728,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"Gouveia C. C., Duque S., Campos L.. Lipothymia by hypovolemia ? a case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes.. 2019;14(1)Sup:1-2",71.0,YR,E,M,Y,,,20220728,,MD,PT,PT,2022,Q3,Elderly
161298285,16129828,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Skin disorder,,2022,Q3,5,F,20180101.0,20220722.0,20190328,20220728,EXP,,TR-SA-2019SA080421,SANOFI AVENTIS,"Gouveia C. C., Duque S., Campos L.. Lipothymia by hypovolemia ? a case of empagliflozin iatrogeny?. Revista Portuguesa de Diabetes.. 2019;14(1)Sup:1-2",71.0,YR,E,M,Y,,,20220728,,MD,PT,PT,2022,Q3,Elderly
161477356,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Arrhythmia,,2022,Q3,6,F,20180101.0,20220722.0,20190402,20220729,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20220729,,MD,PT,PT,2022,Q3,Elderly
161477356,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Pulmonary oedema,,2022,Q3,6,F,20180101.0,20220722.0,20190402,20220729,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20220729,,MD,PT,PT,2022,Q3,Elderly
161477356,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Haemoglobin increased,,2022,Q3,6,F,20180101.0,20220722.0,20190402,20220729,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20220729,,MD,PT,PT,2022,Q3,Elderly
161477356,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Left atrial dilatation,,2022,Q3,6,F,20180101.0,20220722.0,20190402,20220729,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20220729,,MD,PT,PT,2022,Q3,Elderly
161477356,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Renal disorder,,2022,Q3,6,F,20180101.0,20220722.0,20190402,20220729,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20220729,,MD,PT,PT,2022,Q3,Elderly
161477356,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Acute kidney injury,,2022,Q3,6,F,20180101.0,20220722.0,20190402,20220729,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20220729,,MD,PT,PT,2022,Q3,Elderly
161477356,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,6,F,20180101.0,20220722.0,20190402,20220729,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20220729,,MD,PT,PT,2022,Q3,Elderly
161477356,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Syncope,,2022,Q3,6,F,20180101.0,20220722.0,20190402,20220729,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20220729,,MD,PT,PT,2022,Q3,Elderly
161477356,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Drug interaction,,2022,Q3,6,F,20180101.0,20220722.0,20190402,20220729,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20220729,,MD,PT,PT,2022,Q3,Elderly
161477356,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Oedema peripheral,,2022,Q3,6,F,20180101.0,20220722.0,20190402,20220729,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20220729,,MD,PT,PT,2022,Q3,Elderly
161477356,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Skin disorder,,2022,Q3,6,F,20180101.0,20220722.0,20190402,20220729,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20220729,,MD,PT,PT,2022,Q3,Elderly
161477356,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Dizziness,,2022,Q3,6,F,20180101.0,20220722.0,20190402,20220729,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20220729,,MD,PT,PT,2022,Q3,Elderly
161477356,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Dehydration,,2022,Q3,6,F,20180101.0,20220722.0,20190402,20220729,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20220729,,MD,PT,PT,2022,Q3,Elderly
161477356,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Pulmonary congestion,,2022,Q3,6,F,20180101.0,20220722.0,20190402,20220729,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20220729,,MD,PT,PT,2022,Q3,Elderly
161477356,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Hypovolaemia,,2022,Q3,6,F,20180101.0,20220722.0,20190402,20220729,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20220729,,MD,PT,PT,2022,Q3,Elderly
161477356,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Haematocrit increased,,2022,Q3,6,F,20180101.0,20220722.0,20190402,20220729,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20220729,,MD,PT,PT,2022,Q3,Elderly
161477356,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,6,F,20180101.0,20220722.0,20190402,20220729,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20220729,,MD,PT,PT,2022,Q3,Elderly
161477356,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Bradycardia,,2022,Q3,6,F,20180101.0,20220722.0,20190402,20220729,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20220729,,MD,PT,PT,2022,Q3,Elderly
161477356,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Presyncope,,2022,Q3,6,F,20180101.0,20220722.0,20190402,20220729,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20220729,,MD,PT,PT,2022,Q3,Elderly
161477356,16147735,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Mucosal dryness,,2022,Q3,6,F,20180101.0,20220722.0,20190402,20220729,EXP,,PT-BAUSCH-BL-2019-009329,BAUSCH AND LOMB,,71.0,YR,,M,Y,,,20220729,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Mucosal dryness,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Hypovolaemia,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Renal disorder,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Drug interaction,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Syncope,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Oedema peripheral,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Pulmonary congestion,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Skin disorder,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Hypovolaemia,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Hypovolaemia,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Haemoglobin increased,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Arrhythmia,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Bradycardia,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Presyncope,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Dizziness,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Left atrial dilatation,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Syncope,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Haematocrit increased,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Dehydration,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, UNK",,,U,,,,,,,,,2022,Q3,Acute kidney injury,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Mucosal dryness,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Hypovolaemia,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Renal disorder,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Drug interaction,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Syncope,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Oedema peripheral,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Pulmonary congestion,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Skin disorder,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Hypovolaemia,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Hypovolaemia,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Haemoglobin increased,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Arrhythmia,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Bradycardia,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Presyncope,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Dizziness,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Left atrial dilatation,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Syncope,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Haematocrit increased,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Dehydration,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
1616373313,16163733,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Acute kidney injury,,2022,Q3,13,F,20180101.0,20220728.0,20190405,20220803,EXP,,PT-PFIZER INC-2019149489,PFIZER,"Gouveia, C.. Lipothymia by hypovolaemia - a case of iatrogeny to empagliflozin?. Revista Portuguesa de Diabtes. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,MD,PT,PT,2022,Q3,Elderly
161708345,16170834,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2022,Q3,Gastrointestinal disorder,,2022,Q3,5,F,20190212.0,20220224.0,20190408,20220823,EXP,,CN-JNJFOC-20190215869,JOHNSON AND JOHNSON,,46.0,YR,A,M,Y,75.0,KG,20220823,,MD,CN,CN,2022,Q3,Adult
161708345,16170834,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2022,Q3,Hepatotoxicity,,2022,Q3,5,F,20190212.0,20220224.0,20190408,20220823,EXP,,CN-JNJFOC-20190215869,JOHNSON AND JOHNSON,,46.0,YR,A,M,Y,75.0,KG,20220823,,MD,CN,CN,2022,Q3,Adult
161708345,16170834,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2022,Q3,Haemoglobin decreased,,2022,Q3,5,F,20190212.0,20220224.0,20190408,20220823,EXP,,CN-JNJFOC-20190215869,JOHNSON AND JOHNSON,,46.0,YR,A,M,Y,75.0,KG,20220823,,MD,CN,CN,2022,Q3,Adult
161708345,16170834,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,Unknown,,2022,Q3,Electrocardiogram QT prolonged,,2022,Q3,5,F,20190212.0,20220224.0,20190408,20220823,EXP,,CN-JNJFOC-20190215869,JOHNSON AND JOHNSON,,46.0,YR,A,M,Y,75.0,KG,20220823,,MD,CN,CN,2022,Q3,Adult
1820848928,18208489,98,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 IU, ?CO",,,U,,,,,1.0,IU,,,2022,Q3,Toxic epidermal necrolysis,,2022,Q3,28,F,20200809.0,20220906.0,20200828,20220912,EXP,,FR-BAUSCH-BL-2020-024487,BAUSCH AND LOMB,,74.0,YR,,M,Y,,,20220912,,MD,FR,FR,2022,Q3,Elderly
182376115,18237611,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 every 1 Days, 1 every 12 Hours",,,,,,,,,,,BID,2022,Q3,Full blood count abnormal,,2022,Q3,5,F,,20220802.0,20200907,20220812,EXP,CA-MHPD-E2B_03156762,CA-Accord-198951,ACCORD,,83.0,YR,E,M,Y,100.0,KG,20220812,,HP,CA,CA,2022,Q3,Elderly
182376115,18237611,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 every 1 Days, 1 every 12 Hours",,,,,,,,,,,BID,2022,Q3,Asthma,,2022,Q3,5,F,,20220802.0,20200907,20220812,EXP,CA-MHPD-E2B_03156762,CA-Accord-198951,ACCORD,,83.0,YR,E,M,Y,100.0,KG,20220812,,HP,CA,CA,2022,Q3,Elderly
182376115,18237611,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 every 1 Days, 1 every 12 Hours",,,,,,,,,,,BID,2022,Q3,Oropharyngeal pain,,2022,Q3,5,F,,20220802.0,20200907,20220812,EXP,CA-MHPD-E2B_03156762,CA-Accord-198951,ACCORD,,83.0,YR,E,M,Y,100.0,KG,20220812,,HP,CA,CA,2022,Q3,Elderly
182376115,18237611,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 every 1 Days, 1 every 12 Hours",,,,,,,,,,,BID,2022,Q3,Oedema peripheral,,2022,Q3,5,F,,20220802.0,20200907,20220812,EXP,CA-MHPD-E2B_03156762,CA-Accord-198951,ACCORD,,83.0,YR,E,M,Y,100.0,KG,20220812,,HP,CA,CA,2022,Q3,Elderly
182376115,18237611,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 every 1 Days, 1 every 12 Hours",,,,,,,,,,,BID,2022,Q3,Left ventricular hypertrophy,,2022,Q3,5,F,,20220802.0,20200907,20220812,EXP,CA-MHPD-E2B_03156762,CA-Accord-198951,ACCORD,,83.0,YR,E,M,Y,100.0,KG,20220812,,HP,CA,CA,2022,Q3,Elderly
182376115,18237611,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 every 1 Days, 1 every 12 Hours",,,,,,,,,,,BID,2022,Q3,Therapeutic product effect incomplete,,2022,Q3,5,F,,20220802.0,20200907,20220812,EXP,CA-MHPD-E2B_03156762,CA-Accord-198951,ACCORD,,83.0,YR,E,M,Y,100.0,KG,20220812,,HP,CA,CA,2022,Q3,Elderly
182376115,18237611,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 every 1 Days, 1 every 12 Hours",,,,,,,,,,,BID,2022,Q3,Pyrexia,,2022,Q3,5,F,,20220802.0,20200907,20220812,EXP,CA-MHPD-E2B_03156762,CA-Accord-198951,ACCORD,,83.0,YR,E,M,Y,100.0,KG,20220812,,HP,CA,CA,2022,Q3,Elderly
182376115,18237611,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 every 1 Days, 1 every 12 Hours",,,,,,,,,,,BID,2022,Q3,Hypoxia,,2022,Q3,5,F,,20220802.0,20200907,20220812,EXP,CA-MHPD-E2B_03156762,CA-Accord-198951,ACCORD,,83.0,YR,E,M,Y,100.0,KG,20220812,,HP,CA,CA,2022,Q3,Elderly
182376115,18237611,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 every 1 Days, 1 every 12 Hours",,,,,,,,,,,BID,2022,Q3,Cough,,2022,Q3,5,F,,20220802.0,20200907,20220812,EXP,CA-MHPD-E2B_03156762,CA-Accord-198951,ACCORD,,83.0,YR,E,M,Y,100.0,KG,20220812,,HP,CA,CA,2022,Q3,Elderly
182376115,18237611,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 every 1 Days, 1 every 12 Hours",,,,,,,,,,,BID,2022,Q3,Dyspnoea,,2022,Q3,5,F,,20220802.0,20200907,20220812,EXP,CA-MHPD-E2B_03156762,CA-Accord-198951,ACCORD,,83.0,YR,E,M,Y,100.0,KG,20220812,,HP,CA,CA,2022,Q3,Elderly
182376115,18237611,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 every 1 Days, 1 every 12 Hours",,,,,,,,,,,BID,2022,Q3,Diaphragmatic disorder,,2022,Q3,5,F,,20220802.0,20200907,20220812,EXP,CA-MHPD-E2B_03156762,CA-Accord-198951,ACCORD,,83.0,YR,E,M,Y,100.0,KG,20220812,,HP,CA,CA,2022,Q3,Elderly
182376115,18237611,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 every 1 Days, 1 every 12 Hours",,,,,,,,,,,BID,2022,Q3,Obstructive airways disorder,,2022,Q3,5,F,,20220802.0,20200907,20220812,EXP,CA-MHPD-E2B_03156762,CA-Accord-198951,ACCORD,,83.0,YR,E,M,Y,100.0,KG,20220812,,HP,CA,CA,2022,Q3,Elderly
182376115,18237611,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 every 1 Days, 1 every 12 Hours",,,,,,,,,,,BID,2022,Q3,Weight increased,,2022,Q3,5,F,,20220802.0,20200907,20220812,EXP,CA-MHPD-E2B_03156762,CA-Accord-198951,ACCORD,,83.0,YR,E,M,Y,100.0,KG,20220812,,HP,CA,CA,2022,Q3,Elderly
182376115,18237611,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 every 1 Days, 1 every 12 Hours",,,,,,,,,,,BID,2022,Q3,Wheezing,,2022,Q3,5,F,,20220802.0,20200907,20220812,EXP,CA-MHPD-E2B_03156762,CA-Accord-198951,ACCORD,,83.0,YR,E,M,Y,100.0,KG,20220812,,HP,CA,CA,2022,Q3,Elderly
182376115,18237611,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 every 1 Days, 1 every 12 Hours",,,,,,,,,,,BID,2022,Q3,Discomfort,,2022,Q3,5,F,,20220802.0,20200907,20220812,EXP,CA-MHPD-E2B_03156762,CA-Accord-198951,ACCORD,,83.0,YR,E,M,Y,100.0,KG,20220812,,HP,CA,CA,2022,Q3,Elderly
182376115,18237611,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 every 1 Days, 1 every 12 Hours",,,,,,,,,,,BID,2022,Q3,Chest discomfort,,2022,Q3,5,F,,20220802.0,20200907,20220812,EXP,CA-MHPD-E2B_03156762,CA-Accord-198951,ACCORD,,83.0,YR,E,M,Y,100.0,KG,20220812,,HP,CA,CA,2022,Q3,Elderly
1848217510,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2022,Q3,Cataract,,2022,Q3,10,F,20201019.0,20220922.0,20201110,20220928,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20220928,,MD,JP,JP,2022,Q3,Adult
1848217510,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2022,Q3,Rash pruritic,,2022,Q3,10,F,20201019.0,20220922.0,20201110,20220928,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20220928,,MD,JP,JP,2022,Q3,Adult
1848217510,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2022,Q3,Eczema asteatotic,,2022,Q3,10,F,20201019.0,20220922.0,20201110,20220928,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20220928,,MD,JP,JP,2022,Q3,Adult
1848217510,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2022,Q3,Angina pectoris,,2022,Q3,10,F,20201019.0,20220922.0,20201110,20220928,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20220928,,MD,JP,JP,2022,Q3,Adult
1848217510,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2022,Q3,Arthralgia,,2022,Q3,10,F,20201019.0,20220922.0,20201110,20220928,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20220928,,MD,JP,JP,2022,Q3,Adult
1869104720,18691047,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,End stage renal disease,,2022,Q3,20,F,20201202.0,20220712.0,20210101,20220713,EXP,,NVSC2020US325160,NOVARTIS,,73.0,YR,,F,Y,88.8,KG,20220713,,MD,US,US,2022,Q3,Elderly
1878494512,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q3,Peripheral coldness,,2022,Q3,12,F,20210220.0,20220707.0,20210125,20220713,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220713,,HP,CO,CO,2022,Q3,Adult
1878494512,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q3,Diarrhoea haemorrhagic,,2022,Q3,12,F,20210220.0,20220707.0,20210125,20220713,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220713,,HP,CO,CO,2022,Q3,Adult
1878494512,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q3,Abdominal pain upper,,2022,Q3,12,F,20210220.0,20220707.0,20210125,20220713,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220713,,HP,CO,CO,2022,Q3,Adult
1878494512,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q3,Bacterial infection,,2022,Q3,12,F,20210220.0,20220707.0,20210125,20220713,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220713,,HP,CO,CO,2022,Q3,Adult
1878494512,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q3,Rectal tenesmus,,2022,Q3,12,F,20210220.0,20220707.0,20210125,20220713,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220713,,HP,CO,CO,2022,Q3,Adult
1878494512,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q3,COVID-19,,2022,Q3,12,F,20210220.0,20220707.0,20210125,20220713,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220713,,HP,CO,CO,2022,Q3,Adult
1878494512,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q3,Abdominal pain,,2022,Q3,12,F,20210220.0,20220707.0,20210125,20220713,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220713,,HP,CO,CO,2022,Q3,Adult
1878494512,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q3,Haematochezia,,2022,Q3,12,F,20210220.0,20220707.0,20210125,20220713,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220713,,HP,CO,CO,2022,Q3,Adult
1878494512,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q3,Cough,,2022,Q3,12,F,20210220.0,20220707.0,20210125,20220713,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220713,,HP,CO,CO,2022,Q3,Adult
1878494512,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q3,Hyperhidrosis,,2022,Q3,12,F,20210220.0,20220707.0,20210125,20220713,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220713,,HP,CO,CO,2022,Q3,Adult
1878494512,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q3,Blood glucose increased,,2022,Q3,12,F,20210220.0,20220707.0,20210125,20220713,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220713,,HP,CO,CO,2022,Q3,Adult
1878494512,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q3,Pollakiuria,,2022,Q3,12,F,20210220.0,20220707.0,20210125,20220713,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220713,,HP,CO,CO,2022,Q3,Adult
1878494512,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q3,Fatigue,,2022,Q3,12,F,20210220.0,20220707.0,20210125,20220713,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220713,,HP,CO,CO,2022,Q3,Adult
1878494512,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q3,Gastrointestinal inflammation,,2022,Q3,12,F,20210220.0,20220707.0,20210125,20220713,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220713,,HP,CO,CO,2022,Q3,Adult
1878494512,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q3,Colitis ulcerative,,2022,Q3,12,F,20210220.0,20220707.0,20210125,20220713,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220713,,HP,CO,CO,2022,Q3,Adult
1878494512,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q3,Constipation,,2022,Q3,12,F,20210220.0,20220707.0,20210125,20220713,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220713,,HP,CO,CO,2022,Q3,Adult
1878494512,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q3,Thirst,,2022,Q3,12,F,20210220.0,20220707.0,20210125,20220713,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220713,,HP,CO,CO,2022,Q3,Adult
1878494512,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q3,Drug ineffective,,2022,Q3,12,F,20210220.0,20220707.0,20210125,20220713,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220713,,HP,CO,CO,2022,Q3,Adult
1878494512,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q3,Abdominal distension,,2022,Q3,12,F,20210220.0,20220707.0,20210125,20220713,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220713,,HP,CO,CO,2022,Q3,Adult
1878494512,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q3,Proctalgia,,2022,Q3,12,F,20210220.0,20220707.0,20210125,20220713,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220713,,HP,CO,CO,2022,Q3,Adult
1878494512,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q3,General physical health deterioration,,2022,Q3,12,F,20210220.0,20220707.0,20210125,20220713,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220713,,HP,CO,CO,2022,Q3,Adult
1878494512,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q3,Weight increased,,2022,Q3,12,F,20210220.0,20220707.0,20210125,20220713,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220713,,HP,CO,CO,2022,Q3,Adult
1878494512,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q3,Off label use,,2022,Q3,12,F,20210220.0,20220707.0,20210125,20220713,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220713,,HP,CO,CO,2022,Q3,Adult
1878494512,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q3,Dehydration,,2022,Q3,12,F,20210220.0,20220707.0,20210125,20220713,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20220713,,HP,CO,CO,2022,Q3,Adult
188943955,18894395,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Arthralgia,,2022,Q3,5,F,,20220907.0,20210215,20220915,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
188943955,18894395,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Hepatotoxicity,,2022,Q3,5,F,,20220907.0,20210215,20220915,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
188943955,18894395,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Drug intolerance,,2022,Q3,5,F,,20220907.0,20210215,20220915,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
188943955,18894395,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Psoriatic arthropathy,,2022,Q3,5,F,,20220907.0,20210215,20220915,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
188943955,18894395,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,5,F,,20220907.0,20210215,20220915,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
188943955,18894395,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Therapeutic product effect decreased,,2022,Q3,5,F,,20220907.0,20210215,20220915,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
188943955,18894395,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Pain,,2022,Q3,5,F,,20220907.0,20210215,20220915,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
188943955,18894395,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Grip strength decreased,,2022,Q3,5,F,,20220907.0,20210215,20220915,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
188943955,18894395,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Drug ineffective,,2022,Q3,5,F,,20220907.0,20210215,20220915,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
188943955,18894395,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Diabetes mellitus,,2022,Q3,5,F,,20220907.0,20210215,20220915,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
188943955,18894395,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Hepatic cirrhosis,,2022,Q3,5,F,,20220907.0,20210215,20220915,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
188943955,18894395,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Osteoarthritis,,2022,Q3,5,F,,20220907.0,20210215,20220915,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
188943955,18894395,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Pain in extremity,,2022,Q3,5,F,,20220907.0,20210215,20220915,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
188943955,18894395,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Headache,,2022,Q3,5,F,,20220907.0,20210215,20220915,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
188943955,18894395,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Movement disorder,,2022,Q3,5,F,,20220907.0,20210215,20220915,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
188943955,18894395,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Arthropathy,,2022,Q3,5,F,,20220907.0,20210215,20220915,EXP,,CA-JNJFOC-20210220589,JOHNSON AND JOHNSON,,65.0,YR,E,F,Y,,,20220916,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, Once a Day",,,U,,,,,,,,QD,2022,Q3,Oropharyngeal pain,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, Once a Day",,,U,,,,,,,,QD,2022,Q3,Dyspnoea,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, Once a Day",,,U,,,,,,,,QD,2022,Q3,Oedema peripheral,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, Once a Day",,,U,,,,,,,,QD,2022,Q3,Discomfort,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, Once a Day",,,U,,,,,,,,QD,2022,Q3,Wheezing,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, Once a Day",,,U,,,,,,,,QD,2022,Q3,Left ventricular hypertrophy,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, Once a Day",,,U,,,,,,,,QD,2022,Q3,Obstructive airways disorder,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, Once a Day",,,U,,,,,,,,QD,2022,Q3,Asthma,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, Once a Day",,,U,,,,,,,,QD,2022,Q3,Cough,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, Once a Day",,,U,,,,,,,,QD,2022,Q3,Pyrexia,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, Once a Day",,,U,,,,,,,,QD,2022,Q3,Chest discomfort,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, Once a Day",,,U,,,,,,,,QD,2022,Q3,Diaphragmatic disorder,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, Once a Day",,,U,,,,,,,,QD,2022,Q3,Therapeutic product effect incomplete,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, Once a Day",,,U,,,,,,,,QD,2022,Q3,Hypoxia,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, Once a Day",,,U,,,,,,,,QD,2022,Q3,Weight increased,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, Once a Day",,,U,,,,,,,,QD,2022,Q3,Full blood count abnormal,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2022,Q3,Oropharyngeal pain,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2022,Q3,Dyspnoea,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2022,Q3,Oedema peripheral,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2022,Q3,Discomfort,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2022,Q3,Wheezing,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2022,Q3,Left ventricular hypertrophy,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2022,Q3,Obstructive airways disorder,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2022,Q3,Asthma,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2022,Q3,Cough,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2022,Q3,Pyrexia,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2022,Q3,Chest discomfort,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2022,Q3,Diaphragmatic disorder,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2022,Q3,Therapeutic product effect incomplete,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2022,Q3,Hypoxia,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2022,Q3,Weight increased,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189179062,18917906,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, Two Times a Day",,,U,,,,,,,,BID,2022,Q3,Full blood count abnormal,,2022,Q3,2,F,,20220628.0,20210220,20220711,EXP,,CA-AUROBINDO-AUR-APL-2021-006690,AUROBINDO,,83.0,YR,,M,Y,100.0,KG,20220711,,HP,CA,CA,2022,Q3,Elderly
189742072,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, bid",,,,,,,,,,,BID,2022,Q3,Discomfort,,2022,Q3,2,F,,20220627.0,20210305,20220708,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20220708,,HP,CA,CA,2022,Q3,Elderly
189742072,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, bid",,,,,,,,,,,BID,2022,Q3,Cough,,2022,Q3,2,F,,20220627.0,20210305,20220708,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20220708,,HP,CA,CA,2022,Q3,Elderly
189742072,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, bid",,,,,,,,,,,BID,2022,Q3,Left ventricular hypertrophy,,2022,Q3,2,F,,20220627.0,20210305,20220708,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20220708,,HP,CA,CA,2022,Q3,Elderly
189742072,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, bid",,,,,,,,,,,BID,2022,Q3,Dyspnoea,,2022,Q3,2,F,,20220627.0,20210305,20220708,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20220708,,HP,CA,CA,2022,Q3,Elderly
189742072,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, bid",,,,,,,,,,,BID,2022,Q3,Asthma,,2022,Q3,2,F,,20220627.0,20210305,20220708,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20220708,,HP,CA,CA,2022,Q3,Elderly
189742072,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, bid",,,,,,,,,,,BID,2022,Q3,Oedema peripheral,,2022,Q3,2,F,,20220627.0,20210305,20220708,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20220708,,HP,CA,CA,2022,Q3,Elderly
189742072,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, bid",,,,,,,,,,,BID,2022,Q3,Weight increased,,2022,Q3,2,F,,20220627.0,20210305,20220708,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20220708,,HP,CA,CA,2022,Q3,Elderly
189742072,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, bid",,,,,,,,,,,BID,2022,Q3,Pyrexia,,2022,Q3,2,F,,20220627.0,20210305,20220708,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20220708,,HP,CA,CA,2022,Q3,Elderly
189742072,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, bid",,,,,,,,,,,BID,2022,Q3,Diaphragmatic disorder,,2022,Q3,2,F,,20220627.0,20210305,20220708,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20220708,,HP,CA,CA,2022,Q3,Elderly
189742072,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, bid",,,,,,,,,,,BID,2022,Q3,Oropharyngeal pain,,2022,Q3,2,F,,20220627.0,20210305,20220708,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20220708,,HP,CA,CA,2022,Q3,Elderly
189742072,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, bid",,,,,,,,,,,BID,2022,Q3,Hypoxia,,2022,Q3,2,F,,20220627.0,20210305,20220708,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20220708,,HP,CA,CA,2022,Q3,Elderly
189742072,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, bid",,,,,,,,,,,BID,2022,Q3,Obstructive airways disorder,,2022,Q3,2,F,,20220627.0,20210305,20220708,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20220708,,HP,CA,CA,2022,Q3,Elderly
189742072,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, bid",,,,,,,,,,,BID,2022,Q3,Chest discomfort,,2022,Q3,2,F,,20220627.0,20210305,20220708,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20220708,,HP,CA,CA,2022,Q3,Elderly
189742072,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, bid",,,,,,,,,,,BID,2022,Q3,Wheezing,,2022,Q3,2,F,,20220627.0,20210305,20220708,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20220708,,HP,CA,CA,2022,Q3,Elderly
189742072,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, bid",,,,,,,,,,,BID,2022,Q3,Full blood count abnormal,,2022,Q3,2,F,,20220627.0,20210305,20220708,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20220708,,HP,CA,CA,2022,Q3,Elderly
189742072,18974207,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, bid",,,,,,,,,,,BID,2022,Q3,Therapeutic product effect incomplete,,2022,Q3,2,F,,20220627.0,20210305,20220708,EXP,,CA-ELI_LILLY_AND_COMPANY-CA202102011997,ELI LILLY AND CO,,83.0,YR,,M,Y,100.0,KG,20220708,,HP,CA,CA,2022,Q3,Elderly
191945957,19194595,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 U,,,,,,,,,,Injection,QID,2022,Q3,Dizziness,,2022,Q3,7,F,20210416.0,20220729.0,20210429,20220809,EXP,,US-ROCHE-2818631,ROCHE,,70.0,YR,,M,Y,96.2,KG,20220810,,MD,US,,2022,Q3,Elderly
194664952,19466495,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,UNKNOWN,,20563.0,,,Solution for injection,,2022,Q3,Drug ineffective,,2022,Q3,2,F,20220601.0,20220630.0,20210628,20220705,PER,,US-ELI_LILLY_AND_COMPANY-US202106011052,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20220705,,CN,US,US,2022,Q3,Adult
194664952,19466495,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,UNKNOWN,,20563.0,,,Solution for injection,,2022,Q3,Product storage error,,2022,Q3,2,F,20220601.0,20220630.0,20210628,20220705,PER,,US-ELI_LILLY_AND_COMPANY-US202106011052,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20220705,,CN,US,US,2022,Q3,Adult
194664952,19466495,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,UNKNOWN,,20563.0,,,Solution for injection,,2022,Q3,Drug ineffective,,2022,Q3,2,F,20220601.0,20220630.0,20210628,20220705,PER,,US-ELI_LILLY_AND_COMPANY-US202106011052,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20220705,,CN,US,US,2022,Q3,Adult
194664952,19466495,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,UNKNOWN,,20563.0,,,Solution for injection,,2022,Q3,Blood glucose increased,,2022,Q3,2,F,20220601.0,20220630.0,20210628,20220705,PER,,US-ELI_LILLY_AND_COMPANY-US202106011052,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20220705,,CN,US,US,2022,Q3,Adult
194664952,19466495,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,UNKNOWN,,20563.0,,,Solution for injection,,2022,Q3,Blood glucose increased,,2022,Q3,2,F,20220601.0,20220630.0,20210628,20220705,PER,,US-ELI_LILLY_AND_COMPANY-US202106011052,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20220705,,CN,US,US,2022,Q3,Adult
194664952,19466495,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D332676A,,20563.0,,,Solution for injection,,2022,Q3,Drug ineffective,,2022,Q3,2,F,20220601.0,20220630.0,20210628,20220705,PER,,US-ELI_LILLY_AND_COMPANY-US202106011052,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20220705,,CN,US,US,2022,Q3,Adult
194664952,19466495,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D332676A,,20563.0,,,Solution for injection,,2022,Q3,Product storage error,,2022,Q3,2,F,20220601.0,20220630.0,20210628,20220705,PER,,US-ELI_LILLY_AND_COMPANY-US202106011052,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20220705,,CN,US,US,2022,Q3,Adult
194664952,19466495,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D332676A,,20563.0,,,Solution for injection,,2022,Q3,Drug ineffective,,2022,Q3,2,F,20220601.0,20220630.0,20210628,20220705,PER,,US-ELI_LILLY_AND_COMPANY-US202106011052,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20220705,,CN,US,US,2022,Q3,Adult
194664952,19466495,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D332676A,,20563.0,,,Solution for injection,,2022,Q3,Blood glucose increased,,2022,Q3,2,F,20220601.0,20220630.0,20210628,20220705,PER,,US-ELI_LILLY_AND_COMPANY-US202106011052,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20220705,,CN,US,US,2022,Q3,Adult
194664952,19466495,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D332676A,,20563.0,,,Solution for injection,,2022,Q3,Blood glucose increased,,2022,Q3,2,F,20220601.0,20220630.0,20210628,20220705,PER,,US-ELI_LILLY_AND_COMPANY-US202106011052,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20220705,,CN,US,US,2022,Q3,Adult
194840547,19484054,90,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1iu, CO",,,D,,,,,1.0,IU,,,2022,Q3,Toxic epidermal necrolysis,,2022,Q3,7,F,20200809.0,20220905.0,20210701,20220906,EXP,,NVSC2021FR146473,NOVARTIS,,74.0,YR,,M,Y,,,20220906,,MD,FR,FR,2022,Q3,Elderly
194989973,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Myalgia,,2022,Q3,3,F,,20220712.0,20210706,20220714,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220714,,CN,CA,CA,2022,Q3,Adult
194989973,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Cardiac failure congestive,,2022,Q3,3,F,,20220712.0,20210706,20220714,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220714,,CN,CA,CA,2022,Q3,Adult
194989973,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Headache,,2022,Q3,3,F,,20220712.0,20210706,20220714,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220714,,CN,CA,CA,2022,Q3,Adult
194989973,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Neuropathy peripheral,,2022,Q3,3,F,,20220712.0,20210706,20220714,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220714,,CN,CA,CA,2022,Q3,Adult
194989973,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Malnutrition,,2022,Q3,3,F,,20220712.0,20210706,20220714,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220714,,CN,CA,CA,2022,Q3,Adult
194989973,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Diarrhoea,,2022,Q3,3,F,,20220712.0,20210706,20220714,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220714,,CN,CA,CA,2022,Q3,Adult
194989973,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Blood glucose increased,,2022,Q3,3,F,,20220712.0,20210706,20220714,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220714,,CN,CA,CA,2022,Q3,Adult
194989973,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Thyroid disorder,,2022,Q3,3,F,,20220712.0,20210706,20220714,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220714,,CN,CA,CA,2022,Q3,Adult
194989973,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Pulmonary oedema,,2022,Q3,3,F,,20220712.0,20210706,20220714,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220714,,CN,CA,CA,2022,Q3,Adult
194989973,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Arthritis,,2022,Q3,3,F,,20220712.0,20210706,20220714,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220714,,CN,CA,CA,2022,Q3,Adult
194989973,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Pericardial effusion,,2022,Q3,3,F,,20220712.0,20210706,20220714,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220714,,CN,CA,CA,2022,Q3,Adult
194989973,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Chest pain,,2022,Q3,3,F,,20220712.0,20210706,20220714,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220714,,CN,CA,CA,2022,Q3,Adult
194989973,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Weight decreased,,2022,Q3,3,F,,20220712.0,20210706,20220714,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220714,,CN,CA,CA,2022,Q3,Adult
194989973,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Multi-organ disorder,,2022,Q3,3,F,,20220712.0,20210706,20220714,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220714,,CN,CA,CA,2022,Q3,Adult
194989973,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Abdominal pain upper,,2022,Q3,3,F,,20220712.0,20210706,20220714,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220714,,CN,CA,CA,2022,Q3,Adult
194989973,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Eye haemorrhage,,2022,Q3,3,F,,20220712.0,20210706,20220714,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20220714,,CN,CA,CA,2022,Q3,Adult
195049202,19504920,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"according to scheme, injection / infusion solution ()",,,U,,,,,,,,,2022,Q3,Diarrhoea,,2022,Q3,2,F,,20220915.0,20210708,20220930,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-303293,RANBAXY,,78.0,YR,,M,Y,88.4,KG,20220930,,MD,DE,DE,2022,Q3,Elderly
195049202,19504920,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"according to scheme, injection / infusion solution ()",,,U,,,,,,,,,2022,Q3,Night sweats,,2022,Q3,2,F,,20220915.0,20210708,20220930,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-303293,RANBAXY,,78.0,YR,,M,Y,88.4,KG,20220930,,MD,DE,DE,2022,Q3,Elderly
195049202,19504920,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"according to scheme, injection / infusion solution ()",,,U,,,,,,,,,2022,Q3,General physical health deterioration,,2022,Q3,2,F,,20220915.0,20210708,20220930,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-303293,RANBAXY,,78.0,YR,,M,Y,88.4,KG,20220930,,MD,DE,DE,2022,Q3,Elderly
195049202,19504920,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"according to scheme, injection / infusion solution ()",,,U,,,,,,,,,2022,Q3,Medication error,,2022,Q3,2,F,,20220915.0,20210708,20220930,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-303293,RANBAXY,,78.0,YR,,M,Y,88.4,KG,20220930,,MD,DE,DE,2022,Q3,Elderly
195049202,19504920,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"according to scheme, injection / infusion solution ()",,,U,,,,,,,,,2022,Q3,Fatigue,,2022,Q3,2,F,,20220915.0,20210708,20220930,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2021RR-303293,RANBAXY,,78.0,YR,,M,Y,88.4,KG,20220930,,MD,DE,DE,2022,Q3,Elderly
196018282,19601828,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Grip strength decreased,,2022,Q3,2,F,,20220820.0,20210723,20220825,EXP,CA-MHPD-E2B-03367549,CA-Accord-232704,ACCORD,,65.0,YR,E,F,Y,,,20220825,,HP,CA,CA,2022,Q3,Elderly
196018282,19601828,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Diabetes mellitus,,2022,Q3,2,F,,20220820.0,20210723,20220825,EXP,CA-MHPD-E2B-03367549,CA-Accord-232704,ACCORD,,65.0,YR,E,F,Y,,,20220825,,HP,CA,CA,2022,Q3,Elderly
196018282,19601828,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Drug ineffective,,2022,Q3,2,F,,20220820.0,20210723,20220825,EXP,CA-MHPD-E2B-03367549,CA-Accord-232704,ACCORD,,65.0,YR,E,F,Y,,,20220825,,HP,CA,CA,2022,Q3,Elderly
196018282,19601828,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,2,F,,20220820.0,20210723,20220825,EXP,CA-MHPD-E2B-03367549,CA-Accord-232704,ACCORD,,65.0,YR,E,F,Y,,,20220825,,HP,CA,CA,2022,Q3,Elderly
196018282,19601828,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Pain,,2022,Q3,2,F,,20220820.0,20210723,20220825,EXP,CA-MHPD-E2B-03367549,CA-Accord-232704,ACCORD,,65.0,YR,E,F,Y,,,20220825,,HP,CA,CA,2022,Q3,Elderly
196018282,19601828,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Hepatotoxicity,,2022,Q3,2,F,,20220820.0,20210723,20220825,EXP,CA-MHPD-E2B-03367549,CA-Accord-232704,ACCORD,,65.0,YR,E,F,Y,,,20220825,,HP,CA,CA,2022,Q3,Elderly
196018282,19601828,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Headache,,2022,Q3,2,F,,20220820.0,20210723,20220825,EXP,CA-MHPD-E2B-03367549,CA-Accord-232704,ACCORD,,65.0,YR,E,F,Y,,,20220825,,HP,CA,CA,2022,Q3,Elderly
196018282,19601828,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Pain in extremity,,2022,Q3,2,F,,20220820.0,20210723,20220825,EXP,CA-MHPD-E2B-03367549,CA-Accord-232704,ACCORD,,65.0,YR,E,F,Y,,,20220825,,HP,CA,CA,2022,Q3,Elderly
196018282,19601828,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Movement disorder,,2022,Q3,2,F,,20220820.0,20210723,20220825,EXP,CA-MHPD-E2B-03367549,CA-Accord-232704,ACCORD,,65.0,YR,E,F,Y,,,20220825,,HP,CA,CA,2022,Q3,Elderly
196018282,19601828,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Drug intolerance,,2022,Q3,2,F,,20220820.0,20210723,20220825,EXP,CA-MHPD-E2B-03367549,CA-Accord-232704,ACCORD,,65.0,YR,E,F,Y,,,20220825,,HP,CA,CA,2022,Q3,Elderly
196018282,19601828,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Arthropathy,,2022,Q3,2,F,,20220820.0,20210723,20220825,EXP,CA-MHPD-E2B-03367549,CA-Accord-232704,ACCORD,,65.0,YR,E,F,Y,,,20220825,,HP,CA,CA,2022,Q3,Elderly
196018282,19601828,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Therapeutic product effect decreased,,2022,Q3,2,F,,20220820.0,20210723,20220825,EXP,CA-MHPD-E2B-03367549,CA-Accord-232704,ACCORD,,65.0,YR,E,F,Y,,,20220825,,HP,CA,CA,2022,Q3,Elderly
196018282,19601828,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Osteoarthritis,,2022,Q3,2,F,,20220820.0,20210723,20220825,EXP,CA-MHPD-E2B-03367549,CA-Accord-232704,ACCORD,,65.0,YR,E,F,Y,,,20220825,,HP,CA,CA,2022,Q3,Elderly
196018282,19601828,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Hepatic cirrhosis,,2022,Q3,2,F,,20220820.0,20210723,20220825,EXP,CA-MHPD-E2B-03367549,CA-Accord-232704,ACCORD,,65.0,YR,E,F,Y,,,20220825,,HP,CA,CA,2022,Q3,Elderly
196018282,19601828,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Psoriatic arthropathy,,2022,Q3,2,F,,20220820.0,20210723,20220825,EXP,CA-MHPD-E2B-03367549,CA-Accord-232704,ACCORD,,65.0,YR,E,F,Y,,,20220825,,HP,CA,CA,2022,Q3,Elderly
196018282,19601828,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Arthralgia,,2022,Q3,2,F,,20220820.0,20210723,20220825,EXP,CA-MHPD-E2B-03367549,CA-Accord-232704,ACCORD,,65.0,YR,E,F,Y,,,20220825,,HP,CA,CA,2022,Q3,Elderly
196185634,19618563,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q3,Drug ineffective,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q3,Weight increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q3,Blood glucose decreased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q3,Drug ineffective,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q3,Weight increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q3,Blood glucose decreased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q3,Drug ineffective,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q3,Weight increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, prn (daily, sliding scale)",,,,,D261904A,,20563.0,30.0,IU,Injection,,2022,Q3,Blood glucose decreased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Drug ineffective,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Weight increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose decreased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Drug ineffective,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Weight increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose decreased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Drug ineffective,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Weight increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose decreased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Drug ineffective,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Weight increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose decreased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Drug ineffective,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Weight increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose decreased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q3,Drug ineffective,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q3,Weight increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q3,Blood glucose decreased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q3,Drug ineffective,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q3,Weight increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, prn (SS - ^if its 147 I would take 7 units^ x 3 daily)",,,,,D395986A,,20563.0,7.0,IU,Injection,,2022,Q3,Blood glucose decreased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D420813A,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D420813A,,20563.0,,,Injection,,2022,Q3,Drug ineffective,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D420813A,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D420813A,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D420813A,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D420813A,,20563.0,,,Injection,,2022,Q3,Weight increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D420813A,,20563.0,,,Injection,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D420813A,,20563.0,,,Injection,,2022,Q3,Blood glucose decreased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D420813A,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D420813A,,20563.0,,,Injection,,2022,Q3,Drug ineffective,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D420813A,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D420813A,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D420813A,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D420813A,,20563.0,,,Injection,,2022,Q3,Weight increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D420813A,,20563.0,,,Injection,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
196185634,19618563,12,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D420813A,,20563.0,,,Injection,,2022,Q3,Blood glucose decreased,,2022,Q3,4,F,20220101.0,20220707.0,20210728,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202107010933,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
1966698215,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q3,Hepatitis acute,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q3,Treatment noncompliance,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q3,Menstrual disorder,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q3,COVID-19,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q3,Viral infection,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q3,Jaundice,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q3,Influenza,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q3,Laboratory test abnormal,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q3,Therapy interrupted,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q3,Abdominal pain,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q3,Steatohepatitis,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q3,Blood bilirubin increased,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q3,Drug ineffective,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q3,Hyperglycaemia,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q3,Weight decreased,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, qd",,,,,,,,6.0,IU,,QD,2022,Q3,Hepatic cirrhosis,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q3,Hepatitis acute,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q3,Treatment noncompliance,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q3,Menstrual disorder,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q3,COVID-19,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q3,Viral infection,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q3,Jaundice,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q3,Influenza,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q3,Laboratory test abnormal,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q3,Therapy interrupted,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q3,Abdominal pain,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q3,Steatohepatitis,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q3,Blood bilirubin increased,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q3,Drug ineffective,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q3,Hyperglycaemia,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q3,Weight decreased,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
1966698215,19666982,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"9 international unit, qd",,,,,,,,9.0,IU,,QD,2022,Q3,Hepatic cirrhosis,,2022,Q3,15,F,20201201.0,20220902.0,20210806,20220913,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005143,AEGERION,,21.0,YR,,F,Y,44.8,KG,20220913,,CN,US,US,2022,Q3,Youth
196694373,19669437,43,C,INSULINE LISPRO,,1,,,,,,,,,,,,,,2022,Q3,End stage renal disease,,2022,Q3,3,F,20190101.0,20220906.0,20210806,20220914,EXP,,US-AstraZeneca-2021A660415,ASTRAZENECA,,58.0,YR,,M,Y,102.1,KG,20220914,,LW,US,,2022,Q3,Adult
196694373,19669437,43,C,INSULINE LISPRO,,1,,,,,,,,,,,,,,2022,Q3,Chronic kidney disease,,2022,Q3,3,F,20190101.0,20220906.0,20210806,20220914,EXP,,US-AstraZeneca-2021A660415,ASTRAZENECA,,58.0,YR,,M,Y,102.1,KG,20220914,,LW,US,,2022,Q3,Adult
196694373,19669437,43,C,INSULINE LISPRO,,1,,,,,,,,,,,,,,2022,Q3,Gastrooesophageal reflux disease,,2022,Q3,3,F,20190101.0,20220906.0,20210806,20220914,EXP,,US-AstraZeneca-2021A660415,ASTRAZENECA,,58.0,YR,,M,Y,102.1,KG,20220914,,LW,US,,2022,Q3,Adult
198180892,19818089,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Medication dose 20 U (UNIT),,,,,,,,,,Injection,,2022,Q3,Cervical polyp,,2022,Q3,2,F,20210811.0,20220719.0,20210911,20220725,EXP,,RU-ROCHE-2905644,ROCHE,,37.0,YR,,F,Y,84.0,KG,20220725,,MD,RU,,2022,Q3,Adult
198180892,19818089,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Medication dose 20 U (UNIT),,,,,,,,,,Injection,,2022,Q3,Bartholin's abscess,,2022,Q3,2,F,20210811.0,20220719.0,20210911,20220725,EXP,,RU-ROCHE-2905644,ROCHE,,37.0,YR,,F,Y,84.0,KG,20220725,,MD,RU,,2022,Q3,Adult
198479154,19847915,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Acute kidney injury,,2022,Q3,4,F,20210826.0,20220902.0,20210917,20220907,EXP,,NVSC2021US209080,NOVARTIS,,64.0,YR,,F,Y,87.5,KG,20220907,,MD,US,US,2022,Q3,Adult
198479154,19847915,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Fungaemia,,2022,Q3,4,F,20210826.0,20220902.0,20210917,20220907,EXP,,NVSC2021US209080,NOVARTIS,,64.0,YR,,F,Y,87.5,KG,20220907,,MD,US,US,2022,Q3,Adult
198902893,19890289,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, bid (100 U/mL Once after meals and at bedtime)",,,,,,,,,,,BID,2022,Q3,Myopathy,,2022,Q3,3,F,,20220808.0,20210928,20220817,PER,,US-LUPIN PHARMACEUTICALS INC.-2021-18089,LUPIN,"Paramanathan P, Abbas M, Valchev P, Itua P, Taravati. A case of statin-induced myopathy. Consultant. 2021;61(5):e3-e5",79.0,YR,,M,Y,,,20220817,,HP,US,US,2022,Q3,Elderly
199617442,19961744,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q3,Oesophageal varices haemorrhage,,2022,Q3,2,F,20210919.0,20220726.0,20211018,20220728,EXP,,DE-ABBVIE-21K-062-4121976-00,ABBVIE,,72.0,YR,,M,Y,75.0,KG,20220728,,MD,COUNTRY NOT SPECIFIED,DE,2022,Q3,Elderly
200380602,20038060,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2022,Q3,Hyperlipidaemia,,2022,Q3,2,F,20180208.0,20220927.0,20211105,20220930,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20220930,,CN,US,US,2022,Q3,Elderly
200380602,20038060,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2022,Q3,Hyperglycaemia,,2022,Q3,2,F,20180208.0,20220927.0,20211105,20220930,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20220930,,CN,US,US,2022,Q3,Elderly
200380602,20038060,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2022,Q3,Chronic kidney disease,,2022,Q3,2,F,20180208.0,20220927.0,20211105,20220930,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20220930,,CN,US,US,2022,Q3,Elderly
200380602,20038060,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2022,Q3,Diarrhoea,,2022,Q3,2,F,20180208.0,20220927.0,20211105,20220930,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20220930,,CN,US,US,2022,Q3,Elderly
200380602,20038060,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2022,Q3,Drug intolerance,,2022,Q3,2,F,20180208.0,20220927.0,20211105,20220930,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20220930,,CN,US,US,2022,Q3,Elderly
200380602,20038060,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2022,Q3,Diarrhoea,,2022,Q3,2,F,20180208.0,20220927.0,20211105,20220930,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20220930,,CN,US,US,2022,Q3,Elderly
200380602,20038060,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2022,Q3,Vertigo,,2022,Q3,2,F,20180208.0,20220927.0,20211105,20220930,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20220930,,CN,US,US,2022,Q3,Elderly
200380602,20038060,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2022,Q3,Respiratory disorder,,2022,Q3,2,F,20180208.0,20220927.0,20211105,20220930,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20220930,,CN,US,US,2022,Q3,Elderly
200380602,20038060,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2022,Q3,Fatigue,,2022,Q3,2,F,20180208.0,20220927.0,20211105,20220930,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20220930,,CN,US,US,2022,Q3,Elderly
200380602,20038060,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2022,Q3,Dysphagia,,2022,Q3,2,F,20180208.0,20220927.0,20211105,20220930,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20220930,,CN,US,US,2022,Q3,Elderly
200380602,20038060,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2022,Q3,Malaise,,2022,Q3,2,F,20180208.0,20220927.0,20211105,20220930,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20220930,,CN,US,US,2022,Q3,Elderly
200380602,20038060,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,strength 100 unit/ ml?unit dose 300 unit/ml,,,U,,,,,,,Injection,,2022,Q3,Nausea,,2022,Q3,2,F,20180208.0,20220927.0,20211105,20220930,EXP,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2020-BI-063812",BOEHRINGER INGELHEIM,,78.0,YR,E,M,Y,,,20220930,,CN,US,US,2022,Q3,Elderly
200490722,20049072,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,pump,,,,,,,,,,,,2022,Q3,Retinal pigmentation,,2022,Q3,2,F,20191023.0,20220725.0,20211109,20220801,EXP,,US-JNJFOC-20211104505,JOHNSON AND JOHNSON,,63.0,YR,A,F,Y,,,20220801,,LW,US,US,2022,Q3,Adult
200490722,20049072,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,pump,,,,,,,,,,,,2022,Q3,Dry age-related macular degeneration,,2022,Q3,2,F,20191023.0,20220725.0,20211109,20220801,EXP,,US-JNJFOC-20211104505,JOHNSON AND JOHNSON,,63.0,YR,A,F,Y,,,20220801,,LW,US,US,2022,Q3,Adult
201166258,20116625,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,8,F,20211117.0,20220916.0,20211126,20220922,EXP,,US-ROCHE-2963208,ROCHE,,82.0,YR,,M,Y,74.7,KG,20220922,,MD,US,,2022,Q3,Elderly
201166258,20116625,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,,,,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,8,F,20211117.0,20220916.0,20211126,20220922,EXP,,US-ROCHE-2963208,ROCHE,,82.0,YR,,M,Y,74.7,KG,20220922,,MD,US,,2022,Q3,Elderly
201192777,20119277,73,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q3,Pulmonary embolism,,2022,Q3,7,F,20211118.0,20220916.0,20211126,20220923,EXP,,US-ROCHE-2962989,ROCHE,,82.0,YR,,M,Y,74.7,KG,20220923,,MD,US,,2022,Q3,Elderly
201192777,20119277,74,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q3,Pulmonary embolism,,2022,Q3,7,F,20211118.0,20220916.0,20211126,20220923,EXP,,US-ROCHE-2962989,ROCHE,,82.0,YR,,M,Y,74.7,KG,20220923,,MD,US,,2022,Q3,Elderly
201192777,20119277,75,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 U,,,,,,,,,,,,2022,Q3,Pulmonary embolism,,2022,Q3,7,F,20211118.0,20220916.0,20211126,20220923,EXP,,US-ROCHE-2962989,ROCHE,,82.0,YR,,M,Y,74.7,KG,20220923,,MD,US,,2022,Q3,Elderly
201192777,20119277,76,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 U,,,,,,,,,,,,2022,Q3,Pulmonary embolism,,2022,Q3,7,F,20211118.0,20220916.0,20211126,20220923,EXP,,US-ROCHE-2962989,ROCHE,,82.0,YR,,M,Y,74.7,KG,20220923,,MD,US,,2022,Q3,Elderly
201471673,20147167,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Injection,,2022,Q3,Drug ineffective,,2022,Q3,3,F,20211101.0,20220629.0,20211203,20220708,PER,,US-SA-2021SA395167,SANOFI AVENTIS,,43.0,YR,A,F,Y,,,20220708,,MD,US,US,2022,Q3,Adult
201471673,20147167,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Injection,,2022,Q3,Asthma,,2022,Q3,3,F,20211101.0,20220629.0,20211203,20220708,PER,,US-SA-2021SA395167,SANOFI AVENTIS,,43.0,YR,A,F,Y,,,20220708,,MD,US,US,2022,Q3,Adult
201471673,20147167,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Injection,,2022,Q3,SARS-CoV-2 test positive,,2022,Q3,3,F,20211101.0,20220629.0,20211203,20220708,PER,,US-SA-2021SA395167,SANOFI AVENTIS,,43.0,YR,A,F,Y,,,20220708,,MD,US,US,2022,Q3,Adult
201471673,20147167,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Injection,,2022,Q3,Impaired quality of life,,2022,Q3,3,F,20211101.0,20220629.0,20211203,20220708,PER,,US-SA-2021SA395167,SANOFI AVENTIS,,43.0,YR,A,F,Y,,,20220708,,MD,US,US,2022,Q3,Adult
201471673,20147167,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Injection,,2022,Q3,COVID-19,,2022,Q3,3,F,20211101.0,20220629.0,20211203,20220708,PER,,US-SA-2021SA395167,SANOFI AVENTIS,,43.0,YR,A,F,Y,,,20220708,,MD,US,US,2022,Q3,Adult
201564642,20156464,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 dosage form,,,Y,,,,,,,,,2022,Q3,Ovarian cyst,,2022,Q3,2,F,20150318.0,20220628.0,20211207,20220701,EXP,,US-TAKEDA-US-001763,TAKEDA,,56.0,YR,,F,Y,97.959,KG,20220701,,MD,US,US,2022,Q3,Adult
201610448,20161044,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,Unknown,,2022,Q3,Hyperglycaemia,,2022,Q3,8,F,20211203.0,20220117.0,20211208,20220929,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-131602,BRISTOL MYERS SQUIBB,,74.0,YR,E,M,Y,96.0,KG,20220929,,HP,BR,BR,2022,Q3,Elderly
201610448,20161044,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,Unknown,,2022,Q3,Hyperglycaemia,,2022,Q3,8,F,20211203.0,20220117.0,20211208,20220929,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-131602,BRISTOL MYERS SQUIBB,,74.0,YR,E,M,Y,96.0,KG,20220929,,HP,BR,BR,2022,Q3,Elderly
201610448,20161044,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 unit not specified,,,U,,,,,,,Unknown,,2022,Q3,Hyperglycaemia,,2022,Q3,8,F,20211203.0,20220117.0,20211208,20220929,EXP,,BR-BRISTOL-MYERS SQUIBB COMPANY-BMS-2021-131602,BRISTOL MYERS SQUIBB,,74.0,YR,E,M,Y,96.0,KG,20220929,,HP,BR,BR,2022,Q3,Elderly
201828584,20182858,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Ischaemic stroke,,2022,Q3,4,F,20211206.0,20220819.0,20211214,20220831,EXP,,US-ROCHE-2977519,ROCHE,,82.0,YR,,M,Y,77.18,KG,20220831,,MD,US,,2022,Q3,Elderly
201828584,20182858,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Anaemia,,2022,Q3,4,F,20211206.0,20220819.0,20211214,20220831,EXP,,US-ROCHE-2977519,ROCHE,,82.0,YR,,M,Y,77.18,KG,20220831,,MD,US,,2022,Q3,Elderly
201828584,20182858,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Acute respiratory failure,,2022,Q3,4,F,20211206.0,20220819.0,20211214,20220831,EXP,,US-ROCHE-2977519,ROCHE,,82.0,YR,,M,Y,77.18,KG,20220831,,MD,US,,2022,Q3,Elderly
201828584,20182858,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Pneumonia bacterial,,2022,Q3,4,F,20211206.0,20220819.0,20211214,20220831,EXP,,US-ROCHE-2977519,ROCHE,,82.0,YR,,M,Y,77.18,KG,20220831,,MD,US,,2022,Q3,Elderly
201828584,20182858,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Thrombocytopenia,,2022,Q3,4,F,20211206.0,20220819.0,20211214,20220831,EXP,,US-ROCHE-2977519,ROCHE,,82.0,YR,,M,Y,77.18,KG,20220831,,MD,US,,2022,Q3,Elderly
201828584,20182858,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Multiple organ dysfunction syndrome,,2022,Q3,4,F,20211206.0,20220819.0,20211214,20220831,EXP,,US-ROCHE-2977519,ROCHE,,82.0,YR,,M,Y,77.18,KG,20220831,,MD,US,,2022,Q3,Elderly
204206893,20420689,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 iU, TID",,,U,,,,,40.0,IU,,Q8H,2022,Q3,Back injury,,2022,Q3,3,F,20220317.0,20220629.0,20220203,20220705,EXP,,US-SA-2022SA029648,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20220705,,MD,US,US,2022,Q3,Elderly
204206893,20420689,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 iU, TID",,,U,,,,,40.0,IU,,Q8H,2022,Q3,Pulseless electrical activity,,2022,Q3,3,F,20220317.0,20220629.0,20220203,20220705,EXP,,US-SA-2022SA029648,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20220705,,MD,US,US,2022,Q3,Elderly
204206893,20420689,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 iU, TID",,,U,,,,,40.0,IU,,Q8H,2022,Q3,Pyrexia,,2022,Q3,3,F,20220317.0,20220629.0,20220203,20220705,EXP,,US-SA-2022SA029648,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20220705,,MD,US,US,2022,Q3,Elderly
204206893,20420689,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 iU, TID",,,U,,,,,40.0,IU,,Q8H,2022,Q3,Cardiac arrest,,2022,Q3,3,F,20220317.0,20220629.0,20220203,20220705,EXP,,US-SA-2022SA029648,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20220705,,MD,US,US,2022,Q3,Elderly
204206893,20420689,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 iU, TID",,,U,,,,,40.0,IU,,Q8H,2022,Q3,Decubitus ulcer,,2022,Q3,3,F,20220317.0,20220629.0,20220203,20220705,EXP,,US-SA-2022SA029648,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20220705,,MD,US,US,2022,Q3,Elderly
204206893,20420689,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 iU, TID",,,U,,,,,40.0,IU,,Q8H,2022,Q3,Sacral pain,,2022,Q3,3,F,20220317.0,20220629.0,20220203,20220705,EXP,,US-SA-2022SA029648,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20220705,,MD,US,US,2022,Q3,Elderly
204206893,20420689,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 iU, TID",,,U,,,,,40.0,IU,,Q8H,2022,Q3,Sepsis,,2022,Q3,3,F,20220317.0,20220629.0,20220203,20220705,EXP,,US-SA-2022SA029648,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20220705,,MD,US,US,2022,Q3,Elderly
204206893,20420689,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 iU, TID",,,U,,,,,40.0,IU,,Q8H,2022,Q3,COVID-19,,2022,Q3,3,F,20220317.0,20220629.0,20220203,20220705,EXP,,US-SA-2022SA029648,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20220705,,MD,US,US,2022,Q3,Elderly
204206893,20420689,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 iU, TID",,,U,,,,,40.0,IU,,Q8H,2022,Q3,Diarrhoea,,2022,Q3,3,F,20220317.0,20220629.0,20220203,20220705,EXP,,US-SA-2022SA029648,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20220705,,MD,US,US,2022,Q3,Elderly
204486102,20448610,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid (3/day)",,,U,,,,,,,,TID,2022,Q3,Off label use,,2022,Q3,2,F,,20220916.0,20220209,20220929,EXP,,IT-PFIZER INC-202200153933,PFIZER,"Ianniciello, A.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. European Heart Journal. 2021;(SUPPL G):G92-3",68.0,YR,,M,Y,,,20220929,,HP,IT,IT,2022,Q3,Elderly
204486102,20448610,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid (3/day)",,,U,,,,,,,,TID,2022,Q3,Hemiplegia,,2022,Q3,2,F,,20220916.0,20220209,20220929,EXP,,IT-PFIZER INC-202200153933,PFIZER,"Ianniciello, A.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. European Heart Journal. 2021;(SUPPL G):G92-3",68.0,YR,,M,Y,,,20220929,,HP,IT,IT,2022,Q3,Elderly
204486102,20448610,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid (3/day)",,,U,,,,,,,,TID,2022,Q3,Dyspnoea,,2022,Q3,2,F,,20220916.0,20220209,20220929,EXP,,IT-PFIZER INC-202200153933,PFIZER,"Ianniciello, A.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. European Heart Journal. 2021;(SUPPL G):G92-3",68.0,YR,,M,Y,,,20220929,,HP,IT,IT,2022,Q3,Elderly
204486102,20448610,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid (3/day)",,,U,,,,,,,,TID,2022,Q3,Drug effective for unapproved indication,,2022,Q3,2,F,,20220916.0,20220209,20220929,EXP,,IT-PFIZER INC-202200153933,PFIZER,"Ianniciello, A.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. European Heart Journal. 2021;(SUPPL G):G92-3",68.0,YR,,M,Y,,,20220929,,HP,IT,IT,2022,Q3,Elderly
204486102,20448610,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid (3/day)",,,U,,,,,,,,TID,2022,Q3,Acute right ventricular failure,,2022,Q3,2,F,,20220916.0,20220209,20220929,EXP,,IT-PFIZER INC-202200153933,PFIZER,"Ianniciello, A.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. European Heart Journal. 2021;(SUPPL G):G92-3",68.0,YR,,M,Y,,,20220929,,HP,IT,IT,2022,Q3,Elderly
204486102,20448610,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"6/8/8 UI, tid (3/day)",,,U,,,,,,,,TID,2022,Q3,Electrocardiogram ST segment elevation,,2022,Q3,2,F,,20220916.0,20220209,20220929,EXP,,IT-PFIZER INC-202200153933,PFIZER,"Ianniciello, A.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. European Heart Journal. 2021;(SUPPL G):G92-3",68.0,YR,,M,Y,,,20220929,,HP,IT,IT,2022,Q3,Elderly
204486102,20448610,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Off label use,,2022,Q3,2,F,,20220916.0,20220209,20220929,EXP,,IT-PFIZER INC-202200153933,PFIZER,"Ianniciello, A.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. European Heart Journal. 2021;(SUPPL G):G92-3",68.0,YR,,M,Y,,,20220929,,HP,IT,IT,2022,Q3,Elderly
204486102,20448610,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Hemiplegia,,2022,Q3,2,F,,20220916.0,20220209,20220929,EXP,,IT-PFIZER INC-202200153933,PFIZER,"Ianniciello, A.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. European Heart Journal. 2021;(SUPPL G):G92-3",68.0,YR,,M,Y,,,20220929,,HP,IT,IT,2022,Q3,Elderly
204486102,20448610,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,2,F,,20220916.0,20220209,20220929,EXP,,IT-PFIZER INC-202200153933,PFIZER,"Ianniciello, A.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. European Heart Journal. 2021;(SUPPL G):G92-3",68.0,YR,,M,Y,,,20220929,,HP,IT,IT,2022,Q3,Elderly
204486102,20448610,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Drug effective for unapproved indication,,2022,Q3,2,F,,20220916.0,20220209,20220929,EXP,,IT-PFIZER INC-202200153933,PFIZER,"Ianniciello, A.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. European Heart Journal. 2021;(SUPPL G):G92-3",68.0,YR,,M,Y,,,20220929,,HP,IT,IT,2022,Q3,Elderly
204486102,20448610,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Acute right ventricular failure,,2022,Q3,2,F,,20220916.0,20220209,20220929,EXP,,IT-PFIZER INC-202200153933,PFIZER,"Ianniciello, A.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. European Heart Journal. 2021;(SUPPL G):G92-3",68.0,YR,,M,Y,,,20220929,,HP,IT,IT,2022,Q3,Elderly
204486102,20448610,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Electrocardiogram ST segment elevation,,2022,Q3,2,F,,20220916.0,20220209,20220929,EXP,,IT-PFIZER INC-202200153933,PFIZER,"Ianniciello, A.. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. European Heart Journal. 2021;(SUPPL G):G92-3",68.0,YR,,M,Y,,,20220929,,HP,IT,IT,2022,Q3,Elderly
204683386,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2022,Q3,Blood corticotrophin increased,,2022,Q3,6,F,20210728.0,20220818.0,20220214,20220830,EXP,,JP-ROCHE-3018327,ROCHE,,71.0,YR,,M,Y,68.0,KG,20220830,,MD,JP,JP,2022,Q3,Elderly
204683386,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2022,Q3,Aspergillus infection,,2022,Q3,6,F,20210728.0,20220818.0,20220214,20220830,EXP,,JP-ROCHE-3018327,ROCHE,,71.0,YR,,M,Y,68.0,KG,20220830,,MD,JP,JP,2022,Q3,Elderly
204683386,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2022,Q3,Blood thyroid stimulating hormone increased,,2022,Q3,6,F,20210728.0,20220818.0,20220214,20220830,EXP,,JP-ROCHE-3018327,ROCHE,,71.0,YR,,M,Y,68.0,KG,20220830,,MD,JP,JP,2022,Q3,Elderly
204683386,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2022,Q3,Blood thyroid stimulating hormone decreased,,2022,Q3,6,F,20210728.0,20220818.0,20220214,20220830,EXP,,JP-ROCHE-3018327,ROCHE,,71.0,YR,,M,Y,68.0,KG,20220830,,MD,JP,JP,2022,Q3,Elderly
204683386,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2022,Q3,Pyrexia,,2022,Q3,6,F,20210728.0,20220818.0,20220214,20220830,EXP,,JP-ROCHE-3018327,ROCHE,,71.0,YR,,M,Y,68.0,KG,20220830,,MD,JP,JP,2022,Q3,Elderly
204683386,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2022,Q3,COVID-19 pneumonia,,2022,Q3,6,F,20210728.0,20220818.0,20220214,20220830,EXP,,JP-ROCHE-3018327,ROCHE,,71.0,YR,,M,Y,68.0,KG,20220830,,MD,JP,JP,2022,Q3,Elderly
204683386,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2022,Q3,Proteinuria,,2022,Q3,6,F,20210728.0,20220818.0,20220214,20220830,EXP,,JP-ROCHE-3018327,ROCHE,,71.0,YR,,M,Y,68.0,KG,20220830,,MD,JP,JP,2022,Q3,Elderly
204683386,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2022,Q3,Ascites,,2022,Q3,6,F,20210728.0,20220818.0,20220214,20220830,EXP,,JP-ROCHE-3018327,ROCHE,,71.0,YR,,M,Y,68.0,KG,20220830,,MD,JP,JP,2022,Q3,Elderly
204683386,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2022,Q3,Adrenocorticotropic hormone deficiency,,2022,Q3,6,F,20210728.0,20220818.0,20220214,20220830,EXP,,JP-ROCHE-3018327,ROCHE,,71.0,YR,,M,Y,68.0,KG,20220830,,MD,JP,JP,2022,Q3,Elderly
204683386,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2022,Q3,Thrombosis,,2022,Q3,6,F,20210728.0,20220818.0,20220214,20220830,EXP,,JP-ROCHE-3018327,ROCHE,,71.0,YR,,M,Y,68.0,KG,20220830,,MD,JP,JP,2022,Q3,Elderly
204683386,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2022,Q3,Hypertension,,2022,Q3,6,F,20210728.0,20220818.0,20220214,20220830,EXP,,JP-ROCHE-3018327,ROCHE,,71.0,YR,,M,Y,68.0,KG,20220830,,MD,JP,JP,2022,Q3,Elderly
204683386,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2022,Q3,Pneumonitis,,2022,Q3,6,F,20210728.0,20220818.0,20220214,20220830,EXP,,JP-ROCHE-3018327,ROCHE,,71.0,YR,,M,Y,68.0,KG,20220830,,MD,JP,JP,2022,Q3,Elderly
204683386,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2022,Q3,Staphylococcal infection,,2022,Q3,6,F,20210728.0,20220818.0,20220214,20220830,EXP,,JP-ROCHE-3018327,ROCHE,,71.0,YR,,M,Y,68.0,KG,20220830,,MD,JP,JP,2022,Q3,Elderly
204683386,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2022,Q3,Stomatitis,,2022,Q3,6,F,20210728.0,20220818.0,20220214,20220830,EXP,,JP-ROCHE-3018327,ROCHE,,71.0,YR,,M,Y,68.0,KG,20220830,,MD,JP,JP,2022,Q3,Elderly
204683386,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2022,Q3,Hypothyroidism,,2022,Q3,6,F,20210728.0,20220818.0,20220214,20220830,EXP,,JP-ROCHE-3018327,ROCHE,,71.0,YR,,M,Y,68.0,KG,20220830,,MD,JP,JP,2022,Q3,Elderly
204683386,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2022,Q3,Hypoalbuminaemia,,2022,Q3,6,F,20210728.0,20220818.0,20220214,20220830,EXP,,JP-ROCHE-3018327,ROCHE,,71.0,YR,,M,Y,68.0,KG,20220830,,MD,JP,JP,2022,Q3,Elderly
204683386,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2022,Q3,Adrenal insufficiency,,2022,Q3,6,F,20210728.0,20220818.0,20220214,20220830,EXP,,JP-ROCHE-3018327,ROCHE,,71.0,YR,,M,Y,68.0,KG,20220830,,MD,JP,JP,2022,Q3,Elderly
204683386,20468338,9,C,INSULIN LISPRO BS,,2,Subcutaneous,"UNK UNK, tid",,,,,UNKNOWN,,,,,Injection,Q8H,2022,Q3,Hypercalcaemia,,2022,Q3,6,F,20210728.0,20220818.0,20220214,20220830,EXP,,JP-ROCHE-3018327,ROCHE,,71.0,YR,,M,Y,68.0,KG,20220830,,MD,JP,JP,2022,Q3,Elderly
204843667,20484366,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,1-11 units TID AC; 2-7 units nightly,,,,,,,,,,,,2022,Q3,Hypertransaminasaemia,,2022,Q3,7,F,20220202.0,20220921.0,20220217,20220926,EXP,,US-JNJFOC-20220214179,JOHNSON AND JOHNSON,,52.0,YR,A,M,Y,90.8,KG,20220926,,MD,US,US,2022,Q3,Adult
204843667,20484366,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,1-11 units TID AC; 2-7 units nightly,,,,,,,,,,,,2022,Q3,Stevens-Johnson syndrome,,2022,Q3,7,F,20220202.0,20220921.0,20220217,20220926,EXP,,US-JNJFOC-20220214179,JOHNSON AND JOHNSON,,52.0,YR,A,M,Y,90.8,KG,20220926,,MD,US,US,2022,Q3,Adult
205210223,20521022,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,Type 1 diabetes mellitus,,2022,Q3,3,F,20220222.0,20220729.0,20220225,20220802,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-027172,BRISTOL MYERS SQUIBB,,63.0,YR,A,M,Y,,,20220802,,HP,DE,DE,2022,Q3,Adult
205210223,20521022,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,Peripheral motor neuropathy,,2022,Q3,3,F,20220222.0,20220729.0,20220225,20220802,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-027172,BRISTOL MYERS SQUIBB,,63.0,YR,A,M,Y,,,20220802,,HP,DE,DE,2022,Q3,Adult
205239364,20523936,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q3,Intraocular pressure increased,,2022,Q3,4,F,20210806.0,20220804.0,20220228,20220810,EXP,,US-ROCHE-2898802,ROCHE,,68.0,YR,,F,Y,,,20220810,,MD,US,,2022,Q3,Elderly
205239364,20523936,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q3,Iridocyclitis,,2022,Q3,4,F,20210806.0,20220804.0,20220228,20220810,EXP,,US-ROCHE-2898802,ROCHE,,68.0,YR,,F,Y,,,20220810,,MD,US,,2022,Q3,Elderly
205239364,20523936,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q3,Migraine,,2022,Q3,4,F,20210806.0,20220804.0,20220228,20220810,EXP,,US-ROCHE-2898802,ROCHE,,68.0,YR,,F,Y,,,20220810,,MD,US,,2022,Q3,Elderly
205469732,20546973,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Papilloma,,2022,Q3,2,F,,20220901.0,20220303,20220908,EXP,,FR-MYLANLABS-2022M1016185,MYLAN,"Vuillamy C, Arnault J, Attencourt C, Dadban A, Joachim C, Chaby G et al.. Simultaneous occurrence of insulin-derived amyloidosis and acanthosis nigricans at the abdominal site of insulin injection. JAAD Case Reports. 2022;19:94-96",68.0,YR,,F,Y,,,20220908,,MD,FR,FR,2022,Q3,Elderly
205469732,20546973,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Injection site induration,,2022,Q3,2,F,,20220901.0,20220303,20220908,EXP,,FR-MYLANLABS-2022M1016185,MYLAN,"Vuillamy C, Arnault J, Attencourt C, Dadban A, Joachim C, Chaby G et al.. Simultaneous occurrence of insulin-derived amyloidosis and acanthosis nigricans at the abdominal site of insulin injection. JAAD Case Reports. 2022;19:94-96",68.0,YR,,F,Y,,,20220908,,MD,FR,FR,2022,Q3,Elderly
205469732,20546973,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Therapy non-responder,,2022,Q3,2,F,,20220901.0,20220303,20220908,EXP,,FR-MYLANLABS-2022M1016185,MYLAN,"Vuillamy C, Arnault J, Attencourt C, Dadban A, Joachim C, Chaby G et al.. Simultaneous occurrence of insulin-derived amyloidosis and acanthosis nigricans at the abdominal site of insulin injection. JAAD Case Reports. 2022;19:94-96",68.0,YR,,F,Y,,,20220908,,MD,FR,FR,2022,Q3,Elderly
205469732,20546973,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Acanthosis,,2022,Q3,2,F,,20220901.0,20220303,20220908,EXP,,FR-MYLANLABS-2022M1016185,MYLAN,"Vuillamy C, Arnault J, Attencourt C, Dadban A, Joachim C, Chaby G et al.. Simultaneous occurrence of insulin-derived amyloidosis and acanthosis nigricans at the abdominal site of insulin injection. JAAD Case Reports. 2022;19:94-96",68.0,YR,,F,Y,,,20220908,,MD,FR,FR,2022,Q3,Elderly
205469732,20546973,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Acanthosis nigricans,,2022,Q3,2,F,,20220901.0,20220303,20220908,EXP,,FR-MYLANLABS-2022M1016185,MYLAN,"Vuillamy C, Arnault J, Attencourt C, Dadban A, Joachim C, Chaby G et al.. Simultaneous occurrence of insulin-derived amyloidosis and acanthosis nigricans at the abdominal site of insulin injection. JAAD Case Reports. 2022;19:94-96",68.0,YR,,F,Y,,,20220908,,MD,FR,FR,2022,Q3,Elderly
205469732,20546973,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Injection site discolouration,,2022,Q3,2,F,,20220901.0,20220303,20220908,EXP,,FR-MYLANLABS-2022M1016185,MYLAN,"Vuillamy C, Arnault J, Attencourt C, Dadban A, Joachim C, Chaby G et al.. Simultaneous occurrence of insulin-derived amyloidosis and acanthosis nigricans at the abdominal site of insulin injection. JAAD Case Reports. 2022;19:94-96",68.0,YR,,F,Y,,,20220908,,MD,FR,FR,2022,Q3,Elderly
205469732,20546973,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Injection site reaction,,2022,Q3,2,F,,20220901.0,20220303,20220908,EXP,,FR-MYLANLABS-2022M1016185,MYLAN,"Vuillamy C, Arnault J, Attencourt C, Dadban A, Joachim C, Chaby G et al.. Simultaneous occurrence of insulin-derived amyloidosis and acanthosis nigricans at the abdominal site of insulin injection. JAAD Case Reports. 2022;19:94-96",68.0,YR,,F,Y,,,20220908,,MD,FR,FR,2022,Q3,Elderly
205469732,20546973,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Injection site plaque,,2022,Q3,2,F,,20220901.0,20220303,20220908,EXP,,FR-MYLANLABS-2022M1016185,MYLAN,"Vuillamy C, Arnault J, Attencourt C, Dadban A, Joachim C, Chaby G et al.. Simultaneous occurrence of insulin-derived amyloidosis and acanthosis nigricans at the abdominal site of insulin injection. JAAD Case Reports. 2022;19:94-96",68.0,YR,,F,Y,,,20220908,,MD,FR,FR,2022,Q3,Elderly
205469732,20546973,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Hyperkeratosis,,2022,Q3,2,F,,20220901.0,20220303,20220908,EXP,,FR-MYLANLABS-2022M1016185,MYLAN,"Vuillamy C, Arnault J, Attencourt C, Dadban A, Joachim C, Chaby G et al.. Simultaneous occurrence of insulin-derived amyloidosis and acanthosis nigricans at the abdominal site of insulin injection. JAAD Case Reports. 2022;19:94-96",68.0,YR,,F,Y,,,20220908,,MD,FR,FR,2022,Q3,Elderly
205469732,20546973,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Amyloidosis,,2022,Q3,2,F,,20220901.0,20220303,20220908,EXP,,FR-MYLANLABS-2022M1016185,MYLAN,"Vuillamy C, Arnault J, Attencourt C, Dadban A, Joachim C, Chaby G et al.. Simultaneous occurrence of insulin-derived amyloidosis and acanthosis nigricans at the abdominal site of insulin injection. JAAD Case Reports. 2022;19:94-96",68.0,YR,,F,Y,,,20220908,,MD,FR,FR,2022,Q3,Elderly
205530973,20553097,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Ejection fraction decreased,,2022,Q3,3,F,,20220725.0,20220304,20220727,EXP,,NVSJ2022JP003687,NOVARTIS,,57.0,YR,,M,Y,70.0,KG,20220728,,MD,JP,JP,2022,Q3,Adult
205530973,20553097,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Cardio-respiratory arrest,,2022,Q3,3,F,,20220725.0,20220304,20220727,EXP,,NVSJ2022JP003687,NOVARTIS,,57.0,YR,,M,Y,70.0,KG,20220728,,MD,JP,JP,2022,Q3,Adult
205530973,20553097,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Malaise,,2022,Q3,3,F,,20220725.0,20220304,20220727,EXP,,NVSJ2022JP003687,NOVARTIS,,57.0,YR,,M,Y,70.0,KG,20220728,,MD,JP,JP,2022,Q3,Adult
205530973,20553097,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Cardiomegaly,,2022,Q3,3,F,,20220725.0,20220304,20220727,EXP,,NVSJ2022JP003687,NOVARTIS,,57.0,YR,,M,Y,70.0,KG,20220728,,MD,JP,JP,2022,Q3,Adult
205530973,20553097,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Left ventricular dysfunction,,2022,Q3,3,F,,20220725.0,20220304,20220727,EXP,,NVSJ2022JP003687,NOVARTIS,,57.0,YR,,M,Y,70.0,KG,20220728,,MD,JP,JP,2022,Q3,Adult
205530973,20553097,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,3,F,,20220725.0,20220304,20220727,EXP,,NVSJ2022JP003687,NOVARTIS,,57.0,YR,,M,Y,70.0,KG,20220728,,MD,JP,JP,2022,Q3,Adult
205530973,20553097,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Altered state of consciousness,,2022,Q3,3,F,,20220725.0,20220304,20220727,EXP,,NVSJ2022JP003687,NOVARTIS,,57.0,YR,,M,Y,70.0,KG,20220728,,MD,JP,JP,2022,Q3,Adult
205530973,20553097,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Asthenia,,2022,Q3,3,F,,20220725.0,20220304,20220727,EXP,,NVSJ2022JP003687,NOVARTIS,,57.0,YR,,M,Y,70.0,KG,20220728,,MD,JP,JP,2022,Q3,Adult
205530973,20553097,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Hypoxic-ischaemic encephalopathy,,2022,Q3,3,F,,20220725.0,20220304,20220727,EXP,,NVSJ2022JP003687,NOVARTIS,,57.0,YR,,M,Y,70.0,KG,20220728,,MD,JP,JP,2022,Q3,Adult
206646352,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Drug ineffective,,2022,Q3,2,F,,20220913.0,20220401,20220920,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220920,,CN,CA,CA,2022,Q3,Elderly
206646352,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Osteoarthritis,,2022,Q3,2,F,,20220913.0,20220401,20220920,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220920,,CN,CA,CA,2022,Q3,Elderly
206646352,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Drug intolerance,,2022,Q3,2,F,,20220913.0,20220401,20220920,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220920,,CN,CA,CA,2022,Q3,Elderly
206646352,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Psoriatic arthropathy,,2022,Q3,2,F,,20220913.0,20220401,20220920,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220920,,CN,CA,CA,2022,Q3,Elderly
206646352,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Pain,,2022,Q3,2,F,,20220913.0,20220401,20220920,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220920,,CN,CA,CA,2022,Q3,Elderly
206646352,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Arthropathy,,2022,Q3,2,F,,20220913.0,20220401,20220920,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220920,,CN,CA,CA,2022,Q3,Elderly
206646352,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Therapeutic product effect decreased,,2022,Q3,2,F,,20220913.0,20220401,20220920,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220920,,CN,CA,CA,2022,Q3,Elderly
206646352,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Movement disorder,,2022,Q3,2,F,,20220913.0,20220401,20220920,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220920,,CN,CA,CA,2022,Q3,Elderly
206646352,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Hepatic cirrhosis,,2022,Q3,2,F,,20220913.0,20220401,20220920,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220920,,CN,CA,CA,2022,Q3,Elderly
206646352,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Pain in extremity,,2022,Q3,2,F,,20220913.0,20220401,20220920,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220920,,CN,CA,CA,2022,Q3,Elderly
206646352,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Hepatotoxicity,,2022,Q3,2,F,,20220913.0,20220401,20220920,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220920,,CN,CA,CA,2022,Q3,Elderly
206646352,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Diabetes mellitus,,2022,Q3,2,F,,20220913.0,20220401,20220920,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220920,,CN,CA,CA,2022,Q3,Elderly
206646352,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Grip strength decreased,,2022,Q3,2,F,,20220913.0,20220401,20220920,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220920,,CN,CA,CA,2022,Q3,Elderly
206646352,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Headache,,2022,Q3,2,F,,20220913.0,20220401,20220920,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220920,,CN,CA,CA,2022,Q3,Elderly
206646352,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,2,F,,20220913.0,20220401,20220920,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220920,,CN,CA,CA,2022,Q3,Elderly
206646352,20664635,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Arthralgia,,2022,Q3,2,F,,20220913.0,20220401,20220920,EXP,,CA-PFIZER INC-2018298915,PFIZER,,65.0,YR,,F,Y,,,20220920,,CN,CA,CA,2022,Q3,Elderly
206950156,20695015,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"20-30 units,25 units",,,D,,,,,,,,,2022,Q3,Blood glucose decreased,,2022,Q3,6,F,20220403.0,20220707.0,20220411,20220712,PER,,US-SA-2022SA121992,SANOFI AVENTIS,,51.0,YR,A,M,Y,,,20220713,,HP,US,US,2022,Q3,Adult
206950156,20695015,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"20-30 units,25 units",,,D,,,,,,,,,2022,Q3,Inappropriate schedule of product administration,,2022,Q3,6,F,20220403.0,20220707.0,20220411,20220712,PER,,US-SA-2022SA121992,SANOFI AVENTIS,,51.0,YR,A,M,Y,,,20220713,,HP,US,US,2022,Q3,Adult
206950156,20695015,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"20-30 units,25 units",,,D,,,,,,,,,2022,Q3,Blood glucose fluctuation,,2022,Q3,6,F,20220403.0,20220707.0,20220411,20220712,PER,,US-SA-2022SA121992,SANOFI AVENTIS,,51.0,YR,A,M,Y,,,20220713,,HP,US,US,2022,Q3,Adult
206950156,20695015,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"20-30 units,25 units",,,D,,,,,,,,,2022,Q3,Diabetes mellitus inadequate control,,2022,Q3,6,F,20220403.0,20220707.0,20220411,20220712,PER,,US-SA-2022SA121992,SANOFI AVENTIS,,51.0,YR,A,M,Y,,,20220713,,HP,US,US,2022,Q3,Adult
206950156,20695015,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"20-30 units,25 units",,,D,,,,,,,,,2022,Q3,Therapeutic response decreased,,2022,Q3,6,F,20220403.0,20220707.0,20220411,20220712,PER,,US-SA-2022SA121992,SANOFI AVENTIS,,51.0,YR,A,M,Y,,,20220713,,HP,US,US,2022,Q3,Adult
206950156,20695015,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"20-30 units,25 units",,,D,,,,,,,,,2022,Q3,Sleep disorder,,2022,Q3,6,F,20220403.0,20220707.0,20220411,20220712,PER,,US-SA-2022SA121992,SANOFI AVENTIS,,51.0,YR,A,M,Y,,,20220713,,HP,US,US,2022,Q3,Adult
206950156,20695015,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"20-30 units,25 units",,,D,,,,,,,,,2022,Q3,Blood glucose increased,,2022,Q3,6,F,20220403.0,20220707.0,20220411,20220712,PER,,US-SA-2022SA121992,SANOFI AVENTIS,,51.0,YR,A,M,Y,,,20220713,,HP,US,US,2022,Q3,Adult
206950156,20695015,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"20-30 units,25 units",,,D,,,,,,,,,2022,Q3,Dehydration,,2022,Q3,6,F,20220403.0,20220707.0,20220411,20220712,PER,,US-SA-2022SA121992,SANOFI AVENTIS,,51.0,YR,A,M,Y,,,20220713,,HP,US,US,2022,Q3,Adult
206950156,20695015,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"20-30 units,25 units",,,D,,,,,,,,,2022,Q3,Pollakiuria,,2022,Q3,6,F,20220403.0,20220707.0,20220411,20220712,PER,,US-SA-2022SA121992,SANOFI AVENTIS,,51.0,YR,A,M,Y,,,20220713,,HP,US,US,2022,Q3,Adult
206950156,20695015,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"20-30 units,25 units",,,D,,,,,,,,,2022,Q3,Visual impairment,,2022,Q3,6,F,20220403.0,20220707.0,20220411,20220712,PER,,US-SA-2022SA121992,SANOFI AVENTIS,,51.0,YR,A,M,Y,,,20220713,,HP,US,US,2022,Q3,Adult
206950156,20695015,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"20-30 units,25 units",,,D,,,,,,,,,2022,Q3,Extra dose administered,,2022,Q3,6,F,20220403.0,20220707.0,20220411,20220712,PER,,US-SA-2022SA121992,SANOFI AVENTIS,,51.0,YR,A,M,Y,,,20220713,,HP,US,US,2022,Q3,Adult
207233913,20723391,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Respiratory (inhalation),,,,,,,,,,,,,2022,Q3,Arrhythmia,,2022,Q3,3,F,20201101.0,20220928.0,20220419,20220930,EXP,,CN-ROCHE-2725053,ROCHE,,58.0,YR,,M,Y,55.6,KG,20220930,,MD,CN,,2022,Q3,Adult
207312916,20731291,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, q6hr",,,,,,,,1.0,IU,,Q6H,2022,Q3,Hypoxia,,2022,Q3,6,F,20220211.0,20220905.0,20220420,20220908,EXP,,US-TAKEDA-2022TUS023839,TAKEDA,,70.0,YR,,F,Y,28.57,KG,20220908,,MD,US,US,2022,Q3,Elderly
207312916,20731291,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, q6hr",,,,,,,,1.0,IU,,Q6H,2022,Q3,Hypertransaminasaemia,,2022,Q3,6,F,20220211.0,20220905.0,20220420,20220908,EXP,,US-TAKEDA-2022TUS023839,TAKEDA,,70.0,YR,,F,Y,28.57,KG,20220908,,MD,US,US,2022,Q3,Elderly
207312916,20731291,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, q6hr",,,,,,,,1.0,IU,,Q6H,2022,Q3,Pleural effusion,,2022,Q3,6,F,20220211.0,20220905.0,20220420,20220908,EXP,,US-TAKEDA-2022TUS023839,TAKEDA,,70.0,YR,,F,Y,28.57,KG,20220908,,MD,US,US,2022,Q3,Elderly
207312916,20731291,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, q6hr",,,,,,,,1.0,IU,,Q6H,2022,Q3,Alkalosis,,2022,Q3,6,F,20220211.0,20220905.0,20220420,20220908,EXP,,US-TAKEDA-2022TUS023839,TAKEDA,,70.0,YR,,F,Y,28.57,KG,20220908,,MD,US,US,2022,Q3,Elderly
207312916,20731291,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, q6hr",,,,,,,,1.0,IU,,Q6H,2022,Q3,Sepsis,,2022,Q3,6,F,20220211.0,20220905.0,20220420,20220908,EXP,,US-TAKEDA-2022TUS023839,TAKEDA,,70.0,YR,,F,Y,28.57,KG,20220908,,MD,US,US,2022,Q3,Elderly
207312916,20731291,81,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, q6hr",,,,,,,,1.0,IU,,Q6H,2022,Q3,Tachycardia,,2022,Q3,6,F,20220211.0,20220905.0,20220420,20220908,EXP,,US-TAKEDA-2022TUS023839,TAKEDA,,70.0,YR,,F,Y,28.57,KG,20220908,,MD,US,US,2022,Q3,Elderly
207450345,20745034,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q3,Restlessness,,2022,Q3,5,F,20220314.0,20220816.0,20220425,20220824,EXP,,"JP-CATALYST PHARMACEUTICALS, INC-2022CAT00264",CATALYST PHARMA,,57.0,YR,,M,Y,65.1,KG,20220824,,HP,JP,JP,2022,Q3,Adult
207450345,20745034,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q3,Antimicrobial susceptibility test resistant,,2022,Q3,5,F,20220314.0,20220816.0,20220425,20220824,EXP,,"JP-CATALYST PHARMACEUTICALS, INC-2022CAT00264",CATALYST PHARMA,,57.0,YR,,M,Y,65.1,KG,20220824,,HP,JP,JP,2022,Q3,Adult
207450345,20745034,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q3,Dysphagia,,2022,Q3,5,F,20220314.0,20220816.0,20220425,20220824,EXP,,"JP-CATALYST PHARMACEUTICALS, INC-2022CAT00264",CATALYST PHARMA,,57.0,YR,,M,Y,65.1,KG,20220824,,HP,JP,JP,2022,Q3,Adult
207450345,20745034,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q3,Fall,,2022,Q3,5,F,20220314.0,20220816.0,20220425,20220824,EXP,,"JP-CATALYST PHARMACEUTICALS, INC-2022CAT00264",CATALYST PHARMA,,57.0,YR,,M,Y,65.1,KG,20220824,,HP,JP,JP,2022,Q3,Adult
207450345,20745034,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q3,Pneumonia aspiration,,2022,Q3,5,F,20220314.0,20220816.0,20220425,20220824,EXP,,"JP-CATALYST PHARMACEUTICALS, INC-2022CAT00264",CATALYST PHARMA,,57.0,YR,,M,Y,65.1,KG,20220824,,HP,JP,JP,2022,Q3,Adult
207450345,20745034,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q3,Pain,,2022,Q3,5,F,20220314.0,20220816.0,20220425,20220824,EXP,,"JP-CATALYST PHARMACEUTICALS, INC-2022CAT00264",CATALYST PHARMA,,57.0,YR,,M,Y,65.1,KG,20220824,,HP,JP,JP,2022,Q3,Adult
207450345,20745034,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q3,Muscular weakness,,2022,Q3,5,F,20220314.0,20220816.0,20220425,20220824,EXP,,"JP-CATALYST PHARMACEUTICALS, INC-2022CAT00264",CATALYST PHARMA,,57.0,YR,,M,Y,65.1,KG,20220824,,HP,JP,JP,2022,Q3,Adult
207450345,20745034,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q3,Insomnia,,2022,Q3,5,F,20220314.0,20220816.0,20220425,20220824,EXP,,"JP-CATALYST PHARMACEUTICALS, INC-2022CAT00264",CATALYST PHARMA,,57.0,YR,,M,Y,65.1,KG,20220824,,HP,JP,JP,2022,Q3,Adult
207450345,20745034,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q3,Fall,,2022,Q3,5,F,20220314.0,20220816.0,20220425,20220824,EXP,,"JP-CATALYST PHARMACEUTICALS, INC-2022CAT00264",CATALYST PHARMA,,57.0,YR,,M,Y,65.1,KG,20220824,,HP,JP,JP,2022,Q3,Adult
207450345,20745034,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q3,Fall,,2022,Q3,5,F,20220314.0,20220816.0,20220425,20220824,EXP,,"JP-CATALYST PHARMACEUTICALS, INC-2022CAT00264",CATALYST PHARMA,,57.0,YR,,M,Y,65.1,KG,20220824,,HP,JP,JP,2022,Q3,Adult
207450345,20745034,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,5,F,20220314.0,20220816.0,20220425,20220824,EXP,,"JP-CATALYST PHARMACEUTICALS, INC-2022CAT00264",CATALYST PHARMA,,57.0,YR,,M,Y,65.1,KG,20220824,,HP,JP,JP,2022,Q3,Adult
207450345,20745034,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q3,Pyrexia,,2022,Q3,5,F,20220314.0,20220816.0,20220425,20220824,EXP,,"JP-CATALYST PHARMACEUTICALS, INC-2022CAT00264",CATALYST PHARMA,,57.0,YR,,M,Y,65.1,KG,20220824,,HP,JP,JP,2022,Q3,Adult
207450345,20745034,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q3,Altered state of consciousness,,2022,Q3,5,F,20220314.0,20220816.0,20220425,20220824,EXP,,"JP-CATALYST PHARMACEUTICALS, INC-2022CAT00264",CATALYST PHARMA,,57.0,YR,,M,Y,65.1,KG,20220824,,HP,JP,JP,2022,Q3,Adult
207450345,20745034,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q3,Pyrexia,,2022,Q3,5,F,20220314.0,20220816.0,20220425,20220824,EXP,,"JP-CATALYST PHARMACEUTICALS, INC-2022CAT00264",CATALYST PHARMA,,57.0,YR,,M,Y,65.1,KG,20220824,,HP,JP,JP,2022,Q3,Adult
207450345,20745034,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q3,Loss of personal independence in daily activities,,2022,Q3,5,F,20220314.0,20220816.0,20220425,20220824,EXP,,"JP-CATALYST PHARMACEUTICALS, INC-2022CAT00264",CATALYST PHARMA,,57.0,YR,,M,Y,65.1,KG,20220824,,HP,JP,JP,2022,Q3,Adult
207641129,20764112,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,12.0,IU,Solution for injection/infusion,,2022,Q3,Ischaemic stroke,,2022,Q3,9,F,20220419.0,20220715.0,20220428,20220720,PER,,RU-Eisai Medical Research-EC-2022-113891,EISAI,,59.0,YR,A,F,Y,93.5,KG,20220720,,MD,RU,,2022,Q3,Adult
207672173,20767217,36,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Appendicitis perforated,,2022,Q3,3,F,20220325.0,20220712.0,20220429,20220718,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-017325,BRISTOL MYERS SQUIBB,,64.0,YR,A,F,Y,71.2,KG,20220718,,HP,US,US,2022,Q3,Adult
207784384,20778438,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 unit, subcutaneously (SC) at 7.30 a.m.,",,,,,,,,,,,,2022,Q3,Lymphadenopathy,,2022,Q3,4,F,20220101.0,20220815.0,20220503,20220822,PER,,PL-AMGEN-POLSP2022072582,AMGEN,,80.0,YR,E,F,Y,71.0,KG,20220822,,MD,PL,PL,2022,Q3,Elderly
207784384,20778438,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 unit, subcutaneously (SC) at 7.30 a.m.,",,,,,,,,,,,,2022,Q3,Neutropenia,,2022,Q3,4,F,20220101.0,20220815.0,20220503,20220822,PER,,PL-AMGEN-POLSP2022072582,AMGEN,,80.0,YR,E,F,Y,71.0,KG,20220822,,MD,PL,PL,2022,Q3,Elderly
207993232,20799323,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,,,2022,Q3,Blood glucose increased,,2022,Q3,2,F,20220429.0,20220715.0,20220508,20220719,PER,,US-ELI_LILLY_AND_COMPANY-US202205001339,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20220719,,CN,US,US,2022,Q3,Elderly
207993232,20799323,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,,,2022,Q3,Visual impairment,,2022,Q3,2,F,20220429.0,20220715.0,20220508,20220719,PER,,US-ELI_LILLY_AND_COMPANY-US202205001339,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20220719,,CN,US,US,2022,Q3,Elderly
207993232,20799323,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,,,2022,Q3,Blood glucose increased,,2022,Q3,2,F,20220429.0,20220715.0,20220508,20220719,PER,,US-ELI_LILLY_AND_COMPANY-US202205001339,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20220719,,CN,US,US,2022,Q3,Elderly
207993232,20799323,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,,,2022,Q3,Underdose,,2022,Q3,2,F,20220429.0,20220715.0,20220508,20220719,PER,,US-ELI_LILLY_AND_COMPANY-US202205001339,ELI LILLY AND CO,,73.0,YR,,F,Y,,,20220719,,CN,US,US,2022,Q3,Elderly
208173104,20817310,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,Unknown dose,,,,,,,,,,,,2022,Q3,Meningitis aseptic,,2022,Q3,4,F,,20220714.0,20220512,20220726,EXP,,US-UCBSA-2022026121,UCB,"Vickery PB, Roach JK, Vickery S. A Case of Possible Levetiracetam Induced Aseptic Meningitis vs Viral Meningitis. CNS spectrums. 2022;27(2):231-2",54.0,YR,,M,Y,,,20220726,,MD,US,US,2022,Q3,Adult
208265855,20826585,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,sliding scale correctional dose subcutaneously every 4 hours,,,,,,,,,,,,2022,Q3,Meningitis aseptic,,2022,Q3,5,F,,20220718.0,20220513,20220720,EXP,,US-PFIZER INC-202200672628,PFIZER,"Vickery, P.. A Case of Possible Levetiracetam Induced Aseptic Meningitis vs Viral Meningitis. Cns Spectrums. 2022;27(2):231-232",54.0,YR,,M,Y,,,20220720,,HP,US,US,2022,Q3,Adult
208390253,20839025,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,unknown,,,U,,,,,,,UNK,,2022,Q3,Meningitis aseptic,,2022,Q3,3,F,,20220714.0,20220517,20220722,EXP,,US-TORRENT-00011857,TORRENT,,54.0,YR,A,M,Y,,,20220722,,PH,US,US,2022,Q3,Adult
208597813,20859781,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Meningitis aseptic,,2022,Q3,3,F,,20220725.0,20220523,20220803,EXP,,US-35507-2022-07265,LUPIN,"Vickery PB, Roach JK, Vickery S. A case of possible Levetiracetam induced aseptic meningitis vs viral meningitis. CNS Spectrums. 2022;27(2):231-232",54.0,YR,,M,Y,,,20220803,,PH,US,US,2022,Q3,Adult
209063522,20906352,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, tid",,,,,D420813A,,,,,Injection,TID,2022,Q3,Constipation,,2022,Q3,2,F,20220201.0,20220707.0,20220602,20220720,EXP,,US-ELI_LILLY_AND_COMPANY-US202205010555,ELI LILLY AND CO,,76.0,YR,,F,Y,96.145,KG,20220720,,HP,US,US,2022,Q3,Elderly
209063522,20906352,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, tid",,,,,D420813A,,,,,Injection,TID,2022,Q3,Headache,,2022,Q3,2,F,20220201.0,20220707.0,20220602,20220720,EXP,,US-ELI_LILLY_AND_COMPANY-US202205010555,ELI LILLY AND CO,,76.0,YR,,F,Y,96.145,KG,20220720,,HP,US,US,2022,Q3,Elderly
209063522,20906352,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, tid",,,,,D420813A,,,,,Injection,TID,2022,Q3,Diarrhoea,,2022,Q3,2,F,20220201.0,20220707.0,20220602,20220720,EXP,,US-ELI_LILLY_AND_COMPANY-US202205010555,ELI LILLY AND CO,,76.0,YR,,F,Y,96.145,KG,20220720,,HP,US,US,2022,Q3,Elderly
209063522,20906352,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, tid",,,,,D420813A,,,,,Injection,TID,2022,Q3,Fatigue,,2022,Q3,2,F,20220201.0,20220707.0,20220602,20220720,EXP,,US-ELI_LILLY_AND_COMPANY-US202205010555,ELI LILLY AND CO,,76.0,YR,,F,Y,96.145,KG,20220720,,HP,US,US,2022,Q3,Elderly
209063522,20906352,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, tid",,,,,D420813A,,,,,Injection,TID,2022,Q3,Pain,,2022,Q3,2,F,20220201.0,20220707.0,20220602,20220720,EXP,,US-ELI_LILLY_AND_COMPANY-US202205010555,ELI LILLY AND CO,,76.0,YR,,F,Y,96.145,KG,20220720,,HP,US,US,2022,Q3,Elderly
209063522,20906352,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, tid",,,,,D420813A,,,,,Injection,TID,2022,Q3,Renal disorder,,2022,Q3,2,F,20220201.0,20220707.0,20220602,20220720,EXP,,US-ELI_LILLY_AND_COMPANY-US202205010555,ELI LILLY AND CO,,76.0,YR,,F,Y,96.145,KG,20220720,,HP,US,US,2022,Q3,Elderly
209063522,20906352,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, tid",,,,,D420813A,,,,,Injection,TID,2022,Q3,Neck pain,,2022,Q3,2,F,20220201.0,20220707.0,20220602,20220720,EXP,,US-ELI_LILLY_AND_COMPANY-US202205010555,ELI LILLY AND CO,,76.0,YR,,F,Y,96.145,KG,20220720,,HP,US,US,2022,Q3,Elderly
209063522,20906352,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, tid",,,,,D420813A,,,,,Injection,TID,2022,Q3,Pancreatitis,,2022,Q3,2,F,20220201.0,20220707.0,20220602,20220720,EXP,,US-ELI_LILLY_AND_COMPANY-US202205010555,ELI LILLY AND CO,,76.0,YR,,F,Y,96.145,KG,20220720,,HP,US,US,2022,Q3,Elderly
209063522,20906352,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, tid",,,,,D420813A,,,,,Injection,TID,2022,Q3,Hepatic enzyme increased,,2022,Q3,2,F,20220201.0,20220707.0,20220602,20220720,EXP,,US-ELI_LILLY_AND_COMPANY-US202205010555,ELI LILLY AND CO,,76.0,YR,,F,Y,96.145,KG,20220720,,HP,US,US,2022,Q3,Elderly
209063522,20906352,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 to 16 u, tid",,,,,,,,14.0,IU,Injection,TID,2022,Q3,Constipation,,2022,Q3,2,F,20220201.0,20220707.0,20220602,20220720,EXP,,US-ELI_LILLY_AND_COMPANY-US202205010555,ELI LILLY AND CO,,76.0,YR,,F,Y,96.145,KG,20220720,,HP,US,US,2022,Q3,Elderly
209063522,20906352,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 to 16 u, tid",,,,,,,,14.0,IU,Injection,TID,2022,Q3,Headache,,2022,Q3,2,F,20220201.0,20220707.0,20220602,20220720,EXP,,US-ELI_LILLY_AND_COMPANY-US202205010555,ELI LILLY AND CO,,76.0,YR,,F,Y,96.145,KG,20220720,,HP,US,US,2022,Q3,Elderly
209063522,20906352,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 to 16 u, tid",,,,,,,,14.0,IU,Injection,TID,2022,Q3,Diarrhoea,,2022,Q3,2,F,20220201.0,20220707.0,20220602,20220720,EXP,,US-ELI_LILLY_AND_COMPANY-US202205010555,ELI LILLY AND CO,,76.0,YR,,F,Y,96.145,KG,20220720,,HP,US,US,2022,Q3,Elderly
209063522,20906352,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 to 16 u, tid",,,,,,,,14.0,IU,Injection,TID,2022,Q3,Fatigue,,2022,Q3,2,F,20220201.0,20220707.0,20220602,20220720,EXP,,US-ELI_LILLY_AND_COMPANY-US202205010555,ELI LILLY AND CO,,76.0,YR,,F,Y,96.145,KG,20220720,,HP,US,US,2022,Q3,Elderly
209063522,20906352,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 to 16 u, tid",,,,,,,,14.0,IU,Injection,TID,2022,Q3,Pain,,2022,Q3,2,F,20220201.0,20220707.0,20220602,20220720,EXP,,US-ELI_LILLY_AND_COMPANY-US202205010555,ELI LILLY AND CO,,76.0,YR,,F,Y,96.145,KG,20220720,,HP,US,US,2022,Q3,Elderly
209063522,20906352,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 to 16 u, tid",,,,,,,,14.0,IU,Injection,TID,2022,Q3,Renal disorder,,2022,Q3,2,F,20220201.0,20220707.0,20220602,20220720,EXP,,US-ELI_LILLY_AND_COMPANY-US202205010555,ELI LILLY AND CO,,76.0,YR,,F,Y,96.145,KG,20220720,,HP,US,US,2022,Q3,Elderly
209063522,20906352,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 to 16 u, tid",,,,,,,,14.0,IU,Injection,TID,2022,Q3,Neck pain,,2022,Q3,2,F,20220201.0,20220707.0,20220602,20220720,EXP,,US-ELI_LILLY_AND_COMPANY-US202205010555,ELI LILLY AND CO,,76.0,YR,,F,Y,96.145,KG,20220720,,HP,US,US,2022,Q3,Elderly
209063522,20906352,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 to 16 u, tid",,,,,,,,14.0,IU,Injection,TID,2022,Q3,Pancreatitis,,2022,Q3,2,F,20220201.0,20220707.0,20220602,20220720,EXP,,US-ELI_LILLY_AND_COMPANY-US202205010555,ELI LILLY AND CO,,76.0,YR,,F,Y,96.145,KG,20220720,,HP,US,US,2022,Q3,Elderly
209063522,20906352,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 to 16 u, tid",,,,,,,,14.0,IU,Injection,TID,2022,Q3,Hepatic enzyme increased,,2022,Q3,2,F,20220201.0,20220707.0,20220602,20220720,EXP,,US-ELI_LILLY_AND_COMPANY-US202205010555,ELI LILLY AND CO,,76.0,YR,,F,Y,96.145,KG,20220720,,HP,US,US,2022,Q3,Elderly
209609373,20960937,21,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,UNK,,,U,,,,,,,Suspension,,2022,Q3,Acute kidney injury,,2022,Q3,3,F,,20220712.0,20220615,20220721,EXP,,PL-AUROBINDO-AUR-APL-2022-019175,AUROBINDO,"Szymanek-Pasternak A, Janocha-Litwin J, Simon K. Severe chronic atopic dermatitis improvement after hepatitis C virus elimination with sofosbuvir/ledipasvir treatment. ADVANCES IN DERMATOLOGY AND ALLERGOLOGY.. 2022;(2):424?425",59.0,YR,,M,Y,,,20220721,,MD,PL,PL,2022,Q3,Adult
209609373,20960937,21,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,UNK,,,U,,,,,,,Suspension,,2022,Q3,Hypertension,,2022,Q3,3,F,,20220712.0,20220615,20220721,EXP,,PL-AUROBINDO-AUR-APL-2022-019175,AUROBINDO,"Szymanek-Pasternak A, Janocha-Litwin J, Simon K. Severe chronic atopic dermatitis improvement after hepatitis C virus elimination with sofosbuvir/ledipasvir treatment. ADVANCES IN DERMATOLOGY AND ALLERGOLOGY.. 2022;(2):424?425",59.0,YR,,M,Y,,,20220721,,MD,PL,PL,2022,Q3,Adult
209609373,20960937,21,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,UNK,,,U,,,,,,,Suspension,,2022,Q3,Hypoglycaemia,,2022,Q3,3,F,,20220712.0,20220615,20220721,EXP,,PL-AUROBINDO-AUR-APL-2022-019175,AUROBINDO,"Szymanek-Pasternak A, Janocha-Litwin J, Simon K. Severe chronic atopic dermatitis improvement after hepatitis C virus elimination with sofosbuvir/ledipasvir treatment. ADVANCES IN DERMATOLOGY AND ALLERGOLOGY.. 2022;(2):424?425",59.0,YR,,M,Y,,,20220721,,MD,PL,PL,2022,Q3,Adult
209609373,20960937,21,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,UNK,,,U,,,,,,,Suspension,,2022,Q3,Drug ineffective,,2022,Q3,3,F,,20220712.0,20220615,20220721,EXP,,PL-AUROBINDO-AUR-APL-2022-019175,AUROBINDO,"Szymanek-Pasternak A, Janocha-Litwin J, Simon K. Severe chronic atopic dermatitis improvement after hepatitis C virus elimination with sofosbuvir/ledipasvir treatment. ADVANCES IN DERMATOLOGY AND ALLERGOLOGY.. 2022;(2):424?425",59.0,YR,,M,Y,,,20220721,,MD,PL,PL,2022,Q3,Adult
209609373,20960937,21,C,INSULIN LISPRO PROTAMINE SUSPENSION,,1,Unknown,UNK,,,U,,,,,,,Suspension,,2022,Q3,Therapeutic response decreased,,2022,Q3,3,F,,20220712.0,20220615,20220721,EXP,,PL-AUROBINDO-AUR-APL-2022-019175,AUROBINDO,"Szymanek-Pasternak A, Janocha-Litwin J, Simon K. Severe chronic atopic dermatitis improvement after hepatitis C virus elimination with sofosbuvir/ledipasvir treatment. ADVANCES IN DERMATOLOGY AND ALLERGOLOGY.. 2022;(2):424?425",59.0,YR,,M,Y,,,20220721,,MD,PL,PL,2022,Q3,Adult
209615875,20961587,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Hyperkalaemia,,2022,Q3,5,F,20201202.0,20220712.0,20220615,20220714,EXP,,NVSC2022US136012,NOVARTIS,,73.0,YR,,F,Y,,,20220714,,MD,US,US,2022,Q3,Elderly
209736412,20973641,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"26 IU, qd(at 08:00 - 10 IU, 13:00 - 8 IU, 18:00 - 8 IU)",,,,,unknown,,,26.0,IU,,QD,2022,Q3,Type III immune complex mediated reaction,,2022,Q3,2,F,20220525.0,20220729.0,20220617,20220808,EXP,RU-RZN-1465521,RU-NOVOPROD-927805,NOVO NORDISK,,41.0,YR,,F,Y,89.0,KG,20220808,,MD,RU,RU,2022,Q3,Adult
209736412,20973641,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"26 IU, qd(at 08:00 - 10 IU, 13:00 - 8 IU, 18:00 - 8 IU)",,,,,unknown,,,26.0,IU,,QD,2022,Q3,Maternal exposure during pregnancy,,2022,Q3,2,F,20220525.0,20220729.0,20220617,20220808,EXP,RU-RZN-1465521,RU-NOVOPROD-927805,NOVO NORDISK,,41.0,YR,,F,Y,89.0,KG,20220808,,MD,RU,RU,2022,Q3,Adult
209971642,20997164,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,Unknown,,2022,Q3,"Hallucination, visual",,2022,Q3,2,F,20190430.0,20220805.0,20220623,20220810,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20190501185,BRISTOL MYERS SQUIBB,,62.0,YR,A,F,Y,122.4,KG,20220810,,MD,US,US,2022,Q3,Adult
209971642,20997164,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,Unknown,,2022,Q3,Aphasia,,2022,Q3,2,F,20190430.0,20220805.0,20220623,20220810,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20190501185,BRISTOL MYERS SQUIBB,,62.0,YR,A,F,Y,122.4,KG,20220810,,MD,US,US,2022,Q3,Adult
209971642,20997164,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,Unknown,,2022,Q3,Confusional state,,2022,Q3,2,F,20190430.0,20220805.0,20220623,20220810,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20190501185,BRISTOL MYERS SQUIBB,,62.0,YR,A,F,Y,122.4,KG,20220810,,MD,US,US,2022,Q3,Adult
209971642,20997164,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,Unknown,,2022,Q3,Hyperglycaemia,,2022,Q3,2,F,20190430.0,20220805.0,20220623,20220810,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20190501185,BRISTOL MYERS SQUIBB,,62.0,YR,A,F,Y,122.4,KG,20220810,,MD,US,US,2022,Q3,Adult
209980802,20998080,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, daily",,,U,,D386746A,,20563.0,40.0,IU,Solution for injection,QD,2022,Q3,Blood glucose increased,,2022,Q3,2,F,20220603.0,20220714.0,20220623,20220718,PER,,US-ELI_LILLY_AND_COMPANY-US202206010671,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20220718,,CN,US,US,2022,Q3,Elderly
209980802,20998080,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, daily",,,U,,D386746A,,20563.0,40.0,IU,Solution for injection,QD,2022,Q3,Blood glucose increased,,2022,Q3,2,F,20220603.0,20220714.0,20220623,20220718,PER,,US-ELI_LILLY_AND_COMPANY-US202206010671,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20220718,,CN,US,US,2022,Q3,Elderly
209980802,20998080,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, daily",,,U,,D386746A,,20563.0,40.0,IU,Solution for injection,QD,2022,Q3,Drug ineffective,,2022,Q3,2,F,20220603.0,20220714.0,20220623,20220718,PER,,US-ELI_LILLY_AND_COMPANY-US202206010671,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20220718,,CN,US,US,2022,Q3,Elderly
209980802,20998080,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, daily",,,U,,,,20563.0,40.0,IU,Solution for injection,QD,2022,Q3,Blood glucose increased,,2022,Q3,2,F,20220603.0,20220714.0,20220623,20220718,PER,,US-ELI_LILLY_AND_COMPANY-US202206010671,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20220718,,CN,US,US,2022,Q3,Elderly
209980802,20998080,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, daily",,,U,,,,20563.0,40.0,IU,Solution for injection,QD,2022,Q3,Blood glucose increased,,2022,Q3,2,F,20220603.0,20220714.0,20220623,20220718,PER,,US-ELI_LILLY_AND_COMPANY-US202206010671,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20220718,,CN,US,US,2022,Q3,Elderly
209980802,20998080,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 u, daily",,,U,,,,20563.0,40.0,IU,Solution for injection,QD,2022,Q3,Drug ineffective,,2022,Q3,2,F,20220603.0,20220714.0,20220623,20220718,PER,,US-ELI_LILLY_AND_COMPANY-US202206010671,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20220718,,CN,US,US,2022,Q3,Elderly
210024842,21002484,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn (sliding scale)",,,U,,,,20563.0,,,Injection,,2022,Q3,Blood glucose fluctuation,,2022,Q3,2,F,20220601.0,20220630.0,20220624,20220705,PER,,US-ELI_LILLY_AND_COMPANY-US202206011776,ELI LILLY AND CO,,32.0,YR,,M,Y,,,20220705,,CN,US,US,2022,Q3,Young Adult
210024842,21002484,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn (sliding scale)",,,U,,,,20563.0,,,Injection,,2022,Q3,Glycosylated haemoglobin decreased,,2022,Q3,2,F,20220601.0,20220630.0,20220624,20220705,PER,,US-ELI_LILLY_AND_COMPANY-US202206011776,ELI LILLY AND CO,,32.0,YR,,M,Y,,,20220705,,CN,US,US,2022,Q3,Young Adult
210024842,21002484,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn (sliding scale)",,,U,,,,20563.0,,,Injection,,2022,Q3,Drug ineffective,,2022,Q3,2,F,20220601.0,20220630.0,20220624,20220705,PER,,US-ELI_LILLY_AND_COMPANY-US202206011776,ELI LILLY AND CO,,32.0,YR,,M,Y,,,20220705,,CN,US,US,2022,Q3,Young Adult
210024842,21002484,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn (sliding scale)",,,U,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,2,F,20220601.0,20220630.0,20220624,20220705,PER,,US-ELI_LILLY_AND_COMPANY-US202206011776,ELI LILLY AND CO,,32.0,YR,,M,Y,,,20220705,,CN,US,US,2022,Q3,Young Adult
210024842,21002484,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn (sliding scale)",,,U,,,,20563.0,,,Injection,,2022,Q3,Blood glucose fluctuation,,2022,Q3,2,F,20220601.0,20220630.0,20220624,20220705,PER,,US-ELI_LILLY_AND_COMPANY-US202206011776,ELI LILLY AND CO,,32.0,YR,,M,Y,,,20220705,,CN,US,US,2022,Q3,Young Adult
210024842,21002484,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn (sliding scale)",,,U,,,,20563.0,,,Injection,,2022,Q3,Glycosylated haemoglobin decreased,,2022,Q3,2,F,20220601.0,20220630.0,20220624,20220705,PER,,US-ELI_LILLY_AND_COMPANY-US202206011776,ELI LILLY AND CO,,32.0,YR,,M,Y,,,20220705,,CN,US,US,2022,Q3,Young Adult
210024842,21002484,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn (sliding scale)",,,U,,,,20563.0,,,Injection,,2022,Q3,Drug ineffective,,2022,Q3,2,F,20220601.0,20220630.0,20220624,20220705,PER,,US-ELI_LILLY_AND_COMPANY-US202206011776,ELI LILLY AND CO,,32.0,YR,,M,Y,,,20220705,,CN,US,US,2022,Q3,Young Adult
210024842,21002484,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn (sliding scale)",,,U,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,2,F,20220601.0,20220630.0,20220624,20220705,PER,,US-ELI_LILLY_AND_COMPANY-US202206011776,ELI LILLY AND CO,,32.0,YR,,M,Y,,,20220705,,CN,US,US,2022,Q3,Young Adult
210024842,21002484,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn (sliding scale)",,,U,,D456541A,,20563.0,,,Injection,,2022,Q3,Blood glucose fluctuation,,2022,Q3,2,F,20220601.0,20220630.0,20220624,20220705,PER,,US-ELI_LILLY_AND_COMPANY-US202206011776,ELI LILLY AND CO,,32.0,YR,,M,Y,,,20220705,,CN,US,US,2022,Q3,Young Adult
210024842,21002484,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn (sliding scale)",,,U,,D456541A,,20563.0,,,Injection,,2022,Q3,Glycosylated haemoglobin decreased,,2022,Q3,2,F,20220601.0,20220630.0,20220624,20220705,PER,,US-ELI_LILLY_AND_COMPANY-US202206011776,ELI LILLY AND CO,,32.0,YR,,M,Y,,,20220705,,CN,US,US,2022,Q3,Young Adult
210024842,21002484,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn (sliding scale)",,,U,,D456541A,,20563.0,,,Injection,,2022,Q3,Drug ineffective,,2022,Q3,2,F,20220601.0,20220630.0,20220624,20220705,PER,,US-ELI_LILLY_AND_COMPANY-US202206011776,ELI LILLY AND CO,,32.0,YR,,M,Y,,,20220705,,CN,US,US,2022,Q3,Young Adult
210024842,21002484,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn (sliding scale)",,,U,,D456541A,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,2,F,20220601.0,20220630.0,20220624,20220705,PER,,US-ELI_LILLY_AND_COMPANY-US202206011776,ELI LILLY AND CO,,32.0,YR,,M,Y,,,20220705,,CN,US,US,2022,Q3,Young Adult
210024842,21002484,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn (sliding scale)",,,U,,D456541A,,20563.0,,,Injection,,2022,Q3,Blood glucose fluctuation,,2022,Q3,2,F,20220601.0,20220630.0,20220624,20220705,PER,,US-ELI_LILLY_AND_COMPANY-US202206011776,ELI LILLY AND CO,,32.0,YR,,M,Y,,,20220705,,CN,US,US,2022,Q3,Young Adult
210024842,21002484,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn (sliding scale)",,,U,,D456541A,,20563.0,,,Injection,,2022,Q3,Glycosylated haemoglobin decreased,,2022,Q3,2,F,20220601.0,20220630.0,20220624,20220705,PER,,US-ELI_LILLY_AND_COMPANY-US202206011776,ELI LILLY AND CO,,32.0,YR,,M,Y,,,20220705,,CN,US,US,2022,Q3,Young Adult
210024842,21002484,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn (sliding scale)",,,U,,D456541A,,20563.0,,,Injection,,2022,Q3,Drug ineffective,,2022,Q3,2,F,20220601.0,20220630.0,20220624,20220705,PER,,US-ELI_LILLY_AND_COMPANY-US202206011776,ELI LILLY AND CO,,32.0,YR,,M,Y,,,20220705,,CN,US,US,2022,Q3,Young Adult
210024842,21002484,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn (sliding scale)",,,U,,D456541A,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,2,F,20220601.0,20220630.0,20220624,20220705,PER,,US-ELI_LILLY_AND_COMPANY-US202206011776,ELI LILLY AND CO,,32.0,YR,,M,Y,,,20220705,,CN,US,US,2022,Q3,Young Adult
210078044,21007804,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (0-20 units as needed),,,,,,,,,,Injection,,2022,Q3,Malignant neoplasm progression,,2022,Q3,4,F,20220614.0,20220711.0,20220627,20220713,EXP,,NVSC2022US146056,NOVARTIS,,14.0,YR,,,Y,,,20220713,,CN,US,US,2022,Q3,Youth
210078044,21007804,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (0-20 units as needed),,,,,,,,,,Injection,,2022,Q3,Blast cell count increased,,2022,Q3,4,F,20220614.0,20220711.0,20220627,20220713,EXP,,NVSC2022US146056,NOVARTIS,,14.0,YR,,,Y,,,20220713,,CN,US,US,2022,Q3,Youth
210078044,21007804,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (0-20 units as needed),,,,,,,,,,Injection,,2022,Q3,Wrong technique in product usage process,,2022,Q3,4,F,20220614.0,20220711.0,20220627,20220713,EXP,,NVSC2022US146056,NOVARTIS,,14.0,YR,,,Y,,,20220713,,CN,US,US,2022,Q3,Youth
210078044,21007804,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (0-20 units as needed),,,,,,,,,,Injection,,2022,Q3,Acute lymphocytic leukaemia,,2022,Q3,4,F,20220614.0,20220711.0,20220627,20220713,EXP,,NVSC2022US146056,NOVARTIS,,14.0,YR,,,Y,,,20220713,,CN,US,US,2022,Q3,Youth
210228352,21022835,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Essential thrombocythaemia,,2022,Q3,2,F,,20220624.0,20220629,20220723,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-2022-060088,BRISTOL MYERS SQUIBB,"Berard M, Babin M, Bourneau-Martin D, Le Clec^h C. Case report: Nicolau livedoid dermatitis following an intramuscular injection of sustained release octreotide. Therapies. 2022; 386-8. 10.1016/j.therap.2021.04.009",79.0,YR,E,F,Y,,,20220723,,HP,FR,FR,2022,Q3,Elderly
210228352,21022835,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Ulcer,,2022,Q3,2,F,,20220624.0,20220629,20220723,EXP,,FR-BRISTOL-MYERS SQUIBB COMPANY-2022-060088,BRISTOL MYERS SQUIBB,"Berard M, Babin M, Bourneau-Martin D, Le Clec^h C. Case report: Nicolau livedoid dermatitis following an intramuscular injection of sustained release octreotide. Therapies. 2022; 386-8. 10.1016/j.therap.2021.04.009",79.0,YR,E,F,Y,,,20220723,,HP,FR,FR,2022,Q3,Elderly
210244052,21024405,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,100/ml,,,,,,,,,,Injection,,2022,Q3,Product dose omission issue,,2022,Q3,2,F,,20220620.0,20220629,20220711,PER,,US-Vifor (International) Inc.-VIT-2022-03963,VIFOR,,36.0,YR,,F,Y,,,20220711,,HP,US,US,2022,Q3,Adult
210244052,21024405,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,100/ml,,,,,,,,,,Injection,,2022,Q3,Nausea,,2022,Q3,2,F,,20220620.0,20220629,20220711,PER,,US-Vifor (International) Inc.-VIT-2022-03963,VIFOR,,36.0,YR,,F,Y,,,20220711,,HP,US,US,2022,Q3,Adult
210244052,21024405,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,100/ml,,,,,,,,,,Injection,,2022,Q3,Vomiting,,2022,Q3,2,F,,20220620.0,20220629,20220711,PER,,US-Vifor (International) Inc.-VIT-2022-03963,VIFOR,,36.0,YR,,F,Y,,,20220711,,HP,US,US,2022,Q3,Adult
210298752,21029875,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5 units before meal,,,U,,,,,,,,,2022,Q3,Maternal exposure during pregnancy,,2022,Q3,2,F,,20220831.0,20220701,20220902,EXP,,NVSC2022US146521,NOVARTIS,"Abuzeid O, Heiligenstein M, Noureddine L, Heiselman C, Bernasko J. Acute glycogenic hepatopathy in pregnancy: A case report and literature review. CASE REPORTS IN PERINATAL MEDICINE. 2022;11(1):1-4",46.0,YR,,F,Y,,,20220902,,HP,US,US,2022,Q3,Adult
210298752,21029875,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5 units before meal,,,U,,,,,,,,,2022,Q3,Premature delivery,,2022,Q3,2,F,,20220831.0,20220701,20220902,EXP,,NVSC2022US146521,NOVARTIS,"Abuzeid O, Heiligenstein M, Noureddine L, Heiselman C, Bernasko J. Acute glycogenic hepatopathy in pregnancy: A case report and literature review. CASE REPORTS IN PERINATAL MEDICINE. 2022;11(1):1-4",46.0,YR,,F,Y,,,20220902,,HP,US,US,2022,Q3,Adult
210298752,21029875,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5 units before meal,,,U,,,,,,,,,2022,Q3,Contraindicated product administered,,2022,Q3,2,F,,20220831.0,20220701,20220902,EXP,,NVSC2022US146521,NOVARTIS,"Abuzeid O, Heiligenstein M, Noureddine L, Heiselman C, Bernasko J. Acute glycogenic hepatopathy in pregnancy: A case report and literature review. CASE REPORTS IN PERINATAL MEDICINE. 2022;11(1):1-4",46.0,YR,,F,Y,,,20220902,,HP,US,US,2022,Q3,Adult
210361702,21036170,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1 unit for 3 g carbohydrates with meals and snacks,,,U,,,,,,,,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,2,F,,20220706.0,20220701,20220712,EXP,,CA-BAUSCH-BL-2022-016780,BAUSCH AND LOMB,"Shamchuk A, Doulla M, Jetha M. Possible association between diabetic ketoacidosis and use of a sodium-glucose co-transporter 2 inhibitor in a 17-year-old man with type 2 diabetes. CMAJ. 2021 SEP 07;193:E1746-49. doi:10.1503/cmaj.202627-f",17.0,YR,,M,Y,,,20220712,,MD,CA,CA,2022,Q3,Youth
210361702,21036170,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1 unit for 3 g carbohydrates with meals and snacks,,,U,,,,,,,,,2022,Q3,Treatment noncompliance,,2022,Q3,2,F,,20220706.0,20220701,20220712,EXP,,CA-BAUSCH-BL-2022-016780,BAUSCH AND LOMB,"Shamchuk A, Doulla M, Jetha M. Possible association between diabetic ketoacidosis and use of a sodium-glucose co-transporter 2 inhibitor in a 17-year-old man with type 2 diabetes. CMAJ. 2021 SEP 07;193:E1746-49. doi:10.1503/cmaj.202627-f",17.0,YR,,M,Y,,,20220712,,MD,CA,CA,2022,Q3,Youth
210374451,21037445,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D420814C,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220622.0,20220623.0,20220703,20220703,PER,,US-ELI_LILLY_AND_COMPANY-US202206013802,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20220703,,CN,US,US,2022,Q3,Adult
210374451,21037445,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D420814C,,20563.0,,,Injection,,2022,Q3,Product dose omission issue,,2022,Q3,1,I,20220622.0,20220623.0,20220703,20220703,PER,,US-ELI_LILLY_AND_COMPANY-US202206013802,ELI LILLY AND CO,,63.0,YR,,F,Y,,,20220703,,CN,US,US,2022,Q3,Adult
210391491,21039149,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Embolia cutis medicamentosa,,2022,Q3,1,I,20200901.0,20220624.0,20220704,20220704,EXP,,FR-Accord-267655,ACCORD,"Berard M, Babin M, Bourneau-Martin D, Le Clec^h C. Case report: Nicolau livedoid dermatitis following an intramuscular injection of sustained release octreotide. Therapies. 2022;77(3):386-8.",79.0,YR,,F,Y,,,20220704,,MD,FR,FR,2022,Q3,Elderly
210391491,21039149,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Motor dysfunction,,2022,Q3,1,I,20200901.0,20220624.0,20220704,20220704,EXP,,FR-Accord-267655,ACCORD,"Berard M, Babin M, Bourneau-Martin D, Le Clec^h C. Case report: Nicolau livedoid dermatitis following an intramuscular injection of sustained release octreotide. Therapies. 2022;77(3):386-8.",79.0,YR,,F,Y,,,20220704,,MD,FR,FR,2022,Q3,Elderly
210391491,21039149,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Lumbar radiculopathy,,2022,Q3,1,I,20200901.0,20220624.0,20220704,20220704,EXP,,FR-Accord-267655,ACCORD,"Berard M, Babin M, Bourneau-Martin D, Le Clec^h C. Case report: Nicolau livedoid dermatitis following an intramuscular injection of sustained release octreotide. Therapies. 2022;77(3):386-8.",79.0,YR,,F,Y,,,20220704,,MD,FR,FR,2022,Q3,Elderly
210391491,21039149,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Rhabdomyolysis,,2022,Q3,1,I,20200901.0,20220624.0,20220704,20220704,EXP,,FR-Accord-267655,ACCORD,"Berard M, Babin M, Bourneau-Martin D, Le Clec^h C. Case report: Nicolau livedoid dermatitis following an intramuscular injection of sustained release octreotide. Therapies. 2022;77(3):386-8.",79.0,YR,,F,Y,,,20220704,,MD,FR,FR,2022,Q3,Elderly
210410344,21041034,5,C,Insulin lispro bs,,2,Subcutaneous,UNK,,,,,,,,,,Injection,,2022,Q3,Erythema multiforme,,2022,Q3,4,F,20210602.0,20220719.0,20220704,20220726,PER,,JP-AMGEN-JPNSP2022113332,AMGEN,"Ishii K, Yoshibayashi H, Torii M, Nakakimura T, Matsutani Y. A case of male recurrent breast cancer successfully treated with hormone therapy in combination with palbociclib as 1st-line treatment. The 30th Annual Meeting of the Japanese Breast Cancer Society. 2022;312",8.0,DEC,E,M,Y,,,20220725,,MD,JP,JP,2022,Q3,Child
210459221,21045922,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Embolia cutis medicamentosa,,2022,Q3,1,I,20200901.0,20220624.0,20220706,20220706,EXP,,FR-AUROBINDO-AUR-APL-2022-024055,AUROBINDO,"Berard M, Babin M, Bourneau-Martin D, Le Clec^h C. Case report: Nicolau livedoid dermatitis following an intramuscular injection of sustained release octreotide. Therapies. 2022;77(3):386-8",79.0,YR,,F,Y,,,20220706,,MD,FR,FR,2022,Q3,Elderly
210459221,21045922,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Lumbar radiculopathy,,2022,Q3,1,I,20200901.0,20220624.0,20220706,20220706,EXP,,FR-AUROBINDO-AUR-APL-2022-024055,AUROBINDO,"Berard M, Babin M, Bourneau-Martin D, Le Clec^h C. Case report: Nicolau livedoid dermatitis following an intramuscular injection of sustained release octreotide. Therapies. 2022;77(3):386-8",79.0,YR,,F,Y,,,20220706,,MD,FR,FR,2022,Q3,Elderly
210459221,21045922,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Rhabdomyolysis,,2022,Q3,1,I,20200901.0,20220624.0,20220706,20220706,EXP,,FR-AUROBINDO-AUR-APL-2022-024055,AUROBINDO,"Berard M, Babin M, Bourneau-Martin D, Le Clec^h C. Case report: Nicolau livedoid dermatitis following an intramuscular injection of sustained release octreotide. Therapies. 2022;77(3):386-8",79.0,YR,,F,Y,,,20220706,,MD,FR,FR,2022,Q3,Elderly
210459221,21045922,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Motor dysfunction,,2022,Q3,1,I,20200901.0,20220624.0,20220706,20220706,EXP,,FR-AUROBINDO-AUR-APL-2022-024055,AUROBINDO,"Berard M, Babin M, Bourneau-Martin D, Le Clec^h C. Case report: Nicolau livedoid dermatitis following an intramuscular injection of sustained release octreotide. Therapies. 2022;77(3):386-8",79.0,YR,,F,Y,,,20220706,,MD,FR,FR,2022,Q3,Elderly
210509451,21050945,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, each morning",,,,,D395986A,,20563.0,4.0,IU,Injection,QD,2022,Q3,Incorrect dose administered,,2022,Q3,1,I,,20220607.0,20220707,20220707,PER,,US-ELI_LILLY_AND_COMPANY-US202206003936,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220707,,CN,US,US,2022,Q3,Elderly
210509451,21050945,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, each morning",,,,,D395986A,,20563.0,4.0,IU,Injection,QD,2022,Q3,Blood glucose increased,,2022,Q3,1,I,,20220607.0,20220707,20220707,PER,,US-ELI_LILLY_AND_COMPANY-US202206003936,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220707,,CN,US,US,2022,Q3,Elderly
210509451,21050945,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, daily (lunch)",,,,,D395986A,,20563.0,5.0,IU,Injection,QD,2022,Q3,Incorrect dose administered,,2022,Q3,1,I,,20220607.0,20220707,20220707,PER,,US-ELI_LILLY_AND_COMPANY-US202206003936,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220707,,CN,US,US,2022,Q3,Elderly
210509451,21050945,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"5 u, daily (lunch)",,,,,D395986A,,20563.0,5.0,IU,Injection,QD,2022,Q3,Blood glucose increased,,2022,Q3,1,I,,20220607.0,20220707,20220707,PER,,US-ELI_LILLY_AND_COMPANY-US202206003936,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220707,,CN,US,US,2022,Q3,Elderly
210509451,21050945,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, each evening",,,,,D395986A,,20563.0,6.0,IU,Injection,QD,2022,Q3,Incorrect dose administered,,2022,Q3,1,I,,20220607.0,20220707,20220707,PER,,US-ELI_LILLY_AND_COMPANY-US202206003936,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220707,,CN,US,US,2022,Q3,Elderly
210509451,21050945,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, each evening",,,,,D395986A,,20563.0,6.0,IU,Injection,QD,2022,Q3,Blood glucose increased,,2022,Q3,1,I,,20220607.0,20220707,20220707,PER,,US-ELI_LILLY_AND_COMPANY-US202206003936,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220707,,CN,US,US,2022,Q3,Elderly
210552562,21055256,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10-10-10 EI,,,U,,,,,,,,,2022,Q3,Pancreatic failure,,2022,Q3,2,F,20220428.0,20220708.0,20220708,20220810,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-033390,BRISTOL MYERS SQUIBB,,32.0,YR,A,M,Y,,,20220810,,HP,DE,DE,2022,Q3,Young Adult
210559621,21055962,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Somnolence,,2022,Q3,1,I,,20220627.0,20220708,20220708,EXP,,BR-NOVOPROD-933393,NOVO NORDISK,,10.0,YR,,F,Y,27.3,KG,20220708,,MD,BR,BR,2022,Q3,Child
210559621,21055962,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Ketoacidosis,,2022,Q3,1,I,,20220627.0,20220708,20220708,EXP,,BR-NOVOPROD-933393,NOVO NORDISK,,10.0,YR,,F,Y,27.3,KG,20220708,,MD,BR,BR,2022,Q3,Child
210559621,21055962,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Saliva altered,,2022,Q3,1,I,,20220627.0,20220708,20220708,EXP,,BR-NOVOPROD-933393,NOVO NORDISK,,10.0,YR,,F,Y,27.3,KG,20220708,,MD,BR,BR,2022,Q3,Child
210559621,21055962,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,,20220627.0,20220708,20220708,EXP,,BR-NOVOPROD-933393,NOVO NORDISK,,10.0,YR,,F,Y,27.3,KG,20220708,,MD,BR,BR,2022,Q3,Child
210559621,21055962,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Eye contusion,,2022,Q3,1,I,,20220627.0,20220708,20220708,EXP,,BR-NOVOPROD-933393,NOVO NORDISK,,10.0,YR,,F,Y,27.3,KG,20220708,,MD,BR,BR,2022,Q3,Child
210567891,21056789,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5 units,,,,,,,,,,,,2022,Q3,Premature delivery,,2022,Q3,1,I,,20220624.0,20220708,20220708,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-343424,RANBAXY,"Abuzeid O, Heiligenstein M, Noureddine L, Heiselman C, Bernasko J. Acute glycogenic hepatopathy in pregnancy: A case report and literature review. Case Rep Perinat Med. 2022;11(1):no pagination; 20210065 (1-4)",46.0,YR,,F,Y,,,20220708,,MD,US,US,2022,Q3,Adult
210567891,21056789,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5 units,,,,,,,,,,,,2022,Q3,Inferior vena cava syndrome,,2022,Q3,1,I,,20220624.0,20220708,20220708,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-343424,RANBAXY,"Abuzeid O, Heiligenstein M, Noureddine L, Heiselman C, Bernasko J. Acute glycogenic hepatopathy in pregnancy: A case report and literature review. Case Rep Perinat Med. 2022;11(1):no pagination; 20210065 (1-4)",46.0,YR,,F,Y,,,20220708,,MD,US,US,2022,Q3,Adult
210567891,21056789,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5 units,,,,,,,,,,,,2022,Q3,Rash,,2022,Q3,1,I,,20220624.0,20220708,20220708,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-343424,RANBAXY,"Abuzeid O, Heiligenstein M, Noureddine L, Heiselman C, Bernasko J. Acute glycogenic hepatopathy in pregnancy: A case report and literature review. Case Rep Perinat Med. 2022;11(1):no pagination; 20210065 (1-4)",46.0,YR,,F,Y,,,20220708,,MD,US,US,2022,Q3,Adult
210567891,21056789,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5 units,,,,,,,,,,,,2022,Q3,Exposure during pregnancy,,2022,Q3,1,I,,20220624.0,20220708,20220708,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-343424,RANBAXY,"Abuzeid O, Heiligenstein M, Noureddine L, Heiselman C, Bernasko J. Acute glycogenic hepatopathy in pregnancy: A case report and literature review. Case Rep Perinat Med. 2022;11(1):no pagination; 20210065 (1-4)",46.0,YR,,F,Y,,,20220708,,MD,US,US,2022,Q3,Adult
210567891,21056789,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5 units,,,,,,,,,,,,2022,Q3,Drug ineffective,,2022,Q3,1,I,,20220624.0,20220708,20220708,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-343424,RANBAXY,"Abuzeid O, Heiligenstein M, Noureddine L, Heiselman C, Bernasko J. Acute glycogenic hepatopathy in pregnancy: A case report and literature review. Case Rep Perinat Med. 2022;11(1):no pagination; 20210065 (1-4)",46.0,YR,,F,Y,,,20220708,,MD,US,US,2022,Q3,Adult
210583411,21058341,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,20220121.0,20220707.0,20220708,20220708,EXP,SE-MPA-2022-016834,NVSC2022SE155282,NOVARTIS,,54.0,YR,,F,Y,,,20220708,,MD,SE,SE,2022,Q3,Adult
210589081,21058908,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,COVID-19,,2022,Q3,1,I,20220706.0,20220707.0,20220708,20220708,PER,,US-PFIZER INC-202200938396,PFIZER,,79.0,YR,,F,Y,,,20220708,,MD,US,US,2022,Q3,Elderly
210589081,21058908,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Disease recurrence,,2022,Q3,1,I,20220706.0,20220707.0,20220708,20220708,PER,,US-PFIZER INC-202200938396,PFIZER,,79.0,YR,,F,Y,,,20220708,,MD,US,US,2022,Q3,Elderly
210642951,21064295,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,20220121.0,20220708.0,20220711,20220711,EXP,SE-MPA-2022-016834,SE-MYLANLABS-2022M1052102,MYLAN,,54.0,YR,,F,Y,,,20220711,,MD,SE,SE,2022,Q3,Adult
210672501,21067250,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Clostridium test positive,,2022,Q3,1,I,,20220630.0,20220712,20220712,EXP,,CA-AUROBINDO-AUR-APL-2022-025052,AUROBINDO,,58.0,YR,,M,Y,91.0,KG,20220712,,PH,CA,CA,2022,Q3,Adult
210674051,21067405,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Off label use,,2022,Q3,1,I,,20220629.0,20220712,20220712,EXP,,CA-AUROBINDO-AUR-APL-2022-024802,AUROBINDO,"Shamchuk A, Doulla M, Jetha M.. Association possible entre l^acidocetose diabetique et l^utilisation d^un inhibiteur du sodium-glucose co-transporteur 2 chez un jeune de 17 ans atteint de diabete de type 2.. CMAJCanadianMedicalAssociationJournal. 2021;193:E1746-E1749",17.0,YR,,M,Y,,,20220712,,HP,CA,CA,2022,Q3,Youth
210674051,21067405,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Diabetic ketoacidosis,,2022,Q3,1,I,,20220629.0,20220712,20220712,EXP,,CA-AUROBINDO-AUR-APL-2022-024802,AUROBINDO,"Shamchuk A, Doulla M, Jetha M.. Association possible entre l^acidocetose diabetique et l^utilisation d^un inhibiteur du sodium-glucose co-transporteur 2 chez un jeune de 17 ans atteint de diabete de type 2.. CMAJCanadianMedicalAssociationJournal. 2021;193:E1746-E1749",17.0,YR,,M,Y,,,20220712,,HP,CA,CA,2022,Q3,Youth
210674051,21067405,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Product prescribing error,,2022,Q3,1,I,,20220629.0,20220712,20220712,EXP,,CA-AUROBINDO-AUR-APL-2022-024802,AUROBINDO,"Shamchuk A, Doulla M, Jetha M.. Association possible entre l^acidocetose diabetique et l^utilisation d^un inhibiteur du sodium-glucose co-transporteur 2 chez un jeune de 17 ans atteint de diabete de type 2.. CMAJCanadianMedicalAssociationJournal. 2021;193:E1746-E1749",17.0,YR,,M,Y,,,20220712,,HP,CA,CA,2022,Q3,Youth
210676161,21067616,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,20220121.0,20220707.0,20220712,20220712,EXP,SE-MPA-2022-016834,SE-BAUSCH-BL-2022-017455,BAUSCH AND LOMB,,54.0,YR,,F,Y,,,20220712,,MD,SE,SE,2022,Q3,Adult
210703891,21070389,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D473104C,,,,,Injection,,2022,Q3,Blood glucose abnormal,,2022,Q3,1,I,20161001.0,20220630.0,20220712,20220712,EXP,,US-ELI_LILLY_AND_COMPANY-US202207000130,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20220712,,CN,US,US,2022,Q3,Adult
210703891,21070389,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D473104C,,,,,Injection,,2022,Q3,Drug ineffective,,2022,Q3,1,I,20161001.0,20220630.0,20220712,20220712,EXP,,US-ELI_LILLY_AND_COMPANY-US202207000130,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20220712,,CN,US,US,2022,Q3,Adult
210703891,21070389,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D473104C,,,,,Injection,,2022,Q3,Retching,,2022,Q3,1,I,20161001.0,20220630.0,20220712,20220712,EXP,,US-ELI_LILLY_AND_COMPANY-US202207000130,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20220712,,CN,US,US,2022,Q3,Adult
210703891,21070389,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D473104C,,,,,Injection,,2022,Q3,Myocardial infarction,,2022,Q3,1,I,20161001.0,20220630.0,20220712,20220712,EXP,,US-ELI_LILLY_AND_COMPANY-US202207000130,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20220712,,CN,US,US,2022,Q3,Adult
210703891,21070389,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D473104C,,,,,Injection,,2022,Q3,Abdominal discomfort,,2022,Q3,1,I,20161001.0,20220630.0,20220712,20220712,EXP,,US-ELI_LILLY_AND_COMPANY-US202207000130,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20220712,,CN,US,US,2022,Q3,Adult
210703891,21070389,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D473104C,,,,,Injection,,2022,Q3,Injection site pain,,2022,Q3,1,I,20161001.0,20220630.0,20220712,20220712,EXP,,US-ELI_LILLY_AND_COMPANY-US202207000130,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20220712,,CN,US,US,2022,Q3,Adult
210703891,21070389,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D473104C,,,,,Injection,,2022,Q3,Needle track marks,,2022,Q3,1,I,20161001.0,20220630.0,20220712,20220712,EXP,,US-ELI_LILLY_AND_COMPANY-US202207000130,ELI LILLY AND CO,,55.0,YR,,M,Y,,,20220712,,CN,US,US,2022,Q3,Adult
210709271,21070927,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Injection site injury,,2022,Q3,1,I,20220615.0,20220615.0,20220712,20220712,PER,,US-ELI_LILLY_AND_COMPANY-US202206008163,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220712,,CN,US,US,2022,Q3,Adult
210709271,21070927,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220615.0,20220615.0,20220712,20220712,PER,,US-ELI_LILLY_AND_COMPANY-US202206008163,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220712,,CN,US,US,2022,Q3,Adult
210709271,21070927,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Injection site erythema,,2022,Q3,1,I,20220615.0,20220615.0,20220712,20220712,PER,,US-ELI_LILLY_AND_COMPANY-US202206008163,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220712,,CN,US,US,2022,Q3,Adult
210709271,21070927,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Incorrect dose administered,,2022,Q3,1,I,20220615.0,20220615.0,20220712,20220712,PER,,US-ELI_LILLY_AND_COMPANY-US202206008163,ELI LILLY AND CO,,55.0,YR,,F,Y,,,20220712,,CN,US,US,2022,Q3,Adult
210725571,21072557,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Acute kidney injury,,2022,Q3,1,I,,20191028.0,20220712,20220712,EXP,,CA-BAUSCH-BL-2022-016523,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
210725571,21072557,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Post streptococcal glomerulonephritis,,2022,Q3,1,I,,20191028.0,20220712,20220712,EXP,,CA-BAUSCH-BL-2022-016523,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
210725571,21072557,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Extradural abscess,,2022,Q3,1,I,,20191028.0,20220712,20220712,EXP,,CA-BAUSCH-BL-2022-016523,BAUSCH AND LOMB,,64.0,YR,,M,Y,,,20220712,,HP,CA,CA,2022,Q3,Adult
210751712,21075171,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q3,Weight increased,,2022,Q3,2,F,,20220719.0,20220713,20220729,EXP,,CA-TEVA-2022-CA-2052914,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220729,,HP,CA,CA,2022,Q3,Elderly
210751712,21075171,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q3,Full blood count abnormal,,2022,Q3,2,F,,20220719.0,20220713,20220729,EXP,,CA-TEVA-2022-CA-2052914,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220729,,HP,CA,CA,2022,Q3,Elderly
210751712,21075171,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q3,Oedema peripheral,,2022,Q3,2,F,,20220719.0,20220713,20220729,EXP,,CA-TEVA-2022-CA-2052914,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220729,,HP,CA,CA,2022,Q3,Elderly
210751712,21075171,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q3,Obstructive airways disorder,,2022,Q3,2,F,,20220719.0,20220713,20220729,EXP,,CA-TEVA-2022-CA-2052914,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220729,,HP,CA,CA,2022,Q3,Elderly
210751712,21075171,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q3,Therapeutic product effect incomplete,,2022,Q3,2,F,,20220719.0,20220713,20220729,EXP,,CA-TEVA-2022-CA-2052914,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220729,,HP,CA,CA,2022,Q3,Elderly
210751712,21075171,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q3,Chest discomfort,,2022,Q3,2,F,,20220719.0,20220713,20220729,EXP,,CA-TEVA-2022-CA-2052914,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220729,,HP,CA,CA,2022,Q3,Elderly
210751712,21075171,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q3,Pyrexia,,2022,Q3,2,F,,20220719.0,20220713,20220729,EXP,,CA-TEVA-2022-CA-2052914,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220729,,HP,CA,CA,2022,Q3,Elderly
210751712,21075171,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q3,Wheezing,,2022,Q3,2,F,,20220719.0,20220713,20220729,EXP,,CA-TEVA-2022-CA-2052914,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220729,,HP,CA,CA,2022,Q3,Elderly
210751712,21075171,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q3,Hypoxia,,2022,Q3,2,F,,20220719.0,20220713,20220729,EXP,,CA-TEVA-2022-CA-2052914,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220729,,HP,CA,CA,2022,Q3,Elderly
210751712,21075171,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q3,Discomfort,,2022,Q3,2,F,,20220719.0,20220713,20220729,EXP,,CA-TEVA-2022-CA-2052914,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220729,,HP,CA,CA,2022,Q3,Elderly
210751712,21075171,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q3,Left ventricular hypertrophy,,2022,Q3,2,F,,20220719.0,20220713,20220729,EXP,,CA-TEVA-2022-CA-2052914,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220729,,HP,CA,CA,2022,Q3,Elderly
210751712,21075171,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q3,Oropharyngeal pain,,2022,Q3,2,F,,20220719.0,20220713,20220729,EXP,,CA-TEVA-2022-CA-2052914,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220729,,HP,CA,CA,2022,Q3,Elderly
210751712,21075171,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q3,Diaphragmatic disorder,,2022,Q3,2,F,,20220719.0,20220713,20220729,EXP,,CA-TEVA-2022-CA-2052914,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220729,,HP,CA,CA,2022,Q3,Elderly
210751712,21075171,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q3,Dyspnoea,,2022,Q3,2,F,,20220719.0,20220713,20220729,EXP,,CA-TEVA-2022-CA-2052914,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220729,,HP,CA,CA,2022,Q3,Elderly
210751712,21075171,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q3,Cough,,2022,Q3,2,F,,20220719.0,20220713,20220729,EXP,,CA-TEVA-2022-CA-2052914,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220729,,HP,CA,CA,2022,Q3,Elderly
210751712,21075171,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q3,Asthma,,2022,Q3,2,F,,20220719.0,20220713,20220729,EXP,,CA-TEVA-2022-CA-2052914,TEVA,,83.0,YR,E,M,Y,100.0,KG,20220729,,HP,CA,CA,2022,Q3,Elderly
210755852,21075585,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Drug-induced liver injury,,2022,Q3,2,F,,20220704.0,20220713,20220715,EXP,,IT-MYLANLABS-2022M1077504,MYLAN,"Raschi E, Fusaroli M, Gatti M, Caraceni P, Poluzzi E, De Ponti F. Liver Injury with Nintedanib: A Pharmacovigilance- Pharmacokinetic Appraisal. Pharmaceuticals 2022;15(5):645.",64.0,YR,,M,Y,,,20220715,,HP,IT,IT,2022,Q3,Adult
210775791,21077579,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Pain in extremity,,2022,Q3,1,I,20211031.0,,20220713,20220713,DIR,FDA-CDER-CTU-2022-55131,,FDA-CTU,,75.0,YR,,F,N,170.0,LBS,20220713,,CN,US,,2022,Q3,Elderly
210775791,21077579,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Dysstasia,,2022,Q3,1,I,20211031.0,,20220713,20220713,DIR,FDA-CDER-CTU-2022-55131,,FDA-CTU,,75.0,YR,,F,N,170.0,LBS,20220713,,CN,US,,2022,Q3,Elderly
210775791,21077579,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Muscular weakness,,2022,Q3,1,I,20211031.0,,20220713,20220713,DIR,FDA-CDER-CTU-2022-55131,,FDA-CTU,,75.0,YR,,F,N,170.0,LBS,20220713,,CN,US,,2022,Q3,Elderly
210775791,21077579,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Vaginal infection,,2022,Q3,1,I,20211031.0,,20220713,20220713,DIR,FDA-CDER-CTU-2022-55131,,FDA-CTU,,75.0,YR,,F,N,170.0,LBS,20220713,,CN,US,,2022,Q3,Elderly
210775791,21077579,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Fatigue,,2022,Q3,1,I,20211031.0,,20220713,20220713,DIR,FDA-CDER-CTU-2022-55131,,FDA-CTU,,75.0,YR,,F,N,170.0,LBS,20220713,,CN,US,,2022,Q3,Elderly
210775791,21077579,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Myalgia,,2022,Q3,1,I,20211031.0,,20220713,20220713,DIR,FDA-CDER-CTU-2022-55131,,FDA-CTU,,75.0,YR,,F,N,170.0,LBS,20220713,,CN,US,,2022,Q3,Elderly
210775791,21077579,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Hypoaesthesia,,2022,Q3,1,I,20211031.0,,20220713,20220713,DIR,FDA-CDER-CTU-2022-55131,,FDA-CTU,,75.0,YR,,F,N,170.0,LBS,20220713,,CN,US,,2022,Q3,Elderly
210775791,21077579,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Muscle spasms,,2022,Q3,1,I,20211031.0,,20220713,20220713,DIR,FDA-CDER-CTU-2022-55131,,FDA-CTU,,75.0,YR,,F,N,170.0,LBS,20220713,,CN,US,,2022,Q3,Elderly
210775791,21077579,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Blood potassium decreased,,2022,Q3,1,I,20211031.0,,20220713,20220713,DIR,FDA-CDER-CTU-2022-55131,,FDA-CTU,,75.0,YR,,F,N,170.0,LBS,20220713,,CN,US,,2022,Q3,Elderly
210775791,21077579,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Gait disturbance,,2022,Q3,1,I,20211031.0,,20220713,20220713,DIR,FDA-CDER-CTU-2022-55131,,FDA-CTU,,75.0,YR,,F,N,170.0,LBS,20220713,,CN,US,,2022,Q3,Elderly
210775791,21077579,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Muscle atrophy,,2022,Q3,1,I,20211031.0,,20220713,20220713,DIR,FDA-CDER-CTU-2022-55131,,FDA-CTU,,75.0,YR,,F,N,170.0,LBS,20220713,,CN,US,,2022,Q3,Elderly
210775791,21077579,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Paraesthesia,,2022,Q3,1,I,20211031.0,,20220713,20220713,DIR,FDA-CDER-CTU-2022-55131,,FDA-CTU,,75.0,YR,,F,N,170.0,LBS,20220713,,CN,US,,2022,Q3,Elderly
210775791,21077579,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Bacterial infection,,2022,Q3,1,I,20211031.0,,20220713,20220713,DIR,FDA-CDER-CTU-2022-55131,,FDA-CTU,,75.0,YR,,F,N,170.0,LBS,20220713,,CN,US,,2022,Q3,Elderly
210775791,21077579,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Weight increased,,2022,Q3,1,I,20211031.0,,20220713,20220713,DIR,FDA-CDER-CTU-2022-55131,,FDA-CTU,,75.0,YR,,F,N,170.0,LBS,20220713,,CN,US,,2022,Q3,Elderly
210777481,21077748,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Thrombosis,,2022,Q3,1,I,20210626.0,20210714.0,20220713,20220713,PER,,"US-VANDA PHARMACEUTICALS, INC-2021TASUS005117",VANDA PHARMACEUTICALS,,38.0,YR,,F,Y,93.878,KG,20220713,,CN,US,US,2022,Q3,Adult
210793631,21079363,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Product prescribing error,,2022,Q3,1,I,,20220704.0,20220714,20220714,EXP,,CA-TEVA-2022-CA-2053196,TEVA,,17.0,YR,T,M,Y,,,20220714,,HP,CA,CA,2022,Q3,Youth
210793631,21079363,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Diabetic ketoacidosis,,2022,Q3,1,I,,20220704.0,20220714,20220714,EXP,,CA-TEVA-2022-CA-2053196,TEVA,,17.0,YR,T,M,Y,,,20220714,,HP,CA,CA,2022,Q3,Youth
210793631,21079363,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Off label use,,2022,Q3,1,I,,20220704.0,20220714,20220714,EXP,,CA-TEVA-2022-CA-2053196,TEVA,,17.0,YR,T,M,Y,,,20220714,,HP,CA,CA,2022,Q3,Youth
210813663,21081366,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 UNK,,,,,,,,,,,,2022,Q3,Acute kidney injury,,2022,Q3,3,F,20220701.0,20220804.0,20220714,20220809,PER,,US-AMGEN-USACT2022118312,AMGEN,,79.0,YR,E,M,Y,93.73,KG,20220808,,MD,US,US,2022,Q3,Elderly
210821751,21082175,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Vaginal haemorrhage,,2022,Q3,1,I,20220601.0,20220711.0,20220714,20220714,EXP,,US-TAKEDA-2022TUS046710,TAKEDA,,37.0,YR,,F,Y,93.4,KG,20220714,,CN,US,US,2022,Q3,Adult
210821751,21082175,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Fatigue,,2022,Q3,1,I,20220601.0,20220711.0,20220714,20220714,EXP,,US-TAKEDA-2022TUS046710,TAKEDA,,37.0,YR,,F,Y,93.4,KG,20220714,,CN,US,US,2022,Q3,Adult
210862562,21086256,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,sliding scale correctional dose every 4 hours,,,,,Unknown,,,,,,,2022,Q3,Meningitis aseptic,,2022,Q3,2,F,,20220711.0,20220715,20220726,EXP,,US-ALKEM LABORATORIES LIMITED-US-ALKEM-2022-07341,ALKEM,"Vickery SB, Roach JK, Parsons C, Vickery PB. Possible levetiracetam-induced aseptic meningitis versus viral meningitis: Case report and literature review. The Nurse Practitioner. 2022;47(7):32-37",54.0,YR,,M,Y,,,20220726,,HP,US,US,2022,Q3,Adult
210868325,21086832,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Muscular weakness,,2022,Q3,5,F,20220711.0,20220822.0,20220715,20220824,EXP,,"US-SECURA BIO, INC.-2022-SECUR-US000051",SECURA BIO,,63.0,YR,,M,Y,106.6,KG,20220824,,MD,US,US,2022,Q3,Adult
210884961,21088496,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D386746A,,20563.0,,,Solution for injection,,2022,Q3,Visual impairment,,2022,Q3,1,I,20220101.0,20220705.0,20220715,20220715,EXP,,US-ELI_LILLY_AND_COMPANY-US202207001865,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20220715,,CN,US,US,2022,Q3,Elderly
210884961,21088496,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D386746A,,20563.0,,,Solution for injection,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,1,I,20220101.0,20220705.0,20220715,20220715,EXP,,US-ELI_LILLY_AND_COMPANY-US202207001865,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20220715,,CN,US,US,2022,Q3,Elderly
210884961,21088496,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D386746A,,20563.0,,,Solution for injection,,2022,Q3,Pneumonia,,2022,Q3,1,I,20220101.0,20220705.0,20220715,20220715,EXP,,US-ELI_LILLY_AND_COMPANY-US202207001865,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20220715,,CN,US,US,2022,Q3,Elderly
210884961,21088496,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D386746A,,20563.0,,,Solution for injection,,2022,Q3,Incorrect dose administered,,2022,Q3,1,I,20220101.0,20220705.0,20220715,20220715,EXP,,US-ELI_LILLY_AND_COMPANY-US202207001865,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20220715,,CN,US,US,2022,Q3,Elderly
210884961,21088496,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D386746A,,20563.0,,,Solution for injection,,2022,Q3,Cardiac failure,,2022,Q3,1,I,20220101.0,20220705.0,20220715,20220715,EXP,,US-ELI_LILLY_AND_COMPANY-US202207001865,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20220715,,CN,US,US,2022,Q3,Elderly
210884961,21088496,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D386746A,,20563.0,,,Solution for injection,,2022,Q3,Renal impairment,,2022,Q3,1,I,20220101.0,20220705.0,20220715,20220715,EXP,,US-ELI_LILLY_AND_COMPANY-US202207001865,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20220715,,CN,US,US,2022,Q3,Elderly
210884961,21088496,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D386746A,,20563.0,,,Solution for injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220101.0,20220705.0,20220715,20220715,EXP,,US-ELI_LILLY_AND_COMPANY-US202207001865,ELI LILLY AND CO,,69.0,YR,,M,Y,,,20220715,,CN,US,US,2022,Q3,Elderly
210935901,21093590,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Drug ineffective,,2022,Q3,1,I,,20220705.0,20220718,20220718,EXP,,US-MYLANLABS-2022M1077457,MYLAN,"Woloshuk A, Lee M, Assmus M, Agarwal D, Krambeck A, Large T. A case of ureteral fungal mass removal in a patient taking empagliflozin. CEN-Case-Rep 2021;10(4):603-607.",67.0,YR,,F,Y,,,20220718,,HP,US,US,2022,Q3,Elderly
210958201,21095820,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,25,,,U,,,,,,,,,2022,Q3,Confusional state,,2022,Q3,1,I,20220707.0,20220713.0,20220718,20220718,EXP,,NVSC2022GB159486,NOVARTIS,,63.0,YR,,M,Y,,,20220718,,PH,GB,GB,2022,Q3,Adult
210958201,21095820,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,25,,,U,,,,,,,,,2022,Q3,Blood triglycerides increased,,2022,Q3,1,I,20220707.0,20220713.0,20220718,20220718,EXP,,NVSC2022GB159486,NOVARTIS,,63.0,YR,,M,Y,,,20220718,,PH,GB,GB,2022,Q3,Adult
210958201,21095820,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,25,,,U,,,,,,,,,2022,Q3,Mobility decreased,,2022,Q3,1,I,20220707.0,20220713.0,20220718,20220718,EXP,,NVSC2022GB159486,NOVARTIS,,63.0,YR,,M,Y,,,20220718,,PH,GB,GB,2022,Q3,Adult
211016041,21101604,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Drug-induced liver injury,Drug-induced liver injury,2022,Q3,1,I,,20220711.0,20220719,20220719,EXP,,IT-TEVA-2022-IT-2055691,TEVA,,64.0,YR,A,M,Y,,,20220719,,HP,IT,IT,2022,Q3,Adult
211041301,21104130,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,dinner 6- 8 units,,,U,,,,,8.0,IU,,,2022,Q3,Overdose,,2022,Q3,1,I,20190901.0,20220713.0,20220720,20220720,EXP,,PL-Accord-269804,ACCORD,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda-Pawelska J, Romaszko-Wojtowicz A, et al. Hepatorenal Syndrome and Other Post-Liver Transplantation Complications: Case Studies and Literature Review. Transplantation Proceedings. 2022:1-8.",55.0,YR,A,F,Y,,,20220720,,HP,PL,PL,2022,Q3,Adult
211041301,21104130,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,dinner 6- 8 units,,,U,,,,,8.0,IU,,,2022,Q3,Toxicity to various agents,,2022,Q3,1,I,20190901.0,20220713.0,20220720,20220720,EXP,,PL-Accord-269804,ACCORD,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda-Pawelska J, Romaszko-Wojtowicz A, et al. Hepatorenal Syndrome and Other Post-Liver Transplantation Complications: Case Studies and Literature Review. Transplantation Proceedings. 2022:1-8.",55.0,YR,A,F,Y,,,20220720,,HP,PL,PL,2022,Q3,Adult
211041301,21104130,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,dinner 6- 8 units,,,U,,,,,8.0,IU,,,2022,Q3,Chronic kidney disease,,2022,Q3,1,I,20190901.0,20220713.0,20220720,20220720,EXP,,PL-Accord-269804,ACCORD,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda-Pawelska J, Romaszko-Wojtowicz A, et al. Hepatorenal Syndrome and Other Post-Liver Transplantation Complications: Case Studies and Literature Review. Transplantation Proceedings. 2022:1-8.",55.0,YR,A,F,Y,,,20220720,,HP,PL,PL,2022,Q3,Adult
211076311,21107631,1,PS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"3 u, daily (2 or 3 units with each meal)",,,U,,D361914F,,20563.0,3.0,IU,Injection,QD,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220601.0,20220620.0,20220720,20220720,PER,,US-ELI_LILLY_AND_COMPANY-US202206009955,ELI LILLY AND CO,,16.0,YR,,M,Y,,,20220720,,CN,US,US,2022,Q3,Youth
211077382,21107738,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Diarrhoea,,2022,Q3,2,F,20220703.0,20220815.0,20220720,20220816,PER,,US-GILEAD-2022-0589792,GILEAD,,64.0,YR,A,M,Y,,,20220816,,HP,US,US,2022,Q3,Adult
211077382,21107738,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Lethargy,,2022,Q3,2,F,20220703.0,20220815.0,20220720,20220816,PER,,US-GILEAD-2022-0589792,GILEAD,,64.0,YR,A,M,Y,,,20220816,,HP,US,US,2022,Q3,Adult
211077382,21107738,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Pyrexia,,2022,Q3,2,F,20220703.0,20220815.0,20220720,20220816,PER,,US-GILEAD-2022-0589792,GILEAD,,64.0,YR,A,M,Y,,,20220816,,HP,US,US,2022,Q3,Adult
211077382,21107738,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Cytokine release syndrome,,2022,Q3,2,F,20220703.0,20220815.0,20220720,20220816,PER,,US-GILEAD-2022-0589792,GILEAD,,64.0,YR,A,M,Y,,,20220816,,HP,US,US,2022,Q3,Adult
211082521,21108252,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,20 iU,,,,,,,,20.0,IU,Solution for injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,,20220712.0,20220720,20220720,PER,,US-SA-2022SA279068,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20220721,,CN,US,US,2022,Q3,Elderly
211082521,21108252,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,20 iU,,,,,,,,20.0,IU,Solution for injection,,2022,Q3,Visual impairment,,2022,Q3,1,I,,20220712.0,20220720,20220720,PER,,US-SA-2022SA279068,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20220721,,CN,US,US,2022,Q3,Elderly
211082521,21108252,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,10 iU,,,,,,,,10.0,IU,Solution for injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,,20220712.0,20220720,20220720,PER,,US-SA-2022SA279068,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20220721,,CN,US,US,2022,Q3,Elderly
211082521,21108252,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,10 iU,,,,,,,,10.0,IU,Solution for injection,,2022,Q3,Visual impairment,,2022,Q3,1,I,,20220712.0,20220720,20220720,PER,,US-SA-2022SA279068,SANOFI AVENTIS,,70.0,YR,E,F,Y,,,20220721,,CN,US,US,2022,Q3,Elderly
211086681,21108668,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,UNKNOWN,,,,,,,2022,Q3,Metabolic acidosis,,2022,Q3,1,I,20220121.0,20220713.0,20220721,20220721,EXP,SE-MPA-2022-016834,SE-TEVA-2022-SE-2056523,TEVA,,54.0,YR,A,F,Y,,,20220721,,MD,SE,SE,2022,Q3,Adult
211087831,21108783,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,30 to 35 units daily,,,U,,,,,,,,,2022,Q3,Prostatic disorder,,2022,Q3,1,I,,20220713.0,20220721,20220721,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-073823,BRISTOL MYERS SQUIBB,,79.0,YR,E,M,Y,94.0,KG,20220721,,CN,US,US,2022,Q3,Elderly
211087831,21108783,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,30 to 35 units daily,,,U,,,,,,,,,2022,Q3,Prescribed underdose,,2022,Q3,1,I,,20220713.0,20220721,20220721,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-073823,BRISTOL MYERS SQUIBB,,79.0,YR,E,M,Y,94.0,KG,20220721,,CN,US,US,2022,Q3,Elderly
211110531,21111053,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Epistaxis,,2022,Q3,1,I,20220716.0,,20220720,20220720,DIR,623867,,FDA-CTU,,14.0,YR,,F,N,38.5,KG,20220720,N,CN,US,,2022,Q3,Youth
211110531,21111053,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Mucosal inflammation,,2022,Q3,1,I,20220716.0,,20220720,20220720,DIR,623867,,FDA-CTU,,14.0,YR,,F,N,38.5,KG,20220720,N,CN,US,,2022,Q3,Youth
211110531,21111053,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Idiopathic pneumonia syndrome,,2022,Q3,1,I,20220716.0,,20220720,20220720,DIR,623867,,FDA-CTU,,14.0,YR,,F,N,38.5,KG,20220720,N,CN,US,,2022,Q3,Youth
211110531,21111053,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Pleural effusion,,2022,Q3,1,I,20220716.0,,20220720,20220720,DIR,623867,,FDA-CTU,,14.0,YR,,F,N,38.5,KG,20220720,N,CN,US,,2022,Q3,Youth
211110531,21111053,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Hypoxia,,2022,Q3,1,I,20220716.0,,20220720,20220720,DIR,623867,,FDA-CTU,,14.0,YR,,F,N,38.5,KG,20220720,N,CN,US,,2022,Q3,Youth
211110531,21111053,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Hypervolaemia,,2022,Q3,1,I,20220716.0,,20220720,20220720,DIR,623867,,FDA-CTU,,14.0,YR,,F,N,38.5,KG,20220720,N,CN,US,,2022,Q3,Youth
211110531,21111053,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Respiratory failure,,2022,Q3,1,I,20220716.0,,20220720,20220720,DIR,623867,,FDA-CTU,,14.0,YR,,F,N,38.5,KG,20220720,N,CN,US,,2022,Q3,Youth
211128082,21112808,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"8 international unit, qd (dinner 6- 8 units)",,,U,,unknown,,,8.0,IU,,QD,2022,Q3,Toxicity to various agents,,2022,Q3,2,F,20190901.0,20220917.0,20220721,20220927,EXP,,PL-VELOXIS PHARMACEUTICALS-2022VELPL-000459,VELOXIS PHARMACEUTICALS,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda-Pawelska J, Romaszko-Wojtowicz A et al.. Hepatorenal Syndrome and Other Post?Liver Transplantation Complications: Case Studies and Literature Review.. Transplantation Proceedings.. 2022;000:1-8",55.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Adult
211128082,21112808,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"8 international unit, qd (dinner 6- 8 units)",,,U,,unknown,,,8.0,IU,,QD,2022,Q3,Overdose,,2022,Q3,2,F,20190901.0,20220917.0,20220721,20220927,EXP,,PL-VELOXIS PHARMACEUTICALS-2022VELPL-000459,VELOXIS PHARMACEUTICALS,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda-Pawelska J, Romaszko-Wojtowicz A et al.. Hepatorenal Syndrome and Other Post?Liver Transplantation Complications: Case Studies and Literature Review.. Transplantation Proceedings.. 2022;000:1-8",55.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Adult
211128082,21112808,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"8 international unit, qd (dinner 6- 8 units)",,,U,,unknown,,,8.0,IU,,QD,2022,Q3,Oesophageal candidiasis,,2022,Q3,2,F,20190901.0,20220917.0,20220721,20220927,EXP,,PL-VELOXIS PHARMACEUTICALS-2022VELPL-000459,VELOXIS PHARMACEUTICALS,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda-Pawelska J, Romaszko-Wojtowicz A et al.. Hepatorenal Syndrome and Other Post?Liver Transplantation Complications: Case Studies and Literature Review.. Transplantation Proceedings.. 2022;000:1-8",55.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Adult
211128082,21112808,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"8 international unit, qd (dinner 6- 8 units)",,,U,,unknown,,,8.0,IU,,QD,2022,Q3,Chronic kidney disease,,2022,Q3,2,F,20190901.0,20220917.0,20220721,20220927,EXP,,PL-VELOXIS PHARMACEUTICALS-2022VELPL-000459,VELOXIS PHARMACEUTICALS,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda-Pawelska J, Romaszko-Wojtowicz A et al.. Hepatorenal Syndrome and Other Post?Liver Transplantation Complications: Case Studies and Literature Review.. Transplantation Proceedings.. 2022;000:1-8",55.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Adult
211128082,21112808,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"8 international unit, qd (dinner 6- 8 units)",,,U,,unknown,,,8.0,IU,,QD,2022,Q3,Product use in unapproved indication,,2022,Q3,2,F,20190901.0,20220917.0,20220721,20220927,EXP,,PL-VELOXIS PHARMACEUTICALS-2022VELPL-000459,VELOXIS PHARMACEUTICALS,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda-Pawelska J, Romaszko-Wojtowicz A et al.. Hepatorenal Syndrome and Other Post?Liver Transplantation Complications: Case Studies and Literature Review.. Transplantation Proceedings.. 2022;000:1-8",55.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Adult
211128082,21112808,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,"20 international unit, qd (8-10 units at breakfast and supper)",,,U,,unknown,,,20.0,IU,,QD,2022,Q3,Toxicity to various agents,,2022,Q3,2,F,20190901.0,20220917.0,20220721,20220927,EXP,,PL-VELOXIS PHARMACEUTICALS-2022VELPL-000459,VELOXIS PHARMACEUTICALS,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda-Pawelska J, Romaszko-Wojtowicz A et al.. Hepatorenal Syndrome and Other Post?Liver Transplantation Complications: Case Studies and Literature Review.. Transplantation Proceedings.. 2022;000:1-8",55.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Adult
211128082,21112808,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,"20 international unit, qd (8-10 units at breakfast and supper)",,,U,,unknown,,,20.0,IU,,QD,2022,Q3,Overdose,,2022,Q3,2,F,20190901.0,20220917.0,20220721,20220927,EXP,,PL-VELOXIS PHARMACEUTICALS-2022VELPL-000459,VELOXIS PHARMACEUTICALS,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda-Pawelska J, Romaszko-Wojtowicz A et al.. Hepatorenal Syndrome and Other Post?Liver Transplantation Complications: Case Studies and Literature Review.. Transplantation Proceedings.. 2022;000:1-8",55.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Adult
211128082,21112808,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,"20 international unit, qd (8-10 units at breakfast and supper)",,,U,,unknown,,,20.0,IU,,QD,2022,Q3,Oesophageal candidiasis,,2022,Q3,2,F,20190901.0,20220917.0,20220721,20220927,EXP,,PL-VELOXIS PHARMACEUTICALS-2022VELPL-000459,VELOXIS PHARMACEUTICALS,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda-Pawelska J, Romaszko-Wojtowicz A et al.. Hepatorenal Syndrome and Other Post?Liver Transplantation Complications: Case Studies and Literature Review.. Transplantation Proceedings.. 2022;000:1-8",55.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Adult
211128082,21112808,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,"20 international unit, qd (8-10 units at breakfast and supper)",,,U,,unknown,,,20.0,IU,,QD,2022,Q3,Chronic kidney disease,,2022,Q3,2,F,20190901.0,20220917.0,20220721,20220927,EXP,,PL-VELOXIS PHARMACEUTICALS-2022VELPL-000459,VELOXIS PHARMACEUTICALS,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda-Pawelska J, Romaszko-Wojtowicz A et al.. Hepatorenal Syndrome and Other Post?Liver Transplantation Complications: Case Studies and Literature Review.. Transplantation Proceedings.. 2022;000:1-8",55.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Adult
211128082,21112808,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,"20 international unit, qd (8-10 units at breakfast and supper)",,,U,,unknown,,,20.0,IU,,QD,2022,Q3,Product use in unapproved indication,,2022,Q3,2,F,20190901.0,20220917.0,20220721,20220927,EXP,,PL-VELOXIS PHARMACEUTICALS-2022VELPL-000459,VELOXIS PHARMACEUTICALS,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda-Pawelska J, Romaszko-Wojtowicz A et al.. Hepatorenal Syndrome and Other Post?Liver Transplantation Complications: Case Studies and Literature Review.. Transplantation Proceedings.. 2022;000:1-8",55.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Adult
211128082,21112808,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,"16 international unit, qd (8-10 units at breakfast and supper)",,,U,,unknown,,,16.0,IU,,QD,2022,Q3,Toxicity to various agents,,2022,Q3,2,F,20190901.0,20220917.0,20220721,20220927,EXP,,PL-VELOXIS PHARMACEUTICALS-2022VELPL-000459,VELOXIS PHARMACEUTICALS,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda-Pawelska J, Romaszko-Wojtowicz A et al.. Hepatorenal Syndrome and Other Post?Liver Transplantation Complications: Case Studies and Literature Review.. Transplantation Proceedings.. 2022;000:1-8",55.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Adult
211128082,21112808,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,"16 international unit, qd (8-10 units at breakfast and supper)",,,U,,unknown,,,16.0,IU,,QD,2022,Q3,Overdose,,2022,Q3,2,F,20190901.0,20220917.0,20220721,20220927,EXP,,PL-VELOXIS PHARMACEUTICALS-2022VELPL-000459,VELOXIS PHARMACEUTICALS,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda-Pawelska J, Romaszko-Wojtowicz A et al.. Hepatorenal Syndrome and Other Post?Liver Transplantation Complications: Case Studies and Literature Review.. Transplantation Proceedings.. 2022;000:1-8",55.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Adult
211128082,21112808,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,"16 international unit, qd (8-10 units at breakfast and supper)",,,U,,unknown,,,16.0,IU,,QD,2022,Q3,Oesophageal candidiasis,,2022,Q3,2,F,20190901.0,20220917.0,20220721,20220927,EXP,,PL-VELOXIS PHARMACEUTICALS-2022VELPL-000459,VELOXIS PHARMACEUTICALS,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda-Pawelska J, Romaszko-Wojtowicz A et al.. Hepatorenal Syndrome and Other Post?Liver Transplantation Complications: Case Studies and Literature Review.. Transplantation Proceedings.. 2022;000:1-8",55.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Adult
211128082,21112808,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,"16 international unit, qd (8-10 units at breakfast and supper)",,,U,,unknown,,,16.0,IU,,QD,2022,Q3,Chronic kidney disease,,2022,Q3,2,F,20190901.0,20220917.0,20220721,20220927,EXP,,PL-VELOXIS PHARMACEUTICALS-2022VELPL-000459,VELOXIS PHARMACEUTICALS,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda-Pawelska J, Romaszko-Wojtowicz A et al.. Hepatorenal Syndrome and Other Post?Liver Transplantation Complications: Case Studies and Literature Review.. Transplantation Proceedings.. 2022;000:1-8",55.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Adult
211128082,21112808,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,"16 international unit, qd (8-10 units at breakfast and supper)",,,U,,unknown,,,16.0,IU,,QD,2022,Q3,Product use in unapproved indication,,2022,Q3,2,F,20190901.0,20220917.0,20220721,20220927,EXP,,PL-VELOXIS PHARMACEUTICALS-2022VELPL-000459,VELOXIS PHARMACEUTICALS,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda-Pawelska J, Romaszko-Wojtowicz A et al.. Hepatorenal Syndrome and Other Post?Liver Transplantation Complications: Case Studies and Literature Review.. Transplantation Proceedings.. 2022;000:1-8",55.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Adult
211128082,21112808,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,"6 international unit, qd (dinner 6- 8 units)",,,U,,unknown,,,6.0,IU,,QD,2022,Q3,Toxicity to various agents,,2022,Q3,2,F,20190901.0,20220917.0,20220721,20220927,EXP,,PL-VELOXIS PHARMACEUTICALS-2022VELPL-000459,VELOXIS PHARMACEUTICALS,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda-Pawelska J, Romaszko-Wojtowicz A et al.. Hepatorenal Syndrome and Other Post?Liver Transplantation Complications: Case Studies and Literature Review.. Transplantation Proceedings.. 2022;000:1-8",55.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Adult
211128082,21112808,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,"6 international unit, qd (dinner 6- 8 units)",,,U,,unknown,,,6.0,IU,,QD,2022,Q3,Overdose,,2022,Q3,2,F,20190901.0,20220917.0,20220721,20220927,EXP,,PL-VELOXIS PHARMACEUTICALS-2022VELPL-000459,VELOXIS PHARMACEUTICALS,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda-Pawelska J, Romaszko-Wojtowicz A et al.. Hepatorenal Syndrome and Other Post?Liver Transplantation Complications: Case Studies and Literature Review.. Transplantation Proceedings.. 2022;000:1-8",55.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Adult
211128082,21112808,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,"6 international unit, qd (dinner 6- 8 units)",,,U,,unknown,,,6.0,IU,,QD,2022,Q3,Oesophageal candidiasis,,2022,Q3,2,F,20190901.0,20220917.0,20220721,20220927,EXP,,PL-VELOXIS PHARMACEUTICALS-2022VELPL-000459,VELOXIS PHARMACEUTICALS,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda-Pawelska J, Romaszko-Wojtowicz A et al.. Hepatorenal Syndrome and Other Post?Liver Transplantation Complications: Case Studies and Literature Review.. Transplantation Proceedings.. 2022;000:1-8",55.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Adult
211128082,21112808,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,"6 international unit, qd (dinner 6- 8 units)",,,U,,unknown,,,6.0,IU,,QD,2022,Q3,Chronic kidney disease,,2022,Q3,2,F,20190901.0,20220917.0,20220721,20220927,EXP,,PL-VELOXIS PHARMACEUTICALS-2022VELPL-000459,VELOXIS PHARMACEUTICALS,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda-Pawelska J, Romaszko-Wojtowicz A et al.. Hepatorenal Syndrome and Other Post?Liver Transplantation Complications: Case Studies and Literature Review.. Transplantation Proceedings.. 2022;000:1-8",55.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Adult
211128082,21112808,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,"6 international unit, qd (dinner 6- 8 units)",,,U,,unknown,,,6.0,IU,,QD,2022,Q3,Product use in unapproved indication,,2022,Q3,2,F,20190901.0,20220917.0,20220721,20220927,EXP,,PL-VELOXIS PHARMACEUTICALS-2022VELPL-000459,VELOXIS PHARMACEUTICALS,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda-Pawelska J, Romaszko-Wojtowicz A et al.. Hepatorenal Syndrome and Other Post?Liver Transplantation Complications: Case Studies and Literature Review.. Transplantation Proceedings.. 2022;000:1-8",55.0,YR,,F,Y,,,20220927,,MD,PL,PL,2022,Q3,Adult
211167703,21116770,1,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 U, TID",,,D,,,,,,,Solution for injection,Q8H,2022,Q3,Intentional overdose,,2022,Q3,3,F,,20220729.0,20220722,20220802,EXP,,JP-SA-2022SA289582,SANOFI AVENTIS,,30.0,YR,A,F,Y,,,20220802,,MD,JP,JP,2022,Q3,Young Adult
211167703,21116770,1,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 U, TID",,,D,,,,,,,Solution for injection,Q8H,2022,Q3,Hypoglycaemia,,2022,Q3,3,F,,20220729.0,20220722,20220802,EXP,,JP-SA-2022SA289582,SANOFI AVENTIS,,30.0,YR,A,F,Y,,,20220802,,MD,JP,JP,2022,Q3,Young Adult
211167703,21116770,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Overdose,,,D,,,,,,,Solution for injection,,2022,Q3,Intentional overdose,,2022,Q3,3,F,,20220729.0,20220722,20220802,EXP,,JP-SA-2022SA289582,SANOFI AVENTIS,,30.0,YR,A,F,Y,,,20220802,,MD,JP,JP,2022,Q3,Young Adult
211167703,21116770,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Overdose,,,D,,,,,,,Solution for injection,,2022,Q3,Hypoglycaemia,,2022,Q3,3,F,,20220729.0,20220722,20220802,EXP,,JP-SA-2022SA289582,SANOFI AVENTIS,,30.0,YR,A,F,Y,,,20220802,,MD,JP,JP,2022,Q3,Young Adult
211232511,21123251,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Memory impairment,,2022,Q3,1,I,20220701.0,20220720.0,20220724,20220724,PER,,US-SA-2022SA295319,SANOFI AVENTIS,,80.0,YR,E,F,Y,,,20220724,,CN,US,US,2022,Q3,Elderly
211238241,21123824,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Inappropriate schedule of product administration,,2022,Q3,1,I,,20220718.0,20220725,20220725,PER,,US-SA-2022SA292131,SANOFI AVENTIS,,58.0,YR,A,F,Y,,,20220725,,CN,US,US,2022,Q3,Adult
211245081,21124508,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, Sliding scale correctional dose every 4 hours",,,D,,,,,,,,,2022,Q3,Meningitis aseptic,,2022,Q3,1,I,,20220714.0,20220725,20220725,EXP,,US-CIPLA LTD.-2022US04523,CIPLA,"Vickery SB, Roach JK, Parsons C, Vickery PB.. Possible levetiracetam-induced aseptic meningitis versus viral meningitis: Case report and literature review.. The Nurse practitioner. 2022;47(7):32 to 37",54.0,YR,,M,Y,,,20220725,,PH,US,US,2022,Q3,Adult
211264011,21126401,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Clostridium test positive,,2022,Q3,1,I,,20220721.0,20220725,20220725,EXP,,NVSC2022CA166904,NOVARTIS,,65.0,YR,,M,Y,105.0,KG,20220725,,PH,CA,CA,2022,Q3,Elderly
211281021,21128102,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 u, tid",,,,,UNKNOWN,,,24.0,IU,Injection,TID,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220719.0,20220719.0,20220725,20220725,PER,,US-ELI_LILLY_AND_COMPANY-US202207009084,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20220725,,CN,US,US,2022,Q3,Adult
211281021,21128102,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 u, tid",,,,,UNKNOWN,,,24.0,IU,Injection,TID,2022,Q3,Weight decreased,,2022,Q3,1,I,20220719.0,20220719.0,20220725,20220725,PER,,US-ELI_LILLY_AND_COMPANY-US202207009084,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20220725,,CN,US,US,2022,Q3,Adult
211281021,21128102,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 u, tid",,,,,UNKNOWN,,,24.0,IU,Injection,TID,2022,Q3,Blood glucose decreased,,2022,Q3,1,I,20220719.0,20220719.0,20220725,20220725,PER,,US-ELI_LILLY_AND_COMPANY-US202207009084,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20220725,,CN,US,US,2022,Q3,Adult
211281021,21128102,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 u, tid",,,,,UNKNOWN,,,24.0,IU,Injection,TID,2022,Q3,Starvation,,2022,Q3,1,I,20220719.0,20220719.0,20220725,20220725,PER,,US-ELI_LILLY_AND_COMPANY-US202207009084,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20220725,,CN,US,US,2022,Q3,Adult
211281021,21128102,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 u, tid",,,,,D420814A,,,24.0,IU,Injection,TID,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220719.0,20220719.0,20220725,20220725,PER,,US-ELI_LILLY_AND_COMPANY-US202207009084,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20220725,,CN,US,US,2022,Q3,Adult
211281021,21128102,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 u, tid",,,,,D420814A,,,24.0,IU,Injection,TID,2022,Q3,Weight decreased,,2022,Q3,1,I,20220719.0,20220719.0,20220725,20220725,PER,,US-ELI_LILLY_AND_COMPANY-US202207009084,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20220725,,CN,US,US,2022,Q3,Adult
211281021,21128102,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 u, tid",,,,,D420814A,,,24.0,IU,Injection,TID,2022,Q3,Blood glucose decreased,,2022,Q3,1,I,20220719.0,20220719.0,20220725,20220725,PER,,US-ELI_LILLY_AND_COMPANY-US202207009084,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20220725,,CN,US,US,2022,Q3,Adult
211281021,21128102,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 u, tid",,,,,D420814A,,,24.0,IU,Injection,TID,2022,Q3,Starvation,,2022,Q3,1,I,20220719.0,20220719.0,20220725,20220725,PER,,US-ELI_LILLY_AND_COMPANY-US202207009084,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20220725,,CN,US,US,2022,Q3,Adult
211281021,21128102,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 u, tid",,,,,D420814A,,,24.0,IU,Injection,TID,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220719.0,20220719.0,20220725,20220725,PER,,US-ELI_LILLY_AND_COMPANY-US202207009084,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20220725,,CN,US,US,2022,Q3,Adult
211281021,21128102,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 u, tid",,,,,D420814A,,,24.0,IU,Injection,TID,2022,Q3,Weight decreased,,2022,Q3,1,I,20220719.0,20220719.0,20220725,20220725,PER,,US-ELI_LILLY_AND_COMPANY-US202207009084,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20220725,,CN,US,US,2022,Q3,Adult
211281021,21128102,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 u, tid",,,,,D420814A,,,24.0,IU,Injection,TID,2022,Q3,Blood glucose decreased,,2022,Q3,1,I,20220719.0,20220719.0,20220725,20220725,PER,,US-ELI_LILLY_AND_COMPANY-US202207009084,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20220725,,CN,US,US,2022,Q3,Adult
211281021,21128102,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 u, tid",,,,,D420814A,,,24.0,IU,Injection,TID,2022,Q3,Starvation,,2022,Q3,1,I,20220719.0,20220719.0,20220725,20220725,PER,,US-ELI_LILLY_AND_COMPANY-US202207009084,ELI LILLY AND CO,,63.0,YR,,M,Y,,,20220725,,CN,US,US,2022,Q3,Adult
211313661,21131366,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Disease progression,,2022,Q3,1,I,20220627.0,,20220725,20220725,DIR,624500,,FDA-CTU,,62.0,YR,,F,N,60.3,KG,20220725,N,,US,,2022,Q3,Adult
211326581,21132658,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q3,Product dose omission issue,,2022,Q3,1,I,20220713.0,20220714.0,20220726,20220726,EXP,,US-ELI_LILLY_AND_COMPANY-US202207007029,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20220726,,CN,US,US,2022,Q3,Elderly
211326581,21132658,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q3,Ligament sprain,,2022,Q3,1,I,20220713.0,20220714.0,20220726,20220726,EXP,,US-ELI_LILLY_AND_COMPANY-US202207007029,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20220726,,CN,US,US,2022,Q3,Elderly
211326581,21132658,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q3,End stage renal disease,,2022,Q3,1,I,20220713.0,20220714.0,20220726,20220726,EXP,,US-ELI_LILLY_AND_COMPANY-US202207007029,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20220726,,CN,US,US,2022,Q3,Elderly
211326581,21132658,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q3,Gouty arthritis,,2022,Q3,1,I,20220713.0,20220714.0,20220726,20220726,EXP,,US-ELI_LILLY_AND_COMPANY-US202207007029,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20220726,,CN,US,US,2022,Q3,Elderly
211326581,21132658,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220713.0,20220714.0,20220726,20220726,EXP,,US-ELI_LILLY_AND_COMPANY-US202207007029,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20220726,,CN,US,US,2022,Q3,Elderly
211326581,21132658,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q3,Illness,,2022,Q3,1,I,20220713.0,20220714.0,20220726,20220726,EXP,,US-ELI_LILLY_AND_COMPANY-US202207007029,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20220726,,CN,US,US,2022,Q3,Elderly
211326581,21132658,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,20563.0,,,Injection,,2022,Q3,Macular degeneration,,2022,Q3,1,I,20220713.0,20220714.0,20220726,20220726,EXP,,US-ELI_LILLY_AND_COMPANY-US202207007029,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20220726,,CN,US,US,2022,Q3,Elderly
211326581,21132658,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,D371847A,,20563.0,,,Injection,,2022,Q3,Product dose omission issue,,2022,Q3,1,I,20220713.0,20220714.0,20220726,20220726,EXP,,US-ELI_LILLY_AND_COMPANY-US202207007029,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20220726,,CN,US,US,2022,Q3,Elderly
211326581,21132658,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,D371847A,,20563.0,,,Injection,,2022,Q3,Ligament sprain,,2022,Q3,1,I,20220713.0,20220714.0,20220726,20220726,EXP,,US-ELI_LILLY_AND_COMPANY-US202207007029,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20220726,,CN,US,US,2022,Q3,Elderly
211326581,21132658,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,D371847A,,20563.0,,,Injection,,2022,Q3,End stage renal disease,,2022,Q3,1,I,20220713.0,20220714.0,20220726,20220726,EXP,,US-ELI_LILLY_AND_COMPANY-US202207007029,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20220726,,CN,US,US,2022,Q3,Elderly
211326581,21132658,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,D371847A,,20563.0,,,Injection,,2022,Q3,Gouty arthritis,,2022,Q3,1,I,20220713.0,20220714.0,20220726,20220726,EXP,,US-ELI_LILLY_AND_COMPANY-US202207007029,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20220726,,CN,US,US,2022,Q3,Elderly
211326581,21132658,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,D371847A,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220713.0,20220714.0,20220726,20220726,EXP,,US-ELI_LILLY_AND_COMPANY-US202207007029,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20220726,,CN,US,US,2022,Q3,Elderly
211326581,21132658,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,D371847A,,20563.0,,,Injection,,2022,Q3,Illness,,2022,Q3,1,I,20220713.0,20220714.0,20220726,20220726,EXP,,US-ELI_LILLY_AND_COMPANY-US202207007029,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20220726,,CN,US,US,2022,Q3,Elderly
211326581,21132658,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,D371847A,,20563.0,,,Injection,,2022,Q3,Macular degeneration,,2022,Q3,1,I,20220713.0,20220714.0,20220726,20220726,EXP,,US-ELI_LILLY_AND_COMPANY-US202207007029,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20220726,,CN,US,US,2022,Q3,Elderly
211334651,21133465,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Death,,2022,Q3,1,I,20220701.0,20220722.0,20220726,20220726,EXP,,US-TAKEDA-2022TUS050297,TAKEDA,,66.0,YR,,M,Y,53.51,KG,20220726,,HP,US,US,2022,Q3,Elderly
211341151,21134115,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2022,Q3,Infection,,2022,Q3,1,I,20220708.0,20220715.0,20220726,20220726,EXP,,US-ELI_LILLY_AND_COMPANY-US202207007122,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220726,,CN,US,US,2022,Q3,Elderly
211341151,21134115,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220708.0,20220715.0,20220726,20220726,EXP,,US-ELI_LILLY_AND_COMPANY-US202207007122,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220726,,CN,US,US,2022,Q3,Elderly
211341692,21134169,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15 u, unknown (10-15 units)",,,U,,D456541A,,20563.0,15.0,IU,Injection,,2022,Q3,Drug ineffective,,2022,Q3,2,F,20220721.0,20220802.0,20220726,20220809,PER,,US-ELI_LILLY_AND_COMPANY-US202207009424,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20220809,,MD,US,US,2022,Q3,Elderly
211341692,21134169,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15 u, unknown (10-15 units)",,,U,,D456541A,,20563.0,15.0,IU,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,2,F,20220721.0,20220802.0,20220726,20220809,PER,,US-ELI_LILLY_AND_COMPANY-US202207009424,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20220809,,MD,US,US,2022,Q3,Elderly
211341692,21134169,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"15 u, unknown (10-15 units)",,,U,,D456541A,,20563.0,15.0,IU,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,2,F,20220721.0,20220802.0,20220726,20220809,PER,,US-ELI_LILLY_AND_COMPANY-US202207009424,ELI LILLY AND CO,,83.0,YR,,M,Y,,,20220809,,MD,US,US,2022,Q3,Elderly
211351641,21135164,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, other per meal",,,U,,D473104C,,20563.0,20.0,IU,Injection,,2022,Q3,Diarrhoea,,2022,Q3,1,I,20220601.0,20220722.0,20220727,20220727,PER,,US-ELI_LILLY_AND_COMPANY-US202207011378,ELI LILLY AND CO,,25.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Young Adult
211351641,21135164,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, other per meal",,,U,,D473104C,,20563.0,20.0,IU,Injection,,2022,Q3,Viral infection,,2022,Q3,1,I,20220601.0,20220722.0,20220727,20220727,PER,,US-ELI_LILLY_AND_COMPANY-US202207011378,ELI LILLY AND CO,,25.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Young Adult
211351641,21135164,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, other per meal",,,U,,D473104C,,20563.0,20.0,IU,Injection,,2022,Q3,Nausea,,2022,Q3,1,I,20220601.0,20220722.0,20220727,20220727,PER,,US-ELI_LILLY_AND_COMPANY-US202207011378,ELI LILLY AND CO,,25.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Young Adult
211351641,21135164,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, other per meal",,,U,,D473104C,,20563.0,20.0,IU,Injection,,2022,Q3,Drug ineffective,,2022,Q3,1,I,20220601.0,20220722.0,20220727,20220727,PER,,US-ELI_LILLY_AND_COMPANY-US202207011378,ELI LILLY AND CO,,25.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Young Adult
211351641,21135164,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, other per meal",,,U,,D473104C,,20563.0,20.0,IU,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220601.0,20220722.0,20220727,20220727,PER,,US-ELI_LILLY_AND_COMPANY-US202207011378,ELI LILLY AND CO,,25.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Young Adult
211351641,21135164,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, other per meal",,,U,,,,20563.0,20.0,IU,Injection,,2022,Q3,Diarrhoea,,2022,Q3,1,I,20220601.0,20220722.0,20220727,20220727,PER,,US-ELI_LILLY_AND_COMPANY-US202207011378,ELI LILLY AND CO,,25.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Young Adult
211351641,21135164,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, other per meal",,,U,,,,20563.0,20.0,IU,Injection,,2022,Q3,Viral infection,,2022,Q3,1,I,20220601.0,20220722.0,20220727,20220727,PER,,US-ELI_LILLY_AND_COMPANY-US202207011378,ELI LILLY AND CO,,25.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Young Adult
211351641,21135164,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, other per meal",,,U,,,,20563.0,20.0,IU,Injection,,2022,Q3,Nausea,,2022,Q3,1,I,20220601.0,20220722.0,20220727,20220727,PER,,US-ELI_LILLY_AND_COMPANY-US202207011378,ELI LILLY AND CO,,25.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Young Adult
211351641,21135164,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, other per meal",,,U,,,,20563.0,20.0,IU,Injection,,2022,Q3,Drug ineffective,,2022,Q3,1,I,20220601.0,20220722.0,20220727,20220727,PER,,US-ELI_LILLY_AND_COMPANY-US202207011378,ELI LILLY AND CO,,25.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Young Adult
211351641,21135164,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, other per meal",,,U,,,,20563.0,20.0,IU,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220601.0,20220722.0,20220727,20220727,PER,,US-ELI_LILLY_AND_COMPANY-US202207011378,ELI LILLY AND CO,,25.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Young Adult
211351641,21135164,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, other per meal",,,U,,,,20563.0,20.0,IU,Injection,,2022,Q3,Diarrhoea,,2022,Q3,1,I,20220601.0,20220722.0,20220727,20220727,PER,,US-ELI_LILLY_AND_COMPANY-US202207011378,ELI LILLY AND CO,,25.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Young Adult
211351641,21135164,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, other per meal",,,U,,,,20563.0,20.0,IU,Injection,,2022,Q3,Viral infection,,2022,Q3,1,I,20220601.0,20220722.0,20220727,20220727,PER,,US-ELI_LILLY_AND_COMPANY-US202207011378,ELI LILLY AND CO,,25.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Young Adult
211351641,21135164,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, other per meal",,,U,,,,20563.0,20.0,IU,Injection,,2022,Q3,Nausea,,2022,Q3,1,I,20220601.0,20220722.0,20220727,20220727,PER,,US-ELI_LILLY_AND_COMPANY-US202207011378,ELI LILLY AND CO,,25.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Young Adult
211351641,21135164,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, other per meal",,,U,,,,20563.0,20.0,IU,Injection,,2022,Q3,Drug ineffective,,2022,Q3,1,I,20220601.0,20220722.0,20220727,20220727,PER,,US-ELI_LILLY_AND_COMPANY-US202207011378,ELI LILLY AND CO,,25.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Young Adult
211351641,21135164,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"20 u, other per meal",,,U,,,,20563.0,20.0,IU,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220601.0,20220722.0,20220727,20220727,PER,,US-ELI_LILLY_AND_COMPANY-US202207011378,ELI LILLY AND CO,,25.0,YR,,M,Y,,,20220727,,CN,US,US,2022,Q3,Young Adult
211371881,21137188,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,12 + 15 + 15 IU/day,,,,,,,,42.0,IU,,,2022,Q3,Intentional product misuse,,2022,Q3,1,I,20220221.0,20220722.0,20220727,20220727,EXP,IT-MINISAL02-875749,IT-SA-2022SA299313,SANOFI AVENTIS,,48.0,YR,A,M,Y,,,20220727,,MD,IT,IT,2022,Q3,Adult
211371881,21137188,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,12 + 15 + 15 IU/day,,,,,,,,42.0,IU,,,2022,Q3,Diabetic ketoacidosis,,2022,Q3,1,I,20220221.0,20220722.0,20220727,20220727,EXP,IT-MINISAL02-875749,IT-SA-2022SA299313,SANOFI AVENTIS,,48.0,YR,A,M,Y,,,20220727,,MD,IT,IT,2022,Q3,Adult
211384921,21138492,11,C,LISPRO INJECTION,,2,,,,,,,,,,,,,,2022,Q3,Therapy interrupted,,2022,Q3,1,I,,,20220727,20220727,DIR,FDA-CDER-CTU-2022-59381,,FDA-CTU,,78.0,YR,,,N,,,20220727,N,,US,,2022,Q3,Elderly
211384921,21138492,11,C,LISPRO INJECTION,,2,,,,,,,,,,,,,,2022,Q3,COVID-19,,2022,Q3,1,I,,,20220727,20220727,DIR,FDA-CDER-CTU-2022-59381,,FDA-CTU,,78.0,YR,,,N,,,20220727,N,,US,,2022,Q3,Elderly
211413242,21141324,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 u, daily",,,,,D493131A,,20563.0,80.0,IU,Solution for injection,QD,2022,Q3,Blood glucose increased,,2022,Q3,2,F,20220718.0,20220801.0,20220728,20220803,PER,,US-ELI_LILLY_AND_COMPANY-US202207009380,ELI LILLY AND CO,,45.0,YR,,M,Y,,,20220803,,CN,US,US,2022,Q3,Adult
211413242,21141324,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 u, daily",,,,,D493131A,,20563.0,80.0,IU,Solution for injection,QD,2022,Q3,Drug ineffective,,2022,Q3,2,F,20220718.0,20220801.0,20220728,20220803,PER,,US-ELI_LILLY_AND_COMPANY-US202207009380,ELI LILLY AND CO,,45.0,YR,,M,Y,,,20220803,,CN,US,US,2022,Q3,Adult
211413242,21141324,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 u, daily",,,,,,,20563.0,80.0,IU,Solution for injection,QD,2022,Q3,Blood glucose increased,,2022,Q3,2,F,20220718.0,20220801.0,20220728,20220803,PER,,US-ELI_LILLY_AND_COMPANY-US202207009380,ELI LILLY AND CO,,45.0,YR,,M,Y,,,20220803,,CN,US,US,2022,Q3,Adult
211413242,21141324,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"80 u, daily",,,,,,,20563.0,80.0,IU,Solution for injection,QD,2022,Q3,Drug ineffective,,2022,Q3,2,F,20220718.0,20220801.0,20220728,20220803,PER,,US-ELI_LILLY_AND_COMPANY-US202207009380,ELI LILLY AND CO,,45.0,YR,,M,Y,,,20220803,,CN,US,US,2022,Q3,Adult
211415262,21141526,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Cardio-respiratory arrest,,2022,Q3,2,F,20220715.0,20220805.0,20220728,20220809,EXP,PT-INFARMED-V202207-3242,PT-PFIZER INC-202201002977,PFIZER,,65.0,YR,,M,Y,,,20220809,,MD,PT,PT,2022,Q3,Elderly
211415262,21141526,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Contraindicated product administered,,2022,Q3,2,F,20220715.0,20220805.0,20220728,20220809,EXP,PT-INFARMED-V202207-3242,PT-PFIZER INC-202201002977,PFIZER,,65.0,YR,,M,Y,,,20220809,,MD,PT,PT,2022,Q3,Elderly
211415262,21141526,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Pancreatitis acute,,2022,Q3,2,F,20220715.0,20220805.0,20220728,20220809,EXP,PT-INFARMED-V202207-3242,PT-PFIZER INC-202201002977,PFIZER,,65.0,YR,,M,Y,,,20220809,,MD,PT,PT,2022,Q3,Elderly
211443402,21144340,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 u,,,,,D409633J,,,,,,Q8H,2022,Q3,Blood glucose increased,,2022,Q3,2,F,,20220902.0,20220728,20220906,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-184295",BOEHRINGER INGELHEIM,,78.0,YR,E,F,Y,,,20220906,,CN,US,US,2022,Q3,Elderly
211443402,21144340,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 u,,,,,D409633J,,,,,,Q8H,2022,Q3,Fungal infection,,2022,Q3,2,F,,20220902.0,20220728,20220906,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-184295",BOEHRINGER INGELHEIM,,78.0,YR,E,F,Y,,,20220906,,CN,US,US,2022,Q3,Elderly
211443402,21144340,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 u,,,,,D409633J,,,,,,Q8H,2022,Q3,Product dose omission issue,,2022,Q3,2,F,,20220902.0,20220728,20220906,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-184295",BOEHRINGER INGELHEIM,,78.0,YR,E,F,Y,,,20220906,,CN,US,US,2022,Q3,Elderly
211443402,21144340,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 u,,,,,D409633J,,,,,,Q8H,2022,Q3,Incorrect dose administered,,2022,Q3,2,F,,20220902.0,20220728,20220906,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-184295",BOEHRINGER INGELHEIM,,78.0,YR,E,F,Y,,,20220906,,CN,US,US,2022,Q3,Elderly
211443402,21144340,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 u,,,,,D409633J,,,,,,Q8H,2022,Q3,Injection site haemorrhage,,2022,Q3,2,F,,20220902.0,20220728,20220906,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-184295",BOEHRINGER INGELHEIM,,78.0,YR,E,F,Y,,,20220906,,CN,US,US,2022,Q3,Elderly
211443402,21144340,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 u,,,,,D409633J,,,,,,Q8H,2022,Q3,Blood glucose increased,,2022,Q3,2,F,,20220902.0,20220728,20220906,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-184295",BOEHRINGER INGELHEIM,,78.0,YR,E,F,Y,,,20220906,,CN,US,US,2022,Q3,Elderly
211443402,21144340,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 u,,,,,D409633J,,,,,,Q8H,2022,Q3,Fungal infection,,2022,Q3,2,F,,20220902.0,20220728,20220906,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-184295",BOEHRINGER INGELHEIM,,78.0,YR,E,F,Y,,,20220906,,CN,US,US,2022,Q3,Elderly
211443402,21144340,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 u,,,,,D409633J,,,,,,Q8H,2022,Q3,Product dose omission issue,,2022,Q3,2,F,,20220902.0,20220728,20220906,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-184295",BOEHRINGER INGELHEIM,,78.0,YR,E,F,Y,,,20220906,,CN,US,US,2022,Q3,Elderly
211443402,21144340,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 u,,,,,D409633J,,,,,,Q8H,2022,Q3,Incorrect dose administered,,2022,Q3,2,F,,20220902.0,20220728,20220906,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-184295",BOEHRINGER INGELHEIM,,78.0,YR,E,F,Y,,,20220906,,CN,US,US,2022,Q3,Elderly
211443402,21144340,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,10 u,,,,,D409633J,,,,,,Q8H,2022,Q3,Injection site haemorrhage,,2022,Q3,2,F,,20220902.0,20220728,20220906,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-184295",BOEHRINGER INGELHEIM,,78.0,YR,E,F,Y,,,20220906,,CN,US,US,2022,Q3,Elderly
211459921,21145992,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"22 u, unknown (21-22 units)",,,U,,,,20563.0,22.0,IU,Injection,,2022,Q3,Cataract,,2022,Q3,1,I,20211101.0,20220720.0,20220729,20220729,PER,,US-ELI_LILLY_AND_COMPANY-US202207009207,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20220729,,CN,US,US,2022,Q3,Elderly
211459921,21145992,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"22 u, unknown (21-22 units)",,,U,,D473104C,,20563.0,22.0,IU,Injection,,2022,Q3,Cataract,,2022,Q3,1,I,20211101.0,20220720.0,20220729,20220729,PER,,US-ELI_LILLY_AND_COMPANY-US202207009207,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20220729,,CN,US,US,2022,Q3,Elderly
211483381,21148338,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 iU, TID,  sc before breakfast, lunch, dinner",,,Y,,,,,8.0,IU,Solution for injection,Q8H,2022,Q3,Hypoglycaemia,,2022,Q3,1,I,20220405.0,20220722.0,20220729,20220729,EXP,IT-MINISAL02-875410,IT-SA-2022SA301958,SANOFI AVENTIS,,34.0,YR,A,F,Y,,,20220729,,PH,IT,IT,2022,Q3,Young Adult
211483381,21148338,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 iU, TID,  sc before breakfast, lunch, dinner",,,Y,,,,,8.0,IU,Solution for injection,Q8H,2022,Q3,Vomiting,,2022,Q3,1,I,20220405.0,20220722.0,20220729,20220729,EXP,IT-MINISAL02-875410,IT-SA-2022SA301958,SANOFI AVENTIS,,34.0,YR,A,F,Y,,,20220729,,PH,IT,IT,2022,Q3,Young Adult
211549216,21154921,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q3,Acute respiratory failure,,2022,Q3,6,F,20220625.0,20220909.0,20220801,20220913,EXP,,US-ROCHE-3128122,ROCHE,,73.0,YR,,F,Y,,,20220913,,MD,US,,2022,Q3,Elderly
211549216,21154921,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q3,Nephrogenic anaemia,,2022,Q3,6,F,20220625.0,20220909.0,20220801,20220913,EXP,,US-ROCHE-3128122,ROCHE,,73.0,YR,,F,Y,,,20220913,,MD,US,,2022,Q3,Elderly
211549216,21154921,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q3,Device related sepsis,,2022,Q3,6,F,20220625.0,20220909.0,20220801,20220913,EXP,,US-ROCHE-3128122,ROCHE,,73.0,YR,,F,Y,,,20220913,,MD,US,,2022,Q3,Elderly
211549216,21154921,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q3,Toxic encephalopathy,,2022,Q3,6,F,20220625.0,20220909.0,20220801,20220913,EXP,,US-ROCHE-3128122,ROCHE,,73.0,YR,,F,Y,,,20220913,,MD,US,,2022,Q3,Elderly
211558631,21155863,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 international unit, tid",,,Y,,,,20563.0,8.0,IU,,TID,2022,Q3,Hypoglycaemia,,2022,Q3,1,I,20220405.0,20220719.0,20220801,20220801,EXP,IT-MINISAL02-875410,IT-ELI_LILLY_AND_COMPANY-IT202207007740,ELI LILLY AND CO,,34.0,YR,,F,Y,,,20220801,,CN,IT,IT,2022,Q3,Young Adult
211558631,21155863,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 international unit, tid",,,Y,,,,20563.0,8.0,IU,,TID,2022,Q3,Vomiting,,2022,Q3,1,I,20220405.0,20220719.0,20220801,20220801,EXP,IT-MINISAL02-875410,IT-ELI_LILLY_AND_COMPANY-IT202207007740,ELI LILLY AND CO,,34.0,YR,,F,Y,,,20220801,,CN,IT,IT,2022,Q3,Young Adult
211558631,21155863,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (reduced dose)",,,Y,,,,20563.0,,,,,2022,Q3,Hypoglycaemia,,2022,Q3,1,I,20220405.0,20220719.0,20220801,20220801,EXP,IT-MINISAL02-875410,IT-ELI_LILLY_AND_COMPANY-IT202207007740,ELI LILLY AND CO,,34.0,YR,,F,Y,,,20220801,,CN,IT,IT,2022,Q3,Young Adult
211558631,21155863,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown (reduced dose)",,,Y,,,,20563.0,,,,,2022,Q3,Vomiting,,2022,Q3,1,I,20220405.0,20220719.0,20220801,20220801,EXP,IT-MINISAL02-875410,IT-ELI_LILLY_AND_COMPANY-IT202207007740,ELI LILLY AND CO,,34.0,YR,,F,Y,,,20220801,,CN,IT,IT,2022,Q3,Young Adult
211578091,21157809,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 u, daily",,,,,,,,90.0,IU,Injection,QD,2022,Q3,Gait disturbance,,2022,Q3,1,I,20220427.0,20220720.0,20220801,20220801,EXP,,US-ELI_LILLY_AND_COMPANY-US202207010435,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20220801,,CN,US,US,2022,Q3,Adult
211578091,21157809,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 u, daily",,,,,,,,90.0,IU,Injection,QD,2022,Q3,Hypokinesia,,2022,Q3,1,I,20220427.0,20220720.0,20220801,20220801,EXP,,US-ELI_LILLY_AND_COMPANY-US202207010435,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20220801,,CN,US,US,2022,Q3,Adult
211578091,21157809,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 u, daily",,,,,,,,90.0,IU,Injection,QD,2022,Q3,Staphylococcal infection,,2022,Q3,1,I,20220427.0,20220720.0,20220801,20220801,EXP,,US-ELI_LILLY_AND_COMPANY-US202207010435,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20220801,,CN,US,US,2022,Q3,Adult
211578091,21157809,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 u, daily",,,,,,,,90.0,IU,Solution for injection,QD,2022,Q3,Gait disturbance,,2022,Q3,1,I,20220427.0,20220720.0,20220801,20220801,EXP,,US-ELI_LILLY_AND_COMPANY-US202207010435,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20220801,,CN,US,US,2022,Q3,Adult
211578091,21157809,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 u, daily",,,,,,,,90.0,IU,Solution for injection,QD,2022,Q3,Hypokinesia,,2022,Q3,1,I,20220427.0,20220720.0,20220801,20220801,EXP,,US-ELI_LILLY_AND_COMPANY-US202207010435,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20220801,,CN,US,US,2022,Q3,Adult
211578091,21157809,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 u, daily",,,,,,,,90.0,IU,Solution for injection,QD,2022,Q3,Staphylococcal infection,,2022,Q3,1,I,20220427.0,20220720.0,20220801,20220801,EXP,,US-ELI_LILLY_AND_COMPANY-US202207010435,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20220801,,CN,US,US,2022,Q3,Adult
211591392,21159139,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"55 u, tid",,,U,,,,,55.0,IU,Injection,TID,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,2,F,20220726.0,20220805.0,20220802,20220817,PER,,US-ELI_LILLY_AND_COMPANY-US202208000700,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20220817,,CN,US,US,2022,Q3,Adult
211591392,21159139,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"55 u, tid",,,U,,,,,55.0,IU,Injection,TID,2022,Q3,Attention deficit hyperactivity disorder,,2022,Q3,2,F,20220726.0,20220805.0,20220802,20220817,PER,,US-ELI_LILLY_AND_COMPANY-US202208000700,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20220817,,CN,US,US,2022,Q3,Adult
211591392,21159139,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"55 u, tid",,,U,,,,,55.0,IU,Injection,TID,2022,Q3,Blood glucose increased,,2022,Q3,2,F,20220726.0,20220805.0,20220802,20220817,PER,,US-ELI_LILLY_AND_COMPANY-US202208000700,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20220817,,CN,US,US,2022,Q3,Adult
211591392,21159139,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"55 u, tid",,,U,,,,,55.0,IU,Injection,TID,2022,Q3,Product dispensing error,,2022,Q3,2,F,20220726.0,20220805.0,20220802,20220817,PER,,US-ELI_LILLY_AND_COMPANY-US202208000700,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20220817,,CN,US,US,2022,Q3,Adult
211591392,21159139,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"55 u, tid",,,U,,,,,55.0,IU,Injection,TID,2022,Q3,Blood glucose decreased,,2022,Q3,2,F,20220726.0,20220805.0,20220802,20220817,PER,,US-ELI_LILLY_AND_COMPANY-US202208000700,ELI LILLY AND CO,,58.0,YR,,F,Y,,,20220817,,CN,US,US,2022,Q3,Adult
211608851,21160885,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,,,2022,Q3,Drug interaction,,2022,Q3,1,I,20211101.0,20220523.0,20220802,20220802,EXP,,US-AMNEAL PHARMACEUTICALS-2022-AMRX-01631,AMNEAL,,35.0,YR,,F,Y,,,20220802,,HP,US,US,2022,Q3,Adult
211608851,21160885,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,,,2022,Q3,Somnolence,,2022,Q3,1,I,20211101.0,20220523.0,20220802,20220802,EXP,,US-AMNEAL PHARMACEUTICALS-2022-AMRX-01631,AMNEAL,,35.0,YR,,F,Y,,,20220802,,HP,US,US,2022,Q3,Adult
211608851,21160885,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,U,,,,,,,,2022,Q3,Fatigue,,2022,Q3,1,I,20211101.0,20220523.0,20220802,20220802,EXP,,US-AMNEAL PHARMACEUTICALS-2022-AMRX-01631,AMNEAL,,35.0,YR,,F,Y,,,20220802,,HP,US,US,2022,Q3,Adult
211613491,21161349,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2022,Q3,Pain in extremity,,2022,Q3,1,I,20220701.0,20220729.0,20220802,20220802,PER,,US-ELI_LILLY_AND_COMPANY-US202208000261,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20220802,,CN,US,US,2022,Q3,Adult
211613491,21161349,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2022,Q3,Road traffic accident,,2022,Q3,1,I,20220701.0,20220729.0,20220802,20220802,PER,,US-ELI_LILLY_AND_COMPANY-US202208000261,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20220802,,CN,US,US,2022,Q3,Adult
211613491,21161349,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2022,Q3,Joint dislocation,,2022,Q3,1,I,20220701.0,20220729.0,20220802,20220802,PER,,US-ELI_LILLY_AND_COMPANY-US202208000261,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20220802,,CN,US,US,2022,Q3,Adult
211613491,21161349,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2022,Q3,Malaise,,2022,Q3,1,I,20220701.0,20220729.0,20220802,20220802,PER,,US-ELI_LILLY_AND_COMPANY-US202208000261,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20220802,,CN,US,US,2022,Q3,Adult
211656901,21165690,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Drug interaction,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Oedema peripheral,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Skin disorder,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Arrhythmia,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Bradycardia,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Dehydration,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Dizziness,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Haematocrit increased,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Pulmonary congestion,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Mucosal dryness,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Syncope,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Haemoglobin increased,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Renal disorder,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Hypovolaemia,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Left atrial dilatation,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q3,Presyncope,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Drug interaction,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Oedema peripheral,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Skin disorder,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Arrhythmia,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Bradycardia,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Dehydration,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Dizziness,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Haematocrit increased,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Pulmonary congestion,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Mucosal dryness,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Syncope,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Haemoglobin increased,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Renal disorder,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Hypovolaemia,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Left atrial dilatation,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211656901,21165690,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Presyncope,,2022,Q3,1,I,20180101.0,20220729.0,20220803,20220803,EXP,,NVSC2019PT097027,NOVARTIS,"Gouveia C, Duque S, Campos L. Lipotymia by hypovolemia-a case of iatrogenia to empagliflozina. PORTUGUESE JOURNAL OF DIABTES. 2019;14(1):74",71.0,YR,,M,Y,,,20220803,,HP,PT,PT,2022,Q3,Elderly
211668861,21166886,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 E/ml,,,,,,,,,,,,2022,Q3,Pancreatitis,,2022,Q3,1,I,20220723.0,20220728.0,20220803,20220803,EXP,,CH-ROCHE-3150538,ROCHE,,52.0,YR,,M,Y,58.0,KG,20220803,,MD,CH,,2022,Q3,Adult
211668861,21166886,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 E/ml,,,,,,,,,,,,2022,Q3,Pneumonia,,2022,Q3,1,I,20220723.0,20220728.0,20220803,20220803,EXP,,CH-ROCHE-3150538,ROCHE,,52.0,YR,,M,Y,58.0,KG,20220803,,MD,CH,,2022,Q3,Adult
211706961,21170696,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,About 40-50 units,,,D,,SAKNAS,,209196.0,,,Solution for injection,,2022,Q3,Depressed level of consciousness,,2022,Q3,1,I,20220712.0,20220728.0,20220804,20220804,EXP,SE-MPA-2022-017429,SE-SA-2022SA311373,SANOFI AVENTIS,,43.0,YR,A,M,Y,,,20220804,,MD,SE,SE,2022,Q3,Adult
211706961,21170696,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,About 40-50 units,,,D,,SAKNAS,,209196.0,,,Solution for injection,,2022,Q3,Hypoglycaemic seizure,,2022,Q3,1,I,20220712.0,20220728.0,20220804,20220804,EXP,SE-MPA-2022-017429,SE-SA-2022SA311373,SANOFI AVENTIS,,43.0,YR,A,M,Y,,,20220804,,MD,SE,SE,2022,Q3,Adult
211706961,21170696,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,About 40-50 units,,,D,,SAKNAS,,209196.0,,,Solution for injection,,2022,Q3,Intentional overdose,,2022,Q3,1,I,20220712.0,20220728.0,20220804,20220804,EXP,SE-MPA-2022-017429,SE-SA-2022SA311373,SANOFI AVENTIS,,43.0,YR,A,M,Y,,,20220804,,MD,SE,SE,2022,Q3,Adult
211706961,21170696,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,About 40-50 units,,,D,,SAKNAS,,209196.0,,,Solution for injection,,2022,Q3,Hypoglycaemia,,2022,Q3,1,I,20220712.0,20220728.0,20220804,20220804,EXP,SE-MPA-2022-017429,SE-SA-2022SA311373,SANOFI AVENTIS,,43.0,YR,A,M,Y,,,20220804,,MD,SE,SE,2022,Q3,Adult
211706961,21170696,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,About 40-50 units,,,D,,SAKNAS,,209196.0,,,Solution for injection,,2022,Q3,Toxicity to various agents,,2022,Q3,1,I,20220712.0,20220728.0,20220804,20220804,EXP,SE-MPA-2022-017429,SE-SA-2022SA311373,SANOFI AVENTIS,,43.0,YR,A,M,Y,,,20220804,,MD,SE,SE,2022,Q3,Adult
211706961,21170696,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,About 40-50 units,,,D,,SAKNAS,,209196.0,,,Solution for injection,,2022,Q3,Intentional self-injury,,2022,Q3,1,I,20220712.0,20220728.0,20220804,20220804,EXP,SE-MPA-2022-017429,SE-SA-2022SA311373,SANOFI AVENTIS,,43.0,YR,A,M,Y,,,20220804,,MD,SE,SE,2022,Q3,Adult
211706961,21170696,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,About 40-50 units,,,D,,SAKNAS,,209196.0,,,Solution for injection,,2022,Q3,Hypokalaemia,,2022,Q3,1,I,20220712.0,20220728.0,20220804,20220804,EXP,SE-MPA-2022-017429,SE-SA-2022SA311373,SANOFI AVENTIS,,43.0,YR,A,M,Y,,,20220804,,MD,SE,SE,2022,Q3,Adult
211764291,21176429,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Myocardial infarction,,2022,Q3,1,I,,20220801.0,20220805,20220805,EXP,,ZA-TAKEDA-2022TUS052969,TAKEDA,,78.0,YR,,M,Y,,,20220805,,CN,ZA,ZA,2022,Q3,Elderly
211764291,21176429,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Death,,2022,Q3,1,I,,20220801.0,20220805,20220805,EXP,,ZA-TAKEDA-2022TUS052969,TAKEDA,,78.0,YR,,M,Y,,,20220805,,CN,ZA,ZA,2022,Q3,Elderly
211782021,21178202,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D390489A,,20563.0,,,Solution for injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220706.0,20220708.0,20220805,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202207005298,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
211782021,21178202,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D390489A,,20563.0,,,Solution for injection,,2022,Q3,Hypertension,,2022,Q3,1,I,20220706.0,20220708.0,20220805,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202207005298,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
211782021,21178202,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D390489A,,20563.0,,,Solution for injection,,2022,Q3,Nausea,,2022,Q3,1,I,20220706.0,20220708.0,20220805,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202207005298,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
211782021,21178202,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220706.0,20220708.0,20220805,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202207005298,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
211782021,21178202,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2022,Q3,Hypertension,,2022,Q3,1,I,20220706.0,20220708.0,20220805,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202207005298,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
211782021,21178202,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2022,Q3,Nausea,,2022,Q3,1,I,20220706.0,20220708.0,20220805,20220805,PER,,US-ELI_LILLY_AND_COMPANY-US202207005298,ELI LILLY AND CO,,72.0,YR,,M,Y,,,20220805,,CN,US,US,2022,Q3,Elderly
211783011,21178301,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, unknown",,,U,,,,20563.0,30.0,IU,Solution for injection,,2022,Q3,Pollakiuria,,2022,Q3,1,I,20170901.0,20220725.0,20220805,20220805,EXP,,US-ELI_LILLY_AND_COMPANY-US202208001896,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Adult
211783011,21178301,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, unknown",,,U,,,,20563.0,30.0,IU,Solution for injection,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,1,I,20170901.0,20220725.0,20220805,20220805,EXP,,US-ELI_LILLY_AND_COMPANY-US202208001896,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Adult
211783011,21178301,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, unknown",,,U,,,,20563.0,30.0,IU,Solution for injection,,2022,Q3,Fibromyalgia,,2022,Q3,1,I,20170901.0,20220725.0,20220805,20220805,EXP,,US-ELI_LILLY_AND_COMPANY-US202208001896,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Adult
211783011,21178301,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, unknown",,,U,,,,20563.0,30.0,IU,Solution for injection,,2022,Q3,Oesophageal carcinoma,,2022,Q3,1,I,20170901.0,20220725.0,20220805,20220805,EXP,,US-ELI_LILLY_AND_COMPANY-US202208001896,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Adult
211783011,21178301,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, unknown",,,U,,,,20563.0,30.0,IU,Solution for injection,,2022,Q3,Diabetic ketoacidosis,,2022,Q3,1,I,20170901.0,20220725.0,20220805,20220805,EXP,,US-ELI_LILLY_AND_COMPANY-US202208001896,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Adult
211783011,21178301,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, unknown",,,U,,,,20563.0,30.0,IU,Solution for injection,,2022,Q3,Osteoarthritis,,2022,Q3,1,I,20170901.0,20220725.0,20220805,20220805,EXP,,US-ELI_LILLY_AND_COMPANY-US202208001896,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Adult
211783011,21178301,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, unknown",,,U,,,,20563.0,30.0,IU,Solution for injection,,2022,Q3,Gastrointestinal haemorrhage,,2022,Q3,1,I,20170901.0,20220725.0,20220805,20220805,EXP,,US-ELI_LILLY_AND_COMPANY-US202208001896,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Adult
211783011,21178301,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, unknown",,,U,,,,20563.0,30.0,IU,Solution for injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20170901.0,20220725.0,20220805,20220805,EXP,,US-ELI_LILLY_AND_COMPANY-US202208001896,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Adult
211783011,21178301,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, unknown",,,U,,D386746A,,20563.0,30.0,IU,Solution for injection,,2022,Q3,Pollakiuria,,2022,Q3,1,I,20170901.0,20220725.0,20220805,20220805,EXP,,US-ELI_LILLY_AND_COMPANY-US202208001896,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Adult
211783011,21178301,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, unknown",,,U,,D386746A,,20563.0,30.0,IU,Solution for injection,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,1,I,20170901.0,20220725.0,20220805,20220805,EXP,,US-ELI_LILLY_AND_COMPANY-US202208001896,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Adult
211783011,21178301,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, unknown",,,U,,D386746A,,20563.0,30.0,IU,Solution for injection,,2022,Q3,Fibromyalgia,,2022,Q3,1,I,20170901.0,20220725.0,20220805,20220805,EXP,,US-ELI_LILLY_AND_COMPANY-US202208001896,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Adult
211783011,21178301,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, unknown",,,U,,D386746A,,20563.0,30.0,IU,Solution for injection,,2022,Q3,Oesophageal carcinoma,,2022,Q3,1,I,20170901.0,20220725.0,20220805,20220805,EXP,,US-ELI_LILLY_AND_COMPANY-US202208001896,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Adult
211783011,21178301,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, unknown",,,U,,D386746A,,20563.0,30.0,IU,Solution for injection,,2022,Q3,Diabetic ketoacidosis,,2022,Q3,1,I,20170901.0,20220725.0,20220805,20220805,EXP,,US-ELI_LILLY_AND_COMPANY-US202208001896,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Adult
211783011,21178301,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, unknown",,,U,,D386746A,,20563.0,30.0,IU,Solution for injection,,2022,Q3,Osteoarthritis,,2022,Q3,1,I,20170901.0,20220725.0,20220805,20220805,EXP,,US-ELI_LILLY_AND_COMPANY-US202208001896,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Adult
211783011,21178301,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, unknown",,,U,,D386746A,,20563.0,30.0,IU,Solution for injection,,2022,Q3,Gastrointestinal haemorrhage,,2022,Q3,1,I,20170901.0,20220725.0,20220805,20220805,EXP,,US-ELI_LILLY_AND_COMPANY-US202208001896,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Adult
211783011,21178301,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"30 u, unknown",,,U,,D386746A,,20563.0,30.0,IU,Solution for injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20170901.0,20220725.0,20220805,20220805,EXP,,US-ELI_LILLY_AND_COMPANY-US202208001896,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220805,,CN,US,US,2022,Q3,Adult
211789391,21178939,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8-9 u, prn (with each meal)",,,N,,,,20563.0,9.0,IU,,,2022,Q3,Headache,,2022,Q3,1,I,,20220726.0,20220805,20220805,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202207012305,ELI LILLY AND CO,,75.0,YR,,F,Y,98.0,KG,20220805,,CN,GB,GB,2022,Q3,Elderly
211789391,21178939,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8-9 u, prn (with each meal)",,,N,,,,20563.0,9.0,IU,,,2022,Q3,Tachycardia,,2022,Q3,1,I,,20220726.0,20220805,20220805,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202207012305,ELI LILLY AND CO,,75.0,YR,,F,Y,98.0,KG,20220805,,CN,GB,GB,2022,Q3,Elderly
211789391,21178939,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8-9 u, prn (with each meal)",,,N,,,,20563.0,9.0,IU,,,2022,Q3,Lip swelling,,2022,Q3,1,I,,20220726.0,20220805,20220805,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202207012305,ELI LILLY AND CO,,75.0,YR,,F,Y,98.0,KG,20220805,,CN,GB,GB,2022,Q3,Elderly
211789391,21178939,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8-9 u, prn (with each meal)",,,N,,,,20563.0,9.0,IU,,,2022,Q3,Chest discomfort,,2022,Q3,1,I,,20220726.0,20220805,20220805,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202207012305,ELI LILLY AND CO,,75.0,YR,,F,Y,98.0,KG,20220805,,CN,GB,GB,2022,Q3,Elderly
211789391,21178939,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8-9 u, prn (with each meal)",,,N,,,,20563.0,9.0,IU,,,2022,Q3,Vision blurred,,2022,Q3,1,I,,20220726.0,20220805,20220805,EXP,,GB-ELI_LILLY_AND_COMPANY-GB202207012305,ELI LILLY AND CO,,75.0,YR,,F,Y,98.0,KG,20220805,,CN,GB,GB,2022,Q3,Elderly
211789642,21178964,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"9 international unit, qd",,,U,,,,,9.0,IU,Injection,QD,2022,Q3,Type 1 diabetes mellitus,,2022,Q3,2,F,20190318.0,20220726.0,20220805,20220810,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-027741,BRISTOL MYERS SQUIBB,"Karahashi T, et al. A case of multiple endocrine diseases due to combined use of nivolumab and ipilimumab. The Japanese Journal of Endocrinology 2019;95(2):779.",69.0,YR,E,M,Y,,,20220810,,MD,JP,JP,2022,Q3,Elderly
211789642,21178964,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"9 international unit, qd",,,U,,,,,9.0,IU,Injection,QD,2022,Q3,Secondary adrenocortical insufficiency,,2022,Q3,2,F,20190318.0,20220726.0,20220805,20220810,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-027741,BRISTOL MYERS SQUIBB,"Karahashi T, et al. A case of multiple endocrine diseases due to combined use of nivolumab and ipilimumab. The Japanese Journal of Endocrinology 2019;95(2):779.",69.0,YR,E,M,Y,,,20220810,,MD,JP,JP,2022,Q3,Elderly
211789642,21178964,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"9 international unit, qd",,,U,,,,,9.0,IU,Injection,QD,2022,Q3,Hyperthyroidism,,2022,Q3,2,F,20190318.0,20220726.0,20220805,20220810,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-027741,BRISTOL MYERS SQUIBB,"Karahashi T, et al. A case of multiple endocrine diseases due to combined use of nivolumab and ipilimumab. The Japanese Journal of Endocrinology 2019;95(2):779.",69.0,YR,E,M,Y,,,20220810,,MD,JP,JP,2022,Q3,Elderly
211789642,21178964,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"9 international unit, qd",,,U,,,,,9.0,IU,Injection,QD,2022,Q3,Diabetic ketoacidosis,,2022,Q3,2,F,20190318.0,20220726.0,20220805,20220810,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-027741,BRISTOL MYERS SQUIBB,"Karahashi T, et al. A case of multiple endocrine diseases due to combined use of nivolumab and ipilimumab. The Japanese Journal of Endocrinology 2019;95(2):779.",69.0,YR,E,M,Y,,,20220810,,MD,JP,JP,2022,Q3,Elderly
211789642,21178964,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"9 international unit, qd",,,U,,,,,9.0,IU,Injection,QD,2022,Q3,Adrenocortical insufficiency acute,,2022,Q3,2,F,20190318.0,20220726.0,20220805,20220810,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-027741,BRISTOL MYERS SQUIBB,"Karahashi T, et al. A case of multiple endocrine diseases due to combined use of nivolumab and ipilimumab. The Japanese Journal of Endocrinology 2019;95(2):779.",69.0,YR,E,M,Y,,,20220810,,MD,JP,JP,2022,Q3,Elderly
211789642,21178964,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"9 international unit, qd",,,U,,,,,9.0,IU,Injection,QD,2022,Q3,Central hypothyroidism,,2022,Q3,2,F,20190318.0,20220726.0,20220805,20220810,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-027741,BRISTOL MYERS SQUIBB,"Karahashi T, et al. A case of multiple endocrine diseases due to combined use of nivolumab and ipilimumab. The Japanese Journal of Endocrinology 2019;95(2):779.",69.0,YR,E,M,Y,,,20220810,,MD,JP,JP,2022,Q3,Elderly
211789642,21178964,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"9 international unit, qd",,,U,,,,,9.0,IU,Injection,QD,2022,Q3,Pyrexia,,2022,Q3,2,F,20190318.0,20220726.0,20220805,20220810,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-027741,BRISTOL MYERS SQUIBB,"Karahashi T, et al. A case of multiple endocrine diseases due to combined use of nivolumab and ipilimumab. The Japanese Journal of Endocrinology 2019;95(2):779.",69.0,YR,E,M,Y,,,20220810,,MD,JP,JP,2022,Q3,Elderly
211789642,21178964,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"9 international unit, qd",,,U,,,,,9.0,IU,Injection,QD,2022,Q3,Thyroiditis,,2022,Q3,2,F,20190318.0,20220726.0,20220805,20220810,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-BMS-2019-027741,BRISTOL MYERS SQUIBB,"Karahashi T, et al. A case of multiple endocrine diseases due to combined use of nivolumab and ipilimumab. The Japanese Journal of Endocrinology 2019;95(2):779.",69.0,YR,E,M,Y,,,20220810,,MD,JP,JP,2022,Q3,Elderly
211848921,21184892,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D484040C,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20210201.0,20220727.0,20220808,20220808,EXP,,US-ELI_LILLY_AND_COMPANY-US202207013963,ELI LILLY AND CO,,34.0,YR,,M,Y,,,20220808,,CN,US,US,2022,Q3,Young Adult
211848921,21184892,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D484040C,,20563.0,,,Injection,,2022,Q3,Cerebrovascular accident,,2022,Q3,1,I,20210201.0,20220727.0,20220808,20220808,EXP,,US-ELI_LILLY_AND_COMPANY-US202207013963,ELI LILLY AND CO,,34.0,YR,,M,Y,,,20220808,,CN,US,US,2022,Q3,Young Adult
211848921,21184892,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D484040C,,20563.0,,,Injection,,2022,Q3,Drug ineffective,,2022,Q3,1,I,20210201.0,20220727.0,20220808,20220808,EXP,,US-ELI_LILLY_AND_COMPANY-US202207013963,ELI LILLY AND CO,,34.0,YR,,M,Y,,,20220808,,CN,US,US,2022,Q3,Young Adult
211848921,21184892,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D371847A,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20210201.0,20220727.0,20220808,20220808,EXP,,US-ELI_LILLY_AND_COMPANY-US202207013963,ELI LILLY AND CO,,34.0,YR,,M,Y,,,20220808,,CN,US,US,2022,Q3,Young Adult
211848921,21184892,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D371847A,,20563.0,,,Injection,,2022,Q3,Cerebrovascular accident,,2022,Q3,1,I,20210201.0,20220727.0,20220808,20220808,EXP,,US-ELI_LILLY_AND_COMPANY-US202207013963,ELI LILLY AND CO,,34.0,YR,,M,Y,,,20220808,,CN,US,US,2022,Q3,Young Adult
211848921,21184892,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D371847A,,20563.0,,,Injection,,2022,Q3,Drug ineffective,,2022,Q3,1,I,20210201.0,20220727.0,20220808,20220808,EXP,,US-ELI_LILLY_AND_COMPANY-US202207013963,ELI LILLY AND CO,,34.0,YR,,M,Y,,,20220808,,CN,US,US,2022,Q3,Young Adult
211848921,21184892,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D341138C,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20210201.0,20220727.0,20220808,20220808,EXP,,US-ELI_LILLY_AND_COMPANY-US202207013963,ELI LILLY AND CO,,34.0,YR,,M,Y,,,20220808,,CN,US,US,2022,Q3,Young Adult
211848921,21184892,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D341138C,,20563.0,,,Injection,,2022,Q3,Cerebrovascular accident,,2022,Q3,1,I,20210201.0,20220727.0,20220808,20220808,EXP,,US-ELI_LILLY_AND_COMPANY-US202207013963,ELI LILLY AND CO,,34.0,YR,,M,Y,,,20220808,,CN,US,US,2022,Q3,Young Adult
211848921,21184892,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D341138C,,20563.0,,,Injection,,2022,Q3,Drug ineffective,,2022,Q3,1,I,20210201.0,20220727.0,20220808,20220808,EXP,,US-ELI_LILLY_AND_COMPANY-US202207013963,ELI LILLY AND CO,,34.0,YR,,M,Y,,,20220808,,CN,US,US,2022,Q3,Young Adult
211848921,21184892,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20210201.0,20220727.0,20220808,20220808,EXP,,US-ELI_LILLY_AND_COMPANY-US202207013963,ELI LILLY AND CO,,34.0,YR,,M,Y,,,20220808,,CN,US,US,2022,Q3,Young Adult
211848921,21184892,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,,,20563.0,,,Injection,,2022,Q3,Cerebrovascular accident,,2022,Q3,1,I,20210201.0,20220727.0,20220808,20220808,EXP,,US-ELI_LILLY_AND_COMPANY-US202207013963,ELI LILLY AND CO,,34.0,YR,,M,Y,,,20220808,,CN,US,US,2022,Q3,Young Adult
211848921,21184892,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,,,20563.0,,,Injection,,2022,Q3,Drug ineffective,,2022,Q3,1,I,20210201.0,20220727.0,20220808,20220808,EXP,,US-ELI_LILLY_AND_COMPANY-US202207013963,ELI LILLY AND CO,,34.0,YR,,M,Y,,,20220808,,CN,US,US,2022,Q3,Young Adult
211861841,21186184,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Hyponatraemia,,2022,Q3,1,I,20220609.0,20220729.0,20220808,20220808,EXP,,US-TEVA-2022-US-2062008,TEVA,,83.0,YR,E,F,Y,54.4,KG,20220808,,MD,US,US,2022,Q3,Elderly
211882961,21188296,37,C,INSULINE LISPRO,,1,,,,,,,,,,,,,,2022,Q3,Post procedural haemorrhage,,2022,Q3,1,I,20220725.0,20220728.0,20220809,20220809,EXP,,US-ROCHE-3148830,ROCHE,,75.0,YR,,,Y,,,20220809,,MD,US,,2022,Q3,Elderly
211902031,21190203,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Death,,2022,Q3,1,I,20220807.0,,20220809,20220809,DIR,FDA-CDER-CTU-2022-63294,,FDA-CTU,,64.0,YR,,F,N,68.95,KG,20220809,N,CN,US,,2022,Q3,Adult
211914791,21191479,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Pneumocystis jirovecii pneumonia,,2022,Q3,1,I,20200715.0,20220805.0,20220809,20220809,EXP,,US-BAXTER-2021BAX007976,BAXTER,,69.0,YR,,M,Y,103.1,KG,20220809,,MD,US,US,2022,Q3,Elderly
211914791,21191479,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Pneumocystis jirovecii pneumonia,,2022,Q3,1,I,20200715.0,20220805.0,20220809,20220809,EXP,,US-BAXTER-2021BAX007976,BAXTER,,69.0,YR,,M,Y,103.1,KG,20220809,,MD,US,US,2022,Q3,Elderly
211930761,21193076,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 E/ml,,,,,,,,,,,,2022,Q3,Pancreatitis,,2022,Q3,1,I,20220723.0,20220805.0,20220810,20220810,EXP,,AT-ROCHE-3150538,ROCHE,,52.0,YR,,M,Y,58.0,KG,20220810,,MD,AT,,2022,Q3,Adult
211930761,21193076,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 E/ml,,,,,,,,,,,,2022,Q3,Pneumonia,,2022,Q3,1,I,20220723.0,20220805.0,20220810,20220810,EXP,,AT-ROCHE-3150538,ROCHE,,52.0,YR,,M,Y,58.0,KG,20220810,,MD,AT,,2022,Q3,Adult
211947321,21194732,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,Unknown,,,10.0,IU,,TID,2022,Q3,Diarrhoea,,2022,Q3,1,I,20220701.0,20220802.0,20220810,20220810,EXP,,CN-AstraZeneca-2022A278945,ASTRAZENECA,,60.0,YR,,M,Y,85.0,KG,20220810,,CN,CN,,2022,Q3,Adult
211947321,21194732,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,Unknown,,,10.0,IU,,TID,2022,Q3,Heart rate increased,,2022,Q3,1,I,20220701.0,20220802.0,20220810,20220810,EXP,,CN-AstraZeneca-2022A278945,ASTRAZENECA,,60.0,YR,,M,Y,85.0,KG,20220810,,CN,CN,,2022,Q3,Adult
211952541,21195254,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Death,,2022,Q3,1,I,,,20220809,20220809,DIR,FDA-CDER-CTU-2022-63597,,FDA-CTU,,73.0,YR,,F,N,150.1,LBS,20220809,N,,US,,2022,Q3,Elderly
211953221,21195322,2,C,INSULIN LISPRO BS,,2,Subcutaneous,"8 international unit, tid",,,,,,,,8.0,IU,Injection,TID,2022,Q3,Completed suicide,,2022,Q3,1,I,,20220804.0,20220810,20220810,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202207010740,ELI LILLY AND CO,,35.0,YR,,F,Y,,,20220810,,CN,JP,JP,2022,Q3,Adult
211953221,21195322,2,C,INSULIN LISPRO BS,,2,Subcutaneous,"8 international unit, tid",,,,,,,,8.0,IU,Injection,TID,2022,Q3,Hypoglycaemia,,2022,Q3,1,I,,20220804.0,20220810,20220810,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202207010740,ELI LILLY AND CO,,35.0,YR,,F,Y,,,20220810,,CN,JP,JP,2022,Q3,Adult
211953221,21195322,2,C,INSULIN LISPRO BS,,2,Subcutaneous,"8 international unit, tid",,,,,,,,8.0,IU,Injection,TID,2022,Q3,Incorrect dose administered,,2022,Q3,1,I,,20220804.0,20220810,20220810,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202207010740,ELI LILLY AND CO,,35.0,YR,,F,Y,,,20220810,,CN,JP,JP,2022,Q3,Adult
212002651,21200265,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,Y,,"T2H001230,T2H001231,T2H001232,01233",,,8.0,IU,Injection,Q8H,2022,Q3,Hypokalaemia,,2022,Q3,1,I,20220621.0,20220801.0,20220811,20220811,EXP,,CN-EMD Serono-9342067,EMD SERONO INC,,58.0,YR,A,M,Y,,,20220811,,HP,CN,,2022,Q3,Adult
212002651,21200265,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,Y,,"T2H001230,T2H001231,T2H001232,01233",,,8.0,IU,Injection,Q8H,2022,Q3,Left ventricular hypertrophy,,2022,Q3,1,I,20220621.0,20220801.0,20220811,20220811,EXP,,CN-EMD Serono-9342067,EMD SERONO INC,,58.0,YR,A,M,Y,,,20220811,,HP,CN,,2022,Q3,Adult
212002651,21200265,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,Y,,"T2H001230,T2H001231,T2H001232,01233",,,8.0,IU,Injection,Q8H,2022,Q3,Renal cyst,,2022,Q3,1,I,20220621.0,20220801.0,20220811,20220811,EXP,,CN-EMD Serono-9342067,EMD SERONO INC,,58.0,YR,A,M,Y,,,20220811,,HP,CN,,2022,Q3,Adult
212002651,21200265,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,Y,,"T2H001230,T2H001231,T2H001232,01233",,,8.0,IU,Injection,Q8H,2022,Q3,Hypocalcaemia,,2022,Q3,1,I,20220621.0,20220801.0,20220811,20220811,EXP,,CN-EMD Serono-9342067,EMD SERONO INC,,58.0,YR,A,M,Y,,,20220811,,HP,CN,,2022,Q3,Adult
212002651,21200265,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,Y,,"T2H001230,T2H001231,T2H001232,01233",,,8.0,IU,Injection,Q8H,2022,Q3,Demyelination,,2022,Q3,1,I,20220621.0,20220801.0,20220811,20220811,EXP,,CN-EMD Serono-9342067,EMD SERONO INC,,58.0,YR,A,M,Y,,,20220811,,HP,CN,,2022,Q3,Adult
212002651,21200265,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,Y,,"T2H001230,T2H001231,T2H001232,01233",,,8.0,IU,Injection,Q8H,2022,Q3,Mitral valve incompetence,,2022,Q3,1,I,20220621.0,20220801.0,20220811,20220811,EXP,,CN-EMD Serono-9342067,EMD SERONO INC,,58.0,YR,A,M,Y,,,20220811,,HP,CN,,2022,Q3,Adult
212002651,21200265,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,Y,,"T2H001230,T2H001231,T2H001232,01233",,,8.0,IU,Injection,Q8H,2022,Q3,Hypoglycaemic coma,,2022,Q3,1,I,20220621.0,20220801.0,20220811,20220811,EXP,,CN-EMD Serono-9342067,EMD SERONO INC,,58.0,YR,A,M,Y,,,20220811,,HP,CN,,2022,Q3,Adult
212002651,21200265,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,Y,,"T2H001230,T2H001231,T2H001232,01233",,,8.0,IU,Injection,Q8H,2022,Q3,Left ventricular end-diastolic pressure decreased,,2022,Q3,1,I,20220621.0,20220801.0,20220811,20220811,EXP,,CN-EMD Serono-9342067,EMD SERONO INC,,58.0,YR,A,M,Y,,,20220811,,HP,CN,,2022,Q3,Adult
212009641,21200964,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,20563.0,,,,,2022,Q3,Hypoglycaemic coma,,2022,Q3,1,I,,20220731.0,20220811,20220811,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202208002637,ELI LILLY AND CO,Kong Y; Zhang Y; Cheng L; Ling C; Hu X..Recurrent hypoglycemic coma and diabetic ketoacidosis caused by insulin antibody. A rare case of type 1 diabetes mellitus..Revista Medica de Chile 2022;150(1):115-119.,45.0,YR,,M,Y,67.0,KG,20220811,,HP,CN,CN,2022,Q3,Adult
212009641,21200964,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,20563.0,,,,,2022,Q3,Diabetic ketoacidosis,,2022,Q3,1,I,,20220731.0,20220811,20220811,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202208002637,ELI LILLY AND CO,Kong Y; Zhang Y; Cheng L; Ling C; Hu X..Recurrent hypoglycemic coma and diabetic ketoacidosis caused by insulin antibody. A rare case of type 1 diabetes mellitus..Revista Medica de Chile 2022;150(1):115-119.,45.0,YR,,M,Y,67.0,KG,20220811,,HP,CN,CN,2022,Q3,Adult
212009641,21200964,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, unknown",,,,,,,20563.0,,,,,2022,Q3,Anti-insulin antibody,,2022,Q3,1,I,,20220731.0,20220811,20220811,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202208002637,ELI LILLY AND CO,Kong Y; Zhang Y; Cheng L; Ling C; Hu X..Recurrent hypoglycemic coma and diabetic ketoacidosis caused by insulin antibody. A rare case of type 1 diabetes mellitus..Revista Medica de Chile 2022;150(1):115-119.,45.0,YR,,M,Y,67.0,KG,20220811,,HP,CN,CN,2022,Q3,Adult
212009861,21200986,6,C,INSULIN LISPRO,,1,,,,,,,,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,20220726.0,,20220810,20220810,DIR,FDA-CDER-CTU-2022-63993,,FDA-CTU,,56.0,YR,,M,N,,,20220810,Y,PH,US,,2022,Q3,Adult
212009861,21200986,6,C,INSULIN LISPRO,,1,,,,,,,,,,,,,,2022,Q3,Infection masked,,2022,Q3,1,I,20220726.0,,20220810,20220810,DIR,FDA-CDER-CTU-2022-63993,,FDA-CTU,,56.0,YR,,M,N,,,20220810,Y,PH,US,,2022,Q3,Adult
212009861,21200986,6,C,INSULIN LISPRO,,1,,,,,,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,1,I,20220726.0,,20220810,20220810,DIR,FDA-CDER-CTU-2022-63993,,FDA-CTU,,56.0,YR,,M,N,,,20220810,Y,PH,US,,2022,Q3,Adult
212009861,21200986,6,C,INSULIN LISPRO,,1,,,,,,,,,,,,,,2022,Q3,Dizziness,,2022,Q3,1,I,20220726.0,,20220810,20220810,DIR,FDA-CDER-CTU-2022-63993,,FDA-CTU,,56.0,YR,,M,N,,,20220810,Y,PH,US,,2022,Q3,Adult
212009861,21200986,6,C,INSULIN LISPRO,,1,,,,,,,,,,,,,,2022,Q3,Dialysis,,2022,Q3,1,I,20220726.0,,20220810,20220810,DIR,FDA-CDER-CTU-2022-63993,,FDA-CTU,,56.0,YR,,M,N,,,20220810,Y,PH,US,,2022,Q3,Adult
212014781,21201478,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Peripheral swelling,,2022,Q3,1,I,20220412.0,20220614.0,20220811,20220811,PER,,US-AURINIA PHARMACEUTICALS INC.-AUR-001591,AURINIA PHARMACEUTICALS,,46.0,YR,,F,Y,68.0,KG,20220811,,CN,US,US,2022,Q3,Adult
212033903,21203390,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 units/ml,,,U,,,,,,,Unknown,QD,2022,Q3,Ejection fraction decreased,,2022,Q3,3,F,20220621.0,20220913.0,20220811,20220920,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-063886,BRISTOL MYERS SQUIBB,,56.0,YR,A,M,Y,,,20220920,,HP,US,US,2022,Q3,Adult
212033903,21203390,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 units/ml,,,U,,,,,,,Unknown,QD,2022,Q3,Heat exhaustion,,2022,Q3,3,F,20220621.0,20220913.0,20220811,20220920,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-063886,BRISTOL MYERS SQUIBB,,56.0,YR,A,M,Y,,,20220920,,HP,US,US,2022,Q3,Adult
212033903,21203390,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 units/ml,,,U,,,,,,,Unknown,QD,2022,Q3,Acute myocardial infarction,,2022,Q3,3,F,20220621.0,20220913.0,20220811,20220920,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-063886,BRISTOL MYERS SQUIBB,,56.0,YR,A,M,Y,,,20220920,,HP,US,US,2022,Q3,Adult
212063421,21206342,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,15-27 units 3 times daily before meals per sliding scale,,,,,,,,,,,TID,2022,Q3,Pancreatitis acute,,2022,Q3,1,I,20220807.0,20220808.0,20220812,20220812,EXP,,US-PFIZER INC-PV202200039661,PFIZER,,35.0,YR,,M,Y,129.5,KG,20220812,,MD,US,US,2022,Q3,Adult
212065901,21206590,9,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,according to glycemia,,,,,,,,,,,,2022,Q3,Photosensitivity reaction,,2022,Q3,1,I,20220711.0,20220808.0,20220812,20220812,EXP,FR-AFSSAPS-AM20221910,FR-SANOFI US-2022SA330407,SANOFI AVENTIS,,75.0,YR,E,M,Y,74.0,KG,20220812,,PH,FR,FR,2022,Q3,Elderly
212073491,21207349,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Headache,,2022,Q3,1,I,20220806.0,20220810.0,20220812,20220812,PER,,US-PFIZER INC-202201051660,PFIZER,,65.0,YR,,F,Y,,,20220812,,HP,US,US,2022,Q3,Elderly
212073491,21207349,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Fatigue,,2022,Q3,1,I,20220806.0,20220810.0,20220812,20220812,PER,,US-PFIZER INC-202201051660,PFIZER,,65.0,YR,,F,Y,,,20220812,,HP,US,US,2022,Q3,Elderly
212073491,21207349,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Dyspepsia,,2022,Q3,1,I,20220806.0,20220810.0,20220812,20220812,PER,,US-PFIZER INC-202201051660,PFIZER,,65.0,YR,,F,Y,,,20220812,,HP,US,US,2022,Q3,Elderly
212073491,21207349,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Arthralgia,,2022,Q3,1,I,20220806.0,20220810.0,20220812,20220812,PER,,US-PFIZER INC-202201051660,PFIZER,,65.0,YR,,F,Y,,,20220812,,HP,US,US,2022,Q3,Elderly
212101342,21210134,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2022,Q3,Drug ineffective,,2022,Q3,2,F,,20220812.0,20220814,20220911,PER,,US-SA-2022SA331424,SANOFI AVENTIS,,55.0,YR,A,M,Y,,,20220911,,HP,US,US,2022,Q3,Adult
212101342,21210134,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2022,Q3,Product storage error,,2022,Q3,2,F,,20220812.0,20220814,20220911,PER,,US-SA-2022SA331424,SANOFI AVENTIS,,55.0,YR,A,M,Y,,,20220911,,HP,US,US,2022,Q3,Adult
212101342,21210134,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2022,Q3,Blood glucose increased,,2022,Q3,2,F,,20220812.0,20220814,20220911,PER,,US-SA-2022SA331424,SANOFI AVENTIS,,55.0,YR,A,M,Y,,,20220911,,HP,US,US,2022,Q3,Adult
212116071,21211607,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D379508A,,20563.0,,,Injection,,2022,Q3,Fall,,2022,Q3,1,I,20220501.0,20220802.0,20220815,20220815,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005250,ELI LILLY AND CO,,87.0,YR,,F,Y,,,20220815,,CN,US,US,2022,Q3,Elderly
212116071,21211607,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D379508A,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220501.0,20220802.0,20220815,20220815,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005250,ELI LILLY AND CO,,87.0,YR,,F,Y,,,20220815,,CN,US,US,2022,Q3,Elderly
212116071,21211607,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D379508A,,20563.0,,,Injection,,2022,Q3,Blood lactic acid increased,,2022,Q3,1,I,20220501.0,20220802.0,20220815,20220815,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005250,ELI LILLY AND CO,,87.0,YR,,F,Y,,,20220815,,CN,US,US,2022,Q3,Elderly
212116071,21211607,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D379508A,,20563.0,,,Injection,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,1,I,20220501.0,20220802.0,20220815,20220815,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005250,ELI LILLY AND CO,,87.0,YR,,F,Y,,,20220815,,CN,US,US,2022,Q3,Elderly
212116071,21211607,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D379508A,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220501.0,20220802.0,20220815,20220815,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005250,ELI LILLY AND CO,,87.0,YR,,F,Y,,,20220815,,CN,US,US,2022,Q3,Elderly
212116071,21211607,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D379508A,,20563.0,,,Injection,,2022,Q3,Incorrect product administration duration,,2022,Q3,1,I,20220501.0,20220802.0,20220815,20220815,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005250,ELI LILLY AND CO,,87.0,YR,,F,Y,,,20220815,,CN,US,US,2022,Q3,Elderly
212116071,21211607,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D379508A,,20563.0,,,Injection,,2022,Q3,Balance disorder,,2022,Q3,1,I,20220501.0,20220802.0,20220815,20220815,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005250,ELI LILLY AND CO,,87.0,YR,,F,Y,,,20220815,,CN,US,US,2022,Q3,Elderly
212126311,21212631,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Other,OTHER QUANTITY : 30 Injection(s);?OTHER FREQUENCY : daily insulin pump;?OTHER ROUTE : injected via insulin pump;?,,,Y,Y,? have box,20240930.0,99.0,,,Injection,999,2022,Q3,Product substitution issue,,2022,Q3,1,I,20220814.0,,20220814,20220814,DIR,627431,,FDA-CTU,,42.0,YR,,M,N,65.25,KG,20220814,N,CN,US,,2022,Q3,Adult
212126311,21212631,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Other,OTHER QUANTITY : 30 Injection(s);?OTHER FREQUENCY : daily insulin pump;?OTHER ROUTE : injected via insulin pump;?,,,Y,Y,? have box,20240930.0,99.0,,,Injection,999,2022,Q3,Eye pain,,2022,Q3,1,I,20220814.0,,20220814,20220814,DIR,627431,,FDA-CTU,,42.0,YR,,M,N,65.25,KG,20220814,N,CN,US,,2022,Q3,Adult
212187581,21218758,5,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,Y,,,,21017.0,,,Injection,,2022,Q3,Therapeutic response delayed,,2022,Q3,1,I,20220812.0,20220812.0,20220816,20220816,PER,,US-ELI_LILLY_AND_COMPANY-US202208007363,ELI LILLY AND CO,,88.0,YR,,F,Y,,,20220816,,CN,US,US,2022,Q3,Elderly
212187581,21218758,5,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,Y,,,,21017.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220812.0,20220812.0,20220816,20220816,PER,,US-ELI_LILLY_AND_COMPANY-US202208007363,ELI LILLY AND CO,,88.0,YR,,F,Y,,,20220816,,CN,US,US,2022,Q3,Elderly
212229031,21222903,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Death,,2022,Q3,1,I,20220806.0,,20220816,20220816,DIR,FDA-CDER-CTU-2022-65722,,FDA-CTU,,71.0,YR,,F,N,,,20220816,Y,PH,US,,2022,Q3,Elderly
212238631,21223863,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (100 U/mL once after meals and at bedtime),,,U,U,,,,,,Injection,,2022,Q3,Myopathy toxic,,2022,Q3,1,I,,20220808.0,20220817,20220817,EXP,,US-MYLANLABS-2022M1086206,MYLAN,"Paramanathan P, Abbas M, Valchev P, Itua P, Taravati P. A case of statin-induced myopathy. Consultant 2021;61(5):1-3.",79.0,YR,,M,Y,,,20220817,,HP,US,US,2022,Q3,Elderly
212298761,21229876,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,Inject 15-27 units three times daily before meals per sliding scale. Discard pen 28 days after first,,,,,,,,,,,TID,2022,Q3,Febrile neutropenia,,2022,Q3,1,I,20220812.0,20220812.0,20220818,20220818,EXP,,US-PFIZER INC-PV202200043015,PFIZER,,35.0,YR,,M,Y,124.4,KG,20220818,,MD,US,US,2022,Q3,Adult
212305031,21230503,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,100U/ML,,,,,,,,,,,,2022,Q3,Palpitations,,2022,Q3,1,I,20220812.0,20220817.0,20220818,20220818,EXP,,US-ABBVIE-22K-163-4509402-00,ABBVIE,,58.0,YR,,M,Y,,,20220818,,CN,COUNTRY NOT SPECIFIED,US,2022,Q3,Adult
212318821,21231882,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 U/mL once after meals and at bedtime,,,D,,,,,,,,BID,2022,Q3,Myopathy toxic,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,US-APOTEX-2022AP011149,APOTEX,"Paramanathan P, Abbas M, Valchev P, Itua P, Taravati P.. A Case of Statin-Induced Myopathy. Consultant. 2021;61(5):E3-E5",79.0,YR,,M,Y,,,20220819,,HP,US,US,2022,Q3,Elderly
212319511,21231951,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Lid lag,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,GR-ALS-000763,ALIGNSCIENCE PHARMA,"Xenou M., Zoupas I., Lygnos D., Fousteris E. Diabetic ketoacidosis as first presentation of latent autoimmune diabetes in adults in a patient with hashitoxicosis as first presentation of Hashimoto^s thyroiditis: a case report. J Med Case Rep 2022; 16(1):297. doi:10.1186/s13256-022-03523-3.",29.0,YR,A,M,Y,,,20220818,,HP,GR,GR,2022,Q3,Young Adult
212319511,21231951,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Hashitoxicosis,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,GR-ALS-000763,ALIGNSCIENCE PHARMA,"Xenou M., Zoupas I., Lygnos D., Fousteris E. Diabetic ketoacidosis as first presentation of latent autoimmune diabetes in adults in a patient with hashitoxicosis as first presentation of Hashimoto^s thyroiditis: a case report. J Med Case Rep 2022; 16(1):297. doi:10.1186/s13256-022-03523-3.",29.0,YR,A,M,Y,,,20220818,,HP,GR,GR,2022,Q3,Young Adult
212319511,21231951,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Tachycardia,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,GR-ALS-000763,ALIGNSCIENCE PHARMA,"Xenou M., Zoupas I., Lygnos D., Fousteris E. Diabetic ketoacidosis as first presentation of latent autoimmune diabetes in adults in a patient with hashitoxicosis as first presentation of Hashimoto^s thyroiditis: a case report. J Med Case Rep 2022; 16(1):297. doi:10.1186/s13256-022-03523-3.",29.0,YR,A,M,Y,,,20220818,,HP,GR,GR,2022,Q3,Young Adult
212319511,21231951,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Off label use,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,GR-ALS-000763,ALIGNSCIENCE PHARMA,"Xenou M., Zoupas I., Lygnos D., Fousteris E. Diabetic ketoacidosis as first presentation of latent autoimmune diabetes in adults in a patient with hashitoxicosis as first presentation of Hashimoto^s thyroiditis: a case report. J Med Case Rep 2022; 16(1):297. doi:10.1186/s13256-022-03523-3.",29.0,YR,A,M,Y,,,20220818,,HP,GR,GR,2022,Q3,Young Adult
212319511,21231951,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Disease progression,,2022,Q3,1,I,,20220808.0,20220819,20220819,EXP,,GR-ALS-000763,ALIGNSCIENCE PHARMA,"Xenou M., Zoupas I., Lygnos D., Fousteris E. Diabetic ketoacidosis as first presentation of latent autoimmune diabetes in adults in a patient with hashitoxicosis as first presentation of Hashimoto^s thyroiditis: a case report. J Med Case Rep 2022; 16(1):297. doi:10.1186/s13256-022-03523-3.",29.0,YR,A,M,Y,,,20220818,,HP,GR,GR,2022,Q3,Young Adult
212349331,21234933,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,,,2022,Q3,Product dose omission issue,,2022,Q3,1,I,20220401.0,20220817.0,20220821,20220821,PER,,US-ELI_LILLY_AND_COMPANY-US202208009774,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20220821,,CN,US,US,2022,Q3,Adult
212349331,21234933,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,,,2022,Q3,Injection site pain,,2022,Q3,1,I,20220401.0,20220817.0,20220821,20220821,PER,,US-ELI_LILLY_AND_COMPANY-US202208009774,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20220821,,CN,US,US,2022,Q3,Adult
212380001,21238000,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Injection,,2022,Q3,Diarrhoea,,2022,Q3,1,I,20220810.0,20220816.0,20220822,20220822,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-091229,BRISTOL MYERS SQUIBB,,75.0,YR,E,M,Y,218.0,KG,20220822,,HP,US,US,2022,Q3,Elderly
212394092,21239409,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,"pen-injector, Inject 15-27 U 3x daily before meals per SS. Discard pen 28 days after 1st use",,,,,,,,,,,TID,2022,Q3,Febrile neutropenia,,2022,Q3,2,F,20220817.0,20220826.0,20220822,20220831,EXP,,US-PFIZER INC-PV202200045440,PFIZER,,35.0,YR,,M,Y,121.2,KG,20220831,,MD,US,US,2022,Q3,Adult
212394741,21239474,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 u, tid with meals",,,,,D484040C,,20563.0,14.0,IU,Injection,TID,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220623.0,20220810.0,20220822,20220822,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005444,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220822,,CN,US,US,2022,Q3,Adult
212394741,21239474,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 u, tid with meals",,,,,D484040C,,20563.0,14.0,IU,Injection,TID,2022,Q3,Exostosis,,2022,Q3,1,I,20220623.0,20220810.0,20220822,20220822,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005444,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220822,,CN,US,US,2022,Q3,Adult
212394741,21239474,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 u, tid with meals",,,,,D484040C,,20563.0,14.0,IU,Injection,TID,2022,Q3,Wrong technique in product usage process,,2022,Q3,1,I,20220623.0,20220810.0,20220822,20220822,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005444,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220822,,CN,US,US,2022,Q3,Adult
212394741,21239474,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 u, tid with meals",,,,,D484040C,,20563.0,14.0,IU,Injection,TID,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220623.0,20220810.0,20220822,20220822,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005444,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220822,,CN,US,US,2022,Q3,Adult
212394741,21239474,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 u, tid with meals",,,,,D484040C,,20563.0,14.0,IU,Injection,TID,2022,Q3,Exostosis,,2022,Q3,1,I,20220623.0,20220810.0,20220822,20220822,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005444,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220822,,CN,US,US,2022,Q3,Adult
212394741,21239474,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 u, tid with meals",,,,,D484040C,,20563.0,14.0,IU,Injection,TID,2022,Q3,Wrong technique in product usage process,,2022,Q3,1,I,20220623.0,20220810.0,20220822,20220822,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005444,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220822,,CN,US,US,2022,Q3,Adult
212394741,21239474,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, daily sliding scale bedtime",,,,,D484040C,,20563.0,,,Injection,QD,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220623.0,20220810.0,20220822,20220822,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005444,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220822,,CN,US,US,2022,Q3,Adult
212394741,21239474,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, daily sliding scale bedtime",,,,,D484040C,,20563.0,,,Injection,QD,2022,Q3,Exostosis,,2022,Q3,1,I,20220623.0,20220810.0,20220822,20220822,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005444,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220822,,CN,US,US,2022,Q3,Adult
212394741,21239474,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, daily sliding scale bedtime",,,,,D484040C,,20563.0,,,Injection,QD,2022,Q3,Wrong technique in product usage process,,2022,Q3,1,I,20220623.0,20220810.0,20220822,20220822,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005444,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220822,,CN,US,US,2022,Q3,Adult
212394741,21239474,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, daily sliding scale bedtime",,,,,D484040C,,20563.0,,,Injection,QD,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220623.0,20220810.0,20220822,20220822,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005444,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220822,,CN,US,US,2022,Q3,Adult
212394741,21239474,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, daily sliding scale bedtime",,,,,D484040C,,20563.0,,,Injection,QD,2022,Q3,Exostosis,,2022,Q3,1,I,20220623.0,20220810.0,20220822,20220822,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005444,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220822,,CN,US,US,2022,Q3,Adult
212394741,21239474,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, daily sliding scale bedtime",,,,,D484040C,,20563.0,,,Injection,QD,2022,Q3,Wrong technique in product usage process,,2022,Q3,1,I,20220623.0,20220810.0,20220822,20220822,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005444,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220822,,CN,US,US,2022,Q3,Adult
212394741,21239474,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 u, tid with meals",,,,,D484040C,,20563.0,14.0,IU,Injection,TID,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220623.0,20220810.0,20220822,20220822,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005444,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220822,,CN,US,US,2022,Q3,Adult
212394741,21239474,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 u, tid with meals",,,,,D484040C,,20563.0,14.0,IU,Injection,TID,2022,Q3,Exostosis,,2022,Q3,1,I,20220623.0,20220810.0,20220822,20220822,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005444,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220822,,CN,US,US,2022,Q3,Adult
212394741,21239474,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 u, tid with meals",,,,,D484040C,,20563.0,14.0,IU,Injection,TID,2022,Q3,Wrong technique in product usage process,,2022,Q3,1,I,20220623.0,20220810.0,20220822,20220822,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005444,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220822,,CN,US,US,2022,Q3,Adult
212394741,21239474,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 u, tid with meals",,,,,D484040C,,20563.0,14.0,IU,Injection,TID,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220623.0,20220810.0,20220822,20220822,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005444,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220822,,CN,US,US,2022,Q3,Adult
212394741,21239474,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 u, tid with meals",,,,,D484040C,,20563.0,14.0,IU,Injection,TID,2022,Q3,Exostosis,,2022,Q3,1,I,20220623.0,20220810.0,20220822,20220822,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005444,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220822,,CN,US,US,2022,Q3,Adult
212394741,21239474,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 u, tid with meals",,,,,D484040C,,20563.0,14.0,IU,Injection,TID,2022,Q3,Wrong technique in product usage process,,2022,Q3,1,I,20220623.0,20220810.0,20220822,20220822,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005444,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220822,,CN,US,US,2022,Q3,Adult
212394741,21239474,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, daily sliding scale bedtime",,,,,D484040C,,20563.0,,,Injection,QD,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220623.0,20220810.0,20220822,20220822,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005444,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220822,,CN,US,US,2022,Q3,Adult
212394741,21239474,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, daily sliding scale bedtime",,,,,D484040C,,20563.0,,,Injection,QD,2022,Q3,Exostosis,,2022,Q3,1,I,20220623.0,20220810.0,20220822,20220822,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005444,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220822,,CN,US,US,2022,Q3,Adult
212394741,21239474,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, daily sliding scale bedtime",,,,,D484040C,,20563.0,,,Injection,QD,2022,Q3,Wrong technique in product usage process,,2022,Q3,1,I,20220623.0,20220810.0,20220822,20220822,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005444,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220822,,CN,US,US,2022,Q3,Adult
212394741,21239474,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, daily sliding scale bedtime",,,,,D484040C,,20563.0,,,Injection,QD,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220623.0,20220810.0,20220822,20220822,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005444,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220822,,CN,US,US,2022,Q3,Adult
212394741,21239474,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, daily sliding scale bedtime",,,,,D484040C,,20563.0,,,Injection,QD,2022,Q3,Exostosis,,2022,Q3,1,I,20220623.0,20220810.0,20220822,20220822,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005444,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220822,,CN,US,US,2022,Q3,Adult
212394741,21239474,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, daily sliding scale bedtime",,,,,D484040C,,20563.0,,,Injection,QD,2022,Q3,Wrong technique in product usage process,,2022,Q3,1,I,20220623.0,20220810.0,20220822,20220822,EXP,,US-ELI_LILLY_AND_COMPANY-US202208005444,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220822,,CN,US,US,2022,Q3,Adult
212439741,21243974,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Death,,2022,Q3,1,I,20220806.0,20220816.0,20220823,20220823,EXP,,US-BAYER-2022A115540,BAYER,,71.0,YR,E,F,Y,,,20220823,,PH,US,US,2022,Q3,Elderly
212468181,21246818,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D473104C,,20563.0,,,Injection,,2022,Q3,Incorrect dose administered,,2022,Q3,1,I,20220724.0,20220725.0,20220824,20220824,PER,,US-ELI_LILLY_AND_COMPANY-US202207011813,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20220824,,CN,US,US,2022,Q3,Elderly
212504721,21250472,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"13 u, prn",,,U,,,,20563.0,13.0,IU,Injection,,2022,Q3,Product dose omission issue,,2022,Q3,1,I,20220701.0,20220725.0,20220824,20220824,PER,,US-ELI_LILLY_AND_COMPANY-US202207011816,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20220824,,CN,US,US,2022,Q3,Elderly
212504721,21250472,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"13 u, prn",,,U,,,,20563.0,13.0,IU,Injection,,2022,Q3,Blood glucose decreased,,2022,Q3,1,I,20220701.0,20220725.0,20220824,20220824,PER,,US-ELI_LILLY_AND_COMPANY-US202207011816,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20220824,,CN,US,US,2022,Q3,Elderly
212504721,21250472,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"13 u, prn",,,U,,,,20563.0,13.0,IU,Injection,,2022,Q3,Product dose omission issue,,2022,Q3,1,I,20220701.0,20220725.0,20220824,20220824,PER,,US-ELI_LILLY_AND_COMPANY-US202207011816,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20220824,,CN,US,US,2022,Q3,Elderly
212504721,21250472,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"13 u, prn",,,U,,,,20563.0,13.0,IU,Injection,,2022,Q3,Blood glucose decreased,,2022,Q3,1,I,20220701.0,20220725.0,20220824,20220824,PER,,US-ELI_LILLY_AND_COMPANY-US202207011816,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20220824,,CN,US,US,2022,Q3,Elderly
212504721,21250472,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"13 u, prn",,,U,,D420813A,,20563.0,13.0,IU,Injection,,2022,Q3,Product dose omission issue,,2022,Q3,1,I,20220701.0,20220725.0,20220824,20220824,PER,,US-ELI_LILLY_AND_COMPANY-US202207011816,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20220824,,CN,US,US,2022,Q3,Elderly
212504721,21250472,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"13 u, prn",,,U,,D420813A,,20563.0,13.0,IU,Injection,,2022,Q3,Blood glucose decreased,,2022,Q3,1,I,20220701.0,20220725.0,20220824,20220824,PER,,US-ELI_LILLY_AND_COMPANY-US202207011816,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20220824,,CN,US,US,2022,Q3,Elderly
212504721,21250472,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"13 u, prn",,,U,,D420813A,,20563.0,13.0,IU,Injection,,2022,Q3,Product dose omission issue,,2022,Q3,1,I,20220701.0,20220725.0,20220824,20220824,PER,,US-ELI_LILLY_AND_COMPANY-US202207011816,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20220824,,CN,US,US,2022,Q3,Elderly
212504721,21250472,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"13 u, prn",,,U,,D420813A,,20563.0,13.0,IU,Injection,,2022,Q3,Blood glucose decreased,,2022,Q3,1,I,20220701.0,20220725.0,20220824,20220824,PER,,US-ELI_LILLY_AND_COMPANY-US202207011816,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20220824,,CN,US,US,2022,Q3,Elderly
212541801,21254180,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,Inject 12 units under the skin 3 times a day before meals AND PLUS 0 to 8 units 4 times per day per,,,,,,,,,,Injection,,2022,Q3,Febrile neutropenia,,2022,Q3,1,I,20220822.0,20220823.0,20220825,20220825,EXP,,US-PFIZER INC-PV202200049269,PFIZER,,34.0,YR,,M,Y,88.9,KG,20220825,,MD,US,US,2022,Q3,Young Adult
212571782,21257178,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q3,Cataract,,2022,Q3,2,F,20220718.0,20220829.0,20220826,20220901,EXP,,JP-KADMON-JP-KAD-22-00672,KADMON,,47.0,YR,,M,Y,,,20220901,,MD,JP,JP,2022,Q3,Adult
212571782,21257178,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q3,Pneumonia,,2022,Q3,2,F,20220718.0,20220829.0,20220826,20220901,EXP,,JP-KADMON-JP-KAD-22-00672,KADMON,,47.0,YR,,M,Y,,,20220901,,MD,JP,JP,2022,Q3,Adult
212583241,21258324,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50 u, bid",,,,,D456541A,,20563.0,50.0,IU,Injection,BID,2022,Q3,Product dose omission issue,,2022,Q3,1,I,,20220728.0,20220826,20220826,PER,,US-ELI_LILLY_AND_COMPANY-US202207013287,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20220826,,CN,US,US,2022,Q3,Adult
212583241,21258324,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50 u, bid",,,,,D456541A,,20563.0,50.0,IU,Injection,BID,2022,Q3,Blood glucose increased,,2022,Q3,1,I,,20220728.0,20220826,20220826,PER,,US-ELI_LILLY_AND_COMPANY-US202207013287,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20220826,,CN,US,US,2022,Q3,Adult
212583241,21258324,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50 u, bid",,,,,D456541A,,20563.0,50.0,IU,Injection,BID,2022,Q3,Product dose omission issue,,2022,Q3,1,I,,20220728.0,20220826,20220826,PER,,US-ELI_LILLY_AND_COMPANY-US202207013287,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20220826,,CN,US,US,2022,Q3,Adult
212583241,21258324,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50 u, bid",,,,,D456541A,,20563.0,50.0,IU,Injection,BID,2022,Q3,Blood glucose increased,,2022,Q3,1,I,,20220728.0,20220826,20220826,PER,,US-ELI_LILLY_AND_COMPANY-US202207013287,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20220826,,CN,US,US,2022,Q3,Adult
212583241,21258324,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50 u, bid",,,,,,,20563.0,50.0,IU,Injection,BID,2022,Q3,Product dose omission issue,,2022,Q3,1,I,,20220728.0,20220826,20220826,PER,,US-ELI_LILLY_AND_COMPANY-US202207013287,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20220826,,CN,US,US,2022,Q3,Adult
212583241,21258324,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50 u, bid",,,,,,,20563.0,50.0,IU,Injection,BID,2022,Q3,Blood glucose increased,,2022,Q3,1,I,,20220728.0,20220826,20220826,PER,,US-ELI_LILLY_AND_COMPANY-US202207013287,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20220826,,CN,US,US,2022,Q3,Adult
212583241,21258324,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50 u, bid",,,,,,,20563.0,50.0,IU,Injection,BID,2022,Q3,Product dose omission issue,,2022,Q3,1,I,,20220728.0,20220826,20220826,PER,,US-ELI_LILLY_AND_COMPANY-US202207013287,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20220826,,CN,US,US,2022,Q3,Adult
212583241,21258324,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50 u, bid",,,,,,,20563.0,50.0,IU,Injection,BID,2022,Q3,Blood glucose increased,,2022,Q3,1,I,,20220728.0,20220826,20220826,PER,,US-ELI_LILLY_AND_COMPANY-US202207013287,ELI LILLY AND CO,,59.0,YR,,F,Y,,,20220826,,CN,US,US,2022,Q3,Adult
212593321,21259332,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, daily plus sliding scale",,,,,,,20563.0,15.0,IU,Injection,QD,2022,Q3,Seizure,,2022,Q3,1,I,20210701.0,20220822.0,20220826,20220826,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011906,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20220826,,CN,US,US,2022,Q3,Elderly
212593321,21259332,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, daily plus sliding scale",,,,,,,20563.0,15.0,IU,Injection,QD,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20210701.0,20220822.0,20220826,20220826,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011906,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20220826,,CN,US,US,2022,Q3,Elderly
212593321,21259332,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, daily plus sliding scale",,,,,,,20563.0,15.0,IU,Injection,QD,2022,Q3,Mitral valve stenosis,,2022,Q3,1,I,20210701.0,20220822.0,20220826,20220826,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011906,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20220826,,CN,US,US,2022,Q3,Elderly
212593321,21259332,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, daily plus sliding scale",,,,,,,20563.0,15.0,IU,Injection,QD,2022,Q3,Fall,,2022,Q3,1,I,20210701.0,20220822.0,20220826,20220826,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011906,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20220826,,CN,US,US,2022,Q3,Elderly
212593321,21259332,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, daily plus sliding scale",,,,,,,20563.0,15.0,IU,Injection,QD,2022,Q3,Skin laceration,,2022,Q3,1,I,20210701.0,20220822.0,20220826,20220826,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011906,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20220826,,CN,US,US,2022,Q3,Elderly
212593321,21259332,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, daily plus sliding scale",,,,,,,20563.0,15.0,IU,Injection,QD,2022,Q3,Cardiac arrest,,2022,Q3,1,I,20210701.0,20220822.0,20220826,20220826,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011906,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20220826,,CN,US,US,2022,Q3,Elderly
212593321,21259332,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, daily plus sliding scale",,,,,,,20563.0,15.0,IU,Injection,QD,2022,Q3,Cellulitis,,2022,Q3,1,I,20210701.0,20220822.0,20220826,20220826,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011906,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20220826,,CN,US,US,2022,Q3,Elderly
212593321,21259332,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, daily plus sliding scale",,,,,,,20563.0,15.0,IU,Injection,QD,2022,Q3,Sepsis,,2022,Q3,1,I,20210701.0,20220822.0,20220826,20220826,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011906,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20220826,,CN,US,US,2022,Q3,Elderly
212593321,21259332,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, daily plus sliding scale",,,,,,,20563.0,15.0,IU,Injection,QD,2022,Q3,Renal failure,,2022,Q3,1,I,20210701.0,20220822.0,20220826,20220826,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011906,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20220826,,CN,US,US,2022,Q3,Elderly
212593321,21259332,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, daily plus sliding scale",,,,,D379507A,,20563.0,15.0,IU,Injection,QD,2022,Q3,Seizure,,2022,Q3,1,I,20210701.0,20220822.0,20220826,20220826,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011906,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20220826,,CN,US,US,2022,Q3,Elderly
212593321,21259332,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, daily plus sliding scale",,,,,D379507A,,20563.0,15.0,IU,Injection,QD,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20210701.0,20220822.0,20220826,20220826,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011906,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20220826,,CN,US,US,2022,Q3,Elderly
212593321,21259332,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, daily plus sliding scale",,,,,D379507A,,20563.0,15.0,IU,Injection,QD,2022,Q3,Mitral valve stenosis,,2022,Q3,1,I,20210701.0,20220822.0,20220826,20220826,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011906,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20220826,,CN,US,US,2022,Q3,Elderly
212593321,21259332,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, daily plus sliding scale",,,,,D379507A,,20563.0,15.0,IU,Injection,QD,2022,Q3,Fall,,2022,Q3,1,I,20210701.0,20220822.0,20220826,20220826,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011906,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20220826,,CN,US,US,2022,Q3,Elderly
212593321,21259332,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, daily plus sliding scale",,,,,D379507A,,20563.0,15.0,IU,Injection,QD,2022,Q3,Skin laceration,,2022,Q3,1,I,20210701.0,20220822.0,20220826,20220826,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011906,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20220826,,CN,US,US,2022,Q3,Elderly
212593321,21259332,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, daily plus sliding scale",,,,,D379507A,,20563.0,15.0,IU,Injection,QD,2022,Q3,Cardiac arrest,,2022,Q3,1,I,20210701.0,20220822.0,20220826,20220826,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011906,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20220826,,CN,US,US,2022,Q3,Elderly
212593321,21259332,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, daily plus sliding scale",,,,,D379507A,,20563.0,15.0,IU,Injection,QD,2022,Q3,Cellulitis,,2022,Q3,1,I,20210701.0,20220822.0,20220826,20220826,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011906,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20220826,,CN,US,US,2022,Q3,Elderly
212593321,21259332,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, daily plus sliding scale",,,,,D379507A,,20563.0,15.0,IU,Injection,QD,2022,Q3,Sepsis,,2022,Q3,1,I,20210701.0,20220822.0,20220826,20220826,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011906,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20220826,,CN,US,US,2022,Q3,Elderly
212593321,21259332,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 u, daily plus sliding scale",,,,,D379507A,,20563.0,15.0,IU,Injection,QD,2022,Q3,Renal failure,,2022,Q3,1,I,20210701.0,20220822.0,20220826,20220826,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011906,ELI LILLY AND CO,,82.0,YR,,F,Y,,,20220826,,CN,US,US,2022,Q3,Elderly
212597081,21259708,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Acute left ventricular failure,,2022,Q3,1,I,20220822.0,,20220825,20220825,DIR,FDA-CDER-CTU-2022-68386,,FDA-CTU,,76.0,YR,,M,N,,,20220825,Y,PH,US,,2022,Q3,Elderly
212597081,21259708,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Cellulitis,,2022,Q3,1,I,20220822.0,,20220825,20220825,DIR,FDA-CDER-CTU-2022-68386,,FDA-CTU,,76.0,YR,,M,N,,,20220825,Y,PH,US,,2022,Q3,Elderly
212597081,21259708,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Deep vein thrombosis,,2022,Q3,1,I,20220822.0,,20220825,20220825,DIR,FDA-CDER-CTU-2022-68386,,FDA-CTU,,76.0,YR,,M,N,,,20220825,Y,PH,US,,2022,Q3,Elderly
212608061,21260806,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D473104C,,20563.0,,,Injection,,2022,Q3,Hip fracture,,2022,Q3,1,I,20220725.0,20220815.0,20220826,20220826,EXP,,US-ELI_LILLY_AND_COMPANY-US202208007962,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20220826,,CN,US,US,2022,Q3,Adult
212608061,21260806,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D473104C,,20563.0,,,Injection,,2022,Q3,Head injury,,2022,Q3,1,I,20220725.0,20220815.0,20220826,20220826,EXP,,US-ELI_LILLY_AND_COMPANY-US202208007962,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20220826,,CN,US,US,2022,Q3,Adult
212608061,21260806,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D473104C,,20563.0,,,Injection,,2022,Q3,Fall,,2022,Q3,1,I,20220725.0,20220815.0,20220826,20220826,EXP,,US-ELI_LILLY_AND_COMPANY-US202208007962,ELI LILLY AND CO,,51.0,YR,,M,Y,,,20220826,,CN,US,US,2022,Q3,Adult
212618432,21261843,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,Unknown,,,,,,,2022,Q3,Exposure during pregnancy,,2022,Q3,2,F,,20220920.0,20220827,20220930,PER,,US-LUPIN PHARMACEUTICALS INC.-2022-10491,LUPIN,"Deleon AM, Gaiha RD, Peralta FM. The successful anesthetic management of a cesarean delivery in a patient with fanconi-bickel syndrome. Case Reports in Anesthesiology. 2022;3220486:1-3",22.0,YR,,F,Y,,,20220930,,HP,US,US,2022,Q3,Youth
212634501,21263450,7,C,INSULINE LISPRO,,1,Subcutaneous,"12 international unit, Once a Day",,,Y,,,,,12.0,IU,,QD,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220802.0,20220819.0,20220829,20220829,EXP,,FR-AUROBINDO-AUR-APL-2022-033855,AUROBINDO,,72.0,YR,,M,Y,,,20220829,,MD,FR,FR,2022,Q3,Elderly
212634501,21263450,7,C,INSULINE LISPRO,,1,Subcutaneous,"12 international unit, Once a Day",,,Y,,,,,12.0,IU,,QD,2022,Q3,Hyperkalaemia,,2022,Q3,1,I,20220802.0,20220819.0,20220829,20220829,EXP,,FR-AUROBINDO-AUR-APL-2022-033855,AUROBINDO,,72.0,YR,,M,Y,,,20220829,,MD,FR,FR,2022,Q3,Elderly
212634501,21263450,7,C,INSULINE LISPRO,,1,Subcutaneous,"12 international unit, Once a Day",,,Y,,,,,12.0,IU,,QD,2022,Q3,Atrioventricular block second degree,,2022,Q3,1,I,20220802.0,20220819.0,20220829,20220829,EXP,,FR-AUROBINDO-AUR-APL-2022-033855,AUROBINDO,,72.0,YR,,M,Y,,,20220829,,MD,FR,FR,2022,Q3,Elderly
212636671,21263667,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 u, tid",,,N,,D456541A,,20563.0,8.0,IU,Injection,TID,2022,Q3,Hyperhidrosis,,2022,Q3,1,I,20220824.0,20220825.0,20220829,20220829,PER,,US-ELI_LILLY_AND_COMPANY-US202208014289,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20220829,,CN,US,US,2022,Q3,Elderly
212670081,21267008,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 iU, QD",,,U,,,,,12.0,IU,,QD,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220802.0,20220824.0,20220829,20220829,EXP,FR-AFSSAPS-AN20221833,FR-SA-2022SA355057,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20220829,,MD,FR,FR,2022,Q3,Elderly
212670081,21267008,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 iU, QD",,,U,,,,,12.0,IU,,QD,2022,Q3,Atrioventricular block second degree,,2022,Q3,1,I,20220802.0,20220824.0,20220829,20220829,EXP,FR-AFSSAPS-AN20221833,FR-SA-2022SA355057,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20220829,,MD,FR,FR,2022,Q3,Elderly
212670081,21267008,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 iU, QD",,,U,,,,,12.0,IU,,QD,2022,Q3,Hyperkalaemia,,2022,Q3,1,I,20220802.0,20220824.0,20220829,20220829,EXP,FR-AFSSAPS-AN20221833,FR-SA-2022SA355057,SANOFI AVENTIS,,72.0,YR,E,M,Y,,,20220829,,MD,FR,FR,2022,Q3,Elderly
212672491,21267249,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Klebsiella infection,,2022,Q3,1,I,20220812.0,20220817.0,20220829,20220829,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-096249,BRISTOL MYERS SQUIBB,,14.0,YR,T,F,Y,40.3,KG,20220829,,HP,US,US,2022,Q3,Youth
212672491,21267249,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Staphylococcal infection,,2022,Q3,1,I,20220812.0,20220817.0,20220829,20220829,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-096249,BRISTOL MYERS SQUIBB,,14.0,YR,T,F,Y,40.3,KG,20220829,,HP,US,US,2022,Q3,Youth
212672491,21267249,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Blood pressure increased,,2022,Q3,1,I,20220812.0,20220817.0,20220829,20220829,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-096249,BRISTOL MYERS SQUIBB,,14.0,YR,T,F,Y,40.3,KG,20220829,,HP,US,US,2022,Q3,Youth
212672491,21267249,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Tachycardia,,2022,Q3,1,I,20220812.0,20220817.0,20220829,20220829,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-096249,BRISTOL MYERS SQUIBB,,14.0,YR,T,F,Y,40.3,KG,20220829,,HP,US,US,2022,Q3,Youth
212708041,21270804,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,Solution for injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,,20220824.0,20220830,20220830,EXP,,CA-SA-2022SA355118,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20220830,,CN,CA,CA,2022,Q3,Elderly
212708041,21270804,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,Solution for injection,,2022,Q3,Gait disturbance,,2022,Q3,1,I,,20220824.0,20220830,20220830,EXP,,CA-SA-2022SA355118,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20220830,,CN,CA,CA,2022,Q3,Elderly
212708041,21270804,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,Solution for injection,,2022,Q3,Pain,,2022,Q3,1,I,,20220824.0,20220830,20220830,EXP,,CA-SA-2022SA355118,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20220830,,CN,CA,CA,2022,Q3,Elderly
212708041,21270804,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,Solution for injection,,2022,Q3,Spinal compression fracture,,2022,Q3,1,I,,20220824.0,20220830,20220830,EXP,,CA-SA-2022SA355118,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20220830,,CN,CA,CA,2022,Q3,Elderly
212708041,21270804,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,Solution for injection,,2022,Q3,Arthritis,,2022,Q3,1,I,,20220824.0,20220830,20220830,EXP,,CA-SA-2022SA355118,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20220830,,CN,CA,CA,2022,Q3,Elderly
212708041,21270804,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,Solution for injection,,2022,Q3,Spinal cord disorder,,2022,Q3,1,I,,20220824.0,20220830,20220830,EXP,,CA-SA-2022SA355118,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20220830,,CN,CA,CA,2022,Q3,Elderly
212708841,21270884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn",,,U,,,,20563.0,,,Injection,,2022,Q3,Deafness unilateral,,2022,Q3,1,I,20201201.0,20220818.0,20220830,20220830,EXP,,US-ELI_LILLY_AND_COMPANY-US202208010395,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220830,,CN,US,US,2022,Q3,Adult
212708841,21270884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn",,,U,,,,20563.0,,,Injection,,2022,Q3,Overweight,,2022,Q3,1,I,20201201.0,20220818.0,20220830,20220830,EXP,,US-ELI_LILLY_AND_COMPANY-US202208010395,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220830,,CN,US,US,2022,Q3,Adult
212708841,21270884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn",,,U,,,,20563.0,,,Injection,,2022,Q3,Visual impairment,,2022,Q3,1,I,20201201.0,20220818.0,20220830,20220830,EXP,,US-ELI_LILLY_AND_COMPANY-US202208010395,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220830,,CN,US,US,2022,Q3,Adult
212708841,21270884,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn",,,U,,,,20563.0,,,Injection,,2022,Q3,Incorrect dose administered,,2022,Q3,1,I,20201201.0,20220818.0,20220830,20220830,EXP,,US-ELI_LILLY_AND_COMPANY-US202208010395,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220830,,CN,US,US,2022,Q3,Adult
212708841,21270884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn",,,U,,D371840A,,20563.0,,,Injection,,2022,Q3,Deafness unilateral,,2022,Q3,1,I,20201201.0,20220818.0,20220830,20220830,EXP,,US-ELI_LILLY_AND_COMPANY-US202208010395,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220830,,CN,US,US,2022,Q3,Adult
212708841,21270884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn",,,U,,D371840A,,20563.0,,,Injection,,2022,Q3,Overweight,,2022,Q3,1,I,20201201.0,20220818.0,20220830,20220830,EXP,,US-ELI_LILLY_AND_COMPANY-US202208010395,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220830,,CN,US,US,2022,Q3,Adult
212708841,21270884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn",,,U,,D371840A,,20563.0,,,Injection,,2022,Q3,Visual impairment,,2022,Q3,1,I,20201201.0,20220818.0,20220830,20220830,EXP,,US-ELI_LILLY_AND_COMPANY-US202208010395,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220830,,CN,US,US,2022,Q3,Adult
212708841,21270884,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn",,,U,,D371840A,,20563.0,,,Injection,,2022,Q3,Incorrect dose administered,,2022,Q3,1,I,20201201.0,20220818.0,20220830,20220830,EXP,,US-ELI_LILLY_AND_COMPANY-US202208010395,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220830,,CN,US,US,2022,Q3,Adult
212708841,21270884,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, daily",,,U,,,,20563.0,10.0,IU,Injection,QD,2022,Q3,Deafness unilateral,,2022,Q3,1,I,20201201.0,20220818.0,20220830,20220830,EXP,,US-ELI_LILLY_AND_COMPANY-US202208010395,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220830,,CN,US,US,2022,Q3,Adult
212708841,21270884,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, daily",,,U,,,,20563.0,10.0,IU,Injection,QD,2022,Q3,Overweight,,2022,Q3,1,I,20201201.0,20220818.0,20220830,20220830,EXP,,US-ELI_LILLY_AND_COMPANY-US202208010395,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220830,,CN,US,US,2022,Q3,Adult
212708841,21270884,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, daily",,,U,,,,20563.0,10.0,IU,Injection,QD,2022,Q3,Visual impairment,,2022,Q3,1,I,20201201.0,20220818.0,20220830,20220830,EXP,,US-ELI_LILLY_AND_COMPANY-US202208010395,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220830,,CN,US,US,2022,Q3,Adult
212708841,21270884,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, daily",,,U,,,,20563.0,10.0,IU,Injection,QD,2022,Q3,Incorrect dose administered,,2022,Q3,1,I,20201201.0,20220818.0,20220830,20220830,EXP,,US-ELI_LILLY_AND_COMPANY-US202208010395,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220830,,CN,US,US,2022,Q3,Adult
212712861,21271286,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2022,Q3,Drug withdrawal syndrome,,2022,Q3,1,I,,20220825.0,20220830,20220830,EXP,,"US-ARBOR PHARMACEUTICALS, LLC-US-2022ARB001829",ARBOR,"Custodio A.R., Guerrero R., Bashour C., Khan H.. Addressing data gaps: A gabapentin withdrawal case report. J. Gen. Intern. Med.. 2022;37:S395-S396",71.0,YR,,M,Y,,,20220830,,HP,US,US,2022,Q3,Elderly
212751221,21275122,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,,,20563.0,10.0,IU,Injection,,2022,Q3,Hip fracture,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,,,20563.0,10.0,IU,Injection,,2022,Q3,Fall,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,,,20563.0,10.0,IU,Injection,,2022,Q3,Fall,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,,,20563.0,10.0,IU,Injection,,2022,Q3,Eye disorder,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,,,20563.0,10.0,IU,Injection,,2022,Q3,Myelopathy,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,,,20563.0,10.0,IU,Injection,,2022,Q3,Fracture,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,,,20563.0,10.0,IU,Injection,,2022,Q3,Fall,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,,,20563.0,10.0,IU,Injection,,2022,Q3,Upper limb fracture,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,,,20563.0,10.0,IU,Injection,,2022,Q3,Hip fracture,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,,,20563.0,10.0,IU,Injection,,2022,Q3,Fall,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,,,20563.0,10.0,IU,Injection,,2022,Q3,Fall,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,,,20563.0,10.0,IU,Injection,,2022,Q3,Eye disorder,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,,,20563.0,10.0,IU,Injection,,2022,Q3,Myelopathy,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,,,20563.0,10.0,IU,Injection,,2022,Q3,Fracture,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,,,20563.0,10.0,IU,Injection,,2022,Q3,Fall,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,,,20563.0,10.0,IU,Injection,,2022,Q3,Upper limb fracture,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,D473104C,,20563.0,10.0,IU,Injection,,2022,Q3,Hip fracture,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,D473104C,,20563.0,10.0,IU,Injection,,2022,Q3,Fall,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,D473104C,,20563.0,10.0,IU,Injection,,2022,Q3,Fall,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,D473104C,,20563.0,10.0,IU,Injection,,2022,Q3,Eye disorder,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,D473104C,,20563.0,10.0,IU,Injection,,2022,Q3,Myelopathy,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,D473104C,,20563.0,10.0,IU,Injection,,2022,Q3,Fracture,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,D473104C,,20563.0,10.0,IU,Injection,,2022,Q3,Fall,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,D473104C,,20563.0,10.0,IU,Injection,,2022,Q3,Upper limb fracture,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,D473104C,,20563.0,10.0,IU,Injection,,2022,Q3,Hip fracture,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,D473104C,,20563.0,10.0,IU,Injection,,2022,Q3,Fall,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,D473104C,,20563.0,10.0,IU,Injection,,2022,Q3,Fall,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,D473104C,,20563.0,10.0,IU,Injection,,2022,Q3,Eye disorder,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,D473104C,,20563.0,10.0,IU,Injection,,2022,Q3,Myelopathy,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,D473104C,,20563.0,10.0,IU,Injection,,2022,Q3,Fracture,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,D473104C,,20563.0,10.0,IU,Injection,,2022,Q3,Fall,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751221,21275122,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 u, unknown(sliding scale)",,,,,D473104C,,20563.0,10.0,IU,Injection,,2022,Q3,Upper limb fracture,,2022,Q3,1,I,20220201.0,20220819.0,20220831,20220831,EXP,,US-ELI_LILLY_AND_COMPANY-US202208011154,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Adult
212751711,21275171,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Encephalopathy,,2022,Q3,1,I,,20220822.0,20220831,20220831,EXP,,US-PFIZER INC-PV202200047966,PFIZER,"Custodio, A.. ADDRESSING DATA GAPS: A GABAPENTIN WITHDRAWAL CASE REPORT.. Journal of General Internal Medicine. 2022;37 (Suppl 2):S395-S396",71.0,YR,,M,Y,,,20220831,,HP,US,US,2022,Q3,Elderly
212751711,21275171,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q3,Drug withdrawal syndrome,,2022,Q3,1,I,,20220822.0,20220831,20220831,EXP,,US-PFIZER INC-PV202200047966,PFIZER,"Custodio, A.. ADDRESSING DATA GAPS: A GABAPENTIN WITHDRAWAL CASE REPORT.. Journal of General Internal Medicine. 2022;37 (Suppl 2):S395-S396",71.0,YR,,M,Y,,,20220831,,HP,US,US,2022,Q3,Elderly
212755881,21275588,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn",,,,,D420814C,,20563.0,,,Injection,,2022,Q3,Accidental underdose,,2022,Q3,1,I,20220731.0,20220801.0,20220831,20220831,PER,,US-ELI_LILLY_AND_COMPANY-US202208000802,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Elderly
212755881,21275588,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn",,,,,D420814C,,20563.0,,,Injection,,2022,Q3,Injection site haemorrhage,,2022,Q3,1,I,20220731.0,20220801.0,20220831,20220831,PER,,US-ELI_LILLY_AND_COMPANY-US202208000802,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Elderly
212755881,21275588,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn",,,,,D420814C,,20563.0,,,Injection,,2022,Q3,Incorrect product administration duration,,2022,Q3,1,I,20220731.0,20220801.0,20220831,20220831,PER,,US-ELI_LILLY_AND_COMPANY-US202208000802,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Elderly
212755881,21275588,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn",,,,,D420814C,,20563.0,,,Injection,,2022,Q3,Product storage error,,2022,Q3,1,I,20220731.0,20220801.0,20220831,20220831,PER,,US-ELI_LILLY_AND_COMPANY-US202208000802,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Elderly
212755881,21275588,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn",,,,,D420814C,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220731.0,20220801.0,20220831,20220831,PER,,US-ELI_LILLY_AND_COMPANY-US202208000802,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Elderly
212755881,21275588,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn",,,,,D420814C,,20563.0,,,Injection,,2022,Q3,Accidental underdose,,2022,Q3,1,I,20220731.0,20220801.0,20220831,20220831,PER,,US-ELI_LILLY_AND_COMPANY-US202208000802,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Elderly
212755881,21275588,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn",,,,,D420814C,,20563.0,,,Injection,,2022,Q3,Injection site haemorrhage,,2022,Q3,1,I,20220731.0,20220801.0,20220831,20220831,PER,,US-ELI_LILLY_AND_COMPANY-US202208000802,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Elderly
212755881,21275588,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn",,,,,D420814C,,20563.0,,,Injection,,2022,Q3,Incorrect product administration duration,,2022,Q3,1,I,20220731.0,20220801.0,20220831,20220831,PER,,US-ELI_LILLY_AND_COMPANY-US202208000802,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Elderly
212755881,21275588,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn",,,,,D420814C,,20563.0,,,Injection,,2022,Q3,Product storage error,,2022,Q3,1,I,20220731.0,20220801.0,20220831,20220831,PER,,US-ELI_LILLY_AND_COMPANY-US202208000802,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Elderly
212755881,21275588,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn",,,,,D420814C,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220731.0,20220801.0,20220831,20220831,PER,,US-ELI_LILLY_AND_COMPANY-US202208000802,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Elderly
212755881,21275588,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Accidental underdose,,2022,Q3,1,I,20220731.0,20220801.0,20220831,20220831,PER,,US-ELI_LILLY_AND_COMPANY-US202208000802,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Elderly
212755881,21275588,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Injection site haemorrhage,,2022,Q3,1,I,20220731.0,20220801.0,20220831,20220831,PER,,US-ELI_LILLY_AND_COMPANY-US202208000802,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Elderly
212755881,21275588,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Incorrect product administration duration,,2022,Q3,1,I,20220731.0,20220801.0,20220831,20220831,PER,,US-ELI_LILLY_AND_COMPANY-US202208000802,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Elderly
212755881,21275588,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Product storage error,,2022,Q3,1,I,20220731.0,20220801.0,20220831,20220831,PER,,US-ELI_LILLY_AND_COMPANY-US202208000802,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Elderly
212755881,21275588,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220731.0,20220801.0,20220831,20220831,PER,,US-ELI_LILLY_AND_COMPANY-US202208000802,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Elderly
212755881,21275588,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Accidental underdose,,2022,Q3,1,I,20220731.0,20220801.0,20220831,20220831,PER,,US-ELI_LILLY_AND_COMPANY-US202208000802,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Elderly
212755881,21275588,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Injection site haemorrhage,,2022,Q3,1,I,20220731.0,20220801.0,20220831,20220831,PER,,US-ELI_LILLY_AND_COMPANY-US202208000802,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Elderly
212755881,21275588,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Incorrect product administration duration,,2022,Q3,1,I,20220731.0,20220801.0,20220831,20220831,PER,,US-ELI_LILLY_AND_COMPANY-US202208000802,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Elderly
212755881,21275588,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Product storage error,,2022,Q3,1,I,20220731.0,20220801.0,20220831,20220831,PER,,US-ELI_LILLY_AND_COMPANY-US202208000802,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Elderly
212755881,21275588,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220731.0,20220801.0,20220831,20220831,PER,,US-ELI_LILLY_AND_COMPANY-US202208000802,ELI LILLY AND CO,,75.0,YR,,F,Y,,,20220831,,CN,US,US,2022,Q3,Elderly
212794841,21279484,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,Off label use,,2022,Q3,1,I,20220801.0,20220829.0,20220901,20220901,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-097744,BRISTOL MYERS SQUIBB,,63.0,YR,A,F,Y,144.7,KG,20220901,,PH,US,US,2022,Q3,Adult
212794841,21279484,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,Muscle spasms,,2022,Q3,1,I,20220801.0,20220829.0,20220901,20220901,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-097744,BRISTOL MYERS SQUIBB,,63.0,YR,A,F,Y,144.7,KG,20220901,,PH,US,US,2022,Q3,Adult
212796521,21279652,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"90 ml, inject 7 units, TID plus scale up to max 90 units/day (100 unit/ml)",,,,,,,,,,"Injection, solution",,2022,Q3,COVID-19 pneumonia,,2022,Q3,1,I,20220818.0,20220824.0,20220901,20220901,EXP,,US-UNITED THERAPEUTICS-UNT-2022-019175,UNITED THERAPEUTICS,,57.0,YR,,M,Y,106.58,KG,20220901,,CN,US,US,2022,Q3,Adult
212834131,21283413,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Head injury,,2022,Q3,1,I,20220724.0,,20220831,20220831,DIR,FDA-CDER-CTU-2022-70011,,FDA-CTU,,76.0,YR,,M,N,,,20220831,Y,PH,US,,2022,Q3,Elderly
212834131,21283413,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Fall,,2022,Q3,1,I,20220724.0,,20220831,20220831,DIR,FDA-CDER-CTU-2022-70011,,FDA-CTU,,76.0,YR,,M,N,,,20220831,Y,PH,US,,2022,Q3,Elderly
212834131,21283413,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Skin laceration,,2022,Q3,1,I,20220724.0,,20220831,20220831,DIR,FDA-CDER-CTU-2022-70011,,FDA-CTU,,76.0,YR,,M,N,,,20220831,Y,PH,US,,2022,Q3,Elderly
212846421,21284642,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 IU, tid",,,,,unknown,,,40.0,IU,,TID,2022,Q3,Maternal exposure during pregnancy,,2022,Q3,1,I,,20220822.0,20220902,20220902,EXP,,JP-NOVOPROD-953218,NOVO NORDISK,Yuto Yamaryo. A case of type 2 diabetes mellitus during maintenance haemodialysis leading to the fifth abortion.. Journal of the Japan Diabetes Society 2022. 2022,40.0,YR,,F,Y,,,20220902,,MD,JP,JP,2022,Q3,Adult
212846421,21284642,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"40 IU, tid",,,,,unknown,,,40.0,IU,,TID,2022,Q3,Abortion missed,,2022,Q3,1,I,,20220822.0,20220902,20220902,EXP,,JP-NOVOPROD-953218,NOVO NORDISK,Yuto Yamaryo. A case of type 2 diabetes mellitus during maintenance haemodialysis leading to the fifth abortion.. Journal of the Japan Diabetes Society 2022. 2022,40.0,YR,,F,Y,,,20220902,,MD,JP,JP,2022,Q3,Adult
212846421,21284642,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, tid",,,,,unknown,,,10.0,IU,,TID,2022,Q3,Maternal exposure during pregnancy,,2022,Q3,1,I,,20220822.0,20220902,20220902,EXP,,JP-NOVOPROD-953218,NOVO NORDISK,Yuto Yamaryo. A case of type 2 diabetes mellitus during maintenance haemodialysis leading to the fifth abortion.. Journal of the Japan Diabetes Society 2022. 2022,40.0,YR,,F,Y,,,20220902,,MD,JP,JP,2022,Q3,Adult
212846421,21284642,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 IU, tid",,,,,unknown,,,10.0,IU,,TID,2022,Q3,Abortion missed,,2022,Q3,1,I,,20220822.0,20220902,20220902,EXP,,JP-NOVOPROD-953218,NOVO NORDISK,Yuto Yamaryo. A case of type 2 diabetes mellitus during maintenance haemodialysis leading to the fifth abortion.. Journal of the Japan Diabetes Society 2022. 2022,40.0,YR,,F,Y,,,20220902,,MD,JP,JP,2022,Q3,Adult
212848871,21284887,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D509664C,,20563.0,,,Solution for injection,,2022,Q3,Drug ineffective,,2022,Q3,1,I,20220811.0,20220901.0,20220902,20220902,PER,,US-ELI_LILLY_AND_COMPANY-US202209000825,ELI LILLY AND CO,,44.0,YR,,F,Y,,,20220902,,CN,US,US,2022,Q3,Adult
212848871,21284887,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D509664C,,20563.0,,,Solution for injection,,2022,Q3,Pain in extremity,,2022,Q3,1,I,20220811.0,20220901.0,20220902,20220902,PER,,US-ELI_LILLY_AND_COMPANY-US202209000825,ELI LILLY AND CO,,44.0,YR,,F,Y,,,20220902,,CN,US,US,2022,Q3,Adult
212848871,21284887,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D509664C,,20563.0,,,Solution for injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220811.0,20220901.0,20220902,20220902,PER,,US-ELI_LILLY_AND_COMPANY-US202209000825,ELI LILLY AND CO,,44.0,YR,,F,Y,,,20220902,,CN,US,US,2022,Q3,Adult
212857951,21285795,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q3,Anxiety,,2022,Q3,1,I,20220812.0,20220823.0,20220902,20220902,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-02181,HIKMA,,77.0,YR,,F,Y,77.4,KG,20220902,,MD,US,,2022,Q3,Elderly
212857951,21285795,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q3,Headache,,2022,Q3,1,I,20220812.0,20220823.0,20220902,20220902,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-02181,HIKMA,,77.0,YR,,F,Y,77.4,KG,20220902,,MD,US,,2022,Q3,Elderly
212857951,21285795,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q3,Depression,,2022,Q3,1,I,20220812.0,20220823.0,20220902,20220902,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-02181,HIKMA,,77.0,YR,,F,Y,77.4,KG,20220902,,MD,US,,2022,Q3,Elderly
212857951,21285795,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,UNKNOWN,,,,,Unknown,,2022,Q3,Dizziness,,2022,Q3,1,I,20220812.0,20220823.0,20220902,20220902,EXP,,US-Hikma Pharmaceuticals USA Inc.-US-H14001-22-02181,HIKMA,,77.0,YR,,F,Y,77.4,KG,20220902,,MD,US,,2022,Q3,Elderly
212860561,21286056,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Death,,2022,Q3,1,I,,,20220901,20220901,DIR,FDA-CDER-CTU-2022-70384,,FDA-CTU,,74.0,YR,,M,N,77.56,KG,20220901,N,,US,,2022,Q3,Elderly
212869951,21286995,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Withdrawal syndrome,,2022,Q3,1,I,,20220825.0,20220902,20220902,EXP,,US-STRIDES ARCOLAB LIMITED-2022SP011057,STRIDES,"Custodio AR, Guerrero R, Bashour C, Khan H.. ADDRESSING DATA GAPS: A GABAPENTIN WITHDRAWAL CASE REPORT.. J-Gen-Intern-Med.. 2022;37(2):S395-S396",71.0,YR,,M,Y,,,20220902,,HP,US,US,2022,Q3,Elderly
212869951,21286995,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Encephalopathy,,2022,Q3,1,I,,20220825.0,20220902,20220902,EXP,,US-STRIDES ARCOLAB LIMITED-2022SP011057,STRIDES,"Custodio AR, Guerrero R, Bashour C, Khan H.. ADDRESSING DATA GAPS: A GABAPENTIN WITHDRAWAL CASE REPORT.. J-Gen-Intern-Med.. 2022;37(2):S395-S396",71.0,YR,,M,Y,,,20220902,,HP,US,US,2022,Q3,Elderly
212898131,21289813,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Deep vein thrombosis,,2022,Q3,1,I,20220822.0,20220825.0,20220902,20220902,EXP,,US-BAYER-2022A121124,BAYER,,76.0,YR,E,M,Y,,,20220902,,PH,US,US,2022,Q3,Elderly
212898131,21289813,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Acute left ventricular failure,,2022,Q3,1,I,20220822.0,20220825.0,20220902,20220902,EXP,,US-BAYER-2022A121124,BAYER,,76.0,YR,E,M,Y,,,20220902,,PH,US,US,2022,Q3,Elderly
212898131,21289813,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Oedema peripheral,,2022,Q3,1,I,20220822.0,20220825.0,20220902,20220902,EXP,,US-BAYER-2022A121124,BAYER,,76.0,YR,E,M,Y,,,20220902,,PH,US,US,2022,Q3,Elderly
212898131,21289813,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Cellulitis,,2022,Q3,1,I,20220822.0,20220825.0,20220902,20220902,EXP,,US-BAYER-2022A121124,BAYER,,76.0,YR,E,M,Y,,,20220902,,PH,US,US,2022,Q3,Elderly
212925601,21292560,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Withdrawal syndrome,,2022,Q3,1,I,,20220825.0,20220905,20220905,EXP,,US-LUPIN PHARMACEUTICALS INC.-2022-10788,LUPIN,"Custodio AR, Guerrero R, Bashour C, Khan H. Addressing data gaps: a Gabapentin withdrawal case report. Journal of General Internal Medicine. 2022;37(2):S395-S396",71.0,YR,,M,Y,,,20220905,,HP,US,US,2022,Q3,Elderly
212925601,21292560,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Encephalopathy,,2022,Q3,1,I,,20220825.0,20220905,20220905,EXP,,US-LUPIN PHARMACEUTICALS INC.-2022-10788,LUPIN,"Custodio AR, Guerrero R, Bashour C, Khan H. Addressing data gaps: a Gabapentin withdrawal case report. Journal of General Internal Medicine. 2022;37(2):S395-S396",71.0,YR,,M,Y,,,20220905,,HP,US,US,2022,Q3,Elderly
212931051,21293105,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Withdrawal syndrome,,2022,Q3,1,I,,20220824.0,20220905,20220905,EXP,,US-CIPLA LTD.-2022US05269,CIPLA,"Custodio AR, Guerrero R, Bashour C, Khan H.. Addressing Data Gaps: A Gabapentin Withdrawal Case Report. JGIM. S395",71.0,YR,,M,Y,,,20220905,,HP,US,US,2022,Q3,Elderly
212931051,21293105,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Agitation,,2022,Q3,1,I,,20220824.0,20220905,20220905,EXP,,US-CIPLA LTD.-2022US05269,CIPLA,"Custodio AR, Guerrero R, Bashour C, Khan H.. Addressing Data Gaps: A Gabapentin Withdrawal Case Report. JGIM. S395",71.0,YR,,M,Y,,,20220905,,HP,US,US,2022,Q3,Elderly
212931051,21293105,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Disorientation,,2022,Q3,1,I,,20220824.0,20220905,20220905,EXP,,US-CIPLA LTD.-2022US05269,CIPLA,"Custodio AR, Guerrero R, Bashour C, Khan H.. Addressing Data Gaps: A Gabapentin Withdrawal Case Report. JGIM. S395",71.0,YR,,M,Y,,,20220905,,HP,US,US,2022,Q3,Elderly
212931051,21293105,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Dysarthria,,2022,Q3,1,I,,20220824.0,20220905,20220905,EXP,,US-CIPLA LTD.-2022US05269,CIPLA,"Custodio AR, Guerrero R, Bashour C, Khan H.. Addressing Data Gaps: A Gabapentin Withdrawal Case Report. JGIM. S395",71.0,YR,,M,Y,,,20220905,,HP,US,US,2022,Q3,Elderly
212931051,21293105,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Hypertensive urgency,,2022,Q3,1,I,,20220824.0,20220905,20220905,EXP,,US-CIPLA LTD.-2022US05269,CIPLA,"Custodio AR, Guerrero R, Bashour C, Khan H.. Addressing Data Gaps: A Gabapentin Withdrawal Case Report. JGIM. S395",71.0,YR,,M,Y,,,20220905,,HP,US,US,2022,Q3,Elderly
212931051,21293105,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Encephalopathy,,2022,Q3,1,I,,20220824.0,20220905,20220905,EXP,,US-CIPLA LTD.-2022US05269,CIPLA,"Custodio AR, Guerrero R, Bashour C, Khan H.. Addressing Data Gaps: A Gabapentin Withdrawal Case Report. JGIM. S395",71.0,YR,,M,Y,,,20220905,,HP,US,US,2022,Q3,Elderly
212938463,21293846,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,via insulin pump,,,,,UNKNOWN,,,,,,,2022,Q3,Thrombocytopenia,,2022,Q3,3,F,,20220920.0,20220905,20220930,EXP,,US-drreddys-SPO/USA/22/0154165,DR REDDYS,"Raimonde A, Dennis A. Carvedilol-Induced Thrombocytopenia: A Case Report. Hosp Pharm. 2022;UNK:1-4. doi:10.1177/00185787221108719",44.0,YR,A,F,Y,,,20220930,,PH,US,US,2022,Q3,Adult
212951071,21295107,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"16 u, bid",,,U,,D460779D,,20563.0,16.0,IU,Injection,BID,2022,Q3,Incorrect dose administered,,2022,Q3,1,I,20220901.0,20220901.0,20220905,20220905,PER,,US-ELI_LILLY_AND_COMPANY-US202209000848,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20220905,,CN,US,US,2022,Q3,Adult
212951071,21295107,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"16 u, bid",,,U,,D460779D,,20563.0,16.0,IU,Injection,BID,2022,Q3,Incorrect dose administered,,2022,Q3,1,I,20220901.0,20220901.0,20220905,20220905,PER,,US-ELI_LILLY_AND_COMPANY-US202209000848,ELI LILLY AND CO,,62.0,YR,,F,Y,,,20220905,,CN,US,US,2022,Q3,Adult
212968091,21296809,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 iU, TID",,,U,,,,,15.0,IU,,Q8H,2022,Q3,Hypoglycaemia,,2022,Q3,1,I,20210401.0,20220825.0,20220906,20220906,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20220906,,MD,FI,FI,2022,Q3,Adult
212968091,21296809,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 iU, TID",,,U,,,,,15.0,IU,,Q8H,2022,Q3,Albuminuria,,2022,Q3,1,I,20210401.0,20220825.0,20220906,20220906,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20220906,,MD,FI,FI,2022,Q3,Adult
212968091,21296809,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 iU, TID",,,U,,,,,15.0,IU,,Q8H,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20210401.0,20220825.0,20220906,20220906,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20220906,,MD,FI,FI,2022,Q3,Adult
212968091,21296809,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 iU, TID",,,U,,,,,15.0,IU,,Q8H,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,1,I,20210401.0,20220825.0,20220906,20220906,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20220906,,MD,FI,FI,2022,Q3,Adult
212968091,21296809,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 iU, TID",,,U,,,,,15.0,IU,,Q8H,2022,Q3,Angina pectoris,,2022,Q3,1,I,20210401.0,20220825.0,20220906,20220906,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20220906,,MD,FI,FI,2022,Q3,Adult
212968091,21296809,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 iU, TID",,,U,,,,,15.0,IU,,Q8H,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,20210401.0,20220825.0,20220906,20220906,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20220906,,MD,FI,FI,2022,Q3,Adult
212968091,21296809,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 iU, TID",,,U,,,,,15.0,IU,,Q8H,2022,Q3,Balanoposthitis,,2022,Q3,1,I,20210401.0,20220825.0,20220906,20220906,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20220906,,MD,FI,FI,2022,Q3,Adult
212968091,21296809,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 iU, afternoon",,,U,,,,,10.0,IU,,,2022,Q3,Hypoglycaemia,,2022,Q3,1,I,20210401.0,20220825.0,20220906,20220906,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20220906,,MD,FI,FI,2022,Q3,Adult
212968091,21296809,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 iU, afternoon",,,U,,,,,10.0,IU,,,2022,Q3,Albuminuria,,2022,Q3,1,I,20210401.0,20220825.0,20220906,20220906,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20220906,,MD,FI,FI,2022,Q3,Adult
212968091,21296809,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 iU, afternoon",,,U,,,,,10.0,IU,,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20210401.0,20220825.0,20220906,20220906,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20220906,,MD,FI,FI,2022,Q3,Adult
212968091,21296809,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 iU, afternoon",,,U,,,,,10.0,IU,,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,1,I,20210401.0,20220825.0,20220906,20220906,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20220906,,MD,FI,FI,2022,Q3,Adult
212968091,21296809,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 iU, afternoon",,,U,,,,,10.0,IU,,,2022,Q3,Angina pectoris,,2022,Q3,1,I,20210401.0,20220825.0,20220906,20220906,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20220906,,MD,FI,FI,2022,Q3,Adult
212968091,21296809,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 iU, afternoon",,,U,,,,,10.0,IU,,,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,20210401.0,20220825.0,20220906,20220906,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20220906,,MD,FI,FI,2022,Q3,Adult
212968091,21296809,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 iU, afternoon",,,U,,,,,10.0,IU,,,2022,Q3,Balanoposthitis,,2022,Q3,1,I,20210401.0,20220825.0,20220906,20220906,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20220906,,MD,FI,FI,2022,Q3,Adult
212970101,21297010,7,C,BIPHASIC ISOPHANE RECOMBINANT INSULIN LISPRO,,2,,"BIPHASIC ISOPHANE RECOMBINANT, ((BACTERIA/ESCHERICHIA COLI)), Therapy start date :  Asked But Unknow",,,Y,,Unknown,,,12.0,IU,,,2022,Q3,Atrioventricular block second degree,,2022,Q3,1,I,20220802.0,20220828.0,20220906,20220906,EXP,FR-AFSSAPS-AN20221833,FR-TEVA-2022-FR-2069068,TEVA,,72.0,YR,E,M,Y,,,20220906,,MD,FR,FR,2022,Q3,Elderly
212970101,21297010,7,C,BIPHASIC ISOPHANE RECOMBINANT INSULIN LISPRO,,2,,"BIPHASIC ISOPHANE RECOMBINANT, ((BACTERIA/ESCHERICHIA COLI)), Therapy start date :  Asked But Unknow",,,Y,,Unknown,,,12.0,IU,,,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220802.0,20220828.0,20220906,20220906,EXP,FR-AFSSAPS-AN20221833,FR-TEVA-2022-FR-2069068,TEVA,,72.0,YR,E,M,Y,,,20220906,,MD,FR,FR,2022,Q3,Elderly
212970101,21297010,7,C,BIPHASIC ISOPHANE RECOMBINANT INSULIN LISPRO,,2,,"BIPHASIC ISOPHANE RECOMBINANT, ((BACTERIA/ESCHERICHIA COLI)), Therapy start date :  Asked But Unknow",,,Y,,Unknown,,,12.0,IU,,,2022,Q3,Hyperkalaemia,,2022,Q3,1,I,20220802.0,20220828.0,20220906,20220906,EXP,FR-AFSSAPS-AN20221833,FR-TEVA-2022-FR-2069068,TEVA,,72.0,YR,E,M,Y,,,20220906,,MD,FR,FR,2022,Q3,Elderly
212977071,21297707,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Encephalopathy,,2022,Q3,1,I,,20220825.0,20220906,20220906,EXP,,US-MYLANLABS-2022M1090802,MYLAN,"Custodio AR, Guerrero R, Bashour C, Khan H. ADDRESSING DATA GAPS: A GABAPENTIN WITHDRAWAL CASE REPORT. J-Gen-Intern-Med 2022;37 (Suppl. 2):S395-S396.",71.0,YR,,M,Y,,,20220906,,HP,US,US,2022,Q3,Elderly
212977071,21297707,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Withdrawal syndrome,,2022,Q3,1,I,,20220825.0,20220906,20220906,EXP,,US-MYLANLABS-2022M1090802,MYLAN,"Custodio AR, Guerrero R, Bashour C, Khan H. ADDRESSING DATA GAPS: A GABAPENTIN WITHDRAWAL CASE REPORT. J-Gen-Intern-Med 2022;37 (Suppl. 2):S395-S396.",71.0,YR,,M,Y,,,20220906,,HP,US,US,2022,Q3,Elderly
212998501,21299850,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown (between 5-6 times a day)",,,U,,D420813A,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220801.0,20220829.0,20220906,20220906,PER,,US-ELI_LILLY_AND_COMPANY-US202209000685,ELI LILLY AND CO,,71.0,YR,,M,Y,,,20220906,,CN,US,US,2022,Q3,Elderly
212999261,21299926,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D395986A,,20563.0,,,Injection,,2022,Q3,Weight increased,,2022,Q3,1,I,20210801.0,20220823.0,20220906,20220906,PER,,US-ELI_LILLY_AND_COMPANY-US202208013998,ELI LILLY AND CO,,64.0,YR,,,Y,,,20220906,,CN,US,US,2022,Q3,Adult
212999261,21299926,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,D395986A,,20563.0,,,Injection,,2022,Q3,Weight decreased,,2022,Q3,1,I,20210801.0,20220823.0,20220906,20220906,PER,,US-ELI_LILLY_AND_COMPANY-US202208013998,ELI LILLY AND CO,,64.0,YR,,,Y,,,20220906,,CN,US,US,2022,Q3,Adult
213011971,21301197,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Agitation,,2022,Q3,1,I,,20220825.0,20220907,20220907,EXP,,US-APOTEX-2022AP012258,APOTEX,"Custodio AR, Guerrero R, Bashour C, Khan H. ADDRESSING DATA GAPS: A GABAPENTIN WITHDRAWAL CASE REPORT. Journal of General Internal Medicine. 2022;37(Suppl.2):S395-S396",71.0,YR,,M,Y,,,20220907,,HP,US,US,2022,Q3,Elderly
213011971,21301197,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Encephalopathy,,2022,Q3,1,I,,20220825.0,20220907,20220907,EXP,,US-APOTEX-2022AP012258,APOTEX,"Custodio AR, Guerrero R, Bashour C, Khan H. ADDRESSING DATA GAPS: A GABAPENTIN WITHDRAWAL CASE REPORT. Journal of General Internal Medicine. 2022;37(Suppl.2):S395-S396",71.0,YR,,M,Y,,,20220907,,HP,US,US,2022,Q3,Elderly
213011971,21301197,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Drug withdrawal syndrome,,2022,Q3,1,I,,20220825.0,20220907,20220907,EXP,,US-APOTEX-2022AP012258,APOTEX,"Custodio AR, Guerrero R, Bashour C, Khan H. ADDRESSING DATA GAPS: A GABAPENTIN WITHDRAWAL CASE REPORT. Journal of General Internal Medicine. 2022;37(Suppl.2):S395-S396",71.0,YR,,M,Y,,,20220907,,HP,US,US,2022,Q3,Elderly
213011971,21301197,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Disorientation,,2022,Q3,1,I,,20220825.0,20220907,20220907,EXP,,US-APOTEX-2022AP012258,APOTEX,"Custodio AR, Guerrero R, Bashour C, Khan H. ADDRESSING DATA GAPS: A GABAPENTIN WITHDRAWAL CASE REPORT. Journal of General Internal Medicine. 2022;37(Suppl.2):S395-S396",71.0,YR,,M,Y,,,20220907,,HP,US,US,2022,Q3,Elderly
213011971,21301197,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Hypertensive urgency,,2022,Q3,1,I,,20220825.0,20220907,20220907,EXP,,US-APOTEX-2022AP012258,APOTEX,"Custodio AR, Guerrero R, Bashour C, Khan H. ADDRESSING DATA GAPS: A GABAPENTIN WITHDRAWAL CASE REPORT. Journal of General Internal Medicine. 2022;37(Suppl.2):S395-S396",71.0,YR,,M,Y,,,20220907,,HP,US,US,2022,Q3,Elderly
213020811,21302081,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q3,Muscle rupture,,2022,Q3,1,I,20211001.0,20220902.0,20220907,20220907,PER,,US-ELI_LILLY_AND_COMPANY-US202209002705,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20220907,,CN,US,US,2022,Q3,Elderly
213020811,21302081,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q3,Osteoarthritis,,2022,Q3,1,I,20211001.0,20220902.0,20220907,20220907,PER,,US-ELI_LILLY_AND_COMPANY-US202209002705,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20220907,,CN,US,US,2022,Q3,Elderly
213020811,21302081,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D473104C,,20563.0,,,Injection,,2022,Q3,Muscle rupture,,2022,Q3,1,I,20211001.0,20220902.0,20220907,20220907,PER,,US-ELI_LILLY_AND_COMPANY-US202209002705,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20220907,,CN,US,US,2022,Q3,Elderly
213020811,21302081,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D473104C,,20563.0,,,Injection,,2022,Q3,Osteoarthritis,,2022,Q3,1,I,20211001.0,20220902.0,20220907,20220907,PER,,US-ELI_LILLY_AND_COMPANY-US202209002705,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20220907,,CN,US,US,2022,Q3,Elderly
213056262,21305626,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3 international unit (with meals),,,U,,,,,3.0,IU,,,2022,Q3,Immunosuppressant drug level increased,,2022,Q3,2,F,,20220912.0,20220908,20220922,EXP,,US-AUROBINDO-AUR-APL-2022-035463,AUROBINDO,"Gough S, Borgetti S, Fernandes CR. Orthostatic hypotension as the initial presentation of disseminated cryptococcosis in a kidney transplant recipient. IDCases. 2022;29:e01567",69.0,YR,,M,Y,,,20220922,,MD,US,US,2022,Q3,Elderly
213056262,21305626,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3 international unit (with meals),,,U,,,,,3.0,IU,,,2022,Q3,Disseminated cryptococcosis,,2022,Q3,2,F,,20220912.0,20220908,20220922,EXP,,US-AUROBINDO-AUR-APL-2022-035463,AUROBINDO,"Gough S, Borgetti S, Fernandes CR. Orthostatic hypotension as the initial presentation of disseminated cryptococcosis in a kidney transplant recipient. IDCases. 2022;29:e01567",69.0,YR,,M,Y,,,20220922,,MD,US,US,2022,Q3,Elderly
213074221,21307422,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Drug ineffective,,2022,Q3,1,I,,20220830.0,20220908,20220908,EXP,,CA-TEVA-2022-CA-2069818,TEVA,,65.0,YR,E,F,Y,,,20220908,,HP,CA,CA,2022,Q3,Elderly
213074221,21307422,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Hepatotoxicity,,2022,Q3,1,I,,20220830.0,20220908,20220908,EXP,,CA-TEVA-2022-CA-2069818,TEVA,,65.0,YR,E,F,Y,,,20220908,,HP,CA,CA,2022,Q3,Elderly
213074221,21307422,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Movement disorder,,2022,Q3,1,I,,20220830.0,20220908,20220908,EXP,,CA-TEVA-2022-CA-2069818,TEVA,,65.0,YR,E,F,Y,,,20220908,,HP,CA,CA,2022,Q3,Elderly
213074221,21307422,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Pain in extremity,,2022,Q3,1,I,,20220830.0,20220908,20220908,EXP,,CA-TEVA-2022-CA-2069818,TEVA,,65.0,YR,E,F,Y,,,20220908,,HP,CA,CA,2022,Q3,Elderly
213074221,21307422,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Headache,,2022,Q3,1,I,,20220830.0,20220908,20220908,EXP,,CA-TEVA-2022-CA-2069818,TEVA,,65.0,YR,E,F,Y,,,20220908,,HP,CA,CA,2022,Q3,Elderly
213074221,21307422,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Arthropathy,,2022,Q3,1,I,,20220830.0,20220908,20220908,EXP,,CA-TEVA-2022-CA-2069818,TEVA,,65.0,YR,E,F,Y,,,20220908,,HP,CA,CA,2022,Q3,Elderly
213074221,21307422,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Diabetes mellitus,,2022,Q3,1,I,,20220830.0,20220908,20220908,EXP,,CA-TEVA-2022-CA-2069818,TEVA,,65.0,YR,E,F,Y,,,20220908,,HP,CA,CA,2022,Q3,Elderly
213074221,21307422,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Arthralgia,,2022,Q3,1,I,,20220830.0,20220908,20220908,EXP,,CA-TEVA-2022-CA-2069818,TEVA,,65.0,YR,E,F,Y,,,20220908,,HP,CA,CA,2022,Q3,Elderly
213074221,21307422,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Hepatic cirrhosis,,2022,Q3,1,I,,20220830.0,20220908,20220908,EXP,,CA-TEVA-2022-CA-2069818,TEVA,,65.0,YR,E,F,Y,,,20220908,,HP,CA,CA,2022,Q3,Elderly
213074221,21307422,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Psoriatic arthropathy,,2022,Q3,1,I,,20220830.0,20220908,20220908,EXP,,CA-TEVA-2022-CA-2069818,TEVA,,65.0,YR,E,F,Y,,,20220908,,HP,CA,CA,2022,Q3,Elderly
213074221,21307422,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Osteoarthritis,,2022,Q3,1,I,,20220830.0,20220908,20220908,EXP,,CA-TEVA-2022-CA-2069818,TEVA,,65.0,YR,E,F,Y,,,20220908,,HP,CA,CA,2022,Q3,Elderly
213074221,21307422,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Drug intolerance,,2022,Q3,1,I,,20220830.0,20220908,20220908,EXP,,CA-TEVA-2022-CA-2069818,TEVA,,65.0,YR,E,F,Y,,,20220908,,HP,CA,CA,2022,Q3,Elderly
213074221,21307422,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Therapeutic product effect decreased,,2022,Q3,1,I,,20220830.0,20220908,20220908,EXP,,CA-TEVA-2022-CA-2069818,TEVA,,65.0,YR,E,F,Y,,,20220908,,HP,CA,CA,2022,Q3,Elderly
213074221,21307422,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Pain,,2022,Q3,1,I,,20220830.0,20220908,20220908,EXP,,CA-TEVA-2022-CA-2069818,TEVA,,65.0,YR,E,F,Y,,,20220908,,HP,CA,CA,2022,Q3,Elderly
213074221,21307422,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Grip strength decreased,,2022,Q3,1,I,,20220830.0,20220908,20220908,EXP,,CA-TEVA-2022-CA-2069818,TEVA,,65.0,YR,E,F,Y,,,20220908,,HP,CA,CA,2022,Q3,Elderly
213074221,21307422,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220830.0,20220908,20220908,EXP,,CA-TEVA-2022-CA-2069818,TEVA,,65.0,YR,E,F,Y,,,20220908,,HP,CA,CA,2022,Q3,Elderly
213090241,21309024,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,with meals,,,U,,,,,3.0,IU,,,2022,Q3,Disseminated cryptococcosis,,2022,Q3,1,I,,20220829.0,20220908,20220908,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-099390,BRISTOL MYERS SQUIBB,"Gough S, Borgetti S, Fernandes CR. Orthostatic hypotension as the initial presentation of disseminated cryptococcosis in a kidney transplant recipient. IDCases. 2022; 29: 1-3. 10.1016/j.idcr.2022.e01567",69.0,YR,E,M,Y,,,20220908,,HP,US,US,2022,Q3,Elderly
213106191,21310619,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,Solution for injection,,2022,Q3,Loss of consciousness,,2022,Q3,1,I,20220718.0,20220901.0,20220909,20220909,EXP,IT-MINISAL02-882692,IT-SA-2022SA369179,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20220909,,MD,IT,IT,2022,Q3,Elderly
213106191,21310619,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,Solution for injection,,2022,Q3,Hypoglycaemia,,2022,Q3,1,I,20220718.0,20220901.0,20220909,20220909,EXP,IT-MINISAL02-882692,IT-SA-2022SA369179,SANOFI AVENTIS,,83.0,YR,E,M,Y,,,20220909,,MD,IT,IT,2022,Q3,Elderly
213123481,21312348,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, qid (100U; 0-18U four times a day)",,,U,U,,,,,,,QID,2022,Q3,Diabetic ketoacidosis,,2022,Q3,1,I,,20220829.0,20220909,20220909,EXP,,US-MYLANLABS-2022M1091589,MYLAN,"Sexe J, Mayes C, Tofts P. Euglycemic Diabetic Ketoacidosis in a Lung Cancer Patient Using Empagliflozin. Case-Rep-Crit-Care 2020;null:null.",58.0,YR,,M,Y,,,20220909,,HP,US,US,2022,Q3,Adult
213123481,21312348,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, qid (100U; 0-18U four times a day)",,,U,U,,,,,,,QID,2022,Q3,Symptom masked,,2022,Q3,1,I,,20220829.0,20220909,20220909,EXP,,US-MYLANLABS-2022M1091589,MYLAN,"Sexe J, Mayes C, Tofts P. Euglycemic Diabetic Ketoacidosis in a Lung Cancer Patient Using Empagliflozin. Case-Rep-Crit-Care 2020;null:null.",58.0,YR,,M,Y,,,20220909,,HP,US,US,2022,Q3,Adult
213123711,21312371,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,100/ml vial,,,,,,,,,,,,2022,Q3,Eye pain,,2022,Q3,1,I,20220527.0,20220531.0,20220909,20220909,PER,,US-FARMAPROD-202206-1001,DOMPE FARMACEUTICI,,51.0,YR,A,M,Y,,,20220906,,CN,US,,2022,Q3,Adult
213123711,21312371,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,100/ml vial,,,,,,,,,,,,2022,Q3,Headache,,2022,Q3,1,I,20220527.0,20220531.0,20220909,20220909,PER,,US-FARMAPROD-202206-1001,DOMPE FARMACEUTICI,,51.0,YR,A,M,Y,,,20220906,,CN,US,,2022,Q3,Adult
213123711,21312371,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,100/ml vial,,,,,,,,,,,,2022,Q3,Device use issue,,2022,Q3,1,I,20220527.0,20220531.0,20220909,20220909,PER,,US-FARMAPROD-202206-1001,DOMPE FARMACEUTICI,,51.0,YR,A,M,Y,,,20220906,,CN,US,,2022,Q3,Adult
213132911,21313291,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,INTERMITTENT,,,,,,,,,,,,2022,Q3,Fournier's gangrene,,2022,Q3,1,I,20220601.0,20220905.0,20220909,20220909,EXP,,DE-AstraZeneca-2022A304182,ASTRAZENECA,,61.0,YR,,M,Y,105.0,KG,20220909,,MD,DE,,2022,Q3,Adult
213132911,21313291,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,INTERMITTENT,,,,,,,,,,,,2022,Q3,Erythema,,2022,Q3,1,I,20220601.0,20220905.0,20220909,20220909,EXP,,DE-AstraZeneca-2022A304182,ASTRAZENECA,,61.0,YR,,M,Y,105.0,KG,20220909,,MD,DE,,2022,Q3,Adult
213132911,21313291,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,INTERMITTENT,,,,,,,,,,,,2022,Q3,Scrotal swelling,,2022,Q3,1,I,20220601.0,20220905.0,20220909,20220909,EXP,,DE-AstraZeneca-2022A304182,ASTRAZENECA,,61.0,YR,,M,Y,105.0,KG,20220909,,MD,DE,,2022,Q3,Adult
213132911,21313291,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,INTERMITTENT,,,,,,,,,,,,2022,Q3,Scrotal abscess,,2022,Q3,1,I,20220601.0,20220905.0,20220909,20220909,EXP,,DE-AstraZeneca-2022A304182,ASTRAZENECA,,61.0,YR,,M,Y,105.0,KG,20220909,,MD,DE,,2022,Q3,Adult
213132911,21313291,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,INTERMITTENT,,,,,,,,,,,,2022,Q3,Intertrigo,,2022,Q3,1,I,20220601.0,20220905.0,20220909,20220909,EXP,,DE-AstraZeneca-2022A304182,ASTRAZENECA,,61.0,YR,,M,Y,105.0,KG,20220909,,MD,DE,,2022,Q3,Adult
213161601,21316160,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q3,Thrombocytopenia,,2022,Q3,1,I,,20220903.0,20220910,20220910,PER,,US-LUPIN PHARMACEUTICALS INC.-2022-10975,LUPIN,"Raimonde AR, Dennis AK. Carvedilol-induced thrombocytopenia: A case report. Hospital Pharmacy. 2022;1-4",44.0,YR,,F,Y,,,20220910,,HP,US,US,2022,Q3,Adult
213169962,21316996,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Contusion,,2022,Q3,2,F,20220817.0,20220819.0,20220911,20220911,PER,,US-SA-2022SA343636,SANOFI AVENTIS,,44.0,YR,A,F,Y,,,20220911,,HP,US,US,2022,Q3,Adult
213169962,21316996,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Pain,,2022,Q3,2,F,20220817.0,20220819.0,20220911,20220911,PER,,US-SA-2022SA343636,SANOFI AVENTIS,,44.0,YR,A,F,Y,,,20220911,,HP,US,US,2022,Q3,Adult
213179181,21317918,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,U,,,,,,,,Q12H,2022,Q3,Inappropriate schedule of product administration,,2022,Q3,1,I,20220823.0,20220824.0,20220911,20220911,PER,,US-SA-2022SA358255,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20220911,,CN,US,US,2022,Q3,Elderly
213179181,21317918,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,U,,,,,,,,Q12H,2022,Q3,Accidental exposure to product,,2022,Q3,1,I,20220823.0,20220824.0,20220911,20220911,PER,,US-SA-2022SA358255,SANOFI AVENTIS,,76.0,YR,E,M,Y,,,20220911,,CN,US,US,2022,Q3,Elderly
213179811,21317981,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q3,Intentional product misuse,,2022,Q3,1,I,,20220822.0,20220911,20220911,PER,,US-SA-2022SA352106,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20220911,,CN,US,US,2022,Q3,Adult
213179811,21317981,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q3,Hyperhidrosis,,2022,Q3,1,I,,20220822.0,20220911,20220911,PER,,US-SA-2022SA352106,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20220911,,CN,US,US,2022,Q3,Adult
213179811,21317981,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q3,Blood glucose fluctuation,,2022,Q3,1,I,,20220822.0,20220911,20220911,PER,,US-SA-2022SA352106,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20220911,,CN,US,US,2022,Q3,Adult
213179811,21317981,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220822.0,20220911,20220911,PER,,US-SA-2022SA352106,SANOFI AVENTIS,,63.0,YR,A,F,Y,,,20220911,,CN,US,US,2022,Q3,Adult
213204991,21320499,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2022,Q3,Product use issue,,2022,Q3,1,I,,20220907.0,20220911,20220911,PER,,US-SA-2022SA373517,SANOFI AVENTIS,,58.0,YR,A,M,Y,,,20220912,,CN,US,US,2022,Q3,Adult
213238451,21323845,10,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1iu, CO",,,D,,,,,1.0,IU,Unknown,,2022,Q3,Toxic epidermal necrolysis,,2022,Q3,1,I,20200809.0,20220902.0,20220912,20220912,EXP,FR-EMA-DD-20220830-7180173-082651,FR-JNJFOC-20200841529,JOHNSON AND JOHNSON,,74.0,YR,E,M,Y,,,20220912,,MD,FR,FR,2022,Q3,Elderly
213257611,21325761,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,900 IU (International Unit),,,U,,,,,300.0,IU,Injection,,2022,Q3,Hypotension,,2022,Q3,1,I,20160823.0,20220907.0,20220913,20220913,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-2016087436,BRISTOL MYERS SQUIBB,,61.0,YR,E,F,Y,113.0,KG,20220913,,MD,US,US,2022,Q3,Adult
213257611,21325761,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,900 IU (International Unit),,,U,,,,,300.0,IU,Injection,,2022,Q3,Portal vein thrombosis,,2022,Q3,1,I,20160823.0,20220907.0,20220913,20220913,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-2016087436,BRISTOL MYERS SQUIBB,,61.0,YR,E,F,Y,113.0,KG,20220913,,MD,US,US,2022,Q3,Adult
213257611,21325761,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,900 IU (International Unit),,,U,,,,,300.0,IU,Injection,,2022,Q3,Dyspnoea,,2022,Q3,1,I,20160823.0,20220907.0,20220913,20220913,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-2016087436,BRISTOL MYERS SQUIBB,,61.0,YR,E,F,Y,113.0,KG,20220913,,MD,US,US,2022,Q3,Adult
213257611,21325761,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,900 IU (International Unit),,,U,,,,,300.0,IU,Injection,,2022,Q3,Portal vein occlusion,,2022,Q3,1,I,20160823.0,20220907.0,20220913,20220913,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-2016087436,BRISTOL MYERS SQUIBB,,61.0,YR,E,F,Y,113.0,KG,20220913,,MD,US,US,2022,Q3,Adult
213257611,21325761,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,900 IU (International Unit),,,U,,,,,300.0,IU,Injection,,2022,Q3,Malignant neoplasm progression,,2022,Q3,1,I,20160823.0,20220907.0,20220913,20220913,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-2016087436,BRISTOL MYERS SQUIBB,,61.0,YR,E,F,Y,113.0,KG,20220913,,MD,US,US,2022,Q3,Adult
213257611,21325761,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,900 IU (International Unit),,,U,,,,,300.0,IU,Injection,,2022,Q3,Generalised oedema,,2022,Q3,1,I,20160823.0,20220907.0,20220913,20220913,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-2016087436,BRISTOL MYERS SQUIBB,,61.0,YR,E,F,Y,113.0,KG,20220913,,MD,US,US,2022,Q3,Adult
213257611,21325761,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,900 IU (International Unit),,,U,,,,,300.0,IU,Injection,,2022,Q3,Anaemia,,2022,Q3,1,I,20160823.0,20220907.0,20220913,20220913,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-2016087436,BRISTOL MYERS SQUIBB,,61.0,YR,E,F,Y,113.0,KG,20220913,,MD,US,US,2022,Q3,Adult
213257611,21325761,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,60 IU (International Unit),,,U,,,,,20.0,IU,Injection,,2022,Q3,Hypotension,,2022,Q3,1,I,20160823.0,20220907.0,20220913,20220913,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-2016087436,BRISTOL MYERS SQUIBB,,61.0,YR,E,F,Y,113.0,KG,20220913,,MD,US,US,2022,Q3,Adult
213257611,21325761,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,60 IU (International Unit),,,U,,,,,20.0,IU,Injection,,2022,Q3,Portal vein thrombosis,,2022,Q3,1,I,20160823.0,20220907.0,20220913,20220913,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-2016087436,BRISTOL MYERS SQUIBB,,61.0,YR,E,F,Y,113.0,KG,20220913,,MD,US,US,2022,Q3,Adult
213257611,21325761,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,60 IU (International Unit),,,U,,,,,20.0,IU,Injection,,2022,Q3,Dyspnoea,,2022,Q3,1,I,20160823.0,20220907.0,20220913,20220913,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-2016087436,BRISTOL MYERS SQUIBB,,61.0,YR,E,F,Y,113.0,KG,20220913,,MD,US,US,2022,Q3,Adult
213257611,21325761,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,60 IU (International Unit),,,U,,,,,20.0,IU,Injection,,2022,Q3,Portal vein occlusion,,2022,Q3,1,I,20160823.0,20220907.0,20220913,20220913,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-2016087436,BRISTOL MYERS SQUIBB,,61.0,YR,E,F,Y,113.0,KG,20220913,,MD,US,US,2022,Q3,Adult
213257611,21325761,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,60 IU (International Unit),,,U,,,,,20.0,IU,Injection,,2022,Q3,Malignant neoplasm progression,,2022,Q3,1,I,20160823.0,20220907.0,20220913,20220913,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-2016087436,BRISTOL MYERS SQUIBB,,61.0,YR,E,F,Y,113.0,KG,20220913,,MD,US,US,2022,Q3,Adult
213257611,21325761,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,60 IU (International Unit),,,U,,,,,20.0,IU,Injection,,2022,Q3,Generalised oedema,,2022,Q3,1,I,20160823.0,20220907.0,20220913,20220913,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-2016087436,BRISTOL MYERS SQUIBB,,61.0,YR,E,F,Y,113.0,KG,20220913,,MD,US,US,2022,Q3,Adult
213257611,21325761,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,60 IU (International Unit),,,U,,,,,20.0,IU,Injection,,2022,Q3,Anaemia,,2022,Q3,1,I,20160823.0,20220907.0,20220913,20220913,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-2016087436,BRISTOL MYERS SQUIBB,,61.0,YR,E,F,Y,113.0,KG,20220913,,MD,US,US,2022,Q3,Adult
213277041,21327704,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,,,2022,Q3,Thrombocytopenia,,2022,Q3,1,I,,20220903.0,20220913,20220913,EXP,,US-MYLANLABS-2022M1092467,MYLAN,"Raimonde AR, Dennis AK. Carvedilol-Induced Thrombocytopenia: A Case Report. Hosp-Pharm 2022;null:null.",44.0,YR,,F,Y,,,20220913,,HP,US,US,2022,Q3,Adult
213303951,21330395,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,7 iU,,,,,,,,7.0,IU,,,2022,Q3,Therapy non-responder,,2022,Q3,1,I,,20220908.0,20220913,20220913,EXP,,CA-PFIZER INC-202201150569,PFIZER,,20.0,YR,,F,Y,47.0,KG,20220913,,HP,CA,CA,2022,Q3,Youth
213303951,21330395,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3 iU,,,,,,,,3.0,IU,,,2022,Q3,Therapy non-responder,,2022,Q3,1,I,,20220908.0,20220913,20220913,EXP,,CA-PFIZER INC-202201150569,PFIZER,,20.0,YR,,F,Y,47.0,KG,20220913,,HP,CA,CA,2022,Q3,Youth
213303951,21330395,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5 iU,,,,,,,,5.0,IU,,,2022,Q3,Therapy non-responder,,2022,Q3,1,I,,20220908.0,20220913,20220913,EXP,,CA-PFIZER INC-202201150569,PFIZER,,20.0,YR,,F,Y,47.0,KG,20220913,,HP,CA,CA,2022,Q3,Youth
213303951,21330395,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 iU,,,,,,,,2.0,IU,,,2022,Q3,Therapy non-responder,,2022,Q3,1,I,,20220908.0,20220913,20220913,EXP,,CA-PFIZER INC-202201150569,PFIZER,,20.0,YR,,F,Y,47.0,KG,20220913,,HP,CA,CA,2022,Q3,Youth
213303951,21330395,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,9 iU,,,,,,,,9.0,IU,,,2022,Q3,Therapy non-responder,,2022,Q3,1,I,,20220908.0,20220913,20220913,EXP,,CA-PFIZER INC-202201150569,PFIZER,,20.0,YR,,F,Y,47.0,KG,20220913,,HP,CA,CA,2022,Q3,Youth
213303951,21330395,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,6 iU,,,,,,,,6.0,IU,,,2022,Q3,Therapy non-responder,,2022,Q3,1,I,,20220908.0,20220913,20220913,EXP,,CA-PFIZER INC-202201150569,PFIZER,,20.0,YR,,F,Y,47.0,KG,20220913,,HP,CA,CA,2022,Q3,Youth
213303951,21330395,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8 iU,,,,,,,,8.0,IU,,,2022,Q3,Therapy non-responder,,2022,Q3,1,I,,20220908.0,20220913,20220913,EXP,,CA-PFIZER INC-202201150569,PFIZER,,20.0,YR,,F,Y,47.0,KG,20220913,,HP,CA,CA,2022,Q3,Youth
213303951,21330395,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10 iU,,,,,,,,10.0,IU,,,2022,Q3,Therapy non-responder,,2022,Q3,1,I,,20220908.0,20220913,20220913,EXP,,CA-PFIZER INC-202201150569,PFIZER,,20.0,YR,,F,Y,47.0,KG,20220913,,HP,CA,CA,2022,Q3,Youth
213303951,21330395,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1 iU,,,,,,,,1.0,IU,,,2022,Q3,Therapy non-responder,,2022,Q3,1,I,,20220908.0,20220913,20220913,EXP,,CA-PFIZER INC-202201150569,PFIZER,,20.0,YR,,F,Y,47.0,KG,20220913,,HP,CA,CA,2022,Q3,Youth
213303951,21330395,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,4 iU,,,,,,,,4.0,IU,,,2022,Q3,Therapy non-responder,,2022,Q3,1,I,,20220908.0,20220913,20220913,EXP,,CA-PFIZER INC-202201150569,PFIZER,,20.0,YR,,F,Y,47.0,KG,20220913,,HP,CA,CA,2022,Q3,Youth
213303991,21330399,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 iU, BID",,,,,,,,24.0,IU,Solution for injection,Q12H,2022,Q3,Hypoglycaemia,,2022,Q3,1,I,20220802.0,20220907.0,20220913,20220913,PER,,US-SA-2022SA373902,SANOFI AVENTIS,,64.0,YR,A,F,Y,95.2,KG,20220913,,HP,US,US,2022,Q3,Adult
213326951,21332695,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-6-0",,,U,,,,,,,Injection,,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,,20220912.0,20220914,20220914,EXP,,NVSC2022DE205297,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20220914,,PH,DE,DE,2022,Q3,Elderly
213326951,21332695,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-6-0",,,U,,,,,,,Injection,,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220912.0,20220914,20220914,EXP,,NVSC2022DE205297,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20220914,,PH,DE,DE,2022,Q3,Elderly
213326951,21332695,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-6-0",,,U,,,,,,,Injection,,2022,Q3,Bradycardia,,2022,Q3,1,I,,20220912.0,20220914,20220914,EXP,,NVSC2022DE205297,NOVARTIS,,76.0,YR,,M,Y,82.0,KG,20220914,,PH,DE,DE,2022,Q3,Elderly
213340291,21334029,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2022,Q3,Renal failure,,2022,Q3,1,I,,20220907.0,20220914,20220914,EXP,,US-ELI_LILLY_AND_COMPANY-US202209004790,ELI LILLY AND CO,,84.0,YR,,F,Y,,,20220914,,CN,US,US,2022,Q3,Elderly
213340291,21334029,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2022,Q3,Blood pressure decreased,,2022,Q3,1,I,,20220907.0,20220914,20220914,EXP,,US-ELI_LILLY_AND_COMPANY-US202209004790,ELI LILLY AND CO,,84.0,YR,,F,Y,,,20220914,,CN,US,US,2022,Q3,Elderly
213340291,21334029,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,,,,Injection,,2022,Q3,Cardiac failure congestive,,2022,Q3,1,I,,20220907.0,20220914,20220914,EXP,,US-ELI_LILLY_AND_COMPANY-US202209004790,ELI LILLY AND CO,,84.0,YR,,F,Y,,,20220914,,CN,US,US,2022,Q3,Elderly
213351101,21335110,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,3.0 Dosage forms,,,U,,,,,,,,QD,2022,Q3,Coagulopathy,,2022,Q3,1,I,,20220912.0,20220914,20220914,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-191857",BOEHRINGER INGELHEIM,,86.0,YR,E,M,Y,69.0,KG,20220915,,CN,CA,CA,2022,Q3,Elderly
213351101,21335110,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,3.0 Dosage forms,,,U,,,,,,,,QD,2022,Q3,Coagulation test abnormal,,2022,Q3,1,I,,20220912.0,20220914,20220914,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-191857",BOEHRINGER INGELHEIM,,86.0,YR,E,M,Y,69.0,KG,20220915,,CN,CA,CA,2022,Q3,Elderly
213351101,21335110,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,3.0 Dosage forms,,,U,,,,,,,,QD,2022,Q3,Melaena,,2022,Q3,1,I,,20220912.0,20220914,20220914,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-191857",BOEHRINGER INGELHEIM,,86.0,YR,E,M,Y,69.0,KG,20220915,,CN,CA,CA,2022,Q3,Elderly
213351101,21335110,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,3.0 Dosage forms,,,U,,,,,,,,QD,2022,Q3,Haemodynamic instability,,2022,Q3,1,I,,20220912.0,20220914,20220914,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-191857",BOEHRINGER INGELHEIM,,86.0,YR,E,M,Y,69.0,KG,20220915,,CN,CA,CA,2022,Q3,Elderly
213351101,21335110,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,3.0 Dosage forms,,,U,,,,,,,,QD,2022,Q3,Haematuria,,2022,Q3,1,I,,20220912.0,20220914,20220914,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-191857",BOEHRINGER INGELHEIM,,86.0,YR,E,M,Y,69.0,KG,20220915,,CN,CA,CA,2022,Q3,Elderly
213351101,21335110,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,3.0 Dosage forms,,,U,,,,,,,,QD,2022,Q3,Haemoglobin decreased,,2022,Q3,1,I,,20220912.0,20220914,20220914,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-191857",BOEHRINGER INGELHEIM,,86.0,YR,E,M,Y,69.0,KG,20220915,,CN,CA,CA,2022,Q3,Elderly
213361201,21336120,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Death,,2022,Q3,1,I,,,20220914,20220914,DIR,FDA-CDER-CTU-2022-73608,,FDA-CTU,,77.0,YR,,M,N,104.78,KG,20220914,N,,US,,2022,Q3,Elderly
213372721,21337272,3,C,INSULINE LISPRO,,1,,,,,U,,,,,,,,,2022,Q3,End stage renal disease,,2022,Q3,1,I,,20220906.0,20220915,20220915,EXP,,US-SA-2022SA376776,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20220915,,CN,US,US,2022,Q3,Adult
213372721,21337272,3,C,INSULINE LISPRO,,1,,,,,U,,,,,,,,,2022,Q3,Injection site pain,,2022,Q3,1,I,,20220906.0,20220915,20220915,EXP,,US-SA-2022SA376776,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20220915,,CN,US,US,2022,Q3,Adult
213372721,21337272,3,C,INSULINE LISPRO,,1,,,,,U,,,,,,,,,2022,Q3,Blood glucose decreased,,2022,Q3,1,I,,20220906.0,20220915,20220915,EXP,,US-SA-2022SA376776,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20220915,,CN,US,US,2022,Q3,Adult
213372721,21337272,3,C,INSULINE LISPRO,,1,,,,,U,,,,,,,,,2022,Q3,Surgery,,2022,Q3,1,I,,20220906.0,20220915,20220915,EXP,,US-SA-2022SA376776,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20220915,,CN,US,US,2022,Q3,Adult
213381491,21338149,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,12-15 u,,,U,,D498888C,,20563.0,15.0,IU,Injection,,2022,Q3,Incorrect dose administered,,2022,Q3,1,I,20220815.0,20220816.0,20220915,20220915,PER,,US-ELI_LILLY_AND_COMPANY-US202208011028,ELI LILLY AND CO,,86.0,YR,,F,Y,,,20220915,,CN,US,US,2022,Q3,Elderly
213387411,21338741,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q3,Abdominal adhesions,,2022,Q3,1,I,20070901.0,20220908.0,20220915,20220915,PER,,US-ELI_LILLY_AND_COMPANY-US202209005246,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220915,,CN,US,US,2022,Q3,Adult
213387411,21338741,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q3,Drug ineffective,,2022,Q3,1,I,20070901.0,20220908.0,20220915,20220915,PER,,US-ELI_LILLY_AND_COMPANY-US202209005246,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220915,,CN,US,US,2022,Q3,Adult
213387411,21338741,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20070901.0,20220908.0,20220915,20220915,PER,,US-ELI_LILLY_AND_COMPANY-US202209005246,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220915,,CN,US,US,2022,Q3,Adult
213387411,21338741,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3 or 4 units per meal,,,U,,D509664C,,20563.0,,,Injection,,2022,Q3,Abdominal adhesions,,2022,Q3,1,I,20070901.0,20220908.0,20220915,20220915,PER,,US-ELI_LILLY_AND_COMPANY-US202209005246,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220915,,CN,US,US,2022,Q3,Adult
213387411,21338741,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3 or 4 units per meal,,,U,,D509664C,,20563.0,,,Injection,,2022,Q3,Drug ineffective,,2022,Q3,1,I,20070901.0,20220908.0,20220915,20220915,PER,,US-ELI_LILLY_AND_COMPANY-US202209005246,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220915,,CN,US,US,2022,Q3,Adult
213387411,21338741,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3 or 4 units per meal,,,U,,D509664C,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20070901.0,20220908.0,20220915,20220915,PER,,US-ELI_LILLY_AND_COMPANY-US202209005246,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220915,,CN,US,US,2022,Q3,Adult
213387411,21338741,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10 units taken for high carb meal,,,U,,D509664C,,20563.0,10.0,IU,Injection,,2022,Q3,Abdominal adhesions,,2022,Q3,1,I,20070901.0,20220908.0,20220915,20220915,PER,,US-ELI_LILLY_AND_COMPANY-US202209005246,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220915,,CN,US,US,2022,Q3,Adult
213387411,21338741,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10 units taken for high carb meal,,,U,,D509664C,,20563.0,10.0,IU,Injection,,2022,Q3,Drug ineffective,,2022,Q3,1,I,20070901.0,20220908.0,20220915,20220915,PER,,US-ELI_LILLY_AND_COMPANY-US202209005246,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220915,,CN,US,US,2022,Q3,Adult
213387411,21338741,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10 units taken for high carb meal,,,U,,D509664C,,20563.0,10.0,IU,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20070901.0,20220908.0,20220915,20220915,PER,,US-ELI_LILLY_AND_COMPANY-US202209005246,ELI LILLY AND CO,,61.0,YR,,F,Y,,,20220915,,CN,US,US,2022,Q3,Adult
213387801,21338780,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 u, other, sliding scale",,,U,,D484040C,,20563.0,14.0,IU,Injection,,2022,Q3,Accidental underdose,,2022,Q3,1,I,20220908.0,20220909.0,20220915,20220915,PER,,US-ELI_LILLY_AND_COMPANY-US202209005286,ELI LILLY AND CO,,65.0,YR,,M,Y,,,20220915,,CN,US,US,2022,Q3,Elderly
213401111,21340111,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Respiratory failure,,2022,Q3,1,I,,20220908.0,20220916,20220916,EXP,,US-STRIDES ARCOLAB LIMITED-2022SP011702,STRIDES,"Flowers RC, Ocampo J, Krautbauer J, Kupin WL.. Hypercalcaemia in Mycobacterium kansasii pulmonary infection.. BMJ-Case-Rep. 2021;14(11)",7.0,DEC,,M,Y,,,20220916,,MD,US,US,2022,Q3,Child
213401111,21340111,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Mycobacterium kansasii infection,,2022,Q3,1,I,,20220908.0,20220916,20220916,EXP,,US-STRIDES ARCOLAB LIMITED-2022SP011702,STRIDES,"Flowers RC, Ocampo J, Krautbauer J, Kupin WL.. Hypercalcaemia in Mycobacterium kansasii pulmonary infection.. BMJ-Case-Rep. 2021;14(11)",7.0,DEC,,M,Y,,,20220916,,MD,US,US,2022,Q3,Child
213401111,21340111,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Septic shock,,2022,Q3,1,I,,20220908.0,20220916,20220916,EXP,,US-STRIDES ARCOLAB LIMITED-2022SP011702,STRIDES,"Flowers RC, Ocampo J, Krautbauer J, Kupin WL.. Hypercalcaemia in Mycobacterium kansasii pulmonary infection.. BMJ-Case-Rep. 2021;14(11)",7.0,DEC,,M,Y,,,20220916,,MD,US,US,2022,Q3,Child
213401111,21340111,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Anaemia,,2022,Q3,1,I,,20220908.0,20220916,20220916,EXP,,US-STRIDES ARCOLAB LIMITED-2022SP011702,STRIDES,"Flowers RC, Ocampo J, Krautbauer J, Kupin WL.. Hypercalcaemia in Mycobacterium kansasii pulmonary infection.. BMJ-Case-Rep. 2021;14(11)",7.0,DEC,,M,Y,,,20220916,,MD,US,US,2022,Q3,Child
213401111,21340111,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Renal failure,,2022,Q3,1,I,,20220908.0,20220916,20220916,EXP,,US-STRIDES ARCOLAB LIMITED-2022SP011702,STRIDES,"Flowers RC, Ocampo J, Krautbauer J, Kupin WL.. Hypercalcaemia in Mycobacterium kansasii pulmonary infection.. BMJ-Case-Rep. 2021;14(11)",7.0,DEC,,M,Y,,,20220916,,MD,US,US,2022,Q3,Child
213401111,21340111,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Ischaemic hepatitis,,2022,Q3,1,I,,20220908.0,20220916,20220916,EXP,,US-STRIDES ARCOLAB LIMITED-2022SP011702,STRIDES,"Flowers RC, Ocampo J, Krautbauer J, Kupin WL.. Hypercalcaemia in Mycobacterium kansasii pulmonary infection.. BMJ-Case-Rep. 2021;14(11)",7.0,DEC,,M,Y,,,20220916,,MD,US,US,2022,Q3,Child
213401111,21340111,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Lactic acidosis,,2022,Q3,1,I,,20220908.0,20220916,20220916,EXP,,US-STRIDES ARCOLAB LIMITED-2022SP011702,STRIDES,"Flowers RC, Ocampo J, Krautbauer J, Kupin WL.. Hypercalcaemia in Mycobacterium kansasii pulmonary infection.. BMJ-Case-Rep. 2021;14(11)",7.0,DEC,,M,Y,,,20220916,,MD,US,US,2022,Q3,Child
213401111,21340111,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Pneumonia,,2022,Q3,1,I,,20220908.0,20220916,20220916,EXP,,US-STRIDES ARCOLAB LIMITED-2022SP011702,STRIDES,"Flowers RC, Ocampo J, Krautbauer J, Kupin WL.. Hypercalcaemia in Mycobacterium kansasii pulmonary infection.. BMJ-Case-Rep. 2021;14(11)",7.0,DEC,,M,Y,,,20220916,,MD,US,US,2022,Q3,Child
213410142,21341014,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Injection site pain,,2022,Q3,2,F,20220603.0,20220919.0,20220916,20220924,PER,,US-SA-2022SA383905,SANOFI AVENTIS,,78.0,YR,E,F,Y,95.0,KG,20220924,,MD,US,US,2022,Q3,Elderly
213410142,21341014,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Injection site pain,,2022,Q3,2,F,20220603.0,20220919.0,20220916,20220924,PER,,US-SA-2022SA383905,SANOFI AVENTIS,,78.0,YR,E,F,Y,95.0,KG,20220924,,MD,US,US,2022,Q3,Elderly
213410142,21341014,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Incorrect dose administered,,2022,Q3,2,F,20220603.0,20220919.0,20220916,20220924,PER,,US-SA-2022SA383905,SANOFI AVENTIS,,78.0,YR,E,F,Y,95.0,KG,20220924,,MD,US,US,2022,Q3,Elderly
213410142,21341014,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q3,Product use issue,,2022,Q3,2,F,20220603.0,20220919.0,20220916,20220924,PER,,US-SA-2022SA383905,SANOFI AVENTIS,,78.0,YR,E,F,Y,95.0,KG,20220924,,MD,US,US,2022,Q3,Elderly
213413881,21341388,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,Unknown,,,,,UNK,,2022,Q3,Drug withdrawal syndrome,,2022,Q3,1,I,,20220907.0,20220916,20220916,EXP,,US-GRANULES-US-2022GRALIT00228,GRANULES INDIA,Custodio AR.Addressing Data Gaps: A Gabapentin Withdrawal Case Report. Journal of General Internal Medicine.JUN-2022;37:S395-S396,71.0,YR,E,M,Y,,,20220916,,HP,US,US,2022,Q3,Elderly
213413881,21341388,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,Unknown,,,,,UNK,,2022,Q3,Encephalopathy,,2022,Q3,1,I,,20220907.0,20220916,20220916,EXP,,US-GRANULES-US-2022GRALIT00228,GRANULES INDIA,Custodio AR.Addressing Data Gaps: A Gabapentin Withdrawal Case Report. Journal of General Internal Medicine.JUN-2022;37:S395-S396,71.0,YR,E,M,Y,,,20220916,,HP,US,US,2022,Q3,Elderly
213443921,21344392,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,Unknown,,2022,Q3,Dyspepsia,,2022,Q3,1,I,20211101.0,20220915.0,20220916,20220916,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-106979,BRISTOL MYERS SQUIBB,,72.0,YR,E,M,Y,72.0,KG,20220916,,HP,US,US,2022,Q3,Elderly
213443921,21344392,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,Unknown,,2022,Q3,Flatulence,,2022,Q3,1,I,20211101.0,20220915.0,20220916,20220916,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-106979,BRISTOL MYERS SQUIBB,,72.0,YR,E,M,Y,72.0,KG,20220916,,HP,US,US,2022,Q3,Elderly
213459121,21345912,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Nausea,,2022,Q3,1,I,20220826.0,20220907.0,20220916,20220916,EXP,,US-TEVA-2022-US-2073162,TEVA,,35.0,YR,A,M,Y,112.1,KG,20220916,,MD,US,US,2022,Q3,Adult
213459121,21345912,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Abdominal pain,,2022,Q3,1,I,20220826.0,20220907.0,20220916,20220916,EXP,,US-TEVA-2022-US-2073162,TEVA,,35.0,YR,A,M,Y,112.1,KG,20220916,,MD,US,US,2022,Q3,Adult
213459121,21345912,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Vomiting,,2022,Q3,1,I,20220826.0,20220907.0,20220916,20220916,EXP,,US-TEVA-2022-US-2073162,TEVA,,35.0,YR,A,M,Y,112.1,KG,20220916,,MD,US,US,2022,Q3,Adult
213481401,21348140,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,Skin discolouration,,2022,Q3,1,I,,20220913.0,20220919,20220919,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-106823,BRISTOL MYERS SQUIBB,,83.0,YR,E,M,Y,,,20220919,,CN,US,US,2022,Q3,Elderly
213482191,21348219,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 dosage form, QD (4-6-8-0)",,,U,,,,,,,,QD,2022,Q3,Haematemesis,,2022,Q3,1,I,,20220915.0,20220919,20220919,EXP,,NVSC2022DE208598,NOVARTIS,,96.0,YR,,M,Y,65.0,KG,20220919,,PH,DE,DE,2022,Q3,Elderly
213482191,21348219,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 dosage form, QD (4-6-8-0)",,,U,,,,,,,,QD,2022,Q3,Dehydration,,2022,Q3,1,I,,20220915.0,20220919,20220919,EXP,,NVSC2022DE208598,NOVARTIS,,96.0,YR,,M,Y,65.0,KG,20220919,,PH,DE,DE,2022,Q3,Elderly
213483071,21348307,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, (6-6-6-0)",,,U,,,,,1.0,IU,Solution for injection/infusion,,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220909.0,20220919,20220919,EXP,,DE-AUROBINDO-AUR-APL-2022-036867,AUROBINDO,,76.0,YR,,M,Y,82.0,KG,20220919,,PH,DE,DE,2022,Q3,Elderly
213483071,21348307,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, (6-6-6-0)",,,U,,,,,1.0,IU,Solution for injection/infusion,,2022,Q3,Bradycardia,,2022,Q3,1,I,,20220909.0,20220919,20220919,EXP,,DE-AUROBINDO-AUR-APL-2022-036867,AUROBINDO,,76.0,YR,,M,Y,82.0,KG,20220919,,PH,DE,DE,2022,Q3,Elderly
213483071,21348307,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit, (6-6-6-0)",,,U,,,,,1.0,IU,Solution for injection/infusion,,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,,20220909.0,20220919,20220919,EXP,,DE-AUROBINDO-AUR-APL-2022-036867,AUROBINDO,,76.0,YR,,M,Y,82.0,KG,20220919,,PH,DE,DE,2022,Q3,Elderly
213490631,21349063,24,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1iu, CO",,,D,,,,,1.0,IU,,,2022,Q3,Toxic epidermal necrolysis,,2022,Q3,1,I,20200809.0,20220905.0,20220919,20220919,EXP,,FR-SUN PHARMACEUTICAL INDUSTRIES LTD-2020RR-260803,RANBAXY,,74.0,YR,,M,Y,,,20220919,,PH,FR,FR,2022,Q3,Elderly
213503391,21350339,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (100 IE/ml, 60-60-60-0)",,,U,,,,,,,,,2022,Q3,COVID-19 pneumonia,,2022,Q3,1,I,20201206.0,20220915.0,20220919,20220919,EXP,,NVSC2022DE208569,NOVARTIS,,59.0,YR,,M,Y,,,20220919,,PH,DE,DE,2022,Q3,Adult
213503391,21350339,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (100 IE/ml, 60-60-60-0)",,,U,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,1,I,20201206.0,20220915.0,20220919,20220919,EXP,,NVSC2022DE208569,NOVARTIS,,59.0,YR,,M,Y,,,20220919,,PH,DE,DE,2022,Q3,Adult
213507571,21350757,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Unknown IU, according to scheme",,,,,Unknown,,,,,Solution for injection,,2022,Q3,Hypotension,,2022,Q3,1,I,20190712.0,20220915.0,20220919,20220919,EXP,DE-ADRED-04034-01,DE-PFIZER INC-202201164298,PFIZER,,69.0,YR,,M,Y,,,20220919,,MD,DE,DE,2022,Q3,Elderly
213507571,21350757,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Unknown IU, according to scheme",,,,,Unknown,,,,,Solution for injection,,2022,Q3,Syncope,,2022,Q3,1,I,20190712.0,20220915.0,20220919,20220919,EXP,DE-ADRED-04034-01,DE-PFIZER INC-202201164298,PFIZER,,69.0,YR,,M,Y,,,20220919,,MD,DE,DE,2022,Q3,Elderly
213507571,21350757,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Unknown IU, according to scheme",,,,,Unknown,,,,,Solution for injection,,2022,Q3,Diarrhoea,,2022,Q3,1,I,20190712.0,20220915.0,20220919,20220919,EXP,DE-ADRED-04034-01,DE-PFIZER INC-202201164298,PFIZER,,69.0,YR,,M,Y,,,20220919,,MD,DE,DE,2022,Q3,Elderly
213507571,21350757,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Unknown IU, according to scheme",,,,,Unknown,,,,,Solution for injection,,2022,Q3,Dehydration,,2022,Q3,1,I,20190712.0,20220915.0,20220919,20220919,EXP,DE-ADRED-04034-01,DE-PFIZER INC-202201164298,PFIZER,,69.0,YR,,M,Y,,,20220919,,MD,DE,DE,2022,Q3,Elderly
213507571,21350757,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Unknown IU, according to scheme",,,,,Unknown,,,,,Solution for injection,,2022,Q3,Circulatory collapse,,2022,Q3,1,I,20190712.0,20220915.0,20220919,20220919,EXP,DE-ADRED-04034-01,DE-PFIZER INC-202201164298,PFIZER,,69.0,YR,,M,Y,,,20220919,,MD,DE,DE,2022,Q3,Elderly
213507841,21350784,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (NK IE, nach Schema;Liprolog 100 Einheiten/ml Injektionslosung)",,,U,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,1,I,20190712.0,20220915.0,20220919,20220919,EXP,,NVSC2022DE208636,NOVARTIS,,69.0,YR,,M,Y,,,20220919,,MD,DE,DE,2022,Q3,Elderly
213507841,21350784,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (NK IE, nach Schema;Liprolog 100 Einheiten/ml Injektionslosung)",,,U,,,,,,,,,2022,Q3,Circulatory collapse,,2022,Q3,1,I,20190712.0,20220915.0,20220919,20220919,EXP,,NVSC2022DE208636,NOVARTIS,,69.0,YR,,M,Y,,,20220919,,MD,DE,DE,2022,Q3,Elderly
213507841,21350784,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (NK IE, nach Schema;Liprolog 100 Einheiten/ml Injektionslosung)",,,U,,,,,,,,,2022,Q3,Syncope,,2022,Q3,1,I,20190712.0,20220915.0,20220919,20220919,EXP,,NVSC2022DE208636,NOVARTIS,,69.0,YR,,M,Y,,,20220919,,MD,DE,DE,2022,Q3,Elderly
213507841,21350784,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (NK IE, nach Schema;Liprolog 100 Einheiten/ml Injektionslosung)",,,U,,,,,,,,,2022,Q3,Diarrhoea,,2022,Q3,1,I,20190712.0,20220915.0,20220919,20220919,EXP,,NVSC2022DE208636,NOVARTIS,,69.0,YR,,M,Y,,,20220919,,MD,DE,DE,2022,Q3,Elderly
213507841,21350784,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (NK IE, nach Schema;Liprolog 100 Einheiten/ml Injektionslosung)",,,U,,,,,,,,,2022,Q3,Dehydration,,2022,Q3,1,I,20190712.0,20220915.0,20220919,20220919,EXP,,NVSC2022DE208636,NOVARTIS,,69.0,YR,,M,Y,,,20220919,,MD,DE,DE,2022,Q3,Elderly
213524011,21352401,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Solution for injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220901.0,20220909.0,20220920,20220920,PER,,US-ELI_LILLY_AND_COMPANY-US202209007294,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20220920,,CN,US,US,2022,Q3,Elderly
213524011,21352401,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Solution for injection,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,1,I,20220901.0,20220909.0,20220920,20220920,PER,,US-ELI_LILLY_AND_COMPANY-US202209007294,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20220920,,CN,US,US,2022,Q3,Elderly
213524011,21352401,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Solution for injection,,2022,Q3,Infusion site pain,,2022,Q3,1,I,20220901.0,20220909.0,20220920,20220920,PER,,US-ELI_LILLY_AND_COMPANY-US202209007294,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20220920,,CN,US,US,2022,Q3,Elderly
213524011,21352401,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,,,,Solution for injection,,2022,Q3,Wrong technique in product usage process,,2022,Q3,1,I,20220901.0,20220909.0,20220920,20220920,PER,,US-ELI_LILLY_AND_COMPANY-US202209007294,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20220920,,CN,US,US,2022,Q3,Elderly
213524011,21352401,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D477301A,,,,,Solution for injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220901.0,20220909.0,20220920,20220920,PER,,US-ELI_LILLY_AND_COMPANY-US202209007294,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20220920,,CN,US,US,2022,Q3,Elderly
213524011,21352401,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D477301A,,,,,Solution for injection,,2022,Q3,Glycosylated haemoglobin increased,,2022,Q3,1,I,20220901.0,20220909.0,20220920,20220920,PER,,US-ELI_LILLY_AND_COMPANY-US202209007294,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20220920,,CN,US,US,2022,Q3,Elderly
213524011,21352401,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D477301A,,,,,Solution for injection,,2022,Q3,Infusion site pain,,2022,Q3,1,I,20220901.0,20220909.0,20220920,20220920,PER,,US-ELI_LILLY_AND_COMPANY-US202209007294,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20220920,,CN,US,US,2022,Q3,Elderly
213524011,21352401,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,D477301A,,,,,Solution for injection,,2022,Q3,Wrong technique in product usage process,,2022,Q3,1,I,20220901.0,20220909.0,20220920,20220920,PER,,US-ELI_LILLY_AND_COMPANY-US202209007294,ELI LILLY AND CO,,68.0,YR,,M,Y,,,20220920,,CN,US,US,2022,Q3,Elderly
213525312,21352531,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,Unknown,,2022,Q3,Peripheral ischaemia,,2022,Q3,2,F,20220817.0,20220916.0,20220920,20220921,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-2022-106737,BRISTOL MYERS SQUIBB,,52.0,YR,A,M,Y,94.0,KG,20220921,,CN,ES,ES,2022,Q3,Adult
213525312,21352531,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,Unknown,,2022,Q3,Localised infection,,2022,Q3,2,F,20220817.0,20220916.0,20220920,20220921,EXP,,ES-BRISTOL-MYERS SQUIBB COMPANY-2022-106737,BRISTOL MYERS SQUIBB,,52.0,YR,A,M,Y,94.0,KG,20220921,,CN,ES,ES,2022,Q3,Adult
213533161,21353316,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q3,Maternal exposure during pregnancy,,2022,Q3,1,I,,20220816.0,20220920,20220920,PER,,US-STRIDES ARCOLAB LIMITED-2022SP010603,STRIDES,"Deleon AM, Gaiha RD, Peralta FM.. The Successful Anesthetic Management of a Cesarean Delivery in a Patient with Fanconi-Bickel Syndrome.. Case-Rep-Anesthesiol. 2022",22.0,YR,,F,Y,,,20220920,,HP,US,US,2022,Q3,Youth
213544821,21354482,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,U,,,,,,,,2022,Q3,Encephalopathy,,2022,Q3,1,I,,20220909.0,20220920,20220920,EXP,,"US-Zhejiang Yongtai pharmaceuticals Co..,Ltd.-2133005",ZHEJIANG YONGTAI,"Custodio AR, Guerrero R, Bashour C, khan H. ADDRESSING DATA GAPS: A GABAPENTIN WITHDRAWAL CASE REPORT. Journal of General Internal Medicine 37 (Suppl. 2): S395-S396, Jun 2022. http://doi.org/10.1007/s11606-022-07653-8",71.0,YR,,M,Y,,,20220920,,HP,US,US,2022,Q3,Elderly
213544821,21354482,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,U,,,,,,,,2022,Q3,Drug withdrawal syndrome,,2022,Q3,1,I,,20220909.0,20220920,20220920,EXP,,"US-Zhejiang Yongtai pharmaceuticals Co..,Ltd.-2133005",ZHEJIANG YONGTAI,"Custodio AR, Guerrero R, Bashour C, khan H. ADDRESSING DATA GAPS: A GABAPENTIN WITHDRAWAL CASE REPORT. Journal of General Internal Medicine 37 (Suppl. 2): S395-S396, Jun 2022. http://doi.org/10.1007/s11606-022-07653-8",71.0,YR,,M,Y,,,20220920,,HP,US,US,2022,Q3,Elderly
213546101,21354610,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Feeling abnormal,,2022,Q3,1,I,20220915.0,,20220919,20220919,DIR,631850,,FDA-CTU,,54.0,YR,,F,N,112.05,KG,20220919,N,CN,US,,2022,Q3,Adult
213546101,21354610,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Abdominal pain upper,,2022,Q3,1,I,20220915.0,,20220919,20220919,DIR,631850,,FDA-CTU,,54.0,YR,,F,N,112.05,KG,20220919,N,CN,US,,2022,Q3,Adult
213546101,21354610,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Kidney infection,,2022,Q3,1,I,20220915.0,,20220919,20220919,DIR,631850,,FDA-CTU,,54.0,YR,,F,N,112.05,KG,20220919,N,CN,US,,2022,Q3,Adult
213546101,21354610,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,1,I,20220915.0,,20220919,20220919,DIR,631850,,FDA-CTU,,54.0,YR,,F,N,112.05,KG,20220919,N,CN,US,,2022,Q3,Adult
213546101,21354610,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Hypoaesthesia,,2022,Q3,1,I,20220915.0,,20220919,20220919,DIR,631850,,FDA-CTU,,54.0,YR,,F,N,112.05,KG,20220919,N,CN,US,,2022,Q3,Adult
213546101,21354610,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Eye pain,,2022,Q3,1,I,20220915.0,,20220919,20220919,DIR,631850,,FDA-CTU,,54.0,YR,,F,N,112.05,KG,20220919,N,CN,US,,2022,Q3,Adult
213546101,21354610,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Migraine,,2022,Q3,1,I,20220915.0,,20220919,20220919,DIR,631850,,FDA-CTU,,54.0,YR,,F,N,112.05,KG,20220919,N,CN,US,,2022,Q3,Adult
213556511,21355651,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q3,Diarrhoea,,2022,Q3,1,I,20190712.0,20220916.0,20220920,20220920,EXP,,DE-SA-2022SA388385,SANOFI AVENTIS,,69.0,YR,E,M,Y,,,20220920,,MD,DE,DE,2022,Q3,Elderly
213556511,21355651,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q3,Circulatory collapse,,2022,Q3,1,I,20190712.0,20220916.0,20220920,20220920,EXP,,DE-SA-2022SA388385,SANOFI AVENTIS,,69.0,YR,E,M,Y,,,20220920,,MD,DE,DE,2022,Q3,Elderly
213556511,21355651,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q3,Syncope,,2022,Q3,1,I,20190712.0,20220916.0,20220920,20220920,EXP,,DE-SA-2022SA388385,SANOFI AVENTIS,,69.0,YR,E,M,Y,,,20220920,,MD,DE,DE,2022,Q3,Elderly
213556511,21355651,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,1,I,20190712.0,20220916.0,20220920,20220920,EXP,,DE-SA-2022SA388385,SANOFI AVENTIS,,69.0,YR,E,M,Y,,,20220920,,MD,DE,DE,2022,Q3,Elderly
213556511,21355651,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q3,Dehydration,,2022,Q3,1,I,20190712.0,20220916.0,20220920,20220920,EXP,,DE-SA-2022SA388385,SANOFI AVENTIS,,69.0,YR,E,M,Y,,,20220920,,MD,DE,DE,2022,Q3,Elderly
213564791,21356479,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 iU, 1x/day (1 IE, 1-0-0-0)",,,U,,,,,1.0,IU,,QD,2022,Q3,Renal impairment,,2022,Q3,1,I,,20220916.0,20220920,20220920,EXP,DE-ADRED-07767-01,DE-PFIZER INC-202201167719,PFIZER,,48.0,YR,,M,Y,72.0,KG,20220920,,PH,DE,DE,2022,Q3,Adult
213568811,21356881,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK,3 units",,,,,,,,,,,,2022,Q3,Orthostatic hypotension,,2022,Q3,1,I,,20220906.0,20220920,20220920,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-355195,RANBAXY,"Gough S, Borgetti S,Fernandes CR. Orthostatic hypotension as the initial presentation of disseminated cryptococcosis in a kidney transplant recipient. IDCases. 2022;29:e01567;1-3",69.0,YR,,M,Y,,,20220921,,HP,US,US,2022,Q3,Elderly
213568811,21356881,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK,3 units",,,,,,,,,,,,2022,Q3,Disseminated cryptococcosis,,2022,Q3,1,I,,20220906.0,20220920,20220920,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-355195,RANBAXY,"Gough S, Borgetti S,Fernandes CR. Orthostatic hypotension as the initial presentation of disseminated cryptococcosis in a kidney transplant recipient. IDCases. 2022;29:e01567;1-3",69.0,YR,,M,Y,,,20220921,,HP,US,US,2022,Q3,Elderly
213578851,21357885,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,Hypersensitivity,,2022,Q3,1,I,,20220919.0,20220921,20220921,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-108989,BRISTOL MYERS SQUIBB,,79.0,YR,E,F,Y,,,20220921,,CN,US,US,2022,Q3,Elderly
213578851,21357885,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,Intentional product use issue,,2022,Q3,1,I,,20220919.0,20220921,20220921,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-108989,BRISTOL MYERS SQUIBB,,79.0,YR,E,F,Y,,,20220921,,CN,US,US,2022,Q3,Elderly
213595731,21359573,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK  (26-0-16-0),,,U,,,,,,,,,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220919.0,20220921,20220921,EXP,,NVSC2022DE210987,NOVARTIS,,78.0,YR,,M,Y,,,20220921,,PH,DE,DE,2022,Q3,Elderly
213595731,21359573,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK  (26-0-16-0),,,U,,,,,,,,,2022,Q3,Systemic infection,,2022,Q3,1,I,,20220919.0,20220921,20220921,EXP,,NVSC2022DE210987,NOVARTIS,,78.0,YR,,M,Y,,,20220921,,PH,DE,DE,2022,Q3,Elderly
213595731,21359573,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK  (26-0-16-0),,,U,,,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,,20220919.0,20220921,20220921,EXP,,NVSC2022DE210987,NOVARTIS,,78.0,YR,,M,Y,,,20220921,,PH,DE,DE,2022,Q3,Elderly
213595731,21359573,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK  (26-0-16-0),,,U,,,,,,,,,2022,Q3,Tachycardia,,2022,Q3,1,I,,20220919.0,20220921,20220921,EXP,,NVSC2022DE210987,NOVARTIS,,78.0,YR,,M,Y,,,20220921,,PH,DE,DE,2022,Q3,Elderly
213595731,21359573,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK  (26-0-16-0),,,U,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220919.0,20220921,20220921,EXP,,NVSC2022DE210987,NOVARTIS,,78.0,YR,,M,Y,,,20220921,,PH,DE,DE,2022,Q3,Elderly
213595731,21359573,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK  (26-0-16-0),,,U,,,,,,,,,2022,Q3,Renal impairment,,2022,Q3,1,I,,20220919.0,20220921,20220921,EXP,,NVSC2022DE210987,NOVARTIS,,78.0,YR,,M,Y,,,20220921,,PH,DE,DE,2022,Q3,Elderly
213595731,21359573,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK  (26-0-16-0),,,U,,,,,,,,,2022,Q3,Acute myocardial infarction,,2022,Q3,1,I,,20220919.0,20220921,20220921,EXP,,NVSC2022DE210987,NOVARTIS,,78.0,YR,,M,Y,,,20220921,,PH,DE,DE,2022,Q3,Elderly
213595731,21359573,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK  (26-0-16-0),,,U,,,,,,,,,2022,Q3,Hyperglycaemia,,2022,Q3,1,I,,20220919.0,20220921,20220921,EXP,,NVSC2022DE210987,NOVARTIS,,78.0,YR,,M,Y,,,20220921,,PH,DE,DE,2022,Q3,Elderly
213595731,21359573,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK  (26-0-16-0),,,U,,,,,,,,,2022,Q3,Acute respiratory failure,,2022,Q3,1,I,,20220919.0,20220921,20220921,EXP,,NVSC2022DE210987,NOVARTIS,,78.0,YR,,M,Y,,,20220921,,PH,DE,DE,2022,Q3,Elderly
213595731,21359573,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK  (26-0-16-0),,,U,,,,,,,,,2022,Q3,Electrocardiogram abnormal,,2022,Q3,1,I,,20220919.0,20220921,20220921,EXP,,NVSC2022DE210987,NOVARTIS,,78.0,YR,,M,Y,,,20220921,,PH,DE,DE,2022,Q3,Elderly
213595731,21359573,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK  (26-0-16-0),,,U,,,,,,,,,2022,Q3,Arrhythmia,,2022,Q3,1,I,,20220919.0,20220921,20220921,EXP,,NVSC2022DE210987,NOVARTIS,,78.0,YR,,M,Y,,,20220921,,PH,DE,DE,2022,Q3,Elderly
213597922,21359792,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Humalog: 8+8+8 IU/day,,,,,,,,24.0,IU,,QD,2022,Q3,Dizziness,,2022,Q3,2,F,20211001.0,20220915.0,20220921,20220926,EXP,IT-MINISAL02-884341,IT-SA-2022SA385696,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20220926,,PH,IT,IT,2022,Q3,Elderly
213597922,21359792,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Humalog: 8+8+8 IU/day,,,,,,,,24.0,IU,,QD,2022,Q3,Intentional product misuse,,2022,Q3,2,F,20211001.0,20220915.0,20220921,20220926,EXP,IT-MINISAL02-884341,IT-SA-2022SA385696,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20220926,,PH,IT,IT,2022,Q3,Elderly
213597922,21359792,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Humalog: 8+8+8 IU/day,,,,,,,,24.0,IU,,QD,2022,Q3,Polydipsia,,2022,Q3,2,F,20211001.0,20220915.0,20220921,20220926,EXP,IT-MINISAL02-884341,IT-SA-2022SA385696,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20220926,,PH,IT,IT,2022,Q3,Elderly
213597922,21359792,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Humalog: 8+8+8 IU/day,,,,,,,,24.0,IU,,QD,2022,Q3,Asthenia,,2022,Q3,2,F,20211001.0,20220915.0,20220921,20220926,EXP,IT-MINISAL02-884341,IT-SA-2022SA385696,SANOFI AVENTIS,,67.0,YR,E,M,Y,,,20220926,,PH,IT,IT,2022,Q3,Elderly
213615371,21361537,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q3,Drug intolerance,,2022,Q3,1,I,20200119.0,20220304.0,20220921,20220921,EXP,,CO-TAKEDA-2020TUS005207,TAKEDA,,50.0,YR,,M,Y,76.0,KG,20220921,,HP,CO,CO,2022,Q3,Adult
213615371,21361537,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q3,Swollen tongue,,2022,Q3,1,I,20200119.0,20220304.0,20220921,20220921,EXP,,CO-TAKEDA-2020TUS005207,TAKEDA,,50.0,YR,,M,Y,76.0,KG,20220921,,HP,CO,CO,2022,Q3,Adult
213615371,21361537,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q3,Pneumonia,,2022,Q3,1,I,20200119.0,20220304.0,20220921,20220921,EXP,,CO-TAKEDA-2020TUS005207,TAKEDA,,50.0,YR,,M,Y,76.0,KG,20220921,,HP,CO,CO,2022,Q3,Adult
213615371,21361537,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q3,Breath odour,,2022,Q3,1,I,20200119.0,20220304.0,20220921,20220921,EXP,,CO-TAKEDA-2020TUS005207,TAKEDA,,50.0,YR,,M,Y,76.0,KG,20220921,,HP,CO,CO,2022,Q3,Adult
213629881,21362988,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,nach Schema,,,U,U,,,,,,,,2022,Q3,Night sweats,,2022,Q3,1,I,,20220913.0,20220922,20220922,PER,DE-ADRED-06096-02,DE-Shilpa Medicare Limited-SML-DE-2022-01151,SHILPA MEDICARE,,78.0,YR,E,M,Y,88.4,KG,20220922,,MD,DE,DE,2022,Q3,Elderly
213629881,21362988,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,nach Schema,,,U,U,,,,,,,,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220913.0,20220922,20220922,PER,DE-ADRED-06096-02,DE-Shilpa Medicare Limited-SML-DE-2022-01151,SHILPA MEDICARE,,78.0,YR,E,M,Y,88.4,KG,20220922,,MD,DE,DE,2022,Q3,Elderly
213629881,21362988,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,nach Schema,,,U,U,,,,,,,,2022,Q3,Medication error,,2022,Q3,1,I,,20220913.0,20220922,20220922,PER,DE-ADRED-06096-02,DE-Shilpa Medicare Limited-SML-DE-2022-01151,SHILPA MEDICARE,,78.0,YR,E,M,Y,88.4,KG,20220922,,MD,DE,DE,2022,Q3,Elderly
213629881,21362988,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,nach Schema,,,U,U,,,,,,,,2022,Q3,Fatigue,,2022,Q3,1,I,,20220913.0,20220922,20220922,PER,DE-ADRED-06096-02,DE-Shilpa Medicare Limited-SML-DE-2022-01151,SHILPA MEDICARE,,78.0,YR,E,M,Y,88.4,KG,20220922,,MD,DE,DE,2022,Q3,Elderly
213629881,21362988,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,nach Schema,,,U,U,,,,,,,,2022,Q3,Diarrhoea,,2022,Q3,1,I,,20220913.0,20220922,20220922,PER,DE-ADRED-06096-02,DE-Shilpa Medicare Limited-SML-DE-2022-01151,SHILPA MEDICARE,,78.0,YR,E,M,Y,88.4,KG,20220922,,MD,DE,DE,2022,Q3,Elderly
213635681,21363568,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, daily",,,U,,,,,6.0,IU,,QD,2022,Q3,Dyspepsia,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007800,ELI LILLY AND CO,,47.0,YR,,M,Y,83.0,KG,20220922,,CN,DE,DE,2022,Q3,Adult
213635681,21363568,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, daily",,,U,,,,,6.0,IU,,QD,2022,Q3,Diabetes mellitus inadequate control,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007800,ELI LILLY AND CO,,47.0,YR,,M,Y,83.0,KG,20220922,,CN,DE,DE,2022,Q3,Adult
213635681,21363568,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, daily",,,U,,,,,6.0,IU,,QD,2022,Q3,Abdominal pain,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007800,ELI LILLY AND CO,,47.0,YR,,M,Y,83.0,KG,20220922,,CN,DE,DE,2022,Q3,Adult
213635681,21363568,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, daily",,,U,,,,,6.0,IU,,QD,2022,Q3,Hyperglycaemia,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007800,ELI LILLY AND CO,,47.0,YR,,M,Y,83.0,KG,20220922,,CN,DE,DE,2022,Q3,Adult
213635681,21363568,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, daily",,,U,,,,,6.0,IU,,QD,2022,Q3,Nausea,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007800,ELI LILLY AND CO,,47.0,YR,,M,Y,83.0,KG,20220922,,CN,DE,DE,2022,Q3,Adult
213635681,21363568,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, daily",,,U,,,,,6.0,IU,,QD,2022,Q3,Product monitoring error,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007800,ELI LILLY AND CO,,47.0,YR,,M,Y,83.0,KG,20220922,,CN,DE,DE,2022,Q3,Adult
213635681,21363568,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, daily",,,U,,,,,6.0,IU,,QD,2022,Q3,Diabetic ketoacidosis,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007800,ELI LILLY AND CO,,47.0,YR,,M,Y,83.0,KG,20220922,,CN,DE,DE,2022,Q3,Adult
213635681,21363568,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, daily",,,U,,,,,6.0,IU,,QD,2022,Q3,Vomiting,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007800,ELI LILLY AND CO,,47.0,YR,,M,Y,83.0,KG,20220922,,CN,DE,DE,2022,Q3,Adult
213635681,21363568,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, bid",,,U,,,,,5.0,IU,,BID,2022,Q3,Dyspepsia,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007800,ELI LILLY AND CO,,47.0,YR,,M,Y,83.0,KG,20220922,,CN,DE,DE,2022,Q3,Adult
213635681,21363568,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, bid",,,U,,,,,5.0,IU,,BID,2022,Q3,Diabetes mellitus inadequate control,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007800,ELI LILLY AND CO,,47.0,YR,,M,Y,83.0,KG,20220922,,CN,DE,DE,2022,Q3,Adult
213635681,21363568,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, bid",,,U,,,,,5.0,IU,,BID,2022,Q3,Abdominal pain,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007800,ELI LILLY AND CO,,47.0,YR,,M,Y,83.0,KG,20220922,,CN,DE,DE,2022,Q3,Adult
213635681,21363568,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, bid",,,U,,,,,5.0,IU,,BID,2022,Q3,Hyperglycaemia,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007800,ELI LILLY AND CO,,47.0,YR,,M,Y,83.0,KG,20220922,,CN,DE,DE,2022,Q3,Adult
213635681,21363568,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, bid",,,U,,,,,5.0,IU,,BID,2022,Q3,Nausea,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007800,ELI LILLY AND CO,,47.0,YR,,M,Y,83.0,KG,20220922,,CN,DE,DE,2022,Q3,Adult
213635681,21363568,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, bid",,,U,,,,,5.0,IU,,BID,2022,Q3,Product monitoring error,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007800,ELI LILLY AND CO,,47.0,YR,,M,Y,83.0,KG,20220922,,CN,DE,DE,2022,Q3,Adult
213635681,21363568,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, bid",,,U,,,,,5.0,IU,,BID,2022,Q3,Diabetic ketoacidosis,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007800,ELI LILLY AND CO,,47.0,YR,,M,Y,83.0,KG,20220922,,CN,DE,DE,2022,Q3,Adult
213635681,21363568,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, bid",,,U,,,,,5.0,IU,,BID,2022,Q3,Vomiting,,2022,Q3,1,I,,20220916.0,20220922,20220922,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007800,ELI LILLY AND CO,,47.0,YR,,M,Y,83.0,KG,20220922,,CN,DE,DE,2022,Q3,Adult
213642771,21364277,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,U,,,,,,,,2022,Q3,Encephalopathy,,2022,Q3,1,I,,20220909.0,20220922,20220922,EXP,,US-ACI HealthCare Limited-2133082,ACI HEALTHCARE,"Custodio AR, Guerrero R, Bashour C, Khan H. ADDRESSING DATA GAPS: A GABAPENTIN WITHDRAWAL CASE REPORT. Journal of General Internal Medicine 37 (Suppl. 2): S395-S396, Jun 2022. URL: http://doi.org/10.1007/s11606-022-07653-8",71.0,YR,,M,Y,,,20220922,,HP,US,US,2022,Q3,Elderly
213642771,21364277,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,U,,,,,,,,2022,Q3,Drug withdrawal syndrome,,2022,Q3,1,I,,20220909.0,20220922,20220922,EXP,,US-ACI HealthCare Limited-2133082,ACI HEALTHCARE,"Custodio AR, Guerrero R, Bashour C, Khan H. ADDRESSING DATA GAPS: A GABAPENTIN WITHDRAWAL CASE REPORT. Journal of General Internal Medicine 37 (Suppl. 2): S395-S396, Jun 2022. URL: http://doi.org/10.1007/s11606-022-07653-8",71.0,YR,,M,Y,,,20220922,,HP,US,US,2022,Q3,Elderly
213660571,21366057,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Visual impairment,,2022,Q3,1,I,20220822.0,20220823.0,20220922,20220922,PER,,US-ELI_LILLY_AND_COMPANY-US202208014499,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220922,,CN,US,US,2022,Q3,Elderly
213660571,21366057,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220822.0,20220823.0,20220922,20220922,PER,,US-ELI_LILLY_AND_COMPANY-US202208014499,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220922,,CN,US,US,2022,Q3,Elderly
213660571,21366057,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Product dose omission issue,,2022,Q3,1,I,20220822.0,20220823.0,20220922,20220922,PER,,US-ELI_LILLY_AND_COMPANY-US202208014499,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220922,,CN,US,US,2022,Q3,Elderly
213660571,21366057,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220822.0,20220823.0,20220922,20220922,PER,,US-ELI_LILLY_AND_COMPANY-US202208014499,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220922,,CN,US,US,2022,Q3,Elderly
213660571,21366057,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Thirst,,2022,Q3,1,I,20220822.0,20220823.0,20220922,20220922,PER,,US-ELI_LILLY_AND_COMPANY-US202208014499,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220922,,CN,US,US,2022,Q3,Elderly
213660571,21366057,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Visual impairment,,2022,Q3,1,I,20220822.0,20220823.0,20220922,20220922,PER,,US-ELI_LILLY_AND_COMPANY-US202208014499,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220922,,CN,US,US,2022,Q3,Elderly
213660571,21366057,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220822.0,20220823.0,20220922,20220922,PER,,US-ELI_LILLY_AND_COMPANY-US202208014499,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220922,,CN,US,US,2022,Q3,Elderly
213660571,21366057,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Product dose omission issue,,2022,Q3,1,I,20220822.0,20220823.0,20220922,20220922,PER,,US-ELI_LILLY_AND_COMPANY-US202208014499,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220922,,CN,US,US,2022,Q3,Elderly
213660571,21366057,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220822.0,20220823.0,20220922,20220922,PER,,US-ELI_LILLY_AND_COMPANY-US202208014499,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220922,,CN,US,US,2022,Q3,Elderly
213660571,21366057,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q3,Thirst,,2022,Q3,1,I,20220822.0,20220823.0,20220922,20220922,PER,,US-ELI_LILLY_AND_COMPANY-US202208014499,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220922,,CN,US,US,2022,Q3,Elderly
213660571,21366057,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,D456541A,,20563.0,,,Injection,,2022,Q3,Visual impairment,,2022,Q3,1,I,20220822.0,20220823.0,20220922,20220922,PER,,US-ELI_LILLY_AND_COMPANY-US202208014499,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220922,,CN,US,US,2022,Q3,Elderly
213660571,21366057,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,D456541A,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220822.0,20220823.0,20220922,20220922,PER,,US-ELI_LILLY_AND_COMPANY-US202208014499,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220922,,CN,US,US,2022,Q3,Elderly
213660571,21366057,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,D456541A,,20563.0,,,Injection,,2022,Q3,Product dose omission issue,,2022,Q3,1,I,20220822.0,20220823.0,20220922,20220922,PER,,US-ELI_LILLY_AND_COMPANY-US202208014499,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220922,,CN,US,US,2022,Q3,Elderly
213660571,21366057,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,D456541A,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220822.0,20220823.0,20220922,20220922,PER,,US-ELI_LILLY_AND_COMPANY-US202208014499,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220922,,CN,US,US,2022,Q3,Elderly
213660571,21366057,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,D456541A,,20563.0,,,Injection,,2022,Q3,Thirst,,2022,Q3,1,I,20220822.0,20220823.0,20220922,20220922,PER,,US-ELI_LILLY_AND_COMPANY-US202208014499,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220922,,CN,US,US,2022,Q3,Elderly
213660571,21366057,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,D456541A,,20563.0,,,Injection,,2022,Q3,Visual impairment,,2022,Q3,1,I,20220822.0,20220823.0,20220922,20220922,PER,,US-ELI_LILLY_AND_COMPANY-US202208014499,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220922,,CN,US,US,2022,Q3,Elderly
213660571,21366057,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,D456541A,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220822.0,20220823.0,20220922,20220922,PER,,US-ELI_LILLY_AND_COMPANY-US202208014499,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220922,,CN,US,US,2022,Q3,Elderly
213660571,21366057,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,D456541A,,20563.0,,,Injection,,2022,Q3,Product dose omission issue,,2022,Q3,1,I,20220822.0,20220823.0,20220922,20220922,PER,,US-ELI_LILLY_AND_COMPANY-US202208014499,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220922,,CN,US,US,2022,Q3,Elderly
213660571,21366057,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,D456541A,,20563.0,,,Injection,,2022,Q3,Blood glucose increased,,2022,Q3,1,I,20220822.0,20220823.0,20220922,20220922,PER,,US-ELI_LILLY_AND_COMPANY-US202208014499,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220922,,CN,US,US,2022,Q3,Elderly
213660571,21366057,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,D456541A,,20563.0,,,Injection,,2022,Q3,Thirst,,2022,Q3,1,I,20220822.0,20220823.0,20220922,20220922,PER,,US-ELI_LILLY_AND_COMPANY-US202208014499,ELI LILLY AND CO,,68.0,YR,,F,Y,,,20220922,,CN,US,US,2022,Q3,Elderly
213664491,21366449,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Mycobacterium kansasii infection,,2022,Q3,1,I,,20220908.0,20220923,20220923,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-355370,RANBAXY,"Flowers RC, Ocampo J, Krautbauer J, Kupin WL. Hypercalcaemia in Mycobacterium kansasii pulmonary infection. BMJ Case Rep. 2021;14(11):e245800",7.0,DEC,,M,Y,,,20220923,,HP,US,US,2022,Q3,Child
213664491,21366449,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Hypercalcaemia,,2022,Q3,1,I,,20220908.0,20220923,20220923,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-355370,RANBAXY,"Flowers RC, Ocampo J, Krautbauer J, Kupin WL. Hypercalcaemia in Mycobacterium kansasii pulmonary infection. BMJ Case Rep. 2021;14(11):e245800",7.0,DEC,,M,Y,,,20220923,,HP,US,US,2022,Q3,Child
213664491,21366449,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Blood parathyroid hormone decreased,,2022,Q3,1,I,,20220908.0,20220923,20220923,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-355370,RANBAXY,"Flowers RC, Ocampo J, Krautbauer J, Kupin WL. Hypercalcaemia in Mycobacterium kansasii pulmonary infection. BMJ Case Rep. 2021;14(11):e245800",7.0,DEC,,M,Y,,,20220923,,HP,US,US,2022,Q3,Child
213664491,21366449,11,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q3,Pancytopenia,,2022,Q3,1,I,,20220908.0,20220923,20220923,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-355370,RANBAXY,"Flowers RC, Ocampo J, Krautbauer J, Kupin WL. Hypercalcaemia in Mycobacterium kansasii pulmonary infection. BMJ Case Rep. 2021;14(11):e245800",7.0,DEC,,M,Y,,,20220923,,HP,US,US,2022,Q3,Child
213665391,21366539,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2022,Q3,Hyperkeratosis,,2022,Q3,1,I,,20220912.0,20220923,20220923,EXP,FR-EMA-2022909-AUTODUP-1662754854800,FR-NOVOPROD-958167,NOVO NORDISK,,68.0,YR,,F,Y,,,20220923,,MD,FR,FR,2022,Q3,Elderly
213665391,21366539,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2022,Q3,Amyloidosis,,2022,Q3,1,I,,20220912.0,20220923,20220923,EXP,FR-EMA-2022909-AUTODUP-1662754854800,FR-NOVOPROD-958167,NOVO NORDISK,,68.0,YR,,F,Y,,,20220923,,MD,FR,FR,2022,Q3,Elderly
213665391,21366539,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2022,Q3,Acanthosis,,2022,Q3,1,I,,20220912.0,20220923,20220923,EXP,FR-EMA-2022909-AUTODUP-1662754854800,FR-NOVOPROD-958167,NOVO NORDISK,,68.0,YR,,F,Y,,,20220923,,MD,FR,FR,2022,Q3,Elderly
213665391,21366539,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2022,Q3,Acanthosis nigricans,,2022,Q3,1,I,,20220912.0,20220923,20220923,EXP,FR-EMA-2022909-AUTODUP-1662754854800,FR-NOVOPROD-958167,NOVO NORDISK,,68.0,YR,,F,Y,,,20220923,,MD,FR,FR,2022,Q3,Elderly
213665391,21366539,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2022,Q3,Papilloma,,2022,Q3,1,I,,20220912.0,20220923,20220923,EXP,FR-EMA-2022909-AUTODUP-1662754854800,FR-NOVOPROD-958167,NOVO NORDISK,,68.0,YR,,F,Y,,,20220923,,MD,FR,FR,2022,Q3,Elderly
213665391,21366539,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2022,Q3,Injection site induration,,2022,Q3,1,I,,20220912.0,20220923,20220923,EXP,FR-EMA-2022909-AUTODUP-1662754854800,FR-NOVOPROD-958167,NOVO NORDISK,,68.0,YR,,F,Y,,,20220923,,MD,FR,FR,2022,Q3,Elderly
213665391,21366539,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2022,Q3,Injection site plaque,,2022,Q3,1,I,,20220912.0,20220923,20220923,EXP,FR-EMA-2022909-AUTODUP-1662754854800,FR-NOVOPROD-958167,NOVO NORDISK,,68.0,YR,,F,Y,,,20220923,,MD,FR,FR,2022,Q3,Elderly
213665391,21366539,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,Solution for injection,,2022,Q3,Injection site discolouration,,2022,Q3,1,I,,20220912.0,20220923,20220923,EXP,FR-EMA-2022909-AUTODUP-1662754854800,FR-NOVOPROD-958167,NOVO NORDISK,,68.0,YR,,F,Y,,,20220923,,MD,FR,FR,2022,Q3,Elderly
213686271,21368627,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Scheme,,,,,,,,,,Unknown,,2022,Q3,Systemic infection,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-JNJFOC-20220938419,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,105.0,KG,20220923,,PH,DE,DE,2022,Q3,Adult
213686271,21368627,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Scheme,,,,,,,,,,Unknown,,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-JNJFOC-20220938419,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,105.0,KG,20220923,,PH,DE,DE,2022,Q3,Adult
213686271,21368627,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Scheme,,,,,,,,,,Unknown,,2022,Q3,Nausea,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-JNJFOC-20220938419,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,105.0,KG,20220923,,PH,DE,DE,2022,Q3,Adult
213686271,21368627,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Scheme,,,,,,,,,,Unknown,,2022,Q3,Weight increased,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-JNJFOC-20220938419,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,105.0,KG,20220923,,PH,DE,DE,2022,Q3,Adult
213686271,21368627,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Scheme,,,,,,,,,,Unknown,,2022,Q3,Chest pain,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-JNJFOC-20220938419,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,105.0,KG,20220923,,PH,DE,DE,2022,Q3,Adult
213686271,21368627,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Scheme,,,,,,,,,,Unknown,,2022,Q3,Pain,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-JNJFOC-20220938419,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,105.0,KG,20220923,,PH,DE,DE,2022,Q3,Adult
213686271,21368627,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Scheme,,,,,,,,,,Unknown,,2022,Q3,Diarrhoea,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-JNJFOC-20220938419,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,105.0,KG,20220923,,PH,DE,DE,2022,Q3,Adult
213686271,21368627,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Scheme,,,,,,,,,,Unknown,,2022,Q3,Pyrexia,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-JNJFOC-20220938419,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,105.0,KG,20220923,,PH,DE,DE,2022,Q3,Adult
213686271,21368627,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Scheme,,,,,,,,,,Unknown,,2022,Q3,Arthralgia,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-JNJFOC-20220938419,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,105.0,KG,20220923,,PH,DE,DE,2022,Q3,Adult
213686271,21368627,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Scheme,,,,,,,,,,Unknown,,2022,Q3,Haematochezia,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-JNJFOC-20220938419,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,105.0,KG,20220923,,PH,DE,DE,2022,Q3,Adult
213686271,21368627,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Scheme,,,,,,,,,,Unknown,,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-JNJFOC-20220938419,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,105.0,KG,20220923,,PH,DE,DE,2022,Q3,Adult
213686271,21368627,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Scheme,,,,,,,,,,Unknown,,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-JNJFOC-20220938419,JOHNSON AND JOHNSON,,63.0,YR,A,M,Y,105.0,KG,20220923,,PH,DE,DE,2022,Q3,Adult
213688161,21368816,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"breakfast 8-10 units, dinner 6- 8 units, supper 8-10 units",,,U,,,,,,,,,2022,Q3,Product use in unapproved indication,,2022,Q3,1,I,,20220914.0,20220923,20220923,EXP,,PL-AUROBINDO-AUR-APL-2022-037778,AUROBINDO,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda-Pawelska J, Romaszko-Wojtowicz A et, al.. Hepatorenal Syndrome and Other Post-Liver Transplantation Complications. Case Studies and Literature Review. Transplant Proc. 2022;54(4):1029-1036",55.0,YR,,F,Y,,,20220923,,HP,PL,PL,2022,Q3,Adult
213688161,21368816,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"breakfast 8-10 units, dinner 6- 8 units, supper 8-10 units",,,U,,,,,,,,,2022,Q3,Oesophageal candidiasis,,2022,Q3,1,I,,20220914.0,20220923,20220923,EXP,,PL-AUROBINDO-AUR-APL-2022-037778,AUROBINDO,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda-Pawelska J, Romaszko-Wojtowicz A et, al.. Hepatorenal Syndrome and Other Post-Liver Transplantation Complications. Case Studies and Literature Review. Transplant Proc. 2022;54(4):1029-1036",55.0,YR,,F,Y,,,20220923,,HP,PL,PL,2022,Q3,Adult
213688241,21368824,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, 50-0-40-0",,,U,,,,209196.0,,,Solution for injection,,2022,Q3,Hypoglycaemia,,2022,Q3,1,I,,20220920.0,20220923,20220923,EXP,,DE-SA-2022SA391745,SANOFI AVENTIS,,78.0,YR,E,M,Y,,,20220923,,PH,DE,DE,2022,Q3,Elderly
213688241,21368824,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, 50-0-40-0",,,U,,,,209196.0,,,Solution for injection,,2022,Q3,Personality change,,2022,Q3,1,I,,20220920.0,20220923,20220923,EXP,,DE-SA-2022SA391745,SANOFI AVENTIS,,78.0,YR,E,M,Y,,,20220923,,PH,DE,DE,2022,Q3,Elderly
213688241,21368824,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, 50-0-40-0",,,U,,,,209196.0,,,Solution for injection,,2022,Q3,Condition aggravated,,2022,Q3,1,I,,20220920.0,20220923,20220923,EXP,,DE-SA-2022SA391745,SANOFI AVENTIS,,78.0,YR,E,M,Y,,,20220923,,PH,DE,DE,2022,Q3,Elderly
213688241,21368824,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, 50-0-40-0",,,U,,,,209196.0,,,Solution for injection,,2022,Q3,Agitation,,2022,Q3,1,I,,20220920.0,20220923,20220923,EXP,,DE-SA-2022SA391745,SANOFI AVENTIS,,78.0,YR,E,M,Y,,,20220923,,PH,DE,DE,2022,Q3,Elderly
213688241,21368824,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, 50-0-40-0",,,U,,,,209196.0,,,Solution for injection,,2022,Q3,Renal impairment,,2022,Q3,1,I,,20220920.0,20220923,20220923,EXP,,DE-SA-2022SA391745,SANOFI AVENTIS,,78.0,YR,E,M,Y,,,20220923,,PH,DE,DE,2022,Q3,Elderly
213688241,21368824,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, 50-0-40-0",,,U,,,,209196.0,,,Solution for injection,,2022,Q3,Disorientation,,2022,Q3,1,I,,20220920.0,20220923,20220923,EXP,,DE-SA-2022SA391745,SANOFI AVENTIS,,78.0,YR,E,M,Y,,,20220923,,PH,DE,DE,2022,Q3,Elderly
213688241,21368824,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, 50-0-40-0",,,U,,,,209196.0,,,Solution for injection,,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220920.0,20220923,20220923,EXP,,DE-SA-2022SA391745,SANOFI AVENTIS,,78.0,YR,E,M,Y,,,20220923,,PH,DE,DE,2022,Q3,Elderly
213702981,21370298,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 1-0-0-0, solution for injection/infusion",,,U,,,,209196.0,1.0,IU,Solution for injection,QD,2022,Q3,Renal impairment,,2022,Q3,1,I,,20220919.0,20220923,20220923,EXP,,DE-SA-2022SA392707,SANOFI AVENTIS,,48.0,YR,A,M,Y,72.0,KG,20220923,,PH,DE,DE,2022,Q3,Adult
213717051,21371705,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,Solution for injection,,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-SA-2022SA389392,SANOFI AVENTIS,,78.0,YR,E,M,Y,88.4,KG,20220923,,MD,DE,DE,2022,Q3,Elderly
213717051,21371705,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,Solution for injection,,2022,Q3,Medication error,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-SA-2022SA389392,SANOFI AVENTIS,,78.0,YR,E,M,Y,88.4,KG,20220923,,MD,DE,DE,2022,Q3,Elderly
213717051,21371705,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,Solution for injection,,2022,Q3,Fatigue,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-SA-2022SA389392,SANOFI AVENTIS,,78.0,YR,E,M,Y,88.4,KG,20220923,,MD,DE,DE,2022,Q3,Elderly
213717051,21371705,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,Solution for injection,,2022,Q3,Night sweats,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-SA-2022SA389392,SANOFI AVENTIS,,78.0,YR,E,M,Y,88.4,KG,20220923,,MD,DE,DE,2022,Q3,Elderly
213717051,21371705,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,Solution for injection,,2022,Q3,Diarrhoea,,2022,Q3,1,I,,20220916.0,20220923,20220923,EXP,,DE-SA-2022SA389392,SANOFI AVENTIS,,78.0,YR,E,M,Y,88.4,KG,20220923,,MD,DE,DE,2022,Q3,Elderly
213719101,21371910,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 IE, 8-8-8-0",,,,,,,,,,,Q8H,2022,Q3,Abdominal pain lower,,2022,Q3,1,I,,20220919.0,20220923,20220923,EXP,DE-ADRED-08091-01,DE-DSJP-DSE-2022-134056,DAIICHI,,66.0,YR,,F,Y,140.0,KG,20220923,,PH,DE,DE,2022,Q3,Elderly
213719101,21371910,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 IE, 8-8-8-0",,,,,,,,,,,Q8H,2022,Q3,Angina pectoris,,2022,Q3,1,I,,20220919.0,20220923,20220923,EXP,DE-ADRED-08091-01,DE-DSJP-DSE-2022-134056,DAIICHI,,66.0,YR,,F,Y,140.0,KG,20220923,,PH,DE,DE,2022,Q3,Elderly
213719101,21371910,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 IE, 8-8-8-0",,,,,,,,,,,Q8H,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220919.0,20220923,20220923,EXP,DE-ADRED-08091-01,DE-DSJP-DSE-2022-134056,DAIICHI,,66.0,YR,,F,Y,140.0,KG,20220923,,PH,DE,DE,2022,Q3,Elderly
213719101,21371910,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 IE, 8-8-8-0",,,,,,,,,,,Q8H,2022,Q3,Haematochezia,,2022,Q3,1,I,,20220919.0,20220923,20220923,EXP,DE-ADRED-08091-01,DE-DSJP-DSE-2022-134056,DAIICHI,,66.0,YR,,F,Y,140.0,KG,20220923,,PH,DE,DE,2022,Q3,Elderly
213719101,21371910,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 IE, 8-8-8-0",,,,,,,,,,,Q8H,2022,Q3,Chest pain,,2022,Q3,1,I,,20220919.0,20220923,20220923,EXP,DE-ADRED-08091-01,DE-DSJP-DSE-2022-134056,DAIICHI,,66.0,YR,,F,Y,140.0,KG,20220923,,PH,DE,DE,2022,Q3,Elderly
213720531,21372053,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"28 international unit, daily",,,Y,,,,20563.0,28.0,IU,,QD,2022,Q3,Cutaneous amyloidosis,,2022,Q3,1,I,,20220913.0,20220923,20220923,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202209007558,ELI LILLY AND CO,Kanazawa Y.CASE REPORT Two cases of improvement in glycemic control by simultaneous divided administration of insulin glargine U-100.diabetes practice 2022;39(5):574-579.,73.0,YR,,F,Y,65.0,KG,20220923,,MD,JP,JP,2022,Q3,Elderly
213720531,21372053,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"28 international unit, daily",,,Y,,,,20563.0,28.0,IU,,QD,2022,Q3,Diabetes mellitus inadequate control,,2022,Q3,1,I,,20220913.0,20220923,20220923,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202209007558,ELI LILLY AND CO,Kanazawa Y.CASE REPORT Two cases of improvement in glycemic control by simultaneous divided administration of insulin glargine U-100.diabetes practice 2022;39(5):574-579.,73.0,YR,,F,Y,65.0,KG,20220923,,MD,JP,JP,2022,Q3,Elderly
213720531,21372053,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"26 international unit, daily",,,Y,,,,20563.0,26.0,IU,,QD,2022,Q3,Cutaneous amyloidosis,,2022,Q3,1,I,,20220913.0,20220923,20220923,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202209007558,ELI LILLY AND CO,Kanazawa Y.CASE REPORT Two cases of improvement in glycemic control by simultaneous divided administration of insulin glargine U-100.diabetes practice 2022;39(5):574-579.,73.0,YR,,F,Y,65.0,KG,20220923,,MD,JP,JP,2022,Q3,Elderly
213720531,21372053,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"26 international unit, daily",,,Y,,,,20563.0,26.0,IU,,QD,2022,Q3,Diabetes mellitus inadequate control,,2022,Q3,1,I,,20220913.0,20220923,20220923,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202209007558,ELI LILLY AND CO,Kanazawa Y.CASE REPORT Two cases of improvement in glycemic control by simultaneous divided administration of insulin glargine U-100.diabetes practice 2022;39(5):574-579.,73.0,YR,,F,Y,65.0,KG,20220923,,MD,JP,JP,2022,Q3,Elderly
213726651,21372665,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, (300 IE/3ml, 5-0-0-0, Fertigspritzen)",,,U,,,,,,,,QD,2022,Q3,Anaemia,,2022,Q3,1,I,,20220919.0,20220924,20220924,EXP,,NVSC2022DE211861,NOVARTIS,,84.0,YR,,F,Y,69.0,KG,20220924,,PH,DE,DE,2022,Q3,Elderly
213726651,21372665,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, (300 IE/3ml, 5-0-0-0, Fertigspritzen)",,,U,,,,,,,,QD,2022,Q3,Upper gastrointestinal haemorrhage,,2022,Q3,1,I,,20220919.0,20220924,20220924,EXP,,NVSC2022DE211861,NOVARTIS,,84.0,YR,,F,Y,69.0,KG,20220924,,PH,DE,DE,2022,Q3,Elderly
213726651,21372665,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, (300 IE/3ml, 5-0-0-0, Fertigspritzen)",,,U,,,,,,,,QD,2022,Q3,Melaena,,2022,Q3,1,I,,20220919.0,20220924,20220924,EXP,,NVSC2022DE211861,NOVARTIS,,84.0,YR,,F,Y,69.0,KG,20220924,,PH,DE,DE,2022,Q3,Elderly
213726651,21372665,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, (300 IE/3ml, 5-0-0-0, Fertigspritzen)",,,U,,,,,,,,QD,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220919.0,20220924,20220924,EXP,,NVSC2022DE211861,NOVARTIS,,84.0,YR,,F,Y,69.0,KG,20220924,,PH,DE,DE,2022,Q3,Elderly
213726651,21372665,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, (300 IE/3ml, 5-0-0-0, Fertigspritzen)",,,U,,,,,,,,QD,2022,Q3,Haematochezia,,2022,Q3,1,I,,20220919.0,20220924,20220924,EXP,,NVSC2022DE211861,NOVARTIS,,84.0,YR,,F,Y,69.0,KG,20220924,,PH,DE,DE,2022,Q3,Elderly
213726651,21372665,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, (300 IE/3ml, 5-0-0-0, Fertigspritzen)",,,U,,,,,,,,QD,2022,Q3,Night sweats,,2022,Q3,1,I,,20220919.0,20220924,20220924,EXP,,NVSC2022DE211861,NOVARTIS,,84.0,YR,,F,Y,69.0,KG,20220924,,PH,DE,DE,2022,Q3,Elderly
213737421,21373742,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE/ml, 60-60-60-0",,,U,,,,,,,Solution for injection in pre-filled syringe,,2022,Q3,COVID-19 pneumonia,,2022,Q3,1,I,20201206.0,20220913.0,20220926,20220926,EXP,,DE-AUROBINDO-AUR-APL-2022-037461,AUROBINDO,,59.0,YR,,M,Y,,,20220926,,PH,DE,DE,2022,Q3,Adult
213737421,21373742,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE/ml, 60-60-60-0",,,U,,,,,,,Solution for injection in pre-filled syringe,,2022,Q3,Dyspnoea,,2022,Q3,1,I,20201206.0,20220913.0,20220926,20220926,EXP,,DE-AUROBINDO-AUR-APL-2022-037461,AUROBINDO,,59.0,YR,,M,Y,,,20220926,,PH,DE,DE,2022,Q3,Adult
213738651,21373865,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q3,Thyroid disorder,,2022,Q3,1,I,20220810.0,20220921.0,20220926,20220926,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-109421,BRISTOL MYERS SQUIBB,,63.0,YR,A,M,Y,97.522,KG,20220926,,CN,US,US,2022,Q3,Adult
213739781,21373978,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other (before each meal)",,,U,,D498888C,,20563.0,,,Injection,,2022,Q3,Maternal exposure during pregnancy,,2022,Q3,1,I,20220801.0,20220916.0,20220926,20220926,PER,,US-ELI_LILLY_AND_COMPANY-US202209009538,ELI LILLY AND CO,,36.0,YR,,F,Y,,,20220926,,CN,US,US,2022,Q3,Adult
213739781,21373978,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other (before each meal)",,,U,,D498888C,,20563.0,,,Injection,,2022,Q3,Blood glucose abnormal,,2022,Q3,1,I,20220801.0,20220916.0,20220926,20220926,PER,,US-ELI_LILLY_AND_COMPANY-US202209009538,ELI LILLY AND CO,,36.0,YR,,F,Y,,,20220926,,CN,US,US,2022,Q3,Adult
213744191,21374419,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, nach BZ, Injektions-/Infusionslosung)",,,U,,,,,,,,,2022,Q3,C-reactive protein increased,,2022,Q3,1,I,,20220922.0,20220926,20220926,EXP,,NVSC2022DE214629,NOVARTIS,,82.0,YR,,F,Y,54.0,KG,20220926,,PH,DE,DE,2022,Q3,Elderly
213744191,21374419,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, nach BZ, Injektions-/Infusionslosung)",,,U,,,,,,,,,2022,Q3,Diarrhoea,,2022,Q3,1,I,,20220922.0,20220926,20220926,EXP,,NVSC2022DE214629,NOVARTIS,,82.0,YR,,F,Y,54.0,KG,20220926,,PH,DE,DE,2022,Q3,Elderly
213744191,21374419,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (1 IE, nach BZ, Injektions-/Infusionslosung)",,,U,,,,,,,,,2022,Q3,Muscular weakness,,2022,Q3,1,I,,20220922.0,20220926,20220926,EXP,,NVSC2022DE214629,NOVARTIS,,82.0,YR,,F,Y,54.0,KG,20220926,,PH,DE,DE,2022,Q3,Elderly
213744331,21374433,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,U,,,,,,,,,2022,Q3,Arthralgia,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,NVSC2022DE209809,NOVARTIS,,63.0,YR,,M,Y,105.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213744331,21374433,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,U,,,,,,,,,2022,Q3,Haematochezia,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,NVSC2022DE209809,NOVARTIS,,63.0,YR,,M,Y,105.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213744331,21374433,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,U,,,,,,,,,2022,Q3,Nausea,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,NVSC2022DE209809,NOVARTIS,,63.0,YR,,M,Y,105.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213744331,21374433,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,U,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,NVSC2022DE209809,NOVARTIS,,63.0,YR,,M,Y,105.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213744331,21374433,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,U,,,,,,,,,2022,Q3,Weight increased,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,NVSC2022DE209809,NOVARTIS,,63.0,YR,,M,Y,105.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213744331,21374433,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,U,,,,,,,,,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,NVSC2022DE209809,NOVARTIS,,63.0,YR,,M,Y,105.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213744331,21374433,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,U,,,,,,,,,2022,Q3,Systemic infection,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,NVSC2022DE209809,NOVARTIS,,63.0,YR,,M,Y,105.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213744331,21374433,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,U,,,,,,,,,2022,Q3,Pyrexia,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,NVSC2022DE209809,NOVARTIS,,63.0,YR,,M,Y,105.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213744331,21374433,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,U,,,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,NVSC2022DE209809,NOVARTIS,,63.0,YR,,M,Y,105.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213744331,21374433,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,U,,,,,,,,,2022,Q3,Chest pain,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,NVSC2022DE209809,NOVARTIS,,63.0,YR,,M,Y,105.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213744331,21374433,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,U,,,,,,,,,2022,Q3,Pain,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,NVSC2022DE209809,NOVARTIS,,63.0,YR,,M,Y,105.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213744331,21374433,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,U,,,,,,,,,2022,Q3,Diarrhoea,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,NVSC2022DE209809,NOVARTIS,,63.0,YR,,M,Y,105.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213750491,21375049,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2022,Q3,Toe amputation,,2022,Q3,1,I,,20220921.0,20220926,20220926,EXP,ES-AEMPS-1255999,ES-SA-2022SA394494,SANOFI AVENTIS,,52.0,YR,A,M,Y,94.0,KG,20220926,,CN,ES,ES,2022,Q3,Adult
213750491,21375049,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2022,Q3,Peripheral ischaemia,,2022,Q3,1,I,,20220921.0,20220926,20220926,EXP,ES-AEMPS-1255999,ES-SA-2022SA394494,SANOFI AVENTIS,,52.0,YR,A,M,Y,94.0,KG,20220926,,CN,ES,ES,2022,Q3,Adult
213756081,21375608,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, each morning",,,U,,,,20563.0,50.0,IU,,QD,2022,Q3,Condition aggravated,,2022,Q3,1,I,,20220915.0,20220926,20220926,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007007,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220926,,CN,DE,DE,2022,Q3,Elderly
213756081,21375608,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, each morning",,,U,,,,20563.0,50.0,IU,,QD,2022,Q3,Personality change,,2022,Q3,1,I,,20220915.0,20220926,20220926,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007007,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220926,,CN,DE,DE,2022,Q3,Elderly
213756081,21375608,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, each morning",,,U,,,,20563.0,50.0,IU,,QD,2022,Q3,Hypoglycaemia,,2022,Q3,1,I,,20220915.0,20220926,20220926,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007007,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220926,,CN,DE,DE,2022,Q3,Elderly
213756081,21375608,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, each morning",,,U,,,,20563.0,50.0,IU,,QD,2022,Q3,Disorientation,,2022,Q3,1,I,,20220915.0,20220926,20220926,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007007,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220926,,CN,DE,DE,2022,Q3,Elderly
213756081,21375608,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, each morning",,,U,,,,20563.0,50.0,IU,,QD,2022,Q3,Agitation,,2022,Q3,1,I,,20220915.0,20220926,20220926,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007007,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220926,,CN,DE,DE,2022,Q3,Elderly
213756081,21375608,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, each morning",,,U,,,,20563.0,50.0,IU,,QD,2022,Q3,Renal impairment,,2022,Q3,1,I,,20220915.0,20220926,20220926,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007007,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220926,,CN,DE,DE,2022,Q3,Elderly
213756081,21375608,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 u, each morning",,,U,,,,20563.0,50.0,IU,,QD,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220915.0,20220926,20220926,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007007,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220926,,CN,DE,DE,2022,Q3,Elderly
213756081,21375608,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 u, each evening",,,U,,,,20563.0,40.0,IU,,QD,2022,Q3,Condition aggravated,,2022,Q3,1,I,,20220915.0,20220926,20220926,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007007,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220926,,CN,DE,DE,2022,Q3,Elderly
213756081,21375608,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 u, each evening",,,U,,,,20563.0,40.0,IU,,QD,2022,Q3,Personality change,,2022,Q3,1,I,,20220915.0,20220926,20220926,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007007,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220926,,CN,DE,DE,2022,Q3,Elderly
213756081,21375608,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 u, each evening",,,U,,,,20563.0,40.0,IU,,QD,2022,Q3,Hypoglycaemia,,2022,Q3,1,I,,20220915.0,20220926,20220926,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007007,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220926,,CN,DE,DE,2022,Q3,Elderly
213756081,21375608,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 u, each evening",,,U,,,,20563.0,40.0,IU,,QD,2022,Q3,Disorientation,,2022,Q3,1,I,,20220915.0,20220926,20220926,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007007,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220926,,CN,DE,DE,2022,Q3,Elderly
213756081,21375608,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 u, each evening",,,U,,,,20563.0,40.0,IU,,QD,2022,Q3,Agitation,,2022,Q3,1,I,,20220915.0,20220926,20220926,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007007,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220926,,CN,DE,DE,2022,Q3,Elderly
213756081,21375608,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 u, each evening",,,U,,,,20563.0,40.0,IU,,QD,2022,Q3,Renal impairment,,2022,Q3,1,I,,20220915.0,20220926,20220926,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007007,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220926,,CN,DE,DE,2022,Q3,Elderly
213756081,21375608,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"40 u, each evening",,,U,,,,20563.0,40.0,IU,,QD,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220915.0,20220926,20220926,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209007007,ELI LILLY AND CO,,78.0,YR,,M,Y,,,20220926,,CN,DE,DE,2022,Q3,Elderly
213756211,21375621,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,,,,,,2022,Q3,Renal impairment,,2022,Q3,1,I,,20220914.0,20220926,20220926,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209006323,ELI LILLY AND CO,,48.0,YR,,M,Y,72.0,KG,20220926,,CN,DE,DE,2022,Q3,Adult
213764701,21376470,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6-5-5-0, TID",,,D,,,,,,,Solution for injection,Q8H,2022,Q3,Product monitoring error,,2022,Q3,1,I,,20220921.0,20220926,20220926,EXP,,DE-SA-2022SA394977,SANOFI AVENTIS,,47.0,YR,A,M,Y,83.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213764701,21376470,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6-5-5-0, TID",,,D,,,,,,,Solution for injection,Q8H,2022,Q3,Dyspepsia,,2022,Q3,1,I,,20220921.0,20220926,20220926,EXP,,DE-SA-2022SA394977,SANOFI AVENTIS,,47.0,YR,A,M,Y,83.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213764701,21376470,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6-5-5-0, TID",,,D,,,,,,,Solution for injection,Q8H,2022,Q3,Diabetes mellitus inadequate control,,2022,Q3,1,I,,20220921.0,20220926,20220926,EXP,,DE-SA-2022SA394977,SANOFI AVENTIS,,47.0,YR,A,M,Y,83.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213764701,21376470,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6-5-5-0, TID",,,D,,,,,,,Solution for injection,Q8H,2022,Q3,Vomiting,,2022,Q3,1,I,,20220921.0,20220926,20220926,EXP,,DE-SA-2022SA394977,SANOFI AVENTIS,,47.0,YR,A,M,Y,83.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213764701,21376470,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6-5-5-0, TID",,,D,,,,,,,Solution for injection,Q8H,2022,Q3,Nausea,,2022,Q3,1,I,,20220921.0,20220926,20220926,EXP,,DE-SA-2022SA394977,SANOFI AVENTIS,,47.0,YR,A,M,Y,83.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213764701,21376470,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6-5-5-0, TID",,,D,,,,,,,Solution for injection,Q8H,2022,Q3,Hyperglycaemia,,2022,Q3,1,I,,20220921.0,20220926,20220926,EXP,,DE-SA-2022SA394977,SANOFI AVENTIS,,47.0,YR,A,M,Y,83.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213764701,21376470,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6-5-5-0, TID",,,D,,,,,,,Solution for injection,Q8H,2022,Q3,Abdominal pain,,2022,Q3,1,I,,20220921.0,20220926,20220926,EXP,,DE-SA-2022SA394977,SANOFI AVENTIS,,47.0,YR,A,M,Y,83.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213764701,21376470,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6-5-5-0, TID",,,D,,,,,,,Solution for injection,Q8H,2022,Q3,Diabetic ketoacidosis,,2022,Q3,1,I,,20220921.0,20220926,20220926,EXP,,DE-SA-2022SA394977,SANOFI AVENTIS,,47.0,YR,A,M,Y,83.0,KG,20220926,,PH,DE,DE,2022,Q3,Adult
213773451,21377345,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 international unit, qd",,,Y,,,,,12.0,IU,,QD,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20220802.0,20220920.0,20220926,20220926,EXP,FR-AFSSAPS-AN20221833,FR-MYLANLABS-2022M1096009,MYLAN,,72.0,YR,,M,Y,,,20220926,,MD,FR,FR,2022,Q3,Elderly
213773451,21377345,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 international unit, qd",,,Y,,,,,12.0,IU,,QD,2022,Q3,Atrioventricular block second degree,,2022,Q3,1,I,20220802.0,20220920.0,20220926,20220926,EXP,FR-AFSSAPS-AN20221833,FR-MYLANLABS-2022M1096009,MYLAN,,72.0,YR,,M,Y,,,20220926,,MD,FR,FR,2022,Q3,Elderly
213773451,21377345,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 international unit, qd",,,Y,,,,,12.0,IU,,QD,2022,Q3,Hyperkalaemia,,2022,Q3,1,I,20220802.0,20220920.0,20220926,20220926,EXP,FR-AFSSAPS-AN20221833,FR-MYLANLABS-2022M1096009,MYLAN,,72.0,YR,,M,Y,,,20220926,,MD,FR,FR,2022,Q3,Elderly
213775681,21377568,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,6/8/8 UI three times a day,,,,,,,,,,,TID,2022,Q3,Ischaemic stroke,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,IT-PFIZER INC-PV202200065840,PFIZER,"Ianniciello, A.. Late Onset Occurrence of Concomitant Myocardial Infarction and Ischemic Stroke in Hospitalized COVID-19 Patient: A Case Report. International Journal of General Medicine. 2022;15:6621-6626",68.0,YR,,M,Y,,,20220926,,HP,IT,IT,2022,Q3,Elderly
213775681,21377568,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,6/8/8 UI three times a day,,,,,,,,,,,TID,2022,Q3,Myocardial infarction,,2022,Q3,1,I,,20220916.0,20220926,20220926,EXP,,IT-PFIZER INC-PV202200065840,PFIZER,"Ianniciello, A.. Late Onset Occurrence of Concomitant Myocardial Infarction and Ischemic Stroke in Hospitalized COVID-19 Patient: A Case Report. International Journal of General Medicine. 2022;15:6621-6626",68.0,YR,,M,Y,,,20220926,,HP,IT,IT,2022,Q3,Elderly
213784451,21378445,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"NK IE, according to scheme; Liprolog 100 units/ml solution for injection",,,U,,,,,,,Solution for injection,,2022,Q3,Dehydration,,2022,Q3,1,I,20190712.0,20220913.0,20220927,20220927,EXP,,DE-AUROBINDO-AUR-APL-2022-037390,AUROBINDO,,69.0,YR,,M,Y,,,20220927,,MD,DE,DE,2022,Q3,Elderly
213784451,21378445,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"NK IE, according to scheme; Liprolog 100 units/ml solution for injection",,,U,,,,,,,Solution for injection,,2022,Q3,Hypotension,,2022,Q3,1,I,20190712.0,20220913.0,20220927,20220927,EXP,,DE-AUROBINDO-AUR-APL-2022-037390,AUROBINDO,,69.0,YR,,M,Y,,,20220927,,MD,DE,DE,2022,Q3,Elderly
213784451,21378445,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"NK IE, according to scheme; Liprolog 100 units/ml solution for injection",,,U,,,,,,,Solution for injection,,2022,Q3,Syncope,,2022,Q3,1,I,20190712.0,20220913.0,20220927,20220927,EXP,,DE-AUROBINDO-AUR-APL-2022-037390,AUROBINDO,,69.0,YR,,M,Y,,,20220927,,MD,DE,DE,2022,Q3,Elderly
213784451,21378445,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"NK IE, according to scheme; Liprolog 100 units/ml solution for injection",,,U,,,,,,,Solution for injection,,2022,Q3,Diarrhoea,,2022,Q3,1,I,20190712.0,20220913.0,20220927,20220927,EXP,,DE-AUROBINDO-AUR-APL-2022-037390,AUROBINDO,,69.0,YR,,M,Y,,,20220927,,MD,DE,DE,2022,Q3,Elderly
213784451,21378445,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"NK IE, according to scheme; Liprolog 100 units/ml solution for injection",,,U,,,,,,,Solution for injection,,2022,Q3,Circulatory collapse,,2022,Q3,1,I,20190712.0,20220913.0,20220927,20220927,EXP,,DE-AUROBINDO-AUR-APL-2022-037390,AUROBINDO,,69.0,YR,,M,Y,,,20220927,,MD,DE,DE,2022,Q3,Elderly
213785851,21378585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"18 Dosage forms Daily; 1 IU, 6-6-6-0, Unit dose : 6 DF , frequency : 3 times a day",,,,,,,,,,Solution for injection/infusion,TID,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220918.0,20220927,20220927,EXP,,DE-TEVA-2022-DE-2075951,TEVA,,76.0,YR,E,M,Y,82.0,KG,20220927,,PH,DE,DE,2022,Q3,Elderly
213785851,21378585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"18 Dosage forms Daily; 1 IU, 6-6-6-0, Unit dose : 6 DF , frequency : 3 times a day",,,,,,,,,,Solution for injection/infusion,TID,2022,Q3,Bradycardia,,2022,Q3,1,I,,20220918.0,20220927,20220927,EXP,,DE-TEVA-2022-DE-2075951,TEVA,,76.0,YR,E,M,Y,82.0,KG,20220927,,PH,DE,DE,2022,Q3,Elderly
213785851,21378585,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"18 Dosage forms Daily; 1 IU, 6-6-6-0, Unit dose : 6 DF , frequency : 3 times a day",,,,,,,,,,Solution for injection/infusion,TID,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,,20220918.0,20220927,20220927,EXP,,DE-TEVA-2022-DE-2075951,TEVA,,76.0,YR,E,M,Y,82.0,KG,20220927,,PH,DE,DE,2022,Q3,Elderly
213788111,21378811,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(26-0-16-0),,,U,,,,,,,,,2022,Q3,Systemic infection,,2022,Q3,1,I,,20220915.0,20220927,20220927,EXP,,DE-AUROBINDO-AUR-APL-2022-038091,AUROBINDO,,78.0,YR,,M,Y,,,20220927,,PH,DE,DE,2022,Q3,Elderly
213788111,21378811,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(26-0-16-0),,,U,,,,,,,,,2022,Q3,Acute respiratory failure,,2022,Q3,1,I,,20220915.0,20220927,20220927,EXP,,DE-AUROBINDO-AUR-APL-2022-038091,AUROBINDO,,78.0,YR,,M,Y,,,20220927,,PH,DE,DE,2022,Q3,Elderly
213788111,21378811,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(26-0-16-0),,,U,,,,,,,,,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220915.0,20220927,20220927,EXP,,DE-AUROBINDO-AUR-APL-2022-038091,AUROBINDO,,78.0,YR,,M,Y,,,20220927,,PH,DE,DE,2022,Q3,Elderly
213788111,21378811,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(26-0-16-0),,,U,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220915.0,20220927,20220927,EXP,,DE-AUROBINDO-AUR-APL-2022-038091,AUROBINDO,,78.0,YR,,M,Y,,,20220927,,PH,DE,DE,2022,Q3,Elderly
213788111,21378811,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(26-0-16-0),,,U,,,,,,,,,2022,Q3,Hyperglycaemia,,2022,Q3,1,I,,20220915.0,20220927,20220927,EXP,,DE-AUROBINDO-AUR-APL-2022-038091,AUROBINDO,,78.0,YR,,M,Y,,,20220927,,PH,DE,DE,2022,Q3,Elderly
213788111,21378811,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(26-0-16-0),,,U,,,,,,,,,2022,Q3,Electrocardiogram abnormal,,2022,Q3,1,I,,20220915.0,20220927,20220927,EXP,,DE-AUROBINDO-AUR-APL-2022-038091,AUROBINDO,,78.0,YR,,M,Y,,,20220927,,PH,DE,DE,2022,Q3,Elderly
213788111,21378811,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(26-0-16-0),,,U,,,,,,,,,2022,Q3,Arrhythmia,,2022,Q3,1,I,,20220915.0,20220927,20220927,EXP,,DE-AUROBINDO-AUR-APL-2022-038091,AUROBINDO,,78.0,YR,,M,Y,,,20220927,,PH,DE,DE,2022,Q3,Elderly
213788111,21378811,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(26-0-16-0),,,U,,,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,,20220915.0,20220927,20220927,EXP,,DE-AUROBINDO-AUR-APL-2022-038091,AUROBINDO,,78.0,YR,,M,Y,,,20220927,,PH,DE,DE,2022,Q3,Elderly
213788111,21378811,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(26-0-16-0),,,U,,,,,,,,,2022,Q3,Acute myocardial infarction,,2022,Q3,1,I,,20220915.0,20220927,20220927,EXP,,DE-AUROBINDO-AUR-APL-2022-038091,AUROBINDO,,78.0,YR,,M,Y,,,20220927,,PH,DE,DE,2022,Q3,Elderly
213788111,21378811,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(26-0-16-0),,,U,,,,,,,,,2022,Q3,Renal impairment,,2022,Q3,1,I,,20220915.0,20220927,20220927,EXP,,DE-AUROBINDO-AUR-APL-2022-038091,AUROBINDO,,78.0,YR,,M,Y,,,20220927,,PH,DE,DE,2022,Q3,Elderly
213788111,21378811,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(26-0-16-0),,,U,,,,,,,,,2022,Q3,Tachycardia,,2022,Q3,1,I,,20220915.0,20220927,20220927,EXP,,DE-AUROBINDO-AUR-APL-2022-038091,AUROBINDO,,78.0,YR,,M,Y,,,20220927,,PH,DE,DE,2022,Q3,Elderly
213792901,21379290,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,1,I,20201206.0,20220913.0,20220927,20220927,EXP,DE-ADRED-07514-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10051,ALKEM,,59.0,YR,,M,Y,,,20220927,,PH,DE,DE,2022,Q3,Adult
213792901,21379290,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,Unknown,,,,,,,2022,Q3,COVID-19 pneumonia,,2022,Q3,1,I,20201206.0,20220913.0,20220927,20220927,EXP,DE-ADRED-07514-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10051,ALKEM,,59.0,YR,,M,Y,,,20220927,,PH,DE,DE,2022,Q3,Adult
213805731,21380573,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50/50 international unit (IU), depending on blood glucose",,,,,,,,,,,,2022,Q3,Pain,,2022,Q3,1,I,,20220923.0,20220927,20220927,EXP,,DE-ORGANON-O2209DEU002002,ORGANON,,74.0,YR,,F,Y,,,20220927,,PH,DE,DE,2022,Q3,Elderly
213805731,21380573,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50/50 international unit (IU), depending on blood glucose",,,,,,,,,,,,2022,Q3,Musculoskeletal pain,,2022,Q3,1,I,,20220923.0,20220927,20220927,EXP,,DE-ORGANON-O2209DEU002002,ORGANON,,74.0,YR,,F,Y,,,20220927,,PH,DE,DE,2022,Q3,Elderly
213805731,21380573,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50/50 international unit (IU), depending on blood glucose",,,,,,,,,,,,2022,Q3,Condition aggravated,,2022,Q3,1,I,,20220923.0,20220927,20220927,EXP,,DE-ORGANON-O2209DEU002002,ORGANON,,74.0,YR,,F,Y,,,20220927,,PH,DE,DE,2022,Q3,Elderly
213805731,21380573,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50/50 international unit (IU), depending on blood glucose",,,,,,,,,,,,2022,Q3,Gait disturbance,,2022,Q3,1,I,,20220923.0,20220927,20220927,EXP,,DE-ORGANON-O2209DEU002002,ORGANON,,74.0,YR,,F,Y,,,20220927,,PH,DE,DE,2022,Q3,Elderly
213805731,21380573,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50/50 international unit (IU), depending on blood glucose",,,,,,,,,,,,2022,Q3,Product prescribing error,,2022,Q3,1,I,,20220923.0,20220927,20220927,EXP,,DE-ORGANON-O2209DEU002002,ORGANON,,74.0,YR,,F,Y,,,20220927,,PH,DE,DE,2022,Q3,Elderly
213805731,21380573,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50/50 international unit (IU), depending on blood glucose",,,,,,,,,,,,2022,Q3,Arthralgia,,2022,Q3,1,I,,20220923.0,20220927,20220927,EXP,,DE-ORGANON-O2209DEU002002,ORGANON,,74.0,YR,,F,Y,,,20220927,,PH,DE,DE,2022,Q3,Elderly
213809541,21380954,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, other (1 IE, 5-12-6-0)",,,,,,,,,,,,2022,Q3,Fall,,2022,Q3,1,I,,20220920.0,20220927,20220927,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209009217,ELI LILLY AND CO,,66.0,YR,,M,Y,90.0,KG,20220927,,CN,DE,DE,2022,Q3,Elderly
213809541,21380954,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, other (1 IE, 5-12-6-0)",,,,,,,,,,,,2022,Q3,Cerebral haemorrhage,,2022,Q3,1,I,,20220920.0,20220927,20220927,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209009217,ELI LILLY AND CO,,66.0,YR,,M,Y,90.0,KG,20220927,,CN,DE,DE,2022,Q3,Elderly
213809541,21380954,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, other (1 IE, 5-12-6-0)",,,,,,,,,,,,2022,Q3,Death,,2022,Q3,1,I,,20220920.0,20220927,20220927,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209009217,ELI LILLY AND CO,,66.0,YR,,M,Y,90.0,KG,20220927,,CN,DE,DE,2022,Q3,Elderly
213809541,21380954,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, other (1 IE, 5-12-6-0)",,,,,,,,,,,,2022,Q3,Loss of consciousness,,2022,Q3,1,I,,20220920.0,20220927,20220927,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209009217,ELI LILLY AND CO,,66.0,YR,,M,Y,90.0,KG,20220927,,CN,DE,DE,2022,Q3,Elderly
213816461,21381646,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50|50 mg, early morning and evening depending on the value",,,,,,,,,,,,2022,Q3,Gait disturbance,,2022,Q3,1,I,,20220923.0,20220927,20220927,EXP,,DE-ORGANON-O2209DEU001997,ORGANON,,73.0,YR,,F,Y,,,20220927,,PH,DE,DE,2022,Q3,Elderly
213816461,21381646,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50|50 mg, early morning and evening depending on the value",,,,,,,,,,,,2022,Q3,Hypoaesthesia,,2022,Q3,1,I,,20220923.0,20220927,20220927,EXP,,DE-ORGANON-O2209DEU001997,ORGANON,,73.0,YR,,F,Y,,,20220927,,PH,DE,DE,2022,Q3,Elderly
213816461,21381646,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50|50 mg, early morning and evening depending on the value",,,,,,,,,,,,2022,Q3,Pain,,2022,Q3,1,I,,20220923.0,20220927,20220927,EXP,,DE-ORGANON-O2209DEU001997,ORGANON,,73.0,YR,,F,Y,,,20220927,,PH,DE,DE,2022,Q3,Elderly
213816461,21381646,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50|50 mg, early morning and evening depending on the value",,,,,,,,,,,,2022,Q3,Musculoskeletal pain,,2022,Q3,1,I,,20220923.0,20220927,20220927,EXP,,DE-ORGANON-O2209DEU001997,ORGANON,,73.0,YR,,F,Y,,,20220927,,PH,DE,DE,2022,Q3,Elderly
213836321,21383632,30,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: As Needed?1 IU (International Unit),,,,,,,,1.0,IU,Unknown,,2022,Q3,Acute kidney injury,Acute kidney injury,2022,Q3,1,I,20170913.0,20220922.0,20220927,20220927,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20170904150,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,113.0,KG,20220928,,MD,US,US,2022,Q3,Elderly
213836321,21383632,30,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: As Needed?1 IU (International Unit),,,,,,,,1.0,IU,Unknown,,2022,Q3,Alanine aminotransferase increased,,2022,Q3,1,I,20170913.0,20220922.0,20220927,20220927,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20170904150,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,113.0,KG,20220928,,MD,US,US,2022,Q3,Elderly
213836321,21383632,30,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: As Needed?1 IU (International Unit),,,,,,,,1.0,IU,Unknown,,2022,Q3,Acute kidney injury,,2022,Q3,1,I,20170913.0,20220922.0,20220927,20220927,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20170904150,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,113.0,KG,20220928,,MD,US,US,2022,Q3,Elderly
213836321,21383632,30,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: As Needed?1 IU (International Unit),,,,,,,,1.0,IU,Unknown,,2022,Q3,Aspartate aminotransferase increased,,2022,Q3,1,I,20170913.0,20220922.0,20220927,20220927,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20170904150,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,113.0,KG,20220928,,MD,US,US,2022,Q3,Elderly
213838421,21383842,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, scheme",,,U,,,,,,,,,2022,Q3,Arthralgia,,2022,Q3,1,I,,20220914.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037660,AUROBINDO,,63.0,YR,,M,Y,105.0,KG,20220928,,PH,DE,DE,2022,Q3,Adult
213838421,21383842,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, scheme",,,U,,,,,,,,,2022,Q3,Diarrhoea,,2022,Q3,1,I,,20220914.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037660,AUROBINDO,,63.0,YR,,M,Y,105.0,KG,20220928,,PH,DE,DE,2022,Q3,Adult
213838421,21383842,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, scheme",,,U,,,,,,,,,2022,Q3,Chest pain,,2022,Q3,1,I,,20220914.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037660,AUROBINDO,,63.0,YR,,M,Y,105.0,KG,20220928,,PH,DE,DE,2022,Q3,Adult
213838421,21383842,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, scheme",,,U,,,,,,,,,2022,Q3,Haematochezia,,2022,Q3,1,I,,20220914.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037660,AUROBINDO,,63.0,YR,,M,Y,105.0,KG,20220928,,PH,DE,DE,2022,Q3,Adult
213838421,21383842,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, scheme",,,U,,,,,,,,,2022,Q3,Pain,,2022,Q3,1,I,,20220914.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037660,AUROBINDO,,63.0,YR,,M,Y,105.0,KG,20220928,,PH,DE,DE,2022,Q3,Adult
213838421,21383842,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, scheme",,,U,,,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220914.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037660,AUROBINDO,,63.0,YR,,M,Y,105.0,KG,20220928,,PH,DE,DE,2022,Q3,Adult
213838421,21383842,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, scheme",,,U,,,,,,,,,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220914.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037660,AUROBINDO,,63.0,YR,,M,Y,105.0,KG,20220928,,PH,DE,DE,2022,Q3,Adult
213838421,21383842,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, scheme",,,U,,,,,,,,,2022,Q3,Weight increased,,2022,Q3,1,I,,20220914.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037660,AUROBINDO,,63.0,YR,,M,Y,105.0,KG,20220928,,PH,DE,DE,2022,Q3,Adult
213838421,21383842,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, scheme",,,U,,,,,,,,,2022,Q3,Pyrexia,,2022,Q3,1,I,,20220914.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037660,AUROBINDO,,63.0,YR,,M,Y,105.0,KG,20220928,,PH,DE,DE,2022,Q3,Adult
213838421,21383842,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, scheme",,,U,,,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,,20220914.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037660,AUROBINDO,,63.0,YR,,M,Y,105.0,KG,20220928,,PH,DE,DE,2022,Q3,Adult
213838421,21383842,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, scheme",,,U,,,,,,,,,2022,Q3,Systemic infection,,2022,Q3,1,I,,20220914.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037660,AUROBINDO,,63.0,YR,,M,Y,105.0,KG,20220928,,PH,DE,DE,2022,Q3,Adult
213838421,21383842,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, scheme",,,U,,,,,,,,,2022,Q3,Nausea,,2022,Q3,1,I,,20220914.0,20220928,20220928,EXP,,DE-AUROBINDO-AUR-APL-2022-037660,AUROBINDO,,63.0,YR,,M,Y,105.0,KG,20220928,,PH,DE,DE,2022,Q3,Adult
213850751,21385075,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 iU, as needed",,,,,,,,1.0,IU,,,2022,Q3,Acute kidney injury,,2022,Q3,1,I,,20220926.0,20220928,20220928,EXP,DE-ADRED-08444-01,DE-PFIZER INC-202201187016,PFIZER,,80.0,YR,,F,Y,65.0,KG,20220928,,PH,DE,DE,2022,Q3,Elderly
213850751,21385075,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 iU, as needed",,,,,,,,1.0,IU,,,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220926.0,20220928,20220928,EXP,DE-ADRED-08444-01,DE-PFIZER INC-202201187016,PFIZER,,80.0,YR,,F,Y,65.0,KG,20220928,,PH,DE,DE,2022,Q3,Elderly
213850751,21385075,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 iU, as needed",,,,,,,,1.0,IU,,,2022,Q3,Cardiac failure,,2022,Q3,1,I,,20220926.0,20220928,20220928,EXP,DE-ADRED-08444-01,DE-PFIZER INC-202201187016,PFIZER,,80.0,YR,,F,Y,65.0,KG,20220928,,PH,DE,DE,2022,Q3,Elderly
213850751,21385075,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 iU, as needed",,,,,,,,1.0,IU,,,2022,Q3,Anaemia,,2022,Q3,1,I,,20220926.0,20220928,20220928,EXP,DE-ADRED-08444-01,DE-PFIZER INC-202201187016,PFIZER,,80.0,YR,,F,Y,65.0,KG,20220928,,PH,DE,DE,2022,Q3,Elderly
213850751,21385075,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 iU, as needed",,,,,,,,1.0,IU,,,2022,Q3,Renal impairment,,2022,Q3,1,I,,20220926.0,20220928,20220928,EXP,DE-ADRED-08444-01,DE-PFIZER INC-202201187016,PFIZER,,80.0,YR,,F,Y,65.0,KG,20220928,,PH,DE,DE,2022,Q3,Elderly
213858661,21385866,11,C,Insulin lispro Sanofi 100Einheiten/ml Fertigpen 3ml,,2,Subcutaneous,"100 IE/ml, 60-60-60-0",,,,,UNKNOWN,,,,,,TID,2022,Q3,COVID-19 pneumonia,,2022,Q3,1,I,20201206.0,20220919.0,20220928,20220928,EXP,,DE-drreddys-SPO/GER/22/0154862,DR REDDYS,,59.0,YR,A,M,Y,,,20220928,,PH,DE,DE,2022,Q3,Adult
213858661,21385866,11,C,Insulin lispro Sanofi 100Einheiten/ml Fertigpen 3ml,,2,Subcutaneous,"100 IE/ml, 60-60-60-0",,,,,UNKNOWN,,,,,,TID,2022,Q3,Dyspnoea,,2022,Q3,1,I,20201206.0,20220919.0,20220928,20220928,EXP,,DE-drreddys-SPO/GER/22/0154862,DR REDDYS,,59.0,YR,A,M,Y,,,20220928,,PH,DE,DE,2022,Q3,Adult
213892771,21389277,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,,20220914.0,20220929,20220929,EXP,DE-ADRED-07662-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10118,ALKEM,,63.0,YR,,M,Y,105.0,KG,20220929,,PH,DE,DE,2022,Q3,Adult
213892771,21389277,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Nausea,,2022,Q3,1,I,,20220914.0,20220929,20220929,EXP,DE-ADRED-07662-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10118,ALKEM,,63.0,YR,,M,Y,105.0,KG,20220929,,PH,DE,DE,2022,Q3,Adult
213892771,21389277,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Haematochezia,,2022,Q3,1,I,,20220914.0,20220929,20220929,EXP,DE-ADRED-07662-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10118,ALKEM,,63.0,YR,,M,Y,105.0,KG,20220929,,PH,DE,DE,2022,Q3,Adult
213892771,21389277,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Arthralgia,,2022,Q3,1,I,,20220914.0,20220929,20220929,EXP,DE-ADRED-07662-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10118,ALKEM,,63.0,YR,,M,Y,105.0,KG,20220929,,PH,DE,DE,2022,Q3,Adult
213892771,21389277,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Systemic infection,,2022,Q3,1,I,,20220914.0,20220929,20220929,EXP,DE-ADRED-07662-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10118,ALKEM,,63.0,YR,,M,Y,105.0,KG,20220929,,PH,DE,DE,2022,Q3,Adult
213892771,21389277,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Pyrexia,,2022,Q3,1,I,,20220914.0,20220929,20220929,EXP,DE-ADRED-07662-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10118,ALKEM,,63.0,YR,,M,Y,105.0,KG,20220929,,PH,DE,DE,2022,Q3,Adult
213892771,21389277,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Weight increased,,2022,Q3,1,I,,20220914.0,20220929,20220929,EXP,DE-ADRED-07662-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10118,ALKEM,,63.0,YR,,M,Y,105.0,KG,20220929,,PH,DE,DE,2022,Q3,Adult
213892771,21389277,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Pain,,2022,Q3,1,I,,20220914.0,20220929,20220929,EXP,DE-ADRED-07662-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10118,ALKEM,,63.0,YR,,M,Y,105.0,KG,20220929,,PH,DE,DE,2022,Q3,Adult
213892771,21389277,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220914.0,20220929,20220929,EXP,DE-ADRED-07662-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10118,ALKEM,,63.0,YR,,M,Y,105.0,KG,20220929,,PH,DE,DE,2022,Q3,Adult
213892771,21389277,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220914.0,20220929,20220929,EXP,DE-ADRED-07662-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10118,ALKEM,,63.0,YR,,M,Y,105.0,KG,20220929,,PH,DE,DE,2022,Q3,Adult
213892771,21389277,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Diarrhoea,,2022,Q3,1,I,,20220914.0,20220929,20220929,EXP,DE-ADRED-07662-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10118,ALKEM,,63.0,YR,,M,Y,105.0,KG,20220929,,PH,DE,DE,2022,Q3,Adult
213892771,21389277,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Chest pain,,2022,Q3,1,I,,20220914.0,20220929,20220929,EXP,DE-ADRED-07662-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10118,ALKEM,,63.0,YR,,M,Y,105.0,KG,20220929,,PH,DE,DE,2022,Q3,Adult
213894531,21389453,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50|50 IU, depending on the BG",,,U,,,,,,,,,2022,Q3,Musculoskeletal pain,,2022,Q3,1,I,,20220919.0,20220929,20220929,EXP,,DE-AUROBINDO-AUR-APL-2022-038658,AUROBINDO,,74.0,YR,,F,Y,,,20220929,,PH,DE,DE,2022,Q3,Elderly
213894531,21389453,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50|50 IU, depending on the BG",,,U,,,,,,,,,2022,Q3,Pain,,2022,Q3,1,I,,20220919.0,20220929,20220929,EXP,,DE-AUROBINDO-AUR-APL-2022-038658,AUROBINDO,,74.0,YR,,F,Y,,,20220929,,PH,DE,DE,2022,Q3,Elderly
213894531,21389453,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50|50 IU, depending on the BG",,,U,,,,,,,,,2022,Q3,Product prescribing error,,2022,Q3,1,I,,20220919.0,20220929,20220929,EXP,,DE-AUROBINDO-AUR-APL-2022-038658,AUROBINDO,,74.0,YR,,F,Y,,,20220929,,PH,DE,DE,2022,Q3,Elderly
213894531,21389453,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50|50 IU, depending on the BG",,,U,,,,,,,,,2022,Q3,Arthralgia,,2022,Q3,1,I,,20220919.0,20220929,20220929,EXP,,DE-AUROBINDO-AUR-APL-2022-038658,AUROBINDO,,74.0,YR,,F,Y,,,20220929,,PH,DE,DE,2022,Q3,Elderly
213894531,21389453,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50|50 IU, depending on the BG",,,U,,,,,,,,,2022,Q3,Condition aggravated,,2022,Q3,1,I,,20220919.0,20220929,20220929,EXP,,DE-AUROBINDO-AUR-APL-2022-038658,AUROBINDO,,74.0,YR,,F,Y,,,20220929,,PH,DE,DE,2022,Q3,Elderly
213894531,21389453,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50|50 IU, depending on the BG",,,U,,,,,,,,,2022,Q3,Gait disturbance,,2022,Q3,1,I,,20220919.0,20220929,20220929,EXP,,DE-AUROBINDO-AUR-APL-2022-038658,AUROBINDO,,74.0,YR,,F,Y,,,20220929,,PH,DE,DE,2022,Q3,Elderly
213899241,21389924,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220915.0,20220929,20220929,EXP,DE-ADRED-07815-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10132,ALKEM,,78.0,YR,,M,Y,,,20220929,,PH,DE,DE,2022,Q3,Elderly
213899241,21389924,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Tachycardia,,2022,Q3,1,I,,20220915.0,20220929,20220929,EXP,DE-ADRED-07815-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10132,ALKEM,,78.0,YR,,M,Y,,,20220929,,PH,DE,DE,2022,Q3,Elderly
213899241,21389924,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Hyperglycaemia,,2022,Q3,1,I,,20220915.0,20220929,20220929,EXP,DE-ADRED-07815-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10132,ALKEM,,78.0,YR,,M,Y,,,20220929,,PH,DE,DE,2022,Q3,Elderly
213899241,21389924,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Dyspnoea,,2022,Q3,1,I,,20220915.0,20220929,20220929,EXP,DE-ADRED-07815-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10132,ALKEM,,78.0,YR,,M,Y,,,20220929,,PH,DE,DE,2022,Q3,Elderly
213899241,21389924,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Arrhythmia,,2022,Q3,1,I,,20220915.0,20220929,20220929,EXP,DE-ADRED-07815-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10132,ALKEM,,78.0,YR,,M,Y,,,20220929,,PH,DE,DE,2022,Q3,Elderly
213899241,21389924,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Acute respiratory failure,,2022,Q3,1,I,,20220915.0,20220929,20220929,EXP,DE-ADRED-07815-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10132,ALKEM,,78.0,YR,,M,Y,,,20220929,,PH,DE,DE,2022,Q3,Elderly
213899241,21389924,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,,20220915.0,20220929,20220929,EXP,DE-ADRED-07815-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10132,ALKEM,,78.0,YR,,M,Y,,,20220929,,PH,DE,DE,2022,Q3,Elderly
213899241,21389924,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Acute myocardial infarction,,2022,Q3,1,I,,20220915.0,20220929,20220929,EXP,DE-ADRED-07815-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10132,ALKEM,,78.0,YR,,M,Y,,,20220929,,PH,DE,DE,2022,Q3,Elderly
213899241,21389924,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Electrocardiogram abnormal,,2022,Q3,1,I,,20220915.0,20220929,20220929,EXP,DE-ADRED-07815-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10132,ALKEM,,78.0,YR,,M,Y,,,20220929,,PH,DE,DE,2022,Q3,Elderly
213899241,21389924,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Renal impairment,,2022,Q3,1,I,,20220915.0,20220929,20220929,EXP,DE-ADRED-07815-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10132,ALKEM,,78.0,YR,,M,Y,,,20220929,,PH,DE,DE,2022,Q3,Elderly
213899241,21389924,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,Unknown,,,,,,,2022,Q3,Systemic infection,,2022,Q3,1,I,,20220915.0,20220929,20220929,EXP,DE-ADRED-07815-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10132,ALKEM,,78.0,YR,,M,Y,,,20220929,,PH,DE,DE,2022,Q3,Elderly
213900941,21390094,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Hyperglycaemia,,2022,Q3,1,I,,20220919.0,20220929,20220929,EXP,,CA-TEVA-2022-CA-2077336,TEVA,,77.0,YR,E,M,Y,90.0,KG,20220929,,HP,CA,CA,2022,Q3,Elderly
213900941,21390094,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Therapy interrupted,,2022,Q3,1,I,,20220919.0,20220929,20220929,EXP,,CA-TEVA-2022-CA-2077336,TEVA,,77.0,YR,E,M,Y,90.0,KG,20220929,,HP,CA,CA,2022,Q3,Elderly
213909041,21390904,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 5-12-6-0",,,U,,,,,1.0,IU,UNK,,2022,Q3,Loss of consciousness,,2022,Q3,1,I,,20220919.0,20220929,20220929,EXP,DE-ADRED-08104-01,DE-TORRENT-00023290,TORRENT,,66.0,YR,E,M,Y,90.0,KG,20220929,,PH,DE,DE,2022,Q3,Elderly
213909041,21390904,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 5-12-6-0",,,U,,,,,1.0,IU,UNK,,2022,Q3,Fall,,2022,Q3,1,I,,20220919.0,20220929,20220929,EXP,DE-ADRED-08104-01,DE-TORRENT-00023290,TORRENT,,66.0,YR,E,M,Y,90.0,KG,20220929,,PH,DE,DE,2022,Q3,Elderly
213909041,21390904,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 5-12-6-0",,,U,,,,,1.0,IU,UNK,,2022,Q3,Cerebral haemorrhage,,2022,Q3,1,I,,20220919.0,20220929,20220929,EXP,DE-ADRED-08104-01,DE-TORRENT-00023290,TORRENT,,66.0,YR,E,M,Y,90.0,KG,20220929,,PH,DE,DE,2022,Q3,Elderly
213913061,21391306,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK , 300 IU/3ml, according to the scheme, pre-filled syringes",,,U,,,,,,,PRE-FILLED SYRINGE,,2022,Q3,Restlessness,,2022,Q3,1,I,20210604.0,20220926.0,20220929,20220929,EXP,,NVSC2022DE217312,NOVARTIS,,86.0,YR,,M,Y,77.0,KG,20220929,,PH,DE,DE,2022,Q3,Elderly
213913061,21391306,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK , 300 IU/3ml, according to the scheme, pre-filled syringes",,,U,,,,,,,PRE-FILLED SYRINGE,,2022,Q3,Weight increased,,2022,Q3,1,I,20210604.0,20220926.0,20220929,20220929,EXP,,NVSC2022DE217312,NOVARTIS,,86.0,YR,,M,Y,77.0,KG,20220929,,PH,DE,DE,2022,Q3,Elderly
213913061,21391306,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK , 300 IU/3ml, according to the scheme, pre-filled syringes",,,U,,,,,,,PRE-FILLED SYRINGE,,2022,Q3,Bradycardia,,2022,Q3,1,I,20210604.0,20220926.0,20220929,20220929,EXP,,NVSC2022DE217312,NOVARTIS,,86.0,YR,,M,Y,77.0,KG,20220929,,PH,DE,DE,2022,Q3,Elderly
213913061,21391306,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK , 300 IU/3ml, according to the scheme, pre-filled syringes",,,U,,,,,,,PRE-FILLED SYRINGE,,2022,Q3,Atrial fibrillation,,2022,Q3,1,I,20210604.0,20220926.0,20220929,20220929,EXP,,NVSC2022DE217312,NOVARTIS,,86.0,YR,,M,Y,77.0,KG,20220929,,PH,DE,DE,2022,Q3,Elderly
213913061,21391306,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK , 300 IU/3ml, according to the scheme, pre-filled syringes",,,U,,,,,,,PRE-FILLED SYRINGE,,2022,Q3,Product prescribing error,,2022,Q3,1,I,20210604.0,20220926.0,20220929,20220929,EXP,,NVSC2022DE217312,NOVARTIS,,86.0,YR,,M,Y,77.0,KG,20220929,,PH,DE,DE,2022,Q3,Elderly
213913061,21391306,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK , 300 IU/3ml, according to the scheme, pre-filled syringes",,,U,,,,,,,PRE-FILLED SYRINGE,,2022,Q3,Tachycardia,,2022,Q3,1,I,20210604.0,20220926.0,20220929,20220929,EXP,,NVSC2022DE217312,NOVARTIS,,86.0,YR,,M,Y,77.0,KG,20220929,,PH,DE,DE,2022,Q3,Elderly
213913061,21391306,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK , 300 IU/3ml, according to the scheme, pre-filled syringes",,,U,,,,,,,PRE-FILLED SYRINGE,,2022,Q3,Product prescribing error,,2022,Q3,1,I,20210604.0,20220926.0,20220929,20220929,EXP,,NVSC2022DE217312,NOVARTIS,,86.0,YR,,M,Y,77.0,KG,20220929,,PH,DE,DE,2022,Q3,Elderly
213913061,21391306,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK , 300 IU/3ml, according to the scheme, pre-filled syringes",,,U,,,,,,,PRE-FILLED SYRINGE,,2022,Q3,Dyspnoea,,2022,Q3,1,I,20210604.0,20220926.0,20220929,20220929,EXP,,NVSC2022DE217312,NOVARTIS,,86.0,YR,,M,Y,77.0,KG,20220929,,PH,DE,DE,2022,Q3,Elderly
213934371,21393437,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Liver function test increased,,2022,Q3,1,I,20220901.0,20220923.0,20220929,20220929,EXP,,US-GILEAD-2022-0599288,GILEAD,,43.0,YR,A,M,Y,,,20220929,,HP,US,US,2022,Q3,Adult
213934371,21393437,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q3,Cytokine release syndrome,,2022,Q3,1,I,20220901.0,20220923.0,20220929,20220929,EXP,,US-GILEAD-2022-0599288,GILEAD,,43.0,YR,A,M,Y,,,20220929,,HP,US,US,2022,Q3,Adult
213941811,21394181,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 international unit (5-12-6-0),,,U,,,,,1.0,IU,,,2022,Q3,Fall,,2022,Q3,1,I,,20220919.0,20220930,20220930,EXP,,DE-AUROBINDO-AUR-APL-2022-038661,AUROBINDO,,66.0,YR,,M,Y,90.0,KG,20220930,,PH,DE,DE,2022,Q3,Elderly
213941811,21394181,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 international unit (5-12-6-0),,,U,,,,,1.0,IU,,,2022,Q3,Loss of consciousness,,2022,Q3,1,I,,20220919.0,20220930,20220930,EXP,,DE-AUROBINDO-AUR-APL-2022-038661,AUROBINDO,,66.0,YR,,M,Y,90.0,KG,20220930,,PH,DE,DE,2022,Q3,Elderly
213941811,21394181,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 international unit (5-12-6-0),,,U,,,,,1.0,IU,,,2022,Q3,Cerebral haemorrhage,,2022,Q3,1,I,,20220919.0,20220930,20220930,EXP,,DE-AUROBINDO-AUR-APL-2022-038661,AUROBINDO,,66.0,YR,,M,Y,90.0,KG,20220930,,PH,DE,DE,2022,Q3,Elderly
213942801,21394280,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"NK IE, according to scheme; Liprolog 100 units/ml solution for injection, liprolog 100",,,,,"UNKNOWN,Unknown",,,,,Solution for injection,,2022,Q3,Syncope,,2022,Q3,1,I,20190712.0,20220920.0,20220930,20220930,EXP,,DE-TEVA-2022-DE-2076927,TEVA,,69.0,YR,E,M,Y,,,20220930,,MD,DE,DE,2022,Q3,Elderly
213942801,21394280,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"NK IE, according to scheme; Liprolog 100 units/ml solution for injection, liprolog 100",,,,,"UNKNOWN,Unknown",,,,,Solution for injection,,2022,Q3,Diarrhoea,,2022,Q3,1,I,20190712.0,20220920.0,20220930,20220930,EXP,,DE-TEVA-2022-DE-2076927,TEVA,,69.0,YR,E,M,Y,,,20220930,,MD,DE,DE,2022,Q3,Elderly
213942801,21394280,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"NK IE, according to scheme; Liprolog 100 units/ml solution for injection, liprolog 100",,,,,"UNKNOWN,Unknown",,,,,Solution for injection,,2022,Q3,Dehydration,,2022,Q3,1,I,20190712.0,20220920.0,20220930,20220930,EXP,,DE-TEVA-2022-DE-2076927,TEVA,,69.0,YR,E,M,Y,,,20220930,,MD,DE,DE,2022,Q3,Elderly
213942801,21394280,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"NK IE, according to scheme; Liprolog 100 units/ml solution for injection, liprolog 100",,,,,"UNKNOWN,Unknown",,,,,Solution for injection,,2022,Q3,Circulatory collapse,,2022,Q3,1,I,20190712.0,20220920.0,20220930,20220930,EXP,,DE-TEVA-2022-DE-2076927,TEVA,,69.0,YR,E,M,Y,,,20220930,,MD,DE,DE,2022,Q3,Elderly
213942801,21394280,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"NK IE, according to scheme; Liprolog 100 units/ml solution for injection, liprolog 100",,,,,"UNKNOWN,Unknown",,,,,Solution for injection,,2022,Q3,Hypotension,,2022,Q3,1,I,20190712.0,20220920.0,20220930,20220930,EXP,,DE-TEVA-2022-DE-2076927,TEVA,,69.0,YR,E,M,Y,,,20220930,,MD,DE,DE,2022,Q3,Elderly
213943331,21394333,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"180 Dosage forms Daily; 100 IE/ml, 60-60-60-0, Insulin lispro Sanofi 100 units/ml pre-filled pen 3ml",,,,,,,,,,,TID,2022,Q3,COVID-19 pneumonia,,2022,Q3,1,I,20201206.0,20220920.0,20220930,20220930,EXP,,DE-TEVA-2022-DE-2076848,TEVA,,59.0,YR,A,M,Y,,,20220930,,PH,DE,DE,2022,Q3,Adult
213943331,21394333,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"180 Dosage forms Daily; 100 IE/ml, 60-60-60-0, Insulin lispro Sanofi 100 units/ml pre-filled pen 3ml",,,,,,,,,,,TID,2022,Q3,Dyspnoea,,2022,Q3,1,I,20201206.0,20220920.0,20220930,20220930,EXP,,DE-TEVA-2022-DE-2076848,TEVA,,59.0,YR,A,M,Y,,,20220930,,PH,DE,DE,2022,Q3,Adult
213954081,21395408,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"NK IE, according to scheme; Liprolog 100 units/ml solution for injection",,,U,,,,,,,,,2022,Q3,Diarrhoea,,2022,Q3,1,I,20190712.0,20220915.0,20220930,20220930,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-356712,RANBAXY,,69.0,YR,,M,Y,,,20220930,,MD,DE,DE,2022,Q3,Elderly
213954081,21395408,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"NK IE, according to scheme; Liprolog 100 units/ml solution for injection",,,U,,,,,,,,,2022,Q3,Syncope,,2022,Q3,1,I,20190712.0,20220915.0,20220930,20220930,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-356712,RANBAXY,,69.0,YR,,M,Y,,,20220930,,MD,DE,DE,2022,Q3,Elderly
213954081,21395408,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"NK IE, according to scheme; Liprolog 100 units/ml solution for injection",,,U,,,,,,,,,2022,Q3,Dehydration,,2022,Q3,1,I,20190712.0,20220915.0,20220930,20220930,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-356712,RANBAXY,,69.0,YR,,M,Y,,,20220930,,MD,DE,DE,2022,Q3,Elderly
213954081,21395408,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"NK IE, according to scheme; Liprolog 100 units/ml solution for injection",,,U,,,,,,,,,2022,Q3,Circulatory collapse,,2022,Q3,1,I,20190712.0,20220915.0,20220930,20220930,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-356712,RANBAXY,,69.0,YR,,M,Y,,,20220930,,MD,DE,DE,2022,Q3,Elderly
213954081,21395408,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"NK IE, according to scheme; Liprolog 100 units/ml solution for injection",,,U,,,,,,,,,2022,Q3,Hypotension,,2022,Q3,1,I,20190712.0,20220915.0,20220930,20220930,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-356712,RANBAXY,,69.0,YR,,M,Y,,,20220930,,MD,DE,DE,2022,Q3,Elderly
213954591,21395459,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,"18 Dosage forms Daily; 4-6-8-0, Unit dose: 18 DF, frequency time : 1 day",,,,,"UNKNOWN,Unknown",,,,,,,2022,Q3,Dehydration,,2022,Q3,1,I,,20220920.0,20220930,20220930,EXP,,DE-TEVA-2022-DE-2076027,TEVA,,96.0,YR,E,M,Y,65.0,KG,20220930,,PH,DE,DE,2022,Q3,Elderly
213954591,21395459,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,"18 Dosage forms Daily; 4-6-8-0, Unit dose: 18 DF, frequency time : 1 day",,,,,"UNKNOWN,Unknown",,,,,,,2022,Q3,Haematemesis,,2022,Q3,1,I,,20220920.0,20220930,20220930,EXP,,DE-TEVA-2022-DE-2076027,TEVA,,96.0,YR,E,M,Y,65.0,KG,20220930,,PH,DE,DE,2022,Q3,Elderly
213954741,21395474,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"according to scheme, medication errors",,,U,,UNKNOWN,,,,,,,2022,Q3,Diarrhoea,,2022,Q3,1,I,,20220920.0,20220930,20220930,EXP,,DE-TEVA-2022-DE-2077017,TEVA,,78.0,YR,E,M,Y,88.4,KG,20220930,,MD,DE,DE,2022,Q3,Elderly
213954741,21395474,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"according to scheme, medication errors",,,U,,UNKNOWN,,,,,,,2022,Q3,General physical health deterioration,,2022,Q3,1,I,,20220920.0,20220930,20220930,EXP,,DE-TEVA-2022-DE-2077017,TEVA,,78.0,YR,E,M,Y,88.4,KG,20220930,,MD,DE,DE,2022,Q3,Elderly
213954741,21395474,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"according to scheme, medication errors",,,U,,UNKNOWN,,,,,,,2022,Q3,Medication error,,2022,Q3,1,I,,20220920.0,20220930,20220930,EXP,,DE-TEVA-2022-DE-2077017,TEVA,,78.0,YR,E,M,Y,88.4,KG,20220930,,MD,DE,DE,2022,Q3,Elderly
213954741,21395474,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"according to scheme, medication errors",,,U,,UNKNOWN,,,,,,,2022,Q3,Fatigue,,2022,Q3,1,I,,20220920.0,20220930,20220930,EXP,,DE-TEVA-2022-DE-2077017,TEVA,,78.0,YR,E,M,Y,88.4,KG,20220930,,MD,DE,DE,2022,Q3,Elderly
213954741,21395474,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"according to scheme, medication errors",,,U,,UNKNOWN,,,,,,,2022,Q3,Night sweats,,2022,Q3,1,I,,20220920.0,20220930,20220930,EXP,,DE-TEVA-2022-DE-2077017,TEVA,,78.0,YR,E,M,Y,88.4,KG,20220930,,MD,DE,DE,2022,Q3,Elderly
213955521,21395552,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 1-0-0-0, Injektions-/Infusionsl?sung",,,U,,,,,,,,,2022,Q3,Renal impairment,,2022,Q3,1,I,,20220916.0,20220930,20220930,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-357094,RANBAXY,,48.0,YR,,M,Y,72.0,KG,20220930,,PH,DE,DE,2022,Q3,Adult
1302369512,13023695,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (75/25 Kwik pen),,,,,,,,,,,,2022,Q4,Laboratory test abnormal,,2022,Q4,12,F,20151222.0,20221007.0,20161213,20221013,EXP,,US-PFIZER INC-2016571070,PFIZER,,68.0,YR,,M,Y,84.0,KG,20221013,,CN,US,US,2022,Q4,Elderly
1302369512,13023695,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (75/25 Kwik pen),,,,,,,,,,,,2022,Q4,Drug ineffective,,2022,Q4,12,F,20151222.0,20221007.0,20161213,20221013,EXP,,US-PFIZER INC-2016571070,PFIZER,,68.0,YR,,M,Y,84.0,KG,20221013,,CN,US,US,2022,Q4,Elderly
1302369512,13023695,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (75/25 Kwik pen),,,,,,,,,,,,2022,Q4,Cerebrovascular accident,,2022,Q4,12,F,20151222.0,20221007.0,20161213,20221013,EXP,,US-PFIZER INC-2016571070,PFIZER,,68.0,YR,,M,Y,84.0,KG,20221013,,CN,US,US,2022,Q4,Elderly
1302369512,13023695,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (75/25 Kwik pen),,,,,,,,,,,,2022,Q4,Product use in unapproved indication,,2022,Q4,12,F,20151222.0,20221007.0,20161213,20221013,EXP,,US-PFIZER INC-2016571070,PFIZER,,68.0,YR,,M,Y,84.0,KG,20221013,,CN,US,US,2022,Q4,Elderly
1302369512,13023695,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (75/25 Kwik pen),,,,,,,,,,,,2022,Q4,Dysphemia,,2022,Q4,12,F,20151222.0,20221007.0,20161213,20221013,EXP,,US-PFIZER INC-2016571070,PFIZER,,68.0,YR,,M,Y,84.0,KG,20221013,,CN,US,US,2022,Q4,Elderly
1302369512,13023695,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (75/25 Kwik pen),,,,,,,,,,,,2022,Q4,Renal disorder,,2022,Q4,12,F,20151222.0,20221007.0,20161213,20221013,EXP,,US-PFIZER INC-2016571070,PFIZER,,68.0,YR,,M,Y,84.0,KG,20221013,,CN,US,US,2022,Q4,Elderly
1302369512,13023695,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (75/25 Kwik pen),,,,,,,,,,,,2022,Q4,Aphasia,,2022,Q4,12,F,20151222.0,20221007.0,20161213,20221013,EXP,,US-PFIZER INC-2016571070,PFIZER,,68.0,YR,,M,Y,84.0,KG,20221013,,CN,US,US,2022,Q4,Elderly
132596439,13259643,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"[Insulin Lispro Protamine Suspension 75]/[ Insulin Lispro 25], Two a day",,,,,,,,,,,,2022,Q4,Blindness,,2022,Q4,9,F,20161201.0,20221017.0,20170222,20221018,EXP,,US-PFIZER INC-2017077124,PFIZER,,67.0,YR,,M,Y,79.83,KG,20221018,,CN,US,US,2022,Q4,Elderly
132596439,13259643,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"[Insulin Lispro Protamine Suspension 75]/[ Insulin Lispro 25], Two a day",,,,,,,,,,,,2022,Q4,Visual impairment,,2022,Q4,9,F,20161201.0,20221017.0,20170222,20221018,EXP,,US-PFIZER INC-2017077124,PFIZER,,67.0,YR,,M,Y,79.83,KG,20221018,,CN,US,US,2022,Q4,Elderly
132596439,13259643,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,"[Insulin Lispro Protamine Suspension 75]/[ Insulin Lispro 25], Two a day",,,,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,9,F,20161201.0,20221017.0,20170222,20221018,EXP,,US-PFIZER INC-2017077124,PFIZER,,67.0,YR,,M,Y,79.83,KG,20221018,,CN,US,US,2022,Q4,Elderly
144843516,14484351,42,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Renal failure,,2022,Q4,6,F,20100722.0,20221017.0,20180205,20221020,EXP,,US-AstraZeneca-2018SE12552,ASTRAZENECA,,23698.0,DY,,M,Y,104.3,KG,20221020,,LW,US,,2022,Q4,Elderly
144843516,14484351,42,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Chronic kidney disease,,2022,Q4,6,F,20100722.0,20221017.0,20180205,20221020,EXP,,US-AstraZeneca-2018SE12552,ASTRAZENECA,,23698.0,DY,,M,Y,104.3,KG,20221020,,LW,US,,2022,Q4,Elderly
144843516,14484351,42,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Chronic kidney disease-mineral and bone disorder,,2022,Q4,6,F,20100722.0,20221017.0,20180205,20221020,EXP,,US-AstraZeneca-2018SE12552,ASTRAZENECA,,23698.0,DY,,M,Y,104.3,KG,20221020,,LW,US,,2022,Q4,Elderly
144843516,14484351,42,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,6,F,20100722.0,20221017.0,20180205,20221020,EXP,,US-AstraZeneca-2018SE12552,ASTRAZENECA,,23698.0,DY,,M,Y,104.3,KG,20221020,,LW,US,,2022,Q4,Elderly
144843516,14484351,42,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Hyperkalaemia,,2022,Q4,6,F,20100722.0,20221017.0,20180205,20221020,EXP,,US-AstraZeneca-2018SE12552,ASTRAZENECA,,23698.0,DY,,M,Y,104.3,KG,20221020,,LW,US,,2022,Q4,Elderly
144843516,14484351,42,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Nephrogenic anaemia,,2022,Q4,6,F,20100722.0,20221017.0,20180205,20221020,EXP,,US-AstraZeneca-2018SE12552,ASTRAZENECA,,23698.0,DY,,M,Y,104.3,KG,20221020,,LW,US,,2022,Q4,Elderly
1577022120,15770221,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Feeling abnormal,,2022,Q4,20,F,,20221207.0,20181228,20221213,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20221213,,MD,US,US,2022,Q4,Elderly
1577022120,15770221,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Pruritus,,2022,Q4,20,F,,20221207.0,20181228,20221213,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20221213,,MD,US,US,2022,Q4,Elderly
1577022120,15770221,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Product prescribing error,,2022,Q4,20,F,,20221207.0,20181228,20221213,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20221213,,MD,US,US,2022,Q4,Elderly
1577022120,15770221,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Urinary tract infection,,2022,Q4,20,F,,20221207.0,20181228,20221213,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20221213,,MD,US,US,2022,Q4,Elderly
1577022120,15770221,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Product dispensing error,,2022,Q4,20,F,,20221207.0,20181228,20221213,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20221213,,MD,US,US,2022,Q4,Elderly
1577022120,15770221,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Rash,,2022,Q4,20,F,,20221207.0,20181228,20221213,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20221213,,MD,US,US,2022,Q4,Elderly
1577022120,15770221,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Off label use,,2022,Q4,20,F,,20221207.0,20181228,20221213,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20221213,,MD,US,US,2022,Q4,Elderly
1577022120,15770221,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Pain in extremity,,2022,Q4,20,F,,20221207.0,20181228,20221213,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20221213,,MD,US,US,2022,Q4,Elderly
1577022120,15770221,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Feeling jittery,,2022,Q4,20,F,,20221207.0,20181228,20221213,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20221213,,MD,US,US,2022,Q4,Elderly
1577022120,15770221,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Pain,,2022,Q4,20,F,,20221207.0,20181228,20221213,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20221213,,MD,US,US,2022,Q4,Elderly
1577022120,15770221,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Neuropathy peripheral,,2022,Q4,20,F,,20221207.0,20181228,20221213,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20221213,,MD,US,US,2022,Q4,Elderly
1577022120,15770221,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Fungal infection,,2022,Q4,20,F,,20221207.0,20181228,20221213,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20221213,,MD,US,US,2022,Q4,Elderly
1577022120,15770221,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Self esteem decreased,,2022,Q4,20,F,,20221207.0,20181228,20221213,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20221213,,MD,US,US,2022,Q4,Elderly
1577022120,15770221,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Bladder cancer,,2022,Q4,20,F,,20221207.0,20181228,20221213,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20221213,,MD,US,US,2022,Q4,Elderly
1577022120,15770221,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Nervousness,,2022,Q4,20,F,,20221207.0,20181228,20221213,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20221213,,MD,US,US,2022,Q4,Elderly
1577022120,15770221,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Infection,,2022,Q4,20,F,,20221207.0,20181228,20221213,EXP,,US-PFIZER INC-2018490187,PFIZER,,78.0,YR,,F,Y,74.84,KG,20221213,,MD,US,US,2022,Q4,Elderly
160015707,16001570,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,End stage renal disease,,2022,Q4,7,F,20130101.0,20221219.0,20190225,20221228,EXP,,US-AstraZeneca-2018SF64993,ASTRAZENECA,,79.0,YR,,F,Y,68.9,KG,20221228,,LW,US,,2022,Q4,Elderly
160015707,16001570,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Chronic kidney disease,,2022,Q4,7,F,20130101.0,20221219.0,20190225,20221228,EXP,,US-AstraZeneca-2018SF64993,ASTRAZENECA,,79.0,YR,,F,Y,68.9,KG,20221228,,LW,US,,2022,Q4,Elderly
160015707,16001570,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Chronic kidney disease-mineral and bone disorder,,2022,Q4,7,F,20130101.0,20221219.0,20190225,20221228,EXP,,US-AstraZeneca-2018SF64993,ASTRAZENECA,,79.0,YR,,F,Y,68.9,KG,20221228,,LW,US,,2022,Q4,Elderly
160015707,16001570,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Nephrogenic anaemia,,2022,Q4,7,F,20130101.0,20221219.0,20190225,20221228,EXP,,US-AstraZeneca-2018SF64993,ASTRAZENECA,,79.0,YR,,F,Y,68.9,KG,20221228,,LW,US,,2022,Q4,Elderly
160015707,16001570,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,7,F,20130101.0,20221219.0,20190225,20221228,EXP,,US-AstraZeneca-2018SF64993,ASTRAZENECA,,79.0,YR,,F,Y,68.9,KG,20221228,,LW,US,,2022,Q4,Elderly
160015707,16001570,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Renal injury,,2022,Q4,7,F,20130101.0,20221219.0,20190225,20221228,EXP,,US-AstraZeneca-2018SF64993,ASTRAZENECA,,79.0,YR,,F,Y,68.9,KG,20221228,,LW,US,,2022,Q4,Elderly
160015707,16001570,40,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Renal failure,,2022,Q4,7,F,20130101.0,20221219.0,20190225,20221228,EXP,,US-AstraZeneca-2018SF64993,ASTRAZENECA,,79.0,YR,,F,Y,68.9,KG,20221228,,LW,US,,2022,Q4,Elderly
164133505,16413350,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Chronic kidney disease,,2022,Q4,5,F,20180301.0,20221031.0,20190611,20221104,EXP,,US-AstraZeneca-2018SF65039,ASTRAZENECA,,20528.0,DY,,M,Y,127.0,KG,20221104,,LW,US,,2022,Q4,Elderly
164133505,16413350,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Nephrogenic anaemia,,2022,Q4,5,F,20180301.0,20221031.0,20190611,20221104,EXP,,US-AstraZeneca-2018SF65039,ASTRAZENECA,,20528.0,DY,,M,Y,127.0,KG,20221104,,LW,US,,2022,Q4,Elderly
164133505,16413350,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Renal injury,,2022,Q4,5,F,20180301.0,20221031.0,20190611,20221104,EXP,,US-AstraZeneca-2018SF65039,ASTRAZENECA,,20528.0,DY,,M,Y,127.0,KG,20221104,,LW,US,,2022,Q4,Elderly
164133505,16413350,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Gastrooesophageal reflux disease,,2022,Q4,5,F,20180301.0,20221031.0,20190611,20221104,EXP,,US-AstraZeneca-2018SF65039,ASTRAZENECA,,20528.0,DY,,M,Y,127.0,KG,20221104,,LW,US,,2022,Q4,Elderly
164133505,16413350,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Renal failure,,2022,Q4,5,F,20180301.0,20221031.0,20190611,20221104,EXP,,US-AstraZeneca-2018SF65039,ASTRAZENECA,,20528.0,DY,,M,Y,127.0,KG,20221104,,LW,US,,2022,Q4,Elderly
164133505,16413350,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Dyspepsia,,2022,Q4,5,F,20180301.0,20221031.0,20190611,20221104,EXP,,US-AstraZeneca-2018SF65039,ASTRAZENECA,,20528.0,DY,,M,Y,127.0,KG,20221104,,LW,US,,2022,Q4,Elderly
164133505,16413350,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,5,F,20180301.0,20221031.0,20190611,20221104,EXP,,US-AstraZeneca-2018SF65039,ASTRAZENECA,,20528.0,DY,,M,Y,127.0,KG,20221104,,LW,US,,2022,Q4,Elderly
164133505,16413350,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,End stage renal disease,,2022,Q4,5,F,20180301.0,20221031.0,20190611,20221104,EXP,,US-AstraZeneca-2018SF65039,ASTRAZENECA,,20528.0,DY,,M,Y,127.0,KG,20221104,,LW,US,,2022,Q4,Elderly
164133505,16413350,51,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Tubulointerstitial nephritis,,2022,Q4,5,F,20180301.0,20221031.0,20190611,20221104,EXP,,US-AstraZeneca-2018SF65039,ASTRAZENECA,,20528.0,DY,,M,Y,127.0,KG,20221104,,LW,US,,2022,Q4,Elderly
164171983,16417198,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK; (75/25 PEN),,,,,,,,,,,,2022,Q4,Hip arthroplasty,,2022,Q4,3,F,20190101.0,20221129.0,20190611,20221202,EXP,,US-PFIZER INC-2019249928,PFIZER,,63.0,YR,,F,Y,,,20221202,,HP,US,US,2022,Q4,Adult
164171983,16417198,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK; (75/25 PEN),,,,,,,,,,,,2022,Q4,Headache,,2022,Q4,3,F,20190101.0,20221129.0,20190611,20221202,EXP,,US-PFIZER INC-2019249928,PFIZER,,63.0,YR,,F,Y,,,20221202,,HP,US,US,2022,Q4,Adult
164171983,16417198,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK; (75/25 PEN),,,,,,,,,,,,2022,Q4,Fatigue,,2022,Q4,3,F,20190101.0,20221129.0,20190611,20221202,EXP,,US-PFIZER INC-2019249928,PFIZER,,63.0,YR,,F,Y,,,20221202,,HP,US,US,2022,Q4,Adult
169390672,16939067,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q4,Extradural abscess,,2022,Q4,2,F,,20221124.0,20191020,20221128,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2019-BI-108533",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
169390672,16939067,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q4,Post streptococcal glomerulonephritis,,2022,Q4,2,F,,20221124.0,20191020,20221128,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2019-BI-108533",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
169390672,16939067,13,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,2,F,,20221124.0,20191020,20221128,EXP,,"CA-B.I. Pharmaceuticals,Inc./Ridgefield-2019-BI-108533",BOEHRINGER INGELHEIM,,64.0,YR,A,M,Y,,,20221128,,HP,CA,CA,2022,Q4,Adult
174087406,17408740,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Pneumonia,,2022,Q4,6,F,20200201.0,20221206.0,20200212,20221208,EXP,,NVSC2020JP028745,NOVARTIS,,60.0,YR,,M,Y,92.5,KG,20221208,,MD,JP,JP,2022,Q4,Adult
181369895,18136989,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,Q12H,2022,Q4,Hypoxia,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,Q12H,2022,Q4,Oedema peripheral,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,Q12H,2022,Q4,Cough,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,Q12H,2022,Q4,Diaphragmatic disorder,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,Q12H,2022,Q4,Therapeutic product effect incomplete,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,Q12H,2022,Q4,Pyrexia,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,Q12H,2022,Q4,Full blood count abnormal,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,Q12H,2022,Q4,Obstructive airways disorder,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,Q12H,2022,Q4,Chest discomfort,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,Q12H,2022,Q4,Oropharyngeal pain,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,Q12H,2022,Q4,Asthma,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,Q12H,2022,Q4,Wheezing,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,Q12H,2022,Q4,Weight increased,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,Q12H,2022,Q4,Dyspnoea,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,Q12H,2022,Q4,Discomfort,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,31,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,Q12H,2022,Q4,Left ventricular hypertrophy,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2022,Q4,Hypoxia,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2022,Q4,Oedema peripheral,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2022,Q4,Cough,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2022,Q4,Diaphragmatic disorder,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2022,Q4,Therapeutic product effect incomplete,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2022,Q4,Pyrexia,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2022,Q4,Full blood count abnormal,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2022,Q4,Obstructive airways disorder,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2022,Q4,Chest discomfort,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2022,Q4,Oropharyngeal pain,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2022,Q4,Asthma,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2022,Q4,Wheezing,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2022,Q4,Discomfort,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,32,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2022,Q4,Left ventricular hypertrophy,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q4,Hypoxia,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q4,Oedema peripheral,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q4,Cough,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q4,Diaphragmatic disorder,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q4,Therapeutic product effect incomplete,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q4,Pyrexia,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q4,Full blood count abnormal,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q4,Obstructive airways disorder,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q4,Chest discomfort,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q4,Oropharyngeal pain,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q4,Asthma,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q4,Wheezing,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q4,Weight increased,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q4,Dyspnoea,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q4,Discomfort,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,42,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,Q12H,2022,Q4,Left ventricular hypertrophy,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q4,Hypoxia,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q4,Oedema peripheral,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q4,Cough,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q4,Diaphragmatic disorder,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q4,Therapeutic product effect incomplete,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q4,Pyrexia,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q4,Full blood count abnormal,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q4,Obstructive airways disorder,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q4,Chest discomfort,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q4,Oropharyngeal pain,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q4,Asthma,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q4,Wheezing,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q4,Discomfort,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181369895,18136989,43,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q4,Left ventricular hypertrophy,,2022,Q4,5,F,,20221121.0,20200811,20221124,EXP,,CA-BAUSCH-BL-2020-022251,BAUSCH AND LOMB,,83.0,YR,,M,Y,100.0,KG,20221124,,CN,CA,CA,2022,Q4,Elderly
181371673,18137167,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,nach Wert (by value),,,,,UNKNOWN,,,,,,,2022,Q4,Cough,,2022,Q4,3,F,,20221114.0,20200812,20221124,EXP,,DE-drreddys-GER/GER/20/0125784,DR REDDYS,,83.0,YR,E,M,Y,,,20221124,,PH,DE,DE,2022,Q4,Elderly
181371673,18137167,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,nach Wert (by value),,,,,UNKNOWN,,,,,,,2022,Q4,Oedema peripheral,,2022,Q4,3,F,,20221114.0,20200812,20221124,EXP,,DE-drreddys-GER/GER/20/0125784,DR REDDYS,,83.0,YR,E,M,Y,,,20221124,,PH,DE,DE,2022,Q4,Elderly
181371673,18137167,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,nach Wert (by value),,,,,UNKNOWN,,,,,,,2022,Q4,Weight increased,,2022,Q4,3,F,,20221114.0,20200812,20221124,EXP,,DE-drreddys-GER/GER/20/0125784,DR REDDYS,,83.0,YR,E,M,Y,,,20221124,,PH,DE,DE,2022,Q4,Elderly
181371673,18137167,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,nach Wert (by value),,,,,UNKNOWN,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,3,F,,20221114.0,20200812,20221124,EXP,,DE-drreddys-GER/GER/20/0125784,DR REDDYS,,83.0,YR,E,M,Y,,,20221124,,PH,DE,DE,2022,Q4,Elderly
181371673,18137167,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,nach Wert (by value),,,,,UNKNOWN,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,3,F,,20221114.0,20200812,20221124,EXP,,DE-drreddys-GER/GER/20/0125784,DR REDDYS,,83.0,YR,E,M,Y,,,20221124,,PH,DE,DE,2022,Q4,Elderly
181380615,18138061,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, (by value)",,,U,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,5,F,,20221011.0,20200812,20221020,EXP,,DE-AUROBINDO-AUR-APL-2020-038770,AUROBINDO,,83.0,YR,,M,Y,,,20221020,,PH,DE,DE,2022,Q4,Elderly
181380615,18138061,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, (by value)",,,U,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,5,F,,20221011.0,20200812,20221020,EXP,,DE-AUROBINDO-AUR-APL-2020-038770,AUROBINDO,,83.0,YR,,M,Y,,,20221020,,PH,DE,DE,2022,Q4,Elderly
181380615,18138061,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, (by value)",,,U,,,,,,,,,2022,Q4,Cough,,2022,Q4,5,F,,20221011.0,20200812,20221020,EXP,,DE-AUROBINDO-AUR-APL-2020-038770,AUROBINDO,,83.0,YR,,M,Y,,,20221020,,PH,DE,DE,2022,Q4,Elderly
181380615,18138061,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, (by value)",,,U,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,5,F,,20221011.0,20200812,20221020,EXP,,DE-AUROBINDO-AUR-APL-2020-038770,AUROBINDO,,83.0,YR,,M,Y,,,20221020,,PH,DE,DE,2022,Q4,Elderly
181380615,18138061,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, (by value)",,,U,,,,,,,,,2022,Q4,Oedema peripheral,,2022,Q4,5,F,,20221011.0,20200812,20221020,EXP,,DE-AUROBINDO-AUR-APL-2020-038770,AUROBINDO,,83.0,YR,,M,Y,,,20221020,,PH,DE,DE,2022,Q4,Elderly
181509643,18150964,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,by value,,,,,,,,,,,,2022,Q4,Cough,,2022,Q4,3,F,,20221119.0,20200814,20221202,EXP,DE-BFARM-20008561,DE-Accord-195398,ACCORD,,83.0,YR,E,M,Y,,,20221202,,PH,DE,DE,2022,Q4,Elderly
181509643,18150964,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,by value,,,,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,3,F,,20221119.0,20200814,20221202,EXP,DE-BFARM-20008561,DE-Accord-195398,ACCORD,,83.0,YR,E,M,Y,,,20221202,,PH,DE,DE,2022,Q4,Elderly
181509643,18150964,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,by value,,,,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,3,F,,20221119.0,20200814,20221202,EXP,DE-BFARM-20008561,DE-Accord-195398,ACCORD,,83.0,YR,E,M,Y,,,20221202,,PH,DE,DE,2022,Q4,Elderly
181509643,18150964,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,by value,,,,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,3,F,,20221119.0,20200814,20221202,EXP,DE-BFARM-20008561,DE-Accord-195398,ACCORD,,83.0,YR,E,M,Y,,,20221202,,PH,DE,DE,2022,Q4,Elderly
181509643,18150964,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,by value,,,,,,,,,,,,2022,Q4,Oedema peripheral,,2022,Q4,3,F,,20221119.0,20200814,20221202,EXP,DE-BFARM-20008561,DE-Accord-195398,ACCORD,,83.0,YR,E,M,Y,,,20221202,,PH,DE,DE,2022,Q4,Elderly
181561933,18156193,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, (nach Wert)",,,U,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,3,F,,20221013.0,20200817,20221019,EXP,,NVSC2020DE222294,NOVARTIS,,83.0,YR,,M,Y,,,20221019,,PH,DE,DE,2022,Q4,Elderly
181561933,18156193,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, (nach Wert)",,,U,,,,,,,,,2022,Q4,Oedema peripheral,,2022,Q4,3,F,,20221013.0,20200817,20221019,EXP,,NVSC2020DE222294,NOVARTIS,,83.0,YR,,M,Y,,,20221019,,PH,DE,DE,2022,Q4,Elderly
181561933,18156193,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, (nach Wert)",,,U,,,,,,,,,2022,Q4,Cough,,2022,Q4,3,F,,20221013.0,20200817,20221019,EXP,,NVSC2020DE222294,NOVARTIS,,83.0,YR,,M,Y,,,20221019,,PH,DE,DE,2022,Q4,Elderly
181561933,18156193,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, (nach Wert)",,,U,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,3,F,,20221013.0,20200817,20221019,EXP,,NVSC2020DE222294,NOVARTIS,,83.0,YR,,M,Y,,,20221019,,PH,DE,DE,2022,Q4,Elderly
181561933,18156193,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, (nach Wert)",,,U,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,3,F,,20221013.0,20200817,20221019,EXP,,NVSC2020DE222294,NOVARTIS,,83.0,YR,,M,Y,,,20221019,,PH,DE,DE,2022,Q4,Elderly
181658323,18165832,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,by value,,,U,U,,,,,,Injection,,2022,Q4,Weight increased,,2022,Q4,3,F,,20221205.0,20200818,20221212,EXP,,DE-MYLANLABS-2020M1071405,MYLAN,,83.0,YR,,M,Y,,,20221212,,PH,DE,DE,2022,Q4,Elderly
181658323,18165832,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,by value,,,U,U,,,,,,Injection,,2022,Q4,Oedema peripheral,,2022,Q4,3,F,,20221205.0,20200818,20221212,EXP,,DE-MYLANLABS-2020M1071405,MYLAN,,83.0,YR,,M,Y,,,20221212,,PH,DE,DE,2022,Q4,Elderly
181658323,18165832,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,by value,,,U,U,,,,,,Injection,,2022,Q4,Acute kidney injury,,2022,Q4,3,F,,20221205.0,20200818,20221212,EXP,,DE-MYLANLABS-2020M1071405,MYLAN,,83.0,YR,,M,Y,,,20221212,,PH,DE,DE,2022,Q4,Elderly
181658323,18165832,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,by value,,,U,U,,,,,,Injection,,2022,Q4,General physical health deterioration,,2022,Q4,3,F,,20221205.0,20200818,20221212,EXP,,DE-MYLANLABS-2020M1071405,MYLAN,,83.0,YR,,M,Y,,,20221212,,PH,DE,DE,2022,Q4,Elderly
181658323,18165832,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,by value,,,U,U,,,,,,Injection,,2022,Q4,Cough,,2022,Q4,3,F,,20221205.0,20200818,20221212,EXP,,DE-MYLANLABS-2020M1071405,MYLAN,,83.0,YR,,M,Y,,,20221212,,PH,DE,DE,2022,Q4,Elderly
181807613,18180761,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,As per value,,,U,,,,,,,UNK,,2022,Q4,Weight increased,,2022,Q4,3,F,,20221012.0,20200821,20221021,EXP,DE-ADRED-05240-01,DE-TORRENT-00018179,TORRENT,,83.0,YR,E,M,Y,,,20221021,,PH,DE,DE,2022,Q4,Elderly
181807613,18180761,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,As per value,,,U,,,,,,,UNK,,2022,Q4,Cough,,2022,Q4,3,F,,20221012.0,20200821,20221021,EXP,DE-ADRED-05240-01,DE-TORRENT-00018179,TORRENT,,83.0,YR,E,M,Y,,,20221021,,PH,DE,DE,2022,Q4,Elderly
181807613,18180761,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,As per value,,,U,,,,,,,UNK,,2022,Q4,Oedema peripheral,,2022,Q4,3,F,,20221012.0,20200821,20221021,EXP,DE-ADRED-05240-01,DE-TORRENT-00018179,TORRENT,,83.0,YR,E,M,Y,,,20221021,,PH,DE,DE,2022,Q4,Elderly
181807613,18180761,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,As per value,,,U,,,,,,,UNK,,2022,Q4,Acute kidney injury,,2022,Q4,3,F,,20221012.0,20200821,20221021,EXP,DE-ADRED-05240-01,DE-TORRENT-00018179,TORRENT,,83.0,YR,E,M,Y,,,20221021,,PH,DE,DE,2022,Q4,Elderly
181807613,18180761,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,As per value,,,U,,,,,,,UNK,,2022,Q4,General physical health deterioration,,2022,Q4,3,F,,20221012.0,20200821,20221021,EXP,DE-ADRED-05240-01,DE-TORRENT-00018179,TORRENT,,83.0,YR,E,M,Y,,,20221021,,PH,DE,DE,2022,Q4,Elderly
182004915,18200491,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,By value,,,U,,,,,,,,,2022,Q4,Cough,,2022,Q4,5,F,,20221017.0,20200826,20221021,EXP,,DE-009507513-2008DEU011909,MERCK,,83.0,YR,,M,Y,,,20221021,,PH,DE,DE,2022,Q4,Elderly
182004915,18200491,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,By value,,,U,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,5,F,,20221017.0,20200826,20221021,EXP,,DE-009507513-2008DEU011909,MERCK,,83.0,YR,,M,Y,,,20221021,,PH,DE,DE,2022,Q4,Elderly
182004915,18200491,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,By value,,,U,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,5,F,,20221017.0,20200826,20221021,EXP,,DE-009507513-2008DEU011909,MERCK,,83.0,YR,,M,Y,,,20221021,,PH,DE,DE,2022,Q4,Elderly
182004915,18200491,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,By value,,,U,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,5,F,,20221017.0,20200826,20221021,EXP,,DE-009507513-2008DEU011909,MERCK,,83.0,YR,,M,Y,,,20221021,,PH,DE,DE,2022,Q4,Elderly
182004915,18200491,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,By value,,,U,,,,,,,,,2022,Q4,Oedema peripheral,,2022,Q4,5,F,,20221017.0,20200826,20221021,EXP,,DE-009507513-2008DEU011909,MERCK,,83.0,YR,,M,Y,,,20221021,,PH,DE,DE,2022,Q4,Elderly
1820299715,18202997,148,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 iu, CO",,,D,,,,,1.0,IU,,,2022,Q4,Toxic epidermal necrolysis,,2022,Q4,15,F,20200809.0,20221219.0,20200827,20221227,EXP,,NVSC2020FR235135,NOVARTIS,,74.0,YR,,M,Y,,,20221227,,MD,FR,FR,2022,Q4,Elderly
1820593322,18205933,79,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 international unit, unknown",,,U,,,,,1.0,IU,,,2022,Q4,Toxic epidermal necrolysis,,2022,Q4,22,F,20200809.0,20221219.0,20200827,20221222,EXP,,FR-ELI_LILLY_AND_COMPANY-FR202008010103,ELI LILLY AND CO,,74.0,YR,,M,Y,,,20221222,,CN,FR,FR,2022,Q4,Elderly
1820848929,18208489,98,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 IU, ?CO",,,U,,,,,1.0,IU,,,2022,Q4,Toxic epidermal necrolysis,,2022,Q4,29,F,20200809.0,20221128.0,20200828,20221207,EXP,,FR-BAUSCH-BL-2020-024487,BAUSCH AND LOMB,,74.0,YR,,M,Y,,,20221207,,MD,FR,FR,2022,Q4,Elderly
1822548716,18225487,55,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),1 international unit,,,U,,,,,1.0,IU,,,2022,Q4,Toxic epidermal necrolysis,,2022,Q4,16,F,20200809.0,20221217.0,20200903,20221231,EXP,,FR-AUROBINDO-AUR-APL-2020-045739,AUROBINDO,,74.0,YR,,M,Y,,,20221231,,MD,FR,FR,2022,Q4,Elderly
1822823735,18228237,100,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 iU, CO",,,U,,,,,1.0,IU,,,2022,Q4,Toxic epidermal necrolysis,,2022,Q4,35,F,20200809.0,20221128.0,20200903,20221208,EXP,,FR-PFIZER INC-2020340763,PFIZER,,74.0,YR,,M,Y,,,20221208,,MD,FR,FR,2022,Q4,Elderly
182416596,18241659,41,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1iu, CO",,,D,,,,,1.0,IU,,,2022,Q4,Toxic epidermal necrolysis,,2022,Q4,6,F,20200809.0,20221010.0,20200908,20221021,EXP,FR-EMA-DD-20200828-KUMARVN_P-112010,FR-Accord-199762,ACCORD,,75.0,YR,E,M,Y,,,20221021,,MD,FR,FR,2022,Q4,Elderly
182832922,18283292,27,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Small intestinal obstruction,,2022,Q4,2,F,,20221129.0,20200918,20221207,EXP,,CA-AstraZeneca-2020SF17121,ASTRAZENECA,,72.0,YR,,F,Y,,,20221207,,MD,CA,,2022,Q4,Elderly
182832922,18283292,27,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Abdominal pain,,2022,Q4,2,F,,20221129.0,20200918,20221207,EXP,,CA-AstraZeneca-2020SF17121,ASTRAZENECA,,72.0,YR,,F,Y,,,20221207,,MD,CA,,2022,Q4,Elderly
182832922,18283292,27,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Dehydration,,2022,Q4,2,F,,20221129.0,20200918,20221207,EXP,,CA-AstraZeneca-2020SF17121,ASTRAZENECA,,72.0,YR,,F,Y,,,20221207,,MD,CA,,2022,Q4,Elderly
182832922,18283292,27,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Urinary tract obstruction,,2022,Q4,2,F,,20221129.0,20200918,20221207,EXP,,CA-AstraZeneca-2020SF17121,ASTRAZENECA,,72.0,YR,,F,Y,,,20221207,,MD,CA,,2022,Q4,Elderly
182832922,18283292,27,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Pyrexia,,2022,Q4,2,F,,20221129.0,20200918,20221207,EXP,,CA-AstraZeneca-2020SF17121,ASTRAZENECA,,72.0,YR,,F,Y,,,20221207,,MD,CA,,2022,Q4,Elderly
182836042,18283604,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Pulmonary arterial hypertension,,2022,Q4,2,F,20170331.0,20221118.0,20200918,20221123,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202009006853,ELI LILLY AND CO,,69.0,YR,,M,Y,69.5,KG,20221123,,CN,JP,JP,2022,Q4,Elderly
182836042,18283604,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Epistaxis,,2022,Q4,2,F,20170331.0,20221118.0,20200918,20221123,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202009006853,ELI LILLY AND CO,,69.0,YR,,M,Y,69.5,KG,20221123,,CN,JP,JP,2022,Q4,Elderly
182836042,18283604,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Diarrhoea,,2022,Q4,2,F,20170331.0,20221118.0,20200918,20221123,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202009006853,ELI LILLY AND CO,,69.0,YR,,M,Y,69.5,KG,20221123,,CN,JP,JP,2022,Q4,Elderly
182836042,18283604,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Diarrhoea,,2022,Q4,2,F,20170331.0,20221118.0,20200918,20221123,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202009006853,ELI LILLY AND CO,,69.0,YR,,M,Y,69.5,KG,20221123,,CN,JP,JP,2022,Q4,Elderly
182836042,18283604,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Myalgia,,2022,Q4,2,F,20170331.0,20221118.0,20200918,20221123,EXP,,JP-ELI_LILLY_AND_COMPANY-JP202009006853,ELI LILLY AND CO,,69.0,YR,,M,Y,69.5,KG,20221123,,CN,JP,JP,2022,Q4,Elderly
183057542,18305754,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU UNK,,,U,N,,,,,,,,2022,Q4,Nausea,,2022,Q4,2,F,,20221021.0,20200923,20221026,EXP,,DE-ANIPHARMA-2020-DE-000212,ANI,,83.0,YR,,F,Y,,,20221026,,PH,DE,DE,2022,Q4,Elderly
183057542,18305754,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU UNK,,,U,N,,,,,,,,2022,Q4,Thirst,,2022,Q4,2,F,,20221021.0,20200923,20221026,EXP,,DE-ANIPHARMA-2020-DE-000212,ANI,,83.0,YR,,F,Y,,,20221026,,PH,DE,DE,2022,Q4,Elderly
183057542,18305754,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU UNK,,,U,N,,,,,,,,2022,Q4,Cough,,2022,Q4,2,F,,20221021.0,20200923,20221026,EXP,,DE-ANIPHARMA-2020-DE-000212,ANI,,83.0,YR,,F,Y,,,20221026,,PH,DE,DE,2022,Q4,Elderly
183057542,18305754,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU UNK,,,U,N,,,,,,,,2022,Q4,Dizziness,,2022,Q4,2,F,,20221021.0,20200923,20221026,EXP,,DE-ANIPHARMA-2020-DE-000212,ANI,,83.0,YR,,F,Y,,,20221026,,PH,DE,DE,2022,Q4,Elderly
183057542,18305754,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU UNK,,,U,N,,,,,,,,2022,Q4,Infection,,2022,Q4,2,F,,20221021.0,20200923,20221026,EXP,,DE-ANIPHARMA-2020-DE-000212,ANI,,83.0,YR,,F,Y,,,20221026,,PH,DE,DE,2022,Q4,Elderly
183057542,18305754,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU UNK,,,U,N,,,,,,,,2022,Q4,Dehydration,,2022,Q4,2,F,,20221021.0,20200923,20221026,EXP,,DE-ANIPHARMA-2020-DE-000212,ANI,,83.0,YR,,F,Y,,,20221026,,PH,DE,DE,2022,Q4,Elderly
183057542,18305754,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU UNK,,,U,N,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221021.0,20200923,20221026,EXP,,DE-ANIPHARMA-2020-DE-000212,ANI,,83.0,YR,,F,Y,,,20221026,,PH,DE,DE,2022,Q4,Elderly
183057542,18305754,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU UNK,,,U,N,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,2,F,,20221021.0,20200923,20221026,EXP,,DE-ANIPHARMA-2020-DE-000212,ANI,,83.0,YR,,F,Y,,,20221026,,PH,DE,DE,2022,Q4,Elderly
183361272,18336127,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit(1 IE, 18-14-16-0, Ampullen)",,,,,,,,,,,,2022,Q4,Infection,,2022,Q4,2,F,,20221205.0,20201001,20221212,EXP,,DE-MYLANLABS-2020M1082316,MYLAN,,83.0,YR,,F,Y,,,20221212,,PH,DE,DE,2022,Q4,Elderly
183361272,18336127,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit(1 IE, 18-14-16-0, Ampullen)",,,,,,,,,,,,2022,Q4,Cough,,2022,Q4,2,F,,20221205.0,20201001,20221212,EXP,,DE-MYLANLABS-2020M1082316,MYLAN,,83.0,YR,,F,Y,,,20221212,,PH,DE,DE,2022,Q4,Elderly
183361272,18336127,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit(1 IE, 18-14-16-0, Ampullen)",,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,2,F,,20221205.0,20201001,20221212,EXP,,DE-MYLANLABS-2020M1082316,MYLAN,,83.0,YR,,F,Y,,,20221212,,PH,DE,DE,2022,Q4,Elderly
183361272,18336127,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit(1 IE, 18-14-16-0, Ampullen)",,,,,,,,,,,,2022,Q4,Dehydration,,2022,Q4,2,F,,20221205.0,20201001,20221212,EXP,,DE-MYLANLABS-2020M1082316,MYLAN,,83.0,YR,,F,Y,,,20221212,,PH,DE,DE,2022,Q4,Elderly
183361272,18336127,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit(1 IE, 18-14-16-0, Ampullen)",,,,,,,,,,,,2022,Q4,Nausea,,2022,Q4,2,F,,20221205.0,20201001,20221212,EXP,,DE-MYLANLABS-2020M1082316,MYLAN,,83.0,YR,,F,Y,,,20221212,,PH,DE,DE,2022,Q4,Elderly
183361272,18336127,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit(1 IE, 18-14-16-0, Ampullen)",,,,,,,,,,,,2022,Q4,Dizziness,,2022,Q4,2,F,,20221205.0,20201001,20221212,EXP,,DE-MYLANLABS-2020M1082316,MYLAN,,83.0,YR,,F,Y,,,20221212,,PH,DE,DE,2022,Q4,Elderly
183361272,18336127,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit(1 IE, 18-14-16-0, Ampullen)",,,,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221205.0,20201001,20221212,EXP,,DE-MYLANLABS-2020M1082316,MYLAN,,83.0,YR,,F,Y,,,20221212,,PH,DE,DE,2022,Q4,Elderly
183361272,18336127,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit(1 IE, 18-14-16-0, Ampullen)",,,,,,,,,,,,2022,Q4,Thirst,,2022,Q4,2,F,,20221205.0,20201001,20221212,EXP,,DE-MYLANLABS-2020M1082316,MYLAN,,83.0,YR,,F,Y,,,20221212,,PH,DE,DE,2022,Q4,Elderly
1848217511,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2022,Q4,Angina pectoris,,2022,Q4,11,F,20201019.0,20221110.0,20201110,20221114,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20221114,,MD,JP,JP,2022,Q4,Adult
1848217511,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2022,Q4,Arthralgia,,2022,Q4,11,F,20201019.0,20221110.0,20201110,20221114,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20221114,,MD,JP,JP,2022,Q4,Adult
1848217511,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2022,Q4,Rash pruritic,,2022,Q4,11,F,20201019.0,20221110.0,20201110,20221114,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20221114,,MD,JP,JP,2022,Q4,Adult
1848217511,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2022,Q4,Cataract,,2022,Q4,11,F,20201019.0,20221110.0,20201110,20221114,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20221114,,MD,JP,JP,2022,Q4,Adult
1848217511,18482175,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,QD,2022,Q4,Eczema asteatotic,,2022,Q4,11,F,20201019.0,20221110.0,20201110,20221114,EXP,,JP-ABBVIE-20K-087-3639069-00,ABBVIE,,61.0,YR,,F,Y,,,20221114,,MD,JP,JP,2022,Q4,Adult
184936634,18493663,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,200 international unit,,,U,U,,,,200.0,IU,,,2022,Q4,Cystitis,,2022,Q4,4,F,20191201.0,20221122.0,20201111,20221129,EXP,,CA-TAKEDA-CA202002212,TAKEDA,,55.0,YR,,M,Y,,,20221129,,MD,CA,CA,2022,Q4,Adult
184936634,18493663,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,200 international unit,,,U,U,,,,200.0,IU,,,2022,Q4,Blood cholesterol abnormal,,2022,Q4,4,F,20191201.0,20221122.0,20201111,20221129,EXP,,CA-TAKEDA-CA202002212,TAKEDA,,55.0,YR,,M,Y,,,20221129,,MD,CA,CA,2022,Q4,Adult
184936634,18493663,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,200 international unit,,,U,U,,,,200.0,IU,,,2022,Q4,Lung disorder,,2022,Q4,4,F,20191201.0,20221122.0,20201111,20221129,EXP,,CA-TAKEDA-CA202002212,TAKEDA,,55.0,YR,,M,Y,,,20221129,,MD,CA,CA,2022,Q4,Adult
184936634,18493663,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,200 international unit,,,U,U,,,,200.0,IU,,,2022,Q4,Diabetes mellitus,,2022,Q4,4,F,20191201.0,20221122.0,20201111,20221129,EXP,,CA-TAKEDA-CA202002212,TAKEDA,,55.0,YR,,M,Y,,,20221129,,MD,CA,CA,2022,Q4,Adult
184981832,18498183,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit(1 IE, 75-25-46-0, ampoules)",,,U,,,,,1.0,IU,Ampoules,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221012.0,20201113,20221021,EXP,,DE-AUROBINDO-AUR-APL-2020-055526,AUROBINDO,,69.0,YR,,F,Y,,,20221021,,PH,DE,DE,2022,Q4,Elderly
184981832,18498183,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit(1 IE, 75-25-46-0, ampoules)",,,U,,,,,1.0,IU,Ampoules,,2022,Q4,Fatigue,,2022,Q4,2,F,,20221012.0,20201113,20221021,EXP,,DE-AUROBINDO-AUR-APL-2020-055526,AUROBINDO,,69.0,YR,,F,Y,,,20221021,,PH,DE,DE,2022,Q4,Elderly
184981832,18498183,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit(1 IE, 75-25-46-0, ampoules)",,,U,,,,,1.0,IU,Ampoules,,2022,Q4,Electrolyte imbalance,,2022,Q4,2,F,,20221012.0,20201113,20221021,EXP,,DE-AUROBINDO-AUR-APL-2020-055526,AUROBINDO,,69.0,YR,,F,Y,,,20221021,,PH,DE,DE,2022,Q4,Elderly
184981832,18498183,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit(1 IE, 75-25-46-0, ampoules)",,,U,,,,,1.0,IU,Ampoules,,2022,Q4,Condition aggravated,,2022,Q4,2,F,,20221012.0,20201113,20221021,EXP,,DE-AUROBINDO-AUR-APL-2020-055526,AUROBINDO,,69.0,YR,,F,Y,,,20221021,,PH,DE,DE,2022,Q4,Elderly
184981832,18498183,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit(1 IE, 75-25-46-0, ampoules)",,,U,,,,,1.0,IU,Ampoules,,2022,Q4,Dyspnoea,,2022,Q4,2,F,,20221012.0,20201113,20221021,EXP,,DE-AUROBINDO-AUR-APL-2020-055526,AUROBINDO,,69.0,YR,,F,Y,,,20221021,,PH,DE,DE,2022,Q4,Elderly
184981832,18498183,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit(1 IE, 75-25-46-0, ampoules)",,,U,,,,,1.0,IU,Ampoules,,2022,Q4,Anuria,,2022,Q4,2,F,,20221012.0,20201113,20221021,EXP,,DE-AUROBINDO-AUR-APL-2020-055526,AUROBINDO,,69.0,YR,,F,Y,,,20221021,,PH,DE,DE,2022,Q4,Elderly
185019512,18501951,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"(1 IE, 75-25-46-0, ampullen)",,,U,,,,,,,,,2022,Q4,Electrolyte imbalance,,2022,Q4,2,F,,20221014.0,20201113,20221019,EXP,,NVSC2020DE298512,NOVARTIS,,69.0,YR,,F,Y,,,20221019,,PH,DE,DE,2022,Q4,Elderly
185019512,18501951,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"(1 IE, 75-25-46-0, ampullen)",,,U,,,,,,,,,2022,Q4,Condition aggravated,,2022,Q4,2,F,,20221014.0,20201113,20221019,EXP,,NVSC2020DE298512,NOVARTIS,,69.0,YR,,F,Y,,,20221019,,PH,DE,DE,2022,Q4,Elderly
185019512,18501951,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"(1 IE, 75-25-46-0, ampullen)",,,U,,,,,,,,,2022,Q4,Fatigue,,2022,Q4,2,F,,20221014.0,20201113,20221019,EXP,,NVSC2020DE298512,NOVARTIS,,69.0,YR,,F,Y,,,20221019,,PH,DE,DE,2022,Q4,Elderly
185019512,18501951,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"(1 IE, 75-25-46-0, ampullen)",,,U,,,,,,,,,2022,Q4,Anuria,,2022,Q4,2,F,,20221014.0,20201113,20221019,EXP,,NVSC2020DE298512,NOVARTIS,,69.0,YR,,F,Y,,,20221019,,PH,DE,DE,2022,Q4,Elderly
185019512,18501951,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"(1 IE, 75-25-46-0, ampullen)",,,U,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221014.0,20201113,20221019,EXP,,NVSC2020DE298512,NOVARTIS,,69.0,YR,,F,Y,,,20221019,,PH,DE,DE,2022,Q4,Elderly
185019512,18501951,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"(1 IE, 75-25-46-0, ampullen)",,,U,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,2,F,,20221014.0,20201113,20221019,EXP,,NVSC2020DE298512,NOVARTIS,,69.0,YR,,F,Y,,,20221019,,PH,DE,DE,2022,Q4,Elderly
186639097,18663909,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Parasitic gastroenteritis,,2022,Q4,7,F,20200504.0,20221107.0,20201225,20221114,EXP,,IT-ROCHE-2628853,ROCHE,,53.0,YR,,M,Y,,,20221114,,MD,IT,,2022,Q4,Adult
186639097,18663909,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Cytomegalovirus enteritis,,2022,Q4,7,F,20200504.0,20221107.0,20201225,20221114,EXP,,IT-ROCHE-2628853,ROCHE,,53.0,YR,,M,Y,,,20221114,,MD,IT,,2022,Q4,Adult
1869104721,18691047,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,End stage renal disease,,2022,Q4,21,F,20201202.0,20221114.0,20210101,20221116,EXP,,NVSC2020US325160,NOVARTIS,,73.0,YR,,F,Y,88.8,KG,20221116,,MD,US,US,2022,Q4,Elderly
1878494513,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q4,Weight increased,,2022,Q4,13,F,20210220.0,20221021.0,20210125,20221026,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20221026,,HP,CO,CO,2022,Q4,Adult
1878494513,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q4,Asthenia,,2022,Q4,13,F,20210220.0,20221021.0,20210125,20221026,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20221026,,HP,CO,CO,2022,Q4,Adult
1878494513,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q4,Gastrointestinal inflammation,,2022,Q4,13,F,20210220.0,20221021.0,20210125,20221026,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20221026,,HP,CO,CO,2022,Q4,Adult
1878494513,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q4,Fatigue,,2022,Q4,13,F,20210220.0,20221021.0,20210125,20221026,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20221026,,HP,CO,CO,2022,Q4,Adult
1878494513,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q4,Thirst,,2022,Q4,13,F,20210220.0,20221021.0,20210125,20221026,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20221026,,HP,CO,CO,2022,Q4,Adult
1878494513,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q4,Diarrhoea haemorrhagic,,2022,Q4,13,F,20210220.0,20221021.0,20210125,20221026,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20221026,,HP,CO,CO,2022,Q4,Adult
1878494513,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q4,Bacterial infection,,2022,Q4,13,F,20210220.0,20221021.0,20210125,20221026,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20221026,,HP,CO,CO,2022,Q4,Adult
1878494513,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q4,Proctalgia,,2022,Q4,13,F,20210220.0,20221021.0,20210125,20221026,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20221026,,HP,CO,CO,2022,Q4,Adult
1878494513,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q4,Colitis ulcerative,,2022,Q4,13,F,20210220.0,20221021.0,20210125,20221026,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20221026,,HP,CO,CO,2022,Q4,Adult
1878494513,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q4,Dehydration,,2022,Q4,13,F,20210220.0,20221021.0,20210125,20221026,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20221026,,HP,CO,CO,2022,Q4,Adult
1878494513,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q4,Abdominal distension,,2022,Q4,13,F,20210220.0,20221021.0,20210125,20221026,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20221026,,HP,CO,CO,2022,Q4,Adult
1878494513,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q4,COVID-19,,2022,Q4,13,F,20210220.0,20221021.0,20210125,20221026,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20221026,,HP,CO,CO,2022,Q4,Adult
1878494513,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q4,Pollakiuria,,2022,Q4,13,F,20210220.0,20221021.0,20210125,20221026,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20221026,,HP,CO,CO,2022,Q4,Adult
1878494513,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q4,Cough,,2022,Q4,13,F,20210220.0,20221021.0,20210125,20221026,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20221026,,HP,CO,CO,2022,Q4,Adult
1878494513,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q4,General physical health deterioration,,2022,Q4,13,F,20210220.0,20221021.0,20210125,20221026,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20221026,,HP,CO,CO,2022,Q4,Adult
1878494513,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q4,Constipation,,2022,Q4,13,F,20210220.0,20221021.0,20210125,20221026,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20221026,,HP,CO,CO,2022,Q4,Adult
1878494513,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q4,Diarrhoea,,2022,Q4,13,F,20210220.0,20221021.0,20210125,20221026,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20221026,,HP,CO,CO,2022,Q4,Adult
1878494513,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q4,Blood glucose increased,,2022,Q4,13,F,20210220.0,20221021.0,20210125,20221026,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20221026,,HP,CO,CO,2022,Q4,Adult
1878494513,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q4,Drug ineffective,,2022,Q4,13,F,20210220.0,20221021.0,20210125,20221026,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20221026,,HP,CO,CO,2022,Q4,Adult
1878494513,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q4,Abdominal pain upper,,2022,Q4,13,F,20210220.0,20221021.0,20210125,20221026,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20221026,,HP,CO,CO,2022,Q4,Adult
1878494513,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q4,Rectal haemorrhage,,2022,Q4,13,F,20210220.0,20221021.0,20210125,20221026,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20221026,,HP,CO,CO,2022,Q4,Adult
1878494513,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q4,Haematochezia,,2022,Q4,13,F,20210220.0,20221021.0,20210125,20221026,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20221026,,HP,CO,CO,2022,Q4,Adult
1878494513,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q4,Hyperhidrosis,,2022,Q4,13,F,20210220.0,20221021.0,20210125,20221026,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20221026,,HP,CO,CO,2022,Q4,Adult
1878494513,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q4,Abdominal pain,,2022,Q4,13,F,20210220.0,20221021.0,20210125,20221026,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20221026,,HP,CO,CO,2022,Q4,Adult
1878494513,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q4,Rectal tenesmus,,2022,Q4,13,F,20210220.0,20221021.0,20210125,20221026,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20221026,,HP,CO,CO,2022,Q4,Adult
1878494513,18784945,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"4 international unit, qd",,,,,,,,4.0,IU,,QD,2022,Q4,Peripheral coldness,,2022,Q4,13,F,20210220.0,20221021.0,20210125,20221026,EXP,,CO-TAKEDA-2021TUS004638,TAKEDA,,53.0,YR,,M,Y,114.0,KG,20221026,,HP,CO,CO,2022,Q4,Adult
188761863,18876186,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Death,,2022,Q4,3,F,20210101.0,20220922.0,20210211,20221003,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005076,AEGERION,,25.0,YR,,F,Y,48.073,KG,20221003,,CN,US,US,2022,Q4,Young Adult
188761863,18876186,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Dry skin,,2022,Q4,3,F,20210101.0,20220922.0,20210211,20221003,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005076,AEGERION,,25.0,YR,,F,Y,48.073,KG,20221003,,CN,US,US,2022,Q4,Young Adult
188761863,18876186,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Cerebrovascular accident,,2022,Q4,3,F,20210101.0,20220922.0,20210211,20221003,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005076,AEGERION,,25.0,YR,,F,Y,48.073,KG,20221003,,CN,US,US,2022,Q4,Young Adult
188761863,18876186,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Therapy interrupted,,2022,Q4,3,F,20210101.0,20220922.0,20210211,20221003,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005076,AEGERION,,25.0,YR,,F,Y,48.073,KG,20221003,,CN,US,US,2022,Q4,Young Adult
188761863,18876186,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Product dose omission issue,,2022,Q4,3,F,20210101.0,20220922.0,20210211,20221003,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005076,AEGERION,,25.0,YR,,F,Y,48.073,KG,20221003,,CN,US,US,2022,Q4,Young Adult
188761863,18876186,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Insurance issue,,2022,Q4,3,F,20210101.0,20220922.0,20210211,20221003,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005076,AEGERION,,25.0,YR,,F,Y,48.073,KG,20221003,,CN,US,US,2022,Q4,Young Adult
188761863,18876186,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Pain,,2022,Q4,3,F,20210101.0,20220922.0,20210211,20221003,EXP,,US-AMRYT PHARMACEUTICALS DAC-AEGR005076,AEGERION,,25.0,YR,,F,Y,48.073,KG,20221003,,CN,US,US,2022,Q4,Young Adult
189792973,18979297,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK , daily",,,U,U,,,,,,,,2022,Q4,Myocardial infarction,,2022,Q4,3,F,,20210307.0,20210308,20221202,EXP,GB-MHRA-ADR 24817899,GB-NOVOPROD-791000,NOVO NORDISK,,72.0,YR,,F,Y,,,20221202,,MD,GB,GB,2022,Q4,Elderly
193233503,19323350,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,by value,,,,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,3,F,,20221013.0,20210528,20221021,EXP,DE-ADRED-05240-01,DE-BAUSCH-BL-2021-017787,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221021,,PH,DE,DE,2022,Q4,Elderly
193233503,19323350,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,by value,,,,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,3,F,,20221013.0,20210528,20221021,EXP,DE-ADRED-05240-01,DE-BAUSCH-BL-2021-017787,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221021,,PH,DE,DE,2022,Q4,Elderly
193233503,19323350,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,by value,,,,,,,,,,,,2022,Q4,Oedema peripheral,,2022,Q4,3,F,,20221013.0,20210528,20221021,EXP,DE-ADRED-05240-01,DE-BAUSCH-BL-2021-017787,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221021,,PH,DE,DE,2022,Q4,Elderly
193233503,19323350,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,by value,,,,,,,,,,,,2022,Q4,Cough,,2022,Q4,3,F,,20221013.0,20210528,20221021,EXP,DE-ADRED-05240-01,DE-BAUSCH-BL-2021-017787,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221021,,PH,DE,DE,2022,Q4,Elderly
193233503,19323350,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,by value,,,,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,3,F,,20221013.0,20210528,20221021,EXP,DE-ADRED-05240-01,DE-BAUSCH-BL-2021-017787,BAUSCH AND LOMB,,83.0,YR,,M,Y,,,20221021,,PH,DE,DE,2022,Q4,Elderly
194842302,19484230,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (according to schedule, injection/infusion solution)",,,,,,,,,,Solution for injection/infusion,,2022,Q4,Haematochezia,,2022,Q4,2,F,,20221017.0,20210701,20221020,EXP,DE-ADRED-06411-02,DE-DSJP-DSE-2021-119629,DAIICHI,,84.0,YR,,M,Y,,,20221020,,MD,DE,DE,2022,Q4,Elderly
194842302,19484230,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (according to schedule, injection/infusion solution)",,,,,,,,,,Solution for injection/infusion,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221017.0,20210701,20221020,EXP,DE-ADRED-06411-02,DE-DSJP-DSE-2021-119629,DAIICHI,,84.0,YR,,M,Y,,,20221020,,MD,DE,DE,2022,Q4,Elderly
194842302,19484230,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK (according to schedule, injection/infusion solution)",,,,,,,,,,Solution for injection/infusion,,2022,Q4,Haematochezia,,2022,Q4,2,F,,20221017.0,20210701,20221020,EXP,DE-ADRED-06411-02,DE-DSJP-DSE-2021-119629,DAIICHI,,84.0,YR,,M,Y,,,20221020,,MD,DE,DE,2022,Q4,Elderly
194974262,19497426,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, as needed",,,D,,,,,,,Solution for injection,,2022,Q4,Foot amputation,,2022,Q4,2,F,20200922.0,20221019.0,20210706,20221029,EXP,DE-ADRED-06530-01,DE-SA-2021SA212380,SANOFI AVENTIS,,71.0,YR,E,M,Y,93.0,KG,20221029,,PH,DE,DE,2022,Q4,Elderly
194974262,19497426,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, as needed",,,D,,,,,,,Solution for injection,,2022,Q4,Wound dehiscence,,2022,Q4,2,F,20200922.0,20221019.0,20210706,20221029,EXP,DE-ADRED-06530-01,DE-SA-2021SA212380,SANOFI AVENTIS,,71.0,YR,E,M,Y,93.0,KG,20221029,,PH,DE,DE,2022,Q4,Elderly
194989974,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Myalgia,,2022,Q4,4,F,,20221129.0,20210706,20221205,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
194989974,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Blood glucose increased,,2022,Q4,4,F,,20221129.0,20210706,20221205,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
194989974,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Abdominal pain upper,,2022,Q4,4,F,,20221129.0,20210706,20221205,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
194989974,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Eye haemorrhage,,2022,Q4,4,F,,20221129.0,20210706,20221205,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
194989974,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Multi-organ disorder,,2022,Q4,4,F,,20221129.0,20210706,20221205,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
194989974,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Neuropathy peripheral,,2022,Q4,4,F,,20221129.0,20210706,20221205,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
194989974,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Arthritis,,2022,Q4,4,F,,20221129.0,20210706,20221205,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
194989974,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Pulmonary oedema,,2022,Q4,4,F,,20221129.0,20210706,20221205,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
194989974,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Cardiac failure congestive,,2022,Q4,4,F,,20221129.0,20210706,20221205,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
194989974,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Malnutrition,,2022,Q4,4,F,,20221129.0,20210706,20221205,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
194989974,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Pericardial effusion,,2022,Q4,4,F,,20221129.0,20210706,20221205,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
194989974,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Headache,,2022,Q4,4,F,,20221129.0,20210706,20221205,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
194989974,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Diarrhoea,,2022,Q4,4,F,,20221129.0,20210706,20221205,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
194989974,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Weight decreased,,2022,Q4,4,F,,20221129.0,20210706,20221205,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
194989974,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Thyroid disorder,,2022,Q4,4,F,,20221129.0,20210706,20221205,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
194989974,19498997,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Chest pain,,2022,Q4,4,F,,20221129.0,20210706,20221205,EXP,,CA-SA-2021SA212881,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221205,,CN,CA,CA,2022,Q4,Adult
194992972,19499297,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, prn",,,U,,,,20563.0,300.0,IU,Injection,,2022,Q4,Foot amputation,,2022,Q4,2,F,20200922.0,20221014.0,20210706,20221026,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011393,ELI LILLY AND CO,,71.0,YR,,M,Y,93.0,KG,20221026,,CN,DE,DE,2022,Q4,Elderly
194992972,19499297,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, prn",,,U,,,,20563.0,300.0,IU,Injection,,2022,Q4,Wound dehiscence,,2022,Q4,2,F,20200922.0,20221014.0,20210706,20221026,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202106011393,ELI LILLY AND CO,,71.0,YR,,M,Y,93.0,KG,20221026,,CN,DE,DE,2022,Q4,Elderly
195879512,19587951,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"According to the scheme, solution for injection/infusion",,,U,,,,,,,,,2022,Q4,Fatigue,,2022,Q4,2,F,,20221104.0,20210721,20221118,EXP,DE-BFARM-21005977,DE-Accord-232288,ACCORD,,78.0,YR,E,M,Y,88.4,KG,20221118,,MD,DE,DE,2022,Q4,Elderly
195879512,19587951,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"According to the scheme, solution for injection/infusion",,,U,,,,,,,,,2022,Q4,Diarrhoea,,2022,Q4,2,F,,20221104.0,20210721,20221118,EXP,DE-BFARM-21005977,DE-Accord-232288,ACCORD,,78.0,YR,E,M,Y,88.4,KG,20221118,,MD,DE,DE,2022,Q4,Elderly
195879512,19587951,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"According to the scheme, solution for injection/infusion",,,U,,,,,,,,,2022,Q4,Medication error,,2022,Q4,2,F,,20221104.0,20210721,20221118,EXP,DE-BFARM-21005977,DE-Accord-232288,ACCORD,,78.0,YR,E,M,Y,88.4,KG,20221118,,MD,DE,DE,2022,Q4,Elderly
195879512,19587951,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"According to the scheme, solution for injection/infusion",,,U,,,,,,,,,2022,Q4,Night sweats,,2022,Q4,2,F,,20221104.0,20210721,20221118,EXP,DE-BFARM-21005977,DE-Accord-232288,ACCORD,,78.0,YR,E,M,Y,88.4,KG,20221118,,MD,DE,DE,2022,Q4,Elderly
195879512,19587951,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"According to the scheme, solution for injection/infusion",,,U,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221104.0,20210721,20221118,EXP,DE-BFARM-21005977,DE-Accord-232288,ACCORD,,78.0,YR,E,M,Y,88.4,KG,20221118,,MD,DE,DE,2022,Q4,Elderly
196952502,19695250,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40-0-25-0),,,U,,,,,,,,,2022,Q4,Atrial fibrillation,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40-0-25-0),,,U,,,,,,,,,2022,Q4,Oedema peripheral,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40-0-25-0),,,U,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40-0-25-0),,,U,,,,,,,,,2022,Q4,Tachypnoea,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40-0-25-0),,,U,,,,,,,,,2022,Q4,Constipation,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40-0-25-0),,,U,,,,,,,,,2022,Q4,Abdominal pain,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40-0-25-0),,,U,,,,,,,,,2022,Q4,Dysuria,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40-0-25-0),,,U,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40-0-25-0),,,U,,,,,,,,,2022,Q4,Cough,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40-0-25-0),,,U,,,,,,,,,2022,Q4,Pyrexia,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40-0-25-0),,,U,,,,,,,,,2022,Q4,Electrocardiogram abnormal,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40-0-25-0),,,U,,,,,,,,,2022,Q4,Urinary tract infection,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40-0-25-0),,,U,,,,,,,,,2022,Q4,Hydronephrosis,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40-0-25-0),,,U,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK(40-0-25-0),,,U,,,,,,,,,2022,Q4,Vomiting,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,U,,,,,,,,,2022,Q4,Atrial fibrillation,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,U,,,,,,,,,2022,Q4,Oedema peripheral,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,U,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,U,,,,,,,,,2022,Q4,Tachypnoea,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,U,,,,,,,,,2022,Q4,Constipation,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,U,,,,,,,,,2022,Q4,Abdominal pain,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,U,,,,,,,,,2022,Q4,Dysuria,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,U,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,U,,,,,,,,,2022,Q4,Cough,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,U,,,,,,,,,2022,Q4,Pyrexia,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,U,,,,,,,,,2022,Q4,Electrocardiogram abnormal,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,U,,,,,,,,,2022,Q4,Urinary tract infection,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,U,,,,,,,,,2022,Q4,Hydronephrosis,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,U,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
196952502,19695250,15,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,U,,,,,,,,,2022,Q4,Vomiting,,2022,Q4,2,F,,20221017.0,20210813,20221019,EXP,,NVSC2021DE178446,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221019,,PH,DE,DE,2022,Q4,Elderly
197099132,19709913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"3 U, TID (before breakfast, lunch and dinner)",,,Y,,,,209196.0,,,,Q8H,2022,Q4,Microalbuminuria,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"3 U, TID (before breakfast, lunch and dinner)",,,Y,,,,209196.0,,,,Q8H,2022,Q4,Pain in extremity,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"3 U, TID (before breakfast, lunch and dinner)",,,Y,,,,209196.0,,,,Q8H,2022,Q4,Autonomic nervous system imbalance,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"3 U, TID (before breakfast, lunch and dinner)",,,Y,,,,209196.0,,,,Q8H,2022,Q4,Orthostatic hypotension,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"3 U, TID (before breakfast, lunch and dinner)",,,Y,,,,209196.0,,,,Q8H,2022,Q4,Pain,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"3 U, TID (before breakfast, lunch and dinner)",,,Y,,,,209196.0,,,,Q8H,2022,Q4,Hypoglycaemia,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"3 U, TID (before breakfast, lunch and dinner)",,,Y,,,,209196.0,,,,Q8H,2022,Q4,Acute painful neuropathy of rapid glycaemic control,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"3 U, TID (before breakfast, lunch and dinner)",,,Y,,,,209196.0,,,,Q8H,2022,Q4,Nausea,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"3 U, TID (before breakfast, lunch and dinner)",,,Y,,,,209196.0,,,,Q8H,2022,Q4,Vomiting,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"3 U, TID (before breakfast, lunch and dinner)",,,Y,,,,209196.0,,,,Q8H,2022,Q4,Peripheral sensory neuropathy,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"3 U, TID (before breakfast, lunch and dinner)",,,Y,,,,209196.0,,,,Q8H,2022,Q4,Dizziness,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"3 U, TID (before breakfast, lunch and dinner)",,,Y,,,,209196.0,,,,Q8H,2022,Q4,Diabetic retinopathy,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"3 U, TID (before breakfast, lunch and dinner)",,,Y,,,,209196.0,,,,Q8H,2022,Q4,Impaired gastric emptying,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 U, QD (before breakfast)",,,Y,,,,209196.0,,,,QD,2022,Q4,Microalbuminuria,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 U, QD (before breakfast)",,,Y,,,,209196.0,,,,QD,2022,Q4,Pain in extremity,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 U, QD (before breakfast)",,,Y,,,,209196.0,,,,QD,2022,Q4,Autonomic nervous system imbalance,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 U, QD (before breakfast)",,,Y,,,,209196.0,,,,QD,2022,Q4,Orthostatic hypotension,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 U, QD (before breakfast)",,,Y,,,,209196.0,,,,QD,2022,Q4,Pain,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 U, QD (before breakfast)",,,Y,,,,209196.0,,,,QD,2022,Q4,Hypoglycaemia,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 U, QD (before breakfast)",,,Y,,,,209196.0,,,,QD,2022,Q4,Acute painful neuropathy of rapid glycaemic control,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 U, QD (before breakfast)",,,Y,,,,209196.0,,,,QD,2022,Q4,Nausea,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 U, QD (before breakfast)",,,Y,,,,209196.0,,,,QD,2022,Q4,Vomiting,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 U, QD (before breakfast)",,,Y,,,,209196.0,,,,QD,2022,Q4,Peripheral sensory neuropathy,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 U, QD (before breakfast)",,,Y,,,,209196.0,,,,QD,2022,Q4,Dizziness,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 U, QD (before breakfast)",,,Y,,,,209196.0,,,,QD,2022,Q4,Diabetic retinopathy,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"9 U, QD (before breakfast)",,,Y,,,,209196.0,,,,QD,2022,Q4,Impaired gastric emptying,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, BID (before lunch and dinner)",,,Y,,,,209196.0,,,,Q12H,2022,Q4,Microalbuminuria,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, BID (before lunch and dinner)",,,Y,,,,209196.0,,,,Q12H,2022,Q4,Pain in extremity,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, BID (before lunch and dinner)",,,Y,,,,209196.0,,,,Q12H,2022,Q4,Autonomic nervous system imbalance,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, BID (before lunch and dinner)",,,Y,,,,209196.0,,,,Q12H,2022,Q4,Orthostatic hypotension,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, BID (before lunch and dinner)",,,Y,,,,209196.0,,,,Q12H,2022,Q4,Pain,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, BID (before lunch and dinner)",,,Y,,,,209196.0,,,,Q12H,2022,Q4,Hypoglycaemia,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, BID (before lunch and dinner)",,,Y,,,,209196.0,,,,Q12H,2022,Q4,Acute painful neuropathy of rapid glycaemic control,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, BID (before lunch and dinner)",,,Y,,,,209196.0,,,,Q12H,2022,Q4,Nausea,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, BID (before lunch and dinner)",,,Y,,,,209196.0,,,,Q12H,2022,Q4,Vomiting,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, BID (before lunch and dinner)",,,Y,,,,209196.0,,,,Q12H,2022,Q4,Peripheral sensory neuropathy,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, BID (before lunch and dinner)",,,Y,,,,209196.0,,,,Q12H,2022,Q4,Dizziness,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, BID (before lunch and dinner)",,,Y,,,,209196.0,,,,Q12H,2022,Q4,Diabetic retinopathy,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"10 U, BID (before lunch and dinner)",,,Y,,,,209196.0,,,,Q12H,2022,Q4,Impaired gastric emptying,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 U, BID (before breakfast and dinner)",,,Y,,,,209196.0,,,,Q12H,2022,Q4,Microalbuminuria,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 U, BID (before breakfast and dinner)",,,Y,,,,209196.0,,,,Q12H,2022,Q4,Pain in extremity,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 U, BID (before breakfast and dinner)",,,Y,,,,209196.0,,,,Q12H,2022,Q4,Autonomic nervous system imbalance,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 U, BID (before breakfast and dinner)",,,Y,,,,209196.0,,,,Q12H,2022,Q4,Orthostatic hypotension,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 U, BID (before breakfast and dinner)",,,Y,,,,209196.0,,,,Q12H,2022,Q4,Pain,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 U, BID (before breakfast and dinner)",,,Y,,,,209196.0,,,,Q12H,2022,Q4,Hypoglycaemia,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 U, BID (before breakfast and dinner)",,,Y,,,,209196.0,,,,Q12H,2022,Q4,Acute painful neuropathy of rapid glycaemic control,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 U, BID (before breakfast and dinner)",,,Y,,,,209196.0,,,,Q12H,2022,Q4,Nausea,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 U, BID (before breakfast and dinner)",,,Y,,,,209196.0,,,,Q12H,2022,Q4,Vomiting,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 U, BID (before breakfast and dinner)",,,Y,,,,209196.0,,,,Q12H,2022,Q4,Peripheral sensory neuropathy,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 U, BID (before breakfast and dinner)",,,Y,,,,209196.0,,,,Q12H,2022,Q4,Dizziness,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 U, BID (before breakfast and dinner)",,,Y,,,,209196.0,,,,Q12H,2022,Q4,Diabetic retinopathy,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"2 U, BID (before breakfast and dinner)",,,Y,,,,209196.0,,,,Q12H,2022,Q4,Impaired gastric emptying,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, QD (before lunchtime)",,,Y,,,,209196.0,,,,QD,2022,Q4,Microalbuminuria,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, QD (before lunchtime)",,,Y,,,,209196.0,,,,QD,2022,Q4,Pain in extremity,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, QD (before lunchtime)",,,Y,,,,209196.0,,,,QD,2022,Q4,Autonomic nervous system imbalance,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, QD (before lunchtime)",,,Y,,,,209196.0,,,,QD,2022,Q4,Orthostatic hypotension,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, QD (before lunchtime)",,,Y,,,,209196.0,,,,QD,2022,Q4,Pain,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, QD (before lunchtime)",,,Y,,,,209196.0,,,,QD,2022,Q4,Hypoglycaemia,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, QD (before lunchtime)",,,Y,,,,209196.0,,,,QD,2022,Q4,Acute painful neuropathy of rapid glycaemic control,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, QD (before lunchtime)",,,Y,,,,209196.0,,,,QD,2022,Q4,Nausea,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, QD (before lunchtime)",,,Y,,,,209196.0,,,,QD,2022,Q4,Vomiting,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, QD (before lunchtime)",,,Y,,,,209196.0,,,,QD,2022,Q4,Peripheral sensory neuropathy,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, QD (before lunchtime)",,,Y,,,,209196.0,,,,QD,2022,Q4,Dizziness,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, QD (before lunchtime)",,,Y,,,,209196.0,,,,QD,2022,Q4,Diabetic retinopathy,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197099132,19709913,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, QD (before lunchtime)",,,Y,,,,209196.0,,,,QD,2022,Q4,Impaired gastric emptying,,2022,Q4,2,F,,20220927.0,20210816,20221004,EXP,,CA-SA-2021SA262118,SANOFI AVENTIS,,20.0,YR,A,F,Y,47.8,KG,20221004,,HP,CA,CA,2022,Q4,Youth
197278302,19727830,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Oedema peripheral,,2022,Q4,2,F,,20221023.0,20210820,20221102,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
197278302,19727830,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Cough,,2022,Q4,2,F,,20221023.0,20210820,20221102,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
197278302,19727830,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Tachypnoea,,2022,Q4,2,F,,20221023.0,20210820,20221102,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
197278302,19727830,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,2,F,,20221023.0,20210820,20221102,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
197278302,19727830,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221023.0,20210820,20221102,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
197278302,19727830,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Vomiting,,2022,Q4,2,F,,20221023.0,20210820,20221102,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
197278302,19727830,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Atrial fibrillation,,2022,Q4,2,F,,20221023.0,20210820,20221102,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
197278302,19727830,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Hydronephrosis,,2022,Q4,2,F,,20221023.0,20210820,20221102,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
197278302,19727830,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Dysuria,,2022,Q4,2,F,,20221023.0,20210820,20221102,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
197278302,19727830,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Constipation,,2022,Q4,2,F,,20221023.0,20210820,20221102,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
197278302,19727830,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Abdominal pain,,2022,Q4,2,F,,20221023.0,20210820,20221102,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
197278302,19727830,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,2,F,,20221023.0,20210820,20221102,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
197278302,19727830,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Electrocardiogram abnormal,,2022,Q4,2,F,,20221023.0,20210820,20221102,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
197278302,19727830,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Urinary tract infection,,2022,Q4,2,F,,20221023.0,20210820,20221102,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
197278302,19727830,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Pyrexia,,2022,Q4,2,F,,20221023.0,20210820,20221102,EXP,,DE-TEVA-2021-DE-1942247,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Urinary tract obstruction,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Localised infection,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Pyrexia,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Renal colic,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Renal pain,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Renal failure,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Cough,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Renal impairment,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Constipation,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Calculus urinary,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Abdominal pain,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Pyelonephritis,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Vomiting,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Abdominal pain,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Hydronephrosis,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Weight increased,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Flank pain,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Condition aggravated,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Postrenal failure,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Atrial fibrillation,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Electrocardiogram abnormal,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Oedema peripheral,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Candida infection,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Tachypnoea,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Ureterolithiasis,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Blood glucose increased,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Urinary tract infection,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Urinary tract infection,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40 - 0 -  25 - 0,,,,,Unknown,,,,,,,2022,Q4,Dysuria,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Urinary tract obstruction,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Localised infection,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Dyspnoea,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Pyrexia,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Renal colic,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Renal pain,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Renal failure,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Cough,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Hyperglycaemia,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Renal impairment,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Constipation,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Calculus urinary,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Abdominal pain,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Pyelonephritis,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Vomiting,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Abdominal pain,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Hydronephrosis,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Weight increased,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Flank pain,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Condition aggravated,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,General physical health deterioration,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Postrenal failure,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Atrial fibrillation,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Electrocardiogram abnormal,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Oedema peripheral,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Candida infection,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Tachypnoea,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Ureterolithiasis,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Blood glucose increased,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Urinary tract infection,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Urinary tract infection,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56 - 0 - 36 - 0",,,,,,,,50.0,IU,,,2022,Q4,Dysuria,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Urinary tract obstruction,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Localised infection,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Dyspnoea,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Pyrexia,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Renal colic,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Renal pain,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Renal failure,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Cough,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Hyperglycaemia,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Renal impairment,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Constipation,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Calculus urinary,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Abdominal pain,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Pyelonephritis,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Vomiting,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Abdominal pain,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Hydronephrosis,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Weight increased,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Flank pain,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Condition aggravated,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,General physical health deterioration,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Postrenal failure,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Atrial fibrillation,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Electrocardiogram abnormal,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Oedema peripheral,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Candida infection,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Tachypnoea,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Ureterolithiasis,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Blood glucose increased,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Urinary tract infection,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Urinary tract infection,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197289073,19728907,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,2x/day (40-0-25-0),,,,,,,,,,,BID,2022,Q4,Dysuria,,2022,Q4,3,F,,20221017.0,20210820,20221025,EXP,DE-ADRED-07014-01,DE-PFIZER INC-202101009983,PFIZER,,73.0,YR,,F,Y,100.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
197857413,19785741,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,U,,,,,,,,,2022,Q4,Vomiting,,2022,Q4,3,F,,20221121.0,20210903,20221206,EXP,DE-BFARM-21007554,DE-Accord-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20221206,,PH,DE,DE,2022,Q4,Elderly
197857413,19785741,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,U,,,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,3,F,,20221121.0,20210903,20221206,EXP,DE-BFARM-21007554,DE-Accord-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20221206,,PH,DE,DE,2022,Q4,Elderly
197857413,19785741,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,U,,,,,,,,,2022,Q4,Flank pain,,2022,Q4,3,F,,20221121.0,20210903,20221206,EXP,DE-BFARM-21007554,DE-Accord-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20221206,,PH,DE,DE,2022,Q4,Elderly
197857413,19785741,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,U,,,,,,,,,2022,Q4,Electrocardiogram abnormal,,2022,Q4,3,F,,20221121.0,20210903,20221206,EXP,DE-BFARM-21007554,DE-Accord-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20221206,,PH,DE,DE,2022,Q4,Elderly
197857413,19785741,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,U,,,,,,,,,2022,Q4,Urinary tract infection,,2022,Q4,3,F,,20221121.0,20210903,20221206,EXP,DE-BFARM-21007554,DE-Accord-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20221206,,PH,DE,DE,2022,Q4,Elderly
197857413,19785741,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,U,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,3,F,,20221121.0,20210903,20221206,EXP,DE-BFARM-21007554,DE-Accord-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20221206,,PH,DE,DE,2022,Q4,Elderly
197857413,19785741,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,U,,,,,,,,,2022,Q4,Dysuria,,2022,Q4,3,F,,20221121.0,20210903,20221206,EXP,DE-BFARM-21007554,DE-Accord-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20221206,,PH,DE,DE,2022,Q4,Elderly
197857413,19785741,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,U,,,,,,,,,2022,Q4,Renal pain,,2022,Q4,3,F,,20221121.0,20210903,20221206,EXP,DE-BFARM-21007554,DE-Accord-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20221206,,PH,DE,DE,2022,Q4,Elderly
197857413,19785741,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,U,,,,,,,,,2022,Q4,Condition aggravated,,2022,Q4,3,F,,20221121.0,20210903,20221206,EXP,DE-BFARM-21007554,DE-Accord-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20221206,,PH,DE,DE,2022,Q4,Elderly
197857413,19785741,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,U,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,3,F,,20221121.0,20210903,20221206,EXP,DE-BFARM-21007554,DE-Accord-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20221206,,PH,DE,DE,2022,Q4,Elderly
197857413,19785741,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,U,,,,,,,,,2022,Q4,Hydronephrosis,,2022,Q4,3,F,,20221121.0,20210903,20221206,EXP,DE-BFARM-21007554,DE-Accord-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20221206,,PH,DE,DE,2022,Q4,Elderly
197857413,19785741,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,U,,,,,,,,,2022,Q4,Abdominal pain,,2022,Q4,3,F,,20221121.0,20210903,20221206,EXP,DE-BFARM-21007554,DE-Accord-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20221206,,PH,DE,DE,2022,Q4,Elderly
197857413,19785741,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,U,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,3,F,,20221121.0,20210903,20221206,EXP,DE-BFARM-21007554,DE-Accord-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20221206,,PH,DE,DE,2022,Q4,Elderly
197857413,19785741,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,U,,,,,,,,,2022,Q4,Tachypnoea,,2022,Q4,3,F,,20221121.0,20210903,20221206,EXP,DE-BFARM-21007554,DE-Accord-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20221206,,PH,DE,DE,2022,Q4,Elderly
197857413,19785741,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,U,,,,,,,,,2022,Q4,Renal impairment,,2022,Q4,3,F,,20221121.0,20210903,20221206,EXP,DE-BFARM-21007554,DE-Accord-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20221206,,PH,DE,DE,2022,Q4,Elderly
197857413,19785741,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,U,,,,,,,,,2022,Q4,Pyrexia,,2022,Q4,3,F,,20221121.0,20210903,20221206,EXP,DE-BFARM-21007554,DE-Accord-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20221206,,PH,DE,DE,2022,Q4,Elderly
197857413,19785741,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,U,,,,,,,,,2022,Q4,Constipation,,2022,Q4,3,F,,20221121.0,20210903,20221206,EXP,DE-BFARM-21007554,DE-Accord-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20221206,,PH,DE,DE,2022,Q4,Elderly
197857413,19785741,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,U,,,,,,,,,2022,Q4,Cough,,2022,Q4,3,F,,20221121.0,20210903,20221206,EXP,DE-BFARM-21007554,DE-Accord-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20221206,,PH,DE,DE,2022,Q4,Elderly
197857413,19785741,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,U,,,,,,,,,2022,Q4,Oedema peripheral,,2022,Q4,3,F,,20221121.0,20210903,20221206,EXP,DE-BFARM-21007554,DE-Accord-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20221206,,PH,DE,DE,2022,Q4,Elderly
197857413,19785741,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,U,,,,,,,,,2022,Q4,Atrial fibrillation,,2022,Q4,3,F,,20221121.0,20210903,20221206,EXP,DE-BFARM-21007554,DE-Accord-236915,ACCORD,,73.0,YR,E,F,Y,100.0,KG,20221206,,PH,DE,DE,2022,Q4,Elderly
197966119,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Thrombocytopenia,,2022,Q4,9,F,20210815.0,20221107.0,20210907,20221109,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20221109,,MD,US,US,2022,Q4,Adult
197966119,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Nausea,,2022,Q4,9,F,20210815.0,20221107.0,20210907,20221109,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20221109,,MD,US,US,2022,Q4,Adult
197966119,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Sepsis,,2022,Q4,9,F,20210815.0,20221107.0,20210907,20221109,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20221109,,MD,US,US,2022,Q4,Adult
197966119,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Febrile neutropenia,,2022,Q4,9,F,20210815.0,20221107.0,20210907,20221109,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20221109,,MD,US,US,2022,Q4,Adult
197966119,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Haemoptysis,,2022,Q4,9,F,20210815.0,20221107.0,20210907,20221109,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20221109,,MD,US,US,2022,Q4,Adult
197966119,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Asthenia,,2022,Q4,9,F,20210815.0,20221107.0,20210907,20221109,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20221109,,MD,US,US,2022,Q4,Adult
197966119,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Hypoxia,,2022,Q4,9,F,20210815.0,20221107.0,20210907,20221109,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20221109,,MD,US,US,2022,Q4,Adult
197966119,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Thrombophlebitis,,2022,Q4,9,F,20210815.0,20221107.0,20210907,20221109,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20221109,,MD,US,US,2022,Q4,Adult
197966119,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Septic shock,,2022,Q4,9,F,20210815.0,20221107.0,20210907,20221109,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20221109,,MD,US,US,2022,Q4,Adult
197966119,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Pulmonary mass,,2022,Q4,9,F,20210815.0,20221107.0,20210907,20221109,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20221109,,MD,US,US,2022,Q4,Adult
197966119,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Decreased appetite,,2022,Q4,9,F,20210815.0,20221107.0,20210907,20221109,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20221109,,MD,US,US,2022,Q4,Adult
197966119,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Hypotension,,2022,Q4,9,F,20210815.0,20221107.0,20210907,20221109,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20221109,,MD,US,US,2022,Q4,Adult
197966119,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Pleural effusion,,2022,Q4,9,F,20210815.0,20221107.0,20210907,20221109,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20221109,,MD,US,US,2022,Q4,Adult
197966119,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Pyrexia,,2022,Q4,9,F,20210815.0,20221107.0,20210907,20221109,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20221109,,MD,US,US,2022,Q4,Adult
197966119,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Cytokine release syndrome,,2022,Q4,9,F,20210815.0,20221107.0,20210907,20221109,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20221109,,MD,US,US,2022,Q4,Adult
197966119,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Deep vein thrombosis,,2022,Q4,9,F,20210815.0,20221107.0,20210907,20221109,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20221109,,MD,US,US,2022,Q4,Adult
197966119,19796611,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Tachycardia,,2022,Q4,9,F,20210815.0,20221107.0,20210907,20221109,EXP,,NVSC2021US195548,NOVARTIS,,54.0,YR,,M,Y,,,20221109,,MD,US,US,2022,Q4,Adult
198098202,19809820,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,Scheme,,,,,,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,2,F,,20221019.0,20210909,20221024,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198098202,19809820,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,Scheme,,,,,,,,,,,,2022,Q4,Tachycardia,,2022,Q4,2,F,,20221019.0,20210909,20221024,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198098202,19809820,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,Scheme,,,,,,,,,,,,2022,Q4,Condition aggravated,,2022,Q4,2,F,,20221019.0,20210909,20221024,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198098202,19809820,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,Scheme,,,,,,,,,,,,2022,Q4,Renal impairment,,2022,Q4,2,F,,20221019.0,20210909,20221024,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198098202,19809820,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,Scheme,,,,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221019.0,20210909,20221024,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198098202,19809820,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,Scheme,,,,,,,,,,,,2022,Q4,Pyrexia,,2022,Q4,2,F,,20221019.0,20210909,20221024,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198098202,19809820,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,Scheme,,,,,,,,,,,,2022,Q4,Constipation,,2022,Q4,2,F,,20221019.0,20210909,20221024,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198098202,19809820,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,Scheme,,,,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,2,F,,20221019.0,20210909,20221024,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198098202,19809820,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,Scheme,,,,,,,,,,,,2022,Q4,Chills,,2022,Q4,2,F,,20221019.0,20210909,20221024,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198098202,19809820,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,Scheme,,,,,,,,,,,,2022,Q4,Tachypnoea,,2022,Q4,2,F,,20221019.0,20210909,20221024,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198098202,19809820,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,Scheme,,,,,,,,,,,,2022,Q4,Systemic infection,,2022,Q4,2,F,,20221019.0,20210909,20221024,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198098202,19809820,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,Scheme,,,,,,,,,,,,2022,Q4,Sepsis,,2022,Q4,2,F,,20221019.0,20210909,20221024,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198098202,19809820,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,Scheme,,,,,,,,,,,,2022,Q4,Anaemia,,2022,Q4,2,F,,20221019.0,20210909,20221024,PER,,DE-AMGEN-DEUSP2021137135,AMGEN,,69.0,YR,E,F,Y,91.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198180893,19818089,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Medication dose 20 U (UNIT),,,,,,,,,,Injection,,2022,Q4,Cervical polyp,,2022,Q4,3,F,20210811.0,20221108.0,20210911,20221111,EXP,,RU-ROCHE-2905644,ROCHE,,37.0,YR,,F,Y,84.0,KG,20221111,,MD,RU,,2022,Q4,Adult
198180893,19818089,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Medication dose 20 U (UNIT),,,,,,,,,,Injection,,2022,Q4,Bartholin's abscess,,2022,Q4,3,F,20210811.0,20221108.0,20210911,20221111,EXP,,RU-ROCHE-2905644,ROCHE,,37.0,YR,,F,Y,84.0,KG,20221111,,MD,RU,,2022,Q4,Adult
198275952,19827595,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 56-0-36-0",,,U,,,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,2,F,,20221017.0,20210914,20221024,EXP,,NVSC2021DE205307,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198275952,19827595,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 56-0-36-0",,,U,,,,,,,,,2022,Q4,Renal pain,,2022,Q4,2,F,,20221017.0,20210914,20221024,EXP,,NVSC2021DE205307,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198275952,19827595,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 56-0-36-0",,,U,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221017.0,20210914,20221024,EXP,,NVSC2021DE205307,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198275952,19827595,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 56-0-36-0",,,U,,,,,,,,,2022,Q4,Flank pain,,2022,Q4,2,F,,20221017.0,20210914,20221024,EXP,,NVSC2021DE205307,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198275952,19827595,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 56-0-36-0",,,U,,,,,,,,,2022,Q4,Pyelonephritis,,2022,Q4,2,F,,20221017.0,20210914,20221024,EXP,,NVSC2021DE205307,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198275952,19827595,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 56-0-36-0",,,U,,,,,,,,,2022,Q4,Abdominal pain,,2022,Q4,2,F,,20221017.0,20210914,20221024,EXP,,NVSC2021DE205307,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198275952,19827595,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 56-0-36-0",,,U,,,,,,,,,2022,Q4,Condition aggravated,,2022,Q4,2,F,,20221017.0,20210914,20221024,EXP,,NVSC2021DE205307,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198275952,19827595,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 56-0-36-0",,,U,,,,,,,,,2022,Q4,Pyrexia,,2022,Q4,2,F,,20221017.0,20210914,20221024,EXP,,NVSC2021DE205307,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198275952,19827595,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 56-0-36-0",,,U,,,,,,,,,2022,Q4,Urinary tract infection,,2022,Q4,2,F,,20221017.0,20210914,20221024,EXP,,NVSC2021DE205307,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198276412,19827641,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,U,,,,,,,,,2022,Q4,Sepsis,,2022,Q4,2,F,,20221017.0,20210914,20221025,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20221025,,PH,DE,DE,2022,Q4,Elderly
198276412,19827641,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,U,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221017.0,20210914,20221025,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20221025,,PH,DE,DE,2022,Q4,Elderly
198276412,19827641,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,U,,,,,,,,,2022,Q4,Renal impairment,,2022,Q4,2,F,,20221017.0,20210914,20221025,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20221025,,PH,DE,DE,2022,Q4,Elderly
198276412,19827641,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,U,,,,,,,,,2022,Q4,Systemic infection,,2022,Q4,2,F,,20221017.0,20210914,20221025,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20221025,,PH,DE,DE,2022,Q4,Elderly
198276412,19827641,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,U,,,,,,,,,2022,Q4,Musculoskeletal pain,,2022,Q4,2,F,,20221017.0,20210914,20221025,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20221025,,PH,DE,DE,2022,Q4,Elderly
198276412,19827641,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,U,,,,,,,,,2022,Q4,Tachycardia,,2022,Q4,2,F,,20221017.0,20210914,20221025,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20221025,,PH,DE,DE,2022,Q4,Elderly
198276412,19827641,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,U,,,,,,,,,2022,Q4,Condition aggravated,,2022,Q4,2,F,,20221017.0,20210914,20221025,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20221025,,PH,DE,DE,2022,Q4,Elderly
198276412,19827641,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,U,,,,,,,,,2022,Q4,Electrocardiogram abnormal,,2022,Q4,2,F,,20221017.0,20210914,20221025,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20221025,,PH,DE,DE,2022,Q4,Elderly
198276412,19827641,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,U,,,,,,,,,2022,Q4,Tachypnoea,,2022,Q4,2,F,,20221017.0,20210914,20221025,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20221025,,PH,DE,DE,2022,Q4,Elderly
198276412,19827641,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,U,,,,,,,,,2022,Q4,Anaemia,,2022,Q4,2,F,,20221017.0,20210914,20221025,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20221025,,PH,DE,DE,2022,Q4,Elderly
198276412,19827641,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,U,,,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,2,F,,20221017.0,20210914,20221025,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20221025,,PH,DE,DE,2022,Q4,Elderly
198276412,19827641,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,U,,,,,,,,,2022,Q4,Oedema peripheral,,2022,Q4,2,F,,20221017.0,20210914,20221025,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20221025,,PH,DE,DE,2022,Q4,Elderly
198276412,19827641,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,U,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,2,F,,20221017.0,20210914,20221025,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20221025,,PH,DE,DE,2022,Q4,Elderly
198276412,19827641,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,U,,,,,,,,,2022,Q4,Pyrexia,,2022,Q4,2,F,,20221017.0,20210914,20221025,EXP,,NVSC2021DE202906,NOVARTIS,,70.0,YR,,F,Y,,,20221025,,PH,DE,DE,2022,Q4,Elderly
198394162,19839416,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IE, 56-0-36-0",,,U,,,,,50.0,IU,,,2022,Q4,Flank pain,,2022,Q4,2,F,,20221017.0,20210916,20221024,EXP,,NVSC2021DE205364,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198394162,19839416,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IE, 56-0-36-0",,,U,,,,,50.0,IU,,,2022,Q4,Renal colic,,2022,Q4,2,F,,20221017.0,20210916,20221024,EXP,,NVSC2021DE205364,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198394162,19839416,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IE, 56-0-36-0",,,U,,,,,50.0,IU,,,2022,Q4,Renal impairment,,2022,Q4,2,F,,20221017.0,20210916,20221024,EXP,,NVSC2021DE205364,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198394162,19839416,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IE, 56-0-36-0",,,U,,,,,50.0,IU,,,2022,Q4,Urinary tract infection,,2022,Q4,2,F,,20221017.0,20210916,20221024,EXP,,NVSC2021DE205364,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198394162,19839416,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IE, 56-0-36-0",,,U,,,,,50.0,IU,,,2022,Q4,Candida infection,,2022,Q4,2,F,,20221017.0,20210916,20221024,EXP,,NVSC2021DE205364,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198394162,19839416,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IE, 56-0-36-0",,,U,,,,,50.0,IU,,,2022,Q4,Calculus urinary,,2022,Q4,2,F,,20221017.0,20210916,20221024,EXP,,NVSC2021DE205364,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198394162,19839416,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IE, 56-0-36-0",,,U,,,,,50.0,IU,,,2022,Q4,Abdominal pain,,2022,Q4,2,F,,20221017.0,20210916,20221024,EXP,,NVSC2021DE205364,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198394162,19839416,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IE, 56-0-36-0",,,U,,,,,50.0,IU,,,2022,Q4,Postrenal failure,,2022,Q4,2,F,,20221017.0,20210916,20221024,EXP,,NVSC2021DE205364,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198394162,19839416,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IE, 56-0-36-0",,,U,,,,,50.0,IU,,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221017.0,20210916,20221024,EXP,,NVSC2021DE205364,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198394162,19839416,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IE, 56-0-36-0",,,U,,,,,50.0,IU,,,2022,Q4,Weight increased,,2022,Q4,2,F,,20221017.0,20210916,20221024,EXP,,NVSC2021DE205364,NOVARTIS,,73.0,YR,,F,Y,95.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198479155,19847915,21,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Fungaemia,,2022,Q4,5,F,20210829.0,20221104.0,20210917,20221108,EXP,,NVSC2021US209080,NOVARTIS,,64.0,YR,,F,Y,87.3,KG,20221108,,MD,US,US,2022,Q4,Adult
198496322,19849632,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Chills,,2022,Q4,2,F,,20221017.0,20210917,20221027,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20221027,,PH,DE,DE,2022,Q4,Elderly
198496322,19849632,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Renal impairment,,2022,Q4,2,F,,20221017.0,20210917,20221027,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20221027,,PH,DE,DE,2022,Q4,Elderly
198496322,19849632,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221017.0,20210917,20221027,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20221027,,PH,DE,DE,2022,Q4,Elderly
198496322,19849632,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Tachycardia,,2022,Q4,2,F,,20221017.0,20210917,20221027,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20221027,,PH,DE,DE,2022,Q4,Elderly
198496322,19849632,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Pyrexia,,2022,Q4,2,F,,20221017.0,20210917,20221027,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20221027,,PH,DE,DE,2022,Q4,Elderly
198496322,19849632,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Condition aggravated,,2022,Q4,2,F,,20221017.0,20210917,20221027,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20221027,,PH,DE,DE,2022,Q4,Elderly
198496322,19849632,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Tachypnoea,,2022,Q4,2,F,,20221017.0,20210917,20221027,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20221027,,PH,DE,DE,2022,Q4,Elderly
198496322,19849632,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,2,F,,20221017.0,20210917,20221027,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20221027,,PH,DE,DE,2022,Q4,Elderly
198496322,19849632,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,2,F,,20221017.0,20210917,20221027,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20221027,,PH,DE,DE,2022,Q4,Elderly
198496322,19849632,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Anaemia,,2022,Q4,2,F,,20221017.0,20210917,20221027,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20221027,,PH,DE,DE,2022,Q4,Elderly
198496322,19849632,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Constipation,,2022,Q4,2,F,,20221017.0,20210917,20221027,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20221027,,PH,DE,DE,2022,Q4,Elderly
198496322,19849632,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Systemic infection,,2022,Q4,2,F,,20221017.0,20210917,20221027,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20221027,,PH,DE,DE,2022,Q4,Elderly
198496322,19849632,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Sepsis,,2022,Q4,2,F,,20221017.0,20210917,20221027,EXP,DE-ADRED-07152-03,DE-PFIZER INC-202101149149,PFIZER,,69.0,YR,,F,Y,91.0,KG,20221027,,PH,DE,DE,2022,Q4,Elderly
198684492,19868449,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56-0-36-0, humalog mix 50",,,,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221023.0,20210921,20221102,EXP,,DE-TEVA-2021-DE-1955914,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
198684492,19868449,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56-0-36-0, humalog mix 50",,,,,,,,,,,,2022,Q4,Pyrexia,,2022,Q4,2,F,,20221023.0,20210921,20221102,EXP,,DE-TEVA-2021-DE-1955914,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
198684492,19868449,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56-0-36-0, humalog mix 50",,,,,,,,,,,,2022,Q4,Pyelonephritis,,2022,Q4,2,F,,20221023.0,20210921,20221102,EXP,,DE-TEVA-2021-DE-1955914,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
198684492,19868449,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56-0-36-0, humalog mix 50",,,,,,,,,,,,2022,Q4,Renal pain,,2022,Q4,2,F,,20221023.0,20210921,20221102,EXP,,DE-TEVA-2021-DE-1955914,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
198684492,19868449,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56-0-36-0, humalog mix 50",,,,,,,,,,,,2022,Q4,Abdominal pain,,2022,Q4,2,F,,20221023.0,20210921,20221102,EXP,,DE-TEVA-2021-DE-1955914,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
198684492,19868449,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56-0-36-0, humalog mix 50",,,,,,,,,,,,2022,Q4,Condition aggravated,,2022,Q4,2,F,,20221023.0,20210921,20221102,EXP,,DE-TEVA-2021-DE-1955914,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
198684492,19868449,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56-0-36-0, humalog mix 50",,,,,,,,,,,,2022,Q4,Flank pain,,2022,Q4,2,F,,20221023.0,20210921,20221102,EXP,,DE-TEVA-2021-DE-1955914,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
198684492,19868449,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56-0-36-0, humalog mix 50",,,,,,,,,,,,2022,Q4,Urinary tract infection,,2022,Q4,2,F,,20221023.0,20210921,20221102,EXP,,DE-TEVA-2021-DE-1955914,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
198684492,19868449,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50 IU, 56-0-36-0, humalog mix 50",,,,,,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,2,F,,20221023.0,20210921,20221102,EXP,,DE-TEVA-2021-DE-1955914,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
198727532,19872753,2,C,Insulin lispro/Insulin lispro-Isophan,,2,,"50 IE, 56-0-36-0",,,,,,,,,,,,2022,Q4,Urinary tract infection,,2022,Q4,2,F,,20221023.0,20210922,20221102,EXP,,DE-TEVA-2021-DE-1955915,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
198727532,19872753,2,C,Insulin lispro/Insulin lispro-Isophan,,2,,"50 IE, 56-0-36-0",,,,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221023.0,20210922,20221102,EXP,,DE-TEVA-2021-DE-1955915,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
198727532,19872753,2,C,Insulin lispro/Insulin lispro-Isophan,,2,,"50 IE, 56-0-36-0",,,,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,2,F,,20221023.0,20210922,20221102,EXP,,DE-TEVA-2021-DE-1955915,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
198727532,19872753,2,C,Insulin lispro/Insulin lispro-Isophan,,2,,"50 IE, 56-0-36-0",,,,,,,,,,,,2022,Q4,Abdominal pain,,2022,Q4,2,F,,20221023.0,20210922,20221102,EXP,,DE-TEVA-2021-DE-1955915,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
198727532,19872753,2,C,Insulin lispro/Insulin lispro-Isophan,,2,,"50 IE, 56-0-36-0",,,,,,,,,,,,2022,Q4,Renal impairment,,2022,Q4,2,F,,20221023.0,20210922,20221102,EXP,,DE-TEVA-2021-DE-1955915,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
198727532,19872753,2,C,Insulin lispro/Insulin lispro-Isophan,,2,,"50 IE, 56-0-36-0",,,,,,,,,,,,2022,Q4,Postrenal failure,,2022,Q4,2,F,,20221023.0,20210922,20221102,EXP,,DE-TEVA-2021-DE-1955915,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
198727532,19872753,2,C,Insulin lispro/Insulin lispro-Isophan,,2,,"50 IE, 56-0-36-0",,,,,,,,,,,,2022,Q4,Candida infection,,2022,Q4,2,F,,20221023.0,20210922,20221102,EXP,,DE-TEVA-2021-DE-1955915,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
198727532,19872753,2,C,Insulin lispro/Insulin lispro-Isophan,,2,,"50 IE, 56-0-36-0",,,,,,,,,,,,2022,Q4,Calculus urinary,,2022,Q4,2,F,,20221023.0,20210922,20221102,EXP,,DE-TEVA-2021-DE-1955915,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
198727532,19872753,2,C,Insulin lispro/Insulin lispro-Isophan,,2,,"50 IE, 56-0-36-0",,,,,,,,,,,,2022,Q4,Renal colic,,2022,Q4,2,F,,20221023.0,20210922,20221102,EXP,,DE-TEVA-2021-DE-1955915,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
198727532,19872753,2,C,Insulin lispro/Insulin lispro-Isophan,,2,,"50 IE, 56-0-36-0",,,,,,,,,,,,2022,Q4,Flank pain,,2022,Q4,2,F,,20221023.0,20210922,20221102,EXP,,DE-TEVA-2021-DE-1955915,TEVA,,73.0,YR,E,F,Y,95.0,KG,20221102,,PH,DE,DE,2022,Q4,Elderly
198727672,19872767,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IU, 56-0-36-0",,,U,,,,,50.0,IU,,,2022,Q4,Renal failure,,2022,Q4,2,F,,20221017.0,20210922,20221024,EXP,,NVSC2021DE205438,NOVARTIS,,73.0,YR,,F,Y,100.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198727672,19872767,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IU, 56-0-36-0",,,U,,,,,50.0,IU,,,2022,Q4,Vomiting,,2022,Q4,2,F,,20221017.0,20210922,20221024,EXP,,NVSC2021DE205438,NOVARTIS,,73.0,YR,,F,Y,100.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198727672,19872767,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IU, 56-0-36-0",,,U,,,,,50.0,IU,,,2022,Q4,Abdominal pain,,2022,Q4,2,F,,20221017.0,20210922,20221024,EXP,,NVSC2021DE205438,NOVARTIS,,73.0,YR,,F,Y,100.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198727672,19872767,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IU, 56-0-36-0",,,U,,,,,50.0,IU,,,2022,Q4,Flank pain,,2022,Q4,2,F,,20221017.0,20210922,20221024,EXP,,NVSC2021DE205438,NOVARTIS,,73.0,YR,,F,Y,100.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198727672,19872767,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IU, 56-0-36-0",,,U,,,,,50.0,IU,,,2022,Q4,Ureterolithiasis,,2022,Q4,2,F,,20221017.0,20210922,20221024,EXP,,NVSC2021DE205438,NOVARTIS,,73.0,YR,,F,Y,100.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198727672,19872767,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IU, 56-0-36-0",,,U,,,,,50.0,IU,,,2022,Q4,Candida infection,,2022,Q4,2,F,,20221017.0,20210922,20221024,EXP,,NVSC2021DE205438,NOVARTIS,,73.0,YR,,F,Y,100.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198727672,19872767,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IU, 56-0-36-0",,,U,,,,,50.0,IU,,,2022,Q4,Hyperglycaemia,,2022,Q4,2,F,,20221017.0,20210922,20221024,EXP,,NVSC2021DE205438,NOVARTIS,,73.0,YR,,F,Y,100.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198727672,19872767,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IU, 56-0-36-0",,,U,,,,,50.0,IU,,,2022,Q4,Renal impairment,,2022,Q4,2,F,,20221017.0,20210922,20221024,EXP,,NVSC2021DE205438,NOVARTIS,,73.0,YR,,F,Y,100.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198727672,19872767,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IU, 56-0-36-0",,,U,,,,,50.0,IU,,,2022,Q4,Weight increased,,2022,Q4,2,F,,20221017.0,20210922,20221024,EXP,,NVSC2021DE205438,NOVARTIS,,73.0,YR,,F,Y,100.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198727672,19872767,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IU, 56-0-36-0",,,U,,,,,50.0,IU,,,2022,Q4,Urinary tract obstruction,,2022,Q4,2,F,,20221017.0,20210922,20221024,EXP,,NVSC2021DE205438,NOVARTIS,,73.0,YR,,F,Y,100.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198727672,19872767,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IU, 56-0-36-0",,,U,,,,,50.0,IU,,,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,2,F,,20221017.0,20210922,20221024,EXP,,NVSC2021DE205438,NOVARTIS,,73.0,YR,,F,Y,100.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198727672,19872767,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"50 IU, 56-0-36-0",,,U,,,,,50.0,IU,,,2022,Q4,Localised infection,,2022,Q4,2,F,,20221017.0,20210922,20221024,EXP,,NVSC2021DE205438,NOVARTIS,,73.0,YR,,F,Y,100.0,KG,20221024,,PH,DE,DE,2022,Q4,Elderly
198783182,19878318,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, requirement, pre-filled syringes",,,U,,,,,,,,,2022,Q4,Wound dehiscence,,2022,Q4,2,F,20200922.0,20221020.0,20210924,20221028,EXP,,DE-009507513-2109DEU004147,MERCK,,71.0,YR,,M,Y,93.0,KG,20221028,,PH,DE,DE,2022,Q4,Elderly
198783182,19878318,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, requirement, pre-filled syringes",,,U,,,,,,,,,2022,Q4,Foot amputation,,2022,Q4,2,F,20200922.0,20221020.0,20210924,20221028,EXP,,DE-009507513-2109DEU004147,MERCK,,71.0,YR,,M,Y,93.0,KG,20221028,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Cough,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Oedema peripheral,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Atrial fibrillation,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Vomiting,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Tachypnoea,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Hydronephrosis,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Electrocardiogram abnormal,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Dysuria,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Urinary tract infection,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Pyrexia,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Abdominal pain,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Constipation,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Cough,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Oedema peripheral,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Atrial fibrillation,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Vomiting,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Tachypnoea,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Hydronephrosis,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Electrocardiogram abnormal,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Dysuria,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Urinary tract infection,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Pyrexia,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Abdominal pain,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
198839812,19883981,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,40-0-25-0,,,,,,,,,,,,2022,Q4,Constipation,,2022,Q4,2,F,,20221018.0,20210927,20221021,EXP,DE-UCBSA-2021043600,DE-UCBSA-2021043600,UCB,,73.0,YR,,F,Y,95.0,KG,20221021,,PH,DE,DE,2022,Q4,Elderly
199388435,19938843,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Pneumonia,,2022,Q4,5,F,20210808.0,20221027.0,20211011,20221031,EXP,,NVSC2021US181359,NOVARTIS,,67.0,YR,,M,Y,96.0,KG,20221031,,MD,US,US,2022,Q4,Elderly
199436013,19943601,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"nach Schema, Injektions/Infusionslosung",,,U,U,,,,,,Solution for injection,,2022,Q4,General physical health deterioration,,2022,Q4,3,F,,20221031.0,20211012,20221109,EXP,,DE-MYLANLABS-2021M1070354,MYLAN,,78.0,YR,,M,Y,88.4,KG,20221109,,MD,DE,DE,2022,Q4,Elderly
199436013,19943601,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"nach Schema, Injektions/Infusionslosung",,,U,U,,,,,,Solution for injection,,2022,Q4,Medication error,,2022,Q4,3,F,,20221031.0,20211012,20221109,EXP,,DE-MYLANLABS-2021M1070354,MYLAN,,78.0,YR,,M,Y,88.4,KG,20221109,,MD,DE,DE,2022,Q4,Elderly
199436013,19943601,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"nach Schema, Injektions/Infusionslosung",,,U,U,,,,,,Solution for injection,,2022,Q4,Diarrhoea,,2022,Q4,3,F,,20221031.0,20211012,20221109,EXP,,DE-MYLANLABS-2021M1070354,MYLAN,,78.0,YR,,M,Y,88.4,KG,20221109,,MD,DE,DE,2022,Q4,Elderly
199436013,19943601,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"nach Schema, Injektions/Infusionslosung",,,U,U,,,,,,Solution for injection,,2022,Q4,Night sweats,,2022,Q4,3,F,,20221031.0,20211012,20221109,EXP,,DE-MYLANLABS-2021M1070354,MYLAN,,78.0,YR,,M,Y,88.4,KG,20221109,,MD,DE,DE,2022,Q4,Elderly
199436013,19943601,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"nach Schema, Injektions/Infusionslosung",,,U,U,,,,,,Solution for injection,,2022,Q4,Fatigue,,2022,Q4,3,F,,20221031.0,20211012,20221109,EXP,,DE-MYLANLABS-2021M1070354,MYLAN,,78.0,YR,,M,Y,88.4,KG,20221109,,MD,DE,DE,2022,Q4,Elderly
200351082,20035108,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,2,F,,20221206.0,20211104,20221213,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20221213,,PH,DE,DE,2022,Q4,Elderly
200351082,20035108,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,2,F,,20221206.0,20211104,20221213,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20221213,,PH,DE,DE,2022,Q4,Elderly
200351082,20035108,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,,,,,,,,,,2022,Q4,Abdominal pain,,2022,Q4,2,F,,20221206.0,20211104,20221213,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20221213,,PH,DE,DE,2022,Q4,Elderly
200351082,20035108,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,,,,,,,,,,2022,Q4,Hydronephrosis,,2022,Q4,2,F,,20221206.0,20211104,20221213,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20221213,,PH,DE,DE,2022,Q4,Elderly
200351082,20035108,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,,,,,,,,,,2022,Q4,Constipation,,2022,Q4,2,F,,20221206.0,20211104,20221213,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20221213,,PH,DE,DE,2022,Q4,Elderly
200351082,20035108,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,,,,,,,,,,2022,Q4,Tachypnoea,,2022,Q4,2,F,,20221206.0,20211104,20221213,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20221213,,PH,DE,DE,2022,Q4,Elderly
200351082,20035108,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,,,,,,,,,,2022,Q4,Oedema peripheral,,2022,Q4,2,F,,20221206.0,20211104,20221213,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20221213,,PH,DE,DE,2022,Q4,Elderly
200351082,20035108,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,,,,,,,,,,2022,Q4,Cough,,2022,Q4,2,F,,20221206.0,20211104,20221213,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20221213,,PH,DE,DE,2022,Q4,Elderly
200351082,20035108,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,,,,,,,,,,2022,Q4,Urinary tract infection,,2022,Q4,2,F,,20221206.0,20211104,20221213,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20221213,,PH,DE,DE,2022,Q4,Elderly
200351082,20035108,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,,,,,,,,,,2022,Q4,Pyrexia,,2022,Q4,2,F,,20221206.0,20211104,20221213,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20221213,,PH,DE,DE,2022,Q4,Elderly
200351082,20035108,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221206.0,20211104,20221213,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20221213,,PH,DE,DE,2022,Q4,Elderly
200351082,20035108,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,,,,,,,,,,2022,Q4,Dysuria,,2022,Q4,2,F,,20221206.0,20211104,20221213,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20221213,,PH,DE,DE,2022,Q4,Elderly
200351082,20035108,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,,,,,,,,,,2022,Q4,Electrocardiogram abnormal,,2022,Q4,2,F,,20221206.0,20211104,20221213,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20221213,,PH,DE,DE,2022,Q4,Elderly
200351082,20035108,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,,,,,,,,,,2022,Q4,Vomiting,,2022,Q4,2,F,,20221206.0,20211104,20221213,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20221213,,PH,DE,DE,2022,Q4,Elderly
200351082,20035108,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,40-0-25-0,,,,,,,,,,,,2022,Q4,Atrial fibrillation,,2022,Q4,2,F,,20221206.0,20211104,20221213,EXP,,DE-MYLANLABS-2021M1079699,MYLAN,,73.0,YR,,F,Y,95.0,KG,20221213,,PH,DE,DE,2022,Q4,Elderly
200376725,20037672,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U,,,,,,,,,,Injection,TID,2022,Q4,Hyponatraemia,,2022,Q4,5,F,20211025.0,20221117.0,20211105,20221121,EXP,,US-ROCHE-2945935,ROCHE,,74.0,YR,,M,Y,79.0,KG,20221121,,MD,US,,2022,Q4,Elderly
200376725,20037672,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 U,,,,,,,,,,Injection,TID,2022,Q4,Adrenal insufficiency,,2022,Q4,5,F,20211025.0,20221117.0,20211105,20221121,EXP,,US-ROCHE-2945935,ROCHE,,74.0,YR,,M,Y,79.0,KG,20221121,,MD,US,,2022,Q4,Elderly
200755755,20075575,5,C,INSULINE LISPRO,,1,,,,,,,,,,,,,,2022,Q4,Immune-mediated hepatitis,,2022,Q4,5,F,20210923.0,20221005.0,20211116,20221008,EXP,,IT-ROCHE-2952017,ROCHE,,45.0,YR,,F,Y,65.0,KG,20221009,,MD,IT,,2022,Q4,Adult
200829683,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,,,,,,,,,,2022,Q4,Systemic infection,,2022,Q4,3,F,,20221206.0,20211117,20221213,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20221213,,PH,DE,DE,2022,Q4,Elderly
200829683,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,,,,,,,,,,2022,Q4,Renal impairment,,2022,Q4,3,F,,20221206.0,20211117,20221213,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20221213,,PH,DE,DE,2022,Q4,Elderly
200829683,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,,,,,,,,,,2022,Q4,Tachypnoea,,2022,Q4,3,F,,20221206.0,20211117,20221213,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20221213,,PH,DE,DE,2022,Q4,Elderly
200829683,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,,,,,,,,,,2022,Q4,Sepsis,,2022,Q4,3,F,,20221206.0,20211117,20221213,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20221213,,PH,DE,DE,2022,Q4,Elderly
200829683,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,3,F,,20221206.0,20211117,20221213,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20221213,,PH,DE,DE,2022,Q4,Elderly
200829683,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,,,,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,3,F,,20221206.0,20211117,20221213,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20221213,,PH,DE,DE,2022,Q4,Elderly
200829683,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,,,,,,,,,,2022,Q4,Pyrexia,,2022,Q4,3,F,,20221206.0,20211117,20221213,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20221213,,PH,DE,DE,2022,Q4,Elderly
200829683,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,,,,,,,,,,2022,Q4,Tachycardia,,2022,Q4,3,F,,20221206.0,20211117,20221213,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20221213,,PH,DE,DE,2022,Q4,Elderly
200829683,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,,,,,,,,,,2022,Q4,Musculoskeletal pain,,2022,Q4,3,F,,20221206.0,20211117,20221213,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20221213,,PH,DE,DE,2022,Q4,Elderly
200829683,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,,,,,,,,,,2022,Q4,Condition aggravated,,2022,Q4,3,F,,20221206.0,20211117,20221213,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20221213,,PH,DE,DE,2022,Q4,Elderly
200829683,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,,,,,,,,,,2022,Q4,Oedema peripheral,,2022,Q4,3,F,,20221206.0,20211117,20221213,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20221213,,PH,DE,DE,2022,Q4,Elderly
200829683,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,,,,,,,,,,2022,Q4,Anaemia,,2022,Q4,3,F,,20221206.0,20211117,20221213,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20221213,,PH,DE,DE,2022,Q4,Elderly
200829683,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,,,,,,,,,,2022,Q4,Electrocardiogram abnormal,,2022,Q4,3,F,,20221206.0,20211117,20221213,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20221213,,PH,DE,DE,2022,Q4,Elderly
200829683,20082968,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK (Schema),,,,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,3,F,,20221206.0,20211117,20221213,EXP,,DE-MYLANLABS-2021M1084341,MYLAN,,70.0,YR,,F,Y,,,20221213,,PH,DE,DE,2022,Q4,Elderly
200832232,20083223,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (nach Wert),,,U,U,,,,,,Injection,,2022,Q4,Oedema peripheral,,2022,Q4,2,F,,20221207.0,20211117,20221208,EXP,DE-EMA-DD-20210526-Bisht_p-105858,DE-MYLANLABS-2021M1084721,MYLAN,,83.0,YR,,M,Y,,,20221208,,PH,DE,DE,2022,Q4,Elderly
200832232,20083223,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (nach Wert),,,U,U,,,,,,Injection,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221207.0,20211117,20221208,EXP,DE-EMA-DD-20210526-Bisht_p-105858,DE-MYLANLABS-2021M1084721,MYLAN,,83.0,YR,,M,Y,,,20221208,,PH,DE,DE,2022,Q4,Elderly
200832232,20083223,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (nach Wert),,,U,U,,,,,,Injection,,2022,Q4,Weight increased,,2022,Q4,2,F,,20221207.0,20211117,20221208,EXP,DE-EMA-DD-20210526-Bisht_p-105858,DE-MYLANLABS-2021M1084721,MYLAN,,83.0,YR,,M,Y,,,20221208,,PH,DE,DE,2022,Q4,Elderly
200832232,20083223,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK (nach Wert),,,U,U,,,,,,Injection,,2022,Q4,Cough,,2022,Q4,2,F,,20221207.0,20211117,20221208,EXP,DE-EMA-DD-20210526-Bisht_p-105858,DE-MYLANLABS-2021M1084721,MYLAN,,83.0,YR,,M,Y,,,20221208,,PH,DE,DE,2022,Q4,Elderly
201677453,20167745,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 unit/ml,,,,,,,,,,,,2022,Q4,Cardiac failure congestive,,2022,Q4,3,F,20221202.0,20221207.0,20211210,20221216,EXP,,US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-004044,ACADIA PHARMACEUTICALS,,88.0,YR,,M,Y,,,20221216,,CN,US,US,2022,Q4,Elderly
201677453,20167745,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 unit/ml,,,,,,,,,,,,2022,Q4,Peripheral swelling,,2022,Q4,3,F,20221202.0,20221207.0,20211210,20221216,EXP,,US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-004044,ACADIA PHARMACEUTICALS,,88.0,YR,,M,Y,,,20221216,,CN,US,US,2022,Q4,Elderly
201677453,20167745,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,100 unit/ml,,,,,,,,,,,,2022,Q4,Memory impairment,,2022,Q4,3,F,20221202.0,20221207.0,20211210,20221216,EXP,,US-ACADIA PHARMACEUTICALS INC.-ACA-2021-PIM-004044,ACADIA PHARMACEUTICALS,,88.0,YR,,M,Y,,,20221216,,CN,US,US,2022,Q4,Elderly
201945582,20194558,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,U,,,,20563.0,,,,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221014.0,20211216,20221026,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112004938,ELI LILLY AND CO,,82.0,YR,,F,Y,105.0,KG,20221026,,CN,DE,DE,2022,Q4,Elderly
201945582,20194558,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,U,,,,20563.0,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,2,F,,20221014.0,20211216,20221026,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112004938,ELI LILLY AND CO,,82.0,YR,,F,Y,105.0,KG,20221026,,CN,DE,DE,2022,Q4,Elderly
201945582,20194558,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,U,,,,20563.0,,,,,2022,Q4,Atrial fibrillation,,2022,Q4,2,F,,20221014.0,20211216,20221026,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112004938,ELI LILLY AND CO,,82.0,YR,,F,Y,105.0,KG,20221026,,CN,DE,DE,2022,Q4,Elderly
201945582,20194558,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,U,,,,20563.0,,,,,2022,Q4,Oedema peripheral,,2022,Q4,2,F,,20221014.0,20211216,20221026,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112004938,ELI LILLY AND CO,,82.0,YR,,F,Y,105.0,KG,20221026,,CN,DE,DE,2022,Q4,Elderly
201945582,20194558,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,U,,,,20563.0,,,,,2022,Q4,Product dose omission issue,,2022,Q4,2,F,,20221014.0,20211216,20221026,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112004938,ELI LILLY AND CO,,82.0,YR,,F,Y,105.0,KG,20221026,,CN,DE,DE,2022,Q4,Elderly
201945582,20194558,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,U,,,,20563.0,,,,,2022,Q4,Renal impairment,,2022,Q4,2,F,,20221014.0,20211216,20221026,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112004938,ELI LILLY AND CO,,82.0,YR,,F,Y,105.0,KG,20221026,,CN,DE,DE,2022,Q4,Elderly
201945582,20194558,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,U,,,,20563.0,,,,,2022,Q4,Condition aggravated,,2022,Q4,2,F,,20221014.0,20211216,20221026,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112004938,ELI LILLY AND CO,,82.0,YR,,F,Y,105.0,KG,20221026,,CN,DE,DE,2022,Q4,Elderly
201945582,20194558,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,U,,,,20563.0,,,,,2022,Q4,Electrocardiogram abnormal,,2022,Q4,2,F,,20221014.0,20211216,20221026,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112004938,ELI LILLY AND CO,,82.0,YR,,F,Y,105.0,KG,20221026,,CN,DE,DE,2022,Q4,Elderly
201945582,20194558,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, other",,,U,,,,20563.0,,,,,2022,Q4,Product administration error,,2022,Q4,2,F,,20221014.0,20211216,20221026,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112004938,ELI LILLY AND CO,,82.0,YR,,F,Y,105.0,KG,20221026,,CN,DE,DE,2022,Q4,Elderly
201963382,20196338,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, tid",,,U,,,,20563.0,300.0,IU,,TID,2022,Q4,Pain,,2022,Q4,2,F,,20221017.0,20211216,20221028,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112005573,ELI LILLY AND CO,,64.0,YR,,F,Y,63.0,KG,20221028,,CN,DE,DE,2022,Q4,Adult
201963382,20196338,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, tid",,,U,,,,20563.0,300.0,IU,,TID,2022,Q4,Peripheral arterial occlusive disease,,2022,Q4,2,F,,20221017.0,20211216,20221028,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112005573,ELI LILLY AND CO,,64.0,YR,,F,Y,63.0,KG,20221028,,CN,DE,DE,2022,Q4,Adult
201963382,20196338,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, tid",,,U,,,,20563.0,300.0,IU,,TID,2022,Q4,Peripheral coldness,,2022,Q4,2,F,,20221017.0,20211216,20221028,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112005573,ELI LILLY AND CO,,64.0,YR,,F,Y,63.0,KG,20221028,,CN,DE,DE,2022,Q4,Adult
201963382,20196338,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, tid",,,U,,,,20563.0,300.0,IU,,TID,2022,Q4,Pain,,2022,Q4,2,F,,20221017.0,20211216,20221028,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112005573,ELI LILLY AND CO,,64.0,YR,,F,Y,63.0,KG,20221028,,CN,DE,DE,2022,Q4,Adult
201963382,20196338,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 international unit, tid",,,U,,,,20563.0,300.0,IU,,TID,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,2,F,,20221017.0,20211216,20221028,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112005573,ELI LILLY AND CO,,64.0,YR,,F,Y,63.0,KG,20221028,,CN,DE,DE,2022,Q4,Adult
202057292,20205729,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,2,F,,20221014.0,20211220,20221025,EXP,DE-ADRED-07076-01,DE-NOVOPROD-874834,NOVO NORDISK,,82.0,YR,,F,Y,105.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
202057292,20205729,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221014.0,20211220,20221025,EXP,DE-ADRED-07076-01,DE-NOVOPROD-874834,NOVO NORDISK,,82.0,YR,,F,Y,105.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
202057292,20205729,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q4,Oedema peripheral,,2022,Q4,2,F,,20221014.0,20211220,20221025,EXP,DE-ADRED-07076-01,DE-NOVOPROD-874834,NOVO NORDISK,,82.0,YR,,F,Y,105.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
202057292,20205729,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q4,Product dose omission issue,,2022,Q4,2,F,,20221014.0,20211220,20221025,EXP,DE-ADRED-07076-01,DE-NOVOPROD-874834,NOVO NORDISK,,82.0,YR,,F,Y,105.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
202057292,20205729,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q4,Atrial fibrillation,,2022,Q4,2,F,,20221014.0,20211220,20221025,EXP,DE-ADRED-07076-01,DE-NOVOPROD-874834,NOVO NORDISK,,82.0,YR,,F,Y,105.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
202057292,20205729,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q4,Renal impairment,,2022,Q4,2,F,,20221014.0,20211220,20221025,EXP,DE-ADRED-07076-01,DE-NOVOPROD-874834,NOVO NORDISK,,82.0,YR,,F,Y,105.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
202057292,20205729,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q4,Electrocardiogram abnormal,,2022,Q4,2,F,,20221014.0,20211220,20221025,EXP,DE-ADRED-07076-01,DE-NOVOPROD-874834,NOVO NORDISK,,82.0,YR,,F,Y,105.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
202057292,20205729,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q4,Product administration error,,2022,Q4,2,F,,20221014.0,20211220,20221025,EXP,DE-ADRED-07076-01,DE-NOVOPROD-874834,NOVO NORDISK,,82.0,YR,,F,Y,105.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
202057292,20205729,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q4,Treatment noncompliance,,2022,Q4,2,F,,20221014.0,20211220,20221025,EXP,DE-ADRED-07076-01,DE-NOVOPROD-874834,NOVO NORDISK,,82.0,YR,,F,Y,105.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
202057292,20205729,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q4,Condition aggravated,,2022,Q4,2,F,,20221014.0,20211220,20221025,EXP,DE-ADRED-07076-01,DE-NOVOPROD-874834,NOVO NORDISK,,82.0,YR,,F,Y,105.0,KG,20221025,,PH,DE,DE,2022,Q4,Elderly
202062632,20206263,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,D,,,,209196.0,,,,,2022,Q4,Oedema peripheral,,2022,Q4,2,F,,20221019.0,20211220,20221028,EXP,DE-ADRED-07076-01,DE-SA-2021SA419674,SANOFI AVENTIS,,82.0,YR,E,F,Y,105.0,KG,20221028,,PH,DE,DE,2022,Q4,Elderly
202062632,20206263,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,D,,,,209196.0,,,,,2022,Q4,Atrial fibrillation,,2022,Q4,2,F,,20221019.0,20211220,20221028,EXP,DE-ADRED-07076-01,DE-SA-2021SA419674,SANOFI AVENTIS,,82.0,YR,E,F,Y,105.0,KG,20221028,,PH,DE,DE,2022,Q4,Elderly
202062632,20206263,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,D,,,,209196.0,,,,,2022,Q4,Electrocardiogram abnormal,,2022,Q4,2,F,,20221019.0,20211220,20221028,EXP,DE-ADRED-07076-01,DE-SA-2021SA419674,SANOFI AVENTIS,,82.0,YR,E,F,Y,105.0,KG,20221028,,PH,DE,DE,2022,Q4,Elderly
202062632,20206263,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,D,,,,209196.0,,,,,2022,Q4,Product administration error,,2022,Q4,2,F,,20221019.0,20211220,20221028,EXP,DE-ADRED-07076-01,DE-SA-2021SA419674,SANOFI AVENTIS,,82.0,YR,E,F,Y,105.0,KG,20221028,,PH,DE,DE,2022,Q4,Elderly
202062632,20206263,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,D,,,,209196.0,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,2,F,,20221019.0,20211220,20221028,EXP,DE-ADRED-07076-01,DE-SA-2021SA419674,SANOFI AVENTIS,,82.0,YR,E,F,Y,105.0,KG,20221028,,PH,DE,DE,2022,Q4,Elderly
202062632,20206263,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,D,,,,209196.0,,,,,2022,Q4,Product dose omission issue,,2022,Q4,2,F,,20221019.0,20211220,20221028,EXP,DE-ADRED-07076-01,DE-SA-2021SA419674,SANOFI AVENTIS,,82.0,YR,E,F,Y,105.0,KG,20221028,,PH,DE,DE,2022,Q4,Elderly
202062632,20206263,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,D,,,,209196.0,,,,,2022,Q4,Condition aggravated,,2022,Q4,2,F,,20221019.0,20211220,20221028,EXP,DE-ADRED-07076-01,DE-SA-2021SA419674,SANOFI AVENTIS,,82.0,YR,E,F,Y,105.0,KG,20221028,,PH,DE,DE,2022,Q4,Elderly
202062632,20206263,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,D,,,,209196.0,,,,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221019.0,20211220,20221028,EXP,DE-ADRED-07076-01,DE-SA-2021SA419674,SANOFI AVENTIS,,82.0,YR,E,F,Y,105.0,KG,20221028,,PH,DE,DE,2022,Q4,Elderly
202062632,20206263,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,D,,,,209196.0,,,,,2022,Q4,Renal impairment,,2022,Q4,2,F,,20221019.0,20211220,20221028,EXP,DE-ADRED-07076-01,DE-SA-2021SA419674,SANOFI AVENTIS,,82.0,YR,E,F,Y,105.0,KG,20221028,,PH,DE,DE,2022,Q4,Elderly
202108212,20210821,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, TID (300 IE, 1-1-1-0, Injektions-/Infusionsl?sung)",,,U,,,,,300.0,IU,Solution for infusion,TID,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,2,F,,20221017.0,20211221,20221025,EXP,,NVSC2021DE286294,NOVARTIS,,64.0,YR,,F,Y,63.0,KG,20221025,,PH,DE,DE,2022,Q4,Adult
202108212,20210821,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, TID (300 IE, 1-1-1-0, Injektions-/Infusionsl?sung)",,,U,,,,,300.0,IU,Solution for infusion,TID,2022,Q4,Pain,,2022,Q4,2,F,,20221017.0,20211221,20221025,EXP,,NVSC2021DE286294,NOVARTIS,,64.0,YR,,F,Y,63.0,KG,20221025,,PH,DE,DE,2022,Q4,Adult
202108212,20210821,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, TID (300 IE, 1-1-1-0, Injektions-/Infusionsl?sung)",,,U,,,,,300.0,IU,Solution for infusion,TID,2022,Q4,Peripheral coldness,,2022,Q4,2,F,,20221017.0,20211221,20221025,EXP,,NVSC2021DE286294,NOVARTIS,,64.0,YR,,F,Y,63.0,KG,20221025,,PH,DE,DE,2022,Q4,Adult
202108212,20210821,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, TID (300 IE, 1-1-1-0, Injektions-/Infusionsl?sung)",,,U,,,,,300.0,IU,Solution for infusion,TID,2022,Q4,Therapeutic drug monitoring analysis not performed,,2022,Q4,2,F,,20221017.0,20211221,20221025,EXP,,NVSC2021DE286294,NOVARTIS,,64.0,YR,,F,Y,63.0,KG,20221025,,PH,DE,DE,2022,Q4,Adult
202108212,20210821,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, TID (300 IE, 1-1-1-0, Injektions-/Infusionsl?sung)",,,U,,,,,300.0,IU,Solution for infusion,TID,2022,Q4,Peripheral arterial occlusive disease,,2022,Q4,2,F,,20221017.0,20211221,20221025,EXP,,NVSC2021DE286294,NOVARTIS,,64.0,YR,,F,Y,63.0,KG,20221025,,PH,DE,DE,2022,Q4,Adult
202108212,20210821,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, TID (300 IE, 1-1-1-0, Injektions-/Infusionsl?sung)",,,U,,,,,300.0,IU,Solution for infusion,TID,2022,Q4,Pain,,2022,Q4,2,F,,20221017.0,20211221,20221025,EXP,,NVSC2021DE286294,NOVARTIS,,64.0,YR,,F,Y,63.0,KG,20221025,,PH,DE,DE,2022,Q4,Adult
202135392,20213539,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"600|3 IE/ml, 18-24-25-0, Injektions-/Infusionsl?sung",,,U,,,,20563.0,,,,,2022,Q4,Wrong product administered,,2022,Q4,2,F,20210808.0,20221017.0,20211221,20221028,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112006312,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20221028,,CN,DE,DE,2022,Q4,Elderly
202135392,20213539,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"600|3 IE/ml, 18-24-25-0, Injektions-/Infusionsl?sung",,,U,,,,20563.0,,,,,2022,Q4,Anxiety,,2022,Q4,2,F,20210808.0,20221017.0,20211221,20221028,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112006312,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20221028,,CN,DE,DE,2022,Q4,Elderly
202135392,20213539,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"600|3 IE/ml, 18-24-25-0, Injektions-/Infusionsl?sung",,,U,,,,20563.0,,,,,2022,Q4,Hypoglycaemia,,2022,Q4,2,F,20210808.0,20221017.0,20211221,20221028,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202112006312,ELI LILLY AND CO,,73.0,YR,,M,Y,,,20221028,,CN,DE,DE,2022,Q4,Elderly
202141602,20214160,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,18-24-25 iU,,,D,,,,209196.0,,,,,2022,Q4,Hypoglycaemia,,2022,Q4,2,F,20210808.0,20221020.0,20211221,20221101,EXP,DE-ADRED-07410-01,DE-SA-2021SA423163,SANOFI AVENTIS,,73.0,YR,E,M,Y,,,20221101,,MD,DE,DE,2022,Q4,Elderly
202141602,20214160,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,18-24-25 iU,,,D,,,,209196.0,,,,,2022,Q4,Wrong product administered,,2022,Q4,2,F,20210808.0,20221020.0,20211221,20221101,EXP,DE-ADRED-07410-01,DE-SA-2021SA423163,SANOFI AVENTIS,,73.0,YR,E,M,Y,,,20221101,,MD,DE,DE,2022,Q4,Elderly
202141602,20214160,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,18-24-25 iU,,,D,,,,209196.0,,,,,2022,Q4,Fear of disease,,2022,Q4,2,F,20210808.0,20221020.0,20211221,20221101,EXP,DE-ADRED-07410-01,DE-SA-2021SA423163,SANOFI AVENTIS,,73.0,YR,E,M,Y,,,20221101,,MD,DE,DE,2022,Q4,Elderly
202141602,20214160,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,18-24-25 iU,,,D,,,,209196.0,,,,,2022,Q4,Anxiety,,2022,Q4,2,F,20210808.0,20221020.0,20211221,20221101,EXP,DE-ADRED-07410-01,DE-SA-2021SA423163,SANOFI AVENTIS,,73.0,YR,E,M,Y,,,20221101,,MD,DE,DE,2022,Q4,Elderly
202216642,20221664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 international unit (Solution for injection / infusion),,,U,,,,,300.0,IU,,,2022,Q4,Pain,,2022,Q4,2,F,,20221017.0,20211223,20221101,EXP,,DE-AUROBINDO-AUR-APL-2021-052205,AUROBINDO,,64.0,YR,,F,Y,63.0,KG,20221101,,PH,DE,DE,2022,Q4,Adult
202216642,20221664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 international unit (Solution for injection / infusion),,,U,,,,,300.0,IU,,,2022,Q4,Therapeutic drug monitoring analysis not performed,,2022,Q4,2,F,,20221017.0,20211223,20221101,EXP,,DE-AUROBINDO-AUR-APL-2021-052205,AUROBINDO,,64.0,YR,,F,Y,63.0,KG,20221101,,PH,DE,DE,2022,Q4,Adult
202216642,20221664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 international unit (Solution for injection / infusion),,,U,,,,,300.0,IU,,,2022,Q4,Peripheral coldness,,2022,Q4,2,F,,20221017.0,20211223,20221101,EXP,,DE-AUROBINDO-AUR-APL-2021-052205,AUROBINDO,,64.0,YR,,F,Y,63.0,KG,20221101,,PH,DE,DE,2022,Q4,Adult
202216642,20221664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 international unit (Solution for injection / infusion),,,U,,,,,300.0,IU,,,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,2,F,,20221017.0,20211223,20221101,EXP,,DE-AUROBINDO-AUR-APL-2021-052205,AUROBINDO,,64.0,YR,,F,Y,63.0,KG,20221101,,PH,DE,DE,2022,Q4,Adult
202216642,20221664,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,300 international unit (Solution for injection / infusion),,,U,,,,,300.0,IU,,,2022,Q4,Peripheral arterial occlusive disease,,2022,Q4,2,F,,20221017.0,20211223,20221101,EXP,,DE-AUROBINDO-AUR-APL-2021-052205,AUROBINDO,,64.0,YR,,F,Y,63.0,KG,20221101,,PH,DE,DE,2022,Q4,Adult
202474272,20247427,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,900 IU (International Unit) Daily; 1-1-1-0,,,U,,UNKNOWN,,,300.0,IU,Solution for injection/infusion,TID,2022,Q4,Pain,,2022,Q4,2,F,,20221024.0,20211229,20221103,EXP,,DE-TEVA-2021-DE-1992242,TEVA,,64.0,YR,A,F,Y,63.0,KG,20221103,,PH,DE,DE,2022,Q4,Adult
202474272,20247427,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,900 IU (International Unit) Daily; 1-1-1-0,,,U,,UNKNOWN,,,300.0,IU,Solution for injection/infusion,TID,2022,Q4,Peripheral arterial occlusive disease,,2022,Q4,2,F,,20221024.0,20211229,20221103,EXP,,DE-TEVA-2021-DE-1992242,TEVA,,64.0,YR,A,F,Y,63.0,KG,20221103,,PH,DE,DE,2022,Q4,Adult
202474272,20247427,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,900 IU (International Unit) Daily; 1-1-1-0,,,U,,UNKNOWN,,,300.0,IU,Solution for injection/infusion,TID,2022,Q4,Pain,,2022,Q4,2,F,,20221024.0,20211229,20221103,EXP,,DE-TEVA-2021-DE-1992242,TEVA,,64.0,YR,A,F,Y,63.0,KG,20221103,,PH,DE,DE,2022,Q4,Adult
202474272,20247427,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,900 IU (International Unit) Daily; 1-1-1-0,,,U,,UNKNOWN,,,300.0,IU,Solution for injection/infusion,TID,2022,Q4,Peripheral coldness,,2022,Q4,2,F,,20221024.0,20211229,20221103,EXP,,DE-TEVA-2021-DE-1992242,TEVA,,64.0,YR,A,F,Y,63.0,KG,20221103,,PH,DE,DE,2022,Q4,Adult
202474272,20247427,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,900 IU (International Unit) Daily; 1-1-1-0,,,U,,UNKNOWN,,,300.0,IU,Solution for injection/infusion,TID,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,2,F,,20221024.0,20211229,20221103,EXP,,DE-TEVA-2021-DE-1992242,TEVA,,64.0,YR,A,F,Y,63.0,KG,20221103,,PH,DE,DE,2022,Q4,Adult
202474272,20247427,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,900 IU (International Unit) Daily; 1-1-1-0,,,U,,UNKNOWN,,,300.0,IU,Solution for injection/infusion,TID,2022,Q4,Therapeutic drug monitoring analysis not performed,,2022,Q4,2,F,,20221024.0,20211229,20221103,EXP,,DE-TEVA-2021-DE-1992242,TEVA,,64.0,YR,A,F,Y,63.0,KG,20221103,,PH,DE,DE,2022,Q4,Adult
202795852,20279585,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, 1-1-1-0, injection/infusion solution",,,U,U,,,,,,Injection,,2022,Q4,Peripheral coldness,,2022,Q4,2,F,,20221207.0,20220103,20221214,EXP,,DE-MYLANLABS-2021M1096448,MYLAN,,64.0,YR,,F,Y,63.0,KG,20221214,,PH,DE,DE,2022,Q4,Adult
202795852,20279585,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, 1-1-1-0, injection/infusion solution",,,U,U,,,,,,Injection,,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,2,F,,20221207.0,20220103,20221214,EXP,,DE-MYLANLABS-2021M1096448,MYLAN,,64.0,YR,,F,Y,63.0,KG,20221214,,PH,DE,DE,2022,Q4,Adult
202795852,20279585,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, 1-1-1-0, injection/infusion solution",,,U,U,,,,,,Injection,,2022,Q4,Therapeutic drug monitoring analysis not performed,,2022,Q4,2,F,,20221207.0,20220103,20221214,EXP,,DE-MYLANLABS-2021M1096448,MYLAN,,64.0,YR,,F,Y,63.0,KG,20221214,,PH,DE,DE,2022,Q4,Adult
202795852,20279585,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, 1-1-1-0, injection/infusion solution",,,U,U,,,,,,Injection,,2022,Q4,Peripheral arterial occlusive disease,,2022,Q4,2,F,,20221207.0,20220103,20221214,EXP,,DE-MYLANLABS-2021M1096448,MYLAN,,64.0,YR,,F,Y,63.0,KG,20221214,,PH,DE,DE,2022,Q4,Adult
202795852,20279585,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, 1-1-1-0, injection/infusion solution",,,U,U,,,,,,Injection,,2022,Q4,Medication error,,2022,Q4,2,F,,20221207.0,20220103,20221214,EXP,,DE-MYLANLABS-2021M1096448,MYLAN,,64.0,YR,,F,Y,63.0,KG,20221214,,PH,DE,DE,2022,Q4,Adult
202795852,20279585,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU, 1-1-1-0, injection/infusion solution",,,U,U,,,,,,Injection,,2022,Q4,Pain,,2022,Q4,2,F,,20221207.0,20220103,20221214,EXP,,DE-MYLANLABS-2021M1096448,MYLAN,,64.0,YR,,F,Y,63.0,KG,20221214,,PH,DE,DE,2022,Q4,Adult
202922142,20292214,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"14 iU, PRN",,,U,,,,209196.0,14.0,IU,Solution for injection,,2022,Q4,Hypokalaemia,,2022,Q4,2,F,20201105.0,20221115.0,20220104,20221123,EXP,,CA-SA-2021SA433038,SANOFI AVENTIS,,33.0,YR,A,M,Y,,,20221123,,PH,CA,CA,2022,Q4,Young Adult
203041112,20304111,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"By regime, injection solution/infusion solution",,,,,,,,,,Injection,,2022,Q4,Labelled drug-drug interaction medication error,,2022,Q4,2,F,20200630.0,20221205.0,20220106,20221208,EXP,,DE-MYLANLABS-2021M1097721,MYLAN,,67.0,YR,,M,Y,95.0,KG,20221208,,PH,DE,DE,2022,Q4,Elderly
203041112,20304111,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"By regime, injection solution/infusion solution",,,,,,,,,,Injection,,2022,Q4,Melaena,,2022,Q4,2,F,20200630.0,20221205.0,20220106,20221208,EXP,,DE-MYLANLABS-2021M1097721,MYLAN,,67.0,YR,,M,Y,95.0,KG,20221208,,PH,DE,DE,2022,Q4,Elderly
203041112,20304111,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"By regime, injection solution/infusion solution",,,,,,,,,,Injection,,2022,Q4,Gastrointestinal haemorrhage,,2022,Q4,2,F,20200630.0,20221205.0,20220106,20221208,EXP,,DE-MYLANLABS-2021M1097721,MYLAN,,67.0,YR,,M,Y,95.0,KG,20221208,,PH,DE,DE,2022,Q4,Elderly
203041112,20304111,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"By regime, injection solution/infusion solution",,,,,,,,,,Injection,,2022,Q4,Medication error,,2022,Q4,2,F,20200630.0,20221205.0,20220106,20221208,EXP,,DE-MYLANLABS-2021M1097721,MYLAN,,67.0,YR,,M,Y,95.0,KG,20221208,,PH,DE,DE,2022,Q4,Elderly
203041112,20304111,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"By regime, injection solution/infusion solution",,,,,,,,,,Injection,,2022,Q4,Varices oesophageal,,2022,Q4,2,F,20200630.0,20221205.0,20220106,20221208,EXP,,DE-MYLANLABS-2021M1097721,MYLAN,,67.0,YR,,M,Y,95.0,KG,20221208,,PH,DE,DE,2022,Q4,Elderly
203041112,20304111,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"By regime, injection solution/infusion solution",,,,,,,,,,Injection,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,20200630.0,20221205.0,20220106,20221208,EXP,,DE-MYLANLABS-2021M1097721,MYLAN,,67.0,YR,,M,Y,95.0,KG,20221208,,PH,DE,DE,2022,Q4,Elderly
203041112,20304111,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"By regime, injection solution/infusion solution",,,,,,,,,,Injection,,2022,Q4,Haematochezia,,2022,Q4,2,F,20200630.0,20221205.0,20220106,20221208,EXP,,DE-MYLANLABS-2021M1097721,MYLAN,,67.0,YR,,M,Y,95.0,KG,20221208,,PH,DE,DE,2022,Q4,Elderly
203041112,20304111,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"By regime, injection solution/infusion solution",,,,,,,,,,Injection,,2022,Q4,Asthenia,,2022,Q4,2,F,20200630.0,20221205.0,20220106,20221208,EXP,,DE-MYLANLABS-2021M1097721,MYLAN,,67.0,YR,,M,Y,95.0,KG,20221208,,PH,DE,DE,2022,Q4,Elderly
203041112,20304111,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"By regime, injection solution/infusion solution",,,,,,,,,,Injection,,2022,Q4,Shock haemorrhagic,,2022,Q4,2,F,20200630.0,20221205.0,20220106,20221208,EXP,,DE-MYLANLABS-2021M1097721,MYLAN,,67.0,YR,,M,Y,95.0,KG,20221208,,PH,DE,DE,2022,Q4,Elderly
203041112,20304111,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"By regime, injection solution/infusion solution",,,,,,,,,,Injection,,2022,Q4,Angina pectoris,,2022,Q4,2,F,20200630.0,20221205.0,20220106,20221208,EXP,,DE-MYLANLABS-2021M1097721,MYLAN,,67.0,YR,,M,Y,95.0,KG,20221208,,PH,DE,DE,2022,Q4,Elderly
203943662,20394366,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,according to scheme Solution for injection/infusion,,,,,,,,,,,,2022,Q4,Gastrointestinal haemorrhage,,2022,Q4,2,F,20200630.0,20221119.0,20220129,20221202,EXP,DE-BFARM-21011797,DE-Accord-251657,ACCORD,,67.0,YR,E,M,Y,95.0,KG,20221202,,PH,DE,DE,2022,Q4,Elderly
203943662,20394366,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,according to scheme Solution for injection/infusion,,,,,,,,,,,,2022,Q4,Angina pectoris,,2022,Q4,2,F,20200630.0,20221119.0,20220129,20221202,EXP,DE-BFARM-21011797,DE-Accord-251657,ACCORD,,67.0,YR,E,M,Y,95.0,KG,20221202,,PH,DE,DE,2022,Q4,Elderly
203943662,20394366,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,according to scheme Solution for injection/infusion,,,,,,,,,,,,2022,Q4,Varices oesophageal,,2022,Q4,2,F,20200630.0,20221119.0,20220129,20221202,EXP,DE-BFARM-21011797,DE-Accord-251657,ACCORD,,67.0,YR,E,M,Y,95.0,KG,20221202,,PH,DE,DE,2022,Q4,Elderly
203943662,20394366,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,according to scheme Solution for injection/infusion,,,,,,,,,,,,2022,Q4,Medication error,,2022,Q4,2,F,20200630.0,20221119.0,20220129,20221202,EXP,DE-BFARM-21011797,DE-Accord-251657,ACCORD,,67.0,YR,E,M,Y,95.0,KG,20221202,,PH,DE,DE,2022,Q4,Elderly
203943662,20394366,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,according to scheme Solution for injection/infusion,,,,,,,,,,,,2022,Q4,Labelled drug-drug interaction medication error,,2022,Q4,2,F,20200630.0,20221119.0,20220129,20221202,EXP,DE-BFARM-21011797,DE-Accord-251657,ACCORD,,67.0,YR,E,M,Y,95.0,KG,20221202,,PH,DE,DE,2022,Q4,Elderly
203943662,20394366,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,according to scheme Solution for injection/infusion,,,,,,,,,,,,2022,Q4,Melaena,,2022,Q4,2,F,20200630.0,20221119.0,20220129,20221202,EXP,DE-BFARM-21011797,DE-Accord-251657,ACCORD,,67.0,YR,E,M,Y,95.0,KG,20221202,,PH,DE,DE,2022,Q4,Elderly
203943662,20394366,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,according to scheme Solution for injection/infusion,,,,,,,,,,,,2022,Q4,Haematochezia,,2022,Q4,2,F,20200630.0,20221119.0,20220129,20221202,EXP,DE-BFARM-21011797,DE-Accord-251657,ACCORD,,67.0,YR,E,M,Y,95.0,KG,20221202,,PH,DE,DE,2022,Q4,Elderly
203943662,20394366,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,according to scheme Solution for injection/infusion,,,,,,,,,,,,2022,Q4,Asthenia,,2022,Q4,2,F,20200630.0,20221119.0,20220129,20221202,EXP,DE-BFARM-21011797,DE-Accord-251657,ACCORD,,67.0,YR,E,M,Y,95.0,KG,20221202,,PH,DE,DE,2022,Q4,Elderly
203943662,20394366,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,according to scheme Solution for injection/infusion,,,,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,20200630.0,20221119.0,20220129,20221202,EXP,DE-BFARM-21011797,DE-Accord-251657,ACCORD,,67.0,YR,E,M,Y,95.0,KG,20221202,,PH,DE,DE,2022,Q4,Elderly
203943662,20394366,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,according to scheme Solution for injection/infusion,,,,,,,,,,,,2022,Q4,Shock haemorrhagic,,2022,Q4,2,F,20200630.0,20221119.0,20220129,20221202,EXP,DE-BFARM-21011797,DE-Accord-251657,ACCORD,,67.0,YR,E,M,Y,95.0,KG,20221202,,PH,DE,DE,2022,Q4,Elderly
204126142,20412614,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, tid (6/8/8 UI three times a day)",,,,,,,,,,,TID,2022,Q4,Off label use,,2022,Q4,2,F,,20221129.0,20220201,20221210,PER,,IT-LUPIN PHARMACEUTICALS INC.-2022-01077,LUPIN,"Ianniciello A, Attena E, Uccello A, Caso VM, Golino P, Russo V. Myocardial infarcion and ischaemic stroke in a COVID-19 patient: Nothing happens by chance. European Heart Journal Supplements. 2021;23:1-2",68.0,YR,,M,Y,,,20221210,,HP,IT,IT,2022,Q4,Elderly
205210225,20521022,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Type 1 diabetes mellitus,,2022,Q4,5,F,20220222.0,20221220.0,20220225,20221220,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-027172,BRISTOL MYERS SQUIBB,,63.0,YR,A,M,Y,,,20221220,,HP,DE,DE,2022,Q4,Adult
205210225,20521022,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Peripheral motor neuropathy,,2022,Q4,5,F,20220222.0,20221220.0,20220225,20221220,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-BMS-2022-027172,BRISTOL MYERS SQUIBB,,63.0,YR,A,M,Y,,,20221220,,HP,DE,DE,2022,Q4,Adult
205288662,20528866,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q4,Chest discomfort,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q4,Obstructive airways disorder,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q4,Discomfort,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q4,Diaphragmatic disorder,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q4,Hypoxia,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q4,Pyrexia,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q4,Weight increased,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q4,Full blood count abnormal,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q4,Therapeutic product effect incomplete,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q4,Oedema peripheral,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q4,Oropharyngeal pain,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q4,Left ventricular hypertrophy,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q4,Cough,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q4,Wheezing,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q4,Dyspnoea,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 dosage form, qd (1 every 1 Days)",,,,,,,,,,,QD,2022,Q4,Asthma,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 every 1 Day,,,,,,,,,,,BID,2022,Q4,Chest discomfort,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 every 1 Day,,,,,,,,,,,BID,2022,Q4,Obstructive airways disorder,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 every 1 Day,,,,,,,,,,,BID,2022,Q4,Discomfort,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 every 1 Day,,,,,,,,,,,BID,2022,Q4,Diaphragmatic disorder,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 every 1 Day,,,,,,,,,,,BID,2022,Q4,Hypoxia,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 every 1 Day,,,,,,,,,,,BID,2022,Q4,Pyrexia,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 every 1 Day,,,,,,,,,,,BID,2022,Q4,Weight increased,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 every 1 Day,,,,,,,,,,,BID,2022,Q4,Full blood count abnormal,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 every 1 Day,,,,,,,,,,,BID,2022,Q4,Therapeutic product effect incomplete,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 every 1 Day,,,,,,,,,,,BID,2022,Q4,Oedema peripheral,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 every 1 Day,,,,,,,,,,,BID,2022,Q4,Oropharyngeal pain,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 every 1 Day,,,,,,,,,,,BID,2022,Q4,Left ventricular hypertrophy,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 every 1 Day,,,,,,,,,,,BID,2022,Q4,Cough,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 every 1 Day,,,,,,,,,,,BID,2022,Q4,Wheezing,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 every 1 Day,,,,,,,,,,,BID,2022,Q4,Dyspnoea,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205288662,20528866,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 every 1 Day,,,,,,,,,,,BID,2022,Q4,Asthma,,2022,Q4,2,F,,20221212.0,20220228,20221216,EXP,,CA-ORGANON-2005CAN002517,ORGANON,,83.0,YR,,M,Y,100.0,KG,20221216,,CN,CA,CA,2022,Q4,Elderly
205469733,20546973,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,Solution for injection,,2022,Q4,Amyloidosis,,2022,Q4,3,F,,20221031.0,20220303,20221104,EXP,,FR-MYLANLABS-2022M1016185,MYLAN,"Vuillamy C, Arnault J, Attencourt C, Dadban A, Joachim C, Chaby G et al.. Simultaneous occurrence of insulin-derived amyloidosis and acanthosis nigricans at the abdominal site of insulin injection. JAAD Case Reports. 2022;19:94-96",68.0,YR,,F,Y,,,20221104,,MD,FR,FR,2022,Q4,Elderly
205469733,20546973,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,Solution for injection,,2022,Q4,Papilloma,,2022,Q4,3,F,,20221031.0,20220303,20221104,EXP,,FR-MYLANLABS-2022M1016185,MYLAN,"Vuillamy C, Arnault J, Attencourt C, Dadban A, Joachim C, Chaby G et al.. Simultaneous occurrence of insulin-derived amyloidosis and acanthosis nigricans at the abdominal site of insulin injection. JAAD Case Reports. 2022;19:94-96",68.0,YR,,F,Y,,,20221104,,MD,FR,FR,2022,Q4,Elderly
205469733,20546973,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,Solution for injection,,2022,Q4,Injection site plaque,,2022,Q4,3,F,,20221031.0,20220303,20221104,EXP,,FR-MYLANLABS-2022M1016185,MYLAN,"Vuillamy C, Arnault J, Attencourt C, Dadban A, Joachim C, Chaby G et al.. Simultaneous occurrence of insulin-derived amyloidosis and acanthosis nigricans at the abdominal site of insulin injection. JAAD Case Reports. 2022;19:94-96",68.0,YR,,F,Y,,,20221104,,MD,FR,FR,2022,Q4,Elderly
205469733,20546973,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,Solution for injection,,2022,Q4,Acanthosis nigricans,,2022,Q4,3,F,,20221031.0,20220303,20221104,EXP,,FR-MYLANLABS-2022M1016185,MYLAN,"Vuillamy C, Arnault J, Attencourt C, Dadban A, Joachim C, Chaby G et al.. Simultaneous occurrence of insulin-derived amyloidosis and acanthosis nigricans at the abdominal site of insulin injection. JAAD Case Reports. 2022;19:94-96",68.0,YR,,F,Y,,,20221104,,MD,FR,FR,2022,Q4,Elderly
205469733,20546973,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,Solution for injection,,2022,Q4,Hyperkeratosis,,2022,Q4,3,F,,20221031.0,20220303,20221104,EXP,,FR-MYLANLABS-2022M1016185,MYLAN,"Vuillamy C, Arnault J, Attencourt C, Dadban A, Joachim C, Chaby G et al.. Simultaneous occurrence of insulin-derived amyloidosis and acanthosis nigricans at the abdominal site of insulin injection. JAAD Case Reports. 2022;19:94-96",68.0,YR,,F,Y,,,20221104,,MD,FR,FR,2022,Q4,Elderly
205469733,20546973,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,Solution for injection,,2022,Q4,Therapy non-responder,,2022,Q4,3,F,,20221031.0,20220303,20221104,EXP,,FR-MYLANLABS-2022M1016185,MYLAN,"Vuillamy C, Arnault J, Attencourt C, Dadban A, Joachim C, Chaby G et al.. Simultaneous occurrence of insulin-derived amyloidosis and acanthosis nigricans at the abdominal site of insulin injection. JAAD Case Reports. 2022;19:94-96",68.0,YR,,F,Y,,,20221104,,MD,FR,FR,2022,Q4,Elderly
205469733,20546973,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,Solution for injection,,2022,Q4,Injection site induration,,2022,Q4,3,F,,20221031.0,20220303,20221104,EXP,,FR-MYLANLABS-2022M1016185,MYLAN,"Vuillamy C, Arnault J, Attencourt C, Dadban A, Joachim C, Chaby G et al.. Simultaneous occurrence of insulin-derived amyloidosis and acanthosis nigricans at the abdominal site of insulin injection. JAAD Case Reports. 2022;19:94-96",68.0,YR,,F,Y,,,20221104,,MD,FR,FR,2022,Q4,Elderly
205469733,20546973,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,Solution for injection,,2022,Q4,Injection site reaction,,2022,Q4,3,F,,20221031.0,20220303,20221104,EXP,,FR-MYLANLABS-2022M1016185,MYLAN,"Vuillamy C, Arnault J, Attencourt C, Dadban A, Joachim C, Chaby G et al.. Simultaneous occurrence of insulin-derived amyloidosis and acanthosis nigricans at the abdominal site of insulin injection. JAAD Case Reports. 2022;19:94-96",68.0,YR,,F,Y,,,20221104,,MD,FR,FR,2022,Q4,Elderly
205469733,20546973,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,Solution for injection,,2022,Q4,Acanthosis,,2022,Q4,3,F,,20221031.0,20220303,20221104,EXP,,FR-MYLANLABS-2022M1016185,MYLAN,"Vuillamy C, Arnault J, Attencourt C, Dadban A, Joachim C, Chaby G et al.. Simultaneous occurrence of insulin-derived amyloidosis and acanthosis nigricans at the abdominal site of insulin injection. JAAD Case Reports. 2022;19:94-96",68.0,YR,,F,Y,,,20221104,,MD,FR,FR,2022,Q4,Elderly
205469733,20546973,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,U,,,,,,Solution for injection,,2022,Q4,Injection site discolouration,,2022,Q4,3,F,,20221031.0,20220303,20221104,EXP,,FR-MYLANLABS-2022M1016185,MYLAN,"Vuillamy C, Arnault J, Attencourt C, Dadban A, Joachim C, Chaby G et al.. Simultaneous occurrence of insulin-derived amyloidosis and acanthosis nigricans at the abdominal site of insulin injection. JAAD Case Reports. 2022;19:94-96",68.0,YR,,F,Y,,,20221104,,MD,FR,FR,2022,Q4,Elderly
206160814,20616081,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q4,Toxic epidermal necrolysis,,2022,Q4,4,F,20220120.0,20221215.0,20220321,20221221,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,,71.0,YR,,M,Y,,,20221221,,MD,JP,JP,2022,Q4,Elderly
206160814,20616081,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q4,Renal failure,,2022,Q4,4,F,20220120.0,20221215.0,20220321,20221221,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,,71.0,YR,,M,Y,,,20221221,,MD,JP,JP,2022,Q4,Elderly
206160814,20616081,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q4,Myelosuppression,,2022,Q4,4,F,20220120.0,20221215.0,20220321,20221221,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,,71.0,YR,,M,Y,,,20221221,,MD,JP,JP,2022,Q4,Elderly
206160814,20616081,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q4,Oral candidiasis,,2022,Q4,4,F,20220120.0,20221215.0,20220321,20221221,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,,71.0,YR,,M,Y,,,20221221,,MD,JP,JP,2022,Q4,Elderly
206160814,20616081,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q4,Multiple organ dysfunction syndrome,,2022,Q4,4,F,20220120.0,20221215.0,20220321,20221221,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,,71.0,YR,,M,Y,,,20221221,,MD,JP,JP,2022,Q4,Elderly
206160814,20616081,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown freq.",,,,,,,,,,Formulation unknown,,2022,Q4,Hyperglycaemia,,2022,Q4,4,F,20220120.0,20221215.0,20220321,20221221,EXP,,JP-ASTELLAS-2022JP001091,ASTELLAS,,71.0,YR,,M,Y,,,20221221,,MD,JP,JP,2022,Q4,Elderly
206318772,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q4,Pericardial effusion,,2022,Q4,2,F,,20221020.0,20220324,20221101,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221101,,CN,CA,CA,2022,Q4,Adult
206318772,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q4,Blood glucose increased,,2022,Q4,2,F,,20221020.0,20220324,20221101,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221101,,CN,CA,CA,2022,Q4,Adult
206318772,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q4,Neuropathy peripheral,,2022,Q4,2,F,,20221020.0,20220324,20221101,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221101,,CN,CA,CA,2022,Q4,Adult
206318772,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q4,Malnutrition,,2022,Q4,2,F,,20221020.0,20220324,20221101,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221101,,CN,CA,CA,2022,Q4,Adult
206318772,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q4,Eye haemorrhage,,2022,Q4,2,F,,20221020.0,20220324,20221101,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221101,,CN,CA,CA,2022,Q4,Adult
206318772,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q4,Diarrhoea,,2022,Q4,2,F,,20221020.0,20220324,20221101,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221101,,CN,CA,CA,2022,Q4,Adult
206318772,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q4,Chest pain,,2022,Q4,2,F,,20221020.0,20220324,20221101,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221101,,CN,CA,CA,2022,Q4,Adult
206318772,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q4,Abdominal pain upper,,2022,Q4,2,F,,20221020.0,20220324,20221101,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221101,,CN,CA,CA,2022,Q4,Adult
206318772,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q4,Headache,,2022,Q4,2,F,,20221020.0,20220324,20221101,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221101,,CN,CA,CA,2022,Q4,Adult
206318772,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q4,Multi-organ disorder,,2022,Q4,2,F,,20221020.0,20220324,20221101,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221101,,CN,CA,CA,2022,Q4,Adult
206318772,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q4,Weight decreased,,2022,Q4,2,F,,20221020.0,20220324,20221101,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221101,,CN,CA,CA,2022,Q4,Adult
206318772,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q4,Thyroid disorder,,2022,Q4,2,F,,20221020.0,20220324,20221101,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221101,,CN,CA,CA,2022,Q4,Adult
206318772,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q4,Myalgia,,2022,Q4,2,F,,20221020.0,20220324,20221101,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221101,,CN,CA,CA,2022,Q4,Adult
206318772,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q4,Pulmonary oedema,,2022,Q4,2,F,,20221020.0,20220324,20221101,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221101,,CN,CA,CA,2022,Q4,Adult
206318772,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q4,Arthritis,,2022,Q4,2,F,,20221020.0,20220324,20221101,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221101,,CN,CA,CA,2022,Q4,Adult
206318772,20631877,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q4,Cardiac failure congestive,,2022,Q4,2,F,,20221020.0,20220324,20221101,EXP,,CA-SA-2022SA092457,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221101,,CN,CA,CA,2022,Q4,Adult
206917473,20691747,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,Injection,,2022,Q4,Hypopituitarism,,2022,Q4,3,F,20211215.0,20221110.0,20220408,20221118,EXP,,JP-009507513-2203JPN001295J,MERCK,"Onoyama I. O46-4 Uterus, chemotherapy and immunotherapy; two cases of corpus uteri carcinoma in which ACTH deficiency developed during treatment with pembrolizumab. The 60th Annual Meeting of Japan Society of Clinical Oncology. 2022",56.0,YR,,F,Y,51.0,KG,20221118,,MD,JP,JP,2022,Q4,Adult
206917473,20691747,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,Injection,,2022,Q4,Adrenal insufficiency,,2022,Q4,3,F,20211215.0,20221110.0,20220408,20221118,EXP,,JP-009507513-2203JPN001295J,MERCK,"Onoyama I. O46-4 Uterus, chemotherapy and immunotherapy; two cases of corpus uteri carcinoma in which ACTH deficiency developed during treatment with pembrolizumab. The 60th Annual Meeting of Japan Society of Clinical Oncology. 2022",56.0,YR,,F,Y,51.0,KG,20221118,,MD,JP,JP,2022,Q4,Adult
206917473,20691747,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,Injection,,2022,Q4,Secondary adrenocortical insufficiency,,2022,Q4,3,F,20211215.0,20221110.0,20220408,20221118,EXP,,JP-009507513-2203JPN001295J,MERCK,"Onoyama I. O46-4 Uterus, chemotherapy and immunotherapy; two cases of corpus uteri carcinoma in which ACTH deficiency developed during treatment with pembrolizumab. The 60th Annual Meeting of Japan Society of Clinical Oncology. 2022",56.0,YR,,F,Y,51.0,KG,20221118,,MD,JP,JP,2022,Q4,Adult
206917473,20691747,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,Injection,,2022,Q4,Hyperkalaemia,,2022,Q4,3,F,20211215.0,20221110.0,20220408,20221118,EXP,,JP-009507513-2203JPN001295J,MERCK,"Onoyama I. O46-4 Uterus, chemotherapy and immunotherapy; two cases of corpus uteri carcinoma in which ACTH deficiency developed during treatment with pembrolizumab. The 60th Annual Meeting of Japan Society of Clinical Oncology. 2022",56.0,YR,,F,Y,51.0,KG,20221118,,MD,JP,JP,2022,Q4,Adult
206917473,20691747,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,Injection,,2022,Q4,Adrenocorticotropic hormone deficiency,,2022,Q4,3,F,20211215.0,20221110.0,20220408,20221118,EXP,,JP-009507513-2203JPN001295J,MERCK,"Onoyama I. O46-4 Uterus, chemotherapy and immunotherapy; two cases of corpus uteri carcinoma in which ACTH deficiency developed during treatment with pembrolizumab. The 60th Annual Meeting of Japan Society of Clinical Oncology. 2022",56.0,YR,,F,Y,51.0,KG,20221118,,MD,JP,JP,2022,Q4,Adult
206917473,20691747,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,Injection,,2022,Q4,Dehydration,,2022,Q4,3,F,20211215.0,20221110.0,20220408,20221118,EXP,,JP-009507513-2203JPN001295J,MERCK,"Onoyama I. O46-4 Uterus, chemotherapy and immunotherapy; two cases of corpus uteri carcinoma in which ACTH deficiency developed during treatment with pembrolizumab. The 60th Annual Meeting of Japan Society of Clinical Oncology. 2022",56.0,YR,,F,Y,51.0,KG,20221118,,MD,JP,JP,2022,Q4,Adult
207215592,20721559,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Low Dose,,,,,,,,,,,Q4H,2022,Q4,Slow speech,,2022,Q4,2,F,20200101.0,20221116.0,20220418,20221122,EXP,,US-BAUSCH-BL-2020-012298,BAUSCH AND LOMB,,68.0,YR,,F,Y,,,20221122,,CN,US,US,2022,Q4,Elderly
207215592,20721559,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Low Dose,,,,,,,,,,,Q4H,2022,Q4,Therapy cessation,,2022,Q4,2,F,20200101.0,20221116.0,20220418,20221122,EXP,,US-BAUSCH-BL-2020-012298,BAUSCH AND LOMB,,68.0,YR,,F,Y,,,20221122,,CN,US,US,2022,Q4,Elderly
207215592,20721559,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Low Dose,,,,,,,,,,,Q4H,2022,Q4,Confusional state,,2022,Q4,2,F,20200101.0,20221116.0,20220418,20221122,EXP,,US-BAUSCH-BL-2020-012298,BAUSCH AND LOMB,,68.0,YR,,F,Y,,,20221122,,CN,US,US,2022,Q4,Elderly
207215592,20721559,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Low Dose,,,,,,,,,,,Q4H,2022,Q4,Mental status changes,,2022,Q4,2,F,20200101.0,20221116.0,20220418,20221122,EXP,,US-BAUSCH-BL-2020-012298,BAUSCH AND LOMB,,68.0,YR,,F,Y,,,20221122,,CN,US,US,2022,Q4,Elderly
207215592,20721559,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Low Dose,,,,,,,,,,,Q4H,2022,Q4,Liver transplant,,2022,Q4,2,F,20200101.0,20221116.0,20220418,20221122,EXP,,US-BAUSCH-BL-2020-012298,BAUSCH AND LOMB,,68.0,YR,,F,Y,,,20221122,,CN,US,US,2022,Q4,Elderly
207215592,20721559,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Low Dose,,,,,,,,,,,Q4H,2022,Q4,Bradyphrenia,,2022,Q4,2,F,20200101.0,20221116.0,20220418,20221122,EXP,,US-BAUSCH-BL-2020-012298,BAUSCH AND LOMB,,68.0,YR,,F,Y,,,20221122,,CN,US,US,2022,Q4,Elderly
207215592,20721559,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Low Dose,,,,,,,,,,,Q4H,2022,Q4,Constipation,,2022,Q4,2,F,20200101.0,20221116.0,20220418,20221122,EXP,,US-BAUSCH-BL-2020-012298,BAUSCH AND LOMB,,68.0,YR,,F,Y,,,20221122,,CN,US,US,2022,Q4,Elderly
207215592,20721559,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Low Dose,,,,,,,,,,,Q4H,2022,Q4,Intentional product use issue,,2022,Q4,2,F,20200101.0,20221116.0,20220418,20221122,EXP,,US-BAUSCH-BL-2020-012298,BAUSCH AND LOMB,,68.0,YR,,F,Y,,,20221122,,CN,US,US,2022,Q4,Elderly
207215592,20721559,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Low Dose,,,,,,,,,,,Q4H,2022,Q4,Insurance issue,,2022,Q4,2,F,20200101.0,20221116.0,20220418,20221122,EXP,,US-BAUSCH-BL-2020-012298,BAUSCH AND LOMB,,68.0,YR,,F,Y,,,20221122,,CN,US,US,2022,Q4,Elderly
207215592,20721559,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Low Dose,,,,,,,,,,,Q4H,2022,Q4,Liver disorder,,2022,Q4,2,F,20200101.0,20221116.0,20220418,20221122,EXP,,US-BAUSCH-BL-2020-012298,BAUSCH AND LOMB,,68.0,YR,,F,Y,,,20221122,,CN,US,US,2022,Q4,Elderly
207215592,20721559,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Low Dose,,,,,,,,,,,Q4H,2022,Q4,Gait disturbance,,2022,Q4,2,F,20200101.0,20221116.0,20220418,20221122,EXP,,US-BAUSCH-BL-2020-012298,BAUSCH AND LOMB,,68.0,YR,,F,Y,,,20221122,,CN,US,US,2022,Q4,Elderly
207215592,20721559,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Low Dose,,,,,,,,,,,Q4H,2022,Q4,Ammonia increased,,2022,Q4,2,F,20200101.0,20221116.0,20220418,20221122,EXP,,US-BAUSCH-BL-2020-012298,BAUSCH AND LOMB,,68.0,YR,,F,Y,,,20221122,,CN,US,US,2022,Q4,Elderly
207292135,20729213,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Abdominal pain,,2022,Q4,5,F,20210310.0,20221027.0,20220420,20221031,EXP,,NVSC2021US057591,NOVARTIS,,62.0,YR,,M,Y,70.9,KG,20221031,,MD,US,US,2022,Q4,Adult
207292135,20729213,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Incisional hernia,,2022,Q4,5,F,20210310.0,20221027.0,20220420,20221031,EXP,,NVSC2021US057591,NOVARTIS,,62.0,YR,,M,Y,70.9,KG,20221031,,MD,US,US,2022,Q4,Adult
207292135,20729213,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Ileus,,2022,Q4,5,F,20210310.0,20221027.0,20220420,20221031,EXP,,NVSC2021US057591,NOVARTIS,,62.0,YR,,M,Y,70.9,KG,20221031,,MD,US,US,2022,Q4,Adult
207292135,20729213,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Enterococcal infection,,2022,Q4,5,F,20210310.0,20221027.0,20220420,20221031,EXP,,NVSC2021US057591,NOVARTIS,,62.0,YR,,M,Y,70.9,KG,20221031,,MD,US,US,2022,Q4,Adult
207435072,20743507,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 iU, according to plan",,,,,,,,100.0,IU,,,2022,Q4,Gastrointestinal haemorrhage,,2022,Q4,2,F,20220301.0,20221124.0,20220425,20221202,EXP,,DE-PFIZER INC-202200558600,PFIZER,,83.0,YR,,M,Y,87.0,KG,20221202,,MD,DE,DE,2022,Q4,Elderly
207435072,20743507,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 iU, according to plan",,,,,,,,100.0,IU,,,2022,Q4,Protein deficiency,,2022,Q4,2,F,20220301.0,20221124.0,20220425,20221202,EXP,,DE-PFIZER INC-202200558600,PFIZER,,83.0,YR,,M,Y,87.0,KG,20221202,,MD,DE,DE,2022,Q4,Elderly
207435072,20743507,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 iU, according to plan",,,,,,,,100.0,IU,,,2022,Q4,Anal haemorrhage,,2022,Q4,2,F,20220301.0,20221124.0,20220425,20221202,EXP,,DE-PFIZER INC-202200558600,PFIZER,,83.0,YR,,M,Y,87.0,KG,20221202,,MD,DE,DE,2022,Q4,Elderly
207435072,20743507,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 iU, according to plan",,,,,,,,100.0,IU,,,2022,Q4,Nausea,,2022,Q4,2,F,20220301.0,20221124.0,20220425,20221202,EXP,,DE-PFIZER INC-202200558600,PFIZER,,83.0,YR,,M,Y,87.0,KG,20221202,,MD,DE,DE,2022,Q4,Elderly
207435072,20743507,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 iU, according to plan",,,,,,,,100.0,IU,,,2022,Q4,Oedema peripheral,,2022,Q4,2,F,20220301.0,20221124.0,20220425,20221202,EXP,,DE-PFIZER INC-202200558600,PFIZER,,83.0,YR,,M,Y,87.0,KG,20221202,,MD,DE,DE,2022,Q4,Elderly
207435072,20743507,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 iU, according to plan",,,,,,,,100.0,IU,,,2022,Q4,Diarrhoea,,2022,Q4,2,F,20220301.0,20221124.0,20220425,20221202,EXP,,DE-PFIZER INC-202200558600,PFIZER,,83.0,YR,,M,Y,87.0,KG,20221202,,MD,DE,DE,2022,Q4,Elderly
207435072,20743507,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 iU, according to plan",,,,,,,,100.0,IU,,,2022,Q4,Off label use,,2022,Q4,2,F,20220301.0,20221124.0,20220425,20221202,EXP,,DE-PFIZER INC-202200558600,PFIZER,,83.0,YR,,M,Y,87.0,KG,20221202,,MD,DE,DE,2022,Q4,Elderly
207435072,20743507,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100 iU, according to plan",,,,,,,,100.0,IU,,,2022,Q4,Hypochromic anaemia,,2022,Q4,2,F,20220301.0,20221124.0,20220425,20221202,EXP,,DE-PFIZER INC-202200558600,PFIZER,,83.0,YR,,M,Y,87.0,KG,20221202,,MD,DE,DE,2022,Q4,Elderly
207491275,20749127,112,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q4hr",,,,,,,,,,,Q4H,2022,Q4,Hypercapnia,,2022,Q4,5,F,20220226.0,20221214.0,20220426,20221219,EXP,,US-TAKEDA-2022TUS025564,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20221219,,MD,US,US,2022,Q4,Elderly
207491275,20749127,112,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q4hr",,,,,,,,,,,Q4H,2022,Q4,Bacteraemia,,2022,Q4,5,F,20220226.0,20221214.0,20220426,20221219,EXP,,US-TAKEDA-2022TUS025564,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20221219,,MD,US,US,2022,Q4,Elderly
207491275,20749127,112,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q4hr",,,,,,,,,,,Q4H,2022,Q4,Long QT syndrome,,2022,Q4,5,F,20220226.0,20221214.0,20220426,20221219,EXP,,US-TAKEDA-2022TUS025564,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20221219,,MD,US,US,2022,Q4,Elderly
207491275,20749127,112,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, q4hr",,,,,,,,,,,Q4H,2022,Q4,Hypokalaemia,,2022,Q4,5,F,20220226.0,20221214.0,20220426,20221219,EXP,,US-TAKEDA-2022TUS025564,TAKEDA,,70.0,YR,,F,Y,29.0,KG,20221219,,MD,US,US,2022,Q4,Elderly
2076411210,20764112,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,12.0,IU,Solution for injection/infusion,,2022,Q4,Ischaemic stroke,,2022,Q4,10,F,20220419.0,20221122.0,20220428,20221128,PER,,RU-Eisai Medical Research-EC-2022-113891,EISAI,,59.0,YR,A,F,Y,93.5,KG,20221128,,MD,RU,,2022,Q4,Adult
208517582,20851758,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, q.4h.",,,D,,,,,,,,Q4H,2022,Q4,Meningitis aseptic,,2022,Q4,2,F,,20221129.0,20220520,20221208,EXP,,US-APOTEX-2022AP007799,APOTEX,"Vickery PB, Roach JK, Vickery S.. A Case of Possible Levetiracetam Induced Aseptic Meningitis vs Viral Meningitis.. CNS-Spectrums. 2022;27 (2):231-232",54.0,YR,,M,Y,,,20221208,,PH,US,US,2022,Q4,Adult
208597814,20859781,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Meningitis aseptic,,2022,Q4,4,F,,20221129.0,20220523,20221212,EXP,,US-35507-2022-07265,LUPIN,"Vickery PB, Roach JK, Vickery S. A case of possible Levetiracetam induced aseptic meningitis vs viral meningitis. CNS Spectrums. 2022;27(2):231-232",54.0,YR,,M,Y,,,20221212,,PH,US,US,2022,Q4,Adult
208670902,20867090,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,Solution for injection,,2022,Q4,Blood glucose increased,,2022,Q4,2,F,20211115.0,20221129.0,20220524,20221202,EXP,,CA-SA-2022SA184364,SANOFI AVENTIS,,77.0,YR,E,M,Y,80.0,KG,20221202,,CN,CA,CA,2022,Q4,Elderly
208670902,20867090,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,Solution for injection,,2022,Q4,Inappropriate schedule of product administration,,2022,Q4,2,F,20211115.0,20221129.0,20220524,20221202,EXP,,CA-SA-2022SA184364,SANOFI AVENTIS,,77.0,YR,E,M,Y,80.0,KG,20221202,,CN,CA,CA,2022,Q4,Elderly
208670902,20867090,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,Solution for injection,,2022,Q4,Product use in unapproved indication,,2022,Q4,2,F,20211115.0,20221129.0,20220524,20221202,EXP,,CA-SA-2022SA184364,SANOFI AVENTIS,,77.0,YR,E,M,Y,80.0,KG,20221202,,CN,CA,CA,2022,Q4,Elderly
208670902,20867090,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,Solution for injection,,2022,Q4,Diabetic ketoacidosis,,2022,Q4,2,F,20211115.0,20221129.0,20220524,20221202,EXP,,CA-SA-2022SA184364,SANOFI AVENTIS,,77.0,YR,E,M,Y,80.0,KG,20221202,,CN,CA,CA,2022,Q4,Elderly
208670902,20867090,3,PS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,209196.0,,,Solution for injection,,2022,Q4,Hyperglycaemia,,2022,Q4,2,F,20211115.0,20221129.0,20220524,20221202,EXP,,CA-SA-2022SA184364,SANOFI AVENTIS,,77.0,YR,E,M,Y,80.0,KG,20221202,,CN,CA,CA,2022,Q4,Elderly
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Dyspnoea,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Oxygen saturation abnormal,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Death,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Hypervolaemia,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Palpitations,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Staphylococcal infection,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Breast pain,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Sinusitis,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Pneumonia,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Death of relative,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Product dose omission issue,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Migraine,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Sluggishness,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Lethargy,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Sputum discoloured,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Rales,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Headache,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Fall,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Streptococcal infection,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Pain,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Oedema peripheral,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Total lung capacity decreased,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Infection,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Incontinence,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Bronchitis,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Sciatica,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Incorrect dose administered,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Chest pain,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Asthenia,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Pain in extremity,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Loss of consciousness,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Incorrect drug administration rate,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Confusional state,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Back pain,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Arthralgia,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
2086889016,20868890,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,UNK,,2022,Q4,Productive cough,,2022,Q4,16,F,20221215.0,20221220.0,20220524,20221223,EXP,,US-TAKEDA-2022TUS015686,TAKEDA,,55.0,YR,,F,Y,113.0,KG,20221223,,HP,US,US,2022,Q4,Adult
209001902,20900190,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,,,20563.0,12.0,IU,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,,,20563.0,12.0,IU,Injection,,2022,Q4,Injection site dryness,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,,,20563.0,12.0,IU,Injection,,2022,Q4,Blood glucose decreased,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,,,20563.0,12.0,IU,Injection,,2022,Q4,Accidental underdose,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,,,20563.0,12.0,IU,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,,,20563.0,12.0,IU,Injection,,2022,Q4,Injection site dryness,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,,,20563.0,12.0,IU,Injection,,2022,Q4,Blood glucose decreased,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,,,20563.0,12.0,IU,Injection,,2022,Q4,Accidental underdose,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,,,20563.0,12.0,IU,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,,,20563.0,12.0,IU,Injection,,2022,Q4,Injection site dryness,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,,,20563.0,12.0,IU,Injection,,2022,Q4,Blood glucose decreased,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,,,20563.0,12.0,IU,Injection,,2022,Q4,Accidental underdose,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D420814C,,20563.0,12.0,IU,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D420814C,,20563.0,12.0,IU,Injection,,2022,Q4,Injection site dryness,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D420814C,,20563.0,12.0,IU,Injection,,2022,Q4,Blood glucose decreased,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D420814C,,20563.0,12.0,IU,Injection,,2022,Q4,Accidental underdose,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D420814C,,20563.0,12.0,IU,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D420814C,,20563.0,12.0,IU,Injection,,2022,Q4,Injection site dryness,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D420814C,,20563.0,12.0,IU,Injection,,2022,Q4,Blood glucose decreased,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D420814C,,20563.0,12.0,IU,Injection,,2022,Q4,Accidental underdose,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D473104C,,20563.0,12.0,IU,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D473104C,,20563.0,12.0,IU,Injection,,2022,Q4,Injection site dryness,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D473104C,,20563.0,12.0,IU,Injection,,2022,Q4,Blood glucose decreased,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D473104C,,20563.0,12.0,IU,Injection,,2022,Q4,Accidental underdose,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D473104C,,20563.0,12.0,IU,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D473104C,,20563.0,12.0,IU,Injection,,2022,Q4,Injection site dryness,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D473104C,,20563.0,12.0,IU,Injection,,2022,Q4,Blood glucose decreased,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209001902,20900190,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 u, unknown",,,U,,D473104C,,20563.0,12.0,IU,Injection,,2022,Q4,Accidental underdose,,2022,Q4,2,F,20220520.0,20221213.0,20220601,20221219,PER,,US-ELI_LILLY_AND_COMPANY-US202205009276,ELI LILLY AND CO,,76.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
209166494,20916649,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 units per meal?Subcutaneous solution,,,U,,,,,,,,,2022,Q4,Headache,,2022,Q4,4,F,20220422.0,20221005.0,20220605,20221008,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-042842,BRISTOL MYERS SQUIBB,,80.0,YR,E,M,Y,77.56,KG,20221008,,HP,US,US,2022,Q4,Elderly
209166494,20916649,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 units per meal?Subcutaneous solution,,,U,,,,,,,,,2022,Q4,Liver function test decreased,,2022,Q4,4,F,20220422.0,20221005.0,20220605,20221008,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-042842,BRISTOL MYERS SQUIBB,,80.0,YR,E,M,Y,77.56,KG,20221008,,HP,US,US,2022,Q4,Elderly
209166494,20916649,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 units per meal?Subcutaneous solution,,,U,,,,,,,,,2022,Q4,Fatigue,,2022,Q4,4,F,20220422.0,20221005.0,20220605,20221008,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-042842,BRISTOL MYERS SQUIBB,,80.0,YR,E,M,Y,77.56,KG,20221008,,HP,US,US,2022,Q4,Elderly
209166494,20916649,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 units per meal?Subcutaneous solution,,,U,,,,,,,,,2022,Q4,Thrombocytopenia,,2022,Q4,4,F,20220422.0,20221005.0,20220605,20221008,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-042842,BRISTOL MYERS SQUIBB,,80.0,YR,E,M,Y,77.56,KG,20221008,,HP,US,US,2022,Q4,Elderly
209166494,20916649,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 units per meal?Subcutaneous solution,,,U,,,,,,,,,2022,Q4,Off label use,,2022,Q4,4,F,20220422.0,20221005.0,20220605,20221008,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-042842,BRISTOL MYERS SQUIBB,,80.0,YR,E,M,Y,77.56,KG,20221008,,HP,US,US,2022,Q4,Elderly
209166494,20916649,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 units per meal?Subcutaneous solution,,,U,,,,,,,,,2022,Q4,Tremor,,2022,Q4,4,F,20220422.0,20221005.0,20220605,20221008,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-042842,BRISTOL MYERS SQUIBB,,80.0,YR,E,M,Y,77.56,KG,20221008,,HP,US,US,2022,Q4,Elderly
209615877,20961587,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Hyperkalaemia,,2022,Q4,7,F,20201130.0,20221115.0,20220615,20221118,EXP,,NVSC2022US136012,NOVARTIS,,73.0,YR,,F,Y,88.8,KG,20221118,,MD,US,US,2022,Q4,Elderly
209670132,20967013,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,1 unit for 3 g of carbohydrate with meals and snacks,,,D,,,,,,,,,2022,Q4,Diabetic ketoacidosis,,2022,Q4,2,F,,20221222.0,20220616,20221228,EXP,,CA-SA-2022SA213299,SANOFI AVENTIS,Unknown. Unknown. Unknown. Unk;Unknown:Unknown,17.0,YR,T,M,Y,,,20221228,,HP,CA,CA,2022,Q4,Youth
209670132,20967013,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,1 unit for 3 g of carbohydrate with meals and snacks,,,D,,,,,,,,,2022,Q4,Off label use,,2022,Q4,2,F,,20221222.0,20220616,20221228,EXP,,CA-SA-2022SA213299,SANOFI AVENTIS,Unknown. Unknown. Unknown. Unk;Unknown:Unknown,17.0,YR,T,M,Y,,,20221228,,HP,CA,CA,2022,Q4,Youth
209670132,20967013,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,1 unit for 3 g of carbohydrate with meals and snacks,,,D,,,,,,,,,2022,Q4,Product prescribing error,,2022,Q4,2,F,,20221222.0,20220616,20221228,EXP,,CA-SA-2022SA213299,SANOFI AVENTIS,Unknown. Unknown. Unknown. Unk;Unknown:Unknown,17.0,YR,T,M,Y,,,20221228,,HP,CA,CA,2022,Q4,Youth
210096694,21009669,2,C,INSULIN LISPRO BS,,2,Unknown,"Morning, noon and evening, 2 -2 -4",,,,,,,,,,Solution for injection,,2022,Q4,Toxic epidermal necrolysis,,2022,Q4,4,F,20220422.0,20221003.0,20220627,20221011,EXP,,JP-009507513-2206JPN002581J,MERCK,"Nagata Y, Yoshimoto N, Kurosawa S, Seo T, Sugai T, Morita Y, et al.. [6 A case of difficult-to-treat toxic epidermal necrolysis caused by pembrolizumab]. The Dermatology Subcommittee Meeting of the 102nd Hokkaido Medical Congress [the. 15",71.0,YR,,F,Y,63.0,KG,20221011,,MD,JP,JP,2022,Q4,Elderly
210407734,21040773,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100U/3ml kwikpen 3ML?Inject up to 30 units under the skin three times daly before meals according to,,,U,,,,,,,Unknown,,2022,Q4,Tremor,,2022,Q4,4,F,20220601.0,20221010.0,20220704,20221013,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-063600,BRISTOL MYERS SQUIBB,,63.0,YR,E,F,Y,141.97,KG,20221013,,PH,US,US,2022,Q4,Adult
210407734,21040773,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100U/3ml kwikpen 3ML?Inject up to 30 units under the skin three times daly before meals according to,,,U,,,,,,,Unknown,,2022,Q4,Off label use,,2022,Q4,4,F,20220601.0,20221010.0,20220704,20221013,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-063600,BRISTOL MYERS SQUIBB,,63.0,YR,E,F,Y,141.97,KG,20221013,,PH,US,US,2022,Q4,Adult
210407734,21040773,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100U/3ml kwikpen 3ML?Inject up to 30 units under the skin three times daly before meals according to,,,U,,,,,,,Unknown,,2022,Q4,Heart rate increased,,2022,Q4,4,F,20220601.0,20221010.0,20220704,20221013,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-063600,BRISTOL MYERS SQUIBB,,63.0,YR,E,F,Y,141.97,KG,20221013,,PH,US,US,2022,Q4,Adult
210407734,21040773,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100U/3ml kwikpen 3ML?Inject up to 30 units under the skin three times daly before meals according to,,,U,,,,,,,Unknown,,2022,Q4,Dyspnoea,,2022,Q4,4,F,20220601.0,20221010.0,20220704,20221013,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-063600,BRISTOL MYERS SQUIBB,,63.0,YR,E,F,Y,141.97,KG,20221013,,PH,US,US,2022,Q4,Adult
210407734,21040773,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100U/3ml kwikpen 3ML?Inject up to 30 units under the skin three times daly before meals according to,,,U,,,,,,,Unknown,,2022,Q4,Swelling of eyelid,,2022,Q4,4,F,20220601.0,20221010.0,20220704,20221013,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-063600,BRISTOL MYERS SQUIBB,,63.0,YR,E,F,Y,141.97,KG,20221013,,PH,US,US,2022,Q4,Adult
210407734,21040773,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100U/3ml kwikpen 3ML?Inject up to 30 units under the skin three times daly before meals according to,,,U,,,,,,,Unknown,,2022,Q4,Visual impairment,,2022,Q4,4,F,20220601.0,20221010.0,20220704,20221013,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-063600,BRISTOL MYERS SQUIBB,,63.0,YR,E,F,Y,141.97,KG,20221013,,PH,US,US,2022,Q4,Adult
210407734,21040773,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100U/3ml kwikpen 3ML?Inject up to 30 units under the skin three times daly before meals according to,,,U,,,,,,,Unknown,,2022,Q4,Condition aggravated,,2022,Q4,4,F,20220601.0,20221010.0,20220704,20221013,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-063600,BRISTOL MYERS SQUIBB,,63.0,YR,E,F,Y,141.97,KG,20221013,,PH,US,US,2022,Q4,Adult
210407734,21040773,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100U/3ml kwikpen 3ML?Inject up to 30 units under the skin three times daly before meals according to,,,U,,,,,,,Unknown,,2022,Q4,Joint swelling,,2022,Q4,4,F,20220601.0,20221010.0,20220704,20221013,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-063600,BRISTOL MYERS SQUIBB,,63.0,YR,E,F,Y,141.97,KG,20221013,,PH,US,US,2022,Q4,Adult
210407734,21040773,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100U/3ml kwikpen 3ML?Inject up to 30 units under the skin three times daly before meals according to,,,U,,,,,,,Unknown,,2022,Q4,Headache,,2022,Q4,4,F,20220601.0,20221010.0,20220704,20221013,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-063600,BRISTOL MYERS SQUIBB,,63.0,YR,E,F,Y,141.97,KG,20221013,,PH,US,US,2022,Q4,Adult
210407734,21040773,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100U/3ml kwikpen 3ML?Inject up to 30 units under the skin three times daly before meals according to,,,U,,,,,,,Unknown,,2022,Q4,Fatigue,,2022,Q4,4,F,20220601.0,20221010.0,20220704,20221013,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-063600,BRISTOL MYERS SQUIBB,,63.0,YR,E,F,Y,141.97,KG,20221013,,PH,US,US,2022,Q4,Adult
210407734,21040773,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100U/3ml kwikpen 3ML?Inject up to 30 units under the skin three times daly before meals according to,,,U,,,,,,,Unknown,,2022,Q4,Abdominal pain,,2022,Q4,4,F,20220601.0,20221010.0,20220704,20221013,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-063600,BRISTOL MYERS SQUIBB,,63.0,YR,E,F,Y,141.97,KG,20221013,,PH,US,US,2022,Q4,Adult
210407734,21040773,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100U/3ml kwikpen 3ML?Inject up to 30 units under the skin three times daly before meals according to,,,U,,,,,,,Unknown,,2022,Q4,Sciatica,,2022,Q4,4,F,20220601.0,20221010.0,20220704,20221013,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-063600,BRISTOL MYERS SQUIBB,,63.0,YR,E,F,Y,141.97,KG,20221013,,PH,US,US,2022,Q4,Adult
210407734,21040773,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100U/3ml kwikpen 3ML?Inject up to 30 units under the skin three times daly before meals according to,,,U,,,,,,,Unknown,,2022,Q4,Paraesthesia,,2022,Q4,4,F,20220601.0,20221010.0,20220704,20221013,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-063600,BRISTOL MYERS SQUIBB,,63.0,YR,E,F,Y,141.97,KG,20221013,,PH,US,US,2022,Q4,Adult
210407734,21040773,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100U/3ml kwikpen 3ML?Inject up to 30 units under the skin three times daly before meals according to,,,U,,,,,,,Unknown,,2022,Q4,Pyrexia,,2022,Q4,4,F,20220601.0,20221010.0,20220704,20221013,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-063600,BRISTOL MYERS SQUIBB,,63.0,YR,E,F,Y,141.97,KG,20221013,,PH,US,US,2022,Q4,Adult
210407734,21040773,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100U/3ml kwikpen 3ML?Inject up to 30 units under the skin three times daly before meals according to,,,U,,,,,,,Unknown,,2022,Q4,Nausea,,2022,Q4,4,F,20220601.0,20221010.0,20220704,20221013,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-063600,BRISTOL MYERS SQUIBB,,63.0,YR,E,F,Y,141.97,KG,20221013,,PH,US,US,2022,Q4,Adult
210639153,21063915,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q4,Epistaxis,,2022,Q4,3,F,20211217.0,20221007.0,20220711,20221015,EXP,,US-ABBVIE-22K-163-4428432-00,ABBVIE,,75.0,YR,,M,Y,106.59,KG,20221015,,CN,US,US,2022,Q4,Elderly
210639153,21063915,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q4,Anaemia,,2022,Q4,3,F,20211217.0,20221007.0,20220711,20221015,EXP,,US-ABBVIE-22K-163-4428432-00,ABBVIE,,75.0,YR,,M,Y,106.59,KG,20221015,,CN,US,US,2022,Q4,Elderly
210639153,21063915,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q4,Cataract,,2022,Q4,3,F,20211217.0,20221007.0,20220711,20221015,EXP,,US-ABBVIE-22K-163-4428432-00,ABBVIE,,75.0,YR,,M,Y,106.59,KG,20221015,,CN,US,US,2022,Q4,Elderly
210639153,21063915,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q4,Asthenia,,2022,Q4,3,F,20211217.0,20221007.0,20220711,20221015,EXP,,US-ABBVIE-22K-163-4428432-00,ABBVIE,,75.0,YR,,M,Y,106.59,KG,20221015,,CN,US,US,2022,Q4,Elderly
210639153,21063915,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q4,Thrombosis,,2022,Q4,3,F,20211217.0,20221007.0,20220711,20221015,EXP,,US-ABBVIE-22K-163-4428432-00,ABBVIE,,75.0,YR,,M,Y,106.59,KG,20221015,,CN,US,US,2022,Q4,Elderly
210639153,21063915,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q4,Cardiac failure congestive,,2022,Q4,3,F,20211217.0,20221007.0,20220711,20221015,EXP,,US-ABBVIE-22K-163-4428432-00,ABBVIE,,75.0,YR,,M,Y,106.59,KG,20221015,,CN,US,US,2022,Q4,Elderly
210639153,21063915,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,,,,,,,,,,2022,Q4,Epistaxis,,2022,Q4,3,F,20211217.0,20221007.0,20220711,20221015,EXP,,US-ABBVIE-22K-163-4428432-00,ABBVIE,,75.0,YR,,M,Y,106.59,KG,20221015,,CN,US,US,2022,Q4,Elderly
210674052,21067405,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Off label use,,2022,Q4,2,F,,20221202.0,20220712,20221216,EXP,,CA-AUROBINDO-AUR-APL-2022-024802,AUROBINDO,"Shamchuk A, Doulla M, Jetha M.. Association possible entre l^acidocetose diabetique et l^utilisation d^un inhibiteur du sodium-glucose co-transporteur 2 chez un jeune de 17 ans atteint de diabete de type 2.. CMAJCanadianMedicalAssociationJournal. 2021;193:E1746-E1749",17.0,YR,,M,Y,,,20221216,,HP,CA,CA,2022,Q4,Youth
210674052,21067405,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Product prescribing error,,2022,Q4,2,F,,20221202.0,20220712,20221216,EXP,,CA-AUROBINDO-AUR-APL-2022-024802,AUROBINDO,"Shamchuk A, Doulla M, Jetha M.. Association possible entre l^acidocetose diabetique et l^utilisation d^un inhibiteur du sodium-glucose co-transporteur 2 chez un jeune de 17 ans atteint de diabete de type 2.. CMAJCanadianMedicalAssociationJournal. 2021;193:E1746-E1749",17.0,YR,,M,Y,,,20221216,,HP,CA,CA,2022,Q4,Youth
210674052,21067405,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Diabetic ketoacidosis,,2022,Q4,2,F,,20221202.0,20220712,20221216,EXP,,CA-AUROBINDO-AUR-APL-2022-024802,AUROBINDO,"Shamchuk A, Doulla M, Jetha M.. Association possible entre l^acidocetose diabetique et l^utilisation d^un inhibiteur du sodium-glucose co-transporteur 2 chez un jeune de 17 ans atteint de diabete de type 2.. CMAJCanadianMedicalAssociationJournal. 2021;193:E1746-E1749",17.0,YR,,M,Y,,,20221216,,HP,CA,CA,2022,Q4,Youth
210852522,21085252,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q4,Neutropenia,,2022,Q4,2,F,20221011.0,20221024.0,20220714,20221031,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-070088,BRISTOL MYERS SQUIBB,,78.0,YR,E,M,Y,91.2,KG,20221031,,PH,US,US,2022,Q4,Elderly
210852522,21085252,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q4,Hypotension,,2022,Q4,2,F,20221011.0,20221024.0,20220714,20221031,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-070088,BRISTOL MYERS SQUIBB,,78.0,YR,E,M,Y,91.2,KG,20221031,,PH,US,US,2022,Q4,Elderly
210852522,21085252,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q4,Acute kidney injury,,2022,Q4,2,F,20221011.0,20221024.0,20220714,20221031,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-070088,BRISTOL MYERS SQUIBB,,78.0,YR,E,M,Y,91.2,KG,20221031,,PH,US,US,2022,Q4,Elderly
210852522,21085252,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q4,Pneumonia,,2022,Q4,2,F,20221011.0,20221024.0,20220714,20221031,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-070088,BRISTOL MYERS SQUIBB,,78.0,YR,E,M,Y,91.2,KG,20221031,,PH,US,US,2022,Q4,Elderly
210852522,21085252,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q4,Off label use,,2022,Q4,2,F,20221011.0,20221024.0,20220714,20221031,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-070088,BRISTOL MYERS SQUIBB,,78.0,YR,E,M,Y,91.2,KG,20221031,,PH,US,US,2022,Q4,Elderly
210979145,21097914,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 unit not specified, Once",,,U,,,,,,,Unknown,,2022,Q4,Pneumonitis,,2022,Q4,5,F,20220717.0,20221207.0,20220719,20221207,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-075559,BRISTOL MYERS SQUIBB,,67.0,YR,E,M,Y,64.0,KG,20221208,,HP,JP,JP,2022,Q4,Elderly
2114551111,21145511,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Sunconjunctival,,,,,,,,,1.0,IU,Injection,,2022,Q4,Hyperthyroidism,,2022,Q4,11,F,20211201.0,20221206.0,20220729,20221209,EXP,,CA-ROCHE-2972753,ROCHE,,60.0,YR,,F,Y,94.1,KG,20221209,,MD,CA,,2022,Q4,Adult
2114551111,21145511,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Sunconjunctival,,,,,,,,,1.0,IU,Injection,,2022,Q4,Diabetic ketoacidosis,,2022,Q4,11,F,20211201.0,20221206.0,20220729,20221209,EXP,,CA-ROCHE-2972753,ROCHE,,60.0,YR,,F,Y,94.1,KG,20221209,,MD,CA,,2022,Q4,Adult
2114551111,21145511,49,C,INSULIN LISPRO,INSULIN LISPRO,1,Sunconjunctival,,,,,,,,,1.0,IU,Injection,,2022,Q4,Hyperglycaemia,,2022,Q4,11,F,20211201.0,20221206.0,20220729,20221209,EXP,,CA-ROCHE-2972753,ROCHE,,60.0,YR,,F,Y,94.1,KG,20221209,,MD,CA,,2022,Q4,Adult
211882964,21188296,36,C,INSULINE LISPRO,,1,,,,,,,,,,,,,,2022,Q4,Post procedural haemorrhage,,2022,Q4,4,F,20220726.0,20221124.0,20220809,20221129,EXP,,US-ROCHE-3148830,ROCHE,,75.0,YR,,,Y,,,20221129,,MD,US,,2022,Q4,Elderly
211886616,21188661,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Empyema,,2022,Q4,6,F,20220626.0,20221103.0,20220809,20221109,EXP,,US-EXELIXIS-CABO-22053998,EXELIXIS,,79.0,YR,,M,Y,,,20221109,,HP,US,US,2022,Q4,Elderly
211886616,21188661,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Cardiac failure congestive,,2022,Q4,6,F,20220626.0,20221103.0,20220809,20221109,EXP,,US-EXELIXIS-CABO-22053998,EXELIXIS,,79.0,YR,,M,Y,,,20221109,,HP,US,US,2022,Q4,Elderly
211886616,21188661,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Lung consolidation,,2022,Q4,6,F,20220626.0,20221103.0,20220809,20221109,EXP,,US-EXELIXIS-CABO-22053998,EXELIXIS,,79.0,YR,,M,Y,,,20221109,,HP,US,US,2022,Q4,Elderly
211886616,21188661,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Eye disorder,,2022,Q4,6,F,20220626.0,20221103.0,20220809,20221109,EXP,,US-EXELIXIS-CABO-22053998,EXELIXIS,,79.0,YR,,M,Y,,,20221109,,HP,US,US,2022,Q4,Elderly
211886616,21188661,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Pneumothorax,,2022,Q4,6,F,20220626.0,20221103.0,20220809,20221109,EXP,,US-EXELIXIS-CABO-22053998,EXELIXIS,,79.0,YR,,M,Y,,,20221109,,HP,US,US,2022,Q4,Elderly
211886616,21188661,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Pulmonary oedema,,2022,Q4,6,F,20220626.0,20221103.0,20220809,20221109,EXP,,US-EXELIXIS-CABO-22053998,EXELIXIS,,79.0,YR,,M,Y,,,20221109,,HP,US,US,2022,Q4,Elderly
211886616,21188661,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Hypervolaemia,,2022,Q4,6,F,20220626.0,20221103.0,20220809,20221109,EXP,,US-EXELIXIS-CABO-22053998,EXELIXIS,,79.0,YR,,M,Y,,,20221109,,HP,US,US,2022,Q4,Elderly
211886616,21188661,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Thrombocytopenia,,2022,Q4,6,F,20220626.0,20221103.0,20220809,20221109,EXP,,US-EXELIXIS-CABO-22053998,EXELIXIS,,79.0,YR,,M,Y,,,20221109,,HP,US,US,2022,Q4,Elderly
211886616,21188661,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Skin exfoliation,,2022,Q4,6,F,20220626.0,20221103.0,20220809,20221109,EXP,,US-EXELIXIS-CABO-22053998,EXELIXIS,,79.0,YR,,M,Y,,,20221109,,HP,US,US,2022,Q4,Elderly
211886616,21188661,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Metastases to bone,,2022,Q4,6,F,20220626.0,20221103.0,20220809,20221109,EXP,,US-EXELIXIS-CABO-22053998,EXELIXIS,,79.0,YR,,M,Y,,,20221109,,HP,US,US,2022,Q4,Elderly
211886616,21188661,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Ascites,,2022,Q4,6,F,20220626.0,20221103.0,20220809,20221109,EXP,,US-EXELIXIS-CABO-22053998,EXELIXIS,,79.0,YR,,M,Y,,,20221109,,HP,US,US,2022,Q4,Elderly
211886616,21188661,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Diffuse idiopathic skeletal hyperostosis,,2022,Q4,6,F,20220626.0,20221103.0,20220809,20221109,EXP,,US-EXELIXIS-CABO-22053998,EXELIXIS,,79.0,YR,,M,Y,,,20221109,,HP,US,US,2022,Q4,Elderly
211886616,21188661,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Inappropriate schedule of product administration,,2022,Q4,6,F,20220626.0,20221103.0,20220809,20221109,EXP,,US-EXELIXIS-CABO-22053998,EXELIXIS,,79.0,YR,,M,Y,,,20221109,,HP,US,US,2022,Q4,Elderly
211886616,21188661,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Generalised oedema,,2022,Q4,6,F,20220626.0,20221103.0,20220809,20221109,EXP,,US-EXELIXIS-CABO-22053998,EXELIXIS,,79.0,YR,,M,Y,,,20221109,,HP,US,US,2022,Q4,Elderly
211886616,21188661,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Diarrhoea,,2022,Q4,6,F,20220626.0,20221103.0,20220809,20221109,EXP,,US-EXELIXIS-CABO-22053998,EXELIXIS,,79.0,YR,,M,Y,,,20221109,,HP,US,US,2022,Q4,Elderly
211886616,21188661,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Bladder hypertrophy,,2022,Q4,6,F,20220626.0,20221103.0,20220809,20221109,EXP,,US-EXELIXIS-CABO-22053998,EXELIXIS,,79.0,YR,,M,Y,,,20221109,,HP,US,US,2022,Q4,Elderly
211886616,21188661,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Normocytic anaemia,,2022,Q4,6,F,20220626.0,20221103.0,20220809,20221109,EXP,,US-EXELIXIS-CABO-22053998,EXELIXIS,,79.0,YR,,M,Y,,,20221109,,HP,US,US,2022,Q4,Elderly
211886616,21188661,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Abdominal distension,,2022,Q4,6,F,20220626.0,20221103.0,20220809,20221109,EXP,,US-EXELIXIS-CABO-22053998,EXELIXIS,,79.0,YR,,M,Y,,,20221109,,HP,US,US,2022,Q4,Elderly
211886616,21188661,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Blood albumin decreased,,2022,Q4,6,F,20220626.0,20221103.0,20220809,20221109,EXP,,US-EXELIXIS-CABO-22053998,EXELIXIS,,79.0,YR,,M,Y,,,20221109,,HP,US,US,2022,Q4,Elderly
211886616,21188661,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Atelectasis,,2022,Q4,6,F,20220626.0,20221103.0,20220809,20221109,EXP,,US-EXELIXIS-CABO-22053998,EXELIXIS,,79.0,YR,,M,Y,,,20221109,,HP,US,US,2022,Q4,Elderly
211886616,21188661,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Pneumonia,,2022,Q4,6,F,20220626.0,20221103.0,20220809,20221109,EXP,,US-EXELIXIS-CABO-22053998,EXELIXIS,,79.0,YR,,M,Y,,,20221109,,HP,US,US,2022,Q4,Elderly
211886616,21188661,12,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Pleural effusion,,2022,Q4,6,F,20220626.0,20221103.0,20220809,20221109,EXP,,US-EXELIXIS-CABO-22053998,EXELIXIS,,79.0,YR,,M,Y,,,20221109,,HP,US,US,2022,Q4,Elderly
211919693,21191969,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,,,,,,,,,,,Unknown,,2022,Q4,Graft versus host disease,,2022,Q4,3,F,20191009.0,20221222.0,20220809,20221230,EXP,,US-BIOGEN-2022BI01146072,BIOGEN,,71.0,YR,,M,Y,87.5,KG,20221230,,HP,US,US,2022,Q4,Elderly
211919693,21191969,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,,,,,,,,,,,Unknown,,2022,Q4,Sepsis,,2022,Q4,3,F,20191009.0,20221222.0,20220809,20221230,EXP,,US-BIOGEN-2022BI01146072,BIOGEN,,71.0,YR,,M,Y,87.5,KG,20221230,,HP,US,US,2022,Q4,Elderly
212033904,21203390,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 units/ml,,,U,,,,,,,Unknown,QD,2022,Q4,Heat exhaustion,,2022,Q4,4,F,20220621.0,20221116.0,20220811,20221123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-063886,BRISTOL MYERS SQUIBB,,56.0,YR,A,M,Y,,,20221123,,HP,US,US,2022,Q4,Adult
212033904,21203390,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 units/ml,,,U,,,,,,,Unknown,QD,2022,Q4,Acute myocardial infarction,,2022,Q4,4,F,20220621.0,20221116.0,20220811,20221123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-063886,BRISTOL MYERS SQUIBB,,56.0,YR,A,M,Y,,,20221123,,HP,US,US,2022,Q4,Adult
212033904,21203390,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 units/ml,,,U,,,,,,,Unknown,QD,2022,Q4,Ejection fraction decreased,,2022,Q4,4,F,20220621.0,20221116.0,20220811,20221123,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-063886,BRISTOL MYERS SQUIBB,,56.0,YR,A,M,Y,,,20221123,,HP,US,US,2022,Q4,Adult
212509363,21250936,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Nausea,,2022,Q4,3,F,20190101.0,20221028.0,20220824,20221104,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-188762",BOEHRINGER INGELHEIM,,61.0,YR,A,M,Y,,,20221104,,CN,US,US,2022,Q4,Adult
212509363,21250936,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,COVID-19,,2022,Q4,3,F,20190101.0,20221028.0,20220824,20221104,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-188762",BOEHRINGER INGELHEIM,,61.0,YR,A,M,Y,,,20221104,,CN,US,US,2022,Q4,Adult
212509363,21250936,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Vomiting,,2022,Q4,3,F,20190101.0,20221028.0,20220824,20221104,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-188762",BOEHRINGER INGELHEIM,,61.0,YR,A,M,Y,,,20221104,,CN,US,US,2022,Q4,Adult
212509363,21250936,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Diabetic ketoacidosis,,2022,Q4,3,F,20190101.0,20221028.0,20220824,20221104,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-188762",BOEHRINGER INGELHEIM,,61.0,YR,A,M,Y,,,20221104,,CN,US,US,2022,Q4,Adult
212509363,21250936,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Diabetic ketoacidosis,,2022,Q4,3,F,20190101.0,20221028.0,20220824,20221104,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-188762",BOEHRINGER INGELHEIM,,61.0,YR,A,M,Y,,,20221104,,CN,US,US,2022,Q4,Adult
212509363,21250936,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Cough,,2022,Q4,3,F,20190101.0,20221028.0,20220824,20221104,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-188762",BOEHRINGER INGELHEIM,,61.0,YR,A,M,Y,,,20221104,,CN,US,US,2022,Q4,Adult
212509363,21250936,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Gastric pH decreased,,2022,Q4,3,F,20190101.0,20221028.0,20220824,20221104,PER,,"US-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-188762",BOEHRINGER INGELHEIM,,61.0,YR,A,M,Y,,,20221104,,CN,US,US,2022,Q4,Adult
212666483,21266648,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QD",,,,,,,,,,,QD,2022,Q4,Cardiac failure chronic,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,14,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, QD",,,,,,,,,,,QD,2022,Q4,Pneumonia,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, TID",,,,,,,,,,,Q8H,2022,Q4,Cardiac failure chronic,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, TID",,,,,,,,,,,Q8H,2022,Q4,Pneumonia,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, QD",,,,,,,,,,,QD,2022,Q4,Cardiac failure chronic,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, QD",,,,,,,,,,,QD,2022,Q4,Pneumonia,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,Q12H,2022,Q4,Cardiac failure chronic,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,17,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,Q12H,2022,Q4,Pneumonia,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, QD",,,,,,,,,,,QD,2022,Q4,Cardiac failure chronic,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,18,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, QD",,,,,,,,,,,QD,2022,Q4,Pneumonia,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, TID",,,,,,,,,,,Q8H,2022,Q4,Cardiac failure chronic,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,19,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, TID",,,,,,,,,,,Q8H,2022,Q4,Pneumonia,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,Q12H,2022,Q4,Cardiac failure chronic,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,Q12H,2022,Q4,Pneumonia,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, TID",,,,,,,,,,,Q8H,2022,Q4,Cardiac failure chronic,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,21,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, TID",,,,,,,,,,,Q8H,2022,Q4,Pneumonia,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,Q12H,2022,Q4,Cardiac failure chronic,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,22,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,Q12H,2022,Q4,Pneumonia,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, QD",,,,,,,,,,,QD,2022,Q4,Cardiac failure chronic,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,23,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, QD",,,,,,,,,,,QD,2022,Q4,Pneumonia,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, TID",,,,,,,,,,,Q8H,2022,Q4,Cardiac failure chronic,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,24,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, TID",,,,,,,,,,,Q8H,2022,Q4,Pneumonia,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,Q12H,2022,Q4,Cardiac failure chronic,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,25,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,Q12H,2022,Q4,Pneumonia,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,Q12H,2022,Q4,Cardiac failure chronic,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,26,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,Q12H,2022,Q4,Pneumonia,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,27,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, TID",,,,,,,,,,,Q8H,2022,Q4,Cardiac failure chronic,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,27,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, TID",,,,,,,,,,,Q8H,2022,Q4,Pneumonia,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,28,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,Q12H,2022,Q4,Cardiac failure chronic,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212666483,21266648,28,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, BID",,,,,,,,,,,Q12H,2022,Q4,Pneumonia,,2022,Q4,3,F,20220817.0,20220929.0,20220829,20221003,EXP,,JP-GILEAD-2022-0593851,GILEAD,,76.0,YR,E,M,Y,38.4,KG,20221003,,PH,JP,JP,2022,Q4,Elderly
212672492,21267249,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Klebsiella infection,,2022,Q4,2,F,20220812.0,20221206.0,20220829,20221207,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-096249,BRISTOL MYERS SQUIBB,,14.0,YR,T,F,Y,40.3,KG,20221207,,HP,US,US,2022,Q4,Youth
212672492,21267249,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Staphylococcal infection,,2022,Q4,2,F,20220812.0,20221206.0,20220829,20221207,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-096249,BRISTOL MYERS SQUIBB,,14.0,YR,T,F,Y,40.3,KG,20221207,,HP,US,US,2022,Q4,Youth
212672492,21267249,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Blood pressure increased,,2022,Q4,2,F,20220812.0,20221206.0,20220829,20221207,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-096249,BRISTOL MYERS SQUIBB,,14.0,YR,T,F,Y,40.3,KG,20221207,,HP,US,US,2022,Q4,Youth
212708044,21270804,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,Solution for injection,,2022,Q4,Arthritis,,2022,Q4,4,F,,20221121.0,20220830,20221215,EXP,,CA-SA-2022SA355118,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20221215,,CN,CA,CA,2022,Q4,Elderly
212708044,21270804,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,Solution for injection,,2022,Q4,Spinal compression fracture,,2022,Q4,4,F,,20221121.0,20220830,20221215,EXP,,CA-SA-2022SA355118,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20221215,,CN,CA,CA,2022,Q4,Elderly
212708044,21270804,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,Solution for injection,,2022,Q4,Spinal cord disorder,,2022,Q4,4,F,,20221121.0,20220830,20221215,EXP,,CA-SA-2022SA355118,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20221215,,CN,CA,CA,2022,Q4,Elderly
212708044,21270804,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,Solution for injection,,2022,Q4,Pain,,2022,Q4,4,F,,20221121.0,20220830,20221215,EXP,,CA-SA-2022SA355118,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20221215,,CN,CA,CA,2022,Q4,Elderly
212708044,21270804,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,Solution for injection,,2022,Q4,Blood glucose abnormal,,2022,Q4,4,F,,20221121.0,20220830,20221215,EXP,,CA-SA-2022SA355118,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20221215,,CN,CA,CA,2022,Q4,Elderly
212708044,21270804,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,Solution for injection,,2022,Q4,Spinal compression fracture,,2022,Q4,4,F,,20221121.0,20220830,20221215,EXP,,CA-SA-2022SA355118,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20221215,,CN,CA,CA,2022,Q4,Elderly
212708044,21270804,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,Solution for injection,,2022,Q4,Gait disturbance,,2022,Q4,4,F,,20221121.0,20220830,20221215,EXP,,CA-SA-2022SA355118,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20221215,,CN,CA,CA,2022,Q4,Elderly
212708044,21270804,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,Solution for injection,,2022,Q4,Blood glucose increased,,2022,Q4,4,F,,20221121.0,20220830,20221215,EXP,,CA-SA-2022SA355118,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20221215,,CN,CA,CA,2022,Q4,Elderly
212708044,21270804,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,209196.0,,,Solution for injection,,2022,Q4,Pain,,2022,Q4,4,F,,20221121.0,20220830,20221215,EXP,,CA-SA-2022SA355118,SANOFI AVENTIS,,77.0,YR,E,M,Y,,,20221215,,CN,CA,CA,2022,Q4,Elderly
212968092,21296809,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 iU, TID",,,U,,,,,15.0,IU,,Q8H,2022,Q4,Glycosylated haemoglobin increased,,2022,Q4,2,F,,20221108.0,20220906,20221115,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221115,,MD,FI,FI,2022,Q4,Adult
212968092,21296809,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 iU, TID",,,U,,,,,15.0,IU,,Q8H,2022,Q4,Balanoposthitis,,2022,Q4,2,F,,20221108.0,20220906,20221115,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221115,,MD,FI,FI,2022,Q4,Adult
212968092,21296809,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 iU, TID",,,U,,,,,15.0,IU,,Q8H,2022,Q4,Hypoglycaemia,,2022,Q4,2,F,,20221108.0,20220906,20221115,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221115,,MD,FI,FI,2022,Q4,Adult
212968092,21296809,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 iU, TID",,,U,,,,,15.0,IU,,Q8H,2022,Q4,Blood glucose increased,,2022,Q4,2,F,,20221108.0,20220906,20221115,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221115,,MD,FI,FI,2022,Q4,Adult
212968092,21296809,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 iU, TID",,,U,,,,,15.0,IU,,Q8H,2022,Q4,Angina pectoris,,2022,Q4,2,F,,20221108.0,20220906,20221115,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221115,,MD,FI,FI,2022,Q4,Adult
212968092,21296809,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 iU, afternoon",,,U,,,,,10.0,IU,,,2022,Q4,Glycosylated haemoglobin increased,,2022,Q4,2,F,,20221108.0,20220906,20221115,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221115,,MD,FI,FI,2022,Q4,Adult
212968092,21296809,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 iU, afternoon",,,U,,,,,10.0,IU,,,2022,Q4,Balanoposthitis,,2022,Q4,2,F,,20221108.0,20220906,20221115,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221115,,MD,FI,FI,2022,Q4,Adult
212968092,21296809,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 iU, afternoon",,,U,,,,,10.0,IU,,,2022,Q4,Hypoglycaemia,,2022,Q4,2,F,,20221108.0,20220906,20221115,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221115,,MD,FI,FI,2022,Q4,Adult
212968092,21296809,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 iU, afternoon",,,U,,,,,10.0,IU,,,2022,Q4,Blood glucose increased,,2022,Q4,2,F,,20221108.0,20220906,20221115,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221115,,MD,FI,FI,2022,Q4,Adult
212968092,21296809,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 iU, afternoon",,,U,,,,,10.0,IU,,,2022,Q4,Angina pectoris,,2022,Q4,2,F,,20221108.0,20220906,20221115,EXP,,FI-SA-2022SA359473,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221115,,MD,FI,FI,2022,Q4,Adult
213033793,21303379,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNK,,,,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,3,F,20220511.0,20220930.0,20220907,20221007,PER,,US-AMGEN-USACT2022082687,AMGEN,,54.0,YR,A,M,Y,98.64,KG,20221007,,MD,US,US,2022,Q4,Adult
213033793,21303379,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 UNK,,,,,,,,,,,,2022,Q4,Anaemia,,2022,Q4,3,F,20220511.0,20220930.0,20220907,20221007,PER,,US-AMGEN-USACT2022082687,AMGEN,,54.0,YR,A,M,Y,98.64,KG,20221007,,MD,US,US,2022,Q4,Adult
213101812,21310181,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Breast cancer,,2022,Q4,2,F,20201221.0,20221003.0,20220909,20221027,EXP,,US-ACADIA PHARMACEUTICALS INC.-ACA-2022-PIM-002977,ACADIA PHARMACEUTICALS,,70.0,YR,,F,Y,,,20221028,,CN,US,US,2022,Q4,Elderly
213303952,21330395,22,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,7 iU,,,,,,,,7.0,IU,,,2022,Q4,Therapy non-responder,,2022,Q4,2,F,,20221108.0,20220913,20221114,EXP,,CA-PFIZER INC-202201150569,PFIZER,,20.0,YR,,F,Y,47.0,KG,20221114,,HP,CA,CA,2022,Q4,Youth
213303952,21330395,23,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3 iU,,,,,,,,3.0,IU,,,2022,Q4,Therapy non-responder,,2022,Q4,2,F,,20221108.0,20220913,20221114,EXP,,CA-PFIZER INC-202201150569,PFIZER,,20.0,YR,,F,Y,47.0,KG,20221114,,HP,CA,CA,2022,Q4,Youth
213303952,21330395,24,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,5 iU,,,,,,,,5.0,IU,,,2022,Q4,Therapy non-responder,,2022,Q4,2,F,,20221108.0,20220913,20221114,EXP,,CA-PFIZER INC-202201150569,PFIZER,,20.0,YR,,F,Y,47.0,KG,20221114,,HP,CA,CA,2022,Q4,Youth
213303952,21330395,25,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,2 iU,,,,,,,,2.0,IU,,,2022,Q4,Therapy non-responder,,2022,Q4,2,F,,20221108.0,20220913,20221114,EXP,,CA-PFIZER INC-202201150569,PFIZER,,20.0,YR,,F,Y,47.0,KG,20221114,,HP,CA,CA,2022,Q4,Youth
213303952,21330395,26,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,9 iU,,,,,,,,9.0,IU,,,2022,Q4,Therapy non-responder,,2022,Q4,2,F,,20221108.0,20220913,20221114,EXP,,CA-PFIZER INC-202201150569,PFIZER,,20.0,YR,,F,Y,47.0,KG,20221114,,HP,CA,CA,2022,Q4,Youth
213303952,21330395,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,6 iU,,,,,,,,6.0,IU,,,2022,Q4,Therapy non-responder,,2022,Q4,2,F,,20221108.0,20220913,20221114,EXP,,CA-PFIZER INC-202201150569,PFIZER,,20.0,YR,,F,Y,47.0,KG,20221114,,HP,CA,CA,2022,Q4,Youth
213303952,21330395,28,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8 iU,,,,,,,,8.0,IU,,,2022,Q4,Therapy non-responder,,2022,Q4,2,F,,20221108.0,20220913,20221114,EXP,,CA-PFIZER INC-202201150569,PFIZER,,20.0,YR,,F,Y,47.0,KG,20221114,,HP,CA,CA,2022,Q4,Youth
213303952,21330395,29,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,10 iU,,,,,,,,10.0,IU,,,2022,Q4,Therapy non-responder,,2022,Q4,2,F,,20221108.0,20220913,20221114,EXP,,CA-PFIZER INC-202201150569,PFIZER,,20.0,YR,,F,Y,47.0,KG,20221114,,HP,CA,CA,2022,Q4,Youth
213303952,21330395,30,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,1 iU,,,,,,,,1.0,IU,,,2022,Q4,Therapy non-responder,,2022,Q4,2,F,,20221108.0,20220913,20221114,EXP,,CA-PFIZER INC-202201150569,PFIZER,,20.0,YR,,F,Y,47.0,KG,20221114,,HP,CA,CA,2022,Q4,Youth
213303952,21330395,31,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,4 iU,,,,,,,,4.0,IU,,,2022,Q4,Therapy non-responder,,2022,Q4,2,F,,20221108.0,20220913,20221114,EXP,,CA-PFIZER INC-202201150569,PFIZER,,20.0,YR,,F,Y,47.0,KG,20221114,,HP,CA,CA,2022,Q4,Youth
213303952,21330395,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"7 iU, 1x/day",,,,,,,,7.0,IU,,QD,2022,Q4,Therapy non-responder,,2022,Q4,2,F,,20221108.0,20220913,20221114,EXP,,CA-PFIZER INC-202201150569,PFIZER,,20.0,YR,,F,Y,47.0,KG,20221114,,HP,CA,CA,2022,Q4,Youth
213303952,21330395,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"1 iU, 1x/day",,,,,,,,1.0,IU,,QD,2022,Q4,Therapy non-responder,,2022,Q4,2,F,,20221108.0,20220913,20221114,EXP,,CA-PFIZER INC-202201150569,PFIZER,,20.0,YR,,F,Y,47.0,KG,20221114,,HP,CA,CA,2022,Q4,Youth
213303952,21330395,34,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 iU, 1x/day",,,,,,,,5.0,IU,,QD,2022,Q4,Therapy non-responder,,2022,Q4,2,F,,20221108.0,20220913,20221114,EXP,,CA-PFIZER INC-202201150569,PFIZER,,20.0,YR,,F,Y,47.0,KG,20221114,,HP,CA,CA,2022,Q4,Youth
213303952,21330395,35,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"8 iU, 1x/day",,,,,,,,8.0,IU,,QD,2022,Q4,Therapy non-responder,,2022,Q4,2,F,,20221108.0,20220913,20221114,EXP,,CA-PFIZER INC-202201150569,PFIZER,,20.0,YR,,F,Y,47.0,KG,20221114,,HP,CA,CA,2022,Q4,Youth
213303952,21330395,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"2 iU, 1x/day",,,,,,,,2.0,IU,,QD,2022,Q4,Therapy non-responder,,2022,Q4,2,F,,20221108.0,20220913,20221114,EXP,,CA-PFIZER INC-202201150569,PFIZER,,20.0,YR,,F,Y,47.0,KG,20221114,,HP,CA,CA,2022,Q4,Youth
213366892,21336689,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q4,Encephalopathy,,2022,Q4,2,F,,20220921.0,20220915,20221001,EXP,,US-TEVA-2022-US-2071822,TEVA,,71.0,YR,E,M,Y,,,20221001,,HP,US,US,2022,Q4,Elderly
213366892,21336689,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q4,Drug withdrawal syndrome,,2022,Q4,2,F,,20220921.0,20220915,20221001,EXP,,US-TEVA-2022-US-2071822,TEVA,,71.0,YR,E,M,Y,,,20221001,,HP,US,US,2022,Q4,Elderly
213416532,21341653,27,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Oliguria,,2022,Q4,2,F,20220906.0,20221027.0,20220916,20221102,EXP,,US-ROCHE-3175481,ROCHE,,72.0,YR,,M,Y,107.0,KG,20221102,,MD,US,,2022,Q4,Elderly
213416532,21341653,27,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Death,,2022,Q4,2,F,20220906.0,20221027.0,20220916,20221102,EXP,,US-ROCHE-3175481,ROCHE,,72.0,YR,,M,Y,107.0,KG,20221102,,MD,US,,2022,Q4,Elderly
213482209,21348220,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Acute respiratory failure,,2022,Q4,9,F,20220910.0,20221213.0,20220919,20221215,EXP,,NVSC2022US209258,NOVARTIS,,66.0,YR,,F,Y,111.5,KG,20221215,,MD,US,US,2022,Q4,Elderly
213482209,21348220,50,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Acute respiratory distress syndrome,,2022,Q4,9,F,20220910.0,20221213.0,20220919,20221215,EXP,,NVSC2022US209258,NOVARTIS,,66.0,YR,,F,Y,111.5,KG,20221215,,MD,US,US,2022,Q4,Elderly
213507572,21350757,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Unknown IU, according to scheme",,,U,,Unknown,,,,,Solution for injection,,2022,Q4,Syncope,,2022,Q4,2,F,20190712.0,20221031.0,20220919,20221104,EXP,DE-ADRED-04034-01,DE-PFIZER INC-202201164298,MYLAN,,69.0,YR,,M,Y,,,20221104,,MD,DE,DE,2022,Q4,Elderly
213507572,21350757,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Unknown IU, according to scheme",,,U,,Unknown,,,,,Solution for injection,,2022,Q4,Dehydration,,2022,Q4,2,F,20190712.0,20221031.0,20220919,20221104,EXP,DE-ADRED-04034-01,DE-PFIZER INC-202201164298,MYLAN,,69.0,YR,,M,Y,,,20221104,,MD,DE,DE,2022,Q4,Elderly
213507572,21350757,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Unknown IU, according to scheme",,,U,,Unknown,,,,,Solution for injection,,2022,Q4,Diarrhoea,,2022,Q4,2,F,20190712.0,20221031.0,20220919,20221104,EXP,DE-ADRED-04034-01,DE-PFIZER INC-202201164298,MYLAN,,69.0,YR,,M,Y,,,20221104,,MD,DE,DE,2022,Q4,Elderly
213507572,21350757,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Unknown IU, according to scheme",,,U,,Unknown,,,,,Solution for injection,,2022,Q4,Hypotension,,2022,Q4,2,F,20190712.0,20221031.0,20220919,20221104,EXP,DE-ADRED-04034-01,DE-PFIZER INC-202201164298,MYLAN,,69.0,YR,,M,Y,,,20221104,,MD,DE,DE,2022,Q4,Elderly
213507572,21350757,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Unknown IU, according to scheme",,,U,,Unknown,,,,,Solution for injection,,2022,Q4,Circulatory collapse,,2022,Q4,2,F,20190712.0,20221031.0,20220919,20221104,EXP,DE-ADRED-04034-01,DE-PFIZER INC-202201164298,MYLAN,,69.0,YR,,M,Y,,,20221104,,MD,DE,DE,2022,Q4,Elderly
213507572,21350757,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"[presumably,IU] according to sheme; 100 units/ml",,,U,,,,,,,Solution for injection,,2022,Q4,Syncope,,2022,Q4,2,F,20190712.0,20221031.0,20220919,20221104,EXP,DE-ADRED-04034-01,DE-PFIZER INC-202201164298,MYLAN,,69.0,YR,,M,Y,,,20221104,,MD,DE,DE,2022,Q4,Elderly
213507572,21350757,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"[presumably,IU] according to sheme; 100 units/ml",,,U,,,,,,,Solution for injection,,2022,Q4,Dehydration,,2022,Q4,2,F,20190712.0,20221031.0,20220919,20221104,EXP,DE-ADRED-04034-01,DE-PFIZER INC-202201164298,MYLAN,,69.0,YR,,M,Y,,,20221104,,MD,DE,DE,2022,Q4,Elderly
213507572,21350757,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"[presumably,IU] according to sheme; 100 units/ml",,,U,,,,,,,Solution for injection,,2022,Q4,Diarrhoea,,2022,Q4,2,F,20190712.0,20221031.0,20220919,20221104,EXP,DE-ADRED-04034-01,DE-PFIZER INC-202201164298,MYLAN,,69.0,YR,,M,Y,,,20221104,,MD,DE,DE,2022,Q4,Elderly
213507572,21350757,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"[presumably,IU] according to sheme; 100 units/ml",,,U,,,,,,,Solution for injection,,2022,Q4,Hypotension,,2022,Q4,2,F,20190712.0,20221031.0,20220919,20221104,EXP,DE-ADRED-04034-01,DE-PFIZER INC-202201164298,MYLAN,,69.0,YR,,M,Y,,,20221104,,MD,DE,DE,2022,Q4,Elderly
213507572,21350757,12,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"[presumably,IU] according to sheme; 100 units/ml",,,U,,,,,,,Solution for injection,,2022,Q4,Circulatory collapse,,2022,Q4,2,F,20190712.0,20221031.0,20220919,20221104,EXP,DE-ADRED-04034-01,DE-PFIZER INC-202201164298,MYLAN,,69.0,YR,,M,Y,,,20221104,,MD,DE,DE,2022,Q4,Elderly
213605202,21360520,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,Injection,,2022,Q4,Pneumonia aspiration,,2022,Q4,2,F,20220902.0,20220929.0,20220921,20221005,EXP,,JP-PFIZER INC-PV202200064280,PFIZER,,74.0,YR,,M,Y,60.0,KG,20221005,,MD,JP,JP,2022,Q4,Elderly
213638072,21363807,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3 units with meal,,,U,,,,,,,,,2022,Q4,Cryptococcosis,,2022,Q4,2,F,,20220927.0,20220922,20221007,EXP,,US-TEVA-2022-US-2074202,TEVA,,69.0,YR,E,M,Y,,,20221007,,HP,US,US,2022,Q4,Elderly
213638072,21363807,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,3 units with meal,,,U,,,,,,,,,2022,Q4,Cryptococcosis,,2022,Q4,2,F,,20220927.0,20220922,20221007,EXP,,US-TEVA-2022-US-2074202,TEVA,,69.0,YR,E,M,Y,,,20221007,,HP,US,US,2022,Q4,Elderly
213705852,21370585,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Prior to 2020),,,,,,,,,,,,2022,Q4,Disease recurrence,,2022,Q4,2,F,20220921.0,20221003.0,20220923,20221005,PER,,US-PFIZER INC-202201181992,PFIZER,,62.0,YR,,M,Y,74.5,KG,20221005,,CN,US,US,2022,Q4,Adult
213705852,21370585,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK (Prior to 2020),,,,,,,,,,,,2022,Q4,COVID-19,,2022,Q4,2,F,20220921.0,20221003.0,20220923,20221005,PER,,US-PFIZER INC-202201181992,PFIZER,,62.0,YR,,M,Y,74.5,KG,20221005,,CN,US,US,2022,Q4,Adult
213851532,21385153,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 unit,,,,,,,,,,Injection,,2022,Q4,Nephritis,,2022,Q4,2,F,20200914.0,20221020.0,20220928,20221026,EXP,,CA-ROCHE-2678626,ROCHE,,81.0,YR,,M,Y,69.0,KG,20221026,,MD,CA,,2022,Q4,Elderly
213851532,21385153,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 unit,,,,,,,,,,Injection,,2022,Q4,Nephritis,,2022,Q4,2,F,20200914.0,20221020.0,20220928,20221026,EXP,,CA-ROCHE-2678626,ROCHE,,81.0,YR,,M,Y,69.0,KG,20221026,,MD,CA,,2022,Q4,Elderly
213931352,21393135,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,100 IU,,,,,Unknown,,,,,,,2022,Q4,Toxic skin eruption,,2022,Q4,2,F,20220902.0,20220921.0,20220929,20221012,EXP,,PT-AstraZeneca-2022A324152,ASTRAZENECA,,74.0,YR,,F,Y,,,20221012,,MD,PT,,2022,Q4,Elderly
213972772,21397277,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 units,,,,,,,,,,,,2022,Q4,Cytokine release syndrome,,2022,Q4,2,F,20220913.0,20221030.0,20220930,20221101,PER,,US-GILEAD-2022-0599688,GILEAD,,75.0,YR,E,F,Y,95.9,KG,20221101,,HP,US,US,2022,Q4,Elderly
213972772,21397277,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 units,,,,,,,,,,,,2022,Q4,Immune effector cell-associated neurotoxicity syndrome,,2022,Q4,2,F,20220913.0,20221030.0,20220930,20221101,PER,,US-GILEAD-2022-0599688,GILEAD,,75.0,YR,E,F,Y,95.9,KG,20221101,,HP,US,US,2022,Q4,Elderly
213979552,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2022,Q4,Thyroid disorder,,2022,Q4,2,F,,20220927.0,20220930,20221006,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221006,,CN,CA,CA,2022,Q4,Adult
213979552,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2022,Q4,Neuropathy peripheral,,2022,Q4,2,F,,20220927.0,20220930,20221006,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221006,,CN,CA,CA,2022,Q4,Adult
213979552,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2022,Q4,Chest pain,,2022,Q4,2,F,,20220927.0,20220930,20221006,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221006,,CN,CA,CA,2022,Q4,Adult
213979552,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2022,Q4,Headache,,2022,Q4,2,F,,20220927.0,20220930,20221006,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221006,,CN,CA,CA,2022,Q4,Adult
213979552,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2022,Q4,Abdominal pain upper,,2022,Q4,2,F,,20220927.0,20220930,20221006,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221006,,CN,CA,CA,2022,Q4,Adult
213979552,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2022,Q4,Multi-organ disorder,,2022,Q4,2,F,,20220927.0,20220930,20221006,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221006,,CN,CA,CA,2022,Q4,Adult
213979552,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2022,Q4,Arthritis,,2022,Q4,2,F,,20220927.0,20220930,20221006,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221006,,CN,CA,CA,2022,Q4,Adult
213979552,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2022,Q4,Malnutrition,,2022,Q4,2,F,,20220927.0,20220930,20221006,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221006,,CN,CA,CA,2022,Q4,Adult
213979552,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2022,Q4,Cardiac failure congestive,,2022,Q4,2,F,,20220927.0,20220930,20221006,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221006,,CN,CA,CA,2022,Q4,Adult
213979552,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2022,Q4,Pulmonary oedema,,2022,Q4,2,F,,20220927.0,20220930,20221006,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221006,,CN,CA,CA,2022,Q4,Adult
213979552,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2022,Q4,Eye haemorrhage,,2022,Q4,2,F,,20220927.0,20220930,20221006,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221006,,CN,CA,CA,2022,Q4,Adult
213979552,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2022,Q4,Weight decreased,,2022,Q4,2,F,,20220927.0,20220930,20221006,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221006,,CN,CA,CA,2022,Q4,Adult
213979552,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2022,Q4,Pericardial effusion,,2022,Q4,2,F,,20220927.0,20220930,20221006,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221006,,CN,CA,CA,2022,Q4,Adult
213979552,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2022,Q4,Diarrhoea,,2022,Q4,2,F,,20220927.0,20220930,20221006,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221006,,CN,CA,CA,2022,Q4,Adult
213979552,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2022,Q4,Myalgia,,2022,Q4,2,F,,20220927.0,20220930,20221006,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221006,,CN,CA,CA,2022,Q4,Adult
213979552,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2022,Q4,Inappropriate schedule of product administration,,2022,Q4,2,F,,20220927.0,20220930,20221006,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221006,,CN,CA,CA,2022,Q4,Adult
213979552,21397955,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,Solution for injection,,2022,Q4,Blood glucose increased,,2022,Q4,2,F,,20220927.0,20220930,20221006,EXP,,CA-SA-2022SA400021,SANOFI AVENTIS,,54.0,YR,A,F,Y,,,20221006,,CN,CA,CA,2022,Q4,Adult
213981643,21398164,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q4,Overdose,,2022,Q4,3,F,20220901.0,20221013.0,20220930,20221019,PER,,US-SA-2022SA400149,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20221019,,HP,US,US,2022,Q4,Adult
213981643,21398164,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q4,Blood glucose decreased,,2022,Q4,3,F,20220901.0,20221013.0,20220930,20221019,PER,,US-SA-2022SA400149,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20221019,,HP,US,US,2022,Q4,Adult
213981643,21398164,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q4,Inappropriate schedule of product administration,,2022,Q4,3,F,20220901.0,20221013.0,20220930,20221019,PER,,US-SA-2022SA400149,SANOFI AVENTIS,,52.0,YR,A,M,Y,,,20221019,,HP,US,US,2022,Q4,Adult
213987031,21398703,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK,50|50 mg, morning and evening depending on the value",,,U,,,,,,,,,2022,Q4,Pain,,2022,Q4,1,I,,20220919.0,20221001,20221001,EXP,,DE-AUROBINDO-AUR-APL-2022-038660,AUROBINDO,,73.0,YR,,F,Y,,,20221001,,PH,DE,DE,2022,Q4,Elderly
213987031,21398703,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK,50|50 mg, morning and evening depending on the value",,,U,,,,,,,,,2022,Q4,Musculoskeletal pain,,2022,Q4,1,I,,20220919.0,20221001,20221001,EXP,,DE-AUROBINDO-AUR-APL-2022-038660,AUROBINDO,,73.0,YR,,F,Y,,,20221001,,PH,DE,DE,2022,Q4,Elderly
213987031,21398703,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK,50|50 mg, morning and evening depending on the value",,,U,,,,,,,,,2022,Q4,Gait disturbance,,2022,Q4,1,I,,20220919.0,20221001,20221001,EXP,,DE-AUROBINDO-AUR-APL-2022-038660,AUROBINDO,,73.0,YR,,F,Y,,,20221001,,PH,DE,DE,2022,Q4,Elderly
213987031,21398703,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK,50|50 mg, morning and evening depending on the value",,,U,,,,,,,,,2022,Q4,Hypoaesthesia,,2022,Q4,1,I,,20220919.0,20221001,20221001,EXP,,DE-AUROBINDO-AUR-APL-2022-038660,AUROBINDO,,73.0,YR,,F,Y,,,20221001,,PH,DE,DE,2022,Q4,Elderly
213992501,21399250,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Pneumonia aspiration,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,CA-AUROBINDO-AUR-APL-2022-039383,AUROBINDO,,73.0,YR,,M,Y,67.0,KG,20221001,,PH,CA,CA,2022,Q4,Elderly
213992501,21399250,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Oxygen consumption increased,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,CA-AUROBINDO-AUR-APL-2022-039383,AUROBINDO,,73.0,YR,,M,Y,67.0,KG,20221001,,PH,CA,CA,2022,Q4,Elderly
213992501,21399250,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Clostridium test positive,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,CA-AUROBINDO-AUR-APL-2022-039383,AUROBINDO,,73.0,YR,,M,Y,67.0,KG,20221001,,PH,CA,CA,2022,Q4,Elderly
213994391,21399439,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU (International Unit) Daily; 1 IU, 1-0-0-0,",,,U,,UNKNOWN,,,1.0,IU,Solution for injection/infusion,QD,2022,Q4,Renal impairment,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077080,TEVA,,48.0,YR,A,M,Y,72.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213995341,21399534,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Pain,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077633,TEVA,,63.0,YR,A,M,Y,105.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213995341,21399534,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Arthralgia,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077633,TEVA,,63.0,YR,A,M,Y,105.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213995341,21399534,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Haematochezia,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077633,TEVA,,63.0,YR,A,M,Y,105.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213995341,21399534,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Diarrhoea,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077633,TEVA,,63.0,YR,A,M,Y,105.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213995341,21399534,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Pyrexia,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077633,TEVA,,63.0,YR,A,M,Y,105.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213995341,21399534,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077633,TEVA,,63.0,YR,A,M,Y,105.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213995341,21399534,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077633,TEVA,,63.0,YR,A,M,Y,105.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213995341,21399534,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Systemic infection,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077633,TEVA,,63.0,YR,A,M,Y,105.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213995341,21399534,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Nausea,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077633,TEVA,,63.0,YR,A,M,Y,105.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213995341,21399534,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Atrial fibrillation,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077633,TEVA,,63.0,YR,A,M,Y,105.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213995341,21399534,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077633,TEVA,,63.0,YR,A,M,Y,105.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
213995341,21399534,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Chest pain,,2022,Q4,1,I,,20220921.0,20221001,20221001,EXP,,DE-TEVA-2022-DE-2077633,TEVA,,63.0,YR,A,M,Y,105.0,KG,20221001,,PH,DE,DE,2022,Q4,Adult
214000071,21400007,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,26-0-16-0,,,,,,,,,,,,2022,Q4,Acute respiratory failure,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077750,TEVA,,78.0,YR,E,M,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214000071,21400007,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,26-0-16-0,,,,,,,,,,,,2022,Q4,Renal impairment,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077750,TEVA,,78.0,YR,E,M,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214000071,21400007,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,26-0-16-0,,,,,,,,,,,,2022,Q4,Tachycardia,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077750,TEVA,,78.0,YR,E,M,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214000071,21400007,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,26-0-16-0,,,,,,,,,,,,2022,Q4,Arrhythmia,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077750,TEVA,,78.0,YR,E,M,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214000071,21400007,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,26-0-16-0,,,,,,,,,,,,2022,Q4,Atrial fibrillation,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077750,TEVA,,78.0,YR,E,M,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214000071,21400007,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,26-0-16-0,,,,,,,,,,,,2022,Q4,Electrocardiogram abnormal,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077750,TEVA,,78.0,YR,E,M,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214000071,21400007,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,26-0-16-0,,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077750,TEVA,,78.0,YR,E,M,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214000071,21400007,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,26-0-16-0,,,,,,,,,,,,2022,Q4,Systemic infection,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077750,TEVA,,78.0,YR,E,M,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214000071,21400007,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,26-0-16-0,,,,,,,,,,,,2022,Q4,Acute myocardial infarction,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077750,TEVA,,78.0,YR,E,M,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214000071,21400007,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,26-0-16-0,,,,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077750,TEVA,,78.0,YR,E,M,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214000071,21400007,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,26-0-16-0,,,,,,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077750,TEVA,,78.0,YR,E,M,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214001011,21400101,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077718,TEVA,,82.0,YR,E,F,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214001011,21400101,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Hypotension,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077718,TEVA,,82.0,YR,E,F,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214001011,21400101,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Anaemia,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077718,TEVA,,82.0,YR,E,F,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214001011,21400101,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Hyperkalaemia,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077718,TEVA,,82.0,YR,E,F,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214001011,21400101,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077718,TEVA,,82.0,YR,E,F,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214001011,21400101,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Electrocardiogram abnormal,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077718,TEVA,,82.0,YR,E,F,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214001011,21400101,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Tachycardia,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077718,TEVA,,82.0,YR,E,F,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214001011,21400101,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Toxicity to various agents,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077718,TEVA,,82.0,YR,E,F,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214001011,21400101,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Renal impairment,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077718,TEVA,,82.0,YR,E,F,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214001011,21400101,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Loss of consciousness,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077718,TEVA,,82.0,YR,E,F,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214001011,21400101,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Acute respiratory failure,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077718,TEVA,,82.0,YR,E,F,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214001011,21400101,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077718,TEVA,,82.0,YR,E,F,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214001011,21400101,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,scheme,,,,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2077718,TEVA,,82.0,YR,E,F,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214001071,21400107,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"24-0-20-0 , humalog mix 25",,,,,,,,,,,,2022,Q4,Renal impairment,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2078066,TEVA,,71.0,YR,E,M,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214001071,21400107,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"24-0-20-0 , humalog mix 25",,,,,,,,,,,,2022,Q4,COVID-19,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2078066,TEVA,,71.0,YR,E,M,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214001071,21400107,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"24-0-20-0 , humalog mix 25",,,,,,,,,,,,2022,Q4,Hyponatraemia,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2078066,TEVA,,71.0,YR,E,M,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214001071,21400107,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"24-0-20-0 , humalog mix 25",,,,,,,,,,,,2022,Q4,Hypokalaemia,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2078066,TEVA,,71.0,YR,E,M,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214001071,21400107,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"24-0-20-0 , humalog mix 25",,,,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2078066,TEVA,,71.0,YR,E,M,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214001071,21400107,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"24-0-20-0 , humalog mix 25",,,,,,,,,,,,2022,Q4,Dizziness,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2078066,TEVA,,71.0,YR,E,M,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214001071,21400107,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"24-0-20-0 , humalog mix 25",,,,,,,,,,,,2022,Q4,Systemic infection,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2078066,TEVA,,71.0,YR,E,M,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214001071,21400107,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"24-0-20-0 , humalog mix 25",,,,,,,,,,,,2022,Q4,Anaemia,,2022,Q4,1,I,,20220922.0,20221002,20221002,EXP,,DE-TEVA-2022-DE-2078066,TEVA,,71.0,YR,E,M,Y,,,20221002,,PH,DE,DE,2022,Q4,Elderly
214007521,21400752,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q4,Puncture site swelling,,2022,Q4,1,I,20210714.0,20220922.0,20221003,20221003,EXP,DE-BFARM-22007763,DE-NOVOPROD-962025,NOVO NORDISK,,55.0,YR,,M,Y,96.0,KG,20221003,,PH,DE,DE,2022,Q4,Adult
214007521,21400752,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,U,,,,,,,,,2022,Q4,Puncture site pain,,2022,Q4,1,I,20210714.0,20220922.0,20221003,20221003,EXP,DE-BFARM-22007763,DE-NOVOPROD-962025,NOVO NORDISK,,55.0,YR,,M,Y,96.0,KG,20221003,,PH,DE,DE,2022,Q4,Adult
214011771,21401177,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IU/ml, scheme, pre-filled syringes",,,U,,,,209196.0,,,Solution for injection,,2022,Q4,Puncture site swelling,,2022,Q4,1,I,20210714.0,20220927.0,20221003,20221003,EXP,,DE-SA-2022SA401180,SANOFI AVENTIS,,55.0,YR,A,M,Y,96.0,KG,20221003,,PH,DE,DE,2022,Q4,Adult
214011771,21401177,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IU/ml, scheme, pre-filled syringes",,,U,,,,209196.0,,,Solution for injection,,2022,Q4,Puncture site pain,,2022,Q4,1,I,20210714.0,20220927.0,20221003,20221003,EXP,,DE-SA-2022SA401180,SANOFI AVENTIS,,55.0,YR,A,M,Y,96.0,KG,20221003,,PH,DE,DE,2022,Q4,Adult
214014671,21401467,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,,,,,,Unknown,,2022,Q4,Circulatory collapse,,2022,Q4,1,I,20190712.0,20220919.0,20221003,20221003,EXP,,DE-Hikma Pharmaceuticals USA Inc.-DE-H14001-22-58854,HIKMA,,69.0,YR,,M,Y,,,20221003,,MD,DE,DE,2022,Q4,Elderly
214014671,21401467,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,,,,,,Unknown,,2022,Q4,Dehydration,,2022,Q4,1,I,20190712.0,20220919.0,20221003,20221003,EXP,,DE-Hikma Pharmaceuticals USA Inc.-DE-H14001-22-58854,HIKMA,,69.0,YR,,M,Y,,,20221003,,MD,DE,DE,2022,Q4,Elderly
214014671,21401467,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,,,,,,Unknown,,2022,Q4,Hypotension,,2022,Q4,1,I,20190712.0,20220919.0,20221003,20221003,EXP,,DE-Hikma Pharmaceuticals USA Inc.-DE-H14001-22-58854,HIKMA,,69.0,YR,,M,Y,,,20221003,,MD,DE,DE,2022,Q4,Elderly
214014671,21401467,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,,,,,,Unknown,,2022,Q4,Syncope,,2022,Q4,1,I,20190712.0,20220919.0,20221003,20221003,EXP,,DE-Hikma Pharmaceuticals USA Inc.-DE-H14001-22-58854,HIKMA,,69.0,YR,,M,Y,,,20221003,,MD,DE,DE,2022,Q4,Elderly
214014671,21401467,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Unknown,,,,,,,,,,Unknown,,2022,Q4,Diarrhoea,,2022,Q4,1,I,20190712.0,20220919.0,20221003,20221003,EXP,,DE-Hikma Pharmaceuticals USA Inc.-DE-H14001-22-58854,HIKMA,,69.0,YR,,M,Y,,,20221003,,MD,DE,DE,2022,Q4,Elderly
214018761,21401876,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, unknown",,,U,,D508134D,,20563.0,5.0,IU,Injection,,2022,Q4,Product dose omission issue,,2022,Q4,1,I,20220912.0,20220912.0,20221003,20221003,PER,,US-ELI_LILLY_AND_COMPANY-US202209005459,ELI LILLY AND CO,,20.0,YR,,M,Y,,,20221003,,CN,US,US,2022,Q4,Youth
214018761,21401876,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"5 u, unknown",,,U,,D508134D,,20563.0,5.0,IU,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20220912.0,20220912.0,20221003,20221003,PER,,US-ELI_LILLY_AND_COMPANY-US202209005459,ELI LILLY AND CO,,20.0,YR,,M,Y,,,20221003,,CN,US,US,2022,Q4,Youth
214018921,21401892,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Bowel movement irregularity,,2022,Q4,1,I,,20220921.0,20221003,20221003,EXP,,CA-AUROBINDO-AUR-APL-2022-039435,AUROBINDO,,83.0,YR,,M,Y,,,20221003,,PH,CA,CA,2022,Q4,Elderly
214018921,21401892,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Clostridium test positive,,2022,Q4,1,I,,20220921.0,20221003,20221003,EXP,,CA-AUROBINDO-AUR-APL-2022-039435,AUROBINDO,,83.0,YR,,M,Y,,,20221003,,PH,CA,CA,2022,Q4,Elderly
214024771,21402477,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,,,2022,Q4,Puncture site pain,,2022,Q4,1,I,20210714.0,20220922.0,20221003,20221003,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209010552,ELI LILLY AND CO,,55.0,YR,,M,Y,96.0,KG,20221003,,CN,DE,DE,2022,Q4,Adult
214024771,21402477,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, unknown",,,U,,,,20563.0,,,,,2022,Q4,Puncture site swelling,,2022,Q4,1,I,20210714.0,20220922.0,20221003,20221003,EXP,,DE-ELI_LILLY_AND_COMPANY-DE202209010552,ELI LILLY AND CO,,55.0,YR,,M,Y,96.0,KG,20221003,,CN,DE,DE,2022,Q4,Adult
214024982,21402498,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D490289M,,20563.0,,,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,2,F,20220927.0,20220927.0,20221003,20221007,PER,,US-ELI_LILLY_AND_COMPANY-US202209013449,ELI LILLY AND CO,,79.0,YR,,M,Y,,,20221007,,CN,US,US,2022,Q4,Elderly
214036791,21403679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, PRN",,,U,,,,,1.0,IU,Solution for injection/infusion,,2022,Q4,Cardiac failure,,2022,Q4,1,I,,20220926.0,20221003,20221003,EXP,,NVSC2022DE217301,NOVARTIS,,80.0,YR,,F,Y,65.0,KG,20221003,,PH,DE,DE,2022,Q4,Elderly
214036791,21403679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, PRN",,,U,,,,,1.0,IU,Solution for injection/infusion,,2022,Q4,Renal impairment,,2022,Q4,1,I,,20220926.0,20221003,20221003,EXP,,NVSC2022DE217301,NOVARTIS,,80.0,YR,,F,Y,65.0,KG,20221003,,PH,DE,DE,2022,Q4,Elderly
214036791,21403679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, PRN",,,U,,,,,1.0,IU,Solution for injection/infusion,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20220926.0,20221003,20221003,EXP,,NVSC2022DE217301,NOVARTIS,,80.0,YR,,F,Y,65.0,KG,20221003,,PH,DE,DE,2022,Q4,Elderly
214036791,21403679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, PRN",,,U,,,,,1.0,IU,Solution for injection/infusion,,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20220926.0,20221003,20221003,EXP,,NVSC2022DE217301,NOVARTIS,,80.0,YR,,F,Y,65.0,KG,20221003,,PH,DE,DE,2022,Q4,Elderly
214036791,21403679,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, PRN",,,U,,,,,1.0,IU,Solution for injection/infusion,,2022,Q4,Anaemia,,2022,Q4,1,I,,20220926.0,20221003,20221003,EXP,,NVSC2022DE217301,NOVARTIS,,80.0,YR,,F,Y,65.0,KG,20221003,,PH,DE,DE,2022,Q4,Elderly
214046911,21404691,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, bid",,,U,,D379507A,,,10.0,IU,Injection,BID,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20220920.0,20220921.0,20221003,20221003,EXP,,US-ELI_LILLY_AND_COMPANY-US202209012107,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20221003,,PH,US,US,2022,Q4,Elderly
214046911,21404691,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, bid",,,U,,D379507A,,,10.0,IU,Injection,BID,2022,Q4,Incorrect dose administered,,2022,Q4,1,I,20220920.0,20220921.0,20221003,20221003,EXP,,US-ELI_LILLY_AND_COMPANY-US202209012107,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20221003,,PH,US,US,2022,Q4,Elderly
214046911,21404691,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, bid",,,U,,D379507A,,,10.0,IU,Injection,BID,2022,Q4,Cardiac disorder,,2022,Q4,1,I,20220920.0,20220921.0,20221003,20221003,EXP,,US-ELI_LILLY_AND_COMPANY-US202209012107,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20221003,,PH,US,US,2022,Q4,Elderly
214046911,21404691,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, bid",,,U,,D379507A,,,10.0,IU,Injection,BID,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20220920.0,20220921.0,20221003,20221003,EXP,,US-ELI_LILLY_AND_COMPANY-US202209012107,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20221003,,PH,US,US,2022,Q4,Elderly
214046911,21404691,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, bid",,,U,,D379507A,,,10.0,IU,Injection,BID,2022,Q4,Incorrect dose administered,,2022,Q4,1,I,20220920.0,20220921.0,20221003,20221003,EXP,,US-ELI_LILLY_AND_COMPANY-US202209012107,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20221003,,PH,US,US,2022,Q4,Elderly
214046911,21404691,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, bid",,,U,,D379507A,,,10.0,IU,Injection,BID,2022,Q4,Cardiac disorder,,2022,Q4,1,I,20220920.0,20220921.0,20221003,20221003,EXP,,US-ELI_LILLY_AND_COMPANY-US202209012107,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20221003,,PH,US,US,2022,Q4,Elderly
214046911,21404691,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, daily",,,U,,,,,10.0,IU,Injection,BID,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20220920.0,20220921.0,20221003,20221003,EXP,,US-ELI_LILLY_AND_COMPANY-US202209012107,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20221003,,PH,US,US,2022,Q4,Elderly
214046911,21404691,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, daily",,,U,,,,,10.0,IU,Injection,BID,2022,Q4,Incorrect dose administered,,2022,Q4,1,I,20220920.0,20220921.0,20221003,20221003,EXP,,US-ELI_LILLY_AND_COMPANY-US202209012107,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20221003,,PH,US,US,2022,Q4,Elderly
214046911,21404691,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, daily",,,U,,,,,10.0,IU,Injection,BID,2022,Q4,Cardiac disorder,,2022,Q4,1,I,20220920.0,20220921.0,20221003,20221003,EXP,,US-ELI_LILLY_AND_COMPANY-US202209012107,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20221003,,PH,US,US,2022,Q4,Elderly
214046911,21404691,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, daily",,,U,,,,,10.0,IU,Injection,BID,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20220920.0,20220921.0,20221003,20221003,EXP,,US-ELI_LILLY_AND_COMPANY-US202209012107,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20221003,,PH,US,US,2022,Q4,Elderly
214046911,21404691,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, daily",,,U,,,,,10.0,IU,Injection,BID,2022,Q4,Incorrect dose administered,,2022,Q4,1,I,20220920.0,20220921.0,20221003,20221003,EXP,,US-ELI_LILLY_AND_COMPANY-US202209012107,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20221003,,PH,US,US,2022,Q4,Elderly
214046911,21404691,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, daily",,,U,,,,,10.0,IU,Injection,BID,2022,Q4,Cardiac disorder,,2022,Q4,1,I,20220920.0,20220921.0,20221003,20221003,EXP,,US-ELI_LILLY_AND_COMPANY-US202209012107,ELI LILLY AND CO,,82.0,YR,,M,Y,,,20221003,,PH,US,US,2022,Q4,Elderly
214051121,21405112,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, Q8H",,,U,,,,209196.0,,,Solution for injection,Q8H,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,1,I,,20220927.0,20221004,20221004,EXP,,CA-SA-2022SA400414,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20221004,,CN,CA,CA,2022,Q4,Adult
214051121,21405112,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, Q8H",,,U,,,,209196.0,,,Solution for injection,Q8H,2022,Q4,Klebsiella infection,,2022,Q4,1,I,,20220927.0,20221004,20221004,EXP,,CA-SA-2022SA400414,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20221004,,CN,CA,CA,2022,Q4,Adult
214051121,21405112,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, Q8H",,,U,,,,209196.0,,,Solution for injection,Q8H,2022,Q4,Pancreatic abscess,,2022,Q4,1,I,,20220927.0,20221004,20221004,EXP,,CA-SA-2022SA400414,SANOFI AVENTIS,,54.0,YR,A,M,Y,,,20221004,,CN,CA,CA,2022,Q4,Adult
214060001,21406000,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,UNKNOWN,,,,,,,2022,Q4,Pyrexia,,2022,Q4,1,I,,20220922.0,20221004,20221004,EXP,,DE-drreddys-SPO/GER/22/0155099,DR REDDYS,,63.0,YR,A,M,Y,105.0,KG,20221004,,PH,DE,DE,2022,Q4,Adult
214060001,21406000,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,UNKNOWN,,,,,,,2022,Q4,Diarrhoea,,2022,Q4,1,I,,20220922.0,20221004,20221004,EXP,,DE-drreddys-SPO/GER/22/0155099,DR REDDYS,,63.0,YR,A,M,Y,105.0,KG,20221004,,PH,DE,DE,2022,Q4,Adult
214060001,21406000,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,UNKNOWN,,,,,,,2022,Q4,Weight increased,,2022,Q4,1,I,,20220922.0,20221004,20221004,EXP,,DE-drreddys-SPO/GER/22/0155099,DR REDDYS,,63.0,YR,A,M,Y,105.0,KG,20221004,,PH,DE,DE,2022,Q4,Adult
214060001,21406000,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,UNKNOWN,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20220922.0,20221004,20221004,EXP,,DE-drreddys-SPO/GER/22/0155099,DR REDDYS,,63.0,YR,A,M,Y,105.0,KG,20221004,,PH,DE,DE,2022,Q4,Adult
214060001,21406000,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,UNKNOWN,,,,,,,2022,Q4,Systemic infection,,2022,Q4,1,I,,20220922.0,20221004,20221004,EXP,,DE-drreddys-SPO/GER/22/0155099,DR REDDYS,,63.0,YR,A,M,Y,105.0,KG,20221004,,PH,DE,DE,2022,Q4,Adult
214060001,21406000,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,UNKNOWN,,,,,,,2022,Q4,Arthralgia,,2022,Q4,1,I,,20220922.0,20221004,20221004,EXP,,DE-drreddys-SPO/GER/22/0155099,DR REDDYS,,63.0,YR,A,M,Y,105.0,KG,20221004,,PH,DE,DE,2022,Q4,Adult
214060001,21406000,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,UNKNOWN,,,,,,,2022,Q4,Chest pain,,2022,Q4,1,I,,20220922.0,20221004,20221004,EXP,,DE-drreddys-SPO/GER/22/0155099,DR REDDYS,,63.0,YR,A,M,Y,105.0,KG,20221004,,PH,DE,DE,2022,Q4,Adult
214060001,21406000,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,UNKNOWN,,,,,,,2022,Q4,Pain,,2022,Q4,1,I,,20220922.0,20221004,20221004,EXP,,DE-drreddys-SPO/GER/22/0155099,DR REDDYS,,63.0,YR,A,M,Y,105.0,KG,20221004,,PH,DE,DE,2022,Q4,Adult
214060001,21406000,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,UNKNOWN,,,,,,,2022,Q4,Atrial fibrillation,,2022,Q4,1,I,,20220922.0,20221004,20221004,EXP,,DE-drreddys-SPO/GER/22/0155099,DR REDDYS,,63.0,YR,A,M,Y,105.0,KG,20221004,,PH,DE,DE,2022,Q4,Adult
214060001,21406000,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,UNKNOWN,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20220922.0,20221004,20221004,EXP,,DE-drreddys-SPO/GER/22/0155099,DR REDDYS,,63.0,YR,A,M,Y,105.0,KG,20221004,,PH,DE,DE,2022,Q4,Adult
214060001,21406000,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,UNKNOWN,,,,,,,2022,Q4,Haematochezia,,2022,Q4,1,I,,20220922.0,20221004,20221004,EXP,,DE-drreddys-SPO/GER/22/0155099,DR REDDYS,,63.0,YR,A,M,Y,105.0,KG,20221004,,PH,DE,DE,2022,Q4,Adult
214060001,21406000,9,C,INSULIN LISPRO,INSULIN LISPRO,1,,Schema,,,,,UNKNOWN,,,,,,,2022,Q4,Nausea,,2022,Q4,1,I,,20220922.0,20221004,20221004,EXP,,DE-drreddys-SPO/GER/22/0155099,DR REDDYS,,63.0,YR,A,M,Y,105.0,KG,20221004,,PH,DE,DE,2022,Q4,Adult
214078861,21407886,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 unit, subcutaneously (SC) at 7.30 a.m.,",,,,,,,,,,Injection,QD,2022,Q4,Lymphadenopathy,,2022,Q4,1,I,20220101.0,20220928.0,20221004,20221004,EXP,,PL-MYLANLABS-2022M1036146,MYLAN,,80.0,YR,,F,Y,71.0,KG,20221004,,MD,PL,PL,2022,Q4,Elderly
214078861,21407886,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 unit, subcutaneously (SC) at 7.30 a.m.,",,,,,,,,,,Injection,QD,2022,Q4,Neutropenia,,2022,Q4,1,I,20220101.0,20220928.0,20221004,20221004,EXP,,PL-MYLANLABS-2022M1036146,MYLAN,,80.0,YR,,F,Y,71.0,KG,20221004,,MD,PL,PL,2022,Q4,Elderly
2140936212,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,Unknown,,2022,Q4,Death,,2022,Q4,12,F,20210702.0,20221209.0,20221004,20221213,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20221214,,PH,DE,DE,2022,Q4,Adult
2140936212,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,Unknown,,2022,Q4,Pain,,2022,Q4,12,F,20210702.0,20221209.0,20221004,20221213,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20221214,,PH,DE,DE,2022,Q4,Adult
2140936212,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,Unknown,,2022,Q4,Systemic infection,,2022,Q4,12,F,20210702.0,20221209.0,20221004,20221213,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20221214,,PH,DE,DE,2022,Q4,Adult
2140936212,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,Unknown,,2022,Q4,Vomiting,,2022,Q4,12,F,20210702.0,20221209.0,20221004,20221213,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20221214,,PH,DE,DE,2022,Q4,Adult
2140936212,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,Unknown,,2022,Q4,Depressed level of consciousness,,2022,Q4,12,F,20210702.0,20221209.0,20221004,20221213,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20221214,,PH,DE,DE,2022,Q4,Adult
2140936212,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,Unknown,,2022,Q4,Cachexia,,2022,Q4,12,F,20210702.0,20221209.0,20221004,20221213,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20221214,,PH,DE,DE,2022,Q4,Adult
2140936212,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,Unknown,,2022,Q4,Fatigue,,2022,Q4,12,F,20210702.0,20221209.0,20221004,20221213,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20221214,,PH,DE,DE,2022,Q4,Adult
2140936212,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,Unknown,,2022,Q4,Nausea,,2022,Q4,12,F,20210702.0,20221209.0,20221004,20221213,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20221214,,PH,DE,DE,2022,Q4,Adult
2140936212,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,Unknown,,2022,Q4,Haematochezia,,2022,Q4,12,F,20210702.0,20221209.0,20221004,20221213,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20221214,,PH,DE,DE,2022,Q4,Adult
2140936212,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,Unknown,,2022,Q4,General physical health deterioration,,2022,Q4,12,F,20210702.0,20221209.0,20221004,20221213,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20221214,,PH,DE,DE,2022,Q4,Adult
2140936212,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,Unknown,,2022,Q4,Tenderness,,2022,Q4,12,F,20210702.0,20221209.0,20221004,20221213,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20221214,,PH,DE,DE,2022,Q4,Adult
2140936212,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,Unknown,,2022,Q4,Anaemia,,2022,Q4,12,F,20210702.0,20221209.0,20221004,20221213,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20221214,,PH,DE,DE,2022,Q4,Adult
2140936212,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,Unknown,,2022,Q4,Dehydration,,2022,Q4,12,F,20210702.0,20221209.0,20221004,20221213,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20221214,,PH,DE,DE,2022,Q4,Adult
2140936212,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,Unknown,,2022,Q4,Condition aggravated,,2022,Q4,12,F,20210702.0,20221209.0,20221004,20221213,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20221214,,PH,DE,DE,2022,Q4,Adult
2140936212,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,Unknown,,2022,Q4,Tachycardia,,2022,Q4,12,F,20210702.0,20221209.0,20221004,20221213,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20221214,,PH,DE,DE,2022,Q4,Adult
2140936212,21409362,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,Unknown,,2022,Q4,Hyperglycaemia,,2022,Q4,12,F,20210702.0,20221209.0,20221004,20221213,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-115355,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20221214,,PH,DE,DE,2022,Q4,Adult
214173291,21417329,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,,,,,,,,,,,,,2022,Q4,Suicidal ideation,,2022,Q4,1,I,20220822.0,20220928.0,20221006,20221006,EXP,,US-VERTEX PHARMACEUTICALS-2022-013917,VERTEX,,52.0,YR,,F,Y,,,20221006,,CN,US,US,2022,Q4,Adult
214173291,21417329,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,,,,,,,,,,,,,2022,Q4,Pneumonia,,2022,Q4,1,I,20220822.0,20220928.0,20221006,20221006,EXP,,US-VERTEX PHARMACEUTICALS-2022-013917,VERTEX,,52.0,YR,,F,Y,,,20221006,,CN,US,US,2022,Q4,Adult
214173291,21417329,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,,,,,,,,,,,,,2022,Q4,Stress,,2022,Q4,1,I,20220822.0,20220928.0,20221006,20221006,EXP,,US-VERTEX PHARMACEUTICALS-2022-013917,VERTEX,,52.0,YR,,F,Y,,,20221006,,CN,US,US,2022,Q4,Adult
214173291,21417329,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Oral,,,,,,,,,,,,,2022,Q4,Depression,,2022,Q4,1,I,20220822.0,20220928.0,20221006,20221006,EXP,,US-VERTEX PHARMACEUTICALS-2022-013917,VERTEX,,52.0,YR,,F,Y,,,20221006,,CN,US,US,2022,Q4,Adult
214181701,21418170,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, 5-12-6-0",,,,,,,,,,,,2022,Q4,Loss of consciousness,,2022,Q4,1,I,,20220926.0,20221006,20221006,EXP,,DE-TEVA-2022-DE-2078693,TEVA,,66.0,YR,E,M,Y,90.0,KG,20221006,,PH,DE,DE,2022,Q4,Elderly
214181701,21418170,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, 5-12-6-0",,,,,,,,,,,,2022,Q4,Fall,,2022,Q4,1,I,,20220926.0,20221006,20221006,EXP,,DE-TEVA-2022-DE-2078693,TEVA,,66.0,YR,E,M,Y,90.0,KG,20221006,,PH,DE,DE,2022,Q4,Elderly
214181701,21418170,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, 5-12-6-0",,,,,,,,,,,,2022,Q4,Cerebral haemorrhage,,2022,Q4,1,I,,20220926.0,20221006,20221006,EXP,,DE-TEVA-2022-DE-2078693,TEVA,,66.0,YR,E,M,Y,90.0,KG,20221006,,PH,DE,DE,2022,Q4,Elderly
214191411,21419141,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50|50 mg, morning and evening depending on the value",,,,,,,,,,,,2022,Q4,Gait disturbance,,2022,Q4,1,I,,20220926.0,20221006,20221006,EXP,,DE-TEVA-2022-DE-2078995,TEVA,,73.0,YR,E,F,Y,,,20221006,,PH,DE,DE,2022,Q4,Elderly
214191411,21419141,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50|50 mg, morning and evening depending on the value",,,,,,,,,,,,2022,Q4,Musculoskeletal pain,,2022,Q4,1,I,,20220926.0,20221006,20221006,EXP,,DE-TEVA-2022-DE-2078995,TEVA,,73.0,YR,E,F,Y,,,20221006,,PH,DE,DE,2022,Q4,Elderly
214191411,21419141,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50|50 mg, morning and evening depending on the value",,,,,,,,,,,,2022,Q4,Pain,,2022,Q4,1,I,,20220926.0,20221006,20221006,EXP,,DE-TEVA-2022-DE-2078995,TEVA,,73.0,YR,E,F,Y,,,20221006,,PH,DE,DE,2022,Q4,Elderly
214191411,21419141,3,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50|50 mg, morning and evening depending on the value",,,,,,,,,,,,2022,Q4,Hypoaesthesia,,2022,Q4,1,I,,20220926.0,20221006,20221006,EXP,,DE-TEVA-2022-DE-2078995,TEVA,,73.0,YR,E,F,Y,,,20221006,,PH,DE,DE,2022,Q4,Elderly
214191591,21419159,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50|50 IU, depending on the BG",,,,,,,,,,,,2022,Q4,Condition aggravated,,2022,Q4,1,I,,20220926.0,20221006,20221006,EXP,,DE-TEVA-2022-DE-2078997,TEVA,,74.0,YR,E,F,Y,,,20221006,,PH,DE,DE,2022,Q4,Elderly
214191591,21419159,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50|50 IU, depending on the BG",,,,,,,,,,,,2022,Q4,Musculoskeletal pain,,2022,Q4,1,I,,20220926.0,20221006,20221006,EXP,,DE-TEVA-2022-DE-2078997,TEVA,,74.0,YR,E,F,Y,,,20221006,,PH,DE,DE,2022,Q4,Elderly
214191591,21419159,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50|50 IU, depending on the BG",,,,,,,,,,,,2022,Q4,Gait disturbance,,2022,Q4,1,I,,20220926.0,20221006,20221006,EXP,,DE-TEVA-2022-DE-2078997,TEVA,,74.0,YR,E,F,Y,,,20221006,,PH,DE,DE,2022,Q4,Elderly
214191591,21419159,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50|50 IU, depending on the BG",,,,,,,,,,,,2022,Q4,Arthralgia,,2022,Q4,1,I,,20220926.0,20221006,20221006,EXP,,DE-TEVA-2022-DE-2078997,TEVA,,74.0,YR,E,F,Y,,,20221006,,PH,DE,DE,2022,Q4,Elderly
214191591,21419159,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50|50 IU, depending on the BG",,,,,,,,,,,,2022,Q4,Pain,,2022,Q4,1,I,,20220926.0,20221006,20221006,EXP,,DE-TEVA-2022-DE-2078997,TEVA,,74.0,YR,E,F,Y,,,20221006,,PH,DE,DE,2022,Q4,Elderly
214191591,21419159,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50|50 IU, depending on the BG",,,,,,,,,,,,2022,Q4,Product prescribing error,,2022,Q4,1,I,,20220926.0,20221006,20221006,EXP,,DE-TEVA-2022-DE-2078997,TEVA,,74.0,YR,E,F,Y,,,20221006,,PH,DE,DE,2022,Q4,Elderly
214194312,21419431,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,,,,1.0,IU,,,2022,Q4,Condition aggravated,,2022,Q4,2,F,,20221021.0,20221006,20221027,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20221027,,PH,DE,DE,2022,Q4,Adult
214194312,21419431,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,,,,1.0,IU,,,2022,Q4,Systemic infection,,2022,Q4,2,F,,20221021.0,20221006,20221027,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20221027,,PH,DE,DE,2022,Q4,Adult
214194312,21419431,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,,,,1.0,IU,,,2022,Q4,Hyperglycaemia,,2022,Q4,2,F,,20221021.0,20221006,20221027,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20221027,,PH,DE,DE,2022,Q4,Adult
214194312,21419431,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,,,,1.0,IU,,,2022,Q4,Depressed level of consciousness,,2022,Q4,2,F,,20221021.0,20221006,20221027,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20221027,,PH,DE,DE,2022,Q4,Adult
214194312,21419431,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,,,,1.0,IU,,,2022,Q4,Pain,,2022,Q4,2,F,,20221021.0,20221006,20221027,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20221027,,PH,DE,DE,2022,Q4,Adult
214194312,21419431,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,,,,1.0,IU,,,2022,Q4,Fatigue,,2022,Q4,2,F,,20221021.0,20221006,20221027,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20221027,,PH,DE,DE,2022,Q4,Adult
214194312,21419431,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,,,,1.0,IU,,,2022,Q4,Dehydration,,2022,Q4,2,F,,20221021.0,20221006,20221027,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20221027,,PH,DE,DE,2022,Q4,Adult
214194312,21419431,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,,,,1.0,IU,,,2022,Q4,Nausea,,2022,Q4,2,F,,20221021.0,20221006,20221027,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20221027,,PH,DE,DE,2022,Q4,Adult
214194312,21419431,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,,,,1.0,IU,,,2022,Q4,Haematochezia,,2022,Q4,2,F,,20221021.0,20221006,20221027,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20221027,,PH,DE,DE,2022,Q4,Adult
214194312,21419431,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,,,,1.0,IU,,,2022,Q4,Vomiting,,2022,Q4,2,F,,20221021.0,20221006,20221027,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20221027,,PH,DE,DE,2022,Q4,Adult
214194312,21419431,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,,,,1.0,IU,,,2022,Q4,Tachycardia,,2022,Q4,2,F,,20221021.0,20221006,20221027,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20221027,,PH,DE,DE,2022,Q4,Adult
214194312,21419431,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,,,,1.0,IU,,,2022,Q4,Anaemia,,2022,Q4,2,F,,20221021.0,20221006,20221027,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20221027,,PH,DE,DE,2022,Q4,Adult
214194312,21419431,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,,,,1.0,IU,,,2022,Q4,Tenderness,,2022,Q4,2,F,,20221021.0,20221006,20221027,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20221027,,PH,DE,DE,2022,Q4,Adult
214194312,21419431,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,,,,1.0,IU,,,2022,Q4,Cachexia,,2022,Q4,2,F,,20221021.0,20221006,20221027,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20221027,,PH,DE,DE,2022,Q4,Adult
214194312,21419431,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,,,,1.0,IU,,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221021.0,20221006,20221027,EXP,,DE-BAUSCH-BL-2022-023086,BAUSCH AND LOMB,,48.0,YR,,M,Y,68.0,KG,20221027,,PH,DE,DE,2022,Q4,Adult
214195172,21419517,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q4,Haemobilia,,2022,Q4,2,F,20220928.0,20221012.0,20221006,20221019,EXP,,JP-SEATTLE GENETICS-2022SGN09243,SEATTLE GENETICS,,75.0,YR,,M,Y,66.4,KG,20221019,,MD,JP,JP,2022,Q4,Elderly
214206151,21420615,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Blood glucose abnormal,,2022,Q4,1,I,,20221004.0,20221007,20221007,PER,,US-ELI_LILLY_AND_COMPANY-US202210002605,ELI LILLY AND CO,,75.0,YR,,M,Y,,,20221007,,CN,US,US,2022,Q4,Elderly
214206161,21420616,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"10 u, unknown",,,U,,D508134D,,20563.0,10.0,IU,Injection,,2022,Q4,Incorrect dose administered,,2022,Q4,1,I,20221004.0,20221004.0,20221007,20221007,PER,,US-ELI_LILLY_AND_COMPANY-US202210002597,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20221007,,CN,US,US,2022,Q4,Elderly
214216951,21421695,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, according to BZ, injection/infusion solution",,,,,,,,1.0,IU,,,2022,Q4,Diarrhoea,,2022,Q4,1,I,,20220927.0,20221007,20221007,EXP,,DE-TEVA-2022-DE-2079296,TEVA,,82.0,YR,E,F,Y,54.0,KG,20221007,,PH,DE,DE,2022,Q4,Elderly
214216951,21421695,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, according to BZ, injection/infusion solution",,,,,,,,1.0,IU,,,2022,Q4,C-reactive protein increased,,2022,Q4,1,I,,20220927.0,20221007,20221007,EXP,,DE-TEVA-2022-DE-2079296,TEVA,,82.0,YR,E,F,Y,54.0,KG,20221007,,PH,DE,DE,2022,Q4,Elderly
214216951,21421695,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, according to BZ, injection/infusion solution",,,,,,,,1.0,IU,,,2022,Q4,Muscular weakness,,2022,Q4,1,I,,20220927.0,20221007,20221007,EXP,,DE-TEVA-2022-DE-2079296,TEVA,,82.0,YR,E,F,Y,54.0,KG,20221007,,PH,DE,DE,2022,Q4,Elderly
214302101,21430210,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, as needed",,,,,,,,,,Solution for injection/infusion,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20220929.0,20221009,20221009,EXP,,DE-TEVA-2022-DE-2080961,TEVA,,80.0,YR,E,F,Y,65.0,KG,20221009,,PH,DE,DE,2022,Q4,Elderly
214302101,21430210,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, as needed",,,,,,,,,,Solution for injection/infusion,,2022,Q4,Anaemia,,2022,Q4,1,I,,20220929.0,20221009,20221009,EXP,,DE-TEVA-2022-DE-2080961,TEVA,,80.0,YR,E,F,Y,65.0,KG,20221009,,PH,DE,DE,2022,Q4,Elderly
214302101,21430210,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, as needed",,,,,,,,,,Solution for injection/infusion,,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20220929.0,20221009,20221009,EXP,,DE-TEVA-2022-DE-2080961,TEVA,,80.0,YR,E,F,Y,65.0,KG,20221009,,PH,DE,DE,2022,Q4,Elderly
214302101,21430210,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, as needed",,,,,,,,,,Solution for injection/infusion,,2022,Q4,Cardiac failure,,2022,Q4,1,I,,20220929.0,20221009,20221009,EXP,,DE-TEVA-2022-DE-2080961,TEVA,,80.0,YR,E,F,Y,65.0,KG,20221009,,PH,DE,DE,2022,Q4,Elderly
214302101,21430210,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, as needed",,,,,,,,,,Solution for injection/infusion,,2022,Q4,Renal impairment,,2022,Q4,1,I,,20220929.0,20221009,20221009,EXP,,DE-TEVA-2022-DE-2080961,TEVA,,80.0,YR,E,F,Y,65.0,KG,20221009,,PH,DE,DE,2022,Q4,Elderly
214348916,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU (1 IU, scheme)",,,U,,,,,1.0,IU,,,2022,Q4,Cachexia,,2022,Q4,6,F,,20221202.0,20221010,20221205,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20221205,,PH,DE,DE,2022,Q4,Adult
214348916,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU (1 IU, scheme)",,,U,,,,,1.0,IU,,,2022,Q4,Tenderness,,2022,Q4,6,F,,20221202.0,20221010,20221205,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20221205,,PH,DE,DE,2022,Q4,Adult
214348916,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU (1 IU, scheme)",,,U,,,,,1.0,IU,,,2022,Q4,Depressed level of consciousness,,2022,Q4,6,F,,20221202.0,20221010,20221205,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20221205,,PH,DE,DE,2022,Q4,Adult
214348916,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU (1 IU, scheme)",,,U,,,,,1.0,IU,,,2022,Q4,Tachycardia,,2022,Q4,6,F,,20221202.0,20221010,20221205,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20221205,,PH,DE,DE,2022,Q4,Adult
214348916,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU (1 IU, scheme)",,,U,,,,,1.0,IU,,,2022,Q4,Condition aggravated,,2022,Q4,6,F,,20221202.0,20221010,20221205,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20221205,,PH,DE,DE,2022,Q4,Adult
214348916,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU (1 IU, scheme)",,,U,,,,,1.0,IU,,,2022,Q4,Haematochezia,,2022,Q4,6,F,,20221202.0,20221010,20221205,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20221205,,PH,DE,DE,2022,Q4,Adult
214348916,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU (1 IU, scheme)",,,U,,,,,1.0,IU,,,2022,Q4,Hyperglycaemia,,2022,Q4,6,F,,20221202.0,20221010,20221205,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20221205,,PH,DE,DE,2022,Q4,Adult
214348916,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU (1 IU, scheme)",,,U,,,,,1.0,IU,,,2022,Q4,Nausea,,2022,Q4,6,F,,20221202.0,20221010,20221205,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20221205,,PH,DE,DE,2022,Q4,Adult
214348916,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU (1 IU, scheme)",,,U,,,,,1.0,IU,,,2022,Q4,Condition aggravated,,2022,Q4,6,F,,20221202.0,20221010,20221205,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20221205,,PH,DE,DE,2022,Q4,Adult
214348916,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU (1 IU, scheme)",,,U,,,,,1.0,IU,,,2022,Q4,Dehydration,,2022,Q4,6,F,,20221202.0,20221010,20221205,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20221205,,PH,DE,DE,2022,Q4,Adult
214348916,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU (1 IU, scheme)",,,U,,,,,1.0,IU,,,2022,Q4,Systemic infection,,2022,Q4,6,F,,20221202.0,20221010,20221205,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20221205,,PH,DE,DE,2022,Q4,Adult
214348916,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU (1 IU, scheme)",,,U,,,,,1.0,IU,,,2022,Q4,Vomiting,,2022,Q4,6,F,,20221202.0,20221010,20221205,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20221205,,PH,DE,DE,2022,Q4,Adult
214348916,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU (1 IU, scheme)",,,U,,,,,1.0,IU,,,2022,Q4,Anaemia,,2022,Q4,6,F,,20221202.0,20221010,20221205,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20221205,,PH,DE,DE,2022,Q4,Adult
214348916,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU (1 IU, scheme)",,,U,,,,,1.0,IU,,,2022,Q4,General physical health deterioration,,2022,Q4,6,F,,20221202.0,20221010,20221205,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20221205,,PH,DE,DE,2022,Q4,Adult
214348916,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU (1 IU, scheme)",,,U,,,,,1.0,IU,,,2022,Q4,Death,,2022,Q4,6,F,,20221202.0,20221010,20221205,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20221205,,PH,DE,DE,2022,Q4,Adult
214348916,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU (1 IU, scheme)",,,U,,,,,1.0,IU,,,2022,Q4,Pain,,2022,Q4,6,F,,20221202.0,20221010,20221205,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20221205,,PH,DE,DE,2022,Q4,Adult
214348916,21434891,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU (1 IU, scheme)",,,U,,,,,1.0,IU,,,2022,Q4,Fatigue,,2022,Q4,6,F,,20221202.0,20221010,20221205,EXP,,NVSC2022DE222618,NOVARTIS,,48.0,YR,,M,Y,68.0,KG,20221205,,PH,DE,DE,2022,Q4,Adult
214362951,21436295,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q4,Atrial fibrillation,,2022,Q4,1,I,20210604.0,20220929.0,20221010,20221010,EXP,,DE-BAYER-2022A136229,BAYER,,86.0,YR,E,M,Y,77.0,KG,20221010,,PH,DE,DE,2022,Q4,Elderly
214362951,21436295,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q4,Product prescribing error,,2022,Q4,1,I,20210604.0,20220929.0,20221010,20221010,EXP,,DE-BAYER-2022A136229,BAYER,,86.0,YR,E,M,Y,77.0,KG,20221010,,PH,DE,DE,2022,Q4,Elderly
214362951,21436295,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q4,Tachycardia,,2022,Q4,1,I,20210604.0,20220929.0,20221010,20221010,EXP,,DE-BAYER-2022A136229,BAYER,,86.0,YR,E,M,Y,77.0,KG,20221010,,PH,DE,DE,2022,Q4,Elderly
214362951,21436295,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,1,I,20210604.0,20220929.0,20221010,20221010,EXP,,DE-BAYER-2022A136229,BAYER,,86.0,YR,E,M,Y,77.0,KG,20221010,,PH,DE,DE,2022,Q4,Elderly
214362951,21436295,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,20210604.0,20220929.0,20221010,20221010,EXP,,DE-BAYER-2022A136229,BAYER,,86.0,YR,E,M,Y,77.0,KG,20221010,,PH,DE,DE,2022,Q4,Elderly
214362951,21436295,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q4,Product prescribing error,,2022,Q4,1,I,20210604.0,20220929.0,20221010,20221010,EXP,,DE-BAYER-2022A136229,BAYER,,86.0,YR,E,M,Y,77.0,KG,20221010,,PH,DE,DE,2022,Q4,Elderly
214362951,21436295,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q4,Bradycardia,,2022,Q4,1,I,20210604.0,20220929.0,20221010,20221010,EXP,,DE-BAYER-2022A136229,BAYER,,86.0,YR,E,M,Y,77.0,KG,20221010,,PH,DE,DE,2022,Q4,Elderly
214362951,21436295,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q4,Restlessness,,2022,Q4,1,I,20210604.0,20220929.0,20221010,20221010,EXP,,DE-BAYER-2022A136229,BAYER,,86.0,YR,E,M,Y,77.0,KG,20221010,,PH,DE,DE,2022,Q4,Elderly
214379451,21437945,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"12 u, tid",,,U,,D498888C,,20563.0,12.0,IU,Injection,TID,2022,Q4,Illness,,2022,Q4,1,I,20220925.0,20220926.0,20221011,20221011,PER,,US-ELI_LILLY_AND_COMPANY-US202209012011,ELI LILLY AND CO,,31.0,YR,,F,Y,,,20221011,,CN,US,US,2022,Q4,Young Adult
214379451,21437945,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"12 u, tid",,,U,,D498888C,,20563.0,12.0,IU,Injection,TID,2022,Q4,Dizziness,,2022,Q4,1,I,20220925.0,20220926.0,20221011,20221011,PER,,US-ELI_LILLY_AND_COMPANY-US202209012011,ELI LILLY AND CO,,31.0,YR,,F,Y,,,20221011,,CN,US,US,2022,Q4,Young Adult
214379451,21437945,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"12 u, tid",,,U,,D498888C,,20563.0,12.0,IU,Injection,TID,2022,Q4,Product dose omission issue,,2022,Q4,1,I,20220925.0,20220926.0,20221011,20221011,PER,,US-ELI_LILLY_AND_COMPANY-US202209012011,ELI LILLY AND CO,,31.0,YR,,F,Y,,,20221011,,CN,US,US,2022,Q4,Young Adult
214379451,21437945,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"12 u, tid",,,U,,D498888C,,20563.0,12.0,IU,Injection,TID,2022,Q4,Blood glucose fluctuation,,2022,Q4,1,I,20220925.0,20220926.0,20221011,20221011,PER,,US-ELI_LILLY_AND_COMPANY-US202209012011,ELI LILLY AND CO,,31.0,YR,,F,Y,,,20221011,,CN,US,US,2022,Q4,Young Adult
214391201,21439120,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, sliding scale",,,U,U,,,,,,,,2022,Q4,Parkinsonism,,2022,Q4,1,I,20190101.0,20221003.0,20221011,20221011,EXP,,US-MYLANLABS-2022M1112227,MYLAN,"Lindenmayer J-P, Burke E, Tsuboyama G, Chahal Y, Grewal HK. Valbenazine Treatment of Tardive Dyskinesia and of Positive Symptoms. J-Clin-Psychopharmacol 2022;42(1):109-111.",63.0,YR,,F,Y,,,20221011,,MD,US,US,2022,Q4,Adult
214391201,21439120,32,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, sliding scale",,,U,U,,,,,,,,2022,Q4,Sedation complication,,2022,Q4,1,I,20190101.0,20221003.0,20221011,20221011,EXP,,US-MYLANLABS-2022M1112227,MYLAN,"Lindenmayer J-P, Burke E, Tsuboyama G, Chahal Y, Grewal HK. Valbenazine Treatment of Tardive Dyskinesia and of Positive Symptoms. J-Clin-Psychopharmacol 2022;42(1):109-111.",63.0,YR,,F,Y,,,20221011,,MD,US,US,2022,Q4,Adult
214393681,21439368,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Solution for injection,,2022,Q4,Atrial fibrillation,,2022,Q4,1,I,20220801.0,20220928.0,20221011,20221011,EXP,,US-ELI_LILLY_AND_COMPANY-US202209014044,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20221011,,CN,US,US,2022,Q4,Elderly
214393681,21439368,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,,,,,20563.0,,,Solution for injection,,2022,Q4,Atrial fibrillation,,2022,Q4,1,I,20220801.0,20220928.0,20221011,20221011,EXP,,US-ELI_LILLY_AND_COMPANY-US202209014044,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20221011,,CN,US,US,2022,Q4,Elderly
214400221,21440022,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,26-0-16-0,,,,,UNKNOWN,,,,,,BID,2022,Q4,Acute respiratory failure,,2022,Q4,1,I,,20220928.0,20221011,20221011,EXP,,DE-drreddys-SPO/GER/22/0155377,DR REDDYS,,78.0,YR,E,M,Y,,,20221011,,PH,DE,DE,2022,Q4,Elderly
214400221,21440022,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,26-0-16-0,,,,,UNKNOWN,,,,,,BID,2022,Q4,Acute myocardial infarction,,2022,Q4,1,I,,20220928.0,20221011,20221011,EXP,,DE-drreddys-SPO/GER/22/0155377,DR REDDYS,,78.0,YR,E,M,Y,,,20221011,,PH,DE,DE,2022,Q4,Elderly
214400221,21440022,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,26-0-16-0,,,,,UNKNOWN,,,,,,BID,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20220928.0,20221011,20221011,EXP,,DE-drreddys-SPO/GER/22/0155377,DR REDDYS,,78.0,YR,E,M,Y,,,20221011,,PH,DE,DE,2022,Q4,Elderly
214400221,21440022,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,26-0-16-0,,,,,UNKNOWN,,,,,,BID,2022,Q4,Atrial fibrillation,,2022,Q4,1,I,,20220928.0,20221011,20221011,EXP,,DE-drreddys-SPO/GER/22/0155377,DR REDDYS,,78.0,YR,E,M,Y,,,20221011,,PH,DE,DE,2022,Q4,Elderly
214400221,21440022,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,26-0-16-0,,,,,UNKNOWN,,,,,,BID,2022,Q4,Systemic infection,,2022,Q4,1,I,,20220928.0,20221011,20221011,EXP,,DE-drreddys-SPO/GER/22/0155377,DR REDDYS,,78.0,YR,E,M,Y,,,20221011,,PH,DE,DE,2022,Q4,Elderly
214400221,21440022,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,26-0-16-0,,,,,UNKNOWN,,,,,,BID,2022,Q4,Electrocardiogram abnormal,,2022,Q4,1,I,,20220928.0,20221011,20221011,EXP,,DE-drreddys-SPO/GER/22/0155377,DR REDDYS,,78.0,YR,E,M,Y,,,20221011,,PH,DE,DE,2022,Q4,Elderly
214400221,21440022,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,26-0-16-0,,,,,UNKNOWN,,,,,,BID,2022,Q4,Arrhythmia,,2022,Q4,1,I,,20220928.0,20221011,20221011,EXP,,DE-drreddys-SPO/GER/22/0155377,DR REDDYS,,78.0,YR,E,M,Y,,,20221011,,PH,DE,DE,2022,Q4,Elderly
214400221,21440022,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,26-0-16-0,,,,,UNKNOWN,,,,,,BID,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20220928.0,20221011,20221011,EXP,,DE-drreddys-SPO/GER/22/0155377,DR REDDYS,,78.0,YR,E,M,Y,,,20221011,,PH,DE,DE,2022,Q4,Elderly
214400221,21440022,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,26-0-16-0,,,,,UNKNOWN,,,,,,BID,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,,20220928.0,20221011,20221011,EXP,,DE-drreddys-SPO/GER/22/0155377,DR REDDYS,,78.0,YR,E,M,Y,,,20221011,,PH,DE,DE,2022,Q4,Elderly
214400221,21440022,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,26-0-16-0,,,,,UNKNOWN,,,,,,BID,2022,Q4,Tachycardia,,2022,Q4,1,I,,20220928.0,20221011,20221011,EXP,,DE-drreddys-SPO/GER/22/0155377,DR REDDYS,,78.0,YR,E,M,Y,,,20221011,,PH,DE,DE,2022,Q4,Elderly
214400221,21440022,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,26-0-16-0,,,,,UNKNOWN,,,,,,BID,2022,Q4,Renal impairment,,2022,Q4,1,I,,20220928.0,20221011,20221011,EXP,,DE-drreddys-SPO/GER/22/0155377,DR REDDYS,,78.0,YR,E,M,Y,,,20221011,,PH,DE,DE,2022,Q4,Elderly
214409481,21440948,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU INT,,,U,N,,,,,,,,2022,Q4,Renal impairment,,2022,Q4,1,I,,20221006.0,20221011,20221011,EXP,,DE-ANIPHARMA-2022-DE-000181,ANI,,80.0,YR,,F,Y,,,20221011,,PH,DE,DE,2022,Q4,Elderly
214409481,21440948,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU INT,,,U,N,,,,,,,,2022,Q4,Cardiac failure,,2022,Q4,1,I,,20221006.0,20221011,20221011,EXP,,DE-ANIPHARMA-2022-DE-000181,ANI,,80.0,YR,,F,Y,,,20221011,,PH,DE,DE,2022,Q4,Elderly
214409481,21440948,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU INT,,,U,N,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20221006.0,20221011,20221011,EXP,,DE-ANIPHARMA-2022-DE-000181,ANI,,80.0,YR,,F,Y,,,20221011,,PH,DE,DE,2022,Q4,Elderly
214409481,21440948,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU INT,,,U,N,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20221006.0,20221011,20221011,EXP,,DE-ANIPHARMA-2022-DE-000181,ANI,,80.0,YR,,F,Y,,,20221011,,PH,DE,DE,2022,Q4,Elderly
214409481,21440948,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU INT,,,U,N,,,,,,,,2022,Q4,Anaemia,,2022,Q4,1,I,,20221006.0,20221011,20221011,EXP,,DE-ANIPHARMA-2022-DE-000181,ANI,,80.0,YR,,F,Y,,,20221011,,PH,DE,DE,2022,Q4,Elderly
214412631,21441263,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Hypotension,,2022,Q4,1,I,20220914.0,,20221010,20221010,DIR,634176,,FDA-CTU,,78.0,YR,,M,N,168.5,KG,20221010,N,PH,US,,2022,Q4,Elderly
214412631,21441263,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Incorrect dose administered,,2022,Q4,1,I,20220914.0,,20221010,20221010,DIR,634176,,FDA-CTU,,78.0,YR,,M,N,168.5,KG,20221010,N,PH,US,,2022,Q4,Elderly
214412631,21441263,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Acidosis,,2022,Q4,1,I,20220914.0,,20221010,20221010,DIR,634176,,FDA-CTU,,78.0,YR,,M,N,168.5,KG,20221010,N,PH,US,,2022,Q4,Elderly
214437005,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2022,Q4,Dehydration,,2022,Q4,5,F,20210207.0,20221117.0,20221012,20221201,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
214437005,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2022,Q4,Cachexia,,2022,Q4,5,F,20210207.0,20221117.0,20221012,20221201,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
214437005,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2022,Q4,General physical health deterioration,,2022,Q4,5,F,20210207.0,20221117.0,20221012,20221201,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
214437005,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2022,Q4,Condition aggravated,,2022,Q4,5,F,20210207.0,20221117.0,20221012,20221201,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
214437005,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2022,Q4,Systemic infection,,2022,Q4,5,F,20210207.0,20221117.0,20221012,20221201,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
214437005,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2022,Q4,Nausea,,2022,Q4,5,F,20210207.0,20221117.0,20221012,20221201,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
214437005,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2022,Q4,Tenderness,,2022,Q4,5,F,20210207.0,20221117.0,20221012,20221201,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
214437005,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2022,Q4,Fatigue,,2022,Q4,5,F,20210207.0,20221117.0,20221012,20221201,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
214437005,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2022,Q4,Pain,,2022,Q4,5,F,20210207.0,20221117.0,20221012,20221201,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
214437005,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2022,Q4,Vomiting,,2022,Q4,5,F,20210207.0,20221117.0,20221012,20221201,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
214437005,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2022,Q4,Depressed level of consciousness,,2022,Q4,5,F,20210207.0,20221117.0,20221012,20221201,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
214437005,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2022,Q4,Haematochezia,,2022,Q4,5,F,20210207.0,20221117.0,20221012,20221201,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
214437005,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2022,Q4,Hyperglycaemia,,2022,Q4,5,F,20210207.0,20221117.0,20221012,20221201,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
214437005,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2022,Q4,Tachycardia,,2022,Q4,5,F,20210207.0,20221117.0,20221012,20221201,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
214437005,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2022,Q4,Death,,2022,Q4,5,F,20210207.0,20221117.0,20221012,20221201,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
214437005,21443700,9,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 international unit,UNK,1 IE, Schema",,,U,,,,,1.0,IU,,,2022,Q4,Anaemia,,2022,Q4,5,F,20210207.0,20221117.0,20221012,20221201,EXP,,DE-AUROBINDO-AUR-APL-2022-041142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221201,,PH,DE,DE,2022,Q4,Adult
214462421,21446242,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q4,COVID-19,,2022,Q4,1,I,20220801.0,20221003.0,20221012,20221012,PER,,US-SA-2022SA409825,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20221012,,MD,US,US,2022,Q4,Elderly
214462421,21446242,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q4,Pruritus,,2022,Q4,1,I,20220801.0,20221003.0,20221012,20221012,PER,,US-SA-2022SA409825,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20221012,,MD,US,US,2022,Q4,Elderly
214462421,21446242,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q4,Fall,,2022,Q4,1,I,20220801.0,20221003.0,20221012,20221012,PER,,US-SA-2022SA409825,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20221012,,MD,US,US,2022,Q4,Elderly
214462421,21446242,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q4,Arthralgia,,2022,Q4,1,I,20220801.0,20221003.0,20221012,20221012,PER,,US-SA-2022SA409825,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20221012,,MD,US,US,2022,Q4,Elderly
214462421,21446242,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q4,Skin haemorrhage,,2022,Q4,1,I,20220801.0,20221003.0,20221012,20221012,PER,,US-SA-2022SA409825,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20221012,,MD,US,US,2022,Q4,Elderly
214462421,21446242,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q4,Skin swelling,,2022,Q4,1,I,20220801.0,20221003.0,20221012,20221012,PER,,US-SA-2022SA409825,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20221012,,MD,US,US,2022,Q4,Elderly
214462421,21446242,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q4,Therapeutic product effect incomplete,,2022,Q4,1,I,20220801.0,20221003.0,20221012,20221012,PER,,US-SA-2022SA409825,SANOFI AVENTIS,,81.0,YR,E,F,Y,,,20221012,,MD,US,US,2022,Q4,Elderly
214473661,21447366,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"300 IU/3ml, according to the scheme, pre-filled syringes",,,,,,,,,,,,2022,Q4,Bradycardia,,2022,Q4,1,I,20210604.0,20221002.0,20221012,20221012,EXP,,DE-TEVA-2022-DE-2081921,TEVA,,86.0,YR,E,M,Y,77.0,KG,20221012,,PH,DE,DE,2022,Q4,Elderly
214473661,21447366,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"300 IU/3ml, according to the scheme, pre-filled syringes",,,,,,,,,,,,2022,Q4,Product prescribing error,,2022,Q4,1,I,20210604.0,20221002.0,20221012,20221012,EXP,,DE-TEVA-2022-DE-2081921,TEVA,,86.0,YR,E,M,Y,77.0,KG,20221012,,PH,DE,DE,2022,Q4,Elderly
214473661,21447366,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"300 IU/3ml, according to the scheme, pre-filled syringes",,,,,,,,,,,,2022,Q4,Product prescribing error,,2022,Q4,1,I,20210604.0,20221002.0,20221012,20221012,EXP,,DE-TEVA-2022-DE-2081921,TEVA,,86.0,YR,E,M,Y,77.0,KG,20221012,,PH,DE,DE,2022,Q4,Elderly
214473661,21447366,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"300 IU/3ml, according to the scheme, pre-filled syringes",,,,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,1,I,20210604.0,20221002.0,20221012,20221012,EXP,,DE-TEVA-2022-DE-2081921,TEVA,,86.0,YR,E,M,Y,77.0,KG,20221012,,PH,DE,DE,2022,Q4,Elderly
214473661,21447366,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"300 IU/3ml, according to the scheme, pre-filled syringes",,,,,,,,,,,,2022,Q4,Tachycardia,,2022,Q4,1,I,20210604.0,20221002.0,20221012,20221012,EXP,,DE-TEVA-2022-DE-2081921,TEVA,,86.0,YR,E,M,Y,77.0,KG,20221012,,PH,DE,DE,2022,Q4,Elderly
214473661,21447366,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"300 IU/3ml, according to the scheme, pre-filled syringes",,,,,,,,,,,,2022,Q4,Atrial fibrillation,,2022,Q4,1,I,20210604.0,20221002.0,20221012,20221012,EXP,,DE-TEVA-2022-DE-2081921,TEVA,,86.0,YR,E,M,Y,77.0,KG,20221012,,PH,DE,DE,2022,Q4,Elderly
214473661,21447366,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"300 IU/3ml, according to the scheme, pre-filled syringes",,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,20210604.0,20221002.0,20221012,20221012,EXP,,DE-TEVA-2022-DE-2081921,TEVA,,86.0,YR,E,M,Y,77.0,KG,20221012,,PH,DE,DE,2022,Q4,Elderly
214473661,21447366,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"300 IU/3ml, according to the scheme, pre-filled syringes",,,,,,,,,,,,2022,Q4,Restlessness,,2022,Q4,1,I,20210604.0,20221002.0,20221012,20221012,EXP,,DE-TEVA-2022-DE-2081921,TEVA,,86.0,YR,E,M,Y,77.0,KG,20221012,,PH,DE,DE,2022,Q4,Elderly
214493986,21449398,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2022,Q4,Depressed level of consciousness,,2022,Q4,6,F,20210702.0,20221129.0,20221013,20221214,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20221214,,CN,DE,DE,2022,Q4,Adult
214493986,21449398,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2022,Q4,Anaemia,,2022,Q4,6,F,20210702.0,20221129.0,20221013,20221214,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20221214,,CN,DE,DE,2022,Q4,Adult
214493986,21449398,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2022,Q4,Condition aggravated,,2022,Q4,6,F,20210702.0,20221129.0,20221013,20221214,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20221214,,CN,DE,DE,2022,Q4,Adult
214493986,21449398,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2022,Q4,Tachycardia,,2022,Q4,6,F,20210702.0,20221129.0,20221013,20221214,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20221214,,CN,DE,DE,2022,Q4,Adult
214493986,21449398,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,6,F,20210702.0,20221129.0,20221013,20221214,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20221214,,CN,DE,DE,2022,Q4,Adult
214493986,21449398,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2022,Q4,Fatigue,,2022,Q4,6,F,20210702.0,20221129.0,20221013,20221214,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20221214,,CN,DE,DE,2022,Q4,Adult
214493986,21449398,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2022,Q4,Vomiting,,2022,Q4,6,F,20210702.0,20221129.0,20221013,20221214,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20221214,,CN,DE,DE,2022,Q4,Adult
214493986,21449398,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2022,Q4,Nausea,,2022,Q4,6,F,20210702.0,20221129.0,20221013,20221214,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20221214,,CN,DE,DE,2022,Q4,Adult
214493986,21449398,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2022,Q4,Systemic infection,,2022,Q4,6,F,20210702.0,20221129.0,20221013,20221214,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20221214,,CN,DE,DE,2022,Q4,Adult
214493986,21449398,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2022,Q4,Death,,2022,Q4,6,F,20210702.0,20221129.0,20221013,20221214,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20221214,,CN,DE,DE,2022,Q4,Adult
214493986,21449398,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,6,F,20210702.0,20221129.0,20221013,20221214,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20221214,,CN,DE,DE,2022,Q4,Adult
214493986,21449398,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2022,Q4,Pain,,2022,Q4,6,F,20210702.0,20221129.0,20221013,20221214,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20221214,,CN,DE,DE,2022,Q4,Adult
214493986,21449398,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2022,Q4,Cachexia,,2022,Q4,6,F,20210702.0,20221129.0,20221013,20221214,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20221214,,CN,DE,DE,2022,Q4,Adult
214493986,21449398,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2022,Q4,Tenderness,,2022,Q4,6,F,20210702.0,20221129.0,20221013,20221214,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20221214,,CN,DE,DE,2022,Q4,Adult
214493986,21449398,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2022,Q4,Haematochezia,,2022,Q4,6,F,20210702.0,20221129.0,20221013,20221214,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20221214,,CN,DE,DE,2022,Q4,Adult
214493986,21449398,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 IU international unit(s),,,,,Unknown,,,,,,,2022,Q4,Dehydration,,2022,Q4,6,F,20210702.0,20221129.0,20221013,20221214,EXP,DE-ADRED-08249-01,DE-ALKEM LABORATORIES LIMITED-DE-ALKEM-2022-10789,ALKEM,,48.0,YR,,M,Y,68.0,KG,20221214,,CN,DE,DE,2022,Q4,Adult
214522671,21452267,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 international unit, tid",,,Y,,,,20563.0,8.0,IU,,TID,2022,Q4,Diabetic ketoacidosis,,2022,Q4,1,I,,20221002.0,20221013,20221013,EXP,,US-ELI_LILLY_AND_COMPANY-US202210002022,ELI LILLY AND CO,"Hussien S.M.,Imanli H.,Tran D.H.,Chow R.D.,Sood A..Insulin Edema Syndrome due to Rapid Glucose Correction in a Diabetic Patient..Case Reports in Medicine. 2022;2022:.DOI:https://doi.org/10.1155/2022/3027530",46.0,YR,,M,Y,,,20221013,,HP,US,US,2022,Q4,Adult
214522671,21452267,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 international unit, tid",,,Y,,,,20563.0,8.0,IU,,TID,2022,Q4,Peripheral swelling,,2022,Q4,1,I,,20221002.0,20221013,20221013,EXP,,US-ELI_LILLY_AND_COMPANY-US202210002022,ELI LILLY AND CO,"Hussien S.M.,Imanli H.,Tran D.H.,Chow R.D.,Sood A..Insulin Edema Syndrome due to Rapid Glucose Correction in a Diabetic Patient..Case Reports in Medicine. 2022;2022:.DOI:https://doi.org/10.1155/2022/3027530",46.0,YR,,M,Y,,,20221013,,HP,US,US,2022,Q4,Adult
214525646,21452564,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 U,,,,,,,,,,Injection,QD,2022,Q4,Haemophagocytic lymphohistiocytosis,,2022,Q4,6,F,20221001.0,20221128.0,20221013,20221201,EXP,,US-ROCHE-3195833,ROCHE,,67.0,YR,,M,Y,98.0,KG,20221201,,MD,US,,2022,Q4,Elderly
214525646,21452564,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 U,,,,,,,,,,Injection,QD,2022,Q4,Acute myeloid leukaemia,,2022,Q4,6,F,20221001.0,20221128.0,20221013,20221201,EXP,,US-ROCHE-3195833,ROCHE,,67.0,YR,,M,Y,98.0,KG,20221201,,MD,US,,2022,Q4,Elderly
214525646,21452564,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 U,,,,,,,,,,Injection,TID,2022,Q4,Haemophagocytic lymphohistiocytosis,,2022,Q4,6,F,20221001.0,20221128.0,20221013,20221201,EXP,,US-ROCHE-3195833,ROCHE,,67.0,YR,,M,Y,98.0,KG,20221201,,MD,US,,2022,Q4,Elderly
214525646,21452564,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 U,,,,,,,,,,Injection,TID,2022,Q4,Acute myeloid leukaemia,,2022,Q4,6,F,20221001.0,20221128.0,20221013,20221201,EXP,,US-ROCHE-3195833,ROCHE,,67.0,YR,,M,Y,98.0,KG,20221201,,MD,US,,2022,Q4,Elderly
214527392,21452739,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Haemobilia,,2022,Q4,2,F,20220708.0,20221019.0,20221013,20221021,EXP,,JP-ROCHE-3141234,ROCHE,,75.0,YR,,M,Y,66.4,KG,20221021,,MD,JP,,2022,Q4,Elderly
214527392,21452739,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Cholangitis,,2022,Q4,2,F,20220708.0,20221019.0,20221013,20221021,EXP,,JP-ROCHE-3141234,ROCHE,,75.0,YR,,M,Y,66.4,KG,20221021,,MD,JP,,2022,Q4,Elderly
214541512,21454151,20,C,INSULIN LISPRO BS,,2,Subcutaneous,"dose 1, units not provided",,,,,,,,,,Injection,,2022,Q4,Respiratory failure,,2022,Q4,2,F,20221005.0,20221014.0,20221013,20221020,EXP,,JP-JNJFOC-20221010288,JOHNSON AND JOHNSON,,67.0,YR,E,M,Y,,,20221020,,MD,JP,JP,2022,Q4,Elderly
214549151,21454915,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D478386C,,20563.0,,,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20220916.0,20220916.0,20221014,20221014,PER,,US-ELI_LILLY_AND_COMPANY-US202209010372,ELI LILLY AND CO,,56.0,YR,,F,Y,,,20221014,,CN,US,US,2022,Q4,Adult
214554591,21455459,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE/3ml, according to the scheme, pre-filled syringes",,,U,,,,,,,,,2022,Q4,Product prescribing error,,2022,Q4,1,I,20210604.0,20220929.0,20221014,20221014,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-358970,RANBAXY,,86.0,YR,,M,Y,77.0,KG,20221014,,PH,DE,DE,2022,Q4,Elderly
214554591,21455459,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE/3ml, according to the scheme, pre-filled syringes",,,U,,,,,,,,,2022,Q4,Restlessness,,2022,Q4,1,I,20210604.0,20220929.0,20221014,20221014,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-358970,RANBAXY,,86.0,YR,,M,Y,77.0,KG,20221014,,PH,DE,DE,2022,Q4,Elderly
214554591,21455459,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE/3ml, according to the scheme, pre-filled syringes",,,U,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,1,I,20210604.0,20220929.0,20221014,20221014,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-358970,RANBAXY,,86.0,YR,,M,Y,77.0,KG,20221014,,PH,DE,DE,2022,Q4,Elderly
214554591,21455459,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE/3ml, according to the scheme, pre-filled syringes",,,U,,,,,,,,,2022,Q4,Tachycardia,,2022,Q4,1,I,20210604.0,20220929.0,20221014,20221014,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-358970,RANBAXY,,86.0,YR,,M,Y,77.0,KG,20221014,,PH,DE,DE,2022,Q4,Elderly
214554591,21455459,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE/3ml, according to the scheme, pre-filled syringes",,,U,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,20210604.0,20220929.0,20221014,20221014,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-358970,RANBAXY,,86.0,YR,,M,Y,77.0,KG,20221014,,PH,DE,DE,2022,Q4,Elderly
214554591,21455459,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE/3ml, according to the scheme, pre-filled syringes",,,U,,,,,,,,,2022,Q4,Product prescribing error,,2022,Q4,1,I,20210604.0,20220929.0,20221014,20221014,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-358970,RANBAXY,,86.0,YR,,M,Y,77.0,KG,20221014,,PH,DE,DE,2022,Q4,Elderly
214554591,21455459,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE/3ml, according to the scheme, pre-filled syringes",,,U,,,,,,,,,2022,Q4,Bradycardia,,2022,Q4,1,I,20210604.0,20220929.0,20221014,20221014,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-358970,RANBAXY,,86.0,YR,,M,Y,77.0,KG,20221014,,PH,DE,DE,2022,Q4,Elderly
214554591,21455459,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE/3ml, according to the scheme, pre-filled syringes",,,U,,,,,,,,,2022,Q4,Atrial fibrillation,,2022,Q4,1,I,20210604.0,20220929.0,20221014,20221014,EXP,,DE-SUN PHARMACEUTICAL INDUSTRIES LTD-2022RR-358970,RANBAXY,,86.0,YR,,M,Y,77.0,KG,20221014,,PH,DE,DE,2022,Q4,Elderly
214583391,21458339,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Blood glucose abnormal,,2022,Q4,1,I,,20221003.0,20221014,20221014,EXP,,US-MYLANLABS-2022M1112880,MYLAN,"Naritsin A, Peck J. Critical presentation and management of an acute gastrointestinal haemorrhage as a result of an arterioenteric fistula secondary to a failed pancreatic allograft. BMJ-Case-Rep 2021;14:No. 7.",60.0,YR,,F,Y,,,20221014,,MD,US,US,2022,Q4,Adult
214583391,21458339,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Drug ineffective,,2022,Q4,1,I,,20221003.0,20221014,20221014,EXP,,US-MYLANLABS-2022M1112880,MYLAN,"Naritsin A, Peck J. Critical presentation and management of an acute gastrointestinal haemorrhage as a result of an arterioenteric fistula secondary to a failed pancreatic allograft. BMJ-Case-Rep 2021;14:No. 7.",60.0,YR,,F,Y,,,20221014,,MD,US,US,2022,Q4,Adult
214583391,21458339,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2022,Q4,Blood glucose abnormal,,2022,Q4,1,I,,20221003.0,20221014,20221014,EXP,,US-MYLANLABS-2022M1112880,MYLAN,"Naritsin A, Peck J. Critical presentation and management of an acute gastrointestinal haemorrhage as a result of an arterioenteric fistula secondary to a failed pancreatic allograft. BMJ-Case-Rep 2021;14:No. 7.",60.0,YR,,F,Y,,,20221014,,MD,US,US,2022,Q4,Adult
214583391,21458339,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2022,Q4,Drug ineffective,,2022,Q4,1,I,,20221003.0,20221014,20221014,EXP,,US-MYLANLABS-2022M1112880,MYLAN,"Naritsin A, Peck J. Critical presentation and management of an acute gastrointestinal haemorrhage as a result of an arterioenteric fistula secondary to a failed pancreatic allograft. BMJ-Case-Rep 2021;14:No. 7.",60.0,YR,,F,Y,,,20221014,,MD,US,US,2022,Q4,Adult
214586292,21458629,40,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 iU, as needed",,,,,,,,6.0,IU,,,2022,Q4,"Hallucination, visual",,2022,Q4,2,F,20220503.0,20221028.0,20221014,20221116,PER,,US-PFIZER INC-202201225406,PFIZER,,62.0,YR,,M,Y,98.9,KG,20221116,,HP,US,US,2022,Q4,Adult
214596371,21459637,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"32 u, prn (3 to 4 times a day)",,,U,,,,20563.0,32.0,IU,Injection,,2022,Q4,Dizziness,,2022,Q4,1,I,20220930.0,20221003.0,20221014,20221014,EXP,,US-ELI_LILLY_AND_COMPANY-US202210003412,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221014,,CN,US,US,2022,Q4,Elderly
214596371,21459637,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"32 u, prn (3 to 4 times a day)",,,U,,,,20563.0,32.0,IU,Injection,,2022,Q4,Benign renal neoplasm,,2022,Q4,1,I,20220930.0,20221003.0,20221014,20221014,EXP,,US-ELI_LILLY_AND_COMPANY-US202210003412,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221014,,CN,US,US,2022,Q4,Elderly
214596371,21459637,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"32 u, prn (3 to 4 times a day)",,,U,,,,20563.0,32.0,IU,Injection,,2022,Q4,Heart rate decreased,,2022,Q4,1,I,20220930.0,20221003.0,20221014,20221014,EXP,,US-ELI_LILLY_AND_COMPANY-US202210003412,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221014,,CN,US,US,2022,Q4,Elderly
214596371,21459637,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"32 u, prn (3 to 4 times a day)",,,U,,,,20563.0,32.0,IU,Injection,,2022,Q4,Chronic kidney disease,,2022,Q4,1,I,20220930.0,20221003.0,20221014,20221014,EXP,,US-ELI_LILLY_AND_COMPANY-US202210003412,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221014,,CN,US,US,2022,Q4,Elderly
214596371,21459637,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"32 u, prn (3 to 4 times a day)",,,U,,D455780C,,20563.0,32.0,IU,Injection,,2022,Q4,Dizziness,,2022,Q4,1,I,20220930.0,20221003.0,20221014,20221014,EXP,,US-ELI_LILLY_AND_COMPANY-US202210003412,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221014,,CN,US,US,2022,Q4,Elderly
214596371,21459637,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"32 u, prn (3 to 4 times a day)",,,U,,D455780C,,20563.0,32.0,IU,Injection,,2022,Q4,Benign renal neoplasm,,2022,Q4,1,I,20220930.0,20221003.0,20221014,20221014,EXP,,US-ELI_LILLY_AND_COMPANY-US202210003412,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221014,,CN,US,US,2022,Q4,Elderly
214596371,21459637,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"32 u, prn (3 to 4 times a day)",,,U,,D455780C,,20563.0,32.0,IU,Injection,,2022,Q4,Heart rate decreased,,2022,Q4,1,I,20220930.0,20221003.0,20221014,20221014,EXP,,US-ELI_LILLY_AND_COMPANY-US202210003412,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221014,,CN,US,US,2022,Q4,Elderly
214596371,21459637,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"32 u, prn (3 to 4 times a day)",,,U,,D455780C,,20563.0,32.0,IU,Injection,,2022,Q4,Chronic kidney disease,,2022,Q4,1,I,20220930.0,20221003.0,20221014,20221014,EXP,,US-ELI_LILLY_AND_COMPANY-US202210003412,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221014,,CN,US,US,2022,Q4,Elderly
214631241,21463124,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,UNKNOWN,,,,,,,2022,Q4,Nasal congestion,,2022,Q4,1,I,20211207.0,20220825.0,20221017,20221017,PER,,US-CHIESI-2022CHF04437,CHIESI,,60.0,YR,,M,Y,83.0,KG,20221017,,CN,US,US,2022,Q4,Adult
214631241,21463124,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,UNKNOWN,,,,,,,2022,Q4,Off label use,,2022,Q4,1,I,20211207.0,20220825.0,20221017,20221017,PER,,US-CHIESI-2022CHF04437,CHIESI,,60.0,YR,,M,Y,83.0,KG,20221017,,CN,US,US,2022,Q4,Adult
214631241,21463124,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,UNKNOWN,,,,,,,2022,Q4,Periorbital swelling,,2022,Q4,1,I,20211207.0,20220825.0,20221017,20221017,PER,,US-CHIESI-2022CHF04437,CHIESI,,60.0,YR,,M,Y,83.0,KG,20221017,,CN,US,US,2022,Q4,Adult
214631241,21463124,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,UNKNOWN,,,,,,,2022,Q4,Off label use,,2022,Q4,1,I,20211207.0,20220825.0,20221017,20221017,PER,,US-CHIESI-2022CHF04437,CHIESI,,60.0,YR,,M,Y,83.0,KG,20221017,,CN,US,US,2022,Q4,Adult
214664371,21466437,2,C,Insulin Lispro solution of 25% + Insulin lispro protamin 75%,,2,,26 U (units) in the morning and 18 U before dinner,,,U,,,,,,,,Q12H,2022,Q4,Tracheobronchitis,,2022,Q4,1,I,,20221010.0,20221017,20221017,EXP,,"PT-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-196567",BOEHRINGER INGELHEIM,"Antunes A, Antunes A, Faria C, Falc?o C, Miragaia A. P No. 1827 The bitterness of diabetic ketoacidosis. Medicina Interna. 2022 Oct; 969-",61.0,YR,A,M,Y,,,20221017,,HP,PT,PT,2022,Q4,Adult
214664371,21466437,2,C,Insulin Lispro solution of 25% + Insulin lispro protamin 75%,,2,,26 U (units) in the morning and 18 U before dinner,,,U,,,,,,,,Q12H,2022,Q4,Diabetic metabolic decompensation,,2022,Q4,1,I,,20221010.0,20221017,20221017,EXP,,"PT-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-196567",BOEHRINGER INGELHEIM,"Antunes A, Antunes A, Faria C, Falc?o C, Miragaia A. P No. 1827 The bitterness of diabetic ketoacidosis. Medicina Interna. 2022 Oct; 969-",61.0,YR,A,M,Y,,,20221017,,HP,PT,PT,2022,Q4,Adult
214664371,21466437,2,C,Insulin Lispro solution of 25% + Insulin lispro protamin 75%,,2,,26 U (units) in the morning and 18 U before dinner,,,U,,,,,,,,Q12H,2022,Q4,Euglycaemic diabetic ketoacidosis,,2022,Q4,1,I,,20221010.0,20221017,20221017,EXP,,"PT-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-196567",BOEHRINGER INGELHEIM,"Antunes A, Antunes A, Faria C, Falc?o C, Miragaia A. P No. 1827 The bitterness of diabetic ketoacidosis. Medicina Interna. 2022 Oct; 969-",61.0,YR,A,M,Y,,,20221017,,HP,PT,PT,2022,Q4,Adult
214665041,21466504,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, unknown",,,U,,D484040C,,20563.0,8.0,IU,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20221012.0,20221012.0,20221017,20221017,PER,,US-ELI_LILLY_AND_COMPANY-US202210006570,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20221017,,CN,US,US,2022,Q4,Elderly
214665041,21466504,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, unknown",,,U,,D484040C,,20563.0,8.0,IU,Injection,,2022,Q4,Product dose omission issue,,2022,Q4,1,I,20221012.0,20221012.0,20221017,20221017,PER,,US-ELI_LILLY_AND_COMPANY-US202210006570,ELI LILLY AND CO,,77.0,YR,,F,Y,,,20221017,,CN,US,US,2022,Q4,Elderly
214717562,21471756,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"55 u, unknown",,,U,,D514820C,,20563.0,55.0,IU,Injection,,2022,Q4,Product dose omission issue,,2022,Q4,2,F,20220701.0,20221103.0,20221018,20221115,EXP,,US-ELI_LILLY_AND_COMPANY-US202210001592,ELI LILLY AND CO,,76.0,YR,,M,Y,107.0,KG,20221115,,MD,US,US,2022,Q4,Elderly
214717562,21471756,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"55 u, unknown",,,U,,D514820C,,20563.0,55.0,IU,Injection,,2022,Q4,Rhabdomyolysis,,2022,Q4,2,F,20220701.0,20221103.0,20221018,20221115,EXP,,US-ELI_LILLY_AND_COMPANY-US202210001592,ELI LILLY AND CO,,76.0,YR,,M,Y,107.0,KG,20221115,,MD,US,US,2022,Q4,Elderly
214717562,21471756,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"55 u, unknown",,,U,,D514820C,,20563.0,55.0,IU,Injection,,2022,Q4,Hydrocephalus,,2022,Q4,2,F,20220701.0,20221103.0,20221018,20221115,EXP,,US-ELI_LILLY_AND_COMPANY-US202210001592,ELI LILLY AND CO,,76.0,YR,,M,Y,107.0,KG,20221115,,MD,US,US,2022,Q4,Elderly
214717562,21471756,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"55 u, unknown",,,U,,D514820C,,20563.0,55.0,IU,Injection,,2022,Q4,Product dose omission issue,,2022,Q4,2,F,20220701.0,20221103.0,20221018,20221115,EXP,,US-ELI_LILLY_AND_COMPANY-US202210001592,ELI LILLY AND CO,,76.0,YR,,M,Y,107.0,KG,20221115,,MD,US,US,2022,Q4,Elderly
214717562,21471756,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"55 u, unknown",,,U,,D514820C,,20563.0,55.0,IU,Injection,,2022,Q4,Rhabdomyolysis,,2022,Q4,2,F,20220701.0,20221103.0,20221018,20221115,EXP,,US-ELI_LILLY_AND_COMPANY-US202210001592,ELI LILLY AND CO,,76.0,YR,,M,Y,107.0,KG,20221115,,MD,US,US,2022,Q4,Elderly
214717562,21471756,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"55 u, unknown",,,U,,D514820C,,20563.0,55.0,IU,Injection,,2022,Q4,Hydrocephalus,,2022,Q4,2,F,20220701.0,20221103.0,20221018,20221115,EXP,,US-ELI_LILLY_AND_COMPANY-US202210001592,ELI LILLY AND CO,,76.0,YR,,M,Y,107.0,KG,20221115,,MD,US,US,2022,Q4,Elderly
214717562,21471756,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Product dose omission issue,,2022,Q4,2,F,20220701.0,20221103.0,20221018,20221115,EXP,,US-ELI_LILLY_AND_COMPANY-US202210001592,ELI LILLY AND CO,,76.0,YR,,M,Y,107.0,KG,20221115,,MD,US,US,2022,Q4,Elderly
214717562,21471756,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Rhabdomyolysis,,2022,Q4,2,F,20220701.0,20221103.0,20221018,20221115,EXP,,US-ELI_LILLY_AND_COMPANY-US202210001592,ELI LILLY AND CO,,76.0,YR,,M,Y,107.0,KG,20221115,,MD,US,US,2022,Q4,Elderly
214717562,21471756,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Hydrocephalus,,2022,Q4,2,F,20220701.0,20221103.0,20221018,20221115,EXP,,US-ELI_LILLY_AND_COMPANY-US202210001592,ELI LILLY AND CO,,76.0,YR,,M,Y,107.0,KG,20221115,,MD,US,US,2022,Q4,Elderly
214717562,21471756,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Product dose omission issue,,2022,Q4,2,F,20220701.0,20221103.0,20221018,20221115,EXP,,US-ELI_LILLY_AND_COMPANY-US202210001592,ELI LILLY AND CO,,76.0,YR,,M,Y,107.0,KG,20221115,,MD,US,US,2022,Q4,Elderly
214717562,21471756,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Rhabdomyolysis,,2022,Q4,2,F,20220701.0,20221103.0,20221018,20221115,EXP,,US-ELI_LILLY_AND_COMPANY-US202210001592,ELI LILLY AND CO,,76.0,YR,,M,Y,107.0,KG,20221115,,MD,US,US,2022,Q4,Elderly
214717562,21471756,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Hydrocephalus,,2022,Q4,2,F,20220701.0,20221103.0,20221018,20221115,EXP,,US-ELI_LILLY_AND_COMPANY-US202210001592,ELI LILLY AND CO,,76.0,YR,,M,Y,107.0,KG,20221115,,MD,US,US,2022,Q4,Elderly
214724723,21472472,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 times per day, Unit dose 100 , UNITS NOS",,,,,,,,,,Unknown,,2022,Q4,Pneumonitis,,2022,Q4,3,F,20220915.0,20221103.0,20221018,20221107,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-108075,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,101.0,KG,20221107,,HP,CA,CA,2022,Q4,Adult
214724723,21472472,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"3 times per day, Unit dose 100 , UNITS NOS",,,,,,,,,,Unknown,,2022,Q4,Pneumonia,,2022,Q4,3,F,20220915.0,20221103.0,20221018,20221107,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-2022-108075,BRISTOL MYERS SQUIBB,,61.0,YR,A,M,Y,101.0,KG,20221107,,HP,CA,CA,2022,Q4,Adult
214758692,21475869,36,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q4,Cardiac failure congestive,,2022,Q4,2,F,20220623.0,20221018.0,20221019,20221020,EXP,,US-ROCHE-3128825,ROCHE,,80.0,YR,,F,Y,,,20221020,,MD,US,,2022,Q4,Elderly
214800473,21480047,43,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Immune effector cell-associated neurotoxicity syndrome,,2022,Q4,3,F,20221013.0,20221108.0,20221019,20221110,EXP,,US-GILEAD-2022-0601786,GILEAD,,52.0,YR,A,M,Y,124.9,KG,20221110,,HP,US,US,2022,Q4,Adult
214800473,21480047,43,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Cytokine release syndrome,,2022,Q4,3,F,20221013.0,20221108.0,20221019,20221110,EXP,,US-GILEAD-2022-0601786,GILEAD,,52.0,YR,A,M,Y,124.9,KG,20221110,,HP,US,US,2022,Q4,Adult
214805171,21480517,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Drug ineffective,,2022,Q4,1,I,20080101.0,20221012.0,20221019,20221019,EXP,,NVSC2022CA232272,NOVARTIS,,20.0,YR,,F,Y,,,20221019,,HP,CA,CA,2022,Q4,Youth
214805171,21480517,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Colitis ulcerative,,2022,Q4,1,I,20080101.0,20221012.0,20221019,20221019,EXP,,NVSC2022CA232272,NOVARTIS,,20.0,YR,,F,Y,,,20221019,,HP,CA,CA,2022,Q4,Youth
214805171,21480517,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Product dose omission issue,,2022,Q4,1,I,20080101.0,20221012.0,20221019,20221019,EXP,,NVSC2022CA232272,NOVARTIS,,20.0,YR,,F,Y,,,20221019,,HP,CA,CA,2022,Q4,Youth
214805171,21480517,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Nausea,,2022,Q4,1,I,20080101.0,20221012.0,20221019,20221019,EXP,,NVSC2022CA232272,NOVARTIS,,20.0,YR,,F,Y,,,20221019,,HP,CA,CA,2022,Q4,Youth
214845701,21484570,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2022,Q4,Glycosylated haemoglobin increased,,2022,Q4,1,I,20180901.0,20220923.0,20221020,20221020,PER,,US-ELI_LILLY_AND_COMPANY-US202209012252,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20221020,,CN,US,US,2022,Q4,Adult
214845701,21484570,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2022,Q4,Insulin resistance,,2022,Q4,1,I,20180901.0,20220923.0,20221020,20221020,PER,,US-ELI_LILLY_AND_COMPANY-US202209012252,ELI LILLY AND CO,,50.0,YR,,M,Y,,,20221020,,CN,US,US,2022,Q4,Adult
214847041,21484704,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Scheme",,,,,,,,,,,,2022,Q4,Haematochezia,,2022,Q4,1,I,,20221012.0,20221020,20221020,EXP,,DE-TEVA-2022-DE-2817095,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214847041,21484704,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Scheme",,,,,,,,,,,,2022,Q4,Systemic infection,,2022,Q4,1,I,,20221012.0,20221020,20221020,EXP,,DE-TEVA-2022-DE-2817095,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214847041,21484704,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Scheme",,,,,,,,,,,,2022,Q4,Dehydration,,2022,Q4,1,I,,20221012.0,20221020,20221020,EXP,,DE-TEVA-2022-DE-2817095,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214847041,21484704,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Scheme",,,,,,,,,,,,2022,Q4,Pain,,2022,Q4,1,I,,20221012.0,20221020,20221020,EXP,,DE-TEVA-2022-DE-2817095,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214847041,21484704,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Scheme",,,,,,,,,,,,2022,Q4,Vomiting,,2022,Q4,1,I,,20221012.0,20221020,20221020,EXP,,DE-TEVA-2022-DE-2817095,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214847041,21484704,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Scheme",,,,,,,,,,,,2022,Q4,Anaemia,,2022,Q4,1,I,,20221012.0,20221020,20221020,EXP,,DE-TEVA-2022-DE-2817095,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214847041,21484704,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Scheme",,,,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20221012.0,20221020,20221020,EXP,,DE-TEVA-2022-DE-2817095,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214847041,21484704,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Scheme",,,,,,,,,,,,2022,Q4,Fatigue,,2022,Q4,1,I,,20221012.0,20221020,20221020,EXP,,DE-TEVA-2022-DE-2817095,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214847041,21484704,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Scheme",,,,,,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,,20221012.0,20221020,20221020,EXP,,DE-TEVA-2022-DE-2817095,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214847041,21484704,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Scheme",,,,,,,,,,,,2022,Q4,Cachexia,,2022,Q4,1,I,,20221012.0,20221020,20221020,EXP,,DE-TEVA-2022-DE-2817095,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214847041,21484704,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Scheme",,,,,,,,,,,,2022,Q4,Condition aggravated,,2022,Q4,1,I,,20221012.0,20221020,20221020,EXP,,DE-TEVA-2022-DE-2817095,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214847041,21484704,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Scheme",,,,,,,,,,,,2022,Q4,Tenderness,,2022,Q4,1,I,,20221012.0,20221020,20221020,EXP,,DE-TEVA-2022-DE-2817095,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214847041,21484704,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Scheme",,,,,,,,,,,,2022,Q4,Depressed level of consciousness,,2022,Q4,1,I,,20221012.0,20221020,20221020,EXP,,DE-TEVA-2022-DE-2817095,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214847041,21484704,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Scheme",,,,,,,,,,,,2022,Q4,Nausea,,2022,Q4,1,I,,20221012.0,20221020,20221020,EXP,,DE-TEVA-2022-DE-2817095,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214847041,21484704,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Scheme",,,,,,,,,,,,2022,Q4,Tachycardia,,2022,Q4,1,I,,20221012.0,20221020,20221020,EXP,,DE-TEVA-2022-DE-2817095,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221020,,PH,DE,DE,2022,Q4,Adult
214852251,21485225,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"15 iU, TID",,,N,,,,,15.0,IU,,Q8H,2022,Q4,Lung neoplasm malignant,,2022,Q4,1,I,,20221016.0,20221020,20221020,EXP,,RU-SA-2022SA425491,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20221020,,CN,RU,RU,2022,Q4,Adult
214852251,21485225,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"15 iU, TID",,,N,,,,,15.0,IU,,Q8H,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,,20221016.0,20221020,20221020,EXP,,RU-SA-2022SA425491,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20221020,,CN,RU,RU,2022,Q4,Adult
214852251,21485225,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 iU, TID",,,N,,,,,10.0,IU,,Q8H,2022,Q4,Lung neoplasm malignant,,2022,Q4,1,I,,20221016.0,20221020,20221020,EXP,,RU-SA-2022SA425491,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20221020,,CN,RU,RU,2022,Q4,Adult
214852251,21485225,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"10 iU, TID",,,N,,,,,10.0,IU,,Q8H,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,,20221016.0,20221020,20221020,EXP,,RU-SA-2022SA425491,SANOFI AVENTIS,,62.0,YR,A,M,Y,,,20221020,,CN,RU,RU,2022,Q4,Adult
214868342,21486834,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Schema",,,,,,,,,,,,2022,Q4,Depressed level of consciousness,,2022,Q4,2,F,,20221023.0,20221020,20221024,EXP,,DE-DEXPHARM-20222093,DEXCEL,,48.0,YR,A,M,Y,68.0,KG,20221024,,PH,DE,DE,2022,Q4,Adult
214868342,21486834,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Schema",,,,,,,,,,,,2022,Q4,Vomiting,,2022,Q4,2,F,,20221023.0,20221020,20221024,EXP,,DE-DEXPHARM-20222093,DEXCEL,,48.0,YR,A,M,Y,68.0,KG,20221024,,PH,DE,DE,2022,Q4,Adult
214868342,21486834,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Schema",,,,,,,,,,,,2022,Q4,Condition aggravated,,2022,Q4,2,F,,20221023.0,20221020,20221024,EXP,,DE-DEXPHARM-20222093,DEXCEL,,48.0,YR,A,M,Y,68.0,KG,20221024,,PH,DE,DE,2022,Q4,Adult
214868342,21486834,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Schema",,,,,,,,,,,,2022,Q4,Haematochezia,,2022,Q4,2,F,,20221023.0,20221020,20221024,EXP,,DE-DEXPHARM-20222093,DEXCEL,,48.0,YR,A,M,Y,68.0,KG,20221024,,PH,DE,DE,2022,Q4,Adult
214868342,21486834,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Schema",,,,,,,,,,,,2022,Q4,Systemic infection,,2022,Q4,2,F,,20221023.0,20221020,20221024,EXP,,DE-DEXPHARM-20222093,DEXCEL,,48.0,YR,A,M,Y,68.0,KG,20221024,,PH,DE,DE,2022,Q4,Adult
214868342,21486834,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Schema",,,,,,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,2,F,,20221023.0,20221020,20221024,EXP,,DE-DEXPHARM-20222093,DEXCEL,,48.0,YR,A,M,Y,68.0,KG,20221024,,PH,DE,DE,2022,Q4,Adult
214868342,21486834,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Schema",,,,,,,,,,,,2022,Q4,Fatigue,,2022,Q4,2,F,,20221023.0,20221020,20221024,EXP,,DE-DEXPHARM-20222093,DEXCEL,,48.0,YR,A,M,Y,68.0,KG,20221024,,PH,DE,DE,2022,Q4,Adult
214868342,21486834,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Schema",,,,,,,,,,,,2022,Q4,Pain,,2022,Q4,2,F,,20221023.0,20221020,20221024,EXP,,DE-DEXPHARM-20222093,DEXCEL,,48.0,YR,A,M,Y,68.0,KG,20221024,,PH,DE,DE,2022,Q4,Adult
214868342,21486834,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Schema",,,,,,,,,,,,2022,Q4,Nausea,,2022,Q4,2,F,,20221023.0,20221020,20221024,EXP,,DE-DEXPHARM-20222093,DEXCEL,,48.0,YR,A,M,Y,68.0,KG,20221024,,PH,DE,DE,2022,Q4,Adult
214868342,21486834,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Schema",,,,,,,,,,,,2022,Q4,Tachycardia,,2022,Q4,2,F,,20221023.0,20221020,20221024,EXP,,DE-DEXPHARM-20222093,DEXCEL,,48.0,YR,A,M,Y,68.0,KG,20221024,,PH,DE,DE,2022,Q4,Adult
214868342,21486834,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Schema",,,,,,,,,,,,2022,Q4,Anaemia,,2022,Q4,2,F,,20221023.0,20221020,20221024,EXP,,DE-DEXPHARM-20222093,DEXCEL,,48.0,YR,A,M,Y,68.0,KG,20221024,,PH,DE,DE,2022,Q4,Adult
214868342,21486834,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Schema",,,,,,,,,,,,2022,Q4,Tenderness,,2022,Q4,2,F,,20221023.0,20221020,20221024,EXP,,DE-DEXPHARM-20222093,DEXCEL,,48.0,YR,A,M,Y,68.0,KG,20221024,,PH,DE,DE,2022,Q4,Adult
214868342,21486834,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Schema",,,,,,,,,,,,2022,Q4,Cachexia,,2022,Q4,2,F,,20221023.0,20221020,20221024,EXP,,DE-DEXPHARM-20222093,DEXCEL,,48.0,YR,A,M,Y,68.0,KG,20221024,,PH,DE,DE,2022,Q4,Adult
214868342,21486834,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Schema",,,,,,,,,,,,2022,Q4,Dehydration,,2022,Q4,2,F,,20221023.0,20221020,20221024,EXP,,DE-DEXPHARM-20222093,DEXCEL,,48.0,YR,A,M,Y,68.0,KG,20221024,,PH,DE,DE,2022,Q4,Adult
214868342,21486834,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IE, Schema",,,,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221023.0,20221020,20221024,EXP,,DE-DEXPHARM-20222093,DEXCEL,,48.0,YR,A,M,Y,68.0,KG,20221024,,PH,DE,DE,2022,Q4,Adult
214871562,21487156,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2022,Q4,Drug ineffective,,2022,Q4,2,F,,20221029.0,20221020,20221108,EXP,,US-TEVA-2022-US-2816624,TEVA,,60.0,YR,A,F,Y,,,20221108,,MD,US,US,2022,Q4,Adult
214871562,21487156,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,D,,,,,,,,,2022,Q4,Blood glucose abnormal,,2022,Q4,2,F,,20221029.0,20221020,20221108,EXP,,US-TEVA-2022-US-2816624,TEVA,,60.0,YR,A,F,Y,,,20221108,,MD,US,US,2022,Q4,Adult
214873372,21487337,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,sliding scale,,,U,,,,,,,,,2022,Q4,Sedation complication,,2022,Q4,2,F,20190101.0,20221028.0,20221020,20221108,EXP,,US-TEVA-2022-US-2816619,TEVA,,63.0,YR,A,F,Y,,,20221107,,MD,US,US,2022,Q4,Adult
214873372,21487337,33,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,sliding scale,,,U,,,,,,,,,2022,Q4,Parkinsonism,,2022,Q4,2,F,20190101.0,20221028.0,20221020,20221108,EXP,,US-TEVA-2022-US-2816619,TEVA,,63.0,YR,A,F,Y,,,20221107,,MD,US,US,2022,Q4,Adult
214895152,21489515,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,82 Arbitrary units,,,U,,,,,,,,,2022,Q4,Concomitant disease progression,,2022,Q4,2,F,,20221205.0,20221021,20221211,EXP,,NVSJ2022JP099311,NOVARTIS,,47.0,YR,,M,Y,100.7,KG,20221212,,MD,JP,JP,2022,Q4,Adult
214895152,21489515,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,82 Arbitrary units,,,U,,,,,,,,,2022,Q4,Obesity,,2022,Q4,2,F,,20221205.0,20221021,20221211,EXP,,NVSJ2022JP099311,NOVARTIS,,47.0,YR,,M,Y,100.7,KG,20221212,,MD,JP,JP,2022,Q4,Adult
214895152,21489515,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,82 Arbitrary units,,,U,,,,,,,,,2022,Q4,Protein urine present,,2022,Q4,2,F,,20221205.0,20221021,20221211,EXP,,NVSJ2022JP099311,NOVARTIS,,47.0,YR,,M,Y,100.7,KG,20221212,,MD,JP,JP,2022,Q4,Adult
214895152,21489515,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,82 Arbitrary units,,,U,,,,,,,,,2022,Q4,Hypertension,,2022,Q4,2,F,,20221205.0,20221021,20221211,EXP,,NVSJ2022JP099311,NOVARTIS,,47.0,YR,,M,Y,100.7,KG,20221212,,MD,JP,JP,2022,Q4,Adult
214895152,21489515,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,82 Arbitrary units,,,U,,,,,,,,,2022,Q4,Nephropathy,,2022,Q4,2,F,,20221205.0,20221021,20221211,EXP,,NVSJ2022JP099311,NOVARTIS,,47.0,YR,,M,Y,100.7,KG,20221212,,MD,JP,JP,2022,Q4,Adult
214895152,21489515,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,82 Arbitrary units,,,U,,,,,,,,,2022,Q4,Body mass index increased,,2022,Q4,2,F,,20221205.0,20221021,20221211,EXP,,NVSJ2022JP099311,NOVARTIS,,47.0,YR,,M,Y,100.7,KG,20221212,,MD,JP,JP,2022,Q4,Adult
214895152,21489515,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,82 Arbitrary units,,,U,,,,,,,,,2022,Q4,Insulin resistance,,2022,Q4,2,F,,20221205.0,20221021,20221211,EXP,,NVSJ2022JP099311,NOVARTIS,,47.0,YR,,M,Y,100.7,KG,20221212,,MD,JP,JP,2022,Q4,Adult
214915442,21491544,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q4,Renal failure,,2022,Q4,2,F,20220627.0,20221024.0,20221021,20221028,EXP,,US-ROCHE-3141006,ROCHE,,77.0,YR,,M,Y,,,20221028,,MD,US,,2022,Q4,Elderly
214915442,21491544,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q4,End stage renal disease,,2022,Q4,2,F,20220627.0,20221024.0,20221021,20221028,EXP,,US-ROCHE-3141006,ROCHE,,77.0,YR,,M,Y,,,20221028,,MD,US,,2022,Q4,Elderly
214925471,21492547,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q4,Glycosylated haemoglobin abnormal,,2022,Q4,1,I,,20221017.0,20221021,20221021,PER,,US-SA-2022SA431767,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20221021,,CN,US,US,2022,Q4,Elderly
214928442,21492844,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, cyclic",,,,,,,,,,,,2022,Q4,Condition aggravated,,2022,Q4,2,F,20210119.0,20221026.0,20221021,20221101,EXP,DE-ADRED-07152-01,DE-PFIZER INC-202201234852,PFIZER,,70.0,YR,,F,Y,,,20221101,,PH,DE,DE,2022,Q4,Elderly
214928442,21492844,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, cyclic",,,,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,20210119.0,20221026.0,20221021,20221101,EXP,DE-ADRED-07152-01,DE-PFIZER INC-202201234852,PFIZER,,70.0,YR,,F,Y,,,20221101,,PH,DE,DE,2022,Q4,Elderly
214928442,21492844,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, cyclic",,,,,,,,,,,,2022,Q4,Sepsis,,2022,Q4,2,F,20210119.0,20221026.0,20221021,20221101,EXP,DE-ADRED-07152-01,DE-PFIZER INC-202201234852,PFIZER,,70.0,YR,,F,Y,,,20221101,,PH,DE,DE,2022,Q4,Elderly
214928442,21492844,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, cyclic",,,,,,,,,,,,2022,Q4,Tachypnoea,,2022,Q4,2,F,20210119.0,20221026.0,20221021,20221101,EXP,DE-ADRED-07152-01,DE-PFIZER INC-202201234852,PFIZER,,70.0,YR,,F,Y,,,20221101,,PH,DE,DE,2022,Q4,Elderly
214928442,21492844,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, cyclic",,,,,,,,,,,,2022,Q4,Tachycardia,,2022,Q4,2,F,20210119.0,20221026.0,20221021,20221101,EXP,DE-ADRED-07152-01,DE-PFIZER INC-202201234852,PFIZER,,70.0,YR,,F,Y,,,20221101,,PH,DE,DE,2022,Q4,Elderly
214928442,21492844,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, cyclic",,,,,,,,,,,,2022,Q4,Pyrexia,,2022,Q4,2,F,20210119.0,20221026.0,20221021,20221101,EXP,DE-ADRED-07152-01,DE-PFIZER INC-202201234852,PFIZER,,70.0,YR,,F,Y,,,20221101,,PH,DE,DE,2022,Q4,Elderly
214928442,21492844,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, cyclic",,,,,,,,,,,,2022,Q4,Renal impairment,,2022,Q4,2,F,20210119.0,20221026.0,20221021,20221101,EXP,DE-ADRED-07152-01,DE-PFIZER INC-202201234852,PFIZER,,70.0,YR,,F,Y,,,20221101,,PH,DE,DE,2022,Q4,Elderly
214928442,21492844,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, cyclic",,,,,,,,,,,,2022,Q4,Musculoskeletal pain,,2022,Q4,2,F,20210119.0,20221026.0,20221021,20221101,EXP,DE-ADRED-07152-01,DE-PFIZER INC-202201234852,PFIZER,,70.0,YR,,F,Y,,,20221101,,PH,DE,DE,2022,Q4,Elderly
214928442,21492844,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, cyclic",,,,,,,,,,,,2022,Q4,Anaemia,,2022,Q4,2,F,20210119.0,20221026.0,20221021,20221101,EXP,DE-ADRED-07152-01,DE-PFIZER INC-202201234852,PFIZER,,70.0,YR,,F,Y,,,20221101,,PH,DE,DE,2022,Q4,Elderly
214928442,21492844,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, cyclic",,,,,,,,,,,,2022,Q4,Systemic infection,,2022,Q4,2,F,20210119.0,20221026.0,20221021,20221101,EXP,DE-ADRED-07152-01,DE-PFIZER INC-202201234852,PFIZER,,70.0,YR,,F,Y,,,20221101,,PH,DE,DE,2022,Q4,Elderly
214928442,21492844,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, cyclic",,,,,,,,,,,,2022,Q4,Electrocardiogram abnormal,,2022,Q4,2,F,20210119.0,20221026.0,20221021,20221101,EXP,DE-ADRED-07152-01,DE-PFIZER INC-202201234852,PFIZER,,70.0,YR,,F,Y,,,20221101,,PH,DE,DE,2022,Q4,Elderly
214928442,21492844,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, cyclic",,,,,,,,,,,,2022,Q4,Death,,2022,Q4,2,F,20210119.0,20221026.0,20221021,20221101,EXP,DE-ADRED-07152-01,DE-PFIZER INC-202201234852,PFIZER,,70.0,YR,,F,Y,,,20221101,,PH,DE,DE,2022,Q4,Elderly
214928442,21492844,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, cyclic",,,,,,,,,,,,2022,Q4,Oedema peripheral,,2022,Q4,2,F,20210119.0,20221026.0,20221021,20221101,EXP,DE-ADRED-07152-01,DE-PFIZER INC-202201234852,PFIZER,,70.0,YR,,F,Y,,,20221101,,PH,DE,DE,2022,Q4,Elderly
214928442,21492844,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, cyclic",,,,,,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,2,F,20210119.0,20221026.0,20221021,20221101,EXP,DE-ADRED-07152-01,DE-PFIZER INC-202201234852,PFIZER,,70.0,YR,,F,Y,,,20221101,,PH,DE,DE,2022,Q4,Elderly
214928442,21492844,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK, cyclic",,,,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,2,F,20210119.0,20221026.0,20221021,20221101,EXP,DE-ADRED-07152-01,DE-PFIZER INC-202201234852,PFIZER,,70.0,YR,,F,Y,,,20221101,,PH,DE,DE,2022,Q4,Elderly
214981801,21498180,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 u/ml kwikpen 3ml,,,U,,,,,,,Unknown,,2022,Q4,Anaemia,,2022,Q4,1,I,20220701.0,20221018.0,20221024,20221024,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-123945,BRISTOL MYERS SQUIBB,,70.0,YR,E,F,Y,92.5,KG,20221024,,PH,US,US,2022,Q4,Elderly
214981801,21498180,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,100 u/ml kwikpen 3ml,,,U,,,,,,,Unknown,,2022,Q4,Neutropenia,,2022,Q4,1,I,20220701.0,20221018.0,20221024,20221024,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-123945,BRISTOL MYERS SQUIBB,,70.0,YR,E,F,Y,92.5,KG,20221024,,PH,US,US,2022,Q4,Elderly
214995901,21499590,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 unit / ml,,,U,,,,,,,,,2022,Q4,Off label use,,2022,Q4,1,I,20220721.0,20221019.0,20221024,20221024,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-124836,BRISTOL MYERS SQUIBB,,72.0,YR,E,F,Y,70.31,KG,20221024,,HP,US,US,2022,Q4,Elderly
214995901,21499590,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100 unit / ml,,,U,,,,,,,,,2022,Q4,Thrombosis,,2022,Q4,1,I,20220721.0,20221019.0,20221024,20221024,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-124836,BRISTOL MYERS SQUIBB,,72.0,YR,E,F,Y,70.31,KG,20221024,,HP,US,US,2022,Q4,Elderly
215003062,21500306,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,unk,,,,,,,2022,Q4,Diabetic ketoacidosis,,2022,Q4,2,F,,20221028.0,20221024,20221108,EXP,,JP-NOVOPROD-969860,NOVO NORDISK,,52.0,YR,,M,Y,,,20221108,,MD,JP,JP,2022,Q4,Adult
215003062,21500306,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,unk,,,,,,,2022,Q4,Surgery,,2022,Q4,2,F,,20221028.0,20221024,20221108,EXP,,JP-NOVOPROD-969860,NOVO NORDISK,,52.0,YR,,M,Y,,,20221108,,MD,JP,JP,2022,Q4,Adult
215042963,21504296,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,COVID-19 pneumonia,,2022,Q4,3,F,,20221019.0,20221025,20221122,EXP,,JP-ORGANON-O2210JPN001723,ORGANON,"Wada T, Sakai S, Funakubo Y, Mimura T.. A case of continued tocilizumab administration to a rheumatoid arthritis patient after severe COVID-19 infection. Proceedings of Kanto Rheumatology Conference. 2022;54:68-71",69.0,YR,,F,Y,,,20221122,,HP,JP,JP,2022,Q4,Elderly
215049571,21504957,2,C,INSULIN LISPRO BIOSIMILAR 1,,2,Unknown,"13 units in the morning, 11 units in the afternoon, 6 units in the evening",,,,,UNKNOWN,,,,,,,2022,Q4,COVID-19 pneumonia,,2022,Q4,1,I,,20221017.0,20221025,20221025,EXP,,JP-ROCHE-3206310,ROCHE,"PRIVACY P, Wada T, Sakai S, Hunakubo Y, Mimura T 19 A case of a patient who received treatment with tocilizumab for rheumatoid arthritis and continued to receive tocilizumab after the onset of severe COVID-19.. Proceedings of Kanto Rheumatology Conference, Interesting cases and the problems. 2022;(54):68-71.",69.0,YR,,F,Y,,,20221026,,MD,JP,JP,2022,Q4,Elderly
215050581,21505058,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Blood glucose abnormal,,2022,Q4,1,I,,20221019.0,20221025,20221025,EXP,,US-NOVITIUMPHARMA-2022USNVP00244,NOVITIUM PHARMA,Dr Anastasia Naritsin.Critical presentation and management of an acute gastrointestinal haemorrhage as a result of an arterioenteric fistula secondary to a failed pancreatic allograft..BMJ Case Reports.17-JUN-2021;14:1-5,60.0,YR,A,F,Y,,,20221026,,HP,US,US,2022,Q4,Adult
215050581,21505058,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,End stage renal disease,,2022,Q4,1,I,,20221019.0,20221025,20221025,EXP,,US-NOVITIUMPHARMA-2022USNVP00244,NOVITIUM PHARMA,Dr Anastasia Naritsin.Critical presentation and management of an acute gastrointestinal haemorrhage as a result of an arterioenteric fistula secondary to a failed pancreatic allograft..BMJ Case Reports.17-JUN-2021;14:1-5,60.0,YR,A,F,Y,,,20221026,,HP,US,US,2022,Q4,Adult
215061472,21506147,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 international unit, 3 Times a Day",,,U,,,,,12.0,IU,,TID,2022,Q4,Hypoglycaemia,,2022,Q4,2,F,20220508.0,20221019.0,20221026,20221031,EXP,,IT-AUROBINDO-AUR-APL-2022-044077,AUROBINDO,,81.0,YR,,F,Y,,,20221031,,MD,IT,IT,2022,Q4,Elderly
215069092,21506909,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q4,Cellulitis,,2022,Q4,2,F,20220910.0,20221020.0,20221026,20221102,EXP,,US-ROCHE-3205294,ROCHE,,57.0,YR,,M,Y,,,20221101,,MD,US,,2022,Q4,Adult
215076171,21507617,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50|50 IE, je nach BZ?50|50 IU, depending on BG",,,,,UNKNOWN,,,,,,,2022,Q4,Product prescribing error,,2022,Q4,1,I,,20221013.0,20221026,20221026,PER,,DE-drreddys-SPO/GER/22/0156015,DR REDDYS,,74.0,YR,E,F,Y,,,20221026,,PH,DE,DE,2022,Q4,Elderly
215076171,21507617,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50|50 IE, je nach BZ?50|50 IU, depending on BG",,,,,UNKNOWN,,,,,,,2022,Q4,Gait disturbance,,2022,Q4,1,I,,20221013.0,20221026,20221026,PER,,DE-drreddys-SPO/GER/22/0156015,DR REDDYS,,74.0,YR,E,F,Y,,,20221026,,PH,DE,DE,2022,Q4,Elderly
215076171,21507617,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50|50 IE, je nach BZ?50|50 IU, depending on BG",,,,,UNKNOWN,,,,,,,2022,Q4,Arthralgia,,2022,Q4,1,I,,20221013.0,20221026,20221026,PER,,DE-drreddys-SPO/GER/22/0156015,DR REDDYS,,74.0,YR,E,F,Y,,,20221026,,PH,DE,DE,2022,Q4,Elderly
215076171,21507617,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50|50 IE, je nach BZ?50|50 IU, depending on BG",,,,,UNKNOWN,,,,,,,2022,Q4,Musculoskeletal pain,,2022,Q4,1,I,,20221013.0,20221026,20221026,PER,,DE-drreddys-SPO/GER/22/0156015,DR REDDYS,,74.0,YR,E,F,Y,,,20221026,,PH,DE,DE,2022,Q4,Elderly
215076171,21507617,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50|50 IE, je nach BZ?50|50 IU, depending on BG",,,,,UNKNOWN,,,,,,,2022,Q4,Pain,,2022,Q4,1,I,,20221013.0,20221026,20221026,PER,,DE-drreddys-SPO/GER/22/0156015,DR REDDYS,,74.0,YR,E,F,Y,,,20221026,,PH,DE,DE,2022,Q4,Elderly
215076171,21507617,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50|50 IE, je nach BZ?50|50 IU, depending on BG",,,,,UNKNOWN,,,,,,,2022,Q4,Condition aggravated,,2022,Q4,1,I,,20221013.0,20221026,20221026,PER,,DE-drreddys-SPO/GER/22/0156015,DR REDDYS,,74.0,YR,E,F,Y,,,20221026,,PH,DE,DE,2022,Q4,Elderly
215076181,21507618,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50|50 mg, fr?h und abend je nach Wert (50|50 mg, morning and evening depending on value)",,,,,UNKNOWN,,,1.0,MG,,BID,2022,Q4,Musculoskeletal pain,,2022,Q4,1,I,,20221013.0,20221026,20221026,EXP,,DE-drreddys-SPO/GER/22/0156045,DR REDDYS,,73.0,YR,E,F,Y,,,20221026,,PH,DE,DE,2022,Q4,Elderly
215076181,21507618,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50|50 mg, fr?h und abend je nach Wert (50|50 mg, morning and evening depending on value)",,,,,UNKNOWN,,,1.0,MG,,BID,2022,Q4,Gait disturbance,,2022,Q4,1,I,,20221013.0,20221026,20221026,EXP,,DE-drreddys-SPO/GER/22/0156045,DR REDDYS,,73.0,YR,E,F,Y,,,20221026,,PH,DE,DE,2022,Q4,Elderly
215076181,21507618,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50|50 mg, fr?h und abend je nach Wert (50|50 mg, morning and evening depending on value)",,,,,UNKNOWN,,,1.0,MG,,BID,2022,Q4,Hypoaesthesia,,2022,Q4,1,I,,20221013.0,20221026,20221026,EXP,,DE-drreddys-SPO/GER/22/0156045,DR REDDYS,,73.0,YR,E,F,Y,,,20221026,,PH,DE,DE,2022,Q4,Elderly
215076181,21507618,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50|50 mg, fr?h und abend je nach Wert (50|50 mg, morning and evening depending on value)",,,,,UNKNOWN,,,1.0,MG,,BID,2022,Q4,Pain,,2022,Q4,1,I,,20221013.0,20221026,20221026,EXP,,DE-drreddys-SPO/GER/22/0156045,DR REDDYS,,73.0,YR,E,F,Y,,,20221026,,PH,DE,DE,2022,Q4,Elderly
215127071,21512707,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q4,Hypertension,,2022,Q4,1,I,20221014.0,20221017.0,20221027,20221027,EXP,,US-SA-2022SA431445,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20221027,,CN,US,US,2022,Q4,Elderly
215127071,21512707,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q4,Injection site pain,,2022,Q4,1,I,20221014.0,20221017.0,20221027,20221027,EXP,,US-SA-2022SA431445,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20221027,,CN,US,US,2022,Q4,Elderly
215127071,21512707,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q4,Neoplasm malignant,,2022,Q4,1,I,20221014.0,20221017.0,20221027,20221027,EXP,,US-SA-2022SA431445,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20221027,,CN,US,US,2022,Q4,Elderly
215127071,21512707,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,20221014.0,20221017.0,20221027,20221027,EXP,,US-SA-2022SA431445,SANOFI AVENTIS,,68.0,YR,E,F,Y,,,20221027,,CN,US,US,2022,Q4,Elderly
215136311,21513631,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q4,Death,,2022,Q4,1,I,20221021.0,20221024.0,20221027,20221027,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-127210,BRISTOL MYERS SQUIBB,,78.0,YR,E,M,Y,91.2,KG,20221027,,PH,US,US,2022,Q4,Elderly
215136311,21513631,18,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,Unknown,,2022,Q4,Off label use,,2022,Q4,1,I,20221021.0,20221024.0,20221027,20221027,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-127210,BRISTOL MYERS SQUIBB,,78.0,YR,E,M,Y,91.2,KG,20221027,,PH,US,US,2022,Q4,Elderly
215143881,21514388,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown (10/14/8VARIABILE)",,,U,,,,20563.0,,,,,2022,Q4,Confusional state,,2022,Q4,1,I,20220516.0,20221014.0,20221027,20221027,EXP,IT-MINISAL02-888961,IT-ELI_LILLY_AND_COMPANY-IT202210006806,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20221027,,CN,IT,IT,2022,Q4,Elderly
215143881,21514388,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, unknown (10/14/8VARIABILE)",,,U,,,,20563.0,,,,,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20220516.0,20221014.0,20221027,20221027,EXP,IT-MINISAL02-888961,IT-ELI_LILLY_AND_COMPANY-IT202210006806,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20221027,,CN,IT,IT,2022,Q4,Elderly
215173881,21517388,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Gait disturbance,,2022,Q4,1,I,20221017.0,20221017.0,20221028,20221028,PER,,US-ELI_LILLY_AND_COMPANY-US202210009949,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20221028,,CN,US,US,2022,Q4,Elderly
215173881,21517388,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Gait disturbance,,2022,Q4,1,I,20221017.0,20221017.0,20221028,20221028,PER,,US-ELI_LILLY_AND_COMPANY-US202210009949,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20221028,,CN,US,US,2022,Q4,Elderly
215173881,21517388,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D484040C,,20563.0,,,Injection,,2022,Q4,Gait disturbance,,2022,Q4,1,I,20221017.0,20221017.0,20221028,20221028,PER,,US-ELI_LILLY_AND_COMPANY-US202210009949,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20221028,,CN,US,US,2022,Q4,Elderly
215173881,21517388,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D392597D,,20563.0,,,Injection,,2022,Q4,Gait disturbance,,2022,Q4,1,I,20221017.0,20221017.0,20221028,20221028,PER,,US-ELI_LILLY_AND_COMPANY-US202210009949,ELI LILLY AND CO,,78.0,YR,,F,Y,,,20221028,,CN,US,US,2022,Q4,Elderly
215232941,21523294,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"25 iU, BID",,,,,,,,25.0,IU,Solution for injection,Q12H,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20220802.0,20221019.0,20221029,20221029,PER,,US-SA-2022SA435505,SANOFI AVENTIS,,64.0,YR,A,F,Y,95.2,KG,20221029,,HP,US,US,2022,Q4,Adult
215306981,21530698,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q4,Diabetic ketoacidosis,,2022,Q4,1,I,,20221027.0,20221031,20221031,EXP,,CA-BAUSCH-BL-2022-024430,BAUSCH AND LOMB,UNKNOWN. Unspecified article. Unspecified Journal.,17.0,YR,,M,Y,,,20221031,,HP,CA,CA,2022,Q4,Youth
215372331,21537233,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Limb injury,,2022,Q4,1,I,20220501.0,20221020.0,20221101,20221101,PER,,US-ELI_LILLY_AND_COMPANY-US202210012881,ELI LILLY AND CO,,58.0,YR,,,Y,,,20221101,,CN,US,US,2022,Q4,Adult
215372331,21537233,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Cellulitis,,2022,Q4,1,I,20220501.0,20221020.0,20221101,20221101,PER,,US-ELI_LILLY_AND_COMPANY-US202210012881,ELI LILLY AND CO,,58.0,YR,,,Y,,,20221101,,CN,US,US,2022,Q4,Adult
215400264,21540026,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 international unit,,,U,,,,,1.0,IU,,,2022,Q4,Pain,,2022,Q4,4,F,20210702.0,20221209.0,20221102,20221223,EXP,,DE-AUROBINDO-AUR-APL-2022-046142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221223,,PH,DE,DE,2022,Q4,Adult
215400264,21540026,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 international unit,,,U,,,,,1.0,IU,,,2022,Q4,Fatigue,,2022,Q4,4,F,20210702.0,20221209.0,20221102,20221223,EXP,,DE-AUROBINDO-AUR-APL-2022-046142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221223,,PH,DE,DE,2022,Q4,Adult
215400264,21540026,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 international unit,,,U,,,,,1.0,IU,,,2022,Q4,General physical health deterioration,,2022,Q4,4,F,20210702.0,20221209.0,20221102,20221223,EXP,,DE-AUROBINDO-AUR-APL-2022-046142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221223,,PH,DE,DE,2022,Q4,Adult
215400264,21540026,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 international unit,,,U,,,,,1.0,IU,,,2022,Q4,Vomiting,,2022,Q4,4,F,20210702.0,20221209.0,20221102,20221223,EXP,,DE-AUROBINDO-AUR-APL-2022-046142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221223,,PH,DE,DE,2022,Q4,Adult
215400264,21540026,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 international unit,,,U,,,,,1.0,IU,,,2022,Q4,Tachycardia,,2022,Q4,4,F,20210702.0,20221209.0,20221102,20221223,EXP,,DE-AUROBINDO-AUR-APL-2022-046142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221223,,PH,DE,DE,2022,Q4,Adult
215400264,21540026,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 international unit,,,U,,,,,1.0,IU,,,2022,Q4,Haematochezia,,2022,Q4,4,F,20210702.0,20221209.0,20221102,20221223,EXP,,DE-AUROBINDO-AUR-APL-2022-046142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221223,,PH,DE,DE,2022,Q4,Adult
215400264,21540026,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 international unit,,,U,,,,,1.0,IU,,,2022,Q4,Hyperglycaemia,,2022,Q4,4,F,20210702.0,20221209.0,20221102,20221223,EXP,,DE-AUROBINDO-AUR-APL-2022-046142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221223,,PH,DE,DE,2022,Q4,Adult
215400264,21540026,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 international unit,,,U,,,,,1.0,IU,,,2022,Q4,Anaemia,,2022,Q4,4,F,20210702.0,20221209.0,20221102,20221223,EXP,,DE-AUROBINDO-AUR-APL-2022-046142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221223,,PH,DE,DE,2022,Q4,Adult
215400264,21540026,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 international unit,,,U,,,,,1.0,IU,,,2022,Q4,Dehydration,,2022,Q4,4,F,20210702.0,20221209.0,20221102,20221223,EXP,,DE-AUROBINDO-AUR-APL-2022-046142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221223,,PH,DE,DE,2022,Q4,Adult
215400264,21540026,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 international unit,,,U,,,,,1.0,IU,,,2022,Q4,Nausea,,2022,Q4,4,F,20210702.0,20221209.0,20221102,20221223,EXP,,DE-AUROBINDO-AUR-APL-2022-046142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221223,,PH,DE,DE,2022,Q4,Adult
215400264,21540026,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 international unit,,,U,,,,,1.0,IU,,,2022,Q4,Systemic infection,,2022,Q4,4,F,20210702.0,20221209.0,20221102,20221223,EXP,,DE-AUROBINDO-AUR-APL-2022-046142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221223,,PH,DE,DE,2022,Q4,Adult
215400264,21540026,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 international unit,,,U,,,,,1.0,IU,,,2022,Q4,Cachexia,,2022,Q4,4,F,20210702.0,20221209.0,20221102,20221223,EXP,,DE-AUROBINDO-AUR-APL-2022-046142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221223,,PH,DE,DE,2022,Q4,Adult
215400264,21540026,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 international unit,,,U,,,,,1.0,IU,,,2022,Q4,Condition aggravated,,2022,Q4,4,F,20210702.0,20221209.0,20221102,20221223,EXP,,DE-AUROBINDO-AUR-APL-2022-046142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221223,,PH,DE,DE,2022,Q4,Adult
215400264,21540026,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 international unit,,,U,,,,,1.0,IU,,,2022,Q4,Death,,2022,Q4,4,F,20210702.0,20221209.0,20221102,20221223,EXP,,DE-AUROBINDO-AUR-APL-2022-046142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221223,,PH,DE,DE,2022,Q4,Adult
215400264,21540026,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 international unit,,,U,,,,,1.0,IU,,,2022,Q4,Tenderness,,2022,Q4,4,F,20210702.0,20221209.0,20221102,20221223,EXP,,DE-AUROBINDO-AUR-APL-2022-046142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221223,,PH,DE,DE,2022,Q4,Adult
215400264,21540026,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,1 international unit,,,U,,,,,1.0,IU,,,2022,Q4,Depressed level of consciousness,,2022,Q4,4,F,20210702.0,20221209.0,20221102,20221223,EXP,,DE-AUROBINDO-AUR-APL-2022-046142,AUROBINDO,,48.0,YR,,M,Y,68.0,KG,20221223,,PH,DE,DE,2022,Q4,Adult
215420801,21542080,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,D509664C,,20563.0,,,Injection,,2022,Q4,COVID-19,,2022,Q4,1,I,20220701.0,20221003.0,20221102,20221102,PER,,US-ELI_LILLY_AND_COMPANY-US202210001537,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20221102,,CN,US,US,2022,Q4,Elderly
215420801,21542080,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,D509664C,,20563.0,,,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20220701.0,20221003.0,20221102,20221102,PER,,US-ELI_LILLY_AND_COMPANY-US202210001537,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20221102,,CN,US,US,2022,Q4,Elderly
215420801,21542080,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q4,COVID-19,,2022,Q4,1,I,20220701.0,20221003.0,20221102,20221102,PER,,US-ELI_LILLY_AND_COMPANY-US202210001537,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20221102,,CN,US,US,2022,Q4,Elderly
215420801,21542080,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, prn",,,,,,,20563.0,,,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20220701.0,20221003.0,20221102,20221102,PER,,US-ELI_LILLY_AND_COMPANY-US202210001537,ELI LILLY AND CO,,70.0,YR,,F,Y,,,20221102,,CN,US,US,2022,Q4,Elderly
215445322,21544532,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"breakfast 8-10 units, dinner 6- 8 units, supper 8-10 units",,,,,,,,,,,,2022,Q4,Product use in unapproved indication,,2022,Q4,2,F,,20221104.0,20221102,20221109,EXP,,PL-MYLANLABS-2022M1119816,MYLAN,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda - Pawelska J, Romaszko-Wojtowicz A, Shevchuk A and Slupski M.. Hepatorenal Syndrome and Other Post-Liver Transplantation Complications: Case Studies and Literature Review. Transplantation Proceedings. 2022;54 (4):1029-36",55.0,YR,,F,Y,,,20221109,,HP,PL,PL,2022,Q4,Adult
215445322,21544532,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"breakfast 8-10 units, dinner 6- 8 units, supper 8-10 units",,,,,,,,,,,,2022,Q4,Bacteraemia,,2022,Q4,2,F,,20221104.0,20221102,20221109,EXP,,PL-MYLANLABS-2022M1119816,MYLAN,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda - Pawelska J, Romaszko-Wojtowicz A, Shevchuk A and Slupski M.. Hepatorenal Syndrome and Other Post-Liver Transplantation Complications: Case Studies and Literature Review. Transplantation Proceedings. 2022;54 (4):1029-36",55.0,YR,,F,Y,,,20221109,,HP,PL,PL,2022,Q4,Adult
215445322,21544532,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"breakfast 8-10 units, dinner 6- 8 units, supper 8-10 units",,,,,,,,,,,,2022,Q4,Oesophageal candidiasis,,2022,Q4,2,F,,20221104.0,20221102,20221109,EXP,,PL-MYLANLABS-2022M1119816,MYLAN,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda - Pawelska J, Romaszko-Wojtowicz A, Shevchuk A and Slupski M.. Hepatorenal Syndrome and Other Post-Liver Transplantation Complications: Case Studies and Literature Review. Transplantation Proceedings. 2022;54 (4):1029-36",55.0,YR,,F,Y,,,20221109,,HP,PL,PL,2022,Q4,Adult
215445322,21544532,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"breakfast 8-10 units, dinner 6- 8 units, supper 8-10 units",,,,,,,,,,,,2022,Q4,Urinary tract infection,,2022,Q4,2,F,,20221104.0,20221102,20221109,EXP,,PL-MYLANLABS-2022M1119816,MYLAN,"Januszko-Giergielewicz B, Kobryn A, Donderski R, Trzcinska J, Theda - Pawelska J, Romaszko-Wojtowicz A, Shevchuk A and Slupski M.. Hepatorenal Syndrome and Other Post-Liver Transplantation Complications: Case Studies and Literature Review. Transplantation Proceedings. 2022;54 (4):1029-36",55.0,YR,,F,Y,,,20221109,,HP,PL,PL,2022,Q4,Adult
215489131,21548913,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-6-0, Injection/Infusion Solution",,,,,,,,,,Injection,,2022,Q4,Bradycardia,,2022,Q4,1,I,,20221027.0,20221103,20221103,EXP,,DE-MYLANLABS-2022M1119443,MYLAN,,76.0,YR,,M,Y,82.0,KG,20221103,,PH,DE,DE,2022,Q4,Elderly
215489131,21548913,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-6-0, Injection/Infusion Solution",,,,,,,,,,Injection,,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20221027.0,20221103,20221103,EXP,,DE-MYLANLABS-2022M1119443,MYLAN,,76.0,YR,,M,Y,82.0,KG,20221103,,PH,DE,DE,2022,Q4,Elderly
215489131,21548913,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, 6-6-6-0, Injection/Infusion Solution",,,,,,,,,,Injection,,2022,Q4,Atrial fibrillation,,2022,Q4,1,I,,20221027.0,20221103,20221103,EXP,,DE-MYLANLABS-2022M1119443,MYLAN,,76.0,YR,,M,Y,82.0,KG,20221103,,PH,DE,DE,2022,Q4,Elderly
215492211,21549221,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Death,,2022,Q4,1,I,20220913.0,20221024.0,20221103,20221103,PER,,US-IGSA-BIG0020916,GRIFOLS,,85.0,YR,,M,Y,,,20221103,,CN,US,US,2022,Q4,Elderly
215541191,21554119,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,UNKNOWN,,,,,,,2022,Q4,Ascites,,2022,Q4,1,I,20210110.0,20221026.0,20221104,20221104,EXP,,JP-ROCHE-3211081,ROCHE,,79.0,YR,,F,Y,74.0,KG,20221103,,MD,JP,JP,2022,Q4,Elderly
215541191,21554119,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,UNKNOWN,,,,,,,2022,Q4,Diarrhoea,,2022,Q4,1,I,20210110.0,20221026.0,20221104,20221104,EXP,,JP-ROCHE-3211081,ROCHE,,79.0,YR,,F,Y,74.0,KG,20221103,,MD,JP,JP,2022,Q4,Elderly
215556031,21555603,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Infusion related reaction,,2022,Q4,1,I,20220909.0,,20221103,20221103,DIR,637201,,FDA-CTU,,71.0,YR,,M,N,135.0,KG,20221103,N,PH,US,,2022,Q4,Elderly
215556031,21555603,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Bradycardia,,2022,Q4,1,I,20220909.0,,20221103,20221103,DIR,637201,,FDA-CTU,,71.0,YR,,M,N,135.0,KG,20221103,N,PH,US,,2022,Q4,Elderly
215556031,21555603,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Pulseless electrical activity,,2022,Q4,1,I,20220909.0,,20221103,20221103,DIR,637201,,FDA-CTU,,71.0,YR,,M,N,135.0,KG,20221103,N,PH,US,,2022,Q4,Elderly
215556383,21555638,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU",,,U,,,,,1.0,IU,,,2022,Q4,Cachexia,,2022,Q4,3,F,,20221124.0,20221104,20221203,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221203,,PH,DE,DE,2022,Q4,Adult
215556383,21555638,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU",,,U,,,,,1.0,IU,,,2022,Q4,Tenderness,,2022,Q4,3,F,,20221124.0,20221104,20221203,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221203,,PH,DE,DE,2022,Q4,Adult
215556383,21555638,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU",,,U,,,,,1.0,IU,,,2022,Q4,Haematochezia,,2022,Q4,3,F,,20221124.0,20221104,20221203,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221203,,PH,DE,DE,2022,Q4,Adult
215556383,21555638,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU",,,U,,,,,1.0,IU,,,2022,Q4,Death,,2022,Q4,3,F,,20221124.0,20221104,20221203,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221203,,PH,DE,DE,2022,Q4,Adult
215556383,21555638,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU",,,U,,,,,1.0,IU,,,2022,Q4,Dehydration,,2022,Q4,3,F,,20221124.0,20221104,20221203,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221203,,PH,DE,DE,2022,Q4,Adult
215556383,21555638,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU",,,U,,,,,1.0,IU,,,2022,Q4,Condition aggravated,,2022,Q4,3,F,,20221124.0,20221104,20221203,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221203,,PH,DE,DE,2022,Q4,Adult
215556383,21555638,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU",,,U,,,,,1.0,IU,,,2022,Q4,Systemic infection,,2022,Q4,3,F,,20221124.0,20221104,20221203,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221203,,PH,DE,DE,2022,Q4,Adult
215556383,21555638,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU",,,U,,,,,1.0,IU,,,2022,Q4,Anaemia,,2022,Q4,3,F,,20221124.0,20221104,20221203,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221203,,PH,DE,DE,2022,Q4,Adult
215556383,21555638,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU",,,U,,,,,1.0,IU,,,2022,Q4,Pain,,2022,Q4,3,F,,20221124.0,20221104,20221203,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221203,,PH,DE,DE,2022,Q4,Adult
215556383,21555638,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU",,,U,,,,,1.0,IU,,,2022,Q4,Depressed level of consciousness,,2022,Q4,3,F,,20221124.0,20221104,20221203,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221203,,PH,DE,DE,2022,Q4,Adult
215556383,21555638,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU",,,U,,,,,1.0,IU,,,2022,Q4,General physical health deterioration,,2022,Q4,3,F,,20221124.0,20221104,20221203,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221203,,PH,DE,DE,2022,Q4,Adult
215556383,21555638,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU",,,U,,,,,1.0,IU,,,2022,Q4,Tachycardia,,2022,Q4,3,F,,20221124.0,20221104,20221203,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221203,,PH,DE,DE,2022,Q4,Adult
215556383,21555638,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU",,,U,,,,,1.0,IU,,,2022,Q4,Vomiting,,2022,Q4,3,F,,20221124.0,20221104,20221203,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221203,,PH,DE,DE,2022,Q4,Adult
215556383,21555638,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU",,,U,,,,,1.0,IU,,,2022,Q4,Fatigue,,2022,Q4,3,F,,20221124.0,20221104,20221203,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221203,,PH,DE,DE,2022,Q4,Adult
215556383,21555638,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU",,,U,,,,,1.0,IU,,,2022,Q4,Nausea,,2022,Q4,3,F,,20221124.0,20221104,20221203,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221203,,PH,DE,DE,2022,Q4,Adult
215556383,21555638,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 iu , unit dose : 1 IU",,,U,,,,,1.0,IU,,,2022,Q4,Hyperglycaemia,,2022,Q4,3,F,,20221124.0,20221104,20221203,EXP,DE-EMA-DD-20221018-186141-083804,DE-TEVA-2022-DE-2821444,TEVA,,48.0,YR,A,M,Y,68.0,KG,20221203,,PH,DE,DE,2022,Q4,Adult
215557451,21555745,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK, tid sliding scale",,,,,D514823C,,20563.0,,,Injection,TID,2022,Q4,Gun shot wound,,2022,Q4,1,I,20220820.0,20221025.0,20221104,20221104,EXP,,US-ELI_LILLY_AND_COMPANY-US202210013229,ELI LILLY AND CO,,34.0,YR,,F,Y,,,20221104,,CN,US,US,2022,Q4,Young Adult
215557781,21555778,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE/ml, 60-60-60-0",,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,20201206.0,20221031.0,20221104,20221104,EXP,,DE-MYLANLABS-2022M1120541,MYLAN,,59.0,YR,,M,Y,,,20221104,,PH,DE,DE,2022,Q4,Adult
215557781,21555778,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE/ml, 60-60-60-0",,,,,,,,,,,,2022,Q4,COVID-19 pneumonia,,2022,Q4,1,I,20201206.0,20221031.0,20221104,20221104,EXP,,DE-MYLANLABS-2022M1120541,MYLAN,,59.0,YR,,M,Y,,,20221104,,PH,DE,DE,2022,Q4,Adult
215579501,21557950,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, nach Bedarf, Injektions-/Infusionsl?sung",,,,,UNKNOWN,,,1.0,IU,Injection,,2022,Q4,Renal impairment,,2022,Q4,1,I,,20221029.0,20221106,20221106,EXP,,DE-drreddys-SPO/GER/22/0156737,DR REDDYS,,80.0,YR,E,F,Y,65.0,KG,20221107,,PH,DE,DE,2022,Q4,Elderly
215579501,21557950,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, nach Bedarf, Injektions-/Infusionsl?sung",,,,,UNKNOWN,,,1.0,IU,Injection,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20221029.0,20221106,20221106,EXP,,DE-drreddys-SPO/GER/22/0156737,DR REDDYS,,80.0,YR,E,F,Y,65.0,KG,20221107,,PH,DE,DE,2022,Q4,Elderly
215579501,21557950,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, nach Bedarf, Injektions-/Infusionsl?sung",,,,,UNKNOWN,,,1.0,IU,Injection,,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20221029.0,20221106,20221106,EXP,,DE-drreddys-SPO/GER/22/0156737,DR REDDYS,,80.0,YR,E,F,Y,65.0,KG,20221107,,PH,DE,DE,2022,Q4,Elderly
215579501,21557950,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, nach Bedarf, Injektions-/Infusionsl?sung",,,,,UNKNOWN,,,1.0,IU,Injection,,2022,Q4,Cardiac failure,,2022,Q4,1,I,,20221029.0,20221106,20221106,EXP,,DE-drreddys-SPO/GER/22/0156737,DR REDDYS,,80.0,YR,E,F,Y,65.0,KG,20221107,,PH,DE,DE,2022,Q4,Elderly
215579501,21557950,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, nach Bedarf, Injektions-/Infusionsl?sung",,,,,UNKNOWN,,,1.0,IU,Injection,,2022,Q4,Anaemia,,2022,Q4,1,I,,20221029.0,20221106,20221106,EXP,,DE-drreddys-SPO/GER/22/0156737,DR REDDYS,,80.0,YR,E,F,Y,65.0,KG,20221107,,PH,DE,DE,2022,Q4,Elderly
215597402,21559740,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2022,Q4,Diabetic ketoacidosis,,2022,Q4,2,F,,20221202.0,20221107,20221205,EXP,,CA-SA-2022SA447150,SANOFI AVENTIS,,17.0,YR,T,M,Y,,,20221205,,HP,CA,CA,2022,Q4,Youth
215597402,21559740,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2022,Q4,Treatment noncompliance,,2022,Q4,2,F,,20221202.0,20221107,20221205,EXP,,CA-SA-2022SA447150,SANOFI AVENTIS,,17.0,YR,T,M,Y,,,20221205,,HP,CA,CA,2022,Q4,Youth
215597402,21559740,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,D,,,,,,,,,2022,Q4,Glycosylated haemoglobin increased,,2022,Q4,2,F,,20221202.0,20221107,20221205,EXP,,CA-SA-2022SA447150,SANOFI AVENTIS,,17.0,YR,T,M,Y,,,20221205,,HP,CA,CA,2022,Q4,Youth
215647331,21564733,16,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,100ml 8-10 units prior to meals,,,U,,,,,,,Unknown,,2022,Q4,Death,,2022,Q4,1,I,20221030.0,20221101.0,20221108,20221108,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-131114,BRISTOL MYERS SQUIBB,,64.0,YR,A,F,Y,,,20221108,,HP,US,US,2022,Q4,Adult
215673131,21567313,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,U,,,,,,,,,2022,Q4,Inappropriate schedule of product administration,,2022,Q4,1,I,,20221031.0,20221108,20221108,PER,,US-SA-2022SA452832,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20221108,,CN,US,US,2022,Q4,Elderly
215691651,21569165,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Solution for injection,,2022,Q4,Therapeutic response decreased,,2022,Q4,1,I,,20221102.0,20221109,20221109,PER,,US-SA-2022SA458730,SANOFI AVENTIS,,67.0,YR,E,F,Y,81.646,KG,20221109,,MD,US,US,2022,Q4,Elderly
215716412,21571641,3,C,PREMIX INSULIN LISPRO 25/75,,2,,,,,Y,,,,,16.0,IU,,Q8H,2022,Q4,Musculoskeletal stiffness,,2022,Q4,2,F,20221001.0,20221110.0,20221109,20221117,EXP,,"ID-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-196531",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,66.0,KG,20221117,,CN,ID,ID,2022,Q4,Adult
215716412,21571641,3,C,PREMIX INSULIN LISPRO 25/75,,2,,,,,Y,,,,,16.0,IU,,Q8H,2022,Q4,Pain in extremity,,2022,Q4,2,F,20221001.0,20221110.0,20221109,20221117,EXP,,"ID-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-196531",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,66.0,KG,20221117,,CN,ID,ID,2022,Q4,Adult
215716412,21571641,3,C,PREMIX INSULIN LISPRO 25/75,,2,,,,,Y,,,,,16.0,IU,,Q8H,2022,Q4,Dysgeusia,,2022,Q4,2,F,20221001.0,20221110.0,20221109,20221117,EXP,,"ID-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-196531",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,66.0,KG,20221117,,CN,ID,ID,2022,Q4,Adult
215716412,21571641,3,C,PREMIX INSULIN LISPRO 25/75,,2,,,,,Y,,,,,16.0,IU,,Q8H,2022,Q4,Abdominal distension,,2022,Q4,2,F,20221001.0,20221110.0,20221109,20221117,EXP,,"ID-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-196531",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,66.0,KG,20221117,,CN,ID,ID,2022,Q4,Adult
215716412,21571641,3,C,PREMIX INSULIN LISPRO 25/75,,2,,,,,Y,,,,,16.0,IU,,Q8H,2022,Q4,Pollakiuria,,2022,Q4,2,F,20221001.0,20221110.0,20221109,20221117,EXP,,"ID-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-196531",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,66.0,KG,20221117,,CN,ID,ID,2022,Q4,Adult
215716412,21571641,3,C,PREMIX INSULIN LISPRO 25/75,,2,,,,,Y,,,,,16.0,IU,,Q8H,2022,Q4,Thirst,,2022,Q4,2,F,20221001.0,20221110.0,20221109,20221117,EXP,,"ID-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-196531",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,66.0,KG,20221117,,CN,ID,ID,2022,Q4,Adult
215716412,21571641,3,C,PREMIX INSULIN LISPRO 25/75,,2,,,,,Y,,,,,16.0,IU,,Q8H,2022,Q4,Cyst,,2022,Q4,2,F,20221001.0,20221110.0,20221109,20221117,EXP,,"ID-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-196531",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,66.0,KG,20221117,,CN,ID,ID,2022,Q4,Adult
215716412,21571641,3,C,PREMIX INSULIN LISPRO 25/75,,2,,,,,Y,,,,,16.0,IU,,Q8H,2022,Q4,Dry mouth,,2022,Q4,2,F,20221001.0,20221110.0,20221109,20221117,EXP,,"ID-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-196531",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,66.0,KG,20221117,,CN,ID,ID,2022,Q4,Adult
215716412,21571641,3,C,PREMIX INSULIN LISPRO 25/75,,2,,,,,Y,,,,,16.0,IU,,Q8H,2022,Q4,Blood glucose increased,,2022,Q4,2,F,20221001.0,20221110.0,20221109,20221117,EXP,,"ID-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-196531",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,66.0,KG,20221117,,CN,ID,ID,2022,Q4,Adult
215716412,21571641,3,C,PREMIX INSULIN LISPRO 25/75,,2,,,,,Y,,,,,16.0,IU,,Q8H,2022,Q4,Gait inability,,2022,Q4,2,F,20221001.0,20221110.0,20221109,20221117,EXP,,"ID-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-196531",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,66.0,KG,20221117,,CN,ID,ID,2022,Q4,Adult
215716412,21571641,3,C,PREMIX INSULIN LISPRO 25/75,,2,,,,,Y,,,,,16.0,IU,,Q8H,2022,Q4,Nausea,,2022,Q4,2,F,20221001.0,20221110.0,20221109,20221117,EXP,,"ID-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-196531",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,66.0,KG,20221117,,CN,ID,ID,2022,Q4,Adult
215716412,21571641,3,C,PREMIX INSULIN LISPRO 25/75,,2,,,,,Y,,,,,16.0,IU,,Q8H,2022,Q4,Nausea,,2022,Q4,2,F,20221001.0,20221110.0,20221109,20221117,EXP,,"ID-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-196531",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,66.0,KG,20221117,,CN,ID,ID,2022,Q4,Adult
215716412,21571641,3,C,PREMIX INSULIN LISPRO 25/75,,2,,,,,Y,,,,,16.0,IU,,Q8H,2022,Q4,Chills,,2022,Q4,2,F,20221001.0,20221110.0,20221109,20221117,EXP,,"ID-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-196531",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,66.0,KG,20221117,,CN,ID,ID,2022,Q4,Adult
215716412,21571641,3,C,PREMIX INSULIN LISPRO 25/75,,2,,,,,Y,,,,,16.0,IU,,Q8H,2022,Q4,Vomiting,,2022,Q4,2,F,20221001.0,20221110.0,20221109,20221117,EXP,,"ID-B.I. Pharmaceuticals,Inc./Ridgefield-2022-BI-196531",BOEHRINGER INGELHEIM,,43.0,YR,A,F,Y,66.0,KG,20221117,,CN,ID,ID,2022,Q4,Adult
215720921,21572092,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D395986A,,20563.0,,,Injection,,2022,Q4,Cerebrovascular accident,,2022,Q4,1,I,20221021.0,20221031.0,20221109,20221109,EXP,,US-ELI_LILLY_AND_COMPANY-US202211000290,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20221109,,CN,US,US,2022,Q4,Adult
215720921,21572092,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D395986A,,20563.0,,,Injection,,2022,Q4,Cerebrovascular accident,,2022,Q4,1,I,20221021.0,20221031.0,20221109,20221109,EXP,,US-ELI_LILLY_AND_COMPANY-US202211000290,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20221109,,CN,US,US,2022,Q4,Adult
215720921,21572092,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D508134D,,20563.0,,,Injection,,2022,Q4,Cerebrovascular accident,,2022,Q4,1,I,20221021.0,20221031.0,20221109,20221109,EXP,,US-ELI_LILLY_AND_COMPANY-US202211000290,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20221109,,CN,US,US,2022,Q4,Adult
215720921,21572092,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D508134D,,20563.0,,,Injection,,2022,Q4,Cerebrovascular accident,,2022,Q4,1,I,20221021.0,20221031.0,20221109,20221109,EXP,,US-ELI_LILLY_AND_COMPANY-US202211000290,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20221109,,CN,US,US,2022,Q4,Adult
215720921,21572092,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Cerebrovascular accident,,2022,Q4,1,I,20221021.0,20221031.0,20221109,20221109,EXP,,US-ELI_LILLY_AND_COMPANY-US202211000290,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20221109,,CN,US,US,2022,Q4,Adult
215720921,21572092,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Cerebrovascular accident,,2022,Q4,1,I,20221021.0,20221031.0,20221109,20221109,EXP,,US-ELI_LILLY_AND_COMPANY-US202211000290,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20221109,,CN,US,US,2022,Q4,Adult
215720921,21572092,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Cerebrovascular accident,,2022,Q4,1,I,20221021.0,20221031.0,20221109,20221109,EXP,,US-ELI_LILLY_AND_COMPANY-US202211000290,ELI LILLY AND CO,,53.0,YR,,F,Y,,,20221109,,CN,US,US,2022,Q4,Adult
215767071,21576707,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, TID, 15 + 35 + 35 IU/day",,,U,,,,,,,Solution for injection,Q8H,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20221008.0,20221102.0,20221110,20221110,EXP,IT-MINISAL02-891363,IT-SA-2022SA457791,SANOFI AVENTIS,,66.0,YR,E,M,Y,,,20221110,,MD,IT,IT,2022,Q4,Elderly
215767071,21576707,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,"UNK UNK, TID, 15 + 35 + 35 IU/day",,,U,,,,,,,Solution for injection,Q8H,2022,Q4,Loss of consciousness,,2022,Q4,1,I,20221008.0,20221102.0,20221110,20221110,EXP,IT-MINISAL02-891363,IT-SA-2022SA457791,SANOFI AVENTIS,,66.0,YR,E,M,Y,,,20221110,,MD,IT,IT,2022,Q4,Elderly
215768971,21576897,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, unknown",,,U,,D490290E,,20563.0,6.0,IU,Injection,,2022,Q4,Accidental underdose,,2022,Q4,1,I,20221108.0,20221108.0,20221110,20221110,PER,,US-ELI_LILLY_AND_COMPANY-US202211005056,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20221110,,CN,US,US,2022,Q4,Elderly
215768971,21576897,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 u, unknown",,,U,,D490290E,,20563.0,6.0,IU,Injection,,2022,Q4,Accidental underdose,,2022,Q4,1,I,20221108.0,20221108.0,20221110,20221110,PER,,US-ELI_LILLY_AND_COMPANY-US202211005056,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20221110,,CN,US,US,2022,Q4,Elderly
215768971,21576897,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D473104C,,20563.0,,,Injection,,2022,Q4,Accidental underdose,,2022,Q4,1,I,20221108.0,20221108.0,20221110,20221110,PER,,US-ELI_LILLY_AND_COMPANY-US202211005056,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20221110,,CN,US,US,2022,Q4,Elderly
215768971,21576897,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D473104C,,20563.0,,,Injection,,2022,Q4,Accidental underdose,,2022,Q4,1,I,20221108.0,20221108.0,20221110,20221110,PER,,US-ELI_LILLY_AND_COMPANY-US202211005056,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20221110,,CN,US,US,2022,Q4,Elderly
215768971,21576897,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Accidental underdose,,2022,Q4,1,I,20221108.0,20221108.0,20221110,20221110,PER,,US-ELI_LILLY_AND_COMPANY-US202211005056,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20221110,,CN,US,US,2022,Q4,Elderly
215768971,21576897,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Accidental underdose,,2022,Q4,1,I,20221108.0,20221108.0,20221110,20221110,PER,,US-ELI_LILLY_AND_COMPANY-US202211005056,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20221110,,CN,US,US,2022,Q4,Elderly
215768971,21576897,7,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Accidental underdose,,2022,Q4,1,I,20221108.0,20221108.0,20221110,20221110,PER,,US-ELI_LILLY_AND_COMPANY-US202211005056,ELI LILLY AND CO,,81.0,YR,,F,Y,,,20221110,,CN,US,US,2022,Q4,Elderly
215775621,21577562,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,,,,,,,,,,2022,Q4,Arthralgia,,2022,Q4,1,I,,20221104.0,20221110,20221110,EXP,,DE-MYLANLABS-2022M1122877,MYLAN,,63.0,YR,,M,Y,105.0,KG,20221110,,PH,DE,DE,2022,Q4,Adult
215775621,21577562,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,,,,,,,,,,2022,Q4,Pyrexia,,2022,Q4,1,I,,20221104.0,20221110,20221110,EXP,,DE-MYLANLABS-2022M1122877,MYLAN,,63.0,YR,,M,Y,105.0,KG,20221110,,PH,DE,DE,2022,Q4,Adult
215775621,21577562,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,,,,,,,,,,2022,Q4,Pain,,2022,Q4,1,I,,20221104.0,20221110,20221110,EXP,,DE-MYLANLABS-2022M1122877,MYLAN,,63.0,YR,,M,Y,105.0,KG,20221110,,PH,DE,DE,2022,Q4,Adult
215775621,21577562,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,,,,,,,,,,2022,Q4,Weight increased,,2022,Q4,1,I,,20221104.0,20221110,20221110,EXP,,DE-MYLANLABS-2022M1122877,MYLAN,,63.0,YR,,M,Y,105.0,KG,20221110,,PH,DE,DE,2022,Q4,Adult
215775621,21577562,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,,,,,,,,,,2022,Q4,Diarrhoea,,2022,Q4,1,I,,20221104.0,20221110,20221110,EXP,,DE-MYLANLABS-2022M1122877,MYLAN,,63.0,YR,,M,Y,105.0,KG,20221110,,PH,DE,DE,2022,Q4,Adult
215775621,21577562,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20221104.0,20221110,20221110,EXP,,DE-MYLANLABS-2022M1122877,MYLAN,,63.0,YR,,M,Y,105.0,KG,20221110,,PH,DE,DE,2022,Q4,Adult
215775621,21577562,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20221104.0,20221110,20221110,EXP,,DE-MYLANLABS-2022M1122877,MYLAN,,63.0,YR,,M,Y,105.0,KG,20221110,,PH,DE,DE,2022,Q4,Adult
215775621,21577562,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,,,,,,,,,,2022,Q4,Nausea,,2022,Q4,1,I,,20221104.0,20221110,20221110,EXP,,DE-MYLANLABS-2022M1122877,MYLAN,,63.0,YR,,M,Y,105.0,KG,20221110,,PH,DE,DE,2022,Q4,Adult
215775621,21577562,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,,,,,,,,,,2022,Q4,Atrial fibrillation,,2022,Q4,1,I,,20221104.0,20221110,20221110,EXP,,DE-MYLANLABS-2022M1122877,MYLAN,,63.0,YR,,M,Y,105.0,KG,20221110,,PH,DE,DE,2022,Q4,Adult
215775621,21577562,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,,,,,,,,,,2022,Q4,Chest pain,,2022,Q4,1,I,,20221104.0,20221110,20221110,EXP,,DE-MYLANLABS-2022M1122877,MYLAN,,63.0,YR,,M,Y,105.0,KG,20221110,,PH,DE,DE,2022,Q4,Adult
215775621,21577562,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,,,,,,,,,,2022,Q4,Haematochezia,,2022,Q4,1,I,,20221104.0,20221110,20221110,EXP,,DE-MYLANLABS-2022M1122877,MYLAN,,63.0,YR,,M,Y,105.0,KG,20221110,,PH,DE,DE,2022,Q4,Adult
215775621,21577562,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,Schema,,,,,,,,,,,,2022,Q4,Systemic infection,,2022,Q4,1,I,,20221104.0,20221110,20221110,EXP,,DE-MYLANLABS-2022M1122877,MYLAN,,63.0,YR,,M,Y,105.0,KG,20221110,,PH,DE,DE,2022,Q4,Adult
215810891,21581089,9,C,INSULIN LISPRO BS,,2,Unknown,,,,U,,,,,,,Injection,,2022,Q4,Rectal ulcer,,2022,Q4,1,I,20220818.0,20221102.0,20221111,20221111,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-132297,BRISTOL MYERS SQUIBB,,74.0,YR,E,F,Y,37.9,KG,20221111,,PH,JP,JP,2022,Q4,Elderly
215810891,21581089,9,C,INSULIN LISPRO BS,,2,Unknown,,,,U,,,,,,,Injection,,2022,Q4,Melaena,,2022,Q4,1,I,20220818.0,20221102.0,20221111,20221111,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-132297,BRISTOL MYERS SQUIBB,,74.0,YR,E,F,Y,37.9,KG,20221111,,PH,JP,JP,2022,Q4,Elderly
215810891,21581089,9,C,INSULIN LISPRO BS,,2,Unknown,,,,U,,,,,,,Injection,,2022,Q4,Decreased appetite,,2022,Q4,1,I,20220818.0,20221102.0,20221111,20221111,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-132297,BRISTOL MYERS SQUIBB,,74.0,YR,E,F,Y,37.9,KG,20221111,,PH,JP,JP,2022,Q4,Elderly
215810891,21581089,9,C,INSULIN LISPRO BS,,2,Unknown,,,,U,,,,,,,Injection,,2022,Q4,Anaemia,,2022,Q4,1,I,20220818.0,20221102.0,20221111,20221111,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-132297,BRISTOL MYERS SQUIBB,,74.0,YR,E,F,Y,37.9,KG,20221111,,PH,JP,JP,2022,Q4,Elderly
215810891,21581089,9,C,INSULIN LISPRO BS,,2,Unknown,,,,U,,,,,,,Injection,,2022,Q4,Lower gastrointestinal haemorrhage,,2022,Q4,1,I,20220818.0,20221102.0,20221111,20221111,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-132297,BRISTOL MYERS SQUIBB,,74.0,YR,E,F,Y,37.9,KG,20221111,,PH,JP,JP,2022,Q4,Elderly
215817501,21581750,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"45 iU, QD",,,Y,,,,,45.0,IU,,QD,2022,Q4,Urticaria,,2022,Q4,1,I,,20221103.0,20221111,20221111,EXP,,RU-SA-2022SA457234,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20221111,,MD,RU,RU,2022,Q4,Adult
215817501,21581750,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"45 iU, QD",,,Y,,,,,45.0,IU,,QD,2022,Q4,Rash,,2022,Q4,1,I,,20221103.0,20221111,20221111,EXP,,RU-SA-2022SA457234,SANOFI AVENTIS,,64.0,YR,A,F,Y,,,20221111,,MD,RU,RU,2022,Q4,Adult
215834211,21583421,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Schema,,,,,,,,,,Injection,,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,,20221107.0,20221111,20221111,EXP,,DE-MYLANLABS-2022M1123425,MYLAN,,82.0,YR,,F,Y,,,20221111,,PH,DE,DE,2022,Q4,Elderly
215834211,21583421,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Schema,,,,,,,,,,Injection,,2022,Q4,Electrocardiogram abnormal,,2022,Q4,1,I,,20221107.0,20221111,20221111,EXP,,DE-MYLANLABS-2022M1123425,MYLAN,,82.0,YR,,F,Y,,,20221111,,PH,DE,DE,2022,Q4,Elderly
215834211,21583421,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Schema,,,,,,,,,,Injection,,2022,Q4,Hyperkalaemia,,2022,Q4,1,I,,20221107.0,20221111,20221111,EXP,,DE-MYLANLABS-2022M1123425,MYLAN,,82.0,YR,,F,Y,,,20221111,,PH,DE,DE,2022,Q4,Elderly
215834211,21583421,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Schema,,,,,,,,,,Injection,,2022,Q4,Renal impairment,,2022,Q4,1,I,,20221107.0,20221111,20221111,EXP,,DE-MYLANLABS-2022M1123425,MYLAN,,82.0,YR,,F,Y,,,20221111,,PH,DE,DE,2022,Q4,Elderly
215834211,21583421,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Schema,,,,,,,,,,Injection,,2022,Q4,Loss of consciousness,,2022,Q4,1,I,,20221107.0,20221111,20221111,EXP,,DE-MYLANLABS-2022M1123425,MYLAN,,82.0,YR,,F,Y,,,20221111,,PH,DE,DE,2022,Q4,Elderly
215834211,21583421,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Schema,,,,,,,,,,Injection,,2022,Q4,Tachycardia,,2022,Q4,1,I,,20221107.0,20221111,20221111,EXP,,DE-MYLANLABS-2022M1123425,MYLAN,,82.0,YR,,F,Y,,,20221111,,PH,DE,DE,2022,Q4,Elderly
215834211,21583421,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Schema,,,,,,,,,,Injection,,2022,Q4,Hypotension,,2022,Q4,1,I,,20221107.0,20221111,20221111,EXP,,DE-MYLANLABS-2022M1123425,MYLAN,,82.0,YR,,F,Y,,,20221111,,PH,DE,DE,2022,Q4,Elderly
215834211,21583421,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Schema,,,,,,,,,,Injection,,2022,Q4,Anaemia,,2022,Q4,1,I,,20221107.0,20221111,20221111,EXP,,DE-MYLANLABS-2022M1123425,MYLAN,,82.0,YR,,F,Y,,,20221111,,PH,DE,DE,2022,Q4,Elderly
215834211,21583421,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Schema,,,,,,,,,,Injection,,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20221107.0,20221111,20221111,EXP,,DE-MYLANLABS-2022M1123425,MYLAN,,82.0,YR,,F,Y,,,20221111,,PH,DE,DE,2022,Q4,Elderly
215834211,21583421,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Schema,,,,,,,,,,Injection,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20221107.0,20221111,20221111,EXP,,DE-MYLANLABS-2022M1123425,MYLAN,,82.0,YR,,F,Y,,,20221111,,PH,DE,DE,2022,Q4,Elderly
215834211,21583421,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Schema,,,,,,,,,,Injection,,2022,Q4,Acute respiratory failure,,2022,Q4,1,I,,20221107.0,20221111,20221111,EXP,,DE-MYLANLABS-2022M1123425,MYLAN,,82.0,YR,,F,Y,,,20221111,,PH,DE,DE,2022,Q4,Elderly
215834211,21583421,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Schema,,,,,,,,,,Injection,,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20221107.0,20221111,20221111,EXP,,DE-MYLANLABS-2022M1123425,MYLAN,,82.0,YR,,F,Y,,,20221111,,PH,DE,DE,2022,Q4,Elderly
215834211,21583421,6,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Schema,,,,,,,,,,Injection,,2022,Q4,Toxicity to various agents,,2022,Q4,1,I,,20221107.0,20221111,20221111,EXP,,DE-MYLANLABS-2022M1123425,MYLAN,,82.0,YR,,F,Y,,,20221111,,PH,DE,DE,2022,Q4,Elderly
215851391,21585139,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, tid",,,Y,,D353894,,20563.0,6.0,IU,,TID,2022,Q4,Somnolence,,2022,Q4,1,I,20220906.0,20221101.0,20221111,20221111,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211001113,ELI LILLY AND CO,,81.0,YR,,M,Y,55.0,KG,20221111,,CN,CN,CN,2022,Q4,Elderly
215851391,21585139,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, tid",,,Y,,D353894,,20563.0,6.0,IU,,TID,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20220906.0,20221101.0,20221111,20221111,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211001113,ELI LILLY AND CO,,81.0,YR,,M,Y,55.0,KG,20221111,,CN,CN,CN,2022,Q4,Elderly
215851391,21585139,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, tid",,,Y,,D353894,,20563.0,6.0,IU,,TID,2022,Q4,Pain,,2022,Q4,1,I,20220906.0,20221101.0,20221111,20221111,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211001113,ELI LILLY AND CO,,81.0,YR,,M,Y,55.0,KG,20221111,,CN,CN,CN,2022,Q4,Elderly
215851391,21585139,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, each morning before meals",,,Y,,D353894,,20563.0,6.0,IU,,QD,2022,Q4,Somnolence,,2022,Q4,1,I,20220906.0,20221101.0,20221111,20221111,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211001113,ELI LILLY AND CO,,81.0,YR,,M,Y,55.0,KG,20221111,,CN,CN,CN,2022,Q4,Elderly
215851391,21585139,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, each morning before meals",,,Y,,D353894,,20563.0,6.0,IU,,QD,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20220906.0,20221101.0,20221111,20221111,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211001113,ELI LILLY AND CO,,81.0,YR,,M,Y,55.0,KG,20221111,,CN,CN,CN,2022,Q4,Elderly
215851391,21585139,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, each morning before meals",,,Y,,D353894,,20563.0,6.0,IU,,QD,2022,Q4,Pain,,2022,Q4,1,I,20220906.0,20221101.0,20221111,20221111,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211001113,ELI LILLY AND CO,,81.0,YR,,M,Y,55.0,KG,20221111,,CN,CN,CN,2022,Q4,Elderly
215851391,21585139,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, daily (at noon) before meals",,,Y,,D353894,,20563.0,6.0,IU,,QD,2022,Q4,Somnolence,,2022,Q4,1,I,20220906.0,20221101.0,20221111,20221111,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211001113,ELI LILLY AND CO,,81.0,YR,,M,Y,55.0,KG,20221111,,CN,CN,CN,2022,Q4,Elderly
215851391,21585139,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, daily (at noon) before meals",,,Y,,D353894,,20563.0,6.0,IU,,QD,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20220906.0,20221101.0,20221111,20221111,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211001113,ELI LILLY AND CO,,81.0,YR,,M,Y,55.0,KG,20221111,,CN,CN,CN,2022,Q4,Elderly
215851391,21585139,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"6 international unit, daily (at noon) before meals",,,Y,,D353894,,20563.0,6.0,IU,,QD,2022,Q4,Pain,,2022,Q4,1,I,20220906.0,20221101.0,20221111,20221111,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211001113,ELI LILLY AND CO,,81.0,YR,,M,Y,55.0,KG,20221111,,CN,CN,CN,2022,Q4,Elderly
215851391,21585139,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 international unit, each evening before meals",,,Y,,D353894,,20563.0,4.0,IU,,QD,2022,Q4,Somnolence,,2022,Q4,1,I,20220906.0,20221101.0,20221111,20221111,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211001113,ELI LILLY AND CO,,81.0,YR,,M,Y,55.0,KG,20221111,,CN,CN,CN,2022,Q4,Elderly
215851391,21585139,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 international unit, each evening before meals",,,Y,,D353894,,20563.0,4.0,IU,,QD,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20220906.0,20221101.0,20221111,20221111,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211001113,ELI LILLY AND CO,,81.0,YR,,M,Y,55.0,KG,20221111,,CN,CN,CN,2022,Q4,Elderly
215851391,21585139,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 international unit, each evening before meals",,,Y,,D353894,,20563.0,4.0,IU,,QD,2022,Q4,Pain,,2022,Q4,1,I,20220906.0,20221101.0,20221111,20221111,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211001113,ELI LILLY AND CO,,81.0,YR,,M,Y,55.0,KG,20221111,,CN,CN,CN,2022,Q4,Elderly
215867411,21586741,70,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: as needed,,,,,,,,8.0,IU,Unknown,,2022,Q4,Cholecystitis acute,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215867411,21586741,70,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: as needed,,,,,,,,8.0,IU,Unknown,,2022,Q4,Peripheral ischaemia,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215867411,21586741,70,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: as needed,,,,,,,,8.0,IU,Unknown,,2022,Q4,Sepsis,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215867411,21586741,71,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: As needed?2 Units,,,,,,,,,,Unknown,,2022,Q4,Cholecystitis acute,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215867411,21586741,71,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: As needed?2 Units,,,,,,,,,,Unknown,,2022,Q4,Peripheral ischaemia,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215867411,21586741,71,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: As needed?2 Units,,,,,,,,,,Unknown,,2022,Q4,Sepsis,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215867411,21586741,72,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: As needed?3 Units,,,,,,,,,,Unknown,,2022,Q4,Cholecystitis acute,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215867411,21586741,72,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: As needed?3 Units,,,,,,,,,,Unknown,,2022,Q4,Peripheral ischaemia,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215867411,21586741,72,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: As needed?3 Units,,,,,,,,,,Unknown,,2022,Q4,Sepsis,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215867411,21586741,73,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 Units,,,,,,,,,,Unknown,QD,2022,Q4,Cholecystitis acute,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215867411,21586741,73,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 Units,,,,,,,,,,Unknown,QD,2022,Q4,Peripheral ischaemia,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215867411,21586741,73,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,4 Units,,,,,,,,,,Unknown,QD,2022,Q4,Sepsis,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215867411,21586741,74,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: As needed?6 units,,,,,,,,,,Unknown,,2022,Q4,Cholecystitis acute,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215867411,21586741,74,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: As needed?6 units,,,,,,,,,,Unknown,,2022,Q4,Peripheral ischaemia,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215867411,21586741,74,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,Frequency text: As needed?6 units,,,,,,,,,,Unknown,,2022,Q4,Sepsis,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215867411,21586741,75,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 Units,,,,,,,,,,Unknown,QD,2022,Q4,Cholecystitis acute,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215867411,21586741,75,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 Units,,,,,,,,,,Unknown,QD,2022,Q4,Peripheral ischaemia,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215867411,21586741,75,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,7 Units,,,,,,,,,,Unknown,QD,2022,Q4,Sepsis,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215867411,21586741,76,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 Units,,,,,,,,,,Unknown,QD,2022,Q4,Cholecystitis acute,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215867411,21586741,76,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 Units,,,,,,,,,,Unknown,QD,2022,Q4,Peripheral ischaemia,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215867411,21586741,76,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,6 Units,,,,,,,,,,Unknown,QD,2022,Q4,Sepsis,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215867411,21586741,77,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 Units,,,,,,,,,,Unknown,QD,2022,Q4,Cholecystitis acute,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215867411,21586741,77,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 Units,,,,,,,,,,Unknown,QD,2022,Q4,Peripheral ischaemia,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215867411,21586741,77,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,8 Units,,,,,,,,,,Unknown,QD,2022,Q4,Sepsis,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215867411,21586741,78,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,16 Units,,,,,,,,,,Unknown,QD,2022,Q4,Cholecystitis acute,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215867411,21586741,78,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,16 Units,,,,,,,,,,Unknown,QD,2022,Q4,Peripheral ischaemia,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215867411,21586741,78,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,16 Units,,,,,,,,,,Unknown,QD,2022,Q4,Sepsis,,2022,Q4,1,I,20200603.0,20221104.0,20221113,20221113,EXP,,US-BRISTOL-MYERS SQUIBB COMPANY-USA-20200700184,BRISTOL MYERS SQUIBB,,62.0,YR,E,M,Y,,,20221113,,MD,US,US,2022,Q4,Adult
215869051,21586905,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Infection,,2022,Q4,1,I,,,20221110,20221110,DIR,FDA-CDER-CTU-2022-90328,,FDA-CTU,,79.0,YR,,M,N,240.1,LBS,20221110,N,,US,,2022,Q4,Elderly
215869051,21586905,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Urinary tract infection,,2022,Q4,1,I,,,20221110,20221110,DIR,FDA-CDER-CTU-2022-90328,,FDA-CTU,,79.0,YR,,M,N,240.1,LBS,20221110,N,,US,,2022,Q4,Elderly
215876992,21587699,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,1.0,IU,Unknown,,2022,Q4,No adverse event,,2022,Q4,2,F,,20221108.0,20221114,20221117,EXP,,DE-BRISTOL-MYERS SQUIBB COMPANY-2022-135659,BRISTOL MYERS SQUIBB,,48.0,YR,A,M,Y,68.0,KG,20221118,,CN,DE,DE,2022,Q4,Adult
215883701,21588370,1,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"1 u, unknown (1 units every 8 carbs)",,,U,,,,,1.0,IU,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20221109.0,20221110.0,20221114,20221114,PER,,US-ELI_LILLY_AND_COMPANY-US202211006747,ELI LILLY AND CO,,11.0,YR,,M,Y,,,20221114,,CN,US,US,2022,Q4,Child
215883701,21588370,1,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"1 u, unknown (1 units every 8 carbs)",,,U,,,,,1.0,IU,Injection,,2022,Q4,Drug ineffective,,2022,Q4,1,I,20221109.0,20221110.0,20221114,20221114,PER,,US-ELI_LILLY_AND_COMPANY-US202211006747,ELI LILLY AND CO,,11.0,YR,,M,Y,,,20221114,,CN,US,US,2022,Q4,Child
215883701,21588370,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"1 u, unknown (1 units every 8 carbs)",,,U,,,,,1.0,IU,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20221109.0,20221110.0,20221114,20221114,PER,,US-ELI_LILLY_AND_COMPANY-US202211006747,ELI LILLY AND CO,,11.0,YR,,M,Y,,,20221114,,CN,US,US,2022,Q4,Child
215883701,21588370,2,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"1 u, unknown (1 units every 8 carbs)",,,U,,,,,1.0,IU,Injection,,2022,Q4,Drug ineffective,,2022,Q4,1,I,20221109.0,20221110.0,20221114,20221114,PER,,US-ELI_LILLY_AND_COMPANY-US202211006747,ELI LILLY AND CO,,11.0,YR,,M,Y,,,20221114,,CN,US,US,2022,Q4,Child
215883701,21588370,3,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"1 u, unknown (1 units every 8 carbs)",,,U,,D429199D,,,1.0,IU,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20221109.0,20221110.0,20221114,20221114,PER,,US-ELI_LILLY_AND_COMPANY-US202211006747,ELI LILLY AND CO,,11.0,YR,,M,Y,,,20221114,,CN,US,US,2022,Q4,Child
215883701,21588370,3,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"1 u, unknown (1 units every 8 carbs)",,,U,,D429199D,,,1.0,IU,Injection,,2022,Q4,Drug ineffective,,2022,Q4,1,I,20221109.0,20221110.0,20221114,20221114,PER,,US-ELI_LILLY_AND_COMPANY-US202211006747,ELI LILLY AND CO,,11.0,YR,,M,Y,,,20221114,,CN,US,US,2022,Q4,Child
215883701,21588370,4,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"1 u, unknown (1 units every 8 carbs)",,,U,,D429199D,,,1.0,IU,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20221109.0,20221110.0,20221114,20221114,PER,,US-ELI_LILLY_AND_COMPANY-US202211006747,ELI LILLY AND CO,,11.0,YR,,M,Y,,,20221114,,CN,US,US,2022,Q4,Child
215883701,21588370,4,SS,INSULIN LISPRO JUNIOR KWIKPEN,INSULIN LISPRO,1,Subcutaneous,"1 u, unknown (1 units every 8 carbs)",,,U,,D429199D,,,1.0,IU,Injection,,2022,Q4,Drug ineffective,,2022,Q4,1,I,20221109.0,20221110.0,20221114,20221114,PER,,US-ELI_LILLY_AND_COMPANY-US202211006747,ELI LILLY AND CO,,11.0,YR,,M,Y,,,20221114,,CN,US,US,2022,Q4,Child
215904471,21590447,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE/ml, 6-5-5-0, pre filled syringe",,,U,U,,,,,,Injection,,2022,Q4,Dyspepsia,,2022,Q4,1,I,,20221108.0,20221114,20221114,EXP,,DE-MYLANLABS-2022M1124004,MYLAN,,47.0,YR,,M,Y,83.0,KG,20221114,,PH,DE,DE,2022,Q4,Adult
215904471,21590447,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE/ml, 6-5-5-0, pre filled syringe",,,U,U,,,,,,Injection,,2022,Q4,Vomiting,,2022,Q4,1,I,,20221108.0,20221114,20221114,EXP,,DE-MYLANLABS-2022M1124004,MYLAN,,47.0,YR,,M,Y,83.0,KG,20221114,,PH,DE,DE,2022,Q4,Adult
215904471,21590447,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE/ml, 6-5-5-0, pre filled syringe",,,U,U,,,,,,Injection,,2022,Q4,Abdominal pain,,2022,Q4,1,I,,20221108.0,20221114,20221114,EXP,,DE-MYLANLABS-2022M1124004,MYLAN,,47.0,YR,,M,Y,83.0,KG,20221114,,PH,DE,DE,2022,Q4,Adult
215904471,21590447,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE/ml, 6-5-5-0, pre filled syringe",,,U,U,,,,,,Injection,,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,,20221108.0,20221114,20221114,EXP,,DE-MYLANLABS-2022M1124004,MYLAN,,47.0,YR,,M,Y,83.0,KG,20221114,,PH,DE,DE,2022,Q4,Adult
215904471,21590447,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE/ml, 6-5-5-0, pre filled syringe",,,U,U,,,,,,Injection,,2022,Q4,Nausea,,2022,Q4,1,I,,20221108.0,20221114,20221114,EXP,,DE-MYLANLABS-2022M1124004,MYLAN,,47.0,YR,,M,Y,83.0,KG,20221114,,PH,DE,DE,2022,Q4,Adult
215904471,21590447,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE/ml, 6-5-5-0, pre filled syringe",,,U,U,,,,,,Injection,,2022,Q4,Diabetic ketoacidosis,,2022,Q4,1,I,,20221108.0,20221114,20221114,EXP,,DE-MYLANLABS-2022M1124004,MYLAN,,47.0,YR,,M,Y,83.0,KG,20221114,,PH,DE,DE,2022,Q4,Adult
215904471,21590447,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE/ml, 6-5-5-0, pre filled syringe",,,U,U,,,,,,Injection,,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,1,I,,20221108.0,20221114,20221114,EXP,,DE-MYLANLABS-2022M1124004,MYLAN,,47.0,YR,,M,Y,83.0,KG,20221114,,PH,DE,DE,2022,Q4,Adult
215904471,21590447,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"100 IE/ml, 6-5-5-0, pre filled syringe",,,U,U,,,,,,Injection,,2022,Q4,Product monitoring error,,2022,Q4,1,I,,20221108.0,20221114,20221114,EXP,,DE-MYLANLABS-2022M1124004,MYLAN,,47.0,YR,,M,Y,83.0,KG,20221114,,PH,DE,DE,2022,Q4,Adult
215907721,21590772,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, tid",,,U,,,,20563.0,4.0,IU,Solution for injection,TID,2022,Q4,Hunger,,2022,Q4,1,I,20221030.0,20221101.0,20221114,20221114,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211001682,ELI LILLY AND CO,,47.0,YR,,F,Y,60.0,KG,20221114,,CN,CN,CN,2022,Q4,Adult
215907721,21590772,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, tid",,,U,,,,20563.0,4.0,IU,Solution for injection,TID,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20221030.0,20221101.0,20221114,20221114,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211001682,ELI LILLY AND CO,,47.0,YR,,F,Y,60.0,KG,20221114,,CN,CN,CN,2022,Q4,Adult
215907721,21590772,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, tid",,,U,,,,20563.0,4.0,IU,Solution for injection,TID,2022,Q4,Diabetic neuropathy,,2022,Q4,1,I,20221030.0,20221101.0,20221114,20221114,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211001682,ELI LILLY AND CO,,47.0,YR,,F,Y,60.0,KG,20221114,,CN,CN,CN,2022,Q4,Adult
215907721,21590772,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, daily",,,U,,,,20563.0,7.0,IU,Solution for injection,QD,2022,Q4,Hunger,,2022,Q4,1,I,20221030.0,20221101.0,20221114,20221114,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211001682,ELI LILLY AND CO,,47.0,YR,,F,Y,60.0,KG,20221114,,CN,CN,CN,2022,Q4,Adult
215907721,21590772,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, daily",,,U,,,,20563.0,7.0,IU,Solution for injection,QD,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20221030.0,20221101.0,20221114,20221114,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211001682,ELI LILLY AND CO,,47.0,YR,,F,Y,60.0,KG,20221114,,CN,CN,CN,2022,Q4,Adult
215907721,21590772,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"7 u, daily",,,U,,,,20563.0,7.0,IU,Solution for injection,QD,2022,Q4,Diabetic neuropathy,,2022,Q4,1,I,20221030.0,20221101.0,20221114,20221114,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211001682,ELI LILLY AND CO,,47.0,YR,,F,Y,60.0,KG,20221114,,CN,CN,CN,2022,Q4,Adult
215907721,21590772,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, bid",,,U,,,,20563.0,4.0,IU,Solution for injection,BID,2022,Q4,Hunger,,2022,Q4,1,I,20221030.0,20221101.0,20221114,20221114,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211001682,ELI LILLY AND CO,,47.0,YR,,F,Y,60.0,KG,20221114,,CN,CN,CN,2022,Q4,Adult
215907721,21590772,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, bid",,,U,,,,20563.0,4.0,IU,Solution for injection,BID,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20221030.0,20221101.0,20221114,20221114,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211001682,ELI LILLY AND CO,,47.0,YR,,F,Y,60.0,KG,20221114,,CN,CN,CN,2022,Q4,Adult
215907721,21590772,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"4 u, bid",,,U,,,,20563.0,4.0,IU,Solution for injection,BID,2022,Q4,Diabetic neuropathy,,2022,Q4,1,I,20221030.0,20221101.0,20221114,20221114,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211001682,ELI LILLY AND CO,,47.0,YR,,F,Y,60.0,KG,20221114,,CN,CN,CN,2022,Q4,Adult
215907721,21590772,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, daily",,,U,,,,20563.0,8.0,IU,Solution for injection,QD,2022,Q4,Hunger,,2022,Q4,1,I,20221030.0,20221101.0,20221114,20221114,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211001682,ELI LILLY AND CO,,47.0,YR,,F,Y,60.0,KG,20221114,,CN,CN,CN,2022,Q4,Adult
215907721,21590772,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, daily",,,U,,,,20563.0,8.0,IU,Solution for injection,QD,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20221030.0,20221101.0,20221114,20221114,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211001682,ELI LILLY AND CO,,47.0,YR,,F,Y,60.0,KG,20221114,,CN,CN,CN,2022,Q4,Adult
215907721,21590772,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"8 u, daily",,,U,,,,20563.0,8.0,IU,Solution for injection,QD,2022,Q4,Diabetic neuropathy,,2022,Q4,1,I,20221030.0,20221101.0,20221114,20221114,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211001682,ELI LILLY AND CO,,47.0,YR,,F,Y,60.0,KG,20221114,,CN,CN,CN,2022,Q4,Adult
215908101,21590810,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,26-0-16-0,,,,,,,,,,,,2022,Q4,Acute myocardial infarction,,2022,Q4,1,I,,20221107.0,20221114,20221114,EXP,,DE-MYLANLABS-2022M1124304,MYLAN,,78.0,YR,,M,Y,,,20221114,,PH,DE,DE,2022,Q4,Elderly
215908101,21590810,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,26-0-16-0,,,,,,,,,,,,2022,Q4,Atrial fibrillation,,2022,Q4,1,I,,20221107.0,20221114,20221114,EXP,,DE-MYLANLABS-2022M1124304,MYLAN,,78.0,YR,,M,Y,,,20221114,,PH,DE,DE,2022,Q4,Elderly
215908101,21590810,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,26-0-16-0,,,,,,,,,,,,2022,Q4,Arrhythmia,,2022,Q4,1,I,,20221107.0,20221114,20221114,EXP,,DE-MYLANLABS-2022M1124304,MYLAN,,78.0,YR,,M,Y,,,20221114,,PH,DE,DE,2022,Q4,Elderly
215908101,21590810,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,26-0-16-0,,,,,,,,,,,,2022,Q4,Acute respiratory failure,,2022,Q4,1,I,,20221107.0,20221114,20221114,EXP,,DE-MYLANLABS-2022M1124304,MYLAN,,78.0,YR,,M,Y,,,20221114,,PH,DE,DE,2022,Q4,Elderly
215908101,21590810,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,26-0-16-0,,,,,,,,,,,,2022,Q4,Renal impairment,,2022,Q4,1,I,,20221107.0,20221114,20221114,EXP,,DE-MYLANLABS-2022M1124304,MYLAN,,78.0,YR,,M,Y,,,20221114,,PH,DE,DE,2022,Q4,Elderly
215908101,21590810,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,26-0-16-0,,,,,,,,,,,,2022,Q4,Electrocardiogram abnormal,,2022,Q4,1,I,,20221107.0,20221114,20221114,EXP,,DE-MYLANLABS-2022M1124304,MYLAN,,78.0,YR,,M,Y,,,20221114,,PH,DE,DE,2022,Q4,Elderly
215908101,21590810,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,26-0-16-0,,,,,,,,,,,,2022,Q4,Systemic infection,,2022,Q4,1,I,,20221107.0,20221114,20221114,EXP,,DE-MYLANLABS-2022M1124304,MYLAN,,78.0,YR,,M,Y,,,20221114,,PH,DE,DE,2022,Q4,Elderly
215908101,21590810,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,26-0-16-0,,,,,,,,,,,,2022,Q4,Tachycardia,,2022,Q4,1,I,,20221107.0,20221114,20221114,EXP,,DE-MYLANLABS-2022M1124304,MYLAN,,78.0,YR,,M,Y,,,20221114,,PH,DE,DE,2022,Q4,Elderly
215908101,21590810,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,26-0-16-0,,,,,,,,,,,,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20221107.0,20221114,20221114,EXP,,DE-MYLANLABS-2022M1124304,MYLAN,,78.0,YR,,M,Y,,,20221114,,PH,DE,DE,2022,Q4,Elderly
215908101,21590810,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,26-0-16-0,,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20221107.0,20221114,20221114,EXP,,DE-MYLANLABS-2022M1124304,MYLAN,,78.0,YR,,M,Y,,,20221114,,PH,DE,DE,2022,Q4,Elderly
215908101,21590810,7,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,26-0-16-0,,,,,,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,,20221107.0,20221114,20221114,EXP,,DE-MYLANLABS-2022M1124304,MYLAN,,78.0,YR,,M,Y,,,20221114,,PH,DE,DE,2022,Q4,Elderly
215950381,21595038,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"45 IU, qd",,,Y,,,,,45.0,IU,,QD,2022,Q4,Urticaria,,2022,Q4,1,I,,20221104.0,20221115,20221115,EXP,RU-RZN-1613721,RU-NOVOPROD-978577,NOVO NORDISK,,64.0,YR,,F,Y,,,20221115,,HP,RU,RU,2022,Q4,Adult
215950381,21595038,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"45 IU, qd",,,Y,,,,,45.0,IU,,QD,2022,Q4,Rash,,2022,Q4,1,I,,20221104.0,20221115,20221115,EXP,RU-RZN-1613721,RU-NOVOPROD-978577,NOVO NORDISK,,64.0,YR,,F,Y,,,20221115,,HP,RU,RU,2022,Q4,Adult
216017481,21601748,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D498888C,,20563.0,,,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20220801.0,20221024.0,20221116,20221116,EXP,,US-ELI_LILLY_AND_COMPANY-US202211004122,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20221116,,CN,US,US,2022,Q4,Elderly
216017481,21601748,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D498888C,,20563.0,,,Injection,,2022,Q4,Glaucoma,,2022,Q4,1,I,20220801.0,20221024.0,20221116,20221116,EXP,,US-ELI_LILLY_AND_COMPANY-US202211004122,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20221116,,CN,US,US,2022,Q4,Elderly
216017481,21601748,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D498888C,,20563.0,,,Injection,,2022,Q4,Macular degeneration,,2022,Q4,1,I,20220801.0,20221024.0,20221116,20221116,EXP,,US-ELI_LILLY_AND_COMPANY-US202211004122,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20221116,,CN,US,US,2022,Q4,Elderly
216017481,21601748,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D484040C,,20563.0,,,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20220801.0,20221024.0,20221116,20221116,EXP,,US-ELI_LILLY_AND_COMPANY-US202211004122,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20221116,,CN,US,US,2022,Q4,Elderly
216017481,21601748,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D484040C,,20563.0,,,Injection,,2022,Q4,Glaucoma,,2022,Q4,1,I,20220801.0,20221024.0,20221116,20221116,EXP,,US-ELI_LILLY_AND_COMPANY-US202211004122,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20221116,,CN,US,US,2022,Q4,Elderly
216017481,21601748,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D484040C,,20563.0,,,Injection,,2022,Q4,Macular degeneration,,2022,Q4,1,I,20220801.0,20221024.0,20221116,20221116,EXP,,US-ELI_LILLY_AND_COMPANY-US202211004122,ELI LILLY AND CO,,87.0,YR,,M,Y,,,20221116,,CN,US,US,2022,Q4,Elderly
216071231,21607123,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE/3ml, according to scheme, pre-filled syringes",,,,,UNKNOWN,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,20210604.0,20221108.0,20221117,20221117,EXP,,DE-drreddys-SPO/GER/22/0157030,DR REDDYS,,86.0,YR,E,M,Y,77.0,KG,20221117,,PH,DE,DE,2022,Q4,Elderly
216071231,21607123,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE/3ml, according to scheme, pre-filled syringes",,,,,UNKNOWN,,,,,,,2022,Q4,Product prescribing error,,2022,Q4,1,I,20210604.0,20221108.0,20221117,20221117,EXP,,DE-drreddys-SPO/GER/22/0157030,DR REDDYS,,86.0,YR,E,M,Y,77.0,KG,20221117,,PH,DE,DE,2022,Q4,Elderly
216071231,21607123,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE/3ml, according to scheme, pre-filled syringes",,,,,UNKNOWN,,,,,,,2022,Q4,Product prescribing error,,2022,Q4,1,I,20210604.0,20221108.0,20221117,20221117,EXP,,DE-drreddys-SPO/GER/22/0157030,DR REDDYS,,86.0,YR,E,M,Y,77.0,KG,20221117,,PH,DE,DE,2022,Q4,Elderly
216071231,21607123,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE/3ml, according to scheme, pre-filled syringes",,,,,UNKNOWN,,,,,,,2022,Q4,Tachycardia,,2022,Q4,1,I,20210604.0,20221108.0,20221117,20221117,EXP,,DE-drreddys-SPO/GER/22/0157030,DR REDDYS,,86.0,YR,E,M,Y,77.0,KG,20221117,,PH,DE,DE,2022,Q4,Elderly
216071231,21607123,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE/3ml, according to scheme, pre-filled syringes",,,,,UNKNOWN,,,,,,,2022,Q4,Atrial fibrillation,,2022,Q4,1,I,20210604.0,20221108.0,20221117,20221117,EXP,,DE-drreddys-SPO/GER/22/0157030,DR REDDYS,,86.0,YR,E,M,Y,77.0,KG,20221117,,PH,DE,DE,2022,Q4,Elderly
216071231,21607123,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE/3ml, according to scheme, pre-filled syringes",,,,,UNKNOWN,,,,,,,2022,Q4,Bradycardia,,2022,Q4,1,I,20210604.0,20221108.0,20221117,20221117,EXP,,DE-drreddys-SPO/GER/22/0157030,DR REDDYS,,86.0,YR,E,M,Y,77.0,KG,20221117,,PH,DE,DE,2022,Q4,Elderly
216071231,21607123,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE/3ml, according to scheme, pre-filled syringes",,,,,UNKNOWN,,,,,,,2022,Q4,Weight increased,,2022,Q4,1,I,20210604.0,20221108.0,20221117,20221117,EXP,,DE-drreddys-SPO/GER/22/0157030,DR REDDYS,,86.0,YR,E,M,Y,77.0,KG,20221117,,PH,DE,DE,2022,Q4,Elderly
216071231,21607123,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IE/3ml, according to scheme, pre-filled syringes",,,,,UNKNOWN,,,,,,,2022,Q4,Restlessness,,2022,Q4,1,I,20210604.0,20221108.0,20221117,20221117,EXP,,DE-drreddys-SPO/GER/22/0157030,DR REDDYS,,86.0,YR,E,M,Y,77.0,KG,20221117,,PH,DE,DE,2022,Q4,Elderly
216073401,21607340,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,38 units/vial,,,U,,,,,,,Injection,,2022,Q4,Nausea,,2022,Q4,1,I,,20211117.0,20221117,20221117,PER,,US-AUROBINDO-AUR-APL-2021-048068,AUROBINDO,,64.0,YR,,F,Y,117.0,KG,20221117,,CN,US,US,2022,Q4,Adult
216073401,21607340,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,38 units/vial,,,U,,,,,,,Injection,,2022,Q4,Vomiting,,2022,Q4,1,I,,20211117.0,20221117,20221117,PER,,US-AUROBINDO-AUR-APL-2021-048068,AUROBINDO,,64.0,YR,,F,Y,117.0,KG,20221117,,CN,US,US,2022,Q4,Adult
216073401,21607340,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,38 units/vial,,,U,,,,,,,Injection,,2022,Q4,Muscle spasms,,2022,Q4,1,I,,20211117.0,20221117,20221117,PER,,US-AUROBINDO-AUR-APL-2021-048068,AUROBINDO,,64.0,YR,,F,Y,117.0,KG,20221117,,CN,US,US,2022,Q4,Adult
216073401,21607340,17,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,38 units/vial,,,U,,,,,,,Injection,,2022,Q4,Asthenia,,2022,Q4,1,I,,20211117.0,20221117,20221117,PER,,US-AUROBINDO-AUR-APL-2021-048068,AUROBINDO,,64.0,YR,,F,Y,117.0,KG,20221117,,CN,US,US,2022,Q4,Adult
216088921,21608892,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50|50 mg,early and evening according to value",,,,,,,,,,,,2022,Q4,Arthralgia,,2022,Q4,1,I,,20221110.0,20221117,20221117,EXP,,DE-MYLANLABS-2022M1125923,MYLAN,,73.0,YR,,F,Y,,,20221117,,PH,DE,DE,2022,Q4,Elderly
216088921,21608892,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50|50 mg,early and evening according to value",,,,,,,,,,,,2022,Q4,Gait disturbance,,2022,Q4,1,I,,20221110.0,20221117,20221117,EXP,,DE-MYLANLABS-2022M1125923,MYLAN,,73.0,YR,,F,Y,,,20221117,,PH,DE,DE,2022,Q4,Elderly
216088921,21608892,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50|50 mg,early and evening according to value",,,,,,,,,,,,2022,Q4,Pain,,2022,Q4,1,I,,20221110.0,20221117,20221117,EXP,,DE-MYLANLABS-2022M1125923,MYLAN,,73.0,YR,,F,Y,,,20221117,,PH,DE,DE,2022,Q4,Elderly
216088921,21608892,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50|50 mg,early and evening according to value",,,,,,,,,,,,2022,Q4,Musculoskeletal pain,,2022,Q4,1,I,,20221110.0,20221117,20221117,EXP,,DE-MYLANLABS-2022M1125923,MYLAN,,73.0,YR,,F,Y,,,20221117,,PH,DE,DE,2022,Q4,Elderly
216088921,21608892,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50|50 mg,early and evening according to value",,,,,,,,,,,,2022,Q4,Product prescribing error,,2022,Q4,1,I,,20221110.0,20221117,20221117,EXP,,DE-MYLANLABS-2022M1125923,MYLAN,,73.0,YR,,F,Y,,,20221117,,PH,DE,DE,2022,Q4,Elderly
216088921,21608892,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50|50 mg,early and evening according to value",,,,,,,,,,,,2022,Q4,Hypoaesthesia,,2022,Q4,1,I,,20221110.0,20221117,20221117,EXP,,DE-MYLANLABS-2022M1125923,MYLAN,,73.0,YR,,F,Y,,,20221117,,PH,DE,DE,2022,Q4,Elderly
216088921,21608892,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"50|50 mg,early and evening according to value",,,,,,,,,,,,2022,Q4,Condition aggravated,,2022,Q4,1,I,,20221110.0,20221117,20221117,EXP,,DE-MYLANLABS-2022M1125923,MYLAN,,73.0,YR,,F,Y,,,20221117,,PH,DE,DE,2022,Q4,Elderly
216117441,21611744,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100, NK IU, according to scheme Liprolog 100 units/ml solution for injection, As Necessary",,,,,,,,,,,,2022,Q4,Dehydration,,2022,Q4,1,I,20190712.0,20221104.0,20221117,20221117,EXP,DE-BFARM-22006603,DE-Accord-285715,ACCORD,,69.0,YR,E,M,Y,,,20221117,,MD,DE,DE,2022,Q4,Elderly
216117441,21611744,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100, NK IU, according to scheme Liprolog 100 units/ml solution for injection, As Necessary",,,,,,,,,,,,2022,Q4,Syncope,,2022,Q4,1,I,20190712.0,20221104.0,20221117,20221117,EXP,DE-BFARM-22006603,DE-Accord-285715,ACCORD,,69.0,YR,E,M,Y,,,20221117,,MD,DE,DE,2022,Q4,Elderly
216117441,21611744,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100, NK IU, according to scheme Liprolog 100 units/ml solution for injection, As Necessary",,,,,,,,,,,,2022,Q4,Hypotension,,2022,Q4,1,I,20190712.0,20221104.0,20221117,20221117,EXP,DE-BFARM-22006603,DE-Accord-285715,ACCORD,,69.0,YR,E,M,Y,,,20221117,,MD,DE,DE,2022,Q4,Elderly
216117441,21611744,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100, NK IU, according to scheme Liprolog 100 units/ml solution for injection, As Necessary",,,,,,,,,,,,2022,Q4,Diarrhoea,,2022,Q4,1,I,20190712.0,20221104.0,20221117,20221117,EXP,DE-BFARM-22006603,DE-Accord-285715,ACCORD,,69.0,YR,E,M,Y,,,20221117,,MD,DE,DE,2022,Q4,Elderly
216117441,21611744,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"100, NK IU, according to scheme Liprolog 100 units/ml solution for injection, As Necessary",,,,,,,,,,,,2022,Q4,Circulatory collapse,,2022,Q4,1,I,20190712.0,20221104.0,20221117,20221117,EXP,DE-BFARM-22006603,DE-Accord-285715,ACCORD,,69.0,YR,E,M,Y,,,20221117,,MD,DE,DE,2022,Q4,Elderly
216124842,21612484,8,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Subcutaneous,UNK,,,U,,,,,,,Injection,,2022,Q4,Acute kidney injury,,2022,Q4,2,F,20220622.0,20221128.0,20221118,20221130,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-138710,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,60.0,KG,20221201,,MD,JP,JP,2022,Q4,Elderly
216124842,21612484,8,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Subcutaneous,UNK,,,U,,,,,,,Injection,,2022,Q4,Tubulointerstitial nephritis,,2022,Q4,2,F,20220622.0,20221128.0,20221118,20221130,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-138710,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,60.0,KG,20221201,,MD,JP,JP,2022,Q4,Elderly
216124842,21612484,8,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Subcutaneous,UNK,,,U,,,,,,,Injection,,2022,Q4,Blood creatinine increased,,2022,Q4,2,F,20220622.0,20221128.0,20221118,20221130,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-138710,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,60.0,KG,20221201,,MD,JP,JP,2022,Q4,Elderly
216124842,21612484,8,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Subcutaneous,UNK,,,U,,,,,,,Injection,,2022,Q4,Pneumonia aspiration,,2022,Q4,2,F,20220622.0,20221128.0,20221118,20221130,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-138710,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,60.0,KG,20221201,,MD,JP,JP,2022,Q4,Elderly
216124842,21612484,8,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Subcutaneous,UNK,,,U,,,,,,,Injection,,2022,Q4,Malignant neoplasm progression,,2022,Q4,2,F,20220622.0,20221128.0,20221118,20221130,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-138710,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,60.0,KG,20221201,,MD,JP,JP,2022,Q4,Elderly
216124842,21612484,8,C,INSULIN LISPRO(GENETICAL RECOMBINATION),,2,Subcutaneous,UNK,,,U,,,,,,,Injection,,2022,Q4,Urinary tract disorder,,2022,Q4,2,F,20220622.0,20221128.0,20221118,20221130,EXP,,JP-BRISTOL-MYERS SQUIBB COMPANY-2022-138710,BRISTOL MYERS SQUIBB,,76.0,YR,E,M,Y,60.0,KG,20221201,,MD,JP,JP,2022,Q4,Elderly
216208051,21620805,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Product storage error,,2022,Q4,1,I,20221112.0,20221114.0,20221121,20221121,PER,,US-ELI_LILLY_AND_COMPANY-US202211007615,ELI LILLY AND CO,,21.0,YR,,F,Y,,,20221121,,CN,US,US,2022,Q4,Youth
216208051,21620805,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20221112.0,20221114.0,20221121,20221121,PER,,US-ELI_LILLY_AND_COMPANY-US202211007615,ELI LILLY AND CO,,21.0,YR,,F,Y,,,20221121,,CN,US,US,2022,Q4,Youth
216208051,21620805,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Wrong technique in product usage process,,2022,Q4,1,I,20221112.0,20221114.0,20221121,20221121,PER,,US-ELI_LILLY_AND_COMPANY-US202211007615,ELI LILLY AND CO,,21.0,YR,,F,Y,,,20221121,,CN,US,US,2022,Q4,Youth
216208051,21620805,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D420813A,,20563.0,,,Injection,,2022,Q4,Product storage error,,2022,Q4,1,I,20221112.0,20221114.0,20221121,20221121,PER,,US-ELI_LILLY_AND_COMPANY-US202211007615,ELI LILLY AND CO,,21.0,YR,,F,Y,,,20221121,,CN,US,US,2022,Q4,Youth
216208051,21620805,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D420813A,,20563.0,,,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20221112.0,20221114.0,20221121,20221121,PER,,US-ELI_LILLY_AND_COMPANY-US202211007615,ELI LILLY AND CO,,21.0,YR,,F,Y,,,20221121,,CN,US,US,2022,Q4,Youth
216208051,21620805,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D420813A,,20563.0,,,Injection,,2022,Q4,Wrong technique in product usage process,,2022,Q4,1,I,20221112.0,20221114.0,20221121,20221121,PER,,US-ELI_LILLY_AND_COMPANY-US202211007615,ELI LILLY AND CO,,21.0,YR,,F,Y,,,20221121,,CN,US,US,2022,Q4,Youth
216213701,21621370,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 iU, BID",,,,,,,,24.0,IU,Solution for injection,Q12H,2022,Q4,Blood potassium abnormal,,2022,Q4,1,I,20220806.0,20221109.0,20221121,20221121,EXP,,US-SA-2022SA468144,SANOFI AVENTIS,,64.0,YR,A,F,Y,95.2,KG,20221121,,HP,US,US,2022,Q4,Adult
216213701,21621370,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 iU, BID",,,,,,,,24.0,IU,Solution for injection,Q12H,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20220806.0,20221109.0,20221121,20221121,EXP,,US-SA-2022SA468144,SANOFI AVENTIS,,64.0,YR,A,F,Y,95.2,KG,20221121,,HP,US,US,2022,Q4,Adult
216213701,21621370,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"24 iU, BID",,,,,,,,24.0,IU,Solution for injection,Q12H,2022,Q4,Loss of consciousness,,2022,Q4,1,I,20220806.0,20221109.0,20221121,20221121,EXP,,US-SA-2022SA468144,SANOFI AVENTIS,,64.0,YR,A,F,Y,95.2,KG,20221121,,HP,US,US,2022,Q4,Adult
216234751,21623475,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, as required",,,,,,,,,,Solution for injection/infusion,,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20221115.0,20221121,20221121,EXP,,DE-MYLANLABS-2022M1129336,MYLAN,,80.0,YR,,F,Y,65.0,KG,20221121,,PH,DE,DE,2022,Q4,Elderly
216234751,21623475,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, as required",,,,,,,,,,Solution for injection/infusion,,2022,Q4,Renal impairment,,2022,Q4,1,I,,20221115.0,20221121,20221121,EXP,,DE-MYLANLABS-2022M1129336,MYLAN,,80.0,YR,,F,Y,65.0,KG,20221121,,PH,DE,DE,2022,Q4,Elderly
216234751,21623475,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, as required",,,,,,,,,,Solution for injection/infusion,,2022,Q4,Anaemia,,2022,Q4,1,I,,20221115.0,20221121,20221121,EXP,,DE-MYLANLABS-2022M1129336,MYLAN,,80.0,YR,,F,Y,65.0,KG,20221121,,PH,DE,DE,2022,Q4,Elderly
216234751,21623475,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, as required",,,,,,,,,,Solution for injection/infusion,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20221115.0,20221121,20221121,EXP,,DE-MYLANLABS-2022M1129336,MYLAN,,80.0,YR,,F,Y,65.0,KG,20221121,,PH,DE,DE,2022,Q4,Elderly
216234751,21623475,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, as required",,,,,,,,,,Solution for injection/infusion,,2022,Q4,Cardiac failure,,2022,Q4,1,I,,20221115.0,20221121,20221121,EXP,,DE-MYLANLABS-2022M1129336,MYLAN,,80.0,YR,,F,Y,65.0,KG,20221121,,PH,DE,DE,2022,Q4,Elderly
216245054,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2022,Q4,Fatigue,,2022,Q4,4,F,,20221212.0,20221121,20221221,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20221221,,PH,DE,DE,2022,Q4,Adult
216245054,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2022,Q4,Hyperglycaemia,,2022,Q4,4,F,,20221212.0,20221121,20221221,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20221221,,PH,DE,DE,2022,Q4,Adult
216245054,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2022,Q4,Anaemia,,2022,Q4,4,F,,20221212.0,20221121,20221221,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20221221,,PH,DE,DE,2022,Q4,Adult
216245054,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2022,Q4,Condition aggravated,,2022,Q4,4,F,,20221212.0,20221121,20221221,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20221221,,PH,DE,DE,2022,Q4,Adult
216245054,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2022,Q4,Death,,2022,Q4,4,F,,20221212.0,20221121,20221221,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20221221,,PH,DE,DE,2022,Q4,Adult
216245054,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2022,Q4,Cachexia,,2022,Q4,4,F,,20221212.0,20221121,20221221,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20221221,,PH,DE,DE,2022,Q4,Adult
216245054,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2022,Q4,Vomiting,,2022,Q4,4,F,,20221212.0,20221121,20221221,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20221221,,PH,DE,DE,2022,Q4,Adult
216245054,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2022,Q4,Tenderness,,2022,Q4,4,F,,20221212.0,20221121,20221221,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20221221,,PH,DE,DE,2022,Q4,Adult
216245054,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2022,Q4,General physical health deterioration,,2022,Q4,4,F,,20221212.0,20221121,20221221,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20221221,,PH,DE,DE,2022,Q4,Adult
216245054,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2022,Q4,Pain,,2022,Q4,4,F,,20221212.0,20221121,20221221,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20221221,,PH,DE,DE,2022,Q4,Adult
216245054,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2022,Q4,Haematochezia,,2022,Q4,4,F,,20221212.0,20221121,20221221,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20221221,,PH,DE,DE,2022,Q4,Adult
216245054,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2022,Q4,Systemic infection,,2022,Q4,4,F,,20221212.0,20221121,20221221,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20221221,,PH,DE,DE,2022,Q4,Adult
216245054,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2022,Q4,Dehydration,,2022,Q4,4,F,,20221212.0,20221121,20221221,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20221221,,PH,DE,DE,2022,Q4,Adult
216245054,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2022,Q4,Depressed level of consciousness,,2022,Q4,4,F,,20221212.0,20221121,20221221,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20221221,,PH,DE,DE,2022,Q4,Adult
216245054,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2022,Q4,Nausea,,2022,Q4,4,F,,20221212.0,20221121,20221221,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20221221,,PH,DE,DE,2022,Q4,Adult
216245054,21624505,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IE, Schema",,,,,UNKNOWN,,,1.0,IU,,,2022,Q4,Tachycardia,,2022,Q4,4,F,,20221212.0,20221121,20221221,EXP,,DE-drreddys-SPO/GER/22/0157136,DR REDDYS,,48.0,YR,A,M,Y,68.0,KG,20221221,,PH,DE,DE,2022,Q4,Adult
216255481,21625548,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Cardiac disorder,,2022,Q4,1,I,20200702.0,20221117.0,20221122,20221122,EXP,,US-BAUSCH-BL-2021-004498,BAUSCH AND LOMB,,72.0,YR,,M,Y,78.542,KG,20221122,,MD,US,US,2022,Q4,Elderly
216255481,21625548,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Alpha 1 foetoprotein decreased,,2022,Q4,1,I,20200702.0,20221117.0,20221122,20221122,EXP,,US-BAUSCH-BL-2021-004498,BAUSCH AND LOMB,,72.0,YR,,M,Y,78.542,KG,20221122,,MD,US,US,2022,Q4,Elderly
216278851,21627885,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU/3ml, By regimen, Prefilled syringes",,,,,,,,,,Injection,,2022,Q4,Bradycardia,,2022,Q4,1,I,20210604.0,20221117.0,20221122,20221122,EXP,,DE-MYLANLABS-2022M1130407,MYLAN,,86.0,YR,,M,Y,77.0,KG,20221122,,PH,DE,DE,2022,Q4,Elderly
216278851,21627885,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU/3ml, By regimen, Prefilled syringes",,,,,,,,,,Injection,,2022,Q4,Weight increased,,2022,Q4,1,I,20210604.0,20221117.0,20221122,20221122,EXP,,DE-MYLANLABS-2022M1130407,MYLAN,,86.0,YR,,M,Y,77.0,KG,20221122,,PH,DE,DE,2022,Q4,Elderly
216278851,21627885,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU/3ml, By regimen, Prefilled syringes",,,,,,,,,,Injection,,2022,Q4,Tachycardia,,2022,Q4,1,I,20210604.0,20221117.0,20221122,20221122,EXP,,DE-MYLANLABS-2022M1130407,MYLAN,,86.0,YR,,M,Y,77.0,KG,20221122,,PH,DE,DE,2022,Q4,Elderly
216278851,21627885,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU/3ml, By regimen, Prefilled syringes",,,,,,,,,,Injection,,2022,Q4,Product prescribing error,,2022,Q4,1,I,20210604.0,20221117.0,20221122,20221122,EXP,,DE-MYLANLABS-2022M1130407,MYLAN,,86.0,YR,,M,Y,77.0,KG,20221122,,PH,DE,DE,2022,Q4,Elderly
216278851,21627885,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU/3ml, By regimen, Prefilled syringes",,,,,,,,,,Injection,,2022,Q4,Dyspnoea,,2022,Q4,1,I,20210604.0,20221117.0,20221122,20221122,EXP,,DE-MYLANLABS-2022M1130407,MYLAN,,86.0,YR,,M,Y,77.0,KG,20221122,,PH,DE,DE,2022,Q4,Elderly
216278851,21627885,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU/3ml, By regimen, Prefilled syringes",,,,,,,,,,Injection,,2022,Q4,Atrial fibrillation,,2022,Q4,1,I,20210604.0,20221117.0,20221122,20221122,EXP,,DE-MYLANLABS-2022M1130407,MYLAN,,86.0,YR,,M,Y,77.0,KG,20221122,,PH,DE,DE,2022,Q4,Elderly
216278851,21627885,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"300 IU/3ml, By regimen, Prefilled syringes",,,,,,,,,,Injection,,2022,Q4,Restlessness,,2022,Q4,1,I,20210604.0,20221117.0,20221122,20221122,EXP,,DE-MYLANLABS-2022M1130407,MYLAN,,86.0,YR,,M,Y,77.0,KG,20221122,,PH,DE,DE,2022,Q4,Elderly
216282161,21628216,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Hip surgery,,2022,Q4,1,I,20220501.0,20221118.0,20221122,20221122,EXP,,US-ABBVIE-4208943,ABBVIE,,65.0,YR,,F,Y,,,20221122,,CN,US,US,2022,Q4,Elderly
216282161,21628216,13,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Accident,,2022,Q4,1,I,20220501.0,20221118.0,20221122,20221122,EXP,,US-ABBVIE-4208943,ABBVIE,,65.0,YR,,F,Y,,,20221122,,CN,US,US,2022,Q4,Elderly
216294482,21629448,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Other,,,,,,,,,,,Unknown,,2022,Q4,COVID-19,,2022,Q4,2,F,20221102.0,20221206.0,20221122,20221209,PER,,US-BIOGEN-2022BI01170128,BIOGEN,,63.0,YR,,F,Y,,,20221209,,CN,US,US,2022,Q4,Adult
216297701,21629770,6,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Treatment delayed,,2022,Q4,1,I,,20221117.0,20221122,20221122,PER,,US-GILEAD-2022-0605857,GILEAD,,55.0,YR,A,M,Y,,,20221122,,CN,US,US,2022,Q4,Adult
216317961,21631796,2,C,INSULIN LISPRO,INSULIN LISPRO,1,,"25 u, tid",,,,,,,,25.0,IU,,TID,2022,Q4,Extra dose administered,,2022,Q4,1,I,20221001.0,20221027.0,20221123,20221123,PER,,US-ELI_LILLY_AND_COMPANY-US202211002713,ELI LILLY AND CO,,59.0,YR,,M,Y,,,20221123,,HP,US,US,2022,Q4,Adult
216356081,21635608,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,20221115.0,20221116.0,20221123,20221123,EXP,,US-SEATTLE GENETICS-2022SGN10891,SEATTLE GENETICS,,74.0,YR,,M,Y,93.424,KG,20221123,,MD,US,US,2022,Q4,Elderly
216357721,21635772,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8 U immediately before each meal,,,U,,,,,,,,,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,,20221114.0,20221123,20221123,EXP,,JP-SA-2022SA435530,SANOFI AVENTIS,,36.0,YR,A,M,Y,,,20221124,,PH,JP,JP,2022,Q4,Adult
216357721,21635772,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8 U immediately before each meal,,,U,,,,,,,,,2022,Q4,Acetabulum fracture,,2022,Q4,1,I,,20221114.0,20221123,20221123,EXP,,JP-SA-2022SA435530,SANOFI AVENTIS,,36.0,YR,A,M,Y,,,20221124,,PH,JP,JP,2022,Q4,Adult
216357721,21635772,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8 U immediately before each meal,,,U,,,,,,,,,2022,Q4,Chondropathy,,2022,Q4,1,I,,20221114.0,20221123,20221123,EXP,,JP-SA-2022SA435530,SANOFI AVENTIS,,36.0,YR,A,M,Y,,,20221124,,PH,JP,JP,2022,Q4,Adult
216357721,21635772,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8 U immediately before each meal,,,U,,,,,,,,,2022,Q4,Seizure,,2022,Q4,1,I,,20221114.0,20221123,20221123,EXP,,JP-SA-2022SA435530,SANOFI AVENTIS,,36.0,YR,A,M,Y,,,20221124,,PH,JP,JP,2022,Q4,Adult
216357721,21635772,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8 U immediately before each meal,,,U,,,,,,,,,2022,Q4,Arthralgia,,2022,Q4,1,I,,20221114.0,20221123,20221123,EXP,,JP-SA-2022SA435530,SANOFI AVENTIS,,36.0,YR,A,M,Y,,,20221124,,PH,JP,JP,2022,Q4,Adult
216357721,21635772,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,8 U immediately before each meal,,,U,,,,,,,,,2022,Q4,Loss of consciousness,,2022,Q4,1,I,,20221114.0,20221123,20221123,EXP,,JP-SA-2022SA435530,SANOFI AVENTIS,,36.0,YR,A,M,Y,,,20221124,,PH,JP,JP,2022,Q4,Adult
216400221,21640022,5,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,UNKNOWN,,,,,,,2022,Q4,Diabetic ketoacidosis,,2022,Q4,1,I,,20221111.0,20221124,20221124,EXP,,CA-TEVA-2022-CA-2827315,TEVA,,17.0,YR,T,M,Y,,,20221124,,HP,CA,CA,2022,Q4,Youth
216436151,21643615,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D508134D,,20563.0,,,Injection,,2022,Q4,Gastric disorder,,2022,Q4,1,I,20221110.0,20221111.0,20221125,20221125,EXP,,US-ELI_LILLY_AND_COMPANY-US202211009377,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20221125,,CN,US,US,2022,Q4,Elderly
216436151,21643615,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D508134D,,20563.0,,,Injection,,2022,Q4,Nausea,,2022,Q4,1,I,20221110.0,20221111.0,20221125,20221125,EXP,,US-ELI_LILLY_AND_COMPANY-US202211009377,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20221125,,CN,US,US,2022,Q4,Elderly
216436151,21643615,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D508134D,,20563.0,,,Injection,,2022,Q4,Haematemesis,,2022,Q4,1,I,20221110.0,20221111.0,20221125,20221125,EXP,,US-ELI_LILLY_AND_COMPANY-US202211009377,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20221125,,CN,US,US,2022,Q4,Elderly
216436151,21643615,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,20563.0,,,Injection,,2022,Q4,Gastric disorder,,2022,Q4,1,I,20221110.0,20221111.0,20221125,20221125,EXP,,US-ELI_LILLY_AND_COMPANY-US202211009377,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20221125,,CN,US,US,2022,Q4,Elderly
216436151,21643615,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,20563.0,,,Injection,,2022,Q4,Nausea,,2022,Q4,1,I,20221110.0,20221111.0,20221125,20221125,EXP,,US-ELI_LILLY_AND_COMPANY-US202211009377,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20221125,,CN,US,US,2022,Q4,Elderly
216436151,21643615,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,20563.0,,,Injection,,2022,Q4,Haematemesis,,2022,Q4,1,I,20221110.0,20221111.0,20221125,20221125,EXP,,US-ELI_LILLY_AND_COMPANY-US202211009377,ELI LILLY AND CO,,65.0,YR,,F,Y,,,20221125,,CN,US,US,2022,Q4,Elderly
216497481,21649748,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,,,,Solution for injection,,2022,Q4,Spinal pain,,2022,Q4,1,I,,20221122.0,20221128,20221128,EXP,,RU-SA-2022SA480425,SANOFI AVENTIS,,81.0,YR,E,F,Y,72.0,KG,20221128,,MD,RU,RU,2022,Q4,Elderly
216497481,21649748,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,,,,Solution for injection,,2022,Q4,Headache,,2022,Q4,1,I,,20221122.0,20221128,20221128,EXP,,RU-SA-2022SA480425,SANOFI AVENTIS,,81.0,YR,E,F,Y,72.0,KG,20221128,,MD,RU,RU,2022,Q4,Elderly
216497481,21649748,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,,,,Solution for injection,,2022,Q4,Hyperhidrosis,,2022,Q4,1,I,,20221122.0,20221128,20221128,EXP,,RU-SA-2022SA480425,SANOFI AVENTIS,,81.0,YR,E,F,Y,72.0,KG,20221128,,MD,RU,RU,2022,Q4,Elderly
216497481,21649748,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,,,,Solution for injection,,2022,Q4,Pain,,2022,Q4,1,I,,20221122.0,20221128,20221128,EXP,,RU-SA-2022SA480425,SANOFI AVENTIS,,81.0,YR,E,F,Y,72.0,KG,20221128,,MD,RU,RU,2022,Q4,Elderly
216497481,21649748,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,,,,Solution for injection,,2022,Q4,Labile blood pressure,,2022,Q4,1,I,,20221122.0,20221128,20221128,EXP,,RU-SA-2022SA480425,SANOFI AVENTIS,,81.0,YR,E,F,Y,72.0,KG,20221128,,MD,RU,RU,2022,Q4,Elderly
216497481,21649748,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,,,,Solution for injection,,2022,Q4,Head discomfort,,2022,Q4,1,I,,20221122.0,20221128,20221128,EXP,,RU-SA-2022SA480425,SANOFI AVENTIS,,81.0,YR,E,F,Y,72.0,KG,20221128,,MD,RU,RU,2022,Q4,Elderly
216497481,21649748,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,Y,,,,,,,Solution for injection,,2022,Q4,Memory impairment,,2022,Q4,1,I,,20221122.0,20221128,20221128,EXP,,RU-SA-2022SA480425,SANOFI AVENTIS,,81.0,YR,E,F,Y,72.0,KG,20221128,,MD,RU,RU,2022,Q4,Elderly
216539101,21653910,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"UNK UNK, TID",,,U,,,,,,,Solution for injection,Q8H,2022,Q4,Syncope,,2022,Q4,1,I,20220218.0,20221122.0,20221129,20221129,EXP,IT-MINISAL02-894442,IT-SA-2022SA485388,SANOFI AVENTIS,,86.0,YR,E,M,Y,,,20221129,,MD,IT,IT,2022,Q4,Elderly
216577482,21657748,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Off label use,,2022,Q4,2,F,20220516.0,20221228.0,20221129,20221230,EXP,,CA-PFIZER INC-202200731581,PFIZER,,74.0,YR,,F,Y,,,20221230,,HP,CA,CA,2022,Q4,Elderly
216577482,21657748,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Off label use,,2022,Q4,2,F,20220516.0,20221228.0,20221129,20221230,EXP,,CA-PFIZER INC-202200731581,PFIZER,,74.0,YR,,F,Y,,,20221230,,HP,CA,CA,2022,Q4,Elderly
216577482,21657748,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Off label use,,2022,Q4,2,F,20220516.0,20221228.0,20221129,20221230,EXP,,CA-PFIZER INC-202200731581,PFIZER,,74.0,YR,,F,Y,,,20221230,,HP,CA,CA,2022,Q4,Elderly
216577482,21657748,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Off label use,,2022,Q4,2,F,20220516.0,20221228.0,20221129,20221230,EXP,,CA-PFIZER INC-202200731581,PFIZER,,74.0,YR,,F,Y,,,20221230,,HP,CA,CA,2022,Q4,Elderly
216577482,21657748,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Product use issue,,2022,Q4,2,F,20220516.0,20221228.0,20221129,20221230,EXP,,CA-PFIZER INC-202200731581,PFIZER,,74.0,YR,,F,Y,,,20221230,,HP,CA,CA,2022,Q4,Elderly
216577482,21657748,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Intentional product use issue,,2022,Q4,2,F,20220516.0,20221228.0,20221129,20221230,EXP,,CA-PFIZER INC-202200731581,PFIZER,,74.0,YR,,F,Y,,,20221230,,HP,CA,CA,2022,Q4,Elderly
216577482,21657748,16,C,INSULIN LISPRO,INSULIN LISPRO,1,,UNK,,,,,,,,,,,,2022,Q4,Coronary artery disease,,2022,Q4,2,F,20220516.0,20221228.0,20221129,20221230,EXP,,CA-PFIZER INC-202200731581,PFIZER,,74.0,YR,,F,Y,,,20221230,,HP,CA,CA,2022,Q4,Elderly
216581771,21658177,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50, 50 IE,  depending on the BZ",,,,,,,,,,,,2022,Q4,Pain,,2022,Q4,1,I,,20221116.0,20221129,20221129,EXP,DE-BFARM-22007332,DE-Accord-287928,ACCORD,,74.0,YR,E,F,Y,,,20221129,,PH,DE,DE,2022,Q4,Elderly
216581771,21658177,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50, 50 IE,  depending on the BZ",,,,,,,,,,,,2022,Q4,Product prescribing error,,2022,Q4,1,I,,20221116.0,20221129,20221129,EXP,DE-BFARM-22007332,DE-Accord-287928,ACCORD,,74.0,YR,E,F,Y,,,20221129,,PH,DE,DE,2022,Q4,Elderly
216581771,21658177,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50, 50 IE,  depending on the BZ",,,,,,,,,,,,2022,Q4,Condition aggravated,,2022,Q4,1,I,,20221116.0,20221129,20221129,EXP,DE-BFARM-22007332,DE-Accord-287928,ACCORD,,74.0,YR,E,F,Y,,,20221129,,PH,DE,DE,2022,Q4,Elderly
216581771,21658177,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50, 50 IE,  depending on the BZ",,,,,,,,,,,,2022,Q4,Musculoskeletal pain,,2022,Q4,1,I,,20221116.0,20221129,20221129,EXP,DE-BFARM-22007332,DE-Accord-287928,ACCORD,,74.0,YR,E,F,Y,,,20221129,,PH,DE,DE,2022,Q4,Elderly
216581771,21658177,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50, 50 IE,  depending on the BZ",,,,,,,,,,,,2022,Q4,Arthralgia,,2022,Q4,1,I,,20221116.0,20221129,20221129,EXP,DE-BFARM-22007332,DE-Accord-287928,ACCORD,,74.0,YR,E,F,Y,,,20221129,,PH,DE,DE,2022,Q4,Elderly
216581771,21658177,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"50, 50 IE,  depending on the BZ",,,,,,,,,,,,2022,Q4,Gait disturbance,,2022,Q4,1,I,,20221116.0,20221129,20221129,EXP,DE-BFARM-22007332,DE-Accord-287928,ACCORD,,74.0,YR,E,F,Y,,,20221129,,PH,DE,DE,2022,Q4,Elderly
216626041,21662604,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,,,,,,,,,,2022,Q4,Hypotension,,2022,Q4,1,I,,20221118.0,20221130,20221130,PER,,US-LUPIN PHARMACEUTICALS INC.-2022-13897,LUPIN,"Waters CM, Pelczar K, Adlesic EC, Schwartz PJ, Giovannitti JA. ACE-Inhibitor or ARB-Induced refractory hypotension treated with vasopressin in patients undergoing general anesthesia for dentistry: Two case reports. Anesthesia Progress. 2022;69(3):30-35",53.0,YR,,F,Y,110.0,KG,20221130,,MD,US,US,2022,Q4,Adult
216638211,21663821,20,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"Two units, 1x/day:qd",,,D,,,,,,,,QD,2022,Q4,Medical device site pain,,2022,Q4,1,I,20160620.0,20221125.0,20221130,20221130,EXP,,US-TAKEDA-US201611806,TAKEDA,,57.0,YR,,M,Y,74.7,KG,20221130,,MD,US,US,2022,Q4,Adult
216638681,21663868,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, as required, solution for injection/infusion",,,,,,,,,,,,2022,Q4,Renal impairment,,2022,Q4,1,I,,20221118.0,20221130,20221130,EXP,DE-BFARM-22007723,DE-Accord-288298,ACCORD,,80.0,YR,E,F,Y,65.0,KG,20221130,,PH,DE,DE,2022,Q4,Elderly
216638681,21663868,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, as required, solution for injection/infusion",,,,,,,,,,,,2022,Q4,Anaemia,,2022,Q4,1,I,,20221118.0,20221130,20221130,EXP,DE-BFARM-22007723,DE-Accord-288298,ACCORD,,80.0,YR,E,F,Y,65.0,KG,20221130,,PH,DE,DE,2022,Q4,Elderly
216638681,21663868,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, as required, solution for injection/infusion",,,,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20221118.0,20221130,20221130,EXP,DE-BFARM-22007723,DE-Accord-288298,ACCORD,,80.0,YR,E,F,Y,65.0,KG,20221130,,PH,DE,DE,2022,Q4,Elderly
216638681,21663868,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, as required, solution for injection/infusion",,,,,,,,,,,,2022,Q4,Cardiac failure,,2022,Q4,1,I,,20221118.0,20221130,20221130,EXP,DE-BFARM-22007723,DE-Accord-288298,ACCORD,,80.0,YR,E,F,Y,65.0,KG,20221130,,PH,DE,DE,2022,Q4,Elderly
216638681,21663868,10,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, as required, solution for injection/infusion",,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20221118.0,20221130,20221130,EXP,DE-BFARM-22007723,DE-Accord-288298,ACCORD,,80.0,YR,E,F,Y,65.0,KG,20221130,,PH,DE,DE,2022,Q4,Elderly
216670062,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2022,Q4,General physical health deterioration,,2022,Q4,2,F,,20221130.0,20221201,20221212,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20221212,,PH,DE,DE,2022,Q4,Adult
216670062,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2022,Q4,Vomiting,,2022,Q4,2,F,,20221130.0,20221201,20221212,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20221212,,PH,DE,DE,2022,Q4,Adult
216670062,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2022,Q4,Hyperglycaemia,,2022,Q4,2,F,,20221130.0,20221201,20221212,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20221212,,PH,DE,DE,2022,Q4,Adult
216670062,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2022,Q4,Fatigue,,2022,Q4,2,F,,20221130.0,20221201,20221212,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20221212,,PH,DE,DE,2022,Q4,Adult
216670062,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2022,Q4,Cachexia,,2022,Q4,2,F,,20221130.0,20221201,20221212,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20221212,,PH,DE,DE,2022,Q4,Adult
216670062,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2022,Q4,Pain,,2022,Q4,2,F,,20221130.0,20221201,20221212,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20221212,,PH,DE,DE,2022,Q4,Adult
216670062,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2022,Q4,Haematochezia,,2022,Q4,2,F,,20221130.0,20221201,20221212,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20221212,,PH,DE,DE,2022,Q4,Adult
216670062,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2022,Q4,Death,,2022,Q4,2,F,,20221130.0,20221201,20221212,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20221212,,PH,DE,DE,2022,Q4,Adult
216670062,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2022,Q4,Condition aggravated,,2022,Q4,2,F,,20221130.0,20221201,20221212,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20221212,,PH,DE,DE,2022,Q4,Adult
216670062,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2022,Q4,Tachycardia,,2022,Q4,2,F,,20221130.0,20221201,20221212,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20221212,,PH,DE,DE,2022,Q4,Adult
216670062,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2022,Q4,Systemic infection,,2022,Q4,2,F,,20221130.0,20221201,20221212,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20221212,,PH,DE,DE,2022,Q4,Adult
216670062,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2022,Q4,Nausea,,2022,Q4,2,F,,20221130.0,20221201,20221212,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20221212,,PH,DE,DE,2022,Q4,Adult
216670062,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2022,Q4,Depressed level of consciousness,,2022,Q4,2,F,,20221130.0,20221201,20221212,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20221212,,PH,DE,DE,2022,Q4,Adult
216670062,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2022,Q4,Tenderness,,2022,Q4,2,F,,20221130.0,20221201,20221212,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20221212,,PH,DE,DE,2022,Q4,Adult
216670062,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2022,Q4,Anaemia,,2022,Q4,2,F,,20221130.0,20221201,20221212,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20221212,,PH,DE,DE,2022,Q4,Adult
216670062,21667006,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"1 IU, scheme",,,,,,,,1.0,IU,,,2022,Q4,Dehydration,,2022,Q4,2,F,,20221130.0,20221201,20221212,EXP,DE-BFARM-22008072,DE-Accord-288430,ACCORD,,48.0,YR,A,M,Y,68.0,KG,20221212,,PH,DE,DE,2022,Q4,Adult
216691481,21669148,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Pain in extremity,,2022,Q4,1,I,20221115.0,,20221130,20221130,DIR,FDA-CDER-CTU-2022-95364,,FDA-CTU,,68.0,YR,,F,N,,,20221130,Y,PH,US,,2022,Q4,Elderly
216691481,21669148,15,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Muscular weakness,,2022,Q4,1,I,20221115.0,,20221130,20221130,DIR,FDA-CDER-CTU-2022-95364,,FDA-CTU,,68.0,YR,,F,N,,,20221130,Y,PH,US,,2022,Q4,Elderly
216728701,21672870,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"15 U in the morning, 12 U at noon and 15 U at night",,,,,,,,,,,,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,1,I,20210101.0,20221129.0,20221202,20221202,EXP,,CN-009507513-2212CHN000822,MERCK,"Zhang N, Tian Y.. Refractory type 2 diabetes mellitus with multi?drug combination transferred to semaglutide: a case report. Chin J Diabetes Mellitus. 2022;14:194-7",39.0,YR,,M,Y,82.0,KG,20221202,,HP,CN,CN,2022,Q4,Adult
216728701,21672870,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,30 U in the morning and 25 U at night before the meal,,,,,,,,,,,,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,1,I,20210101.0,20221129.0,20221202,20221202,EXP,,CN-009507513-2212CHN000822,MERCK,"Zhang N, Tian Y.. Refractory type 2 diabetes mellitus with multi?drug combination transferred to semaglutide: a case report. Chin J Diabetes Mellitus. 2022;14:194-7",39.0,YR,,M,Y,82.0,KG,20221202,,HP,CN,CN,2022,Q4,Adult
216728701,21672870,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,35 U in the morning and 30 U at night (before the meal)UNK,,,,,,,,,,,,2022,Q4,Diabetes mellitus inadequate control,,2022,Q4,1,I,20210101.0,20221129.0,20221202,20221202,EXP,,CN-009507513-2212CHN000822,MERCK,"Zhang N, Tian Y.. Refractory type 2 diabetes mellitus with multi?drug combination transferred to semaglutide: a case report. Chin J Diabetes Mellitus. 2022;14:194-7",39.0,YR,,M,Y,82.0,KG,20221202,,HP,CN,CN,2022,Q4,Adult
216730141,21673014,11,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,U,,,,,,,Unknown,,2022,Q4,Pleural effusion,,2022,Q4,1,I,20221101.0,20221129.0,20221202,20221202,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-134269,BRISTOL MYERS SQUIBB,,71.0,YR,E,M,Y,,,20221202,,HP,US,US,2022,Q4,Elderly
216821761,21682176,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, TID (with meals)",,,U,,,,209196.0,,,Solution for injection,Q8H,2022,Q4,Muscle contractions involuntary,,2022,Q4,1,I,,20221128.0,20221205,20221205,EXP,,US-SA-2022SA489588,SANOFI AVENTIS,"Maza AJ, Parkash A, Fellechner B, Marulanda D.. Iatrogenic Insulin-induced Neuropathy in a Poorly Controlled Type 2 Diabetic Patient: A Case Report.. PM and R. 2022;14(Suppl 1):S103",48.0,YR,A,M,Y,,,20221205,,HP,US,US,2022,Q4,Adult
216821761,21682176,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, TID (with meals)",,,U,,,,209196.0,,,Solution for injection,Q8H,2022,Q4,Hypoaesthesia,,2022,Q4,1,I,,20221128.0,20221205,20221205,EXP,,US-SA-2022SA489588,SANOFI AVENTIS,"Maza AJ, Parkash A, Fellechner B, Marulanda D.. Iatrogenic Insulin-induced Neuropathy in a Poorly Controlled Type 2 Diabetic Patient: A Case Report.. PM and R. 2022;14(Suppl 1):S103",48.0,YR,A,M,Y,,,20221205,,HP,US,US,2022,Q4,Adult
216821761,21682176,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, TID (with meals)",,,U,,,,209196.0,,,Solution for injection,Q8H,2022,Q4,Neuropathy peripheral,,2022,Q4,1,I,,20221128.0,20221205,20221205,EXP,,US-SA-2022SA489588,SANOFI AVENTIS,"Maza AJ, Parkash A, Fellechner B, Marulanda D.. Iatrogenic Insulin-induced Neuropathy in a Poorly Controlled Type 2 Diabetic Patient: A Case Report.. PM and R. 2022;14(Suppl 1):S103",48.0,YR,A,M,Y,,,20221205,,HP,US,US,2022,Q4,Adult
216821761,21682176,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, TID (with meals)",,,U,,,,209196.0,,,Solution for injection,Q8H,2022,Q4,Asthenia,,2022,Q4,1,I,,20221128.0,20221205,20221205,EXP,,US-SA-2022SA489588,SANOFI AVENTIS,"Maza AJ, Parkash A, Fellechner B, Marulanda D.. Iatrogenic Insulin-induced Neuropathy in a Poorly Controlled Type 2 Diabetic Patient: A Case Report.. PM and R. 2022;14(Suppl 1):S103",48.0,YR,A,M,Y,,,20221205,,HP,US,US,2022,Q4,Adult
216821761,21682176,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,"5 U, TID (with meals)",,,U,,,,209196.0,,,Solution for injection,Q8H,2022,Q4,Piriformis syndrome,,2022,Q4,1,I,,20221128.0,20221205,20221205,EXP,,US-SA-2022SA489588,SANOFI AVENTIS,"Maza AJ, Parkash A, Fellechner B, Marulanda D.. Iatrogenic Insulin-induced Neuropathy in a Poorly Controlled Type 2 Diabetic Patient: A Case Report.. PM and R. 2022;14(Suppl 1):S103",48.0,YR,A,M,Y,,,20221205,,HP,US,US,2022,Q4,Adult
216824882,21682488,11,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,Unknown,,2022,Q4,Cerebrovascular accident,,2022,Q4,2,F,20221101.0,20221222.0,20221205,20221223,PER,,US-BRISTOL-MYERS SQUIBB COMPANY-2022-147617,BRISTOL MYERS SQUIBB,,77.0,YR,E,M,Y,75.8,KG,20221223,,PH,US,US,2022,Q4,Elderly
216877101,21687710,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 international unit, each morning",9660.0,IU,U,,D442926,,21017.0,18.0,IU,,QD,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20221118.0,20221124.0,20221206,20221206,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211013933,ELI LILLY AND CO,,82.0,YR,,M,Y,70.0,KG,20221206,,CN,CN,CN,2022,Q4,Elderly
216877101,21687710,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 international unit, each morning",9660.0,IU,U,,D442926,,21017.0,18.0,IU,,QD,2022,Q4,Hypertension,,2022,Q4,1,I,20221118.0,20221124.0,20221206,20221206,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211013933,ELI LILLY AND CO,,82.0,YR,,M,Y,70.0,KG,20221206,,CN,CN,CN,2022,Q4,Elderly
216877101,21687710,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"18 international unit, each morning",9660.0,IU,U,,D442926,,21017.0,18.0,IU,,QD,2022,Q4,Cerebral infarction,,2022,Q4,1,I,20221118.0,20221124.0,20221206,20221206,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211013933,ELI LILLY AND CO,,82.0,YR,,M,Y,70.0,KG,20221206,,CN,CN,CN,2022,Q4,Elderly
216877101,21687710,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 international unit, each evening",9660.0,IU,U,,D442926,,21017.0,12.0,IU,,QD,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20221118.0,20221124.0,20221206,20221206,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211013933,ELI LILLY AND CO,,82.0,YR,,M,Y,70.0,KG,20221206,,CN,CN,CN,2022,Q4,Elderly
216877101,21687710,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 international unit, each evening",9660.0,IU,U,,D442926,,21017.0,12.0,IU,,QD,2022,Q4,Hypertension,,2022,Q4,1,I,20221118.0,20221124.0,20221206,20221206,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211013933,ELI LILLY AND CO,,82.0,YR,,M,Y,70.0,KG,20221206,,CN,CN,CN,2022,Q4,Elderly
216877101,21687710,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"12 international unit, each evening",9660.0,IU,U,,D442926,,21017.0,12.0,IU,,QD,2022,Q4,Cerebral infarction,,2022,Q4,1,I,20221118.0,20221124.0,20221206,20221206,EXP,,CN-ELI_LILLY_AND_COMPANY-CN202211013933,ELI LILLY AND CO,,82.0,YR,,M,Y,70.0,KG,20221206,,CN,CN,CN,2022,Q4,Elderly
216934001,21693400,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,900 units,,,D,,,,209196.0,900.0,IU,Solution for injection,,2022,Q4,Toxicity to various agents,,2022,Q4,1,I,20220101.0,20221201.0,20221207,20221207,EXP,SE-MPA-2022-021358,SE-SA-2022SA493253,SANOFI AVENTIS,,35.0,YR,A,F,Y,,,20221207,,MD,SE,SE,2022,Q4,Adult
216934001,21693400,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,900 units,,,D,,,,209196.0,900.0,IU,Solution for injection,,2022,Q4,Suicide attempt,,2022,Q4,1,I,20220101.0,20221201.0,20221207,20221207,EXP,SE-MPA-2022-021358,SE-SA-2022SA493253,SANOFI AVENTIS,,35.0,YR,A,F,Y,,,20221207,,MD,SE,SE,2022,Q4,Adult
216934001,21693400,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,900 units,,,D,,,,209196.0,900.0,IU,Solution for injection,,2022,Q4,Seizure,,2022,Q4,1,I,20220101.0,20221201.0,20221207,20221207,EXP,SE-MPA-2022-021358,SE-SA-2022SA493253,SANOFI AVENTIS,,35.0,YR,A,F,Y,,,20221207,,MD,SE,SE,2022,Q4,Adult
216934001,21693400,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,,900 units,,,D,,,,209196.0,900.0,IU,Solution for injection,,2022,Q4,Intentional overdose,,2022,Q4,1,I,20220101.0,20221201.0,20221207,20221207,EXP,SE-MPA-2022-021358,SE-SA-2022SA493253,SANOFI AVENTIS,,35.0,YR,A,F,Y,,,20221207,,MD,SE,SE,2022,Q4,Adult
216947601,21694760,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 iU, TID",,,U,,,,,15.0,IU,,Q8H,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20170101.0,20221108.0,20221207,20221207,EXP,,FI-SA-2022SA494758,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221207,,MD,FI,FI,2022,Q4,Adult
216947601,21694760,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 iU, TID",,,U,,,,,15.0,IU,,Q8H,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20170101.0,20221108.0,20221207,20221207,EXP,,FI-SA-2022SA494758,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221207,,MD,FI,FI,2022,Q4,Adult
216947601,21694760,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 iU, TID",,,U,,,,,15.0,IU,,Q8H,2022,Q4,Balanoposthitis,,2022,Q4,1,I,20170101.0,20221108.0,20221207,20221207,EXP,,FI-SA-2022SA494758,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221207,,MD,FI,FI,2022,Q4,Adult
216947601,21694760,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 iU, TID",,,U,,,,,15.0,IU,,Q8H,2022,Q4,Atrial fibrillation,,2022,Q4,1,I,20170101.0,20221108.0,20221207,20221207,EXP,,FI-SA-2022SA494758,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221207,,MD,FI,FI,2022,Q4,Adult
216947601,21694760,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 iU, TID",,,U,,,,,15.0,IU,,Q8H,2022,Q4,Coronary artery disease,,2022,Q4,1,I,20170101.0,20221108.0,20221207,20221207,EXP,,FI-SA-2022SA494758,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221207,,MD,FI,FI,2022,Q4,Adult
216947601,21694760,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 iU, TID",,,U,,,,,15.0,IU,,Q8H,2022,Q4,Albuminuria,,2022,Q4,1,I,20170101.0,20221108.0,20221207,20221207,EXP,,FI-SA-2022SA494758,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221207,,MD,FI,FI,2022,Q4,Adult
216947601,21694760,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 iU, TID",,,U,,,,,15.0,IU,,Q8H,2022,Q4,Glycosylated haemoglobin increased,,2022,Q4,1,I,20170101.0,20221108.0,20221207,20221207,EXP,,FI-SA-2022SA494758,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221207,,MD,FI,FI,2022,Q4,Adult
216947601,21694760,7,C,INSULIN LISPRO,INSULIN LISPRO,1,,"15 iU, TID",,,U,,,,,15.0,IU,,Q8H,2022,Q4,Angina pectoris,,2022,Q4,1,I,20170101.0,20221108.0,20221207,20221207,EXP,,FI-SA-2022SA494758,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221207,,MD,FI,FI,2022,Q4,Adult
216947601,21694760,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 iU, afternoon",,,U,,,,,10.0,IU,,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20170101.0,20221108.0,20221207,20221207,EXP,,FI-SA-2022SA494758,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221207,,MD,FI,FI,2022,Q4,Adult
216947601,21694760,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 iU, afternoon",,,U,,,,,10.0,IU,,,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,20170101.0,20221108.0,20221207,20221207,EXP,,FI-SA-2022SA494758,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221207,,MD,FI,FI,2022,Q4,Adult
216947601,21694760,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 iU, afternoon",,,U,,,,,10.0,IU,,,2022,Q4,Balanoposthitis,,2022,Q4,1,I,20170101.0,20221108.0,20221207,20221207,EXP,,FI-SA-2022SA494758,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221207,,MD,FI,FI,2022,Q4,Adult
216947601,21694760,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 iU, afternoon",,,U,,,,,10.0,IU,,,2022,Q4,Atrial fibrillation,,2022,Q4,1,I,20170101.0,20221108.0,20221207,20221207,EXP,,FI-SA-2022SA494758,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221207,,MD,FI,FI,2022,Q4,Adult
216947601,21694760,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 iU, afternoon",,,U,,,,,10.0,IU,,,2022,Q4,Coronary artery disease,,2022,Q4,1,I,20170101.0,20221108.0,20221207,20221207,EXP,,FI-SA-2022SA494758,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221207,,MD,FI,FI,2022,Q4,Adult
216947601,21694760,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 iU, afternoon",,,U,,,,,10.0,IU,,,2022,Q4,Albuminuria,,2022,Q4,1,I,20170101.0,20221108.0,20221207,20221207,EXP,,FI-SA-2022SA494758,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221207,,MD,FI,FI,2022,Q4,Adult
216947601,21694760,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 iU, afternoon",,,U,,,,,10.0,IU,,,2022,Q4,Glycosylated haemoglobin increased,,2022,Q4,1,I,20170101.0,20221108.0,20221207,20221207,EXP,,FI-SA-2022SA494758,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221207,,MD,FI,FI,2022,Q4,Adult
216947601,21694760,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,"10 iU, afternoon",,,U,,,,,10.0,IU,,,2022,Q4,Angina pectoris,,2022,Q4,1,I,20170101.0,20221108.0,20221207,20221207,EXP,,FI-SA-2022SA494758,SANOFI AVENTIS,,64.0,YR,A,M,Y,,,20221207,,MD,FI,FI,2022,Q4,Adult
217014092,21701409,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q4,Hypotension,,2022,Q4,2,F,,20221215.0,20221208,20221219,EXP,,US-TEVA-2022-US-2832647,TEVA,,53.0,YR,A,F,Y,,,20221219,,MD,US,US,2022,Q4,Adult
217076601,21707660,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,,,2022,Q4,Suicide attempt,,2022,Q4,1,I,20220101.0,20221128.0,20221209,20221209,EXP,SE-MPA-2022-021358,SE-ELI_LILLY_AND_COMPANY-SE202211013868,ELI LILLY AND CO,,35.0,YR,,F,Y,,,20221209,,CN,SE,SE,2022,Q4,Adult
217076601,21707660,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,,,2022,Q4,Toxicity to various agents,,2022,Q4,1,I,20220101.0,20221128.0,20221209,20221209,EXP,SE-MPA-2022-021358,SE-ELI_LILLY_AND_COMPANY-SE202211013868,ELI LILLY AND CO,,35.0,YR,,F,Y,,,20221209,,CN,SE,SE,2022,Q4,Adult
217076601,21707660,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,,,2022,Q4,Seizure,,2022,Q4,1,I,20220101.0,20221128.0,20221209,20221209,EXP,SE-MPA-2022-021358,SE-ELI_LILLY_AND_COMPANY-SE202211013868,ELI LILLY AND CO,,35.0,YR,,F,Y,,,20221209,,CN,SE,SE,2022,Q4,Adult
217076601,21707660,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,,,2022,Q4,Intentional overdose,,2022,Q4,1,I,20220101.0,20221128.0,20221209,20221209,EXP,SE-MPA-2022-021358,SE-ELI_LILLY_AND_COMPANY-SE202211013868,ELI LILLY AND CO,,35.0,YR,,F,Y,,,20221209,,CN,SE,SE,2022,Q4,Adult
217076601,21707660,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"900 international unit, single",,,U,,,,20563.0,900.0,IU,,,2022,Q4,Suicide attempt,,2022,Q4,1,I,20220101.0,20221128.0,20221209,20221209,EXP,SE-MPA-2022-021358,SE-ELI_LILLY_AND_COMPANY-SE202211013868,ELI LILLY AND CO,,35.0,YR,,F,Y,,,20221209,,CN,SE,SE,2022,Q4,Adult
217076601,21707660,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"900 international unit, single",,,U,,,,20563.0,900.0,IU,,,2022,Q4,Toxicity to various agents,,2022,Q4,1,I,20220101.0,20221128.0,20221209,20221209,EXP,SE-MPA-2022-021358,SE-ELI_LILLY_AND_COMPANY-SE202211013868,ELI LILLY AND CO,,35.0,YR,,F,Y,,,20221209,,CN,SE,SE,2022,Q4,Adult
217076601,21707660,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"900 international unit, single",,,U,,,,20563.0,900.0,IU,,,2022,Q4,Seizure,,2022,Q4,1,I,20220101.0,20221128.0,20221209,20221209,EXP,SE-MPA-2022-021358,SE-ELI_LILLY_AND_COMPANY-SE202211013868,ELI LILLY AND CO,,35.0,YR,,F,Y,,,20221209,,CN,SE,SE,2022,Q4,Adult
217076601,21707660,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"900 international unit, single",,,U,,,,20563.0,900.0,IU,,,2022,Q4,Intentional overdose,,2022,Q4,1,I,20220101.0,20221128.0,20221209,20221209,EXP,SE-MPA-2022-021358,SE-ELI_LILLY_AND_COMPANY-SE202211013868,ELI LILLY AND CO,,35.0,YR,,F,Y,,,20221209,,CN,SE,SE,2022,Q4,Adult
217079281,21707928,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q4,Cerebral infarction,,2022,Q4,1,I,20221108.0,20221205.0,20221209,20221209,EXP,,US-JNJFOC-20221203415,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,123.94,KG,20221209,,MD,US,US,2022,Q4,Adult
217079281,21707928,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q4,Tachycardia,,2022,Q4,1,I,20221108.0,20221205.0,20221209,20221209,EXP,,US-JNJFOC-20221203415,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,123.94,KG,20221209,,MD,US,US,2022,Q4,Adult
217079281,21707928,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q4,Somnolence,,2022,Q4,1,I,20221108.0,20221205.0,20221209,20221209,EXP,,US-JNJFOC-20221203415,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,123.94,KG,20221209,,MD,US,US,2022,Q4,Adult
217079281,21707928,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,20221108.0,20221205.0,20221209,20221209,EXP,,US-JNJFOC-20221203415,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,123.94,KG,20221209,,MD,US,US,2022,Q4,Adult
217079281,21707928,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q4,Sepsis,,2022,Q4,1,I,20221108.0,20221205.0,20221209,20221209,EXP,,US-JNJFOC-20221203415,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,123.94,KG,20221209,,MD,US,US,2022,Q4,Adult
217079281,21707928,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q4,Cytokine release syndrome,,2022,Q4,1,I,20221108.0,20221205.0,20221209,20221209,EXP,,US-JNJFOC-20221203415,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,123.94,KG,20221209,,MD,US,US,2022,Q4,Adult
217079281,21707928,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q4,Pyrexia,,2022,Q4,1,I,20221108.0,20221205.0,20221209,20221209,EXP,,US-JNJFOC-20221203415,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,123.94,KG,20221209,,MD,US,US,2022,Q4,Adult
217079281,21707928,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q4,Haemophagocytic lymphohistiocytosis,,2022,Q4,1,I,20221108.0,20221205.0,20221209,20221209,EXP,,US-JNJFOC-20221203415,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,123.94,KG,20221209,,MD,US,US,2022,Q4,Adult
217079281,21707928,27,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,,,,,,,,,,,,,2022,Q4,Pneumonia aspiration,,2022,Q4,1,I,20221108.0,20221205.0,20221209,20221209,EXP,,US-JNJFOC-20221203415,JOHNSON AND JOHNSON,,56.0,YR,A,M,Y,123.94,KG,20221209,,MD,US,US,2022,Q4,Adult
217134431,21713443,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Therapy cessation,,2022,Q4,1,I,20221122.0,,20221208,20221208,DIR,FDA-CDER-CTU-2022-97941,,FDA-CTU,,56.0,YR,,M,N,122.0,KG,20221208,N,PH,US,,2022,Q4,Adult
217134431,21713443,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Seizure,,2022,Q4,1,I,20221122.0,,20221208,20221208,DIR,FDA-CDER-CTU-2022-97941,,FDA-CTU,,56.0,YR,,M,N,122.0,KG,20221208,N,PH,US,,2022,Q4,Adult
217144461,21714446,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Syncope,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Chest pain,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Myocardial infarction,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Somnolence,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Pain in extremity,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Drug ineffective,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Feeling abnormal,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Coronary artery occlusion,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Syncope,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Chest pain,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Myocardial infarction,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Somnolence,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Pain in extremity,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Drug ineffective,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Feeling abnormal,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Coronary artery occlusion,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D455780C,,20563.0,,,Injection,,2022,Q4,Syncope,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D455780C,,20563.0,,,Injection,,2022,Q4,Chest pain,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D455780C,,20563.0,,,Injection,,2022,Q4,Myocardial infarction,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D455780C,,20563.0,,,Injection,,2022,Q4,Somnolence,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D455780C,,20563.0,,,Injection,,2022,Q4,Pain in extremity,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D455780C,,20563.0,,,Injection,,2022,Q4,Drug ineffective,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D455780C,,20563.0,,,Injection,,2022,Q4,Feeling abnormal,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D455780C,,20563.0,,,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,3,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D455780C,,20563.0,,,Injection,,2022,Q4,Coronary artery occlusion,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D455780C,,20563.0,,,Injection,,2022,Q4,Syncope,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D455780C,,20563.0,,,Injection,,2022,Q4,Chest pain,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D455780C,,20563.0,,,Injection,,2022,Q4,Myocardial infarction,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D455780C,,20563.0,,,Injection,,2022,Q4,Somnolence,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D455780C,,20563.0,,,Injection,,2022,Q4,Pain in extremity,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D455780C,,20563.0,,,Injection,,2022,Q4,Drug ineffective,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D455780C,,20563.0,,,Injection,,2022,Q4,Feeling abnormal,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D455780C,,20563.0,,,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144461,21714446,4,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, prn (sliding scale)",,,U,,D455780C,,20563.0,,,Injection,,2022,Q4,Coronary artery occlusion,,2022,Q4,1,I,20220801.0,20221128.0,20221212,20221212,EXP,,US-ELI_LILLY_AND_COMPANY-US202212003607,ELI LILLY AND CO,,71.0,YR,,F,Y,,,20221212,,CN,US,US,2022,Q4,Elderly
217144861,21714486,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 75-25-46-0, Ampoules",,,,,,,,,,Tablet,,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20221205.0,20221212,20221212,EXP,,DE-MYLANLABS-2022M1136710,MYLAN,,69.0,YR,,F,Y,,,20221212,,PH,DE,DE,2022,Q4,Elderly
217144861,21714486,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 75-25-46-0, Ampoules",,,,,,,,,,Tablet,,2022,Q4,Anuria,,2022,Q4,1,I,,20221205.0,20221212,20221212,EXP,,DE-MYLANLABS-2022M1136710,MYLAN,,69.0,YR,,F,Y,,,20221212,,PH,DE,DE,2022,Q4,Elderly
217144861,21714486,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 75-25-46-0, Ampoules",,,,,,,,,,Tablet,,2022,Q4,Fatigue,,2022,Q4,1,I,,20221205.0,20221212,20221212,EXP,,DE-MYLANLABS-2022M1136710,MYLAN,,69.0,YR,,F,Y,,,20221212,,PH,DE,DE,2022,Q4,Elderly
217144861,21714486,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 75-25-46-0, Ampoules",,,,,,,,,,Tablet,,2022,Q4,Electrolyte imbalance,,2022,Q4,1,I,,20221205.0,20221212,20221212,EXP,,DE-MYLANLABS-2022M1136710,MYLAN,,69.0,YR,,F,Y,,,20221212,,PH,DE,DE,2022,Q4,Elderly
217144861,21714486,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 75-25-46-0, Ampoules",,,,,,,,,,Tablet,,2022,Q4,Condition aggravated,,2022,Q4,1,I,,20221205.0,20221212,20221212,EXP,,DE-MYLANLABS-2022M1136710,MYLAN,,69.0,YR,,F,Y,,,20221212,,PH,DE,DE,2022,Q4,Elderly
217144861,21714486,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,"1 IU, 75-25-46-0, Ampoules",,,,,,,,,,Tablet,,2022,Q4,General physical health deterioration,,2022,Q4,1,I,,20221205.0,20221212,20221212,EXP,,DE-MYLANLABS-2022M1136710,MYLAN,,69.0,YR,,F,Y,,,20221212,,PH,DE,DE,2022,Q4,Elderly
217187761,21718776,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 3 units with meal",,,D,,,,,,,,,2022,Q4,Cryptococcosis,,2022,Q4,1,I,,20220906.0,20221213,20221213,PER,,US-STRIDES ARCOLAB LIMITED-2022SP011562,STRIDES,"Gough S, Borgetti S, Fernandes CR.. Orthostatic hypotension as the initial presentation of disseminated cryptococcosis in a kidney transplant recipient.. IDCases. 2022;29e01567",69.0,YR,,M,Y,,,20221213,,HP,US,US,2022,Q4,Elderly
217187761,21718776,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 3 units with meal",,,D,,,,,,,,,2022,Q4,Cryptococcosis,,2022,Q4,1,I,,20220906.0,20221213,20221213,PER,,US-STRIDES ARCOLAB LIMITED-2022SP011562,STRIDES,"Gough S, Borgetti S, Fernandes CR.. Orthostatic hypotension as the initial presentation of disseminated cryptococcosis in a kidney transplant recipient.. IDCases. 2022;29e01567",69.0,YR,,M,Y,,,20221213,,HP,US,US,2022,Q4,Elderly
217187761,21718776,5,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK, 3 units with meal",,,D,,,,,,,,,2022,Q4,Pneumonia,,2022,Q4,1,I,,20220906.0,20221213,20221213,PER,,US-STRIDES ARCOLAB LIMITED-2022SP011562,STRIDES,"Gough S, Borgetti S, Fernandes CR.. Orthostatic hypotension as the initial presentation of disseminated cryptococcosis in a kidney transplant recipient.. IDCases. 2022;29e01567",69.0,YR,,M,Y,,,20221213,,HP,US,US,2022,Q4,Elderly
217188712,21718871,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Injection,,2022,Q4,Nasopharyngitis,,2022,Q4,2,F,20221201.0,20221209.0,20221213,20221216,PER,,US-ELI_LILLY_AND_COMPANY-US202212005244,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20221216,,CN,US,US,2022,Q4,Adult
217188712,21718871,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D493130D,,20563.0,,,Injection,,2022,Q4,Nasopharyngitis,,2022,Q4,2,F,20221201.0,20221209.0,20221213,20221216,PER,,US-ELI_LILLY_AND_COMPANY-US202212005244,ELI LILLY AND CO,,64.0,YR,,F,Y,,,20221216,,CN,US,US,2022,Q4,Adult
217189701,21718970,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Blood glucose abnormal,,2022,Q4,1,I,,20221003.0,20221213,20221213,PER,,US-STRIDES ARCOLAB LIMITED-2022SP013267,STRIDES,"Naritsin A, Peck J.. Critical presentation and management of an acute gastrointestinal haemorrhage as a result of an arterioenteric fistula secondary to a failed pancreatic allograft.. BMJ-Case-Rep. 2021;14(7)",60.0,YR,,F,Y,,,20221213,,MD,US,US,2022,Q4,Adult
217189701,21718970,3,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Drug ineffective,,2022,Q4,1,I,,20221003.0,20221213,20221213,PER,,US-STRIDES ARCOLAB LIMITED-2022SP013267,STRIDES,"Naritsin A, Peck J.. Critical presentation and management of an acute gastrointestinal haemorrhage as a result of an arterioenteric fistula secondary to a failed pancreatic allograft.. BMJ-Case-Rep. 2021;14(7)",60.0,YR,,F,Y,,,20221213,,MD,US,US,2022,Q4,Adult
217189701,21718970,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2022,Q4,Blood glucose abnormal,,2022,Q4,1,I,,20221003.0,20221213,20221213,PER,,US-STRIDES ARCOLAB LIMITED-2022SP013267,STRIDES,"Naritsin A, Peck J.. Critical presentation and management of an acute gastrointestinal haemorrhage as a result of an arterioenteric fistula secondary to a failed pancreatic allograft.. BMJ-Case-Rep. 2021;14(7)",60.0,YR,,F,Y,,,20221213,,MD,US,US,2022,Q4,Adult
217189701,21718970,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,,,,,,2022,Q4,Drug ineffective,,2022,Q4,1,I,,20221003.0,20221213,20221213,PER,,US-STRIDES ARCOLAB LIMITED-2022SP013267,STRIDES,"Naritsin A, Peck J.. Critical presentation and management of an acute gastrointestinal haemorrhage as a result of an arterioenteric fistula secondary to a failed pancreatic allograft.. BMJ-Case-Rep. 2021;14(7)",60.0,YR,,F,Y,,,20221213,,MD,US,US,2022,Q4,Adult
217246412,21724641,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK every 4 hours,,,,,,,,,,,,2022,Q4,Meningitis viral,,2022,Q4,2,F,,20221206.0,20221213,20221221,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365380,RANBAXY,"Vickery SB, Roach JK, Parsons C, Vickery PB. Possible levetiracetam-induced aseptic meningitis versus viral meningitis: Case report and literature review. Nurse Pract. 2022;Jul; 47(7):32-37",54.0,YR,,M,Y,,,20221221,,PH,US,US,2022,Q4,Adult
217246412,21724641,4,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK every 4 hours,,,,,,,,,,,,2022,Q4,Meningitis aseptic,,2022,Q4,2,F,,20221206.0,20221213,20221221,EXP,,US-SUN PHARMACEUTICAL INDUSTRIES LTD-2022R1-365380,RANBAXY,"Vickery SB, Roach JK, Parsons C, Vickery PB. Possible levetiracetam-induced aseptic meningitis versus viral meningitis: Case report and literature review. Nurse Pract. 2022;Jul; 47(7):32-37",54.0,YR,,M,Y,,,20221221,,PH,US,US,2022,Q4,Adult
217281422,21728142,19,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,2 units the evening prior,,,U,,unknown,,,,,Unknown,,2022,Q4,Therapeutic product effect decreased,,2022,Q4,2,F,20221205.0,20221216.0,20221214,20221228,PER,,US-FreseniusKabi-FK202217570,FRESENIUS KABI,,71.0,YR,E,F,Y,90.3,KG,20221228,,PH,US,US,2022,Q4,Elderly
217347991,21734799,6,C,Lispro and Toujeo,,2,Unknown,,,,,,,,,,,,,2022,Q4,Erythema,,2022,Q4,1,I,20220901.0,20220907.0,20221215,20221215,EXP,,US-NKFPHARMA-2022MPSPO00151,NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL,,75.0,YR,,F,Y,200.0,KG,20221214,,CN,US,US,2022,Q4,Elderly
217347991,21734799,6,C,Lispro and Toujeo,,2,Unknown,,,,,,,,,,,,,2022,Q4,Cognitive disorder,,2022,Q4,1,I,20220901.0,20220907.0,20221215,20221215,EXP,,US-NKFPHARMA-2022MPSPO00151,NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL,,75.0,YR,,F,Y,200.0,KG,20221214,,CN,US,US,2022,Q4,Elderly
217347991,21734799,6,C,Lispro and Toujeo,,2,Unknown,,,,,,,,,,,,,2022,Q4,Wheezing,,2022,Q4,1,I,20220901.0,20220907.0,20221215,20221215,EXP,,US-NKFPHARMA-2022MPSPO00151,NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL,,75.0,YR,,F,Y,200.0,KG,20221214,,CN,US,US,2022,Q4,Elderly
217347991,21734799,6,C,Lispro and Toujeo,,2,Unknown,,,,,,,,,,,,,2022,Q4,Chest discomfort,,2022,Q4,1,I,20220901.0,20220907.0,20221215,20221215,EXP,,US-NKFPHARMA-2022MPSPO00151,NANJING KING-FRIEND BIOCHEMICAL PHARMACEUTICAL,,75.0,YR,,F,Y,200.0,KG,20221214,,CN,US,US,2022,Q4,Elderly
217379851,21737985,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,Unknown,,2022,Q4,Pyrexia,,2022,Q4,1,I,,20221207.0,20221216,20221216,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20200210711,BRISTOL MYERS SQUIBB,,72.0,YR,E,F,Y,,,20221216,,HP,CA,CA,2022,Q4,Elderly
217379851,21737985,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,Unknown,,2022,Q4,Small intestinal obstruction,,2022,Q4,1,I,,20221207.0,20221216,20221216,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20200210711,BRISTOL MYERS SQUIBB,,72.0,YR,E,F,Y,,,20221216,,HP,CA,CA,2022,Q4,Elderly
217379851,21737985,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,Unknown,,2022,Q4,Abdominal pain,,2022,Q4,1,I,,20221207.0,20221216,20221216,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20200210711,BRISTOL MYERS SQUIBB,,72.0,YR,E,F,Y,,,20221216,,HP,CA,CA,2022,Q4,Elderly
217379851,21737985,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,Unknown,,2022,Q4,Dehydration,,2022,Q4,1,I,,20221207.0,20221216,20221216,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20200210711,BRISTOL MYERS SQUIBB,,72.0,YR,E,F,Y,,,20221216,,HP,CA,CA,2022,Q4,Elderly
217379851,21737985,20,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,Unknown,,2022,Q4,Urinary tract obstruction,,2022,Q4,1,I,,20221207.0,20221216,20221216,EXP,,CA-BRISTOL-MYERS SQUIBB COMPANY-CAN-20200210711,BRISTOL MYERS SQUIBB,,72.0,YR,E,F,Y,,,20221216,,HP,CA,CA,2022,Q4,Elderly
217418331,21741833,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Glycosylated haemoglobin increased,,2022,Q4,1,I,,20221209.0,20221216,20221216,EXP,,CA-APOTEX-2022AP016747,APOTEX,,17.0,YR,,M,Y,,,20221216,,HP,CA,CA,2022,Q4,Youth
217418331,21741833,6,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Treatment noncompliance,,2022,Q4,1,I,,20221209.0,20221216,20221216,EXP,,CA-APOTEX-2022AP016747,APOTEX,,17.0,YR,,M,Y,,,20221216,,HP,CA,CA,2022,Q4,Youth
217423111,21742311,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D520950E,,20563.0,,,Injection,,2022,Q4,Incorrect dose administered,,2022,Q4,1,I,20221115.0,20221116.0,20221216,20221216,PER,,US-ELI_LILLY_AND_COMPANY-US202211010103,ELI LILLY AND CO,,57.0,YR,,F,Y,,,20221216,,CN,US,US,2022,Q4,Adult
217423111,21742311,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D520950E,,20563.0,,,Injection,,2022,Q4,Visual impairment,,2022,Q4,1,I,20221115.0,20221116.0,20221216,20221216,PER,,US-ELI_LILLY_AND_COMPANY-US202211010103,ELI LILLY AND CO,,57.0,YR,,F,Y,,,20221216,,CN,US,US,2022,Q4,Adult
217423111,21742311,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D520950E,,20563.0,,,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20221115.0,20221116.0,20221216,20221216,PER,,US-ELI_LILLY_AND_COMPANY-US202211010103,ELI LILLY AND CO,,57.0,YR,,F,Y,,,20221216,,CN,US,US,2022,Q4,Adult
217451551,21745155,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,with each meal,,,,,,,,,,Solution for injection,,2022,Q4,Bone pain,,2022,Q4,1,I,20221211.0,20221216.0,20221219,20221219,EXP,,CO-ABBVIE-4241578,ABBVIE,,86.0,YR,,M,Y,88.0,KG,20221219,,CN,CO,CO,2022,Q4,Elderly
217451551,21745155,2,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,with each meal,,,,,,,,,,Solution for injection,,2022,Q4,COVID-19,,2022,Q4,1,I,20221211.0,20221216.0,20221219,20221219,EXP,,CO-ABBVIE-4241578,ABBVIE,,86.0,YR,,M,Y,88.0,KG,20221219,,CN,CO,CO,2022,Q4,Elderly
217471081,21747108,5,C,Insulin Lispro Injection,,2,,,,,,,,,,,,,,2022,Q4,Asthenia,,2022,Q4,1,I,20221215.0,20221215.0,20221219,20221219,PER,,US-ABBVIE-4241645,ABBVIE,,65.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
217471081,21747108,5,C,Insulin Lispro Injection,,2,,,,,,,,,,,,,,2022,Q4,Death,,2022,Q4,1,I,20221215.0,20221215.0,20221219,20221219,PER,,US-ABBVIE-4241645,ABBVIE,,65.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
217471081,21747108,5,C,Insulin Lispro Injection,,2,,,,,,,,,,,,,,2022,Q4,Pneumonia,,2022,Q4,1,I,20221215.0,20221215.0,20221219,20221219,PER,,US-ABBVIE-4241645,ABBVIE,,65.0,YR,,F,Y,,,20221219,,CN,US,US,2022,Q4,Elderly
217510891,21751089,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"14 u, unknown",,,,,D356008AT,,20563.0,14.0,IU,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20221121.0,20221121.0,20221220,20221220,PER,,US-ELI_LILLY_AND_COMPANY-US202211012321,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20221219,,CN,US,US,2022,Q4,Adult
217510891,21751089,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"16 u, unknown",,,,,D356008AT,,20563.0,16.0,IU,Injection,,2022,Q4,Blood glucose increased,,2022,Q4,1,I,20221121.0,20221121.0,20221220,20221220,PER,,US-ELI_LILLY_AND_COMPANY-US202211012321,ELI LILLY AND CO,,61.0,YR,,M,Y,,,20221219,,CN,US,US,2022,Q4,Adult
217617771,21761777,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Acute kidney injury,,2022,Q4,1,I,,20221212.0,20221221,20221221,EXP,,CA-APOTEX-2022AP016819,APOTEX,,64.0,YR,,M,Y,,,20221221,,HP,CA,CA,2022,Q4,Adult
217617771,21761777,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Extradural abscess,,2022,Q4,1,I,,20221212.0,20221221,20221221,EXP,,CA-APOTEX-2022AP016819,APOTEX,,64.0,YR,,M,Y,,,20221221,,HP,CA,CA,2022,Q4,Adult
217617771,21761777,8,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,D,,,,,,,,,2022,Q4,Post streptococcal glomerulonephritis,,2022,Q4,1,I,,20221212.0,20221221,20221221,EXP,,CA-APOTEX-2022AP016819,APOTEX,,64.0,YR,,M,Y,,,20221221,,HP,CA,CA,2022,Q4,Adult
217630652,21763065,1,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D484040C,,,,,Injection,,2022,Q4,Product dispensing error,,2022,Q4,2,F,20221001.0,20221215.0,20221221,20221223,EXP,,US-ELI_LILLY_AND_COMPANY-US202212010310,ELI LILLY AND CO,,95.0,YR,,F,Y,,,20221223,,CN,US,US,2022,Q4,Elderly
217630652,21763065,1,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D484040C,,,,,Injection,,2022,Q4,Drug hypersensitivity,,2022,Q4,2,F,20221001.0,20221215.0,20221221,20221223,EXP,,US-ELI_LILLY_AND_COMPANY-US202212010310,ELI LILLY AND CO,,95.0,YR,,F,Y,,,20221223,,CN,US,US,2022,Q4,Elderly
217630652,21763065,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D514820C,,,,,Injection,,2022,Q4,Product dispensing error,,2022,Q4,2,F,20221001.0,20221215.0,20221221,20221223,EXP,,US-ELI_LILLY_AND_COMPANY-US202212010310,ELI LILLY AND CO,,95.0,YR,,F,Y,,,20221223,,CN,US,US,2022,Q4,Elderly
217630652,21763065,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,D514820C,,,,,Injection,,2022,Q4,Drug hypersensitivity,,2022,Q4,2,F,20221001.0,20221215.0,20221221,20221223,EXP,,US-ELI_LILLY_AND_COMPANY-US202212010310,ELI LILLY AND CO,,95.0,YR,,F,Y,,,20221223,,CN,US,US,2022,Q4,Elderly
217642171,21764217,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q4,Glycosylated haemoglobin increased,,2022,Q4,1,I,,20221214.0,20221222,20221222,EXP,,CA-TEVA-2022-CA-2837757,TEVA,,17.0,YR,T,M,Y,,,20221222,,HP,CA,CA,2022,Q4,Youth
217642171,21764217,8,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,,,,U,,,,,,,,,2022,Q4,Treatment noncompliance,,2022,Q4,1,I,,20221214.0,20221222,20221222,EXP,,CA-TEVA-2022-CA-2837757,TEVA,,17.0,YR,T,M,Y,,,20221222,,HP,CA,CA,2022,Q4,Youth
217659051,21765905,1,PS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,"UNK UNK, unknown",,,U,,,,20563.0,,,Solution for injection,,2022,Q4,Glycosylated haemoglobin increased,,2022,Q4,1,I,,20221219.0,20221222,20221222,PER,,US-ELI_LILLY_AND_COMPANY-US202212011523,ELI LILLY AND CO,,62.0,YR,,M,Y,,,20221222,,HP,US,US,2022,Q4,Adult
217666232,21766623,151,SS,INSULIN LISPRO,INSULIN LISPRO,1,Intravenous (not otherwise specified),"1 IU, CO",,,D,,,,,1.0,IU,,,2022,Q4,Toxic epidermal necrolysis,,2022,Q4,2,F,20200809.0,20221219.0,20221222,20221226,EXP,,NVSC2020FR370649,NOVARTIS,,74.0,YR,,M,Y,,,20221226,,MD,FR,FR,2022,Q4,Elderly
217760281,21776028,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q4,Fatigue,,2022,Q4,1,I,20211219.0,20221220.0,20221226,20221226,PER,,US-SA-2022SA518867,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20221226,,MD,US,US,2022,Q4,Elderly
217760281,21776028,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q4,Coronary artery bypass,,2022,Q4,1,I,20211219.0,20221220.0,20221226,20221226,PER,,US-SA-2022SA518867,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20221226,,MD,US,US,2022,Q4,Elderly
217760281,21776028,5,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,U,,,,,,,,,2022,Q4,Asthenia,,2022,Q4,1,I,20211219.0,20221220.0,20221226,20221226,PER,,US-SA-2022SA518867,SANOFI AVENTIS,,65.0,YR,E,M,Y,,,20221226,,MD,US,US,2022,Q4,Elderly
217764141,21776414,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q4,Interstitial lung disease,,2022,Q4,1,I,,20221213.0,20221226,20221226,EXP,,JP-NOVOPROD-1003373,NOVO NORDISK,,82.0,YR,,F,Y,55.0,KG,20221226,,MD,JP,JP,2022,Q4,Elderly
217764141,21776414,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Subcutaneous,UNK,,,,,,,,,,,,2022,Q4,Hyperglycaemia,,2022,Q4,1,I,,20221213.0,20221226,20221226,EXP,,JP-NOVOPROD-1003373,NOVO NORDISK,,82.0,YR,,F,Y,55.0,KG,20221226,,MD,JP,JP,2022,Q4,Elderly
217792011,21779201,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Product dispensing error,,2022,Q4,1,I,20221216.0,20221219.0,20221226,20221226,EXP,,CA-JNJFOC-20221201719,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,,,20221226,,HP,CA,CA,2022,Q4,Elderly
217792011,21779201,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Dizziness,,2022,Q4,1,I,20221216.0,20221219.0,20221226,20221226,EXP,,CA-JNJFOC-20221201719,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,,,20221226,,HP,CA,CA,2022,Q4,Elderly
217792011,21779201,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Asthenia,,2022,Q4,1,I,20221216.0,20221219.0,20221226,20221226,EXP,,CA-JNJFOC-20221201719,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,,,20221226,,HP,CA,CA,2022,Q4,Elderly
217792011,21779201,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Cerebrovascular accident,,2022,Q4,1,I,20221216.0,20221219.0,20221226,20221226,EXP,,CA-JNJFOC-20221201719,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,,,20221226,,HP,CA,CA,2022,Q4,Elderly
217792011,21779201,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Headache,,2022,Q4,1,I,20221216.0,20221219.0,20221226,20221226,EXP,,CA-JNJFOC-20221201719,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,,,20221226,,HP,CA,CA,2022,Q4,Elderly
217792011,21779201,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Overdose,,2022,Q4,1,I,20221216.0,20221219.0,20221226,20221226,EXP,,CA-JNJFOC-20221201719,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,,,20221226,,HP,CA,CA,2022,Q4,Elderly
217792011,21779201,8,C,INSULIN LISPRO,INSULIN LISPRO,1,,,,,,,,,,,,,,2022,Q4,Drug intolerance,,2022,Q4,1,I,20221216.0,20221219.0,20221226,20221226,EXP,,CA-JNJFOC-20221201719,JOHNSON AND JOHNSON,,75.0,YR,E,F,Y,,,20221226,,HP,CA,CA,2022,Q4,Elderly
217814431,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Pain in extremity,,2022,Q4,1,I,,20221220.0,20221227,20221227,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20221227,,HP,CA,CA,2022,Q4,Elderly
217814431,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Diabetes mellitus,,2022,Q4,1,I,,20221220.0,20221227,20221227,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20221227,,HP,CA,CA,2022,Q4,Elderly
217814431,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Grip strength decreased,,2022,Q4,1,I,,20221220.0,20221227,20221227,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20221227,,HP,CA,CA,2022,Q4,Elderly
217814431,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Psoriatic arthropathy,,2022,Q4,1,I,,20221220.0,20221227,20221227,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20221227,,HP,CA,CA,2022,Q4,Elderly
217814431,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Therapeutic product effect decreased,,2022,Q4,1,I,,20221220.0,20221227,20221227,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20221227,,HP,CA,CA,2022,Q4,Elderly
217814431,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Drug intolerance,,2022,Q4,1,I,,20221220.0,20221227,20221227,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20221227,,HP,CA,CA,2022,Q4,Elderly
217814431,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Headache,,2022,Q4,1,I,,20221220.0,20221227,20221227,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20221227,,HP,CA,CA,2022,Q4,Elderly
217814431,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Osteoarthritis,,2022,Q4,1,I,,20221220.0,20221227,20221227,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20221227,,HP,CA,CA,2022,Q4,Elderly
217814431,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Hepatic cirrhosis,,2022,Q4,1,I,,20221220.0,20221227,20221227,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20221227,,HP,CA,CA,2022,Q4,Elderly
217814431,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Hepatotoxicity,,2022,Q4,1,I,,20221220.0,20221227,20221227,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20221227,,HP,CA,CA,2022,Q4,Elderly
217814431,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Drug ineffective,,2022,Q4,1,I,,20221220.0,20221227,20221227,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20221227,,HP,CA,CA,2022,Q4,Elderly
217814431,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Dyspnoea,,2022,Q4,1,I,,20221220.0,20221227,20221227,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20221227,,HP,CA,CA,2022,Q4,Elderly
217814431,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Movement disorder,,2022,Q4,1,I,,20221220.0,20221227,20221227,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20221227,,HP,CA,CA,2022,Q4,Elderly
217814431,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Pain,,2022,Q4,1,I,,20221220.0,20221227,20221227,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20221227,,HP,CA,CA,2022,Q4,Elderly
217814431,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Arthropathy,,2022,Q4,1,I,,20221220.0,20221227,20221227,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20221227,,HP,CA,CA,2022,Q4,Elderly
217814431,21781443,10,C,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Arthralgia,,2022,Q4,1,I,,20221220.0,20221227,20221227,EXP,,NVSC2022CA296147,NOVARTIS,,65.0,YR,,F,Y,,,20221227,,HP,CA,CA,2022,Q4,Elderly
217824751,21782475,18,C,INSULINE LISPRO,,1,Unknown,"8 IU, Q8H",,,D,,,,,8.0,IU,,Q8H,2022,Q4,Hyperkalaemia,,2022,Q4,1,I,20220922.0,20221226.0,20221227,20221227,EXP,FR-AFSSAPS-ST20222481,NVSC2022FR298247,NOVARTIS,,72.0,YR,,M,Y,95.0,KG,20221227,,CN,FR,FR,2022,Q4,Elderly
217925921,21792592,20,C,INSULINE LISPRO,,1,,"8 iU, TID",,,U,,,,,8.0,IU,,Q8H,2022,Q4,Hyperkalaemia,,2022,Q4,1,I,20220922.0,20221227.0,20221229,20221229,EXP,FR-AFSSAPS-ST20222481,FR-SA-2022SA523121,SANOFI AVENTIS,,72.0,YR,E,M,Y,95.0,KG,20221229,,CN,FR,FR,2022,Q4,Elderly
217942201,21794220,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,209196.0,,,,,2022,Q4,Intentional overdose,,2022,Q4,1,I,,20221226.0,20221229,20221229,EXP,,JP-SA-2022SA521530,SANOFI AVENTIS,"Sayaka N, Rutsuko Y, Fumiko C, Suguru T, Hirotaro I.. An autopsy case of fatal insulin preparation overdose. Toxicologie Analytique et Clinique. 2022;34(3):S166",30.0,YR,A,F,Y,,,20221229,,HP,JP,JP,2022,Q4,Young Adult
217942201,21794220,2,PS,INSULIN LISPRO,INSULIN LISPRO,1,,,,,D,,,,209196.0,,,,,2022,Q4,Hypoglycaemia,,2022,Q4,1,I,,20221226.0,20221229,20221229,EXP,,JP-SA-2022SA521530,SANOFI AVENTIS,"Sayaka N, Rutsuko Y, Fumiko C, Suguru T, Hirotaro I.. An autopsy case of fatal insulin preparation overdose. Toxicologie Analytique et Clinique. 2022;34(3):S166",30.0,YR,A,F,Y,,,20221229,,HP,JP,JP,2022,Q4,Young Adult
217977091,21797709,2,C,PROTAMINE ZINC RECOMBINANT HUMAN INSULIN LISPRO,,2,Subcutaneous,,,,,,D433953A,,,10.0,UG,Injection,BID,2022,Q4,Hypokalaemia,,2022,Q4,1,I,20221218.0,20221228.0,20221230,20221230,EXP,,CN-AstraZeneca-2022A419663,ASTRAZENECA,,80.0,YR,,F,Y,,,20221230,,MD,CN,,2022,Q4,Elderly
217994981,21799498,15,C,INSULIN LISPRO,,1,,,,,,,,,,,,,,2022,Q4,Accident,,2022,Q4,1,I,20221204.0,,20221229,20221229,DIR,FDA-CDER-CTU-2022-103753,,FDA-CTU,,68.0,YR,,F,N,,,20221229,Y,PH,US,,2022,Q4,Elderly
217994981,21799498,15,C,INSULIN LISPRO,,1,,,,,,,,,,,,,,2022,Q4,Type 2 diabetes mellitus,,2022,Q4,1,I,20221204.0,,20221229,20221229,DIR,FDA-CDER-CTU-2022-103753,,FDA-CTU,,68.0,YR,,F,N,,,20221229,Y,PH,US,,2022,Q4,Elderly
217994981,21799498,15,C,INSULIN LISPRO,,1,,,,,,,,,,,,,,2022,Q4,Influenza,,2022,Q4,1,I,20221204.0,,20221229,20221229,DIR,FDA-CDER-CTU-2022-103753,,FDA-CTU,,68.0,YR,,F,N,,,20221229,Y,PH,US,,2022,Q4,Elderly
217994981,21799498,15,C,INSULIN LISPRO,,1,,,,,,,,,,,,,,2022,Q4,Dysuria,,2022,Q4,1,I,20221204.0,,20221229,20221229,DIR,FDA-CDER-CTU-2022-103753,,FDA-CTU,,68.0,YR,,F,N,,,20221229,Y,PH,US,,2022,Q4,Elderly
217994981,21799498,15,C,INSULIN LISPRO,,1,,,,,,,,,,,,,,2022,Q4,Urine analysis abnormal,,2022,Q4,1,I,20221204.0,,20221229,20221229,DIR,FDA-CDER-CTU-2022-103753,,FDA-CTU,,68.0,YR,,F,N,,,20221229,Y,PH,US,,2022,Q4,Elderly
217994981,21799498,15,C,INSULIN LISPRO,,1,,,,,,,,,,,,,,2022,Q4,Ketoacidosis,,2022,Q4,1,I,20221204.0,,20221229,20221229,DIR,FDA-CDER-CTU-2022-103753,,FDA-CTU,,68.0,YR,,F,N,,,20221229,Y,PH,US,,2022,Q4,Elderly
217994981,21799498,15,C,INSULIN LISPRO,,1,,,,,,,,,,,,,,2022,Q4,Fall,,2022,Q4,1,I,20221204.0,,20221229,20221229,DIR,FDA-CDER-CTU-2022-103753,,FDA-CTU,,68.0,YR,,F,N,,,20221229,Y,PH,US,,2022,Q4,Elderly
217995271,21799527,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,5+16+16IU/day,,,U,,,,,,,,,2022,Q4,Hyperhidrosis,,2022,Q4,1,I,20220526.0,20221228.0,20221230,20221230,EXP,IT-MINISAL02-901434,IT-SA-2022SA524147,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20221230,,MD,IT,IT,2022,Q4,Elderly
217995271,21799527,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,5+16+16IU/day,,,U,,,,,,,,,2022,Q4,Presyncope,,2022,Q4,1,I,20220526.0,20221228.0,20221230,20221230,EXP,IT-MINISAL02-901434,IT-SA-2022SA524147,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20221230,,MD,IT,IT,2022,Q4,Elderly
217995271,21799527,4,C,INSULIN LISPRO,INSULIN LISPRO,1,,5+16+16IU/day,,,U,,,,,,,,,2022,Q4,Bradycardia,,2022,Q4,1,I,20220526.0,20221228.0,20221230,20221230,EXP,IT-MINISAL02-901434,IT-SA-2022SA524147,SANOFI AVENTIS,,71.0,YR,E,F,Y,,,20221230,,MD,IT,IT,2022,Q4,Elderly
218023821,21802382,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Maternal exposure during pregnancy,,2022,Q4,1,I,,20221228.0,20221230,20221230,EXP,,NVSC2022DE300315,NOVARTIS,"Dargel S, Schleubner E, Kloos C, Groten T, Weschenfelder F. Awareness of euglycaemic diabetic ketoacidosis during pregnancy prevents recurrence of devastating outcomes: a case report of two pregnancies in one patient. BMC PREGNANCY AND CHILDBIRTH. 2021;21(1):1-5",23.0,YR,,F,Y,,,20221231,,HP,DE,DE,2022,Q4,Youth
218023821,21802382,2,SS,INSULIN LISPRO,INSULIN LISPRO,1,Unknown,UNK,,,U,,,,,,,,,2022,Q4,Stillbirth,,2022,Q4,1,I,,20221228.0,20221230,20221230,EXP,,NVSC2022DE300315,NOVARTIS,"Dargel S, Schleubner E, Kloos C, Groten T, Weschenfelder F. Awareness of euglycaemic diabetic ketoacidosis during pregnancy prevents recurrence of devastating outcomes: a case report of two pregnancies in one patient. BMC PREGNANCY AND CHILDBIRTH. 2021;21(1):1-5",23.0,YR,,F,Y,,,20221231,,HP,DE,DE,2022,Q4,Youth
